PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Artmann, S; Jung, K; Bleckmann, A; Beissbarth, T				Artmann, Stephan; Jung, Klaus; Bleckmann, Annalen; Beissbarth, Tim			Detection of Simultaneous Group Effects in MicroRNA Expression and Related Target Gene Sets	PLOS ONE			English	Article							GLOBAL TEST; PROFILES; VARIANCE	Expression levels of mRNAs are among other factors regulated by microRNAs. A particular microRNA can bind specifically to several target mRNAs and lead to their degradation. Expression levels of both, mRNAs and microRNAs, can be obtained by microarray experiments. In order to increase the power of detecting microRNAs that are differentially expressed between two different groups of samples, we incorporate expression levels of their related target gene sets. Group effects are determined individually for each microRNA, and by enrichment tests and global tests for target gene sets. The resulting lists of p-values from individual and set-wise testing are combined by means of meta analysis. We propose a new approach to connect microRNA-wise and gene set-wise information by means of p-value combination as often used in meta-analysis. In this context, we evaluate the usefulness of different approaches of gene set tests. In a simulation study we reveal that our combination approach is more powerful than microRNA-wise testing alone. Furthermore, we show that combining microRNA-wise results with 'competitive' gene set tests maintains a pre-specified false discovery rate. In contrast, a combination with 'self-contained' gene set tests can harm the false discovery rate, particularly when gene sets are not disjunct.	[Artmann, Stephan; Jung, Klaus; Bleckmann, Annalen; Beissbarth, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Bleckmann, Annalen] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany	University of Gottingen; University of Gottingen	Artmann, S (corresponding author), Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany.	tim.beissbarth@med.uni-goettingen.de	Beissbarth, Tim/B-3129-2013	Beissbarth, Tim/0000-0001-6509-2143; Jung, Klaus/0000-0001-9955-748X	Deutsche Forschungsgemeinschaft (clinical research group KFO 179); German Ministry of Education and Research (BMBF) grant BreastSys from the platform MedSys; Deutsche Forschungsgemeinschaft, research group FOR 942	Deutsche Forschungsgemeinschaft (clinical research group KFO 179)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) grant BreastSys from the platform MedSys(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft, research group FOR 942(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) (clinical research group KFO 179), research group FOR 942 as well as from the German Ministry of Education and Research (BMBF) (http://www.bmbf.de/) grant BreastSys from the platform MedSys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley AN, 2011, CLIN CANCER RES, V17, P7283, DOI 10.1158/1078-0432.CCR-11-1452; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brunner E., 2009, P 6 ST PET WORKSH SI, P605; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fisher R., 1970, STAT METHODS RES WOR; Genovesi LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023935; Goeman JJ, 2008, BIOINFORMATICS, V24, P537, DOI 10.1093/bioinformatics/btm628; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Jung K, 2011, BIOINFORMATICS, V27, P1377, DOI 10.1093/bioinformatics/btr152; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Langsrud O, 2005, STAT COMPUT, V15, P53, DOI 10.1007/s11222-005-4789-5; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Manakov SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-419; Mansmann U, 2005, METHOD INFORM MED, V44, P449; Marot G, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1368; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stouffer S. A., 1949, AM SOLDIER, V1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401	38	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38365	10.1371/journal.pone.0038365	http://dx.doi.org/10.1371/journal.pone.0038365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723856	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700014
J	Cai, XL; Han, XY; Luo, YY; Ji, LN				Cai, Xiaoling; Han, Xueyao; Luo, Yingying; Ji, Linong			Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients with Intensive Insulin Treatment	PLOS ONE			English	Article							BASAL-BOLUS REGIMEN; BEDTIME NPH INSULIN; CONSENSUS ALGORITHM; GLYCEMIC CONTROL; THERAPY; GLARGINE; MANAGEMENT; DETEMIR; HYPERGLYCEMIA; HYPOGLYCEMIA	Background: To investigate the daily insulin doses and the ratio of basal insulin to total daily insulin in Chinese type 2 diabetic patients who received basal bolus insulin therapy. Methodology/Principal Findings: Totally 2480 patients prescribed with pre-meal bolus insulin and bedtime basal insulin were included. The mean daily insulin doses was 38.22 +/- 14.92 IU/day, the mean daily insulin doses per weight was 0.58 +/- 0.22 IU/kg, the mean bolus insulin dose was 0.44 +/- 0.17 IU/kg and the mean basal insulin dose was 0.13 +/- 0.08 IU/kg. The mean basal/total daily insulin ratio (BD/TDD) was 0.23 +/- 0.08. In most patients (47.94%), the BD/TDD was between 0.20 and 0.30. Diabetic duration, BMI, HbA1c, fasting and postprandial blood glucose level were positively associated with daily insulin dose, while age was negatively associated with daily insulin dose. Diabetic duration, BMI, HbA1c, fasting blood glucose level, and using metformin were positively associated with BD/TDD ratio, while age, postprandial C peptide, postprandial blood glucose level and CRE level were negatively associated with BD/TDD ratio. Conclusions/Significance: The daily insulin doses of intensive treatment in Chinese type 2 diabetic patients was 38.22 IU/day, the mean daily insulin doses per weight was 0.58 IU/kg, mean BD/TDD ratio was 0.23.	[Cai, Xiaoling; Han, Xueyao; Luo, Yingying; Ji, Linong] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing 100871, Peoples R China	Peking University	Cai, XL (corresponding author), Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing 100871, Peoples R China.	prof_jilinong@yahoo.cn	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543				Fonseca V, 2004, AM J MED SCI, V328, P274, DOI 10.1097/00000441-200411000-00007; Goudswaard AN, 2004, COCHRANE DATABASE SY; Hirsch I, 2005, CLIN DIABETES, V23, P78, DOI DOI 10.2337/DIACLIN.23.2.78]; Hollander P, 2008, CLIN THER, V30, P1976, DOI 10.1016/j.clinthera.2008.11.001; Masuda H, 2008, DIABETES OBES METAB, V10, P1261, DOI 10.1111/j.1463-1326.2008.00897.x; Miyashita Y, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-16; Nathan DM, 2006, DIABETOLOGIA, V49, P1711, DOI 10.1007/s00125-006-0316-2; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Raskin P, 2009, DIABETES-METAB RES, V25, P542, DOI 10.1002/dmrr.989; Rosenstock J, 2004, AM J MED, V116, P10, DOI 10.1016/j.amjmed.2003.12.004; Rosenstock J, 2008, DIABETES CARE, V31, P20, DOI 10.2337/dc07-1122; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamaki M, 2008, DIABETES RES CLIN PR, V81, P296, DOI 10.1016/j.diabres.2008.03.021; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierrez GE, 2008, J CLIN ENDOCR METAB, P1441; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295; Vague P, 2003, DIABETES CARE, V26, P590, DOI 10.2337/diacare.26.3.590; Yki-Jarvinen H, 2000, DIABETES CARE, V23, P1130, DOI 10.2337/diacare.23.8.1130; Yokoyama H, 2006, DIABETES RES CLIN PR, V73, P35, DOI 10.1016/j.diabres.2005.12.009	19	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38962	10.1371/journal.pone.0038962	http://dx.doi.org/10.1371/journal.pone.0038962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22720003	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300071
J	Cheng, XY; Huang, WJ; Hu, SC; Zhang, HL; Wang, H; Zhang, JX; Lin, HH; Chen, YZ; Zou, Q; Ji, ZL				Cheng, Xian-Ying; Huang, Wei-Juan; Hu, Shi-Chang; Zhang, Hai-Lei; Wang, Hao; Zhang, Jing-Xian; Lin, Hong-Huang; Chen, Yu-Zong; Zou, Quan; Ji, Zhi-Liang			A Global Characterization and Identification of Multifunctional Enzymes	PLOS ONE			English	Article							MITOCHONDRIAL C-1-TETRAHYDROFOLATE SYNTHASE; MOONLIGHTING PROTEINS; BIOSYNTHESIS; EVOLUTION; DATABASE; PATHWAY; CLASSIFICATION; PROMISCUITY	Multi-functional enzymes are enzymes that perform multiple physiological functions. Characterization and identification of multi-functional enzymes are critical for communication and cooperation between different functions and pathways within a complex cellular system or between cells. In present study, we collected literature-reported 6,799 multi-functional enzymes and systematically characterized them in structural, functional, and evolutionary aspects. It was found that four physiochemical properties, that is, charge, polarizability, hydrophobicity, and solvent accessibility, are important for characterization of multi-functional enzymes. Accordingly, a combinational model of support vector machine and random forest model was constructed, based on which 6,956 potential novel multi-functional enzymes were successfully identified from the ENZYME database. Moreover, it was observed that multi-functional enzymes are non-evenly distributed in species, and that Bacteria have relatively more multi-functional enzymes than Archaebacteria and Eukaryota. Comparative analysis indicated that the multi-functional enzymes experienced a fluctuation of gene gain and loss during the evolution from S. cerevisiae to H. sapiens. Further pathway analyses indicated that a majority of multi-functional enzymes were well preserved in catalyzing several essential cellular processes, for example, metabolisms of carbohydrates, nucleotides, and amino acids. What's more, a database of known multi-functional enzymes and a server for novel multi-functional enzyme prediction were also constructed for free access at http://bioinf.xmu.edu.cn/databases/MFEs/index.htm.	[Cheng, Xian-Ying; Huang, Wei-Juan; Wang, Hao; Ji, Zhi-Liang] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China; [Hu, Shi-Chang; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China; [Zhang, Hai-Lei; Zhang, Jing-Xian; Lin, Hong-Huang; Chen, Yu-Zong] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Ji, Zhi-Liang] Xiamen Univ, Key Lab Chem Biol Fujian Prov, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; National University of Singapore; Xiamen University	Cheng, XY (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China.	zouquan@xmu.edu.cn; appo@xmu.edu.cn	Lin, Honghuang/A-3269-2019; Zhang, Jing/GWZ-7332-2022; Zou, Quan/A-7801-2015	Lin, Honghuang/0000-0003-3043-3942; Chen, Yu Zong/0000-0002-5473-8022	Natural Science Foundation of China (NSFC) [30873159]; Fundamental Research Funds for the Central Universities [2010121084]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Financial support from the Natural Science Foundation of China (NSFC#30873159) and the Fundamental Research Funds for the Central Universities (#2010121084) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Breitling R, 2001, MOL CELL ENDOCRINOL, V171, P205, DOI 10.1016/S0303-7207(00)00415-9; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Canada KA, 2002, J BACTERIOL, V184, P344, DOI 10.1128/JB.184.2.344-349.2002; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Elkins JM, 2005, BIOCHEM J, V385, P565, DOI 10.1042/BJ20040814; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Genschel U, 2004, MOL BIOL EVOL, V21, P1242, DOI 10.1093/molbev/msh119; Gomez A, 2003, BIOINFORMATICS, V19, P895, DOI 10.1093/bioinformatics/btg111; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2003, ANN MED, V35, P28, DOI 10.1080/07853890310004101; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Lee HC, 1997, ADV EXP MED BIOL, V419, P411; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchot P, 2012, PROTEIN PEPTIDE LETT, V19, P132, DOI 10.2174/092986612799080284; Mohammad TAS, 2011, J BIOINF COMPUT BIOL, V9, P489, DOI 10.1142/S0219720011005422; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; SAKANYAN V, 1993, J GEN MICROBIOL, V139, P393, DOI 10.1099/00221287-139-3-393; Schmidt S, 2003, TRENDS BIOCHEM SCI, V28, P336, DOI 10.1016/S0968-0004(03)00114-2; Timofeyeva NA, 2009, J BIOMOL STRUCT DYN, V26, P637, DOI 10.1080/07391102.2009.10507278; Tochio H, 1998, NAT STRUCT BIOL, V5, P965, DOI 10.1038/2940; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; WHITEHEAD TR, 1988, J BACTERIOL, V170, P995, DOI 10.1128/jb.170.2.995-997.1988; Zheng WP, 2001, CHEM BIOL, V8, P379, DOI 10.1016/S1074-5521(01)00020-5; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	41	46	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38979	10.1371/journal.pone.0038979	http://dx.doi.org/10.1371/journal.pone.0038979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723914	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300076
J	Espelund, M; Minge, MA; Gabrielsen, TM; Nederbragt, AJ; Shalchian-Tabrizi, K; Otis, C; Turmel, M; Lemieux, C; Jakobsen, KS				Espelund, Mari; Minge, Marianne A.; Gabrielsen, Tove M.; Nederbragt, Alexander J.; Shalchian-Tabrizi, Kamran; Otis, Christian; Turmel, Monique; Lemieux, Claude; Jakobsen, Kjetill S.			Genome Fragmentation Is Not Confined to the Peridinin Plastid in Dinoflagellates	PLOS ONE			English	Article							CHLOROPHYLL-A; GREEN DINOFLAGELLATE; GENE MINICIRCLES; LARGE SUBUNIT; CHLOROPLAST; APICOMPLEXAN; EVOLUTIONARY; SEQUENCE; ORIGIN; RNA	When plastids are transferred between eukaryote lineages through series of endosymbiosis, their environment changes dramatically. Comparison of dinoflagellate plastids that originated from different algal groups has revealed convergent evolution, suggesting that the host environment mainly influences the evolution of the newly acquired organelle. Recently the genome from the anomalously pigmented dinoflagellate Karlodinium veneficum plastid was uncovered as a conventional chromosome. To determine if this haptophyte-derived plastid contains additional chromosomal fragments that resemble the mini-circles of the peridin-containing plastids, we have investigated its genome by in-depth sequencing using 454 pyrosequencing technology, PCR and clone library analysis. Sequence analyses show several genes with significantly higher copy numbers than present in the chromosome. These genes are most likely extrachromosomal fragments, and the ones with highest copy numbers include genes encoding the chaperone DnaK(Hsp70), the rubisco large subunit (rbcL), and two tRNAs (trnE and trnM). In addition, some photosystem genes such as psaB, psaA, psbB and psbD are overrepresented. Most of the dnaK and rbcL sequences are found as shortened or fragmented gene sequences, typically missing the 3'-terminal portion. Both dnaK and rbcL are associated with a common sequence element consisting of about 120 bp of highly conserved AT-rich sequence followed by a trnE gene, possibly serving as a control region. Decatenation assays and Southern blot analysis indicate that the extrachromosomal plastid sequences do not have the same organization or lengths as the minicircles of the peridinin dinoflagellates. The fragmentation of the haptophyte-derived plastid genome K. veneficum suggests that it is likely a sign of a host-driven process shaping the plastid genomes of dinoflagellates.	[Espelund, Mari; Minge, Marianne A.; Gabrielsen, Tove M.; Nederbragt, Alexander J.; Jakobsen, Kjetill S.] Univ Oslo, CEES, Dept Biol, Oslo, Norway; [Shalchian-Tabrizi, Kamran; Jakobsen, Kjetill S.] Univ Oslo, MERG, Dept Biol, Oslo, Norway; [Otis, Christian; Turmel, Monique; Lemieux, Claude] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	University of Oslo; University of Oslo; Laval University	Espelund, M (corresponding author), Norwegian Def Res Estab FFI, Kjeller, Norway.	k.s.jakobsen@bio.uio.no	Turmel, Monique/AAC-9752-2020; Lemieux, Claude/L-8831-2015	Turmel, Monique/0000-0001-7060-035X; Lemieux, Claude/0000-0001-9580-8042; Nederbragt, Lex/0000-0001-5539-0999	Research Council of Norway; Natural Sciences and Engineering Research Council of Canada; University of Oslo	Research Council of Norway(Research Council of Norway); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Oslo	The project was supported by a grant from The Research Council of Norway to KSJ and by a grant from the Natural Sciences and Engineering Research Council of Canada (to MT and CL). KST received starting grants from University of Oslo and travelling grants from The Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Bergholtz T, 2006, J PHYCOL, V42, P170, DOI 10.1111/j.1529-8817.2006.00172.x; Cohen I, 2005, PLANT PHYSIOL, V137, P738, DOI 10.1104/pp.104.056341; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Elbrachter M, 1996, PHYCOLOGIA, V35, P381, DOI 10.2216/i0031-8884-35-5-381.1; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Howe CJ, 2007, PROTIST, V158, P121, DOI 10.1016/j.protis.2007.02.002; Iida S, 2010, PLANT CELL PHYSIOL, V51, P1869, DOI 10.1093/pcp/pcq152; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; KATO J, 1992, J BIOL CHEM, V267, P25676; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kim E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-73; Koumandou VL, 2007, PROTIST, V158, P89, DOI 10.1016/j.protis.2006.08.003; Koumandou VL, 2004, TRENDS GENET, V20, P261, DOI 10.1016/j.tig.2004.03.008; Krause K, 2008, CURR GENET, V54, P111, DOI 10.1007/s00294-008-0208-8; Kumar AM, 1996, TRENDS PLANT SCI, V1, P371, DOI 10.1016/S1360-1385(96)80311-6; Laatsch T, 2004, MOL BIOL EVOL, V21, P1318, DOI 10.1093/molbev/msh127; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; Leung SK, 2009, NUCLEIC ACIDS RES; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Maddison WP, 1992, MACCLADE VERSION 3 A; Minge MA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-191; Nosenko T, 2006, MOL BIOL EVOL, V23, P2026, DOI 10.1093/molbev/msl074; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Sambrook J, 1989, MOL CLONING LAB MANU, V2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHNEPF E, 1988, BOT ACTA, V101, P196, DOI 10.1111/j.1438-8677.1988.tb00033.x; Shalchian-Tabrizi K, 2006, MOL BIOL EVOL, V23, P1504, DOI 10.1093/molbev/msl011; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Takishita K, 2008, GENE, V410, P26, DOI 10.1016/j.gene.2007.11.008; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; WATANABE M M, 1991, Journal of Phycology, V27, P75; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; WATANABE MM, 1987, J PHYCOL, V23, P382, DOI 10.1111/j.1529-8817.1987.tb04148.x; Yosef I, 2004, J BIOL CHEM, V279, P10148, DOI 10.1074/jbc.M308602200; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099; Zhang ZD, 2001, MOL BIOL EVOL, V18, P1558, DOI 10.1093/oxfordjournals.molbev.a003942	51	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38809	10.1371/journal.pone.0038809	http://dx.doi.org/10.1371/journal.pone.0038809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719952	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300052
J	Hu, MG; Li, ZJ; Wang, JF; Jia, L; Liao, YL; Lai, SJ; Guo, YS; Zhao, D; Yang, WZ				Hu, Maogui; Li, Zhongjie; Wang, Jinfeng; Jia, Lin; Liao, Yilan; Lai, Shengjie; Guo, Yansha; Zhao, Dan; Yang, Weizhong			Determinants of the Incidence of Hand, Foot and Mouth Disease in China Using Geographically Weighted Regression Models	PLOS ONE			English	Article							EPIDEMIOLOGY	Background: Over the past two decades, major epidemics of hand, foot, and mouth disease (HFMD) have occurred throughout most of the West-Pacific Region countries, causing thousands of deaths among children. However, few studies have examined potential determinants of the incidence of HFMD. Methods: Reported HFMD cases from 2912 counties in China were obtained for May 2008. The monthly HFMD cumulative incidence was calculated for children aged 9 years and younger. Child population density (CPD) and six climate factors (average-temperature [AT], average-minimum-temperature [AT(min)], average-maximum-temperature [AT(max)], average-temperature-difference [AT(diff)], average-relative-humidity [ARH], and monthly precipitation [MP]) were selected as potential explanatory variables for the study. Geographically weighted regression (GWR) models were used to explore the associations between the selected factors and HFMD incidence at county level. Results: There were 176,111 HFMD cases reported in the studied counties. The adjusted monthly cumulative incidence by county ranged from 0.26 cases per 100,000 children to 2549.00 per 100,000 children. For local univariate GWR models, the percentage of counties with statistical significance (p < 0.05) between HFMD incidence and each of the seven factors were: CPD 84.3%, AT(max) 54.9%, AT 57.8%, AT(min) 61.2%, ARH 54.4%, MP 50.3%, and AT(diff) 51.6%. The R-2 for the seven factors' univariate GWR models are CPD 0.56, AT(max) 0.53, AT 0.52, MP 0.51, AT(min) 0.52, ARH 0.51, and AT(diff) 0.51, respectively. CPD, MP, AT, ARH and AT(diff) were further included in the multivariate GWR model, with R-2 0.62, and all counties show statistically significant relationship. Conclusion: Child population density and climate factors are potential determinants of the HFMD incidence in most areas in China. The strength and direction of association between these factors and the incidence of HFDM is spatially heterogeneous at the local geographic level, and child population density has a greater influence on the incidence of HFMD than the climate factors.	[Hu, Maogui; Wang, Jinfeng] Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Li, Zhongjie; Lai, Shengjie; Zhao, Dan; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Key Lab Infect Dis Surveillance & Early Warning, Beijing, Peoples R China; [Jia, Lin] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Liao, Yilan] Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China; [Guo, Yansha] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Center for Disease Control & Prevention; Chinese Research Academy of Environmental Sciences; Peking University; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Hu, MG (corresponding author), Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	humg@lreis.ac.cn; yangwz@chinacdc.cn	Hu, Maogui/N-7105-2013	Hu, Maogui/0000-0002-7671-7863; Lai, Shengjie/0000-0001-9781-8148; Wang, Jinfeng/0000-0002-6687-9420	MOST (Ministry of Science and Technology of the People's Republic of China) [2012CB955500, 2011AA120305, 2009ZX10004-201, 200802025]; NSFC (The National Natural Science Foundation of China) [41023010]; CAS (Chinese Academy of Sciences) [XDA05090102]; LREIS (Laboratory of Resources and Environment Information System) [08R8B650KA]	MOST (Ministry of Science and Technology of the People's Republic of China)(Ministry of Science and Technology, China); NSFC (The National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); CAS (Chinese Academy of Sciences)(Chinese Academy of Sciences); LREIS (Laboratory of Resources and Environment Information System)	This study was supported by the following grants: MOST (Ministry of Science and Technology of the People's Republic of China) (2012CB955500, 2011AA120305, 2009ZX10004-201, 200802025), NSFC (The National Natural Science Foundation of China) (41023010), CAS (Chinese Academy of Sciences) (XDA05090102), and LREIS (Laboratory of Resources and Environment Information System) (08R8B650KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; BOER EPJ, 2001, INT J APPL EARTH OBS, V3, P146, DOI DOI 10.1016/S0303-2434(01)85006-6; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gilbert A, 2011, SOC SCI RES, V40, P273, DOI 10.1016/j.ssresearch.2010.08.006; Haining R., 2003, SPATIAL DATA ANAL TH; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hong Y, 2005, INT J CLIMATOL, V25, P1369, DOI 10.1002/joc.1187; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Lawson A. B., 2003, DIS MAPPING WINBUGS; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Porta M, 2008, DICT EPIDEMIOLOGY; Suminski RR, 2008, INT J BIOMETEOROL, V52, P189, DOI 10.1007/s00484-007-0110-y; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tong CYW, 2009, FUTURE VIROL, V4, P501, DOI 10.2217/FVL.09.25; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-52; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; World Health Organization, 2009, HAND FOOT MOUTH DIS; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; [郑景云 ZHENG Jingyun], 2010, [地理学报, Acta Geographica Sinica], V65, P3	27	101	110	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38978	10.1371/journal.pone.0038978	http://dx.doi.org/10.1371/journal.pone.0038978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723913	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300075
J	Zhou, YJ; Meng, X; Zhang, SF; Lee, EYC; Lee, MYWT				Zhou, Yajing; Meng, Xiao; Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.			Characterization of Human DNA Polymerase Delta and Its Subassemblies Reconstituted by Expression in the Multibac System	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; P12 SUBUNIT; CALF THYMUS; CATALYTIC SUBUNIT; DAMAGE RESPONSE; 3RD SUBUNIT; REPLICATION; PCNA; IDENTIFICATION; CHROMATOGRAPHY	Mammalian DNA polymerase delta (Pol delta), a four-subunit enzyme, plays a crucial and versatile role in DNA replication and DNA repair processes. We have reconstituted human Pol delta complexes in insect cells infected with a single baculovirus into which one or more subunits were assembled. This system allowed for the efficient expression of the tetrameric Pol delta holoenzyme, the p125/p50 core dimer, the core+p68 trimer and the core+p12 trimer, as well as the p125 catalytic subunit. These were isolated in milligram amounts with reproducible purity and specific activities by a highly standardized protocol. We have systematically compared their activities in order to gain insights into the roles of the p12 and p68 subunits, as well as their responses to PCNA. The relative specific activities (apparent k(cat)) of the Pol delta holoenzyme, core+p68, core+p12 and p125/p50 core were 100, 109, 40, and 29. The corresponding apparent K-d's for PCNA were 7.1, 8.7, 9.3 and 73 nM. Our results support the hypothesis that Pol delta interacts with PCNA through multiple interactions, and that there may be a redundancy in binding interactions that may permit Pol delta to adopt flexible configurations with PCNA. The abilities of the Pol delta complexes to fully extend singly primed M13 DNA were examined. All the subassemblies except the core+p68 were defective in their abilities to completely extend the primer, showing that the p68 subunit has an important function in synthesis of long stretches of DNA in this assay. The core+p68 trimer could be reconstituted by addition of p12.	[Zhou, Yajing] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Meng, Xiao; Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	Jiangsu University; New York Medical College	Zhou, YJ (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	Marietta_Lee@NYMC.edu		Zhang, Sufang/0000-0003-3883-023X	United States Public Health Service [GM31973, ES14737]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the United States Public Health Service, GM31973 and ES14737 to MYWTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Ducoux M, 2001, J BIOL CHEM, V276, P49258, DOI 10.1074/jbc.M106990200; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Henry RA, 2010, J BIOL CHEM, V285, P28496, DOI 10.1074/jbc.M110.131870; Huang QM, 2010, CANCER RES, V70, P8407, DOI 10.1158/0008-5472.CAN-10-0784; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Hughes P, 1999, NUCLEIC ACIDS RES, V27, P2108, DOI 10.1093/nar/27.10.2108; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; JIANG YQ, 1995, ARCH BIOCHEM BIOPHYS, V320, P297, DOI 10.1016/0003-9861(95)90013-6; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee M Y, 1981, Prog Nucleic Acid Res Mol Biol, V26, P83; LEE MYWT, 1991, J BIOL CHEM, V266, P2423; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1980, BIOCHEMISTRY-US, V19, P2096, DOI 10.1021/bi00551a015; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; Liu W, 2000, NUCLEIC ACIDS RES, V28, P4180, DOI 10.1093/nar/28.21.4180; Lu XQ, 2002, J BIOL CHEM, V277, P24340, DOI 10.1074/jbc.M200065200; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mo JY, 2000, BIOCHEMISTRY-US, V39, P7245, DOI 10.1021/bi0000871; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Rahmeh AA, 2012, BIOCHEMISTRY-US, V51, P416, DOI 10.1021/bi201638e; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Vijayachandran LS, 2011, J STRUCT BIOL, V175, P198, DOI 10.1016/j.jsb.2011.03.007; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002; Zhang P, 1999, J BIOL CHEM, V274, P26647, DOI 10.1074/jbc.274.38.26647; ZHANG SJ, 1995, J BIOL CHEM, V270, P7988, DOI 10.1074/jbc.270.14.7988; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	51	105	107	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39156	10.1371/journal.pone.0039156	http://dx.doi.org/10.1371/journal.pone.0039156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723953	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300107
J	de Llera, AH; Martin-Hidalgo, D; Gil, MC; Garcia-Marin, LJ; Bragado, MJ				Hurtado de Llera, Ana; Martin-Hidalgo, David; Gil, Maria C.; Garcia-Marin, Luis J.; Bragado, Maria J.			AMP-Activated Kinase AMPK Is Expressed in Boar Spermatozoa and Regulates Motility	PLOS ONE			English	Article							CAUSES MALE-INFERTILITY; HUMAN SPERM MOTILITY; PROTEIN-KINASE; CELL-MIGRATION; PHOSPHORYLATION; PATHWAY; INHIBITION; GLYCOLYSIS; HYPOXIA; CALCIUM	The main functions of spermatozoa required for fertilization are dependent on the energy status and metabolism. AMP-activated kinase, AMPK, acts a sensor and regulator of cell metabolism. As AMPK studies have been focused on somatic cells, our aim was to investigate the expression of AMPK protein in spermatozoa and its possible role in regulating motility. Spermatozoa from boar ejaculates were isolated and incubated under different conditions (38,5 degrees C or 17 degrees C, basal medium TBM or medium with Ca2+ and bicarbonate TCM, time from 1-24 hours) in presence or absence of AMPK inhibitor, compound C (CC, 30 mu M). Western blotting reveals that AMPK is expressed in boar spermatozoa at relatively higher levels than in somatic cells. AMPK phosphorylation (activation) in spermatozoa is temperature-dependent, as it is undetectable at semen preservation temperature (17 degrees C) and increases at 38,5 degrees C in a time-dependent manner. AMPK phosphorylation is independent of the presence of Ca2+ and/or bicarbonate in the medium. We confirm that CC effectively blocks AMPK phosphorylation in boar spermatozoa. Analysis of spermatozoa motility by CASA shows that CC treatment either in TBM or in TCM causes a significant reduction of any spermatozoa motility parameter in a time-dependent manner. Thus, AMPK inhibition significantly decreases the percentages of motile and rapid spermatozoa, significantly reduces spermatozoa velocities VAP, VCL and affects other motility parameters and coefficients. CC treatment does not cause additional side effects in spermatozoa that might lead to a lower viability even at 24 h incubation. Our results show that AMPK is expressed in spermatozoa at high levels and is phosphorylated under physiological conditions. Moreover, our study suggests that AMPK regulates a relevant function of spermatozoa, motility, which is essential for their ultimate role of fertilization.	[Hurtado de Llera, Ana; Martin-Hidalgo, David; Gil, Maria C.; Garcia-Marin, Luis J.; Bragado, Maria J.] Univ Extremadura, Sch Vet, Res Grp Intracellular Signalling & Technol Reprod, Caceres, Spain	Universidad de Extremadura	de Llera, AH (corresponding author), Univ Extremadura, Sch Vet, Res Grp Intracellular Signalling & Technol Reprod, Caceres, Spain.	ljgarcia@unex.es; jbragado@unex.es	Hidalgo, David Martín/N-4005-2019; Bragado, M Julia/L-6988-2014; Garcia-Marin, Luis J/L-4680-2014; Hidalgo, David Martín/I-2840-2015; Anaya, Maria Cruz Gil/M-3308-2014	Hidalgo, David Martín/0000-0002-6787-0006; Bragado, M Julia/0000-0001-7770-0775; Garcia-Marin, Luis J/0000-0002-1795-7381; Hidalgo, David Martín/0000-0002-6787-0006; Anaya, Maria Cruz Gil/0000-0001-7041-9673; HURTADO DE LLERA, ANA/0000-0002-6782-9783	National Grant from the Spanish Ministry of Education and Science [AGL2010-15188]; regional Grant from Junta de Extremadura, Spain [PRI09A077, GR10156]; Junta de Extremadura, Spain	National Grant from the Spanish Ministry of Education and Science(German Research Foundation (DFG)); regional Grant from Junta de Extremadura, Spain; Junta de Extremadura, Spain	This work was supported by National Grant AGL2010-15188 (from the Spanish Ministry of Education and Science) and regional Grant PRI09A077 and GR10156 (from Junta de Extremadura, Spain). D. Martin-Hidalgo received a Ph D fellowship award from the Junta de Extremadura, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD K, 1995, ARCH ANDROLOGY, V35, P187, DOI 10.3109/01485019508987871; Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Aparicio IM, 2005, REPRODUCTION, V129, P283, DOI 10.1530/rep.1.00447; Aparicio IM, 2003, BBA-MOL CELL RES, V1643, P37, DOI 10.1016/j.bbamcr.2003.08.007; Bajpai M, 2003, REPRODUCTION, V126, P183, DOI 10.1530/rep.0.1260183; Baron SJ, 2005, CIRC RES, V96, P337, DOI 10.1161/01.RES.0000155723.53868.d2; Bragado MJ, 2010, J CELL BIOCHEM, V109, P65, DOI 10.1002/jcb.22393; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chen JH, 2011, J CELL BIOCHEM, V112, P2931, DOI 10.1002/jcb.23209; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Espinal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022619; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Khan M, 2005, J NEUROSCI RES, V80, P845, DOI 10.1002/jnr.20529; Kim EK, 2011, J BIOL CHEM, V286, P24036, DOI 10.1074/jbc.M110.209908; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Rodriguez-Gil JE, 2006, REPROD DOMEST ANIM, V41, P11, DOI 10.1111/j.1439-0531.2006.00765.x; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Williams AC, 2001, J ANDROL, V22, P680; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Xu B, 2007, Soc Reprod Fertil Suppl, V63, P87; Xu BF, 2008, DEV BIOL, V319, P211, DOI 10.1016/j.ydbio.2008.03.047; Zhang LL, 2000, J NEUROSCI RES, V62, P389, DOI 10.1002/1097-4547(20001101)62:3<389::AID-JNR9>3.0.CO;2-M; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254	38	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38840	10.1371/journal.pone.0038840	http://dx.doi.org/10.1371/journal.pone.0038840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719961	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800022
J	Zhang, YR; Cuevas, S; Asico, LD; Escano, C; Yang, Y; Pascua, AM; Wang, XY; Jones, JE; Grandy, D; Eisner, G; Jose, PA; Armando, I				Zhang, Yanrong; Cuevas, Santiago; Asico, Laureano D.; Escano, Crisanto; Yang, Yu; Pascua, Annabelle M.; Wang, Xiaoyan; Jones, John E.; Grandy, David; Eisner, Gilbert; Jose, Pedro A.; Armando, Ines			Deficient Dopamine D-2 Receptor Function Causes Renal Inflammation Independently of High Blood Pressure	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; BRAIN-DEAD RATS; D2 RECEPTOR; DEPENDENT HYPERTENSION; TAQI POLYMORPHISM; GENE DRD2; T-CELLS; ANGIOTENSIN; EXPRESSION	Renal dopamine receptors participate in the regulation of blood pressure. Genetic factors, including polymorphisms of the dopamine D-2 receptor gene (DRD2) are associated with essential hypertension, but the mechanisms of their contribution are incompletely understood. Mice lacking Drd2 (D-2(-/-)) have elevated blood pressure, increased renal expression of inflammatory factors, and renal injury. We tested the hypothesis that decreased dopamine D-2 receptor (D2R) function increases vulnerability to renal inflammation independently of blood pressure, is an immediate cause of renal injury, and contributes to the subsequent development of hypertension. In D-2(-/-) mice, treatment with apocynin normalized blood pressure and decreased oxidative stress, but did not affect the expression of inflammatory factors. In mouse RPTCs Drd2 silencing increased the expression of TNF alpha and MCP-1, while treatment with a D2R agonist abolished the angiotensin II-induced increase in TNF-alpha and MCP-1. In uni-nephrectomized wild-type mice, selective Drd2 silencing by subcapsular infusion of Drd2 siRNA into the remaining kidney produced the same increase in renal cytokines/chemokines that occurs after Drd2 deletion, increased the expression of markers of renal injury, and increased blood pressure. Moreover, in mice with two intact kidneys, short-term Drd2 silencing in one kidney, leaving the other kidney undisturbed, induced inflammatory factors and markers of renal injury in the treated kidney without increasing blood pressure. Our results demonstrate that the impact of decreased D2R function on renal inflammation is a primary effect, not necessarily associated with enhanced oxidant activity, or blood pressure; renal damage is the cause, not the result, of hypertension. Deficient renal D2R function may be of clinical relevance since common polymorphisms of the human DRD2 gene result in decreased D2R expression and function.	[Zhang, Yanrong; Cuevas, Santiago; Asico, Laureano D.; Escano, Crisanto; Yang, Yu; Pascua, Annabelle M.; Wang, Xiaoyan; Jones, John E.; Jose, Pedro A.; Armando, Ines] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Grandy, David] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Eisner, Gilbert] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA	University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University; Georgetown University	Zhang, YR (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA.	iarmando@medicine.umaryland.edu	Asico, Laureano/AAM-6321-2020; Cuevas, Santiago/AAG-4985-2021; Wang, Xiaoyan/GOK-1663-2022	Cuevas, Santiago/0000-0002-0832-5446; Wang, Xiaoyan/0000-0001-7406-5008	National Institutes of Health [HL068686, HL023081, HL074940, HL092196, DK039308, DK090918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL023081, P01HL074940, P01HL068686, R01HL023081, R01HL092196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090918, R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health, HL068686, HL023081, HL074940, HL092196, DK039308 and DK090918 (www.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Armando I, 2007, HYPERTENSION, V49, P672, DOI 10.1161/01.HYP.0000254486.00883.3d; Bach F, 2002, ACTA ANAESTH SCAND, V46, P1227, DOI 10.1034/j.1399-6576.2002.461010.x; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; BENDELE AM, 1991, J PHARMACOL EXP THER, V259, P169; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Birnbaum J, 2006, CRIT CARE, V10, DOI 10.1186/cc5011; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Donnahoo KK, 1999, J UROLOGY, V162, P196, DOI 10.1097/00005392-199907000-00068; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Fang YJ, 2005, INT J CARDIOL, V102, P111, DOI 10.1016/j.ijcard.2004.05.010; Ferguson SM, 2003, J NEUROCHEM, V86, P33, DOI 10.1046/j.1471-4159.2003.01815.x; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Hasko G, 2002, J NEUROIMMUNOL, V122, P34, DOI 10.1016/S0165-5728(01)00459-3; Hoeger S, 2008, TRANSPL INT, V21, P1072, DOI 10.1111/j.1432-2277.2008.00725.x; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Laengle UW, 2006, EXP EYE RES, V83, P1335, DOI 10.1016/j.exer.2006.07.008; Lavender P, 2000, CHEM IMMUNOL, V78, P16; Lea WB, 2009, KIDNEY INT, V75, P936, DOI 10.1038/ki.2009.9; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li XX, 2001, HYPERTENSION, V38, P303, DOI 10.1161/01.HYP.38.3.303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MORIKAWA K, 1994, CLIN EXP IMMUNOL, V95, P514; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Prasad P, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-26; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Romagnani P, 1999, J AM SOC NEPHROL, V10, P2518; Rosmond R, 2001, J HUM HYPERTENS, V15, P553, DOI 10.1038/sj.jhh.1001231; Ruiz-Ortega M, 2002, KIDNEY INT S, V82, pS12, DOI [10.1046/j.1523-1755.62.s82.4.x, DOI 10.1046/J.1523-1755.62.S82.4.X]; Segerer S, 2007, SEMIN NEPHROL, V27, P260, DOI 10.1016/j.semnephrol.2007.02.003; Shahid M, 2010, AM J PHYSIOL-RENAL, V299, pF217, DOI 10.1152/ajprenal.00611.2009; Takeuchi Y, 2003, J NEUROCHEM, V85, P729, DOI 10.1046/j.1471-4159.2003.01711.x; Thomas GN, 2001, CLIN ENDOCRINOL, V55, P605, DOI 10.1046/j.1365-2265.2001.01404.x; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Wang YP, 2004, KIDNEY INT, V66, P655, DOI 10.1111/j.1523-1755.2004.00786.x; Woost PG, 2006, IN VITRO CELL DEV-AN, V42, P189; Yang M, 2003, MOL PHARMACOL, V64, P447, DOI 10.1124/mol.64.2.447; Yang SL, 2012, AM J PHYSIOL-RENAL, V302, pF742, DOI 10.1152/ajprenal.00583.2011; Yoneda M, 2005, HYPERTENSION, V46, P58, DOI 10.1161/01.HYP.0000171587.44736.ba; Zeng CY, 2008, AM J PHYSIOL-HEART C, V294, pH551, DOI 10.1152/ajpheart.01036.2007; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zheng L, 2008, J HISTOCHEM CYTOCHEM, V56, P517, DOI 10.1369/jhc.7A7368.2008; Zhu JF, 2010, IMMUNOL CELL BIOL, V88, P244, DOI 10.1038/icb.2009.114; Zhu XH, 1997, CYTOKINE, V9, P437, DOI 10.1006/cyto.1996.0186	54	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38745	10.1371/journal.pone.0038745	http://dx.doi.org/10.1371/journal.pone.0038745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719934	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800016
J	Harryson, L; Strandh, M; Hammarstrom, A				Harryson, Lisa; Strandh, Mattias; Hammarstrom, Anne			Domestic Work and Psychological Distress-What Is the Importance of Relative Socioeconomic Position and Gender Inequality in the Couple Relationship?	PLOS ONE			English	Article							PERCEIVED FAIRNESS; HOUSEHOLD LABOR; DIVISION; HEALTH; EQUALITY; WOMEN; MEN; HOUSEWORK; ROLES	Aims: The aim of this study was to investigate whether the relation between responsibility for domestic work and psychological distress was influenced by perception of gender inequality in the couple relationship and relative socioeconomic position. Methods: In the Northern Swedish Cohort, all pupils who studied in the last year of compulsory school in a northern Swedish town in 1981 have been followed regularly until 2007. In this study, participants living with children were selected (n = 371 women, 352 men). The importance of relative socioeconomic position and perception of gender inequality in the couple relationship in combination with domestic work for psychological distress was examined through logistic regression analysis. Results: Two combinations of variables including socioeconomic position ('having less than half of the responsibility for domestic work and partner higher socioeconomic position' and 'having more than half the responsibility for domestic work and equal socioeconomic position') were related to psychological distress. There were also higher ORs for psychological distress for the combinations of having 'less than half of the responsibility for domestic work and gender-unequal couple relationship' and 'more than half the responsibility for domestic work and gender-unequal couple relationship'. Having a lower socioeconomic position than the partner was associated with higher ORs for psychological distress among men. Conclusions: This study showed that domestic work is a highly gendered activity as women tend to have a greater and men a smaller responsibility. Both these directions of inequality in domestic work, in combination with experiencing the couple relationship as gender-unequal, were associated with psychological distress There is a need for more research with a relational approach on inequalities in health in order to capture the power relations within couples in various settings.	[Harryson, Lisa; Strandh, Mattias; Hammarstrom, Anne] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Harryson, Lisa] Umea Univ, Umea Ctr Gender Studies, Natl Grad Sch Gender Studies, Umea, Sweden; [Strandh, Mattias] Umea Univ, Dept Sociol, Umea, Sweden; [Hammarstrom, Anne] Umea Univ, Umea Ctr Gender Studies Med, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Harryson, L (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	lisa.harryson@fammed.umu.se		Hammarstrom, Anne/0000-0002-4095-7961	Swedish Council for Working Life and Social Research [Dnr 2007-2073]; National School for Gender Studies at Umea University	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); National School for Gender Studies at Umea University	Funders: 1) Swedish Council for Working Life and Social Research, grant number: Dnr 2007-2073 (URL:http://www.fas.se/sv/Projektkatalog/?arende = 17071). 2) National School for Gender Studies at Umea University is funding part of the salary for the first author in the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg J, 2008, SOC POLIT, V15, P79, DOI 10.1093/sp/jxn003; Annandale E, 1999, GENDER INEQUALITIES IN HEALTH, P1; [Anonymous], 2005, MAKT ATT FORM SAMH S; Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P39, DOI 10.1136/jech.2007.059774; Backhans MC, 2009, SOC SCI MED, V68, P1388, DOI 10.1016/j.socscimed.2009.01.023; Bartley M, 2004, SOC SCI MED, V59, P1925, DOI 10.1016/j.socscimed.2004.03.002; Bird CE, 1999, J HEALTH SOC BEHAV, V40, P32, DOI 10.2307/2676377; Boye K, 2008, THESIS STOCKHOLM U; Braun M, 2008, J MARRIAGE FAM, V70, P1145, DOI 10.1111/j.1741-3737.2008.00556.x; Claffey ST, 2009, SEX ROLES, V60, P819, DOI 10.1007/s11199-008-9578-0; Connell R, 2009, GENDER WORLD PERSPEC, P72; Evertsson L., 2009, INTERPERSONA, V3, P33, DOI DOI 10.5964/IJPR.V3ISUPP1.68; Evertsson M, 2007, EUR SOCIOL REV, V23, P455, DOI 10.1093/esr/jcm018; Evertsson M, 2009, SOC POLIT, V16, P210, DOI 10.1093/sp/jxp008; Hammarstrom A, 2011, INT J EPIDE IN PRESS; Harryson L, 2012, J EPIDEMIOL COMMUN H, V66, P271, DOI 10.1136/jech.2010.109231; Lahelma E, 2002, SOC SCI MED, V54, P727, DOI 10.1016/S0277-9536(01)00105-8; LENNON MC, 1994, AM J SOCIOL, V100, P506, DOI 10.1086/230545; Macintyre S, 1997, J Health Psychol, V2, P315, DOI 10.1177/135910539700200304; Magnusson E, 2005, NORA, V13, P153, DOI 10.1080/08038740600587661; Magnusson Eva, 2008, CRITICAL STUDIES GEN, P161; Mansdotter A, 2006, J EPIDEMIOL COMMUN H, V60, P616, DOI 10.1136/jech.2005.041327; Matthews S, 2002, SOC SCI MED, V54, P799, DOI 10.1016/S0277-9536(01)00110-1; Mustard CA, 2003, J EPIDEMIOL COMMUN H, V57, P974, DOI 10.1136/jech.57.12.974; Nordenmark M, 2003, EUR J WOMENS STUD, V10, P181, DOI 10.1177/1350506803010002004; Reine I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-159; Staland-Nyman C, 2008, SCAND J PUBLIC HEALT, V36, P21, DOI 10.1177/1403494807085307; *STAT SWED, 1983, SOC IND SEI MEDD SAM; Statistics Sweden, 2010, WOM MEN SWED; Statistics Sweden, 1980, SWED SURV LIV COND; Vaananen A, 2004, WOMEN HEALTH, V40, P1, DOI [10.1300/J013v403_01, 10.1300/J013v40n03_01]	31	15	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38484	10.1371/journal.pone.0038484	http://dx.doi.org/10.1371/journal.pone.0038484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719895	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900032
J	Kujala, MV; Kujala, J; Carlson, S; Hari, R				Kujala, Miiamaaria V.; Kujala, Jan; Carlson, Synnove; Hari, Riitta			Dog Experts' Brains Distinguish Socially Relevant Body Postures Similarly in Dogs and Humans	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; BIOLOGICAL MOTION PERCEPTION; PERSPECTIVE-TAKING; VISUAL-PERCEPTION; FMRI; REPRESENTATIONS; MIND; RECOGNITION; PATTERNS	We read conspecifics' social cues effortlessly, but little is known about our abilities to understand social gestures of other species. To investigate the neural underpinnings of such skills, we used functional magnetic resonance imaging to study the brain activity of experts and non-experts of dog behavior while they observed humans or dogs either interacting with, or facing away from a conspecific. The posterior superior temporal sulcus (pSTS) of both subject groups dissociated humans facing toward each other from humans facing away, and in dog experts, a distinction also occurred for dogs facing toward vs. away in a bilateral area extending from the pSTS to the inferior temporo-occipital cortex: the dissociation of dog behavior was significantly stronger in expert than control group. Furthermore, the control group had stronger pSTS responses to humans than dogs facing toward a conspecific, whereas in dog experts, the responses were of similar magnitude. These findings suggest that dog experts' brains distinguish socially relevant body postures similarly in dogs and humans.	[Kujala, Miiamaaria V.; Kujala, Jan; Carlson, Synnove; Hari, Riitta] Aalto Univ, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Kujala, Miiamaaria V.; Carlson, Synnove; Hari, Riitta] Aalto Univ, Adv Magnet Imaging Ctr, Espoo, Finland; [Carlson, Synnove] Univ Helsinki, Inst Biomed Physiol, Neurosci Unit, Helsinki, Finland	Aalto University; Aalto University; University of Helsinki	Kujala, MV (corresponding author), CNRS, INSERM, U1028, UMR5292,Lyon Neurosci Res Ctr, Bron, France.	miiamaaria.kujala@gmail.com	Kujala, Jan/J-3092-2012; Carlson, Synnöve/G-2210-2013; Carlson, Synnöve/AAM-2655-2021; Kujala, Miiamaaria/K-2629-2012; Carlson, Synnöve/A-6337-2013; Hari, Riitta K/J-1880-2012	Kujala, Jan/0000-0002-3056-753X; Carlson, Synnöve/0000-0003-1462-7560; Hari, Riitta K/0000-0002-3142-2703; Kujala, Miiamaaria/0000-0002-1377-2187	Academy of Finland (National Centers of Excellence Program); Academy of Finland (NEURO program); ERC Advanced Grant [232946]; Sigrid Juselius Foundation; Signe and Ane Gyllenberg Foundation; Foundations' Post Doc Pool (Kone Foundation); UI-ART MIDE Program; aivoAALTO project of the Aalto University; Finnish Graduate School of Neuroscience	Academy of Finland (National Centers of Excellence Program); Academy of Finland (NEURO program); ERC Advanced Grant; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Signe and Ane Gyllenberg Foundation; Foundations' Post Doc Pool (Kone Foundation); UI-ART MIDE Program; aivoAALTO project of the Aalto University; Finnish Graduate School of Neuroscience	This study was supported by the Academy of Finland (National Centers of Excellence Program 2006-2011, and NEURO program), ERC Advanced Grant #232946, Sigrid Juselius Foundation, Signe and Ane Gyllenberg Foundation, Foundations' Post Doc Pool (Kone Foundation), UI-ART MIDE Program and the aivoAALTO project of the Aalto University, and the Finnish Graduate School of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Aichhorn M, 2006, NEUROIMAGE, V30, P1059, DOI 10.1016/j.neuroimage.2005.10.026; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Blonder LX, 2004, COGNITIVE BRAIN RES, V20, P384, DOI 10.1016/j.cogbrainres.2004.03.020; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Centelles L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015749; Davis M. H., 1980, CATALOG SELECTED DOC, V10, P85; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Downing PE, 2007, J NEUROSCI, V27, P226, DOI 10.1523/JNEUROSCI.3619-06.2007; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Itier RJ, 2007, NEUROPSYCHOLOGIA, V45, P1019, DOI 10.1016/j.neuropsychologia.2006.09.004; Kaiser MD, 2011, SOC NEUROSCI, DOI [10.1080/17470919.17472011.17614003, DOI 10.1080/17470919.17472011.17614003]; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kujala MV, 2012, HUM BRAIN MAPP, V33, P1753, DOI 10.1002/hbm.21317; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Merzenich M M, 1993, J Hand Ther, V6, P89; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Pourtois G, 2007, NEUROPSYCHOLOGIA, V45, P2621, DOI 10.1016/j.neuropsychologia.2007.04.005; Puce A, 2003, NEUROIMAGE, V19, P861, DOI 10.1016/S1053-8119(03)00189-7; Pyles JA, 2007, VISION RES, V47, P2786, DOI 10.1016/j.visres.2007.07.017; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Santi A, 2003, J COGNITIVE NEUROSCI, V15, P800, DOI 10.1162/089892903322370726; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838	54	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39145	10.1371/journal.pone.0039145	http://dx.doi.org/10.1371/journal.pone.0039145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22720054	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305341900087
J	Ward, DV; Gevers, D; Giannoukos, G; Earl, AM; Methe, BA; Sodergren, E; Feldgarden, M; Ciulla, DM; Tabbaa, D; Arze, C; Appelbaum, E; Aird, L; Anderson, S; Ayvaz, T; Belter, E; Bihan, M; Bloom, T; Crabtree, J; Courtney, L; Carmichael, L; Dooling, D; Erlich, RL; Farmer, C; Fulton, L; Fulton, R; Gao, HY; Gill, JA; Haas, BJ; Hemphill, L; Hall, O; Hamilton, SG; Hepburn, TA; Lennon, NJ; Joshi, V; Kells, C; Kovar, CL; Kalra, D; Li, K; Lewis, L; Leonard, S; Muzny, DM; Mardis, E; Mihindukulasuriya, K; Magrini, V; O'Laughlin, M; Pohl, C; Qin, X; Ross, K; Ross, MC; Rogers, YHA; Singh, N; Shang, Y; Wilczek-Boney, K; Wortman, JR; Worley, KC; Youmans, BP; Yooseph, S; Zhou, Y; Schloss, PD; Wilson, R; Gibbs, RA; Nelson, KE; Weinstock, G; DeSantis, TZ; Petrosino, JF; Highlander, SK; Birren, BW				Ward, Doyle V.; Gevers, Dirk; Giannoukos, Georgia; Earl, Ashlee M.; Methe, Barbara A.; Sodergren, Erica; Feldgarden, Michael; Ciulla, Dawn M.; Tabbaa, Diana; Arze, Cesar; Appelbaum, Elizabeth; Aird, Leigh; Anderson, Scott; Ayvaz, Tulin; Belter, Edward; Bihan, Monika; Bloom, Toby; Crabtree, Jonathan; Courtney, Laura; Carmichael, Lynn; Dooling, David; Erlich, Rachel L.; Farmer, Candace; Fulton, Lucinda; Fulton, Robert; Gao, Hongyu; Gill, John A.; Haas, Brian J.; Hemphill, Lisa; Hall, Otis; Hamilton, Susanna G.; Hepburn, Theresa A.; Lennon, Niall J.; Joshi, Vandita; Kells, Cristyn; Kovar, Christie L.; Kalra, Divya; Li, Kelvin; Lewis, Lora; Leonard, Shawn; Muzny, Donna M.; Mardis, Elaine; Mihindukulasuriya, Kathie; Magrini, Vincent; O'Laughlin, Michelle; Pohl, Craig; Qin, Xiang; Ross, Keenan; Ross, Matthew C.; Rogers, Yu-Hui A.; Singh, Navjeet; Shang, Yue; Wilczek-Boney, Katarzyna; Wortman, Jennifer R.; Worley, Kim C.; Youmans, Bonnie P.; Yooseph, Shibu; Zhou, Yanjiao; Schloss, Patrick D.; Wilson, Richard; Gibbs, Richard A.; Nelson, Karen E.; Weinstock, George; DeSantis, Todd Z.; Petrosino, Joseph F.; Highlander, Sarah K.; Birren, Bruce W.		Jumpstart Consortium Human Microbi	Evaluation of 16S rDNA-Based Community Profiling for Human Microbiome Research	PLOS ONE			English	Article							DIVERSITY; SEQUENCES; ABUNDANCE	The Human Microbiome Project will establish a reference data set for analysis of the microbiome of healthy adults by surveying multiple body sites from 300 people and generating data from over 12,000 samples. To characterize these samples, the participating sequencing centers evaluated and adopted 16S rDNA community profiling protocols for ABI 3730 and 454 FLX Titanium sequencing. In the course of establishing protocols, we examined the performance and error characteristics of each technology, and the relationship of sequence error to the utility of 16S rDNA regions for classification-and OTU-based analysis of community structure. The data production protocols used for this work are those used by the participating centers to produce 16S rDNA sequence for the Human Microbiome Project. Thus, these results can be informative for interpreting the large body of clinical 16S rDNA data produced for this project.	[Ward, Doyle V.; Gevers, Dirk; Giannoukos, Georgia; Earl, Ashlee M.; Feldgarden, Michael; Ciulla, Dawn M.; Tabbaa, Diana; Anderson, Scott; Bloom, Toby; Erlich, Rachel L.; Haas, Brian J.; Hemphill, Lisa; Hamilton, Susanna G.; Hepburn, Theresa A.; Lennon, Niall J.; Kells, Cristyn; Ross, Keenan; Birren, Bruce W.] Broad Inst, Cambridge, MA USA; [Sodergren, Erica; Appelbaum, Elizabeth; Belter, Edward; Courtney, Laura; Carmichael, Lynn; Dooling, David; Farmer, Candace; Fulton, Lucinda; Fulton, Robert; Gao, Hongyu; Hall, Otis; Leonard, Shawn; Mardis, Elaine; Mihindukulasuriya, Kathie; Magrini, Vincent; O'Laughlin, Michelle; Pohl, Craig; Wilson, Richard; Weinstock, George] Washington Univ Sch Med, Genome Inst, St Louis, MO USA; [Ross, Matthew C.; Youmans, Bonnie P.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Joshi, Vandita; Kovar, Christie L.; Kalra, Divya; Lewis, Lora; Muzny, Donna M.; Qin, Xiang; Shang, Yue; Wilczek-Boney, Katarzyna; Gibbs, Richard A.; Petrosino, Joseph F.; Highlander, Sarah K.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bihan, Monika; Li, Kelvin] J Craig Venter Inst, Rockville, MD USA; [Methe, Barbara A.; Nelson, Karen E.] J Craig Venter Inst, Human Genom Med, Rockville, MD USA; [Yooseph, Shibu] J Craig Venter Inst, San Diego, CA USA; [Gill, John A.; Rogers, Yu-Hui A.] J Craig Venter Inst, Sequencing, Rockville, MD USA; [Singh, Navjeet; DeSantis, Todd Z.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Berkeley, CA 94720 USA; [Arze, Cesar; Crabtree, Jonathan; Wortman, Jennifer R.] Univ Maryland Sch Med, Inst Genome Sci, Baltimore, MD USA; [Schloss, Patrick D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; J. Craig Venter Institute; J. Craig Venter Institute; J. Craig Venter Institute; J. Craig Venter Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan	Ward, DV (corresponding author), Broad Inst, Cambridge, MA USA.		Gevers, Dirk/C-1451-2009; Wilson, Richard K./AAF-4139-2019; Kalra, Divya/N-5453-2014; Petrosino, Joseph F./AAF-1621-2019; Mardis, Elaine/W-2202-2019; Bihan, Monika/C-7469-2014; Magrini, Vincent/AAT-5830-2020; Weinstock, George M/C-6314-2013; Kalra, D/H-6661-2019	Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; Weinstock, George M/0000-0002-2997-4592; Kalra, D/0000-0001-5254-4067; ross, matthew/0000-0002-7621-8829; Arze, Cesar/0000-0002-3606-4183; Earl, Ashlee/0000-0001-7857-9145; Worley, Kim/0000-0002-0282-1000; Schloss, Patrick/0000-0002-6935-4275; Wortman, Jennifer/0000-0002-8713-1227; Yooseph, Shibu/0000-0001-5581-5002	National Institutes of Health [U54HG004973]; Broad Insitute [HHSN2722009000018C, U54HG004969]; J. Craig Venter Institute [U54AI084844]; University of Maryland, Baltimore [1U01HG004866]; Washington University [U54HG003079, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U01HG004866, U54HG004973, U54HG004968, U54HG004969, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Insitute; J. Craig Venter Institute; University of Maryland, Baltimore; Washington University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge National Institutes of Health funding of this work with grants to Baylor College of Medicine (U54HG004973), the Broad Insitute (HHSN2722009000018C and U54HG004969), the J. Craig Venter Institute (U54AI084844), the University of Maryland, Baltimore (1U01HG004866), and Washington University (U54HG003079 and U54HG004968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Coolen MJL, 2005, APPL ENVIRON MICROB, V71, P8729, DOI 10.1128/AEM.71.12.8729-8737.2005; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Garrity G. M., 2007, TAXONOMIC OUTLINE BA, DOI [10.1601/TOBA7.7, DOI 10.1601/TOBA7.7]; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haas BJ, 2011, GENOME RES; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Huffnagle GB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000549; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kunin V, 2009, ENV MICROBIOLOGY, V9999; Larkin M, 2005, MOL TOOLBOX MICROBIA; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Kelvin, 2010, BMC Res Notes, V3, P199, DOI 10.1186/1756-0500-3-199; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; RAVEL J, 2010, P NATL ACAD SCI US; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x	39	169	172	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39315	10.1371/journal.pone.0039315	http://dx.doi.org/10.1371/journal.pone.0039315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720093	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900095
J	Traian, MMD; Cattoni, DI; Levi, V; Flecha, FLG				Dodes Traian, Martin M.; Cattoni, Diego I.; Levi, Valeria; Gonzalez Flecha, F. Luis			A Two-Stage Model for Lipid Modulation of the Activity of Integral Membrane Proteins	PLOS ONE			English	Article							CELL CALCIUM-PUMP; THERMAL-STABILITY; QUANTITATIVE-ANALYSIS; BIOLOGICAL-MEMBRANES; ACIDIC PHOSPHOLIPIDS; CA2+-ATPASE; CA2+-ATPASE; OLIGOMERIZATION; AGGREGATION; TRYPTOPHAN	Lipid-protein interactions play an essential role in the regulation of biological function of integral membrane proteins; however, the underlying molecular mechanisms are not fully understood. Here we explore the modulation by phospholipids of the enzymatic activity of the plasma membrane calcium pump reconstituted in detergent-phospholipid mixed micelles of variable composition. The presence of increasing quantities of phospholipids in the micelles produced a cooperative increase in the ATPase activity of the enzyme. This activation effect was reversible and depended on the phospholipid/detergent ratio and not on the total lipid concentration. Enzyme activation was accompanied by a small structural change at the transmembrane domain reported by 1-aniline-8-naphtalenesulfonate fluorescence. In addition, the composition of the amphipilic environment sensed by the protein was evaluated by measuring the relative affinity of the assayed phospholipid for the transmembrane surface of the protein. The obtained results allow us to postulate a two-stage mechanistic model explaining the modulation of protein activity based on the exchange among non-structural amphiphiles at the hydrophobic transmembrane surface, and a lipid-induced conformational change. The model allowed to obtain a cooperativity coefficient reporting on the efficiency of the transduction step between lipid adsorption and catalytic site activation. This model can be easily applied to other phospholipid/detergent mixtures as well to other membrane proteins. The systematic quantitative evaluation of these systems could contribute to gain insight into the structure-activity relationships between proteins and lipids in biological membranes.	[Dodes Traian, Martin M.; Cattoni, Diego I.; Gonzalez Flecha, F. Luis] Univ Buenos Aires, Lab Biofis Mol, Inst Quim & Fis Quim Biol, CONICET, Buenos Aires, DF, Argentina; [Dodes Traian, Martin M.; Levi, Valeria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Dinam Intracelular, Dept Quim Biol, Buenos Aires, DF, Argentina; [Cattoni, Diego I.] Univ Montpellier 1 & 2, Ctr Biochim Struct, INSERM, U554,CNRS,UMR 5048, Montpellier, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Traian, MMD (corresponding author), Univ Buenos Aires, Lab Biofis Mol, Inst Quim & Fis Quim Biol, CONICET, Buenos Aires, DF, Argentina.	lgf@qb.ffyb.uba.ar	González Flecha, F Luis/J-7060-2014	González Flecha, F Luis/0000-0003-2828-7907; Levi, Valeria/0000-0002-1666-4675; Cattoni, Diego I./0000-0002-0048-8531	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCyT [PICT 2010-1876, PICT 2008-1104]; Universidad de Buenos Aires, UBACyT [20020090200201, 20020100100048]	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCyT(ANPCyT); Universidad de Buenos Aires, UBACyT(University of Buenos Aires)	This work was partially supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCyT (PICT 2010-1876, PICT 2008-1104), and Universidad de Buenos Aires, UBACyT (20020090200201 and 20020100100048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Atkins P., 2006, PHYS CHEM; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CASTELLO PR, 1994, BIOCHEM BIOPH RES CO, V201, P194, DOI 10.1006/bbrc.1994.1688; Castello PR, 1997, PROTEIN SCI, V6, P1708, DOI 10.1002/pro.5560060811; Cattoni DI, 2008, ARCH BIOCHEM BIOPHYS, V471, P198, DOI 10.1016/j.abb.2007.12.013; Cattoni DI, 2009, BBA-PROTEINS PROTEOM, V1794, P1700, DOI 10.1016/j.bbapap.2009.08.007; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; EA Roman, 2012, CIRCULAR DICHROISM T, P217; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Flecha FLG, 1999, J MEMBRANE BIOL, V171, P25, DOI 10.1007/s002329900555; Cohen IPG, 2010, BBA-BIOMEMBRANES, V1798, P2040, DOI 10.1016/j.bbamem.2010.07.035; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jost P C, 1980, Ann N Y Acad Sci, V348, P391, DOI 10.1111/j.1749-6632.1980.tb21315.x; JOST PC, 1973, P NATL ACAD SCI USA, V70, P480, DOI 10.1073/pnas.70.2.480; KOSKKOSICKA D, 1990, MOL CELL BIOCHEM, V99, P75; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Ladokhin AS, 2010, J MEMBRANE BIOL, V236, P247, DOI 10.1007/s00232-010-9291-0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Levi V, 2000, J MEMBRANE BIOL, V173, P215, DOI 10.1007/s002320001021; Levi V, 2000, FEBS LETT, V483, P99, DOI 10.1016/S0014-5793(00)02093-7; Levi V, 2003, ANAL BIOCHEM, V317, P171, DOI 10.1016/S0003-2697(03)00132-5; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Levi V, 2008, BIOCHEM J, V416, P145, DOI 10.1042/BJ20080618; Loura LMS, 2010, EUR BIOPHYS J BIOPHY, V39, P565, DOI [10.1007/s00249-009-0532-z, 10.1007/s00249-010-0580-4]; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Marsh D, 2008, METHODS, V46, P83, DOI 10.1016/j.ymeth.2008.07.001; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; O'Keeffe AH, 2000, BIOPHYS J, V79, P2066, DOI 10.1016/S0006-3495(00)76454-X; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; REED LJ, 1928, J PHYS CHEM, V33, P760, DOI DOI 10.1021/J150299A014; Roman EA, 2010, J MOL BIOL, V397, P550, DOI 10.1016/j.jmb.2010.01.045; RONNER P, 1977, ARCH BIOCHEM BIOPHYS, V179, P578, DOI 10.1016/0003-9861(77)90146-1; Sanders CR, 2011, BIOCHEMISTRY-US, V50, P7858, DOI 10.1021/bi2011527; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seber G., 1989, NONLINEAR REGRESSION; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; TANFORD C, 1980, HYDROPHOBIC EFFECT; Tang DX, 2006, CELL CALCIUM, V39, P209, DOI 10.1016/j.ceca.2005.10.010; TUMMINO PJ, 1993, BIOPHYS J, V64, P1580, DOI 10.1016/S0006-3495(93)81528-5; WALSH JP, 1986, J BIOL CHEM, V261, P5062; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	47	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39255	10.1371/journal.pone.0039255	http://dx.doi.org/10.1371/journal.pone.0039255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723977	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700059
J	van der Ham, IJM; Duijndam, MJA; Raemaekers, M; van Wezel, RJA; Oleksiak, A; Postma, A				van der Ham, Ineke J. M.; Duijndam, Maarten J. A.; Raemaekers, Mathijs; van Wezel, Richard J. A.; Oleksiak, Anna; Postma, Albert			Retinotopic Mapping of Categorical and Coordinate Spatial Relation Processing in Early Visual Cortex	PLOS ONE			English	Article							RECEPTIVE-FIELD SIZE; HEMISPHERIC-SPECIALIZATION; CEREBRAL HEMISPHERES; WORKING-MEMORY; ATTENTION; FMRI; REPRESENTATIONS; LATERALIZATION; REHEARSAL; BRAIN	Spatial relations are commonly divided in two global classes. Categorical relations concern abstract relations which define areas of spatial equivalence, whereas coordinate relations are metric and concern exact distances. Categorical and coordinate relation processing are thought to rely on at least partially separate neurocognitive mechanisms, as reflected by differential lateralization patterns, in particular in the parietal cortex. In this study we address this textbook principle from a new angle. We studied retinotopic activation in early visual cortex, as a reflection of attentional distribution, in a spatial working memory task with either a categorical or a coordinate instruction. Participants were asked to memorize a dot position, with regard to a central cross, and to indicate whether a subsequent dot position matched the first dot position, either categorically (opposite quadrant of the cross) or coordinately (same distance to the centre of the cross). BOLD responses across the retinotopic maps of V1, V2, and V3 indicate that the spatial distribution of cortical activity was different for categorical and coordinate instructions throughout the retention interval; a more local focus was found during categorical processing, whereas focus was more global for coordinate processing. This effect was strongest for V3, approached significance in V2 and was absent in V1. Furthermore, during stimulus presentation the two instructions led to different levels of activation in V3 during stimulus encoding; a stronger increase in activity was found for categorical processing. Together this is the first demonstration that instructions for specific types of spatial relations may yield distinct attentional patterns which are already reflected in activity early in the visual cortex.	[van der Ham, Ineke J. M.; Duijndam, Maarten J. A.; van Wezel, Richard J. A.; Oleksiak, Anna; Postma, Albert] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Raemaekers, Mathijs] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands; [van Wezel, Richard J. A.; Oleksiak, Anna] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [van Wezel, Richard J. A.] Univ Twente, Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Wezel, Richard J. A.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Postma, Albert] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; University of Twente; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	van der Ham, IJM (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	c.j.m.vanderham@uu.nl	van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069; van der Ham, Ineke/0000-0003-2520-7422	Netherlands Organisation for Scientific Research (NWO) [051-14-027]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was made possible by a grant of the Netherlands Organisation for Scientific Research (NWO) (Evolution and Behaviour: 051-14-027) (website: www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Awh E, 1995, ANN NY ACAD SCI, V769, P97, DOI 10.1111/j.1749-6632.1995.tb38134.x; Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; Awh E, 1998, ATTENTIVE BRAIN, P353; Baciu M, 1999, NEUROREPORT, V10, P1373, DOI 10.1097/00001756-199904260-00040; Banich MT, 1999, J COGNITIVE NEUROSCI, V11, P153, DOI 10.1162/089892999563292; Borst G, 2010, NEUROPSYCHOLOGIA, V48, P2769, DOI 10.1016/j.neuropsychologia.2010.04.027; Bruyer R, 1997, BRAIN COGNITION, V33, P245, DOI 10.1006/brcg.1997.0867; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; HELLIGE JB, 1989, MEM COGNITION, V17, P770, DOI 10.3758/BF03202638; Ivry RB, 1997, 2 SIDES PERCEPTION; JACOBS RA, 1994, COGNITIVE SCI, V18, P361, DOI 10.1207/s15516709cog1803_1; Jager G, 2003, NEUROPSYCHOLOGIA, V41, P504, DOI 10.1016/S0028-3932(02)00086-6; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; KOSSLYN SM, 1992, J EXP PSYCHOL HUMAN, V18, P562, DOI 10.1037/0096-1523.18.2.562; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Laeng B, 2003, ASYMMETRICAL BRAIN, P303; LAENG B, 1995, NEUROPSYCHOLOGIA, V33, P421, DOI 10.1016/0028-3932(94)00126-A; Laeng B, 2011, COGNITIVE SCI, V35, P297, DOI 10.1111/j.1551-6709.2010.01139.x; Martin R, 2008, NEUROPSYCHOLOGIA, V46, P576, DOI 10.1016/j.neuropsychologia.2007.10.010; Munneke J, 2010, BRAIN COGNITION, V72, P368, DOI 10.1016/j.bandc.2009.11.001; Okubo M, 2010, ACTA PSYCHOL, V135, P1, DOI 10.1016/j.actpsy.2010.04.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ramsey NF, 1998, NEUROIMAGE, V8, P240, DOI 10.1006/nimg.1998.0358; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Slotnick SD, 2001, J COGNITIVE NEUROSCI, V13, P1088, DOI 10.1162/089892901753294383; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Trojano L, 2006, NEUROPSYCHOLOGIA, V44, P1569, DOI 10.1016/j.neuropsychologia.2006.01.017; Van der Ham IJM, 2011, BRAIN COGNITION; van der Ham IJM, 2007, NEUROPSYCHOLOGIA, V45, P2492, DOI 10.1016/j.neuropsychologia.2007.03.021; van der Ham IJM, 2010, MEM COGNITION, V38, P582, DOI 10.3758/MC.38.5.582; van der Ham IJM, 2009, BRAIN RES, V1297, P70, DOI 10.1016/j.brainres.2009.07.088; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; VANGELDEREN P, 1995, P NATL ACAD SCI USA, V92, P6906, DOI 10.1073/pnas.92.15.6906; VANKLEECK MH, 1989, NEUROPSYCHOLOGIA, V27, P1165, DOI 10.1016/0028-3932(89)90099-7	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38644	10.1371/journal.pone.0038644	http://dx.doi.org/10.1371/journal.pone.0038644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723872	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700018
J	Zhang, Y; Endam, LM; Filali-Mouhim, A; Zhao, LP; Desrosiers, M; Han, DM; Zhang, L				Zhang, Yuan; Endam, Leandra Mfuna; Filali-Mouhim, Abdelali; Zhao, Liping; Desrosiers, Martin; Han, Demin; Zhang, Luo			Polymorphisms in RYBP and AOAH Genes Are Associated with Chronic Rhinosinusitis in a Chinese Population: A Replication Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INNATE	Background: The development of CRS is believed to be the result of combined interactions between the genetic background of the affected subject and environmental factors. Objectives: To replicate and extend our recent findings from genetic association studies in chronic rhinosinusitis (CRS) performed in a Canadian Caucasian population in a Chinese population. Methods: In a case-control replication study, DNA samples were obtained from CRS with (n = 306; CRSwNP) and without (n = 332; CRSsNP) nasal polyps, and controls (n = 315) in a Chinese population. A total of forty-nine single nucleotide polymorphisms (SNPs) selected from previous identified SNPs associated with CRS in Canadian population, and SNPs from the CHB HapMap dataset were individually genotyped. Results: We identified two SNPs respectively in RYBP (rs4532099, p = 2.15E-06, OR = 2.59) and AOAH (rs4504543, p = 0.0001152, OR = 0.58) significantly associated with whole CRS cohort. Subgroup analysis for the presence of nasal polyps (CRSwNP and CRSsNP) displayed significant association in CRSwNP cohorts regarding to one SNP in RYBP (P = 3.24(E)-006, OR = 2.76). Evidence of association in the CRSsNP groups in terms of 2 SNPs (AOAH_rs4504543 and RYBP_rs4532099) was detected as well. Stratifying analysis by gender demonstrated that none of the selected SNPs were associated with CRSwNP as well as CRSsNP. Meanwhile 3 SNPs (IL1A_rs17561, P = 0.005778; IL1A_rs1800587, P = 0.009561; IRAK4_rs4251513, P = 0.03837) were associated with serum total IgE level. Conclusions: These genes are biologically plausible, with roles in regulation of transcription (RYBP) and inflammatory response (AOAH). The present data suggests the potential common genetic basis in the development of CRS in Chinese and Caucasian population.	[Zhang, Yuan; Han, Demin; Zhang, Luo] Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing TongRen Hosp, Beijing, Peoples R China; [Zhang, Yuan; Zhao, Liping; Han, Demin; Zhang, Luo] Beijing Inst Otolaryngol, Key Lab Otolaryngol Head & Neck Surg, Minist Educ China, Beijing, Peoples R China; [Endam, Leandra Mfuna; Filali-Mouhim, Abdelali; Desrosiers, Martin] CRCHUM, Dept Otolaryngol, Montreal, PQ, Canada; [Desrosiers, Martin] McGill Univ, Montreal Gen Hosp, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H3G 1A4, Canada	Capital Medical University; Ministry of Education, China; Universite de Montreal; McGill University	Zhang, Y (corresponding author), Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing TongRen Hosp, Beijing, Peoples R China.	desrosiers_martin@hotmail.com; handm@trhos.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	National Science Fund for Distinguished Young Scholars [81025007]; National Natural Science Foundation of China [30973282, 81100706]; Beijing Natural Science Foundation [7102030]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]; Beijing Nova Program [2010B022]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Special Fund of Sanitation Elite Reconstruction of Beijing; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (81025007), the National Natural Science Foundation of China (30973282 and 81100706), the Beijing Natural Science Foundation (7102030), the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007), and Beijing Nova Program (2010B022) to LZ and YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barnes KC, 2006, J ALLERGY CLIN IMMUN, V118, P70, DOI 10.1016/j.jaci.2006.03.036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Castano R, 2010, OTOLARYNG HEAD NECK, V142, P665, DOI 10.1016/j.otohns.2010.01.004; Castano R, 2009, AMJ RHINOL ALLERGY, V23, P377, DOI 10.2500/ajra.2009.23.3303; Cormier C, 2009, J OTOLARYNGOL-HEAD N, V38, P133, DOI 10.2310/7070.2008.OA0220; Divoy C, 2011, J ALLERGY CLIN IMMUN, V127, pAB2, DOI 10.1016/j.jaci.2011.01.009; Endam LM, 2010, ARCH OTOLARYNGOL, V136, P187, DOI 10.1001/archoto.2009.219; Endam LM, 2009, OTOLARYNG HEAD NECK, V140, P741, DOI 10.1016/j.otohns.2008.12.058; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Kilty SJ, 2010, AM J RHINOL ALLERGY, V24, pE4, DOI 10.2500/ajra.2010.24.3429; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Lee L, 2008, MOL CELL BIOL, V28, P949, DOI 10.1128/MCB.00354-07; Lu MF, 2008, CELL HOST MICROBE, V4, P293, DOI 10.1016/j.chom.2008.06.009; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mfuna-Endam L, 2011, CURR ALLERGY ASTHM R, V11, P236, DOI 10.1007/s11882-011-0189-4; Nader ME, 2010, J OTOLARYNGOL-HEAD N, V39, P69, DOI 10.2310/7070.2009.080223; Ojogun N, 2009, J INFECT DIS, V200, P1685, DOI 10.1086/646616; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; Suzuki N, 2006, TRENDS IMMUNOL, V27, P566, DOI 10.1016/j.it.2006.10.003; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tewfik MA, 2009, ALLERGY, V64, P746, DOI 10.1111/j.1398-9995.2008.01889.x; Tewfik MA, 2010, J OTOLARYNGOL-HEAD N, V39, P62, DOI 10.2310/7070.2009.090009; Tournas A, 2010, J OTOLARYNGOL-HEAD N, V39, P188, DOI 10.2310/7070.2009.090080; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021769; Zhang Y, 2011, AM J RHINOL ALLERGY, V25, pE49, DOI 10.2500/ajra.2011.25.3588	29	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39247	10.1371/journal.pone.0039247	http://dx.doi.org/10.1371/journal.pone.0039247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723975	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700058
J	Caut, S; Angulo, E; Pisanu, B; Ruffino, L; Faulquier, L; Lorvelec, O; Chapuis, JL; Pascal, M; Vidal, E; Courchamp, F				Caut, Stephane; Angulo, Elena; Pisanu, Benoit; Ruffino, Lise; Faulquier, Lucie; Lorvelec, Olivier; Chapuis, Jean-Louis; Pascal, Michel; Vidal, Eric; Courchamp, Franck			Seabird Modulations of Isotopic Nitrogen on Islands	PLOS ONE			English	Article							FOOD WEBS; TERRESTRIAL ECOSYSTEMS; MEDITERRANEAN ISLANDS; INTRODUCED PREDATORS; ALLOCHTHONOUS INPUT; SPECIES RICHNESS; MARINE SUBSIDIES; STABLE-ISOTOPES; PENGUIN ROOKERY; SEA-TURTLES	The transport of nutrients by migratory animals across ecosystem boundaries can significantly enrich recipient food webs, thereby shaping the ecosystems' structure and function. To illustrate the potential role of islands in enabling the transfer of matter across ecosystem boundaries to be gauged, we investigated the influence of seabirds on nitrogen input on islands. Basing our study on four widely differing islands in terms of their biogeography and ecological characteristics, sampled at different spatial and temporal intervals, we analyzed the nitrogen isotopic values of the main terrestrial ecosystem compartments (vascular plants, arthropods, lizards and rodents) and their relationship to seabird values. For each island, the isotopic values of the ecosystem were driven by those of seabirds, which ultimately corresponded to changes in their marine prey. First, terrestrial compartments sampled within seabird colonies were the most enriched in delta N-15 compared with those collected at various distances outside colonies. Second, isotopic values of the whole terrestrial ecosystems changed over time, reflecting the values of seabirds and their prey, showing a fast turnover throughout the ecosystems. Our results demonstrate that seabird-derived nutrients not only spread across the terrestrial ecosystems and trophic webs, but also modulate their isotopic values locally and temporally on these islands. The wealth of experimental possibilities in insular ecosystems justifies greater use of these model systems to further our understanding of the modalities of trans-boundary nutrient transfers.	[Caut, Stephane; Angulo, Elena] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Pisanu, Benoit; Chapuis, Jean-Louis] Museum Natl Hist Nat, Dept EGB, F-75231 Paris, France; [Ruffino, Lise] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Faulquier, Lucie] Soc Ornithol Polynesie, Tahiti, Polynesie, France; [Lorvelec, Olivier; Pascal, Michel] INRA, Batiment, France; [Lorvelec, Olivier; Pascal, Michel] Agrocampus Ouest Ecol & Sante Ecosyst, Batiment, France; [Vidal, Eric] Aix Marseille Univ, IMBE, Ctr IRD Noumea, Noumea, New Caledonia; [Courchamp, Franck] Univ Paris, Lab ESE, F-75252 Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Museum National d'Histoire Naturelle (MNHN); University of Turku; INRAE; Institut Agro; Agrocampus Ouest; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; AgroParisTech; UDICE-French Research Universities; Universite Paris Cite	Caut, S (corresponding author), CSIC, Estn Biol Donana, Avda Americo Vespucio, E-41080 Seville, Spain.	stephanecaut@gmail.com	Angulo, Elena/A-8107-2013; Courchamp, Franck/ABE-7204-2020	Angulo, Elena/0000-0001-5545-4032; Courchamp, Franck/0000-0001-7605-4548	French Navy in New Caledonia; OPT Noumea; IFB; INSU (ACI ECCO-PNBC); Agence Nationale de la Recherche (ALIENS); Government of New Caledonia; Te manu Association; Hua Uka Town Hall; Conseil Regional PACA; The French Polar Institute (IPEV, program 136); Spanish Ministry of Science and Innovation; Consejo Superior de Investigaciones Cientificas	French Navy in New Caledonia; OPT Noumea; IFB; INSU (ACI ECCO-PNBC); Agence Nationale de la Recherche (ALIENS)(French National Research Agency (ANR)); Government of New Caledonia; Te manu Association; Hua Uka Town Hall; Conseil Regional PACA(Region Provence-Alpes-Cote d'Azur); The French Polar Institute (IPEV, program 136); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas	This study was made possible thanks to logistical support from the French Navy in New Caledonia and from OPT Noumea, authorities from Port-Cros National Park and to financial support from IFB, INSU (ACI ECCO-PNBC), Agence Nationale de la Recherche (ALIENS), the Government of New Caledonia, Te manu Association, Hua Uka Town Hall, Conseil Regional PACA, The French Polar Institute (IPEV, program 136), the Spanish Ministry of Science and Innovation (Juan de la Cierva contract to EA) and Consejo Superior de Investigaciones Cientificas (JAE postdoctoral contract to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Anderson WB, 2008, ECOLOGY, V89, P660, DOI 10.1890/07-0234.1; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Beerling DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1821, DOI 10.1098/rspb.1999.0852; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; Brooks ML, 2003, J APPL ECOL, V40, P344, DOI 10.1046/j.1365-2664.2003.00789.x; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Caut S, 2009, BIOL INVASIONS, V11, P1689, DOI 10.1007/s10530-008-9397-9; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; Farina JM, 2003, J ANIM ECOL, V72, P873, DOI 10.1046/j.1365-2656.2003.00760.x; Finney SK, 2003, J APPL ECOL, V40, P545, DOI 10.1046/j.1365-2664.2003.00810.x; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Hannan LB, 2007, ECOLOGY, V88, P1053, DOI 10.1890/06-0629; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Kolb GS, 2011, SEABIRD ISLANDS ECOL; LINDEBOOM HJ, 1984, ECOLOGY, V65, P269, DOI 10.2307/1939479; Markwell TJ, 2002, ECOSCIENCE, V9, P293, DOI 10.1080/11956860.2002.11682715; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; MIZUTANI H, 1988, ECOLOGY, V69, P340, DOI 10.2307/1940432; MIZUTANI H, 1985, GEOCHEM J, V19, P323, DOI 10.2343/geochemj.19.323; Mulder CPH, 2009, BIOL INVASIONS, V11, P1671, DOI 10.1007/s10530-008-9396-x; Mulder CPH, 2011, SEABIRD ISLANDS ECOL; Orgeas J, 2003, ECOSCIENCE, V10, P38; Pascal M, 2009, TE MANU, V65, P6; Pisanu B, 2011, POLAR BIOL, V34, P169, DOI 10.1007/s00300-010-0867-z; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POWELL GVN, 1991, ESTUAR COAST SHELF S, V32, P567, DOI 10.1016/0272-7714(91)90075-M; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Ruffino L, 2011, POPUL ECOL, V53, P535, DOI 10.1007/s10144-011-0265-6; Sanchez-Pinero F, 2000, ECOLOGY, V81, P3117, DOI 10.1890/0012-9658(2000)081[3117:BUDOAI]2.0.CO;2; SAS Institute Inc, 2004, SAS 9 1 3 HELP DOC; Schmidt S, 2004, FUNCT PLANT BIOL, V31, P517, DOI 10.1071/FP04024; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Stapp P, 2003, OIKOS, V102, P111, DOI 10.1034/j.1600-0706.2003.12445.x; Sun LG, 2000, NATURE, V407, P858, DOI 10.1038/35038163; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Vidal E, 1998, BIOL CONSERV, V84, P235, DOI 10.1016/S0006-3207(97)00130-4; Vidal E, 2000, OECOLOGIA, V122, P427, DOI 10.1007/s004420050049; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Wardle DA, 2007, BIOL LETTERS, V3, P479, DOI 10.1098/rsbl.2007.0163; WHITTAKER R, 1961, ECOL MONOGR, V31, P157, DOI 10.2307/1950753; WOOTTON JT, 1991, J EXP MAR BIOL ECOL, V151, P139, DOI 10.1016/0022-0981(91)90121-C	52	41	41	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39125	10.1371/journal.pone.0039125	http://dx.doi.org/10.1371/journal.pone.0039125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723945	Green Published, gold			2022-12-27	WOS:000305583300098
J	Choorapoikayil, S; Willems, B; Strohle, P; Gajewski, M				Choorapoikayil, Suma; Willems, Bernd; Stroehle, Peter; Gajewski, Martin			Analysis of her1 and her7 Mutants Reveals a Spatio Temporal Separation of the Somite Clock Module	PLOS ONE			English	Article							PRESOMITIC MESODERM; ZEBRAFISH SOMITOGENESIS; SEGMENTATION CLOCK; GENE-EXPRESSION; ANTERIOR; OSCILLATOR; BOUNDARIES; DIFFERENTIATION; HAIRY/ENHANCER; REPRESSION	Somitogenesis is controlled by a genetic network consisting of an oscillator (clock) and a gradient (wavefront). The "hairy and Enhancer of Split''- related (her) genes act downstream of the Delta/Notch (D/N) signaling pathway, and are crucial components of the segmentation clock. Due to genome duplication events, the zebrafish genome, possesses two gene copies of the mouse Hes7 homologue: her1 and her7. To better understand the functional consequences of this gene duplication, and to determine possible independent roles for these two genes during segmentation, two zebrafish mutants her1(hu2124) and her7(hu2526) were analyzed. In the course of embryonic development, her1(hu2124) mutants exhibit disruption of the three anterior-most somite borders, whereas her7(hu2526) mutants display somite border defects restricted to somites 8 (+/-3) to 17 (+/-3) along the anterior-posterior axis. Analysis of the molecular defects in her1(hu2124) mutants reveals a her1 auto regulatory feedback loop during early somitogenesis that is crucial for correct patterning and independent of her7 oscillation. This feedback loop appears to be restricted to early segmentation, as cyclic her1 expression is restored in her1(hu2124) embryos at later stages of development. Moreover, only the anterior deltaC expression pattern is disrupted in the presomitic mesoderm of her1(hu2124) mutants, while the posterior expression pattern of deltaC remains unaltered. Together, this data indicates the existence of an independent and genetically separable anterior and posterior deltaC clock modules in the presomitic mesdorm (PSM).	[Choorapoikayil, Suma; Stroehle, Peter; Gajewski, Martin] Univ Cologne, Inst Genet, Cologne, Germany; [Willems, Bernd] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Willems, Bernd] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore	University of Cologne; National University of Singapore; National University of Singapore	Choorapoikayil, S (corresponding author), Hubrecht Inst, Utrecht, Netherlands.	S.Choorapoikayil@hubrecht.eu			Deutsche Forschungsgemeinschaft Sonderforschungsbereich [572]	Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; AOYAMA H, 1988, DEVELOPMENT, V104, P15; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Gajewski M, 2003, DEVELOPMENT, V130, P4269, DOI 10.1242/dev.00627; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kawamura A, 2005, DEV CELL, V9, P735, DOI 10.1016/j.devcel.2005.09.021; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leve C, 2001, DEV GENES EVOL, V211, P493, DOI 10.1007/s00427-001-0181-4; Maul RS, 2001, GENE, V262, P155, DOI 10.1016/S0378-1119(00)00540-0; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sieger D, 2003, MECH DEVELOP, V120, P1083, DOI 10.1016/S0925-4773(03)00154-0; STERN CD, 1987, DEVELOPMENT, V99, P261; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Takke C, 1999, DEVELOPMENT, V126, P3005; Weinberg ES, 1996, DEVELOPMENT, V122, P271	28	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39073	10.1371/journal.pone.0039073	http://dx.doi.org/10.1371/journal.pone.0039073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723933	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300091
J	Larssen, BC; Ong, NT; Hodges, NJ				Larssen, Beverley C.; Ong, Nicole T.; Hodges, Nicola J.			Watch and Learn: Seeing Is Better than Doing when Acquiring Consecutive Motor Tasks	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION; INTERNAL-MODEL; SPATIAL ALIGNMENT; PHYSICAL PRACTICE; WORKING-MEMORY; ABSENCE; INTERFERENCE; COORDINATION; IMAGERY; CORTEX	During motor adaptation learning, consecutive physical practice of two different tasks compromises the retention of the first. However, there is evidence that observational practice, while still effectively aiding acquisition, will not lead to interference and hence prove to be a better practice method. Observers and Actors practised in a clockwise (Task A) followed by a counterclockwise (Task B) visually rotated environment, and retention was immediately assessed. An Observe-all and Act-all group were compared to two groups who both physically practised Task A, but then only observed (ObsB) or did not see or practice Task B (NoB). The two observer groups and the NoB control group better retained Task A than Actors, although importantly only the observer groups learnt Task B. RT data and explicit awareness of the rotation suggested that the observers had acquired their respective tasks in a more strategic manner than Actor and Control groups. We conclude that observational practice benefits learning of multiple tasks more than physical practice due to the lack of updating of implicit, internal models for aiming in the former.	[Larssen, Beverley C.; Ong, Nicole T.; Hodges, Nicola J.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Larssen, BC (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada.	nicola.hodges@ubc.ca	Hodges, Nicola/AAA-8288-2022; Larssen, Beverley/AAW-8001-2021	Larssen, Beverley/0000-0002-2030-8198	Natural Sciences and Engineering Research Council of Canada (NSERC) [15R82559]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Discovery grant operating funds awarded to the corresponding author (Hodges) from The Natural Sciences and Engineering Research Council of Canada (NSERC, # 15R82559; http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Bernier PM, 2006, NEUROREPORT, V17, P1421, DOI 10.1097/01.wnr.0000233096.13032.34; Bird G, 2005, J EXP PSYCHOL HUMAN, V31, P262, DOI 10.1037/0096-1523.31.2.262; Brown LE, 2009, J COGNITIVE NEUROSCI, V21, P1013, DOI 10.1162/jocn.2009.21079; Buchanan JJ, 2008, EXP BRAIN RES, V191, P157, DOI 10.1007/s00221-008-1512-8; Cross ES, 2011, CEREB CORTEX, V19, P315; Fernandez-Ruiz J, 2011, BEHAV BRAIN RES, V219, P8, DOI 10.1016/j.bbr.2010.11.060; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gruetzmacher N, 2011, Q J EXP PSYCHOL, V64, P1111, DOI 10.1080/17470218.2010.543286; Hinder MR, 2007, EXP BRAIN RES, V180, P629, DOI 10.1007/s00221-007-0888-1; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; Hodges NJ, 2007, J SPORT SCI, V25, P531, DOI 10.1080/02640410600946860; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Maslovat D., 2010, VISION GOAL DIRECTED, P315, DOI DOI 10.5040/9781492597322.CH-017; Maslovat D, 2010, EXP BRAIN RES, V204, P119, DOI 10.1007/s00221-010-2302-7; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McCullagh P., 2001, HDB SPORT PSYCHOL, V2nd ed., P205; Melendez-Calderon A, 2011, IEEE T NEUR SYS REH, V19, P298, DOI 10.1109/TNSRE.2011.2125990; Ong NT, 2012, EXP BRAIN RES, V218, P9, DOI 10.1007/s00221-011-2996-1; Ong NT, 2010, EXP BRAIN RES, V205, P325, DOI 10.1007/s00221-010-2366-4; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1993, J MOTOR BEHAV, V25, P75, DOI 10.1080/00222895.1993.9941642; Redding GM, 2002, J MOTOR BEHAV, V34, P126, DOI 10.1080/00222890209601935; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Trempe M, 2011, EXP BRAIN RES, V209, P181, DOI 10.1007/s00221-011-2540-3; Wang JS, 2011, J NEUROPHYSIOL, V106, P259, DOI 10.1152/jn.00254.2011; Weeks DL, 2000, ACTA PSYCHOL, V104, P259, DOI 10.1016/S0001-6918(00)00039-1; Wigmore V, 2002, J EXP PSYCHOL HUMAN, V28, P447, DOI 10.1037//0096-1523.28.2.447; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	40	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38938	10.1371/journal.pone.0038938	http://dx.doi.org/10.1371/journal.pone.0038938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22723909	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300069
J	Lu, CL; Chin, B; Lewandowski, JL; Basinga, P; Hirschhorn, LR; Hill, K; Murray, M; Binagwaho, A				Lu, Chunling; Chin, Brian; Lewandowski, Jiwon Lee; Basinga, Paulin; Hirschhorn, Lisa R.; Hill, Kenneth; Murray, Megan; Binagwaho, Agnes			Towards Universal Health Coverage: An Evaluation of Rwanda Mutuelles in Its First Eight Years	PLOS ONE			English	Article							OUT-OF-POCKET; CARE; INSURANCE; PAYMENTS; SERVICES; IMPACT	Background: Mutuelles is a community-based health insurance program, established since 1999 by the Government of Rwanda as a key component of the national health strategy on providing universal health care. The objective of the study was to evaluate the impact of Mutuelles on achieving universal coverage of medical services and financial risk protection in its first eight years of implementation. Methods and Findings: We conducted a quantitative impact evaluation of Mutuelles between 2000 and 2008 using nationally-representative surveys. At the national and provincial levels, we traced the evolution of Mutuelles coverage and its impact on child and maternal care coverage from 2000 to 2008, as well as household catastrophic health payments from 2000 to 2006. At the individual level, we investigated the impact of Mutuelles' coverage on enrollees' medical care utilization using logistic regression. We focused on three target populations: the general population, under-five children, and women with delivery. At the household level, we used logistic regression to study the relationship between Mutuelles coverage and the probability of incurring catastrophic health spending. The main limitation was that due to insufficient data, we are not able to study the impact of Mutuelles on health outcomes, such as child and maternal mortalities, directly. The findings show that Mutuelles improved medical care utilization and protected households from catastrophic health spending. Among Mutuelles enrollees, those in the poorest expenditure quintile had a significantly lower rate of utilization and higher rate of catastrophic health spending. The findings are robust to various estimation methods and datasets. Conclusions: Rwanda's experience suggests that community-based health insurance schemes can be effective tools for achieving universal health coverage even in the poorest settings. We suggest a future study on how eliminating Mutuelles copayments for the poorest will improve their healthcare utilization, lower their catastrophic health spending, and affect the finances of health care providers.	[Lu, Chunling; Lewandowski, Jiwon Lee; Hirschhorn, Lisa R.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Chin, Brian] Asian Dev Bank, S Asia Dept, Manila, Philippines; [Basinga, Paulin] Natl Univ Rwanda, Sch Publ Hlth, Dept Community Hlth, Kigali, Rwanda; [Hill, Kenneth] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Binagwaho, Agnes] Govt Rwanda, Minist Hlth, Kigali, Rwanda	Harvard University; Harvard Medical School; Asian Development Bank; University of Rwanda; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Lu, CL (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	Chunling_Lu@hms.harvard.edu		Chin, Brian/0000-0002-1789-0359; Hirschhorn, Lisa/0000-0002-4355-7437	Doris Duke Charitable Foundation (DDCF) [2009057]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD071929] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation (DDCF)(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported partially by funding from the Doris Duke Charitable Foundation (DDCF), grant number 2009057. More information about DDCF can be found at the following website: http://www.ddcf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antunes A, 2009, HLTH FINANCING SYSTE; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Chankova S, 2008, HEALTH POLICY PLANN, V23, P264, DOI 10.1093/heapol/czn011; Galarraga O, 2010, EUR J HEALTH ECON, V11, P437, DOI 10.1007/s10198-009-0180-3; Gnawali DP, 2009, HEALTH POLICY, V90, P214, DOI 10.1016/j.healthpol.2008.09.015; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; HIMMELSTEIN DU, 2005, HEALTH AFFAIR, V24, P63, DOI DOI 10.1377/HLTHAFF.W5.63; IRIN Africa, 2010, RWANDA MAT CHILD HLT; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Lu CL, 2012, CONTEMP ECON POLICY, V30, P93, DOI 10.1111/j.1465-7287.2011.00252.x; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Rwanda Ministry of Health, 2010, RWAND NAT HLTH INS P; Saksena P, 2011, HEALTH POLICY, V99, P203, DOI 10.1016/j.healthpol.2010.09.009; Schneider P, 2006, HEALTH ECON, V15, P19, DOI 10.1002/hec.1014; Schneider P, 2005, HLTH FINANCING POOR; Sekabaraga C, 2011, HEALTH POLICY PLANN, V26, pII52, DOI 10.1093/heapol/czr070; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Twahirwa A, 2008, B WORLD HEALTH ORGAN, V86, P823, DOI 10.2471/BLT.08.021108; United Nations, 2010, MILL DEV GOALS REP 2; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2007, J HEALTH ECON, V26, P505, DOI 10.1016/j.jhealeco.2006.10.006; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank and Ministry of Health, 2009, RWAND COUNTR STAT RE; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	31	107	110	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39282	10.1371/journal.pone.0039282	http://dx.doi.org/10.1371/journal.pone.0039282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22723985	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300126
J	Miller, MA; Feng, XJ; Li, GY; Rabitz, HA				Miller, Miles A.; Feng, Xiao-Jiang; Li, Genyuan; Rabitz, Herschel A.			Identifying Biological Network Structure, Predicting Network Behavior, and Classifying Network State With High Dimensional Model Representation (HDMR)	PLOS ONE			English	Article							PROTEIN-SIGNALING NETWORKS; KINASE-B; BETA-GAMMA; RS-HDMR; ACTIVATION; EXPRESSION; PHOSPHORYLATION; RECEPTOR; INFERENCE; DYNAMICS	This work presents an adapted Random Sampling - High Dimensional Model Representation (RS-HDMR) algorithm for synergistically addressing three key problems in network biology: (1) identifying the structure of biological networks from multivariate data, (2) predicting network response under previously unsampled conditions, and (3) inferring experimental perturbations based on the observed network state. RS-HDMR is a multivariate regression method that decomposes network interactions into a hierarchy of non-linear component functions. Sensitivity analysis based on these functions provides a clear physical and statistical interpretation of the underlying network structure. The advantages of RS-HDMR include efficient extraction of nonlinear and cooperative network relationships without resorting to discretization, prediction of network behavior without mechanistic modeling, robustness to data noise, and favorable scalability of the sampling requirement with respect to network size. As a proof-of-principle study, RS-HDMR was applied to experimental data measuring the single-cell response of a protein-protein signaling network to various experimental perturbations. A comparison to network structure identified in the literature and through other inference methods, including Bayesian and mutual-information based algorithms, suggests that RS-HDMR can successfully reveal a network structure with a low false positive rate while still capturing non-linear and cooperative interactions. RS-HDMR identified several higher-order network interactions that correspond to known feedback regulations among multiple network species and that were unidentified by other network inference methods. Furthermore, RS-HDMR has a better ability to predict network response under unsampled conditions in this application than the best statistical inference algorithm presented in the recent DREAM3 signaling-prediction competition. RS-HDMR can discern and predict differences in network state that arise from sources ranging from intrinsic cell-cell variability to altered experimental conditions, such as when drug perturbations are introduced. This ability ultimately allows RS-HDMR to accurately classify the experimental conditions of a given sample based on its observed network state.	[Miller, Miles A.; Feng, Xiao-Jiang; Li, Genyuan; Rabitz, Herschel A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Miller, Miles A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Princeton University; Massachusetts Institute of Technology (MIT)	Miller, MA (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	hrabitz@princeton.edu		Miller, Miles/0000-0001-7638-8898	NSF (National Science Foundation); AFOSR (Air Force Office of Scientific Research); EPA-ebCTC (Environmental Protection Agency - environmental bioinformatics and Computational Toxicology Center)	NSF (National Science Foundation)(National Science Foundation (NSF)); AFOSR (Air Force Office of Scientific Research)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); EPA-ebCTC (Environmental Protection Agency - environmental bioinformatics and Computational Toxicology Center)	The authors acknowledge the NSF (National Science Foundation), the AFOSR (Air Force Office of Scientific Research), and the EPA-ebCTC (Environmental Protection Agency - environmental bioinformatics and Computational Toxicology Center) for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; Alis OF, 2001, J MATH CHEM, V29, P127, DOI 10.1023/A:1010979129659; Ambrosini A, 2000, MOL BRAIN RES, V75, P54, DOI 10.1016/S0169-328X(99)00294-6; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bogdan M, 2004, GENETICS, V167, P989, DOI 10.1534/genetics.103.021683; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BROWN KD, 1984, BIOCHEM BIOPH RES CO, V123, P377, DOI 10.1016/0006-291X(84)90424-8; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; Chatterjee S, 1977, REGRESSION ANAL EXAM; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; D'haeseleer P, 1999, Pac Symp Biocomput, P41; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Deutsch F, 2001, BEST APPROXIMATION I; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fortino V, 2002, CELL MOL LIFE SCI, V59, P2165, DOI 10.1007/s000180200015; Frenkel-Morgenstern M, 2010, NUCLEIC ACIDS RES, V38, pD508, DOI 10.1093/nar/gkp808; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1998, P UAI; Fukuda R, 2003, CANCER RES, V63, P2330; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Greco S, 2006, J ENDOCRINOL, V188, P79, DOI 10.1677/joe.1.06433; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Gringhuis SI, 1997, J BIOL CHEM, V272, P31809, DOI 10.1074/jbc.272.50.31809; Guex N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008012; Honaker J, 2011, J STAT SOFTWARE; Imoto S, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P219, DOI 10.1109/CSB.2002.1039344; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Li G, 2010, J POLYM RES     1022, P1; Li G.Q., 2011, J MATH CHEM, P1; Li GY, 2010, J PHYS CHEM A, V114, P6022, DOI 10.1021/jp9096919; Li GY, 2006, J PHYS CHEM A, V110, P2474, DOI 10.1021/jp054148m; Li GY, 2003, J COMPUT CHEM, V24, P647, DOI 10.1002/jcc.10232; Li GY, 2003, J COMPUT CHEM, V24, P277, DOI 10.1002/jcc.10172; Li GY, 2001, J PHYS CHEM A, V105, P7765, DOI 10.1021/jp010450t; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller MA, 2011, INTEGR BIOL-UK, V3, P422, DOI 10.1039/c0ib00083c; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Neapolitan R.E., 2003, LEARNING BAYESIAN NE; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rabitz H, 1999, COMPUT PHYS COMMUN, V117, P11, DOI 10.1016/S0010-4655(98)00152-0; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shim K, 1998, PHYS REV B, V58, P1940, DOI 10.1103/PhysRevB.58.1940; Shorter JA, 1999, J PHYS CHEM A, V103, P7192, DOI 10.1021/jp9843398; Srividhya J, 2007, PROTEOMICS, V7, P828, DOI 10.1002/pmic.200600428; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; van Someren EP, 2006, BIOINFORMATICS, V22, P477, DOI 10.1093/bioinformatics/bti816; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Wang K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P264; Wang SW, 2003, J PHYS CHEM A, V107, P4707, DOI 10.1021/jp022500f; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zheng M, 2000, J BIOL CHEM, V275, P40635, DOI 10.1074/jbc.M006325200	77	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37664	10.1371/journal.pone.0037664	http://dx.doi.org/10.1371/journal.pone.0037664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723838	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300010
J	Vicentino, ARR; Carneiro, VC; Amarante, AD; Benjamim, CF; de Aguiar, AP; Fantappie, MR				Revoredo Vicentino, Amanda Roberta; Carneiro, Vitor Coutinho; Amarante, Anderson de Mendonca; Benjamim, Claudia Farias; de Aguiar, Alcino Palermo; Fantappie, Marcelo Rosado			Evaluation of 3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole as a Novel Anti-Inflammatory Drug Candidate	PLOS ONE			English	Article							INFLAMMATION; HMGB1; INHIBITORS; KINASES	Background: 3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole (DIC) is a five-membered heterocyclic compound containing a N-O bond. The anti-inflammatory effects of this compound were studied both in vitro and in vivo. Principal Findings: DIC effectively decreased TNF-alpha and IL-6 release from LPS-stimulated macrophages in a dose dependent manner. DIC diminished the levels of COX-2 with subsequent inhibition of PGE(2) production. DIC also compromised HMGB1 translocation from the nucleus to the cytoplasm. Moreover, DIC prevented the nuclear translocation of NF-kappa B and inhibited the MAPK pathway. In vivo, DIC inhibited migration of neutrophils to the peritoneal cavity of mice. Conclusions: This study presents the potential utilization of a synthetic compound, as a lead for the development of novel anti-inflammatory drugs.	[Revoredo Vicentino, Amanda Roberta; Carneiro, Vitor Coutinho; Amarante, Anderson de Mendonca; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, CCS,Ilha Fundao, Rio De Janeiro, Brazil; [Benjamim, Claudia Farias] Univ Fed Rio de Janeiro, Dept Farmacol, Inst Ciencias Biomed, CCS,Ilha Fundao, Rio De Janeiro, Brazil; [de Aguiar, Alcino Palermo] Inst Mil Engn, Dept Quim, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Militar de Engenharia (IME)	Vicentino, ARR (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, CCS,Ilha Fundao, Rio De Janeiro, Brazil.	fantappie@bioqmed.ufrj.br	, Alcino/AAG-1283-2020; de Aguiar, Alcino P/H-4405-2017; Benjamim, Claudia/T-5090-2019	, Alcino/0000-0002-0559-1546; de Aguiar, Alcino P/0000-0002-0559-1546; Benjamim, Claudia/0000-0001-6247-9596; Carneiro, Vitor/0000-0003-1518-7667	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahirwar MK, 2010, ASIAN J CHEM, V22, P7493; Amir M, 2010, MED CHEM RES, V19, P299, DOI 10.1007/s00044-009-9194-8; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; CHRISTL M, 1973, CHEM BER-RECL, V106, P3345, DOI 10.1002/cber.19731061019; Cirillo Pier F., 2002, Current Topics in Medicinal Chemistry, V2, P1021, DOI 10.2174/1568026023393390; Dravyakar BR, 2008, INDIAN J CHEM B, V47, P1559; El Gazzar M, 2007, INFLAMM RES, V56, P162, DOI 10.1007/s00011-006-6112-0; Gallagher TF, 1997, BIOORGAN MED CHEM, V5, P49, DOI 10.1016/S0968-0896(96)00212-X; Habeeb AG, 2001, J MED CHEM, V44, P2921, DOI 10.1021/jm0101287; Holden NS, 2011, J PHARMACOL TOX MET, V63, P7, DOI 10.1016/j.vascn.2010.03.002; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kamal A, 2011, EUR J MED CHEM, V46, P691, DOI 10.1016/j.ejmech.2010.12.004; Kim JY, 2009, FOOD CHEM TOXICOL, V47, P1610, DOI 10.1016/j.fct.2009.04.009; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Laufer SA, 2006, CHEMMEDCHEM, V1, P197, DOI 10.1002/cmdc.200500025; Ozoe Y, 2009, ABSTR PAP AM CHEM S, V238, P380; Ozoe Y, 2010, BIOCHEM BIOPH RES CO, V391, P744, DOI 10.1016/j.bbrc.2009.11.131; Penzo M, 2010, J IMMUNOL, V184, P4497, DOI 10.4049/jimmunol.0903131; Rakesh, 2009, EUR J MED CHEM, V44, P460, DOI 10.1016/j.ejmech.2008.04.007; Rodrigues RD, 2001, SYNTHETIC COMMUN, V31, P3075, DOI 10.1081/SCC-100105879; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Shahnaz G, 2010, J CONTROL RELEASE, V144, P32, DOI 10.1016/j.jconrel.2010.01.033; Sridhara AM, 2011, J BRAZIL CHEM SOC, V22, P849, DOI 10.1590/S0103-50532011000500006; Stojanovic I, 2007, CLIN IMMUNOL, V123, P311, DOI 10.1016/j.clim.2007.03.004; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wagner G, 2006, MED RES REV, V26, P1, DOI 10.1002/med.20042; Wan H, 2009, J LEUKOCYTE BIOL, V86, P361, DOI 10.1189/jlb.0208126; Xu WM, 2005, J COMB CHEM, V7, P726, DOI 10.1021/cc050044+; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019	31	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39104	10.1371/journal.pone.0039104	http://dx.doi.org/10.1371/journal.pone.0039104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723938	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300093
J	Violante, IR; Ribeiro, MJ; Cunha, G; Bernardino, I; Duarte, JV; Ramos, F; Saraiva, J; Silva, E; Castelo-Branco, M				Violante, Ines R.; Ribeiro, Maria J.; Cunha, Gil; Bernardino, Ines; Duarte, Joao V.; Ramos, Fabiana; Saraiva, Jorge; Silva, Eduardo; Castelo-Branco, Miguel			Abnormal Brain Activation in Neurofibromatosis Type 1: A Link between Visual Processing and the Default Mode Network	PLOS ONE			English	Article							PREFRONTAL CORTEX; FMR1 GENE; PATHWAY; SCHIZOPHRENIA; MATURATION; DEACTIVATE; ADVANTAGE; MECHANISM; RESPONSES; CHILDREN	Neurofibromatosis type 1 (NF1) is one of the most common single gene disorders affecting the human nervous system with a high incidence of cognitive deficits, particularly visuospatial. Nevertheless, neurophysiological alterations in low-level visual processing that could be relevant to explain the cognitive phenotype are poorly understood. Here we used functional magnetic resonance imaging (fMRI) to study early cortical visual pathways in children and adults with NF1. We employed two distinct stimulus types differing in contrast and spatial and temporal frequencies to evoke relatively different activation of the magnocellular (M) and parvocellular (P) pathways. Hemodynamic responses were investigated in retinotopically-defined regions V1, V2 and V3 and then over the acquired cortical volume. Relative to matched control subjects, patients with NF1 showed deficient activation of the low-level visual cortex to both stimulus types. Importantly, this finding was observed for children and adults with NF1, indicating that low-level visual processing deficits do not ameliorate with age. Moreover, only during M-biased stimulation patients with NF1 failed to deactivate or even activated anterior and posterior midline regions of the default mode network. The observation that the magnocellular visual pathway is impaired in NF1 in early visual processing and is specifically associated with a deficient deactivation of the default mode network may provide a neural explanation for high-order cognitive deficits present in NF1, particularly visuospatial and attentional. A link between magnocellular and default mode network processing may generalize to neuropsychiatric disorders where such deficits have been separately identified.	[Violante, Ines R.; Ribeiro, Maria J.; Cunha, Gil; Bernardino, Ines; Duarte, Joao V.; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Inst Biomed Res Light & Image, Visual Neurosci Lab, Coimbra, Portugal; [Ramos, Fabiana; Saraiva, Jorge] Pediat Hosp Coimbra, Dept Med Genet, Coimbra, Portugal; [Silva, Eduardo] Univ Hosp Coimbra, Ctr Hereditary Eye Dis, Dept Ophthalmol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)	Violante, IR (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Res Light & Image, Visual Neurosci Lab, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Duarte, João Valente/B-3788-2018; Castelo-Branco, Miguel/F-3866-2019; Bernardino, Inês/D-4487-2018; Castelo-Branco, Miguel/E-5689-2010; Bernardino, Inês/AAF-6741-2020; Ribeiro, Maria J/J-4618-2013	Duarte, João Valente/0000-0001-8586-9554; Castelo-Branco, Miguel/0000-0003-4364-6373; Bernardino, Inês/0000-0003-3123-008X; Bernardino, Inês/0000-0003-3123-008X; Ribeiro, Maria J/0000-0001-6422-3279; Ramos, Fabiana/0000-0001-7780-9762; Violante, Ines/0000-0002-4787-2901; Saraiva, Jorge Manuel/0000-0002-7232-3509; Silva, Eduardo/0000-0002-2739-9854	University of Coimbra [III/14/2008]; Portuguese Foundation for Science and Technology [PIC/IC/83155/2007, PTDC_SAU-ORG_118380, PIC/IC/82986/2007, SFRH/BD/41348/2007, SFRH/BPD/34392/2006, SFRH/BD/41401/2007]	University of Coimbra; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the University of Coimbra [Grant number III/14/2008] and the Portuguese Foundation for Science and Technology [Grant numbers PIC/IC/83155/2007, PTDC_SAU-ORG_118380, PIC/IC/82986/2007, SFRH/BD/41348/2007 to I.R.V., SFRH/BPD/34392/2006 to M.J.R, and SFRH/BD/41401/2007 to I.B.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Billingsley RL, 2003, J CHILD NEUROL, V18, P731, DOI 10.1177/08830738030180110701; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bucher K, 2006, NEUROIMAGE, V31, P1625, DOI 10.1016/j.neuroimage.2006.02.032; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Bullier J, 2001, PROG BRAIN RES, V134, P193; Clements-Stephens AM, 2008, NEUROPSYCHOLOGIA, V46, P690, DOI 10.1016/j.neuropsychologia.2007.09.013; Coleman MJ, 2009, SCHIZOPHRENIA BULL, V35, P1108, DOI 10.1093/schbul/sbp090; Eickhoff SB, 2008, CEREB CORTEX, V18, P2637, DOI 10.1093/cercor/bhn024; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Formisano E, 2004, MAGN RESON IMAGING, V22, P1493, DOI 10.1016/j.mri.2004.10.020; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRIEDMAN JM, 1993, AM J MED GENET, V45, P88, DOI 10.1002/ajmg.1320450121; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; Huijbregts S, 2010, DEV NEUROPSYCHOL, V35, P737, DOI 10.1080/87565641.2010.508670; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Jo HJ, 2007, NEUROIMAGE, V34, P550, DOI 10.1016/j.neuroimage.2006.09.047; Kayl AE, 2000, MENT RETARD DEV D R, V6, P117, DOI 10.1002/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kesler SR, 2004, CEREB CORTEX, V14, P174, DOI 10.1093/cercor/bhg116; Klaver P, 2008, NEUROIMAGE, V39, P1815, DOI 10.1016/j.neuroimage.2007.11.009; Kogan CS, 2004, BRAIN, V127, P591, DOI 10.1093/brain/awh069; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1409, DOI 10.1016/j.neubiorev.2008.04.008; Laycock R, 2007, NEUROSCI BIOBEHAV R, V31, P363, DOI 10.1016/j.neubiorev.2006.10.003; Leventhal A G, 1991, VISION VISUAL DYSFUN, V4; Levine Terry M, 2006, Semin Pediatr Neurol, V13, P8, DOI 10.1016/j.spen.2006.01.006; Liu CSJ, 2006, AM J NEURORADIOL, V27, P1628; Liu TH, 2006, J VISION, V6, P1294, DOI 10.1167/6.11.12; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Loenneker T, HUM BRAIN MAPP, V935- 946; Martinez A, 2008, J NEUROSCI, V28, P7492, DOI 10.1523/JNEUROSCI.1852-08.2008; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Penny W., 2003, HUMAN BRAIN FUNCTION; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raven J. C, 1993, MANUAL RAVENS PROGRE; Ribeiro MJ, 2012, INVEST OPHTH VIS SCI, V53, P287, DOI 10.1167/iovs.11-8225; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Salgado-Pineda P, 2011, SCHIZOPHR RES, V125, P101, DOI 10.1016/j.schres.2010.10.027; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shilyansky C, 2010, P NATL ACAD SCI USA, V107, P13141, DOI 10.1073/pnas.1004829107; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Talairach J., 1988, COPLANAR STEREOTAXIC; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; Wechsler D., 2003, ESCALA INTELIGENCIA	60	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38785	10.1371/journal.pone.0038785	http://dx.doi.org/10.1371/journal.pone.0038785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723888	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300049
J	Wu, J; Cui, N; Wang, R; Li, JW; Wong, JM				Wu, Jing; Cui, Nan; Wang, Rui; Li, Jiwen; Wong, Jiemin			A Role for CARM1-Mediated Histone H3 Arginine Methylation in Protecting Histone Acetylation by Releasing Corepressors from Chromatin	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; RNA-POLYMERASE-II; GENE-EXPRESSION; HETEROCHROMATIN FORMATION; LYSINE-4 METHYLATION; PROTEIN METHYLATION; TRANSCRIPTION; BINDING; COMPLEX; METHYLTRANSFERASE	Arginine methylation broadly occurs in histones and has been linked to transcriptional regulation, cell cycle regulation and DNA repair. While numerous proteins (histone code effectors) that specifically recognize or read the methylated lysine residues in core histones have been identified, little is known for effectors specific for methylated arginines in histones. In this study, we attempted to identify effector(s) recognizing asymmetrically methylated R17 and R26 in H3, which are catalyzed by CARM1/PRMT4, through an unbiased biochemical approach. Although we have yet to identify such effector using this approach, we find that these modifications function cooperatively with histone acetylation to inhibit the binding of the nucleosome remodeling and deacetylase complex (NuRD) and TIF1 family corepressors to H3 tail in vitro. In support of this finding, we show that overexpression of CARM1 in 293 T cells leads to reduced association of NuRD with chromatin, whereas knockdown of CARM1 in HeLa cells leads to increased association of NuRD with chromatin and decreased level of histone acetylation. Furthermore, in the Carm1-/- MEF cells there is an increased association of NuRD and TIF1 beta with chromatin and a global decrease in histone acetylation. By chromatin immunoprecipitation assay, we show that overexpression of CARM1 results in reduced association of NuRD complex and TIF1 beta with an episomal reporter and that CARM1 is required in MEF cells for LPS-induced dissociation of NuRD from a NF-kappa b target gene. Taking together, our study provides evidence for a role of CARM1-mediated arginine methylation in regulation of histone acetylation and transcription: facilitating transcription by discharging corepressors from chromatin.	[Wu, Jing] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Wu, J (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China.	jmweng@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X	National Natural Science Foundation of China [90919025, 30871381]; Ministry of Science and Technology of China [2009CB918402, 2009CB825601, 2010CB944903]; Science and Technology Commission of Shanghai Municipality [09DJ1400400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was partially supported by grants from the National Natural Science Foundation of China (90919025 and 30871381), the Ministry of Science and Technology of China (2009CB918402, 2009CB825601, 2010CB944903), the Science and Technology Commission of Shanghai Municipality (09DJ1400400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kustatscher G, 2007, CURR OPIN CHEM BIOL, V11, P628, DOI 10.1016/j.cbpa.2007.09.011; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	48	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e34692	10.1371/journal.pone.0034692	http://dx.doi.org/10.1371/journal.pone.0034692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723830	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300001
J	Hamerton, I; Howlin, BJ; Kamyszek, G				Hamerton, Ian; Howlin, Brendan J.; Kamyszek, Grzegorz			Predicting Glass Transition Temperatures of Polyarylethersulphones Using QSPR Methods	PLOS ONE			English	Article							AROMATIC POLY(ETHER SULFONE)S; POLY(ARYLENE ETHER SULFONES); MOLECULAR SIMULATION; GAS-TRANSPORT; POLYSULFONE; BLENDS; POLYETHERSULFONES; POLYMERS; KETONE)S	The technique of Quantitative Structure Property Relationships has been applied to the glass transition temperatures of polyarylethersulphones. A general equation is reported that calculates the glass transition temperatures with acceptable accuracy (correlation coefficients of between 90-67%, indicating an error of 10-30% with regard to experimentally determined values) for a series of 42 reported polyarylethersulphones. This method is quite simple in assumption and relies on a relatively small number of parameters associated with the structural unit of the polymer: the number of rotatable bonds, the dipole moment, the heat of formation, the HOMO eigenvalue, the molar mass and molar volume. For smaller subsets of the main group (based on families of derivatives containing different substituents) the model can be simplified further to an equation that uses the volume of the substituents as the principal variable.	[Hamerton, Ian; Howlin, Brendan J.; Kamyszek, Grzegorz] Univ Surrey, Dept Chem, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Surrey	Hamerton, I (corresponding author), Univ Surrey, Dept Chem, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Hamerton, Ian/AAV-8918-2021	Howlin, Brendan J/0000-0002-9398-7152; Hamerton, Ian/0000-0003-3113-0345				*ACC INC, QUANTA; ANDREWS SM, 1992, J POLYM SCI POL CHEM, V30, P221, DOI 10.1002/pola.1992.080300206; ATTWOOD TE, 1981, POLYMER, V22, P1096, DOI 10.1016/0032-3861(81)90299-8; ATTWOOD TE, 1977, POLYMER, V18, P359, DOI 10.1016/0032-3861(77)90083-0; Attwood TE, 1977, POLYMER, V18, P35; Baron L, 1970, MAKROMOL CHEM, V140, P83; Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008; Clendinning RA, 1988, POLYM PREP-ACS, V32, P166; Cotter R.J., 1995, ENG PLASTICS HDB POL; Cotter RJ, 1989, US Patent, Patent No. [4,849,503, 4849503]; Farnham A. G., 1973, Brit. Pat., Patent No. [1,078,234, 1078234]; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; GHOSAL K, 1992, J MEMBRANE SCI, V72, P91, DOI 10.1016/0376-7388(92)80058-R; GOH SH, 1992, POLYM BULL, V29, P521, DOI 10.1007/BF00296713; Hamerton I, 2006, POLYMER, V47, P690, DOI 10.1016/j.polymer.2005.11.082; HAMERTON I, 1995, J MOL GRAPHICS, V13, P14, DOI 10.1016/0263-7855(94)00009-H; Hamerton I, 1996, MODEL SIMUL MATER SC, V4, P151, DOI 10.1088/0965-0393/4/2/003; Hamerton I, 1996, MACROMOL THEOR SIMUL, V5, P305, DOI 10.1002/mats.1996.040050211; Hamerton I, 2011, HANDBOOK OF BENZOXAZINE RESINS, P127, DOI 10.1016/B978-0-444-53790-4.00050-3; Hartmann LA, 1979, US Patent, Patent No. [4,156,068, 4156068]; Howlin BJ, 2012, PLOS1 IN PRESS; Hsaio BS, 1991, ACS POLYM PREP, V32, P258; Ivin KJ, 1968, ADV MACROMOL CHEM, V1, P335; JOHNSON RN, 1967, J POLYM SCI A1, V5, P2375, DOI 10.1002/pol.1967.150050916; Jones M. E. B., 1962, Brit. Pat., Patent No. [1,016,245, 1016245]; KAMPS KMP, 1992, J MEMBRANE SCI, V74, P193, DOI 10.1016/0376-7388(92)87083-A; KIM WG, 1992, J MACROMOL SCI PURE, VA29, P1141, DOI 10.1080/10601329208054147; KOEHLER MG, 1989, POLYMER, V30, P116, DOI 10.1016/0032-3861(89)90392-3; Lee JA, 1993, POLYM PREP-ACS, V34, P570; Maresca LM, 1984, US Patent number, Patent No. [4,473,684, 4473684]; MATSUO S, 1993, J POLYM SCI POL CHEM, V31, P3439, DOI 10.1002/pola.1993.080311333; MCHATTIE JS, 1991, POLYMER, V32, P840, DOI 10.1016/0032-3861(91)90508-G; Mohanty DK, 1982, POLYM PREPRINTS, V23, P284; O'Shea FX, 1974, Can Patent, Patent No. [946,091, 946091]; Pauling L., 1960, NATURE CHEM BOND; PERCEC V, 1991, J POLYM SCI POL CHEM, V29, P965, DOI 10.1002/pola.1991.080290703; PODKOSCIELNY W, 1991, ANGEW MAKROMOL CHEM, V188, P143, DOI 10.1002/apmc.1991.051880113; ROBESON LM, 1983, J APPL POLYM SCI, V28, P2925, DOI 10.1002/app.1983.070280920; Robeson LM, 1975, POLYM PREPR AM CHEM, V16, P476; Robeson M, 1975, ACS, V169, P90; ROSE JB, 1974, POLYMER, V15, P456, DOI 10.1016/0032-3861(74)90111-6; ROSE JB, 1974, CHIMIA, V28, P561; Rose JB, 1968, CHEM IND, V15, P461; Schmidt M, 1998, J POLYM SCI POL PHYS, V36, P1061, DOI 10.1002/(SICI)1099-0488(19980430)36:6<1061::AID-POLB14>3.0.CO;2-4; Stewart JJ, 1990, COMPUT AIDED MOL DES, V4, P1, DOI DOI 10.1007/BF0; TAM CM, 1993, J MEMBRANE SCI, V78, P123; UEDA M, 1991, POLYM J, V23, P297, DOI 10.1295/polymj.23.297; UEDA M, 1993, J POLYM SCI POL CHEM, V31, P853, DOI 10.1002/pola.1993.080310402; VanKrevelen DW, 2009, PROPERTIES OF POLYMERS: THEIR CORRELATION WITH CHEMICAL STRUCTURE; THEIR NUMERICAL ESTIMATION AND PREDICTION FROM ADDITIVE GROUP CONTRIBUTIONS, P1; Vogel H. A., 1963, Brit. Pat., Patent No. [1,060,546, 1060546]; VOGEL HA, 1970, J POLYM SCI A1, V8, P2035, DOI 10.1002/pol.1970.150080812; Wham GK, 1991, POLYM PREPR, V32, P389	52	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38424	10.1371/journal.pone.0038424	http://dx.doi.org/10.1371/journal.pone.0038424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719884	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000016
J	Morris, LM; DeGagne, JM; Kempton, JB; Hausman, F; Trune, DR				Morris, Lisa M.; DeGagne, Jacqueline M.; Kempton, J. Beth; Hausman, Frances; Trune, Dennis R.			Mouse Middle Ear Ion Homeostasis Channels and Intercellular Junctions	PLOS ONE			English	Article							INNER-EAR; OTITIS-MEDIA; EXPRESSION PATTERNS; EPITHELIAL-CELLS; SECRETORY OTITIS; EUSTACHIAN-TUBE; AQUAPORIN-4; CLEARANCE; TRANSPORT; EPIDEMIOLOGY	Hypothesis: The middle ear contains homeostatic mechanisms that control the movement of ions and fluids similar to those present in the inner ear, and are altered during inflammation. Background: The normal middle ear cavity is fluidfree and airfilled to allow for effective sound transmission. Within the inner ear, the regulation of fluid and ion movement is essential for normal auditory and vestibular function. The same ion and fluid channels active in the inner ear may have similar roles with fluid regulation in the middle ear. Methods: Middle and inner ears from BALB/c mice were processed for immunohistochemistry of 10 specific ion homeostasis factors to determine if similar transport and barrier mechanisms are present in the tympanic cavity. Examination also was made of BALB/c mice middle ears after transtympanic injection with heatkilled Haemophilus influenza to determine if these channels are impacted by inflammation. Results: The most prominent ion channels in the middle ear included aquaporins 1, 4 and 5, claudin 3, ENaC and Na+, K+-ATPase. Moderate staining was found for GJB2, KCNJ10 and KCNQ1. The inflamed middle ear epithelium showed increased staining due to expected cellular hypertrophy. Localization of ion channels was preserved within the inflamed middle ear epithelium. Conclusions: The middle ear epithelium is a dynamic environment with intrinsic mechanisms for the control of ion and water transport to keep the middle ear clear of fluids. Compromise of these processes during middle ear disease may underlie the accumulation of effusions and suggests they may be a therapeutic target for effusion control.	[Morris, Lisa M.; DeGagne, Jacqueline M.; Kempton, J. Beth; Hausman, Frances; Trune, Dennis R.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University	Morris, LM (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	truned@ohsu.edu			National Institutes of Health-National Institute on Deafness and Other Communication Disorders [R01 DC009455 and DC005593]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005593, P30DC005983, R01DC009455] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health-National Institute on Deafness and Other Communication Disorders R01 DC009455 and DC005593 (DRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitz E, 2003, CELL MOL NEUROBIOL, V23, P315, DOI 10.1023/A:1023636620721; Choi JY, 2007, EUR J PHARMACOL, V567, P19, DOI 10.1016/j.ejphar.2007.04.026; Choi JY, 2006, HEARING RES, V211, P26, DOI 10.1016/j.heares.2005.08.007; Couloigner V, 2006, PFLUG ARCH EUR J PHY, V453, P11, DOI 10.1007/s00424-006-0103-4; Dinh EH, 2009, BRAIN RES, V1277, P52, DOI 10.1016/j.brainres.2009.02.008; Florian P, 2003, BIOCHEM BIOPH RES CO, V304, P5, DOI 10.1016/S0006-291X(03)00498-4; HERMAN P, 1992, AM J PHYSIOL, V262, pF373, DOI 10.1152/ajprenal.1992.262.3.F373; Herman P, 1998, KIDNEY INT, pS94; HONJO I, 1985, AM J OTOLARYNG, V6, P241, DOI 10.1016/S0196-0709(85)80095-8; Huang DL, 2002, HEARING RES, V165, P85, DOI 10.1016/S0378-5955(02)00288-5; INAGAKI M, 1988, ANN OTO RHINOL LARYN, V97, P313, DOI 10.1177/000348948809700321; Kang SH, 2007, ACTA OTO-LARYNGOL, V127, P687, DOI 10.1080/00016480500452574; Kitajiri S, 2004, HEARING RES, V187, P25, DOI 10.1016/S0378-5955(03)00338-1; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li JP, 2005, HEARING RES, V210, P1, DOI 10.1016/j.heares.2005.04.011; MacArthur CJ, 2006, HEARING RES, V219, P12, DOI 10.1016/j.heares.2006.05.012; MacArthur CJ, 2011, OTOL NEUROTOL, V32, P508, DOI 10.1097/MAO.0b013e31820e6de4; Minami S, 2001, HEARING RES, V158, P51, DOI 10.1016/S0378-5955(01)00284-2; Miyabe Y, 2002, TOHOKU J EXP MED, V196, P247, DOI 10.1620/tjem.196.247; SADE J, 1975, ACTA OTO-LARYNGOL, V79, P277, DOI 10.3109/00016487509124685; Smith DJ, 2008, RESP PHYSIOL NEUROBI, V163, P178, DOI 10.1016/j.resp.2008.03.006; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; TOS M, 1984, AM J OTOL, V5, P459; Trune DR, 2010, CURR OPIN OTOLARYNGO; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009; Zhang Q, 2009, ORL-J OTO-RHIN-LARYN, V71, P70, DOI 10.1159/000182419	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39004	10.1371/journal.pone.0039004	http://dx.doi.org/10.1371/journal.pone.0039004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720014	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000033
J	Nugteren, JJ; Snijder, CA; Hofman, A; Jaddoe, VWV; Steegers, EAP; Burdorf, A				Nugteren, Jaap Jan; Snijder, Claudia A.; Hofman, Albert; Jaddoe, Vincent W. V.; Steegers, Eric A. P.; Burdorf, Alex			Work-Related Maternal Risk Factors and the Risk of Pregnancy Induced Hypertension and Preeclampsia during Pregnancy. The Generation R Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; LOW-BIRTH-WEIGHT; GESTATIONAL HYPERTENSION; OCCUPATIONAL-EXPOSURE; FETAL DEVELOPMENT; BLOOD-PRESSURE; JOB STRAIN; STRESS; CATECHOLAMINES; PATHOGENESIS	Objective: To study the associations between physically demanding work and occupational exposure to chemicals and hypertensive disorders during pregnancy within a large birth cohort study, the Generation R Study. Methods: Associations between occupational characteristics and hypertensive disorders during pregnancy were studied in 4465 pregnant woman participating in a population-based prospective cohort study from early pregnancy onwards in the Netherlands (2002-2006). Mothers who filled out a questionnaire during mid-pregnancy (response 77% of enrolment), were included if they conducted paid employment, had a spontaneously conceived singleton live born pregnancy, and did not suffer from pre-existing hypertension (n = 4465). Questions on physical demanding work were obtained from the Dutch Musculoskeletal Questionnaire and concerned questions on manually handling loads of 25 kg or more, long periods of standing or walking, night shifts, and working hours. To assess occupational exposure to chemicals, job titles and task descriptions were linked to a job-exposure-matrix (JEM), an expert judgment on exposure to chemicals at the workplace. Information on hypertensive disorders during pregnancy was obtained from medical records. Results: We observed no consistent associations between any of the work related risk factors, such as long periods of standing or walking, heavy lifting, night shifts, and working hours, nor exposure to chemicals with hypertensive disorders during pregnancy. Conclusion: This prospective birth cohort study suggests that there is no association of hypertensive disorders during pregnancy with physically demanding work or exposure to chemicals. However, the low prevalence of PIH and PE, combined with the low prevalence of occupational risk factors limit the power for inference and larger studies are needed to corroborate or refute these findings.	[Nugteren, Jaap Jan; Snijder, Claudia A.; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Nugteren, Jaap Jan; Snijder, Claudia A.; Burdorf, Alex] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Paediat, Rotterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Nugteren, JJ (corresponding author), Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands.	a.burdorf@erasmusmc.nl	Burdorf, Alex/A-2226-2008	Burdorf, Alex/0000-0003-3129-2862	Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); European Union [212502]	Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union(European Commission)	The first phase of the Generation R Study is made possible by financial support from: Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw). The present study was conducted in commission of the European project CONTAMED with funding from the European Union's Seventh Framework Programme (FP7) for Research and Technology Development. EU grant agreement no. 212502. There are no commercial associations that may pose any conflict of interest. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2010, J HYPERTENS, V28, P2210, DOI 10.1097/HJH.0b013e32833e2a3d; Bonzini M, 2007, OCCUP ENVIRON MED, V64, P228, DOI 10.1136/oem.2006.026872; Brouwers MM, 2009, OCCUP ENVIRON MED, V66, P607, DOI 10.1136/oem.2008.042184; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Burdorf A, 2011, OCCUP ENVIRON MED, V68, P197, DOI 10.1136/oem.2009.046516; Coolman M, 2010, J CLIN EPIDEMIOL, V63, P932, DOI 10.1016/j.jclinepi.2009.10.010; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; ESKENAZI B, 1988, AM J IND MED, V14, P177, DOI 10.1002/ajim.4700140208; Fujiwara K, 2004, SCAND J WORK ENV HEA, V30, P129, DOI 10.5271/sjweh.770; Gaillard R, 2011, J HYPERTENS, V29, P937, DOI 10.1097/HJH.0b013e328345500c; Haelterman E, 2007, SCAND J WORK ENV HEA, V33, P304, DOI 10.5271/sjweh.1147; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Hildebrandt VH, 2001, ERGONOMICS, V44, P1038, DOI 10.1080/00140130110087437; IRWIN DE, 1994, AM J IND MED, V25, P349, DOI 10.1002/ajim.4700250305; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Jansen PW, 2010, OCCUP ENVIRON MED, V67, P387, DOI 10.1136/oem.2009.046300; Kaaja R, 2008, Minerva Ginecol, V60, P421; KATZ VL, 1991, OBSTET GYNECOL, V77, P338; Khatun S, 1997, EUR J OBSTET GYN R B, V74, P103, DOI 10.1016/S0301-2115(97)00112-7; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Landsbergis PA, 1996, EPIDEMIOLOGY, V7, P346, DOI 10.1097/00001648-199607000-00002; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Marcoux S, 1999, EPIDEMIOLOGY, V10, P376, DOI 10.1097/00001648-199907000-00007; Mozurkewich EL, 2000, OBSTET GYNECOL, V95, P623, DOI 10.1016/S0029-7844(99)00598-0; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; NURMINEN T, 1989, SCAND J WORK ENV HEA, V15, P404, DOI 10.5271/sjweh.1832; NURMINEN T, 1989, SCAND J WORK ENV HEA, V15, P395, DOI 10.5271/sjweh.1833; Pierik FH, 2004, ENVIRON HEALTH PERSP, V112, P1570, DOI 10.1289/ehp.7243; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Saftlas AF, 2004, AM J EPIDEMIOL, V160, P758, DOI 10.1093/aje/kwh277; Saldana TM, 2009, ENVIRON HEALTH PERSP, V117, P1393, DOI 10.1289/ehp.0900672; Schobel HP, 1996, NEW ENGL J MED, V335, P1480, DOI 10.1056/NEJM199611143352002; Snijder CA, 2011, FERTIL STERIL, V95, P2067, DOI 10.1016/j.fertnstert.2011.02.017; Statistics Netherlands, 1992, DUTCH CLASS OCC SBC; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; VANDERBEEK AJ, 1995, OCCUP ENVIRON MED, V52, P464, DOI 10.1136/oem.52.7.464; Vrijheid M, 2003, OCCUP ENVIRON MED, V60, P543, DOI 10.1136/oem.60.8.543; Wigle DT, 2008, J TOXICOL ENV HEAL B, V11, P373, DOI 10.1080/10937400801921320; Young KB, 1998, WILLIAMS TXB ENDOCRI, P665; Zhang J, 1997, EPIDEMIOL REV, V19, P218, DOI 10.1093/oxfordjournals.epirev.a017954	45	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39263	10.1371/journal.pone.0039263	http://dx.doi.org/10.1371/journal.pone.0039263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720087	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350000055
J	Carter, GG; Logsdon, R; Arnold, BD; Menchaca, A; Medellin, RA				Carter, Gerald G.; Logsdon, Ryane; Arnold, Bryan D.; Menchaca, Angelica; Medellin, Rodrigo A.			Adult Vampire Bats Produce Contact Calls When Isolated: Acoustic Variation by Species, Population, Colony, and Individual	PLOS ONE			English	Article							SPEAR-NOSED BATS; SOCIAL CALLS; ECHOLOCATION CALLS; DESMODUS-ROTUNDUS; SPATIAL ORIENTATION; BEHAVIORAL CONTEXT; COMMUNICATION; CONSPECIFICS; DISCRIMINATION; PHYLLOSTOMIDAE	Background: Bat pups produce individually distinct isolation calls to facilitate maternal recognition. Increasing evidence suggests that, in group-living bat species, adults often use similar calls to maintain contact. We investigated if isolated adults from all three species of the highly cooperative vampire bats (Phyllostomidae: Desmodontinae) would produce vocally distinct contact calls when physically isolated. Methods/Principal Findings: We assessed variation in contact calls recorded from isolated captive and wild-caught adult common vampire bats (Desmodus rotundus), white-winged vampire bats (Diaemus youngi) and hairy-legged vampire bats (Diphylla ecaudata). We compared species-typical contact call structure, and used information theory and permuted discriminate function analyses to examine call structure variation, and to determine if the individuality of contact calls is encoded by different call features across species and populations. We found that isolated adult vampire bats produce contact calls that vary by species, population, colony, and individual. However, much variation occurred within a single context and individual. We estimated signature information for captive Diaemus (same colony), captive Desmodus (same colony), and wild Desmodus (different colonies) at 3.21, 3.26, and 3.88 bits, respectively. Contact calls from a captive colony of Desmodus were less individually distinct than calls from wild-caught Desmodus from different colonies. Both the degree of individuality and parameters encoding individuality differed between the bats from a single captive colony and the wild-caught individuals from different groups. This result is consistent with, but not sufficient evidence of, vocal convergence in groups. Conclusion: Our results show that adult vampire bats of all three species produce highly variable contact calls when isolated. Contact calls contain sufficient information for vocal discrimination, but also possess more intra-individual variation than is required for the sole purpose of identifying individuals.	[Carter, Gerald G.] Univ Maryland, College Pk, MD 20742 USA; [Carter, Gerald G.] Org Bat Conservat, Bloomfield Hills, MI USA; [Logsdon, Ryane] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Arnold, Bryan D.] Murray State Univ, Dept Biol Sci, Murray, KY 42071 USA; [Menchaca, Angelica; Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico	University System of Maryland; University of Maryland College Park; University of Rochester; Murray State University; Universidad Nacional Autonoma de Mexico	Carter, GG (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	gcarter@umd.edu			Cosmos Club Foundation of Washington DC; American Society of Mammalogists; Explorer's Club, Washington Group; National Academy of Sciences	Cosmos Club Foundation of Washington DC; American Society of Mammalogists; Explorer's Club, Washington Group; National Academy of Sciences	This work was supported by research grants from the Cosmos Club Foundation of Washington DC, the American Society of Mammalogists, and the Explorer's Club, Washington Group, and the National Academy of Sciences, administered by Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Betke M, 2008, J MAMMAL, V89, P18, DOI 10.1644/07-MAMM-A-011.1; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bohn KM, 2007, ANIM BEHAV, V73, P423, DOI 10.1016/j.anbehav.2006.09.003; Bohn KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006746; Bohn KM, 2006, BIOL LETT-UK, V2, P561, DOI 10.1098/rsbl.2006.0501; Bohn KM, 2004, J COMP PHYSIOL A, V190, P185, DOI 10.1007/s00359-003-0485-0; Boughman JW, 1998, ANIM BEHAV, V55, P1717, DOI 10.1006/anbe.1997.0721; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; CALDWELL MC, 1965, NATURE, V207, P434, DOI 10.1038/207434a0; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; Chaverri G, 2010, BIOL LETTERS, V6, P441, DOI 10.1098/rsbl.2009.0964; Chen SF, 2009, P ROY SOC B-BIOL SCI, V276, P3901, DOI 10.1098/rspb.2009.1185; Cortopassi KA, 2006, ANIM BEHAV, V71, P1141, DOI 10.1016/j.anbehav.2005.09.011; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Dechmann DKN, 2009, P ROY SOC B-BIOL SCI, V276, P2721, DOI 10.1098/rspb.2009.0473; Dechmann DKN, 2002, CONSERV GENET, V3, P455, DOI 10.1023/A:1020574400398; Elizalde-Arellano C, 2007, ACTA CHIROPTEROL, V9, P314, DOI 10.3161/1733-5329(2007)9[314:FSBITH]2.0.CO;2; ESSER KH, 1989, ETHOLOGY, V82, P156; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; Furmankiewicz J, 2011, ETHOLOGY, V117, P480, DOI 10.1111/j.1439-0310.2011.01897.x; Gillam EH, 2012, ANIM BEHAV, V83, P269, DOI 10.1016/j.anbehav.2011.11.002; GOULD E, 1973, J MAMMAL, V54, P998, DOI 10.2307/1379103; Gould E, 1997, BIOL BATS NEW WORLD, P247; Groger U, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-18; Hoffmann FF, 2007, CAN J ZOOL, V85, P863, DOI 10.1139/Z07-069; HOLM S, 1979, SCAND J STAT, V6, P65; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; Knornschild M, 2007, ANIM BEHAV, V74, P1055, DOI 10.1016/j.anbehav.2006.12.024; Knornschild M, 2010, BIOL LETTERS, V6, P156, DOI 10.1098/rsbl.2009.0685; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; MCCRACKEN GF, 1984, SCIENCE, V223, P1090, DOI 10.1126/science.223.4640.1090; Moss CF, 2006, PLOS BIOL, V4, P615, DOI 10.1371/journal.pbio.0040079; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Piaggio AJ, 2008, MOL ECOL RESOUR, V8, P440, DOI 10.1111/j.1471-8286.2007.01986.x; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; SAILLER H, 1978, Z SAUGETIERKD, V43, P249; SCHERRER JA, 1993, ANIM BEHAV, V46, P847, DOI 10.1006/anbe.1993.1270; SCHMIDT U, 1973, Zeitschrift fuer Saeugetierkunde, V38, P14; Schmidt U, 1972, ZOOL BEITR, V23, P310; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schoner CR, 2010, BEHAV ECOL SOCIOBIOL, V64, P2053, DOI 10.1007/s00265-010-1019-8; Sugiura H, 2007, AM J PRIMATOL, V69, P1412, DOI 10.1002/ajp.20447; SUTHERS RA, 1965, J EXP ZOOL, V158, P319, DOI 10.1002/jez.1401580307; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tschapka M, 1999, Z SAUGETIERKD, V64, P239; Weigl R., 2005, KLEINE SENCKENBERG R; Weiss DJ, 2001, J COMP PSYCHOL, V115, P258, DOI 10.1037/0735-7036.115.3.258; WILKINSON GS, 1986, ANIM BEHAV, V34, P1880, DOI 10.1016/S0003-3472(86)80274-3; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Wilkinson GS, 2003, ANIMAL SOCIAL COMPLEXITY, P322; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557	64	42	43	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38791	10.1371/journal.pone.0038791	http://dx.doi.org/10.1371/journal.pone.0038791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719947	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800019
J	Radchuk, V; WallisDeVries, MF; Schtickzelle, N				Radchuk, Viktoriia; WallisDeVries, Michiel F.; Schtickzelle, Nicolas			Spatially and Financially Explicit Population Viability Analysis of Maculinea alcon in The Netherlands	PLOS ONE			English	Article							HABITAT QUALITY; METAPOPULATION DYNAMICS; HOST-SPECIFICITY; MYRMICA ANTS; CONSERVATION; BUTTERFLIES; LEPIDOPTERA; MODEL; REBELI; CONNECTIVITY	Background: The conservation of species structured in metapopulations involves an important dilemma of resource allocation: should investments be directed at restoring/enlarging habitat patches or increasing connectivity. This is still an open question for Maculinea species despite they are among the best studied and emblematic butterfly species, because none of the population dynamics models developed so far included dispersal. Methodology/Principal Findings: We developed the first spatially and financially explicit Population Viability Analysis model for Maculinea alcon, using field data from The Netherlands. Implemented using the RAMAS/GIS platform, the model incorporated both local (contest density dependence, environmental and demographic stochasticities), and regional population dynamics (dispersal rates between habitat patches). We selected four habitat patch networks, contrasting in several basic features (number of habitat patches, their quality, connectivity, and occupancy rate) to test how these features are affecting the ability to enhance population viability of four basic management options, designed to incur the same costs: habitat enlargement, habitat quality improvement, creation of new stepping stone habitat patches, and reintroduction of captive-reared butterflies. The PVA model was validated by the close match between its predictions and independent field observations on the patch occupancy pattern. The four patch networks differed in their sensitivity to model parameters, as well as in the ranking of management options. Overall, the best cost-effective option was enlargement of existing habitat patches, followed by either habitat quality improvement or creation of stepping stones depending on the network features. Reintroduction was predicted to generally be inefficient, except in one specific patch network. Conclusions/Significance: Our results underline the importance of spatial and regional aspects (dispersal and connectivity) in determining the impact of conservation actions, even for a species previously considered as sedentary. They also illustrate that failure to account for the cost of management scenarios can lead to very different conclusions.	[Radchuk, Viktoriia; Schtickzelle, Nicolas] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium; [WallisDeVries, Michiel F.] De Vlinderstichting Dutch Butterfly Conservat, Wageningen, Netherlands; [WallisDeVries, Michiel F.] Wageningen Univ, Entomol Lab, Wageningen, Netherlands	Universite Catholique Louvain; Wageningen University & Research	Radchuk, V (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium.	viktoriia.radchuk@uclouvain.be	Radchuk, Viktoriia/C-6665-2013	Radchuk, Viktoriia/0000-0003-3072-0095	Fonds pour le recherche dans l'industrie et dans l'Agriculture; Fund for Scientific Research	Fonds pour le recherche dans l'industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Fund for Scientific Research	VR was supported by grant from Fonds pour le recherche dans l'industrie et dans l'Agriculture, NS is funded by the Fund for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKCAKAYA HR, 2002, RAMAS GIS LINKING SP; Als TD, 2004, NATURE, V432, P386, DOI 10.1038/nature03020; Als TD, 2001, ANIM BEHAV, V62, P99, DOI 10.1006/anbe.2001.1716; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Boggs C., 2003, BUTTERFLIES ECOLOGY; Calix M., 2018, EUROPEAN RED LIST SA; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Clarke RT, 1998, J INSECT CONSERV, V2, P29, DOI 10.1023/A:1009688622147; Clarke RT, 1997, P ROY SOC B-BIOL SCI, V264, P347, DOI 10.1098/rspb.1997.0050; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Elmes GW, 1998, J INSECT CONSERV, V2, P67, DOI 10.1023/A:1009696823965; Falcy MR, 2007, CONSERV BIOL, V21, P1341, DOI 10.1111/j.1523-1739.2007.00766.x; Gadeberg RME, 1997, J INSECT CONSERV, V1, P99, DOI 10.1023/A:1018439211244; Ginzburg LR, 1982, RISK ANAL, V2, P171, DOI 10.1111/j.1539-6924.1982.tb01379.x; Griebeler EM, 2002, ECOL MODEL, V156, P43, DOI 10.1016/S0304-3800(02)00131-X; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hanski I, 2000, ECOLOGY, V81, P239, DOI 10.1890/0012-9658(2000)081[0239:ETPOSA]2.0.CO;2; HANSKI I, 1994, BIOL CONSERV, V68, P167, DOI 10.1016/0006-3207(94)90348-4; Hanski I., 1999, METAPOPULATION ECOLO; Henein K, 1998, OIKOS, V81, P168, DOI 10.2307/3546479; HOCHBERG ME, 1994, J ANIM ECOL, V63, P375, DOI 10.2307/5555; HOCHBERG ME, 1992, J ANIM ECOL, V61, P397, DOI 10.2307/5331; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Hovestadt T, 2007, AM NAT, V169, P466, DOI 10.1086/512134; Hovestadt T, 2011, J ANIM ECOL, V80, P1070, DOI 10.1111/j.1365-2656.2011.01848.x; Johst K, 2006, J APPL ECOL, V43, P333, DOI 10.1111/j.1365-2664.2006.01125.x; Maes D, 2004, BIOL CONSERV, V120, P229, DOI 10.1016/j.biocon.2004.02.018; Mouquet N, 2005, ECOLOGY, V86, P3160, DOI 10.1890/04-1664; Mouquet N, 2005, ECOL MONOGR, V75, P525, DOI 10.1890/05-0319; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nichols J., 2001, DISPERSAL; Nowicki P, 2005, POPUL ECOL, V47, P193, DOI 10.1007/s10144-005-0222-3; Nowicki P, 2007, BIOL CONSERV, V140, P119, DOI 10.1016/j.biocon.2007.08.001; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Nowicki Piotr, 2005, P144; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.2307/3071767; Schneider C, 2003, ECOL ENTOMOL, V28, P219, DOI 10.1046/j.1365-2311.2003.00494.x; Schonrogge K, 2000, P ROY SOC B-BIOL SCI, V267, P771, DOI 10.1098/rspb.2000.1070; Schtickzelle N, 2005, BIOL CONSERV, V126, P569, DOI 10.1016/j.biocon.2005.06.030; Schtickzelle N, 2005, OIKOS, V109, P89, DOI 10.1111/j.0030-1299.2005.13745.x; Schtickzelle N, 2004, OIKOS, V104, P277, DOI 10.1111/j.0030-1299.2004.12825.x; Schtickzelle Nicolas, 2009, P339; Schultz CB, 2003, CONSERV BIOL, V17, P1372, DOI 10.1046/j.1523-1739.2003.02141.x; Stevens VM, 2008, CONSERV BIOL, V22, P1194, DOI 10.1111/j.1523-1739.2008.00990.x; Stewart A.J., 2007, INSECT CONSERVATION; Thomas JA, 2009, SCIENCE, V325, P80, DOI 10.1126/science.1175726; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Thomas JA, 1998, ECOL ENTOMOL, V23, P457, DOI 10.1046/j.1365-2311.1998.00153.x; THOMAS JA, 1989, OECOLOGIA, V79, P452, DOI 10.1007/BF00378660; van Dyck H, 2000, P ROY SOC B-BIOL SCI, V267, P861, DOI 10.1098/rspb.2000.1082; van Langevelde F, 2009, ANIM CONSERV, V12, P540, DOI 10.1111/j.1469-1795.2009.00281.x; WallisDeVries MF, 2004, CONSERV BIOL, V18, P489; WallisDeVries MF, 2010, RESTOR ECOL, V18, P390, DOI 10.1111/j.1526-100X.2008.00447.x; Wynhoff I., 1996, P15; Zeisset I, 2005, MOL ECOL NOTES, V5, P165, DOI 10.1111/j.1471-8286.2004.00872.x	56	9	9	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38684	10.1371/journal.pone.0038684	http://dx.doi.org/10.1371/journal.pone.0038684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719922	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800014
J	Wada, S; Kawano-Yamashita, E; Koyanagi, M; Terakita, A				Wada, Seiji; Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Terakita, Akihisa			Expression of UV-Sensitive Parapinopsin in the Iguana Parietal Eyes and Its Implication in UV-Sensitivity in Vertebrate Pineal-Related Organs	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; GREEN IGUANA; G-PROTEIN; PIGMENT; OPSIN; PHOTORECEPTORS; MECHANISM; FAMILY	The pineal-related organs of lower vertebrates have the ability to discriminate different wavelengths of light. This wavelength discrimination is achieved through antagonistic light responses to UV or blue and visible light. Previously, we demonstrated that parapinopsin underlies the UV reception in the lamprey pineal organ and identified parapinopsin genes in teleosts and frogs of which the pineal-related organs were reported to discriminate light. In this study, we report the first identification of parapinopsin in the reptile lineage and show its expression in the parietal eye of the green iguana. Spectroscopic analysis revealed that iguana parapinopsin is a UV-sensitive pigment, similar to lamprey parapinopsin. Interestingly, immunohistochemical analyses using antibodies specific to parapinopsin and parietopsin, a parietal eye green-sensitive pigment, revealed that parapinopsin and parietopsin are colocalized in the outer segments of the parietal eye photoreceptor cells in iguanas. These results strongly suggest that parapinopsin underlies the wavelength discrimination involving UV reception in the iguana parietal eye. The current findings support the idea that parapinopsin is a common photopigment underlying the UV-sensitivity in wavelength discrimination of the pineal-related organs found from lampreys to reptiles.	[Wada, Seiji; Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 558, Japan	Osaka Metropolitan University	Wada, S (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 558, Japan.	terakita@sci.osaka-cu.ac.jp	WADA, SEIJI/GZL-0272-2022	Koyanagi, Mitsumasa/0000-0002-7741-918X; Terakita, Akihisa/0000-0002-8379-8913	Japanese Ministry of Education, Science, Sports, and Culture; Naito Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22687005] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (to A. T. and M. K.) and the Naito Foundation (to A. T.). E.K-Y. is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshaw S, 1997, J NEUROSCI, V17, P8083; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; DODT E, 1962, J NEUROPHYSIOL, V25, P405, DOI 10.1152/jn.1962.25.3.405; ELDRED WD, 1978, VISION RES, V18, P29, DOI 10.1016/0042-6989(78)90073-1; FALCON J, 1981, J COMP PHYSIOL, V144, P127, DOI 10.1007/BF00612806; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HAMASAKI DI, 1968, VISION RES, V8, P591, DOI 10.1016/0042-6989(68)90100-4; HAMASAKI DI, 1969, VISION RES, V9, P515, DOI 10.1016/0042-6989(69)90139-4; JENISON G, 1980, BRAIN RES, V194, P506, DOI 10.1016/0006-8993(80)91232-9; KAPPERS J A, 1965, Prog Brain Res, V10, P87; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawano-Yamashita E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016402; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MORITA Y, 1966, PFLUG ARCH GES PHYS, V289, P155, DOI 10.1007/BF00412906; Morita Y, 1973, NOVA ACTA LEOPOLDINA, V38, P331; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; OKSCHE A, 1965, Prog Brain Res, V10, P3; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; UCHIDA K, 1994, PFLUG ARCH EUR J PHY, V427, P373, DOI 10.1007/BF00374547; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107	27	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39003	10.1371/journal.pone.0039003	http://dx.doi.org/10.1371/journal.pone.0039003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720013	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347800035
J	Nishishita, N; Shikamura, M; Takenaka, C; Takada, N; Fusak, N; Kawamata, S				Nishishita, Naoki; Shikamura, Masayuki; Takenaka, Chiemi; Takada, Nozomi; Fusak, Noemi; Kawamata, Shin			Generation of Virus-Free Induced Pluripotent Stem Cell Clones on a Synthetic Matrix via a Single Cell Subcloning in the Naive State	PLOS ONE			English	Article							SENDAI-VIRUS; INDUCTION; FIBROBLASTS	CD34+ cord blood cells can be reprogrammed effectively on dishes coated with a synthetic RGD motif polymer (PronectinF (R)) using a temperature sensitive Sendai virus vector (SeV TS7) carrying reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC. Dish-shaped human ES cell-like colonies emerged in serum-free primate ES cell medium (supplemented with bFGF) in 20% O2 culture conditions. The copy numbers of SeV TS7 vectors in the cytoplasm were drastically reduced by a temperature shift at 38 degrees C for three days. Then, single cells from colonies were seeded on PronectinF (R)-coated 96-well plates and cultured under naive culture conditions (N2B27-based medium supplemented with LIF, forskolin, a MAPK inhibitor, and a GSK inhibitor in 5% O2) for cloning purpose. Dome-shaped mouse ES cell-like colonies from single cells emerged on PronectinF (R)-coated dishes. These cells were collected and cultured again in primate ES cell medium supplemented with bFGF in 20% O2 and maintained on PronectinF (R)-coated dishes. Cells were assessed for reprogramming, including the absence of residual SeV and their potential for three germ layer differentiation. Generation of virus-free induced pluripotent stem cell (iPSC) clones from single cells under feeder-free conditions will solve some of the safety concerns related to use of xeno- or allogeneic-material in culture, and contribute to the characterization and the standardization of iPS cells intended for use in a clinical setting.	[Nishishita, Naoki; Takenaka, Chiemi; Kawamata, Shin] Riken Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan; [Nishishita, Naoki; Shikamura, Masayuki; Takenaka, Chiemi; Takada, Nozomi; Kawamata, Shin] Fdn Biomed Res & Innovat, Chuo Ku, Kobe, Hyogo, Japan; [Fusak, Noemi] DNAVEC Corp, Tsukuba, Ibaragi, Japan; [Fusak, Noemi] Japanese Sci & Technol Agcy, Kawaguchi, Saitama, Japan	RIKEN; Institute for Biomedical Research & Innovation (IBRI); DNAVEC Corporation; Japan Science & Technology Agency (JST)	Nishishita, N (corresponding author), Riken Ctr Dev Biol, Chuo Ku, Minatojima Minamimachi, Kobe, Hyogo, Japan.	kawamata@fbri.org		kawamata, shin/0000-0001-5148-1949	JST Tokyo Japan; JSPS [2210853]; S-Innovation project of JST Tokyo Japan	JST Tokyo Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); S-Innovation project of JST Tokyo Japan	This work was supported by the Regulatory Science Study for Safety issue for pluripotent stem cells of JST Tokyo Japan (2010-2014) and a Grant-in-Aid for JSPS Fellows 2210853 and S-Innovation project of JST Tokyo Japan (2009-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hakala H, 2009, TISSUE ENG PT A, V15, P1775, DOI 10.1089/ten.tea.2008.0316; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Nishishita N, 2011, EMBRYONIC STEM CELL, P399; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Wernet P, 2011, EXP HEMATOL, P1099; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhou HY, 2010, J BIOL CHEM, V285, P29676, DOI 10.1074/jbc.C110.150599	23	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38389	10.1371/journal.pone.0038389	http://dx.doi.org/10.1371/journal.pone.0038389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719883	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900026
J	Prieto-Marquez, A; Chiappe, LM; Joshi, SH				Prieto-Marquez, Albert; Chiappe, Luis M.; Joshi, Shantanu H.			The Lambeosaurine Dinosaur Magnapaulia laticaudus from the Late Cretaceous of Baja California, Northwestern Mexico	PLOS ONE			English	Article							ARAL SEA REGION; HADROSAURIAN DINOSAUR; HYPACROSAURUS-ALTISPINUS; HISTORICAL BIOGEOGRAPHY; NORTHEASTERN CHINA; ORNITHOPODA; ORNITHISCHIA; ANATOMY; PHYLOGENY; KAZAKSTAN	The taxonomy, osteology, phylogenetic position, and historical biogeography of the lambeosaurine hadrosaurid Magnapaulia laticaudus (new combination) are revised. The diagnosis of this species is amended on the basis on two autapomorphies (i.e., longest haemal arches of proximal caudal vertebrae being at least four times longer than the height of their respective centra; base of prezygapophyses in caudal vertebrae merging to form a bowl-shaped surface) and a unique combination of characters (i.e., downturned cranioventral process of the maxilla; tear-shaped external naris with length/width ratio between 1.85 and 2.85; neural spines of dorsal, sacral, and proximal caudal vertebrae being at least four times the height of their respective centra). A maximum parsimony analysis supports a sister taxon relationship between M. laticaudus and Velafrons coahuilensis. Both taxa constitute a clade of southern North American lambeosaurines, which forms a sister relationship with the diverse clade of helmet-crested lambeosaurines from northern North America that includes well-known genera like Corythosaurus, Lambeosaurus, and Hypacrosaurus. According to the results of a Dispersal-Vicariance analysis, southern North American lambeosaurines split from the northern forms via vicariance from a common ancestor that lived in both the northern and southern regions of the continent.	[Prieto-Marquez, Albert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Chiappe, Luis M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA; [Joshi, Shantanu H.] UCLA Sch Med, Lab Neuro Imaging, Dept Neurol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Prieto-Marquez, A (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	redshore@gmail.com	Prieto-Marquez, Albert/AAA-1470-2019; Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001; Prieto-Marquez, Albert/0000-0002-4836-4052; Chiappe, Luis/0000-0001-9661-0601	Dinosaur Institute at the Natural History Museum of Los Angeles County; Alexander von Humboldt Foundation; National Science Foundation [EAR 0207744, DBI 0446224]; Ministry of Education and Science of Spain [CGL2011-30069-C02-01]	Dinosaur Institute at the Natural History Museum of Los Angeles County; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); Ministry of Education and Science of Spain(Spanish Government)	Funds for this project were provided by the Dinosaur Institute at the Natural History Museum of Los Angeles County, the Alexander von Humboldt Foundation, the National Science Foundation (EAR 0207744 and DBI 0446224 grants presented to G. Erickson), and the Ministry of Education and Science of Spain (CGL2011-30069-C02-01 grant presented to A. Galobart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 1998, J VERTEBR PALEONTOL, V18, P739, DOI 10.1080/02724634.1998.10011102; Averianov AO, 2007, CRETACEOUS RES, V28, P532, DOI 10.1016/j.cretres.2006.08.008; AVERIANOV AO, 1995, NEUES JB GEOLOGIE PA, P65; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Brett-Surman Michael K., 2007, P135; BRETTSURMAN MK, 1979, NATURE, V277, P560, DOI 10.1038/277560a0; Brink KS, 2011, THESIS U CALGARY; Brodkorb P., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P67; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Brown B, 1910, B AM MUS NAT HIST, V31, P131; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cope ED, 1885, AM NAT, V19, P1208; Coria R.A., 2009, THESIS U NACL LUJAN; Donoghue M. J, 1992, ANN MISSOURI BOT GAR, V79, P672, DOI 10.2307/2399772; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC., 2007, THESIS U TORONTO; Fang, 2001, SHANTUNGOSAURUS GIGA; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2000, CR ACAD SCI II A, V330, P875, DOI 10.1016/S1251-8050(00)00214-7; Godefroit P, 2003, C R PALEVOL, V2, P143, DOI 10.1016/S1631-0683(03)00017-4; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Godefroit P, 2012, ACTA PALAEONTOL POL, V57, P527, DOI 10.4202/app.2011.0051; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Herrero Lucia, 2010, PalArch's Journal of Vertebrate Palaeontology, V7, P1; Hong JP, 1999, ISL ARC, V8, P80, DOI 10.1046/j.1440-1738.1999.00226.x; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; HORNER JR, 1984, J PALEONTOL, V58, P270; Joshi SH, 2007, P IEEE C COMP VIS PA, V17, P1; Joshi SH, 2007, LECT NOTES COMPUT SC, V4679, P387; Joshi SH, 2011, BIOL J LINN SOC, V104, P217, DOI 10.1111/j.1095-8312.2011.01704.x; Kordikova EG, 2001, J PALEONTOL, V75, P390, DOI 10.1666/0022-3360(2001)075<0390:SVFTLC>2.0.CO;2; Lambe L., 1914, Ottawa Naturalist, V27; Lillegraven J.A., 1972, Contributions Sci, VNo. 232, P1; LUCAS SG, 2006, NEW MEXICO MUSEUM NA, V35, P293; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Manning PL, 2009, P ROY SOC B-BIOL SCI, V276, P3429, DOI 10.1098/rspb.2009.0812; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Milner A.R., 1984, 3 S MESOZOIC TERREST, P145; MOLNAR RE, 1974, J PALEONTOL, V48, P1009; Montellano M, 2005, J VERTEBR PALEONTOL, V25, p93A; MORRIS WJ, 1981, J PALEONTOL, V55, P453; MORRIS WJ, 1972, J PALEONTOL, V46, P777; MORRIS WJ, 1978, J PALEONTOL, V52, P200; MORRIS WJ, 1967, SCIENCE, V155, P1539, DOI 10.1126/science.155.3769.1539; MORRIS WJ, 1973, J PALEONTOL, V47, P551; Morris WJ, 1976, NATL GEOGRAPHIC RES, P305; MORRIS WJ, 1974, GUIDEBOOK GEOLOGY PE, P60; Negro G, 2001, PALEOBIOS S2, V21, P96; Novas F. E., 2009, AGE DINOSAURS S AM; NYDAM RL, 1999, UTAH GEOLOGICAL SURV, P303; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Ostrom J. H., 1962, Postilla, VNo. 62, P1; Owen R., 1842, 11 M BRIT ASS ADV SC, P66; PARKS WA, 1923, U TORONTO STUDIES GE, V15, P5; Pinna G., 1979, MEM SOC ITAL SCI NAT, V22, P33; Powell J.E., 1987, 10 C GEOL ARG ACT, P149; Prieto-Marquez A, 2008, THESIS FLORIDA STATE; Prieto-Marquez A, 2006, J VERTEBR PALEONTOL, V26, P929, DOI 10.1671/0272-4634(2006)26[929:HDFTLC]2.0.CO;2; Prieto-Marquez A, 2007, J VERTEBR PALEONTOL, V27, p131A; Prieto-Marquez A, 2011, ZOOTAXA, P61; Prieto-Marquez A, 2011, J PALEONTOL, V85, P468, DOI 10.1666/10-106.1; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; RONQUIST F, 1996, DIVA VERSION 1 1 COM; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Srivastava A, 2011, IEEE T PATTERN ANAL, V33, P1415, DOI 10.1109/TPAMI.2010.184; Sullivan R.M., 1999, NEW MEXICO MUSEUM NA, V15, P1; Sullivan RM., 2011, NEW MEXICO MUSEUM NA, V53, P405; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P7; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Versluys J., 1923, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V38, P1; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Wegweiser MD, 2006, NEW MEXICO MUSEUM NA, V35, P1422; WEISHAMPEL DB, 1981, J PALEONTOL, V55, P1046; Wideman NK, 2001, PALEOBIOS, V21, P134; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148; YOUNG CC, 1958, PALAEONTOLOGIA SIN C, V16, P53; Young F. W., 1985, ENCY STAT SCI, V5, P649	87	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38207	10.1371/journal.pone.0038207	http://dx.doi.org/10.1371/journal.pone.0038207			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719869	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000014
J	Sivaguru, M; Mander, L; Fried, G; Punyasena, SW				Sivaguru, Mayandi; Mander, Luke; Fried, Glenn; Punyasena, Surangi W.			Capturing the Surface Texture and Shape of Pollen: A Comparison of Microscopy Techniques	PLOS ONE			English	Article							RESOLUTION LIMIT; IMAGE-FORMATION; VEGETATION; RECORDS; ANALOGS; LIGHT	Research on the comparative morphology of pollen grains depends crucially on the application of appropriate microscopy techniques. Information on the performance of microscopy techniques can be used to inform that choice. We compared the ability of several microscopy techniques to provide information on the shape and surface texture of three pollen types with differing morphologies. These techniques are: widefield, apotome, confocal and two-photon microscopy (reflected light techniques), and brightfield and differential interference contrast microscopy (DIC) (transmitted light techniques). We also provide a first view of pollen using super-resolution microscopy. The three pollen types used to contrast the performance of each technique are: Croton hirtus (Euphorbiaceae), Mabea occidentalis (Euphorbiaceae) and Agropyron repens (Poaceae). No single microscopy technique provided an adequate picture of both the shape and surface texture of any of the three pollen types investigated here. The wavelength of incident light, photon-collection ability of the optical technique, signal-to-noise ratio, and the thickness and light absorption characteristics of the exine profoundly affect the recovery of morphological information by a given optical microscopy technique. Reflected light techniques, particularly confocal and two-photon microscopy, best capture pollen shape but provide limited information on very fine surface texture. In contrast, transmitted light techniques, particularly differential interference contrast microscopy, can resolve very fine surface texture but provide limited information on shape. Texture comprising sculptural elements that are spaced near the diffraction limit of light (similar to 250 nm; NDL) presents an acute challenge to optical microscopy. Super-resolution structured illumination microscopy provides data on the NDL texture of A. repens that is more comparable to textural data from scanning electron microscopy than any other optical microscopy technique investigated here. Maximizing the recovery of morphological information from pollen grains should lead to more robust classifications, and an increase in the taxonomic precision with which ancient vegetation can be reconstructed.	[Sivaguru, Mayandi; Fried, Glenn] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Mander, Luke; Punyasena, Surangi W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sivaguru, M (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	punyasena@life.illinois.edu	Sivaguru, Mayandi/M-3393-2019; Punyasena, Surangi/C-9134-2011; Sivaguru, Mayandi/L-7845-2019	Sivaguru, Mayandi/0000-0001-5532-4393; Punyasena, Surangi/0000-0003-2110-5840	US National Science Foundation [DBI-1052997]	US National Science Foundation(National Science Foundation (NSF))	This research was supported by funding from the US National Science Foundation (DBI-1052997 to SWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Biggs DSC., 2010, MICROS TODAY, DOI [DOI 10.1017/S1551929510991311, 10.1017/s1551929510991311]; Biggs DSC, 2010, CURRENT PROTOCOLS CY, V12; Bradbury S., 1998, INTRO LIGHT MICROSCO; Brenner Gilbert J., 1996, P91, DOI 10.1007/978-0-585-23095-5_5; Brenner Gilbert J., 1992, Palynology, V16, P137; Burge HA, 2002, J ALLERGY CLIN IMMUN, V110, P544, DOI 10.1067/mai.2002.128674; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Feijo JA, 2004, PROTOPLASMA, V223, P1, DOI 10.1007/s00709-003-0026-2; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Heimhofer U, 2005, GEOLOGY, V33, P141, DOI 10.1130/G21053.1; Heimhofer U, 2007, REV PALAEOBOT PALYNO, V144, P39, DOI 10.1016/j.revpalbo.2005.09.006; Heintzmann Rainer, 2006, Briefings in Functional Genomics & Proteomics, V5, P289, DOI 10.1093/bfgp/ell036; Hochuli PA, 2004, J MICROPALAEONTOL, V23, P97, DOI 10.1144/jm.23.2.97; Holst I, 2007, P NATL ACAD SCI USA, V104, P17608, DOI 10.1073/pnas.0708736104; Horrocks M, 1998, J FORENSIC SCI, V43, P320; Inoue S., 1997, VIDEO MICROSCOPY FUN; Iversen J, 1989, J BIOGEOGR; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Karadaglic D, 2008, MICRON, V39, P808, DOI 10.1016/j.micron.2008.01.017; KOHLER H, 1981, OPT ACTA, V28, P1691, DOI 10.1080/713820514; Liu CYS, 2007, REV PALAEOBOT PALYNO, V145, P289, DOI 10.1016/j.revpalbo.2006.12.001; Lomax BH, 2008, NAT GEOSCI, V1, P592, DOI 10.1038/ngeo278; Mander L, 2011, J MICROPALAEONTOL, V30, P107, DOI 10.1144/0262-821X11-012; Mander L, 2010, P NATL ACAD SCI USA, V107, P15351, DOI 10.1073/pnas.1004207107; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; Moore P.D., 1991, BLACKWELL SCI PUBLI; Nelson DM, 2006, HOLOCENE, V16, P819, DOI 10.1191/0959683606hol974rp; Oldenbourg RShribakM, 2010, HDB OPTICS GEOMETRIC, P28; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; PAWLEY JB, 2006, HDB BIOL CONFOCAL MI, P265; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Punyasena SW, 2011, SCIENCE, V333, DOI 10.1126/science.1207525; Punyasena SW, NATURE GEOS IN PRESS; Salih A, 1997, GRANA, V36, P215, DOI 10.1080/00173139709362610; Traverse A., 2007, PALEOPALYNOLOGY; Vitha S, 2009, MICROSC MICROANAL, V15, P622, DOI 10.1017/S1431927609094367; Weiss S, 2000, P NATL ACAD SCI USA, V97, P8747, DOI 10.1073/pnas.97.16.8747; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Wodehouse RP., 1935, POLLEN GRAINS	41	49	52	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39129	10.1371/journal.pone.0039129	http://dx.doi.org/10.1371/journal.pone.0039129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720050	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340000066
J	Gandhi, MP; Kumar, AMV; Toshniwal, MN; Reddy, RHR; Oeltmann, JE; Nair, SA; Satyanarayana, S; Dewan, PK; Mannan, S				Gandhi, Mohit Padamchand; Kumar, Ajay M. V.; Toshniwal, Manoj Nandkishor; Reddy, Raveendra H. R.; Oeltmann, John E.; Nair, Sreenivas Achuthan; Satyanarayana, Srinath; Dewan, Puneet Kumar; Mannan, Shamim			Sputum Smear Microscopy at Two Months into Continuation-Phase: Should It Be Done in All Patients with Sputum Smear-Positive Tuberculosis?	PLOS ONE			English	Article								Background: The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up sputum smear examination at two months into the continuation phase of treatment. The main intent of this (mid-CP) follow-up is to detect patients not responding to treatment around two-three months earlier than at the end of the treatment. However, the utility of mid-CP follow-up under programmatic conditions has been questioned. We undertook a multi-district study to determine if mid-CP follow-up is able to detect cases of treatment failures early among all types of patients with sputum smear-positive TB. Methodology: We reviewed existing records of patients with sputum smear-positive TB registered under the RNTCP in 43 districts across three states of India during a three month period in 2009. We estimated proportions of patients that could be detected as a case of treatment failure early, and assessed the impact of various policy options on laboratory workload and number needed to test to detect one case of treatment failure early. Results: Of 10055 cases, mid-CP follow-up was done in 6944 (69%) cases. Mid-CP follow-up could benefit 117/8015 (1.5%) new and 206/2040 (10%) previously-treated sputum smear-positive cases by detecting their treatment failure early. Under the current policy, 31 patients had to be tested to detect one case of treatment failure early. All cases of treatment failure would still be detected early if mid-CP follow-up were discontinued for new sputum smear-positive cases who become sputum smear-negative after the intensive-phase of treatment. This would reduce the related laboratory workload by 69% and only 10 patients would need to be tested to detect one case of treatment failure early. Conclusion: Discontinuation of mid-CP follow-up among new sputum smear-positive cases who become sputum smear-negative after completing the intensive-phase of treatment will reduce the laboratory workload without impacting overall early detection of cases of treatment failure.	[Gandhi, Mohit Padamchand; Toshniwal, Manoj Nandkishor; Nair, Sreenivas Achuthan; Dewan, Puneet Kumar; Mannan, Shamim] Off World Hlth Org Representat India, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath] Int Union TB & Lung Dis, SE Asia Reg Off, New Delhi, India; [Reddy, Raveendra H. R.] Program Appropriate Technol Hlth, Hyderabad, Andhra Pradesh, India; [Oeltmann, John E.] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Kumar, Ajay M. V.] Minist Hlth & Family Welf, Cent TB Div, Directorate Gen Hlth Serv, New Delhi, India	World Health Organization; Centers for Disease Control & Prevention - USA	Gandhi, MP (corresponding author), Off World Hlth Org Representat India, New Delhi, India.	gandhim@tbcindia.nic.in	Gandhi, Mohit P./AAB-7637-2022	Gandhi, Mohit P./0000-0001-8660-8436; Toshniwal, Manoj/0000-0002-3538-5225; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Satyanarayana, Srinath/0000-0002-5420-2551; Nair, Sreenivas/0000-0002-2586-6797	Union from Global Fund Round 9 India TB Project funds; WHO-India from United States Agency for International Development funds	Union from Global Fund Round 9 India TB Project funds; WHO-India from United States Agency for International Development funds(United States Agency for International Development (USAID)World Health Organization)	The study was conducted as a part of the 'TB Operations Research Training Project' aimed to build operational research capacity within the Government of India's Revised National Tuberculosis Control Progra. This training project was conceived and implemented jointly by Central TB Division (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India), The National TB Institute (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India Bangalore, India), World Health Organization (WHO)(India Country Office), The International Union Against Tuberculosis and Lung Diseases (The Union, South-East Asia Regional Office, New Delhi, India) and United States Centers for Disease Control and Prevention (Division of TB Elimination, Atlanta, United States of America). Funding support was provided in part by The Union from Global Fund Round 9 India TB Project funds and by WHO-India from United States Agency for International Development funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Tuberculosis Division, 2011, TRAIN COURS PROGR MA; Central Tuberculosis Division, 2011, TB IND 2011; Thomas A., 2006, Indian Journal of Tuberculosis, V53, P37; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	4	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39296	10.1371/journal.pone.0039296	http://dx.doi.org/10.1371/journal.pone.0039296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723991	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700064
J	Griffiths, CJ; Zuel, N; Tatayah, V; Jones, CG; Griffiths, O; Harris, S				Griffiths, Christine J.; Zuel, Nicolas; Tatayah, Vikash; Jones, Carl G.; Griffiths, Owen; Harris, Stephen			The Welfare Implications of Using Exotic Tortoises as Ecological Replacements	PLOS ONE			English	Article							WILDING NORTH-AMERICA; GIANT TORTOISES; ALDABRA-ATOLL; ASSISTED COLONIZATION; GEOCHELONE-RADIATA; REINTRODUCTION PROGRAMS; NATURAL REGULATION; CONSERVATION TOOL; PLEISTOCENE PARK; GOPHER TORTOISES	Background: Ecological replacement involves the introduction of non-native species to habitats beyond their historical range, a factor identified as increasing the risk of failure for translocations. Yet the effectiveness and success of ecological replacement rely in part on the ability of translocatees to adapt, survive and potentially reproduce in a novel environment. We discuss the welfare aspects of translocating captive-reared non-native tortoises, Aldabrachelys gigantea and Astrochelys radiata, to two offshore Mauritian islands, and the costs and success of the projects to date. Methodology/Principal Findings: Because tortoises are long-lived, late-maturing reptiles, we assessed the progress of the translocation by monitoring the survival, health, growth, and breeding by the founders. Between 2000 and 2011, a total of 26 A. gigantea were introduced to Ile aux Aigrettes, and in 2007 twelve sexually immature A. gigantea and twelve male A. radiata were introduced to Round Island, Mauritius. Annual mortality rates were low, with most animals either maintaining or gaining weight. A minimum of 529 hatchlings were produced on Ile aux Aigrettes in 11 years; there was no potential for breeding on Round Island. Project costs were low. We attribute the success of these introductions to the tortoises' generalist diet, habitat requirements, and innate behaviour. Conclusions/Significance: Feasibility analyses for ecological replacement and assisted colonisation projects should consider the candidate species' welfare during translocation and in its recipient environment. Our study provides a useful model for how this should be done. In addition to serving as ecological replacements for extinct Mauritian tortoises, we found that releasing small numbers of captive-reared A. gigantea and A. radiata is cost-effective and successful in the short term. The ability to release small numbers of animals is a particularly important attribute for ecological replacement projects since it reduces the potential risk and controversy associated with introducing non-native species.	[Griffiths, Christine J.; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Griffiths, Christine J.; Zuel, Nicolas; Tatayah, Vikash; Jones, Carl G.] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Griffiths, Christine J.; Zuel, Nicolas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Jones, Carl G.] Durrell Wildlife Conservat Trust, Trinity, Jersey, England; [Griffiths, Owen] Bioculture Ltd, Senneville, Riviere Des Ang, Mauritius	University of Bristol; University of Zurich	Griffiths, CJ (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	christine.griffiths@bristol.ac.uk			Dulverton Trust; Faculty of Mathematics and Natural Sciences of the University of Zurich; La Vanille Reserve des Mascareignes; Mauritian Wildlife Foundation; National Parks and Conservation Service of Mauritius; Swiss National Science Foundation [631-065950]	Dulverton Trust; Faculty of Mathematics and Natural Sciences of the University of Zurich; La Vanille Reserve des Mascareignes; Mauritian Wildlife Foundation; National Parks and Conservation Service of Mauritius; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided by the Dulverton Trust, the Faculty of Mathematics and Natural Sciences of the University of Zurich, La Vanille Reserve des Mascareignes, Mauritian Wildlife Foundation, National Parks and Conservation Service of Mauritius, and the Swiss National Science Foundation (grant 631-065950 to Christine Muller). The study was a collaborative project and while three of the authors (VT, CGJ, and OG) worked for funding bodies at the time, they had no disproportionate influence on the study design, data collection, and analysis.	[Anonymous], 1998, IUCN GUIDELINES REIN; [Anonymous], 1987, IUCN POSITION STATEM; ARNOLD EN, 1979, PHILOS T ROY SOC B, V286, P127, DOI 10.1098/rstb.1979.0022; Balmer O, 2011, J HERED, V102, P29, DOI 10.1093/jhered/esq096; Bertolero A, 2007, ANIM CONSERV, V10, P360, DOI 10.1111/j.1469-1795.2007.00121.x; BOURN D, 1978, PHILOS T ROY SOC B, V282, P139, DOI 10.1098/rstb.1978.0011; BRATTSTROM BH, 1974, AM ZOOL, V14, P35; Burbidge Andrew A., 2011, Pacific Conservation Biology, V17, P259; Cayford J, 1992, NEW SCI, V1807, P29; Cheke A., 2008, LOST LAND DODO ECOLO; COE MJ, 1979, PHILOS T R SOC B, V286, P163, DOI 10.1098/rstb.1979.0024; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Dinerstein E, 2005, NATURE, V437, P476, DOI 10.1038/437476a; DODD CK, 1991, HERPETOLOGICA, V47, P336; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Field KJ, 2007, BIOL CONSERV, V136, P232, DOI 10.1016/j.biocon.2006.11.022; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Galetti M., 2004, NAT CONSERV, V2, P93; GIBBONS JW, 1987, BIOSCIENCE, V37, P262, DOI 10.2307/1310589; GIBSON CWD, 1984, OECOLOGIA, V61, P230, DOI 10.1007/BF00396766; GIBSON CWD, 1983, OECOLOGIA, V56, P84, DOI 10.1007/BF00378221; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; Griffiths CJ, 2010, RESTOR ECOL, V18, P1, DOI 10.1111/j.1526-100X.2009.00612.x; GRUBB P, 1971, PHILOS T ROY SOC B, V260, P327, DOI 10.1098/rstb.1971.0018; HAMBLER C, 1994, BIOL CONSERV, V69, P293, DOI 10.1016/0006-3207(94)90429-4; Hansen Dennis M., 2010, P111; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; IUCN, IUCN SSC GUID UNPUB; JACKSON OF, 1980, J SMALL ANIM PRACT, V21, P409, DOI 10.1111/j.1748-5827.1980.tb01269.x; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Leuteritz T, 2008, ASTROCHELYS RADIATA; Leuteritz TEJ, 2005, AFR ZOOL, V40, P233; Leuteritz TEJ, 2005, BIOL CONSERV, V124, P451, DOI 10.1016/j.biocon.2005.02.003; Leuteritz Thomas E. J., 2003, African Journal of Herpetology, V52, P127; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lingard M., 2003, CONSERV SOC, V2, P223; MACFARLAND C G, 1974, Biological Conservation, V6, P118, DOI 10.1016/0006-3207(74)90024-X; MERTON L F H, 1976, Biological Conservation, V9, P293, DOI 10.1016/0006-3207(76)90051-3; O'Brien S, 2003, ORYX, V37, P338, DOI 10.1017/S0030605303000590; Oliveira-Santos LGR, 2010, CONSERV BIOL, V24, P4, DOI 10.1111/j.1523-1739.2009.01379.x; Parker KA, 2010, RESTOR ECOL, V18, P269, DOI 10.1111/j.1526-100X.2010.00676.x; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Pedrono M, 2000, BIOL CONSERV, V95, P333, DOI 10.1016/S0006-3207(00)00023-9; Pedrono M., 2008, TORTOISES TURTLES MA; Pemberton JW, 2009, CHELONIAN CONSERV BI, V8, P57, DOI 10.2744/CCB-0728.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RANDRIAMAHAZO H., 2007, POPULATION HABITAT V; REINERT HK, 1991, HERPETOLOGICA, V47, P357; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Rubenstein DR, 2006, BIOL CONSERV, V132, P232, DOI 10.1016/j.biocon.2006.04.003; SAMOUR HJ, 1987, BIOL CONSERV, V41, P147, DOI 10.1016/0006-3207(87)90117-0; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Schlaepfer MA, 2005, NATURE, V437, P951, DOI 10.1038/437951a; Schlaepfer MA, 2009, TRENDS ECOL EVOL, V24, P471, DOI 10.1016/j.tree.2009.05.008; Seddon PJ, 1999, TRENDS ECOL EVOL, V14, P503, DOI 10.1016/S0169-5347(99)01720-6; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Soorae P. S., 2008, GLOBAL REINTRODUCTIO; STODDART DR, 1982, BIOL CONSERV, V24, P67, DOI 10.1016/0006-3207(82)90047-7; SWINGLAND IR, 1979, PHILOS T ROY SOC B, V286, P177, DOI 10.1098/rstb.1979.0025; SWINGLAND IR, 1979, J ANIM ECOL, V48, P639, DOI 10.2307/4184; TAYLOR JD, 1979, PHILOS T ROY SOC B, V286, P47, DOI 10.1098/rstb.1979.0015; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Tuberville TD, 2005, ANIM CONSERV, V8, P349, DOI 10.1017/S1367943005002398; Tuberville TD, 2008, BIOL CONSERV, V141, P2690, DOI 10.1016/j.biocon.2008.08.004; Tuberville TD, 2011, BIOL CONSERV, V144, P175, DOI 10.1016/j.biocon.2010.08.012; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	70	10	10	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39395	10.1371/journal.pone.0039395	http://dx.doi.org/10.1371/journal.pone.0039395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724012	Green Submitted, Green Published, gold			2022-12-27	WOS:000305652700077
J	Johnston, NE; Atlas, LY; Wager, TD				Johnston, Natalie E.; Atlas, Lauren Y.; Wager, Tor D.			Opposing Effects of Expectancy and Somatic Focus on Pain	PLOS ONE			English	Article							BRAIN MEDIATORS; CARDIOVASCULAR-RESPONSES; SOCIAL THREAT; ATTENTION; INTENSITY; ANTICIPATION; EXPECTATIONS; CORTEX; DISTRACTION; INFORMATION	High-pain expectancy increases pain and pain-related brain activity, creating a cycle of psychologically maintained pain. Though these effects are robust, little is known about how expectancy works and what psychological processes either support or mitigate its effects. To address this, we independently manipulated pain expectancy and "top-down" attention to the body, and examined their effects on both a performance-based measure of body-focus and heat-induced pain. Multilevel mediation analyses showed that high-pain expectancy substantially increased pain, replicating previous work. However, attention to the body reduced pain, partially suppressing the effects of expectancy. Furthermore, increased bodyfocus had larger pain-reducing effects when pain expectancy was high, suggesting that attempts to focus on external distractors are counterproductive in this situation. Overall, the results show that attention to the body cannot explain pain-enhancing expectancy effects, and that focusing on sensory/discriminative aspects of pain might be a useful pain-regulation strategy when severe pain is expected.	[Johnston, Natalie E.] Weill Cornell Med Coll, Dept Neurosci, New York, NY USA; [Atlas, Lauren Y.] NYU, Dept Psychol, New York, NY 10003 USA; [Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Cornell University; New York University; University of Colorado System; University of Colorado Boulder	Johnston, NE (corresponding author), Weill Cornell Med Coll, Dept Neurosci, New York, NY USA.	tor.wager@colorado.edu	Atlas, Lauren/W-9619-2019; Atlas, Lauren Yvette/GXV-6811-2022	Atlas, Lauren/0000-0001-5693-4169	National Institutes of Health [NIH MH076136, NIH RC1DA028608, NIH R01DA027794]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028608, R01DA027794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was made possible with the support of the following National Institutes of Health grants awarded to Tor D. Wager: NIH MH076136; NIH RC1DA028608; and NIH R01DA027794. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 1996, J AM STAT ASSOC, V91, P468, DOI 10.2307/2291634; ARNTZ A, 1991, BEHAV RES THER, V29, P41, DOI 10.1016/S0005-7967(09)80006-5; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown CA, 2008, CLIN NEUROPHYSIOL, V119, P2370, DOI 10.1016/j.clinph.2008.06.014; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Buhle JT, 2012, PSYCHOL SCI; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Crombez G, 2005, PAIN RES MANAG, V7, P31; ECCLESTON C, 1995, PAIN, V63, P3, DOI 10.1016/0304-3959(95)00093-8; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Geers AL, 1999, J EXP SOC PSYCHOL, V35, P394, DOI 10.1006/jesp.1999.1377; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kenny DA, 2003, PSYCHOL METHODS, V8, P115, DOI 10.1037/1082-989X.8.2.115; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; LEVENTHAL H, 1979, J PERS SOC PSYCHOL, V37, P688, DOI 10.1037/0022-3514.37.5.688; Lorenz R, 2005, BRAIN BEHAV IMMUN, V19, P283, DOI 10.1016/j.bbi.2005.03.010; LYON DR, 1990, ACTA PSYCHOL, V73, P69, DOI 10.1016/0001-6918(90)90059-O; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MCCAUL KD, 1982, J PERS SOC PSYCHOL, V43, P154, DOI 10.1037/0022-3514.43.1.154; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; MIRON D, 1989, PAIN, V39, P345, DOI 10.1016/0304-3959(89)90048-1; Petrovic P, 2000, PAIN, V85, P19, DOI 10.1016/S0304-3959(99)00232-8; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Plaghki L, 1998, J NEUROPHYSIOL, V79, P2557, DOI 10.1152/jn.1998.79.5.2557; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Shih SI, 2002, PSYCHOL REV, V109, P260, DOI 10.1037//0033-295X.109.2.260; SULS J, 1985, HEALTH PSYCHOL, V4, P249, DOI 10.1037/0278-6133.4.3.249; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wager TD, 2009, NEUROIMAGE, V47, P836, DOI 10.1016/j.neuroimage.2009.05.044; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Willer JC, 1999, NEUROPHYSIOL CLIN, V29, P379, DOI 10.1016/S0987-7053(00)87263-9; Wilson TD, 1989, J PERS SOC	45	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38854	10.1371/journal.pone.0038854	http://dx.doi.org/10.1371/journal.pone.0038854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723896	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700034
J	Novoseltsev, VN; Michalski, AI; Novoseltseva, JA; Yashin, AI; Carey, JR; Ellis, AM				Novoseltsev, Vasiliy N.; Michalski, Anatoli I.; Novoseltseva, Janna A.; Yashin, Anatoliy I.; Carey, James R.; Ellis, Alicia M.			An Age-Structured Extension to the Vectorial Capacity Model	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; ANOPHELES-GAMBIAE; MALARIA TRANSMISSION; RELEASE-RECAPTURE; MORTALITY; SURVIVAL; CULICIDAE; POPULATIONS; MOSQUITOS; RATES	Background: Vectorial capacity and the basic reproductive number (R-0) have been instrumental in structuring thinking about vector-borne pathogen transmission and how best to prevent the diseases they cause. One of the more important simplifying assumptions of these models is age-independent vector mortality. A growing body of evidence indicates that insect vectors exhibit age-dependent mortality, which can have strong and varied affects on pathogen transmission dynamics and strategies for disease prevention. Methodology/Principal Findings: Based on survival analysis we derived new equations for vectorial capacity and R-0 that are valid for any pattern of age-dependent (or age-independent) vector mortality and explore the behavior of the models across various mortality patterns. The framework we present (1) lays the groundwork for an extension and refinement of the vectorial capacity paradigm by introducing an age-structured extension to the model, (2) encourages further research on the actuarial dynamics of vectors in particular and the relationship of vector mortality to pathogen transmission in general, and (3) provides a detailed quantitative basis for understanding the relative impact of reductions in vector longevity compared to other vector-borne disease prevention strategies. Conclusions/Significance: Accounting for age-dependent vector mortality in estimates of vectorial capacity and R-0 was most important when (1) vector densities are relatively low and the pattern of mortality can determine whether pathogen transmission will persist; i.e., determines whether R-0 is above or below 1, (2) vector population growth rate is relatively low and there are complex interactions between birth and death that differ fundamentally from birth-death relationships with age-independent mortality, and (3) the vector exhibits complex patterns of age-dependent mortality and R-0 similar to 1. A limiting factor in the construction and evaluation of new age-dependent mortality models is the paucity of data characterizing vector mortality patterns, particularly for free ranging vectors in the field.	[Novoseltsev, Vasiliy N.; Michalski, Anatoli I.; Novoseltseva, Janna A.] Inst Control Sci, Moscow, Russia; [Yashin, Anatoliy I.] Duke Univ, Durham, NC USA; [Carey, James R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Ellis, Alicia M.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	V.A. Trapeznikov Institute of Control Sciences, Russian Academy of Sciences; Duke University; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Novoseltsev, VN (corresponding author), Inst Control Sci, Moscow, Russia.	mpoctok@yandex.ru	Novoseltseva, Janna/B-9482-2017; Michalski, Anatoli/B-3959-2017	Michalski, Anatoli/0000-0003-1998-1315	California Department of Agriculture and Natural Resources; National Institute of Aging/National Institute of Health [P01 AG022500-01, P01 AG08761-10]; NATIONAL INSTITUTE ON AGING [P01AG008761, P01AG022500] Funding Source: NIH RePORTER	California Department of Agriculture and Natural Resources; National Institute of Aging/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research was supported by the California Department of Agriculture and Natural Resources, National Institute of Aging/National Institute of Health grants P01 AG022500-01 and P01 AG08761-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; ANDERSON R M, 1991; Basanez MG, 1996, PARASITOLOGY, V113, P331, DOI 10.1017/S003118200006649X; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Chaves LF, 2004, ACTA TROP, V92, P119, DOI 10.1016/j.actatropica.2004.06.005; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Cohen JM, 2010, MALARIA J, P22; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; GOLDMAN N, 1986, DEMOGRAPHY, V23, P275, DOI 10.2307/2061621; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Hugo LE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000608; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lord CC, 2007, J AM MOSQUITO CONTR, V23, P252, DOI 10.2987/8756-971X(2007)23[252:MABCOM]2.0.CO;2; Luz PM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000761; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Ross R., 1910, PREVENTION MALARIA; SCOTT T. W., 2008, VECTOR BORNE DIS UND, P132; Sierra F, 2007, ENCY GERONTOLOGY, P10; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216	35	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39479	10.1371/journal.pone.0039479	http://dx.doi.org/10.1371/journal.pone.0039479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724022	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700085
J	Stoyanova, E; Trudel, M; Felfly, H; Lemsaddek, W; Garcia, D; Cloutier, G				Stoyanova, Ekatherina; Trudel, Marie; Felfly, Hady; Lemsaddek, Wafaa; Garcia, Damien; Cloutier, Guy			Vascular Endothelial Dysfunction in beta-Thalassemia Occurs Despite Increased eNOS Expression and Preserved Vascular Smooth Muscle Cell Reactivity to NO	PLOS ONE			English	Article							NITRIC-OXIDE; PULMONARY-HYPERTENSION; OXIDATIVE STRESS; MAJOR PATIENTS; HEMOLYSIS; DISEASE; HEMOGLOBIN; STIFFNESS; BLOOD; MODEL	Aims: The hereditary beta-thalassemia major condition requires regular lifelong blood transfusions. Transfusion-related iron overloading has been associated with the onset of cardiovascular complications, including cardiac dysfunction and vascular anomalies. By using an untransfused murine model of beta-thalassemia major, we tested the hypothesis that vascular endothelial dysfunction, alterations of arterial structure and of its mechanical properties would occur despite the absence of treatments. Methods and Results: Vascular function and structure were evaluated ex vivo. Compared to the controls, endothelium-dependent vasodilation with acetylcholine was blunted in mesenteric resistance arteries of beta-thalassemic mice while the endothelium-independent vasodilator (sodium nitroprusside) produced comparable vessel dilation, indicating endothelial cell impairment with preserved smooth muscle cell reactivity to nitric oxide (NO). While these findings suggest a decrease in NO bioavailability, Western blotting showed heightened expression of aortic endothelial NO synthase (eNOS) in beta-thalassemia. Vascular remodeling of the common carotid arteries revealed increased medial elastin content. Under isobaric conditions, the carotid arteries of beta-thalassemic mice exhibited decreased wall stress and softening due to structural changes of the vessel wall. Conclusions: A complex vasculopathy was identified in untransfused beta-thalassemic mice characterized by altered carotid artery structure and endothelial dysfunction of resistance arterioles, likely attributable to reduced NO bioavailability despite enhanced vascular eNOS expression.	[Stoyanova, Ekatherina; Garcia, Damien; Cloutier, Guy] Univ Montreal Hosp Res Ctr, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Stoyanova, Ekatherina; Trudel, Marie; Felfly, Hady; Lemsaddek, Wafaa] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; [Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Stoyanova, E (corresponding author), Univ Montreal Hosp Res Ctr, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.	guy.cloutier@umontreal.ca	Garcia, Damien/E-2206-2011	Garcia, Damien/0000-0002-8552-1475; Trudel, Marie/0000-0003-0057-2669	Canadian Institutes of Health Research [CIHR CMI-72323]; Heart and Stroke Foundation of Canada [PG-05-0313]; National Institutes of Health of United States of America [RO1HL078655]; Canadian Blood Services (CBS); Programme canadien des bourses de la francophonie studentship; CBS/CIHR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078655] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); National Institutes of Health of United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Blood Services (CBS); Programme canadien des bourses de la francophonie studentship; CBS/CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR CMI-72323), Heart and Stroke Foundation of Canada (PG-05-0313), National Institutes of Health of United States of America (RO1HL078655) and the Canadian Blood Services (CBS). HF was a recipient of the Programme canadien des bourses de la francophonie studentship and WL was a recipient of a CBS/CIHR fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; Aessopos A, 2005, CHEST, V127, P1523, DOI 10.1378/chest.127.5.1523; Aggeli C, 2005, INT J CARDIOL, V105, P80, DOI 10.1016/j.ijcard.2004.12.025; Butthep P, 2002, AM J HEMATOL, V70, P100, DOI 10.1002/ajh.10101; Chen SQ, 1996, AM J PHYSIOL-HEART C, V270, pH1951, DOI 10.1152/ajpheart.1996.270.6.H1951; Cheung YF, 2006, BRIT J HAEMATOL, V135, P732, DOI 10.1111/j.1365-2141.2006.06349.x; Cheung YF, 2002, CIRCULATION, V106, P2561, DOI 10.1161/01.CIR.0000037225.92759.A7; Day SM, 2003, CIRCULATION, V107, P2601, DOI 10.1161/01.CIR.0000066910.02844.D0; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Gedikli O, 2007, ECHOCARDIOGR-J CARD, V24, P830, DOI 10.1111/j.1540-8175.2007.00486.x; Gladwin Mark T, 2005, Hematology Am Soc Hematol Educ Program, P51; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Hahalis G, 2005, AM J MED, V118, P957, DOI 10.1016/j.amjmed.2005.02.021; Hovav T, 1999, BRIT J HAEMATOL, V106, P178; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Kassab-Chekir A, 2003, CLIN CHIM ACTA, V338, P79, DOI 10.1016/j.cccn.2003.07.010; Kyriakou DS, 2001, ANN HEMATOL, V80, P577; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Panigrahi I, 2007, THROMB RES, V120, P783, DOI 10.1016/j.thromres.2007.01.015; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Schiffrin EL, 1997, J HYPERTENS, V15, P571, DOI 10.1097/00004872-199715060-00002; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Stakos DA, 2009, INT J CARDIOL, V134, P207, DOI 10.1016/j.ijcard.2008.01.047; Stakos DA, 2009, EUR J HAEMATOL, V82, P477, DOI 10.1111/j.1600-0609.2009.01236.x; Stoyanova E, 2007, PHYSIOL GENOMICS, V29, P84, DOI 10.1152/physiolgenomics.00305.2005; Ulger Z, 2006, J PEDIAT HEMATOL ONC, V28, P647, DOI 10.1097/01.mph.0000212987.18694.5a; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770	35	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38089	10.1371/journal.pone.0038089	http://dx.doi.org/10.1371/journal.pone.0038089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723848	Green Submitted, Green Published, gold			2022-12-27	WOS:000305652700010
J	Winje, BA; Roald, B; Kristensen, NP; Froen, JF				Winje, Brita Askeland; Roald, Borghild; Kristensen, Nina Petrov; Froen, J. Frederik			Placental Pathology in Pregnancies with Maternally Perceived Decreased Fetal Movement - A Population-Based Nested Case-Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; FETUSES; BEHAVIOR; PREDICTION; SINGLETON; OUTCOMES; QUALITY; DEATH	Background: Decreased fetal movements (DFM) are associated with fetal growth restriction and stillbirth, presumably linked through an underlying placental dysfunction. Yet, the role of placental pathology has received limited attention in DFM studies. Our main objective was to explore whether maternal perceptions of DFM were associated with placental pathology in pregnancies recruited from a low-risk total population. Methods/Principal Findings: Placentas from 129 DFM and 191 non-DFM pregnancies were examined according to standardized macro- and microscopic protocols. DFM was defined as any maternal complaint of DFM leading to a hospital examination. Morphological findings were timed and graded according to their estimated onset and clinical importance, and classified in line with a newly constructed Norwegian classification system for reporting placental pathology. With our population-based approach we were unable to link DFM to an overall measure of all forms of placental pathology (OR 1.3, 95% CI 0.8-2.2, p = 0.249). However, placental pathology leading to imminent delivery could be a competing risk for DFM, making separate subgroup analyses more appropriate. Our study suggests a link between DFM and macroscopic placental pathology related to maternal, uteroplacental vessels, i.e. infarctions, placental lesions (intraplacental hematomas) and abruptions. Although not statistically significant separately, a compound measure showed a significant association with DFM (OR 2.4, 95% CI 1.1-5.0, p = 0.023). This association was strengthened when we accounted for relevant temporal aspects. More subtle microscopic materno-placental ischemic changes outside the areas of localized pathology showed no association with DFM (OR 0.5, 95% CI 0.2-1.4, p = 0.203). There was a strong association between placental pathology and neonatal complications (OR 2.9, 95% CI 1.6-5.1, p < 0.001). Conclusions: In our population-based study we were generally unable to link maternally perceived DFM to placental pathology. Some associations were seen for subgroups.	[Winje, Brita Askeland; Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Roald, Borghild] Univ Oslo, Ulleval Hosp, Ctr Pediat & Pregnancy Related Pathol, Dept Pathol, Oslo, Norway; [Roald, Borghild] Univ Oslo, Fac Med, Oslo, Norway; [Kristensen, Nina Petrov] Ostfold Hosp Trust, Dept Pathol, Fredrikstad, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Winje, BA (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.	brita.winje@fhi.no	Kristensen, Niels/A-8795-2013	Froen Froen, Jahn Frederik/0000-0001-9390-8509	Research Council of Norway [185927/V50]	Research Council of Norway(Research Council of Norway)	This project is funded in whole by the Research Council of Norway, 185927/V50, http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog B, 2011, PLACENTA, V32, P58, DOI 10.1016/j.placenta.2010.10.008; BEKEDAM DJ, 1985, AM J OBSTET GYNECOL, V153, P52, DOI 10.1016/0002-9378(85)90589-7; BEKEDAM DJ, 1985, EARLY HUM DEV, V12, P155, DOI 10.1016/0378-3782(85)90178-1; Bendon RW, 2001, PEDIATR DEVEL PATHOL, V4, P517, DOI 10.1007/s10024001-0084-4; Biswas S, 2008, EARLY HUM DEV, V84, P357, DOI 10.1016/j.earlhumdev.2007.09.017; Bocking AD, 2003, EUR J OBSTET GYN R B, V110, pS108, DOI 10.1016/S0301-2115(03)00180-5; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen J Frederik, 2005, Tidsskr Nor Laegeforen, V125, P2631; Froen JF, 2008, SEMIN PERINATOL, V32, P243, DOI 10.1053/j.semperi.2008.04.004; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Gilbert WM, 2003, AM J OBSTET GYNECOL, V188, P1596, DOI 10.1067/mob.2003.384; Gjessing HK, 2007, ULTRASOUND OBST GYN, V30, P19, DOI 10.1002/uog.4053; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Heazell A E P, 2005, J Obstet Gynaecol, V25, P648; Heazell AEP, 2010, PLACENTA, V31, pA103; Kidron D, 2009, PLACENTA, V30, P700, DOI 10.1016/j.placenta.2009.05.009; Last J, 2008, DICT EPIDEMIOLOGY; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; MARI G, 1992, AM J OBSTET GYNECOL, V166, P1262, DOI 10.1016/S0002-9378(11)90620-6; Norwegian Institute of Public Health, 2011, MED BIRTH REG NORW; PEARSON JF, 1976, BRIT MED J, V1, P1305, DOI 10.1136/bmj.1.6021.1305; Redline RW, 2008, PLACENTA, V29, pS86, DOI 10.1016/j.placenta.2007.09.003; RIBBERT LSM, 1993, BRIT J OBSTET GYNAEC, V100, P653, DOI 10.1111/j.1471-0528.1993.tb14233.x; Roald B, 2010, PLACENTA, V31, pA20; Saastad E, 2008, J MIDWIFERY WOM HEAL, V53, P345, DOI 10.1016/j.jmwh.2008.03.001; Saastad Eli, 2010, BMC Res Notes, V3, P2, DOI 10.1186/1756-0500-3-2; SADOVSKY E, 1973, OBSTET GYNECOL, V41, P845; Salafia CM, 1997, CLIN OBSTET GYNECOL, V40, P740, DOI 10.1097/00003081-199712000-00008; Sergent F, 2005, Gynecol Obstet Fertil, V33, P861, DOI 10.1016/j.gyobfe.2005.07.041; SIVAL DA, 1992, EARLY HUM DEV, V28, P119, DOI 10.1016/0378-3782(92)90107-R; Tveit JVH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-49; Tveit JVH, 2009, ACTA OBSTET GYN SCAN, V88, P1345, DOI 10.3109/00016340903348375; Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32; VALENTIN L, 1986, ACTA OBSTET GYN SCAN, V65, P753, DOI 10.3109/00016348609161495; Vindla S, 1997, ULTRASOUND OBST GYN, V9, P302, DOI 10.1046/j.1469-0705.1997.09050302.x; Vindla S, 1999, FETAL DIAGN THER, V14, P156, DOI 10.1159/000020911; Warrander LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034851; Warrander LK, 2011, MED HYPOTHESES, V76, P17, DOI 10.1016/j.mehy.2010.08.020; WHITTY JE, 1991, AM J OBSTET GYNECOL, V165, P1084, DOI 10.1016/0002-9378(91)90476-8; Winje BA, 2011, BJOG-INT J OBSTET GY, V118, P1229, DOI 10.1111/j.1471-0528.2011.02993.x	43	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39259	10.1371/journal.pone.0039259	http://dx.doi.org/10.1371/journal.pone.0039259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723978	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700060
J	Aggarwal, R; Lu, JW; Kanji, S; Joseph, M; Das, M; Noble, GJ; McMichael, BK; Agarwal, S; Hart, RT; Sun, ZY; Lee, BS; Rosol, TJ; Jackson, R; Mao, HQ; Pompili, VJ; Das, H				Aggarwal, Reeva; Lu, Jingwei; Kanji, Suman; Joseph, Matthew; Das, Manjusri; Noble, Garrett J.; McMichael, Brooke K.; Agarwal, Sudha; Hart, Richard T.; Sun, Zongyang; Lee, Beth S.; Rosol, Thomas J.; Jackson, Rebecca; Mao, Hai-Quan; Pompili, Vincent J.; Das, Hiranmoy			Human Umbilical Cord Blood-Derived CD34(+) Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MESENCHYMAL STEM-CELLS; BONE-FORMATION; IN-VITRO; PROGENITOR CELLS; HIP-FRACTURES; DIFFERENTIATION; EXPRESSION; OSTEOCALCIN; WNT	Background: Osteoporosis is a bone disorder associated with loss of bone mineral density and micro architecture. A balance of osteoblasts and osteoclasts activities maintains bone homeostasis. Increased bone loss due to increased osteoclast and decreased osteoblast activities is considered as an underlying cause of osteoporosis. Methods and Findings: The cures for osteoporosis are limited, consequently the potential of CD34+ cell therapies is currently being considered. We developed a nanofiber-based expansion technology to obtain adequate numbers of CD34(+) cells isolated from human umbilical cord blood, for therapeutic applications. Herein, we show that CD34(+) cells could be differentiated into osteoblastic lineage, in vitro. Systemically delivered CD34(+) cells home to the bone marrow and significantly improve bone deposition, bone mineral density and bone micro-architecture in osteoporotic mice. The elevated levels of osteocalcin, IL-10, GM-CSF, and decreased levels of MCP-1 in serum parallel the improvements in bone micro-architecture. Furthermore, CD34(+) cells improved osteoblast activity and concurrently impaired osteoclast differentiation, maturation and functionality. Conclusions: These findings demonstrate a novel approach utilizing nanofiber-expanded CD34(+) cells as a therapeutic application for the treatment of osteoporosis.	[Aggarwal, Reeva; Lu, Jingwei; Kanji, Suman; Joseph, Matthew; Das, Manjusri; Pompili, Vincent J.; Das, Hiranmoy] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Cardiovasc Stem Cell Res Lab, Columbus, OH 43210 USA; [Noble, Garrett J.; Hart, Richard T.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [McMichael, Brooke K.; Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Agarwal, Sudha; Sun, Zongyang] Ohio State Univ, Coll Dent, Dept Orthoped, Div Oral Biol, Columbus, OH 43210 USA; [Rosol, Thomas J.] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Jackson, Rebecca] Ohio State Univ, Coll Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Mao, Hai-Quan] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Johns Hopkins University	Aggarwal, R (corresponding author), Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Cardiovasc Stem Cell Res Lab, Columbus, OH 43210 USA.	hiranmoy.das@osumc.edu	Rosol, Thomas/G-9585-2011; Hart, Richard T/B-6932-2012; Lee, Beth S/E-9578-2010; Das, Hiranmoy/R-7452-2019	Rosol, Thomas/0000-0003-3737-1190; Lee, Beth S/0000-0002-1468-6387; Mao, Hai-Quan/0000-0002-4262-9988; Das, Hiranmoy/0000-0002-3343-0096	National Institutes of Health [K01 AR054114, SBIR R44 HL092706-01, R21 CA143787]; Ohio State University start-up fund; NATIONAL CANCER INSTITUTE [R21CA143787] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL092706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University start-up fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants, K01 AR054114 (NIAMS), SBIR R44 HL092706-01 (NHLBI), R21 CA143787 (NCI) and The Ohio State University start-up fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Al-Rasheed A, 2003, J DENT RES, V82, P632, DOI 10.1177/154405910308200812; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Borah B, 2000, J BONE MINER RES, V15, P1786, DOI 10.1359/jbmr.2000.15.9.1786; Chappard C, 2005, OSTEOPOROSIS INT, V16, P1193, DOI 10.1007/s00198-004-1829-5; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Ciarelli TE, 2000, J BONE MINER RES, V15, P32, DOI 10.1359/jbmr.2000.15.1.32; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Das H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007325; Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; GODSCHALK MF, 1988, J BONE MINER RES, V3, P113; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lien CY, 2009, J BONE MINER RES, V24, P837, DOI [10.1359/jbmr.081257, 10.1359/JBMR.081257]; MARIE PJ, 1993, J CLIN ENDOCR METAB, V77, P824, DOI 10.1210/jc.77.3.824; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; Mifune Y, 2008, STEM CELLS, V26, P1395, DOI 10.1634/stemcells.2007-0820; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sheng MHC, 1999, BONE, V25, P421, DOI 10.1016/S8756-3282(99)00184-2; Taichman RS, 1996, EXP HEMATOL, V24, P509; Taichman RS, 1997, BLOOD, V89, P1165, DOI 10.1182/blood.V89.4.1165; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wilting I, 2007, BONE, V40, P1252, DOI 10.1016/j.bone.2006.12.055; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhu W, 2011, J BIOL CHEM, V286, P26794, DOI 10.1074/jbc.M111.250985	50	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39365	10.1371/journal.pone.0039365	http://dx.doi.org/10.1371/journal.pone.0039365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724005	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300139
J	Lu, RJ; Yu, XY; Wang, W; Duan, XJ; Zhang, LL; Zhou, WM; Xu, J; Xu, LJ; Hu, Q; Lu, JX; Ruan, L; Wang, Z; Tan, WJ				Lu, Roujian; Yu, Xiaoyan; Wang, Wen; Duan, Xijie; Zhang, Linglin; Zhou, Weimin; Xu, Jin; Xu, Lingjie; Hu, Qin; Lu, Jianxin; Ruan, Li; Wang, Zhong; Tan, Wenjie			Characterization of Human Coronavirus Etiology in Chinese Adults with Acute Upper Respiratory Tract Infection by Real-Time RT-PCR Assays	PLOS ONE			English	Article							HUMAN BOCAVIRUS; CHILDREN; HKU1; ILLNESS; IDENTIFICATION; DIAGNOSIS; VIRUSES; DISEASE; IMPACT; NL63	Background: In addition to SARS associated coronaviruses, 4 non-SARS related human coronaviruses (HCoVs) are recognized as common respiratory pathogens. The etiology and clinical impact of HCoVs in Chinese adults with acute upper respiratory tract infection (URTI) needs to be characterized systematically by molecular detection with excellent sensitivity. Methodology/Principal Findings: In this study, we detected 4 non-SARS related HCoV species by real-time RT-PCR in 981 nasopharyngeal swabs collected from March 2009 to February 2011. All specimens were also tested for the presence of other common respiratory viruses and newly identified viruses, human metapneumovirus (hMPV) and human bocavirus (HBoV). 157 of the 981 (16.0%) nasopharyngeal swabs were positive for HCoVs. The species detected were 229E (96 cases, 9.8%), OC43 (42 cases, 4.3%), HKU1 (16 cases, 1.6%) and NL63 (11 cases, 1.1%). HCoV-229E was circulated in 21 of the 24 months of surveillance. The detection rates for both OC43 and NL63 were showed significantly year-to-year variation between 2009/10 and 2010/11, respectively (P<0.001 and P = 0.003), and there was a higher detection frequency of HKU1 in patients aged over 60 years (P = 0.03). 48 of 157(30.57%) HCoV positive patients were co-infected. Undifferentiated human rhinoviruses and influenza (Flu) A were the most common viruses detected (more than 35%) in HCoV co-infections. Respiratory syncytial virus (RSV), human parainfluenza virus (PIV) and HBoV were detected in very low rate (less than 1%) among adult patients with URTI. Conclusions/Significance: All 4 non-SARS-associated HCoVs were more frequently detected by real-time RT-PCR assay in adults with URTI in Beijing and HCoV-229E led to the most prevalent infection. Our study also suggested that all non-SARS-associated HCoVs contribute significantly to URTI in adult patients in China.	[Lu, Roujian; Yu, Xiaoyan; Wang, Wen; Zhang, Linglin; Zhou, Weimin; Hu, Qin; Ruan, Li; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Duan, Xijie; Xu, Jin; Xu, Lingjie; Wang, Zhong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Yu, Xiaoyan; Hu, Qin; Lu, Jianxin] Wenzhou Med Coll, Minist Educ, Key Lab Lab Med, Zhejiang, Peoples R China; [Yu, Xiaoyan; Hu, Qin; Lu, Jianxin] Wenzhou Med Coll, Inst Med Virol, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Wenzhou Medical University; Wenzhou Medical University	Lu, RJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wangzhong523@vip.163.com; tanwj28@yahoo.cn			National Natural Science Foundation of China [81100062]; 973 Program of China [2011CB504704]; Control and Prevention of Major Infectious Diseases Program in China [2011ZX10004-001]; China-Australia Health and HIV/AIDS Facility [CAHHF EID07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Control and Prevention of Major Infectious Diseases Program in China; China-Australia Health and HIV/AIDS Facility	This work was funded by the Project of the National Natural Science Foundation of China (81100062); 973 Program of China (Grant numbers: 2011CB504704); the Control and Prevention of Major Infectious Diseases Program in China (2011ZX10004-001) and China-Australia Health and HIV/AIDS Facility (CAHHF EID07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Esper F, 2006, EMERG INFECT DIS, V12, P775, DOI 10.3201/eid1205.051316; Esposito S, 2006, J MED VIROL, V78, P1609, DOI 10.1002/jmv.20745; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Garbino J, 2006, CLIN INFECT DIS, V43, P1009, DOI 10.1086/507898; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gerna G, 2007, J CLIN VIROL, V38, P244, DOI 10.1016/j.jcv.2006.12.008; Gorse GJ, 2009, J INFECT DIS, V199, P847, DOI 10.1086/597122; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Koetz A, 2006, CLIN MICROBIOL INFEC, V12, P1089, DOI 10.1111/j.1469-0691.2006.01506.x; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuypers J, 2007, PEDIATRICS, V119, pE70, DOI 10.1542/peds.2006-1406; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Mackay IM, 2003, J CLIN MICROBIOL, V41, P100, DOI 10.1128/JCM.41.1.100-105.2003; Mahony JB, 2011, CRIT REV CL LAB SCI, V48, P217, DOI 10.3109/10408363.2011.640976; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Nokso-Koivisto J, 2000, PEDIATR INFECT DIS J, V19, P164, DOI 10.1097/00006454-200002000-00016; Pene F, 2003, CLIN INFECT DIS, V37, P929, DOI 10.1086/377612; Pyrc K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032582; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Risku M, 2010, J CLIN VIROL, V48, P27, DOI 10.1016/j.jcv.2010.02.013; Shao XP, 2007, J CLIN VIROL, V40, P207, DOI 10.1016/j.jcv.2007.08.007; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Suzuki A, 2005, PEDIATR INFECT DIS J, V24, P645, DOI 10.1097/01.inf.0000168846.71517.ee; Talbot HKB, 2009, J MED VIROL, V81, P853, DOI 10.1002/jmv.21443; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Vabret A, 2003, CLIN INFECT DIS, V36, P985, DOI 10.1086/374222; Vabret A, 2008, J PAEDIATR CHILD H, V44, P176, DOI 10.1111/j.1440-1754.2007.01246.x; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174	38	47	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38638	10.1371/journal.pone.0038638	http://dx.doi.org/10.1371/journal.pone.0038638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719912	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000018
J	Owczarek-Lipska, M; Lauber, B; Molitor, V; Meury, S; Kierczak, M; Tengvall, K; Webster, MT; Jagannathan, V; Schlotter, Y; Willemse, T; Hendricks, A; Bergvall, K; Hedhammar, A; Andersson, G; Lindblad-Toh, K; Favrot, C; Roosje, P; Marti, E; Leeb, T				Owczarek-Lipska, Marta; Lauber, Beatrice; Molitor, Vivianne; Meury, Sabrina; Kierczak, Marcin; Tengvall, Katarina; Webster, Matthew T.; Jagannathan, Vidhya; Schlotter, Yvette; Willemse, Ton; Hendricks, Anke; Bergvall, Kerstin; Hedhammar, Ake; Andersson, Goran; Lindblad-Toh, Kerstin; Favrot, Claude; Roosje, Petra; Marti, Eliane; Leeb, Tosso			Two Loci on Chromosome 5 Are Associated with Serum IgE Levels in Labrador Retrievers	PLOS ONE			English	Article							CANINE ATOPIC-DERMATITIS; ACVD TASK-FORCE; GENOME-WIDE ASSOCIATION; IMMUNOGLOBULIN-E; DIAGNOSTIC-CRITERIA; MITE ALLERGENS; HOUSE-DUST; DOGS; DISEASE; ASTHMA	Crosslinking of immunoglobulin E antibodies (IgE) bound at the surface of mast cells and subsequent mediator release is considered the most important trigger for allergic reactions. Therefore, the genetic control of IgE levels is studied in the context of allergic diseases, such as asthma, atopic rhinitis, or atopic dermatitis (AD). We performed genome-wide association studies in 161 Labrador Retrievers with regard to total and allergen-specific immunoglobulin E (IgE) levels. We identified a genome-wide significant association on CFA 5 with the antigen-specific IgE responsiveness to Acarus siro. We detected a second genome-wide significant association with respect to the antigen-specific IgE responsiveness to Tyrophagus putrescentiae at a different locus on chromosome 5. A. siro and T. putrescentiae both belong to the family Acaridae and represent so-called storage or forage mites. These forage mites are discussed as major allergen sources in canine AD. No obvious candidate gene for the regulation of IgE levels is located under the two association signals. Therefore our studies offer a chance of identifying a novel mechanism controlling the host's IgE response.	[Owczarek-Lipska, Marta; Jagannathan, Vidhya; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Lauber, Beatrice; Marti, Eliane] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [Molitor, Vivianne; Roosje, Petra] Univ Bern, Vetsuisse Fac, Dept Clin Vet Med, Div Clin Dermatol, Bern, Switzerland; [Meury, Sabrina; Favrot, Claude] Univ Zurich, Vetsuisse Fac, Dermatol Unit, Clin Small Anim Internal Med, Zurich, Switzerland; [Kierczak, Marcin; Andersson, Goran] Swedish Univ Agr Sci, Dept Clin Sci, Computat Genet Grp, Uppsala, Sweden; [Tengvall, Katarina; Webster, Matthew T.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Schlotter, Yvette; Willemse, Ton] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Hendricks, Anke] Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England; [Bergvall, Kerstin; Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	University of Bern; University of Bern; University of Bern; University of Zurich; Swedish University of Agricultural Sciences; Uppsala University; Utrecht University; University of London; University of London Royal Veterinary College; Swedish University of Agricultural Sciences	Owczarek-Lipska, M (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Andersson, Goran/AAK-6564-2020; Jagannathan, Vidhya/P-1055-2019; Tengvall, Katarina/L-1933-2019; Leeb, Tosso/G-3187-2014	Andersson, Goran/0000-0001-5131-3144; Jagannathan, Vidhya/0000-0002-8155-0041; Leeb, Tosso/0000-0003-0553-4880; Webster, Matthew/0000-0003-1141-2863; Hedhammar, Ake/0000-0001-7048-3851; FAVROT, Claude/0000-0002-0821-0956; Kierczak, Marcin/0000-0003-2629-5655	European Commission (LUPA) [GA-201370]; Albert-Heim Foundation	European Commission (LUPA)(European CommissionEuropean Commission Joint Research Centre); Albert-Heim Foundation	This work was funded thanks to grants from the European Commission (LUPA, GA-201370) and the Albert-Heim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 2003, AM J VET RES, V64, P32, DOI 10.2460/ajvr.2003.64.32; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bensignor E, 2002, VET DERMATOL, V13, P37, DOI 10.1046/j.0959-4493.2001.00270.x; Brazis P, 2008, VET DERMATOL, V19, P209, DOI 10.1111/j.1365-3164.2008.00676.x; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; DEBOER DJ, 1993, VET IMMUNOL IMMUNOP, V37, P183, DOI 10.1016/0165-2427(93)90193-8; DeBoer DJ, 2001, VET IMMUNOL IMMUNOP, V81, P271, DOI 10.1016/S0165-2427(01)00312-9; deWeck AL, 1997, INT ARCH ALLERGY IMM, V113, P55, DOI 10.1159/000237507; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Griffin CE, 2001, VET IMMUNOL IMMUNOP, V81, P255, DOI 10.1016/S0165-2427(01)00346-4; Halliwell REW, 2001, VET IMMUNOL IMMUNOP, V81, P159, DOI 10.1016/S0165-2427(01)00309-9; Hammerberg B, 1997, VET IMMUNOL IMMUNOP, V60, P33, DOI 10.1016/S0165-2427(97)00119-0; HANSON B, 1991, AM J HUM GENET, V48, P873; Jackola DR, 2002, MOL IMMUNOL, V39, P367, DOI 10.1016/S0161-5890(02)00108-6; Jackola DR, 2007, HUM IMMUNOL, V68, P839, DOI 10.1016/j.humimm.2007.07.006; Jackson HA, 2002, VET IMMUNOL IMMUNOP, V85, P225, DOI 10.1016/S0165-2427(02)00003-X; Jaeger K, 2010, VET DERMATOL, V21, P118, DOI 10.1111/j.1365-3164.2009.00845.x; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Lauber B, 2012, VET IMMUNOL IN PRESS; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; MAZZA G, 1994, RES VET SCI, V57, P133, DOI 10.1016/0034-5288(94)90048-5; McCall C, 2001, VET IMMUNOL IMMUNOP, V78, P231, DOI 10.1016/S0165-2427(00)00258-0; Meury S, 2011, VET DERMATOL, V22, P327, DOI 10.1111/j.1365-3164.2010.00950.x; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nodtvedt A, 2006, VET REC, V159, P241, DOI 10.1136/vr.159.8.241; Notvedt A, 2007, VET DERMATOL, V18, P309, DOI 10.1111/j.1365-3164.2007.00617.x; Nuttall TJ, 2006, VET DERMATOL, V17, P223, DOI 10.1111/j.1365-3164.2006.00532.x; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Potaczek DP, 2012, CLIN EXP ALLERGY, DOI [0.1111/j.1365-2222.2012.03953.x., DOI 10.1111/J.1365-2222.2012.03953.X]; Prelaud P, 1998, REV MED VET-TOULOUSE, V149, P1057; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Reedy LM, 1997, ALLERGIC SKIN DIS DO, P44; Roque JB, 2011, VET DERMATOL, V22, P257, DOI 10.1111/j.1365-3164.2010.00939.x; Schlotter YM, 2011, VET IMMUNOL IMMUNOP, V143, P20, DOI 10.1016/j.vetimm.2011.05.025; Sousa CA, 2001, VET IMMUNOL IMMUNOP, V81, P153, DOI 10.1016/S0165-2427(01)00297-5; Strachan DR, 2001, J ALLERGY CLIN IMMUN, V108, P901, DOI 10.1067/mai.2001.119408; Weidinger S, 2010, CURR OPIN ALLERGY CL, V10, P408, DOI 10.1097/ACI.0b013e32833d7d2d; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; WILLEMSE T, 1986, J SMALL ANIM PRACT, V27, P771, DOI 10.1111/j.1748-5827.1986.tb02119.x	41	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39176	10.1371/journal.pone.0039176	http://dx.doi.org/10.1371/journal.pone.0039176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720065	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305350000046
J	Sundar, RP; Becker, MW; Bello, NM; Bix, L				Sundar, Raghav Prashant; Becker, Mark W.; Bello, Nora M.; Bix, Laura			Quantifying Age-Related Differences in Information Processing Behaviors When Viewing Prescription Drug Labels	PLOS ONE			English	Article							MEDICATION ERRORS; ELDERLY-PATIENTS; HEALTH-CARE; MEMORY; LITERACY; ATTENTION; WARNINGS; CONTEXT; EVENTS; SEARCH	Adverse drug events (ADEs) are a significant problem in health care. While effective warnings have the potential to reduce the prevalence of ADEs, little is known about how patients access and use prescription labeling. We investigated the effectiveness of prescription warning labels (PWLs, small, colorful stickers applied at the pharmacy) in conveying warning information to two groups of patients (young adults and those 50+). We evaluated the early stages of information processing by tracking eye movements while participants interacted with prescription vials that had PWLs affixed to them. We later tested participants' recognition memory for the PWLs. During viewing, participants often failed to attend to the PWLs; this effect was more pronounced for older than younger participants. Older participants also performed worse on the subsequent memory test. However, when memory performance was conditionalized on whether or not the participant had fixated the PWL, these age-related differences in memory were no longer significant, suggesting that the difference in memory performance between groups was attributable to differences in attention rather than differences in memory encoding or recall. This is important because older adults are recognized to be at greater risk for ADEs. These data provide a compelling case that understanding consumers' attentive behavior is crucial to developing an effective labeling standard for prescription drugs.	[Sundar, Raghav Prashant; Bix, Laura] Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA; [Becker, Mark W.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Bello, Nora M.] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA	Michigan State University; Michigan State University; Kansas State University	Sundar, RP (corresponding author), Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA.	bixlaura@msu.edu	Bix, Laura/T-5117-2019	Bix, Laura/0000-0002-5779-7474	Center for Food and Pharmaceutical Packaging Research	Center for Food and Pharmaceutical Packaging Research	Research was partially funded through the Center for Food and Pharmaceutical Packaging Research (internally administered). No additional external funding was received to support this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aspden P, 2007, PREVENTING MEDICATIO, Vxvi; Ault H, 2007, WARNING PRESCRIPTION; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; Bass PF, 2003, J GEN INTERN MED, V18, P1036, DOI 10.1111/j.1525-1497.2003.10651.x; Bates DW, 2007, AM J HEALTH-SYST PH, V64, pS3, DOI 10.2146/ajhp070190; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berman Adrienne, 2004, J Med Syst, V28, P9, DOI 10.1023/B:JOMS.0000021518.60670.10; Bix L, 2009, P NATL ACAD SCI USA, V106, P6550, DOI 10.1073/pnas.0810665106; Boyd ST, 2006, J AM PHARM ASSOC, V46, P692, DOI 10.1331/1544-3191.46.6.692.Boyd; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Davis TC, 1998, HEALTH EDUC BEHAV, V25, P613, DOI 10.1177/109019819802500508; Davis TC, 2006, J GEN INTERN MED, V21, P847, DOI 10.1111/j.1525-1497.2006.00529.x; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; de la Fuente J., 2006, USE UNIVERSAL DESIGN; Ecker UKH, 2007, MEM COGNITION, V35, P1483, DOI 10.3758/BF03193618; Epelboim J, 1996, WINDOW MIND WHAT EYE; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Franklin D, 2005, NY TIMES; Gilchrist ID, 2000, CURR BIOL, V10, P1209, DOI 10.1016/S0960-9822(00)00729-6; Godfrey SS, 1983, WARNING MESSAGES WIL; Goldhaber GM, 1989, P HUM FACT SOC 33 AN; GRYFEBECKER BM, 1989, DICP ANN PHARMAC, V23, P324, DOI 10.1177/106002808902300409; Gurwitz J, 2002, GERONTOLOGIST, V42, P189; Hernandez LM, 2008, STANDARDIZING MEDICA, Vxv; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kaufman DW, 2006, PHARMACOEPIDEM DR S, V15, pS65; LaRue C, 1987, P HUM FACT SOC 35 AN, P580; LAUGHERY KR, 1993, SAFETY SCI, V16, P597, DOI 10.1016/0925-7535(93)90025-9; LOCHER PJ, 1996, EMPIRICAL STUDIES AR, V14, P143, DOI DOI 10.2190/D77M-3NU4-DQ88-H1QG; Mannan SK, 1997, SPATIAL VISION, V11, P157, DOI 10.1163/156856897X00177; Meredith S, 2001, J AM GERIATR SOC, V49, P719, DOI 10.1046/j.1532-5415.2001.49147.x; Pharmex, 2009, TOP 40 PHARM ENGL SP; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RAYNER K, 1978, PSYCHOL BULL, V85, P618, DOI 10.1037/0033-2909.85.3.618; Rayner K, 1998, PSYCHOL B, P124; REHDER TL, 1980, AM J HOSP PHARM, V37, P379, DOI 10.1093/ajhp/37.3.379; Rogers WA, 1999, PROCESSING MED INFOR, Vix; Rousseau GK, 1998, PSYCHOL MARKET, V15, P643; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Sheikh A, 2007, BRIT MED B, V83, P259; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; United States Pharmacopeia, 2010, REC PRESCR CONT LAB; Wolf, 2010, ARCH INTERN MED, V170, P608; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Young SL, 1991, P INTERFACE, V89, P73; Zelinsky GJ, 2011, MEM COGNITION, V39, P600, DOI 10.3758/s13421-010-0048-x; ZUCCOLLO G, 1985, AGE AGEING, V14, P371, DOI 10.1093/ageing/14.6.371	50	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38819	10.1371/journal.pone.0038819	http://dx.doi.org/10.1371/journal.pone.0038819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22719955	Green Published, gold			2022-12-27	WOS:000305347800021
J	Zhang, L; Cheng, DX; Tao, N; Zhao, M; Zhang, F; Yuan, YL; Qiu, XP				Zhang, Li; Cheng, Dangxiao; Tao, Ning; Zhao, Min; Zhang, Fan; Yuan, Yulin; Qiu, Xiaoping			Distribution of HLA-A, -B and-DRB1 Genes and Haplotypes in the Tujia Population Living in the Wufeng Region of Hubei Province, China	PLOS ONE			English	Article							FREQUENCIES	Background: The distribution of HLA alleles and haplotypes varies widely between different ethnic populations and geographic areas. Before any genetic marker can be used in a disease-associated study it is therefore essential to investigate allelic frequencies and establish a genetic database. Methodology/Principal Findings: This is the first report of HLA typing in the Tujia group using the Luminex HLA-SSO method HLA-A, -B and -DRB1 allelic distributions were determined in 124 unrelated healthy Tujia individuals, and haplotypic frequencies and linkage disequilibrium parameters were estimated using the maximum-likelihood method. In total 10 alleles were detected at the HLA-A locus, 21 alleles at the HLA-B locus and 14 alleles at the HLA-DRB1 locus. The most frequently observed alleles in the HLA-I group were HLA-A*02 (35.48%), A*11 (28.23%), A*24 (15.73%); HLA-B*40 (25.00%), B*46 (16.13%), and B*15 (15.73%). Among HLA-DRB1 alleles, high frequencies of HLA-DRB1*09 (25.81%) were observed, followed by HLA-DRB1*15 (12.9%), and DRB1*12 (10.89%). The two-locus haplotypes at the highest frequency were A*02-B*46A (8.47%), followed by A*11-B*40 (7.66%), A*02-B*40 (8.87%), A*11-B*15 (6.45%), A*02-B*15 (6.05%), B*40-DRB1*09 (9.27%) and B*46-DRB1*09 (6.45%). The most common three-locus haplotypes found in the Tujia population were A*02-B*46-DRB1*09 (4.84%) and A*02-B*40-DRB1*09 (4.03%). Fourteen two-loci haplotypes had significant linkage disequilibrium. Construction of a neighbor-joining phylogenetic tree and principal component analysis using the allelic frequencies at HLA-A was performed to compare the Tujia group and twelve other previously reported populations. The Tujia population in the Wufeng of Hubei Province had the closest genetic relationship with the central Han population, and then to the Shui, the Miao, the southern Han and the northern Han ethnic groups. Conclusions/Significance: These results will become a valuable source of data for tracing population migration, planning clinical organ transplantation, carrying out HLA-linked disease-associated studies and forensic identification.	[Zhang, Li; Zhao, Min; Qiu, Xiaoping] Wuhan Univ, Sch Med, Inst Virol, Wuhan 430072, Hubei, Peoples R China; [Cheng, Dangxiao] Univ Toronto, Toronto, ON, Canada; [Tao, Ning] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Zhang, Fan] Wuhan Univ, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China; [Yuan, Yulin] Wuhan Univ, Sch Med, Dept Dissect, Wuhan 430072, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; University of Toronto; Chinese Academy of Sciences; Institute of Biophysics, CAS; Wuhan University; Wuhan University	Qiu, XP (corresponding author), Wuhan Univ, Sch Med, Inst Virol, Wuhan 430072, Hubei, Peoples R China.	xpingqiu429@gmail.com	Tao, Ning/AAK-7068-2021	Tao, Ning/0000-0002-0021-4995	National Nature Science Foundation of China [30872935]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Nature Science Foundation of China (No, 30872935). Web of the National Nature Science Foundation of China is http://www.nsfc.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boquan H, 1999, GUIZHOU ETHINIC STUD, V78, P83; Chao D, 2004, ETHNO NATL STUD, V6, P1; Chen S, 2007, HUM IMMUNOL, V68, P928, DOI 10.1016/j.humimm.2007.09.006; Chun-mei S, 2010, PLOS ONE, V5; Chunmei S, 2008, J 4 MIL MED U, V29, P1540; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Guang Dan P, 1995, ETHNOLOGICAL CORPORA; HATTEMER HH, 1982, THEOR APPL GENET, V62, P219, DOI 10.1007/BF00276242; Ivanova M, 2002, TISSUE ANTIGENS, V60, P496, DOI 10.1034/j.1399-0039.2002.600605.x; Lee J, 1990, HLA SYSTEM NEW APPRO, V6, P141; Qiu XP, 2011, ASIAN PAC J CANCER P, V12, P2597; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shankarkumar U, 2003, TISSUE ANTIGENS, V62, P542, DOI 10.1046/j.1399-0039.2003.00118.x; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Shengzhong Z, 2001, J HUBEI U NATL PHYLO, V19, P51; Shi L, 2010, INT J IMMUNOGENET, V37, P467, DOI 10.1111/j.1744-313X.2010.00949.x; Xie Xuan-Hua, 2004, Acta Genetica Sinica, V31, P1023; [赵桐茂 Zhao Tongmao], 2003, [中国输血杂志, Chinese Journal of Blood Transfusion], V16, P381; Zou Jie, 2011, Fudan Xuebao (Yixueban), V38, P204, DOI 10.3969/j.issn.1672-8467.2011.03.004	19	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38774	10.1371/journal.pone.0038774	http://dx.doi.org/10.1371/journal.pone.0038774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719940	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800017
J	Holland, JT; Harper, JC; Dolan, PL; Manginell, MM; Arango, DC; Rawlings, JA; Apblett, CA; Brozik, SM				Holland, J. Todd; Harper, Jason C.; Dolan, Patricia L.; Manginell, Monica M.; Arango, Dulce C.; Rawlings, Julia A.; Apblett, Christopher A.; Brozik, Susan M.			Rational Redesign of Glucose Oxidase for Improved Catalytic Function and Stability	PLOS ONE			English	Article							DIRECTED EVOLUTION; ELECTROCHEMICAL OXIDATION; PLATINUM-ELECTRODES; HYDROGEN-PEROXIDE; PENICILLIUM AMAGASAKIENSE; ASPERGILLUS-NIGER; BIOFUEL CELL; ENZYMES; DEHYDROGENASE; MECHANISM	Glucose oxidase (GOx) is an enzymatic workhorse used in the food and wine industries to combat microbial contamination, to produce wines with lowered alcohol content, as the recognition element in amperometric glucose sensors, and as an anodic catalyst in biofuel cells. It is naturally produced by several species of fungi, and genetic variants are known to differ considerably in both stability and activity. Two of the more widely studied glucose oxidases come from the species Aspergillus niger (A. niger) and Penicillium amagasakiense (P. amag.), which have both had their respective genes isolated and sequenced. GOx from A. niger is known to be more stable than GOx from P. amag., while GOx from P. amag. has a six-fold superior substrate affinity (K-M) and nearly four-fold greater catalytic rate (k(cat)). Here we sought to combine genetic elements from these two varieties to produce an enzyme displaying both superior catalytic capacity and stability. A comparison of the genes from the two organisms revealed 17 residues that differ between their active sites and cofactor binding regions. Fifteen of these residues in a parental A. niger GOx were altered to either mirror the corresponding residues in P. amag. GOx, or mutated into all possible amino acids via saturation mutagenesis. Ultimately, four mutants were identified with significantly improved catalytic activity. A single point mutation from threonine to serine at amino acid 132 (mutant T132S, numbering includes leader peptide) led to a three-fold improvement in k(cat) at the expense of a 3% loss of substrate affinity (increase in apparent K-M for glucose) resulting in a specify constant (k(cat)/K-M) of 23.8 (mM(-1) . s(-1)) compared to 8.39 for the parental (A. niger) GOx and 170 for the P. amag. GOx. Three other mutant enzymes were also identified that had improvements in overall catalysis: V42Y, and the double mutants T132S/T56V and T132S/V42Y, with specificity constants of 31.5, 32.2, and 31.8 mM(-1) . s(-1), respectively. The thermal stability of these mutants was also measured and showed moderate improvement over the parental strain.	[Holland, J. Todd; Harper, Jason C.; Dolan, Patricia L.; Manginell, Monica M.; Arango, Dulce C.; Rawlings, Julia A.; Apblett, Christopher A.; Brozik, Susan M.] Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Brozik, SM (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	smbrozi@sandia.gov			Sandia National Laboratories (SNL) Lab Directed Research and Development Program (LDRD); U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Sandia National Laboratories (SNL) Lab Directed Research and Development Program (LDRD); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This study was funded by the Sandia National Laboratories (SNL) Lab Directed Research and Development Program (LDRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Blake Simmons, Suzanne Ma, Julia Crawford-Dibble, and Joanne Volponi at SNL CA and Swapnil Chhabra (Lawrence Berkeley National Laboratory) for discussion and collaboration as part of the Bio Micro Fuel Cell (B mu FC) Laboratory Directed Research and Development (LDRD) Grand Challenge. Sandia National Laboratories is a multi-program laboratory operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Company, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000.	Bao LL, 2002, ANAL CHEM, V74, P1144, DOI 10.1021/ac0106086; Bornscheuer UT, 1998, ANGEW CHEM INT EDIT, V37, P3105, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3105::AID-ANIE3105>3.0.CO;2-#; Chen LQ, 2002, BIOSENS BIOELECTRON, V17, P851, DOI 10.1016/S0956-5663(02)00051-9; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Hall SB, 1998, ELECTROCHIM ACTA, V43, P2015, DOI 10.1016/S0013-4686(97)10116-5; Hall SB, 1999, ELECTROCHIM ACTA, V44, P2455, DOI 10.1016/S0013-4686(98)00369-7; Hall SB, 1998, ELECTROCHIM ACTA, V43, P579, DOI 10.1016/S0013-4686(97)00125-4; Hall SB, 1999, ELECTROCHIM ACTA, V44, P4573, DOI 10.1016/S0013-4686(99)00183-8; Halliwell CM, 2002, BIOELECTROCHEMISTRY, V55, P21, DOI 10.1016/S1567-5394(01)00172-4; KALISZ HM, 1991, BIOCHIM BIOPHYS ACTA, V1080, P138, DOI 10.1016/0167-4838(91)90140-U; Kalisz HM, 1997, APPL MICROBIOL BIOT, V47, P502, DOI 10.1007/s002530050963; Kiess M, 1998, EUR J BIOCHEM, V252, P90, DOI 10.1046/j.1432-1327.1998.2520090.x; Lin ZL, 1999, BIOTECHNOL PROGR, V15, P467, DOI 10.1021/bp990037r; Lutz S, 2004, CURR OPIN BIOTECH, V15, P291, DOI 10.1016/j.copbio.2004.05.004; Meyer M, 1998, J COMPUT AID MOL DES, V12, P425, DOI 10.1023/A:1008020124326; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Sun LH, 2002, CHEMBIOCHEM, V3, P781, DOI 10.1002/1439-7633(20020802)3:8<781::AID-CBIC781>3.0.CO;2-8; Wong TS, 2003, CURR OPIN BIOTECH, V14, P590, DOI 10.1016/j.copbio.2003.09.008; YANG L, 1995, ANAL CHEM, V67, P1326, DOI 10.1021/ac00104a005; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47; Zhu Ziwei, 2007, Biotechnology Journal, V2, P241, DOI 10.1002/biot.200600185; Zhu ZW, 2006, BIOSENS BIOELECTRON, V21, P2046, DOI 10.1016/j.bios.2005.11.018	24	21	26	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37924	10.1371/journal.pone.0037924	http://dx.doi.org/10.1371/journal.pone.0037924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719855	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900016
J	Roecklein, KA; Schumacher, JA; Miller, MA; Ernecoff, NC				Roecklein, Kathryn A.; Schumacher, Julie A.; Miller, Megan A.; Ernecoff, Natalie C.			Cognitive and Behavioral Predictors of Light Therapy Use	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; ACUTE-PHASE TREATMENT; DEPRESSION OUTCOMES; REUPTAKE INHIBITORS; MAJOR DEPRESSION; MOOD DISORDERS; BRIGHT-LIGHT; METAANALYSIS; HOMEWORK; ADHERENCE	Objective: Although light therapy is effective in the treatment of seasonal affective disorder (SAD) and other mood disorders, only 53-79% of individuals with SAD meet remission criteria after light therapy. Perhaps more importantly, only 12-41% of individuals with SAD continue to use the treatment even after a previous winter of successful treatment. Method: Participants completed surveys regarding (1) social, cognitive, and behavioral variables used to evaluate treatment adherence for other health-related issues, expectations and credibility of light therapy, (2) a depression symptoms scale, and (3) self-reported light therapy use. Results: Individuals age 18 or older responded (n = 40), all reporting having been diagnosed with a mood disorder for which light therapy is indicated. Social support and self-efficacy scores were predictive of light therapy use (p's<.05). Conclusion: The findings suggest that testing social support and self-efficacy in a diagnosed patient population may identify factors related to the decision to use light therapy. Treatments that impact social support and self-efficacy may improve treatment response to light therapy in SAD.	[Roecklein, Kathryn A.; Miller, Megan A.; Ernecoff, Natalie C.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Schumacher, Julie A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Mississippi; University of Mississippi Medical Center	Roecklein, KA (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	kroeck@pitt.edu	Roecklein, Kathryn A./G-2942-2014		NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCRR NIH HHS [UL1 RR024153] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abraham C, 1998, PSYCHOL HEALTH, V13, P569, DOI 10.1080/08870449808407420; Aloia Mark S, 2007, Behav Sleep Med, V5, P89; Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037/0033-2909.120.3.338; Bandura A, 1997, AM J HEALTH PROMOT, V12, P8, DOI 10.4278/0890-1171-12.1.8; Baundra A, 1986, SOCIAL FDN THOUGHT A; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; BURNS DD, 1987, BEHAV RES THER, V25, P223, DOI 10.1016/0005-7967(87)90049-0; BURNS DD, 1991, J CONSULT CLIN PSYCH, V59, P305, DOI 10.1037/0022-006X.59.2.305; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Conner M, 1996, APPETITE, V27, P135, DOI 10.1006/appe.1996.0041; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Fishbein M, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P3; Flory R, 2010, PSYCHIAT RES, V177, P101, DOI 10.1016/j.psychres.2008.08.011; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Gyurcsik NC, 2011, J HEALTH PSYCHOL, V16, P530, DOI 10.1177/1359105310394229; Lam RW, 2010, INT CLIN PSYCHOPHARM, V25, P199, DOI 10.1097/YIC.0b013e32833948d8; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Maddux JE, 1996, EXPECTANCIES SHAPE B, P17; MARCUS BH, 1992, HEALTH PSYCHOL, V11, P386, DOI 10.1037/0278-6133.11.6.386; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; Mausbach BT, 2010, COGNITIVE THER RES, V34, P429, DOI 10.1007/s10608-010-9297-z; Michalak EE, 2002, J AFFECT DISORDERS, V68, P341, DOI 10.1016/S0165-0327(00)00320-7; Michalak EE, 2007, PSYCHIAT RES, V149, P315, DOI 10.1016/j.psychres.2006.05.005; Murray G., 2001, SEASONAL AFFECTIVE D, P55; Neimeyer Robert A., 2008, Cognitive Behaviour Therapy, V37, P199, DOI 10.1080/16506070801981240; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Prochaska J. O., 2018, SYSTEMS PSYCHOTHERAP, V9th; PROCHASKA JO, 1988, J CONSULT CLIN PSYCH, V56, P520, DOI 10.1037/0022-006X.56.4.520; Prochaska JO, 1997, HLTH BEHAV HLTH ED T, P60; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rohan KJ, 2009, BEHAV THER, V40, P225, DOI 10.1016/j.beth.2008.06.004; Schwartz PJ, 1996, AM J PSYCHIAT, V153, P1028; Sheeran P, 2003, PERS SOC PSYCHOL B, V29, P205, DOI 10.1177/0146167202239046; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [10.1080/14792772143000003, DOI 10.1080/14792772143000003]; Sirey JA, 2010, AM J GERIAT PSYCHIAT, V18, P554, DOI 10.1097/JGP.0b013e3181cdeb7d; Stepnowsky Carl J Jr, 2002, Sleep Med, V3, P239, DOI 10.1016/S1389-9457(01)00162-9; TERMAN M, 1989, NEUROPSYCHOPHARMACOL, V2, P1, DOI 10.1016/0893-133X(89)90002-X; Thase ME, 2010, INT CLIN PSYCHOPHARM, V25, P189, DOI 10.1097/YIC.0b013e328330adb2; Tuunainen A, 2004, LIGHT THERAPY NONSEA; Watanabe N, 2008, J CLIN PSYCHIAT, V69, P1404, DOI 10.4088/JCP.v69n0908; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wilson GT, 2004, CLIN PSYCHOL REV, V24, P361, DOI 10.1016/j.cpr.2004.03.003; WORTHINGTON EL, 1986, J COUNS PSYCHOL, V33, P124; Yovel I, 2007, COGNITIVE THER RES, V31, P385, DOI 10.1007/s10608-006-9065-2	45	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39275	10.1371/journal.pone.0039275	http://dx.doi.org/10.1371/journal.pone.0039275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22720089	gold, Green Published			2022-12-27	WOS:000305341900093
J	Rosu-Myles, M; She, YM; Fair, J; Muradia, G; Mehic, J; Menendez, P; Prasad, SS; Cyr, TD				Rosu-Myles, Michael; She, Yi-Min; Fair, Joel; Muradia, Gauri; Mehic, Jelica; Menendez, Pablo; Prasad, Shiv S.; Cyr, Terry D.			Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ALDEHYDE DEHYDROGENASE-ACTIVITY; GROUP BOX-1 PROTEIN; BONE-MARROW; IN-VITRO; MYOCARDIAL-INFARCTION; TGF-BETA; GROWTH; MICE; DIFFERENTIATION	Bone marrow stromal cell cultures contain multipotent cells that may have therapeutic utility for tissue restoration; however, the identity of the cell that maintains this function remains poorly characterized. We have utilized a unique model of murine bone marrow stroma in combination with liquid chromatography mass spectrometry to compare the nuclear, cytoplasmic and membrane associated proteomes of multipotent (MSC) (CD105+) and non-multipotent (CD105-) stromal cells. Among the 25 most reliably identified proteins, 10 were verified by both real-time PCR and Western Blot to be highly enriched, in CD105+ cells and were members of distinct biological pathways and functional networks. Five of these proteins were also identified as potentially expressed in human MSC derived from both standard and serum free human stromal cultures. The quantitative amount of each protein identified in human stromal cells was only minimally affected by media conditions but varied highly between bone marrow donors. This study provides further evidence of heterogeneity among cultured bone marrow stromal cells and identifies potential candidate proteins that may prove useful for identifying and quantifying both murine and human MSC in vitro.	[Rosu-Myles, Michael; She, Yi-Min; Muradia, Gauri; Mehic, Jelica; Prasad, Shiv S.; Cyr, Terry D.] Hlth Canada, Ctr Vaccine Evaluat Biol & Genet Therapies Direct, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada; [Fair, Joel] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Menendez, Pablo] Pfizer Univ Granada, Andalusian Govt Ctr Genom & Oncol Res, Granada, Spain	Health Canada; University of Ottawa; Pfizer; University of Granada	Rosu-Myles, M (corresponding author), Hlth Canada, Ctr Vaccine Evaluat Biol & Genet Therapies Direct, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada.	michael.rosu-myles@hc-sc.gc.ca	Bujan, Pablo Menendez/W-3736-2017	Bujan, Pablo Menendez/0000-0001-9372-1007; She, Yi-Min/0000-0002-0571-4630	Federal Government of Canada	Federal Government of Canada	This work was funded entirely by the Federal Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bagley RG, 2009, INT J ONCOL, V34, P619, DOI 10.3892/ijo_00000187; Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Capoccia BJ, 2009, BLOOD, V113, P5340, DOI 10.1182/blood-2008-04-154567; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ferrari S, 1996, GENOMICS, V35, P367, DOI 10.1006/geno.1996.0369; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Germani A, 2007, J LEUKOCYTE BIOL, V81, P41, DOI 10.1189/jlb.0306165; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Hartmann I, 2010, J IMMUNOL METHODS, V363, P80, DOI 10.1016/j.jim.2010.10.008; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Lax S, 2007, FEBS LETT, V581, P3550, DOI 10.1016/j.febslet.2007.06.063; Lax S, 2010, EUR J IMMUNOL, V40, P1884, DOI 10.1002/eji.200939877; Lee CCI, 2010, EXP HEMATOL, V38, P46, DOI 10.1016/j.exphem.2009.11.001; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lim S, 2012, STEM CELLS      0424, V24; Lotfi R, 2011, EUR J IMMUNOL, V41, P2021, DOI 10.1002/eji.201041324; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Meng ER, 2008, STEM CELLS DEV, V17, P805, DOI 10.1089/scd.2008.0276; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Muraglia A, 2000, J CELL SCI, V113, P1161; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Pearce DJ, 2007, EXP HEMATOL, V35, P1437, DOI 10.1016/j.exphem.2007.06.002; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Remberger M, 2011, BIOL BLOOD MARROW TR, V17, P1688, DOI 10.1016/j.bbmt.2011.05.001; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864; Rosu-Myles M, 2010, CYTOTHERAPY, V12, P818, DOI 10.3109/14653249.2010.501785; She YM, 2012, PROTEOMICS, V12, P369, DOI 10.1002/pmic.201100308; Spooncer E, 2008, MOL CELL PROTEOMICS, V7, P573, DOI 10.1074/mcp.M700292-MCP200; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Tian Ruijun, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.007252; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vanella L, 2011, PROSTAG OTH LIPID M, V96, P54, DOI 10.1016/j.prostaglandins.2011.07.005; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang J, 2012, STEM CELLS DEV  0420, V20; WEN L, 1989, NUCLEIC ACIDS RES, V17, P1197, DOI 10.1093/nar/17.3.1197; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x	60	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38954	10.1371/journal.pone.0038954	http://dx.doi.org/10.1371/journal.pone.0038954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719999	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900068
J	Granieri, L; Marnetto, F; Valentino, P; Frau, J; Patanella, AK; Nytrova, P; Sola, P; Capobianco, M; Jarius, S; Bertolotto, A				Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Frau, Jessica; Patanella, Agata Katia; Nytrova, Petra; Sola, Patrizia; Capobianco, Marco; Jarius, Sven; Bertolotto, Antonio			Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology	PLOS ONE			English	Article							NMO-IGG; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; AQUAPORIN-4; ANTIBODIES; RITUXIMAB; SPECTRUM; QUANTIFICATION; AUTOANTIBODIES; NATALIZUMAB	Background: Neuromyelitis optica (NMO) is a severely disabling autoimmune disorder of the central nervous system, which predominantly affects the optic nerves and spinal cord. In a majority of cases, NMO is associated with antibodies to aquaporin-4 (AQP4) (termed NMO-IgG). Aims: In this study, we evaluated a new multiparametric indirect immunofluorescence (IIF) assay for NMO serology. Methods: Sera from 20 patients with NMO, 41 patients with multiple sclerosis (MS), 30 healthy subjects, and a commercial anti-AQP4 IgG antibody were tested in a commercial composite immunofluorescence assay ("Neurology Mosaic 17"; Euroimmun, Germany), consisting of five different diagnostic substrates (HEK cells transfected with AQP4, non-transfected HEK cells, primate cerebellum, cerebrum, and optic nerve tissue sections). Results: We identified AQP4 specific and non-specific fluorescence staining patterns and established positivity criteria. Based on these criteria, this kit yielded a high sensitivity (95%) and specificity (100%) for NMO and had a significant positive and negative likelihood ratio (LR+=infinity, LR-=0.05). Moreover, a 100% inter- and intra-laboratory reproducibility was found. Conclusions: The biochip mosaic assay tested in this study is a powerful tool for NMO serology, fast to perform, highly sensitive and specific for NMO, reproducible, and suitable for inter-laboratory standardization as required for multi-centre clinical trials.	[Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Capobianco, Marco; Bertolotto, Antonio] Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referring Multiple Sclerosis Ctr CReSM, Turin, Italy; [Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Bertolotto, Antonio] Univ Turin, Neurosci Inst Cavalieri Ottolenghi NICO, Turin, Italy; [Frau, Jessica] Univ Cagliari, Multiple Sclerosis Ctr, Dept Cardiovasc & Neurol Sci, Cagliari, Italy; [Patanella, Agata Katia] Gemelli Hosp, Multiple Sclerosis Ctr, Dept Neurosci, Rome, Italy; [Nytrova, Petra] Gen Univ Hosp Prague, Dept Neurol, Prague, Czech Republic; [Nytrova, Petra] Gen Univ Hosp Prague, Ctr Clin Neurosci, Prague, Czech Republic; [Nytrova, Petra] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Sola, Patrizia] S Agostino Estense Hosp, Multiple Sclerosis Ctr, Modena, Italy; [Jarius, Sven] Heidelberg Univ, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; General University Hospital Prague; General University Hospital Prague; Charles University Prague; Ruprecht Karls University Heidelberg	Granieri, L (corresponding author), Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referring Multiple Sclerosis Ctr CReSM, Turin, Italy.	letiziagranieri@libero.it	Bertolotto, Antonio/K-8346-2015; Frau, Jessica/AAC-1622-2019; Nytrova, Petra/O-9099-2017; Capobianco, Marco/AAC-2215-2022; VALENTINO, Paola/AAA-4243-2019; Valentino, Paola/K-6758-2016	Bertolotto, Antonio/0000-0002-7052-1907; Nytrova, Petra/0000-0003-4885-602X; Capobianco, Marco/0000-0003-2501-2932; VALENTINO, Paola/0000-0001-7863-9195; Valentino, Paola/0000-0003-3819-9409	Alenia Areonautica S.p.A.; FORB (Fondazione per la Ricerca Biomedica, ONLUS); Fondazione San Luigi ONLUS; Czech Ministry of Education [MSM 0021620849]; Grant Agency of Charles University [GAUK 132010]; Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Bayer Vital; Merck Serono; Alenia Aeronautica Spa; Euroimmun, Luebeck, Germany; Biogen Idec; Novartis; Roche; Bayer Schering; Sanofi-Aventis	Alenia Areonautica S.p.A.; FORB (Fondazione per la Ricerca Biomedica, ONLUS); Fondazione San Luigi ONLUS; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of Charles University; Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Bayer Vital(Bayer AG); Merck Serono(Merck & Company); Alenia Aeronautica Spa; Euroimmun, Luebeck, Germany; Biogen Idec(Biogen); Novartis(Novartis); Roche(Roche Holding); Bayer Schering(Bayer AG); Sanofi-Aventis(Sanofi-Aventis)	We also thank Alenia Areonautica S.p.A. for supporting the fellowship of FM.; Financial supports were obtained from the FORB (Fondazione per la Ricerca Biomedica, ONLUS) and from Fondazione San Luigi ONLUS. The work of PN was supported by the Czech Ministry of Education, Research Program MSM 0021620849 and Grant Agency of Charles University (grant GAUK 132010). The work of SJ was supported by a research grant from the Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and by grants from Bayer Vital and from Merck Serono. The work of FM was supported by Alenia Aeronautica Spa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LG and PV received a contribution for attending a scientific meeting from Euroimmun, Luebeck, Germany. PN received a contribution for a fellowship in Oxford by Euroimmun, Luebeck, Germany. LG, FM and PV received consultation fees from Biogen Idec and Merck Serono. MC received consultation fees from Biogen Idec, Merck Serono and Novartis. AB has been on steering committees in clinical trials sponsored by Biogen Idec, Roche, and has received speaker honoraria from Biogen Idec, Merck Serono, TEVA, Bayer Schering, Sanofi-aventis, and Novartis; and his institution has received grant support from Biogen Idec, Bayer Schering, Merck Serono and Sanofi-Aventis. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. The other authors have no financial links with Euroimmun, and they have no competing financial interests.	Banwell B, 2008, NEUROLOGY, V70, P344, DOI 10.1212/01.wnl.0000284600.80782.d5; Barnett MH, 2012, MULT SCLER J, V18, P108, DOI 10.1177/1352458511421185; Bedi GS, 2011, MULT SCLER J, V17, P1225, DOI 10.1177/1352458511404586; Costanzi C, 2011, NEUROLOGY, V77, P659, DOI 10.1212/WNL.0b013e31822a2780; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; De Vidi I, 2011, CLIN IMMUNOL, V138, P239, DOI 10.1016/j.clim.2010.11.012; Fazio R, 2009, MULT SCLER J, V15, P1153, DOI 10.1177/1352458509106851; Fazio R, 2011, J NEUROIMMUNOL, V231, P100, DOI 10.1016/j.jneuroim.2010.10.012; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Hilliam RA, 2005, STAT MED, V24, P1219, DOI 10.1002/sim.1998; Jacob A, 2008, ARCH NEUROL-CHICAGO, V65, P1443, DOI 10.1001/archneur.65.11.noc80069; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2007, NEUROLOGY, V68, P1076, DOI 10.1212/01.wnl.0000256822.01222.bd; Jarius S, 2012, CLIN NEUROL NEUROSUR, V114, P331, DOI 10.1016/j.clineuro.2011.10.048; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2011, MULT SCLER J, V17, P1067, DOI 10.1177/1352458511403958; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P1412, DOI 10.1001/archneurol.2011.154; Kim W, 2011, MULT S IN PRESS 0930; Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lotze TE, 2008, PEDIATRICS, V122, pE1039, DOI 10.1542/peds.2007-2758; Marignier R, 2008, MULT SCLER, V14, P440, DOI 10.1177/1352458507084595; Marnetto F, 2009, J NEUROIMMUNOL, V217, P74, DOI 10.1016/j.jneuroim.2009.10.002; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; McKeon A, 2009, ARCH NEUROL-CHICAGO, V66, P1134, DOI 10.1001/archneurol.2009.178; Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133; Petzold A, 2010, J NEUROL NEUROSUR PS, V81, P109, DOI 10.1136/jnnp.2008.146894; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Wandinger KP, 2010, ARTHRITIS RHEUM-US, V62, P1198, DOI 10.1002/art.27337; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38896	10.1371/journal.pone.0038896	http://dx.doi.org/10.1371/journal.pone.0038896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719979	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000052
J	Dejean, A; Delabie, JHC; Corbara, B; Azemar, F; Groc, S; Orivel, J; Leponce, M				Dejean, Alain; Delabie, Jacques H. C.; Corbara, Bruno; Azemar, Frederic; Groc, Sarah; Orivel, Jerome; Leponce, Maurice			The Ecology and Feeding Habits of the Arboreal Trap-Jawed Ant Daceton armigerum	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; AFRICAN WEAVER ANT; OECOPHYLLA-LONGINODA; PREDATORY BEHAVIOR; HYMENOPTERA; FORMICIDAE; FOOD	Here we show that Daceton armigerum, an arboreal myrmicine ant whose workers are equipped with hypertrophied trap-jaw mandibles, is characterized by a set of unexpected biological traits including colony size, aggressiveness, trophobiosis and hunting behavior. The size of one colony has been evaluated at ca. 952,000 individuals. Intra-and interspecific aggressiveness were tested and an equiprobable null model used to show how D. armigerum colonies react vis-a-vis other arboreal ant species with large colonies; it happens that D. armigerum can share trees with certain of these species. As they hunt by sight, workers occupy their hunting areas only during the daytime, but stay on chemical trails between nests at night so that the center of their home range is occupied 24 hours a day. Workers tend different Hemiptera taxa (i.e., Coccidae, Pseudococcidae, Membracidae and Aethalionidae). Through group-hunting, short-range recruitment and spreadeagling prey, workers can capture a wide range of prey (up to 94.12 times the mean weight of foraging workers).	[Dejean, Alain; Orivel, Jerome] Ecol Forets Guyane, CNRS, UMR 8172, Kourou, France; [Dejean, Alain; Azemar, Frederic] Univ Toulouse, UPS, Ecolab, Toulouse, France; [Delabie, Jacques H. C.] Convenio UESC CEPLAC, UPA Lab Mirmecol, Itabuna, BA, Brazil; [Corbara, Bruno] Univ Blaise Pascal, Lab Microorganismes Genome & Environm, CNRS, UMR 6023, Aubiere, France; [Corbara, Bruno] Univ Blaise Pascal LMGE, Clermont Univ, Clermont Ferrand, France; [Azemar, Frederic] CNRS, Lab Ecol Fonct & Environm, UMR 5245, Toulouse, France; [Groc, Sarah] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil; [Leponce, Maurice] Royal Belgian Inst Nat Sci, Biol Evaluat Sect, Brussels, Belgium	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universidade Estadual de Santa Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universidade Federal de Uberlandia; Royal Belgian Institute of Natural Sciences	Dejean, A (corresponding author), Ecol Forets Guyane, CNRS, UMR 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr	Delabie, Jacques H C/F-3405-2010; Azémar, Frédéric/A-9041-2010	Delabie, Jacques H C/0000-0002-2695-1061; Azémar, Frédéric/0000-0002-3098-8676; Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; CORBARA, Bruno/0000-0003-4232-8234	French CNRS; Region Guyane from the European Community [20072013]; CNPq	French CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Guyane from the European Community; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support for this study was provided by the Programme Amazonie II of the French CNRS (project 2ID), and the Programme Convergence 20072013, Region Guyane from the European Community (project DEGA). JHCD acknowledges his research grant by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azorsa F, 2008, ZOOTAXA, P27, DOI 10.11646/zootaxa.1749.1.3; BEUGNON G, 1992, INSECT SOC, V39, P341, DOI 10.1007/BF01323954; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; BLUM M. S., 1966, PSYCHE J ENTOMOL, V73, P150, DOI 10.1155/1966/16367; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Crawley W. C., 1916, Annals & Magazine of Natural History, V17; Davidson D. W., 1996, NEOTROPICAL BIODIVER, P127; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; DEJEAN A, 1990, PHYSIOL ENTOMOL, V15, P393, DOI 10.1111/j.1365-3032.1990.tb00528.x; DEJEAN A, 1990, WESTV STUD, P472; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2007, CR BIOL, V330, P701, DOI 10.1016/j.crvi.2007.06.005; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019837; Dejean A, 2010, NATURWISSENSCHAFTEN, V97, P925, DOI 10.1007/s00114-010-0710-y; Dejean A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011331; Dejean Alain, 1999, Selbyana, V20, P133; Djieto-Lordon C, 2001, SOCIOBIOLOGY, V38, P765; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, ECOSIM NULL MODELS S; Gronenberg W, 1996, J EXP BIOL, V199, P2021; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOLLDOBLER B, 1990, J CHEM ECOL, V16, P1207, DOI 10.1007/BF01021020; Holldobler B., 1990, pi; Madi Y., 2006, ENTOMOTROPICA, V21, P117; Mercier JL, 1996, INSECT SOC, V43, P17, DOI 10.1007/BF01253952; MOFFETT M W, 1991, Psyche (Cambridge), V98, P283, DOI 10.1155/1991/30265; MOFFETT MW, 1992, RES EXPLOR, V8, P220; MORGAN ED, 1992, J CHEM ECOL, V18, P2161, DOI 10.1007/BF00984943; Parr CL, 2010, ANT ECOLOGY, P77; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; Rifflet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028571; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; WILSON EDWARD O., 1962, BULL MUS COMP ZOOL HARVARD UNIV, V127, P401; Wojtusiak J, 1995, TROP ZOOL, V8, P309, DOI 10.1080/03946975.1995.10539287; Yanoviak SP, 2005, NATURE, V433, P624, DOI 10.1038/nature03254	39	20	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e37683	10.1371/journal.pone.0037683	http://dx.doi.org/10.1371/journal.pone.0037683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737205	Green Published, gold, Green Submitted			2022-12-27	WOS:000305695100004
J	Boudjeltia, KZ; Daher, J; Van Antwerpen, P; Moguilevsky, N; Delree, P; Ducobu, J; Raes, M; Badran, B; Vanhaeverbeek, M; Brohee, D; Remacle, C; Vanhamme, L				Boudjeltia, Karim Zouaoui; Daher, Jalil; Van Antwerpen, Pierre; Moguilevsky, Nicole; Delree, Paul; Ducobu, Jean; Raes, Martine; Badran, Bassam; Vanhaeverbeek, Michel; Brohee, Dany; Remacle, Claude; Vanhamme, Luc			Exposure of Endothelial Cells to Physiological Levels of Myeloperoxidase-Modified LDL Delays Pericellular Fibrinolysis	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; LOW-DENSITY-LIPOPROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; CARDIOVASCULAR RISK; GENE-EXPRESSION; RECEPTOR LOX-1; OXIDIZED LDL; LINE; ASSOCIATION; MECHANISMS	Background: Blood fluidity is maintained by a delicate balance between coagulation and fibrinolysis. The endothelial cell surface is a key player in this equilibrium and cell surface disruptions can upset the balance. We investigated the role of pericellular myeloperoxidase oxidized LDLs (Mox-LDLs) in this balance. Methods and Results: We designed a technical device that enabled us to monitor fibrinolysis in real-time at the surface of an endothelial cell line (EA.hy926), and showed that Mox-LDL decreased pericellular fibrinolysis. There were no changes in fibrinolysis when EA.hy926 endothelial cells were exposed to native LDL (24 hours) at doses of 10, 50, 100 and up to 1250 mu g/ml. However, treatment of EA.hy926 endothelial cells with 10 and 50 mg/ml of Mox-LDL (physiological serum concentrations) increased the lysis time by 15 and 13%, respectively (p<0.001), although this effect was not present at higher concentrations of 100 mg/ml. This effect was not correlated with any changes in PAI-1 or t-PA or PA Receptor (PAR) expression. No effect was observed at the surface of smooth muscle cells used as controls. Conclusion: Our data link the current favorite hypothesis that modified LDL has a causal role in atheroma plaque formation with an old suggestion that fibrin may also play a causal role. Our data help complete the paradigm of atherosclerosis: Modified LDL locally enhances fibrin deposition (present work); fibrin deposits enhance endothelial permeability; this effect allows subendothelial accumulation of lipid and foam cells.	[Boudjeltia, Karim Zouaoui; Ducobu, Jean; Vanhaeverbeek, Michel; Brohee, Dany] Univ Libre Bruxelles, Unit 222, CHU Charleroi, Expt Med Lab, A Vesale, Montigny Le Til, Belgium; [Daher, Jalil; Vanhamme, Luc] Univ Libre Bruxelles, Mol Parasitol Lab, IBMM, Fac Sci, Gosselies, Belgium; [Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem, Brussels, Belgium; [Moguilevsky, Nicole] Fac Univ Notre Dame Paix, Technol Transfer Off, B-5000 Namur, Belgium; [Delree, Paul] Pathol & Genet Inst, Gosselies, Belgium; [Raes, Martine] Fac Univ Notre Dame Paix, Lab Biochem & Cellular Biol, B-5000 Namur, Belgium; [Daher, Jalil; Badran, Bassam] Lebanese Univ, Fac Sci, Immunol Lab, Dept Biochem, Hadath Beirut, Lebanon; [Remacle, Claude] Catholic Univ Louvain, Lab Cellular Biol, Inst Life Sci, B-1348 Louvain, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Namur; University of Namur; Lebanese University; Universite Catholique Louvain	Boudjeltia, KZ (corresponding author), Univ Libre Bruxelles, Unit 222, CHU Charleroi, Expt Med Lab, A Vesale, Montigny Le Til, Belgium.	karim.zouaoui@chu-charleroi.be		Van Antwerpen, Pierre/0000-0002-4934-8863	Intercommunale de Sante Publique du Pays de Charleroi; Institut de Recherche en Pathologie et Genetique Gosselies	Intercommunale de Sante Publique du Pays de Charleroi; Institut de Recherche en Pathologie et Genetique Gosselies	LV is Research Director at the Belgian National Fund for scientific research. This work was supported by a grant from the Intercommunale de Sante Publique du Pays de Charleroi and Institut de Recherche en Pathologie et Genetique Gosselies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 1999, J MOL CELL CARDIOL, V31, P2101, DOI 10.1006/jmcc.1999.1041; Astrup T, 1956, LANCET, V2, P525; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; BERETZ A, 1989, BIOCHEM J, V259, P35, DOI 10.1042/bj2590035; Boudjeltia K Zouaoui, 2002, BMC Biotechnol, V2, P8, DOI 10.1186/1472-6750-2-8; Boudjeltia KZ, 2006, EUR J INTERN MED, V17, P102, DOI 10.1016/j.ejim.2005.11.002; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Carr AC, 2000, FEBS LETT, V487, P176, DOI 10.1016/S0014-5793(00)02227-4; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Cines DB, 1998, BLOOD, V91, P3527; DANG CV, 1985, SCIENCE, V227, P1487, DOI 10.1126/science.4038818; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; EDGELL CJS, 1990, IN VITRO CELL DEV B, V26, P1167; Ellis V, 1997, BLOOD, V90, P2312, DOI 10.1182/blood.V90.6.2312.2312_2312_2322; EMEIS JJ, 1988, BLOOD, V71, P1669; Fukao H, 1997, BIOCHIM BIOPHYS ACTA, V1536, P111; Grosjean A, 2005, CRIT CARE S1, pP155; HAJJAR KA, 1994, J CLIN INVEST, V93, P703, DOI 10.1172/JCI117023; HAJJAR KA, 1995, THROMB HAEMOSTASIS, V74, P294; Handt S, 1996, BLOOD, V87, P4204, DOI 10.1182/blood.V87.10.4204.bloodjournal87104204; Hoshikawa H, 1998, BIOCHEM BIOPH RES CO, V245, P841, DOI 10.1006/bbrc.1998.8526; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Malle E, 2000, EUR J BIOCHEM, V267, P4495, DOI 10.1046/j.1432-1327.2000.01498.x; Mayerl C, 2006, VIRCHOWS ARCH, V449, P96, DOI 10.1007/s00428-006-0176-7; Mazzolai L, 2002, THROMB HAEMOSTASIS, V87, P1062; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Moguilevsky N, 2004, BIOCHEM BIOPH RES CO, V323, P1223, DOI 10.1016/j.bbrc.2004.08.220; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nagase M, 1998, J BIOL CHEM, V273, P33702, DOI 10.1074/jbc.273.50.33702; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Pahor M, 1999, ARCH INTERN MED, V159, P237, DOI 10.1001/archinte.159.3.237; Qi JF, 1997, BLOOD, V90, P3595, DOI 10.1182/blood.V90.9.3595; QI JF, 1995, J IMMUNOL, V155, P867; RIEBER AJ, 1993, THROMB HAEMOSTASIS, V69, P476; SALOMAA V, 1995, CIRCULATION, V91, P284, DOI 10.1161/01.CIR.91.2.284; Sanchez MC, 2001, ARCH BIOCHEM BIOPHYS, V389, P218, DOI 10.1006/abbi.2001.2329; SCHLEEF RR, 1984, ARTERIOSCLEROSIS, V4, P14, DOI 10.1161/01.ATV.4.1.14; SOBEL MI, 1995, AM J OBSTET GYNECOL, V173, P801, DOI 10.1016/0002-9378(95)90344-5; Sueishi K, 1998, SEMIN THROMB HEMOST, V24, P255, DOI 10.1055/s-2007-995851; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; URANO T, 1990, THROMB HAEMOSTASIS, V63, P82; William KJ, 1995, THROMB VASC BIOL, V15, P551; Woolf N, 1978, Adv Exp Med Biol, V104, P145; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38810	10.1371/journal.pone.0038810	http://dx.doi.org/10.1371/journal.pone.0038810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723891	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700032
J	el Azzouzi, H; Leptidis, S; Bourajjaj, M; van Bilsen, M; Martins, PAD; De Windt, LJ				el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; van Bilsen, Marc; Martins, Paula A. da Costa; De Windt, Leon J.			MEK1 Inhibits Cardiac PPAR alpha Activity by Direct Interaction and Prevents Its Nuclear Localization	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; CHRONIC PRESSURE-OVERLOAD; INDUCED HEART-FAILURE; HYPERTROPHIC GROWTH; GENE-EXPRESSION; CALCINEURIN; PROLIFERATION; METABOLISM; GAMMA; PHOSPHORYLATION	Background: The response of the postnatal heart to growth and stress stimuli includes activation of a network of signal transduction cascades, including the stress activated protein kinases such as p38 mitogen-activated protein kinase (MAPK), c-Jun NH2-terminal kinase (JNK) and the extracellular signal-regulated kinase (ERK1/2) pathways. In response to increased workload, the mitogen-activated protein kinase kinase (MAPKK) MEK1 has been shown to be active. Studies embarking on mitogen-activated protein kinase (MAPK) signaling cascades in the heart have indicated peroxisome-proliferators activated-receptors (PPARs) as downstream effectors that can be regulated by this signaling cascade. Despite the importance of PPAR alpha in controlling cardiac metabolism, little is known about the relationship between MAPK signaling and cardiac PPAR alpha signaling. Methodology/Principal Finding: Using co-immunoprecipitation and immunofluorescence approaches we show a complex formation of PPAR alpha with MEK1 and not with ERK1/2. Binding of PPAR alpha to MEK1 is mediated via a LXXLL motif and results in translocation from the nucleus towards the cytoplasm, hereby disabling the transcriptional activity of PPAR alpha. Mice subjected to voluntary running-wheel exercise showed increased cardiac MEK1 activation and complex formation with PPAR alpha, subsequently resulting in reduced PPAR alpha activity. Inhibition of MEK1, using U0126, blunted this effect. Conclusion: Here we show that activation of the MEK1-ERK1/2 pathway leads to specific inhibition of PPAR alpha transcriptional activity. Furthermore we show that this inhibitory effect is mediated by MEK1, and not by its downstream effector kinase ERK1/2, through a mechanism involving direct binding to PPAR alpha and subsequent stimulation of PPAR alpha export from the nucleus.	[el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Martins, Paula A. da Costa] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [el Azzouzi, Hamid; Leptidis, Stefanos; Martins, Paula A. da Costa; De Windt, Leon J.] Maastricht Univ, Dept Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [van Bilsen, Marc] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Maastricht University; Maastricht University	el Azzouzi, H (corresponding author), Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands.	l.dewindt@maastrichtuniversity.nl	de Windt, Leon/AAO-6395-2020; van Bilsen, Marc/E-8342-2016; Leptidis, Stefanos/D-1455-2016	de Windt, Leon/0000-0002-7793-2856; Leptidis, Stefanos/0000-0003-0172-4193; el Azzouzi, Hamid/0000-0003-1242-9691	Netherlands Organization for Health Research and Development (ZonMW) [912-04-054, 912-04-017]; VIDI from The Netherlands Organization for Health Research and Development (ZonMW) [917-863-72]; Netherlands Heart Foundation [NHS2007B167]; European Union [LSHM-CT-2005-018833/EUGeneHeart]; Fondation Leducq Transatlantic Network of Excellence [08-CVD-03]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); VIDI from The Netherlands Organization for Health Research and Development (ZonMW); Netherlands Heart Foundation(Netherlands Heart Foundation); European Union(European Commission); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation)	This work was supported by grants 912-04-054, 912-04-017 and a VIDI award 917-863-72 from The Netherlands Organization for Health Research and Development (ZonMW); The Netherlands Heart Foundation grant NHS2007B167; the European Union Contract No. LSHM-CT-2005-018833/EUGeneHeart; and the Fondation Leducq Transatlantic Network of Excellence program 08-CVD-03 (to LDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Badrian B, 2007, INT J BIOCHEM CELL B, V39, P349, DOI 10.1016/j.biocel.2006.09.002; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Burgermeister E, 2003, J BIOMOL STRUCT DYN, V20, P623, DOI 10.1080/07391102.2003.10506879; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Finck BN, 2002, J MOL CELL CARDIOL, V34, P1249, DOI 10.1006/jmcc.2002.2061; Francis Gary S, 2003, Rev Cardiovasc Med, V4 Suppl 2, pS14; Gelinas R, 2008, AM J PHYSIOL-HEART C, V294, pH1571, DOI 10.1152/ajpheart.01340.2007; Hi R, 1999, J BIOL CHEM, V274, P35152, DOI 10.1074/jbc.274.49.35152; Iemitsu M, 2006, J APPL PHYSIOL, V101, P151, DOI 10.1152/japplphysiol.00392.2005; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Luptak I, 2005, CIRCULATION, V112, P2339, DOI 10.1161/CIRCULATIONAHA.105.534594; Marenda DR, 2006, DEVELOPMENT, V133, P43, DOI 10.1242/dev.02168; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Rybkin II, 2003, J BIOL CHEM, V278, P15927, DOI 10.1074/jbc.M213102200; Sack MN, 1997, P NATL ACAD SCI USA, V94, P6438, DOI 10.1073/pnas.94.12.6438; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Smeets PJH, 2008, PHYSIOL GENOMICS, V36, P15, DOI 10.1152/physiolgenomics.90296.2008; Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Tolwinski NS, 1999, J BIOL CHEM, V274, P6168, DOI 10.1074/jbc.274.10.6168; van Empel VPM, 2006, J AM COLL CARDIOL, V48, P824, DOI 10.1016/j.jacc.2006.02.075; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e36799	10.1371/journal.pone.0036799	http://dx.doi.org/10.1371/journal.pone.0036799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723831	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700001
J	George, I; Cousillas, H; Richard, JP; Hausberger, M				George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine			Experience with Adults Shapes Multisensory Representation of Social Familiarity in the Brain of a Songbird	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; CENTRAL AUDITORY AREA; MALE ZEBRA FINCHES; BIRDS OWN SONG; NEURAL RESPONSE; EQUUS-CABALLUS; RECOGNITION; FOREBRAIN; SPEECH; FACES	Social animals learn to perceive their social environment, and their social skills and preferences are thought to emerge from greater exposure to and hence familiarity with some social signals rather than others. Familiarity appears to be tightly linked to multisensory integration. The ability to differentiate and categorize familiar and unfamiliar individuals and to build a multisensory representation of known individuals emerges from successive social interactions, in particular with adult, experienced models. In different species, adults have been shown to shape the social behavior of young by promoting selective attention to multisensory cues. The question of what representation of known conspecifics adult-deprived animals may build therefore arises. Here we show that starlings raised with no experience with adults fail to develop a multisensory representation of familiar and unfamiliar starlings. Electrophysiological recordings of neuronal activity throughout the primary auditory area of these birds, while they were exposed to audio-only or audiovisual familiar and unfamiliar cues, showed that visual stimuli did, as in wild-caught starlings, modulate auditory responses but that, unlike what was observed in wild-caught birds, this modulation was not influenced by familiarity. Thus, adult-deprived starlings seem to fail to discriminate between familiar and unfamiliar individuals. This suggests that adults may shape multisensory representation of known individuals in the brain, possibly by focusing the young's attention on relevant, multisensory cues. Multisensory stimulation by experienced, adult models may thus be ubiquitously important for the development of social skills (and of the neural properties underlying such skills) in a variety of species.	[George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine] Univ Rennes 1, CNRS, UMR6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, UMR6552, Rennes, France.	Isabelle.George@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French ANR; University of Rennes 1; French CNRS	French ANR(French National Research Agency (ANR)); University of Rennes 1; French CNRS(Centre National de la Recherche Scientifique (CNRS))	This study has been supported by a grant of the French ANR entitled "Intermodality and imitation: behavioral and neuronal aspects (studies in human newborns and birds)'' (INTERIMIT). I.G., J.P.R., H.C. and M.H. were supported by the University of Rennes 1 and the French CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Bertin A, 2009, J COMP PSYCHOL, V123, P195, DOI 10.1037/a0014050; BISCHOF HJ, 1985, BRAIN RES, V326, P370, DOI 10.1016/0006-8993(85)90048-4; Bolhuis JJ, 1999, ANIM BEHAV, V58, P1285, DOI 10.1006/anbe.1999.1266; Bourjade M, 2008, DEV PSYCHOBIOL, V50, P408, DOI 10.1002/dev.20301; Bourjade M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004888; Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; Capsius B, 1999, HEARING RES, V136, P91, DOI 10.1016/S0378-5955(99)00112-4; Coulon M, 2011, INT J BEHAV DEV, V35, P282, DOI 10.1177/0165025410396765; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; Cousillas H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002194; Gentner TQ, 2004, ANN NY ACAD SCI, V1016, P282, DOI 10.1196/annals.1298.008; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2003, J NEUROSCI METH, V125, P65, DOI 10.1016/S0165-0270(03)00025-6; George Isabelle, 2011, Frontiers in Behavioral Neuroscience, V4, P1, DOI 10.3389/fnbeh.2010.00193; George I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014347; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Green DM, 1966, SIGNAL DETECTION THE; Guellai B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018610; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L, 1998, REV ECOL-TERRE VIE, V53, P347; Hernandez AM, 2004, J NEUROBIOL, V59, P247, DOI 10.1002/neu.10312; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Ikebuchi M, 1999, ZOOL SCI, V16, P63, DOI 10.2108/zsj.16.63; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; Martinez L, 2009, ANIM COGN, V12, pS71, DOI 10.1007/s10071-009-0269-1; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Sankey C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018331; Setti A, 2011, NEUROSCI LETT, V492, P19, DOI 10.1016/j.neulet.2011.01.042; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Solis MM, 1999, J NEUROSCI, V19, P4559; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Watanabe S, 2010, BEHAV BRAIN RES, V207, P61, DOI 10.1016/j.bbr.2009.09.041; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0	46	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38764	10.1371/journal.pone.0038764	http://dx.doi.org/10.1371/journal.pone.0038764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723887	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700030
J	Hashimoto, Y; Tazawa, H; Teraishi, F; Kojima, T; Watanabe, Y; Uno, F; Yano, S; Urata, Y; Kagawa, S; Fujiwara, T				Hashimoto, Yuuri; Tazawa, Hiroshi; Teraishi, Fuminori; Kojima, Toru; Watanabe, Yuichi; Uno, Futoshi; Yano, Shuya; Urata, Yasuo; Kagawa, Shunsuke; Fujiwara, Toshiyoshi			The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment	PLOS ONE			English	Article							REPLICATION-SELECTIVE VIROTHERAPY; INDUCIBLE FACTOR-I; CANCER STEM-CELLS; TUMOR HYPOXIA; HEPATOCELLULAR CARCINOMAS; DOWN-REGULATION; UP-REGULATION; TELOMERASE; RECEPTOR; EXPRESSION	Hypoxia is a microenvironmental factor that contributes to the invasion, progression and metastasis of tumor cells. Hypoxic tumor cells often show more resistance to conventional chemoradiotherapy than normoxic tumor cells, suggesting the requirement of novel antitumor therapies to efficiently eliminate the hypoxic tumor cells. We previously generated a tumor-specific replication-competent oncolytic adenovirus (OBP-301: Telomelysin), in which the human telomerase reverse transcriptase (hTERT) promoter drives viral E1 expression. Since the promoter activity of the hTERT gene has been shown to be upregulated by hypoxia, we hypothesized that, under hypoxic conditions, the antitumor effect of OBP-301 with the hTERT promoter would be more efficient than that of the wild-type adenovirus 5 (Ad5). In this study, we investigated the antitumor effects of OBP-301 and Ad5 against human cancer cells under a normoxic (20% oxygen) or a hypoxic (1% oxygen) condition. Hypoxic condition induced nuclear accumulation of the hypoxia-inducible factor-1 alpha and upregulation of hTERT promoter activity in human cancer cells. The cytopathic activity of OBP-301 was significantly higher than that of Ad5 under hypoxic condition. Consistent with their cytopathic activity, the replication of OBP-301 was significantly higher than that of Ad5 under the hypoxic condition. OBP-301-mediated E1A was expressed within hypoxic areas of human xenograft tumors in mice. These results suggest that the cytopathic activity of OBP-301 against hypoxic tumor cells is mediated through hypoxia-mediated activation of the hTERT promoter. Regulation of oncolytic adenoviruses by the hTERT promoter is a promising antitumor strategy, not only for induction of tumor-specific oncolysis, but also for efficient elimination of hypoxic tumor cells.	[Hashimoto, Yuuri; Tazawa, Hiroshi; Teraishi, Fuminori; Kojima, Toru; Watanabe, Yuichi; Uno, Futoshi; Yano, Shuya; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Japan; [Tazawa, Hiroshi] Okayama Univ Hosp, Ctr Gene & Cell Therapy, Okayama, Japan; [Urata, Yasuo] Oncolys BioPharma Inc, Tokyo, Japan	Okayama University; Okayama University; Oncolys BioPharma	Hashimoto, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Japan.	toshi_f@md.okayama-u.ac.jp	TAZAWA, Hiroshi/B-2247-2011; Yano, Shuya/AAL-8028-2020; Kagawa, Shunsuke/B-2189-2011	TAZAWA, Hiroshi/0000-0003-4658-1050; Kagawa, Shunsuke/0000-0002-3610-8211	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to TF and FT, http://www.mext.go.jp/english/) and by grants from the Ministry of Health, Labour and Welfare of Japan (to TF, http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Bauerschmitz GJ, 2008, CANCER RES, V68, P5533, DOI 10.1158/0008-5472.CAN-07-5288; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Castelo-Branco P, 2011, CLIN CANCER RES, V17, P111, DOI 10.1158/1078-0432.CCR-10-2075; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Eriksson M, 2007, MOL THER, V15, P2088, DOI 10.1038/sj.mt.6300300; Guo ZS., 2011, VIRUS ADAPT TREAT, V3, P71, DOI DOI 10.2147/VAAT.S17832; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Hashimoto Y, 2008, CANCER SCI, V99, P385, DOI 10.1111/j.1349-7006.2007.00665.x; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hernandez-Alcoceba R, 2002, HUM GENE THER, V13, P1737, DOI 10.1089/104303402760293574; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kawashima T, 2004, CLIN CANCER RES, V10, P285, DOI 10.1158/1078-0432.CCR-1075-3; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Kuster K, 2010, CANCER GENE THER, V17, P141, DOI 10.1038/cgt.2009.49; Kwon OJ, 2010, CLIN CANCER RES, V16, P6071, DOI 10.1158/1078-0432.CCR-10-0664; Lacher MD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-91; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Niu JX, 2007, EUR J CANCER PREV, V16, P517, DOI 10.1097/CEJ.0b013e3280145c00; Pipiya T, 2005, GENE THER, V12, P911, DOI 10.1038/sj.gt.3302459; Post DE, 2003, ONCOGENE, V22, P2065, DOI 10.1038/sj.onc.1206464; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; Shen BH, 2005, GENE THER, V12, P902, DOI 10.1038/sj.gt.3302448; Short JJ, 2009, MOL CANCER THER, V8, P2096, DOI 10.1158/1535-7163.MCT-09-0367; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Umeoka T, 2004, CANCER RES, V64, P6259, DOI 10.1158/0008-5472.CAN-04-1335; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yatabe N, 2004, ONCOGENE, V23, P3708, DOI 10.1038/sj.onc.1207460; Yoo YG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002072; Zhang XC, 2008, CLIN CANCER RES, V14, P2813, DOI 10.1158/1078-0432.CCR-07-1528	46	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39292	10.1371/journal.pone.0039292	http://dx.doi.org/10.1371/journal.pone.0039292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720091	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350000057
J	Schuster, C; Eikesdal, HP; Puntervoll, H; Geisler, J; Geisler, S; Heinrich, D; Molven, A; Lonning, PE; Akslen, LA; Straume, O				Schuster, Cornelia; Eikesdal, Hans P.; Puntervoll, Hanne; Geisler, Jurgen; Geisler, Stephanie; Heinrich, Daniel; Molven, Anders; Lonning, Per E.; Akslen, Lars A.; Straume, Oddbjorn			Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-II TRIAL; DOSE INTERFERON-ALPHA-2B; MALIGNANT-MELANOMA; BREAST-CANCER; BETA-BLOCKERS; ANGIOGENESIS; LYMPHANGIOGENESIS; DACARBAZINE; PROGRESSION	Background: VEGF driven angiogenesis plays a key role in cancer progression. We determined the clinical efficacy of bevacizumab monotherapy in patients with metastatic melanoma. Methods and Findings: Thirty-five patients with metastatic melanoma in progression were enrolled in this phase II, single arm clinical trial. Each patient received bevacizumab monotherapy 10 mg/kg q14 d until intolerable toxicity or disease progression occurred. Clinical efficacy was evaluated as objective response, disease control (DC), and survival. We observed one complete (3%) and 5 partial (14%) responses. In addition, 5 patients experienced stable disease >6 months (14%) while 24 patients had progressive disease (PD, 69%), corresponding to a total DC at 6 months in 11 out of 35 patients (31%). Median progression free survival (PFS) was 2.14 months and median overall survival (OS) was 9 months (1.12-49). Seven of the 11 patients experiencing DC developed early hypertension (<2 months) compared to 3/24 of patients with PD (P = 0.001), and hypertension was associated with PFS (P = 0.005) and OS (P = 0.013). Conclusion: Bevacizumab monotherapy demonstrated promising clinical efficacy in patients with metastatic melanoma with disease control in 31% of the patients. Induced early hypertension was a marker for clinical efficacy of bevacizumab.	[Schuster, Cornelia; Eikesdal, Hans P.; Geisler, Stephanie; Lonning, Per E.; Straume, Oddbjorn] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Schuster, Cornelia; Puntervoll, Hanne; Molven, Anders; Akslen, Lars A.] Univ Bergen, Gade Inst, Sect Pathol, Bergen, Norway; [Schuster, Cornelia; Puntervoll, Hanne; Molven, Anders; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Geisler, Jurgen; Heinrich, Daniel] Univ Oslo, Inst Clin Med, Div Clin Med & Lab Sci, Oslo, Norway; [Geisler, Jurgen; Heinrich, Daniel] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo	Schuster, C (corresponding author), Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway.	oddbjorn.straume@helse-bergen.no	Akslen, Lars A./AAG-6097-2021; Schuster, Cornelia/AAX-9719-2021; Geisler, Jurgen/AAI-4613-2020; Eikesdal, Hans Petter/AAG-3228-2020; Akslen, Lars A/C-1202-2017; Straume, Oddbjørn/C-2186-2017	Akslen, Lars A./0000-0003-2710-9543; Schuster, Cornelia/0000-0003-2665-9527; Geisler, Jurgen/0000-0001-6239-3856; Eikesdal, Hans Petter/0000-0003-4086-0147; Akslen, Lars A/0000-0003-2710-9543; Straume, Oddbjørn/0000-0001-8867-3645; Lonning, Per Eystein/0000-0002-8890-6303	Norwegian Cancer Association [94070]; Roche Norway [p339]	Norwegian Cancer Association; Roche Norway	The work was supported by grant No 94070 from the Norwegian Cancer Association to OS and by grant No p339 from Roche Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As stated above, the project has received funding from a commercial source (Roche Norway). This includes support for running costs as well as a price reduction for the investigational drug. This study involves Bevacizumab, which is a Roche product. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akslen LA, 2008, MELANOMA RES, V18, P29, DOI 10.1097/CMR.0b013e3282f32517; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Busch C, 2010, EUR J CANCER, V46, P2127, DOI 10.1016/j.ejca.2010.04.023; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corrie P G, 2010, Ther Adv Med Oncol, V2, P367, DOI 10.1177/1758834010380101; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Giorgi V, 2011, ARCH INTERN MED, V171, P779, DOI 10.1001/archinternmed.2011.131; Del Vecchio M, 2010, CLIN CANCER RES, V16, P5862, DOI 10.1158/1078-0432.CCR-10-2363; Facemire CS, 2009, HYPERTENSION, V54, P652, DOI 10.1161/HYPERTENSIONAHA.109.129973; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Fruehauf J, 2011, CLIN CANC RES; Grignol VP, 2011, J IMMUNOTHER, V34, P509, DOI 10.1097/CJI.0b013e31821dcefd; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kim JC, 2011, CLIN CANCER RES, V17, P1200, DOI 10.1158/1078-0432.CCR-10-1907; Kim KB, 2011, J CLIN ONCOL; Lemeshow S, 2011, CANC EPIDEMIOL BIOMA; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; SIMON R, 1994, STAT MED, V13, P417, DOI 10.1002/sim.4780130506; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678; Straume O, 1999, INT J ONCOL, V15, P595; Straume Oddbjorn, 2003, Angiogenesis, V6, P295, DOI 10.1023/B:AGEN.0000029408.08638.aa; Streit M, 2003, ONCOGENE, V22, P3172, DOI 10.1038/sj.onc.1206457; Surnan VJ, 2008, CANCER INVEST, V26, P439, DOI 10.1080/07357900801971057; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Varker KA, 2007, ANN SURG ONCOL, V14, P2367, DOI 10.1245/s10434-007-9389-5; Vihinen PP, 2010, MELANOMA RES, V20, P318, DOI 10.1097/CMR.0b013e3283390365; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	41	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38364	10.1371/journal.pone.0038364	http://dx.doi.org/10.1371/journal.pone.0038364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719881	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000014
J	Chen, YZ; Chen, Z; Gong, YA; Ying, GG				Chen, Yong-Zi; Chen, Zhen; Gong, Yu-Ai; Ying, Guoguang			SUMOhydro: A Novel Method for the Prediction of Sumoylation Sites Based on Hydrophobic Properties	PLOS ONE			English	Article							AMINO-ACID PAIRS; RNA-BINDING SITES; PROTEIN SEQUENCES; WEB SERVER; PSI-BLAST; SUMO; INFORMATION; COLLOCATION; PLANTS; MOTIF	Sumoylation is one of the most essential mechanisms of reversible protein post-translational modifications and is a crucial biochemical process in the regulation of a variety of important biological functions. Sumoylation is also closely involved in various human diseases. The accurate computational identification of sumoylation sites in protein sequences aids in experimental design and mechanistic research in cellular biology. In this study, we introduced amino acid hydrophobicity as a parameter into a traditional binary encoding scheme and developed a novel sumoylation site prediction tool termed SUMOhydro. With the assistance of a support vector machine, the proposed method was trained and tested using a stringent non-redundant sumoylation dataset. In a leave-one-out cross-validation, the proposed method yielded an excellent performance with a correlation coefficient, specificity, sensitivity and accuracy equal to 0.690, 98.6%, 71.1% and 97.5%, respectively. In addition, SUMOhydro has been benchmarked against previously described predictors based on an independent dataset, thereby suggesting that the introduction of hydrophobicity as an additional parameter could assist in the prediction of sumoylation sites. Currently, SUMOhydro is freely accessible at http://protein.cau.edu.cn/others/SUMOhydro/.	[Chen, Yong-Zi; Gong, Yu-Ai; Ying, Guoguang] Tianjin Med Univ, Canc Inst & Hosp Tianjin, Canc Cell Biol Lab, Tianjin, Peoples R China; [Chen, Yong-Zi; Gong, Yu-Ai; Ying, Guoguang] Tianjin Municipal Sci & Technol Commiss, Tianjin Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Chen, Zhen] China Agr Univ, Coll Biol Sci, Bioinformat Ctr, Beijing 100094, Peoples R China	Tianjin Medical University; China Agricultural University	Chen, YZ (corresponding author), Tianjin Med Univ, Canc Inst & Hosp Tianjin, Canc Cell Biol Lab, Tianjin, Peoples R China.	yingguoguang@gmail.com		chen, yongzi/0000-0003-3396-7130; Chen, Zhen/0000-0002-9412-9774	National Basic Research Program of China [2010CB529403, 2011CB933100]; Tianjin TSTC [09ZCZDSF04300]; National Nature Science Foundation of China [NSFC30772528, NSFC81072158]; National Program for Changjiang Scholars and Innovative Research Team in University [IRT1076, IRT0743]	National Basic Research Program of China(National Basic Research Program of China); Tianjin TSTC; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Basic Research Program of China 2010CB529403, 2011CB933100, the Tianjin TSTC grant 09ZCZDSF04300, the National Nature Science Foundation of China NSFC30772528, NSFC81072158, and the National Program for Changjiang Scholars and Innovative Research Team in University IRT1076, IRT0743. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Gao JJ, 2009, LECT N BIOINFORMAT, V5462, P18; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayat M, 2011, J THEOR BIOL; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Miura K, 2007, CURR OPIN PLANT BIOL, V10, P495, DOI 10.1016/j.pbi.2007.07.002; Moschos SJ, 2006, J MOL HISTOL, V37, P309, DOI 10.1007/s10735-006-9030-0; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Song JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-124; Teng S, 2011, AMINO ACIDS; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Xu JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-8; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yan RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-416; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	35	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39195	10.1371/journal.pone.0039195	http://dx.doi.org/10.1371/journal.pone.0039195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720073	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347800055
J	Imai, S; Mamiya, T; Tsukada, A; Sakai, Y; Mouri, A; Nabeshima, T; Ebihara, S				Imai, Saki; Mamiya, Takayoshi; Tsukada, Akira; Sakai, Yasuyuki; Mouri, Akihiro; Nabeshima, Toshitaka; Ebihara, Shizufumi			Ubiquitin-Specific Peptidase 46 (Usp46) Regulates Mouse Immobile Behavior in the Tail Suspension Test through the GABAergic System	PLOS ONE			English	Article							TRAIT LOCUS ANALYSIS; CS MICE; RECEPTORS; DEPRESSION; MODEL; DESPAIR; RHYTHM; SLEEP	The tail suspension test (TST) is widely recognized as a useful experimental paradigm for assessing antidepressant activity and depression-like behavior. We have previously identified ubiquitin-specific peptidase 46 (Usp46) as a quantitative trait gene responsible for decreasing immobility time in the TST in mice. This Usp46 mutation has a 3-bp deletion coding for lysine in the open reading frame, and we indicated that Usp46 is implicated in the regulation of the GABAergic system. However, it is not known precisely how the immobile behavior is regulated by the GABAergic system. Therefore, in the present study, we examined whether the immobility time is influenced by drugs affecting the action mediated by GABA(A) receptor using both 3-bp deleted (the Usp46 mutant) and null Usp46 (Usp46 KO) mice. Nitrazepam, an agonist at the benzodiazepine-binding site of the GABA(A) receptor, which potentiates the action of GABA, produced a dose-dependent increase in TST immobility time in the Usp46 mutant mice without affecting general behaviors. The Usp46 KO mice exhibited short immobility times comparable to the Usp46 mutant mice, which was also increased by nitrazepam administration. The effects of nitrazepam in the Usp46 mutant and KO mice were antagonized by flumazenil. These results indicate that the 3-bp deleted Usp46 mutation causes a loss-of-function phenotype, and that the GABAA receptor might participate in the regulation of TST immobility time.	[Imai, Saki; Sakai, Yasuyuki; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan; [Mamiya, Takayoshi; Mouri, Akihiro; Nabeshima, Toshitaka] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi, Japan; [Tsukada, Akira] Nagoya Univ, Grad Sch Bioagr Sci, Div Appl Genet & Physiol, Nagoya, Aichi 4648601, Japan	Nagoya University; Meijo University; Nagoya University	Imai, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp			Takeda Science Foundation; Life Science Foundation of Japan	Takeda Science Foundation(Takeda Science Foundation (TSF)); Life Science Foundation of Japan(Life Science Foundation of Japan)	This research was supported in part by a Grant-in-Aid for Scientific Research (A), Grant-in-Aid for challenging Exploratory Research, Takeda Science Foundation, Life Science Foundation of Japan to S.E., and Grant-in-Aid for JSPS Fellows to S. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1999, J COMP PHYSIOL A, V184, P243, DOI 10.1007/s003590050322; Abe H, 2007, AM J PHYSIOL-REG I, V292, pR607, DOI 10.1152/ajpregu.00331.2006; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Ebihara S, 2003, BRAIN RES, V980, P121, DOI 10.1016/S0006-8993(03)02947-0; Fiorelli R, 2008, BEHAV PHARMACOL, V19, P582, DOI 10.1097/FBP.0b013e32830dc0c7; Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Liu XQ, 2007, BIOL PSYCHIAT, V62, P81, DOI 10.1016/j.biopsych.2006.08.017; Miller BH, 2010, MAMM GENOME, V21, P247, DOI 10.1007/s00335-010-9266-6; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Suzuki T, 2001, MAMM GENOME, V12, P272, DOI 10.1007/s003350010280; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009; VOTEY SR, 1991, ANN EMERG MED, V20, P181, DOI 10.1016/S0196-0644(05)81219-3; WAMBEBE C, 1985, BRIT J PHARMACOL, V84, P185; Yoshikawa T, 2002, GENOME RES, V12, P357, DOI 10.1101/gr.222602; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026297	21	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39084	10.1371/journal.pone.0039084	http://dx.doi.org/10.1371/journal.pone.0039084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720038	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800043
J	Ke, W; Laurent, AH; Armstrong, MD; Chen, YC; Smith, WE; Liang, J; Wright, CM; Ostermeier, M; van den Akker, F				Ke, Wei; Laurent, Abigail H.; Armstrong, Morgan D.; Chen, Yuchao; Smith, William E.; Liang, Jing; Wright, Chapman M.; Ostermeier, Marc; van den Akker, Focco			Structure of an Engineered beta-Lactamase Maltose Binding Protein Fusion Protein: Insights into Heterotropic Allosteric Regulation	PLOS ONE			English	Article							DIRECTED EVOLUTION; UNRELATED PROTEINS; DOMAIN INSERTION; LIGAND-BINDING; ACTIVE-SITE; SWITCH; TEM1; CRYSTALLOGRAPHY; ANTITHROMBIN; LYSINE-234	Engineering novel allostery into existing proteins is a challenging endeavor to obtain novel sensors, therapeutic proteins, or modulate metabolic and cellular processes. The RG13 protein achieves such allostery by inserting a circularly permuted TEM-1 beta-lactamase gene into the maltose binding protein (MBP). RG13 is positively regulated by maltose yet is, serendipitously, inhibited by Zn2+ at low mu M concentration. To probe the structure and allostery of RG13, we crystallized RG13 in the presence of mM Zn2+ concentration and determined its structure. The structure reveals that the MBP and TEM-1 domains are in close proximity connected via two linkers and a zinc ion bridging both domains. By bridging both TEM-1 and MBP, Zn2+ acts to "twist tie'' the linkers thereby partially dislodging a linker between the two domains from its original catalytically productive position in TEM-1. This linker 1 contains residues normally part of the TEM-1 active site including the critical beta 3 and beta 4 strands important for activity. Mutagenesis of residues comprising the crystallographically observed Zn2+ site only slightly affected Zn2+ inhibition 2- to 4-fold. Combined with previous mutagenesis results we therefore hypothesize the presence of two or more inter-domain mutually exclusive inhibitory Zn2+ sites. Mutagenesis and molecular modeling of an intact TEM-1 domain near MBP within the RG13 framework indicated a close surface proximity of the two domains with maltose switching being critically dependent on MBP linker anchoring residues and linker length. Structural analysis indicated that the linker attachment sites on MBP are at a site that, upon maltose binding, harbors both the largest local C alpha distance changes and displays surface curvature changes, from concave to relatively flat becoming thus less sterically intrusive. Maltose activation and zinc inhibition of RG13 are hypothesized to have opposite effects on productive relaxation of the TEM-1 beta 3 linker region via steric and/or linker juxtapositioning mechanisms.	[Ke, Wei; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Laurent, Abigail H.; Armstrong, Morgan D.; Chen, Yuchao; Smith, William E.; Liang, Jing; Wright, Chapman M.; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Case Western Reserve University; Johns Hopkins University	Ke, W (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Institutes of Health [R01 AI062968, R01 GM066972]; National Science Foundation [MCB 0919377]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0919377] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	FvdA is supported by National Institutes of Health (R01 AI062968). MO was supported by National Institutes of Health (R01 GM066972) and National Science Foundation (MCB 0919377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI H, 1991, J BIOL CHEM, V266, P3186; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Edwards WR, 2010, BIOCHEMISTRY-US, V49, P6541, DOI 10.1021/bi100793y; Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363; ELLERBY LM, 1990, BIOCHEMISTRY-US, V29, P5797, DOI 10.1021/bi00476a022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraz RM, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-15; Greene AC, 2008, BIOTECHNOL BIOENG, V101, P478, DOI 10.1002/bit.21927; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Guntas G, 2004, CHEM BIOL, V11, P1483, DOI 10.1016/j.chembiol.2004.08.020; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Helfand MS, 2002, J BIOL CHEM, V277, P47719, DOI 10.1074/jbc.M207271200; HIGAKI JN, 1990, BIOCHEMISTRY-US, V29, P8582, DOI 10.1021/bi00489a012; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Kim JR, 2006, ARCH BIOCHEM BIOPHYS, V446, P44, DOI 10.1016/j.abb.2005.11.014; Koide S, 2009, CURR OPIN BIOTECH, V20, P398, DOI 10.1016/j.copbio.2009.07.007; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LENFANT F, 1991, J BIOL CHEM, V266, P17187; Liang J, 2007, PROTEIN SCI, V16, P929, DOI 10.1110/ps.062706007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Sampson JM, 2011, ANTIMICROB AGENTS CH; SAVES I, 1995, BIOCHEMISTRY-US, V34, P11660, DOI 10.1021/bi00037a003; Schmidt AM, 1996, CHEM BIOL, V3, P645, DOI 10.1016/S1074-5521(96)90132-5; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Suetomi K, 2002, J BIOL CHEM, V277, P31563, DOI 10.1074/jbc.M204713200; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Telmer PG, 2005, J MOL BIOL, V354, P829, DOI 10.1016/j.jmb.2005.10.016; Thomson JM, 2006, J BIOL CHEM, V281, P26734, DOI 10.1074/jbc.M603222200; Totir MA, 2006, BIOCHEMISTRY-US, V45, P11895, DOI 10.1021/bi060990m; van den Akker F, 1999, ACTA CRYSTALLOGR D, V55, P206, DOI 10.1107/S0907444998007161; Wright CM, 2010, PROTEINS, V78, P1423, DOI 10.1002/prot.22657	37	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39168	10.1371/journal.pone.0039168	http://dx.doi.org/10.1371/journal.pone.0039168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720063	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800051
J	Thoma, EC; Wischmeyer, E; Offen, N; Maurus, K; Siren, AL; Schartl, M; Wagner, TU				Thoma, Eva C.; Wischmeyer, Erhard; Offen, Nils; Maurus, Katja; Siren, Anna-Leena; Schartl, Manfred; Wagner, Toni U.			Ectopic Expression of Neurogenin 2 Alone is Sufficient to Induce Differentiation of Embryonic Stem Cells into Mature Neurons	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; HELIX TRANSCRIPTION FACTORS; TRANSIENT EXPRESSION; DEVELOPING CNS; SELF-RENEWAL; NEURAL FATE; IN-VITRO; MOUSE; OLIG2; GENE	Recent studies show that combinations of defined key developmental transcription factors (TFs) can reprogram somatic cells to pluripotency or induce cell conversion of one somatic cell type to another. However, it is not clear if single genes can define a cells identity and if the cell fate defining potential of TFs is also operative in pluripotent stem cells in vitro. Here, we show that ectopic expression of the neural TF Neurogenin2 (Ngn2) is sufficient to induce rapid and efficient differentiation of embryonic stem cells (ESCs) into mature glutamatergic neurons. Ngn2-induced neuronal differentiation did not require any additional external or internal factors and occurred even under pluripotency-promoting conditions. Differentiated cells displayed neuron-specific morphology, protein expression, and functional features, most importantly the generation of action potentials and contacts with hippocampal neurons. Gene expression analyses revealed that Ngn2-induced in vitro differentiation partially resembled neurogenesis in vivo, as it included specific activation of Ngn2 target genes and interaction partners. These findings demonstrate that a single gene is sufficient to determine cell fate decisions of uncommitted stem cells thus giving insights into the role of key developmental genes during lineage commitment. Furthermore, we present a promising tool to improve directed differentiation strategies for applications in both stem cell research and regenerative medicine.	[Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, Wurzburg, Germany; [Offen, Nils; Siren, Anna-Leena] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Thoma, EC (corresponding author), F Hoffmann La Roche & Cie AG, Stem Cell Platform, Basel, Switzerland.	e.thoma@biozentrum.uni-wuerzburg.de	Sirén, Anna-Leena/AAE-1374-2019	Sirén, Anna-Leena/0000-0002-2217-0081; Schartl, Manfred/0000-0001-9882-5948	EU through Plurigenes [018673]; Boehringer Ingelheim Fonds for basic research in medicine; German Research Foundation (DFG) [GRK1048]; University of Wuerzburg	EU through Plurigenes; Boehringer Ingelheim Fonds for basic research in medicine; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was funded by the EU through Plurigenes (http://www.plurigenes.org/, FP6 project 018673), the Boehringer Ingelheim Fonds (http://www.bifonds.de)for basic research in medicine, the German Research Foundation (DFG, GRK1048) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejar J, 2003, DEVELOPMENT, V130, P6545, DOI 10.1242/dev.00872; Blader P, 1997, DEVELOPMENT, V124, P4557; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Farah MH, 2000, DEVELOPMENT, V127, P693; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Thoma EC, 2012, CELL REPROGRAM, V14, P106, DOI 10.1089/cell.2011.0067; Thoma EC, 2011, STEM CELLS DEV, V20, P1425, DOI 10.1089/scd.2010.0290; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagner TU, 2009, STEM CELLS DEV, V18, P151, DOI 10.1089/scd.2007.0262; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	51	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38651	10.1371/journal.pone.0038651	http://dx.doi.org/10.1371/journal.pone.0038651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719915	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341900041
J	Zamorano, S; Rojas-Rivera, D; Lisbona, F; Parra, V; Court, FA; Villegas, R; Cheng, EH; Korsmeyer, SJ; Lavandero, S; Hetz, C				Zamorano, Sebastian; Rojas-Rivera, Diego; Lisbona, Fernanda; Parra, Valentina; Court, Felipe A.; Villegas, Rosario; Cheng, Emily H.; Korsmeyer, Stanley J.; Lavandero, Sergio; Hetz, Claudio			A BAX/BAK and Cyclophilin D-Independent Intrinsic Apoptosis Pathway	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; UNFOLDED PROTEIN RESPONSE; BCL-2-RELATED OVARIAN KILLER; ENDOPLASMIC-RETICULUM STRESS; BCL-2 FAMILY-MEMBERS; CELL-DEATH; ER STRESS; CYTOCHROME-C; MEMBRANE PERMEABILIZATION; TRIGGERS APOPTOSIS	Most intrinsic death signals converge into the activation of pro-apoptotic BCL-2 family members BAX and BAK at the mitochondria, resulting in the release of cytochrome c and apoptosome activation. Chronic endoplasmic reticulum (ER) stress leads to apoptosis through the upregulation of a subset of pro-apoptotic BH3-only proteins, activating BAX and BAK at the mitochondria. Here we provide evidence indicating that the full resistance of BAX and BAK double deficient (DKO) cells to ER stress is reverted by stimulation in combination with mild serum withdrawal. Cell death under these conditions was characterized by the appearance of classical apoptosis markers, caspase-9 activation, release of cytochrome c, and was inhibited by knocking down caspase-9, but insensitive to BCL-XL overexpression. Similarly, the resistance of BIM and PUMA double deficient cells to ER stress was reverted by mild serum withdrawal. Surprisingly, BAX/BAK-independent cell death did not require Cyclophilin D (CypD) expression, an important regulator of the mitochondrial permeability transition pore. Our results suggest the existence of an alternative intrinsic apoptosis pathway emerging from a cross talk between the ER and the mitochondria.	[Zamorano, Sebastian; Rojas-Rivera, Diego; Lisbona, Fernanda; Hetz, Claudio] Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile; [Zamorano, Sebastian; Rojas-Rivera, Diego; Lisbona, Fernanda; Parra, Valentina; Lavandero, Sergio; Hetz, Claudio] Univ Chile, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago, Chile; [Parra, Valentina; Lavandero, Sergio] Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile; [Court, Felipe A.; Villegas, Rosario] P Catholic Univ Chile, Fac Biol, Santiago, Chile; [Cheng, Emily H.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Korsmeyer, Stanley J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Korsmeyer, Stanley J.] Harvard Univ, Sch Med, Boston, MA USA; [Lavandero, Sergio] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard T.H. Chan School of Public Health	Zamorano, S (corresponding author), Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile.	chetz@med.uchile.cl	Rojas Rivera, Diego/N-1870-2016; Parra, Valentina M/N-3972-2018; Hetz, Claudio/I-1900-2013; Lavandero, Sergio/B-6001-2013; Rojas-Riviera, Diego/AAN-5222-2020; Rivera, Diego Rojas/ABF-5865-2020; Hetz, Claudio/ABD-7514-2021; Court, Felipe/C-5911-2015	Rojas Rivera, Diego/0000-0002-8773-9830; Parra, Valentina M/0000-0002-0080-6472; Hetz, Claudio/0000-0001-7724-1767; Lavandero, Sergio/0000-0003-4258-1483; Rivera, Diego Rojas/0000-0002-8773-9830; Court, Felipe/0000-0002-9394-7601; Court, Felipe/0000-0002-1384-2552	FONDECYT [1100176, 1070377]; Millennium Institute [P09-015-F]; Michael J. Fox Foundation for Parkinson's Research; North American Spine Society; Muscular Dystrophy Association; ALS Therapy Allianze; FONDAP [15010006]; Millennium Nucleus [P-07-011-F]; National Institute of Health [R01CA125562]; American Cancer Society [RSG-10-030-01-CCG]; CONICYT; Alzheimer's Disease Foundation	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute(Takeda Pharmaceutical Company Ltd); Michael J. Fox Foundation for Parkinson's Research; North American Spine Society; Muscular Dystrophy Association(Muscular Dystrophy Association); ALS Therapy Allianze; FONDAP; Millennium Nucleus; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Alzheimer's Disease Foundation	This work was supported by FONDECYT no. 1100176, Millennium Institute no. P09-015-F, Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Disease Foundation, North American Spine Society, Muscular Dystrophy Association, ALS Therapy Allianze (to CH), FONDAP grant no. 15010006 (to CH and SL), Supported by grants from FONDECYT no. 1070377 and Millennium Nucleus no. P-07-011-F (to FC), National Institute of Health R01CA125562 and American Cancer Society RSG-10-030-01-CCG (to EC), and PhD fellowships from CONICYT (to DRR, FL, and VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Kim H, 2006, NAT CELL BIOL; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Llambi F, 2011, MOL CELL; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Mizuta T, 2007, J BIOL CHEM, V282, P16623, DOI 10.1074/jbc.M611060200; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rodriguez D, 2012, EMBO J IN PRESS; Rodriguez JM, 2006, J BIOL CHEM, V281, P22729, DOI 10.1074/jbc.M604705200; Rojas-Rivera D, 2012, CELL DEATH DIFFER; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Suominen JS, 2001, EUR J ENDOCRINOL, V145, P771, DOI 10.1530/eje.0.1450771; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	61	33	35	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37782	10.1371/journal.pone.0037782	http://dx.doi.org/10.1371/journal.pone.0037782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719850	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000005
J	da Silva, PGC; Benton, JL; Beltz, BS; Allodi, S				Chaves da Silva, Paula Grazielle; Benton, Jeanne L.; Beltz, Barbara S.; Allodi, Silvana			Adult Neurogenesis: Ultrastructure of a Neurogenic Niche and Neurovascular Relationships	PLOS ONE			English	Article							NEURAL STEM-CELLS; OLFACTORY PATHWAY; PANULIRUS-ARGUS; TIGHT JUNCTIONS; SUBCOMMISSURAL ORGAN; GLUTAMINE-SYNTHETASE; DECAPOD CRUSTACEANS; SEPTATE JUNCTIONS; REISSNERS FIBER; NERVOUS-SYSTEM	The first-generation precursors producing adult-born neurons in the crayfish (Procambarus clarkii) brain reside in a specialized niche located on the ventral surface of the brain. In the present work, we have explored the organization and ultrastructure of this neurogenic niche, using light-level, confocal and electron microscopic approaches. Our goals were to define characteristics of the niche microenvironment, examine the morphological relationships between the niche and the vasculature and observe specializations at the boundary between the vascular cavity located centrally in the niche. Our results show that the niche is almost fully encapsulated by blood vessels, and that cells in the vasculature come into contact with the niche. This analysis also characterizes the ultrastructure of the cell types in the niche. The Type I niche cells are by far the most numerous, and are the only cell type present superficially in the most ventral cell layers of the niche. More dorsally, Type I cells are intermingled with Types II, III and IV cells, which are observed far less frequently. Type I cells have microvilli on their apical cell surfaces facing the vascular cavity, as well as junctional complexes between adjacent cells, suggesting a role in regulating transport from the blood into the niche cells. These studies demonstrate a close relationship between the neurogenic niche and vascular system in P. clarkii. Furthermore, the specializations of niche cells contacting the vascular cavity are also typical of the interface between the blood/cerebrospinal fluid (CSF)-brain barriers of vertebrates, including cells of the subventricular zone (SVZ) producing new olfactory interneurons in mammals. These data indicate that tissues involved in producing adult-born neurons in the crayfish brain use strategies that may reflect fundamental mechanisms preserved in an evolutionarily broad range of species, as proposed previously. The studies described here extend our understanding of neurovascular relationships in the brain of P. clarkii by characterizing the organization and ultrastructure of the neurogenic niche and associated vascular tissues.	[Chaves da Silva, Paula Grazielle; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21941 Rio De Janeiro, Brazil; [Chaves da Silva, Paula Grazielle; Allodi, Silvana] Univ Fed Rio de Janeiro, Programa Posgrad Ciencias Morfol, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Benton, Jeanne L.; Beltz, Barbara S.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Wellesley College	da Silva, PGC (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21941 Rio De Janeiro, Brazil.	sallodi@biof.ufrj.br	Allodi, Silvana/G-1781-2012; S, Allodi/AAR-7968-2020	Allodi, Silvana/0000-0002-3053-3866; Beltz, Barbara/0000-0001-5335-015X	National Science Foundation (NSF) [IOS 0818259]; NSF IOS [1121345]; Wellesley College	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF IOS(National Science Foundation (NSF)); Wellesley College	National Science Foundation (NSF) IOS 0818259. NSF IOS 1121345. Brachman Hoffman Fellowship from Wellesley College. Brazilian Financial Agencies FAPERJ, CNPq, FUJB/UFRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ABBOTT NJ, 1971, Z ZELLFORSCH MIK ANA, V120, P401, DOI 10.1007/BF00324900; Allodi S, 2006, GLIA, V53, P612, DOI 10.1002/glia.20317; Ayub N, 2011, DEV NEUROBIOL, V71, P351, DOI 10.1002/dneu.20864; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Bazin F, 1969, THESIS; Behr M, 2003, CLAUDIN MEGATRACHEA; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Beltz BS, 2011, EUR J NEUROSCI, V34, P870, DOI 10.1111/j.1460-9568.2011.07802.x; Beltz BS, 2001, P NATL ACAD SCI USA, V98, P12730, DOI 10.1073/pnas.231471298; Benton JL, 2008, GEN COMP ENDOCR, V158, P183, DOI 10.1016/j.ygcen.2008.07.016; Benton JL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-53; Benton JL, 2001, J NEUROBIOL, V46, P193, DOI 10.1002/1097-4695(20010215)46:3<193::AID-NEU1002>3.0.CO;2-8; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Chaves-Da-Silva PG, 2010, CELL TISSUE RES, V342, P179, DOI 10.1007/s00441-010-1045-x; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1997, J NEUROSCI, V17, P5046; Edens HA, 2000, ADV DRUG DELIVER REV, V41, P315, DOI 10.1016/S0169-409X(00)00049-1; FLOWER NE, 1975, J CELL SCI, V17, P221; FRANKE WW, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P14; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Gasparini F, 2007, DEV DYNAM, V236, P719, DOI 10.1002/dvdy.21073; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; HOSE JE, 1990, BIOL BULL, V178, P33, DOI 10.2307/1541535; Hoyo-Becerra C, 2006, CELL TISSUE RES, V326, P771, DOI 10.1007/s00441-006-0231-3; Hoyo-Becerra C, 2005, CELL TISSUE RES, V321, P429, DOI 10.1007/s00441-004-1040-1; Jilani SM, 2003, J HISTOCHEM CYTOCHEM, V51, P597, DOI 10.1177/002215540305100505; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; LANE NJ, 1994, TISSUE CELL, V26, P143, DOI 10.1016/0040-8166(94)90090-6; Linser PJ, 1997, GLIA, V20, P275; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Meiniel A, 2003, INT REV CYTOL, V230, P1, DOI 10.1016/S0074-7696(03)30001-4; Meiniel A, 2001, MICROSC RES TECHNIQ, V52, P484, DOI 10.1002/1097-0029(20010301)52:5<484::AID-JEMT1034>3.0.CO;2-0; NOIROTTIMOTHEE C, 1978, TISSUE CELL, V10, P125, DOI 10.1016/0040-8166(78)90011-3; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Peters AP, 1991, NEUROGLIAL CELLS FIN; Sandeman DC, 2009, DEV NEUROBIOL, V69, P530, DOI 10.1002/dneu.20722; Sandeman DCS, 1992, BIOL BULL, V183, P3044; Sandernan DC, 2011, ARTHROPOD STRUCT DEV, V40, P258, DOI 10.1016/j.asd.2011.03.001; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Schmidt M, 2007, J COMP NEUROL, V503, P64, DOI 10.1002/cne.21366; Schmidt M, 2011, J COMP NEUROL, V519, P2283, DOI 10.1002/cne.22657; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Sintoni S, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-1; Song CK, 2009, ARTHROPOD STRUCT DEV, V38, P339, DOI 10.1016/j.asd.2008.12.004; Sullivan JM, 2007, J MOL HISTOL, V38, P527, DOI 10.1007/s10735-007-9112-7; Sullivan JM, 2007, J COMP NEUROL, V500, P574, DOI 10.1002/cne.21187; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Wen CM, 2008, COMP BIOCHEM PHYS A, V149, P167, DOI 10.1016/j.cbpa.2007.11.005; Wiltrout C, 2007, NEUROCHEM INT, V50, P1028, DOI 10.1016/j.neuint.2007.04.011; WOOD RL, 1959, J BIOPHYS BIOCHEM CY, V6, P343, DOI 10.1083/jcb.6.3.343; Zhang Y, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-2; Zhang Y, 2009, DEV NEUROBIOL, V69, P415, DOI 10.1002/dneu.20717	57	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39267	10.1371/journal.pone.0039267	http://dx.doi.org/10.1371/journal.pone.0039267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723980	Green Published, gold			2022-12-27	WOS:000305652700062
J	Iglesias-Platas, I; Martin-Trujillo, A; Cirillo, D; Court, F; Guillaumet-Adkins, A; Camprubi, C; Bourc'his, D; Hata, K; Feil, R; Tartaglia, G; Arnaud, P; Monk, D				Iglesias-Platas, Isabel; Martin-Trujillo, Alex; Cirillo, Davide; Court, Franck; Guillaumet-Adkins, Amy; Camprubi, Cristina; Bourc'his, Deborah; Hata, Kenichiro; Feil, Robert; Tartaglia, Gian; Arnaud, Philippe; Monk, David			Characterization of Novel Paternal ncRNAs at the Plagl1 Locus, Including Hymai, Predicted to Interact with Regulators of Active Chromatin	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; LONG NONCODING RNAS; CONTROL REGION; ESTABLISHMENT; TRANSCRIPTION; METHYLATION; ZAC/PLAGL1; FAMILY; DOMAIN	Genomic imprinting is a complex epigenetic mechanism of transcriptional control that utilizes DNA methylation and histone modifications to bring about parent-of-origin specific monoallelic expression in mammals. Genes subject to imprinting are often organised in clusters associated with large non-coding RNAs (ncRNAs), some of which have cis-regulatory functions. Here we have undertaken a detailed allelic expression analysis of an imprinted domain on mouse proximal chromosome 10 comprising the paternally expressed Plagl1 gene. We identified three novel Plagl1 transcripts, only one of which contains protein-coding exons. In addition, we characterised two unspliced ncRNAs, Hymai, the mouse orthologue of HYMAI, and Plagl1it (Plagl1 intronic transcript), a transcript located in intron 5 of Plagl1. Imprinted expression of these novel ncRNAs requires DNMT3L-mediated maternal DNA methylation, which is also indispensable for establishing the correct chromatin profile at the Plagl1 DMR. Significantly, the two ncRNAs are retained in the nucleus, consistent with a potential regulatory function at the imprinted domain. Analysis with catRAPID, a protein-ncRNA association prediction algorithm, suggests that Hymai and Plagl1it RNAs both have potentially high affinity for Trithorax chromatin regulators. The two ncRNAs could therefore help to protect the paternal allele from DNA methylation by attracting Trithorax proteins that mediate H3 lysine-4 methylation.	[Iglesias-Platas, Isabel] Hosp St Joan de Deu, Fundacio St Joan de Deu, Serv Neonatol, Barcelona, Spain; [Martin-Trujillo, Alex; Court, Franck; Guillaumet-Adkins, Amy; Camprubi, Cristina; Monk, David] Bellvitge Inst Biomed Res, Canc Epigenet & Biol Program, Imprinting & Canc Grp, Lhospitalet De Llobregat, Catalonia, Spain; [Cirillo, Davide; Tartaglia, Gian] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona, Spain; [Bourc'his, Deborah] Inst Curie, Unite Genet & Biol Dev, INSERM, Paris, France; [Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Feil, Robert; Arnaud, Philippe] CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Feil, Robert; Arnaud, Philippe] Univ Montpellier, F-34059 Montpellier, France	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Iglesias-Platas, I (corresponding author), Hosp St Joan de Deu, Fundacio St Joan de Deu, Serv Neonatol, Barcelona, Spain.	dmonk@idibell.cat	Feil, Robert P/D-2087-2013; Arnaud, Philippe/O-9507-2015; Iglesias-Platas, Isabel/AGY-9649-2022; Tartaglia, Gian Gaetano/K-1229-2014	Feil, Robert P/0000-0002-5671-5860; Arnaud, Philippe/0000-0002-7937-8764; Iglesias-Platas, Isabel/0000-0003-1960-7614; court, franck/0000-0003-0327-9708; Tartaglia, Gian Gaetano/0000-0001-7524-6310; Bourc'his, Deborah/0000-0001-9499-7291	Ayuda Merck Serono- Fundacion Salud; Spanish Ministerio de Educacion y Ciencia [SAF2008-1578]; Centre National de la Recherche Scientifique [34622]; Agence National de la Recherche; 'Ligue Contre le Cancer'; Ligue contre le Cancer comite Herault and Association pour la Recherche sur la cancer-ARC [4980-]; FPU; BebeDue Spain	Ayuda Merck Serono- Fundacion Salud; Spanish Ministerio de Educacion y Ciencia(Spanish Government); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); 'Ligue Contre le Cancer'(Ligue nationale contre le cancer); Ligue contre le Cancer comite Herault and Association pour la Recherche sur la cancer-ARC; FPU(Spanish Government); BebeDue Spain	This work was supported by Ayuda Merck Serono- Fundacion Salud 2000 de Investigacion en Endocrinologia 2009 (to DM and IIP); Spanish Ministerio de Educacion y Ciencia (grant number SAF2008-1578 to DM); Centre National de la Recherche Scientifique "Projects for International Scientific Cooperation'' 34622 (to PA and DM); Agence National de la Recherche (to RF); 'Ligue Contre le Cancer' (to RF); Ligue contre le Cancer comite Herault and Association pour la Recherche sur la cancer-ARC no 4980- (for PA). DM is a Ramon y Cajal research fellow and AGA is funded by a FPU studentship. Research in the Neonatal Unit in Hospital Sant Joan de Deu is partially funded by an unrestricted grant from BebeDue Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, J BIOL CHEM, V278, P6041, DOI 10.1074/jbc.M210361200; Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Arima T, 2006, CYTOGENET GENOME RES, V113, P247, DOI 10.1159/000090839; Arima T, 2001, HUM MOL GENET, V10, P1475, DOI 10.1093/hmg/10.14.1475; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Bourc'his D., 2003, SCIENCE, V21, P2536; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hata K, 2002, DEVELOPMENT, V129, P1983; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Mackay DJG, 2010, AM J MED GENET C, V154C, P335, DOI 10.1002/ajmg.c.30272; Mackay DJG, 2002, HUM GENET, V110, P139, DOI 10.1007/s00439-001-0671-5; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Monk D, 2010, BRIEF FUNCT GENOMICS, V9, P329, DOI 10.1093/bfgp/elq013; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	30	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38907	10.1371/journal.pone.0038907	http://dx.doi.org/10.1371/journal.pone.0038907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723905	Green Published, gold			2022-12-27	WOS:000305652700039
J	Larrayoz, IM; de Luis, A; Rua, O; Velilla, S; Cabello, J; Martinez, A				Larrayoz, Ignacio M.; de Luis, Alberto; Rua, Oscar; Velilla, Sara; Cabello, Juan; Martinez, Alfredo			Molecular Effects of Doxycycline Treatment on Pterygium as Revealed by Massive Transcriptome Sequencing	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ENDOTHELIAL GROWTH-FACTOR; COLORECTAL-CANCER CELLS; RNA-SEQ; DIFFERENTIAL EXPRESSION; EPITHELIAL-CELLS; ACTIVATION; APOPTOSIS; NORMALIZATION	Pterygium is a lesion of the eye surface which involves cell proliferation, migration, angiogenesis, fibrosis, and extracellular matrix remodelling. Surgery is the only approved method to treat this disorder, but high recurrence rates are common. Recently, it has been shown in a mouse model that treatment with doxycycline resulted in reduction of the pterygium lesions. Here we study the mechanism(s) of action by which doxycycline achieves these results, using massive sequencing techniques. Surgically removed pterygia from 10 consecutive patients were set in short term culture and exposed to 0 (control), 50, 200, and 500 mg/ml doxycycline for 24 h, their mRNA was purified, reverse transcribed and sequenced through Illumina's massive sequencing protocols. Acquired data were subjected to quantile normalization and analyzed using cytoscape plugin software to explore the pathways involved. False discovery rate (FDR) methods were used to identify 332 genes which modified their expression in a dose-dependent manner upon exposure to doxycycline. The more represented cellular pathways included all mitochondrial genes, the endoplasmic reticulum stress response, integrins and extracellular matrix components, and growth factors. A high correlation was obtained when comparing ultrasequencing data with qRT-PCR and ELISA results. Doxycycline significantly modified the expression of important cellular pathways in pterygium cells, in a way which is consistent with the observed efficacy of this antibiotic to reduce pterygium lesions in a mouse model. Clinical trials are under way to demonstrate whether there is a benefit for human patients.	[Larrayoz, Ignacio M.; Cabello, Juan; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain; [de Luis, Alberto] Ctr Biomed Res La Rioja CIBIR, Ultrasequencing & Bioinformat Core Facil, Logrono, Spain; [Rua, Oscar; Velilla, Sara] Hosp San Pedro, Ophthalmol Serv, Logrono, Spain		Larrayoz, IM (corresponding author), Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain.	amartinezr@riojasalud.es	Martinez, Alfredo/GQH-5998-2022; Cabello, Juan/AAM-1683-2020; Larrayoz, Ignacio M/I-5613-2012	Martinez, Alfredo/0000-0003-4882-4044; Cabello, Juan/0000-0002-3835-0116; Larrayoz, Ignacio M/0000-0003-1629-152X	Spain's Ministry of Health, Social Policy, and Equality [DIN-021]	Spain's Ministry of Health, Social Policy, and Equality	Supported by a Grant from Spain's Ministry of Health, Social Policy, and Equality, No. DIN-021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Besharati Mohammad Reza, 2011, Acta Med Iran, V49, P179; Bon G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1651; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Bradley JC, 2010, BRIT J OPHTHALMOL, V94, P815, DOI 10.1136/bjo.2008.151852; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Chui J, 2011, AM J PATHOL, V178, P817, DOI 10.1016/j.ajpath.2010.10.037; Coroneo M, 2011, EYE CONTACT LENS, V37, P214, DOI 10.1097/ICL.0b013e318223394e; Cox CA, 2010, OPHTHALMOLOGY, V117, P1782, DOI 10.1016/j.ophtha.2010.01.037; Di Girolamo N, 2004, PROG RETIN EYE RES, V23, P195, DOI 10.1016/j.preteyeres.2004.02.002; Di Girolamo N, 2002, INVEST OPHTH VIS SCI, V43, P3430; DUSHKU N, 1994, CURR EYE RES, V13, P473, DOI 10.3109/02713689408999878; Dzunic B, 2010, BOSNIAN J BASIC MED, V10, P307, DOI 10.17305/bjbms.2010.2677; Golub L M, 1998, Adv Dent Res, V12, P12; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaworski CJ, 2009, MOL VIS, V15, P2421; Jin J, 2003, CORNEA, V22, P473, DOI 10.1097/00003226-200307000-00015; John-Aryankalayil M, 2006, MOL VIS, V12, P55; Kandavel R, 2010, CORNEA, V29, P141, DOI 10.1097/ICO.0b013e3181b11630; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lai HC, 2010, EUR J PHARMACOL, V644, P176, DOI 10.1016/j.ejphar.2010.07.010; Lee CZ, 2004, STROKE, V35, P1715, DOI 10.1161/01.STR.0000129334.05181.b6; Liang D, 2008, CURR EYE RES, V33, P653, DOI 10.1080/02713680802245772; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Marcovich Arie L, 2010, Int Ophthalmol Clin, V50, P47, DOI 10.1097/IIO.0b013e3181e218f7; Mauro J, 2009, SEMIN OPHTHALMOL, V24, P130, DOI 10.1080/08820530902801106; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olgun A, 2007, ANN NY ACAD SCI, V1100, P241, DOI 10.1196/annals.1395.025; Onoda T, 2006, INT J CANCER, V118, P1309, DOI 10.1002/ijc.21447; Onoda T, 2004, J LAB CLIN MED, V143, P207, DOI 10.1016/j.lab.2003.12.012; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Riau AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014687; Rubins JB, 2001, J LAB CLIN MED, V138, P101, DOI 10.1067/mlc.2001.116591; Sagar J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-31; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Sourdeval M, 2006, FRONT BIOSCI-LANDMRK, V11, P3036, DOI 10.2741/2031; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tong L, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-14; Tsai YY, 2008, CORNEA, V27, P476, DOI 10.1097/ICO.0b013e3181644581; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wu J, 2006, CELL MOL LIFE SCI, V63, P949, DOI 10.1007/s00018-005-5565-6; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yeh YC, 2007, BIOCHEM PHARMACOL, V74, P969, DOI 10.1016/j.bcp.2007.06.031; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	54	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39359	10.1371/journal.pone.0039359	http://dx.doi.org/10.1371/journal.pone.0039359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724003	Green Submitted, Green Published, gold			2022-12-27	WOS:000305652700070
J	Rosa-Garrido, M; Ceballos, L; Alonso-Lecue, P; Abraira, C; Delgado, MD; Gandarillas, A				Rosa-Garrido, Manuel; Ceballos, Laura; Alonso-Lecue, Pilar; Abraira, Cristina; Dolores Delgado, M.; Gandarillas, Alberto			A Cell Cycle Role for the Epigenetic Factor CTCF-L/BORIS	PLOS ONE			English	Article							INSULATOR PROTEIN CTCF; DIFFERENTIAL EXPRESSION; NUCLEAR-ORGANIZATION; FACTOR BORIS; GENE; DNA; TRANSCRIPTION; SITES; CENTROSOME; NUCLEOLUS	CTCF is a ubiquitous epigenetic regulator that has been proposed as a master keeper of chromatin organisation. CTCF-like, or BORIS, is thought to antagonise CTCF and has been found in normal testis, ovary and a large variety of tumour cells. The cellular function of BORIS remains intriguing although it might be involved in developmental reprogramming of gene expression patterns. We here unravel the expression of CTCF and BORIS proteins throughout human epidermis. While CTCF is widely distributed within the nucleus, BORIS is confined to the nucleolus and other euchromatin domains. Nascent RNA experiments in primary keratinocytes revealed that endogenous BORIS is present in active transcription sites. Interestingly, BORIS also localises to interphase centrosomes suggesting a role in the cell cycle. Blocking the cell cycle at S phase or mitosis, or causing DNA damage, produced a striking accumulation of BORIS. Consistently, ectopic expression of wild type or GFP-BORIS provoked a higher rate of S phase cells as well as genomic instability by mitosis failure. Furthermore, down-regulation of endogenous BORIS by specific shRNAs inhibited both RNA transcription and cell cycle progression. The results altogether suggest a role for BORIS in coordinating S phase events with mitosis.	[Rosa-Garrido, Manuel; Ceballos, Laura; Alonso-Lecue, Pilar; Gandarillas, Alberto] Fdn Marques de Valdecilla, Cell Cycle Stem Cell Fate & Canc Lab, Inst Formac & Invest Marques de Valdecilla, Santander, Spain; [Rosa-Garrido, Manuel; Ceballos, Laura; Abraira, Cristina; Dolores Delgado, M.; Gandarillas, Alberto] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient,SODERCAN, E-39005 Santander, Spain; [Gandarillas, Alberto] ADR Languedoc Roussillon, INSERM, Montpellier, France	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Rosa-Garrido, M (corresponding author), Fdn Marques de Valdecilla, Cell Cycle Stem Cell Fate & Canc Lab, Inst Formac & Invest Marques de Valdecilla, Santander, Spain.	ifimav.agandarillas@fmdv.org	Rosa-Garrido, Manuel/AAE-4188-2019; Delgado, M. Dolores/K-9056-2014	Rosa-Garrido, Manuel/0000-0002-2169-3972; Delgado, M. Dolores/0000-0003-4682-4040	Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (ISCIII-FIS; National Grants, Spain) [FIS-PI08/0829, FIS-PI11/00397]; Red Tematica de Investigacion Cooperativa en Cancer [RTICC-RD06/0020/017]; Programa Regiones Emergentes-EMER; Societe Francaise de Dermatologie (SFD, France; AG); Universidad de Cantabria-Fundacion Marques de Valdecilla-IFIMAV (Cantabria, Spain; Javier Leon-AG); University of Cantabria; Fundacion Leonardo Torres Quevedo; Fundacion Marque's de Valdecilla-IFIMAV;  [FIS-PI08/0890];  [FIS-PI11/02070]	Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (ISCIII-FIS; National Grants, Spain); Red Tematica de Investigacion Cooperativa en Cancer; Programa Regiones Emergentes-EMER; Societe Francaise de Dermatologie (SFD, France; AG); Universidad de Cantabria-Fundacion Marques de Valdecilla-IFIMAV (Cantabria, Spain; Javier Leon-AG); University of Cantabria; Fundacion Leonardo Torres Quevedo; Fundacion Marque's de Valdecilla-IFIMAV; ; 	This study was supported by the Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (ISCIII-FIS; National Grants, Spain): FIS-PI08/0829, FIS-PI11/00397 and Red Tematica de Investigacion Cooperativa en Cancer-RTICC-RD06/0020/017 (MDD); FIS-PI08/0890, FIS-PI11/02070 and Programa Regiones Emergentes-EMER (AG); by the Societe Francaise de Dermatologie (SFD, France; AG); and by a co-operative grant from Universidad de Cantabria-Fundacion Marques de Valdecilla-IFIMAV (Cantabria, Spain; Javier Leon-AG). MRG was recipient of a fellowship from University of Cantabria. Both MRG and PA were also funded by Fundacion Leonardo Torres Quevedo and Fundacion Marque's de Valdecilla-IFIMAV. AG is 'on leave' at the Institut National de la Sante et de la Recherche Medicale (INSERM, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Campbell AE, 2010, BIOCH BIOPHYS RES CO; Casafont I, 2006, NEUROSCIENCE, V140, P453, DOI 10.1016/j.neuroscience.2006.02.030; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Dazard JE, 2000, ONCOGENE, V19, P3693, DOI 10.1038/sj.onc.1203695; de Necochea-Campion R, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-213; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; Delgado MD, 1999, FEBS LETT, V444, P5, DOI 10.1016/S0014-5793(99)00013-7; Dundr M, 2002, MOL CELL, V9, P5, DOI 10.1016/S1097-2765(02)00433-1; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Fiorentino FP, 2011, J CELL PHYSL; Freije A, 2012, ONCOGENE, DOI [10. 1038/onc.2012.22, DOI 10.1038/ONC.2012.22.]; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gandarillas A, 2000, ONCOGENE, V19, P3278, DOI 10.1038/sj.onc.1203630; GEY GO, 1952, CANCER RES, V12, P264; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Hernandez-Hernandez A, 2012, CYTOGENET GENOME RES, V136, P89, DOI 10.1159/000335752; Hines WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009738; Hutten S, 2011, CHROMOSOMA, V120, P481, DOI 10.1007/s00412-011-0327-8; Jones TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022399; Kaiser BK, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-27; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kovacs LAS, 2010, CELL CYCLE, V9, P1750, DOI 10.4161/cc.9.9.11792; Lewis A, 2004, CURR BIOL, V14, pR284, DOI 10.1016/j.cub.2004.03.026; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Monk M, 2008, MOL HUM REPROD, V14, P347, DOI 10.1093/molehr/gan025; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Rasko JEJ, 2001, CANCER RES, V61, P6002; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Recillas-Targa F, 2006, J CELL MOL MED, V10, P554, DOI 10.1111/j.1582-4934.2006.tb00420.x; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Rheinwald J. G, 1989, CELL GROWTH DIVISION; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Sluder G, 2010, CELL BIOL INT, V34, P1239, DOI 10.1042/CBI20100612; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zanet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015701; Zhang R, 2004, EXP CELL RES, V294, P86, DOI 10.1016/j.yexcr.2003.11.015; Zhang SS, 2004, J CELL SCI, V117, P3935, DOI 10.1242/jcs.01249; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	73	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39371	10.1371/journal.pone.0039371	http://dx.doi.org/10.1371/journal.pone.0039371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724006	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700071
J	Biergans, SD; Jones, JC; Treiber, N; Galizia, CG; Szyszka, P				Biergans, Stephanie D.; Jones, Julia C.; Treiber, Nadine; Galizia, C. Giovanni; Szyszka, Paul			DNA Methylation Mediates the Discriminatory Power of Associative Long-Term Memory in Honeybees	PLOS ONE			English	Article							PROTEIN-KINASE; METHYLTRANSFERASE; INHIBITION; ODOR; PLASTICITY; CELLS; RECONSOLIDATION; ACTIVATION; NEURONS; CLONING	Memory is created by several interlinked processes in the brain, some of which require long-term gene regulation. Epigenetic mechanisms are likely candidates for regulating memory-related genes. Among these, DNA methylation is known to be a long lasting genomic mark and may be involved in the establishment of long-term memory. Here we demonstrate that DNA methyltransferases, which induce and maintain DNA methylation, are involved in a particular aspect of associative long-term memory formation in honeybees, but are not required for short-term memory formation. While long-term memory strength itself was not affected by blocking DNA methyltransferases, odor specificity of the memory (memory discriminatory power) was. Conversely, perceptual discriminatory power was normal. These results suggest that different genetic pathways are involved in mediating the strength and discriminatory power of associative odor memories and provide, to our knowledge, the first indication that DNA methyltransferases are involved in stimulus-specific associative long-term memory formation.	[Biergans, Stephanie D.; Treiber, Nadine; Galizia, C. Giovanni; Szyszka, Paul] Univ Konstanz, Dept Biol Neurobiol, Constance, Germany; [Jones, Julia C.] Univ Konstanz, Dept Biol Zool & Evolutionary Biol, Constance, Germany	University of Konstanz; University of Konstanz	Biergans, SD (corresponding author), Univ Konstanz, Dept Biol Neurobiol, Constance, Germany.	s.biergans@uq.edu.au	Galizia, C Giovanni/A-1771-2009; Jones, Julia/P-2339-2016; Szyszka, Paul/ABC-7508-2020; Biergans, Stephanie/H-4595-2019	Galizia, C Giovanni/0000-0001-8292-6031; Jones, Julia/0000-0002-3557-1941; Szyszka, Paul/0000-0003-2043-6656; Biergans, Stephanie/0000-0002-0120-1301	Bundesministerium fur Bildung und Forschung [01GQ0931]; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Bundesministerium fur Bildung und Forschung (01GQ0931 to P.S. and C.G.G.) and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1985, P NATL ACAD SCI USA, V82, P2674, DOI 10.1073/pnas.82.9.2674; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Beumer JH, 2006, J CHROMATOGR B, V831, P147, DOI 10.1016/j.jchromb.2005.11.048; Champion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012388; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Denker M, 2010, EUR J NEUROSCI, V31, P119, DOI 10.1111/j.1460-9568.2009.07046.x; ERLANSON DA, 1993, J AM CHEM SOC, V115, P12583, DOI 10.1021/ja00079a047; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Faber T, 2001, NATURWISSENSCHAFTEN, V88, P472, DOI 10.1007/s001140100263; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Friedrich A, 2004, J NEUROSCI, V24, P4460, DOI 10.1523/JNEUROSCI.0669-04.2004; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Hourcade B, 2009, LEARN MEMORY, V16, P607, DOI 10.1101/lm.1445609; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Lockett GA, 2011, GENES BRAIN BEHAV; Lockett GA, 2010, NEUROREPORT, V21, P812, DOI 10.1097/WNR.0b013e32833ce5be; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Miklos GLG, 2011, HORM BEHAV, V59, P399, DOI 10.1016/j.yhbeh.2010.05.016; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Sandoz JC, 2003, NEUROSCIENCE, V120, P1137, DOI 10.1016/S0306-4522(03)00384-1; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; SMITH BH, 1994, ANNU REV ENTOMOL, V39, P351, DOI 10.1146/annurev.en.39.010194.002031; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; van Bemmel DM, 2009, BIOCHEM PHARMACOL, V78, P633, DOI 10.1016/j.bcp.2009.05.017; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	50	52	55	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39349	10.1371/journal.pone.0039349	http://dx.doi.org/10.1371/journal.pone.0039349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724000	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300136
J	Cera, N; Delli Pizzi, S; Di Pierro, ED; Gambi, F; Tartaro, A; Vicentini, C; Galatioto, GP; Romani, GL; Ferretti, A				Cera, Nicoletta; Delli Pizzi, Stefano; Di Pierro, Ezio Domenico; Gambi, Francesco; Tartaro, Armando; Vicentini, Carlo; Galatioto, Giuseppe Paradiso; Romani, Gian Luca; Ferretti, Antonio			Macrostructural Alterations of Subcortical Grey Matter in Psychogenic Erectile Dysfunction	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; VISUAL SEXUAL STIMULI; MEDIAL PREOPTIC AREA; NUCLEUS-ACCUMBENS; MALE-RATS; BRAIN ACTIVATION; BEHAVIORAL-INHIBITION; HUMAN MALES; AROUSAL; HYPOTHALAMUS	Psychogenic erectile dysfunction (ED) has been defined as the persistent inability to attain and maintain an erection sufficient to permit sexual performance. It shows a high incidence and prevalence among men, with a significant impact on the quality of life. Few neuroimaging studies have investigated the cerebral basis of erectile dysfunctions observing the role played by prefrontal, cingulate, and parietal cortices during erotic stimulation. In spite of the well-known involvement of subcortical regions such as hypothalamus and caudate nucleus in male sexual response, and the key role of nucleus accumbens in pleasure and reward, poor attention was paid to their role in male sexual dysfunction. In this study, we determined the presence of grey matter (GM) atrophy patterns in subcortical structures such as amygdala, hippocampus, nucleus accumbens, caudate nucleus, putamen, pallidum, thalamus, and hypothalamus in patients with psychogenic ED and healthy men. After Rigiscan evaluation, urological, general medical, metabolic and hormonal, psychological and psychiatric assessment, 17 outpatients with psychogenic ED and 25 healthy controls were recruited for structural MRI session. Significant GM atrophy of nucleus accumbens was observed bilaterally in patients with respect to controls. Shape analysis showed that this atrophy was located in the left medial-anterior and posterior portion of accumbens. Left nucleus accumbens volumes in patients correlated with low erectile functioning as measured by IIEF-5 (International Index of Erectile Function). In addition, a GM atrophy of left hypothalamus was also observed. Our results suggest that atrophy of nucleus accumbens plays an important role in psychogenic erectile dysfunction. We believe that this change can influence the motivation-related component of sexual behavior. Our findings help to elucidate a neural basis of psychogenic erectile dysfunction.	[Cera, Nicoletta; Delli Pizzi, Stefano; Gambi, Francesco; Tartaro, Armando; Romani, Gian Luca; Ferretti, Antonio] Univ G DAnnunzio, Dept Neurosci & Imaging, ITAB, Chieti, Italy; [Di Pierro, Ezio Domenico; Vicentini, Carlo; Galatioto, Giuseppe Paradiso] Univ Aquila, Dept Hlth Sci, I-67100 Laquila, Italy; [Di Pierro, Ezio Domenico; Vicentini, Carlo; Galatioto, Giuseppe Paradiso] Hosp G Mazzini, Teramo, Italy	G d'Annunzio University of Chieti-Pescara; University of L'Aquila	Cera, N (corresponding author), Univ G DAnnunzio, Dept Neurosci & Imaging, ITAB, Chieti, Italy.	n.cera@unich.it	Pizzi, Stefano Delli/J-3935-2016; tartaro, armando at/K-2184-2016	Pizzi, Stefano Delli/0000-0003-4075-0132; tartaro, armando at/0000-0003-0095-2792; FERRETTI, Antonio/0000-0002-8459-0129; VICENTINI, Carlo/0000-0003-0776-0312; PARADISO GALATIOTO, Giuseppe/0000-0002-9453-7858; Cera, Nicoletta/0000-0002-2702-8789				Ambroggi F, 2011, J NEUROSCI, V31, P6820, DOI 10.1523/JNEUROSCI.6491-10.2011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Argiolas A, 2004, PHYSIOL BEHAV, V83, P309, DOI 10.1016/j.physbeh.2004.08.019; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baroncini M, 2012, NEUROIMAGE, V59, P168, DOI 10.1016/j.neuroimage.2011.07.013; Becker JB, 2001, J NEUROSCI, V21, P3236, DOI 10.1523/JNEUROSCI.21-09-03236.2001; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Derogatis LR, 1977, SCL 90R MANUAL 1 SCO; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; Frisoni GB, 2008, NEUROLOGY, V70, P2194, DOI 10.1212/01.wnl.0000313844.18381.a9; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; Giuliano F, 2004, PHYSIOL BEHAV, V83, P189, DOI 10.1016/j.physbeh.2004.08.014; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Harte CB, 2008, J SEX MED, V5, P110, DOI 10.1111/j.1743-6109.2007.00637.x; Holle D, 2011, ANN NEUROL, V69, P533, DOI 10.1002/ana.22188; HOON EF, 1976, ARCH SEX BEHAV, V5, P291, DOI 10.1007/BF01542081; Hurtazo HA, 2008, NEUROSCIENCE, V152, P331, DOI 10.1016/j.neuroscience.2007.10.063; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE IN PRESS; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koch M, 1996, NEUROREPORT, V7, P1442, DOI 10.1097/00001756-199605310-00024; Kondo Y, 1998, BEHAV BRAIN RES, V91, P213; Lloyd SA, 1998, BRAIN RES, V463, P317; LUITEN PGM, 1987, PROG NEUROBIOL, V28, P1, DOI 10.1016/0301-0082(87)90004-9; Montorsi F, 2003, INT J IMPOT RES, V15, P203, DOI 10.1038/sj.ijir.3900999; Montorsi F, 2003, EUR UROL, V43, P405, DOI 10.1016/S0302-2838(03)00053-8; Paredes Raul G., 1997, V8, P68; Paredes RG, 1998, BRAIN RES, V813, P1, DOI 10.1016/S0006-8993(98)00914-7; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Redoute J, 2005, PSYCHONEUROENDOCRINO, V30, P461, DOI 10.1016/j.psyneuen.2004.12.003; Rosen R.C., 1988, PATTERNS SEXUAL AROU; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spielberg C, 1970, STATE TRAIT ANXIETY; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Wespes E, 2005, GUIDELINES ERECTILE; WEST CHK, 1992, BRAIN RES, V585, P49, DOI 10.1016/0006-8993(92)91189-L; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	53	28	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39118	10.1371/journal.pone.0039118	http://dx.doi.org/10.1371/journal.pone.0039118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723943	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300096
J	Dekeirsschieter, J; Stefanuto, PH; Brasseur, C; Haubruge, E; Focant, JF				Dekeirsschieter, Jessica; Stefanuto, Pierre-Hugues; Brasseur, Catherine; Haubruge, Eric; Focant, Jean-Francois			Enhanced Characterization of the Smell of Death by Comprehensive Two-Dimensional Gas Chromatography-Time-of-Flight Mass Spectrometry (GCxGC-TOFMS)	PLOS ONE			English	Article							HUMAN REMAINS; VOLATILE COMPOUNDS; HUMAN CADAVERS; DECOMPOSITION; DECAY; IDENTIFICATION; SEPARATIONS; EXTRACTION; SUCCESSION; DOTHIEPIN	Soon after death, the decay process of mammalian soft tissues begins and leads to the release of cadaveric volatile compounds in the surrounding environment. The study of postmortem decomposition products is an emerging field of study in forensic science. However, a better knowledge of the smell of death and its volatile constituents may have many applications in forensic sciences. Domestic pigs are the most widely used human body analogues in forensic experiments, mainly due to ethical restrictions. Indeed, decomposition trials on human corpses are restricted in many countries worldwide. This article reports on the use of comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOFMS) for thanatochemistry applications. A total of 832 VOCs released by a decaying pig carcass in terrestrial ecosystem, i.e. a forest biotope, were identified by GCxGC-TOFMS. These postmortem compounds belong to many kinds of chemical class, mainly oxygen compounds (alcohols, acids, ketones, aldehydes, esters), sulfur and nitrogen compounds, aromatic compounds such as phenolic molecules and hydrocarbons. The use of GCxGC-TOFMS in study of postmortem volatile compounds instead of conventional GC-MS was successful.	[Dekeirsschieter, Jessica; Haubruge, Eric] Univ Liege, Gembloux Agrobio Tech, Dept Funct & Evolutionary Entomol, Gembloux, Belgium; [Stefanuto, Pierre-Hugues; Brasseur, Catherine; Focant, Jean-Francois] Univ Liege, Dept Chem Organ & Biol Analyt Chem, CART, Liege, Belgium	University of Liege; University of Liege	Dekeirsschieter, J (corresponding author), Univ Liege, Gembloux Agrobio Tech, Dept Funct & Evolutionary Entomol, Gembloux, Belgium.	JF.Focant@ulg.ac.be	Stefanuto, Pierre-Hugues/AAO-2390-2020	Stefanuto, Pierre-Hugues/0000-0002-1224-8869; Haubruge, Eric/0000-0002-8138-0476	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), Belgium; Chemistry Department of the University of Liege	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), Belgium(Fonds de la Recherche Scientifique - FNRS); Chemistry Department of the University of Liege	Jessica Dekeirsschieter was financially supported by a PhD grant from the Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), Belgium. Catherine Brasseur and Pierre-Hugues Stefanuto were financially supported by a teaching assistant PhD grant from the Chemistry Department of the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam RE, 2007, J FORENSIC SCI, V52, P1007, DOI 10.1111/j.1556-4029.2007.00510.x; Akdeniz N, 2010, BIORESOURCE TECHNOL, V101, P71, DOI 10.1016/j.biortech.2009.07.076; Anderson Gail S., 2001, P143; Anderson GS, 1996, J FORENSIC SCI, V41, P617; Bornemissza G. F., 1957, Australian Journal of Zoology, V5, P1; Boumba VA, 2008, FORENSIC SCI INT, V174, P133, DOI 10.1016/j.forsciint.2007.03.018; CALLERY PS, 1984, J NEUROCHEM, V43, P1631, DOI 10.1111/j.1471-4159.1984.tb06088.x; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Cardeal ZL, 2008, TALANTA, V74, P793, DOI 10.1016/j.talanta.2007.07.021; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; Chen X, 2008, CHROMATOGRAPHIA, V68, P941, DOI 10.1365/s10337-008-0835-8; Clark M.A., 1997, FORENSIC TAPHONOMY P, P151; Cordero C, 2010, J CHROMATOGR A, V1217, P5848, DOI 10.1016/j.chroma.2010.07.006; DeGreeff LE, 2011, ANAL BIOANAL CHEM, V401, P1295, DOI 10.1007/s00216-011-5167-0; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dent BB, 2004, ENVIRON GEOL, V45, P576, DOI 10.1007/s00254-003-0913-z; Evans W.E.D, 1963, CHEM DEATH; Focant JF, 2005, J CHROMATOGR A, V1086, P45, DOI 10.1016/j.chroma.2005.05.090; Focant JF, 2005, J CHROMATOGR A, V1067, P265, DOI 10.1016/j.chroma.2004.10.095; Focant JF, 2004, TALANTA, V63, P1231, DOI 10.1016/j.talanta.2004.05.043; Focant JF, 2003, J CHROMATOGR A, V1019, P143, DOI 10.1016/j.chroma.2003.07.007; Frederickx C, 2011, BIOTECHNOL AGRON SOC, V15, P449; Galloway Alison, 1997, P139; Gennard DE, 2007, FORENSIC ENTOMOLOGY; GIDDINGS JC, 1984, ANAL CHEM, V56, P1258, DOI 10.1021/ac00276a003; Gill-King H., 1997, CHEM ULTRASTRUCTURAL, P93; Goff ML, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P1, DOI 10.1007/978-1-4020-9684-6_1; Grassberger M, 2004, J MED ENTOMOL, V41, P511, DOI 10.1603/0022-2585-41.3.511; Hadrich C, 2010, INT J LEGAL MED, V124, P43, DOI 10.1007/s00414-009-0338-7; Harsanyi L., 1993, HISTOLOGY ANCIENT HU, P79; HART AJ, 2005, ANTENNA, V30, P159; Hoffman EM, 2009, FORENSIC SCI INT, V186, P6, DOI 10.1016/j.forsciint.2008.12.022; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; Kaliste E, 2007, WELF LAB AN, P3; Keller T, 2000, FORENSIC SCI INT, V109, P159, DOI 10.1016/S0379-0738(99)00234-0; Killam EW., 1990, DETECTION HUMAN REMA; Komar D, 1999, J FORENSIC SCI, V44, P405; Kovatsi L, 2011, J SEP SCI, V34, P1004, DOI 10.1002/jssc.201000921; Kusano M, 2011, ANAL BIOANAL CHEM, V400, P1817, DOI 10.1007/s00216-011-4950-2; LAMBOURN J, 1974, J INT MED RES, V2, P210, DOI 10.1177/030006057400200305; LeBlanc HN, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P205, DOI 10.1007/978-1-4020-9684-6_11; Leco, 2008, COMP FEAT CHROMATOF; Ledford EB, 2000, HRC-J HIGH RES CHROM, V23, P202; Notter SJ, 2008, EUR J LIPID SCI TECH, V110, P73, DOI 10.1002/ejlt.200700159; Oesterhelweg L, 2008, FORENSIC SCI INT, V174, P35, DOI 10.1016/j.forsciint.2007.02.031; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; Paterson S, 2004, J CHROMATOGR B, V813, P323, DOI 10.1016/j.jchromb.2004.10.036; Patterson DG, 2011, J CHROMATOGR A, V1218, P3274, DOI 10.1016/j.chroma.2010.10.084; Phillips JB, 1999, J CHROMATOGR A, V856, P331, DOI 10.1016/S0021-9673(99)00815-8; Prada PA, 2010, ANAL METHODS-UK, V2, P470, DOI 10.1039/b9ay00239a; Qu GL, 2008, ENVIRON MONIT ASSESS, V144, P277, DOI 10.1007/s10661-007-9991-9; REED H. B., 1958, AMER MIDLAND NAT, V59, P213, DOI 10.2307/2422385; Robards K, 1995, PRINCIPLES PRACTICE; RODRIGUEZ WC, 1983, J FORENSIC SCI, V28, P423, DOI 10.1520/JFS11524J; Schoenly KG, 2007, J MED ENTOMOL, V44, P881, DOI 10.1603/0022-2585(2007)44[881:CPACOF]2.0.CO;2; Schotsmans EMJ, 2012, FORENSIC SCI INT, V217, P50, DOI 10.1016/j.forsciint.2011.09.025; Semard G, 2009, COMP ANAL C, V55, P15, DOI 10.1016/S0166-526X(09)05502-0; Silva I, 2010, J CHROMATOGR A, V1217, P5511, DOI 10.1016/j.chroma.2010.06.050; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Statheropoulos M, 2006, ANAL CHIM ACTA, V566, P207, DOI 10.1016/j.aca.2006.03.023; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Statheropoulos M, 2011, FORENSIC SCI INT, V210, P154, DOI 10.1016/j.forsciint.2011.02.023; Swann LM, 2010, ANAL CHIM ACTA, V682, P9, DOI 10.1016/j.aca.2010.09.052; van Deursen M, 2000, HRC-J HIGH RES CHROM, V23, P507; Vass A.A., 2001, MICROBIOL TODAY, V28, P190; Vass AA, 2002, J FORENSIC SCI, V47, P542; Vass AA, 2004, J FORENSIC SCI, V49, P760; VASS AA, 1992, J FORENSIC SCI, V37, P1236; Vass AA, 2008, J FORENSIC SCI, V53, P384, DOI 10.1111/j.1556-4029.2008.00680.x	69	89	89	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39005	10.1371/journal.pone.0039005	http://dx.doi.org/10.1371/journal.pone.0039005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723918	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300079
J	Mayor, DJ; Thornton, B; Zuur, AF				Mayor, Daniel J.; Thornton, Barry; Zuur, Alain F.			Resource Quantity Affects Benthic Microbial Community Structure and Growth Efficiency in a Temperate Intertidal Mudflat	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; ORGANIC-MATTER; AUSTRALIAN ESTUARY; CARBON-DIOXIDE; FATTY-ACIDS; NITROGEN; METABOLISM; DEGRADATION; SEDIMENTS; ISOTOPE	Estuaries cover <1% of marine habitats, but the carbon dioxide (CO2) effluxes from these net heterotrophic systems contribute significantly to the global carbon cycle. Anthropogenic eutrophication of estuarine waterways increases the supply of labile substrates to the underlying sediments. How such changes affect the form and functioning of the resident microbial communities remains unclear. We employed a carbon-13 pulse-chase experiment to investigate how a temperate estuarine benthic microbial community at 6.5 degrees C responded to additions of marine diatom-derived organic carbon equivalent to 4.16, 41.60 and 416.00 mmol C m(-2). The quantities of carbon mineralized and incorporated into bacterial biomass both increased significantly, albeit differentially, with resource supply. This resulted in bacterial growth efficiency increasing from 0.40 +/- 0.02 to 0.55 +/- 0.04 as substrates became more available. The proportions of diatom-derived carbon incorporated into individual microbial membrane fatty acids also varied with resource supply. Future increases in labile organic substrate supply have the potential to increase both the proportion of organic carbon being retained within the benthic compartment of estuaries and also the absolute quantity of CO2 outgassing from these environments.	[Mayor, Daniel J.] Univ Aberdeen, Oceanlab, Inst Biol & Environm Sci, Aberdeen, Scotland; [Thornton, Barry] James Hutton Inst, Aberdeen, Scotland; [Zuur, Alain F.] Highland Stat Ltd, Newburgh, Aberdeen, Scotland	University of Aberdeen; James Hutton Institute	Mayor, DJ (corresponding author), Univ Aberdeen, Oceanlab, Inst Biol & Environm Sci, Aberdeen, Scotland.	dan.mayor@abdn.ac.uk	Mayor, Daniel/HDN-8520-2022	Mayor, Daniel/0000-0002-1295-0041	United Kingdom's Natural Environment Research Council [NE/G014744/1]; Rural and Environment Science and Analytical Services Division of the Scottish Government; Natural Environment Research Council [NE/G014744/1] Funding Source: researchfish; NERC [NE/G014744/1] Funding Source: UKRI	United Kingdom's Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Rural and Environment Science and Analytical Services Division of the Scottish Government; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DM is funded by the United Kingdom's Natural Environment Research Council (NE/G014744/1). BT received funding from the Rural and Environment Science and Analytical Services Division of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Arnosti C, 1998, MAR ECOL PROG SER, V165, P59, DOI 10.3354/meps165059; BAIRD D, 1981, ESTUAR COAST SHELF S, V13, P455, DOI 10.1016/S0302-3524(81)80041-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOETIUS A, 1994, MAR ECOL PROG SER, V104, P299, DOI 10.3354/meps104299; Borges AV, 2005, ESTUARIES, V28, P3, DOI 10.1007/BF02732750; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; BRINCHIVERSEN J, 1990, FEMS MICROBIOL ECOL, V74, P345; Buhring SI, 2006, LIMNOL OCEANOGR, V51, P157; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Cook PLM, 2004, MAR ECOL PROG SER, V280, P39, DOI 10.3354/meps280039; Cook PLM, 2004, MAR ECOL PROG SER, V280, P25, DOI 10.3354/meps280025; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; del Giorgio PA, 2012, ENVIRON MICROBIOL, V14, P1296, DOI 10.1111/j.1462-2920.2012.02713.x; Edmonds JW, 2008, APPL ENVIRON MICROB, V74, P1836, DOI 10.1128/AEM.00854-07; Eyre BD, 2005, LIMNOL OCEANOGR, V50, P81, DOI 10.4319/lo.2005.50.1.0081; Fenchel T, 2000, BACTERIAL BIOGEOCHEM; FINDLAY S, 1982, MAR ECOL PROG SER, V8, P161, DOI 10.3354/meps008161; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Gazeau F, 2005, MAR ECOL PROG SER, V301, P23, DOI 10.3354/meps301023; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Gontikaki E, 2011, MAR ECOL PROG SER, V421, P39, DOI 10.3354/meps08892; Gontikaki E, 2011, DEEP-SEA RES PT I, V58, P160, DOI 10.1016/j.dsr.2010.11.011; Gribsholt B, 2003, LIMNOL OCEANOGR, V48, P2151, DOI 10.4319/lo.2003.48.6.2151; Grossart HP, 2001, LIMNOL OCEANOGR, V46, P267, DOI 10.4319/lo.2001.46.2.0267; GUCKERT JB, 1985, FEMS MICROBIOL ECOL, V31, P147, DOI 10.1111/j.1574-6968.1985.tb01143.x; GUCKERT JB, 1986, APPL ENVIRON MICROB, V52, P794, DOI 10.1128/AEM.52.4.794-801.1986; Harvey HR, 2006, AQUAT MICROB ECOL, V42, P105, DOI 10.3354/ame042105; Heip CHR, 1995, OCEANOGR MAR BIOL, V33, P1; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Hubas C, 2007, MAR ECOL PROG SER, V344, P39, DOI 10.3354/meps06947; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Jonkers HM, 2005, MICROBIAL ECOL, V49, P291, DOI 10.1007/s00248-004-0260-y; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; KELLEY CA, 1990, LIMNOL OCEANOGR, V35, P372, DOI 10.4319/lo.1990.35.2.0372; KELLY JR, 1984, MAR ECOL PROG SER, V17, P157, DOI 10.3354/meps017157; Kirchman DL, 2005, DEEP-SEA RES PT II, V52, P3386, DOI 10.1016/j.dsr2.2005.09.005; Kostka JE, 1999, MAR ECOL PROG SER, V180, P7, DOI 10.3354/meps180007; Lopez-Urrutia A, 2007, ECOLOGY, V88, P817, DOI 10.1890/06-1641; Mayor DJ, 2012, ISME J, V6, P1740, DOI 10.1038/ismej.2012.14; Mayor DJ, 2011, FUNCT ECOL, V25, P509, DOI 10.1111/j.1365-2435.2010.01791.x; Mayor DJ, 2010, ENVIRON SCI TECHNOL, V44, P2079, DOI 10.1021/es903073h; MIDDELBURG JJ, 1995, HYDROBIOLOGIA, V311, P57, DOI 10.1007/BF00008571; Midwood AJ, 2006, RAPID COMMUN MASS SP, V20, P3379, DOI 10.1002/rcm.2749; Moens T, 2007, POLAR BIOL, V31, P1, DOI 10.1007/s00300-007-0323-x; Moodley L, 2005, J MAR RES, V63, P457, DOI 10.1357/0022240053693662; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Porubsky WP, 2009, ESTUAR COAST SHELF S, V83, P392, DOI 10.1016/j.ecss.2009.04.012; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; Thornton B, 2011, RAPID COMMUN MASS SP, V25, P2433, DOI 10.1002/rcm.5148; Urban-Malinga B, 2006, J SEA RES, V56, P239, DOI 10.1016/j.seares.2006.05.003; van Nugteren P, 2009, MAR BIOL, V156, P2277, DOI 10.1007/s00227-009-1255-5; van Oevelen D, 2006, J MAR RES, V64, P453, DOI 10.1357/002224006778189581; Venables WN., 2002, MODERN APPL STAT S 4; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	62	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38582	10.1371/journal.pone.0038582	http://dx.doi.org/10.1371/journal.pone.0038582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723867	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305583300032
J	Zhang, X; Shi, MM; Shen, DW; Chen, XY				Zhang, Xin; Shi, Miao-Miao; Shen, Dong-Wei; Chen, Xiao-Yong			Habitat Loss other than Fragmentation per se Decreased Nuclear and Chloroplast Genetic Diversity in a Monoecious Tree	PLOS ONE			English	Article							RECENT POPULATION BOTTLENECKS; ALLELE FREQUENCY DATA; VAR. SIEBOLDII NAKAI; WIND-POLLINATED TREE; MICROSATELLITE MARKERS; ISLAND BIOGEOGRAPHY; PLANT-POPULATIONS; FOREST; POLLEN; DIFFERENTIATION	Generally, effect of fragmentation per se on biodiversity has not been separated from the effect of habitat loss. In this paper, using nDNA and cpDNA SSRs, we studied genetic diversity of Castanopsis sclerophylla (Lindl. & Paxton) Schotty populations and decoupled the effects of habitat loss and fragmentation per se. We selected seven nuclear and six cpDNA microsatellite loci and genotyped 460 individuals from mainland and island populations, which were located in the impoundment created in 1959. Number of alleles per locus of populations in larger habitats was significantly higher than that in smaller habitats. There was a significant relationship between the number of alleles per locus and habitat size. Based on this relationship, the predicted genetic diversity of an imaginary population of size equaling the total area of the islands was lower than that of the global population on the islands. Re-sampling demonstrated that low genetic diversity of populations in small habitats was caused by unevenness in sample size. Fisher's alpha index was similar among habitat types. These results indicate that the decreased nuclear and chloroplast genetic diversity of populations in smaller habitats was mainly caused by habitat loss. For nuclear and chloroplast microsatellite loci, values of F-ST were 0.066 and 0.893, respectively, and the calculated pollen/seed dispersal ratio was 162.2. When separated into pre-and post-fragmentation cohorts, pollen/seed ratios were 121.2 and 189.5, respectively. Our results suggest that habitat loss explains the early decrease in genetic diversity, while fragmentation per se may play a major role in inbreeding and differentiation among fragmented populations and later loss of genetic diversity.	[Zhang, Xin; Shi, Miao-Miao; Shen, Dong-Wei; Chen, Xiao-Yong] E China Normal Univ, Sch Resources & Environm Sci, Tiantong Natl Observat Stn Forest Ecosyst, Shanghai 200062, Peoples R China; [Zhang, Xin] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Shi, Miao-Miao] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany	East China Normal University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Zhang, X (corresponding author), E China Normal Univ, Sch Resources & Environm Sci, Tiantong Natl Observat Stn Forest Ecosyst, Shanghai 200062, Peoples R China.	xychen@des.ecnu.edu.cn	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940	National Natural Science Foundation of China [30470287, 30970430]; Fundamental Research Funds for the Central Universities [78220028]; Sino-Swiss Science and Technology Cooperation [EG 33-032010]; "211 Projects'' of East China Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Sino-Swiss Science and Technology Cooperation; "211 Projects'' of East China Normal University	Field works and lab experiments were supported by the National Natural Science Foundation of China (30470287, 30970430) and the Fundamental Research Funds for the Central Universities (78220028). XYC was supported by the Sino-Swiss Science and Technology Cooperation (EG 33-032010) to visit University of Bern for partial data anlysis. "211 Projects'' of East China Normal University supported the equipment of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianoelina O, 2009, ANN BOT-LONDON, V104, P1231, DOI 10.1093/aob/mcp231; [Anonymous], 1997, TFPGA TOOLS POPULATI; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Broadhurst LM, 2008, BIOL CONSERV, V141, P2843, DOI 10.1016/j.biocon.2008.08.021; Chen XY, 2008, FOREST ECOL MANAG, V256, P1143, DOI 10.1016/j.foreco.2008.06.014; Chen XY, 2009, ECOLOGY, V90, P39, DOI 10.1890/08-1520.1; Chen XY, 2011, SCI CHINA LIFE SCI, V54, P1055, DOI 10.1007/s11427-011-4238-y; Chen XY, 2000, ACTA ECOL SIN, V20, P884; Cornuet JM, 1996, GENETICS, V144, P2001; Deguilloux MF, 2003, MOL ECOL NOTES, V3, P24, DOI 10.1046/j.1471-8286.2003.00339.x; Dubreuil M, 2008, AM J BOT, V95, P577, DOI 10.3732/ajb.2007320; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fan XX, 2004, BIOCHEM GENET, V42, P269, DOI 10.1023/B:BIGI.0000034431.15308.57; Fineschi S, 2002, CONSERV GENET, V3, P145, DOI 10.1023/A:1015222230887; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gavish Y, 2012, CONSERV BIOL, V26, P150, DOI 10.1111/j.1523-1739.2011.01799.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HASTINGS A, 1977, THEOR POPUL BIOL, V12, P37, DOI 10.1016/0040-5809(77)90034-X; Honnay O, 2006, BIOL CONSERV, V127, P411, DOI 10.1016/j.biocon.2005.09.006; Jump AS, 2006, P NATL ACAD SCI USA, V103, P8096, DOI 10.1073/pnas.0510127103; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Lu HP, 2006, GENETICA, V128, P409, DOI 10.1007/s10709-006-7542-x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; R Development Core Team, 2012, R LANG ENV STAT COMP; R Development Core Team and contributors worldwide, 2009, R STATS PACK VERS 2; Sebastiani F, 2004, MOL ECOL NOTES, V4, P259, DOI 10.1111/j.1471-8286.2004.00635.x; Squirrell J, 2001, AM J BOT, V88, P1409, DOI 10.2307/3558447; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Trapnell DW, 2004, MOL ECOL, V13, P2655, DOI 10.1111/j.1365-294X.2004.02281.x; Ueno S, 2000, MOL ECOL, V9, P1188, DOI 10.1046/j.1365-294x.2000.00954-11.x; Ueno S, 2003, CONSERV GENET, V4, P813, DOI 10.1023/B:COGE.0000006120.99339.10; Wang R, 2011, MOL ECOL, V20, P4421, DOI 10.1111/j.1365-294X.2011.05293.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Williams DA, 2007, BIOL CONSERV, V138, P256, DOI 10.1016/j.biocon.2007.04.024; Wu, 1980, VEGETATION CHINA; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2; Xu G., 2005, FOR INVENTORY PLAN FOR INVENTORY PLAN, V30, P25; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zhang X, 2006, THESIS E CHINA NORMA; [张欣 ZHANG Xin], 2007, [生态学报, Acta Ecologica Sinica], V27, P424, DOI 10.1016/S1872-2032(07)60014-6; Zhao AL, 2006, BIODIVERS CONSERV, V15, P1339, DOI 10.1007/s10531-005-4875-1	52	11	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39146	10.1371/journal.pone.0039146	http://dx.doi.org/10.1371/journal.pone.0039146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723951	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300105
J	Fitting, C; Parlato, M; Adib-Conquy, M; Memain, N; Philippart, F; Misset, B; Monchi, M; Cavaillon, JM; Adrie, C				Fitting, Catherine; Parlato, Marianna; Adib-Conquy, Minou; Memain, Nathalie; Philippart, Francois; Misset, Benoit; Monchi, Mehran; Cavaillon, Jean-Marc; Adrie, Christophe			DNAemia Detection by Multiplex PCR and Biomarkers for Infection in Systemic Inflammatory Response Syndrome Patients	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; CARDIAC-ARREST; ORGAN FAILURE; APACHE-II; SEPSIS; IDENTIFICATION; DIAGNOSIS; BACTERIAL; EPIDEMIOLOGY; PATHOGENS	Fast and reliable assays to precisely define the nature of the infectious agents causing sepsis are eagerly anticipated. New molecular biology techniques are now available to define the presence of bacterial or fungal DNA within the bloodstream of sepsis patients. We have used a new technique (VYOO (R)) that allows the enrichment of microbial DNA before a multiplex polymerase chain reaction (PCR) for pathogen detection provided by SIRS-Lab (Jena, Germany). We analyzed 72 sepsis patients and 14 non-infectious systemic inflammatory response syndrome (SIRS) patients. Among the sepsis patients, 20 had a positive blood culture and 35 had a positive microbiology in other biological samples. Of these, 51.4% were positive using the VYOO (R) test. Among the sepsis patients with a negative microbiology and the non-infectious SIRS, 29.4% and 14.2% were positive with the VYOO (R) test, respectively. The concordance in bacterial identification between microbiology and the VYOO (R) test was 46.2%. This study demonstrates that these new technologies offer great hopes, but improvements are still needed.	[Fitting, Catherine; Parlato, Marianna; Adib-Conquy, Minou; Cavaillon, Jean-Marc] Inst Pasteur, Dept Infect & Epidemiol, Unit Cytokines & Inflammat, Paris, France; [Memain, Nathalie] Delafontaine Hosp, Serv Reanimat, St Denis, France; [Philippart, Francois; Misset, Benoit] Univ Paris 05, Grp Hosp Paris St Joseph, Serv Reanimat Med Chirurg, Paris, France; [Monchi, Mehran] Jacques Cartier Hosp, Serv Soins Intensifs, Massy Palaiseau, France; [Adrie, Christophe] Univ Paris 05, Cochin Hosp, Serv Physiol & Explorat Fonct, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Jacques Cartier Private Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Fitting, C (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Unit Cytokines & Inflammat, Paris, France.	jean-marc.cavaillon@pasteur.fr	Parlato, Marianna/H-9467-2017; Philippart, Francois/AAF-2791-2019; Misset, Benoit/P-7817-2018	Philippart, Francois/0000-0002-7323-0742; Misset, Benoit/0000-0001-6466-0065				Adib-Conquy M, 2007, SHOCK, V28, P406, DOI 10.1097/shk.0b013e3180488154; Adrie C, 2005, J CRIT CARE, V20, P46, DOI 10.1016/j.jcrc.2004.10.005; Adrie C, 2000, INTENS CARE MED, V26, P364, DOI 10.1007/s001340051169; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006; Birmingham MC, 1997, PHARMACOECONOMICS, V12, P637, DOI 10.2165/00019053-199712060-00004; Bloos F, 2009, CRIT CARE S4, V13, P9; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; Dark PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7886; Funk DJ, 2011, CRIT CARE CLIN, V27, P53, DOI 10.1016/j.ccc.2010.09.008; Gebert S, 2008, J INFECTION, V57, P307, DOI 10.1016/j.jinf.2008.07.013; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jordan JA, 2009, J CLIN MICROBIOL, V47, P368, DOI 10.1128/JCM.01991-08; Jordan JA, 2005, J MOL DIAGN, V7, P105, DOI 10.1016/S1525-1578(10)60015-3; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kobayashi T, 2000, FEMS IMMUNOL MED MIC, V28, P49, DOI 10.1111/j.1574-695X.2000.tb01456.x; Kortgen A, 2009, INFECTION, V37, P44; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; Lamoth F, 2010, J CLIN MICROBIOL, V48, P3510, DOI 10.1128/JCM.00147-10; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Louie RF, 2008, CRIT CARE MED, V36, P1487, DOI 10.1097/CCM.0b013e31816f487c; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maubon D, 2010, J INFECTION, V61, P335, DOI 10.1016/j.jinf.2010.07.004; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Morgenthaler NG, 2005, CRIT CARE, V9, pR37, DOI 10.1186/cc3015; Pasqualini L, 2012, J CLIN MICROBIOL; PHAM LH, 1991, AM REV RESPIR DIS, V143, P1055, DOI 10.1164/ajrccm/143.5_Pt_1.1055; Pletz MW, 2011, INTENS CARE MED, V37, P1069, DOI 10.1007/s00134-011-2245-x; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Sobel JD, 2005, URINARY TRACT INFECT; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; Struck J, 2004, PEPTIDES, V25, P1369, DOI 10.1016/j.peptides.2004.06.019; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Turnidge J, 2003, SCAND J INFECT DIS, V35, P677, DOI 10.1080/00365540310015953; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 1997, CRIT CARE MED, V25, P372, DOI 10.1097/00003246-199702000-00029; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x	48	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38916	10.1371/journal.pone.0038916	http://dx.doi.org/10.1371/journal.pone.0038916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719987	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000029
J	Simmons, SC; McKenzie, EA; Harris, LK; Aplin, JD; Brenchley, PE; Velasco-Garcia, MN; Missailidis, S				Simmons, Suzanne C.; McKenzie, Edward A.; Harris, Lynda K.; Aplin, John D.; Brenchley, Paul E.; Velasco-Garcia, Maria N.; Missailidis, Sotiris			Development of Novel Single-Stranded Nucleic Acid Aptamers against the Pro-Angiogenic and Metastatic Enzyme Heparanase (HPSE1)	PLOS ONE			English	Article							GROWTH-FACTOR; MAMMALIAN HEPARANASE; EXPRESSION; HEPARIN; BINDING; INHIBITION; RAS; INVASION; CELLS; SPECIFICITY	Heparanase is an enzyme involved in extracellular matrix remodelling and heparan sulphate proteoglycan catabolism. It is secreted by metastatic tumour cells, allowing them to penetrate the endothelial cell layer and basement membrane to invade target organs. The release of growth factors at the site of cleaved heparan sulphate chains further enhance the potential of the tumour by encouraging the process of angiogenesis. This leads to increased survival and further proliferation of the tumour. Aptamers are single or double stranded oligonucleotides that recognise specific small molecules, peptides, proteins, or even cells or tissues and have shown great potential over the years as diagnostic and therapeutic agents in anticancer treatment. For the first time, single stranded DNA aptamers were successfully generated against the active heterodimer form of heparanase using a modified SELEX protocol, and eluted based on increasing affinity for the target. Sandwich ELISA assays showed recognition of heparanase by the aptamers at a site distinct from that of a polyclonal HPSE1 antibody. The binding affinities of aptamer to immobilised enzyme were high (7x10(7) to 8x10(7) M-1) as measured by fluorescence spectroscopy. Immunohistochemistry and immunofluorescence studies demonstrated that the aptamers were able to recognise heparanase with staining comparable or in some cases superior to that of the HPSE1 antibody control. Finally, matrigel assay demonstrated that aptamers were able to inhibit heparanase. This study provides clear proof of principle concept that nucleic acid aptamers can be generated against heparanase. These reagents may serve as useful tools to explore the functional role of the enzyme and in the future development of diagnostic assays or therapeutic reagents.	[Simmons, Suzanne C.; Velasco-Garcia, Maria N.; Missailidis, Sotiris] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England; [McKenzie, Edward A.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Greater Manches, England; [Harris, Lynda K.; Aplin, John D.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Greater Manches, England; [Brenchley, Paul E.] Univ Manchester, Renal Res Grp, Manchester, Greater Manches, England	Open University - UK; University of Manchester; University of Manchester; University of Manchester	Simmons, SC (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England.	s.missailidis@open.ac.uk	Harris, Lynda K/I-2628-2019; Aplin, John/AET-4363-2022	Harris, Lynda K/0000-0001-7709-5202; Brenchley, Paul/0000-0003-1290-9919; Aplin, John/0000-0001-8777-9261	Open University	Open University	This project was funded by The Open University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; ADAMS DH, 1994, LANCET, V343, P831, DOI 10.1016/S0140-6736(94)92029-X; BARNER M, 1987, BLOOD, V70, P551; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Chuang WL, 2000, BIOCHEMISTRY-US, V39, P3542, DOI 10.1021/bi9926025; Courtney SM, 2005, BIOORG MED CHEM LETT, V15, P2295, DOI 10.1016/j.bmcl.2005.03.014; Da Pieve C, BIOCONJUG CHEM, V21, P169; ELDOR A, 1987, SEMIN THROMB HEMOST, V13, P475, DOI 10.1055/s-2007-1003524; Famulok M, 1999, CURR TOP MICROBIOL, V243, P123; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; He XT, 2004, CANCER RES, V64, P3928, DOI 10.1158/0008-5472.CAN-03-2718; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hicke BJ, 2006, J NUCL MED, V47, P668; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ikuta M, 2001, ORAL ONCOL, V37, P177, DOI 10.1016/S1368-8375(00)00077-4; Ishida K, 2004, MOL CANCER THER, V3, P1069; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Kimoto M, 2002, EUR J BIOCHEM, V269, P697, DOI 10.1046/j.0014-2956.2001.02703.x; Koliopanos A, 2001, CANCER RES, V61, P4655; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Li JP, 2009, THROMB HAEMOSTASIS, V102, P823, DOI 10.1160/TH09-02-0091; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liss M, 2002, ANAL CHEM, V74, P4488, DOI 10.1021/ac011294p; Marchetti D, 2001, ADV ENZYME REGUL, V41, P343, DOI 10.1016/S0065-2571(00)00016-9; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; McKenzie E, 2003, BIOCHEM J, V373, P423, DOI 10.1042/BJ20030318; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; Missailidis S, 2005, J IMMUNOL METHODS, V296, P45, DOI 10.1016/j.jim.2004.10.011; Missailidis Sotiris, 2004, Methods Mol Biol, V248, P547; Missailidis Sotiris, 2004, Methods Mol Biol, V248, P431; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Parish CR, 1999, CANCER RES, V59, P3433; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Rose Mark J., 2004, Current Drug Targets - Inflammation and Allergy, V3, P221, DOI 10.2174/1568010043343589; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Tang WH, 2002, MODERN PATHOL, V15, P593, DOI 10.1038/modpathol.3880571; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I., 2011, CANC MICROENVIRON; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M., 1999, RNA BIOCH BIOTECHNOL	56	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37938	10.1371/journal.pone.0037938	http://dx.doi.org/10.1371/journal.pone.0037938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719856	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000009
J	Burwell, AK; Thula-Mata, T; Gower, LB; Habeliz, S; Kurylo, M; Ho, SP; Chien, YC; Cheng, J; Cheng, NF; Gansky, SA; Marshall, SJ; Marshall, GW				Burwell, Anora K.; Thula-Mata, Taili; Gower, Laurie B.; Habeliz, Stefan; Kurylo, Michael; Ho, Sunita P.; Chien, Yung-Ching; Cheng, Jing; Cheng, Nancy F.; Gansky, Stuart A.; Marshall, Sally J.; Marshall, Grayson W.			Functional Remineralization of Dentin Lesions Using Polymer-Induced Liquid-Precursor Process	PLOS ONE			English	Article							DEMINERALIZED HUMAN DENTIN; IN-VITRO; MECHANICAL-PROPERTIES; COLLAGEN FIBRILS; CARIES LESIONS; PILP PROCESS; MINERALIZATION; INDENTATION; PERSPECTIVE; INHIBITORS	It was hypothesized that applying the polymer-induced liquid-precursor (PILP) system to artificial lesions would result in time-dependent functional remineralization of carious dentin lesions that restores the mechanical properties of demineralized dentin matrix. 140 mm deep artificial caries lesions were remineralized via the PILP process for 7-28 days at 37 degrees C to determine temporal remineralization characteristics. Poly-L-aspartic acid (27 KDa) was used as the polymeric process-directing agent and was added to the remineralization solution at a calcium-to-phosphate ratio of 2.14 (mol/mol). Nanomechanical properties of hydrated artificial lesions had a low reduced elastic modulus (E-R = 0.2 GPa) region extending about 70 mm into the lesion, with a sloped region to about 140 mm where values reached normal dentin (18-20 GPa). After 7 days specimens recovered mechanical properties in the sloped region by 51% compared to the artificial lesion. Between 7-14 days, recovery of the outer portion of the lesion continued to a level of about 10 GPa with 74% improvement. 28 days of PILP mineralization resulted in 91% improvement of E-R compared to the artificial lesion. These differences were statistically significant as determined from change-point diagrams. Mineral profiles determined by micro x-ray computed tomography were shallower than those determined by nanoindentation, and showed similar changes over time, but full mineral recovery occurred after 14 days in both the outer and sloped portions of the lesion. Scanning electron microscopy and energy dispersive x-ray analysis showed similar morphologies that were distinct from normal dentin with a clear line of demarcation between the outer and sloped portions of the lesion. Transmission electron microscopy and selected area electron diffraction showed that the starting lesions contained some residual mineral in the outer portions, which exhibited poor crystallinity. During remineralization, intrafibrillar mineral increased and crystallinity improved with intrafibrillar mineral exhibiting the orientation found in normal dentin or bone.	[Burwell, Anora K.; Habeliz, Stefan; Kurylo, Michael; Ho, Sunita P.; Chien, Yung-Ching; Cheng, Jing; Cheng, Nancy F.; Gansky, Stuart A.; Marshall, Sally J.; Marshall, Grayson W.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Thula-Mata, Taili; Gower, Laurie B.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA	University of California System; University of California San Francisco; State University System of Florida; University of Florida	Burwell, AK (corresponding author), Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA.	gw.marshall@ucsf.edu	Ho, Sunita P/B-1084-2008; Gower, Laurie B/A-5947-2008	Gower, Laurie B/0000-0003-2927-5406; Marshall, Grayson W/0000-0001-8921-3253; Ho, Sunita/0000-0001-9999-8226	NIH ARRA supplement [R01 DE016849-04S1, R01 DE016849]; NIH [S10 RR026645]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016849, R01DE022032] Funding Source: NIH RePORTER	NIH ARRA supplement; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH ARRA supplement to NIDCR grants R01 DE016849-04S1 and R01 DE016849. MicroXCT (TM) was carried out with support from NIH S10 RR026645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balooch M, 2008, J STRUCT BIOL, V162, P404, DOI 10.1016/j.jsb.2008.02.010; Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O; Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593; Bertassoni LE, 2011, J BIOMECH, V44, P176, DOI 10.1016/j.jbiomech.2010.09.005; Bertassoni LE, 2010, SCANNING, V32, P312, DOI 10.1002/sca.20199; Dai LJ, 2008, J NON-CRYST SOLIDS, V354, P1845, DOI 10.1016/j.jnoncrysol.2007.10.022; Dominicus A, 2008, STAT MED, V27, P5786, DOI 10.1002/sim.3380; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Guo WG, 2007, STAT APPL GENET MOL, V6; Ho SP, 2005, J STRUCT BIOL, V151, P69, DOI 10.1016/j.jsb.2005.05.003; Jee SS, 2010, ACTA BIOMATER, V6, P3676, DOI 10.1016/j.actbio.2010.03.036; Kim J, 2010, ACTA BIOMATER, V6, P2740, DOI 10.1016/j.actbio.2009.12.052; Kim YK, 2010, BIOMATERIALS, V31, P6618, DOI 10.1016/j.biomaterials.2010.04.060; Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204; Mai S, 2010, J DENT RES, V89, P405, DOI 10.1177/0022034510363662; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Marshall GW, 2001, J DENT RES, V80, P1768, DOI 10.1177/00220345010800081701; Martin-De las Heras S, 2000, ARCH ORAL BIOL, V45, P757, DOI 10.1016/S0003-9969(00)00052-2; McIntyre JM, 2000, AUST DENT J, V45, P24, DOI 10.1111/j.1834-7819.2000.tb00238.x; Nascimento FD, 2011, J DENT RES, V90, P506, DOI 10.1177/0022034510391906; Nishitani Y, 2006, EUR J ORAL SCI, V114, P160, DOI 10.1111/j.1600-0722.2006.00342.x; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Olszta MJ, 2003, CONNECT TISSUE RES, V44, P326, DOI 10.1080/03008200390181852; Olszta MJ, 2003, CALCIFIED TISSUE INT, V72, P583, DOI 10.1007/s00223-002-1032-7; Pugach MK, 2009, J DENT RES, V88, P71, DOI 10.1177/0022034508327552; Sulkala M, 2001, J DENT RES, V80, P1545, DOI 10.1177/00220345010800061301; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; ten Cate J M, 2008, Aust Dent J, V53, P281, DOI 10.1111/j.1834-7819.2008.00063.x; ten Cate JM, 2001, J DENT RES, V80, P1407, DOI 10.1177/00220345010800050401; Thula TT, 2011, ACTA BIOMATER, V7, P3158, DOI 10.1016/j.actbio.2011.04.014; Thula-Mata T, 2011, MRS P, DOI [10.1557/opl, DOI 10.1557/OPL]; van Strijp AJP, 2003, CARIES RES, V37, P58, DOI 10.1159/000068223; WHITE JM, 1994, J DENT RES, V73, P1560, DOI 10.1177/00220345940730091201; Zheng L, 2003, EUR J ORAL SCI, V111, P243, DOI 10.1034/j.1600-0722.2003.00038.x	36	85	89	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38852	10.1371/journal.pone.0038852	http://dx.doi.org/10.1371/journal.pone.0038852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719965	gold, Green Published			2022-12-27	WOS:000305341900055
J	Lin, SC; Lin, YF; Chong, P; Wu, SC				Lin, Shih-Chang; Lin, Yu-Fen; Chong, Pele; Wu, Suh-Chin			Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles	PLOS ONE			English	Article							GRAM-NEGATIVE FLAGELLIN; INFLUENZA-VIRUS; VACCINE DESIGN; ANTIGENIC STRUCTURE; GP120; HIV-1; INDUCTION; RESPONSES; EPITOPE; IMMUNOGENICITY	Background: Highly pathogenic avian influenza (HPAI) H5N1 viruses and their transmission capability from birds to humans have raised global concerns about a potential human pandemic. The inherent nature of antigenic changes in influenza viruses has not been sufficiently taken into account in immunogen designs for broadly protective HPAI H5N1 vaccines. Methods: We designed a hyperglycosylated HA vaccine using N-linked glycan masking on highly variable sequences in the HA1 globular head. Immunization of these hyperglycosylated HA DNA vaccines followed by a flagellin-containing virus-like particle booster in mice was conducted to evaluate neutralizing antibody responses against various clades of HPAI H5N1 viruses. Results: We introduced nine N-X-S/T motifs in five HA1 regions: 83NNT, 86NNT, 94NFT, 127NSS, 138NRT, 156NTT, 161NRS, 182NDT, and 252NAT according to sequence alignment analyses from 163 HPAI H5N1 human isolates. Although no significant differences of anti-HA total IgG titers were found with these hyperglycosyalted HA compared to the wild-type control, the 83NNT and 127NSS mutants elicited significantly potent cross-clade neutralizing antibodies against HPAI H5N1 viruses. Conclusions: This finding may have value in terms of novel immunogen design for developing cross-protective H5N1 vaccines.	[Lin, Shih-Chang; Lin, Yu-Fen; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hisnchu, Taiwan; [Chong, Pele; Wu, Suh-Chin] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan	Wu, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hisnchu, Taiwan.	scwu@mx.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021; Chong, Pele/E-3855-2010		National Science Council [NSC-99-2311-B-007-005-MY3, NSC-100-2321-B-007-005]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council (NSC-99-2311-B-007-005-MY3 and NSC-100-2321-B-007-005) and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2009, CURR TOP MICROBIOL, V333, P323, DOI 10.1007/978-3-540-92165-3_16; Barnett SW, 1997, VACCINE, V15, P869, DOI 10.1016/S0264-410X(96)00264-2; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chies MD, 2001, IMMUNOLOGY, V103, P172, DOI 10.1046/j.1365-2567.2001.01242.x; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Delves RJ, 1997, MOL MED TODAY, V3, P55, DOI 10.1016/S1357-4310(96)20036-X; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016563; Garrity RR, 1997, J IMMUNOL, V159, P279; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Moors MA, 2001, INFECT IMMUN, V69, P4424, DOI 10.1128/IAI.69.7.4424-4429.2001; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Richmond JFL, 1998, J VIROL, V72, P9092, DOI 10.1128/JVI.72.11.9092-9100.1998; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Suguitan AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021942; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Wei HJ, 2011, VACCINE, V29, P7163, DOI 10.1016/j.vaccine.2011.05.077; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039	39	26	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39075	10.1371/journal.pone.0039075	http://dx.doi.org/10.1371/journal.pone.0039075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720032	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900079
J	Yu, L; Zhang, L; Sun, LN; Lu, J; Wu, W; Li, C; Zhang, QF; Zhang, FS; Jin, C; Wang, XJ; Bi, ZQ; Li, DX; Liang, MF				Yu, Li; Zhang, Li; Sun, Lina; Lu, Jing; Wu, Wei; Li, Chuan; Zhang, Quanfu; Zhang, Fushun; Jin, Cong; Wang, Xianjun; Bi, Zhenqiang; Li, Dexin; Liang, Mifang			Critical Epitopes in the Nucleocapsid Protein of SFTS Virus Recognized by a Panel of SFTS Patients Derived Human Monoclonal Antibodies	PLOS ONE			English	Article							THROMBOCYTOPENIA SYNDROME BUNYAVIRUS; HUMORAL RESPONSE; ENVELOPE PROTEIN; ANTIGENIC SITES; IGM ANTIBODIES; INDIRECT ELISA; SEVERE FEVER; N-PROTEIN; NUCLEOPROTEIN; IMMUNOASSAYS	Background: SFTS virus (SFTSV) is a newly discovered pathogen to cause severe fever with thrombocytopenia syndrome (SFTS) in human. Successful control of SFTSV epidemic requires better understanding of the antigen target in humoral immune responses to the new bunyavirus infection. Methodology/Principal Findings: We have generated a combinatorial Fab antibody phage library from two SFTS patients recovered from SFTSV infection. To date, 94 unique human antibodies have been generated and characterized from over 1200 Fab antibody clones obtained by screening the library with SFTS purified virions. All those monoclonal antibodies (MAbs) recognized the nucleocapsid (N) protein of SFTSV while none of them were reactive to the viral glycoproteins Gn or Gc. Furthermore, over screening 1000 mouse monoclonal antibody clones derived from SFTSV virions immunization, 462 clones reacted with N protein, while only 16 clones were reactive to glycoprotein. Furthermore, epitope mapping of SFTSV N protein was performed through molecular simulation, site mutation and competitive ELISA, and we found that at least 4 distinct antigenic epitopes within N protein were recognized by those human and mouse MAbs, in particular mutation of Glu10 to Ala10 abolished or significantly reduced the binding activity of nearly most SFTS patients derived MAbs. Conclusions/Significance: The large number of human recombinant MAbs derived from SFTS patients recognized the viral N protein indicated the important role of the N protein in humoral responses to SFTSV infection, and the critical epitopes we defined in this study provided molecular basis for detection and diagnosis of SFTSV infection.	[Yu, Li; Zhang, Li; Sun, Lina; Lu, Jing; Wu, Wei; Li, Chuan; Zhang, Quanfu; Zhang, Fushun; Jin, Cong; Li, Dexin; Liang, Mifang] China CDC, Lab Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Xianjun; Bi, Zhenqiang] Shandong Prov CDC, Shandong Key Lab Infect Dis Prevent & Control, Jinan, Shandong, Peoples R China	Chinese Center for Disease Control & Prevention	Yu, L (corresponding author), China CDC, Lab Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	mifangl@vip.sina.com			Ministry of Science and Technology [2011ZX10004-001]; Ministry of Health; Mount Tai Scholarship of Shandong Province; National Natural Science Foundation of China [81102171]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Mount Tai Scholarship of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was mainly supported by China Mega-Project for Infectious Diseases (2011ZX10004-001) from Ministry of Science and Technology and Ministry of Health, and Mount Tai Scholarship of Shandong Province (D. L.), the National Natural Science Foundation of China (81102171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agostino M, 2009, MOL IMMUNOL, V47, P233, DOI 10.1016/j.molimm.2009.09.031; ARIKAWA J, 1989, J GEN VIROL, V70, P615, DOI 10.1099/0022-1317-70-3-615; ARIKAWA J, 1992, ARCH VIROL, V126, P271, DOI 10.1007/BF01309700; Barbas CF, 1996, TRENDS BIOTECHNOL, V14, P230, DOI 10.1016/0167-7799(96)10029-9; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; BESSELAAR TG, 1991, ARCH VIROL, V121, P111, DOI 10.1007/BF01316748; Boshra H, 2011, VACCINE, V29, P4469, DOI 10.1016/j.vaccine.2011.04.043; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Clark RL, 2006, BIOORGAN MED CHEM, V14, P2674, DOI 10.1016/j.bmc.2005.11.042; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Fafetine JM, 2007, VET MICROBIOL, V121, P29, DOI 10.1016/j.vetmic.2006.11.008; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Katz A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-187; Kaushik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026251; Kearns-Jonker M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-3; Le May N, 2005, J VIROL, V79, P11974, DOI 10.1128/JVI.79.18.11974-11980.2005; Lu Jing, 2011, Chinese Journal of Virology, V27, P515; LUNDKVIST A, 1993, ARCH VIROL, V130, P121, DOI 10.1007/BF01319001; Magurano F, 1999, CLIN DIAGN LAB IMMUN, V6, P55, DOI 10.1128/CDLI.6.1.55-60.1999; Martin-Folgar R, 2010, MABS-AUSTIN, V2, P275, DOI 10.4161/mabs.2.3.11676; Mohl BP, 2009, RNA, V15, P391, DOI 10.1261/rna.1367209; NAKAMURA T, 1985, J INFECT DIS, V151, P691, DOI 10.1093/infdis/151.4.691; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; van Vuren PJ, 2007, J VIROL METHODS, V140, P106, DOI 10.1016/j.jviromet.2006.11.005; van Vuren PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025027; YOSHIMATSU K, 1993, ARCH VIROL, V130, P365, DOI 10.1007/BF01309667; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	31	28	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38291	10.1371/journal.pone.0038291	http://dx.doi.org/10.1371/journal.pone.0038291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719874	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000017
J	Runkel, F; Hintze, M; Griesing, S; Michels, M; Blanck, B; Fukami, K; Guenet, JL; Franz, T				Runkel, Fabian; Hintze, Maik; Griesing, Sebastian; Michels, Marion; Blanck, Birgit; Fukami, Kiyoko; Guenet, Jean-Louis; Franz, Thomas			Alopecia in a Viable Phospholipase C Delta 1 and Phospholipase C Delta 3 Double Mutant	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; HAIR FOLLICLE MORPHOGENESIS; KERATIN-ASSOCIATED PROTEINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; NUCLEAR PROCESSES; CELL-CYCLE; COMPREHENSIVE GUIDE; LABORATORY MICE; PLASMA-MEMBRANE; DOWN-REGULATION	Background: Inositol 1,4,5trisphosphate (IP3) and diacylglycerol (DAG) are important intracellular signalling molecules in various tissues. They are generated by the phospholipase C family of enzymes, of which phospholipase C delta (PLCD) forms one class. Studies with functional inactivation of Plcd isozyme encoding genes in mice have revealed that loss of both Plcd1 and Plcd3 causes early embryonic death. Inactivation of Plcd1 alone causes loss of hair (alopecia), whereas inactivation of Plcd3 alone has no apparent phenotypic effect. To investigate a possible synergy of Plcd1 and Plcd3 in postnatal mice, novel mutations of these genes compatible with life after birth need to be found. Methodology/Principal Findings: We characterise a novel mouse mutant with a spontaneously arisen mutation in Plcd3 (Plcd3(mNab)) that resulted from the insertion of an intracisternal A particle (IAP) into intron 2 of the Plcd3 gene. This mutation leads to the predominant expression of a truncated PLCD3 protein lacking the N-terminal PH domain. C3H mice that carry one or two mutant Plcd3(mNab) alleles are phenotypically normal. However, the presence of one Plcd3(mNab) allele exacerbates the alopecia caused by the loss of functional Plcd1 in Del(9)olt1Pas mutant mice with respect to the number of hair follicles affected and the body region involved. Mice double homozygous for both the Del(9) olt1Pas and the Plcd3(mNab) mutations survive for several weeks and exhibit total alopecia associated with fragile hair shafts showing altered expression of some structural genes and shortened phases of proliferation in hair follicle matrix cells. Conclusions/Significance: The Plcd3(mNab) mutation is a novel hypomorphic mutation of Plcd3. Our investigations suggest that Plcd1 and Plcd3 have synergistic effects on the murine hair follicle in specific regions of the body surface.	[Runkel, Fabian; Hintze, Maik; Griesing, Sebastian; Michels, Marion; Blanck, Birgit; Franz, Thomas] Univ Bonn, Inst Anat, Bonn, Germany; [Hintze, Maik; Griesing, Sebastian] LIMES, Bonn, Germany; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Hachioji, Tokyo 19203, Japan; [Guenet, Jean-Louis] Inst Pasteur, Dept Dev Biol, Paris, France	University of Bonn; University of Bonn; Tokyo University of Pharmacy & Life Sciences; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Runkel, F (corresponding author), Univ Klinikum Munster, Inst Anat, Munster, Germany.	thfranz@uni-bonn.de		Hintze, Maik/0000-0002-1066-6346				Akutagawa A, 2006, J BIOCHEM, V140, P619, DOI 10.1093/jb/mvj194; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Concepcion D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000484; Danielsen SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024419; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Fujii M, 2009, J CELL BIOCHEM, V108, P638, DOI 10.1002/jcb.22297; Fukami K, 2002, J BIOCHEM, V131, P293, DOI 10.1093/oxfordjournals.jbchem.a003102; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Fukami K, 2008, ADV ENZYME REGUL, V48, P261, DOI 10.1016/j.advenzreg.2007.11.010; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Godin CM, 2010, MOL PHARMACOL, V77, P388, DOI 10.1124/mol.109.061069; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Godwin AR, 1999, J INVEST DERM SYMP P, V4, P244, DOI 10.1038/sj.jidsp.5640221; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Hasdemir C, 2010, PACE, V33, P159, DOI 10.1111/j.1540-8159.2009.02606.x; Hirata M, 1998, JPN J PHARMACOL, V76, P255, DOI 10.1254/jjp.76.255; Hirata M, 2011, DIABETES, V60, P1926, DOI 10.2337/db10-1500; Hu XT, 2009, ONCOGENE, V28, P2466, DOI 10.1038/onc.2009.92; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Irino Y, 2004, BIOCHEM BIOPH RES CO, V320, P537, DOI 10.1016/j.bbrc.2004.05.206; Ishikawa S, 1997, CYTOGENET CELL GENET, V78, P58, DOI 10.1159/000134629; Jave-Suarez LF, 2006, ARCH DERMATOL RES, V297, P372, DOI 10.1007/s00403-005-0623-3; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kaproth-Joslin KA, 2008, BIOCHEM J, V415, P439, DOI 10.1042/BJ20080233; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kouchi Z, 2011, J BIOL CHEM, V286, P8459, DOI 10.1074/jbc.M110.171223; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Leung DW, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-15; Lien YC, 2006, CANCER RES, V66, P4329, DOI 10.1158/0008-5472.CAN-05-3424; Lin FG, 2001, BIOCHEM BIOPH RES CO, V286, P274, DOI 10.1006/bbrc.2001.5371; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Mecklenburg L, 2004, J INVEST DERMATOL, V123, P1001, DOI 10.1111/j.0022-202X.2004.23442.x; Mecklenburg L, 2001, EXP MOL PATHOL, V71, P171, DOI 10.1006/exmp.2001.2386; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Naito Y, 2006, J BIOCHEM, V140, P785, DOI 10.1093/jb/mvj209; Nakamura M, 2001, EXP DERMATOL, V10, P369, DOI 10.1034/j.1600-0625.2001.100601.x; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Nakamura Y, 2009, PHYSIOLOGY, V24, P332, DOI 10.1152/physiol.00031.2009; Nebigil CG, 1997, BIOCHEMISTRY-US, V36, P15949, DOI 10.1021/bi971721m; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Okada M, 2010, NEUROSCI LETT, V472, P188, DOI 10.1016/j.neulet.2010.01.081; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Pawelczyk T, 1998, EUR J BIOCHEM, V257, P169, DOI 10.1046/j.1432-1327.1998.2570169.x; Peterson RL, 2005, J INVEST DERM SYMP P, V10, P238, DOI 10.1111/j.1087-0024.2005.10114.x; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Resnick AC, 2008, FRONT BIOSCI-LANDMRK, V13, P856, DOI 10.2741/2726; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rogers MA, 2004, J INVEST DERMATOL, V122, P147, DOI 10.1046/j.0022-202X.2003.22128.x; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Runkel F, 2008, MAMM GENOME, V19, P691, DOI 10.1007/s00335-008-9150-9; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Seeds AM, 2007, ADV ENZYME REGUL, V47, P10, DOI 10.1016/j.advenzreg.2006.12.019; Seeds AM, 2007, BIOCHEM SOC SYMP, V74, P183, DOI 10.1042/BSS2007c16; Shimohama S, 1998, BIOCHEM BIOPH RES CO, V245, P722, DOI 10.1006/bbrc.1998.8307; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Sidhu RS, 2005, J BIOL CHEM, V280, P21933, DOI 10.1074/jbc.M412966200; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sundberg JP, 2005, J INVEST DERM SYMP P, V10, P264, DOI 10.1111/j.1087-0024.2005.10126.x; Takabatake T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn235; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Wilson N, 1999, Exp Dermatol, V8, P367; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Yagisawa H, 2006, J CELL BIOCHEM, V97, P233, DOI 10.1002/jcb.20677; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; Yagisawa H, 1999, BIOCHEM SOC T, V27, P652, DOI 10.1042/bst0270652; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014	98	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39203	10.1371/journal.pone.0039203	http://dx.doi.org/10.1371/journal.pone.0039203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723964	gold, Green Submitted, Green Published			2022-12-27	WOS:000305652700053
J	Sareen, D; Ebert, AD; Heins, BM; McGivern, JV; Ornelas, L; Svendsen, CN				Sareen, Dhruv; Ebert, Allison D.; Heins, Brittany M.; McGivern, Jered V.; Ornelas, Loren; Svendsen, Clive N.			Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							DIRECTED DIFFERENTIATION; MOUSE MODEL; IN-VITRO; SMN GENE; SURVIVAL; PROTEIN; SEVERITY; MICE; INDUCTION; RESVERATROL	Spinal muscular atrophy (SMA) is a genetic disorder caused by a deletion of the survival motor neuron 1 gene leading to motor neuron loss, muscle atrophy, paralysis, and death. We show here that induced pluripotent stem cell (iPSC) lines generated from two Type I SMA subjects-one produced with lentiviral constructs and the second using a virus-free plasmid-based approach-recapitulate the disease phenotype and generate significantly fewer motor neurons at later developmental time periods in culture compared to two separate control subject iPSC lines. During motor neuron development, both SMA lines showed an increase in Fas ligand-mediated apoptosis and increased caspase-8 and-3 activation. Importantly, this could be mitigated by addition of either a Fas blocking antibody or a caspase-3 inhibitor. Together, these data further validate this human stem cell model of SMA, suggesting that specific inhibitors of apoptotic pathways may be beneficial for patients.	[Sareen, Dhruv; Ornelas, Loren; Svendsen, Clive N.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Ebert, Allison D.; Heins, Brittany M.; McGivern, Jered V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Cedars Sinai Medical Center; Medical College of Wisconsin	Sareen, D (corresponding author), Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA.	sareend@cshs.org; aebert@mcw.edu; Clive.Svendsen@cshs.org			National Institutes of Health [R21HD06899]; California Institute for Regenerative Medicine [219509]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by National Institutes of Health grant R21HD06899 (to ADE) and California Institute for Regenerative Medicine grant 219509 (to CNS, DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carter TA, 1997, HUM MOL GENET, V6, P229, DOI 10.1093/hmg/6.2.229; Chang T, 2011, STEM CELLS, V29, P2090, DOI 10.1002/stem.749; Cheah BC, 2010, IDRUGS, V13, P911; Choi K, 2011, J NEUROCHEM, V116, P438, DOI 10.1111/j.1471-4159.2010.07124.x; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Coovert DD, 2000, J MED GENET, V37, P536, DOI 10.1136/jmg.37.7.536; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Ebert AD, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3000; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ito Y, 2011, BRAIN DEV-JPN, V33, P321, DOI 10.1016/j.braindev.2010.06.009; Iwahashi H, 1997, NATURE, V390, P413, DOI 10.1038/37144; Jablonka S, 2000, J NEUROL, V247, P37, DOI 10.1007/s004150050555; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kerr DA, 2000, P NATL ACAD SCI USA, V97, P13312, DOI 10.1073/pnas.230364197; Lafont E, 2010, CELL DEATH DIFFER, V17, P642, DOI 10.1038/cdd.2009.130; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Naoi M, 2010, CURR PHARM DESIGN, V16, P2799, DOI 10.2174/138161210793176527; Ogier C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-68; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Parker GC, 2008, NEUROTOX RES, V13, P39, DOI 10.1007/BF03033366; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Sakla MS, 2008, HUM GENET, V122, P635, DOI 10.1007/s00439-007-0441-0; Sareen D, 2006, INVEST OPHTH VIS SCI, V47, P3708, DOI 10.1167/iovs.06-0119; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sendtner M, 2010, NAT NEUROSCI, V13, P795, DOI 10.1038/nn.2565; Sureda FX, 2011, CURR PHARM DESIGN, V17, P230; Swoboda KJ, 2007, J CHILD NEUROL, V22, P957, DOI 10.1177/0883073807305665; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; The Huntington's Disease iPS Consortium, 2012, CELL STEM CE IN PRES; Trulzsch B, 2007, BRAIN RES, V1183, P1, DOI 10.1016/j.brainres.2007.09.025; Tsai LK, 2008, NEUROBIOL DIS, V31, P361, DOI 10.1016/j.nbd.2008.05.014; Tsai MS, 2006, MOL THER, V13, P1149, DOI 10.1016/j.ymthe.2006.02.008; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Watibayati MS, 2009, BRAIN DEV-JPN, V31, P42, DOI 10.1016/j.braindev.2008.08.012; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Ymlahi-Ouazzani Q, 2010, NEUROGENETICS, V11, P27, DOI 10.1007/s10048-009-0200-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550	58	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39113	10.1371/journal.pone.0039113	http://dx.doi.org/10.1371/journal.pone.0039113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723941	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700049
J	Xia, XY; Ge, M; Wang, ZX; Pan, XM				Xia, Xia-Yu; Ge, Meng; Wang, Zhi-Xin; Pan, Xian-Ming			Accurate Prediction of Protein Structural Class	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SECONDARY STRUCTURE PREDICTION; SEQUENCES; CLASSIFICATION; HOMOLOGY; DATABASE; REPRESENTATION; ALGORITHMS	Because of the increasing gap between the data from sequencing and structural genomics, the accurate prediction of the structural class of a protein domain solely from the primary sequence has remained a challenging problem in structural biology. Traditional sequence-based predictors generally select several sequence features and then feed them directly into a classification program to identify the structural class. The current best sequence-based predictor achieved an overall accuracy of 74.1% when tested on a widely used, non-homologous benchmark dataset 25PDB. In the present work, we built a multiple linear regression (MLR) model to convert the 440-dimensional (440D) sequence feature vector extracted from the Position Specific Scoring Matrix (PSSM) of a protein domain to a 4-dimensinal (4D) structural feature vector, which could then be used to predict the four major structural classes. We performed 10-fold cross-validation and jackknife tests of the method on a large non-homologous dataset containing 8,244 domains distributed among the four major classes. The performance of our approach outperformed all of the existing sequence-based methods and had an overall accuracy of 83.1%, which is even higher than the results of those predicted secondary structure-based methods.	[Xia, Xia-Yu; Ge, Meng; Wang, Zhi-Xin; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University	Xia, XY (corresponding author), Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Natural Science Foundation of China; Ministry of Science and Technology of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was funded by the Natural Science Foundation of China and the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bahar I, 1997, PROTEINS, V29, P172, DOI 10.1002/(SICI)1097-0134(199710)29:2<172::AID-PROT5>3.3.CO;2-D; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Bu WS, 1999, EUR J BIOCHEM, V266, P1043, DOI 10.1046/j.1432-1327.1999.00947.x; Cai YD, 2000, BIOCHIMIE, V82, P783, DOI 10.1016/S0300-9084(00)01161-5; Cai YD, 2003, J THEOR BIOL, V221, P115, DOI 10.1006/jtbi.2003.3179; Cai YD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-3; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 1998, PROTEINS, V31, P97, DOI 10.1002/(SICI)1097-0134(19980401)31:1<97::AID-PROT8>3.0.CO;2-E; Chou KC, 1999, BIOCHEM BIOPH RES CO, V264, P216, DOI 10.1006/bbrc.1999.1325; Costantini S, 2007, COMPUT BIOL CHEM, V31, P389, DOI 10.1016/j.compbiolchem.2007.08.010; Costantini S, 2009, BIOCHIMIE, V91, P226, DOI 10.1016/j.biochi.2008.09.005; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Dong LH, 2006, J BIOMOL STRUCT DYN, V24, P239; Kedarisetti KD, 2006, BIOCHEM BIOPH RES CO, V348, P981, DOI 10.1016/j.bbrc.2006.07.141; Kurgan L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-226; Kurgan L, 2007, BIOCHEM BIOPH RES CO, V357, P453, DOI 10.1016/j.bbrc.2007.03.164; Kurgan LA, 2006, PATTERN RECOGN, V39, P2323, DOI 10.1016/j.patcog.2006.02.014; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2; Liu T, 2011, AMINO ACIDS; Liu TG, 2010, BIOCHIMIE, V92, P1330, DOI 10.1016/j.biochi.2010.06.013; Liu TA, 2010, J THEOR BIOL, V267, P272, DOI 10.1016/j.jtbi.2010.09.007; Luo RY, 2002, EUR J BIOCHEM, V269, P4219, DOI 10.1046/j.1432-1033.2002.03115.x; Mizianty MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-414; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MUSKA SM, 1992, J MOL BIOL, V255, P713; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pan XM, 2001, PROTEINS, V43, P256, DOI 10.1002/prot.1036; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P577, DOI 10.1016/j.bbrc.2005.06.128; Wang ZX, 2000, PROTEINS, V38, P165, DOI 10.1002/(SICI)1097-0134(20000201)38:2<165::AID-PROT5>3.0.CO;2-V; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955; Yang JY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S9; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027	41	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37653	10.1371/journal.pone.0037653	http://dx.doi.org/10.1371/journal.pone.0037653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723837	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700005
J	Bao, YY; Sakinc, T; Laverde, D; Wobser, D; Benachour, A; Theilacker, C; Hartke, A; Huebner, J				Bao, Yinyin; Sakinc, Tuerkan; Laverde, Diana; Wobser, Dominique; Benachour, Abdellah; Theilacker, Christian; Hartke, Axel; Huebner, Johannes			Role of mprF1 and mprF2 in the Pathogenicity of Enterococcus faecalis	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE RESISTANCE; BIOFILM FORMATION; TEICHOIC-ACIDS; CAPSULAR POLYSACCHARIDES; PROLONGED BACTEREMIA; EXTRACELLULAR DNA; VANCOMYCIN; SUSCEPTIBILITY; STREPTOCOCCUS; PHOSPHOLIPIDS	Background: Enterococcus faecalis is one of the leading causes of nosocomial infections. Due to its innate and acquired resistance to most antibiotics, identification of new targets for antimicrobial treatment of E. faecalis is a high priority. The multiple peptide resistance factor MprF, which was first described in Staphylococcus aureus, modifies phosphatidylglycerol with lysin and reduces the negative charge of the membrane, thus increasing resistance to cationic antimicrobial peptides. We studied the effect of mprF in E. faecalis regarding influence on bacterial physiology and virulence. Results: Two putative mprF paralogs (mprF1 and mprF2) were identified in E. faecalis by BLAST search using the well-described S. aureus gene as a lead. Two deletion mutants in E. faecalis 12030 were created by homologous recombination. Analysis of both mutants by thin-layer chromatography showed that inactivation of mprF2 abolishes the synthesis of three distinct amino-phosphatidylglycerols (PGs). In contrast, deletion of mprF1 did not interfere with the biosynthesis of amino-PG. Inactivation of mprF2 increased susceptibility against several antimicrobial peptides and resulted in a 42% increased biofilm formation compared to wild-type mprF. However, resistance to opsonic killing was increased in the mutant, while virulence in a mouse bacteremia model was unchanged. Conclusion: Our data suggest that only mprF2 is involved in the aminoacylation of PG in enterococci, and is probably responsible for synthesis of Lys-PG, Ala-PG, and Arg-PG, while mprF1 does not seem to have a role in aminoacylation. As in other Gram-positive pathogens, aminoacylation through MprF2 increases resistance against cationic antimicrobial peptides. Unlike mprF found in other bacteria, mprF2 does not seem to be a major virulence factor in enterococci.	[Bao, Yinyin; Sakinc, Tuerkan; Laverde, Diana; Wobser, Dominique; Theilacker, Christian; Huebner, Johannes] Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany; [Bao, Yinyin; Benachour, Abdellah; Hartke, Axel] Univ Caen Basse Normandie, Stress Virulence EA4655 U2RM, Caen, France	University of Freiburg; Universite de Caen Normandie	Bao, YY (corresponding author), Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany.	johannes.huebner@uniklinik-freiburg.de		Theilacker, Christian/0000-0003-0821-9202; Huebner, Johannes/0000-0003-1232-4646	German Ministry of Science and Education [0313933, 01 EO 0803]	German Ministry of Science and Education	Supported by grants from the German Ministry of Science and Education (ERA-Net PathoGenoMics 0313933 and BMBF 01 EO 0803). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Callegan MC, 1999, INFECT IMMUN, V67, P3348, DOI 10.1128/IAI.67.7.3348-3356.1999; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Fabretti F, 2005, INT J ARTIF ORGANS, V28, P1079, DOI 10.1177/039139880502801105; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Gould R M, 1967, Biochem Biophys Res Commun, V26, P512; Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x; Ho SW, 2008, EUR BIOPHYS J BIOPHY, V37, P421, DOI 10.1007/s00249-007-0227-2; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Johnston NC, 2004, FEMS MICROBIOL LETT, V233, P65, DOI 10.1016/j.femsle.2004.01.048; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Koch S, 2004, EXPERT OPIN BIOL TH, V4, P1519, DOI 10.1517/14712598.4.9.1519; Koten B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006424; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Kristian SA, 2003, INFECT IMMUN, V71, P546, DOI 10.1128/IAI.71.1.546-549.2003; Le Jeune A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009658; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Patel D, 2011, INT J ANTIMICROB AG, V38, P442, DOI 10.1016/j.ijantimicag.2011.06.010; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Ruzin A, 2003, BBA-GEN SUBJECTS, V1621, P117, DOI 10.1016/S0304-4165(03)00028-X; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Sambrook J., 2001, MOL CLONING; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005	57	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38458	10.1371/journal.pone.0038458	http://dx.doi.org/10.1371/journal.pone.0038458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723861	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300028
J	Chue, CD; Wall, NA; Crabtree, NJ; Zehnder, D; Moody, WE; Edwards, NC; Steeds, RP; Townend, JN; Ferro, CJ				Chue, Colin D.; Wall, Nadezhda A.; Crabtree, Nicola J.; Zehnder, Daniel; Moody, William E.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.; Ferro, Charles J.			Aortic Calcification and Femoral Bone Density Are Independently Associated with Left Ventricular Mass in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; VASCULAR CALCIFICATION; CARDIOVASCULAR RISK; PROGNOSTIC-SIGNIFICANCE; COMPUTED-TOMOGRAPHY; MINERAL DENSITY; STIFFNESS; OSTEOPOROSIS	Background: Vascular calcification and reduced bone density are prevalent in chronic kidney disease and linked to increased cardiovascular risk. The mechanism is unknown. We assessed the relationship between vascular calcification, femoral bone density and left ventricular mass in patients with stage 3 non-diabetic chronic kidney disease in a cross-sectional observational study. Methodology and Principal Findings: A total of 120 patients were recruited (54% male, mean age 55 +/- 14 years, mean glomerular filtration rate 50 +/- 13 ml/min/1.73 m(2)). Abdominal aortic calcification was assessed using lateral lumbar spine radiography and was present in 48%. Mean femoral Z-score measured using dual energy x-ray absorptiometry was 0.60 +/- 1.06. Cardiovascular magnetic resonance imaging was used to determine left ventricular mass. One patient had left ventricular hypertrophy. Subjects with aortic calcification had higher left ventricular mass compared to those without (56 +/- 16 vs. 48 +/- 12 g/m(2), P=0.002), as did patients with femoral Z-scores below zero (56 +/- 15 vs. 49 +/- 13 g/m(2), P=0.01). In univariate analysis presence of aortic calcification correlated with left ventricular mass (r=0.32, P=0.001); mean femoral Z-score inversely correlated with left ventricular mass (r= -0.28, P=0.004). In a multivariate regression model that included presence of aortic calcification, mean femoral Z-score, gender and 24-hour systolic blood pressure, 46% of the variability in left ventricular mass was explained (P < 0.001). Conclusions: In patients with stage 3 non-diabetic chronic kidney disease, lower mean femoral Z-score and presence of aortic calcification are independently associated with increased left ventricular mass. Further research exploring the pathophysiology that underlies these relationships is warranted.	[Chue, Colin D.; Moody, William E.; Edwards, Nicola C.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Chue, Colin D.; Moody, William E.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.] Queen Elizabeth Hosp, Dept Cardiol, Birmingham B15 2TH, W Midlands, England; [Wall, Nadezhda A.] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Crabtree, Nicola J.] Birmingham Childrens Hosp, Dept Endocrinol, Birmingham, W Midlands, England; [Zehnder, Daniel] Univ Warwick, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Ferro, Charles J.] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Warwick; University of Birmingham	Chue, CD (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	charles.ferro@uhb.nhs.uk	Ferro, Charles J./O-8912-2016; ferro, charles/L-7250-2019	Ferro, Charles J./0000-0003-0577-7081; ferro, charles/0000-0003-0577-7081; Steeds, Richard/0000-0001-5687-2535	Genzyme Corporation; British Heart Foundation [PG/11/66/28982, FS/11/17/28700] Funding Source: researchfish; National Institute for Health Research [ACF-2010-09-008] Funding Source: researchfish	Genzyme Corporation(Sanofi-AventisGenzyme Corporation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by an unrestricted educational grant from Genzyme Corporation. Genzyme Corporation had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Adragao T, 2004, NEPHROL DIAL TRANSPL, V19, P1480, DOI 10.1093/ndt/gfh217; BANKS LM, 1994, EUR J CLIN INVEST, V24, P813, DOI 10.1111/j.1365-2362.1994.tb02024.x; Bellasi A, 2006, KIDNEY INT, V70, P1623, DOI 10.1038/sj.ki.5001820; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elder G, 2002, J BONE MINER RES, V17, P2094, DOI 10.1359/jbmr.2002.17.12.2094; Filgueira A, 2011, CLIN J AM SOC NEPHRO, V6, P1456, DOI 10.2215/CJN.10061110; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Gerber Y, 2011, CIRCULATION, V124, P297, DOI 10.1161/CIRCULATIONAHA.110.007195; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Haydar AA, 2004, KIDNEY INT, V65, P1790, DOI 10.1111/j.1523-1755.2004.00581.x; Inaba M, 2006, OSTEOPOROSIS INT, V17, P1506, DOI 10.1007/s00198-006-0154-6; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jankowska EA, 2009, EUR J HEART FAIL, V11, P28, DOI 10.1093/eurjhf/hfn004; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim Young-Hyo, 2010, Korean Circ J, V40, P573, DOI 10.4070/kcj.2010.40.11.573; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Moe SM, 2006, EUR J CLIN INVEST, V36, P51, DOI 10.1111/j.1365-2362.2006.01665.x; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Reinders A, 2006, BLOOD PRESS MONIT, V11, P293, DOI 10.1097/01.mbp.0000217998.96967.fb; Rix M, 1999, KIDNEY INT, V56, P1084, DOI 10.1046/j.1523-1755.1999.00617.x; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; SEEMAN E, 1989, NEW ENGL J MED, V320, P554, DOI 10.1056/NEJM198903023200903; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Sigrist M, 2006, NEPHROL DIAL TRANSPL, V21, P707, DOI 10.1093/ndt/gfi236; Taal MW, 2003, KIDNEY INT, V63, P1116, DOI 10.1046/j.1523-1755.2003.00837.x; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Toussain ND, 2008, NEPHROL DIAL TRANSPL, V23, P586, DOI 10.1093/ndt/gfm660; Turakhia MP, 2008, AM J CARDIOL, V102, P1131, DOI 10.1016/j.amjcard.2008.06.036; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Yildiz A, 2005, NEPHROL DIAL TRANSPL, V20, P760, DOI 10.1093/ndt/gfh611	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39241	10.1371/journal.pone.0039241	http://dx.doi.org/10.1371/journal.pone.0039241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723973	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300120
J	Manabe, YC; Hermans, SM; Lamorde, M; Castelnuovo, B; Mullins, CD; Kuznik, A				Manabe, Yukari C.; Hermans, Sabine M.; Lamorde, Mohammed; Castelnuovo, Barbara; Mullins, C. Daniel; Kuznik, Andreas			Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; 2 8-MONTH REGIMENS; RANDOMIZED-TRIAL; METAANALYSIS; OUTCOMES	Background: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid plus rifampicin for 4 months (4HR) instead of 6HE. We compared the impact of a continuation phase using 6HE or 4HR on total cost and expected mortality from the perspective of the Ugandan national health system. Methodology/Principal Findings: Treatment costs and outcomes were determined by decision analysis. Median daily drug price was US$0.115 for HR and US$0.069 for HE. TB treatment failure or relapse and mortality rates associated with 6HE vs. 4HR were obtained from randomized trials and systematic reviews for HIV-negative (46% of TB cases; failure/relapse -6HE: 10.4% vs. 4HR: 5.2%; mortality -6HE: 5.6% vs. 4HR: 3.5%) and HIV-positive patients (54% of TB cases; failure or relapse -6HE: 13.7% vs. 4HR: 12.4%; mortality -6HE: 16.6% vs. 4HR: 10.5%). When the initial treatment is not successful, retreatment involves an additional 8-month drug-regimen at a cost of $110.70. The model predicted a mortality rate of 13.3% for patients treated with 6HE and 8.8% for 4HR; average treatment cost per patient was predicted at $26.07 for 6HE and $23.64 for 4HR. These results were robust to the inclusion of MDR-TB as an additional outcome after treatment failure or relapse. Conclusions/Significance: Combination therapy with 4HR in the continuation phase dominates 6HE as it is associated with both lower expected costs and lower expected mortality. These data support the WHO recommendation to transition to a continuation phase comprising 4HR.	[Manabe, Yukari C.; Hermans, Sabine M.; Lamorde, Mohammed; Castelnuovo, Barbara] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Hermans, Sabine M.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Lamorde, Mohammed] Trinity Coll Dublin, Dept Pharmacol & Therapeut, Dublin, Ireland; [Mullins, C. Daniel] Univ Maryland, Baltimore, MD 21201 USA; [Kuznik, Andreas] Pfizer Inc, New York, NY USA	Makerere University; Johns Hopkins University; Johns Hopkins Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Trinity College Dublin; University System of Maryland; University of Maryland Baltimore; Pfizer	Manabe, YC (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	ymanabe@jhmi.edu	Kawooya, Ismael/O-4541-2016	Kawooya, Ismael/0000-0002-7159-7153; Kuznik, Andreas/0000-0002-8634-8360; Lamorde, Mohammed/0000-0003-2218-6822; Mullins, C. Daniel/0000-0003-4322-2490; Hermans, Sabine/0000-0001-5146-2932	IDI; National Institutes of Health [N01AI90500C, IR24TW008886-02, 1R25TW009340-01]; Infectious Diseases Network for Treatment and Research in Africa (INTERACT) programme; Netherlands Organization for Scientific Research - WOTRO Science for Global Development: NACCAP [W 07.05.20100]; European Union [SANTE/2006/105-316]; Sewankambo Scholarship Programme at the IDI; Gilead Foundation; FOGARTY INTERNATIONAL CENTER [R24TW008886, R25TW009340] Funding Source: NIH RePORTER	IDI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectious Diseases Network for Treatment and Research in Africa (INTERACT) programme; Netherlands Organization for Scientific Research - WOTRO Science for Global Development: NACCAP; European Union(European Commission); Sewankambo Scholarship Programme at the IDI; Gilead Foundation(Gilead Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by the IDI. The IDI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. YCM is receiving salary support from the National Institutes of Health (N01AI90500C, IR24TW008886-02, 1R25TW009340-01). SH receives monetary support from the Infectious Diseases Network for Treatment and Research in Africa (INTERACT) programme, financially supported by the Netherlands Organization for Scientific Research - WOTRO Science for Global Development: NACCAP [grant number W 07.05.20100] and the European Union [grant number SANTE/2006/105-316]. ML is supported by the Sewankambo Scholarship Programme at the IDI which is funded by Gilead Foundation.	[Anonymous], 2010, MOH UG CLIN GUID 201; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2008, GUID PROGR MAN DRUG; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Hermans SM, 2012, J ACQUIR IM IN PRESS; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Kuznik A, TROPICAL DOCTOR, V42, P5; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Management Sciences for Health (MSH), 2008, INT DRUG PRIC IND GU; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; MOH, 2009, NAT ANT TREATM GUID; MoH, 2010, MIN HLTH MAN NAT TUB; Nunn AJ, 2011, INT J TUBERC LUNG D, V15, P741, DOI 10.5588/ijtld.10.0392; NUNN P, 1991, LANCET, V337, P627; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; WHO, 1991, WHOTUB91161; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, WHO TUB COUNTR PROF; World Health Organization, 1994, WHOTB94179; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd	26	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39187	10.1371/journal.pone.0039187	http://dx.doi.org/10.1371/journal.pone.0039187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723960	gold, Green Published			2022-12-27	WOS:000305583300113
J	Sukseree, S; Mildner, M; Rossiter, H; Pammer, J; Zhang, CF; Watanapokasin, R; Tschachler, E; Eckhart, L				Sukseree, Supawadee; Mildner, Michael; Rossiter, Heidemarie; Pammer, Johannes; Zhang, Cheng-Feng; Watanapokasin, Ramida; Tschachler, Erwin; Eckhart, Leopold			Autophagy in the Thymic Epithelium Is Dispensable for the Development of Self-Tolerance in a Novel Mouse Model	PLOS ONE			English	Article							CELL; DIFFERENTIATION; MACROAUTOPHAGY; PROGENITOR; SELECTION; IMMUNITY; MICE	The thymic epithelium plays critical roles in the positive and negative selection of T cells. Recently, it was proposed that autophagy in thymic epithelial cells is essential for the induction of T cell tolerance to self antigens and thus for the prevention of autoimmune diseases. Here we have tested this hypothesis using mouse models in which autophagy was blocked specifically in epithelial cells expressing keratin 14 (K14), including the precursor of thymic epithelial cells. While the thymic epithelial cells of mice carrying the floxed Atg7 gene (ATG7 f/f) showed a high level of autophagy, as determined by LC3 Western blot analysis and fluorescence detection of the recombinant green fluorescent protein (GFP)-LC3 reporter protein on autophagosomes, autophagy in the thymic epithelium was efficiently suppressed by deletion of the Atg7 gene using the Cre-loxP system (ATG7 f/f K14-Cre). Suppression of autophagy led to the massive accumulation of p62/ sequestosome 1 (SQSTM1) in thymic epithelial cells. However, the structure of the thymic epithelium as well as the organization and the size of the thymus were not altered in mutant mice. The ratio of CD4 to CD8-positive T cells, as well as the frequency of activated (CD69+) CD4 T cells in lymphoid organs, did not differ between mice with autophagy-competent and autophagy-deficient thymic epithelium. Inflammatory infiltrating cells, potentially indicative of autoimmune reactions, were present in the liver, lung, and colon of a similar fraction of ATG7 f/f and ATG7 f/f K14-Cre mice. In contrast to previously reported mice, that had received an autophagy-deficient thymus transplant, ATG7 f/f K14-Cre mice did not suffer from autoimmunity-induced weight loss. In summary, the results of this study suggest that autophagy in the thymic epithelium is dispensable for negative selection of autoreactive T cells.	[Sukseree, Supawadee; Mildner, Michael; Rossiter, Heidemarie; Zhang, Cheng-Feng; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Dept Dermatol, Vienna, Austria; [Sukseree, Supawadee; Watanapokasin, Ramida] Srinakharinwirot Univ, Fac Med, Dept Biochem, Bangkok, Thailand; [Pammer, Johannes] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Zhang, Cheng-Feng] Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai 200433, Peoples R China	Medical University of Vienna; Srinakharinwirot University; Medical University of Vienna; Fudan University	Sukseree, S (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Dept Dermatol, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Sukseree, Supawadee/AAT-6545-2020	Sukseree, Supawadee/0000-0002-7011-9352; Eckhart, Leopold/0000-0002-5645-2036; Mildner, Michael/0000-0002-6892-925X; Tschachler, Erwin/0000-0002-0248-1798	European Cooperation in Science and Technology Action [BM0903]; Austrian South-East Asian University Partnership Network (ASEA-UNINET)	European Cooperation in Science and Technology Action; Austrian South-East Asian University Partnership Network (ASEA-UNINET)	The study was partly supported by the European Cooperation in Science and Technology Action BM0903 (Skin Barrier in Atopic Diseases, SkinBAD) (http://www.cost.eu/domains_actions/bmbs/Actions/BM0903) and Austrian South-East Asian University Partnership Network (ASEA-UNINET) (http://www.oead.at/index.php?id=420&L=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Crotzer VL, 2010, IMMUNOLOGY, V131, P9, DOI 10.1111/j.1365-2567.2010.03321.x; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Ichimura Y, 2011, EXP ANIM TOKYO, V60, P329, DOI 10.1538/expanim.60.329; Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087; Klein L, 2011, TRENDS IMMUNOL, V32, P188, DOI 10.1016/j.it.2011.03.002; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Maronpot R, 1999, PATHOLOGY MOUSE; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nedjic J, 2009, CURR OPIN IMMUNOL, V21, P92, DOI 10.1016/j.coi.2009.01.013; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Santambrogio L, 2011, AUTOPHAGY, V7, P652, DOI 10.4161/auto.7.6.15287; Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	24	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38933	10.1371/journal.pone.0038933	http://dx.doi.org/10.1371/journal.pone.0038933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719991	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300068
J	Tomalova, I; Iachia, C; Mulet, K; Castagnone-Sereno, P				Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe			The map-1 Gene Family in Root-Knot Nematodes, Meloidogyne spp.: A Set of Taxonomically Restricted Genes Specific to Clonal Species	PLOS ONE			English	Article							ACCELERATED EVOLUTION; MODULAR EVOLUTION; SEQUENCE; DOMAIN; PARASITISM; DIVERSITY; RDNA; IDENTIFICATION; DUPLICATION; COMPARTMENT	Taxonomically restricted genes (TRGs), i.e., genes that are restricted to a limited subset of phylogenetically related organisms, may be important in adaptation. In parasitic organisms, TRG-encoded proteins are possible determinants of the specificity of host-parasite interactions. In the root-knot nematode (RKN) Meloidogyne incognita, the map-1 gene family encodes expansin-like proteins that are secreted into plant tissues during parasitism, thought to act as effectors to promote successful root infection. MAP-1 proteins exhibit a modular architecture, with variable number and arrangement of 58 and 13-aa domains in their central part. Here, we address the evolutionary origins of this gene family using a combination of bioinformatics and molecular biology approaches. Map-1 genes were solely identified in one single member of the phylum Nematoda, i.e., the genus Meloidogyne, and not detected in any other nematode, thus indicating that the map-1 gene family is indeed a TRG family. A phylogenetic analysis of the distribution of map-1 genes in RKNs further showed that these genes are specifically present in species that reproduce by mitotic parthenogenesis, with the exception of M. floridensis, and could not be detected in RKNs reproducing by either meiotic parthenogenesis or amphimixis. These results highlight the divergence between mitotic and meiotic RKN species as a critical transition in the evolutionary history of these parasites. Analysis of the sequence conservation and organization of repeated domains in map-1 genes suggests that gene duplication(s) together with domain loss/duplication have contributed to the evolution of the map-1 family, and that some strong selection mechanism may be acting upon these genes to maintain their functional role(s) in the specificity of the plant-RKN interactions.	[Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe] French Natl Inst Agr Res INRA, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe] Univ Nice Sophia Antipolis, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe] CNRS, Inst Sophia Agrobiotech, Sophia Antipolis, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Tomalova, I (corresponding author), Masaryk Univ, Fac Sci, Dept Chem, CS-61137 Brno, Czech Republic.	philippe.castagnone@sophia.inra.fr	Benešová, Iva/AAM-9142-2021		INRA (Institut National de la Recherche Agronomique); EU grant from the ERASMUS Mobility Programme	INRA (Institut National de la Recherche Agronomique); EU grant from the ERASMUS Mobility Programme	Iva Tomalova was the recipient of and EU grant from the ERASMUS Mobility Programme. This work has been financially supported by INRA (Institut National de la Recherche Agronomique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Adam MAM, 2009, NEMATOLOGY, V11, P253, DOI 10.1163/156854109X429583; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2003, ADV PARASIT, V54, P101, DOI 10.1016/S0065-308X(03)54003-9; Blok VC, 2008, BIOESSAYS, V30, P249, DOI 10.1002/bies.20717; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Casewell NR, 2011, MOL BIOL EVOL, V28, P2637, DOI 10.1093/molbev/msr091; Castagnone-Sereno P, 2006, HEREDITY, V96, P282, DOI 10.1038/sj.hdy.6800794; Castagnone-Sereno P, 2009, MOL GENET GENOMICS, V282, P547, DOI 10.1007/s00438-009-0487-x; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; De Ley P, 2004, NEMATOL MONOGR PERSP, V2, P633; Denver DR, 2011, MOL PHYLOGENET EVOL, V61, P584, DOI 10.1016/j.ympev.2011.07.007; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fargette M, 2010, INFECT GENET EVOL, V10, P807, DOI 10.1016/j.meegid.2009.04.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hunt DJ, 2010, ROOT-KNOT NEMATODES, P55; Johnson BR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-164; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; Lunt DH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-194; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; Moens M, 2010, ROOT-KNOT NEMATODES, P1; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Podlaha O, 2006, MOL BIOL EVOL, V23, P1828, DOI 10.1093/molbev/msl066; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Randig O, 2002, GENOME, V45, P862, DOI [10.1139/g02-054, 10.1139/G02-054]; Rasteiro R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-140; Rosso MN, 2011, PLANT SIGNAL BEHAV, V6, P1232, DOI 10.4161/psb.6.8.16290; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Tigano M, 2010, PLANT PATHOL, V59, P1054, DOI 10.1111/j.1365-3059.2010.02350.x; Tigano MS, 2005, NEMATOLOGY, V7, P851, DOI 10.1163/156854105776186325; Triantaphyllou A.C., 1985, ADV TREATISE MELOIDO, VI, P113; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Wu YC, 2012, MOL BIOL EVOL, V29, P689, DOI 10.1093/molbev/msr222; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zijlstra C, 2000, NEMATOLOGY, V2, P847, DOI 10.1163/156854100750112798; Zijlstra C, 2000, EUR J PLANT PATHOL, V106, P283, DOI 10.1023/A:1008765303364	55	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38656	10.1371/journal.pone.0038656	http://dx.doi.org/10.1371/journal.pone.0038656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719916	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300039
J	Yang, F; He, JF; Zhong, HJ; Ke, CW; Zhang, X; Hong, T; Ni, HZ; Lin, JY				Yang, Fen; He, Jianfeng; Zhong, Haojie; Ke, Changwen; Zhang, Xin; Hong, Teng; Ni, Hanzhong; Lin, Jinyan			Temporal Trends of Influenza A (H1N1) Virus Seroprevalence following 2009 Pandemic Wave in Guangdong, China: Three Cross-Sectional Serology Surveys	PLOS ONE			English	Article							HEMAGGLUTINATION INHIBITION; ANTIBODY-RESPONSES	Background: To evaluate the temporal trends of seroprevalence to pH1N1 among the Guangdong population following 2009 H1N1 pandemic wave, we conducted three cross-sectional serology surveys in 2010. Methodology/Principal Findings: Three surveys were carried out consecutively in 2010 from January 8 to January 24, from March 15 to April 10 and from August 23 to September 4. Sample populations comprising of 4725, 4727, and 4721 subjects respectively were randomly selected for study in these three surveys. The level of antibodies against pH1N1 was evaluated by hemagglutination inhibition assay. In survey 1, the seroprevalence of pH1N1 among all the subjects is 25.1%, declining to 18.4% in survey 2 and increasing to 21.4% in survey 3. Among vaccinated subjects, the seroprevalence was 49.0%, 53.0%, and 49.4% in the three consecutive surveys, showing no significant differences. In contrast, among non-vaccinated subjects, the seroprevalence declined significantly from 22.8% (survey 1) to 14.3% (survey 2) and subsequently increased to 18.1% (survey 3). The multivariate logistic regression analysis revealed that seroprevalence to pH1N1 in non-vaccinated individuals correlated with the investigated order of the surveys, age, and region (all P<0.05). However, it was not correlated with gender (P = 0.650), seasonal influenza vaccination history (P = 0.402) and symptoms (P = 0.074). Conclusions/Significance: In Guangdong, the seroprevalance to pH1N1 decreased initially and then rebounded modestly during the first 9 months following the 2009 pandemic wave. Our results suggest that the prevalence of pH1N1 is still correlated with age and population density during the post-pandemic period. An early end to the free pH1N1 vaccination program might be another important reason for the slight rebound in seroprevalance. Our study findings can help the Guangdong authorities to make evidence-based decisions about a long-term vaccination strategy and boost immunity in specific population groups (such as children and people living in the capital-city) to prevent further transmission in the future.	[Yang, Fen; He, Jianfeng; Zhong, Haojie; Ke, Changwen; Zhang, Xin; Hong, Teng; Ni, Hanzhong; Lin, Jinyan] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Yang, F (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	hjf@vip.sina.com			Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province [A2010067]	Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province	This study was supported by the key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province Grant A2010067 (Research on patterns of transmission and intensity of epidemic of Pandemic Influenza H1N1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng AP, 2008, MED, V34, P14; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Grund S, 2011, J VIROL METHODS, V171, P369, DOI 10.1016/j.jviromet.2010.11.024; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jianfeng H, 2010, S CHINA J PREV MED, V36, P4; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lohr Sharon L., 2002, SAMPLING DESIGN ANAL, P12; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; ROSS T, 2010, PLOS CURR INFLUENZA; Sun YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014270; Wang M, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0016809; *WHO, 2010, FOC H1N1 NOW POSTP P; *WHO, 2010, DIR GEN STAT FOLL 7; World Health Organization, 2009, CURR WHO PHAS PAND; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899	25	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38768	10.1371/journal.pone.0038768	http://dx.doi.org/10.1371/journal.pone.0038768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719938	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300047
J	Liu, XY; Fang, H; Chen, HC; Jiang, XL; Fang, DR; Wang, Y; Zhu, DX				Liu, Xiaoyan; Fang, Hong; Chen, Hongchao; Jiang, Xiaoling; Fang, Deren; Wang, Yan; Zhu, Dingxian			An Artificial miRNA against HPSE Suppresses Melanoma Invasion Properties, Correlating with a Down-Regulation of Chemokines and MAPK Phosphorylation	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; HEPARAN-SULFATE PROTEOGLYCANS; ENDOTHELIAL GROWTH-FACTOR; RNA INTERFERENCE; TUMOR PROGRESSION; IN-VITRO; FACTOR EXPRESSION; MAMMALIAN-CELLS; GENE-EXPRESSION; TRANSGENIC MICE	Ribonucleic acid interference (RNAi) based on microRNA (miRNA) context may provide an efficient and safe therapeutic knockdown effect and can be driven by ribonucleic acid polymerase II (RNAP II). In this study, we designed and synthesized miR155-based artificial miRNAs against heparanase (HPSE) constructed with BLOCK-iT (TM) Pol II miR RNAi Expression Vector Kit. The expression levels of HPSE declined significantly in both the mRNA and protein levels in HPSE-miRNA transfected melanoma cells that exhibited reduction of adhesion, migration, and invasion ability in vitro and in vivo. We also observed that HPSE miRNA could inhibit the expressions of chemokines of interleukin-8 (IL8) and chemokine (C-X-C motif) ligand 1 (CXCL1), at both the transcriptional and translational levels. Further study on its probable mechanism declared that down-regulation of IL8 and CXCL1 by HPSE-miRNA may be correlated with reduced growth-factor simulated mitogen-activated kinase (MAPK) phosphorylation including p38 MAPK, c-Jun N-terminal kinase (JNK) and extracellular-signal-regulated kinase (ERK) 1 and 2, which could be rescued by miRNA incompatible mutated HPSE cDNA. In conclusion, we demonstrated that artificial miRNAs against HPSE might serve as an alterative mean of therapy to low HPSE expression and to block the adhesion, invasion, and metastasis of melanoma cells. Furthermore, miRNA-based RNAi was also a powerful tool for gene function study.	[Liu, Xiaoyan; Fang, Hong; Chen, Hongchao; Jiang, Xiaoling; Fang, Deren; Wang, Yan; Zhu, Dingxian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Liu, XY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China.	Fanghongzy@sina.com		Fang, Hong/0000-0002-5917-2283	National Natural Science Foundation of China [30771944]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Natural Science Foundation of China Grants (No. 30771944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Anderson Emily, 2008, V442, P45, DOI 10.1007/978-1-59745-191-8_4; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Casu B, 2010, MATRIX BIOL, V29, P442, DOI 10.1016/j.matbio.2010.04.003; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Fontijn D, 2009, CELL ONCOL, V31, P179, DOI 10.3233/CLO-2009-0477; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khasraw M, 2010, ANN ONCOL, V21, P1302, DOI 10.1093/annonc/mdp524; Koliopanos A, 2001, CANCER RES, V61, P4655; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kudchadkar R, 2008, EXPERT OPIN INV DRUG, V17, P1769, DOI 10.1517/13543784.17.11.1769 ; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Liu XY, 2008, INT J DERMATOL, V47, P448, DOI 10.1111/j.1365-4632.2008.03627.x; Liu YP, 2011, BBA-GENE REGUL MECH, V1809, P732, DOI 10.1016/j.bbagrm.2011.05.014; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Neuder LE, 2009, VET IMMUNOL IMMUNOP, V129, P192, DOI 10.1016/j.vetimm.2008.11.006; Ohtawa Y, 2006, HUM PATHOL, V37, P1145, DOI 10.1016/j.humpath.2006.04.005; Parish CR, 1999, CANCER RES, V59, P3433; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Rasmussen MK, 2008, INFLAMM RES, V57, P329, DOI 10.1007/s00011-007-7220-1; Regina S, 2009, CLIN CHEM, V55, P1834, DOI 10.1373/clinchem.2009.123695; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sato T, 2004, J SURG ONCOL, V87, P174, DOI 10.1002/jso.20097; Scherr M, 2007, CELL CYCLE, V6, P444, DOI 10.4161/cc.6.4.3807; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; Simizu S, 2003, CANCER LETT, V193, P83, DOI 10.1016/S0304-3835(02)00719-X; Singh S, 2009, BRIT J CANCER, V100, P1638, DOI 10.1038/sj.bjc.6605055; Singh S, 2009, CLIN CANCER RES, V15, P2380, DOI 10.1158/1078-0432.CCR-08-2387; Snyder LL, 2008, ANTIVIR RES, V80, P36, DOI 10.1016/j.antiviral.2008.04.001; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Tan FL, 2004, CELL RES, V14, P460, DOI 10.1038/sj.cr.7290248; Timar J, 2002, SEMIN CANCER BIOL, V12, P173, DOI 10.1016/S1044-579X(02)00021-4; Watanabe M, 2003, GYNECOL OBSTET INVES, V56, P77, DOI 10.1159/000072821; Wurm S, 2008, CYTOKINE, V44, P185, DOI 10.1016/j.cyto.2008.08.003; Yuan J, 2006, MOL BIOL REP, V33, P43, DOI 10.1007/s11033-005-3965-1; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhang YL, 2007, BIOCHEM BIOPH RES CO, V358, P124, DOI 10.1016/j.bbrc.2007.04.068; Zhao F, 2009, CLIN CANCER RES, V15, P4382, DOI 10.1158/1078-0432.CCR-09-0399; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	58	44	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38659	10.1371/journal.pone.0038659	http://dx.doi.org/10.1371/journal.pone.0038659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719918	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000020
J	Kawaguchi, T; Sumida, Y; Umemura, A; Matsuo, K; Takahashi, M; Takamura, T; Yasui, K; Saibara, T; Hashimoto, E; Kawanaka, M; Watanabe, S; Kawata, S; Imai, Y; Kokubo, M; Shima, T; Park, H; Tanaka, H; Tajima, K; Yamada, R; Matsuda, F; Okanoue, T				Kawaguchi, Takahisa; Sumida, Yoshio; Umemura, Atsushi; Matsuo, Keitaro; Takahashi, Meiko; Takamura, Toshinari; Yasui, Kohichiroh; Saibara, Toshiji; Hashimoto, Etsuko; Kawanaka, Miwa; Watanabe, Sumio; Kawata, Sumio; Imai, Yasuharu; Kokubo, Miki; Shima, Toshihide; Park, Hyohun; Tanaka, Hideo; Tajima, Kazuo; Yamada, Ryo; Matsuda, Fumihiko; Okanoue, Takeshi		JSG-NAFLD	Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese	PLOS ONE			English	Article							STEATOHEPATITIS; SUSCEPTIBILITY; VARIANT; I148M	Background: Nonalcoholic fatty liver disease (NAFLD) includes a broad range of liver pathologies from simple steatosis to cirrhosis and fibrosis, in which a subtype accompanying hepatocyte degeneration and fibrosis is classified as nonalcoholic steatohepatitis (NASH). NASH accounts for approximately 10-30% of NAFLD and causes a higher frequency of liver-related death, and its progression of NASH has been considered to be complex involving multiple genetic factors interacting with the environment and lifestyle. Principal Findings: To identify genetic factors related to NAFLD in the Japanese, we performed a genome-wide association study recruiting 529 histologically diagnosed NAFLD patients and 932 population controls. A significant association was observed for a cluster of SNPs in PNPLA3 on chromosome 22q13 with the strongest p-value of 1.4x10(-10) (OR = 1.66, 95%CI: 1.43-1.94) for rs738409. Rs738409 also showed the strongest association (p = 3.6x10(-6)) with the histological classifications proposed by Matteoni and colleagues based on the degree of inflammation, ballooning degeneration, fibrosis and Mallory-Denk body. In addition, there were marked differences in rs738409 genotype distributions between type4 subgroup corresponding to NASH and the other three subgroups (p = 4.8x10(-6), OR = 1.96, 95%CI: 1.47-2.62). Moreover, a subgroup analysis of NAFLD patients against controls showed a significant association of rs738409 with type4 (p = 1.7x10(-16), OR = 2.18, 95%CI: 1.81-2.63) whereas no association was obtained for type1 to type3 (p = 0.41). Rs738409 also showed strong associations with three clinical traits related to the prognosis of NAFLD, namely, levels of hyaluronic acid (p = 4.6x10(-4)), HbA1c (p = 0.0011) and iron deposition in the liver (p = 5.6x10(-4)). Conclusions: With these results we clearly demonstrated that Matteoni type4 NAFLD is both a genetically and clinically different subset from the other spectrums of the disease and that the PNPLA3 gene is strongly associated with the progression of NASH in Japanese population.	[Kawaguchi, Takahisa; Takahashi, Meiko; Kokubo, Miki; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Kawaguchi, Takahisa; Watanabe, Sumio; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, U852, Kyoto, Japan; [Sumida, Yoshio] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan; [Umemura, Atsushi; Shima, Toshihide; Park, Hyohun; Okanoue, Takeshi] Saiseikai Suita Hosp, Ctr Gastroenterol & Hepatol, Suita, Osaka, Japan; [Matsuo, Keitaro; Tanaka, Hideo; Tajima, Kazuo] Aichi Canc Ctr, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Yasui, Kohichiroh] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan; [Shima, Toshihide] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Hashimoto, Etsuko] Tokyo Womens Med Univ, Dept Internal Med & Gastroenterol, Tokyo, Japan; [Kawanaka, Miwa] Kawasaki Med Sch, Kawasaki Hosp, Ctr Liver Dis, Okayama, Japan; [Kawata, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan; [Kawata, Sumio] Yamagata Univ, Sch Med, Dept Gastroenterol, Yamagata 99023, Japan; [Imai, Yasuharu] Ikeda Municipal Hosp, Dept Internal Med, Ikeda, Osaka, Japan	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Aichi Cancer Center; Kanazawa University; Kyoto Prefectural University of Medicine; Kochi University; Tokyo Women's Medical University; Kawasaki Medical School; Juntendo University; Yamagata University	Kawaguchi, T (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	fumi@genome.med.kyoto-u.ac.jp	Shima, Toshihide/AAW-9215-2020; Sumida, Yoshio/AAL-6723-2020; Matsuo, Keitaro/H-6758-2019	Shima, Toshihide/0000-0002-4120-9121; Matsuo, Keitaro/0000-0003-1761-6314; Takahashi, Meiko/0000-0002-8344-5472; Umemura, Atsushi/0000-0002-7433-8501; Yamada, Ryo/0000-0002-1587-630X	Ministry of Labor and Welfare Japan, Core Research of Evolutional Science & Technology (CREST) [H20-Hepatitis-general-008]; Grants-in-Aid for Scientific Research [23591301] Funding Source: KAKEN	Ministry of Labor and Welfare Japan, Core Research of Evolutional Science & Technology (CREST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grant from Ministry of Labor and Welfare Japan [T.O., H20-Hepatitis-general-008], Core Research of Evolutional Science & Technology (CREST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Okanoue Takeshi, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P1161; Okanoue T, 2011, J GASTROEN HEPATOL, V26, P153, DOI 10.1111/j.1440-1746.2010.06547.x; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Suzuki T, 2008, CANCER EPIDEM BIOMAR, V17, P2742, DOI 10.1158/1055-9965.EPI-08-0470; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; UENO T, 1993, GASTROENTEROLOGY, V105, P475, DOI 10.1016/0016-5085(93)90722-O; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yamada R, 2009, GENET EPIDEMIOL, V33, P114, DOI 10.1002/gepi.20362; Yasui K, 2011, CLIN GASTROENTEROL H, V9, P428, DOI 10.1016/j.cgh.2011.01.023	26	191	195	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38322	10.1371/journal.pone.0038322	http://dx.doi.org/10.1371/journal.pone.0038322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719876	gold, Green Submitted, Green Published			2022-12-27	WOS:000305347800005
J	Malik, A; Singhal, DK; Albanyan, A; Husain, SA; Kar, P				Malik, Abdul; Singhal, Deepak Kumar; Albanyan, Abdulmajeed; Husain, Syed Akhtar; Kar, P.			Hepatitis B Virus Gene Mutations in Liver Diseases: A Report from New Delhi	PLOS ONE			English	Article							CORE PROMOTER MUTATIONS; HEPATOCELLULAR-CARCINOMA; E-ANTIGEN; HBV GENOTYPES; CLINICAL-SIGNIFICANCE; PRECORE MUTATIONS; RISK; REGIONS; INCREASE; RESISTANCE	Objectives: The study was designed to characterize the surface, core promoter, precore/core region sequences for the presence of mutations in hepatitis B virus (HBV) associated with different liver diseases. Methods: 567 HBV associated patients with different liver diseases were enrolled in this study. All samples were analyzed for HBV surface, core promoter, precore/core region mutations and genotypes using PCR and direct sequencing. Results: HBV genotype D (72.8%) was the predominant type followed by genotype A (27.2%). The serum viral load of HBV was highest in HBsAg carriers group and lowest in patients with hepatocellular carcinoma. 17.9% patients with cirrhosis and 24.6% hepatocellular carcinoma cases were ADV-resistant with rtA181T/V mutations in the S-gene. A1896T was found more frequently in fulminant hepatic failure compared to acute viral hepatitis patients (p = 0.038). T1753V mutation was significantly higher in patients with cirrhosis of liver (34.6%) than in chronic hepatitis (18.9%) and hepatocellular carcinoma patients (21.2%; p = 0.001). T1762/A1764 mutation was observed in all the groups. C1914G core gene mutation was associated with the hepatocellular carcinoma (32.2%) compared to other groups. HBV genotype D predominated in comparison to genotype A. An increased frequency of precore mutation and BCP double mutations amongst the population studied was also observed. Conclusion: Mutations such as T1762/A1764, T1753V and C1914G were usually associated with advanced forms of liver disease and had an increased risk of HCC. The nucleotide variability in the basal core promoter and precore regions possibly plays a role in the progression of HBV disease. Prospective studies on the sequence variations of the preC/C region of the HBV genome and the molecular mechanisms in relation to progression of liver disease would aid in better understanding of the biological significance of HBV strains in India.	[Malik, Abdul; Albanyan, Abdulmajeed] King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Malik, Abdul; Singhal, Deepak Kumar; Kar, P.] Univ Delhi, Maulana Azad Med Coll, Dept Med, New Delhi, India; [Malik, Abdul; Husain, Syed Akhtar] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	King Saud University; Maulana Azad Medical College; University of Delhi; Jamia Millia Islamia	Malik, A (corresponding author), King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia.	abdul.ksu@gmail.com	Malik Moinuddin, Abdul/GQP-0935-2022	, Abdul Malik/0000-0001-9370-8224; husain, syed akhtar/0000-0002-6513-7759				Abbas Z, 2006, BMC GASTROENTEROL, P6; Aggarwal R, 2003, J HEPATOL, V38, P215, DOI 10.1016/S0168-8278(02)00382-3; AKAHANE Y, 1990, GASTROENTEROLOGY, V99, P1113, DOI 10.1016/0016-5085(90)90632-B; AKARCA US, 1994, HEPATOLOGY, V19, P1366; Angus P, 2003, GASTROENTEROLOGY, V125, P292, DOI 10.1016/S0016-5085(03)00939-9; Bartholomeusz A, 2006, J MED VIROL, V78, pS52, DOI 10.1002/jmv.20608; Bruix J, 2001, J EASL PANEL EXPERTS; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Chan HLY, 2000, HEPATOLOGY, V31, P763, DOI 10.1002/hep.510310330; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chen CH, 2006, J HEPATOL, V44, P76, DOI 10.1016/j.jhep.2005.08.022; Chen CH, 2005, J CLIN MICROBIOL, V43, P6000, DOI 10.1128/JCM.43.12.6000-6006.2005; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Chen CH, 2007, LIVER INT, V27, P806, DOI 10.1111/j.1478-3231.2007.01505.x; Du H, 2007, LIVER INT, V27, P240, DOI 10.1111/j.1478-3231.2006.01400.x; Fang ZL, 2008, AM J GASTROENTEROL, V103, P2254, DOI 10.1111/j.1572-0241.2008.01974.x; Gandhe SS, 2003, J VIRAL HEPATITIS, V10, P367, DOI 10.1046/j.1365-2893.2003.00445.x; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Irshad M, 2006, WORLD J GASTROENTERO, V12, P2432, DOI 10.3748/wjg.v12.i15.2432; Jain R C, 1992, J Assoc Physicians India, V40, P390; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Kao JH, 2002, J CLIN MICROBIOL, V40, P1207, DOI 10.1128/JCM.40.4.1207-1209.2002; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Kidd-Ljunggren K, 2004, J CLIN MICROBIOL, V42, P5837, DOI 10.1128/JCM.42.12.5837-5841.2004; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; LIANG TJ, 1991, NEW ENGL J MED, V324, P1705, DOI 10.1056/NEJM199106133242405; Lin CL, 2007, J GASTROEN HEPATOL, V22, P1098, DOI 10.1111/j.1440-1746.2006.04515.x; Mital V N, 1980, J Indian Med Assoc, V74, P105; OKAMOTO H, 1990, J VIROL, V64, P1298, DOI 10.1128/JVI.64.3.1298-1303.1990; Olinger CM, 2007, MED MICROBIOL IMMUN, V196, P247, DOI 10.1007/s00430-007-0050-5; Rezende REF, 2005, J CLIN VIROL, V32, P53, DOI 10.1016/j.jcv.2004.08.001; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Takahashi K, 1999, ARCH VIROL, V144, P1299, DOI 10.1007/s007050050588; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Tatti KM, 2002, ANTIVIR RES, V55, P141, DOI 10.1016/S0166-3542(02)00019-0; Tian YJ, 2007, J CLIN MICROBIOL, V45, P2971, DOI 10.1128/JCM.00508-07; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Trey C, 1970, Prog Liver Dis, V3, P282; Tsai WL, 2008, SCAND J GASTROENTERO, V43, P196, DOI 10.1080/00365520701745693; Tyagarajan SP, 1996, HEPATITIS B INDIA PR, P5; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; Xiao L, 2011, J MED VIROL, V83, P1544, DOI 10.1002/jmv.22159; Xu ZH, 2011, J GASTROENTEROL, V46, P391, DOI 10.1007/s00535-010-0315-4; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859	47	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39028	10.1371/journal.pone.0039028	http://dx.doi.org/10.1371/journal.pone.0039028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720023	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347800039
J	Raudies, F; Mingolla, E; Neumann, H				Raudies, Florian; Mingolla, Ennio; Neumann, Heiko			Active Gaze Control Improves Optic Flow-Based Segmentation and Steering	PLOS ONE			English	Article							SELF-MOTION; OBSTACLE AVOIDANCE; 3-DIMENSIONAL MOTION; MST NEURONS; PERCEPTION; STATISTICS; MODEL; MECHANISMS; FIXATION; PATTERNS	An observer traversing an environment actively relocates gaze to fixate objects. Evidence suggests that gaze is frequently directed toward the center of an object considered as target but more likely toward the edges of an object that appears as an obstacle. We suggest that this difference in gaze might be motivated by specific patterns of optic flow that are generated by either fixating the center or edge of an object. To support our suggestion we derive an analytical model that shows: Tangentially fixating the outer surface of an obstacle leads to strong flow discontinuities that can be used for flow-based segmentation. Fixation of the target center while gaze and heading are locked without head-, body-, or eye-rotations gives rise to a symmetric expansion flow with its center at the point being approached, which facilitates steering toward a target. We conclude that gaze control incorporates ecological constraints to improve the robustness of steering and collision avoidance by actively generating flows appropriate to solve the task.	[Raudies, Florian; Mingolla, Ennio; Neumann, Heiko] Boston Univ, CELEST, Boston, MA 02215 USA; [Raudies, Florian; Mingolla, Ennio] Boston Univ, Ctr Computat Neurosci & Neural Technol CompNet, Boston, MA 02215 USA; [Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, Ulm, Germany	Boston University; Boston University; Ulm University	Raudies, F (corresponding author), Boston Univ, CELEST, Boston, MA 02215 USA.	fraudies@bu.edu		Mingolla, Ennio/0000-0003-2623-3438	CELEST, a National Science Foundation Science of Learning Center [NSF OMA-0835976]; Office of Naval Research [ONR N00014-11-1-0535]; Transregional Collaborative Research Centre [SFB/TRR 62]; German Research Foundation (DFG)	CELEST, a National Science Foundation Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office of Naval Research(Office of Naval Research); Transregional Collaborative Research Centre; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by CELEST, a National Science Foundation Science of Learning Center (NSF OMA-0835976), Office of Naval Research (ONR N00014-11-1-0535), and Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems" funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIV G, 1985, IEEE T PATTERN ANAL, V7, P384, DOI 10.1109/TPAMI.1985.4767678; ALOIMONOS J, 1987, INT J COMPUT VISION, V1, P333; BAJCSY R, 1988, P IEEE, V76, P996, DOI 10.1109/5.5968; Baker S, 2011, INT J COMPUT VISION, V92, P1, DOI 10.1007/s11263-010-0390-2; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Black MJ, 2012, FLOWER GARDEN VIDEO; BLOOMBERG JJ, 1992, ANN NY ACAD SCI, V656, P699; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Calow D, 2007, NETWORK-COMP NEURAL, V18, P343, DOI 10.1080/09548980701642277; Cavalleri P, 2003, VISION RES, V43, P1473, DOI 10.1016/S0042-6989(03)00139-1; Dakin SC, 2005, J VISION, V5, P878, DOI 10.1167/5.10.9; Daniilidis K, 1997, COMPUT VIS IMAGE UND, V68, P158, DOI 10.1006/cviu.1997.0535; Domke J, 2007, LECT NOTES COMPUT SC, V4358, P232; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Elder DM, 2009, J EXP PSYCHOL HUMAN, V35, P1501, DOI 10.1037/a0016459; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; FERMULLER C, 1995, INT J COMPUT VISION, V15, P7, DOI 10.1007/BF01450848; FERMULLER C, 1993, INT J COMPUT VISION, V11, P165, DOI 10.1007/BF01469227; Fermuller C, 2001, COMPUT VIS IMAGE UND, V82, P1, DOI 10.1006/cviu.2000.0900; FERMULLER C, 1995, SCIENCE, V270, P1973, DOI 10.1126/science.270.5244.1973; field, 2021, OIL GAS STUDIES, P25, DOI [DOI 10.1007/978-3-540-24673-2, 10.31660/0445-0108-2021-3-25-36, DOI 10.31660/0445-0108-2021-3-25-36]; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1950, PERCEPTION VISUAL WO; Goldstein H., 2001, CLASSICAL MECH; GORDON DA, 1965, J OPT SOC AM, V55, P1296, DOI 10.1364/JOSA.55.001296; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; HORN BKP, 1988, INT J COMPUT VISION, V2, P51, DOI 10.1007/BF00836281; HORN BKP, 1987, INT J COMPUT VISION, V1, P259, DOI 10.1007/BF00127824; KOENDERINK JJ, 1976, BIOL CYBERN, V24, P51, DOI 10.1007/BF00365595; KOENDERINK JJ, 1976, J OPT SOC AM, V66, P717, DOI 10.1364/JOSA.66.000717; Koenderink JJ, 1985, P NATO ADV STUD I BR, P31; Kohlberger T, 2003, LECT NOTES COMPUT SC, V2695, P432; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; LAPPE M, 1993, NEURAL COMPUT, V5, P374, DOI 10.1162/neco.1993.5.3.374; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; MacLean W. J., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P753, DOI 10.1109/ICCV.1999.790297; McCarthy C, 2012, IEEE T PATTERN ANAL, V34, P1024, DOI 10.1109/TPAMI.2012.27; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; NELSON RC, 1989, IEEE T PATTERN ANAL, V11, P1102, DOI 10.1109/34.42840; Nestares O, 2000, PROC CVPR IEEE, P523, DOI 10.1109/CVPR.2000.855864; Otte M., 1994, Computer Vision - ECCV'94. Third European Conference on Computer Vision. Proceedings. Vol.I, P51; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; PERRONE JA, 1992, J OPT SOC AM A, V9, P177, DOI 10.1364/JOSAA.9.000177; Persistence of Vision Pty. Ltd, 2004, PERS VIS TM RAYTR; Raudies F, 2009, FRONTIERS SYSTEMS NE; RIEGER JH, 1985, J OPT SOC AM A, V2, P354, DOI 10.1364/JOSAA.2.000354; Roth S, 2007, INT J COMPUT VISION, V74, P33, DOI 10.1007/s11263-006-0016-x; Rothkopf CA, 2009, VISUAL NEUROSCI, V26, P81, DOI 10.1017/S0952523808080978; Royden CS, 1997, J OPT SOC AM A, V14, P2128, DOI 10.1364/JOSAA.14.002128; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; SCHWARTZ EL, 1980, VISION RES, V20, P645, DOI 10.1016/0042-6989(80)90090-5; SCHWARTZ EL, 1977, BIOL CYBERN, V25, P181, DOI 10.1007/BF01885636; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; von Helmholtz H., 1925, TREATISE PHYSL OPTIC, V3; WAGNER R, 2004, THESIS BOSTON U; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WAXMAN AM, 1986, IEEE T PATTERN ANAL, V8, P715, DOI 10.1109/TPAMI.1986.4767853; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662	64	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38446	10.1371/journal.pone.0038446	http://dx.doi.org/10.1371/journal.pone.0038446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22719889	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800007
J	Bauwens, M; De Saint-Hubert, M; Cleynhens, J; Brams, L; Devos, E; Mottaghy, FM; Verbruggen, A				Bauwens, Matthias; De Saint-Hubert, Marijke; Cleynhens, Jan; Brams, Laura; Devos, Ellen; Mottaghy, Felix M.; Verbruggen, Alfons			Radioiodinated Phenylalkyl Malonic Acid Derivatives as pH-Sensitive SPECT Tracers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; EXTRACELLULAR PH; CANCER-CELLS; TUMOR PH; APOPTOSIS; THERAPY; DEATH; MICE	Introduction: In vivo pH imaging has been a field of interest for molecular imaging for many years. This is especially important for determining tumor acidity, an important driving force of tumor invasion and metastasis formation, but also in the process of apoptosis. Methods: 2-(4-[I-123] iodophenethyl)-2-methylmalonic acid (IPMM), 2-(4-[I-123] iodophenethyl)-malonic acid (IPM), 2-(4-[I-123] iodobenzyl)-malonic acid (IBMM) and 4-[I-123] iodophthalic acid (IP) were radiolabeled via the Cu+ isotopic nucleophilic exchange method. All tracers were tested in vitro in buffer systems to assess pH driven cell uptake. In vivo biodistribution of [I-123] IPMM and [I-123] IPM was determined in healthy mice and the pH targeting efficacy in vivo of [I-123] IPM was evaluated in an anti-Fas monoclonal antibody (mAb) apoptosis model. In addition a mouse RIF-1 tumor model was explored in which tumor pH was decreased from 7.0 to 6.5 by means of induction of hyperglycemia in combination with administration of meta-iodobenzylguanidine. Results: Radiosynthesis resulted in 15-20% for iodo-bromo exchange and 50-60% yield for iodo-iodo exchange while in vitro experiments showed a pH-sensitive uptake for all tracers. Shelf-life stability and in vivo stability was excellent for all tracers. [I-123] IPMM and [I-123] IPM showed a moderately fast predominantly biliary clearance while a high retention was observed in blood. The biodistribution profile of [I-123] IPM was found to be most favorable in view of pH-specific imaging. [I-123] IPM showed a clear pH-related uptake pattern in the RIF-1 tumor model. Conclusion: Iodine-123 labeled malonic acid derivates such as [I-123] IPM show a clearly pH dependent uptake in tumor cells both in vitro and in vivo which allows to visualize regional acidosis. However, these compounds are not suitable for detection of apoptosis due to a poor acidosis effect.	[Bauwens, Matthias; Cleynhens, Jan; Brams, Laura; Verbruggen, Alfons] Katholieke Univ Leuven, Lab Radiopharm, Fac Pharmaceut Sci, Louvain, Belgium; [De Saint-Hubert, Marijke; Devos, Ellen; Mottaghy, Felix M.] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium; [Mottaghy, Felix M.] Rhein Westfal TH Aachen, D-52062 Aachen, Germany; [Mottaghy, Felix M.] MUMC, Maastricht, Netherlands	KU Leuven; KU Leuven; University Hospital Leuven; RWTH Aachen University; Maastricht University	Bauwens, M (corresponding author), Katholieke Univ Leuven, Lab Radiopharm, Fac Pharmaceut Sci, Louvain, Belgium.	Matthias.bauwens@mumc.nl	Mottaghy, Felix/AAU-2673-2020	Mottaghy, Felix/0000-0002-7212-6521; De Saint-Hubert, Marijke/0000-0003-2374-3280	European Union [Euregional PACT II]; Interreg IV programof Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20)	European Union(European Commission); Interreg IV programof Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20)	This work was financially supported by the European Union through the grant Euregional PACT II by the Interreg IV programof Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloya R, 2006, APOPTOSIS, V11, P2089, DOI 10.1007/s10495-006-0282-7; Bauwens M, 2006, NUCL MED BIOL, V33, P735, DOI 10.1016/j.nucmedbio.2006.05.004; Bauwens M, 2011, NUCL MED BIOL, V38, P381, DOI 10.1016/j.nucmedbio.2010.09.008; Bhujwalla ZM, 1998, BRIT J CANCER, V78, P606, DOI 10.1038/bjc.1998.548; Bhujwalla ZM, 2002, NMR BIOMED, V15, P114, DOI 10.1002/nbm.743; Blanckaert P, 2005, APPL RADIAT ISOTOPES, V62, P737, DOI 10.1016/j.apradiso.2004.10.008; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Cohen A, 2009, CELL RES, V19, P625, DOI 10.1038/cr.2009.17; Gallagher FA, 2008, NAT MED, V43, P940; Garcia-Martin ML, 2006, MAGN RESON MED, V55, P309, DOI 10.1002/mrm.20773; Garcia-Martin ML, 2001, CANCER RES, V61, P6524; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Grunwald F, 2010, SEMIN NUCL MED, V40, P153, DOI 10.1053/j.semnuclmed.2009.11.004; Hill R P, 2001, Novartis Found Symp, V240, P154; HOOLEY JLW, 1984, RADIOTHER ONCOL, V2, P343; JAHDE E, 1992, CANCER RES, V52, P6209; Kersemans V, 2006, EUR J NUCL MED MOL I, V33, P919, DOI 10.1007/s00259-005-0043-9; KLINE RC, 1981, J NUCL MED, V22, P129; McCarthy JR, 2010, MOL ONCOL, V4, P511, DOI 10.1016/j.molonc.2010.08.003; MERTENS J, 1987, EUR J NUCL MED, V13, P380, DOI 10.1007/BF00253000; Nishimura Y, 1997, INT IMMUNOL, V9, P307, DOI 10.1093/intimm/9.2.307; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Raghunand N, 2001, NEOPLASIA, V3, P227, DOI 10.1038/sj.neo.7900151; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; ROTTENBERG DA, 1985, ANN NEUROL, V17, P70, DOI 10.1002/ana.410170116; Rottenberg DA, 1984, ANN NEUROL S, V15, P98; SYROTA A, 1985, J CEREBR BLOOD F MET, V5, P358, DOI 10.1038/jcbfm.1985.50; Vavere AL, 2009, CANCER RES, V69, P4510, DOI 10.1158/0008-5472.CAN-08-3781; VAUPEL P, 1989, CANCER RES, V49, P6449; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waybright SM, 2001, J AM CHEM SOC, V123, P1828, DOI 10.1021/ja000950k; Zhang X, 2010, J NUCL MED, V51, P4	33	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38428	10.1371/journal.pone.0038428	http://dx.doi.org/10.1371/journal.pone.0038428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719886	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900027
J	Makin, ADJ; Poliakoff, E; Ackerley, R; El-Deredy, W				Makin, Alexis D. J.; Poliakoff, Ellen; Ackerley, Rochelle; El-Deredy, Wael			Covert Tracking: A Combined ERP and Fixational Eye Movement Study	PLOS ONE			English	Article							SMOOTH-PURSUIT; SPATIAL ATTENTION; TARGET BLANKING; EXTRAPOLATION; MICROSACCADES; MODULATION; ACTIVATION; MECHANISMS; OBJECTS; CORTEX	Attention can be directed to particular spatial locations, or to objects that appear at anticipated points in time. While most work has focused on spatial or temporal attention in isolation, we investigated covert tracking of smoothly moving objects, which requires continuous coordination of both. We tested two propositions about the neural and cognitive basis of this operation: first that covert tracking is a right hemisphere function, and second that pre-motor components of the oculomotor system are responsible for driving covert spatial attention during tracking. We simultaneously recorded event related potentials (ERPs) and eye position while participants covertly tracked dots that moved leftward or rightward at 12 or 20 degrees/s. ERPs were sensitive to the direction of target motion. Topographic development in the leftward motion was a mirror image of the rightward motion, suggesting that both hemispheres contribute equally to covert tracking. Small shifts in eye position were also lateralized according to the direction of target motion, implying covert activation of the oculomotor system. The data addresses two outstanding questions about the nature of visuospatial tracking. First, covert tracking is reliant upon a symmetrical frontoparietal attentional system, rather than being right lateralized. Second, this same system controls both pursuit eye movements and covert tracking.	[Makin, Alexis D. J.; Poliakoff, Ellen; El-Deredy, Wael] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Makin, Alexis D. J.] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England; [Ackerley, Rochelle] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Ackerley, Rochelle] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	University of Manchester; University of Liverpool; University of Manchester; University of Gothenburg	Makin, ADJ (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	Ellen.Poliakoff@manchester.ac.uk	El-deredy, Wael/H-6521-2015; Ackerley, Rochelle/Q-5719-2017; Poliakoff, Ellen/N-9910-2015; Makin, Alexis/I-9828-2019	El-deredy, Wael/0000-0002-9822-1092; Ackerley, Rochelle/0000-0003-4621-7929; Poliakoff, Ellen/0000-0003-4975-7787; Makin, Alexis/0000-0002-4490-7400	The Economic and Social Sciences Research Council (ESRC); Medical Research Council (MRC)	The Economic and Social Sciences Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Economic and Social Sciences Research Council (ESRC) sponsored Dr. Makin, while the Medical Research Council (MRC) sponsored Dr. Ackerley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Benguigui N, 2004, NEUROSCI LETT, V369, P197, DOI 10.1016/j.neulet.2004.07.051; Bennett SJ, 2006, EXP BRAIN RES, V168, P313, DOI 10.1007/s00221-005-0101-3; Bhattacharya J, 2001, NEUROSCI LETT, V311, P29, DOI 10.1016/S0304-3940(01)02133-4; Bongers RM, 2008, J EXP PSYCHOL HUMAN, V34, P1515, DOI 10.1037/a0011974; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; de'Sperati C, 2006, VISION RES, V46, P2593, DOI 10.1016/j.visres.2005.12.019; DeLucia PR, 1998, J EXP PSYCHOL HUMAN, V24, P901, DOI 10.1037/0096-1523.24.3.901; Dimigen O, 2009, J NEUROSCI, V29, P12321, DOI 10.1523/JNEUROSCI.0911-09.2009; Ding JH, 2009, HUM BRAIN MAPP, V30, P3541, DOI 10.1002/hbm.20777; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Eimer M, 2001, NEUROSCI BIOBEHAV R, V25, P497, DOI 10.1016/S0149-7634(01)00029-X; Eimer M, 2007, BRAIN RES, V1135, P154, DOI 10.1016/j.brainres.2006.12.007; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; Heilman K. M., 2002, COGNITIVE NEURAL BAS, P3; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Horswill MS, 2005, OPTOMETRY VISION SCI, V82, P740, DOI 10.1097/01.opx.0000175563.21423.50; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kerzel D, 2002, VISION RES, V42, P159, DOI 10.1016/S0042-6989(01)00274-7; Kimmig H, 2008, NEUROPSYCHOLOGIA, V46, P2203, DOI 10.1016/j.neuropsychologia.2008.02.021; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Lencer R, 2004, EUR J NEUROSCI, V19, P1430, DOI 10.1111/j.1460-9568.2004.03229.x; Lovejoy LP, 2009, VISION RES, V49, P1275, DOI 10.1016/j.visres.2009.01.011; Luck S.J., 2005, INTRO EVENT RELATED; LYON DR, 1995, ACTA PSYCHOL, V89, P239, DOI 10.1016/0001-6918(95)98945-Z; Makin ADJ, 2008, VISION RES, V48, P1884, DOI 10.1016/j.visres.2008.05.023; Makin ADJ, 2011, Q J EXP PSYCHOL, V64, P1327, DOI 10.1080/17470218.2010.548562; Makin ADJ, 2009, NEUROPSYCHOLOGIA, V47, P1128, DOI 10.1016/j.neuropsychologia.2009.01.010; Makin ADJ, 2009, EXP BRAIN RES, V193, P137, DOI 10.1007/s00221-008-1678-0; Martinez-Conde S, 2008, J VISION, V8, DOI [10.1167/8.14.28, 10.1167/8.14.i]; Mesulam M. M., 2002, COGNITIVE NEURAL BAS, P33, DOI DOI 10.1093/ACPROF:OSO/9780198508335.003.0002; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; Nagel M, 2006, NEUROIMAGE, V29, P1319, DOI 10.1016/j.neuroimage.2005.08.050; Ohlendorf S, 2007, EUR J NEUROSCI, V26, P2096, DOI 10.1111/j.1460-9568.2007.05824.x; Olson IR, 2004, NEUROPSYCHOLOGIA, V42, P95, DOI 10.1016/S0028-3932(03)00151-9; Pastukhov A, 2010, VISION RES, V50, P1173, DOI 10.1016/j.visres.2010.04.007; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Praamstra P, 2005, J NEUROPHYSIOL, V94, P764, DOI 10.1152/jn.01052.2004; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Schutz A. C., 2011, J VISION, V11; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013	46	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38479	10.1371/journal.pone.0038479	http://dx.doi.org/10.1371/journal.pone.0038479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719893	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900031
J	Swanson, EM; Holekamp, KE; Lundrigan, BL; Arsznov, BM; Sakai, ST				Swanson, Eli M.; Holekamp, Kay E.; Lundrigan, Barbara L.; Arsznov, Bradley M.; Sakai, Sharleen T.			Multiple Determinants of Whole and Regional Brain Volume among Terrestrial Carnivorans	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; MAMMALIAN LIFE-HISTORY; FAST-SLOW CONTINUUM; BODY-SIZE; PHYLOGENETIC INFORMATION; FORELIMB DEXTERITY; ENDOCRANIAL VOLUME; MOTOR CORTEX; SOCIAL BRAIN; EVOLUTION	Mammalian brain volumes vary considerably, even after controlling for body size. Although several hypotheses have been proposed to explain this variation, most research in mammals on the evolution of encephalization has focused on primates, leaving the generality of these explanations uncertain. Furthermore, much research still addresses only one hypothesis at a time, despite the demonstrated importance of considering multiple factors simultaneously. We used phylogenetic comparative methods to investigate simultaneously the importance of several factors previously hypothesized to be important in neural evolution among mammalian carnivores, including social complexity, forelimb use, home range size, diet, life history, phylogeny, and recent evolutionary changes in body size. We also tested hypotheses suggesting roles for these variables in determining the relative volume of four brain regions measured using computed tomography. Our data suggest that, in contrast to brain size in primates, carnivoran brain size may lag behind body size over evolutionary time. Moreover, carnivore species that primarily consume vertebrates have the largest brains. Although we found no support for a role of social complexity in overall encephalization, relative cerebrum volume correlated positively with sociality. Finally, our results support negative relationships among different brain regions after accounting for overall endocranial volume, suggesting that increased size of one brain regions is often accompanied by reduced size in other regions rather than overall brain expansion.	[Swanson, Eli M.; Holekamp, Kay E.; Lundrigan, Barbara L.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Swanson, Eli M.; Holekamp, Kay E.; Lundrigan, Barbara L.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Lundrigan, Barbara L.] Michigan State Univ, Michigan State Univ Museum, E Lansing, MI 48824 USA; [Sakai, Sharleen T.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Arsznov, Bradley M.; Sakai, Sharleen T.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Swanson, EM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	eliswanson@gmail.com	Holekamp, Kay E/G-6054-2010; Swanson, Eli/A-1941-2009		National Science Foundation [IOB0618022, IOS1121479]; Michigan State University; National Science Foundation predoctoral fellowship; Direct For Biological Sciences [0819437, 1121474] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Michigan State University; National Science Foundation predoctoral fellowship(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation grants IOB0618022 and IOS1121479 (Dr. Holekamp, Dr. Lundrigan) and an Intramural Research Grants Program (IRGP) grant from Michigan State University (Dr. Sakai, Dr. Holekamp, Dr. Lundrigan). Dr. Swanson was supported on an National Science Foundation predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; ALLMAN J, 1993, P NATL ACAD SCI USA, V90, P118, DOI 10.1073/pnas.90.1.118; [Anonymous], 1997, MACHIAVELLIAN INTELL; Baker R. H., 1983, MICHIGAN MAMMALS; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byrne R., 1988, MACHIAVELLIAN INTELL; Byrne R.W., 1994, P223; Changizi MA, 2009, ENCY NEUROSCIENCE; CLUTTONBROCK TH, 1980, J ZOOL, V190, P309; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Corfield JR, 2008, BRAIN BEHAV EVOLUT, V71, P87, DOI 10.1159/000111456; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; DEACON TW, 1990, AM ZOOL, V30, P629; Deaner RO, 1999, P ROY SOC B-BIOL SCI, V266, P687, DOI 10.1098/rspb.1999.0690; Deaner RO, 2000, BRAIN BEHAV EVOLUT, V55, P44, DOI 10.1159/000006641; Dechmann DKN, 2009, BIOL REV, V84, P161, DOI 10.1111/j.1469-185X.2008.00067.x; Diaz-Uriarte R, 1998, SYST BIOL, V47, P654, DOI 10.1080/106351598260653; Dobson FS, 2007, ECOSCIENCE, V14, P292, DOI 10.2980/1195-6860(2007)14[292:FASLHO]2.0.CO;2; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; EISENBERG JF, 1978, EVOLUTION, V32, P740, DOI 10.1111/j.1558-5646.1978.tb04627.x; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Finarelli JA, 2006, J MAMMAL, V87, P1027, DOI 10.1644/05-MAMM-A-430R1.1; Finarelli JA, 2010, BIOL LETTERS, V6, P350, DOI 10.1098/rsbl.2009.0787; Finarelli JA, 2009, P NATL ACAD SCI USA, V106, P9345, DOI 10.1073/pnas.0901780106; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; Fish JL, 2003, AM J PHYS ANTHROPOL, V120, P171, DOI 10.1002/ajpa.10136; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GITTLEMAN JL, 1992, ANNU REV ECOL SYST, V23, P383; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GORSKA T, 1974, ACTA NEUROBIOL EXP, V34, P171; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; Gould SJ, 1991, BULLY BRONTOSAURUS, P109; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Harcourt AH., 1992, COALITIONS ALLIANCES; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harvey P.H., 1989, Oxford Surveys in Evolutionary Biology, V6, P13; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARVEY PH, 1985, NATURE, V315, P319, DOI 10.1038/315319a0; HASSLER R, 1964, J Hirnforsch, V7, P377; HEALY SD, 1992, P ROY SOC B-BIOL SCI, V248, P241, DOI 10.1098/rspb.1992.0068; Holekamp KE, 2007, J MAMMAL, V88, P545, DOI 10.1644/06-MAMM-S-361R1.1; Holekamp KE, 2007, TRENDS COGN SCI, V11, P65, DOI 10.1016/j.tics.2006.11.003; Holekamp KE, 2010, ADV STUD BEHAV, V42, P189, DOI 10.1016/S0065-3454(10)42006-9; Humphrey NK., 1976, GROWING POINTS ETHOL, P303; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Isler K, 2009, BIOL LETTERS, V5, P125, DOI 10.1098/rsbl.2008.0469; Iwaniuk AN, 1999, BRAIN BEHAV EVOLUT, V54, P167, DOI 10.1159/000006621; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Iwaniuk AN, 2000, CAN J ZOOL, V78, P1110, DOI 10.1139/cjz-78-7-1110; Iwaniuk AN, 2009, CAN J EXP PSYCHOL, V63, P150, DOI 10.1037/a0015678; JERISON HJ, 1985, PHILOS T ROY SOC B, V308, P21, DOI 10.1098/rstb.1985.0007; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koepfli KP, 2006, MOL PHYLOGENET EVOL, V38, P603, DOI 10.1016/j.ympev.2005.10.017; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; MADDISON WP, 2004, MESQUITE MODULAR SYS; Martin R.D., 1985, P147; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mech LD., 1970, WOLF ECOLOGY BEHAV E; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Mills M. G. L., 1998, HYENAS STATUS SURVEY; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nowak R. M., 2005, WALKERS CARNIVORES W; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Perez-Barberia FJ, 2007, EVOLUTION, V61, P2811, DOI 10.1111/j.1558-5646.2007.00229.x; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; RADINSKY LB, 1969, ANN NY ACAD SCI, V167, P277, DOI 10.1111/j.1749-6632.1969.tb20450.x; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Ricard AS, 2010, SURG RADIOL ANAT, V32, P989, DOI 10.1007/s00276-010-0650-4; RISKA B, 1985, SCIENCE, V229, P668, DOI 10.1126/science.229.4714.668; ROHRS M, 1986, Z ZOOL SYST EVOL, V24, P300; ROHRS M, 1989, Z ZOOL SYST EVOL, V27, P169; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Sakai ST, 2011, BRAIN BEHAV EVOLUT, V77, P91, DOI 10.1159/000323849; SAKAI ST, 1982, J COMP NEUROL, V204, P238, DOI 10.1002/cne.902040304; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; Shultz S, 2010, BIOL J LINN SOC, V100, P111, DOI 10.1111/j.1095-8312.2010.01427.x; Sol D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009617; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Sunquist ME, 2002, WILD CATS WORLD; Van Schaik CP, 2003, ANIMAL SOCIAL COMPLEXITY, P5; Watts HE, 2009, P ROY SOC B-BIOL SCI, V276, P2291, DOI 10.1098/rspb.2009.0268; Webster AJ, 2004, J EVOLUTION BIOL, V17, P396, DOI 10.1046/j.1420-9101.2003.00664.x; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107; WELKER WI, 1963, J COMP NEUROL, V120, P19, DOI 10.1002/cne.901200103; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; Wilson DE, HDB MAMMALS WORLD; Young R.M., 1990, MIND BRAIN; YOUNG RW, 1959, AM J ANAT, V105, P383, DOI 10.1002/aja.1001050304; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	116	40	40	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38447	10.1371/journal.pone.0038447	http://dx.doi.org/10.1371/journal.pone.0038447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719890	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900028
J	Eckmann-Scholz, C; Bens, S; Kolarova, J; Schneppenheim, S; Caliebe, A; Heidemann, S; von Kaisenberg, C; Kautza, M; Jonat, W; Siebert, R; Ammerpohl, O				Eckmann-Scholz, Christel; Bens, Susanne; Kolarova, Julia; Schneppenheim, Sina; Caliebe, Almuth; Heidemann, Simone; von Kaisenberg, Constantin; Kautza, Monika; Jonat, Walter; Siebert, Reiner; Ammerpohl, Ole			DNA-Methylation Profiling of Fetal Tissues Reveals Marked Epigenetic Differences between Chorionic and Amniotic Samples	PLOS ONE			English	Article							NONINVASIVE-PRENATAL-DIAGNOSIS; MATERNAL PLASMA; PATTERNS; TRISOMY-21; DISCOVERY; PLACENTA; INSIGHTS	Epigenetic mechanisms including DNA methylation are supposed to play a key role in fetal development. Here we have investigated fetal DNA-methylation levels of 27,578 CpG loci in 47 chorionic villi (CVS) and 16 amniotic cell (AC) samples. Methylation levels differed significantly between karyotypically normal AC and CVS for 2,014 genes. AC showed more extreme DNA-methylation levels of these genes than CVS and the differentially methylated genes are significantly enriched for processes characteristic for the different cell types sampled. Furthermore, we identified 404 genes differentially methylated in CVS with trisomy 21. These genes were significantly enriched for high CG dinucleotid (CpG) content and developmental processes associated with Down syndrome. Our study points to major tissue-specific differences of fetal DNA-methylation and gives rise to the hypothesis that part of the Down syndrome phenotype is epigenetically programmed in the first trimester of pregnancy.	[Eckmann-Scholz, Christel; von Kaisenberg, Constantin; Jonat, Walter] Univ Kiel, Dept Gynecol & Obstet, Kiel, Germany; [Eckmann-Scholz, Christel; Bens, Susanne; Kolarova, Julia; Schneppenheim, Sina; Caliebe, Almuth; Heidemann, Simone; von Kaisenberg, Constantin; Jonat, Walter; Siebert, Reiner; Ammerpohl, Ole] Univ Hosp Schleswig Holstein, Kiel, Germany; [Bens, Susanne; Kolarova, Julia; Schneppenheim, Sina; Caliebe, Almuth; Heidemann, Simone; Siebert, Reiner; Ammerpohl, Ole] Univ Kiel, Inst Human Genet, Kiel, Germany; [von Kaisenberg, Constantin] Hannover Med Sch, Dept Obstet Gynecol & Reprod Med, D-3000 Hannover, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Hannover Medical School	Eckmann-Scholz, C (corresponding author), Univ Kiel, Dept Gynecol & Obstet, Kiel, Germany.	oammerpohl@medgen.uni-kiel.de	Ammerpohl, Ole/G-2691-2010; Siebert, Reiner/A-8049-2010; Caliebe, Almuth/G-1248-2018; von Kaisenberg, Constantin/AAR-2756-2021	Caliebe, Almuth/0000-0003-2157-425X; 	Medical Faculty of the Christian-Albrechts-University Kiel	Medical Faculty of the Christian-Albrechts-University Kiel	This study was made possible by intramural funding of the Medical Faculty of the Christian-Albrechts-University Kiel to the involved institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, ANATOL J CARDIOL, V11, P183, DOI 10.5152/akd.2011.044; Ammerpohl O, 2012, LEUKEMIA, V26, P185, DOI 10.1038/leu.2011.194; Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Banister CE, 2011, EPIGENETICS-US, V6, P920, DOI 10.4161/epi.6.7.16079; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016506; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Chu TJ, 2009, PRENATAL DIAG, V29, P1020, DOI 10.1002/pd.2335; Churakov G, 2009, GENOME RES, V19, P868, DOI 10.1101/gr.090647.108; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gardner RJ, 2004, CHROMOSOME ABNORMALI; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; HOWARD CM, 1993, AM J HUM GENET, V53, P462; Joziasse IC, 2011, EUR J HUM GENET, V19, P389, DOI 10.1038/ejhg.2010.224; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Koch CM, 2012, AGING CELL, V11, P366, DOI 10.1111/j.1474-9726.2011.00784.x; Lambertini L, 2011, REPROD SCI, V18, P1111, DOI 10.1177/1933719111404611; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rexhaj E, 2011, AM J PHYSIOL-HEART C, V301, pH247, DOI 10.1152/ajpheart.01309.2010; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tsui DWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015069; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7	40	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39014	10.1371/journal.pone.0039014	http://dx.doi.org/10.1371/journal.pone.0039014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723920	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700043
J	Kaneko-Kawano, T; Takasu, F; Naoki, H; Sakumura, Y; Ishii, S; Ueba, T; Eiyama, A; Okada, A; Kawano, Y; Suzuki, K				Kaneko-Kawano, Takako; Takasu, Fugo; Naoki, Honda; Sakumura, Yuichi; Ishii, Shin; Ueba, Takahiro; Eiyama, Akinori; Okada, Aiko; Kawano, Yoji; Suzuki, Kenji			Dynamic Regulation of Myosin Light Chain Phosphorylation by Rho-kinase	PLOS ONE			English	Article							BINDING PROTEIN RHO; SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; POSITIVE-FEEDBACK; MOESIN PHOSPHORYLATION; IN-VIVO; PHOSPHATASE; SUBUNIT; THROMBIN; DIFFERENTIATION	Myosin light chain (MLC) phosphorylation plays important roles in various cellular functions such as cellular morphogenesis, motility, and smooth muscle contraction. MLC phosphorylation is determined by the balance between activities of Rho-associated kinase (Rho-kinase) and myosin phosphatase. An impaired balance between Rho-kinase and myosin phosphatase activities induces the abnormal sustained phosphorylation of MLC, which contributes to the pathogenesis of certain vascular diseases, such as vasospasm and hypertension. However, the dynamic principle of the system underlying the regulation of MLC phosphorylation remains to be clarified. Here, to elucidate this dynamic principle whereby Rho-kinase regulates MLC phosphorylation, we developed a mathematical model based on the behavior of thrombin-dependent MLC phosphorylation, which is regulated by the Rho-kinase signaling network. Through analyzing our mathematical model, we predict that MLC phosphorylation and myosin phosphatase activity exhibit bistability, and that a novel signaling pathway leading to the auto-activation of myosin phosphatase is required for the regulatory system of MLC phosphorylation. In addition, on the basis of experimental data, we propose that the auto-activation pathway of myosin phosphatase occurs in vivo. These results indicate that bistability of myosin phosphatase activity is responsible for the bistability of MLC phosphorylation, and the sustained phosphorylation of MLC is attributed to this feature of bistability.	[Kaneko-Kawano, Takako; Eiyama, Akinori; Okada, Aiko; Suzuki, Kenji] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga, Japan; [Takasu, Fugo] Nara Womens Univ, Dept Informat & Comp Sci, Nara 630, Japan; [Naoki, Honda; Ishii, Shin] Kyoto Univ, Dept Syst Sci, Grad Sch Informat, Uji, Kyoto, Japan; [Sakumura, Yuichi] Aichi Prefectural Univ, Dept Informat Sci & Technol, Nagakute, Aichi, Japan; [Ueba, Takahiro; Kawano, Yoji] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 63001, Japan	Ritsumeikan University; Nara Womens University; Kyoto University; Nara Institute of Science & Technology	Kaneko-Kawano, T (corresponding author), Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga, Japan.	takanek@fc.ritsumei.ac.jp	Naoki, Honda/AAW-6284-2020; Naoki, Honda/N-5674-2017; Kawano, Yoji/C-7484-2011	Naoki, Honda/0000-0001-6816-9126; Naoki, Honda/0000-0001-6816-9126; Kawano, Yoji/0000-0003-0687-2777; Ishii, Shin/0000-0001-9385-8230	Astellas Foundation for Research on Metabolic Disorders (Japan); Nagoya University Foundation (Japan); Research Promoting Program of Ritsumeikan University Research Fundation (Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan) [S1001042]; Maekawa Houonkai Foundation (Japan); SEI Group CSR Foundation (Japan); Grants-in-Aid for Scientific Research [23770044, 23127509] Funding Source: KAKEN	Astellas Foundation for Research on Metabolic Disorders (Japan); Nagoya University Foundation (Japan); Research Promoting Program of Ritsumeikan University Research Fundation (Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Maekawa Houonkai Foundation (Japan); SEI Group CSR Foundation (Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from Astellas Foundation for Research on Metabolic Disorders (Japan), Nagoya University Foundation (Japan), Research Promoting Program of Ritsumeikan University Research Fundation (Japan), Strategic Research Foundation Grant-aided Project for Private Universities (S1001042) from Ministry of Education, Culture, Sports, Science, and Technology (Japan), Maekawa Houonkai Foundation (Japan), and SEI Group CSR Foundation (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Damron DS, 2002, AM J PHYSIOL-LUNG C, V283, pL1051, DOI 10.1152/ajplung.00345.2001; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Fujihara H, 1997, MOL BIOL CELL, V8, P2437, DOI 10.1091/mbc.8.12.2437; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hartel FV, 2007, CARDIOVASC RES, V74, P487, DOI 10.1016/j.cardiores.2007.02.013; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kiss A, 2008, CELL SIGNAL, V20, P2059, DOI 10.1016/j.cellsig.2008.07.018; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kolosova IA, 2004, AM J PHYSIOL-LUNG C, V287, pL970, DOI 10.1152/ajplung.00398.2003; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Maeda A, 2006, GENES CELLS, V11, P1071, DOI 10.1111/j.1365-2443.2006.01001.x; Manuck SB, 2002, PHYSIOL BEHAV, V77, P705, DOI 10.1016/S0031-9384(02)00922-8; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Miyazaki K, 2002, J BIOL CHEM, V277, P725, DOI 10.1074/jbc.M108568200; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Retzer M, 2000, CELL SIGNAL, V12, P645, DOI 10.1016/S0898-6568(00)00108-X; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Segel LA, 1998, BIOPHYS CHEM, V72, P223, DOI 10.1016/S0301-4622(98)00136-7; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	50	41	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39269	10.1371/journal.pone.0039269	http://dx.doi.org/10.1371/journal.pone.0039269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723981	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700063
J	Mane, A; Nirmalkar, A; Risbud, AR; Vermund, SH; Mehendale, SM; Sahasrabuddhe, VV				Mane, Arati; Nirmalkar, Amit; Risbud, Arun R.; Vermund, Sten H.; Mehendale, Sanjay M.; Sahasrabuddhe, Vikrant V.			HPV Genotype Distribution in Cervical Intraepithelial Neoplasia among HIV-Infected Women in Pune, India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; RISK-FACTORS; POSITIVE WOMEN; PGMY PRIMERS; PREVALENCE; LESIONS; DNA; TERMINOLOGY; SAMPLES	Background: The distribution of HPV genotypes, their association with rigorously confirmed cervical precancer endpoints, and factors associated with HPV infection have not been previously documented among HIV-infected women in India. We conducted an observational study to expand this evidence base in this population at high risk of cervical cancer. Methods: HIV-infected women (N = 278) in Pune, India underwent HPV genotyping by Linear Array assay. Cervical intraepithelial neoplasia (CIN) disease ascertainment was maximized by detailed assessment using cytology, colposcopy, and histopathology and a composite endpoint. Results: CIN2+ was detected in 11.2% while CIN3 was present in 4.7% participants. HPV genotypes were present in 52.5% (146/278) and 'carcinogenic' HPV genotypes were present in 35.3% (98/278) HIV-infected women. 'Possibly carcinogenic' and 'non/unknown carcinogenic' HPV genotypes were present in 14.7% and 29.5% participants respectively. Multiple (>= 2) HPV genotypes were present in half (50.7%) of women with HPV, while multiple 'carcinogenic' HPV genotypes were present in just over a quarter (27.8%) of women with 'carcinogenic' HPV. HPV16 was the commonest genotype, present in 12% overall, as well as in 47% and 50% in CIN2+ and CIN3 lesions with a single carcinogenic HPV infection, respectively. The carcinogenic HPV genotypes in declining order of prevalence overall included HPV 16, 56, 18, 39, 35, 51, 31, 59, 33, 58, 68, 45 and 52. Factors independently associated with 'carcinogenic' HPV type detection were reporting >= 2 lifetime sexual partners and having lower CD4+ count. HPV16 detection was associated with lower CD4+ cell counts and currently receiving combination antiretroviral therapy. Conclusion: HPV16 was the most common HPV genotype, although a wide diversity and high multiplicity of HPV genotypes was observed. Type-specific attribution of carcinogenic HPV genotypes in CIN3 lesions in HIV-infected women, and etiologic significance of concurrently present non/unknown carcinogenic HPV genotypes await larger studies.	[Mane, Arati; Nirmalkar, Amit; Risbud, Arun R.] Natl AIDS Res Inst, Pune, Maharashtra, India; [Vermund, Sten H.; Sahasrabuddhe, Vikrant V.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Mehendale, Sanjay M.] Natl Inst Epidemiol, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Mane, A (corresponding author), Natl AIDS Res Inst, Pune, Maharashtra, India.	vikrant.sahasrabuddhe@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	U.S. National Institutes of Health (NIH) [R21CA113465, D43TW001035]; Indian Council of Medical Research (ICMR); FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA113465] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research in this manuscript was supported by the U.S. National Institutes of Health (NIH) (through grants R21CA113465 and D43TW001035) and the Indian Council of Medical Research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen LJM, 2006, SEX TRANSM DIS, V33, P259; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Broker T R, 2001, Dev Biol (Basel), V106, P443; Broker TR, 2001, DEV BIOL BASEL, V106, P452; Broker TR, 2001, DEV BIOL BASEL, V106, P465; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Coelho Lima BM, 2009, BRAZIL J INT ASS PHY, V8, P286; Coutlee F, 2002, J CLIN MICROBIOL, V40, P902, DOI 10.1128/JCM.40.3.902-907.2002; Coutlee F, 2006, J CLIN MICROBIOL, V44, P1998, DOI 10.1128/JCM.00104-06; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hankins C, 1999, CAN MED ASSOC J, V160, P185; Hawes SE, 2006, J NATL CANCER I, V98, P100, DOI 10.1093/jnci/djj010; Hernandez Brenda Y, 2008, Infect Agent Cancer, V3, P7, DOI 10.1186/1750-9378-3-7; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP, pv; Joshi SN, 2005, J MED VIROL, V76, P470, DOI 10.1002/jmv.20385; Kitchener H, 2007, INT J CANCER, V121, P2484, DOI 10.1002/ijc.22947; Kornegay JR, 2003, J CLIN MICROBIOL, V41, P1080, DOI 10.1128/JCM.41.3.1080-1086.2003; Levi JE, 2002, J CLIN MICROBIOL, V40, P3341, DOI 10.1128/JCM.40.9.3341-3345.2002; Luque AE, 2006, J INFECT DIS, V194, P428, DOI 10.1086/505876; Luque AE, 2010, INT J INFECT DIS, V14, pE810, DOI 10.1016/j.ijid.2010.03.016; McKenzie ND, 2010, GYNECOL ONCOL, V116, P572, DOI 10.1016/j.ygyno.2009.10.058; Melgaco FG, 2011, ARCH GYNECOL OBSTET, V283, P809, DOI 10.1007/s00404-010-1443-z; Moodley JR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-275; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Nicol AF, 2008, J CLIN PATHOL, V61, P84, DOI 10.1136/jcp.2007.047290; NUOVO GJ, 1991, AM J PATHOL, V138, P53; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Palefsky JM, 2003, JNCI MONOGRAPHS, V2003, P41, DOI DOI 10.1093/0XF0RDJ0URNALS.JNCIM0N0GRAPHS.A003481; Peedicayil A, 2009, J LOW GENIT TRACT DI, V13, P159, DOI 10.1097/LGT.0b013e31818fb40d; RICHART RM, 1990, OBSTET GYNECOL, V75, P131; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Sahasrabuddhe VV, 2011, FUTURE MICROBIOL, V6, P1083, DOI [10.2217/FMB.11.87, 10.2217/fmb.11.87]; Sahasrabuddhe VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008634; Sarkar K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-72; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stanley M, 2010, CURR OPIN INFECT DIS, V23, P70, DOI 10.1097/QCO.0b013e328334c0e1; Steinau M, 2008, J CLIN VIROL, V42, P412, DOI 10.1016/j.jcv.2008.03.004; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Strickler HD, 2008, INT J CANCER, V123, P1224, DOI 10.1002/ijc.23630; Tornesello ML, 2008, J GEN VIROL, V89, P1380, DOI 10.1099/vir.0.83553-0; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528	45	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38731	10.1371/journal.pone.0038731	http://dx.doi.org/10.1371/journal.pone.0038731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723879	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700023
J	Sikorski, C; Luppa, M; Schomerus, G; Werner, P; Konig, HH; Riedel-Heller, SG				Sikorski, Claudia; Luppa, Melanie; Schomerus, Georg; Werner, Perla; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			Public Attitudes towards Prevention of Obesity	PLOS ONE			English	Article							HEALTH; FUTURE; BURDEN; ADULTS; POLICY	Objective: To investigate obesity prevention support in the German general public and to assess determinants of general prevention support as well as support of specific prevention measures. Methods: This study was a cross-sectional analysis of a telephone based representative German study (3,003 subjects (52.8% women, mean age 51.9, s.d. = 18.0, range 18-97 years). Likert scale-based questions on general prevention support and support of specific measures were used. Furthermore willingness to take part in preventive programs and willingness to pay were assessed. Stigmatizing attitudes were assessed with the Fat Phobia Scale (FPS). Causation of obesity was differentiated in three dimensions (internal, e. g. lack of exercise; external, e. g. social surroundings; and genetic factors). Results: Obesity prevention was perceived as possible (98.2%), however, almost exclusively lifestyle changes were named. Participants with higher stigmatizing attitudes were less likely to believe obesity prevention is possible. The majority of participants would take part in preventive programs (59.6%) and pay at least partially themselves (86.9%). Factor analysis revealed three dimensions of preventive measures: promoting healthy eating, restrictive and financial, governmental prevention efforts. In regard to these, promoting healthy eating was the most supported measure. Higher age, female gender and external causation were associated with higher support for all three dimensions of preventive measures. Only for governmental regulation, higher age was associated with lower support. Conclusion: Obesity prevention support in Germany is high. Structural prevention efforts are supported by the majority of the general public in Germany. The vast majority proclaims willingness to pay themselves for programs of weight gain prevention. This could be an indication of higher perceived self-responsibility in the German system but also for risen "fear of fat" in the population due to media coverage. For Germany, the government and communities ought to be encouraged by these results to start the implementation of structural obesity prevention.	[Sikorski, Claudia] Univ Leipzig, Integrated Res & Treatment Ctr AdiposityDis, Leipzig, Germany; [Sikorski, Claudia; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Schomerus, Georg] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, Stralsund, Germany; [Werner, Perla] Univ Haifa, Fac Social Welf & Hlth Sci, IL-31999 Haifa, Israel; [Koenig, Hans-Helmut] Hamburg Eppendorf Univ Med Ctr, Dept Med Sociol & Hlth Econ, Hamburg, Germany	Leipzig University; Leipzig University; Ernst Moritz Arndt Universitat Greifswald; University of Haifa; University of Hamburg; University Medical Center Hamburg-Eppendorf	Sikorski, C (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr AdiposityDis, Leipzig, Germany.	Claudia.Sikorski@medizin.uni-leipzig.de	Werner, Perla/G-6008-2012; König, Hans-Helmut/P-1211-2018; Schomerus, Georg/A-6568-2013; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021	König, Hans-Helmut/0000-0001-5711-6862; Schomerus, Georg/0000-0002-6752-463X; 	Federal Ministry of Education and Research (Bundesministerium fur Forschung und Bildung), Germany [FKZ: 01EO1001]	Federal Ministry of Education and Research (Bundesministerium fur Forschung und Bildung), Germany	This work was supported by the Federal Ministry of Education and Research (Bundesministerium fur Forschung und Bildung), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Bundesanstalt fur Landwirtschaft und Ernahrung, 2011, IN FORM DTSCH LANDS; Bundesverband der Verbraucherzentralen und Verbraucherverbande-Verbraucherzentrale Bundesverband e. V, 2011, LEB; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Crandall CS, 1996, PERS SOC PSYCHOL B, V22, P1165, DOI 10.1177/01461672962211007; CRANDALL CS, 1994, J RES PERS, V28, P461, DOI 10.1006/jrpe.1994.1033; Dube L, 2010, OBESITY PREVENTION: THE ROLE OF BRAIN AND SOCIETY ON INDIVIDUAL BEHAVIOR, P435, DOI 10.1016/B978-0-12-374387-9.00035-0; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Fussenegger D, 2008, OBES REV, V9, P76, DOI 10.1111/j.1467-789X.2007.00405.x; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Hilbert A, 2007, J EPIDEMIOL COMMUN H, V61, P585, DOI 10.1136/jech.2006.050906; Hilbert A, 2009, OBESITY FACTS, V2, P46, DOI 10.1159/000195697; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Konnopka A, 2011, EUR J HEALTH ECON, V12, P345, DOI 10.1007/s10198-010-0242-6; Kremers S, 2010, OBES REV, V11, P371, DOI 10.1111/j.1467-789X.2009.00598.x; Latner JD, 2009, J HEALTH PSYCHOL, V14, P190, DOI 10.1177/1359105308100203; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lund TB, 2011, OBESITY, V19, P1580, DOI 10.1038/oby.2011.84; Malterud K, 2010, PATIENT EDUC COUNS, V81, P47, DOI 10.1016/j.pec.2009.10.022; Muller MJ, 2010, OBES REV, V11, P101, DOI 10.1111/j.1467-789X.2009.00643.x; Raine KD, 2005, CAN J PUBLIC HEALTH, V96, pS8, DOI 10.1007/BF03405195; Ruggs EN, 2010, OBESITY FACTS, V3, P60, DOI 10.1159/000273208; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x; Schomerus G, 2008, J AFFECT DISORDERS, V106, P257, DOI 10.1016/j.jad.2007.06.013; Schomerus G, 2010, PSYCHIAT PRAX, V37, P111, DOI 10.1055/s-0029-1223438; Sikorski C, 2011, OBESITY SILVER UNPUB; Sikorski C, 2012, SCAND J PUB IN PRESS, V40; Sikorski C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-661; StataCorp, 2021, STATA STAT SOFTWARE; The International Obesity Taskforce, 2011, GLOB EP; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organization Regional Office for Europe, 2011, DEV NEW EUR POL HLTH	40	21	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39325	10.1371/journal.pone.0039325	http://dx.doi.org/10.1371/journal.pone.0039325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723996	gold, Green Submitted, Green Published			2022-12-27	WOS:000305652700068
J	He, WG; Qin, QB; Liu, SJ; Li, TL; Wang, J; Xiao, J; Xie, LH; Zhang, C; Liu, Y				He, Weiguo; Qin, Qinbo; Liu, Shaojun; Li, Tangluo; Wang, Jing; Xiao, Jun; Xie, Lihua; Zhang, Chun; Liu, Yun			Organization and Variation Analysis of 5S rDNA in Different Ploidy-level Hybrids of Red Crucian Carp x Topmouth Culter	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; MOLECULAR-ORGANIZATION; NUCLEOTIDE-SEQUENCE; GENOMIC ORGANIZATION; CARASSIUS-AURATUS; POLYPLOID HYBRIDS; ATLANTIC SALMON; EVOLUTION; DNA; ELIMINATION	Through distant crossing, diploid, triploid and tetraploid hybrids of red crucian carp (Carassius auratus red var., RCC female, Cyprininae, 2n = 100) x topmouth culter (Erythroculter ilishaeformis Bleeker, TC male, Cultrinae, 2n = 48) were successfully produced. Diploid hybrids possessed 74 chromosomes with one set from RCC and one set from TC; triploid hybrids harbored 124 chromosomes with two sets from RCC and one set from TC; tetraploid hybrids had 148 chromosomes with two sets from RCC and two sets from TC. The 5S rDNA of the three different ploidy-level hybrids and their parents were sequenced and analyzed. There were three monomeric 5S rDNA classes (designated class I: 203 bp; class II: 340 bp; and class III: 477 bp) in RCC and two monomeric 5S rDNA classes (designated class IV: 188 bp, and class V: 286 bp) in TC. In the hybrid offspring, diploid hybrids inherited three 5S rDNA classes from their female parent (RCC) and only class IV from their male parent (TC). Triploid hybrids inherited class II and class III from their female parent (RCC) and class IV from their male parent (TC). Tetraploid hybrids gained class II and class III from their female parent (RCC), and generated a new 5S rDNA sequence (designated class I-N). The specific paternal 5S rDNA sequence of class V was not found in the hybrid offspring. Sequence analysis of 5S rDNA revealed the influence of hybridization and polyploidization on the organization and variation of 5S rDNA in fish. This is the first report on the coexistence in vertebrates of viable diploid, triploid and tetraploid hybrids produced by crossing parents with different chromosome numbers, and these new hybrids are novel specimens for studying the genomic variation in the first generation of interspecific hybrids, which has significance for evolution and fish genetics.	[He, Weiguo; Qin, Qinbo; Liu, Shaojun; Li, Tangluo; Wang, Jing; Xiao, Jun; Xie, Lihua; Zhang, Chun; Liu, Yun] Hunan Normal Univ, Key Lab Prot Chem & Fish Dev Biol, Educ Minist China, Coll Life Sci, Changsha, Hunan, Peoples R China	Hunan Normal University	Liu, SJ (corresponding author), Hunan Normal Univ, Key Lab Prot Chem & Fish Dev Biol, Educ Minist China, Coll Life Sci, Changsha, Hunan, Peoples R China.	lsj@hunnu.edu.cn	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022		National Natural Science Foundation of China [30930071, 30901100]; Natural Science Fund for Innovative Research Team of Hunan Province [10JJ7004]; National Special Fund for Scientific Research in public benefits [200903046]; Ministry of Education of China [20104306110004]; Natural Science Foundation of Hunan Province [IIJJ40220]; Key Discipline of Hunan Province and China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Innovative Research Team of Hunan Province; National Special Fund for Scientific Research in public benefits; Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Key Discipline of Hunan Province and China	This work was funded by the National Natural Science Foundation of China (Grant No. : 30930071 and 30901100), the Natural Science Fund for Innovative Research Team of Hunan Province (Grant No. : 10JJ7004), the National Special Fund for Scientific Research in public benefits (Grant No. : 200903046), the Doctoral Fund of Ministry of Education of China (Grant No. : 20104306110004), the Natural Science Foundation of Hunan Province (Grant No. : IIJJ40220), and the Construction Project of Key Discipline of Hunan Province and China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI A, 1991, NUCLEIC ACIDS RES, V19, P5073, DOI 10.1093/nar/19.18.5073; Arnold ML, 1996, NATURAL HYBRIDIZATIO; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Badaeva ED, 2002, PLANT SYST EVOL, V231, P163, DOI 10.1007/s006060200018; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; BULLINI L, 1994, TRENDS ECOL EVOL, V9, P422, DOI 10.1016/0169-5347(94)90124-4; Campo D, 2012, GENOME, V55, P33, DOI 10.1139/G11-074; Campo D, 2009, J MOL EVOL, V68, P208, DOI 10.1007/s00239-009-9207-8; CASSIDY JR, 1987, CURR GENET, V12, P33, DOI 10.1007/BF00420724; Chen L, 2009, MOL CELL PROBE, V23, P157, DOI 10.1016/j.mcp.2009.03.001; CIHLAR RL, 1980, NUCLEIC ACIDS RES, V8, P793; DELSENY M, 1990, GENOME, V33, P733, DOI 10.1139/g90-111; Fujiwara M, 2009, GENETICA, V135, P355, DOI 10.1007/s10709-008-9294-2; Gallardo MH, 1999, NATURE, V401, P341, DOI 10.1038/43815; GANAL MW, 1988, MOL GEN GENET, V213, P262, DOI 10.1007/BF00339590; Gornung E, 2007, GENOME, V50, P787, DOI 10.1139/G07-058; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Inafuku J, 2000, CHROMOSOME RES, V8, P193, DOI 10.1023/A:1009292610618; Kashkush K, 2002, GENETICS, V160, P1651; KOMIYA H, 1986, J BIOCHEM-TOKYO, V100, P369, DOI 10.1093/oxfordjournals.jbchem.a121723; Kotseruba V, 2003, GENOME, V46, P156, DOI 10.1139/G02-104; Kramer A, 1985, Dev Biol (N Y 1985), V1, P431; Le Comber SC, 2004, BIOL J LINN SOC, V82, P431; LEAH R, 1990, NUCLEIC ACIDS RES, V18, P7441, DOI 10.1093/nar/18.24.7441; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Liu SJ, 2007, GENETICS, V176, P1023, DOI 10.1534/genetics.107.071373; Liu SJ, 2001, AQUACULTURE, V192, P171, DOI 10.1016/S0044-8486(00)00451-8; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martins C, 2001, GENETICA, V111, P439, DOI 10.1023/A:1013799516717; Martins C, 2001, GENOME, V44, P903, DOI 10.1139/gen-44-5-903; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Moran P, 1996, CYTOGENET CELL GENET, V75, P145, DOI 10.1159/000134466; Negi MS, 2002, GENOME, V45, P1181, DOI 10.1139/G02-094; NELSON DW, 1985, GENE, V38, P245, DOI 10.1016/0378-1119(85)90224-0; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Pamela SS, 1991, SYSTEMATIC BOT, V16, P407; Pasolini P, 2006, J MOL EVOL, V62, P564, DOI 10.1007/s00239-005-0118-z; PENDAS AM, 1995, MOL ECOL, V4, P275, DOI 10.1111/j.1365-294X.1995.tb00220.x; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; Pennell W., 1996, PRINCIPLES SALMONID; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Pinhal D, 2009, GENET RES, V91, P61, DOI 10.1017/S0016672308009993; Qin QB, 2010, J EXP ZOOL PART B, V314B, P403, DOI 10.1002/jez.b.21346; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2001, CURR BIOL, V11, pR925, DOI 10.1016/S0960-9822(01)00556-5; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Robles F, 2005, GENOME, V48, P18, DOI 10.1139/G04-077; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Sajdak SL, 1998, J MOL EVOL, V46, P680, DOI 10.1007/PL00006348; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sola L, 2003, HEREDITAS, V139, P232, DOI 10.1111/j.1601-5223.2003.01814.x; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; SUZUKI H, 1994, MOL BIOL EVOL, V11, P704; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Wasko AP, 2001, GENOME, V44, P893, DOI 10.1139/gen-44-5-893; Xiao J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-20; Yi MS, 2003, CHROMOSOME RES, V11, P665, DOI 10.1023/A:1025985625706; Yu XJ, 1989, CHROMOSOMES CHIMESE	65	47	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38976	10.1371/journal.pone.0038976	http://dx.doi.org/10.1371/journal.pone.0038976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22720007	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300074
J	Van de Sompel, D; Garai, E; Zavaleta, C; Gambhir, SS				Van de Sompel, Dominique; Garai, Ellis; Zavaleta, Cristina; Gambhir, Sanjiv Sam			A Hybrid Least Squares and Principal Component Analysis Algorithm for Raman Spectroscopy	PLOS ONE			English	Article							SUBTRACTION; CALIBRATION; REGRESSION	Raman spectroscopy is a powerful technique for detecting and quantifying analytes in chemical mixtures. A critical part of Raman spectroscopy is the use of a computer algorithm to analyze the measured Raman spectra. The most commonly used algorithm is the classical least squares method, which is popular due to its speed and ease of implementation. However, it is sensitive to inaccuracies or variations in the reference spectra of the analytes (compounds of interest) and the background. Many algorithms, primarily multivariate calibration methods, have been proposed that increase robustness to such variations. In this study, we propose a novel method that improves robustness even further by explicitly modeling variations in both the background and analyte signals. More specifically, it extends the classical least squares model by allowing the declared reference spectra to vary in accordance with the principal components obtained from training sets of spectra measured in prior characterization experiments. The amount of variation allowed is constrained by the eigenvalues of this principal component analysis. We compare the novel algorithm to the least squares method with a low-order polynomial residual model, as well as a state-of-the-art hybrid linear analysis method. The latter is a multivariate calibration method designed specifically to improve robustness to background variability in cases where training spectra of the background, as well as the mean spectrum of the analyte, are available. We demonstrate the novel algorithm's superior performance by comparing quantitative error metrics generated by each method. The experiments consider both simulated data and experimental data acquired from in vitro solutions of Raman-enhanced gold-silica nanoparticles.	[Van de Sompel, Dominique; Garai, Ellis; Zavaleta, Cristina; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA	Stanford University	Van de Sompel, D (corresponding author), Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Zavaleta, Cristina/AAC-2306-2020	Zavaleta, Cristina/0000-0001-7314-2446	Susan G. Komen Postdoctoral Fellowship; Molecular Imaging Program at Stanford (MIPS); National Cancer Institute ICMIC [P50CA114747]; National Cancer Institute CCNE-T [U54 U54CA151459]; Doris Duke Foundation; Canary Foundation; Ben & Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER	Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); Molecular Imaging Program at Stanford (MIPS); National Cancer Institute ICMIC; National Cancer Institute CCNE-T; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Canary Foundation; Ben & Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Van de Sompel is supported by a Susan G. Komen Postdoctoral Fellowship, as well as the Molecular Imaging Program at Stanford (MIPS). The authors would also like to acknowledge funding for the Gambhir laboratory from National Cancer Institute ICMIC P50CA114747, National Cancer Institute CCNE-T U54 U54CA151459, Doris Duke Foundation, Canary Foundation, Ben & Catherine Ivy Foundation, and the Sir Peter Michael Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hatab NA, 2007, APPL SPECTROSC, V61, P1116, DOI 10.1366/000370207782217842; Berger AJ, 1998, ANAL CHEM, V70, P623, DOI 10.1021/ac970721p; Faber K, 1997, J CHEMOMETR, V11, P181, DOI 10.1002/(SICI)1099-128X(199705)11:3<181::AID-CEM459>3.0.CO;2-7; Fortina P, 2005, TRENDS BIOTECHNOL, V23, P168, DOI 10.1016/j.tibtech.2005.02.007; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105; Kode K, 2011, J RAMAN SPE IN PRESS; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Lutz BR, 2008, ACS NANO, V2, P2306, DOI 10.1021/nn800243g; Zavaleta CL, 2011, J NUCL MED, V52, P1839, DOI 10.2967/jnumed.111.087775; Zavaleta CL, 2009, P NATL ACAD SCI USA, V106, P13511, DOI 10.1073/pnas.0813327106; Zhang ZM, 2010, ANALYST, V135, P1138, DOI 10.1039/b922045c; Zhao J, 2007, APPL SPECTROSC, V61, P1225, DOI 10.1366/000370207782597003	14	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38850	10.1371/journal.pone.0038850	http://dx.doi.org/10.1371/journal.pone.0038850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723895	Green Published, gold			2022-12-27	WOS:000305583300060
J	Henry, P; Sim, ZJ; Russello, MA				Henry, Philippe; Sim, Zijian; Russello, Michael A.			Genetic Evidence for Restricted Dispersal along Continuous Altitudinal Gradients in a Climate Change-Sensitive Mammal: The American Pika	PLOS ONE			English	Article							OCHOTONA-PRINCEPS; ENVIRONMENTAL-FACTORS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; GENOTYPING ERRORS; PATTERNS; EVOLUTIONARY; INFERENCE; PACKAGE; DRIVEN	When faced with rapidly changing environments, wildlife species are left to adapt, disperse or disappear. Consequently, there is value in investigating the connectivity of populations of species inhabiting different environments in order to evaluate dispersal as a potential strategy for persistence in the face of climate change. Here, we begin to investigate the processes that shape genetic variation within American pika populations from the northern periphery of their range, the central Coast Mountains of British Columbia, Canada. At these latitudes, pikas inhabit sharp elevation gradients ranging from sea level to 1500 m, providing an excellent system for studying the effects of local environmental conditions on pika population genetic structure and gene flow. We found low levels of neutral genetic variation compared to previous studies from more southerly latitudes, consistent with the relatively recent post-glacial colonization of the study location. Moreover, significant levels of inbreeding and marked genetic structure were detected within and among sites. Although low levels of recent gene flow were revealed among elevations within a transect, potentially admixed individuals and first generation migrants were identified using discriminant analysis of principal components between populations separated by less than five kilometers at the same elevations. There was no evidence for historical population decline, yet there was signal for recent demographic contractions, possibly resulting from environmental stochasticity. Correlative analyses revealed an association between patterns of genetic variation and annual heat-to-moisture ratio, mean annual precipitation, precipitation as snow and mean maximum summer temperature. Changes in climatic regimes forecasted for the region may thus potentially increase the rate of population extirpation by further reducing dispersal between sites. Consequently, American pika may have to rely on local adaptations or phenotypic plasticity in order to survive predicted climate changes, although additional studies are required to investigate the evolutionary potential of this climate change sensitive species.	[Henry, Philippe; Sim, Zijian; Russello, Michael A.] Univ British Columbia, Dept Biol, Kelowna, BC, Canada	University of British Columbia	Henry, P (corresponding author), Univ Calgary, Fac Environm Design & Vet Med, Calgary, AB, Canada.	phenry@alumni.ubc.ca	Henry, Philippe/C-6875-2009; Sim, Zijian/M-8413-2015	Henry, Philippe/0000-0002-6475-1714; Sim, Zijian/0000-0002-1585-8021	NSERC [341711-07]; Swiss National Science Foundation [PBSKP3_128523]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	An NSERC Discovery Grant # 341711-07 to Michael A. Russello provided funding for this work. Philippe Henry was partially supported by doctoral fellowship PBSKP3_128523 from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Fox J, 2005, J STAT SOFTW, V14; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Galbreath KE, 2010, J BIOGEOGR, V37, P344, DOI 10.1111/j.1365-2699.2009.02201.x; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gebremedhin B, 2009, ANIM CONSERV, V12, P107, DOI 10.1111/j.1469-1795.2009.00255.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Henry P, 2011, JOVE, V49; Henry P, NW SCI UNPUB; Henry P, 2011, EUR J WILDLIFE RES, V57, P429, DOI 10.1007/s10344-010-0449-y; IPCC Climate Change, 2022, CLIMATE CHANGE 2022; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Jombart T, 2011, TUTORIAL DISCRIMINAT, V1, P3; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Lovejoy TE, 2005, CLIMATE CHANGE BIODI, Vxiii; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Merideth SJ, 2002, IMPACT HABITAT SPATI; Morin PA, 2009, MOL ECOL RESOUR, V9, P498, DOI 10.1111/j.1755-0998.2008.02502.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peacock MM, 1997, OECOLOGIA, V112, P524, DOI 10.1007/s004420050341; Peacock MM, 2002, MOL ECOL NOTES, V2, P360, DOI 10.1046/j.1471-8286.2002.00249.x; Peacock MM, 1997, MOL ECOL, V6, P801; Peacock MM, 1997, BEHAV ECOL, V8, P340, DOI 10.1093/beheco/8.3.340; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; Smith A.T., 2004, SPECIES, V41, P4; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilson GA, 2003, GENETICS, V163, P1177; Yin BF, 2009, MAMM BIOL, V74, P344, DOI 10.1016/j.mambio.2008.10.001; Zgurski JM, 2009, MOL ECOL RESOUR, V9, P867, DOI 10.1111/j.1755-0998.2008.02397.x	51	32	33	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39077	10.1371/journal.pone.0039077	http://dx.doi.org/10.1371/journal.pone.0039077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720034	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000038
J	Hammond, JC; Meador-Woodruff, JH; Haroutunian, V; McCullumsmith, RE				Hammond, John C.; Meador-Woodruff, James H.; Haroutunian, Vahram; McCullumsmith, Robert E.			Ampa Receptor Subunit Expression in the Endoplasmic Reticulum in Frontal Cortex of Elderly Patients with Schizophrenia	PLOS ONE			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; ANTIPSYCHOTIC-DRUGS; PREFRONTAL CORTEX; TRAFFICKING; DENDRITES; NEURONS; BINDING	Several lines of evidence indicate altered trafficking of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors in schizophrenia. Previous reports have shown potential changes in the trafficking of AMPA receptors based on subunit expression of endosomes, subcellular organelles located near post-synaptic sites. We hypothesized that alterations in AMPA receptor trafficking through the endoplasmic reticulum (ER) may also be altered in schizophrenia. Accordingly, we developed a technique to isolate and measure content of the ER from postmortem brain tissue. We used Western blot and electron microscopy to show that we isolated an ER enriched fraction. We found no changes in the expression of the AMPA receptor subunits, GluR1-4, in the ER from the dorsolateral prefrontal cortex in schizophrenia. These data suggest that AMPA receptor trafficking through the ER is largely intact in schizophrenia.	[Hammond, John C.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Hammond, John C.; Meador-Woodruff, James H.; McCullumsmith, Robert E.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Haroutunian, Vahram] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai	Hammond, JC (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	hammondj@uab.edu	McCullumsmith, Robert/GYR-1547-2022		NIMH [MH086257, MH53327, MH064673, MH066392, MH074016]; Doris Duke Clinical Scientist Award; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH074016, F30MH086257, R01MH064673, P50MH066392, R01MH053327] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided for by the NIMH grants by MH086257 (JCH), MH53327 (JMW), MH064673 (VH), MH066392 (VH), MH074016 (REM), and the Doris Duke Clinical Scientist Award (REM) (http://www.nimh.nih.gov) and (http://www.ddcf.org/Medical-Research/Program-Strategies/Clinical-Research/Clinical-Scientist-Development-Award/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneyto M, 2006, SYNAPSE, V60, P585, DOI 10.1002/syn.20329; Bond D, 2008, BIOL PROCED ONLINE, V10, P20, DOI 10.1251/bpo139; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; BREESE CR, 1995, BRAIN RES, V674, P82, DOI 10.1016/0006-8993(94)01384-T; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; CONTRACTOR A, 2002, SCI STKE, pRE14; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; DAVID V, 1993, J BIOL CHEM, V268, P9585; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; FITZGERALD LW, 1995, J NEUROSCI, V15, P2453, DOI 10.1523/JNEUROSCI.15-03-02453.1995; Fumagalli F, 2008, MOL PHARMACOL, V73, P1484, DOI 10.1124/mol.107.043786; Funk AJ, 2009, NEUROREPORT, V20, P1019, DOI 10.1097/WNR.0b013e32832d30d9; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Hammond J, 2011, SCHIZOPHREN IN PRESS; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Hanley JG, 2010, BIOCHEM SOC T, V38, P460, DOI 10.1042/BST0380460; Healy DJ, 1997, MOL BRAIN RES, V47, P331, DOI 10.1016/S0169-328X(97)00064-8; Hirling H, 2008, NEUROSCIENCE; Jiang JX, 2006, NEUROSIGNALS, V15, P266, DOI 10.1159/000105517; Kantrowitz J, 2009, HDB NEUROCHEMISTRY M, V2; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; Meador-Woodruff JH, 2001, BRAIN RES BULL, V55, P631, DOI 10.1016/S0361-9230(01)00523-8; O'Connor JA, 2007, SCHIZOPHR RES, V90, P28, DOI 10.1016/j.schres.2006.10.004; Ramirez OA, 2011, BIOL RES, V44, P17, DOI 10.4067/S0716-97602011000100004; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Toyooka K, 2002, J NEUROCHEM, V83, P797, DOI 10.1046/j.1471-4159.2002.01181.x; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735	34	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39190	10.1371/journal.pone.0039190	http://dx.doi.org/10.1371/journal.pone.0039190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720072	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800054
J	Ivankovic, S; Dermic, D				Ivankovic, Sinisa; Dermic, Damir			DNA End Resection Controls the Balance between Homologous and Illegitimate Recombination in Escherichia coli	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; WERNER-SYNDROME PROTEIN; RECBCD ENZYME; RECA PROTEIN; EXONUCLEASE-I; BINDING-PROTEIN; REPAIR; HELICASE; MUTANTS; PATHWAY	Even a partial loss of function of human RecQ helicase analogs causes adverse effects such as a cancer-prone Werner, Bloom or Rothmund-Thompson syndrome, whereas a complete RecQ deficiency in Escherichia coli is not deleterious for a cell. We show that this puzzling difference is due to different mechanisms of DNA double strand break (DSB) resection in E. coli and humans. Coupled helicase and RecA loading activities of RecBCD enzyme, which is found exclusively in bacteria, are shown to be responsible for channeling recombinogenic 3' ending tails toward productive, homologous and away from nonproductive, aberrant recombination events. On the other hand, in recB1080/recB1067 mutants, lacking RecBCD's RecA loading activity while preserving its helicase activity, DSB resection is mechanistically more alike that in eukaryotes (by its uncoupling from a recombinase polymerization step), and remarkably, the role of RecQ also becomes akin of its eukaryotic counterparts in a way of promoting homologous and suppressing illegitimate recombination. The sickly phenotype of recB1080 recQ mutant was further exacerbated by inactivation of an exonuclease I, which degrades the unwound 3' tail. The respective recB1080 recQ xonA mutant showed poor viability, DNA repair and homologous recombination deficiency, and very increased illegitimate recombination. These findings demonstrate that the metabolism of the 3' ending overhang is a decisive factor in tuning the balance of homologous and illegitimate recombination in E. coli, thus highlighting the importance of regulating DSB resection for preserving genome integrity. recB mutants used in this study, showing pronounced RecQ helicase and exonuclease I dependence, make up a suitable model system for studying mechanisms of DSB resection in bacteria. Also, these mutants might be useful for investigating functions of the conserved RecQ helicase family members, and congruently serve as a simpler, more defined model system for human oncogenesis.	[Ivankovic, Sinisa] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Dermic, Damir] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia	Rudjer Boskovic Institute; Rudjer Boskovic Institute	Ivankovic, S (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	dermic@irb.hr		Dermic, Damir/0000-0002-5263-2750; Ivankovic, Sinisa/0000-0001-7551-5111	Croatian Ministry of Science, Education and Sports [098-0982913-2862]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported by the Croatian Ministry of Science, Education and Sports (grant no. 098-0982913-2862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLGOOD ND, 1991, GENETICS, V127, P671; Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; BRODY RS, 1986, J BIOL CHEM, V261, P7136; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Dermic D, 2006, GENETICS, V172, P2057, DOI 10.1534/genetics.105.052076; Dermic D, 2005, RES MICROBIOL, V156, P304, DOI 10.1016/j.resmic.2004.10.005; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; IKEDA H, 1995, ADV BIOPHYS, V31, P197, DOI 10.1016/0065-227X(95)99392-3; Ikeda H, 2004, ADV BIOPHYS, V38, P3, DOI 10.1016/S0065-227X(04)80031-5; Ivancic-Bace I, 2005, J BACTERIOL, V187, P1350, DOI 10.1128/JB.187.4.1350-1356.2005; Ivancic-Bace I, 2003, GENETICS, V163, P485; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Jockovich ME, 2001, MOL MICROBIOL, V41, P949, DOI 10.1046/j.1365-2958.2001.02573.x; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KUMAGAI M, 1991, MOL GEN GENET, V230, P60, DOI 10.1007/BF00290651; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov Andrei, 2005, P349; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; MENDONCA VM, 1995, J BACTERIOL, V177, P1326, DOI 10.1128/jb.177.5.1326-1335.1995; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; NAKAYAMA K, 1985, MOL GEN GENET, V200, P266, DOI 10.1007/BF00425434; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SANDIGURSKY M, 1994, NUCLEIC ACIDS RES, V22, P247, DOI 10.1093/nar/22.2.247; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Thoms B, 2008, J BACTERIOL, V190, P179, DOI 10.1128/JB.01052-07; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; UMEZU K, 1994, J BIOL CHEM, V269, P30005; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; Viswanathan M, 1998, GENETICS, V149, P7; Yamaguchi H, 2000, GENES CELLS, V5, P101, DOI 10.1046/j.1365-2443.2000.00309.x; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127	57	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39030	10.1371/journal.pone.0039030	http://dx.doi.org/10.1371/journal.pone.0039030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720024	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347800040
J	Kang, Y; Deng, R; Wang, C; Deng, T; Peng, PC; Cheng, XX; Wang, GQ; Qian, MP; Gao, HF; Han, B; Chen, YS; Hu, YH; Geng, R; Hu, CP; Zhang, W; Yang, JP; Wan, HY; Yu, Q; Wei, LP; Li, JS; Tian, GZ; Wang, QY; Hu, K; Wang, SQ; Wang, RQ; Du, J; He, B; Ma, JJ; Zhong, XN; Mu, L; Cai, SX; Zhu, XD; Xing, WL; Yu, J; Deng, MH; Gao, ZC				Kang, Yu; Deng, Rui; Wang, Can; Deng, Tao; Peng, Peichao; Cheng, Xiaoxing; Wang, Guoqing; Qian, Minping; Gao, Huafang; Han, Bei; Chen, Yusheng; Hu, Yinghui; Geng, Rong; Hu, Chengping; Zhang, Wei; Yang, Jingping; Wan, Huanying; Yu, Qin; Wei, Liping; Li, Jiashu; Tian, Guizhen; Wang, Qiuyue; Hu, Ke; Wang, Siqin; Wang, Ruiqin; Du, Juan; He, Bei; Ma, Jianjun; Zhong, Xiaoning; Mu, Lan; Cai, Shaoxi; Zhu, Xiangdong; Xing, Wanli; Yu, Jun; Deng, Minghua; Gao, Zhancheng			Etiologic Diagnosis of Lower Respiratory Tract Bacterial Infections Using Sputum Samples and Quantitative Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							PNEUMONIA; LAMP; PCR; COLONIZATION; VIRUS; TESTS; ASSAY; DNA	Etiologic diagnoses of lower respiratory tract infections (LRTI) have been relying primarily on bacterial cultures that often fail to return useful results in time. Although DNA-based assays are more sensitive than bacterial cultures in detecting pathogens, the molecular results are often inconsistent and challenged by doubts on false positives, such as those due to system- and environment-derived contaminations. Here we report a nationwide cohort study on 2986 suspected LRTI patients across P. R. China. We compared the performance of a DNA-based assay qLAMP (quantitative Loop-mediated isothermal AMPlification) with that of standard bacterial cultures in detecting a panel of eight common respiratory bacterial pathogens from sputum samples. Our qLAMP assay detects the panel of pathogens in 1047(69.28%) patients from 1533 qualified patients at the end. We found that the bacterial titer quantified based on qLAMP is a predictor of probability that the bacterium in the sample can be detected in culture assay. The relatedness of the two assays fits a logistic regression curve. We used a piecewise linear function to define breakpoints where latent pathogen abruptly change its competitive relationship with others in the panel. These breakpoints, where pathogens start to propagate abnormally, are used as cutoffs to eliminate the influence of contaminations from normal flora. With help of the cutoffs derived from statistical analysis, we are able to identify causative pathogens in 750 (48.92%) patients from qualified patients. In conclusion, qLAMP is a reliable method in quantifying bacterial titer. Despite the fact that there are always latent bacteria contaminated in sputum samples, we can identify causative pathogens based on cutoffs derived from statistical analysis of competitive relationship.	[Peng, Peichao; Cheng, Xiaoxing; Qian, Minping; Deng, Minghua] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Peng, Peichao; Cheng, Xiaoxing; Qian, Minping; Deng, Minghua] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Kang, Yu; Deng, Rui; Gao, Zhancheng] Peking Univ, Peoples Hosp, Dept Resp & Crit Care Med, Beijing 100871, Peoples R China; [Kang, Yu; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wang, Can; Deng, Tao] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Wang, Guoqing; Gao, Huafang; Han, Bei; Xing, Wanli] Capitalbio Corp, Dept Assay Dev, Beijing, Peoples R China; [Chen, Yusheng] Fujian Prov Hosp, Dept Resp Med, Fuzhou, Peoples R China; [Hu, Yinghui] Capital Med Univ, Beijing Childrens Hosp, Dept Resp Med, Beijing, Peoples R China; [Geng, Rong] Capital Med Univ, Beijing Childrens Hosp, Dept Emergency Med, Beijing, Peoples R China; [Hu, Chengping] Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China; [Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Dept Resp Med, Nanchang, Peoples R China; [Yang, Jingping] Inner Mongolia Med Coll, Affiliated Hosp 3, Dept Resp & Crit Care Med, Baotou, Peoples R China; [Wan, Huanying] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Resp Med, Shanghai 200030, Peoples R China; [Yu, Qin] Lanzhou Univ, Hosp 1, Dept Resp Med, Lanzhou 730000, Peoples R China; [Wei, Liping] Guangzhou Med Univ, Affiliated Hosp 3, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Li, Jiashu] Xuzhou Med Coll, Lianyungang Peoples Hosp 1, Dept Resp Med, Lianyungang, Peoples R China; [Tian, Guizhen] Mil Gen Hosp Beijing, Clin Sect 263, Dept Resp Med, Beijing, Peoples R China; [Wang, Qiuyue] China Med Univ, Affiliated Hosp 1, Inst Resp Dis, Shenyang, Peoples R China; [Hu, Ke] Wuhan Univ, Renmin Hosp, Dept Resp Med, Wuhan 430072, Peoples R China; [Wang, Siqin] Henan Prov People Hosp, Dept Resp Med, Zhengzhou, Peoples R China; [Wang, Ruiqin] Tsinghua Univ, Affiliated Hosp 1, Dept Resp Med, Beijing 100084, Peoples R China; [Du, Juan] GuiYang Med Coll, Affiliated Hosp, Dept Resp Med, Guiyang, Peoples R China; [He, Bei] Peking Univ, Hosp 3, Dept Resp Med, Beijing 100871, Peoples R China; [Ma, Jianjun] Lanzhou Pulm Hosp, Dept Resp Med, Lanzhou, Peoples R China; [Zhong, Xiaoning] Guangxi Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanning, Peoples R China; [Mu, Lan] Peking Univ, Space Cent Hosp, Dept Resp Med, Beijing 100871, Peoples R China; [Cai, Shaoxi] So Med Univ, Nanfang Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Zhu, Xiangdong] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med MC 6076, Chicago, IL 60637 USA	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Tsinghua University; Fujian Provincial Hospital; Capital Medical University; Capital Medical University; Central South University; Nanchang University; Inner Mongolia Medical University; Shanghai Jiao Tong University; Lanzhou University; Guangzhou Medical University; Xuzhou Medical University; China Medical University; Wuhan University; Tsinghua University; Guizhou Medical University; Peking University; Guangxi Medical University; Peking University; Southern Medical University - China; University of Chicago	Deng, MH (corresponding author), Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China.	dengmh@pku.edu.cn; zcgao@bjmu.edu.cn	Deng, Minghua/B-1316-2012; wei, li/GSD-3630-2022; Deng, Minghua/B-5430-2012; 黎, 伟/GXM-4040-2022; Wang, Can/J-4222-2013	Deng, Minghua/0000-0002-9143-1898; Wang, Can/0000-0001-6115-0377; yang, jingping/0000-0002-5598-1016; zhu, xiangdong/0000-0002-5627-8082	Chinese Ministry of Science and Technology; Chinese government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese government	This study is completely funded by the Chinese Ministry of Science and Technology, and no external funding was received for this study, including Capitalbio Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In the manuscript, three authors are staffs of Beijing Capitalbio Corporation, which is also named as "National Engineering Research Center for Beijing Biochip Technology'', fully owned by the Chinese government. As a basic research, this study is completely funded by the Chinese government. National Engineering Research Center for Beijing Biochip Technology (Capitalbio Corporation) was one of the 23 cooperating institutes for this project. Based on this study, Capitalbio Corporation may develop products in the future. But currently there is no relevant patent or any product under development and in the market. This does not alter the authors'adherence to all the PLoS ONE policies on sharing data and materials.	Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Anevlavis S, 2010, EXPERT OPIN PHARMACO, V11, P361, DOI 10.1517/14656560903508770; Aoi Y, 2006, J BIOTECHNOL, V125, P484, DOI 10.1016/j.jbiotec.2006.04.007; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Cai ZJ, 2011, J CLIN VIROL, V52, P288, DOI 10.1016/j.jcv.2011.08.013; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Chinese Ministry of Health, 2010, CHIN HLTH STAT DIG 2; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Ding CM, 2004, J BIOCHEM MOL BIOL, V37, P1; Fang XE, 2010, ANAL CHEM, V82, P3002, DOI 10.1021/ac1000652; Geojith G, 2011, J MICROBIOL METH, V84, P71, DOI 10.1016/j.mimet.2010.10.015; Ieven M, 2007, J CLIN VIROL, V40, P259, DOI 10.1016/j.jcv.2007.08.012; Jensen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-140; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Liu You-ning, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P3; MacLean R, 2008, HEREDITY, V100, P471, DOI 10.1038/sj.hdy.6801073x; Monte SV, 2008, AM J MANAG CARE, V14, P190; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Poon LLM, 2006, CLIN CHEM, V52, P303; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Smith J, 2010, SCIENCE, V328, P1700, DOI 10.1126/science.1189675; SUNG RYT, 1993, CLIN INFECT DIS, V17, P894, DOI 10.1093/clinids/17.5.894; Wang Ying-Jian, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P184; Weinreich UM, 2008, CLIN RESPIR J, V2, P116, DOI 10.1111/j.1752-699X.2008.00048.x; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005; Zaki MES, 2009, AM J CLIN PATHOL, V131, P74, DOI 10.1309/AJCP34YZGEHERWRX	32	21	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38743	10.1371/journal.pone.0038743	http://dx.doi.org/10.1371/journal.pone.0038743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719933	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800015
J	Azzopardi, D; Strohm, B; Linsell, L; Hobson, A; Juszczak, E; Kurinczuk, JJ; Brocklehurst, P; Edwards, AD				Azzopardi, Denis; Strohm, Brenda; Linsell, Louise; Hobson, Anna; Juszczak, Edmund; Kurinczuk, Jennifer J.; Brocklehurst, Peter; Edwards, A. David		UK TOBY Cooling Register	Implementation and Conduct of Therapeutic Hypothermia for Perinatal Asphyxial Encephalopathy in the UK - Analysis of National Data	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; AMPLITUDE-INTEGRATED ELECTROENCEPHALOGRAM; WHOLE-BODY HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; SYSTEMIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CEREBRAL-PALSY; PROGNOSTIC VALUE; NEWBORN-INFANTS; TRIAL	Background: Delay in implementing new treatments into clinical practice results in considerable health and economic opportunity costs. Data from the UK TOBY Cooling Register provides the opportunity to examine how one new effective therapy for newborn infants suspected of suffering asphyxial encephalopathy - therapeutic hypothermia-was implemented in the UK. Methodology/Principal Findings: We analysed returned data forms from inception of the Register in December 2006 to the end of July 2011. Data forms were received for 1384 (67%) of the 2069 infants registered. The monthly rate of notifications increased from median {IQR} 18 {15-31} to 33 {30-39} after the announcement of the results of the recent TOBY trial, and to 50 {36-55} after their publication. This rate further increased to 70 {64-83} following official endorsement of the therapy, and is now close to the expected numbers of eligible infants. Cooling was started at 3.3 {1.5-5.5} hours after birth and the time taken to achieve the target 33-34 degrees C rectal temperature was 1 {0-3} hours. The rectal temperature was in the target range in 83% of measurements. From 2006 to 2011 there was evidence of extension of treatment to slightly less severely affected infants. 278 of 1362 (20%) infants died at 2.9 {1.4-4.1} days of age. The rates of death fell slightly over the period of the Register and, at two years of age cerebral palsy was diagnosed in 22% of infants; half of these were spastic bilateral. Factors independently associated with adverse outcome were clinical seizures prior to cooling (p<0.001) and severely abnormal amplitude integrated EEG (p<0.001). Conclusions/Significance: Therapeutic hypothermia was implemented appropriately within the UK, with significant benefit to patients and the health economy. This may be due in part to participation by neonatal units in clinical trials, the establishment of the national Register, and its endorsement by advisory bodies.	[Azzopardi, Denis; Edwards, A. David] Univ London Imperial Coll Sci Technol & Med, Ctr Developing Brain, London, England; [Strohm, Brenda; Linsell, Louise; Hobson, Anna; Juszczak, Edmund; Kurinczuk, Jennifer J.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Brocklehurst, Peter] UCL, Inst Womens Hlth, London, England	Imperial College London; University of Oxford; University of London; University College London	Azzopardi, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Developing Brain, London, England.	d.azzopardi@imperial.ac.uk	Edwards, Anthony/HCI-9626-2022	Edwards, Anthony David/0000-0003-4801-7066	Medical Research Council [G0200270, MC_U120081323, G0100126] Funding Source: Medline; MRC [MC_U120081323, G0200270, G0100126] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AZZOPARDI D, 1989, PEDIATR RES, V25, P445, DOI 10.1203/00006450-198905000-00004; Azzopardi D, 2009, ARCH DIS CHILD-FETAL, V94, pF260, DOI 10.1136/adc.2008.146977; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Blackmon LR, 2006, PEDIATRICS, V117, P942, DOI 10.1542/peds.2005-2950; British Association of Perinatal Medicine, 2010, POS STAT THER COD NE; Cooksey D., 2006, REV UK HLTH RES FUND; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Evans K, 2001, J Obstet Gynaecol, V21, P114, DOI 10.1080/01443610020025967; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Grosse SD, 2009, MED CARE, V47, pS94, DOI 10.1097/MLR.0b013e31819c9571; Gunn AJ, 2005, J PERINAT MED, V33, P340, DOI 10.1515/JPM.2005.061; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Gunn AJ, 2008, J PEDIATR-US, V152, P55, DOI 10.1016/j.jpeds.2007.06.003; Hallberg B, 2010, ACTA PAEDIATR, V99, P531, DOI 10.1111/j.1651-2227.2009.01653.x; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Jacobs SE, 2011, ARCH PEDIAT ADOLESC; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kruse M, 2009, DEV MED CHILD NEUROL, V51, P622, DOI 10.1111/j.1469-8749.2008.03190.x; Li Tongchuan, 2009, Hosp Pract (1995), V37, P147, DOI 10.3810/hp.2009.12.269; National Institute for Health and Clinical Excellence, 2010, THER HYP INTR TEMP M; Office for national statistics UK, 2011, UK 13 7 2011 BIRTHS; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Regier DA, 2010, VALUE HEALTH, V13, P695, DOI 10.1111/j.1524-4733.2010.00731.x; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2011, PEDIATRICS, V128, pE112, DOI 10.1542/peds.2010-2036; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Smith J, 2000, BRIT J OBSTET GYNAEC, V107, P461, DOI 10.1111/j.1471-0528.2000.tb13262.x; Strohm B, 2011, PEDIATRICS, V128, pE450, DOI 10.1542/peds.2010-3508; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030	38	93	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38504	10.1371/journal.pone.0038504	http://dx.doi.org/10.1371/journal.pone.0038504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719897	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900033
J	Cho, MK; Xiang, SQ; Kim, HY; Becker, S; Zweckstetter, M				Cho, Min-Kyu; Xiang, ShengQi; Kim, Hai-Young; Becker, Stefan; Zweckstetter, Markus			Cold-Induced Changes in the Protein Ubiquitin	PLOS ONE			English	Article							SUPERCOOLED WATER; HYDROGEN-BONDS; STRUCTURAL BIOLOGY; NMR-SPECTROSCOPY; DENATURATION; COUPLINGS; DYNAMICS; BIOMOLECULES; (3H)J(NC'); ENSEMBLE	Conformational changes are essential for protein-protein and protein-ligand recognition. Here we probed changes in the structure of the protein ubiquitin at low temperatures in supercooled water using NMR spectroscopy. We demonstrate that ubiquitin is well folded down to 263 K, although slight rearrangements in the hydrophobic core occur. However, amide proton chemical shifts show non-linear temperature dependence in supercooled solution and backbone hydrogen bonds become weaker in the region that is most prone to cold-denaturation. Our data suggest that the weakening of the hydrogen bonds in the beta-sheet of ubiquitin might be one of the first events that occur during cold-denaturation of ubiquitin. Interestingly, the same region is strongly involved in ubiquitin-protein complexes suggesting that this part of ubiquitin more easily adjusts to conformational changes required for complex formation.	[Cho, Min-Kyu; Xiang, ShengQi; Kim, Hai-Young; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany	Max Planck Society	Cho, MK (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany.	mzwecks@gwdg.de	Cho, Min-Kyu/H-1303-2011	Cho, Min-Kyu/0000-0003-0537-2340; Zweckstetter, Markus/0000-0002-2536-6581	Max Planck Society; DFG (Deutsche Forschungsgemeinschaft) [ZW 71/2-2, 3-2]	Max Planck Society(Max Planck Society); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the Max Planck Society and the DFG (Deutsche Forschungsgemeinschaft) (ZW 71/2-2 and 3-2 to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover M, 2010, J AM CHEM SOC, V132, P16240, DOI 10.1021/ja1070174; Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739; Ban D, 2011, ANGEW CHEM INT EDIT, V50, P11437, DOI 10.1002/anie.201105086; Baxter NJ, 1998, J MOL BIOL, V284, P1625, DOI 10.1006/jmbi.1998.2265; Cierpicki T, 2002, J MAGN RESON, V157, P178, DOI 10.1006/jmre.2002.2597; Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498; Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024; Davidovic M, 2009, J AM CHEM SOC, V131, P1025, DOI 10.1021/ja8056419; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Hilser VJ, 1996, J MOL BIOL, V262, P756, DOI 10.1006/jmbi.1996.0550; Kim HY, 2007, CHEMBIOCHEM, V8, P1671, DOI 10.1002/cbic.200700366; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Massi F, 2005, PROTEIN SCI, V14, P735, DOI 10.1110/ps.041139505; Mills JL, 2002, J BIOMOL NMR, V23, P63, DOI 10.1023/A:1015397305148; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Peti W, 2001, J BIOMOL NMR, V19, P153, DOI 10.1023/A:1008307323283; Pometun MS, 2006, J AM CHEM SOC, V128, P10652, DOI 10.1021/ja0628654; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Schroeder KT, 2005, RNA, V11, P1012, DOI 10.1261/rna.2270205; Shan B, 2010, J AM CHEM SOC, V132, P4669, DOI 10.1021/ja908104s; Shen Y, 2008, ANGEW CHEM INT EDIT, V47, P324, DOI 10.1002/anie.200702842; Sidhu A, 2011, J MOL BIOL, V411, P1037, DOI 10.1016/j.jmb.2011.06.044; Skalicky JJ, 2000, J AM CHEM SOC, V122, P3230, DOI 10.1021/ja9938884; Skalicky JJ, 2001, J AM CHEM SOC, V123, P388, DOI 10.1021/ja003220l; Szyperski Thomas, 2011, Journal of Structural and Functional Genomics, V12, P1, DOI 10.1007/s10969-011-9111-5; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Vertrees J, 2005, BIOINFORMATICS, V21, P3318, DOI 10.1093/bioinformatics/bti520; Zar JH., 1999, BIOSTAT ANAL; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	35	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e37270	10.1371/journal.pone.0037270	http://dx.doi.org/10.1371/journal.pone.0037270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737208	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100003
J	Chen, WHC; Kawasaki, N; Nycholat, CM; Han, SF; Pilotte, J; Crocker, PR; Paulson, JC				Chen, Weihsu C.; Kawasaki, Norihito; Nycholat, Corwin M.; Han, Shoufa; Pilotte, Julie; Crocker, Paul R.; Paulson, James C.			Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169	PLOS ONE			English	Article							LYMPH-NODE; B-CELLS; RECEPTOR SIALOADHESIN; IMMUNE-RESPONSES; BINDING-RECEPTOR; DENDRITIC CELLS; IN-VITRO; T-CELLS; LEWIS-X; LIGANDS	Sialoadhesin (Sn, Siglec-1, CD169) is a member of the sialic acid binding Ig-like lectin (siglec) family expressed on macrophages. Its macrophage specific expression makes it an attractive target for delivering antigens to tissue macrophages via Sn-mediated endocytosis. Here we describe a novel approach for delivering antigens to macrophages using liposomal nanoparticles displaying high affinity glycan ligands of Sn. The Sn-targeted liposomes selectively bind to and are internalized by Sn-expressing cells, and accumulate intracellularly over time. Our results show that ligand decorated liposomes are specific for Sn, since they are taken up by bone marrow derived macrophages that are derived from wild type but not Sn-/- mice. Importantly, the Sn-targeted liposomes dramatically enhance the delivery of antigens to macrophages for presentation to and proliferation of antigen-specific T cells. Together, these data provide insights into the potential of cell-specific targeting and delivery of antigens to intracellular organelles of macrophages using Sn-ligand decorated liposomal nanoparticles.	[Chen, Weihsu C.; Kawasaki, Norihito; Nycholat, Corwin M.; Han, Shoufa; Pilotte, Julie; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Chen, Weihsu C.; Kawasaki, Norihito; Nycholat, Corwin M.; Han, Shoufa; Pilotte, Julie; Paulson, James C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Crocker, Paul R.] Univ Dundee, Coll Life Sci, Wellcome Trust Bioctr, Dundee, Scotland	Scripps Research Institute; Scripps Research Institute; University of Dundee	Chen, WHC (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019	Crocker, Paul/0000-0001-6230-0293	National Institutes of Health [AI050143, CA13889, HL107151]; NATIONAL CANCER INSTITUTE [R01CA138891] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI050143, CA13889 and HL107151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanoudse CA, 2008, INT J CANCER, V122, P839, DOI 10.1002/ijc.23101; Adams EW, 2008, CHEMBIOCHEM, V9, P294, DOI 10.1002/cbic.200700310; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Blixt O, 2008, J AM CHEM SOC, V130, P6680, DOI 10.1021/ja801052g; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen WC, 2010, BLOOD, V115, P4778, DOI 10.1182/blood-2009-12-257386; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2008, BIOCHEM SOC T, V36, P1467, DOI 10.1042/BST0361467; Delputte PL, 2007, J INTERF CYTOK RES, V27, P757, DOI 10.1089/jir.2007.0001; Delputte PL, 2007, J VIROL, V81, P9546, DOI 10.1128/JVI.00569-07; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; DiJoseph JF, 2007, LEUKEMIA, V21, P2240, DOI 10.1038/sj.leu.2404866; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; Gersuk GM, 2008, J IMMUNOL METHODS, V329, P157, DOI 10.1016/j.jim.2007.10.003; Graham SA, 2009, J BIOL CHEM, V284, P18537, DOI 10.1074/jbc.M109.012807; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hudson SA, 2009, J PHARMACOL EXP THER, V330, P608, DOI 10.1124/jpet.109.152439; Ikehara Y, 2008, CANCER LETT, V260, P137, DOI 10.1016/j.canlet.2007.10.038; Irache JM, 2008, EXPERT OPIN DRUG DEL, V5, P703, DOI 10.1517/17425247.5.6.703 ; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Kawasaki N, 2011, J INNATE IMMUN, V3, P411, DOI 10.1159/000322375; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Kojima N, 2008, J CONTROL RELEASE; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Nakamura K, 2002, GLYCOBIOLOGY, V12, P209, DOI 10.1093/glycob/12.3.209; O'Reilly MK, 2011, J IMMUNOL, V186, P1554, DOI 10.4049/jimmunol.1003005; O'Reilly MK, 2010, METHOD ENZYMOL, V478, P343, DOI 10.1016/S0076-6879(10)78017-4; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Poderoso T, 2011, VACCINE, V29, P4813, DOI 10.1016/j.vaccine.2011.04.076; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Singh SK, 2011, EUR J IMMUNOL, V41, P916, DOI 10.1002/eji.201040762; Singh SK, 2009, MOL IMMUNOL, V47, P164, DOI 10.1016/j.molimm.2009.09.026; Tang CK, 2007, IMMUNOLOGY, V120, P325, DOI 10.1111/j.1365-2567.2006.02506.x; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yokoi H, 2008, J ALLERGY CLIN IMMUN, V121, P499, DOI 10.1016/j.jaci.2007.10.004; Zaccai NR, 2003, STRUCTURE, V11, P557, DOI 10.1016/S0969-2126(03)00073-X	47	296	300	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39039	10.1371/journal.pone.0039039	http://dx.doi.org/10.1371/journal.pone.0039039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723922	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700045
J	Kurosaki, T; Ueda, S; Ishida, T; Abe, K; Ohno, K; Matsuura, T				Kurosaki, Tatsuaki; Ueda, Shintaroh; Ishida, Takafumi; Abe, Koji; Ohno, Kinji; Matsuura, Tohru			The Unstable CCTG Repeat Responsible for Myotonic Dystrophy Type 2 Originates from an AluSx Element Insertion into an Early Primate Genome	PLOS ONE			English	Article							GENETIC INSTABILITY; EXPANSION; MUTATION; AMPLIFICATION; HAPLOTYPE; FAMILY	Myotonic dystrophy type 2 (DM2) is a subtype of the myotonic dystrophies, caused by expansion of a tetranucleotide CCTG repeat in intron 1 of the zinc finger protein 9 (ZNF9) gene. The expansions are extremely unstable and variable, ranging from 75-11,000 CCTG repeats. This unprecedented repeat size and somatic heterogeneity make molecular diagnosis of DM2 difficult, and yield variable clinical phenotypes. To better understand the mutational origin and instability of the ZNF9 CCTG repeat, we analyzed the repeat configuration and flanking regions in 26 primate species. The 39-end of an AluSx element, flanked by target site duplications (5'-ACTRCCAR-3' or 5'-ACTRCCARTTA-3'), followed the CCTG repeat, suggesting that the repeat was originally derived from the Alu element insertion. In addition, our results revealed lineage-specific repetitive motifs: pyrimidine (CT)-rich repeat motifs in New World monkeys, dinucleotide (TG) repeat motifs in Old World monkeys and gibbons, and dinucleotide (TG) and tetranucleotide (TCTG and/or CCTG) repeat motifs in great apes and humans. Moreover, these di-and tetra-nucleotide repeat motifs arose from the poly (A) tail of the AluSx element, and evolved into unstable CCTG repeats during primate evolution. Alu elements are known to be the source of microsatellite repeats responsible for two other repeat expansion disorders: Friedreich ataxia and spinocerebellar ataxia type 10. Taken together, these findings raise questions as to the mechanism(s) by which Alu-mediated repeats developed into the large, extremely unstable expansions common to these three disorders.	[Kurosaki, Tatsuaki; Ohno, Kinji; Matsuura, Tohru] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Ueda, Shintaroh; Ishida, Takafumi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Abe, Koji; Matsuura, Tohru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama, Japan	Nagoya University; University of Tokyo; Okayama University	Kurosaki, T (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14627 USA.	tohrum@cc.okayama-u.ac.jp	Kurosaki, Tatsuaki/AAR-6251-2021; Ohno, Kinji/H-4020-2012; Ohno, Kinji/ABD-5787-2020; Kurosaki, Tatsuaki/F-9949-2014	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Kurosaki, Tatsuaki/0000-0003-3231-1359	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in Aid from the Ministry of Education, Culture, Sports, Science, and Technology as well as the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Bachinski LL, 2009, NEUROLOGY, V72, P490, DOI 10.1212/01.wnl.0000333665.01888.33; Bachinski LL, 2003, AM J HUM GENET, V73, P835, DOI 10.1086/378566; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chauhan C, 2002, J BIOMOL STRUCT DYN, V20, P253, DOI 10.1080/07391102.2002.10506841; Clark RM, 2004, GENOMICS, V83, P373, DOI 10.1016/j.ygeno.2003.09.001; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dere R, 2004, J BIOL CHEM, V279, P41715, DOI 10.1074/jbc.M406415200; Dere R, 2006, J MOL BIOL, V360, P21, DOI 10.1016/j.jmb.2006.05.012; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Justice CM, 2001, J MOL EVOL, V52, P232, DOI 10.1007/s002390010151; Kass DH, 1996, J MOL EVOL, V42, P7, DOI 10.1007/BF00163205; Kelkar YD, 2011, GENOME RES, V21, P2038, DOI 10.1101/gr.122937.111; Kim J, 1996, J MOL BIOL, V261, P322, DOI 10.1006/jmbi.1996.0464; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kurosaki T, 2009, MOL BIOL EVOL, V26, P2573, DOI 10.1093/molbev/msp172; Lam SL, 2011, NUCLEIC ACIDS RES, V39, P6260, DOI 10.1093/nar/gkr185; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liquori CL, 2003, AM J HUM GENET, V73, P849, DOI 10.1086/378720; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2004, AM J HUM GENET, V74, P1216, DOI 10.1086/421526; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Montermini L, 1997, NEUROLOGY, V49, P606, DOI 10.1212/WNL.49.2.606; Nakayama K, 2006, GENOME RES, V16, P485, DOI 10.1101/gr.4763906; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Saito T, 2008, NEUROGENETICS, V9, P61, DOI 10.1007/s10048-007-0110-4; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schoser BGH, 2004, BRAIN, V127, P1868, DOI 10.1093/brain/awh210; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Udd B, 1997, NEUROMUSCULAR DISORD, V7, P217, DOI 10.1016/S0960-8966(97)00041-2; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	44	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38379	10.1371/journal.pone.0038379	http://dx.doi.org/10.1371/journal.pone.0038379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723857	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700015
J	Meguro, A; Ideta, H; Ota, M; Ito, N; Ideta, R; Yonemoto, J; Takeuchi, M; Uemoto, R; Nishide, T; Iijima, Y; Kawagoe, T; Okada, E; Shiota, T; Hagihara, Y; Oka, A; Inoko, H; Mizuki, N				Meguro, Akira; Ideta, Hidenao; Ota, Masao; Ito, Norihiko; Ideta, Ryuichi; Yonemoto, Junichi; Takeuchi, Masaki; Uemoto, Riyo; Nishide, Tadayuki; Iijima, Yasuhito; Kawagoe, Tatsukata; Okada, Eiichi; Shiota, Tomoko; Hagihara, Yuta; Oka, Akira; Inoko, Hidetoshi; Mizuki, Nobuhisa			Common Variants in the COL4A4 Gene Confer Susceptibility to Lattice Degeneration of the Retina	PLOS ONE			English	Article							BENIGN FAMILIAL HEMATURIA; ASSOCIATION ANALYSIS; ALPORT-SYNDROME; DETACHMENT; MUTATIONS; COLLAGEN; DISEASE	Lattice degeneration of the retina is a vitreoretinal disorder characterized by a visible fundus lesion predisposing the patient to retinal tears and detachment. The etiology of this degeneration is still uncertain, but it is likely that both genetic and environmental factors play important roles in its development. To identify genetic susceptibility regions for lattice degeneration of the retina, we performed a genome-wide association study (GWAS) using a dense panel of 23,465 microsatellite markers covering the entire human genome. This GWAS in a Japanese cohort (294 patients with lattice degeneration and 294 controls) led to the identification of one microsatellite locus, D2S0276i, in the collagen type IV alpha 4 (COL4A4) gene on chromosome 2q36.3. To validate the significance of this observation, we evaluated the D2S0276i region in the GWAS cohort and in an independent Japanese cohort (280 patients and 314 controls) using D2S0276i and 47 single nucleotide polymorphisms covering the region. The strong associations were observed in D2S0276i and rs7558081 in the COL4A4 gene (Pc = 5.8x10(-6), OR = 0.63 and Pc = 1.0x10(-5), OR = 0.69 in a total of 574 patients and 608 controls, respectively). Our findings suggest that variants in the COL4A4 gene may contribute to the development of lattice degeneration of the retina.	[Meguro, Akira; Ito, Norihiko; Yonemoto, Junichi; Takeuchi, Masaki; Uemoto, Riyo; Nishide, Tadayuki; Iijima, Yasuhito; Kawagoe, Tatsukata; Shiota, Tomoko; Hagihara, Yuta; Mizuki, Nobuhisa] Yokohama City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Ideta, Hidenao; Ideta, Ryuichi] Ideta Eye Hosp, Kumamoto, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Okada, Eiichi] Okada Eye Clin, Yokohama, Kanagawa, Japan; [Oka, Akira; Inoko, Hidetoshi] Tokai Univ, Sch Med, Div Mol Life Sci, Dept Genet Informat, Isehara, Kanagawa 25911, Japan	Yokohama City University; Shinshu University; Tokai University	Meguro, A (corresponding author), Yokohama City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	mizunobu@med.yokohama-cu.ac.jp	Ito, Norihiko/ABD-3147-2021	Ota, Masao/0000-0002-6400-5658	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [16209052, 20592052]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (# 16209052, N. Mizuki; # 20592052, Y. Iijima; http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVSHALOM A, 1967, AM J OPHTHALMOL, V64, P387, DOI 10.1016/0002-9394(67)92001-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buzza M, 2003, KIDNEY INT, V63, P447, DOI 10.1046/j.1523-1755.2003.00780.x; Byer N E, 1965, Trans Am Acad Ophthalmol Otolaryngol, V69, P1065; BYER NE, 1979, SURV OPHTHALMOL, V23, P213, DOI 10.1016/0039-6257(79)90048-1; Collins HE, 2000, HUM GENET, V106, P218, DOI 10.1007/s004390051031; FOOS RY, 1984, OPHTHALMOLOGY, V91, P452; Gross O, 2003, NEPHROL DIAL TRANSPL, V18, P1122, DOI 10.1093/ndt/gfg157; HEDRICK PW, 1987, GENETICS, V117, P331; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hui J, 2008, HUM GENET, V123, P297, DOI 10.1007/s00439-008-0477-9; Kawashima M, 2006, AM J HUM GENET, V79, P252, DOI 10.1086/505539; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; MADJAROV B, 1995, RETINA-J RET VIT DIS, V15, P282, DOI 10.1097/00006982-199515040-00002; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Michikawa Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-123; MURAKAMI F, 1982, OPHTHALMOLOGICA, V185, P136, DOI 10.1159/000309235; Oka A, 2003, TISSUE ANTIGENS, V61, P203, DOI 10.1034/j.1399-0039.2003.00007.x; Pescucci C, 2004, KIDNEY INT, V65, P1598, DOI 10.1111/j.1523-1755.2004.00560.x; Sato K, 1971, Nippon Ganka Gakkai Zasshi, V75, P635; Sato K, 1972, Mod Probl Ophthalmol, V10, P133; Shaikh S, 2003, RETINA-J RET VIT DIS, V23, P119, DOI 10.1097/00006982-200302000-00025; Slajpah M, 2007, KIDNEY INT, V71, P1287, DOI 10.1038/sj.ki.5002221; STRAATSMA BR, 1974, T AM ACAD OPHTHALMOL, V78, pOP87; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Vega BT, 2003, AM J KIDNEY DIS, V42, P952, DOI 10.1016/j.ajkd.2003.08.002; Yatsu K, 2007, HYPERTENSION, V49, P446, DOI 10.1161/01.HYP.0000257256.77680.02	28	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39300	10.1371/journal.pone.0039300	http://dx.doi.org/10.1371/journal.pone.0039300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723992	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700065
J	Sawada, D; Nishiyama, Y; Langan, P; Forsyth, VT; Kimura, S; Wada, M				Sawada, Daisuke; Nishiyama, Yoshiharu; Langan, Paul; Forsyth, V. Trevor; Kimura, Satoshi; Wada, Masahisa			Water in Crystalline Fibers of Dihydrate beta-Chitin Results in Unexpected Absence of Intramolecular Hydrogen Bonding	PLOS ONE			English	Article							SYNCHROTRON X-RAY; CELLULOSE-II; NEUTRON-DIFFRACTION; TRANSITION; INSIGHTS; SYSTEM; HYDRATION	The complete crystal structure (including hydrogen) of dihydrate beta-chitin, a homopolymer of N-acetylglucosamine hydrate, was determined using high-resolution X-ray and neutron fiber diffraction data collected from bathophilous tubeworm Lamellibrachia satsuma. Two water molecules per N-acetylglucosamine residue are clearly localized in the structure and these participate in most of the hydrogen bonds. The conformation of the labile acetamide groups and hydroxymethyl groups are similar to those found in anhydrous beta-chitin, but more relaxed. Unexpectedly, the intrachain O-3-H center dot center dot center dot O5 hydrogen bond typically observed for crystalline beta, 1-4 glycans is absent, providing important insights into its relative importance and its relationship to solvation.	[Sawada, Daisuke; Kimura, Satoshi; Wada, Masahisa] Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Tokyo, Japan; [Nishiyama, Yoshiharu] CNRS, Ctr Rech Macromol Vegetales, CERMAV, F-38041 Grenoble, France; [Langan, Paul] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN USA; [Forsyth, V. Trevor] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [Forsyth, V. Trevor] Keele Univ, EPSAM, ISTM, Keele, Staffs, England; [Kimura, Satoshi; Wada, Masahisa] Kyung Hee Univ, Dept Plant & Environm New Resources, Coll Life Sci, Yongin, Gyeonggi Do, South Korea	University of Tokyo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); United States Department of Energy (DOE); Oak Ridge National Laboratory; Institut Laue-Langevin (ILL); Keele University; Kyung Hee University	Sawada, D (corresponding author), Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Tokyo, Japan.	utkspecial@hotmail.com	Nishiyama, Yoshiharu/A-3492-2012; Langan, Paul/N-5237-2015; Forsyth, V. Trevor/A-9129-2010	Nishiyama, Yoshiharu/0000-0003-4069-2307; Langan, Paul/0000-0002-0247-3122; Forsyth, V. Trevor/0000-0003-0380-3477	Japan Society for the Promotion of Science [21/1330]; Agence National de la Recherche [ANR-07-JCJC-21]; Office of Biological and Environmental Research, United States Department of Energy [FWP ERKP752]; Engineering and Physical Sciences Research Council [GR/R47950/01, GR/R99393/01, EP/C015452/1]; EPSRC [EP/C015452/1] Funding Source: UKRI	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agence National de la Recherche(French National Research Agency (ANR)); Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by Japan Society for the Promotion of Science, under 21/1330 http://www.jsps.go.jp/english/index.html. Part of the study was financed by the Agence National de la Recherche (ANR-07-JCJC-21) http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/Genomic Science Program, Office of Biological and Environmental Research, United States Department of Energy, under Contract FWP ERKP752. http://genomicscience.energy.gov/. Engineering and Physical Sciences Research Council under grants GR/R47950/01, GR/R99393/01, EP/C015452/1. http://www.epsrc.ac.uk/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKWEL.J, 1969, BIOPOLYMERS, V7, P281, DOI 10.1002/bip.1969.360070302; BLACKWELL J, 1965, J MAR BIOL ASSOC UK, V45, P659, DOI 10.1017/S0025315400016489; BLACKWELL J, 1967, J MOL BIOL, V28, P383, DOI 10.1016/S0022-2836(67)80018-4; Blackwell J, 1973, BIOPOLYMERS, P464; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRARIS G, 1972, ACTA CRYSTALLOGR B, V28, P3572, DOI 10.1107/S0567740872008362; FORSYTH VT, 1989, INT J BIOL MACROMOL, V11, P236, DOI 10.1016/0141-8130(89)90075-5; French AD, 2005, TETRAHEDRON-ASYMMETR, V16, P577, DOI 10.1016/j.tetasy.2004.12.007; French AD, 2004, CELLULOSE, V11, P5, DOI 10.1023/B:CELL.0000014765.94239.fe; French AD, 1989, CELLULOSE WOOD CHEM; Fuller W, 2004, PHILOS T R SOC B, V359, P1237, DOI 10.1098/rstb.2004.1501; Gardner KH, 2004, MACROMOLECULES, V37, P9654, DOI 10.1021/ma048445l; Haupt M, 2011, ACTA CRYSTALLOGR F, V67, P1428, DOI 10.1107/S1744309111036244; ICHIKAWA K, 1991, MOL PHYS, V73, P79, DOI 10.1080/00268979100101071; Igarashi K, 2007, FEBS J, V274, P1785, DOI 10.1111/j.1742-4658.2007.05727.x; Jeffrey GA, 1994, HYDROGEN BONDING BIO; KAMIDE K, 1985, POLYM J, V17, P701, DOI 10.1295/polymj.17.701; Kobayashi K, 2011, CARBOHYD POLYM, V86, P975, DOI 10.1016/j.carbpol.2011.05.050; Kobayashi K, 2011, CARBOHYD POLYM, V83, P483, DOI 10.1016/j.carbpol.2010.08.006; Kobayashi K, 2010, CARBOHYD POLYM, V80, P491, DOI 10.1016/j.carbpol.2009.12.009; Kobayashi K, 2010, CARBOHYD POLYM, V79, P882, DOI 10.1016/j.carbpol.2009.10.020; Langan P, 1999, J AM CHEM SOC, V121, P9940, DOI 10.1021/ja9916254; Langan P, 1996, J APPL CRYSTALLOGR, V29, P383, DOI 10.1107/S0021889896002816; Langan P, 2001, BIOMACROMOLECULES, V2, P410, DOI 10.1021/bm005612q; LANGAN P, 1992, J BIOMOL STRUCT DYN, V10, P489, DOI 10.1080/07391102.1992.10508664; MAHENDRASINGAM A, 1992, PHYSICA B, V180, P528, DOI 10.1016/0921-4526(92)90813-8; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MO F, 1979, ACTA CHEM SCAND A, V33, P207, DOI 10.3891/acta.chem.scand.33a-0207; MO F, 1978, ACTA CRYSTALLOGR B, V34, P1562, DOI 10.1107/S0567740878006081; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Nishiyama Y, 2008, BIOMACROMOLECULES, V9, P3133, DOI 10.1021/bm800726v; Nishiyama Y, 2011, MACROMOLECULES, V44, P950, DOI 10.1021/ma102240r; Nishiyama Y, 2010, ACTA CRYSTALLOGR D, V66, P1172, DOI 10.1107/S0907444910032397; Noishiki Y, 2004, MACROMOLECULES, V37, P6839, DOI 10.1021/ma0489265; Parthasarathi R, 2011, J PHYS CHEM A, V115, P14191, DOI 10.1021/jp203620x; Rudall K. M., 1963, P257; Saito Y, 2000, INT J BIOL MACROMOL, V28, P81, DOI 10.1016/S0141-8130(00)00147-1; Saito Y., 1997, ADV CHITIN SCI, V2, P507; Sawada D, 2012, BIOMACROMOLECULES, V13, P288, DOI 10.1021/bm201512t; Sheldrick G. M., 1997, SHELX 97 PROGRAM REF; Shen TY, 2009, J AM CHEM SOC, V131, P14786, DOI 10.1021/ja9034158; Shotton MW, 1997, BIOPHYS CHEM, V69, P85, DOI 10.1016/S0301-4622(97)00090-2; Shotton MW, 1998, J APPL CRYSTALLOGR, V31, P758, DOI 10.1107/S0021889898005287; Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e; TANNER SF, 1990, MACROMOLECULES, V23, P3576, DOI 10.1021/ma00217a008; Thibaudeau C, 2004, J AM CHEM SOC, V126, P15668, DOI 10.1021/ja0306718; Tiggelaar SM, 2011, ACTA CRYSTALLOGR F, V67, P332, DOI 10.1107/S1744309111002351; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Wada M, 2006, MACROMOLECULES, V39, P2947, DOI 10.1021/ma060228s; Wada M, 2011, CELLULOSE, V18, P191, DOI 10.1007/s10570-010-9488-5; Wada M, 2009, CELLULOSE, V16, P943, DOI 10.1007/s10570-009-9338-5; Wada M, 2009, BIOMACROMOLECULES, V10, P302, DOI 10.1021/bm8010227	54	52	52	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39376	10.1371/journal.pone.0039376	http://dx.doi.org/10.1371/journal.pone.0039376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724007	Green Submitted, Green Published, gold			2022-12-27	WOS:000305652700072
J	Agren, J; Sundstrom, A; Hafstrom, T; Segerman, B				Agren, Joakim; Sundstrom, Anders; Hafstrom, Therese; Segerman, Bo			Gegenees: Fragmented Alignment of Multiple Genomes for Determining Phylogenomic Distances and Genetic Signatures Unique for Specified Target Groups	PLOS ONE			English	Article							BACILLUS-CEREUS GROUP; ANTHRACIS; SEQUENCE; THURINGIENSIS; OUTBREAK; STRAINS; FOOD	The rapid development of Next Generation Sequencing technologies leads to the accumulation of huge amounts of sequencing data. The scientific community faces an enormous challenge in how to deal with this explosion. Here we present a software tool, 'Gegenees', that uses a fragmented alignment approach to facilitate the comparative analysis of hundreds of microbial genomes. The genomes are fragmented and compared, all against all, by a multithreaded BLAST control engine. Ready-made alignments can be complemented with new genomes without recalculating the existing data points. Gegenees gives a phylogenomic overview of the genomes and the alignment can then be mined for genomic regions with conservation patterns matching a defined target group and absent from a background group. The genomic regions are given biomarker scores forming a uniqueness signature that can be viewed and explored, graphically and in tabular form. A primer/probe alignment tool is also included for specificity verification of currently used or new primers. We exemplify the use of Gegenees on the Bacillus cereus group, on Foot and Mouth Disease Viruses, and on strains from the 2011 Escherichia coli O104:H4 outbreak. Gegenees contributes towards an increased capacity of fast and efficient data mining as more and more genomes become sequenced.	[Agren, Joakim; Sundstrom, Anders; Hafstrom, Therese; Segerman, Bo] Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden; [Agren, Joakim] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Agren, J (corresponding author), Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden.	bo.segerman@sva.se			Swedish Civil Contingencies Agency; European Union [036272, Home/2009/ISEC/AG/191]	Swedish Civil Contingencies Agency; European Union(European Commission)	This work was supported by the Swedish Civil Contingencies Agency (www.MSB.se). The work was also supported by the European Union funded Integrated Project BIOTRACER [contract 036272] under the 6th RTD Framework and by/executed in the framework of the EU-project AniBioThreat [Grant Agreement: Home/2009/ISEC/AG/191] with the financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs. This publication reflects the views only of the authors, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS129, DOI 10.1016/j.ijfoodmicro.2010.07.036; Guinebretiere MH, 2010, J CLIN MICROBIOL, V48, P3388, DOI 10.1128/JCM.00921-10; Gurumurthy CB, 2002, ARCH VIROL, V147, P85, DOI 10.1007/s705-002-8304-y; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hohl Michael, 2002, Bioinformatics, V18 Suppl 1, pS312; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Rausch T, 2008, BIOINFORMATICS, V24, pI187, DOI 10.1093/bioinformatics/btn281; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Segerman B, 2011, INT J FOOD MICROBIOL, V145, pS167, DOI 10.1016/j.ijfoodmicro.2010.06.027; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Takahashi H, 2011, PLASMID, V66, P112, DOI 10.1016/j.plasmid.2011.06.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Tourasse NJ, 2006, J APPL MICROBIOL, V101, P579, DOI 10.1111/j.1365-2672.2006.03087.x; Wielinga PR, 2011, INT J FOOD MICROBIOL, V145, pS137, DOI 10.1016/j.ijfoodmicro.2010.07.039	35	167	173	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39107	10.1371/journal.pone.0039107	http://dx.doi.org/10.1371/journal.pone.0039107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723939	gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300094
J	Bongers, ML; Hogervorst, JGF; Schouten, LJ; Goldbohm, RA; Schouten, HC; van den Brandt, PA				Bongers, Mathilda L.; Hogervorst, Janneke G. F.; Schouten, Leo J.; Goldbohm, R. Alexandra; Schouten, Harry C.; van den Brandt, Piet A.			Dietary Acrylamide Intake and the Risk of Lymphatic Malignancies: The Netherlands Cohort Study on Diet and Cancer	PLOS ONE			English	Article							SCALE PROSPECTIVE COHORT; BREAST-CANCER; LYMPHOID NEOPLASMS; HEMOGLOBIN ADDUCTS; MULTIPLE-MYELOMA; CARCINOGENICITY; GENOTOXICITY; GLYCIDAMIDE; ESTROGEN; POLYMORPHISMS	Background: Acrylamide, a probable human carcinogen, is present in many everyday foods. Since the finding of its presence in foods in 2002, epidemiological studies have found some suggestive associations between dietary acrylamide exposure and the risk of various cancers. The aim of this prospective study is to investigate for the first time the association between dietary acrylamide intake and the risk of several histological subtypes of lymphatic malignancies. Methods: The Netherlands Cohort Study on diet and cancer includes 120,852 men and women followed-up since September 1986. The number of person years at risk was estimated by using a random sample of participants from the total cohort that was chosen at baseline (n = 5,000). Acrylamide intake was estimated from a food frequency questionnaire combined with acrylamide data for Dutch foods. Hazard ratios (HRs) were calculated for acrylamide intake as a continuous variable as well as in categories (quintiles and tertiles), for men and women separately and for never-smokers, using multivariable-adjusted Cox proportional hazards models. Results: After 16.3 years of follow-up, 1,233 microscopically confirmed cases of lymphatic malignancies were available for multivariable-adjusted analysis. For multiple myeloma and follicular lymphoma, HRs for men were 1.14 (95% CI: 1.01, 1.27) and 1.28 (95% CI: 1.03, 1.61) per 10 mu g acrylamide/day increment, respectively. For never-smoking men, the HR for multiple myeloma was 1.98 (95% CI: 1.38, 2.85). No associations were observed for women. Conclusion: We found indications that acrylamide may increase the risk of multiple myeloma and follicular lymphoma in men. This is the first epidemiological study to investigate the association between dietary acrylamide intake and the risk of lymphatic malignancies, and more research into these observed associations is warranted.	[Bongers, Mathilda L.; Hogervorst, Janneke G. F.; Schouten, Leo J.; van den Brandt, Piet A.] Maastricht Univ, Dept Epidemiol, Sch Oncol & Dev Biol GROW, Med Ctr, Maastricht, Netherlands; [Goldbohm, R. Alexandra] Netherlands Org Appl Sci Res TNO, Div Qual Life, Dept Prevent & Hlth, Leiden, Netherlands; [Schouten, Harry C.] Maastricht Univ, Div Hematol, Dept Internal Med, Med Ctr, Maastricht, Netherlands	Maastricht University; Netherlands Organization Applied Science Research; Maastricht University	Bongers, ML (corresponding author), Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands.	jgf.hogervorst@epid.unimaas.nl	Schouten, Leo J/AAB-2275-2019; Schouten, Leo J/G-3713-2012	Schouten, Leo J/0000-0003-3361-7560; van den Brandt, Piet/0000-0001-8781-8099	Dutch Cancer Society; World Cancer Research Fund	Dutch Cancer Society(KWF Kankerbestrijding); World Cancer Research Fund(World Cancer Research Fund International (WCRF))	The Netherlands Cohort Study on diet and cancer was sponsored by various grants from the Dutch Cancer Society and the World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besaratinia A, 2007, CARCINOGENESIS, V28, P519, DOI 10.1093/carcin/bgm006; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Dourson M, 2008, REGUL TOXICOL PHARM, V52, P264, DOI 10.1016/j.yrtph.2008.08.004; EVERAUS H, 1993, LEUKEMIA LYMPHOMA, V11, P453, DOI 10.3109/10428199309067940; Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+; Ghanayem BI, 2005, MUTAT RES-FUND MOL M, V578, P284, DOI 10.1016/j.mrfmmm.2005.05.004; GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Haber LT, 2009, REGUL TOXICOL PHARM, V53, P134, DOI 10.1016/j.yrtph.2008.12.008; HARTGE P, 2006, CANC EPIDEMIOLOGY PR; Hirvonen T, 2010, CANCER CAUSE CONTROL, V21, P2223, DOI 10.1007/s10552-010-9642-2; Hogervorst JG, 2008, AM J CLIN NUTR, V87, P1428, DOI 10.1093/ajcn/87.5.1428; Hogervorst JG, 2007, CANCER EPIDEM BIOMAR, V16, P2304, DOI 10.1158/1055-9965.EPI-07-0581; Hogervorst JGF, 2010, CRIT REV TOXICOL, V40, P485, DOI 10.3109/10408440903524254; Hogervorst JGF, 2009, JNCI-J NATL CANCER I, V101, P651, DOI 10.1093/jnci/djp077; *INT KANK, 1993, INT CLASS DIS ONC AD; International Agency for Research on Cancer, 1994, MON EV CARC RISK HUM; Jaffe ES, 2001, WHO CLASSIFICATION T; Klaunig JE, 2008, J AGR FOOD CHEM, V56, P5984, DOI 10.1021/jf8004492; Konings EJM, 2006, WOODHEAD PUBL FOOD S, P214, DOI 10.1533/9781845692018.2.214; Konings EJM, 2010, EUR J CLIN NUTR, V64, P534, DOI 10.1038/ejcn.2010.17; Konings EJM, 2003, FOOD CHEM TOXICOL, V41, P1569, DOI 10.1016/S0278-6915(03)00187-X; Lamy E, 2008, INT J HYG ENVIR HEAL, V211, P74, DOI 10.1016/j.ijheh.2007.04.004; Mei N, 2010, TOXICOL SCI, V115, P412, DOI 10.1093/toxsci/kfq069; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Morton LM, 2009, INT J CANCER, V124, P2737, DOI 10.1002/ijc.24248; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; Olesen PT, 2008, INT J CANCER, V122, P2094, DOI 10.1002/ijc.23359; Pedersen GS, 2010, BREAST CANCER RES TR, V122, P199, DOI 10.1007/s10549-009-0642-4; Pylypchuk RD, 2009, AM J EPIDEMIOL, V170, P297, DOI 10.1093/aje/kwp123; Renoir JM, 2008, J MOL ENDOCRINOL, V40, P101, DOI 10.1677/JME-07-0143; Schettgen T, 2004, INT J HYG ENVIR HEAL, V207, P531, DOI 10.1078/1438-4639-00324; Schouten LJ, 2009, AM J EPIDEMIOL, V170, P873, DOI 10.1093/aje/kwp213; SEGERBACK D, 1995, CARCINOGENESIS, V16, P1161, DOI 10.1093/carcin/16.5.1161; Skibola CF, 2005, CANCER EPIDEM BIOMAR, V14, P2391, DOI 10.1158/1055-9965.EPI-05-0343; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Stygar D, 2006, CLIN ENDOCRINOL, V64, P74, DOI 10.1111/j.1365-2265.2005.02420.x; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; Vesper HW, 2008, J AGR FOOD CHEM, V56, P6046, DOI 10.1021/jf703750t; Wilson KM, 2010, CANCER EPIDEM BIOMAR, V19, P2503, DOI 10.1158/1055-9965.EPI-10-0391	42	27	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38016	10.1371/journal.pone.0038016	http://dx.doi.org/10.1371/journal.pone.0038016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723843	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300017
J	Godderis, L; Thomas, R; Hubbard, AE; Tabish, AM; Hoet, P; Zhang, LP; Smith, MT; Veulemans, H; McHale, CM				Godderis, Lode; Thomas, Reuben; Hubbard, Alan E.; Tabish, Ali M.; Hoet, Peter; Zhang, Luoping; Smith, Martyn T.; Veulemans, Hendrik; McHale, Cliona M.			Effect of Chemical Mutagens and Carcinogens on Gene Expression Profiles in Human TK6 Cells	PLOS ONE			English	Article							CANCER-RISK-ESTIMATION; NONGENOTOXIC CARCINOGENS; EXPOSED WORKERS; COMET ASSAY; P53 STATUS; GENOTOXICITY; RADIATION; STYRENE; LINES; MOUSE	Characterization of toxicogenomic signatures of carcinogen exposure holds significant promise for mechanistic and predictive toxicology. In vitro transcriptomic studies allow the comparison of the response to chemicals with diverse mode of actions under controlled experimental conditions. We conducted an in vitro study in TK6 cells to characterize gene expression signatures of exposure to 15 genotoxic carcinogens frequently used in European industries. We also examined the dose-responsive changes in gene expression, and perturbation of biochemical pathways in response to these carcinogens. TK6 cells were exposed at 3 dose levels for 24 h with and without S9 human metabolic mix. Since S9 had an impact on gene expression (885 genes), we analyzed the gene expression data from cells cultures incubated with S9 and without S9 independently. The ribosome pathway was affected by all chemical-dose combinations. However in general, no similar gene expression was observed among carcinogens. Further, pathways, i.e. cell cycle, DNA repair mechanisms, RNA degradation, that were common within sets of chemical-dose combination were suggested by clustergram. Linear trends in dose-response of gene expression were observed for Trichloroethylene, Benz[a]anthracene, Epichlorohydrin, Benzene, and Hydroquinone. The significantly altered genes were involved in the regulation of (anti-) apoptosis, maintenance of cell survival, tumor necrosis factor-related pathways and immune response, in agreement with several other studies. Similarly in S9+ cultures, Benz[a]pyrene, Styrene and Trichloroethylene each modified over 1000 genes at high concentrations. Our findings expand our understanding of the transcriptomic response to genotoxic carcinogens, revealing the alteration of diverse sets of genes and pathways involved in cellular homeostasis and cell cycle control.	[Godderis, Lode; Tabish, Ali M.; Hoet, Peter; Veulemans, Hendrik] Katholieke Univ Leuven, Louvain, Belgium; [Godderis, Lode] Idewe, External Serv Prevent & Protect Work, Heverlee, Belgium; [Thomas, Reuben; Zhang, Luoping; Smith, Martyn T.; McHale, Cliona M.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA	KU Leuven; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Godderis, L (corresponding author), Katholieke Univ Leuven, Louvain, Belgium.	Lode.Godderis@med.kuleuven.be	Hoet, Peter/H-9987-2013; Godderis, Lode/AAE-5880-2019	Hoet, Peter/0000-0002-0292-6603; Godderis, Lode/0000-0003-4764-8835	Research Fund K.U. Leuven; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	Research Fund K.U. Leuven(KU Leuven); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project could only be realized thanks to the financing by Research Fund K.U. Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Alexa A., 2007, ENCYCL SYST BIOL, V9, P589; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Andersen ME, 2010, TOXICOL SCI, V118, P716, DOI 10.1093/toxsci/kfq303; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bates D., 2007, LME4 PACKAGE R PACKA, P74; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2006, NAT BIOTECHNOL, V24, P1321, DOI 10.1038/nbt1106-1321; Bryce SM, 2010, ENVIRON MOL MUTAGEN, V51, P260, DOI 10.1002/em.20544; Daston GP, 2010, BIRTH DEFECTS RES C, V90, P110, DOI 10.1002/bdrc.20178; Dickinson DA, 2004, MUTAT RES-FUND MOL M, V549, P29, DOI 10.1016/j.mrfmmm.2004.01.009; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godderis L, 2004, ENVIRON MOL MUTAGEN, V44, P293, DOI 10.1002/em.20069; Godderis L, 2007, MUTAGENESIS, V22, P209, DOI 10.1093/mutage/gem005; Hamadeh HK, 2002, TOXICOL PATHOL, V30, P470, DOI 10.1080/01926230290105712; Hauptmann M, 2003, JNCI-J NATL CANCER I, V95, P1615, DOI 10.1093/jnci/djg083; Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145; Hu T, 2004, MUTAT RES-FUND MOL M, V549, P5, DOI 10.1016/j.mrfmmm.2003.11.012; Huang R, 2011, ENV HLTH PERSPECT, V119; Islaih M, 2005, MUTAT RES-FUND MOL M, V578, P100, DOI 10.1016/j.mrfmmm.2005.04.012; Islaih M, 2004, ENVIRON MOL MUTAGEN, V44, P401, DOI 10.1002/em.20065; Johansson F, 2004, MUTAT RES-GEN TOX EN, V563, P35, DOI 10.1016/j.mrgentox.2004.05.017; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kauppinen T, 2000, OCCUP ENVIRON MED, V57, P10, DOI 10.1136/oem.57.1.10; Kienhuis AS, 2011, TOXICOL APPL PHARM, V250, P96, DOI 10.1016/j.taap.2010.10.013; Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005; KOGEVINAS M, 1994, SCAND J WORK ENV HEA, V20, P251, DOI 10.5271/sjweh.1400; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le Fevre AC, 2007, MUTAT RES-FUND MOL M, V619, P16, DOI 10.1016/j.mrfmmm.2006.12.007; Lee M, 2003, ENVIRON MOL MUTAGEN, V42, P91, DOI 10.1002/em.10177; Li HH, 2007, MUTAT RES-FUND MOL M, V623, P98, DOI 10.1016/j.mrfmmm.2007.03.013; LITTLE JB, 1995, J BIOL CHEM, V270, P11033, DOI 10.1074/jbc.270.19.11033; Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404; Mahadevan B, 2011, ENVIRON MOL MUTAGEN, V52, P339, DOI 10.1002/em.20653; Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229; McHale CM, 2009, GENOMICS, V93, P343, DOI 10.1016/j.ygeno.2008.12.006; McHale CM, 2010, ENV HLTH PERSPECT, V119; Moller P, 2005, BASIC CLIN PHARMACOL, V96, P9; Moore MM, 2002, ENVIRON MOL MUTAGEN, V40, P292, DOI 10.1002/em.10122; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newton RK, 2004, ENVIRON HEALTH PERSP, V112, P420, DOI 10.1289/ehp.6709; NISHI Y, 1984, CANCER RES, V44, P3270; Sarma SN, 2011, ENVIRON TOXICOL PHAR, V32, P285, DOI 10.1016/j.etap.2011.06.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stang A, 2009, MUTAT RES-GEN TOX EN, V675, P5, DOI 10.1016/j.mrgentox.2009.01.007; Team RDC, 2009, R LANG ENV STAT COMP; Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44; Thomas RS, 2007, TOXICOL SCI, V98, P240, DOI 10.1093/toxsci/kfm092; TORNQVIST M, 1995, J OCCUP ENVIRON MED, V37, P1077; Tsuda S, 2000, MUTAT RES-GEN TOX EN, V467, P83, DOI 10.1016/S1383-5718(00)00014-0; van Dartel DAM, 2011, TOXICOLOGY IN PRESS; van Dartel DAM, 2010, TOXICOLOGY LETT; van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006; van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108; van Leeuwen DM, 2005, TOXICOL SCI, V86, P200, DOI 10.1093/toxsci/kfi168; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; WONG O, 1994, OCCUP ENVIRON MED, V51, P386, DOI 10.1136/oem.51.6.386; Wood DK, 2010, P NATL ACAD SCI USA, V107, P10008, DOI 10.1073/pnas.1004056107; XIA F, 1995, CANCER RES, V55, P12	67	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39205	10.1371/journal.pone.0039205	http://dx.doi.org/10.1371/journal.pone.0039205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723965	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300116
J	Kitazoe, K; Park, YS; Kaji, N; Okamoto, Y; Tokeshi, M; Kogure, K; Harashima, H; Baba, Y				Kitazoe, Katsuma; Park, Yeon-Su; Kaji, Noritada; Okamoto, Yukihiro; Tokeshi, Manabu; Kogure, Kentaro; Harashima, Hideyoshi; Baba, Yoshinobu			Fabrication of Functionalized Double-Lamellar Multifunctional Envelope-Type Nanodevices Using a Microfluidic Chip with a Chaotic Mixer Array	PLOS ONE			English	Article							NONVIRAL GENE-THERAPY; NANO DEVICE; CATIONIC LIPOSOMES; IN-VITRO; DELIVERY; DNA; NANOPARTICLES; CELLS	Multifunctional envelope-type nanodevices (MENDs) are very promising non-viral gene delivery vectors because they are biocompatible and enable programmed packaging of various functional elements into an individual nanostructured liposome. Conventionally MENDs have been fabricated by complicated, labor-intensive, time-consuming bulk batch methods. To avoid these problems in MEND fabrication, we adopted a microfluidic chip with a chaotic mixer array on the floor of its reaction channel. The array was composed of 69 cycles of the staggered chaotic mixer with bas-relief structures. Although the reaction channel had very large Peclet numbers (>10(5)) favorable for laminar flows, its chaotic mixer array led to very small mixing lengths (<1.5 cm) and that allowed homogeneous mixing of MEND precursors in a short time. Using the microfluidic chip, we fabricated a double-lamellar MEND (D-MEND) composed of a condensed plasmid DNA core and a lipid bilayer membrane envelope as well as the D-MEND modified with trans-membrane peptide octaarginine. Our lab-on-a-chip approach was much simpler, faster, and more convenient for fabricating the MENDs, as compared with the conventional bulk batch approaches. Further, the physical properties of the on-chip-fabricated MENDs were comparable to or better than those of the bulk batch-fabricated MENDs. Our fabrication strategy using microfluidic chips with short mixing length reaction channels may provide practical ways for constructing more elegant liposome-based non-viral vectors that can effectively penetrate all membranes in cells and lead to high gene transfection efficiency.	[Kitazoe, Katsuma; Park, Yeon-Su; Kaji, Noritada; Okamoto, Yukihiro; Tokeshi, Manabu; Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan; [Park, Yeon-Su; Kaji, Noritada; Okamoto, Yukihiro; Tokeshi, Manabu; Baba, Yoshinobu] Nagoya Univ, FIRST Res Ctr Innovat Nanobiodevices, Nagoya, Aichi 4648601, Japan; [Kogure, Kentaro] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 607, Japan; [Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 060, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Takamatsu, Kagawa, Japan	Nagoya University; Nagoya University; Kyoto Pharmaceutical University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST)	Kitazoe, K (corresponding author), Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan.	yspman@gmail.com	Tokeshi, Manabu/B-6257-2012; Kaji, Noritada/K-5623-2016; Kaji, Noritada/M-8432-2019; Okamoto, Yukihiro/N-4128-2018	Tokeshi, Manabu/0000-0002-4412-2144; Kaji, Noritada/0000-0002-9828-873X; Okamoto, Yukihiro/0000-0001-6511-4162	Nanotechnology Support Project at Nagoya University; Ministry of Education, Culture, Sports, Science and Technology, Japan [07008025]; Japan Society for the Promotion of Science, Japan [27-D1-0001];  [22229001]	Nanotechnology Support Project at Nagoya University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was partly supported by the Nanotechnology Support Project at Nagoya University, the "Nanotechnology Network Project'' of the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant number: 07008025); the Japan Society for the Promotion of Science through its "Funding Program for World-Leading Innovative Research & Development on Science and Technology (FIRST Program)'', Japan (Grant Number: 27-D1-0001); and the Grant-in-Aid for Scientific Research (S), Japan (Grant Number: 22229001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2011, J CONTROL RELEASE, V149, P58, DOI 10.1016/j.jconrel.2010.08.023; Akita H, 2009, BIOMATERIALS, V30, P2940, DOI 10.1016/j.biomaterials.2009.02.009; ALLEN TM, 1987, FEBS LETT, V223, P42, DOI 10.1016/0014-5793(87)80506-9; Choi Seokheun, 2011, Microfluid Nanofluidics, V10, P231, DOI 10.1007/s10404-010-0638-8; Dandamudi S, 2007, BBA-BIOMEMBRANES, V1768, P427, DOI 10.1016/j.bbamem.2006.10.006; De Laporte L, 2006, BIOMATERIALS, V27, P947, DOI 10.1016/j.biomaterials.2005.09.036; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; Haro-Perez C, 2003, J CHEM PHYS, V119, P628, DOI 10.1063/1.1578628; Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001; Hatakeyama H, 2009, J CONTROL RELEASE, V139, P127, DOI 10.1016/j.jconrel.2009.06.008; Kaneda Y, 2006, CANCER SCI, V97, P348, DOI 10.1111/j.1349-7006.2006.00189.x; Khalil IA, 2007, GENE THER, V14, P682, DOI 10.1038/sj.gt.3302910; Kogure K, 2004, J CONTROL RELEASE, V98, P317, DOI 10.1016/j.jconrel.2004.04.024; Kono K, 1999, BBA-BIOMEMBRANES, V1421, P183, DOI 10.1016/S0005-2736(99)00123-6; Kuramoto H, 2008, ANAL BIOANAL CHEM, V391, P2729, DOI 10.1007/s00216-008-2124-7; Lee CY, 2011, INT J MOL SCI, V12, P3263, DOI 10.3390/ijms12053263; LEGENDRE JY, 1992, PHARMACEUT RES, V9, P1235, DOI 10.1023/A:1015836829670; Martin RS, 2006, ANALYST, V131, P1197, DOI 10.1039/b611041j; Moriguchi R, 2006, J CONTROL RELEASE, V110, P605, DOI 10.1016/j.jconrel.2005.10.021; Moriguchi R, 2005, INT J PHARMACEUT, V301, P277, DOI 10.1016/j.ijpharm.2005.05.021; Nakamura Y, 2006, J PHARM PHARMACOL, V58, P431, DOI 10.1211/jpp.58.4.0002; Nakamura Y, 2007, J CONTROL RELEASE, V119, P360, DOI 10.1016/j.jconrel.2007.03.010; Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923; Rusu L, 2010, MACROMOL BIOSCI, V10, P1465, DOI 10.1002/mabi.201000033; Sasaki K, 2005, INT J PHARMACEUT, V296, P142, DOI 10.1016/j.ijpharm.2005.02.020; Simpson PC, 1998, P NATL ACAD SCI USA, V95, P2256, DOI 10.1073/pnas.95.5.2256; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Suzuki R, 2007, BIOL PHARM BULL, V30, P758, DOI 10.1248/bpb.30.758; Thomas M, 2003, APPL MICROBIOL BIOT, V62, P27, DOI 10.1007/s00253-003-1321-8; Tokeshi M, 2002, ANAL CHEM, V74, P1565, DOI 10.1021/ac011111z; Ueno M, 1997, CHEM LETT, P217, DOI 10.1246/cl.1997.217; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yamada Y, 2010, BIOL PHARM BULL, V33, P1218, DOI 10.1248/bpb.33.1218; Yamashita T, 2007, EXP EYE RES, V85, P741, DOI 10.1016/j.exer.2007.08.006; Yasui T, 2011, LAB CHIP, V11, P3356, DOI 10.1039/c1lc20342h; Zhang LF, 2006, NANO LETT, V6, P694, DOI 10.1021/nl052455y	36	6	6	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39057	10.1371/journal.pone.0039057	http://dx.doi.org/10.1371/journal.pone.0039057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723929	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300087
J	Quast, SA; Berger, A; Buttstadt, N; Friebel, K; Schonherr, R; Eberle, J				Quast, Sandra-Annika; Berger, Anja; Buttstaedt, Nicole; Friebel, Kristin; Schoenherr, Roland; Eberle, Juergen			General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC	PLOS ONE			English	Article							LIGAND-INDUCED APOPTOSIS; NF-KAPPA-B; UP-REGULATION; CYTOCHROME-C; ION CHANNELS; K+ CHANNELS; DEATH; RESISTANCE; PROTEINS; ACTIVATION	The death ligand TRAIL represents a promising therapeutic strategy for metastatic melanoma, however prevalent and inducible resistance limit its applicability. A new approach is presented here for sensitization to TRAIL. It is based on inhibition of the membrane potassium channel KCa3.1 (IK1), which serves fundamental cellular functions related to membrane potential. The selective inhibitor TRAM-34 did not induce apoptosis by itself but synergistically enhanced TRAIL sensitivity and overrode TRAIL resistance in a large panel of melanoma cell lines. Expression of IK1 was also found in mitochondria, and its inhibition resulted in mitochondrial membrane hyperpolarization and an early activation of Bax. The combination of TRAM-34 and TRAIL resulted in massive release of mitochondrial factors, cytochrome c, AIF and SMAC/DIABLO. Bax knockdown and Bcl-2 overexpression abolished apoptosis. Overexpression of XIAP diminished apoptosis by two-fold, and SMAC knockdown almost completely abolished apoptosis. These data uncover the existence of a rheostat in melanoma cells, consisting of inhibitor of apoptosis proteins and SMAC, which regulates TRAIL sensitivity. Thus, a new strategy is described based on mitochondrial membrane channels, which correspond to Bax activation. As both TRAIL and IK1 inhibitors had shown only minor side effects in clinical trials, a clinical application of this combination is conceivable.	[Quast, Sandra-Annika; Berger, Anja; Eberle, Juergen] Univ Med Ctr Charite, Skin Canc Ctr, Dept Dermatol & Allergy, Berlin, Germany; [Quast, Sandra-Annika] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Buttstaedt, Nicole; Friebel, Kristin; Schoenherr, Roland] Jena Univ Hosp, Dept Biophys, Ctr Mol Biomed, Jena, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Friedrich Schiller University of Jena	Quast, SA (corresponding author), Univ Med Ctr Charite, Skin Canc Ctr, Dept Dermatol & Allergy, Berlin, Germany.	juergen.eberle@charite.de	Schönherr, Roland/K-8713-2013	Schönherr, Roland/0000-0003-0633-0775; Eberle, Jurgen/0000-0001-8533-1519	German Cancer Aid (Deutsche Krebshilfe); Melanoma Research Network (Melanomverbund) [109716]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Melanoma Research Network (Melanomverbund)	This study was supported by the German Cancer Aid (Deutsche Krebshilfe), Melanoma Research Network (Melanomverbund), project number 109716. The funders had no role in study designe, data collection and analysis, decision to publish, or preparation of the manuskript.	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ataga KI, 2009, EXPERT OPIN INV DRUG, V18, P231, DOI [10.1517/13543780802708011, 10.1517/13543780802708011 ]; Berger A, 2010, BIOCH PHARM; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eberle J, 2003, ONCOGENE, V22, P9131, DOI 10.1038/sj.onc.1207228; Eberle J, 2007, DRUG RESIST UPDATE, V10, P218, DOI 10.1016/j.drup.2007.09.001; Elliott JL, 2003, EMBO REP, V4, P189, DOI 10.1038/sj.embor.embor722; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Hornle M, 2010, ONCOGENE; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Ivanov VN, 2008, EXP CELL RES, V314, P1163, DOI 10.1016/j.yexcr.2007.12.012; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; Kurbanov BM, 2005, J INVEST DERMATOL, V125, P1010, DOI 10.1111/j.0022-202X.2005.23900.x; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lee EL, 2008, AM J PHYSIOL-CELL PH, V294, pC1398, DOI 10.1152/ajpcell.00428.2007; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Li Y, 2006, CANCER RES, V66, P8520, DOI 10.1158/0008-5472.CAN-05-4364; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Raisova M, 2001, J INVEST DERMATOL, V117, P168; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sassi N, 2010, BBA-BIOENERGETICS, V1797, P1260, DOI 10.1016/j.bbabio.2009.12.015; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Schwab A, 1999, CELL PHYSIOL BIOCHEM, V9, P126, DOI 10.1159/000016309; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084; Zhang XD, 2001, CANCER RES, V61, P7339	53	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39290	10.1371/journal.pone.0039290	http://dx.doi.org/10.1371/journal.pone.0039290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723988	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300129
J	Hightower, CM; Vazquez, BYS; Acharya, SA; Subramaniam, S; Intaglietta, M				Hightower, C. Makena; Salazar Vazquez, Beatriz Y.; Acharya, Seetharama A.; Subramaniam, Shankar; Intaglietta, Marcos			PEG-Albumin Plasma Expansion Increases Expression of MCP-1 Evidencing Increased Circulatory Wall Shear Stress: An Experimental Study	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; POLYETHYLENE GLYCOL-ALBUMIN; EXTREME HEMODILUTION; ENDOTHELIAL-CELLS; HEMORRHAGIC-SHOCK; SERUM-ALBUMIN; NITRIC-OXIDE; VISCOSITY; MOBILIZATION; PROTEIN-1	Treatment of blood loss with plasma expanders lowers blood viscosity, increasing cardiac output. However, increased flow velocity by conventional plasma expanders does not compensate for decreased viscosity in maintaining vessel wall shear stress (WSS), decreasing endothelial nitric oxide (NO) production. A new type of plasma expander using polyethylene glycol conjugate albumin (PEG-Alb) causes supra-perfusion when used in extreme hemodilution and is effective in treating hemorrhagic shock, although it is minimally viscogenic. An acute 40% hemodilution/exchange-transfusion protocol was used to compare 4% PEG-Alb to Ringer's lactate, Dextran 70 kDa and 6% Hetastarch (670 kDa) in unanesthetized CD-1 mice. Serum cytokine analysis showed that PEG-Alb elevates monocyte chemotactic protein-1 (MCP-1), a member of a small inducible gene family, as well as expression of MIP-1 alpha, and MIP-2. MCP-1 is specific to increased WSS. Given the direct link between increased WSS and production of NO, the beneficial resuscitation effects due to PEG-Alb plasma expansion appear to be due to increased WSS through increased perfusion and blood flow rather than blood viscosity.	[Hightower, C. Makena; Salazar Vazquez, Beatriz Y.; Subramaniam, Shankar; Intaglietta, Marcos] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Salazar Vazquez, Beatriz Y.] Univ Nacl Autonoma Mexico, Dept Expt Med, Fac Med, Hosp Gen Mexico, Mexico City 04510, DF, Mexico; [Acharya, Seetharama A.] Albert Einstein Coll Med, Dept Med Physiol & Biophys, Bronx, NY 10467 USA	University of California System; University of California San Diego; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Yeshiva University; Albert Einstein College of Medicine	Hightower, CM (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	mintagli@ucsd.edu			USPHS (United States Public Health Service) Bioengineering Research Partnership [R24-HL 064395, R01-HL 062354, R33-HL 08737503, T32-HL 007089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL064395, T32HL007089, R01HL062354] Funding Source: NIH RePORTER	USPHS (United States Public Health Service) Bioengineering Research Partnership; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the USPHS (United States Public Health Service) Bioengineering Research Partnership grant R24-HL 064395 (MI), R01-HL 062354 (MI), R33-HL 08737503 (SS) and T32-HL 007089 (CMH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578; Acharya SA, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P345; Ananda K, 2012, ARTIF CELL BLOOD SUB, V40, P14, DOI 10.3109/10731199.2011.579568; Bao XP, 1999, ARTERIOSCL THROM VAS, V19, P996, DOI 10.1161/01.ATV.19.4.996; Broxmeyer HE, 2007, ANN NY ACAD SCI, V1106, P1, DOI 10.1196/annals.1392.013; Cabrales P, 2005, AM J PHYSIOL-HEART C, V289, pH2392, DOI 10.1152/ajpheart.00225.2005; Cabrales P, 2005, SHOCK, V24, P66, DOI 10.1097/01.shk.0000167111.80753.ef; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH363, DOI 10.1152/ajpheart.01039.2003; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Chien S, 2006, BIORHEOLOGY, V43, P95; de Jager SCA, 2008, J MOL CELL CARDIOL, V45, P446, DOI 10.1016/j.yjmcc.2008.06.003; ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841; FRIESENECKER B, 1994, AM J PHYSIOL-HEART C, V267, pH2204, DOI 10.1152/ajpheart.1994.267.6.H2204; Fujii T, 2006, ARTERIOSCL THROM VAS, V26, P2483, DOI 10.1161/01.ATV.0000244684.23499.bf; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Hangai-Hoger N, 2006, CRIT CARE MED, V34, P108, DOI 10.1097/01.CCM.0000190623.97200.82; Hsieh CH, 2008, J IMMUNOL, V181, P2806, DOI 10.4049/jimmunol.181.4.2806; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; LORD BI, 1995, BLOOD, V85, P3412, DOI 10.1182/blood.V85.12.3412.bloodjournal85123412; Manjula BN, 2003, BIOCONJUGATE CHEM, V14, P464, DOI 10.1021/bc0200733; Martini J, 2008, CRIT CARE, V12, DOI 10.1186/cc6874; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Minamiyama Y, 1996, BIOCHEM BIOPH RES CO, V225, P112, DOI 10.1006/bbrc.1996.1138; Shepro D., 2006, MICROVASCULAR RES; SHYY YJ, 1994, P NATL ACAD SCI USA, V91, P4678, DOI 10.1073/pnas.91.11.4678; Tsai AG, 2005, AM J PHYSIOL-HEART C, V288, pH1730, DOI 10.1152/ajpheart.00998.2004; Tsai AG, 2007, TRANSFUS ALTERN TRAN, V9, P246, DOI DOI 10.1111/j.1778-428X.2007.00086.x; Villela NR, 2009, CURR OPIN ANESTHESIO, V22, P163, DOI 10.1097/ACO.0b013e328328d304; Wang JB, 1997, J LEUKOCYTE BIOL, V62, P503, DOI 10.1002/jlb.62.4.503; Xing H, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P361; Yu HM, 2002, CLIN HEMORHEOL MICRO, V26, P199	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39111	10.1371/journal.pone.0039111	http://dx.doi.org/10.1371/journal.pone.0039111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720043	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800045
J	Betz, MJ; Bielohuby, M; Mauracher, B; Abplanalp, W; Muller, HH; Pieper, K; Ramisch, J; Tschop, MH; Beuschlein, F; Bidlingmaier, M; Slawik, M				Betz, Matthias J.; Bielohuby, Maximilian; Mauracher, Brigitte; Abplanalp, William; Mueller, Hans-Helge; Pieper, Korbinian; Ramisch, Juliane; Tschoep, Matthias H.; Beuschlein, Felix; Bidlingmaier, Martin; Slawik, Marc			Isoenergetic Feeding of Low Carbohydrate-High Fat Diets Does Not Increase Brown Adipose Tissue Thermogenic Capacity in Rats	PLOS ONE			English	Article							LOW PROTEIN DIETS; UNCOUPLING PROTEIN-1; WEIGHT-LOSS; ENERGY-EXPENDITURE; RANDOMIZED-TRIAL; BODY-WEIGHT; EXPRESSION; OBESITY; WHITE; RESISTANCE	Low-carbohydrate, high-fat (LC-HF) diets are popular for inducing weight loss in overweighed adults. Adaptive thermogenesis increased by specific effects of macronutrients on energy expenditure has been postulated to induce this weight loss. We studied brown adipose tissue (BAT) morphology and function following exposure to different LC-HF diets. Methods: Male Wistar rats were fed a standard control diet ad libitum or pair-fed isoenergetic amounts of three experimental diets for 4 weeks. The diets had the following macronutrient composition (% metabolizable energy: carbohydrates, fat, protein): control (64.3/16.7/19), LC-HF-low protein (LC-HF-LP, 1.7/92.8/5.5), LC-HF-normal-protein (LC-HF-NP, 2.2/78.7/19.1), and a high fat diet with carbohydrates ("high fat", 19.4/61.9/18.7). Results: Body weight gain was reduced in all pair-fed experimental groups as compared to rats fed the control diet, with more pronounced effect in rats on LC-HF diets than on the high fat diet with carbohydrates. High fat diets increased expression of PGC1 alpha and ADRB3 in BAT indicating higher SNS outflow. However, UCP1 mRNA expression and expression of UCP1 assessed by immunohistochemistry was not different between diet groups. In accordance, analysis of mitochondrial function in-vitro by extracellular flux analyser (Seahorse Bioscience) and measurement of inducible thermogenesis in vivo (primary endpoint), explored by indirect calorimetry following norepinephrine injection, did not show significant differences between groups. Histology of BAT revealed increased lipid droplet size in rats fed the high-fat diet and both LC-HF diets. Conclusion: All experimental diets upregulated expression of genes which are indicative for increased BAT activity. However, the functional measurements in vivo revealed no increase of inducible BAT thermogenesis. This indicates that lower body weight gain with LC-HF diets and a high fat diet in a pair-feeding setting is not caused by increased adaptive thermogenesis in BAT.	[Betz, Matthias J.; Bielohuby, Maximilian; Mauracher, Brigitte; Ramisch, Juliane; Beuschlein, Felix; Bidlingmaier, Martin; Slawik, Marc] Klin LMU, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany; [Abplanalp, William] Univ Cincinnati, Dept Med, Metab Dis Inst, Cincinnati, OH 45221 USA; [Mueller, Hans-Helge] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Pieper, Korbinian] Univ Munich, Ctr Clin Vet Med, Clin Small Anim Surg & Reprod, Munich, Germany; [Tschoep, Matthias H.] Helmholtz Ctr Hlth & Environm, Inst Diabet & Obes, Munich, Germany; [Tschoep, Matthias H.] Tech Univ, Munich, Germany	University of Munich; University System of Ohio; University of Cincinnati; University of Munich; University of Munich; Technical University of Munich	Betz, MJ (corresponding author), Klin LMU, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany.	Marc.Slawik@med.uni-muenchen.de	Tschoep, Matthias H/I-5443-2014; Bielohuby, Maximilian/A-2304-2015	Bielohuby, Maximilian/0000-0002-9859-8156; Beuschlein, Felix/0000-0001-7826-3984; Tschoep, Matthias/0000-0002-4744-371X; Bidlingmaier, Martin/0000-0002-4681-6668; Betz, Matthias Johannes/0000-0002-6946-1871				Adam-Perrot A, 2006, OBES REV, V7, P49, DOI 10.1111/j.1467-789X.2006.00222.x; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Atkins RC, 1992, DR ATKINSNEW DIET RE; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Becerril S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010962; Bielohuby M, 2011, ENDOCRINOLOGY, V152, P1948, DOI 10.1210/en.2010-1423; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Bielohuby M, 2010, BRIT J NUTR, V103, P1525, DOI 10.1017/S000711450999345X; Blessing W, 2012, PHYSIOL BEHAV, V105, P966, DOI 10.1016/j.physbeh.2011.11.009; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; BRITO MN, 1992, J NUTR, V122, P2081, DOI 10.1093/jn/122.11.2081; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caton SJ, 2009, OBESITY, V17, P283, DOI 10.1038/oby.2008.529; Commins SP, 2000, J BIOL CHEM, V275, P33059, DOI 10.1074/jbc.M006328200; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; GOMEZSIERRA JM, 1993, ARCH INT PHYSIOL BIO, V101, P117, DOI 10.3109/13813459309008879; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kienbaum P, 2000, ANESTHESIOLOGY, V92, P94, DOI 10.1097/00000542-200001000-00019; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; MA SWY, 1989, CAN J PHYSIOL PHARM, V67, P376, DOI 10.1139/y89-061; MA SWY, 1988, CAN J PHYSIOL PHARM, V66, P1347, DOI 10.1139/y88-221; Moura MAF, 2001, METABOLISM, V50, P1493, DOI 10.1053/meta.2001.27197; Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005; Ohlson KBE, 2004, BIOCHEM PHARMACOL, V68, P463, DOI 10.1016/j.bcp.2004.03.028; OHLSON KBE, 1994, ANESTHESIOLOGY, V81, P176, DOI 10.1097/00000542-199407000-00024; Petzke KJ, 2007, J NUTR BIOCHEM, V18, P400, DOI 10.1016/j.jnutbio.2006.07.005; Portillo MP, 1998, INT J OBESITY, V22, P974, DOI 10.1038/sj.ijo.0800706; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rodriguez AM, 2002, PFLUG ARCH EUR J PHY, V444, P484, DOI 10.1007/s00424-002-0829-6; Romestaing C, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-4; ROTHWELL NJ, 1983, METABOLISM, V32, P257, DOI 10.1016/0026-0495(83)90190-7; ROTHWELL NJ, 1987, J NUTR, V117, P1721, DOI 10.1093/jn/117.10.1721; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; SADURSKIS A, 1995, AM J PHYSIOL-ENDOC M, V269, pE351, DOI 10.1152/ajpendo.1995.269.2.E351; SCHWARTZ JH, 1983, J CLIN INVEST, V72, P361, DOI 10.1172/JCI110976; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; Takahashi Y, 2000, BRIT J NUTR, V84, P175; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Westman EC, 2006, INT J CARDIOL, V110, P212, DOI 10.1016/j.ijcard.2005.08.034; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066	53	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38997	10.1371/journal.pone.0038997	http://dx.doi.org/10.1371/journal.pone.0038997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720011	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900071
J	Dunford, L; Carr, MJ; Dean, J; Nguyen, LT; Thu, HTT; Nguyen, BT; Connell, J; Coughlan, S; Nguyen, HT; Hall, WW; Lan, ANT				Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Linh Thuy Nguyen; Thu Hong Ta Thi; Binh Thanh Nguyen; Connell, Jeff; Coughlan, Suzie; Hien Tran Nguyen; Hall, William W.; Lan Anh Nguyen Thi			A Multicentre Molecular Analysis of Hepatitis B and Blood-Borne Virus Coinfections in Viet Nam	PLOS ONE			English	Article							HO-CHI-MINH; GENOTYPE I; HEPATOCELLULAR-CARCINOMA; CORE PROMOTER; DELTA-VIRUS; ANTIRETROVIRAL THERAPY; X/C RECOMBINANT; DRUG-RESISTANT; DISEASE BURDEN; RURAL VIETNAM	Hepatitis B (HBV) infection is endemic in Viet Nam, with up to 8.4 million individuals estimated to be chronically infected. We describe results of a large, multicentre seroepidemiological and molecular study of the prevalence of HBV infection and blood-borne viral coinfections in Viet Nam. Individuals with varying risk factors for infection (n = 8654) were recruited from five centres; Ha Noi, Hai Phong, Da Nang, Khanh Hoa and Can Tho. A mean prevalence rate of 10.7% was observed and levels of HBsAg were significantly higher in injecting drug users (IDUs) (17.4%, n = 174/1000) and dialysis patients (14.3%, n = 82/575) than in lower-risk groups (9.4%; p<0.001). Coinfection with HIV was seen in 28% of HBV-infected IDUs (n = 49/174) and 15.2% of commercial sex workers (CSWs; n = 15/99). HCV infection was present in 89.8% of the HBV-HIV coinfected IDUs (n = 44/49) and 40% of HBV-HIV coinfected CSWs (n = 16/40). Anti-HDV was detected in 10.7% (n = 34/318) of HBsAg positive individuals. Phylogenetic analysis of HBV S gene (n = 187) showed a predominance of genotype B4 (82.6%); genotypes C1 (14.6%), B2 (2.7%) and C5 (0.5%) were also identified. The precore mutation G1896A was identified in 35% of all specimens, and was more frequently observed in genotype B (41%) than genotype C (3%; p<0.0001). In the immunodominant 'a' region of the surface gene, point mutations were identified in 31% (n = 58/187) of sequences, and 2.2% (n = 4/187) and 5.3% (n = 10/187) specimens contained the major vaccine escape mutations G145A/R and P120L/Q/S/T, respectively. 368 HBsAg positive individuals were genotyped for the IL28B SNP rs12979860 and no significant association between the IL28B SNP and clearance of HBsAg, HBV viral load or HBeAg was observed. This study confirms the high prevalence of HBV infection in Viet Nam and also highlights the significant levels of blood-borne virus coinfections, which have important implications for hepatitis-related morbidity and development of effective management strategies.	[Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Linh Thuy Nguyen; Thu Hong Ta Thi; Binh Thanh Nguyen; Connell, Jeff; Coughlan, Suzie; Hien Tran Nguyen; Hall, William W.; Lan Anh Nguyen Thi] Ireland Viet Nam Blood Borne Virus Initiat IVVI, Dublin, Ireland; [Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Linh Thuy Nguyen; Thu Hong Ta Thi; Binh Thanh Nguyen; Connell, Jeff; Coughlan, Suzie; Hien Tran Nguyen; Hall, William W.; Lan Anh Nguyen Thi] Ireland Viet Nam Blood Borne Virus Initiat IVVI, Hanoi, Vietnam; [Dunford, Linda; Carr, Michael J.; Dean, Jonathan; Connell, Jeff; Coughlan, Suzie; Hall, William W.] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 2, Ireland; [Linh Thuy Nguyen; Thu Hong Ta Thi; Binh Thanh Nguyen; Hien Tran Nguyen; Lan Anh Nguyen Thi] Natl Inst Hyg & Epidemiol, Lab Mol Diagnost, Hanoi, Vietnam	University College Dublin; National Institute of Hygiene & Epidemiology (NIHE)	Dunford, L (corresponding author), Ireland Viet Nam Blood Borne Virus Initiat IVVI, Dublin, Ireland.	william.hall@ucd.ie; lananh_2003@yahoo.com	lan, A/HHZ-6588-2022	Carr, Michael/0000-0003-0011-6209	Irish Aid; government of Ireland's programme of assistance to developing countries; Atlantic Philanthropies; IVVI	Irish Aid(CGIAR); government of Ireland's programme of assistance to developing countries; Atlantic Philanthropies; IVVI	This study was jointly funded by Irish Aid, the government of Ireland's programme of assistance to developing countries, and by the Atlantic Philanthropies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was performed under the auspices of the IVVI. The goals of the IVVI are to develop capacity and infrastructure in clinical and diagnostic virology in Viet Nam.	Abbas Z, 2010, WORLD J GASTROENTERO, V16, P554, DOI 10.3748/wjg.v16.i5.554; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Alter MJ, 2003, J HEPATOL, V39, pS64, DOI 10.1016/S0168-8278(03)00141-7; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; Arankalle VA, 2010, J VIRAL HEPATITIS, V17, P501, DOI 10.1111/j.1365-2893.2009.01206.x; Ballard A L, 1999, Commun Dis Public Health, V2, P178; Burland T G, 2000, Methods Mol Biol, V132, P71; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Colson P, 2009, J CLIN VIROL, V45, P165, DOI 10.1016/j.jcv.2009.03.007; Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; Dean J, 2011, AIDS RES HUM RETROV, V27, P797, DOI 10.1089/aid.2011.0013; Fang ZL, 2011, J GEN VIROL, V92, P402, DOI 10.1099/vir.0.026666-0; Farci P, 2003, J HEPATOL, V39, pS212, DOI 10.1016/S0168-8278(03)00331-3; Garson JA, 2005, J VIROL METHODS, V126, P207, DOI 10.1016/j.jviromet.2005.03.001; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GUNTHER S, 1995, J VIROL, V69, P5437; Hall TA, 1999, NUCL ACIDS S SER, V41, P91; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Hipgrave DB, 2003, AM J TROP MED HYG, V69, P288, DOI 10.4269/ajtmh.2003.69.288; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2004, J MED VIROL, V74, P228, DOI 10.1002/jmv.20175; Kakumu S, 1998, J MED VIROL, V54, P243, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;243::AID-JMV2&gt;3.0.CO;2-4; KATELARIS PH, 1995, T ROY SOC TROP MED H, V89, P487, DOI 10.1016/0035-9203(95)90077-2; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Lampertico P., 2012, HEPATOLOGY; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Li JH, 2010, HEPATOLOGY, V51, P1904, DOI 10.1002/hep.23592; Li WY, 2011, LIVER INT, V31, P1118, DOI 10.1111/j.1478-3231.2011.02507.x; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Liu WC, 2007, VIRUS RES, V129, P212, DOI 10.1016/j.virusres.2007.07.016; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Matthews GV, 2006, AIDS, V20, P863, DOI 10.1097/01.aids.0000218550.85081.59; Mumtaz K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-312; NAKATA S, 1994, J GASTROEN HEPATOL, V9, P416, DOI 10.1111/j.1440-1746.1994.tb01265.x; Nguyen LH, 2009, HEPATOLOGY INT; Nguyen VTT, 2008, LIVER INT, V28, P525, DOI 10.1111/j.1478-3231.2007.01646.x; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Osiowy C, 2010, J MED VIROL, V82, P942, DOI 10.1002/jmv.21758; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peters PJ, 2012, J INFECT DIS, V205, P166, DOI 10.1093/infdis/jir728; Phung TBT, 2010, J MED VIROL, V82, P1327, DOI 10.1002/jmv.21775; Qu LS, 2011, HEPATOL RES, V41, P54, DOI 10.1111/j.1872-034X.2010.00732.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Saulnier P, 2003, J VIROL METHODS, V114, P55, DOI 10.1016/j.jviromet.2003.08.012; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; SONG P, 1994, CLIN DIAGN LAB IMMUN, V1, P413, DOI 10.1128/CDLI.1.4.413-418.1994; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Sung JJY, 2008, J VIROL, V82, P3604, DOI 10.1128/JVI.01197-07; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Takahashi K, 1998, ARCH VIROL, V143, P2313, DOI 10.1007/s007050050463; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thai HD, 2009, ASIAN PAC J CANCER P, V10, P97; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Thuy LTT, 2005, J MED VIROL, V76, P161, DOI 10.1002/jmv.20337; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; Truong BX, 2007, J MED VIROL, V79, P1293, DOI 10.1002/jmv.20934; Truong BX, 2007, INT J MOL MED, V19, P293; UNAIDS, 2010, UN GEN ASS M HAN 4 C; VANBE T, 1993, T ROY SOC TROP MED H, V87, P262, DOI 10.1016/0035-9203(93)90118-A; Xin D, 2003, JPN J INFECT DIS, V56, P19; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x; Zachou K, 2010, LIVER INT, V30, P430, DOI 10.1111/j.1478-3231.2009.02140.x; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016349; Zhu Y, 2010, CANCER EPIDEM BIOMAR, V19, P2623, DOI 10.1158/1055-9965.EPI-10-0469	74	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39027	10.1371/journal.pone.0039027	http://dx.doi.org/10.1371/journal.pone.0039027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720022	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900076
J	McCauley, DJ; Hoffmann, E; Young, HS; Micheli, F				McCauley, Douglas J.; Hoffmann, Eva; Young, Hillary S.; Micheli, Fiorenza			Night Shift: Expansion of Temporal Niche Use Following Reductions in Predator Density	PLOS ONE			English	Article							NORTHERN LINE ISLANDS; CORAL-REEF; ACTIVITY PATTERNS; FISH-ASSEMBLAGE; NEW-ZEALAND; EVOLUTION; POPULATION; EXTINCTION; HISTORY; RHYTHMS	Predation shapes many fundamental aspects of ecology. Uncertainty remains, however, about whether predators can influence patterns of temporal niche construction at ecologically relevant timescales. Partitioning of time is an important mechanism by which prey avoid interactions with predators. However, the traits that control a prey organism's capacity to operate during a particular portion of the diel cycle are diverse and complex. Thus, diel prey niches are often assumed to be relatively unlikely to respond to changes in predation risk at short timescales. Here we present evidence to the contrary. We report results that suggest that the anthropogenic depletion of daytime active predators (species that are either diurnal or cathemeral) in a coral reef ecosystem is associated with rapid temporal niche expansions in a multi-species assemblage of nocturnal prey fishes. Diurnal comparisons of nocturnal prey fish abundance in predator rich and predator depleted reefs at two atolls revealed that nocturnal fish were approximately six (biomass) and eight (density) times more common during the day on predator depleted reefs. Amongst these, the prey species that likely were the most specialized for nocturnal living, and thus the most vulnerable to predation (i.e. those with greatest eye size to body length ratio), showed the strongest diurnal increases at sites where daytime active predators were rare. While we were unable to determine whether these observed increases in diurnal abundance by nocturnal prey were the result of a numerical or behavioral response, either effect could be ecologically significant. These results raise the possibility that predation may play an important role in regulating the partitioning of time by prey and that anthropogenic depletions of predators may be capable of causing rapid changes to key properties of temporal community architecture.	[McCauley, Douglas J.; Hoffmann, Eva; Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Young, Hillary S.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Stanford University; Harvard University	McCauley, DJ (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mccauley@berkeley.edu	Young, Hillary/S-1514-2017	Micheli, Fiorenza/0000-0002-6865-1438	National Science Foundation; Woods Institute for the Environment	National Science Foundation(National Science Foundation (NSF)); Woods Institute for the Environment	Funding was provided by the National Science Foundation and the Woods Institute for the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; BROCK RE, 1982, B MAR SCI, V32, P269; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; CULP JM, 1993, OIKOS, V68, P242, DOI 10.2307/3544836; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FENN MGP, 1995, J MAMMAL, V76, P130, DOI 10.2307/1382321; Fishelson L, 2004, ANAT REC PART A, V277A, P249, DOI 10.1002/ar.a.20005; FLECKER AS, 1992, ECOLOGY, V73, P438, DOI 10.2307/1940751; Fraser DF, 2004, ECOLOGY, V85, P312, DOI 10.1890/03-3023; Goatley CHR, 2009, CORAL REEFS, V28, P449, DOI 10.1007/s00338-009-0477-9; Goatley CHR, 2010, PALEOBIOLOGY, V36, P415, DOI 10.1666/09035.1; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; HOLM S, 1979, SCAND J STAT, V6, P65; Hudgens BR, 2011, OECOLOGIA, V165, P699, DOI 10.1007/s00442-010-1761-7; Karpestam B, 2007, J EXP BIOL, V210, P2923, DOI 10.1242/jeb.002956; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; Land M. F., 2002, ANIMAL EYES; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; McCauley DJ, ECOL APPL IN PRESS; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; McCauley DJ, 2010, MAR BIOL, V157, P2739, DOI 10.1007/s00227-010-1533-2; McIntosh AR, 1995, LIMNOL OCEANOGR, V40, P1508, DOI 10.4319/lo.1995.40.8.1508; Metcalfe NB, 1998, P ROY SOC B-BIOL SCI, V265, P1503, DOI 10.1098/rspb.1998.0464; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; NELSON BV, 1979, MAR BIOL, V51, P251, DOI 10.1007/BF00386805; Oliver MD, 2006, NEW ZEAL J MAR FRESH, V40, P605, DOI 10.1080/00288330.2006.9517449; PANKHURST NW, 1989, ENVIRON BIOL FISH, V26, P201, DOI 10.1007/BF00004816; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Roll U, 2006, EVOL ECOL, V20, P479, DOI 10.1007/s10682-006-0015-y; RYDELL J, 1995, BIOL J LINN SOC, V54, P183, DOI 10.1006/bijl.1995.0011; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Terborgh J., 2010, TROPHIC CASCADES PRE	39	22	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38871	10.1371/journal.pone.0038871	http://dx.doi.org/10.1371/journal.pone.0038871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719970	gold, Green Published			2022-12-27	WOS:000305341900058
J	Wiedower, EE; Kouba, AJ; Vance, CK; Hansen, RL; Stuth, JW; Tolleson, DR				Wiedower, Erin E.; Kouba, Andrew J.; Vance, Carrie K.; Hansen, Rachel L.; Stuth, Jerry W.; Tolleson, Douglas R.			Fecal Near Infrared Spectroscopy to Discriminate Physiological Status in Giant Pandas	PLOS ONE			English	Article							REFLECTANCE SPECTROSCOPY; AILUROPODA-MELANOLEUCA; FOLIVOROUS MARSUPIALS; QUALITY; PLANT; PREDICTOR; NUTRIENTS; FECES; DIETS; NIRS	Giant panda (Ailuropoda melanoleuca) monitoring and research often require accurate estimates of population size and density. However, obtaining these estimates has been challenging. Innovative technologies, such as fecal near infrared reflectance spectroscopy (FNIRS), may be used to differentiate between sex, age class, and reproductive status as has been shown for several other species. The objective of this study was to determine if FNIRS could be similarly used for giant panda physiological discriminations. Based on samples from captive animals in four U. S. zoos, FNIRS calibrations correctly identified 78% of samples from adult males, 81% from adult females, 85% from adults, 89% from juveniles, 75% from pregnant and 70% from non-pregnant females. However, diet had an impact on the success of the calibrations. When diet was controlled for plant part such that "leaf only" feces were evaluated, FNIRS calibrations correctly identified 93% of samples from adult males and 95% from adult females. These data show that FNIRS has the potential to differentiate between the sex, age class, and reproductive status in the giant panda and may be applicable for surveying wild populations.	[Wiedower, Erin E.] Texas A&M Univ, Blackland Res & Extens Ctr, Grazingland Anim Nutr Lab, Temple, TX USA; [Kouba, Andrew J.; Hansen, Rachel L.] Memphis Zool Soc, Dept Conservat & Res, Memphis, TN USA; [Vance, Carrie K.] Mississippi State Univ, Dept Biochem & Mol Biol, Mississippi State, MS USA; [Stuth, Jerry W.] Texas A&M Univ, Dept Rangeland Ecol & Management, College Stn, TX 77843 USA; [Tolleson, Douglas R.] Univ Arizona, Sch Nat Resources & Environm, Camp Verde, AZ USA	Texas A&M University System; Mississippi State University; Texas A&M University System; Texas A&M University College Station; University of Arizona	Wiedower, EE (corresponding author), Texas A&M Univ, Blackland Res & Extens Ctr, Grazingland Anim Nutr Lab, Temple, TX USA.	dougt@cals.arizona.edu	Vance, Carrie/AAC-6370-2020	Vance, Carrie/0000-0001-8466-6077	Memphis Zoological Society; U.S. Forest Service, International Programs, Asia-Pacific office	Memphis Zoological Society; U.S. Forest Service, International Programs, Asia-Pacific office	This research was supported by the Memphis Zoological Society and the U.S. Forest Service, International Programs, Asia-Pacific office. Memphis Zoo employees participated in all aspects of the project.	Andre J, 2003, MAR ECOL PROG SER, V257, P259, DOI 10.3354/meps257259; [Anonymous], 2010, BREEDING STRATEGY RE; BLACK HE, 1988, TOXICOL PATHOL, V16, P213, DOI 10.1177/019262338801600214; Calix M., 2018, EUROPEAN RED LIST SA; Dixon R, 2009, J NEAR INFRARED SPEC, V17, P1, DOI 10.1255/jnirs.822; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Foley WJ, 2009, SPECTROSC EUR, V21, P6; Hansen RL, 2010, ZOO BIOL, V29, P470, DOI 10.1002/zoo.20280; He W, 2008, CONSERV GENET, V9, P1541, DOI 10.1007/s10592-007-9493-x; Hu YB, 2010, CONSERV GENET, V11, P2145, DOI 10.1007/s10592-010-0100-1; Kersey DC, 2010, REPROD FERT DEVELOP, V22, P901, DOI 10.1071/RD09178; Kersey DC, 2010, REPRODUCTION, V140, P183, DOI 10.1530/REP-10-0003; Lawler IR, 2006, J CHEM ECOL, V32, P1353, DOI 10.1007/s10886-006-9088-x; Lifeng Z, 2010, BMC GENET, V11, P72; LYONS RK, 1992, J RANGE MANAGE, V45, P238, DOI 10.2307/4002970; MAHALANOBIS PRASANTA CHANDRA, 1930, JOUR AND PROC ASIATIC SOC BENGAL, V26, P541; MAINKA SA, 1990, J ZOO WILDLIFE MED, V21, P334; Martens H., 2001, MULTIVARIATE ANAL QU; McIlwee AM, 2001, OECOLOGIA, V128, P539, DOI 10.1007/s004420100692; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Pan Wenshi, 2004, P81; Schaller G.B., 1985, GIANT PANDAS WOLONG; SHENK JS, 1991, CROP SCI, V31, P469, DOI 10.2135/cropsci1991.0011183X003100020049x; State Forestry Administration of China, 2006, 3 NAT GIANT PAND CEN; Steel RGD, 1980, PRINCIPLES PROCEDURE; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; Sutherland-Smith M, 2004, ZOO BIOL, V23, P449, DOI 10.1002/zoo.20022; Swaisgood R.R., 2003, INT J COMP PSYCHOL, V16, P65; Tolleson D.R., 2010, SHINING LIGHT MANURE, P81; Tolleson DR, 2005, SMALL RUMINANT RES, V57, P141, DOI 10.1016/j.smallrumres.2004.06.020; Volesky JD, 1996, J RANGE MANAGE, V49, P163, DOI 10.2307/4002688; Walker JW, 2007, J ANIM SCI, V85, P518, DOI 10.2527/jas.2006-202; Walker JW, 1998, J RANGE MANAGE, V51, P450, DOI 10.2307/4003333; Wallis IR, 2003, AUST J ZOOL, V51, P95, DOI 10.1071/ZO02027; Wiedower E, 2009, J NEAR INFRARED SPEC, V17, P265, DOI 10.1255/jnirs.848; Willis EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021159; Woolnough AP, 2002, WILDLIFE RES, V29, P91, DOI 10.1071/WR00050; Woolnough AP, 2001, OECOLOGIA, V129, P585, DOI 10.1007/s004420100771; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhu LF, 2010, CONSERV BIOL, V24, P1299, DOI 10.1111/j.1523-1739.2010.01499.x	41	14	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38908	10.1371/journal.pone.0038908	http://dx.doi.org/10.1371/journal.pone.0038908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719982	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900062
J	Hisano, Y; Kobayashi, N; Yamaguchi, A; Nishi, T				Hisano, Yu; Kobayashi, Naoki; Yamaguchi, Akihito; Nishi, Tsuyoshi			Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; MAST-CELLS; LYMPHOCYTE EGRESS; IMMUNOMODULATOR FTY720; PLATELETS; RECEPTOR; RELEASE; BLOOD; ERYTHROCYTES; METABOLISM	Sphingosine-1-phosphate (S1P), a sphingolipid metabolite that is produced inside the cells, regulates a variety of physiological and pathological responses via S1P receptors (S1P1-5). Signal transduction between cells consists of three steps; the synthesis of signaling molecules, their export to the extracellular space and their recognition by receptors. An S1P concentration gradient is essential for the migration of various cell types that express S1P receptors, such as lymphocytes, pre-osteoclasts, cancer cells and endothelial cells. To maintain this concentration gradient, plasma S1P concentration must be at a higher level. However, little is known about the molecular mechanism by which S1P is supplied to extracellular environments such as blood plasma. Here, we show that SPNS2 functions as an S1P transporter in vascular endothelial cells but not in erythrocytes and platelets. Moreover, the plasma S1P concentration of SPNS2-deficient mice was reduced to approximately 60% of wild-type, and SPNS2-deficient mice were lymphopenic. Our results demonstrate that SPNS2 is the first physiological S1P transporter in mammals and is a key determinant of lymphocyte egress from the thymus.	[Hisano, Yu; Kobayashi, Naoki; Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka, Japan; [Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Osaka University; Osaka University	Hisano, Y (corresponding author), RIKEN, Lab Cardiovasc Mol Dynam, Quantitat Biol Ctr, Suita, Osaka, Japan.	tnishi@sanken.osaka-u.ac.jp			Management Expenses Grants for National Universities Corporations; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21200071, 21570137, 19109002]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21200071, 23790093, 21570137] Funding Source: KAKEN	Management Expenses Grants for National Universities Corporations; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Management Expenses Grants for National Universities Corporations, grant-in-aid for Scientific Research (S)(19109002), grants-in-aid for Scientific Research on Innovative area (21200071) and Scientific Research (C) (21570137) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Anada Y, 2007, EUR J PHARMACOL, V568, P106, DOI 10.1016/j.ejphar.2007.04.053; Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100; Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; FINDLATER GS, 1993, J ANAT, V183, P121; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Honig SM, 2003, J CLIN INVEST, V111, P627, DOI 10.1172/JCI200316200; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kambe N, 2004, BLOOD, V103, P860, DOI 10.1182/blood-2003-04-1160; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Limaye V, 2008, ENDOTHELIUM-J ENDOTH, V15, P101, DOI 10.1080/10623320802125342; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Moritz DR, 1998, J IMMUNOL, V161, P4866; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pyne S, 2004, SEMIN CELL DEV BIOL, V15, P491, DOI 10.1016/j.semcdb.2004.05.007; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tanfin Z, 2011, CELL SIGNAL, V23, P1997, DOI 10.1016/j.cellsig.2011.07.010; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Yatomi Y, 2000, BLOOD, V96, P3431; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	54	152	155	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38941	10.1371/journal.pone.0038941	http://dx.doi.org/10.1371/journal.pone.0038941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22723910	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000055
J	Li, RS; Sun, QW; Jia, YM; Cong, RH; Ni, YD; Yang, XJ; Jiang, ZH; Zhao, RQ				Li, Runsheng; Sun, Qinwei; Jia, Yimin; Cong, Rihua; Ni, Yingdong; Yang, Xiaojing; Jiang, Zhihua; Zhao, Ruqian			Coordinated miRNA/mRNA Expression Profiles for Understanding Breed-Specific Metabolic Characters of Liver between Erhualian and Large White Pigs	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; MICRORNA IDENTITY; SYSTEM; TRANSCRIPTOME; ABUNDANCE; DATABASE	MicroRNAs (miRNAs) are involved in the regulation of various metabolic processes in the liver, yet little is known on the breed-specific expression profiles of miRNAs in coordination with those of mRNAs. Here we used two breeds of male newborn piglets with distinct metabolic characteristics, Large White (LW) and Erhualian (EHL), to delineate the hepatic expression profiles of mRNA with microarray and miRNAs with both deep sequencing and microarray, and to analyze the functional relevance of integrated miRNA and mRNA expression in relation to the physiological and biochemical parameters. EHL had significantly lower body weight and liver weight at birth, but showed elevated serum levels of total cholesterol (TCH), high-density lipoprotein cholesterol (HDLC) and low-density lipoprotein cholesterol (LDLC), as well as higher liver content of cholesterol. Higher serum cortisol and lower serum insulin and leptin were also observed in EHL piglets. Compared to LW, 30 up-regulated and 18 down-regulated miRNAs were identified in the liver of EHL, together with 298 up-regulated and 510 down-regulated mRNAs (FDR<10%). RT-PCR validation of some differentially expressed miRNAs (DEMs) further confirmed the high-throughput data analysis. Using a target prediction algorithm, we found significant correlation between the up-regulated miRNAs and down-regulated mRNAs. Moreover, differentially expressed genes (DEGs), which are involved in proteolysis, were predicted to be mediated by DEMs. These findings provide new information on the miRNA and mRNA profiles in porcine liver, which would shed light on the molecular mechanisms underlying the breed-specific traits in the pig, and may serve as a basis for further investigation into the biological functions of miRNAs in porcine liver.	[Li, Runsheng; Sun, Qinwei; Jia, Yimin; Cong, Rihua; Ni, Yingdong; Yang, Xiaojing; Zhao, Ruqian] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China; [Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Washington State University	Li, RS (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	niyingdong@njau.edu.cn; zhao.ruqian@gmail.com	LI, Runsheng/AFR-9519-2022; Jiang, Zhihua/A-3378-2008	LI, Runsheng/0000-0003-1563-1844; Jiang, Zhihua/0000-0003-1986-088X	National Basic Research Program of China [2012CB124703]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; Major National Science & Technology Projects of China [2009ZX08009-138B]; Ministry of Education and State Administration of Foreign Experts Affairs "Overseas Teacher" project [MS2011NJND034]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Major National Science & Technology Projects of China; Ministry of Education and State Administration of Foreign Experts Affairs "Overseas Teacher" project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Basic Research Program of China (2012CB124703), the Special Fund for Agro-scientific Research in the Public Interest (201003011), the Major National Science & Technology Projects of China (2009ZX08009-138B), the Ministry of Education and State Administration of Foreign Experts Affairs "Overseas Teacher" project (MS2011NJND034), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Daniels TF, 2009, INT J BIOL SCI, V5, P474; den Hartog L, 2004, ADVANCES IN PORK PRODUCTION, VOL 15, P17; Desjardins Philippe R, 2011, Curr Protoc Mol Biol, VAppendix 3, p3J, DOI 10.1002/0471142727.mba03js93; Elsik CG, 2010, J BIOMED BIOTECHNOL, V2010, P1; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Goyal R, 2010, REPROD SCI, V17, P227, DOI 10.1177/1933719109351935; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Kawaguchi H, 2011, J PHARMACOL SCI, V115, P115, DOI 10.1254/jphs.10R17FM; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li LA, 2008, STEROIDS, V73, P806, DOI 10.1016/j.steroids.2008.03.002; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Li XD, 2011, PROTEIN CELL, V2, P189, DOI 10.1007/s13238-011-1016-3; Li ZG, 2011, ENVIRON MOL MUTAGEN, V52, P469, DOI 10.1002/em.20645; Lim D, 2009, MAMM GENOME, V20, P60, DOI 10.1007/s00335-008-9156-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Steibel JP, 2009, ANIM GENET, V40, P883, DOI 10.1111/j.1365-2052.2009.01928.x; Sun XJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-111; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang LJ, 2011, GEN COMP ENDOCR, V173, P56, DOI 10.1016/j.ygcen.2011.04.025; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337	43	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38716	10.1371/journal.pone.0038716	http://dx.doi.org/10.1371/journal.pone.0038716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719927	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000041
J	Rapoport, BI; Kedzierski, JT; Sarpeshkar, R				Rapoport, Benjamin I.; Kedzierski, Jakub T.; Sarpeshkar, Rahul			A Glucose Fuel Cell for Implantable Brain-Machine Interfaces	PLOS ONE			English	Article							BIOFUEL CELLS; ELECTRICITY-GENERATION; ELECTRODES; OXIDATION; SILICON; DESIGN	We have developed an implantable fuel cell that generates power through glucose oxidation, producing 3.4 mu W cm(-2) steady-state power and up to 180 mu W cm(-2) peak power. The fuel cell is manufactured using a novel approach, employing semiconductor fabrication techniques, and is therefore well suited for manufacture together with integrated circuits on a single silicon wafer. Thus, it can help enable implantable microelectronic systems with long-lifetime power sources that harvest energy from their surrounds. The fuel reactions are mediated by robust, solid state catalysts. Glucose is oxidized at the nanostructured surface of an activated platinum anode. Oxygen is reduced to water at the surface of a self-assembled network of single-walled carbon nanotubes, embedded in a Nafion film that forms the cathode and is exposed to the biological environment. The catalytic electrodes are separated by a Nafion membrane. The availability of fuel cell reactants, oxygen and glucose, only as a mixture in the physiologic environment, has traditionally posed a design challenge: Net current production requires oxidation and reduction to occur separately and selectively at the anode and cathode, respectively, to prevent electrochemical short circuits. Our fuel cell is configured in a half-open geometry that shields the anode while exposing the cathode, resulting in an oxygen gradient that strongly favors oxygen reduction at the cathode. Glucose reaches the shielded anode by diffusing through the nanotube mesh, which does not catalyze glucose oxidation, and the Nafion layers, which are permeable to small neutral and cationic species. We demonstrate computationally that the natural recirculation of cerebrospinal fluid around the human brain theoretically permits glucose energy harvesting at a rate on the order of at least 1 mW with no adverse physiologic effects. Low-power brain-machine interfaces can thus potentially benefit from having their implanted units powered or recharged by glucose fuel cells.	[Rapoport, Benjamin I.; Sarpeshkar, Rahul] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Rapoport, Benjamin I.; Kedzierski, Jakub T.] MIT, Lincoln Lab, Adv Silicon Technol Grp, Lexington, MA 02173 USA; [Rapoport, Benjamin I.] Harvard Univ, Sch Med, MD PhD Program, Boston, MA USA	Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Rapoport, BI (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	rahuls@mit.edu	Rapoport, Benjamin/ABF-2332-2021		National Institutes of Health [NS-056140]; Office of Naval Research [N00014-09-1-1015]; DARPA Research Assistantship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); DARPA Research Assistantship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by the National Institutes of Health under grant NS-056140, by the Office of Naval Research under grant N00014-09-1-1015, and by a DARPA Research Assistantship to MIT Lincoln Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2008, BRAIN RES, V1218, P77, DOI 10.1016/j.brainres.2008.04.007; [Anonymous], 2010, LT3108 ULTR VOLT STE; Attard GS, 1997, SCIENCE, V278, P838, DOI 10.1126/science.278.5339.838; Attard GS, 1997, ANGEW CHEM INT EDIT, V36, P1315, DOI 10.1002/anie.199713151; Baker MW, 2007, IEEE T BIOMED CIRC S, V1, P28, DOI 10.1109/TBCAS.2007.893180; Bard A. J., 2001, ELECTROCHEMICAL METH; Barrett Kim E, 2010, GANONGS REV MEDICAL; Bullen RA, 2006, BIOSENS BIOELECTRON, V21, P2015, DOI 10.1016/j.bios.2006.01.030; Burke A, 2000, J POWER SOURCES, V91, P37, DOI 10.1016/S0378-7753(00)00485-7; Chaudhry HJ, 2004, FUNDAMENTALS CLIN ME; Davis F, 2007, BIOSENS BIOELECTRON, V22, P1224, DOI 10.1016/j.bios.2006.04.029; Davson H, 1996, PHYSL CSF BLOOD BRAI; Denny M. W., 1993, AIR WATER BIOL PHYS; DRAKE RF, 1970, T AM SOC ART INT ORG, V16, P199; Dudney NJ, 1999, CURR OPIN SOLID ST M, V4, P479, DOI 10.1016/S1359-0286(99)00052-2; Ellenbogen KA, 2000, CLIN CARDIAC PACING; GEBHARDT U, 1976, J APPL ELECTROCHEM, V6, P127, DOI 10.1007/BF00615377; Gold S, 2004, J POWER SOURCES, V135, P198, DOI 10.1016/j jpowsour.2004.03.084; Greenberg M.S, 2010, HDB NEUROSURGERY; Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a; Heller A, 2008, U.S. Patent, Patent No. [7,368,190, 7368190]; Ilic B, 1999, ELECTROCHEM SOLID ST, V2, P86, DOI 10.1149/1.1390743; Jayalakshmi M, 2008, INT J ELECTROCHEM SC, V3, P1196; Kerzenmacher S, 2008, J POWER SOURCES, V182, P66, DOI 10.1016/j.jpowsour.2008.03.049; Kerzenmacher S, 2008, J POWER SOURCES, V182, P1, DOI 10.1016/j.jpowsour.2008.03.031; Kerzenmacher S, 2010, J POWER SOURCES, V195, P6516, DOI 10.1016/j.jpowsour.2010.04.039; Kerzenmacher S, 2010, J POWER SOURCES, V195, P6524, DOI 10.1016/j.jpowsour.2010.04.049; Kim G, 2009, J BIOMAT SCI-POLYM E, V20, P1687, DOI 10.1163/156856208X386273; Kumar K, 2005, ROBBINS COTRANS PATH, V7, P213; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Lee YJ, 2008, IEEE SENS J, V8, P1922, DOI 10.1109/JSEN.2008.2006697; Leonov V, 2007, IEEE SENS J, V7, P650, DOI 10.1109/JSEN.2007.894917; Logan B.E., 2008, MICROBIAL FUEL CELLS; Lu K, 2004, AM J PHYSIOL-HEART C, V286, pH584, DOI 10.1152/ajpheart.00594.2003; MacKay David J.C., 2009, SUSTAINABLE ENERGY H; Maclay J, 1989, U.S. Patent, Patent No. [4,795,543, 4795543]; Mandal S, 2007, IEEE T CIRCUITS-I, V54, P1177, DOI 10.1109/TCSI.2007.895229; Mitcheson PD, 2008, P IEEE, V96, P1457, DOI 10.1109/JPROC.2008.927494; Newman J., 2004, ELECTROCHEMICAL SYST; Niessen J, 2004, ELECTROCHEM COMMUN, V6, P955, DOI 10.1016/j.elecom.2004.07.010; Osman MH, 2010, BIOSENS BIOELECTRON, V26, P953, DOI 10.1016/j.bios.2010.08.057; Panasonic Industry, 2022, ULTRA LOW POWER BIOE, DOI 10.1017/CBO9780511841446; Prilutsky S, 2010, ELECTROCHIM ACTA, V55, P3694, DOI 10.1016/j.electacta.2010.02.005; Rabaey J, 2009, INTEGR CIRCUIT SYST, P1, DOI 10.1007/978-0-387-71713-5; Rabaey K, 2003, BIOTECHNOL LETT, V25, P1531, DOI 10.1023/A:1025484009367; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Rao R, 1975, U.S. Patent, Patent No. [3861397, 3,861,397]; Rapoport B, 2011, SYSTEM CIRCUIT DESIG, P216; Rapoport BI, 2009, P 31 ANN INT C IEEE; RISHPON J, 1994, ELECTROANAL, V6, P17, DOI 10.1002/elan.1140060105; Ropper A.H. a.B., 2005, ADAMS VICTORS PRINCI; ROSENBERG GA, 1990, BRAIN FLUIDS METABOL; Sarpeshkar R, 2005, IEEE T BIO-MED ENG, V52, P711, DOI 10.1109/TBME.2005.844043; Sarpeshkar R, 2008, IEEE T BIOMED CIRC S, V2, P173, DOI 10.1109/TBCAS.2008.2003198; Sharma T, 2011, LAB CHIP, V11, P2460, DOI 10.1039/c1lc20119k; von Stetten F, 2006, HLTH AIMS DISS DAY P, pWP5b; von Sturm F, 1976, U.S. Patent, Patent No. [3,941,135, 3941135]; Wattanapanitch W, 2007, IEEE T BIOMED CIRC S, V1, P136, DOI 10.1109/TBCAS.2007.907868; Weidlich E, 1976, BIOMATERIALS MED DEV, V3-4, P227; Wu G, 2007, J POWER SOURCES, V174, P148, DOI 10.1016/j.jpowsour.2007.08.024; Zaharchuk G, 2005, MAGNET RESON MED, V54, P113, DOI 10.1002/mrm.20546	62	154	160	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38436	10.1371/journal.pone.0038436	http://dx.doi.org/10.1371/journal.pone.0038436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719888	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000023
J	Aliota, MT; Jones, SA; Dupuis, AP; Ciota, AT; Hubalek, Z; Kramer, LD				Aliota, Matthew T.; Jones, Susan A.; Dupuis, Alan P., II; Ciota, Alexander T.; Hubalek, Zdenek; Kramer, Laura D.			Characterization of Rabensburg Virus, a Flavivirus Closely Related to West Nile Virus of the Japanese Encephalitis Antigenic Group	PLOS ONE			English	Article							CULEX-PIPIENS DIPTERA; VECTOR COMPETENCE; VERTICAL TRANSMISSION; DC-SIGN; IDENTIFICATION; CULICIDAE; MOSQUITOS; ASSAY; GENE; GLYCOSYLATION	Rabensburg virus (RABV), a Flavivirus with similar to 76% nucleotide and 90% amino acid identity with representative members of lineage one and two West Nile virus (WNV), previously was isolated from Culex pipiens and Aedes rossicus mosquitoes in the Czech Republic, and phylogenetic and serologic analyses demonstrated that it was likely a new lineage of WNV. However, no direct link between RABV and human disease has been definitively established and the extent to which RABV utilizes the typical WNV transmission cycle is unknown. Herein, we evaluated vector competence and capacity for vertical transmission (VT) in Cx. pipiens; in vitro growth on avian, mammalian, and mosquito cells; and infectivity and viremia production in birds. RABV infection and replication only were detected on mosquito cells. Experimentally inoculated birds did not become infected. Cx. pipiens had poor peroral vector competence and a higher VT rate as compared to US-WNV in Cx. pipiens. As a result, we postulate that RABV is an intermediate between the mosquito-specific and horizontally transmitted flaviviruses.	[Aliota, Matthew T.; Jones, Susan A.; Dupuis, Alan P., II; Ciota, Alexander T.; Kramer, Laura D.] Hlth Wadsworth Ctr, Arbovirus Labs, New York State Dept, Slingerlands, NY USA; [Hubalek, Zdenek] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	Wadsworth Center; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Aliota, MT (corresponding author), Hlth Wadsworth Ctr, Arbovirus Labs, New York State Dept, Slingerlands, NY USA.	kramer@wadsworth.org	Hubalek, Zdenek/AAF-8071-2019; Aliota, Matthew/AAS-6376-2021; Hubalek, Zdenek/G-1111-2014; Ciota, Alexander/E-1634-2017	Hubalek, Zdenek/0000-0003-4732-0987; Ciota, Alexander/0000-0001-6589-4728; Aliota, Matthew/0000-0002-6902-9149; Dupuis, Alan/0000-0003-0703-9250	Wadsworth Center Biodefense and Emerging Infectious Disease postdoctoral fellowship, NIH [T32-AIO55429]	Wadsworth Center Biodefense and Emerging Infectious Disease postdoctoral fellowship, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MTA is supported by the Wadsworth Center Biodefense and Emerging Infectious Disease postdoctoral fellowship, NIH T32-AIO55429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2006, J INFECT DIS, V194, P1577, DOI 10.1086/508754; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Blitvich BJ, 2001, J GEN VIROL, V82, P2251, DOI 10.1099/0022-1317-82-9-2251; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; Ciota AT, 2008, J GEN VIROL, V89, P1633, DOI 10.1099/vir.0.2008/000893-0; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640; Ebel GD, 2005, J MED ENTOMOL, V42, P838, DOI 10.1603/0022-2585(2005)042[0838:CRDCRA]2.0.CO;2; Ebel GD, 2002, EMERG INFECT DIS, V8, P979, DOI 10.3201/eid0809.020152; Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Gu WD, 2003, J MED ENTOMOL, V40, P595, DOI 10.1603/0022-2585-40.5.595; Hubalek Z, 2010, J MED ENTOMOL, V47, P466, DOI 10.1603/ME09219; Hubalek Z, 1998, ACTA VIROL, V42, P119; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P427, DOI 10.1089/vim.2000.13.427; Hubalek Z, 1999, EMERG INFECT DIS, V5, P594, DOI 10.3201/eid0504.990430; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kilpatrick AM, 2010, VECTOR-BORNE ZOONOT, V10, P377, DOI 10.1089/vbz.2009.0029; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lvov DK, 2004, ARCH VIROL, P85; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; MELNICK JL, 1951, P SOC EXP BIOL MED, V77, P661, DOI 10.3181/00379727-77-18884; Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Prilipov A. G., 2002, Voprosy Virusologii, V47, P36; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; SCHLESINGER S, 1985, VIRUS RES, V2, P139, DOI 10.1016/0168-1702(85)90244-8; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; vanDinten LC, 1997, P NATL ACAD SCI USA, V94, P991, DOI 10.1073/pnas.94.3.991; Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112	46	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39387	10.1371/journal.pone.0039387	http://dx.doi.org/10.1371/journal.pone.0039387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724010	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700075
J	Burger-van Paassen, N; Loonen, LMP; Witte-Bouma, J; Korteland-van Male, AM; de Bruijn, ACJM; van der Sluis, M; Lu, P; Van Goudoever, JB; Wells, JM; Dekker, J; Van Seuningen, I; Renes, IB				Burger-van Paassen, Nanda; Loonen, Linda M. P.; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; van der Sluis, Maria; Lu, Peng; Van Goudoever, Johannes B.; Wells, Jerry M.; Dekker, Jan; Van Seuningen, Isabelle; Renes, Ingrid B.			Mucin Muc2 Deficiency and Weaning Influences the Expression of the Innate Defense Genes Reg3 beta, Reg3 gamma and Angiogenin-4	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LECTIN REGIII-GAMMA; PANETH CELLS; INTERLEUKIN-10-DEFICIENT MICE; NECROTIZING ENTEROCOLITIS; GASTROINTESTINAL-TRACT; BACTERICIDAL LECTIN; EPITHELIAL-CELLS; SOLUBLE CD14; HUMAN-MILK	Background: Mucin Muc2 is the structural component of the intestinal mucus layer. Absence of Muc2 leads to loss of this layer allowing direct bacterial-epithelial interactions. We hypothesized that absence of the mucus layer leads to increased expression of innate defense peptides. Specifically, we aimed to study the consequence of Muc2 deficiency (Muc2(-/-)) on the expression of regenerating islet-derived protein 3 beta (Reg3 beta), regenerating islet-derived protein 3 gamma (Reg3 gamma), and angiogenin-4 (Ang4) in the intestine shortly before and after weaning. Methods: Intestinal tissues of Muc2(-/-) and wild-type (WT) mice were collected at postnatal day 14 (P14, i.e. pre-weaning) and P28 (i.e. post-weaning). Reg3 beta, Reg3 gamma, and Ang4 expression was studied by quantitative real-time PCR, Western-blot, in situ hybridization, and immunohistochemistry. Results: Reg3 beta and Reg3 gamma were expressed by diverging epithelial cell types; namely enterocytes, Paneth cells, and goblet cells. Additionally, Ang4 expression was confined to Paneth cells and goblet cells. Expression of Reg3 beta, Reg3 gamma, and Ang4 differed between WT and Muc2(-/-) mice before and after weaning. Interestingly, absence of Muc2 strongly increased Reg3 beta and Reg3 gamma expression in the small intestine and colon. Finally, morphological signs of colitis were only observed in the distal colon of Muc2(-/-) mice at P28, where and when expression levels of Reg3 beta, Reg3 gamma, and Ang4 were the lowest. Conclusions: Expression of Reg3 proteins and Ang4 by goblet cells point to an important role for goblet cells in innate defense. Absence of Muc2 results in up-regulation of Reg3 beta and Reg3 gamma expression, suggesting altered bacterial-epithelial signaling and an innate defense response in Muc2(-/-) mice. The inverse correlation between colitis development and Reg3 beta, Reg3 gamma, and Ang4 expression levels might point toward a role for these innate defense peptides in regulating intestinal inflammation.	[Burger-van Paassen, Nanda; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; van der Sluis, Maria; Lu, Peng; Van Goudoever, Johannes B.; Renes, Ingrid B.] Erasmus MC Sophia, Pediat Lab, Div Neonatol, Rotterdam, Netherlands; [Loonen, Linda M. P.; Wells, Jerry M.] Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands; [Loonen, Linda M. P.; Wells, Jerry M.; Dekker, Jan] Top Inst Food & Nutr, Wageningen, Netherlands; [Dekker, Jan] Wageningen UR, Dept Anim Sci, Wageningen, Netherlands; [Van Seuningen, Isabelle] Jean Pierre Aubert Res Ctr, Team Mucins Epithelial Differentiat & Carcinogene, INSERM, U837, Lille, France	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Top Institute Food & Nutrition; Wageningen University & Research; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Burger-van Paassen, N (corresponding author), Erasmus MC Sophia, Pediat Lab, Div Neonatol, Rotterdam, Netherlands.	i.renes@erasmusmc.nl	VAN SEUNINGEN, Isabelle/N-6176-2016; van Goudoever, Johannes Bernard/Y-4520-2018; Renes, Ingrid/C-4801-2013	VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Loonen, Linda MP/0000-0003-0935-2494				Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Dessein R, 2009, GUT, V58, P771, DOI 10.1136/gut.2008.168443; Filipp D, 2001, P NATL ACAD SCI USA, V98, P603, DOI 10.1073/pnas.98.2.603; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; JACOBS LR, 1985, J CLIN INVEST, V75, P112, DOI 10.1172/JCI111662; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Krimi RB, 2008, INFLAMM BOWEL DIS, V14, P931, DOI 10.1002/ibd.20420; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Labeta MO, 2000, J EXP MED, V191, P1807, DOI 10.1084/jem.191.10.1807; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Renes IB, 2002, J PATHOL, V198, P60, DOI 10.1002/path.1183; Rodenburg W, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-84; Schaart MW, 2009, J PEDIAT GASTROENTER; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Tytgat KMAJ, 1996, BIOCHEM BIOPH RES CO, V224, P397, DOI 10.1006/bbrc.1996.1039; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Ampting MTJ, 2012, INFECT IMMUN, V80, P1115, DOI 10.1128/IAI.06165-11; van Ampting MT, 2009, DIG DIS SCI; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Verburg M, 2000, AM J PHYSIOL-GASTR L, V279, pG1037, DOI 10.1152/ajpgi.2000.279.5.G1037; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	43	55	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38798	10.1371/journal.pone.0038798	http://dx.doi.org/10.1371/journal.pone.0038798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723890	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700031
J	Ma, RM; Yan, W; Zhang, GJ; Lv, H; Liu, ZZ; Fang, F; Zhang, W; Zhang, JX; Tao, T; You, YP; Jiang, T; Kang, XX				Ma, Ruimin; Yan, Wei; Zhang, Guojun; Lv, Hong; Liu, Zhizhong; Fang, Fang; Zhang, Wei; Zhang, Junxia; Tao, Tao; You, Yongping; Jiang, Tao; Kang, Xixiong			Upregulation of miR-196b Confers a Poor Prognosis in Glioblastoma Patients via Inducing a Proliferative Phenotype	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MICRORNA EXPRESSION; GLIOMA-CELLS; THERAPY; OVEREXPRESSION; PROFILES; PATHWAY; CANCER; GENES; MLL	Purpose: To explore the expression pattern, prognostic value and functional role of miR-196b in glioblastoma (GBM) patients using large cohorts. Experimental Design: MiR-196b expression was measured using the Human v2.0 miRNA Expression BeadChip (Illumina) in 198 frozen glioma tissues. The expression levels of miR-196b were also validated in an independent cohort containing 128 formalin-fixed paraffin-embedded (FFPE) glioma samples using qRT-PCR. The presence of other molecular prognostic indicators was assessed centrally in the glioma samples. Whole genome gene profiling was performed to investigate the underlying biological behavior. MiR-196b functional analyses were performed in U87 and U251 cell lines. Results: The expression levels of miR-196b were inversely correlated with overall survival in GBM patients. Gene set enrichment analysis (GSEA) showed that the gene sets relating to cell cycle were significantly enriched in the cases with miR-196b overexpression. Functional analyses in U87 and U251 cells revealed that miR-196b was involved in cell proliferation. Conclusions: MiR-196b is overexpressed and confers a poor prognosis via promoting cellular proliferation in GBM patients.	[Ma, Ruimin; Zhang, Guojun; Lv, Hong; Liu, Zhizhong; Fang, Fang; Kang, Xixiong] Capital Med Univ, Beijing Tiantan Hosp, Lab Diag Ctr, Beijing, Peoples R China; [Yan, Wei; Zhang, Wei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhang, Junxia; Tao, Tao; You, Yongping] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Capital Medical University; Capital Medical University; Nanjing Medical University	Ma, RM (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Lab Diag Ctr, Beijing, Peoples R China.	yypl9@njmu.edu.cn; taojiang1964@yahoo.com.cn; clinical_lab@126.com	jiang, tao/GWC-7108-2022; Jiang, Tao/N-8142-2014		National Key Project of Science and Technology Supporting Programs of China [2007BAI05B08]; National Natural Science Foundation of China [30772238, 30730035]	National Key Project of Science and Technology Supporting Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Key Project of Science and Technology Supporting Programs of China (No. 2007BAI05B08) and National Natural Science Foundation of China (No. 30772238 and 30730035, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bhatia S, 2011, MOL CELL BIOCHEM, V346, P103, DOI 10.1007/s11010-010-0597-0; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Coskun E, 2011, LEUKEMIA RES, V35, P208, DOI 10.1016/j.leukres.2010.05.007; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; Ganesan S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001946; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schotte D, 2010, HAEMATOL-HEMATOL J, V95, P1675, DOI 10.3324/haematol.2010.023481; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Tin AS, 2011, ANTICANCER DRUGS; Tsai KW, 2010, GENE CHROMOSOME CANC, V49, P969, DOI 10.1002/gcc.20804; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Yan W, 2011, BRAIN RES, V1411, P108, DOI 10.1016/j.brainres.2011.07.002; Zhang W, 2009, CHINESE MED J-PEKING, V122, P1250, DOI 10.3760/cma.j.issn.0366-6999.2009.11.003; Zhou CZ, 2008, CHINESE MED J-PEKING, V121, P2479, DOI 10.1097/00029330-200812020-00003; Zuo Z, 2011, BLOOD, V118, P413, DOI 10.1182/blood-2011-01-330704	32	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38096	10.1371/journal.pone.0038096	http://dx.doi.org/10.1371/journal.pone.0038096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723849	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700011
J	Mohr, M; Nybo, L; Grantham, J; Racinais, S				Mohr, Magni; Nybo, Lars; Grantham, Justin; Racinais, Sebastien			Physiological Responses and Physical Performance during Football in the Heat	PLOS ONE			English	Article							PREMIER LEAGUE SOCCER; EXERCISE PERFORMANCE; SPRINT PERFORMANCE; MUSCLE TEMPERATURE; PROLONGED EXERCISE; SIDED GAMES; FATIGUE; TIME; HYPERTHERMIA; MATCHES	Purpose: To examine the impact of hot ambient conditions on physical performance and physiological responses during football match-play. Methods: Two experimental games were completed in temperate (similar to 21 degrees C; CON) and hot ambient conditions (similar to 43 degrees C; HOT). Physical performance was assessed by match analysis in 17 male elite players during the games and a repeated sprint test was conducted after the two game trials. Core and muscle temperature were measured and blood samples were obtained, before and after the games. Results: Muscle and core temperatures were similar to 1 degrees C higher (P<0.05) in HOT (40.3=0.1 and 39.5=0.1 degrees C, respectively) compared to CON (39.2=0.1 and 38.3=0.1 degrees C). Average heart rate, plasma lactate concentration, body weight loss as well as post-game sprint performance were similar between the two conditions. Total game distance declined (P<0.05) by 7% and high intensity running (>14 km.h(-1)) by 26% in HOT compared to CON), but peak sprint speed was 4% higher (P<0.05) in HOT than in CON, while there were no differences in the quantity or length of sprints (>24 km.h(-1)) between CON and HOT. In HOT, success rates for passes and crosses were 8 and 9% higher (P<0.05), respectively, compared to CON. Delta increase in core temperature and absolute core temperature in HOT were correlated to total game distance in the heat (r = 0.85 and r = 0.53, respectively; P<0.05), whereas, total and high intensity distance deficit between CON and HOT were not correlated to absolute or delta changes in muscle or core temperature. Conclusion: Total game distance and especially high intensity running were lower during a football game in the heat, but these changes were not directly related to the absolute or relative changes in core or muscle temperature. However, peak sprinting speed and execution of successful passes and crosses were improved in the HOT condition.	[Mohr, Magni] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Nybo, Lars] Univ Copenhagen, Sect Human Physiol, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Grantham, Justin; Racinais, Sebastien] Qatar Orthopaed & Sports Med Hosp, Res & Educ Ctr, Aspetar, Doha, Qatar	University of Exeter; University of Copenhagen; Aspetar Orthopaedic & Sports Medicine Hospital	Mohr, M (corresponding author), Univ Exeter, Coll Life & Environm Sci, St Lukes Campus, Exeter, Devon, England.	M.Mohr@exeter.ac.uk	Racinais, Sebastien/N-3052-2019; Nybo, Lars/P-6153-2014	Nybo, Lars/0000-0002-9090-1958	Aspetar, Qatar Orthopaedic and Sport Medicine Hospital	Aspetar, Qatar Orthopaedic and Sport Medicine Hospital	The study was funded and supported by Aspetar, Qatar Orthopaedic and Sport Medicine Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2008, J SPORT SCI, V26, P113, DOI 10.1080/02640410701422076; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bendiksen M, 2012, MED SCI SPORTS 0210; Bradley PS, 2011, J SPORT SCI, V29, P821, DOI 10.1080/02640414.2011.561868; Dellal A, 2011, J STRENGTH COND RES, V25, P2371, DOI 10.1519/JSC.0b013e3181fb4296; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Edwards B, 2002, CHRONOBIOL INT, V19, P579, DOI 10.1081/CBI-120004227; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; Gaoua N, 2011, INT J HYPERTHER, V27, P1, DOI 10.3109/02656736.2010.519371; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1165, DOI 10.1249/01.mss.0000222845.89262.cd; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; Mohr M, 2006, EUR J APPL PHYSIOL, V97, P89, DOI 10.1007/s00421-006-0152-6; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Mohr M, 2004, SCAND J MED SCI SPOR, V14, P156, DOI 10.1111/j.1600-0838.2004.00349.x; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Mohr M, 2010, SCAND J MED SCI SPOR, V20, P125, DOI 10.1111/j.1600-0838.2010.01217.x; Mohr M, 2012, J STRENGTH IN PRESS; Morante SM, 2008, BRIT J SPORT MED, V42, P679, DOI 10.1136/bjsm.2007.042499; Nielsen B, 2003, SPORTS MED, V33, P1, DOI 10.2165/00007256-200333010-00001; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Nybo L, 2010, SCAND J MED SCI SPOR, V20, P71, DOI 10.1111/j.1600-0838.2010.01211.x; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Nybo L, 2008, J APPL PHYSIOL, V104, P871, DOI 10.1152/japplphysiol.00910.2007; Owen AL, 2011, J STRENGTH COND RES, V25, P2104, DOI 10.1519/JSC.0b013e3181f0a8a3; Ozgunen KT, 2010, SCAND J MED SCI SPOR, V20, P140, DOI 10.1111/j.1600-0838.2010.01219.x; Racinais S, 2005, MED SCI SPORT EXER, V37, P256, DOI 10.1249/01.MSS.0000149885.82163.9F; Racinais S, 2004, CHRONOBIOL INT, V21, P485, DOI 10.1081/CBI-120038632; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P80, DOI 10.1111/j.1600-0838.2010.01212.x; Racinais S, 2012, PSYCHOPHYSIOLOG 0314; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Tatterson A J, 2000, J Sci Med Sport, V3, P186; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4	38	117	118	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39202	10.1371/journal.pone.0039202	http://dx.doi.org/10.1371/journal.pone.0039202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723963	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700052
J	Tria, F; Galantucci, B; Loreto, V				Tria, Francesca; Galantucci, Bruno; Loreto, Vittorio			Naming a Structured World: A Cultural Route to Duality of Patterning	PLOS ONE			English	Article							SELF-ORGANIZATION; SIGN-LANGUAGE; EVOLUTION; EMERGENCE; ORIGIN	The lexicons of human languages organize their units at two distinct levels. At a first combinatorial level, meaningless forms (typically referred to as phonemes) are combined into meaningful units (typically referred to as morphemes). Thanks to this, many morphemes can be obtained by relatively simple combinations of a small number of phonemes. At a second compositional level of the lexicon, morphemes are composed into larger lexical units, the meaning of which is related to the individual meanings of the composing morphemes. This duality of patterning is not a necessity for lexicons and the question remains wide open regarding how a population of individuals is able to bootstrap such a structure and the evolutionary advantages of its emergence. Here we address this question in the framework of a multi-agents model, where a population of individuals plays simple naming games in a conceptual environment modeled as a graph. We demonstrate that errors in communication as well as a blending repair strategy, which crucially exploits a shared conceptual representation of the environment, are sufficient conditions for the emergence of duality of patterning, that can thus be explained in a pure cultural way. Compositional lexicons turn out to be faster to lead to successful communication than purely combinatorial lexicons, suggesting that meaning played a crucial role in the evolution of language.	[Tria, Francesca; Loreto, Vittorio] Inst Sci Interchange, Complex Syst Lagrange Lab, Turin, Italy; [Galantucci, Bruno] Yeshiva Univ, Dept Psychol, New York, NY 10033 USA; [Galantucci, Bruno] Haskins Labs Inc, New Haven, CT USA; [Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	Yeshiva University; Yale University; Haskins Laboratories; Sapienza University Rome	Tria, F (corresponding author), Inst Sci Interchange, Complex Syst Lagrange Lab, Turin, Italy.	fra_trig@yahoo.it	Galantucci, Bruno/N-3034-2019; Galantucci, Bruno/K-3552-2012; Galantucci, Bruno/AAG-4992-2021	Galantucci, Bruno/0000-0002-3642-1371; Galantucci, Bruno/0000-0002-3642-1371	EveryAware European project under FP7-ICT-2009-C [265432]; National Science Foundation [BCS-1026943]; European Science Foundation; Direct For Social, Behav & Economic Scie [1026943] Funding Source: National Science Foundation	EveryAware European project under FP7-ICT-2009-C; National Science Foundation(National Science Foundation (NSF)); European Science Foundation(European Science Foundation (ESF)European Commission); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Funding provided by EveryAware European project nr. 265432 under FP7-ICT-2009-C, National Science Foundation (BCS-1026943) and European Science Foundation, EuroUnderstanding Collaborative Research Projects, Digging for the roots of understanding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronchelli A, 2008, INT J MOD PHYS C, V19, P785, DOI 10.1142/S0129183108012522; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Batali J., 1998, APPROACHES EVOLUTION, P405; Brighton H, 2002, ARTIF LIFE, V8, P25, DOI 10.1162/106454602753694756; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; De Beule J., 2006, EVOLUTION LANGUAGE, P35, DOI [10.1142/9789812774262_0005, DOI 10.1142/9789812774262_0005]; de Boer B, 2010, ADAPT BEHAV, V18, P141, DOI 10.1177/1059712309345789; den Broeck WV, 2008, P EV 7, P338; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; ERDOS P, 1960, B INT STATIST INST, V38, P343; Galantucci B, 2010, INTERACT STUD, V11, P100, DOI 10.1075/is.11.1.03gal; Gardenfors P., 2004, MIND MATTER, V2, P9; Gilles F, 1998, COGNITI VE SCI, V22, P133; Gong T, 2006, P 6 INT C EV LANG 12, P99; Hockett C.F., 1960, ANIMAL SOUNDS COMMUN, P392; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Hockett CF, 1968, NOTE DESIGN FEATURES, P61; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; Loreto V, 2012, P NATL ACAD SCI USA, V109, P6819, DOI 10.1073/pnas.1113347109; Lupyan Gary, 2010, PLoS One, V5, pe8559, DOI 10.1371/journal.pone.0008559; Maddieson Ian, 1984, PATTERNS SOUNDS; Martinet A, 1960, ELEMENTS GEN LINGUIS; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Nowak MA, 1999, P ROY SOC B-BIOL SCI, V266, P2131, DOI 10.1098/rspb.1999.0898; Oudeyer PY, 2005, CONNECT SCI, V17, P325, DOI 10.1080/09540090500217145; Oudeyer PY, 2005, J THEOR BIOL, V233, P435, DOI 10.1016/j.jtbi.2004.10.025; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Pulleyblank Edwin G., 1995, OUTLINE CLASSICAL CH; Ralli A, 2011, BLEND FORMATION MODE, P61; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Senghas A, 2001, PSYCHOL SCI, V12, P323, DOI 10.1111/1467-9280.00359; Sigurd B, 2004, STUD LINGUISTICA, V58, P37, DOI 10.1111/j.0039-3193.2004.00109.x; Smith K, 2003, ADV COMPLEX SYST, V6, P537, DOI 10.1142/S0219525903001055; Smith K, 2003, ARTIF LIFE, V9, P371, DOI 10.1162/106454603322694825; Smith K, 2008, PHILOS T R SOC B, V363, P3591, DOI 10.1098/rstb.2008.0145; Sole 'RV, 2008, TRENDS COGNITIVE SCI; Sowa J., 1984, CONCEPTUAL STRUCTURE; Steels Luc, 1995, Artificial Life, V2, P319; Tambovtsev Y., 2007, SKASE J THEORETICAL, V4, P1; Udnv Yule G., 1944, STAT STUDY LIT VOCAB; Vogt P, 2005, ARTIF INTELL, V167, P206, DOI 10.1016/j.artint.2005.04.010; Vogt P, 2006, EVOLUTION LANGUAGE, P364; Wilson E.O., 1975, P1; Zuidema W, 2009, J PHONETICS, V37, P125, DOI 10.1016/j.wocn.2008.10.003	47	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37744	10.1371/journal.pone.0037744	http://dx.doi.org/10.1371/journal.pone.0037744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723839	gold, Green Submitted, Green Published			2022-12-27	WOS:000305652700006
J	Xie, J; Xu, GH; Wang, J; Zhang, F; Zhang, YZ				Xie, Jun; Xu, Guanghua; Wang, Jing; Zhang, Feng; Zhang, Yizhuo			Steady-State Motion Visual Evoked Potentials Produced by Oscillating Newton's Rings: Implications for Brain-Computer Interfaces	PLOS ONE			English	Article							ADAPTATION; STIMULI; RESPONSES; TOOLBOX	In this study, we utilize a special visual stimulation protocol, called motion reversal, to present a novel steady-state motion visual evoked potential (SSMVEP)-based BCI paradigm that relied on human perception of motions oscillated in two opposite directions. Four Newton's rings with the oscillating expansion and contraction motions served as visual stimulators to elicit subjects' SSMVEPs. And four motion reversal frequencies of 8.1, 9.8, 12.25 and 14 Hz were tested. According to Canonical Correlation Analysis (CCA), the offline accuracy and ITR (mean +/- standard deviation) over six healthy subjects were 86.56+/-9.63% and 15.93+/-3.83 bits/min, respectively. All subjects except one exceeded the level of 80% mean accuracy. Circular Hotelling's T-Squared test (T-circ(2)) also demonstrated that most subjects exhibited significantly strong stimulus-locked SSMVEP responses. The results of declining exponential fittings exhibited low-adaptation characteristics over the 100-s stimulation sequences in most experimental conditions. Taken together, these results suggest that the proposed paradigm can provide comparable performance with low-adaptation characteristic and less visual discomfort for BCI applications.	[Xie, Jun; Xu, Guanghua; Wang, Jing; Zhang, Feng; Zhang, Yizhuo] Xi An Jiao Tong Univ, Sch Mech Engn, Xian 710049, Shaanxi, Peoples R China; [Xu, Guanghua; Wang, Jing] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xie, J (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian 710049, Shaanxi, Peoples R China.	xugh@mail.xjtu.edu.cn			National Natural Science Foundation of China [51175412]; Research Fund for the Doctoral Program of Higher Education of China [20110201110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Natural Science Foundation of China (51175412) and the Research Fund for the Doctoral Program of Higher Education of China (20110201110022). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales JM, 2009, J VISION, V9, DOI 10.1167/9.7.8; Bartley SH, 1939, PSYCHOL REV, V46, P337, DOI 10.1037/h0055565; Bell CJ, 2008, J NEURAL ENG, V5, P214, DOI 10.1088/1741-2560/5/2/012; Bergholz R, 2008, DOC OPHTHALMOL, V116, P217, DOI 10.1007/s10633-007-9085-6; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Capilla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014543; Chakor H, 2005, DOC OPHTHALMOL, V110, P163, DOI 10.1007/s10633-005-3694-8; Delon-Martin C, 2006, NEUROIMAGE, V31, P1567, DOI 10.1016/j.neuroimage.2006.02.013; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; Heinrich S P, 2001, Doc Ophthalmol, V102, P141, DOI 10.1023/A:1017509717071; Heinrich SP, 2003, CLIN NEUROPHYSIOL, V114, P1359, DOI 10.1016/S1388-2457(03)00088-9; Heinrich SP, 2007, DOC OPHTHALMOL, V114, P83, DOI 10.1007/s10633-006-9043-8; Heinrich SP, 2010, DOC OPHTHALMOL, V120, P205, DOI 10.1007/s10633-010-9212-7; HO WA, 1988, VISION RES, V28, P1287, DOI 10.1016/0042-6989(88)90059-4; Hong B, 2009, CLIN NEUROPHYSIOL, V120, P1658, DOI 10.1016/j.clinph.2009.06.026; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Kremlacek J, 2004, DOC OPHTHALMOL, V109, P169, DOI 10.1007/s10633-004-4048-7; KUBA M, 1992, PHYSIOL RES, V41, P369; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Nishiike S, 2002, NEUROREPORT, V13, P1805, DOI 10.1097/00001756-200210070-00023; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; Rebsamen B, 2010, IEEE T NEUR SYS REH, V18, P590, DOI 10.1109/TNSRE.2010.2049862; Regan D., 1989, HUMAN BRAIN ELECTROP; Snowden RJ, 2004, CURR BIOL, V14, pR828, DOI 10.1016/j.cub.2004.09.033; VICTOR JD, 1991, ELECTROEN CLIN NEURO, V78, P378, DOI 10.1016/0013-4694(91)90099-P; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Zhang Y, 2011, BIOMED SIGN IN PRESS; Zhang Y, 2011, LECT NOTES COMPUT SC, V7062, P287, DOI 10.1007/978-3-642-24955-6_35	32	56	62	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39707	10.1371/journal.pone.0039707	http://dx.doi.org/10.1371/journal.pone.0039707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724028	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700088
J	Lim, CK; Hassan, KA; Tetu, SG; Loper, JE; Paulsen, IT				Lim, Chee Kent; Hassan, Karl A.; Tetu, Sasha G.; Loper, Joyce E.; Paulsen, Ian T.			The Effect of Iron Limitation on the Transcriptome and Proteome of Pseudomonas fluorescens Pf-5	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; MESSENGER-RNA; STARVATION RESPONSE; SIGNAL-TRANSDUCTION; COTTON SEEDLINGS; GENOME SEQUENCE; GENE-EXPRESSION; FUMARASE C; AERUGINOSA	One of the most important micronutrients for bacterial growth is iron, whose bioavailability in soil is limited. Consequently, rhizospheric bacteria such as Pseudomonas fluorescens employ a range of mechanisms to acquire or compete for iron. We investigated the transcriptomic and proteomic effects of iron limitation on P. fluorescens Pf-5 by employing microarray and iTRAQ techniques, respectively. Analysis of this data revealed that genes encoding functions related to iron homeostasis, including pyoverdine and enantio-pyochelin biosynthesis, a number of Ton B-dependent receptor systems, as well as some inner-membrane transporters, were significantly up-regulated in response to iron limitation. Transcription of a ribosomal protein L36-encoding gene was also highly up-regulated during iron limitation. Certain genes or proteins involved in biosynthesis of secondary metabolites such as 2,4-diacetylphloroglucinol (DAPG), orfamide A and pyrrolnitrin, as well as a chitinase, were over-expressed under iron-limited conditions. In contrast, we observed that expression of genes involved in hydrogen cyanide production and flagellar biosynthesis were down-regulated in an iron-depleted culture medium. Phenotypic tests revealed that Pf-5 had reduced swarming motility on semi-solid agar in response to iron limitation. Comparison of the transcriptomic data with the proteomic data suggested that iron acquisition is regulated at both the transcriptional and post-transcriptional levels.	[Lim, Chee Kent; Hassan, Karl A.; Tetu, Sasha G.; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Loper, Joyce E.] Oregon State Univ, USDA ARS Hort Crops Res Lab, Corvallis, OR 97331 USA; [Loper, Joyce E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Macquarie University; Oregon State University; Oregon State University	Lim, CK (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	ian.paulsen@mq.edu.au	Tetu, Sasha/C-8760-2013; Paulsen, Ian T/K-3832-2012; Hassan, Karl/B-2802-2013	Paulsen, Ian T/0000-0001-9015-9418; Tetu, Sasha/0000-0002-8943-3499; Loper, Joyce/0000-0003-3501-5969; Hassan, Karl/0000-0003-2031-9679	Macquarie University Research Excellence Scholarship (CKL); Australian Research Council Discovery [DP110102680]	Macquarie University Research Excellence Scholarship (CKL); Australian Research Council Discovery(Australian Research Council)	This study was supported by a Macquarie University Research Excellence Scholarship (CKL) (http://www.hdr.mq.edu.au/information_abou/scholarships) and an Australian Research Council Discovery Grant DP110102680 (to ITP and KAH) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Akiba N, 2010, APPL ENVIRON MICROB, V76, P3475, DOI 10.1128/AEM.00238-10; Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANGERER A, 1992, J BACTERIOL, V174, P1378, DOI 10.1128/jb.174.4.1378-1387.1992; Basler M, 2006, PROTEOMICS, V6, P6194, DOI 10.1002/pmic.200600312; Blumer C, 2000, MICROBIOL-SGM, V146, P2417, DOI 10.1099/00221287-146-10-2417; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Cha JY, 2012, BIOCHEM BIOPH RES CO, V417, P665, DOI 10.1016/j.bbrc.2011.11.124; Chong PK, 2007, PROTEOMICS, V7, P424, DOI 10.1002/pmic.200600746; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Dandekar T, 1998, BIOINFORMATICS, V14, P271, DOI 10.1093/bioinformatics/14.3.271; Delany I, 2003, MOL MICROBIOL, V50, P1329, DOI 10.1046/j.1365-2958.2003.03757.x; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; ESPUNY MJ, 1991, ANTON LEEUW INT J G, V60, P83, DOI 10.1007/BF00572696; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FUJIWARA T, 1992, J BIOCHEM, V112, P290, DOI 10.1093/oxfordjournals.jbchem.a123893; GarciaAlfonso C, 1996, ARCH ENVIRON CON TOX, V30, P431; Ghysels B, 2004, MICROBIOL-SGM, V150, P1671, DOI 10.1099/mic.0.27035-0; GRANDONI JA, 1989, J BIOL CHEM, V264, P6058; GROSS DC, 1985, J APPL BACTERIOL, V58, P167, DOI 10.1111/j.1365-2672.1985.tb01444.x; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Hard T, 2000, J MOL BIOL, V296, P169, DOI 10.1006/jmbi.1999.3433; Haritha Adhikarla, 2008, BMC Res Notes, V1, P88, DOI 10.1186/1756-0500-1-88; Hartney SL, 2011, BIOMETALS, V24, P193, DOI 10.1007/s10534-010-9385-2; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Hassett DJ, 1997, J BACTERIOL, V179, P1452, DOI 10.1128/jb.179.5.1452-1459.1997; Hassett DJ, 1997, J BACTERIOL, V179, P1442, DOI 10.1128/jb.179.5.1442-1451.1997; HERUTH DP, 1994, J BACTERIOL, V176, P3559, DOI 10.1128/JB.176.12.3559-3567.1994; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoegy F, 2009, J BIOL CHEM, V284, P14949, DOI 10.1074/jbc.M900606200; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; HOWELL CR, 1980, PHYTOPATHOLOGY, V70, P712, DOI 10.1094/Phyto-70-712; Huang X, 2002, FREE RADICAL BIO MED, V32, P84, DOI 10.1016/S0891-5849(01)00770-5; JURAND A, 1971, J EXP ZOOL, V177, P365, DOI 10.1002/jez.1401770311; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kimbrel JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-522; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LALUCAT J, 1982, INT J SYST BACTERIOL, V32, P332, DOI 10.1099/00207713-32-3-332; LINDSAY WL, 1982, J PLANT NUTR, V5, P821, DOI 10.1080/01904168209363012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; LOPER JE, 1991, MOL PLANT MICROBE IN, V4, P5, DOI 10.1094/MPMI-4-005; Loper JE, 2008, APPL ENVIRON MICROB, V74, P3085, DOI 10.1128/AEM.02848-07; Loper JE, 2007, PHYTOPATHOLOGY, V97, P233, DOI 10.1094/PHYTO-97-2-0233; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; MAKAROVA KS, 2001, GENOME BIOL, V2; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Marschner P, 1998, SOIL BIOL BIOCHEM, V30, P1275, DOI 10.1016/S0038-0717(98)00039-X; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Molina MA, 2005, ENVIRON MICROBIOL, V7, P443, DOI 10.1111/j.1462-2920.2005.00720.x; MORGAN MK, 1988, J BACTERIOL, V170, P5689, DOI 10.1128/jb.170.12.5689-5697.1988; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; MULLIGAN CN, 1989, APPL ENVIRON MICROB, V55, P3016, DOI 10.1128/AEM.55.11.3016-3019.1989; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; NOWAKTHOMPSON B, 1994, CAN J MICROBIOL, V40, P1064, DOI 10.1139/m94-168; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; Palma M, 2003, ARCH MICROBIOL, V180, P374, DOI 10.1007/s00203-003-0602-z; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Pieper R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-30; Polack B, 1996, BIOCHEM BIOPH RES CO, V226, P555, DOI 10.1006/bbrc.1996.1393; POND FR, 1989, MICROBIOL REV, V53, P25, DOI 10.1128/MMBR.53.1.25-67.1989; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANDERS JD, 1994, INFECT IMMUN, V62, P4515, DOI 10.1128/IAI.62.10.4515-4525.1994; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Sharifi-Tehrani A, 1998, EUR J PLANT PATHOL, V104, P631, DOI 10.1023/A:1008672104562; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Somerville G, 1999, J BACTERIOL, V181, P1072, DOI 10.1128/JB.181.4.1072-1078.1999; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Stensjo K, 2007, J PROTEOME RES, V6, P621, DOI 10.1021/pr060517v; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suzuki I, 2006, J EXP BOT, V57, P1573, DOI 10.1093/jxb/erj148; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Taguchi F, 2010, J BACTERIOL, V192, P117, DOI 10.1128/JB.00689-09; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tralau T, 2007, J BACTERIOL, V189, P6743, DOI 10.1128/JB.00889-07; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; WELLS B, 1983, MICRON MICROSC ACTA, V14, P329, DOI 10.1016/0047-7206(83)90004-3; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; XU GW, 1986, PHYTOPATHOLOGY, V76, P414, DOI 10.1094/Phyto-76-414; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200; Youard ZA, 2011, BIOMETALS, V24, P513, DOI 10.1007/s10534-010-9399-9; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zaini PA, 2008, J BACTERIOL, V190, P2368, DOI 10.1128/JB.01495-07; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	120	81	83	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39139	10.1371/journal.pone.0039139	http://dx.doi.org/10.1371/journal.pone.0039139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723948	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300101
J	Grin, B; Mahammad, S; Wedig, T; Cleland, MM; Tsai, L; Herrmann, H; Goldman, RD				Grin, Boris; Mahammad, Saleemulla; Wedig, Tatjana; Cleland, Megan M.; Tsai, Lester; Herrmann, Harald; Goldman, Robert D.			Withaferin A Alters Intermediate Filament Organization, Cell Shape and Behavior	PLOS ONE			English	Article							PROTEIN-KINASE; NEUROFILAMENT PROTEIN; PHOSPHORYLATION SITES; CULTURED FIBROBLASTS; DYNAMIC PROPERTIES; EPITHELIAL-CELLS; VIMENTIN; MICROTUBULES; APOPTOSIS; PERIPHERIN	Withaferin A (WFA) is a steroidal lactone present in Withania somnifera which has been shown in vitro to bind to the intermediate filament protein, vimentin. Based upon its affinity for vimentin, it has been proposed that WFA can be used as an anti-tumor agent to target metastatic cells which up-regulate vimentin expression. We show that WFA treatment of human fibroblasts rapidly reorganizes vimentin intermediate filaments (VIF) into a perinuclear aggregate. This reorganization is dose dependent and is accompanied by a change in cell shape, decreased motility and an increase in vimentin phosphorylation at serine-38. Furthermore, vimentin lacking cysteine-328, the proposed WFA binding site, remains sensitive to WFA demonstrating that this site is not required for its cellular effects. Using analytical ultracentrifugation, viscometry, electron microscopy and sedimentation assays we show that WFA has no effect on VIF assembly in vitro. Furthermore, WFA is not specific for vimentin as it disrupts the cellular organization and induces perinuclear aggregates of several other IF networks comprised of peripherin, neurofilament-triplet protein, and keratin. In cells co-expressing keratin IF and VIF, the former are significantly less sensitive to WFA with respect to inducing perinuclear aggregates. The organization of microtubules and actin/microfilaments is also affected by WFA. Microtubules become wavier and sparser and the number of stress fibers appears to increase. Following 24 hrs of exposure to doses of WFA that alter VIF organization and motility, cells undergo apoptosis. Lower doses of the drug do not kill cells but cause them to senesce. In light of our findings that WFA affects multiple IF systems, which are expressed in many tissues of the body, caution is warranted in its use as an anticancer agent, since it may have debilitating organism-wide effects.	[Grin, Boris; Mahammad, Saleemulla; Cleland, Megan M.; Tsai, Lester; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Wedig, Tatjana; Herrmann, Harald] German Canc Res Ctr, Div Biophys Macromol, D-6900 Heidelberg, Germany	Northwestern University; Feinberg School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Grin, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	r-goldman@northwestern.edu		Harwig, Megan/0000-0003-2140-5739	National Institute of General Medical Science [1PO1GM096971]; NIH/NHLBI [T32HL076139]; German Research Foundation (DFG) [HE 1853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institute of General Medical Science grant 1PO1GM096971. M.M.C. was supported in part by NIH/NHLBI training grant T32HL076139. H.H. was supported by grants from the German Research Foundation (DFG, HE 1853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	About Herbs Botanicals & Other Products: Ashwagandha, 2011, HERBS BOT OTH PROD A; Bandyopadhyay Debdutta, 2005, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1809s27; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; BLOOM GS, 1983, J CELL BIOL, V96, P1523, DOI 10.1083/jcb.96.6.1523; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chang L, 2009, J CELL SCI, V122, P2914, DOI 10.1242/jcs.046789; Chou YH, 1996, J CELL SCI, V109, P817; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; COCHARD P, 1984, J NEUROSCI, V4, P2080; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; ESCURAT M, 1990, J NEUROSCI, V10, P764; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013; FRANKE WW, 1979, J CELL BIOL, V81, P570, DOI 10.1083/jcb.81.3.570; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GILLARD BK, 1994, J CELL SCI, V107, P3545; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; GREEN KJ, 1986, CELL MOTIL CYTOSKEL, V6, P406, DOI 10.1002/cm.970060406; GREEN KJ, 1983, CELL MOTIL CYTOSKEL, V3, P283, DOI 10.1002/cm.970030402; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; LAMB NJC, 1989, J CELL BIOL, V108, P2409, DOI 10.1083/jcb.108.6.2409; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; MIGHELI A, 1993, LAB INVEST, V68, P185; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PENA SDJ, 1981, NEUROLOGY, V31, P1470, DOI 10.1212/WNL.31.11.1470; Prahlad V, 2000, J CELL SCI, V113, P3939; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Rudrabhatla P, 2011, FASEB J; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schepis A, 2007, CELL MICROBIOL, V9, P1960, DOI 10.1111/j.1462-5822.2007.00927.x; Schmidt RE, 1997, BRAIN RES, V769, P375, DOI 10.1016/S0006-8993(97)00806-8; SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	58	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39065	10.1371/journal.pone.0039065	http://dx.doi.org/10.1371/journal.pone.0039065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720028	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350000036
J	Keers, R; Pedroso, I; Breen, G; Aitchison, KJ; Nolan, PM; Cichon, S; Nothen, MM; Rietschel, M; Schalkwyk, LC; Fernandes, C				Keers, Robert; Pedroso, Inti; Breen, Gerome; Aitchison, Kathy J.; Nolan, Patrick M.; Cichon, Sven; Noethen, Markus M.; Rietschel, Marcella; Schalkwyk, Leonard C.; Fernandes, Cathy			Reduced Anxiety and Depression-Like Behaviours in the Circadian Period Mutant Mouse Afterhours	PLOS ONE			English	Article							BIPOLAR-I-DISORDER; ERB-ALPHA-GENE; MOOD DISORDERS; CLOCK GENES; METABOLIC SYNDROME; ASSOCIATION; MICE; MODEL; RATS; SCHIZOPHRENIA	Background: Disruption of the circadian rhythm is a key feature of bipolar disorder. Variation in genes encoding components of the molecular circadian clock has been associated with increased risk of the disorder in clinical populations. Similarly in animal models, disruption of the circadian clock can result in altered mood and anxiety which resemble features of human mania; including hyperactivity, reduced anxiety and reduced depression-like behaviour. One such mutant, after hours (Afh), an ENU-derived mutant with a mutation in a recently identified circadian clock gene Fbxl3, results in a disturbed (long) circadian rhythm of approximately 27 hours. Methodology: Anxiety, exploratory and depression-like behaviours were evaluated in Afh mice using the open-field, elevated plus maze, light-dark box, holeboard and forced swim test. To further validate findings for human mania, polymorphisms in the human homologue of FBXL3, genotyped by three genome wide case control studies, were tested for association with bipolar disorder. Principal Findings: Afh mice showed reduced anxiety- and depression-like behaviour in all of the behavioural tests employed, and some evidence of increased locomotor activity in some tests. An analysis of three separate human data sets revealed a gene wide association between variation in FBXL3 and bipolar disorder (P = 0.009). Conclusions: Our results are consistent with previous studies of mutants with extended circadian periods and suggest that disruption of FBXL3 is associated with mania-like behaviours in both mice and humans.	[Keers, Robert; Pedroso, Inti; Breen, Gerome; Aitchison, Kathy J.; Schalkwyk, Leonard C.; Fernandes, Cathy] Kings Coll London, Inst Psychiat, MRC SGDP Ctr, London WC2R 2LS, England; [Nolan, Patrick M.] MRC Mammalian Genet Unit, Didcot, Oxon, England; [Cichon, Sven] Res Ctr Juelich, Struct & Funct Org Brain, INM 1, Julich, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Rietschel, Marcella] Univ Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany	University of London; King's College London; Helmholtz Association; Research Center Julich; University of Bonn; University of Bonn; Central Institute of Mental Health; University of Mannheim	Keers, R (corresponding author), Kings Coll London, Inst Psychiat, MRC SGDP Ctr, London WC2R 2LS, England.	catherine.fernandes@kcl.ac.uk	Nolan, Patrick/W-3918-2019; Schalkwyk, Leonard C/A-2150-2010; Breen, Gerome D/A-5540-2010; Fernandes, Cathy/F-3422-2011; Cichon, Sven/B-9618-2014; Aitchison, Katherine J/G-4476-2013; Breen, Gerome/Y-2706-2019; Cichon, Sven/H-8803-2013; Keers, Robert/C-1014-2009	Nolan, Patrick/0000-0001-5550-0334; Schalkwyk, Leonard C/0000-0001-7030-5756; Breen, Gerome D/0000-0003-2053-1792; Cichon, Sven/0000-0002-9475-086X; Aitchison, Katherine J/0000-0002-1107-3024; Breen, Gerome/0000-0003-2053-1792; Cichon, Sven/0000-0002-9475-086X; Keers, Robert/0000-0001-7954-7583; Pedroso, Inti/0000-0002-5947-4556; Nothen, Markus/0000-0002-8770-2464; Fernandes, Cathy/0000-0001-7318-3352	MRC [MC_U142684173] Funding Source: UKRI; Medical Research Council [G9817803B] Funding Source: researchfish; Medical Research Council [MC_U142684173] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Ahn YM, 2008, BIPOLAR DISORD, V10, P271, DOI 10.1111/j.1399-5618.2007.00573.x; ATKINSON M, 1975, CHRONOBIOLOGIA, V2, P325; Bacon Y, 2004, GENES BRAIN BEHAV, V3, P196, DOI 10.1111/j.1601-183X.2004.00070.x; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Barnard CJ, 2002, BEHAV PROCESS, V60, P53, DOI 10.1016/S0376-6357(02)00121-3; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Easton A, 2003, GENES BRAIN BEHAV, V2, P11, DOI 10.1034/j.1601-183X.2003.00002.x; Fagiolini A, 2005, BIPOLAR DISORD, V7, P424, DOI 10.1111/j.1399-5618.2005.00234.x; Furney SJ, 2011, MOL PSYCHIATR, V16, P1130, DOI 10.1038/mp.2010.123; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; HAFEN T, 1994, PHARMACOL BIOCHEM BE, V49, P975, DOI 10.1016/0091-3057(94)90252-6; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; JOHNSSON A, 1983, International Journal of Chronobiology, V8, P129; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Kennaway DJ, 2010, J PSYCHOPHARMACOL, V24, P5, DOI 10.1177/1359786810372980; Kishi T, 2008, NEUROSCI RES, V62, P211, DOI 10.1016/j.neures.2008.08.008; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lad HV, 2010, PHYSIOL BEHAV, V99, P301, DOI 10.1016/j.physbeh.2009.11.007; Li JD, 2009, NEUROPSYCHOPHARMACOL, V34, P367, DOI 10.1038/npp.2008.61; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Mansour HA, 2005, CHRONOBIOL INT, V22, P571, DOI 10.1081/CBI-200062413; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sei H, 2001, NEUROREPORT, V12, P1461, DOI 10.1097/00001756-200105250-00033; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; StataCorp, 2007, STAT STAT SOFTW REL; Tataroglu O, 2004, BRAIN RES, V1001, P118, DOI 10.1016/j.brainres.2003.11.063; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Uz T, 2005, NEUROSCIENCE, V134, P1309, DOI 10.1016/j.neuroscience.2005.05.003; Wood J, 2009, PSYCHIAT RES, V166, P201, DOI 10.1016/j.psychres.2008.03.003	49	41	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38263	10.1371/journal.pone.0038263	http://dx.doi.org/10.1371/journal.pone.0038263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719873	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305350000012
J	Wu, T; Wang, Y; Yu, CJ; Chiarawipa, R; Zhang, XZ; Han, ZH; Wu, LH				Wu, Ting; Wang, Yi; Yu, Changjiang; Chiarawipa, Rawee; Zhang, Xinzhong; Han, Zhenhai; Wu, Lianhai			Carbon Sequestration by Fruit Trees - Chinese Apple Orchards as an Example	PLOS ONE			English	Article							BIOMASS; GROWTH; RESPIRATION; ECOSYSTEMS; EMISSIONS; FORESTS; BALANCE; STORAGE; SYSTEM; BUDGET	Apple production systems are an important component in the Chinese agricultural sector with 1.99 million ha plantation. The orchards in China could play an important role in the carbon (C) cycle of terrestrial ecosystems and contribute to C sequestration. The carbon sequestration capability in apple orchards was analyzed through identifying a set of potential assessment factors and their weighting factors determined by a field model study and literature. The dynamics of the net C sink in apple orchards in China was estimated based on the apple orchard inventory data from 1990s and the capability analysis. The field study showed that the trees reached the peak of C sequestration capability when they were 18 years old, and then the capability began to decline with age. Carbon emission derived from management practices would not be compensated through C storage in apple trees before reaching the mature stage. The net C sink in apple orchards in China ranged from 14 to 32 Tg C, and C storage in biomass from 230 to 475 Tg C between 1990 and 2010. The estimated net C sequestration in Chinese apple orchards from 1990 to 2010 was equal to 4.5% of the total net C sink in the terrestrial ecosystems in China. Therefore, apple production systems can be potentially considered as C sinks excluding the energy associated with fruit production in addition to provide fruits.	[Wu, Ting; Wang, Yi; Yu, Changjiang; Chiarawipa, Rawee; Zhang, Xinzhong; Han, Zhenhai] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Wu, Lianhai] Rothamsted Res, Wyke, Okehampton, England	China Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Wu, T (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	rschan@cau.edu.cn; lianhai.wu@rothamsted.ac.uk	Chiarawipa, Rawee/AAA-3313-2022	Chiarawipa, Rawee/0000-0001-9897-3756	State Science and Technology Support Program of China [NC2010BF0079]; Key Laboratory of Beijing Municipality of Stress Physiology and Molecular Biology for Fruit Trees of Ministry of Agriculture; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (Nutrition and Physiology) of Ministry of Agriculture; BBSRC [BBS/E/C/00005746, BBS/E/C/00005740] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005740, BBS/E/C/00005746] Funding Source: researchfish	State Science and Technology Support Program of China; Key Laboratory of Beijing Municipality of Stress Physiology and Molecular Biology for Fruit Trees of Ministry of Agriculture; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (Nutrition and Physiology) of Ministry of Agriculture; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the State Science and Technology Support Program of China (NC2010BF0079), and both the Key Laboratory of Beijing Municipality of Stress Physiology and Molecular Biology for Fruit Trees and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (Nutrition and Physiology) of Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, J JPN AGR SYST SOC; Blanke MM, 1996, ENVIRON EXP BOT, V36, P339, DOI 10.1016/0098-8472(96)01003-9; Blanke MM, 1997, ACTA HORTIC, P337, DOI 10.17660/ActaHortic.1997.451.39; Boden TA, 2001, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V02011p, DOI 10.3334/CDIAC/00001_V02011]; Brady NC, 2004, ELEMENTS NATURE PROP; CALDWELL MM, 1974, OECOLOGIA, V17, P123, DOI 10.1007/BF00346275; EBERT G, 1991, GARTENBAUWISSENSCHAF, V56, P130; Editorial C, 2010, CHINAS AGR YB; Falloon PD, 1998, BIOL FERT SOILS, V27, P236, DOI 10.1007/s003740050426; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Forshey C. G., 1989, Horticultural Reviews, V11, P229, DOI 10.1002/9781118060841.ch7; Grossman YL, 1998, J AM SOC HORTIC SCI, V123, P1058, DOI 10.21273/JASHS.123.6.1058; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; GUPTA RK, 1994, CURR SCI INDIA, V66, P378; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Joslin JD, 2006, NEW PHYTOL, V172, P523, DOI 10.1111/j.1469-8137.2006.01847.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; KERCKHOFFS LHJ, 2007, CARBON SEQUESTRATION, P1; Kimmins JP, 1997, FOREST ECOLOGY FDN S; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Lakso AN, 2001, ACTA HORTIC, P473, DOI 10.17660/ActaHortic.2001.557.63; Lakso AN, 1999, HORTSCIENCE, V34, P1040, DOI 10.21273/HORTSCI.34.6.1040; Lal R, 2002, LAND DEGRAD DEV, V13, P45, DOI 10.1002/ldr.477; Lauri PE, 1995, SCI HORTIC-AMSTERDAM, V64, P265, DOI 10.1016/0304-4238(95)00836-5; Lenz F., 2009, NUTR TRANSLOCATION G; Lu AF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006198; Marini RP, 2000, HORTSCIENCE, V35, P837, DOI 10.21273/HORTSCI.35.5.837; Marsal J, 2002, EUR J AGRON, V17, P111, DOI 10.1016/S1161-0301(02)00002-3; Neto C, 2009, EUR J AGRON, V30, P34, DOI 10.1016/j.eja.2008.07.004; Page G, 2011, HORTSCIENCE, V46, P324, DOI 10.21273/HORTSCI.46.2.324; PALMER JW, 1988, J APPL ECOL, V25, P569, DOI 10.2307/2403845; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; PROCTOR JTA, 1976, J AM SOC HORTIC SCI, V101, P579; Ruess RW, 2003, ECOL MONOGR, V73, P643, DOI 10.1890/02-4032; Sekikawa S, 2003, ENV SCI, V16, P97; Sekikawa S., 2002, J JPN AGR SYS SOC, V18, P44; Sofo A, 2005, SCI HORTIC-AMSTERDAM, V107, P17, DOI 10.1016/j.scienta.2005.06.001; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; WIBBE ML, 1993, TREES-STRUCT FUNCT, V8, P56, DOI 10.1007/BF00240982; Zhang Q, 2001, AMBIO, V30, P351, DOI 10.1639/0044-7447(2001)030[0351:CEASPO]2.0.CO;2	41	39	44	9	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38883	10.1371/journal.pone.0038883	http://dx.doi.org/10.1371/journal.pone.0038883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719974	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000026
J	Munoz, P; Toscano, MG; Real, PJ; Benabdellah, K; Cobo, M; Bueno, C; Ramos-Mejia, V; Menendez, P; Anderson, P; Martin, F				Munoz, Pilar; Toscano, Miguel G.; Real, Pedro J.; Benabdellah, Karim; Cobo, Marien; Bueno, Clara; Ramos-Mejia, Veronica; Menendez, Pablo; Anderson, Per; Martin, Francisco			Specific Marking of hESCs-Derived Hematopoietic Lineage by WAS-Promoter Driven Lentiviral Vectors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-THERAPY; IN-VITRO; DIFFERENTIATION; EXPRESSION; TRANSDUCTION; DERIVATION; TRACKING; IDENTIFICATION; BLASTOCYSTS	Genetic manipulation of human embryonic stem cells (hESCs) is instrumental for tracing lineage commitment and to studying human development. Here we used hematopoietic-specific Wiskott-Aldrich syndrome gene (WAS)-promoter driven lentiviral vectors (LVs) to achieve highly specific gene expression in hESCs-derived hematopoietic cells. We first demonstrated that endogenous WAS gene was not expressed in undifferentiated hESCs but was evident in hemogenic progenitors (CD45(-)CD31(+)CD34(+)) and hematopoietic cells (CD45(+)). Accordingly, WAS-promoter driven LVs were unable to express the eGFP transgene in undifferentiated hESCs. eGFP(+) cells only appeared after embryoid body (EB) hematopoietic differentiation. The phenotypic analysis of the eGFP(+) cells showed marking of different subpopulations at different days of differentiation. At days 10-15, AWE LVs tag hemogenic and hematopoietic progenitors cells (CD45(-)CD31(+)CD34(dim) and CD45(+)CD31(+)CD34(dim)) emerging from hESCs and at day 22 its expression became restricted to mature hematopoietic cells (CD45(+)CD33(+)). Surprisingly, at day 10 of differentiation, the AWE vector also marked CD45(-)CD31(low/-)CD34(-) cells, a population that disappeared at later stages of differentiation. We showed that the eGFP(+)CD45(-)CD31(+) population generate 5 times more CD45(+) cells than the eGFP(-)CD45(-)CD31(+) indicating that the AWE vector was identifying a subpopulation inside the CD45(-)CD31(+) cells with higher hemogenic capacity. We also showed generation of CD45(+) cells from the eGFP(+)CD45(-)CD31(low/-)CD34(-) population but not from the eGFP(-)CD45(-)CD31(low/-)CD34(-) cells. This is, to our knowledge, the first report of a gene transfer vector which specifically labels hemogenic progenitors and hematopoietic cells emerging from hESCs. We propose the use of WAS-promoter driven LVs as a novel tool to studying human hematopoietic development.	[Munoz, Pilar; Toscano, Miguel G.; Benabdellah, Karim; Cobo, Marien; Anderson, Per; Martin, Francisco] Univ Granada, Human DNA Variabil Dept, Pfizer, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Granada, Spain; [Real, Pedro J.; Bueno, Clara; Ramos-Mejia, Veronica; Menendez, Pablo] Univ Granada, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Pfizer, Dept Oncol, Granada, Spain	Pfizer; University of Granada; Pfizer; University of Granada	Munoz, P (corresponding author), Univ Granada, Human DNA Variabil Dept, Pfizer, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Granada, Spain.	francisco.martin@genyo.es	Bujan, Pablo Menendez/W-3736-2017; Ramos-Mejia, Veronica/C-4338-2017; Real, Pedro J./ABH-3493-2021; Benabdellah, karim/L-4569-2014; Martin, Francisco/K-8763-2014; Real, Pedro J./K-2994-2014; Munoz, Pilar/N-2277-2016; Benabdellah, karim/F-4209-2016; Toscano, Miguel G. G/I-1053-2015	Bujan, Pablo Menendez/0000-0001-9372-1007; Ramos-Mejia, Veronica/0000-0002-8013-4273; Benabdellah, karim/0000-0003-4673-2111; Martin, Francisco/0000-0003-1961-8612; Real, Pedro J./0000-0001-7968-5353; Munoz, Pilar/0000-0002-7985-9859; Benabdellah, karim/0000-0003-2790-562X; Toscano, Miguel G. G/0000-0002-6384-3123; Anderson, Per/0000-0002-0958-7990	Fondo de Investigaciones Sanitarias (FIS)/Fondo de Desarrollo Regional (FEDER) [PS09/00340]; Consejeria de Innovacion Ciencia y Empresa [P09-CTS-04532, PAIDI-Bio-326]; Consejeria de Salud from Junta de Andalucia [PI0001/2009]; Fondo de Cohesion Europeo (FSE) (Programa operative FEDER/FSE de Andalucia); FEDER; Fundacion Progreso y Salud (Consejeria de Salud - Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - Institute of health Carlos III [CP09/00228]; Junta de Andalucia/FEDER [P08-CTS-3678, SAS-111244, P10-CTS-6406]; FIS/FEDER [PI10/00449, PI11/00119]; MICINN [PLE-2009-0111]; Foundation "Spanish Association Against Cancer"/Junta Provincial de Albacete [CI110023]; ISCIII/Miguel Servet Program [CP07/00059, CP09/006]	Fondo de Investigaciones Sanitarias (FIS)/Fondo de Desarrollo Regional (FEDER); Consejeria de Innovacion Ciencia y Empresa; Consejeria de Salud from Junta de Andalucia(Junta de Andalucia); Fondo de Cohesion Europeo (FSE) (Programa operative FEDER/FSE de Andalucia); FEDER(European Commission); Fundacion Progreso y Salud (Consejeria de Salud - Junta de Andalucia)(Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - Institute of health Carlos III; Junta de Andalucia/FEDER(Junta de AndaluciaEuropean Commission); FIS/FEDER(Instituto de Salud Carlos IIIEuropean Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Foundation "Spanish Association Against Cancer"/Junta Provincial de Albacete; ISCIII/Miguel Servet Program	This work has been supported by the Fondo de Investigaciones Sanitarias (FIS)/Fondo de Desarrollo Regional (FEDER) (grant No. PS09/00340), by the Consejeria de Innovacion Ciencia y Empresa (grants No. P09-CTS-04532 and PAIDI-Bio-326) and Consejeria de Salud (grant No. PI0001/2009) from Junta de Andalucia thanks to the financial support of FEDER and Fondo de Cohesion Europeo (FSE) (Programa operative FEDER/FSE de Andalucia 2007-2013) to F. Martin. M. Cobo. and F. Martin are funded by Fundacion Progreso y Salud (Consejeria de Salud - Junta de Andalucia). K. Benabdellah and M.G. Toscano are financed by P09-CTS-04532 and PI0001/2009 grants, respectively. P. Anderson and P. Munoz have a Miguel Servet (CP09/00228) and Sara Borrell contracts respectively (Fondo de Investigaciones Sanitarias (FIS) - Institute of health Carlos III). P. Menendez's laboratory was funded by the Junta de Andalucia/FEDER (P08-CTS-3678) to P. Menendez and (SAS-111244 and P10-CTS-6406) to P.J. Real, the FIS/FEDER (PI10/00449) to P. Menendez and (PI11/00119) to C. Bueno, the MICINN (PLE-2009-0111) to P. Menendez, and the Foundation "Spanish Association Against Cancer"/Junta Provincial de Albacete (CI110023) to P. Menendez. C. Bueno and P.J. Real were supported by ISCIII/Miguel Servet Program (CP07/00059 to C. Bueno and CP09/006 to P.J. Real). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Ciraci E, 2011, BLOOD, V118, P2105, DOI 10.1182/blood-2010-10-316596; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1026, DOI 10.1002/art.23283; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dravid G, 2011, MOL THER, V19, P768, DOI 10.1038/mt.2010.281; Frecha C, 2008, GENE THER, V15, P930, DOI 10.1038/gt.2008.20; Gallo P, 2008, GENE THER, V15, P161, DOI 10.1038/sj.gt.3303017; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Hagemann TL, 1999, BIOCHEM BIOPH RES CO, V256, P104, DOI 10.1006/bbrc.1999.0292; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Kaufman DS, 2009, BLOOD, V114, P3513, DOI 10.1182/blood-2009-03-191304; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Kraunus J, 2004, GENE THER, V11, P1568, DOI 10.1038/sj.gt.3302309; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Martin F, 2005, GENE THER, V12, P715, DOI 10.1038/sj.gt.3302457; Martin F, 1998, HUM GENE THER, V9, P737, DOI 10.1089/hum.1998.9.5-737; Menendez P, 2004, MOL THER, V10, P1109, DOI 10.1016/j.ymthe.2004.08.016; Menendez P, 2005, CURR GENE THER, V5, P375, DOI 10.2174/1566523054546198; Moreno-Gimeno I, 2010, FEBS J, V277, P5014, DOI 10.1111/j.1742-4658.2010.07926.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Parolini O, 1997, BLOOD, V90, P70; Petrella A, 1998, BLOOD, V91, P4554, DOI 10.1182/blood.V91.12.4554.412k26_4554_4560; Ramos-Mejia V, 2012, STEM CELLS DEV; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Stewart DM, 1996, J CLIN INVEST, V97, P2627, DOI 10.1172/JCI118712; Stewart R, 2008, REGEN MED, V3, P505, DOI 10.2217/17460751.3.4.505; Stojkovic M, 2004, STEM CELLS, V22, P790, DOI 10.1634/stemcells.22-5-790; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2006, STEM CELLS, V24, P1370, DOI 10.1634/stemcells.2005-0340; Toscano MG, 2011, GENE THER, V18, P117, DOI 10.1038/gt.2010.138; Toscano MG, 2004, GENE THER, V11, P956, DOI 10.1038/sj.gt.3302259; Toscano MG, 2008, HUM GENE THER, V19, P179, DOI 10.1089/hum.2007.098; Toscano MG, 2009, HUM GENE THER, V20, P1279, DOI 10.1089/hum.2009.118; Vodyanik Maxim A., 2007, V407, P275, DOI 10.1007/978-1-59745-536-7_19; Wang LS, 2006, METH MOL B, V331, P179; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2005, TRENDS BIOTECHNOL, V23, P42, DOI 10.1016/j.tibtech.2004.11.001; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	49	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39091	10.1371/journal.pone.0039091	http://dx.doi.org/10.1371/journal.pone.0039091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720040	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347800044
J	Nandadasa, S; Tao, QH; Shoemaker, A; Cha, SW; Wylie, C				Nandadasa, Sumeda; Tao, Qinghua; Shoemaker, Amanda; Cha, Sang-wook; Wylie, Christopher			Regulation of Classical Cadherin Membrane Expression and F-Actin Assembly by Alpha-Catenins, during Xenopus Embryogenesis	PLOS ONE			English	Article							CELL-CELL-ADHESION; N-CATENIN; JUNCTIONAL COMPLEX; MOLECULES; EMBRYOS; POLYMERIZATION; IDENTIFICATION; MORPHOGENESIS; LOCALIZATION; ACCUMULATION	Alpha (alpha)-E-catenin is a component of the cadherin complex, and has long been thought to provide a link between cell surface cadherins and the actin skeleton. More recently, it has also been implicated in mechano-sensing, and in the control of tissue size. Here we use the early Xenopus embryos to explore functional differences between two alpha-catenin family members, alpha-E- and alpha-N-catenin, and their interactions with the different classical cadherins that appear as tissues of the embryo become segregated from each other. We show that they play both cadherin-specific and context-specific roles in the emerging tissues of the embryo. alpha-E-catenin interacts with both C- and E-cadherin. It is specifically required for junctional localization of C-cadherin, but not of E-cadherin or N-cadherin at the neurula stage. alpha-N-cadherin interacts only with, and is specifically required for junctional localization of, N-cadherin. In addition, alpha-E-catenin is essential for normal tissue size control in the non-neural ectoderm, but not in the neural ectoderm or the blastula. We also show context specificity in cadherin/alpha-catenin interactions. E-cadherin requires alpha-E-catenin for junctional localization in some tissues, but not in others, during early development. These specific functional cadherin/alpha-catenin interactions may explain the basis of cadherin specificity of actin assembly and morphogenetic movements seen previously in the neural and non-neural ectoderm.	[Nandadasa, Sumeda; Tao, Qinghua; Shoemaker, Amanda; Cha, Sang-wook; Wylie, Christopher] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Nandadasa, Sumeda] Cincinnati Childrens Hosp Res Fdn, Grad Program Mol & Dev Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Nandadasa, S (corresponding author), Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	Christopher.Wylie@cchmc.org	Cha, Sang-Wook/D-3523-2016	Nandadasa, Sumeda/0000-0002-4954-6376	NIH [R01HD044764-07]; Albert J. Ryan Foundation; University of Cincinnati Distinguished Dissertation Completion Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert J. Ryan Foundation; University of Cincinnati Distinguished Dissertation Completion Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by NIH R01HD044764-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the NIH for support of this work. SN was also suppported by the Albert J. Ryan Foundation and the University of Cincinnati Distinguished Dissertation Completion Fellowship. We would like to thank Dr. Masatoshi Takeichi for the ECCD2, and NCAT2 antibodies. We would also like to thank Dr. Cara Gottardi, and Rebecca Daugherty (Northwestern University) for the human alpha-E-catenin construct. We would also like to thank Dr. Matt Koforn for his assistance with confocal microscopy.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Cha SW, 2010, METHODS, V51, P52, DOI 10.1016/j.ymeth.2010.01.029; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; HEASMAN J, 1994, DEVELOPMENT, V120, P49; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; HIRANO S, 1994, INT J DEV BIOL, V38, P379; HOLWILL S, 1987, DEVELOPMENT, V100, P735; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jhingory S, 2010, DEV BIOL, V344, P896, DOI 10.1016/j.ydbio.2010.06.006; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kofron M, 1997, DEVELOPMENT, V124, P1553; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Lien WH, 2008, J CELL BIOL, V183, P989, DOI 10.1083/jcb.200805041; Lloyd B, 2005, DEVELOPMENT, V132, P805, DOI 10.1242/dev.01618; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Nieset JE, 1997, J CELL SCI, V110, P1013; Nieuwkoop P D, 1967, Acta Biotheor, V17, P178, DOI 10.1007/BF01601987; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; SCHNEIDER S, 1993, DEVELOPMENT, V118, P629; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; TAKEICHI M, 1988, CELL DIFFER DEV, V25, P91, DOI 10.1016/0922-3371(88)90104-9; Tao QH, 2005, DEVELOPMENT, V132, P2825, DOI 10.1242/dev.01866; Tao QH, 2007, DEVELOPMENT, V134, P2651, DOI 10.1242/dev.002824; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38756	10.1371/journal.pone.0038756	http://dx.doi.org/10.1371/journal.pone.0038756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719936	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900047
J	Bernardino, I; Mouga, S; Almeida, J; van Asselen, M; Oliveira, G; Castelo-Branco, M				Bernardino, Ines; Mouga, Susana; Almeida, Joana; van Asselen, Marieke; Oliveira, Guiomar; Castelo-Branco, Miguel			A Direct Comparison of Local-Global Integration in Autism and other Developmental Disorders: Implications for the Central Coherence Hypothesis	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; WILLIAMS-SYNDROME; DORSAL-STREAM; VISUAL-SEARCH; SELECTIVE ATTENTION; DIVIDED ATTENTION; ASPERGER-SYNDROME; CHILDREN; MOTION; PERCEPTION	The weak central coherence hypothesis represents one of the current explanatory models in Autism Spectrum Disorders (ASD). Several experimental paradigms based on hierarchical figures have been used to test this controversial account. We addressed this hypothesis by testing central coherence in ASD (n = 19 with intellectual disability and n = 20 without intellectual disability), Williams syndrome (WS, n = 18), matched controls with intellectual disability (n = 20) and chronological age-matched controls (n = 20). We predicted that central coherence should be most impaired in ASD for the weak central coherence account to hold true. An alternative account includes dorsal stream dysfunction which dominates in WS. Central coherence was first measured by requiring subjects to perform local/global preference judgments using hierarchical figures under 6 different experimental settings (memory and perception tasks with 3 distinct geometries with and without local/global manipulations). We replicated these experiments under 4 additional conditions (memory/perception*local/global) in which subjects reported the correct local or global configurations. Finally, we used a visuoconstructive task to measure local/global perceptual interference. WS participants were the most impaired in central coherence whereas ASD participants showed a pattern of coherence loss found in other studies only in four task conditions favoring local analysis but it tended to disappear when matching for intellectual disability. We conclude that abnormal central coherence does not provide a comprehensive explanation of ASD deficits and is more prominent in populations, namely WS, characterized by strongly impaired dorsal stream functioning and other phenotypic traits that contrast with the autistic phenotype. Taken together these findings suggest that other mechanisms such as dorsal stream deficits (largest in WS) may underlie impaired central coherence.	[Bernardino, Ines; Mouga, Susana; van Asselen, Marieke; Oliveira, Guiomar; Castelo-Branco, Miguel] Fac Med, Visual Neurosci Lab, IBILI, Coimbra, Portugal; [Mouga, Susana; Almeida, Joana; Oliveira, Guiomar] Pediat Hosp Coimbra, Autism Dept, Child Ctr, Coimbra, Portugal; [Oliveira, Guiomar] Pediat Hosp Coimbra, Res & Clin Training Dept, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)	Bernardino, I (corresponding author), Fac Med, Visual Neurosci Lab, IBILI, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Bernardino, Inês/AAF-6741-2020; Mouga, Susana/AAE-3497-2022; Oliveira, Guiomar/AAF-3911-2021; Bernardino, Inês/D-4487-2018; Oliveira, Guiomar/I-7255-2013; Castelo-Branco, Miguel/E-5689-2010; Castelo-Branco, Miguel/F-3866-2019; Mouga, Susana/AAF-6690-2020	Bernardino, Inês/0000-0003-3123-008X; Oliveira, Guiomar/0000-0002-7049-1277; Bernardino, Inês/0000-0003-3123-008X; Castelo-Branco, Miguel/0000-0003-4364-6373; Mouga, Susana/0000-0003-1072-4208; Oliveira, Guiomar Goncalves/0000-0003-4031-3880; van Asselen, Marieke/0000-0002-2279-2032	Portuguese Foundation for Science and Technology [PTDC/SAU-NEU/68483/2006, PIC/IC/82986/2007, PTDC/PSI-PCO/108208/2008, SRFH/BD/41401/2007]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This research was supported by the Portuguese Foundation for Science and Technology [grant numbers: PTDC/SAU-NEU/68483/2006 and PIC/IC/82986/2007 to SM and MCB (PI); PTDC/PSI-PCO/108208/2008 to MvA and an individual scholarship - SRFH/BD/41401/2007 to IB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 1994, DIAGN STAT MAN MENT, V4th; Atkinson J, 2006, NEUROPSYCHOLOGIA, V44, P828, DOI 10.1016/j.neuropsychologia.2005.08.002; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bertone A, 2003, J COGNITIVE NEUROSCI, V15, P218, DOI 10.1162/089892903321208150; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Castelo-Branco M, 2007, J CLIN INVEST, V117, P3720, DOI 10.1172/JCI32SS6; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Deruelle C, 2004, J AUTISM DEV DISORD, V34, P199, DOI 10.1023/B:JADD.0000022610.09668.4c; Deruelle C, 2008, BRAIN COGNITION, V66, P115, DOI 10.1016/j.bandc.2007.06.001; Farran EK, 2003, NEUROPSYCHOLOGIA, V41, P676, DOI 10.1016/S0028-3932(02)00219-1; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Frith U., 1989, AUTISM EXPLAINING EN, V6th; HAPPE FGE, 1994, J CHILD PSYCHOL PSYC, V35, P1461, DOI 10.1111/j.1469-7610.1994.tb01287.x; Happe FGE, 1996, J CHILD PSYCHOL PSYC, V37, P873, DOI 10.1111/j.1469-7610.1996.tb01483.x; Jackowski AP, 2009, EUR J PAEDIATR NEURO, V13, P305, DOI 10.1016/j.ejpn.2008.07.002; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kanner L, 1943, NERV CHILD, V2, P217; Keehn B, 2008, J INT NEUROPSYCH SOC, V14, P990, DOI 10.1017/S1355617708081356; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Koldewyn K, 2010, BRAIN, V133, P599, DOI 10.1093/brain/awp272; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 1999, AUTISM DIAGNOSTIC OB; Mendes M, 2005, COGNITIVE BRAIN RES, V25, P788, DOI 10.1016/j.cogbrainres.2005.09.005; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Mobbs D, 2007, DEV MED CHILD NEUROL, V49, P433, DOI 10.1111/j.1469-8749.2007.00433.x; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P203, DOI 10.1111/1469-7610.00433; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2003, J CHILD PSYCHOL PSYC, V44, P904, DOI 10.1111/1469-7610.00174; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P743, DOI 10.1111/1469-7610.00490; Navon D, 2003, ACTA PSYCHOL, V114, P273, DOI 10.1016/j.actpsy.2003.06.002; Navon D, 1977, COGNITIVE PSYCHOL, V9, P253; OZONOFF S, 1994, J CHILD PSYCHOL PSYC, V35, P1015, DOI 10.1111/j.1469-7610.1994.tb01807.x; Perreault A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019519; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Poirel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020879; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Porter MA, 2006, DEV NEUROPSYCHOL, V30, P771, DOI 10.1207/s15326942dn3003_1; Reiss JE, 2005, VISION RES, V45, P3379, DOI 10.1016/j.visres.2005.05.011; Remington AM, 2012, J ABNORM PS IN PRESS; Rinehart NJ, 2000, J CHILD PSYCHOL PSYC, V41, P769, DOI 10.1017/S002196309900596X; Rondan C, 2008, CHILD NEUROPSYCHOL, V14, P237, DOI 10.1080/09297040701346321; Rondan C, 2007, RES DEV DISABIL, V28, P197, DOI 10.1016/j.ridd.2006.02.007; Ropar D, 1999, J CHILD PSYCHOL PSYC, V40, P1283, DOI 10.1017/S0021963099004667; Rutter M., 2003, SOCIAL COMMUNICATION; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Wang LX, 2007, COGN NEUROPSYCHOL, V24, P550, DOI 10.1080/13546800701417096; WANG PP, 1995, BRAIN COGNITION, V29, P54, DOI 10.1006/brcg.1995.1267; Wechsler D., 2003, MANUAL INTELLIGENCE; Wechsler D., 2008, MANUAL INTELLIGENCE	55	28	28	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39351	10.1371/journal.pone.0039351	http://dx.doi.org/10.1371/journal.pone.0039351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22724001	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700069
J	Sasayama, H; Shimamura, M; Tokuda, T; Azuma, Y; Yoshida, T; Mizuno, T; Nakagawa, M; Fujikake, N; Nagai, Y; Yamaguchi, M				Sasayama, Hiroshi; Shimamura, Mai; Tokuda, Takahiko; Azuma, Yumiko; Yoshida, Tomokatsu; Mizuno, Toshiki; Nakagawa, Masanori; Fujikake, Nobuhiro; Nagai, Yoshitaka; Yamaguchi, Masamitsu			Knockdown of the Drosophila Fused in Sarcoma (FUS) Homologue Causes Deficient Locomotive Behavior and Shortening of Motoneuron Terminal Branches	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; RNA-BINDING PROTEIN; TARDBP MUTATIONS; IN-VIVO; TDP-43; ALS; TLS; DISEASE; INCLUSIONS	Mutations in the fused in sarcoma/translated in liposarcoma gene (FUS/TLS, FUS) have been identified in sporadic and familial forms of amyotrophic lateral sclerosis (ALS). FUS is an RNA-binding protein that is normally localized in the nucleus, but is mislocalized to the cytoplasm in ALS, and comprises cytoplasmic inclusions in ALS-affected areas. However, it is still unknown whether the neurodegeneration that occurs in ALS is caused by the loss of FUS nuclear function, or by the gain of toxic function due to cytoplasmic FUS aggregation. Cabeza (Caz) is a Drosophila orthologue of human FUS. Here, we generated Drosophila models with Caz knockdown, and investigated their phenotypes. In wild-type Drosophila, Caz was strongly expressed in the central nervous system of larvae and adults. Caz did not colocalize with a presynaptic marker, suggesting that Caz physiologically functions in neuronal cell bodies and/or their axons. Fly models with neuron-specific Caz knockdown exhibited reduced climbing ability in adulthood and anatomical defects in presynaptic terminals of motoneurons in third instar larvae. Our results demonstrated that decreased expression of Drosophila Caz is sufficient to cause degeneration of motoneurons and locomotive disability in the absence of abnormal cytoplasmic Caz aggregates, suggesting that the pathogenic mechanism underlying FUS-related ALS should be ascribed more to the loss of physiological FUS functions in the nucleus than to the toxicity of cytoplasmic FUS aggregates. Since the Caz-knockdown Drosophila model we presented recapitulates key features of human ALS, it would be a suitable animal model for the screening of genes and chemicals that might modify the pathogenic processes that lead to the degeneration of motoneurons in ALS.	[Sasayama, Hiroshi; Tokuda, Takahiko; Azuma, Yumiko; Yoshida, Tomokatsu; Mizuno, Toshiki; Nakagawa, Masanori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kamigyo Ku, Kyoto, Japan; [Shimamura, Mai; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan; [Shimamura, Mai; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 606, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Pathobiol Brain Dis, Kamigyo Ku, Kyoto, Japan; [Fujikake, Nobuhiro; Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 187, Japan	Kyoto Prefectural University of Medicine; Kyoto Institute of Technology; Kyoto Institute of Technology; Kyoto Prefectural University of Medicine; National Center for Neurology & Psychiatry - Japan	Sasayama, H (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kamigyo Ku, Kyoto, Japan.	ttokuda@koto.kpu-m.ac.jp; myamaguc@kit.ac.jp	Mizuno, Toshiki/AAH-7155-2020	Mizuno, Toshiki/0000-0002-7907-8243; Yamaguchi, Masamitsu/0000-0002-6321-9750	Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [24406030, 23591252, 23390237] Funding Source: KAKEN	Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TT is supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Broustal O, 2010, J ALZHEIMERS DIS, V22, P765, DOI 10.3233/JAD-2010-100837; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Doi H, 2010, NEUROSCI RES, V66, P131, DOI 10.1016/j.neures.2009.10.004; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hewitt C, 2010, ARCH NEUROL-CHICAGO, V67, P455, DOI 10.1001/archneurol.2010.52; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kasyapa CS, 2005, EXP CELL RES, V309, P78, DOI 10.1016/j.yexcr.2005.05.019; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kondo T, 2006, GENES GENET SYST, V81, P129, DOI 10.1266/ggs.81.129; Kovacs GG, 2009, MOVEMENT DISORD, V24, P1843, DOI 10.1002/mds.22697; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Miguel L, 2011, NEUROBIOL DIS, V41, P398, DOI 10.1016/j.nbd.2010.10.007; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Nagai R, 2010, EXP CELL RES, V316, P272, DOI 10.1016/j.yexcr.2009.10.009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PRASAD DDK, 1994, ONCOGENE, V9, P3717; ROBERTSON HM, 1988, GENETICS, V118, P461; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Spradling A. C, 1986, DROSOPHILA PRACTICAL; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stewart BA, 2002, J NEUROBIOL, V51, P261, DOI 10.1002/neu.10059; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STOLOW DT, 1995, NUCLEIC ACIDS RES, V23, P835, DOI 10.1093/nar/23.5.835; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Takahashi Y, 1999, NUCLEIC ACIDS RES, V27, P510, DOI 10.1093/nar/27.2.510; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang JW, 2011, J CLIN INVEST, V121, P4118, DOI 10.1172/JCI57883; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zinszner H, 1997, J CELL SCI, V110, P1741	64	55	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39483	10.1371/journal.pone.0039483	http://dx.doi.org/10.1371/journal.pone.0039483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724023	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700086
J	Cai, Y; Zhu, HX; Li, JM; Luo, XG; Patrylo, PR; Rose, GM; Streeter, J; Hayes, R; Wang, KKW; Yan, XX; Jeromin, A				Cai, Yan; Zhu, Hai-Xia; Li, Jian-Ming; Luo, Xue-Gang; Patrylo, Peter R.; Rose, Gregory M.; Streeter, Jackson; Hayes, Ron; Wang, Kevin K. W.; Yan, Xiao-Xin; Jeromin, Andreas			Age-Related Intraneuronal Elevation of alpha II-Spectrin Breakdown Product SBDP120 in Rodent Forebrain Accelerates in 3 x Tg-AD Mice	PLOS ONE			English	Article							TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; OLFACTORY-BULB; BRAIN SPECTRIN; MOUSE MODEL; CALPAIN; PROTEOLYSIS; BETA; ACTIVATION; MEMBRANE	Spectrins line the intracellular surface of plasmalemma and play a critical role in supporting cytoskeletal stability and flexibility. Spectrins can be proteolytically degraded by calpains and caspases, yielding breakdown products (SBDPs) of various molecular sizes, with SBDP120 being largely derived from caspase-3 cleavage. SBDPs are putative biomarkers for traumatic brain injury. The levels of SBDPs also elevate in the brain during aging and perhaps in Alzheimer's disease (AD), although the cellular basis for this change is currently unclear. Here we examined age-related SBDP120 alteration in forebrain neurons in rats and in the triple transgenic model of AD (3xTg-AD) relative to non-transgenic controls. SBDP120 immunoreactivity (IR) was found in cortical neuronal somata in aged rats, and was prominent in the proximal dendrites of the olfactory bulb mitral cells. Western blot and densitometric analyses in wild-type mice revealed an age-related elevation of intraneuronal SBDP120 in the forebrain which was more robust in their 3xTg-AD counterparts. The intraneuronal SBDP120 occurrence was not spatiotemporally correlated with transgenic amyloid precursor protein (APP) expression, beta-amyloid plaque development, or phosphorylated tau expression over various forebrain regions or lamina. No microscopically detectable in situ activated caspase-3 was found in the nuclei of SBDP120-containing neurons. The present study demonstrates the age-dependent intraneuronal presence of an alpha II-spectrin cleavage fragment in mammalian forebrain which is exacerbated in a transgenic model of AD. This novel neuronal alteration indicates that impairments in membrane protein metabolism, possibly due to neuronal calcium mishandling and/or enhancement of calcium sensitive proteolysis, occur during aging and in transgenic AD mice.	[Cai, Yan; Luo, Xue-Gang; Yan, Xiao-Xin] Cent S Univ, Dept Anat & Neurobiol, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Zhu, Hai-Xia] Third Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Li, Jian-Ming] Changsha Med Univ, Neurosci Res Ctr, Changsha, Hunan, Peoples R China; [Patrylo, Peter R.; Rose, Gregory M.] So Illinois Univ, Sch Med, Dept Anat, Carbondale, IL 62901 USA; [Patrylo, Peter R.; Rose, Gregory M.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Patrylo, Peter R.; Rose, Gregory M.; Yan, Xiao-Xin] So Illinois Univ, Sch Med, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA; [Streeter, Jackson; Hayes, Ron; Wang, Kevin K. W.; Jeromin, Andreas] Banyan Biomarkers, Alachua, FL USA	Central South University; Central South University; Changsha Medical University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Banyan Biomarkers Inc.	Cai, Y (corresponding author), Cent S Univ, Dept Anat & Neurobiol, Xiangya Med Sch, Changsha, Hunan, Peoples R China.	yanxiaoxin@csu.edu.cn; ajeromin@banyanbio.com		Wang, Kevin/0000-0002-9343-6473	National Institute of Health [1R21NS056371]; National Natural Science Foundation of China [81171091]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056371] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (P.R.P., X.X.Y., 1R21NS056371), National Natural Science Foundation of China (X.X.Y., 81171091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Ayala-Grosso C, 2006, NEUROSCIENCE, V141, P863, DOI 10.1016/j.neuroscience.2006.04.041; BAHR BA, 1991, NEUROSCI LETT, V131, P237, DOI 10.1016/0304-3940(91)90622-Z; Baines AJ, 2010, TRANSFUS CLIN BIOL, V17, P95, DOI 10.1016/j.tracli.2010.06.008; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Bernath E, 2006, NEUROBIOL AGING, V27, P624, DOI 10.1016/j.neurobiolaging.2005.02.013; BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Cassano T, 2011, BEHAV BRAIN RES, V224, P408, DOI 10.1016/j.bbr.2011.06.029; Ennis M, 1998, ANN NY ACAD SCI, V855, P457, DOI 10.1111/j.1749-6632.1998.tb10606.x; Gaczynska M., 1992, Cytobios, V72, P197; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Hwang IK, 2008, NEUROSCI LETT, V435, P251, DOI 10.1016/j.neulet.2008.02.050; ISAYAMA T, 1991, J NEUROSCI, V11, P3531; Keil U, 2006, J ALZHEIMERS DIS, V9, P139; Kudryashova I V, 2009, Neurosci Behav Physiol, V39, P13, DOI 10.1007/s11055-008-9089-z; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; MASLIAH E, 1990, BRAIN RES, V531, P36, DOI 10.1016/0006-8993(90)90755-Z; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Nath R, 2000, NEUROCHEM INT, V37, P351, DOI 10.1016/S0197-0186(00)00040-1; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Newcomb JK, 2000, METH MOL B, V144, P219; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; PETERSON C, 1991, NEUROSCI LETT, V121, P239, DOI 10.1016/0304-3940(91)90694-O; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Ramser EM, 2010, MOL CELL NEUROSCI, V45, P66, DOI 10.1016/j.mcn.2010.05.013; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rohn TT, 2008, REV NEUROSCIENCE, V19, P383; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stankewich MC, 2010, P NATL ACAD SCI USA, V107, P6022, DOI 10.1073/pnas.1001522107; STRUBLE RG, 1992, NEUROBIOL AGING, V13, P469, DOI 10.1016/0197-4580(92)90074-8; Susuki K, 2011, P NATL ACAD SCI USA, V108, P8009, DOI 10.1073/pnas.1019600108; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	58	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37599	10.1371/journal.pone.0037599	http://dx.doi.org/10.1371/journal.pone.0037599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723836	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300007
J	Fra, AM; Gooptu, B; Ferrarotti, I; Miranda, E; Scabini, R; Ronzoni, R; Benini, F; Corda, L; Medicina, D; Luisetti, M; Schiaffonati, L				Fra, Anna M.; Gooptu, Bibek; Ferrarotti, Ilaria; Miranda, Elena; Scabini, Roberta; Ronzoni, Riccardo; Benini, Federica; Corda, Luciano; Medicina, Daniela; Luisetti, Maurizio; Schiaffonati, Luisa			Three New Alpha1-Antitrypsin Deficiency Variants Help to Define a C-Terminal Region Regulating Conformational Change and Polymerization	PLOS ONE			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; ALPHA-1-ANTITRYPSIN DEFICIENCY; MOLECULAR CHARACTERIZATION; MECHANISM; DISEASE; LIVER; LOOP; NEUROSERPIN; INHIBITOR; POLYMERS	Alpha1-antitrypsin (AAT) deficiency is a hereditary disorder associated with reduced AAT plasma levels, predisposing adults to pulmonary emphysema. The most common genetic AAT variants found in patients are the mildly deficient S and the severely deficient Z alleles, but several other pathogenic rare alleles have been reported. While the plasma AAT deficiency is a common trait of the disease, only a few AAT variants, including the prototypic Z AAT and some rare variants, form cytotoxic polymers in the endoplasmic reticulum of hepatocytes and predispose to liver disease. Here we report the identification of three new rare AAT variants associated to reduced plasma levels and characterize their molecular behaviour in cellular models. The variants, called Mpisa (Lys259Ile), Etaurisano (Lys368Glu) and Yorzinuovi (Pro391His), showed reduced secretion compared to control M AAT, and accumulated to different extents in the cells as ordered polymeric structures resembling those formed by the Z variant. Structural analysis of the mutations showed that they may facilitate polymerization both by loosening 'latch' interactions constraining the AAT reactive loop and through effects on core packing. In conclusion, the new AAT deficiency variants, besides increasing the risk of lung disease, may predispose to liver disease, particularly if associated with the common Z variant. The new mutations cluster structurally, thus defining a region of the AAT molecule critical for regulating its conformational state.	[Fra, Anna M.; Ronzoni, Riccardo; Schiaffonati, Luisa] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Gooptu, Bibek] Univ London, Birkbeck Coll, Inst Struct Mol Biol Crystallog, London, England; [Ferrarotti, Ilaria; Scabini, Roberta; Luisetti, Maurizio] Univ Pavia, Dept Mol Med, Ist Ricovero Cura Carattere Sci Policlin San Matt, I-27100 Pavia, Italy; [Miranda, Elena] Univ Roma La Sapienza, Dept Biol & Biotechnol, Charles Darwin & Pasteur Inst, Cenci Bolognetti Fdn, Rome, Italy; [Benini, Federica; Corda, Luciano] Spedali Civil Brescia, Div Internal Med, I-25125 Brescia, Italy; [Medicina, Daniela] Spedali Civil Brescia, Dept Pathol, I-25125 Brescia, Italy	University of Brescia; University of London; Birkbeck University London; University of Pavia; Fondazione Cenci Bolognetti; Sapienza University Rome; Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia	Fra, AM (corresponding author), Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy.	fra@med.unibs.it	Fra, Annamaria/I-5532-2012; Miranda, Elena/J-4999-2012; Ferrarotti, Ilaria/AEX-4579-2022	Fra, Annamaria/0000-0002-4327-3004; Miranda, Elena/0000-0002-0586-8795; Ronzoni, Riccardo/0000-0002-3981-8104; ferrarotti, ilaria/0000-0003-4892-4192; Gooptu, Bibek/0000-0002-5223-1121	Italian alpha1AT Association; Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico San Matteo "Ricerca Corrente''; Wellcome Trust	Italian alpha1AT Association; Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico San Matteo "Ricerca Corrente''; Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported in part by the Italian alpha 1AT Association and by Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico San Matteo "Ricerca Corrente''. BG was supported by a Wellcome Trust Intermediate Clinical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belorgey D, 2011, METHODS, V53, P255, DOI 10.1016/j.ymeth.2010.11.008; BRODBECK RM, 1994, J BIOL CHEM, V269, P17252; Chang WSW, 1997, PROTEIN SCI, V6, P89; Chiou A, 2009, BIOPHYS J, V97, P2306, DOI 10.1016/j.bpj.2009.07.057; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Denden S, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-12; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; Elliott PR, 1996, NAT STRUCT BIOL, V3, P910, DOI 10.1038/nsb1196-910; EVANS MD, 1994, AM J PHYSIOL, V266, pL593, DOI 10.1152/ajplung.1994.266.6.L593; Ferrarotti I, 2005, J MED GENET, V42, P282, DOI 10.1136/jmg.2004.023903; Ferrarotti I, 2004, DIAGN MOL PATHOL, V13, P160, DOI 10.1097/01.pdm.0000128700.22128.80; Ferrarotti I, 2007, TRANSL RES, V150, P267, DOI 10.1016/j.trsl.2007.08.001; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gooptu B, 2009, J MOL BIOL, V387, P857, DOI 10.1016/j.jmb.2009.01.069; Gorrini M, 2006, CLIN CHEM, V52, P899, DOI 10.1373/clinchem.2005.062059; Jardi R, 1998, Hum Mutat, V12, P213; Kim MJ, 2006, BIOCHEM BIOPH RES CO, V343, P295, DOI 10.1016/j.bbrc.2006.02.151; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494; Mahadeva R, 1999, J CLIN INVEST, V103, P999, DOI 10.1172/JCI4874; Medicina D, 2009, HUM MUTAT, V30, pE771, DOI 10.1002/humu.21043; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Perlmutter DH, 2002, J CLIN INVEST, V110, P1579, DOI 10.1172/JCI200216787; Poller W, 1999, EUR J HUM GENET, V7, P321, DOI 10.1038/sj.ejhg.5200304; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Wardell MR, 1997, BIOCHEMISTRY-US, V36, P13133, DOI 10.1021/bi970664u; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Zorzetto M, 2008, CLIN CHEM, V54, P1331, DOI 10.1373/clinchem.2007.102798	39	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38405	10.1371/journal.pone.0038405	http://dx.doi.org/10.1371/journal.pone.0038405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723858	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305583300026
J	Nibourg, GAA; Chamuleau, RAFM; van der Hoeven, TV; Maas, MAW; Ruiter, AFC; Lamers, WH; Elferink, RPJO; van Gulik, TM; Hoekstra, R				Nibourg, Geert A. A.; Chamuleau, Robert A. F. M.; van der Hoeven, Tessa V.; Maas, Martinus A. W.; Ruiter, An F. C.; Lamers, Wouter H.; Elferink, Ronald P. J. Oude; van Gulik, Thomas M.; Hoekstra, Ruurdtje			Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure	PLOS ONE			English	Article							ERYTHROID DIFFERENTIATION; HEPATOCYTES; EXPRESSION; OVEREXPRESSION; IMPROVEMENT; INDUCTION; DEVICES; CULTURE; VIRUS	A major roadblock to the application of bioartificial livers is the need for a human liver cell line that displays a high and broad level of hepatic functionality. The human bipotent liver progenitor cell line HepaRG is a promising candidate in this respect, for its potential to differentiate into hepatocytes and bile duct cells. Metabolism and synthesis of HepaRG monolayer cultures is relatively high and their drug metabolism can be enhanced upon treatment with 2% dimethyl sulfoxide (DMSO). However, their potential for bioartificial liver application has not been assessed so far. Therefore, HepaRG cells were cultured in the Academic Medical Center bioartificial liver (AMC-BAL) with and without DMSO and assessed for their hepatic functionality in vitro and in a rat model of acute liver failure. HepaRG-AMC-BALs cultured without DMSO eliminated ammonia and lactate, and produced apolipoprotein A-1 at rates comparable to freshly isolated hepatocytes. Cytochrome P450 3A4 transcript levels and activity were high with 88% and 37%, respectively, of the level of hepatocytes. DMSO treatment of HepaRG-AMC-BALs reduced the cell population and the abovementioned functions drastically. Therefore, solely HepaRG-AMC-BALs cultured without DMSO were tested for efficacy in rats with acute liver failure (n = 6). HepaRG-AMC-BAL treatment increased survival time of acute liver failure rats similar to 50% compared to acellular-BAL treatment. Moreover, HepaRG-AMC-BAL treatment decreased the progression of hepatic encephalopathy, kidney failure, and ammonia accumulation. These results demonstrate that the HepaRG-AMC-BAL is a promising bioartificial liver for clinical application.	[Nibourg, Geert A. A.; Chamuleau, Robert A. F. M.; van der Hoeven, Tessa V.; Lamers, Wouter H.; Elferink, Ronald P. J. Oude; Hoekstra, Ruurdtje] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Nibourg, Geert A. A.; van der Hoeven, Tessa V.; Maas, Martinus A. W.; van Gulik, Thomas M.; Hoekstra, Ruurdtje] Univ Amsterdam, Acad Med Ctr, Dept Surg, Surg Lab, NL-1105 AZ Amsterdam, Netherlands; [Ruiter, An F. C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Endocrinol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Nibourg, GAA (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.hoekstra@amc.uva.nl	Lamers, Wouter H./D-2965-2012; Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973	AMC; Hep-Art Medical Devices BV, The Netherlands	AMC; Hep-Art Medical Devices BV, The Netherlands	This study was partly funded by the Subsidy Regulation Knowledge Exploitation (SKE-fund) of the AMC, and by Hep-Art Medical Devices BV, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bjerring PN, 2010, J HEPATOL, V53, P1054, DOI 10.1016/j.jhep.2010.05.032; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Butterworth RF, 2003, LIVER INT, V23, P5, DOI 10.1034/j.1478-3231.23.s.3.1.x; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Chan AC, 2009, HEPATOL INT, V3, P571, DOI 10.1007/s12072-009-9148-8; Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89; Flendrig LM, 1997, J HEPATOL, V26, P1379, DOI 10.1016/S0168-8278(97)80475-8; Flendrig LM, 1999, J HEPATOL, V30, P311, DOI 10.1016/S0168-8278(99)80078-6; Fruhauf JH, 2009, LIVER INT, V29, P1553, DOI 10.1111/j.1478-3231.2009.02087.x; Greuet J, 1997, HEPATOLOGY, V25, P1166, DOI 10.1002/hep.510250520; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; Hoekstra R, 2011, INT J BIOCHEM CELL B, V43, P1483, DOI 10.1016/j.biocel.2011.06.011; Kim WR, 2006, HEPATOLOGY, V43, P345, DOI 10.1002/hep.21025; LEVY J, 1975, P NATL ACAD SCI USA, V72, P28, DOI 10.1073/pnas.72.1.28; Li Y, 2008, EUR J PHARMACOL, V590, P417, DOI 10.1016/j.ejphar.2008.06.047; Liou IW, 2008, SEMIN LIVER DIS, V28, P201, DOI 10.1055/s-2008-1073119; Nibourg GAA, 2010, LIVER TRANSPLANT, V16, P1075, DOI 10.1002/lt.22110; NYBERG SL, 1994, ANN SURG, V220, P59; Poyck PPC, 2008, ARTIF ORGANS, V32, P116, DOI 10.1111/j.1525-1594.2007.00500.x; Poyck PPC, 2007, TISSUE ENG, V13, P1235, DOI 10.1089/ten.2006.0343; Sen S, 2002, LIVER, V22, P5, DOI 10.1034/j.1600-0676.2002.00001.x; Suh KS, 1999, J SURG RES, V85, P243, DOI 10.1006/jsre.1999.5669; Sumida K, 2011, HUM EXP TOXICOL, V30, P1701, DOI 10.1177/0960327111399325; TERADA M, 1978, CANCER RES, V38, P835; van de Kerkhove MP, 2005, INT J ARTIF ORGANS, V28, P617, DOI 10.1177/039139880502800611	29	44	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38778	10.1371/journal.pone.0038778	http://dx.doi.org/10.1371/journal.pone.0038778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719943	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300048
J	Zhan, JS; Yang, LN; Zhu, W; Shang, LP; Newton, AC				Zhan, Jiasui; Yang, Lina; Zhu, Wen; Shang, Liping; Newton, Adrian C.			Pathogen Populations Evolve to Greater Race Complexity in Agricultural Systems - Evidence from Analysis of Rhynchosporium secalis Virulence Data	PLOS ONE			English	Article							NEAR-ISOGENIC LINES; DISEASE RESISTANCE; BARLEY SCALD; MICROSATELLITE ANALYSES; PHYTOPHTHORA-INFESTANS; GENETIC DIVERSITY; DYNAMICS; TUNISIA; METAPOPULATION; RECOMBINATION	Fitness cost associated with pathogens carrying unnecessary virulence alleles is the fundamental assumption for preventing the emergence of complex races in plant pathogen populations but this hypothesis has rarely been tested empirically on a temporal and spatial scale which is sufficient to distinguish evolutionary signals from experimental error. We analyzed virulence characteristics of similar to 1000 isolates of the barley pathogen Rhynchosporium secalis collected from different parts of the United Kingdom between 1984 and 2005. We found a gradual increase in race complexity over time with a significant correlation between sampling date and race complexity of the pathogen (r(20) = 0.71, p = 0.0002) and an average loss of 0.1 avirulence alleles (corresponding to an average gain of 0.1 virulence alleles) each year. We also found a positive and significant correlation between barley cultivar diversity and R. secalis virulence variation. The conditions assumed to favour complex races were not present in the United Kingdom and we hypothesize that the increase in race complexity is attributable to the combination of natural selection and genetic drift. Host resistance selects for corresponding virulence alleles to fixation or dominant frequency. Because of the weak fitness penalty of carrying the unnecessary virulence alleles, genetic drift associated with other evolutionary forces such as hitch-hiking maintains the frequency of the dominant virulence alleles even after the corresponding resistance factors cease to be used.	[Zhan, Jiasui] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Zhan, Jiasui; Yang, Lina; Zhu, Wen; Shang, Liping] Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Key Lab Plant Virol, Fuzhou, Peoples R China; [Newton, Adrian C.] James Hutton Inst, Dundee, Scotland	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; James Hutton Institute	Zhan, JS (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	jiasui.zhan@fjau.edu.cn	Newton, Adrian C/H-4452-2011	Newton, Adrian C/0000-0003-0303-6706	Chinese National Science Foundation [31071655]; Scottish Government Rural and Environment Research and Analysis Directorate	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Scottish Government Rural and Environment Research and Analysis Directorate	The project was supported by Chinese National Science Foundation Grant no 31071655 and Scottish Government Rural and Environment Research and Analysis Directorate Barley Pathology Work package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abang MM, 2006, PHYTOPATHOLOGY, V96, P1214, DOI 10.1094/PHYTO-96-1214; ALI SM, 1974, AUST J AGR RES, V25, P21, DOI 10.1071/AR9740021; ANDRIVON D, 1994, CAN J BOT, V72, P1681, DOI 10.1139/b94-206; [Anonymous], 1975, STAT ANAL; Arabi MIE, 2008, J PLANT PATHOL, V90, P179; Bahri B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-26; BARUA UM, 1993, HEREDITY, V71, P177, DOI 10.1038/hdy.1993.122; BEVAN JR, 1993, PLANT PATHOL, V42, P622, DOI 10.1111/j.1365-3059.1993.tb01543.x; Bjornstad A, 2002, PHYTOPATHOLOGY, V92, P710, DOI 10.1094/PHYTO.2002.92.7.710; Bouajila A, 2006, AFR J BIOTECHNOL, V5, P570; Bouajila A, 2007, MYCOPATHOLOGIA, V163, P281, DOI 10.1007/s11046-007-9012-0; Bouajila A, 2010, FEMS MICROBIOL LETT, V305, P35, DOI 10.1111/j.1574-6968.2010.01909.x; Brown JKM, 2003, TRENDS GENET, V19, P667, DOI 10.1016/j.tig.2003.10.008; Cox CM, 2004, PHYTOPATHOLOGY, V94, P961, DOI 10.1094/PHYTO.2004.94.9.961; de Vallavieille-Pope C, 2012, PLANT DIS, V96, P131, DOI 10.1094/PDIS-02-11-0078; Forgan AH, 2007, PHYTOPATHOLOGY, V97, P650, DOI 10.1094/PHYTO-97-5-0650; Fraile A, 2011, MOL BIOL EVOL, V28, P1425, DOI 10.1093/molbev/msq327; GILMOUR J, 1973, NATURE, V242, P620, DOI 10.1038/242620a0; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P1047, DOI 10.1094/Phyto-84-1047; GOODWIN SB, 1993, MYCOL RES, V97, P49, DOI 10.1016/S0953-7562(09)81112-X; GOODWIN SB, 1990, PHYTOPATHOLOGY, V80, P1330, DOI 10.1094/Phyto-80-1330; HOUSTON BR, 1957, PHYTOPATHOLOGY, V47, P525; Huang SP, 2001, GENETICS, V159, P1365; JACKSON LF, 1976, PHYTOPATHOLOGY, V66, P726, DOI 10.1094/Phyto-66-726; Jenner CE, 2002, VIRUS RES, V86, P1, DOI 10.1016/S0168-1702(02)00031-X; Kiros-Meles A, 2011, BIOL INVASIONS, V13, P321, DOI 10.1007/s10530-010-9808-6; KIYOSAWA S, 1982, ANNU REV PHYTOPATHOL, V20, P93, DOI 10.1146/annurev.py.20.090182.000521; Lannou C, 1997, THEOR APPL GENET, V94, P991, DOI 10.1007/s001220050506; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187; MCDERMOTT JM, 1989, GENETICS, V122, P561; McDonald BA, 1999, PHYTOPATHOLOGY, V89, P639, DOI 10.1094/PHYTO.1999.89.8.639; Montarry J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-283; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEWMAN PL, 1985, PLANT PATHOL, V34, P338, DOI 10.1111/j.1365-3059.1985.tb01370.x; Ott R.L., 1992, INTRO STAT METHODS D; Rigby MC, 2002, TRENDS PARASITOL, V18, P116, DOI 10.1016/S1471-4922(01)02203-6; ROHE M, 1995, EMBO J, V14, P4168, DOI 10.1002/j.1460-2075.1995.tb00090.x; Salamati S, 2000, PHYTOPATHOLOGY, V90, P901, DOI 10.1094/PHYTO.2000.90.8.901; Schurch S, 2004, MOL PLANT MICROBE IN, V17, P1114, DOI 10.1094/MPMI.2004.17.10.1114; Shipton WA, 1974, ANN REV PLANT PATHOL, V53, P839; Szunics L, 2001, EUPHYTICA, V119, P143, DOI 10.1023/A:1017588816724; Thirugnanasambandam A, 2011, PLANT PATHOL, V60, P513, DOI 10.1111/j.1365-3059.2010.02393.x; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; United Kingdom Cereal Pathogen Virulence Survey Committee, 1984, ANN REP UK CER PATH; Williams K, 2003, AUSTRALAS PLANT PATH, V32, P257, DOI 10.1071/AP03008; Wolfe MS, 2000, NATURE, V406, P681, DOI 10.1038/35021152; WORKMAN PL, 1970, AM J HUM GENET, V22, P24; Xi K, 2000, PHYTOPATHOLOGY, V90, P94, DOI 10.1094/PHYTO.2000.90.1.94; Xi KN, 2003, MYCOL RES, V107, P1485, DOI 10.1017/S0953756203008748; Zaffarano PL, 2011, MYCOLOGIA, V103, P195, DOI 10.3852/10-119; Zhan J, 2008, PLANT PATHOL, V57, P1, DOI 10.1111/j.1365-3059.2007.01691.x; Zhan J, 2006, P 3 INT WORKSH BARL, P88; Zhang Q, 1987, PHYTOPATHOLOGY, V77, P352; ZHANG QF, 1992, PHYTOPATHOLOGY, V82, P798, DOI 10.1094/Phyto-82-798; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	56	14	15	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38611	10.1371/journal.pone.0038611	http://dx.doi.org/10.1371/journal.pone.0038611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723870	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300034
J	De Ingeniis, J; Kazanov, MD; Shatalin, K; Gelfand, MS; Osterman, AL; Sorci, L				De Ingeniis, Jessica; Kazanov, Marat D.; Shatalin, Konstantin; Gelfand, Mikhail S.; Osterman, Andrei L.; Sorci, Leonardo			Glutamine versus Ammonia Utilization in the NAD Synthetase Family	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; COMPARATIVE GENOMICS; BACILLUS-SUBTILIS; ENZYME; DOMAIN; IDENTIFICATION; BIOSYNTHESIS	NAD is a ubiquitous and essential metabolic redox cofactor which also functions as a substrate in certain regulatory pathways. The last step of NAD synthesis is the ATP-dependent amidation of deamido-NAD by NAD synthetase (NADS). Members of the NADS family are present in nearly all species across the three kingdoms of Life. In eukaryotic NADS, the core synthetase domain is fused with a nitrilase-like glutaminase domain supplying ammonia for the reaction. This two-domain NADS arrangement enabling the utilization of glutamine as nitrogen donor is also present in various bacterial lineages. However, many other bacterial members of NADS family do not contain a glutaminase domain, and they can utilize only ammonia (but not glutamine) in vitro. A single-domain NADS is also characteristic for nearly all Archaea, and its dependence on ammonia was demonstrated here for the representative enzyme from Methanocaldococcus jannaschi. However, a question about the actual in vivo nitrogen donor for single-domain members of the NADS family remained open: Is it glutamine hydrolyzed by a committed (but yet unknown) glutaminase subunit, as in most ATP-dependent amidotransferases, or free ammonia as in glutamine synthetase? Here we addressed this dilemma by combining evolutionary analysis of the NADS family with experimental characterization of two representative bacterial systems: a two-subunit NADS from Thermus thermophilus and a single-domain NADS from Salmonella typhimurium providing evidence that ammonia (and not glutamine) is the physiological substrate of a typical single-domain NADS. The latter represents the most likely ancestral form of NADS. The ability to utilize glutamine appears to have evolved via recruitment of a glutaminase subunit followed by domain fusion in an early branch of Bacteria. Further evolution of the NADS family included lineage-specific loss of one of the two alternative forms and horizontal gene transfer events. Lastly, we identified NADS structural elements associated with glutamine-utilizing capabilities.	[De Ingeniis, Jessica; Kazanov, Marat D.; Osterman, Andrei L.; Sorci, Leonardo] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Kazanov, Marat D.; Gelfand, Mikhail S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Shatalin, Konstantin] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Sorci, Leonardo] Polytech Univ Marche, Biochem Sect, Dept Clin Sci, Ancona, Italy	Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; New York University; Lomonosov Moscow State University; Marche Polytechnic University	De Ingeniis, J (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	osterman@sanfordburnham.org; l.sorci@univpm.it	Kazanov, Marat D/D-6381-2013; Gelfand, Mikhail S/F-3425-2012; SORCI, LEONARDO/AAD-7395-2019	Kazanov, Marat D/0000-0002-2314-5507; SORCI, LEONARDO/0000-0002-4356-8873; Gelfand, Mikhail/0000-0003-4181-0846	"Montalcini International Program'' through the Italian Ministry of Education, University and Research; National Institute of Allergy and Infectious Diseases (NIAID) [AI066244]; DOE-BER Genomic Science Program (GSP) as part of Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Program in Molecular and Cellular Biology of the Russian Academy of Sciences; Russian Foundation of Basic Research [10-04-00431, 09-04-92745];  [07.514.11.4007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066244] Funding Source: NIH RePORTER	"Montalcini International Program'' through the Italian Ministry of Education, University and Research; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE-BER Genomic Science Program (GSP) as part of Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Program in Molecular and Cellular Biology of the Russian Academy of Sciences; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was partly supported by "Montalcini International Program'' through the Italian Ministry of Education, University and Research to LS, by the National Institute of Allergy and Infectious Diseases (NIAID) grant AI066244 and by the DOE-BER Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area to ALO, and by the Program in Molecular and Cellular Biology of the Russian Academy of Sciences, grants 10-04-00431 and 09-04-92745 of the Russian Foundation of Basic Research and State contract 07.514.11.4007 to MSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bieganowski P, 2003, J BIOL CHEM, V278, P33056, DOI 10.1074/jbc.M302276200; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; BROACH J, 1976, J BACTERIOL, V128, P86, DOI 10.1128/JB.128.1.86-98.1976; Chuenchor W, 2012, BIOCHEM J, V443, P417, DOI 10.1042/BJ20112210; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Devedjiev Y, 2001, ACTA CRYSTALLOGR D, V57, P806, DOI 10.1107/S0907444901003523; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jauch R, 2005, J BIOL CHEM, V280, P15131, DOI 10.1074/jbc.M413195200; Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391; Kang GB, 2005, PROTEINS, V58, P985, DOI 10.1002/prot.20377; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Maddison W., 2018, MESQUITE MODULAR SYS; McDonald HM, 2007, ACTA CRYSTALLOGR D, V63, P891, DOI 10.1107/S0907444907029769; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; NESSI C, 1995, J BIOL CHEM, V270, P6181, DOI 10.1074/jbc.270.11.6181; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Osterman AL, 2007, PROG DRUG RES, V64, p[131, 133], DOI DOI 10.1007/978-3-7643-7567-6_; Osterman Andrei L, 2007, Prog Drug Res, V64, P133; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Resto M, 2009, BBA-PROTEINS PROTEOM, V1794, P1648, DOI 10.1016/j.bbapap.2009.07.014; Rizzi M, 1996, EMBO J, V15, P5125, DOI 10.1002/j.1460-2075.1996.tb00896.x; Rizzi M, 1998, STRUCTURE, V6, P1129, DOI 10.1016/S0969-2126(98)00114-2; Schneider BL, 1998, J BACTERIOL, V180, P4739, DOI 10.1128/JB.180.17.4739-4741.1998; Sorci L, 2009, TARGETING NAD BIOSYN; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; Sorci L, 2010, J BIOL CHEM, V285, P39490, DOI 10.1074/jbc.M110.185629; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suda Y, 2003, YEAST, V20, P995, DOI 10.1002/yea.1008; Symersky J, 2002, ACTA CRYSTALLOGR D, V58, P1138, DOI 10.1107/S0907444902006698; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Veiga-Malta I, 2004, J BACTERIOL, V186, P419, DOI 10.1128/JB.186.2.419-426.2004; Velu SE, 2007, J MED CHEM, V50, P2612, DOI 10.1021/jm061349l; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WILLISON JC, 1994, J BACTERIOL, V176, P3400, DOI 10.1128/jb.176.11.3400-3402.1994; Wojcik M, 2006, J BIOL CHEM, V281, P33395, DOI 10.1074/jbc.M607111200; Yamaguchi F, 2002, BIOSCI BIOTECH BIOCH, V66, P2052, DOI 10.1271/bbb.66.2052; Yanai I, 2002, GENOME BIOL, V3; ZALKIN H, 1985, METHOD ENZYMOL, V113, P297; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	60	32	31	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39115	10.1371/journal.pone.0039115	http://dx.doi.org/10.1371/journal.pone.0039115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720044	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000040
J	Li, BQ; Hu, LL; Chen, L; Feng, KY; Cai, YD; Chou, KC				Li, Bi-Qing; Hu, Le-Le; Chen, Lei; Feng, Kai-Yan; Cai, Yu-Dong; Chou, Kuo-Chen			Prediction of Protein Domain with mRMR Feature Selection and Analysis	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUBCELLULAR-LOCALIZATION; FUNCTIONAL DOMAIN; CLEAVAGE SITES; WEB-SERVER; SUBNUCLEAR LOCALIZATION; SOLVENT ACCESSIBILITY; AUTOMATED PREDICTION; SECONDARY STRUCTURE; BINDING SITES	The domains are the structural and functional units of proteins. With the avalanche of protein sequences generated in the postgenomic age, it is highly desired to develop effective methods for predicting the protein domains according to the sequences information alone, so as to facilitate the structure prediction of proteins and speed up their functional annotation. However, although many efforts have been made in this regard, prediction of protein domains from the sequence information still remains a challenging and elusive problem. Here, a new method was developed by combing the techniques of RF (random forest), mRMR (maximum relevance minimum redundancy), and IFS (incremental feature selection), as well as by incorporating the features of physicochemical and biochemical properties, sequence conservation, residual disorder, secondary structure, and solvent accessibility. The overall success rate achieved by the new method on an independent dataset was around 73%, which was about 28-40% higher than those by the existing method on the same benchmark dataset. Furthermore, it was revealed by an in-depth analysis that the features of evolution, codon diversity, electrostatic charge, and disorder played more important roles than the others in predicting protein domains, quite consistent with experimental observations. It is anticipated that the new method may become a high-throughput tool in annotating protein domains, or may, at the very least, play a complementary role to the existing domain prediction methods, and that the findings about the key features with high impacts to the domain prediction might provide useful insights or clues for further experimental investigations in this area. Finally, it has not escaped our notice that the current approach can also be utilized to study protein signal peptides, B-cell epitopes, HIV protease cleavage sites, among many other important topics in protein science and biomedicine.	[Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Feng, Kai-Yan] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Maritime University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; kcchou@gordonlifescience.org	Chen, Lei/A-2275-2011; Chou, Kuo-Chen/A-8340-2009	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101) and the Innovation Program of Shanghai Municipal Education Commission (12ZZ087).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Bondugula R, 2009, NUCLEIC ACIDS RES, V37, P452, DOI 10.1093/nar/gkn944; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; CAMPBELL ID, 1994, TRENDS BIOTECHNOL, V12, P168, DOI 10.1016/0167-7799(94)90078-7; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng J, 2007, NUCLEIC ACIDS RES, V35, pW354, DOI 10.1093/nar/gkm390; Cheng JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/s10618-005-0023-5; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Chou KC, 2005, BIOCHEM BIOPH RES CO, V331, P56, DOI 10.1016/j.bbrc.2005.03.123; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 2004, BIOCHEM BIOPH RES CO, V316, P636, DOI 10.1016/j.bbrc.2004.02.098; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 2002, CURR PROTEIN PEPT SC, V3, P615, DOI 10.2174/1389203023380468; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEIN SCI, V4, P1365, DOI 10.1002/pro.5560040712; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Eickholt J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-43; ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; George RA, 2002, J MOL BIOL, V316, P839, DOI 10.1006/jmbi.2001.5387; Gewehr JE, 2006, BIOINFORMATICS, V22, P181, DOI 10.1093/bioinformatics/bti751; Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905; Gong S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-207; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Guerois R, 2001, CURR OPIN STRUC BIOL, V11, P101, DOI 10.1016/S0959-440X(00)00170-6; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Holland TA, 2006, J MOL BIOL, V361, P562, DOI 10.1016/j.jmb.2006.05.060; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Ingolfsson Helgi, 2008, V426, P117, DOI 10.1007/978-1-60327-058-8_7; Jia SC, 2011, PROTEIN PEPTIDE LETT, V18, P609, DOI 10.2174/092986611795222777; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li DD, 2010, PROTEIN PEPTIDE LETT, V17, P1566, DOI 10.2174/0929866511009011566; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li YD, 2009, PROTEIN PEPTIDE LETT, V16, P706, DOI 10.2174/092986609788490096; Li YX, 2011, PROTEIN PEPTIDE LETT, V18, P573, DOI 10.2174/092986611795222731; Lin J, 2011, PROTEIN PEPTIDE LETT, V18, P1219, DOI 10.2174/092986611797642797; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu JF, 2004, NUCLEIC ACIDS RES, V32, P3522, DOI 10.1093/nar/gkh684; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Mbamala EC, 2005, BIOPHYS J, V88, P1702, DOI 10.1529/biophysj.104.048132; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Moses AM, 2009, MOL BIOL EVOL, V26, P527, DOI 10.1093/molbev/msn286; Mundra P, 2007, PATTERN RECOGN LETT, V28, P1610, DOI 10.1016/j.patrec.2007.04.001; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagarajan N, 2004, BIOINFORMATICS, V20, P1335, DOI 10.1093/bioinformatics/bth086; Nielsen PK, 2001, J BIOL CHEM, V276, P10906, DOI 10.1074/jbc.M008743200; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; POORMAN RA, 1991, J BIOL CHEM, V266, P14554; Pugalenthi G, 2012, PROTEIN PEPTIDE LETT, V19, P50, DOI 10.2174/092986612798472875; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Qiu ZJ, 2011, PROTEIN PEPTIDE LETT, V18, P1212, DOI 10.2174/092986611797642788; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Saffari B, 2008, PROTEIN PEPTIDE LETT, V15, P280; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shameer K, 2011, PROTEIN PEPTIDE LETT, V18, P1010, DOI 10.2174/092986611796378729; Shen HB, 2008, ANAL BIOCHEM, V375, P388, DOI 10.1016/j.ab.2008.01.012; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; von Ohsen N, 2004, BIOINFORMATICS, V20, P2228, DOI 10.1093/bioinformatics/bth232; Walsh I, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-195; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang K, 2012, PROTEIN PEPTIDE LETT, V19, P15, DOI 10.2174/092986612798472820; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Witten I.H., 2005, DATA MINING PRACTICA; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao XA, 2011, MOL DIVERS, V15, P149, DOI 10.1007/s11030-010-9227-8; Xiao X, 2009, J APPL CRYSTALLOGR, V42, P169, DOI 10.1107/S0021889809002751; Xiao X, 2009, J COMPUT CHEM, V30, P1414, DOI 10.1002/jcc.21163; Yoon MK, 2009, PROTEIN SCI, V18, P337, DOI 10.1002/pro.34; Zhang YF, 2011, PROTEIN PEPTIDE LETT, V18, P7, DOI 10.2174/092986611794328717; Zhao W, 2011, PROTEIN PEPTIDE LETT, V18, P707, DOI 10.2174/092986611795446094; Zhou GP, 2011, PROTEIN PEPTIDE LETT, V18, P966, DOI 10.2174/0929866511107010966; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006	113	79	83	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39308	10.1371/journal.pone.0039308	http://dx.doi.org/10.1371/journal.pone.0039308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720092	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000058
J	Fang, W; Price, MS; Toffaletti, DL; Tenor, J; Betancourt-Quiroz, M; Price, JL; Pan, WH; Liao, WQ; Perfect, JR				Fang, Wei; Price, Michael S.; Toffaletti, Dena L.; Tenor, Jennifer; Betancourt-Quiroz, Marisol; Price, Jennifer L.; Pan, Wei-hua; Liao, Wan-qing; Perfect, John R.			Pleiotropic Effects of Deubiquitinating Enzyme Ubp5 on Growth and Pathogenesis of Cryptococcus neoformans	PLOS ONE			English	Article							PHOSPHOLIPASE-ACTIVITY; 2-COMPONENT SYSTEM; POLYUBIQUITIN GENE; VIRULENCE FACTOR; UBIQUITIN; YEAST; DEGRADATION; EXPRESSION; PATHWAY; PROMOTES	Ubiquitination is a reversible protein modification that influences various cellular processes in eukaryotic cells. Deubiquitinating enzymes remove ubiquitin, maintain ubiquitin homeostasis and regulate protein degradation via the ubiquitination pathway. Cryptococcus neoformans is an important basidiomycete pathogen that causes life-threatening meningoencephalitis primarily in the immunocompromised population. In order to understand the possible influence deubiquitinases have on growth and virulence of the model pathogenic yeast Cryptococcus neoformans, we generated deletion mutants of seven putative deubiquitinase genes. Compared to other deubiquitinating enzyme mutants, a ubp5 Delta mutant exhibited severely attenuated virulence and many distinct phenotypes, including decreased capsule formation, hypomelanization, defective sporulation, and elevated sensitivity to several external stressors (such as high temperature, oxidative and nitrosative stresses, high salts, and antifungal agents). Ubp5 is likely the major deubiquitinating enzyme for stress responses in C. neoformans, which further delineates the evolutionary divergence of Cryptococcus from the model yeast S. cerevisiae, and provides an important paradigm for understanding the potential role of deubiquitination in virulence by other pathogenic fungi. Other putative deubiquitinase mutants (doa4 Delta and ubp13 Delta) share some phenotypes with the ubp5 Delta mutant, illustrating functional overlap among deubiquitinating enzymes in C. neoformans. Therefore, deubiquitinating enzymes (especially Ubp5) are essential for the virulence composite of C. neoformans and provide an additional yeast survival and propagation advantage in the host.	[Fang, Wei; Pan, Wei-hua; Liao, Wan-qing] Second Mil Med Univ, Changzheng Hosp, PLA Key Lab Mycosis Inst Dermatol & Mycosis, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Fang, Wei; Price, Michael S.; Toffaletti, Dena L.; Tenor, Jennifer; Betancourt-Quiroz, Marisol; Price, Jennifer L.; Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Naval Medical University; Duke University	Fang, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, PLA Key Lab Mycosis Inst Dermatol & Mycosis, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.	liaowanqing@sohu.com; perfe001@mc.duke.edu		Price, Michael/0000-0001-6022-328X; Betancourt Quiroz, Marisol/0000-0002-6920-9182	National Institutes of Health PHS [AI73896, AI28388]; Shanghai Science and Technology Committee [10dz2220100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI028388, R01AI028388, R01AI073896] Funding Source: NIH RePORTER	National Institutes of Health PHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health PHS grants AI73896 and AI28388 (JRP), and also supported by Shanghai Science and Technology Committee grant 10dz2220100 (W-QL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Ballou ER, 2010, MOL MICROBIOL, V75, P763, DOI 10.1111/j.1365-2958.2009.07019.x; Boase NA, 2003, GENETICS, V164, P95; Bozza WP, 2011, BIOCHEMISTRY-US, V50, P6423, DOI 10.1021/bi200529z; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; CHENG L, 1994, MOL GEN GENET, V243, P358, DOI 10.1007/BF00301072; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Ding F, 2011, CURR TOP MED CHEM; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Eisele F, 2006, BIOCHEM BIOPH RES CO, V350, P329, DOI 10.1016/j.bbrc.2006.09.041; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; Enyenihi AH, 2003, GENETICS, V163, P47; Esch RK, 2002, P NATL ACAD SCI USA, V99, P9160, DOI 10.1073/pnas.142034399; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUFFNAGLE GB, 1995, J IMMUNOL, V155, P3507; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Jiang N, 2009, FEMS MICROBIOL LETT, V296, P84, DOI 10.1111/j.1574-6968.2009.01619.x; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kahana A, 2001, BIOCHEM BIOPH RES CO, V282, P916, DOI 10.1006/bbrc.2001.4669; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kozubowski L, 2010, MOL MICROBIOL, V75, P658, DOI 10.1111/j.1365-2958.2009.06983.x; Laney JD, 2003, GENE DEV, V17, P2259, DOI 10.1101/gad.1115703; Lee A, 2010, INFECT IMMUN, V78, P4213, DOI 10.1128/IAI.00551-10; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Liu TB, 2011, EUKARYOT CELL, V10, P791, DOI 10.1128/EC.00004-11; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Nichols CB, 2007, MOL MICROBIOL, V63, P1118, DOI 10.1111/j.1365-2958.2006.05566.x; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Osterholzer JJ, 2009, AM J PATHOL, V174, P932, DOI 10.2353/ajpath.2009.080673; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; Price MS, 2008, INFECT IMMUN, V76, P5729, DOI 10.1128/IAI.00896-08; Price MS, 2011, MBIO, V2, DOI 10.1128/mBio.00103-11; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; RHODES JC, 1982, INFECT IMMUN, V36, P1175, DOI 10.1128/IAI.36.3.1175-1184.1982; Rodrigues ML, 2008, EUKARYOT CELL, V7, P602, DOI 10.1128/EC.00307-07; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Semighini CP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002364; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; SPITZER ED, 1995, GENE, V161, P113, DOI 10.1016/0378-1119(95)00231-T; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; TREGER JM, 1988, MOL CELL BIOL, V8, P1132, DOI 10.1128/MCB.8.3.1132; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Varma A, 1999, GENE, V232, P155, DOI 10.1016/S0378-1119(99)00132-8; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Weiss P, 2008, EUKARYOT CELL, V7, P1888, DOI 10.1128/EC.00194-08; Wilkinson KD, 2004, CELL, V119, P741, DOI 10.1016/S0092-8674(04)01154-7; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	99	17	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38326	10.1371/journal.pone.0038326	http://dx.doi.org/10.1371/journal.pone.0038326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719877	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800006
J	Manuelpillai, U; Lourensz, D; Vaghjiani, V; Tchongue, J; Lacey, D; Tee, JY; Murthi, P; Chan, J; Hodge, A; Sievert, W				Manuelpillai, Ursula; Lourensz, Dinushka; Vaghjiani, Vijesh; Tchongue, Jorge; Lacey, Derek; Tee, Jing-Yang; Murthi, Padma; Chan, James; Hodge, Alexander; Sievert, William			Human Amniotic Epithelial Cell Transplantation Induces Markers of Alternative Macrophage Activation and Reduces Established Hepatic Fibrosis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN FETAL MEMBRANES; LIVER FIBROSIS; AUTOLOGOUS INFUSION; INFLAMMATION; DIFFERENTIATION; REGENERATION; CIRRHOSIS; PLACENTA; THERAPY	Chronic hepatic inflammation from multiple etiologies leads to a fibrogenic response that can progress to cirrhosis and liver failure. Transplantation of human amniotic epithelial cells (hAEC) from term delivered placenta has been shown to decrease mild to moderate hepatic fibrosis in a murine model. To model advanced human liver disease and assess the efficacy of hAEC therapy, we transplanted hAEC in mice with advanced hepatic fibrosis. Immunocompetent C57BL/6 mice were administered carbon tetrachloride (CCl4) twice weekly resulting in bridging fibrosis by 12 weeks. hAEC (2610 6) were infused via the tail vein at week 8 or weeks 8 and 10 (single and double dose, respectively). Human cells were detected in mouse liver four weeks after transplantation showing hAEC engraftment. CCl4 treated mice receiving single or double hAEC doses showed a significant but similar decrease in liver fibrosis area associated with decreased activation of collagen-producing hepatic stellate cells and decreased hepatic protein levels of the pro-fibrogenic cytokine, transforming growth factor-beta1. CCl4 administration caused hepatic T cell infiltration that decreased significantly following hAEC transplantation. Hepatic macrophages play a crucial role in both fibrogenesis and fibrosis resolution. Mice exposed to CCl4 demonstrated increased numbers of hepatic macrophages compared to normal mice; the number of macrophages decreased significantly in CCl4 treated mice given hAEC. These mice had significantly lower hepatic protein levels of the chemokine monocyte chemoattractant protein-1 than mice given CCl4 alone. Alternatively activated M2 macrophages are associated with fibrosis resolution. CCl4 treated mice given hAEC showed increased expression of genes associated with M2 macrophages including YM-1, IL-10 and CD206. We provide novel data showing that hAEC transplantation induces a wound healing M2 macrophage phenotype associated with reduction of established hepatic fibrosis that justifies further investigation of this potential cell-based therapy for advanced hepatic fibrosis.	[Manuelpillai, Ursula; Vaghjiani, Vijesh; Tee, Jing-Yang] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Melbourne, Vic 3004, Australia; [Lourensz, Dinushka; Tchongue, Jorge; Chan, James; Hodge, Alexander; Sievert, William] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [Lacey, Derek] Univ Melbourne, Royal Melbourne Hosp, Arthrit & Inflammat Res Ctr, Melbourne, Vic 3050, Australia; [Murthi, Padma] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Lourensz, Dinushka; Tchongue, Jorge; Hodge, Alexander; Sievert, William] So Hlth, Gastroenterol & Hepatol Unit, Melbourne, Vic, Australia; [Murthi, Padma] Royal Womens Hosp, Pregnancy Res Ctr, Dept Perinatal Med, Melbourne, Vic, Australia	Monash University; Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Manuelpillai, U (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Melbourne, Vic 3004, Australia.	william.sievert@monash.edu	Murthi, Padma/AAY-5395-2021; Tee, Jing Yang/F-2821-2013; Hodge, Alexander/GRJ-5820-2022	Tee, Jing Yang/0000-0003-1605-4938; Vaghjiani, Vijesh/0000-0001-8004-3876	Australian National Health & Medical Research Council [606473, 509140, 436634]; Victorian Government's Operational Infrastructure Support Program	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	Australian National Health & Medical Research Council (www.nhmrc.gov.au) project grants #606473 to UM and WS and #509140 to PM and JC by program grant #436634 with support from the Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Couto BG, 2011, LIVER INT, V31, P391, DOI 10.1111/j.1478-3231.2010.02424.x; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Fang BJ, 2004, TRANSPLANTATION, V78, P83, DOI 10.1097/01.TP.0000128326.95294.14; Friedman Lawrence S, 2010, Trans Am Clin Climatol Assoc, V121, P192; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Hanje J, 2007, NAT CLIN PRACT GASTR, V4, P266, DOI 10.1038/ncpgasthep0794; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Leviar N, 2008, CELL PROLIFERAT, V41, P115, DOI 10.1111/j.1365-2184.2008.00491.x; Liu TJ, 2008, SHOCK, V29, P603, DOI 10.1097/SHK.0b013e318157e845; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Pai M, 2008, AM J GASTROENTEROL, V103, P1952, DOI 10.1111/j.1572-0241.2008.01993.x; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; Ramachandran P, 2009, ANN HEPATOL, V8, P283, DOI 10.1016/S1665-2681(19)31740-5; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Stutchfield BM, 2010, LIVER TRANSPLANT, V16, P827, DOI 10.1002/lt.22083; Takashima S, 2004, CELL STRUCT FUNCT, V29, P73, DOI 10.1247/csf.29.73; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang XX, 2010, NEUROL RES, V32, P1054, DOI 10.1179/016164110X12681290831207	42	84	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38631	10.1371/journal.pone.0038631	http://dx.doi.org/10.1371/journal.pone.0038631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719909	Green Published, gold			2022-12-27	WOS:000305347800011
J	Bharati, A; Kar, M; Sabat, SC				Bharati, Adyasha; Kar, Monaranjan; Sabat, Surendra Chandra			Artemisinin Inhibits Chloroplast Electron Transport Activity: Mode of Action	PLOS ONE			English	Article							A FLUORESCENCE INDUCTION; PHOTOSYSTEM-II; CHLOROPHYLL-A; MECHANISMS; MEMBRANES; ANNUA; SITE	Artemisinin, a secondary metabolite produced in Artemisia plant species, besides having antimalarial properties is also phytotoxic. Although, the phytotoxic activity of the compound has been long recognized, no information is available on the mechanism of action of the compound on photosynthetic activity of the plant. In this report, we have evaluated the effect of artemisinin on photoelectron transport activity of chloroplast thylakoid membrane. The inhibitory effect of the compound, under in vitro condition, was pronounced in loosely and fully coupled thylakoids; being strong in the former. The extent of inhibition was drastically reduced in the presence of uncouplers like ammonium chloride or gramicidin; a characteristic feature described for energy transfer inhibitors. The compound, on the other hand, when applied to plants (in vivo), behaved as a potent inhibitor of photosynthetic electron transport. The major site of its action was identified to be the Q(B); the secondary quinone moiety of photosystemII complex. Analysis of photoreduction kinetics of para-benzoquinone and duroquinone suggest that the inhibition leads to formation of low pool of plastoquinol, which becomes limiting for electron flow through photosystemI. Further it was ascertained that the in vivo inhibitory effect appeared as a consequence of the formation of an unidentified artemisinin-metabolite rather than by the interaction of the compound per se. The putative metabolite of artemisinin is highly reactive in instituting the inhibition of photosynthetic electron flow eventually reducing the plant growth.	[Bharati, Adyasha; Sabat, Surendra Chandra] Inst Life Sci, Stress Biol Lab, Bhubaneswar, Odisha, India; [Kar, Monaranjan] Utkal Univ, Dept Bot, Bhubaneswar 751004, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Utkal University	Bharati, A (corresponding author), Inst Life Sci, Stress Biol Lab, Bhubaneswar, Odisha, India.	surendrachandra@gmail.com			Institute of Life Sciences	Institute of Life Sciences	The financial support was institutional, obtained from Director, Institute of Life Sciences, which is intramural. No extramural funding was used in this study. The intramural funding in the authors' case had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi G. D., 1998, Journal of Medicinal and Aromatic Plant Sciences, V20, P5; Bagchi GD, 1997, PHYTOCHEMISTRY, V45, P1131, DOI 10.1016/S0031-9422(97)00126-X; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; BOWES JM, 1981, ARCH BIOCHEM BIOPHYS, V209, P682, DOI 10.1016/0003-9861(81)90329-5; Bukhov NG, 2003, BBA-BIOENERGETICS, V1604, P115, DOI 10.1016/S0005-2728(03)00042-2; CHEN P K, 1987, Plant Physiology (Rockville), V83, P68; CHEN PK, 1990, J CHEM ECOL, V16, P1867, DOI 10.1007/BF01020500; Dayan FE, 1999, PHYTOCHEMISTRY, V50, P607, DOI 10.1016/S0031-9422(98)00568-8; Dayan FE, 2010, WEED SCI, V58, P340, DOI 10.1614/WS-09-092.1; DEAMER DW, 1967, BIOCHIM BIOPHYS ACTA, V131, P81, DOI 10.1016/0005-2728(67)90032-1; Dudekula S, 2006, J PHOTOCH PHOTOBIO B, V85, P177, DOI 10.1016/j.jphotobiol.2006.07.003; Duke S.O., 1988, ACS SYM SER, V380, P318; Duke SO, 2002, WEED SCI, V50, P138, DOI 10.1614/0043-1745(2002)050[0138:IPCFNF]2.0.CO;2; DUKE SO, 1987, WEED SCI, V35, P499, DOI 10.1017/S0043174500060458; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Izawa S., 1980, METHODS ENZYMOL    C, P413; JOSHI MK, 1995, J SCI IND RES INDIA, V54, P155; Kashino Y, 1996, PLANT CELL PHYSIOL, V37, P976, DOI 10.1093/oxfordjournals.pcp.a029047; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Lydon J, 1997, WEED SCI, V45, P807, DOI 10.1017/S0043174500089001; NISHIO JN, 1991, PLANT PHYSIOL, V95, P522, DOI 10.1104/pp.95.2.522; Nixon PJ, 2000, PHILOS T R SOC B, V355, P1541, DOI 10.1098/rstb.2000.0714; Papageorgiou GC, 2007, PHOTOSYNTH RES, V94, P275, DOI 10.1007/s11120-007-9193-x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Robert A, 2005, ACS SYM SER, V903, P281; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; SAHA S, 1971, J BIOL CHEM, V246, P3204; SATOH K, 1990, CURRENT RESEARCH IN PHOTOSYNTHESIS, VOLS 1-4, pA583; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 2004, ANAL CHLOROPHYLL FLU, V19, DOI [10.1007/978-1-4020- 3218-9_12, DOI 10.1007/978-1-4020-3218-9_12]; Trebst A, 2007, PHOTOSYNTH RES, V92, P217, DOI 10.1007/s11120-007-9213-x; VANRENSEN JJS, 1989, SOC EXP BIOL SEM SER, V38, P21; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582	34	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38942	10.1371/journal.pone.0038942	http://dx.doi.org/10.1371/journal.pone.0038942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719995	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900066
J	Bilal, E; Vassallo, K; Toppmeyer, D; Barnard, N; Rye, IH; Almendro, V; Russnes, H; Borresen-Dale, AL; Levine, AJ; Bhanot, G; Ganesan, S				Bilal, Erhan; Vassallo, Kristen; Toppmeyer, Deborah; Barnard, Nicola; Rye, Inga H.; Almendro, Vanessa; Russnes, Hege; Borresen-Dale, Anne-Lise; Levine, Arnold J.; Bhanot, Gyan; Ganesan, Shridar			Amplified Loci on Chromosomes 8 and 17 Predict Early Relapse in ER-Positive Breast Cancers	PLOS ONE			English	Article							ENDOCRINE THERAPY RESISTANCE; ESTROGEN-RECEPTOR; MOLECULAR SUBTYPES; GROWTH-FACTOR; BONE-MARROW; CYCLIN D1; EXPRESSION; TAMOXIFEN; AMPLIFICATION; GENES	Adjuvant hormonal therapy is administered to all early stage ER+ breast cancers, and has led to significantly improved survival. Unfortunately, a subset of ER+ breast cancers suffer early relapse despite hormonal therapy. To identify molecular markers associated with early relapse in ER+ breast cancer, an outlier analysis method was applied to a published gene expression dataset of 268 ER+ early-stage breast cancers treated with tamoxifen alone. Increased expression of sets of genes that clustered in chromosomal locations consistent with the presence of amplicons at 8q24.3, 8p11.2, 17q12 (HER2 locus) and 17q21.33-q25.1 were each found to be independent markers for early disease recurrence. Distant metastasis free survival (DMFS) after 10 years for cases with any amplicon (DMFS = 56.1%, 95% CI = 48.3-63.9%) was significantly lower (P = 0.0016) than cases without any of the amplicons (DMFS = 87%, 95% CI = 76.3% -97.7%). The association between presence of chromosomal amplifications in these regions and poor outcome in ER+ breast cancers was independent of histologic grade and was confirmed in independent clinical datasets. A separate validation using a FISH-based assay to detect the amplicons at 8q24.3, 8p11.2, and 17q21.33-q25.1 in a set of 36 early stage ER+/HER2- breast cancers treated with tamoxifen suggests that the presence of these amplicons are indeed predictive of early recurrence. We conclude that these amplicons may serve as prognostic markers of early relapse in ER+ breast cancer, and may identify novel therapeutic targets for poor prognosis ER+ breast cancers.	[Bilal, Erhan; Bhanot, Gyan] State Univ New Jersey, Piscataway, NJ USA; [Toppmeyer, Deborah; Levine, Arnold J.; Bhanot, Gyan; Ganesan, Shridar] Canc Inst New Jersey, New Brunswick, NJ USA; [Vassallo, Kristen; Barnard, Nicola] Robert Wood Johnson Univ Hosp, New Brunswick, NJ USA; [Russnes, Hege; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway; [Almendro, Vanessa; Russnes, Hege] Harvard Univ, Dana Farber Canc Inst, Boston, MA 02115 USA; [Rye, Inga H.; Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Oslo, Norway; [Almendro, Vanessa] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Levine, Arnold J.; Bhanot, Gyan] Inst Adv Study, Princeton, NJ 08540 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Oslo; Harvard University; Dana-Farber Cancer Institute; University of Oslo; University of Barcelona; Hospital Clinic de Barcelona; Institute for Advanced Study - USA	Bilal, E (corresponding author), State Univ New Jersey, Piscataway, NJ USA.	gyanbhanot@gmail.com; ganesash@umdnj.edu	Russnes, Hege Elisabeth Giercksky/N-6170-2015	Russnes, Hege Elisabeth Giercksky/0000-0001-8724-1891	New Jersey Commission on Cancer Research; National Institutes of Health; Norwegian Cancer Association; The Norwegian Research Council; Raagholdt Foundation; Thorsteds Foundation; Radiumhospitalets legater; Cellex Foundation	New Jersey Commission on Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Association; The Norwegian Research Council(Research Council of Norway); Raagholdt Foundation; Thorsteds Foundation; Radiumhospitalets legater; Cellex Foundation(Foundation CELLEX)	EB was supported in part by a grant from the New Jersey Commission on Cancer Research. SG has received support from the National Institutes of Health, and the New Jersey Commission on Cancer Research. HR is funded by the Norwegian Cancer Association, The Norwegian Research Council, Raagholdt Foundation, Thorsteds Foundation and Radiumhospitalets legater. VA is funded by Cellex Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Alexe G, 2006, CANCER INFORM, V2, P243; Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Bautista S, 1998, GENE CHROMOSOME CANC, V22, P268, DOI 10.1002/(SICI)1098-2264(199808)22:4<268::AID-GCC2>3.0.CO;2-T; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cingoz S, 2003, CANCER GENET CYTOGEN, V145, P108, DOI 10.1016/S0165-4608(03)00094-3; Clarke M, 1998, LANCET, V351, P1451; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dalgin GS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-291; De Paepe P, 2003, BLOOD, V102, P2638, DOI 10.1182/blood-2003-04-1050; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Gnant M, 2009, CLIN BREAST CANCER, V9, pS18, DOI 10.3816/CBC.2009.s.002; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Hurvitz SA, 2008, CANCER-AM CANCER SOC, V113, P2385, DOI 10.1002/cncr.23875; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Karlsson E, 2009, CANCER RES, V69, P5166, DOI [10.1158/0008-5472.SABCS-09-5166, DOI 10.1158/0008-5472.SABCS-09-5166]; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Orsetti B, 1999, ONCOGENE, V18, P6262, DOI 10.1038/sj.onc.1203006; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parssinen J, 2007, BRIT J CANCER, V96, P1258, DOI 10.1038/sj.bjc.6603692; Patel AS, 2007, CANCER GENET CYTOGEN, V176, P107, DOI 10.1016/j.cancergencyto.2007.04.004; Rastelli F, 2008, TUMORI J, V94, P370; SINGH L, 1988, BRIT J CANCER, V57, P612, DOI 10.1038/bjc.1988.139; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stec I, 2001, GENOMICS, V76, P5, DOI 10.1006/geno.2001.6581; Streicher KL, 2007, ONCOGENE, V26, P2104, DOI 10.1038/sj.onc.1210002; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009	55	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38575	10.1371/journal.pone.0038575	http://dx.doi.org/10.1371/journal.pone.0038575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719901	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900035
J	Hirai, H; Firpo, M; Kikyo, N				Hirai, Hiroyuki; Firpo, Meri; Kikyo, Nobuaki			Establishment of LIF-Dependent Human iPS Cells Closely Related to Basic FGF-Dependent Authentic iPS Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; X-INACTIVATION; SELF-RENEWAL; PLURIPOTENCY; MOUSE; DERIVATION	Human induced pluripotent stem cells (iPSCs) can be divided into a leukemia inhibitory factor (LIF)-dependent naive type and a basic fibroblast growth factor (bFGF)-dependent primed type. Although the former are more undifferentiated than the latter, they require signal transduction inhibitors and sustained expression of the transgenes used for iPSC production. We used a transcriptionally enhanced version of OCT4 to establish LIF-dependent human iPSCs without the use of inhibitors and sustained transgene expression. These cells belong to the primed type of pluripotent stem cell, similar to bFGF-dependent iPSCs. Thus, the particular cytokine required for iPSC production does not necessarily define stem cell phenotypes as previously thought. It is likely that the bFGF and LIF signaling pathways converge on unidentified OCT4 target genes. These findings suggest that our LIF-dependent human iPSCs could provide a novel model to investigate the role of cytokine signaling in cellular reprogramming.	[Hirai, Hiroyuki; Firpo, Meri; Kikyo, Nobuaki] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Hirai, Hiroyuki; Kikyo, Nobuaki] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA; [Firpo, Meri] Univ Minnesota, Dept Med, Div Endocrinol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hirai, H (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.	kikyo001@umn.edu	Hirai, Hiroyuki/A-6866-2019	Hirai, Hiroyuki/0000-0001-7302-7587	Masonic Cancer Center grant from the U.S. National Institutes of Health [P30 CA077598-09]; Richard M. Schulze Family Foundation; U. S. National Institutes of Health [R01 DK082430]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082430] Funding Source: NIH RePORTER	Masonic Cancer Center grant from the U.S. National Institutes of Health; Richard M. Schulze Family Foundation; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Histological preparation and karyotyping were supported by a Masonic Cancer Center grant from the U.S. National Institutes of Health (P30 CA077598-09). M. F. and N.K were supported by the Richard M. Schulze Family Foundation. N.K. was supported by a grant from the U. S. National Institutes of Health (R01 DK082430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V7, P559, DOI 10.1016/j.stem.2010.10.007; Di Stefano B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016092; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hirai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034149; Hirai H, 2011, STEM CELLS, V29, P1349, DOI 10.1002/stem.684; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Kunath T, 2011, CELL STEM CELL, V8, P241, DOI 10.1016/j.stem.2011.02.009; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	20	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39022	10.1371/journal.pone.0039022	http://dx.doi.org/10.1371/journal.pone.0039022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720020	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900074
J	Koenig, CM; Walker, CK; Qi, LH; Pessah, IN; Berman, RF				Koenig, Claire M.; Walker, Cheryl K.; Qi, Lihong; Pessah, Isaac N.; Berman, Robert F.			Lack of Evidence for Neonatal Misoprostol Neurodevelopmental Toxicity in C57BL6/J Mice	PLOS ONE			English	Article							FETAL VALPROATE SYNDROME; SPECTRUM DISORDERS; LABOR INDUCTION; MOBIUS SEQUENCE; CELL-DEATH; PLUS-MAZE; IN-UTERO; AUTISM; RISK; IMMUNE	Misoprostol is a synthetic analogue of prostaglandin E1 that is administered to women at high doses to induce uterine contractions for early pregnancy termination and at low doses to aid in cervical priming during labor. Because of the known teratogenic effects of misoprostol when given during gestation and its effects on axonal growth in vitro, we examined misoprostol for its potential as a neurodevelopmental toxicant when administered to neonatal C57BL6/J mice. Mice were injected subcutaneously (s.c.) with 0.4, 4 or 40 mu g/kg misoprostol on postnatal day 7, the approximate developmental stage in mice of human birth, after which neonatal somatic growth, and sensory and motor system development were assessed. These doses were selected to span the range of human exposure used to induce labor. In addition, adult mice underwent a battery of behavioral tests relevant to neurodevelopmental disorders such as autism including tests for anxiety, stereotyped behaviors, social communication and interactions, and learning and memory. No significant effects of exposure were found for any measure of development or behavioral endpoints. In conclusion, the results of the present study in C57BL/6J mice do not provide support for neurodevelopmental toxicity after misoprostol administration approximating human doses and timed to coincide with the developmental stage of human birth.	[Koenig, Claire M.; Walker, Cheryl K.; Qi, Lihong; Pessah, Isaac N.; Berman, Robert F.] Univ Calif Davis, Ctr Childrens Environm Hlth, Davis, CA 95616 USA; [Koenig, Claire M.; Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Walker, Cheryl K.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [Qi, Lihong] Univ Calif Davis, Dept Publ Hlth, Div Biostat, Davis, CA 95616 USA; [Pessah, Isaac N.] Univ Calif Davis, Dept VM Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Koenig, CM (corresponding author), Univ Calif Davis, Ctr Childrens Environm Hlth, Davis, CA 95616 USA.	rfberman@ucdavis.edu	Qi, LI/AAF-3389-2019; Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X; Koenig, Claire/0000-0003-2546-4031	National Institute of Environmental Health Sciences (NIEHS) [1 P01 ES11269]; U.S. Environmental Protection Agency (U.S. EPA) through the Science to Achieve Results (STAR) program [R833292, R829388]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, R01ES020392] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Environmental Protection Agency (U.S. EPA) through the Science to Achieve Results (STAR) program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grant number National Institute of Environmental Health Sciences (NIEHS) 1 P01 ES11269, the U.S. Environmental Protection Agency (U.S. EPA) through the Science to Achieve Results (STAR) program award numbers R833292 and R829388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwood Paul, 2004, Clin Dev Immunol, V11, P165, DOI 10.1080/10446670410001722096; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Bandim JM, 2003, ARQ NEURO-PSIQUIAT, V61, P181, DOI 10.1590/S0004-282X2003000200004; Beard CM, 2011, MED HYPOTHESES, V77, P15, DOI 10.1016/j.mehy.2011.03.013; Bell Jericho, 2011, J Miss State Med Assoc, V52, P35; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; BORBE HO, 1990, J NEUR TR S, P131; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Choi EJ, 2008, BRAIN RES BULL, V77, P293, DOI 10.1016/j.brainresbull.2008.06.006; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Curran MP, 2011, PEDIATR DRUGS, V13, P197, DOI 10.2165/11207230-000000000-00000; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Enoch J, 1999, Midwifery Today Int Midwife, P22; Evatt ML, 2009, NEUROLOGY, V73, P997, DOI 10.1212/WNL.0b013e3181af0b95; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gillberg C, 1999, ACTA PSYCHIAT SCAND, V99, P399, DOI 10.1111/j.1600-0447.1999.tb00984.x; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Hallmayer J., 2011, ARCH GEN PSYCHIAT; HAYNES DR, 1992, IMMUNOLOGY, V76, P251; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hultman CM, 2010, MOL PSYCHIAT; Irvine EE, 2001, PHARMACOL BIOCHEM BE, V68, P319, DOI 10.1016/S0091-3057(00)00449-4; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Johansson M, 2001, DEV MED CHILD NEUROL, V43, P338, DOI 10.1017/S0012162201000627; Kovacs Z, 2011, J NEUROSCI METH, V197, P133, DOI 10.1016/j.jneumeth.2011.02.005; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Larson SJ, 2002, J GEN PSYCHOL, V129, P401, DOI 10.1080/00221300209602104; Lawler CP, 2004, MENT RETARD DEV D R, V10, P292, DOI 10.1002/mrdd.20043; LePage Keith T., 2005, Critical Reviews in Neurobiology, V17, P27; Li J, 2008, NEUROSCI LETT, V438, P210, DOI 10.1016/j.neulet.2008.04.054; LIM SP, 1994, DIGEST DIS SCI, V39, P1249; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McGovern V, 2007, ENVIRON HEALTH PERSP, V115, pA504, DOI 10.1289/ehp.115-a504a; Mehler MF, 1999, ADV PROTEIN CHEM, V52, P223; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Miller MT, 2009, BIRTH DEFECTS RES A, V85, P667, DOI 10.1002/bdra.20609; MILLER RC, 1994, RADIAT RES, V139, P109, DOI 10.2307/3578740; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nuthalapaty FS, 2005, AM J OBSTET GYNECOL, V193, P1065, DOI 10.1016/j.ajog.2005.05.087; Parker Charles W., 1995, Am J Ther, V2, P772, DOI 10.1097/00045391-199510000-00007; Paxinos G., 2001, MOUSE BRAIN STEROTAX; Pessah IN, 2008, NEUROTOXICOLOGY, V29, P532, DOI 10.1016/j.neuro.2008.02.006; Pottie K, 1999, CAN FAM PHYSICIAN, V45, P315; Reichenberg A, 2010, AM J PUBLIC HEALTH, V100, P772, DOI 10.2105/AJPH.2009.187708; Rice C, 2010, DISABIL HEALTH J, V3, P186, DOI 10.1016/j.dhjo.2009.10.008; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rus V., 1995, Am J Ther, V2, P911, DOI 10.1097/00045391-199512000-00002; Schmidt RJ, 2011, EPIDEMIOLOGY, V22, P476, DOI 10.1097/EDE.0b013e31821d0e30; SHIELD MJ, 1992, SCAND J RHEUMATOL, P31; Silverstein FE, 1998, DIGEST DIS SCI, V43, P447, DOI 10.1023/A:1018895417831; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stromland Kerstin, 2002, Eur J Paediatr Neurol, V6, P35, DOI 10.1053/ejpn.2001.0540; Sullivan KM, 2008, ENVIRON HEALTH PERSP, V116, pA155, DOI [10.1289/elip.11010, 10.1289/ehp.11010]; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tamiji J, 2010, BIOCHEM BIOPH RES CO, V399, P565, DOI 10.1016/j.bbrc.2010.07.112; Tamiji J, 2010, BIOCHEM BIOPH RES CO, V398, P450, DOI 10.1016/j.bbrc.2010.06.098; Taniguchi H, 2011, NEUROSCI LETT, V504, P185, DOI 10.1016/j.neulet.2011.09.005; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; WAHLSTEN D, 1974, BRAIN RES, V72, P251, DOI 10.1016/0006-8993(74)90863-4; Walker CKKP, 2008, 7 ANN INT M AUT RES; WALSH TJ, 1988, TOXICOLOGY, V49, P137, DOI 10.1016/0300-483X(88)90185-0; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Williams PG, 1997, DEV MED CHILD NEUROL, V39, P632; Wing DA, 1999, AM J OBSTET GYNECOL, V181, P339, DOI 10.1016/S0002-9378(99)70558-2; Wing DA, 2008, J REPROD MED, V53, P695; Witter FR, 2011, AM J OBSTET GYNECOL; Wong Vincent W S, 2005, ACP J Club, V142, P75; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]	77	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38911	10.1371/journal.pone.0038911	http://dx.doi.org/10.1371/journal.pone.0038911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719983	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341900063
J	Weeks, BK; Beck, BR				Weeks, Benjamin K.; Beck, Belinda R.			Are Bone and Muscle Changes from POWER PE, an 8-month In-school Jumping Intervention, Maintained at Three Years?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; EXERCISE INTERVENTION; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; MASS; HEALTH; GIRLS; HIP; CHILDREN; MEN	Our aim was to determine if the musculoskeletal benefits of a twice-weekly, school-based, jumping regime in healthy adolescent boys and girls were maintained three years later. Subjects of the original POWER PE trial (n = 99) were contacted and asked to undergo retesting three years after cessation of the intervention. All original measures were completed including: sitting height, standing height, weight, calcaneal broadband ultrasound attenuation (BUA), whole body, hip and spine bone mineral content (BMC), lean tissue mass, and fat mass. Physical activity was recorded with the bone-specific physical activity questionnaire (BPAQ) and calcium intake was estimated with a calcium-focussed food questionnaire. Maturity was determined by Tanner staging and estimation of the age of peak height velocity (PHV). Twenty-nine adolescents aged 17.3+/-0.4 years agreed to participate. Three years after the intervention, there were no differences in subject characteristics between control and intervention groups (p>0.05). Three-year change in weight, lean mass, and fat mass were similar between groups (p>0.05). There were no significant group differences in three-year change in BUA or BMC at any site (p>0.05), although the between-group difference in femoral neck BMC at follow-up exceeded the least significant change. While significant group differences were not observed three years after cessation of the intervention, changes in bone parameters occurred in parallel for intervention and control groups such that the original benefits of the intervention observed within the treatment group were sustained.	[Weeks, Benjamin K.; Beck, Belinda R.] Griffith Univ, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia	Griffith University	Weeks, BK (corresponding author), Griffith Univ, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia.	b.weeks@griffith.edu.au	Beck, Belinda/B-9079-2008; Weeks, Benjamin K/B-9322-2008	Beck, Belinda/0000-0003-1295-6395; Weeks, Benjamin K/0000-0001-7335-6911	Arthritis Australia	Arthritis Australia	The study was supported by an Arthritis Australia Grant-in-Aid (www.arthritisaustralia.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Beck BR., 2010, J BONE MINER RES, V25, pS306; Binkley T, 2004, BONE, V35, P1383, DOI 10.1016/j.bone.2004.08.012; Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148; Fuchs RK, 2002, J PEDIATR-US, V141, P357, DOI 10.1067/mpd.2002.127275; Gunter K, 2008, BONE, V42, P710, DOI 10.1016/j.bone.2008.01.002; Heinonen A, 2000, OSTEOPOROSIS INT, V11, P1010, DOI 10.1007/s001980070021; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Katzmarzyk PT, 2006, DIABETES CARE, V29, P404, DOI 10.2337/diacare.29.02.06.dc05-1636; Kontulainen SA, 2002, INT J SPORTS MED, V23, P575, DOI 10.1055/s-2002-35543; MacKelvie KJ, 2003, PEDIATRICS, V112, pE447, DOI 10.1542/peds.112.6.e447; McKay HA, 2005, BRIT J SPORT MED, V39, P521, DOI 10.1136/bjsm.2004.014266; McVey K., 2006, ONLINE CALCIUM INFOR; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Morris FL, 1997, J BONE MINER RES, V12, P1453, DOI 10.1359/jbmr.1997.12.9.1453; Reijman M, 2007, ANN RHEUM DIS, V66, P158, DOI 10.1136/ard.2006.053538; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Stear SJ, 2003, AM J CLIN NUTR, V77, P985, DOI 10.1093/ajcn/77.4.985; Van Langendonck L, 2003, AM J EPIDEMIOL, V158, P525, DOI 10.1093/aje/kwg170; Weeks BK, 2008, OSTEOPOROSIS INT, V19, P1567, DOI 10.1007/s00198-008-0606-2; Weeks B. K., 2011, Gazzetta Medica Italiana Archivio per le Scienze Mediche, V170, P229; Weeks B, 2011, SALUD CIENC, V18, P538; Weeks BK, 2008, J BONE MINER RES, V23, P1002, DOI 10.1359/JBMR.080226; Weeks BK, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/546593; Weeks BK, 2012, PEDIAT OBES IN PRESS, DOI [10.1111/j.2047-6310.1120, DOI 10.1111/J.2047-6310.1120]; Witzke KA, 2000, MED SCI SPORT EXER, V32, P1051, DOI 10.1097/00005768-200006000-00003	26	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39133	10.1371/journal.pone.0039133	http://dx.doi.org/10.1371/journal.pone.0039133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720051	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900085
J	Pena, C; Malm, T				Pena, Carlos; Malm, Tobias			VoSeq: A Voucher and DNA Sequence Web Application	PLOS ONE			English	Article								There is an ever growing number of molecular phylogenetic studies published, due to, in part, the advent of new techniques that allow cheap and quick DNA sequencing. Hence, the demand for relational databases with which to manage and annotate the amassing DNA sequences, genes, voucher specimens and associated biological data is increasing. In addition, a user-friendly interface is necessary for easy integration and management of the data stored in the database back-end. Available databases allow management of a wide variety of biological data. However, most database systems are not specifically constructed with the aim of being an organizational tool for researchers working in phylogenetic inference. We here report a new software facilitating easy management of voucher and sequence data, consisting of a relational database as back-end for a graphic user interface accessed via a web browser. The application, VoSeq, includes tools for creating molecular datasets of DNA or amino acid sequences ready to be used in commonly used phylogenetic software such as RAxML, TNT, MrBayes and PAUP, as well as for creating tables ready for publishing. It also has inbuilt BLAST capabilities against all DNA sequences stored in VoSeq as well as sequences in NCBI GenBank. By using mash-ups and calls to web services, VoSeq allows easy integration with public services such as Yahoo! Maps, Flickr, Encyclopedia of Life (EOL) and GBIF (by generating data-dumps that can be processed with GBIF's Integrated Publishing Toolkit).	[Pena, Carlos] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Malm, Tobias] Univ Eastern Finland, Dept Biol, Joensuu, Finland	University of Turku; University of Eastern Finland	Pena, C (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	carlos.pena@utu.fi	Peña, Carlos/A-1270-2009	Peña, Carlos/0000-0002-3766-0489	Kone Foundation, Finland	Kone Foundation, Finland	This work was supported by a grant from the Kone Foundation, Finland to Niklas Wahlberg and Tommi Nyman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DNA SEQ SUBM UPD TOO; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goloboff P, 2008, CLADISTICS, V24, P91; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Page RDM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-187; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith VS, 2011, ZOOKEYS, P53, DOI 10.3897/zookeys.150.2193; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642	12	141	142	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39071	10.1371/journal.pone.0039071	http://dx.doi.org/10.1371/journal.pone.0039071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720030	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000064
J	Stratton, P; Cheung, A; Wiles, J; Kiyatkin, E; Sah, P; Windels, F				Stratton, Peter; Cheung, Allen; Wiles, Janet; Kiyatkin, Eugene; Sah, Pankaj; Windels, Francois			Action Potential Waveform Variability Limits Multi-Unit Separation in Freely Behaving Rats	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; UNRESTRAINED RATS; CORTICAL-NEURONS; BASAL GANGLIA; TOTAL NUMBER; IN-VIVO; RECORDINGS; CORTEX; CAT	Extracellular multi-unit recording is a widely used technique to study spontaneous and evoked neuronal activity in awake behaving animals. These recordings are done using either single-wire or mulitwire electrodes such as tetrodes. In this study we have tested the ability of single-wire electrodes to discriminate activity from multiple neurons under conditions of varying noise and neuronal cell density. Using extracellular single-unit recording, coupled with iontophoresis to drive cell activity across a wide dynamic range, we studied spike waveform variability, and explored systematic differences in single-unit spike waveform within and between brain regions as well as the influence of signal-to-noise ratio (SNR) on the similarity of spike waveforms. We also modelled spike misclassification for a range of cell densities based on neuronal recordings obtained at different SNRs. Modelling predictions were confirmed by classifying spike waveforms from multiple cells with various SNRs using a leading commercial spike-sorting system. Our results show that for single-wire recordings, multiple units can only be reliably distinguished under conditions of high recording SNR (>= 4) and low neuronal density (approximate to 20,000/mm(3)). Physiological and behavioural changes, as well as technical limitations typical of awake animal preparations, reduce the accuracy of single-channel spike classification, resulting in serious classification errors. For SNR <4, the probability of misclassifying spikes approaches 100% in many cases. Our results suggest that in studies where the SNR is low or neuronal density is high, separation of distinct units needs to be evaluated with great caution.	[Stratton, Peter; Cheung, Allen; Sah, Pankaj; Windels, Francois] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Stratton, Peter; Wiles, Janet] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia; [Kiyatkin, Eugene] NIA, Behav Neurosci Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD 21224 USA	University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stratton, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.windels@uq.edu.au	Windels, Francois/G-5432-2010; Cheung, Allen/C-8305-2009; Sah, Pankaj/C-8175-2009; Wiles, Janet/C-1989-2008	Cheung, Allen/0000-0001-9770-217X; Stratton, Peter/0000-0002-3312-7505; Wiles, Janet/0000-0002-4051-4116; Windels, Francois/0000-0001-5341-2197; Kiyatkin, Eugene A./0000-0002-3744-0873; Sah, Pankaj/0000-0001-5063-1589	National Health and Medical Research Council (NHMRC); thinking system ARC grant	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); thinking system ARC grant	This work was funded by the National Health and Medical Research Council (NHMRC) (http://www.nhmrc.gov.au/) and a thinking system ARC grant (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURQUE CW, 1985, J PHYSIOL-LONDON, V363, P429, DOI 10.1113/jphysiol.1985.sp015720; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cromwell HC, 2005, BRAIN RES, V1043, P12, DOI 10.1016/j.brainres.2005.01.106; CUCCHIARO JB, 1991, NEUROSCIENCE, V41, P213, DOI 10.1016/0306-4522(91)90211-6; de Polavieja GG, 2005, J NEUROSCI, V25, P5657, DOI 10.1523/JNEUROSCI.0242-05.2005; Fee MS, 1996, J NEUROPHYSIOL, V76, P3823, DOI 10.1152/jn.1996.76.6.3823; Gentet LJ, 2007, J NEUROSCI, V27, P1892, DOI 10.1523/JNEUROSCI.5234-06.2007; Girardin CC, 2009, NEUROSCIENCE, V164, P777, DOI 10.1016/j.neuroscience.2009.07.064; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GROFOVA I, 1982, J COMP NEUROL, V208, P352, DOI 10.1002/cne.902080406; Guatteo E, 2005, J NEUROPHYSIOL, V94, P3069, DOI 10.1152/jn.00066.2005; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Humphrey DR, 1990, NEUROPHYSIOLOGICAL T, P1, DOI [10.1385/0-89603-185-3:1, DOI 10.1385/0-89603-185-3:1]; Karlsen AS, 2011, CEREB CORTEX, V21, P2519, DOI 10.1093/cercor/bhr033; Kiyatkin EA, 2010, FRONT BIOSCI-LANDMRK, V15, P73, DOI 10.2741/3608; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mechler F, 2012, J COMPUT NEUROSCI, V32, P73, DOI 10.1007/s10827-011-0341-0; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; OTTERSEN OP, 1984, ANAT EMBRYOL, V170, P197, DOI 10.1007/BF00319005; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; RALL WILFRID, 1962, BIOPHYS JOUR, V2, P145; REBEC GV, 1993, J NEUROSCI METH, V47, P53, DOI 10.1016/0165-0270(93)90021-I; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; TERZUOLO CA, 1961, ANN NY ACAD SCI, V94, P547, DOI 10.1111/j.1749-6632.1961.tb35558.x; THOMPSON SM, 1985, J NEUROSCI, V5, P817; TOWE AL, 1970, EXP NEUROL, V29, P366, DOI 10.1016/0014-4886(70)90065-8; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Windels F, 2003, EUR J NEUROSCI, V17, P613, DOI 10.1046/j.1460-9568.2003.02492.x; Windels F, 2004, J NEUROSCI, V24, P6751, DOI 10.1523/JNEUROSCI.1528-04.2004; Windels F, 2006, BRAIN RES, V1086, P104, DOI 10.1016/j.brainres.2006.02.064; YEDLIN M, 1974, EXP NEUROL, V43, P555, DOI 10.1016/0014-4886(74)90195-2; Zhang R, 2006, J ANAT, V208, P577, DOI 10.1111/j.1469-7580.2006.00573.x	39	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38482	10.1371/journal.pone.0038482	http://dx.doi.org/10.1371/journal.pone.0038482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719894	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000024
J	van Bochove, K; van Schalkwijk, DB; Parnell, LD; Lai, CQ; Ordovas, JM; de Graaf, AA; van Ommen, B; Arnett, DK				van Bochove, Kees; van Schalkwijk, Daniel B.; Parnell, Laurence D.; Lai, Chao-Qiang; Ordovas, Jose M.; de Graaf, Albert A.; van Ommen, Ben; Arnett, Donna K.			Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HDL-CHOLESTEROL; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; ARTERY-DISEASE; RISK; MEN; LDL; TRIGLYCERIDE; GEMFIBROZIL	Fibrates lower triglycerides and raise HDL cholesterol in dyslipidemic patients, but show heterogeneous treatment response. We used k-means clustering to identify three representative NMR lipoprotein profiles for 775 subjects from the GOLDN population, and study the response to fenofibrate in corresponding subgroups. The subjects in each subgroup showed differences in conventional lipid characteristics and in presence/absence of cardiovascular risk factors at baseline; there were subgroups with a low, medium and high degree of dyslipidemia. Modeling analysis suggests that the difference between the subgroups with low and medium dyslipidemia is influenced mainly by hepatic uptake dysfunction, while the difference between subgroups with medium and high dyslipidemia is influenced mainly by extrahepatic lipolysis disfunction. The medium and high dyslipidemia subgroups showed a positive, yet distinct lipid response to fenofibrate treatment. When comparing our subgroups to known subgrouping methods, we identified an additional 33% of the population with favorable lipid response to fenofibrate compared to a standard baseline triglyceride cutoff method. Compared to a standard HDL cholesterol cutoff method, the addition was 18%. In conclusion, by using constructing subgroups based on representative lipoprotein profiles, we have identified two subgroups of subjects with positive lipid response to fenofibrate therapy and with different underlying disturbances in lipoprotein metabolism. The total subgroup with positive lipid response to fenofibrate is larger than subgroups identified with baseline triglyceride and HDL cholesterol cutoffs.	[van Bochove, Kees; van Schalkwijk, Daniel B.; de Graaf, Albert A.; van Ommen, Ben] TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands; [van Bochove, Kees; van Schalkwijk, Daniel B.; de Graaf, Albert A.; van Ommen, Ben] TNO, Dept Microbiol & Syst Biol, Leiden, Netherlands; [van Schalkwijk, Daniel B.] Leiden Amsterdam Ctr Drug Res, Analyt Sci Div, Leiden, Netherlands; [van Schalkwijk, Daniel B.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Parnell, Laurence D.; Lai, Chao-Qiang; Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC; Tufts University; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham	van Bochove, K (corresponding author), TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands.	daan.vanschalkwijk@tno.nl	; Ordovas, Jose/B-8727-2013	Lai, Chao-Qiang/0000-0003-1107-8375; van Bochove, Kees/0000-0002-8589-0609; de Graaf, Albert/0000-0002-1067-3570; Ordovas, Jose/0000-0002-7581-5680	NIH Heart, Lung and Blood Institute [U01HL72524]; European Nutrigenomics Organisation [DS08-008]; Netherlands Bioinformatics Centre, Biorange project [SP3.3.1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Nutrigenomics Organisation; Netherlands Bioinformatics Centre, Biorange project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH Heart, Lung and Blood Institute grant U01HL72524, Genetic and Environmental Determinants of Triglycerides. KvB was supported by the European Nutrigenomics Organisation exchange grant DS08-008. DBvS was supported by The Netherlands Bioinformatics Centre, Biorange project SP3.3.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; Bruckert E, 2011, J CARDIOVASC PHARM, V57, P267, DOI 10.1097/FJC.0b013e318202709f; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Elam M, 2011, CURR OPIN LIPIDOL, V22, P55, DOI 10.1097/MOL.0b013e328341a5a8; Freedman DS, 2004, CLIN CHEM, V50, P1189, DOI 10.1373/clinchem.2004.032763; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2007, AM J CARDIOL, V99, p56I, DOI 10.1016/j.amjcard.2007.03.024; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meade T, 2002, BRIT MED J, V325, P1139, DOI 10.1136/bmj.325.7373.1139; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; Otvos James D, 2002, Clin Lab, V48, P171; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Otvos JD, 2002, AM J CARDIOL, V90, p22I; Packard CJ, 2000, J LIPID RES, V41, P305; Robins SJ, 2003, DIABETES CARE, V26, P1513, DOI 10.2337/diacare.26.5.1513; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Scott R, 2007, CIRCULATION, V116, P838; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Steiner G, 2001, LANCET, V357, P905; Usui S, 2002, J LIPID RES, V43, P805; van Schalkwijk Daniel B, 2011, J Clin Bioinforma, V1, P29, DOI 10.1186/2043-9113-1-29; van Schalkwijk DB, 2010, BRIEF BIOINFORM, V11, P403, DOI 10.1093/bib/bbp071; van Schalkwijk DB, 2009, J LIPID RES, V50, P2398, DOI 10.1194/jlr.M800354-JLR200; Wierzbicki AS, 2010, CURR OPIN LIPIDOL, V21, P352, DOI 10.1097/MOL.0b013e32833c1e74; Wierzbicki AS, 2006, INT J CLIN PRACT, V60, P442, DOI 10.1111/j.1368-5031.2006.00882.x; Zeljkovic A, 2008, CLIN EXP MED, V8, P109, DOI 10.1007/s10238-008-0165-z	38	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38072	10.1371/journal.pone.0038072	http://dx.doi.org/10.1371/journal.pone.0038072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719863	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340000010
J	Jaager, K; Islam, S; Zajac, P; Linnarsson, S; Neuman, T				Jaeaeger, Kersti; Islam, Saiful; Zajac, Pawel; Linnarsson, Sten; Neuman, Toomas			RNA-Seq Analysis Reveals Different Dynamics of Differentiation of Human Dermis- and Adipose-Derived Stromal Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; BONE-MARROW; FIBROBLASTS EXHIBIT; CORD BLOOD; TISSUE; SKIN; IDENTIFICATION; PROFILE; LINES	Background: Tissue regeneration and recovery in the adult body depends on self-renewal and differentiation of stem and progenitor cells. Mesenchymal stem cells (MSCs) that have the ability to differentiate into various cell types, have been isolated from the stromal fraction of virtually all tissues. However, little is known about the true identity of MSCs. MSC populations exhibit great tissue-, location-and patient-specific variation in gene expression and are heterogeneous in cell composition. Methodology/Principal Findings: Our aim was to analyze the dynamics of differentiation of two closely related stromal cell types, adipose tissue-derived MSCs (AdMSCs) and dermal fibroblasts (FBs) along adipogenic, osteogenic and chondrogenic lineages using multiplex RNA-seq technology. We found that undifferentiated donor-matched AdMSCs and FBs are distinct populations that stay different upon differentiation into adipocytes, osteoblasts and chondrocytes. The changes in lineage-specific gene expression occur early in differentiation and persist over time in both AdMSCs and FBs. Further, AdMSCs and FBs exhibit similar dynamics of adipogenic and osteogenic differentiation but different dynamics of chondrogenic differentiation. Conclusions/Significance: Our findings suggest that stromal stem cells including AdMSCs and dermal FBs exploit different molecular mechanisms of differentiation to reach a common cell fate. The early mechanisms of differentiation are lineage-specific and are similar for adipogenic and osteogenic differentiation but are distinct for chondrogenic differentiation between AdMSCs and FBs.	[Jaeaeger, Kersti; Neuman, Toomas] Tallinn Univ Technol, Inst Gene Technol, Tallinn, Estonia; [Jaeaeger, Kersti] Cellin Technol LLC, Tallinn, Estonia; [Islam, Saiful; Zajac, Pawel; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Neuman, Toomas] Protobios LLC, Tallinn, Estonia	Tallinn University of Technology; Karolinska Institutet; Protobios LLC	Jaager, K (corresponding author), Tallinn Univ Technol, Inst Gene Technol, Tallinn, Estonia.	kersti.jaager@cellintechnologies.com	Linnarsson, Sten/HCH-3909-2022; Jaager, Kersti/G-2786-2017	Jaager, Kersti/0000-0002-0503-9292				Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hanson SE, 2010, LARYNGOSCOPE, V120, P546, DOI 10.1002/lary.20797; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaager K, 2011, STEM CELLS DEV, V20, P1327, DOI 10.1089/scd.2010.0258; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuklick L, 2002, BLOOD, V100, p167B; Lin TM, 2007, BIOCHEM BIOPH RES CO, V361, P883, DOI 10.1016/j.bbrc.2007.07.116; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Song L, 2006, STEM CELLS, V24, P1707, DOI 10.1634/stemcells.2005-0604; Takashima A, 2001, Curr Protoc Cell Biol, VChapter 2, DOI 10.1002/0471143030.cb0201s00; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	32	41	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38833	10.1371/journal.pone.0038833	http://dx.doi.org/10.1371/journal.pone.0038833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723894	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700033
J	Xu, DZ; Huang, Y; Geng, QR; Guan, YX; Li, YF; Wang, W; Yuan, SQ; Sun, XW; Chen, YB; Li, W; Zhou, ZW; Zhan, YQ				Xu, Dazhi; Huang, Ying; Geng, Qirong; Guan, Yuanxiang; Li, Yuanfang; Wang, Wei; Yuan, Shuqiang; Sun, Xiaowei; Chen, Yingbo; Li, Wei; Zhou, Zhiwei; Zhan, Youqing			Effect of Lymph Node Number on Survival of Patients with Lymph Node-Negative Gastric Cancer according to the 7th Edition UICC TNM System	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; SINGLE-INSTITUTION; STAGING SYSTEM; RESECTION; MICROMETASTASIS; ADENOCARCINOMA; CLASSIFICATION; DISPARITIES; STATISTICS; DISSECTION	Background: For the patients with node-negative gastric cancer, the 7th edition classification does not define the minimum number of lymph nodes necessary. We aimed to explore the prognostic significance of examined lymph nodes and determine how many nodes must be examined. Methodology/Principal Findings: 435 patients underwent D2 gastrectomy with node-negative gastric cancer between December 1992 and December 2006 were obtained. Patients were classified into 4 groups by the number of negative LNs examined during surgery (1-6LNs, 7-10 LNs, 11-15 LNs, and >= 16 LNs). Stratified and Cox regression analyses were used to evaluate the association between survival and the number of negative LNs. Survival was significantly better in the >= 16 LNs, compared with the 1-5 LNs, 6-10 LNs and 11-15 LNs group in T2-4 patients; Multivariate analysis demonstrated tumor size, depth of invasion, 7th UICC stage and the number of examined nodes are strongly independent predictors of survival. Conclusions: This study first demonstrates that patients with lymph node-negative gastric cancer underwent D2 dissection should have at least 16 LNs examined, especially in advanced gastric cancer. These results are a reasonable supplement to our previous tumor-ratio-metastasis staging system and a stratification criterion in clinical pratice.	[Xu, Dazhi; Huang, Ying; Geng, Qirong; Guan, Yuanxiang; Li, Yuanfang; Wang, Wei; Yuan, Shuqiang; Sun, Xiaowei; Chen, Yingbo; Li, Wei; Zhou, Zhiwei; Zhan, Youqing] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Xu, Dazhi; Guan, Yuanxiang; Li, Yuanfang; Wang, Wei; Yuan, Shuqiang; Sun, Xiaowei; Chen, Yingbo; Li, Wei; Zhou, Zhiwei; Zhan, Youqing] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Ying] Sun Yat Sen Univ, Dept Radiotherapy, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Geng, Qirong] Sun Yat Sen Univ, Dept Hematol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xu, DZ (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	xudzh@sysucc.org.cn; zhanyq@sysucc.org.cn	Li, Yuan/GXV-1310-2022		Science and Technology Projects of Guangdong Province [2010B031600071]	Science and Technology Projects of Guangdong Province	This work was supported by Science and Technology Projects of Guangdong Province [Grant number 2010B031600071]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiocchi GL, 2010, ANN SURG, V252, P70, DOI 10.1097/SLA.0b013e3181e4585e; Bouvier AM, 2002, CANCER, V94, P2862, DOI 10.1002/cncr.10550; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Estes NC, 1998, AM SURGEON, V64, P680; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Grambsch PM, 1995, BIOMETRICS, V51, P1469, DOI 10.2307/2533277; Greenstein AJ, 2008, CANCER-AM CANCER SOC, V112, P1239, DOI 10.1002/cncr.23309; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Huang BJ, 2009, ANN SURG ONCOL, V16, P61, DOI 10.1245/s10434-008-0193-7; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KAJITANI T, 1981, JPN J SURG, V11, P127; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kasakura Y, 2002, J SURG RES, V103, P252, DOI 10.1006/jsre.2002.6368; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; Kim JH, 2008, J SURG ONCOL, V97, P125, DOI 10.1002/jso.20937; Kooby DA, 2003, ANN SURG, V237, P828, DOI 10.1097/00000658-200306000-00011; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Namikawa T, 2010, J GASTROINTEST SURG, V14, P52, DOI 10.1007/s11605-009-1059-4; Noda N, 1998, BRIT J SURG, V85, P831; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Roviello F, 2006, J SURG ONCOL, V94, P275, DOI 10.1002/jso.20566; Saito H, 2010, J SURG ONCOL, V101, P622, DOI 10.1002/jso.21562; Siewert J Rudiger, 2005, Gastric Cancer, V8, P59, DOI 10.1007/s10120-005-0323-x; Sobin LH., 2010, TNM CLASSIFICATION M; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716; Wijnhoven BPL, 2007, ANN SURG, V245, P717, DOI 10.1097/01.sla.0000251703.35919.02; Wong SL, 2007, JAMA-J AM MED ASSOC, V298, P2149, DOI 10.1001/jama.298.18.2149; Wu ZY, 2007, WORLD J GASTROENTERO, V13, P4122, DOI 10.3748/wjg.v13.i30.4122; Xu DZ, 2010, ANN SURG ONCOL, V17, P659, DOI 10.1245/s10434-009-0793-x; Xu DZ, 2009, ANN SURG ONCOL, V16, P319, DOI 10.1245/s10434-008-0240-4; Yang HX, 2010, ANN SURG ONCOL, V17, P1901, DOI 10.1245/s10434-010-0948-9; Yasuda K, 2002, ANN SURG ONCOL, V9, P771, DOI 10.1245/ASO.2002.01.001	35	42	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38681	10.1371/journal.pone.0038681	http://dx.doi.org/10.1371/journal.pone.0038681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723875	gold, Green Submitted, Green Published			2022-12-27	WOS:000305652700020
J	Fonollosa, J; Gutierrez-Galvez, A; Marco, S				Fonollosa, Jordi; Gutierrez-Galvez, Agustin; Marco, Santiago			Quality Coding by Neural Populations in the Early Olfactory Pathway: Analysis Using Information Theory and Lessons for Artificial Olfactory Systems	PLOS ONE			English	Article							ODORANT RECEPTORS; GLOMERULAR LAYER; RESPONSES; CELLS; NEURONS; ARRAYS; CODES; MAP	In this article, we analyze the ability of the early olfactory system to detect and discriminate different odors by means of information theory measurements applied to olfactory bulb activity images. We have studied the role that the diversity and number of receptor neuron types play in encoding chemical information. Our results show that the olfactory receptors of the biological system are low correlated and present good coverage of the input space. The coding capacity of ensembles of olfactory receptors with the same receptive range is maximized when the receptors cover half of the odor input space -a configuration that corresponds to receptors that are not particularly selective. However, the ensemble's performance slightly increases when mixing uncorrelated receptors of different receptive ranges. Our results confirm that the low correlation between sensors could be more significant than the sensor selectivity for general purpose chemo-sensory systems, whether these are biological or biomimetic.	[Fonollosa, Jordi; Gutierrez-Galvez, Agustin; Marco, Santiago] Univ Barcelona, Dept Elect, Barcelona, Spain; [Fonollosa, Jordi; Gutierrez-Galvez, Agustin; Marco, Santiago] Inst Bioengn Catalonia, Artificial Olfact Grp, Barcelona, Spain	University of Barcelona; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya	Fonollosa, J (corresponding author), Univ Barcelona, Dept Elect, Barcelona, Spain.	smarco@ibecbarcelona.eu	Fonollosa, Jordi/L-2303-2014; marco, santiago/A-6111-2009; Fonollosa, Jordi/AAF-5152-2019; marco, santiago/H-3203-2019	Fonollosa, Jordi/0000-0001-8854-8588; marco, santiago/0000-0003-2663-2965; Fonollosa, Jordi/0000-0001-8854-8588; marco, santiago/0000-0003-2663-2965	European Project NEUROCHEM [FP7-216916]; Spanish project SMART-IMS [TEC2011-26143]; Spanish project BIOENCODE [TEC2011-26988]; Generalitat de Catalunya [2009SGR-0753]	European Project NEUROCHEM; Spanish project SMART-IMS; Spanish project BIOENCODE; Generalitat de Catalunya(Generalitat de Catalunya)	The authors are members of a consolidated research group by the Generalitat de Catalunya (2009SGR-0753). This work has been partially funded by European Project NEUROCHEM: Biologically Inspired Computation for Chemical Sensing (FP7-216916), and Spanish projects SMART-IMS (TEC2011-26143) and BIOENCODE (TEC2011-26988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkasab TK, 2002, CHEM SENSES, V27, P261, DOI 10.1093/chemse/27.3.261; Alkasab TK, 1999, TRENDS NEUROSCI, V22, P102, DOI 10.1016/S0166-2236(98)01351-4; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Beccherelli R, 2010, SENSOR ACTUAT B-CHEM, V146, P446, DOI 10.1016/j.snb.2009.11.031; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Di Natale C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003139; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Fonollosa J, 2011, PROCEDIA COMPUT SCI, V7, P226, DOI 10.1016/j.procs.2011.09.066; GARDNER JW, 1994, SENSOR ACTUAT B-CHEM, V18, P211; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Haddad R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040018; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hamana H, 2003, CHEM SENSES, V28, P87, DOI 10.1093/chemse/28.2.87; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Johnson BA, 1999, J COMP NEUROL, V409, P529; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kostal L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000053; Kraskov A, 2004, PHYS REV E, V69; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; Leon M, 2009, CELL MOL LIFE SCI, V66, P2135, DOI 10.1007/s00018-009-0011-9; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Moddemeijer R, 1999, SIGNAL PROCESS, V75, P51, DOI 10.1016/S0165-1684(98)00224-2; Mori K, 2003, BIOCHEM SOC T, V31, P134, DOI 10.1042/bst0310134; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Reisert J, 2009, CHEM SENSES, V34, P535, DOI 10.1093/chemse/bjp028; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanchez-Montanes MA, 2002, BIOSYSTEMS, V67, P229, DOI 10.1016/S0303-2647(02)00081-3; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Ulmer H, 2000, SENSOR ACTUAT B-CHEM, V65, P79, DOI 10.1016/S0925-4005(99)00330-5; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; ZEKI S, 1983, NEUROSCIENCE, V9, P741, DOI 10.1016/0306-4522(83)90265-8; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	45	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37809	10.1371/journal.pone.0037809	http://dx.doi.org/10.1371/journal.pone.0037809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719851	gold, Green Published			2022-12-27	WOS:000305583300013
J	Pellegrin, S; Heesom, KJ; Satchwell, TJ; Hawley, BR; Daniels, G; van den Akker, E; Toye, AM				Pellegrin, Stephanie; Heesom, Kate J.; Satchwell, Timothy J.; Hawley, Bethan R.; Daniels, Geoff; van den Akker, Emile; Toye, Ashley M.			Differential Proteomic Analysis of Human Erythroblasts Undergoing Apoptosis Induced by Epo-Withdrawal	PLOS ONE			English	Article							GROWTH-FACTOR WITHDRAWAL; ERYTHROID PROGENITOR CELLS; HEAT-SHOCK PROTEINS; ERYTHROPOIETIN RECEPTOR; JURKAT CELLS; CLEAVAGE; KINASE; PHOSPHORYLATION; ACTIVATION; PATHWAY	The availability of Erythropoietin (Epo) is essential for the survival of erythroid progenitors. Here we study the effects of Epo removal on primary human erythroblasts grown from peripheral blood CD34(+) cells. The erythroblasts died rapidly from apoptosis, even in the presence of SCF, and within 24 hours of Epo withdrawal 60% of the cells were Annexin V positive. Other classical hallmarks of apoptosis were also observed, including cytochrome c release into the cytosol, loss of mitochondrial membrane potential, Bax translocation to the mitochondria and caspase activation. We adopted a 2D DIGE approach to compare the proteomes of erythroblasts maintained for 12 hours in the presence or absence of Epo. Proteomic comparisons demonstrated significant and reproducible alterations in the abundance of proteins between the two growth conditions, with 18 and 31 proteins exhibiting altered abundance in presence or absence of Epo, respectively. We observed that Epo withdrawal induced the proteolysis of the multi-functional proteins Hsp90 alpha, Hsp90 beta, SET, 14-3-3 beta, 143-3 gamma, 14-3-3 epsilon, and RPSA, thereby targeting multiple signaling pathways and cellular processes simultaneously. We also observed that 14 proteins were differentially phosphorylated and confirmed the phosphorylation of the Hsp90 alpha and Hsp90 beta proteolytic fragments in apoptotic cells using Nano LC mass spectrometry. Our analysis of the global changes occurring in the proteome of primary human erythroblasts in response to Epo removal has increased the repertoire of proteins affected by Epo withdrawal and identified proteins whose aberrant regulation may contribute to ineffective erythropoiesis.	[Pellegrin, Stephanie; Satchwell, Timothy J.; Hawley, Bethan R.; Toye, Ashley M.] Univ Walk, Sch Biochem, Bristol, Avon, England; [Heesom, Kate J.] Univ Walk, Univ Bristol, Prote Facil, Bristol, Avon, England; [Daniels, Geoff; Toye, Ashley M.] NHS Blood & Transplant, Bristol Inst Transfus Sci, Bristol, Avon, England; [van den Akker, Emile] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands	University of Bristol; University of Bristol	Pellegrin, S (corresponding author), Univ Walk, Sch Biochem, Med Sci Bldg, Bristol, Avon, England.	ash.m.toye@bristol.ac.uk	Toye, Ashley Mark/AAV-7199-2021; Toye, Ashley Mark/AFO-2320-2022	Toye, Ashley Mark/0000-0003-4395-9396; Toye, Ashley Mark/0000-0003-4395-9396	National Health Service Blood and Transplant (NHSBT); National Institute for Health [RP-PG-0310-1004-AMT]; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Health Service Blood and Transplant (NHSBT); National Institute for Health; National Institute for Health Research(National Institute for Health Research (NIHR))	SP was funded by National Health Service Blood and Transplant (NHSBT) projects grants to GD and AMT. This work was funded in part by National Institute for Health Research programme grant to NHSBT (RP-PG-0310-1004-AMT). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abutin RM, 2009, EXP HEMATOL, V37, P151, DOI 10.1016/j.exphem.2008.10.008; Ando K, 2011, EXP HEMATOL, V39, P179, DOI 10.1016/j.exphem.2010.11.001; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Chen HH, 2009, MOL CELL BIOL, V29, P3657, DOI 10.1128/MCB.01640-08; Chepanoske CL, 2005, RAPID COMMUN MASS SP, V19, P9, DOI 10.1002/rcm.1741; Christian KJ, 2008, MOL PHARMACOL, V73, P1558, DOI 10.1124/mol.107.042507; Cornelis S, 2005, ONCOGENE, V24, P1552, DOI 10.1038/sj.onc.1208401; DAMEN JE, 1995, J BIOL CHEM, V270, P23402, DOI 10.1074/jbc.270.40.23402; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; de Thonel A, 2010, BLOOD, V116, P85, DOI 10.1182/blood-2009-09-241778; Deng HB, 2011, INT J BIOCHEM CELL B, V43, P409, DOI 10.1016/j.biocel.2010.11.011; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; HellstromLindberg E, 1997, LEUKEMIA RES, V21, P415, DOI 10.1016/S0145-2126(96)00110-5; Jelkmann WE, 2010, J PHYSL; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Kurokawa M, 2008, MOL CELL BIOL, V28, P5494, DOI 10.1128/MCB.00265-08; Kuzelova K, 2009, J CELL BIOCHEM, V106, P673, DOI 10.1002/jcb.22061; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lui JCK, 2007, FEBS LETT, V581, P109, DOI 10.1016/j.febslet.2006.11.082; Malygin AA, 2011, BIOCHIMIE, V93, P612, DOI 10.1016/j.biochi.2010.12.005; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; MUTA K, 1994, J CLIN INVEST, V94, P34, DOI 10.1172/JCI117327; Ohtsuka R, 2007, EUR J HAEMATOL, V79, P114, DOI 10.1111/j.1600-0609.2007.00870.x; Polzien L, 2009, J BIOL CHEM, V284, P28004, DOI 10.1074/jbc.M109.010702; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Quelo I, 2004, BIOCHEMISTRY-US, V43, P2906, DOI 10.1021/bi036256+; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rudel T, 1998, J IMMUNOL, V160, P7; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shay KP, 2005, MOL CANCER RES, V3, P170; Somervaille TCP, 2001, BLOOD, V98, P1374, DOI 10.1182/blood.V98.5.1374; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Vera J, 2006, ONCOGENE, V25, P260, DOI 10.1038/sj.onc.1209050; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wessely O, 1997, EMBO J, V16, P267, DOI 10.1093/emboj/16.2.267; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wojchowski DM, 2010, CURR OPIN HEMATOL, V17, P169, DOI 10.1097/MOH.0b013e328338008b; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	61	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38356	10.1371/journal.pone.0038356	http://dx.doi.org/10.1371/journal.pone.0038356			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723854	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300024
J	Hirota, SK; Nitta, K; Kim, Y; Kato, A; Kawakubo, N; Yasumoto, AA; Yahara, T				Hirota, Shun K.; Nitta, Kozue; Kim, Yuni; Kato, Aya; Kawakubo, Nobumitsu; Yasumoto, Akiko A.; Yahara, Tetsukazu			Relative Role of Flower Color and Scent on Pollinator Attraction: Experimental Tests using F1 and F2 Hybrids of Daylily and Nightlily	PLOS ONE			English	Article							BUTTERFLY PAPILIO-XUTHUS; MANDUCA-SEXTA; HEMEROCALLIS-FULVA; INNATE PREFERENCES; REPRODUCTIVE ISOLATION; MACROGLOSSUM-STELLATARUM; NOCTURNAL HAWKMOTHS; NATURAL-SELECTION; VISUAL PIGMENTS; SWALLOWTAIL	The daylily (Hemerocallis fulva) and nightlily (H. citrina) are typical examples of a butterfly-pollination system and a hawkmoth-pollination system, respectively. H. fulva has diurnal, reddish or orange-colored flowers and is mainly pollinated by diurnal swallowtail butterflies. H. citrina has nocturnal, yellowish flowers with a sweet fragrance and is pollinated by nocturnal hawkmoths. We evaluated the relative roles of flower color and scent on the evolutionary shift from a diurnally flowering ancestor to H. citrina. We conducted a series of experiments that mimic situations in which mutants differing in either flower color, floral scent or both appeared in a diurnally flowering population. An experimental array of 666 potted plants, mixed with 24 plants of H. fulva and 12 plants of either F1 or F2 hybrids, were placed in the field, and visitations of swallowtail butterflies and nocturnal hawkmoths were recorded with camcorders. Swallowtail butterflies preferentially visited reddish or orange-colored flowers and hawkmoths preferentially visited yellowish flowers. Neither swallowtail butterflies nor nocturnal hawkmoths showed significant preferences for overall scent emission. Our results suggest that mutations in flower color would be more relevant to the adaptive shift from a diurnally flowering ancestor to H. citrina than that in floral scent.	[Hirota, Shun K.; Nitta, Kozue; Yasumoto, Akiko A.; Yahara, Tetsukazu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Kim, Yuni; Kato, Aya; Kawakubo, Nobumitsu] Gifu Univ, Fac Appl Biol Sci, Dept Environm Sci, Gifu, Japan	Kyushu University; Gifu University	Hirota, SK (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	shhirscb@kyushu-u.org		Yasumoto, Akiko/0000-0002-8997-6768; Yahara, Tetsukazu/0000-0001-5105-7152	Japan Society for the Promotion of Science [21370013, 22.3799]; Grants-in-Aid for Scientific Research [23128510] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by Grant-in-Aid for Scientific Research (B) (No. 21370013) and Grant-in-Aid for JSPS Fellows (22.3799) from Japan Society for the Promotion of Science. http://www.jsps.go.jp/english/index.html. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Ando T, 2001, ANN BOT-LONDON, V88, P403, DOI 10.1006/anbo.2001.1485; ARIKAWA K, 1987, NATURWISSENSCHAFTEN, V74, P297, DOI 10.1007/BF00366422; Balkenius A, 2004, J EXP BIOL, V207, P3307, DOI 10.1242/jeb.01158; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Balkenius A, 2006, NATURWISSENSCHAFTEN, V93, P255, DOI 10.1007/s00114-006-0099-9; BENNETT RR, 1985, VISION RES, V25, P1771, DOI 10.1016/0042-6989(85)90002-1; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Campbell DR, 2004, NEW PHYTOL, V161, P83, DOI 10.1046/j.1469-8137.2003.00919.x; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; Darwin C., 1877, VARIOUS CONTRIVANCES; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; Goyret J, 2009, P ROY SOC B-BIOL SCI, V276, P2739, DOI 10.1098/rspb.2009.0456; GRANT V, 1985, BOT GAZ, V146, P517, DOI 10.1086/337557; GRANT V, 1983, BOT GAZ, V144, P439, DOI 10.1086/337395; GRANT V, 1993, P NATL ACAD SCI USA, V90, P7729, DOI 10.1073/pnas.90.16.7729; Hasegawa M, 2006, J PLANT RES, V119, P63, DOI 10.1007/s10265-005-0241-3; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; HOGLUND G, 1973, J COMP PHYSIOL, V86, P265, DOI 10.1007/BF00696344; Ippolito A, 2004, EVOLUTION, V58, P2634, DOI 10.1111/j.0014-3820.2004.tb01617.x; Johnson SD, 2006, S AFR J BOT, V72, P24, DOI 10.1016/j.sajb.2005.04.002; JOHNSON SD, 1995, NORD J BOT, V15, P121, DOI 10.1111/j.1756-1051.1995.tb00128.x; JOHNSTON MO, 1991, EVOLUTION, V45, P1468, DOI [10.2307/2409893, 10.1111/j.1558-5646.1991.tb02649.x]; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 2002, P ROY SOC B-BIOL SCI, V269, P2573, DOI 10.1098/rspb.2002.2201; Kelber A, 1997, J EXP BIOL, V200, P827; Kelber A, 2010, BEHAV ECOL, V21, P1093, DOI 10.1093/beheco/arq115; Kinoshita M, 1999, J EXP BIOL, V202, P95; Kinoshita M, 2000, J EXP BIOL, V203, P3521; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Maad J, 2000, EVOLUTION, V54, P112, DOI 10.1111/j.0014-3820.2000.tb00012.x; Miyake T, 1998, J PLANT RES, V111, P199, DOI 10.1007/BF02512170; Morinaga SI, 2009, POPUL ECOL, V51, P187, DOI 10.1007/s10144-008-0097-1; Nitta K, 2010, AM J BOT, V97, P261, DOI 10.3732/ajb.0900001; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; SCHWEMER J, 1973, J COMP PHYSIOL, V86, P215, DOI 10.1007/BF00696341; Sokal R.R., 2012, BIOMETRY; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; STANTON ML, 1989, EVOLUTION, V43, P335, DOI [10.1111/j.1558-5646.1989.tb04231.x, 10.2307/2409211]; SWIHART CA, 1970, ANIM BEHAV, V18, P60, DOI 10.1016/0003-3472(70)90071-0; Takeuchi Y, 2006, J EXP BIOL, V209, P2873, DOI 10.1242/jeb.02311; VANDERPIJL L, 1961, EVOLUTION, V15, P44, DOI 10.2307/2405842; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357; Weiss MR, 2003, ANIM BEHAV, V65, P425, DOI 10.1006/anbe.2003.2084; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Yasumoto AA, 2008, J PLANT RES, V121, P287, DOI 10.1007/s10265-008-0152-1; Yasumoto AA, 2006, J PLANT RES, V119, P617, DOI 10.1007/s10265-006-0028-1; Yokota S, 2012, PLANT SPEC BIOL, V27, P96, DOI 10.1111/j.1442-1984.2011.00336.x	56	43	44	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39010	10.1371/journal.pone.0039010	http://dx.doi.org/10.1371/journal.pone.0039010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720016	gold, Green Published			2022-12-27	WOS:000305350000034
J	Wang, HJ; Zhang, PJ; Chen, WJ; Feng, D; Jia, YH; Xie, LX				Wang, Huijuan; Zhang, Pengjun; Chen, Weijun; Feng, Dan; Jia, Yanhong; Xie, Lixin			Serum MicroRNA Signatures Identified by Solexa Sequencing Predict Sepsis Patients' Mortality: A Prospective Observational Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SEPTIC SHOCK; LUNG-CANCER; PROGNOSTIC MARKER; ORGAN FAILURE; T-CELLS; EXPRESSION; PROCALCITONIN; MICROVESICLES; FINGERPRINTS	Background: Sepsis is the leading cause of death in Intensive Care Units. Novel sepsis biomarkers and targets for treatment are needed to improve mortality from sepsis. MicroRNAs (miRNAs) have recently been used as finger prints for sepsis, and our goal in this prospective study was to investigate if serum miRNAs identified in genome-wide scans could predict sepsis mortality. Methodology/Principal Findings: We enrolled 214 sepsis patients (117 survivors and 97 non-survivors based on 28-day mortality). Solexa sequencing followed by quantitative reverse transcriptase polymerase chain reaction assays was used to test for differences in the levels of miRNAs between survivors and non-survivors. miR-223, miR-15a, miR-16, miR-122, miR-193*, and miR-483-5p were significantly differentially expressed. Receiver operating characteristic curves were generated and the areas under the curve (AUC) for these six miRNAs for predicting sepsis mortality ranged from 0.610 (95% CI: 0.523-0.697) to 0.790 (95% CI: 0.719-0.861). Logistic regression analysis showed that sepsis stage, Sequential Organ Failure Assessment scores, Acute Physiology and Chronic Health Evaluation II scores, miR-15a, miR-16, miR-193b*, and miR-483-5p were associated with death from sepsis. An analysis was done using these seven variables combined. The AUC for these combined variables' predictive probability was 0.953 (95% CI: 0.923-0.983), which was much higher than the AUCs for Acute Physiology and Chronic Health Evaluation II scores (0.782; 95% CI: 0.712-0.851), Sequential Organ Failure Assessment scores (0.752; 95% CI: 0.672-0.832), and procalcitonin levels (0.689; 95% CI: 0.611-0.784). With a cut-off point of 0.550, the predictive value of the seven variables had a sensitivity of 88.5% and a specificity of 90.4%. Additionally, miR-193b* had the highest odds ratio for sepsis mortality of 9.23 (95% CI: 1.20-71.16). Conclusion/Significance: Six serum miRNA's were identified as prognostic predictors for sepsis patients.	[Wang, Huijuan; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China; [Wang, Huijuan; Zhang, Pengjun] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Wang, Huijuan; Jia, Yanhong; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China; [Zhang, Pengjun] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China; [Chen, Weijun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Airport Ind B6, Beijing, Peoples R China; [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Dept Med Stat, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese People's Liberation Army General Hospital	Wang, HJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China.	xielx@263.net	Xie, li/HGE-6052-2022		Chinese National Science & Technology Pillar Program [2009BAI86B03]	Chinese National Science & Technology Pillar Program	This work was supported by the Chinese National Science & Technology Pillar Program (2009BAI86B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chen J, 2011, AM J PATHOL; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen SJ, 2011, INTERNAL MED, V50, P871, DOI 10.2169/internalmedicine.50.4312; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Fritz HG, 2003, ACTA ANAESTH SCAND, V47, P1276, DOI 10.1046/j.1399-6576.2003.00239.x; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hillas G, 2010, EUR RESPIR J, V35, P805, DOI 10.1183/09031936.00051309; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Kampmeier TG, 2010, MINERVA ANESTESIOL, V76, P844; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Wang ZX, 2011, J SURG ONCOL; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Zhu EL, 2010, NUCLEIC ACIDS RES, V38, pW392, DOI 10.1093/nar/gkq393	37	103	122	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38885	10.1371/journal.pone.0038885	http://dx.doi.org/10.1371/journal.pone.0038885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719975	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000027
J	Angell, AR; Pirozzi, I; de Nys, R; Paul, NA				Angell, Alex R.; Pirozzi, Igor; de Nys, Rocky; Paul, Nicholas A.			Feeding Preferences and the Nutritional Value of Tropical Algae for the Abalone Haliotis asinina	PLOS ONE			English	Article							SOUTH-AFRICAN ABALONE; DIETARY-PROTEIN LEVEL; BROWN-ALGAE; CHEMICAL DEFENSES; SEA-URCHIN; AUSTRALIAN ABALONE; JUVENILE ABALONE; GROWTH; MIDAE; EFFICIENCY	Understanding the feeding preferences of abalone (high-value marine herbivores) is integral to new species development in aquaculture because of the expected link between preference and performance. Performance relates directly to the nutritional value of algae - or any feedstock - which in turn is driven by the amino acid content and profile, and specifically the content of the limiting essential amino acids. However, the relationship between feeding preferences, consumption and amino acid content of algae have rarely been simultaneously investigated for abalone, and never for the emerging target species Haliotis asinina. Here we found that the tropical H. asinina had strong and consistent preferences for the red alga Hypnea pannosa and the green alga Ulva flexuosa, but no overarching relationship between protein content (sum of amino acids) and preference existed. For example, preferred Hypnea and Ulva had distinctly different protein contents (12.64 vs. 2.99 g 100 g(-1)) and the protein-rich Asparagopsis taxiformis (>15 g 100 g(-1) of dry weight) was one of the least preferred algae. The limiting amino acid in all algae was methionine, followed by histidine or lysine. Furthermore we demonstrated that preferences can largely be removed using carrageenan as a binder for dried alga, most likely acting as a feeding attractant or stimulant. The apparent decoupling between feeding preference and algal nutritive values may be due to a trade off between nutritive values and grazing deterrence associated with physical and chemical properties.	[Angell, Alex R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Angell, AR (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	alex.angell@my.jcu.edu.au	de Nys, Rocky/D-6741-2012; Paul, Nicholas/B-6496-2009	de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Advanced Manufacturing Cooperative Research Centre; Australian Government's Cooperative Research Centre Scheme	Advanced Manufacturing Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Advanced Manufacturing Cooperative Research Centre, funded through the Australian Government's Cooperative Research Centre Scheme. http://www.mbdenergy.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara LB, 2005, J SHELLFISH RES, V24, P1169; Allen VJ, 2006, AQUACULTURE, V257, P294, DOI 10.1016/j.aquaculture.2006.02.070; BARKAI R, 1988, J MOLLUS STUD, V54, P43, DOI 10.1093/mollus/54.1.43; Bautista-Teruel MN, 2003, AQUACULTURE, V219, P645, DOI 10.1016/S0044-8486(02)00410-6; Bautista-Teruel MN, 1999, AQUACULTURE, V178, P117, DOI 10.1016/S0044-8486(99)00121-0; Britz PJ, 1996, AQUACULTURE, V140, P55, DOI 10.1016/0044-8486(95)01198-6; Capinpin EC, 1996, AQUACULTURE, V144, P81, DOI 10.1016/S0044-8486(96)01332-4; Conover W.J., 1981, PRACTICAL NONPARAMET; Coote TA, 2000, AQUACULT NUTR, V6, P213, DOI 10.1046/j.1365-2095.2000.006004213.x; Cornwall CE, 2009, J SHELLFISH RES, V28, P589, DOI 10.2983/035.028.0323; Day EG, 2002, J EXP MAR BIOL ECOL, V276, P1, DOI 10.1016/S0022-0981(02)00204-6; DAY RW, 1995, MAR FRESHWATER RES, V46, P623, DOI 10.1071/MF9950623; Dunstan GA, 2010, AQUACULT NUTR, V16, P1, DOI 10.1111/j.1365-2095.2008.00629.x; Dworjanyn SA, 2007, AQUACULTURE, V273, P624, DOI 10.1016/j.aquaculture.2007.08.023; FLEMING AE, 1995, AQUACULTURE, V134, P279, DOI 10.1016/0044-8486(95)00055-7; FLEMING AE, 1995, AQUACULTURE, V132, P297, DOI 10.1016/0044-8486(94)00347-Q; FOALE S, 1992, AUST J MAR FRESH RES, V43, P1331; FOX JM, 1995, AQUACULTURE, V131, P279, DOI 10.1016/0044-8486(94)00348-R; Guzman del Proo Sergio A., 2003, Pacific Science, V57, P319, DOI 10.1353/psc.2003.0025; Hwang EK, 2008, J APPL PHYCOL, V20, P147, DOI 10.1007/s10811-007-9198-z; Lemire M, 1996, MAR BIOL, V127, P73, DOI 10.1007/BF00993646; Mai K, 1995, AQUACULTURE, V136, P165, DOI 10.1016/0044-8486(95)01041-6; Marsden ID, 1996, J SHELLFISH RES, V15, P401; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McDonald P., 2002, ANIMAL NUTR; MCSHANE PE, 1994, J EXP MAR BIOL ECOL, V178, P299; Myer RO, 2004, J APPL ANIM RES, V25, P85, DOI 10.1080/09712119.2004.9706482; NEIGHBORS MA, 1991, MAR BIOL, V108, P471, DOI 10.1007/BF01313657; Nose T., 1979, Finfish nutrition and fishfeed technology. Volume 1, P145; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Paul NA, 2006, MAR ECOL PROG SER, V323, P1, DOI 10.3354/meps323001; PENAFLORIDA VD, 1989, AQUACULTURE, V83, P319, DOI 10.1016/0044-8486(89)90043-4; POORE G C B, 1972, New Zealand Journal of Marine and Freshwater Research, V6, P11; Prince JS, 2004, OECOLOGIA, V138, P1, DOI 10.1007/s00442-003-1413-2; Qari R, 1988, J SCI IND RES INDIA, V31, P94; Reis RP, 2008, J APPL PHYCOL, V20, P1, DOI 10.1007/s10811-007-9173-8; Renaud SM, 2006, J APPL PHYCOL, V18, P381, DOI 10.1007/s10811-006-9034-x; Rogers CN, 2002, MAR ECOL PROG SER, V236, P241, DOI 10.3354/meps236241; SCHUPP PJ, 1994, ECOLOGY, V75, P1172, DOI 10.2307/1939440; Shepherd S.A., 1992, P169; Shpigel M, 1999, J SHELLFISH RES, V18, P227; STEINBERG PD, 1985, ECOL MONOGR, V55, P333, DOI 10.2307/1942581; STEINBERG PD, 1986, OECOLOGIA, V69, P628, DOI 10.1007/BF00410374; STEINBERG PD, 1990, MAR ECOL PROG SER, V58, P253; STEINBERG PD, 1991, MAR BIOL, V109, P335, DOI 10.1007/BF01319401; STENECK RS, 1982, MAR BIOL, V68, P299, DOI 10.1007/BF00409596; Stepto NK, 1996, J SHELLFISH RES, V15, P653; TAGHON GL, 1984, ECOLOGY, V65, P549, DOI 10.2307/1941417; Tahil AS, 1999, AQUAC RES, V30, P95, DOI 10.1046/j.1365-2109.1999.00294.x; Taylor Barbara, 1992, Journal of Shellfish Research, V11, P556; UKI N, 1986, B JPN SOC SCI FISH, V52, P1005; Van Alstyne KL, 2009, J EXP MAR BIOL ECOL, V379, P85, DOI 10.1016/j.jembe.2009.08.002; WELLS FE, 1989, AUST J MAR FRESH RES, V40, P187; WILSON RP, 1985, COMP BIOCHEM PHYS B, V80, P385, DOI 10.1016/0305-0491(85)90224-X; WINTER FC, 1992, J EXP MAR BIOL ECOL, V155, P263, DOI 10.1016/0022-0981(92)90067-K; Wood AD, 1996, S AFR J MARINE SCI, V17, P61	57	29	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38857	10.1371/journal.pone.0038857	http://dx.doi.org/10.1371/journal.pone.0038857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719967	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000305347800023
J	Chan, YS; Wong, JH; Fang, EF; Pan, WL; Ng, TB				Chan, Yau Sang; Wong, Jack Ho; Fang, Evandro Fei; Pan, Wenliang; Ng, Tzi Bun			Isolation of a Glucosamine Binding Leguminous Lectin with Mitogenic Activity towards Splenocytes and Anti-Proliferative Activity towards Tumor Cells	PLOS ONE			English	Article							PHASEOLUS-VULGARIS LECTIN; CYCAS-REVOLUTA THUNB.; FRENCH BEAN-SEEDS; ANTITUMOR-ACTIVITY; JAPANESE CYCAD; CANCER-CELLS; IN-VITRO; PURIFICATION; CARCINOMA; HEMAGGLUTININ	A dimeric 64-kDa glucosamine-specific lectin was purified from seeds of Phaseolus vulgaris cv. "brown kidney bean." The simple 2-step purification protocol involved affinity chromatography on Affi-gel blue gel and gel filtration by FPLC on Superdex 75. The lectin was absorbed on Affi-gel blue gel and desorbed using 1M NaCl in the starting buffer. Gel filtration on Superdex 75 yielded a major absorbance peak that gave a single 32-kDa band in SDS-PAGE. Hemagglutinating activity was completely preserved when the ambient temperature was in the range of 20 degrees C-60 degrees C. However, drastic reduction of the activity occurred at temperatures above 65 degrees C. Full hemagglutinating activity of the lectin was observed at an ambient pH of 3 to 12. About 50% activity remained at pH 0-2, and only residual activity was observed at pH 13-14. Hemagglutinating activity of the lectin was inhibited by glucosamine. The brown kidney bean lectin elicited maximum mitogenic activity toward murine splenocytes at 2.5 mu M. The mitogenic activity was nearly completely eliminated in the presence of 250 mM glucosamine. The lectin also increased mRNA expression of the cytokines IL-2, TNF-alpha and IFN-gamma. The lectin exhibited antiproliferative activity toward human breast cancer (MCF7) cells, hepatoma (HepG2) cells and nasopharyngeal carcinoma (CNE1 and CNE2) cells with IC50 of 5.12 mu M, 32.85 mu M, 3.12 mu M and 40.12 mu M respectively after treatment for 24 hours. Flow cytometry with Annexin V and propidum iodide staining indicated apoptosis of MCF7 cells. Hoechst 33342 staining also indicated formation of apoptotic bodies in MCF7 cells after exposure to brown kidney bean lectin. Western blotting revealed that the lectin-induced apoptosis involved ER stress and unfolded protein response.	[Chan, Yau Sang; Wong, Jack Ho; Pan, Wenliang; Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Fang, Evandro Fei] NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA	Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chan, YS (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	b021770@mailserv.cuhk.edu.hk	Fang, Evandro Fei/AAC-5511-2019; Fang, Evandro Fei/AAV-4653-2020	Fang, Evandro Fei/0000-0003-0355-7202; WONG, Jack/0000-0002-9732-986X				Abdullaev FI, 1995, BIOFACTORS, V5, P133; Alizadeh H, 2011, PHYTOCHEMISTRY, V72, P94, DOI 10.1016/j.phytochem.2010.11.002; Beuth J., 1997, ANTI CANC DRUGS, V8, P53; BOCCI V, 1993, J BIOL REG HOMEOS AG, V7, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao X, 2010, J INSECT SCI, V10; Chan YS, 2011, PROTEIN PEPTIDE LETT, V18, P194; Chan YS, 2010, PROTEIN PEPTIDE LETT, V17, P823; Chang YH, 2009, BIOSCI BIOTECH BIOCH, V73, P2589, DOI 10.1271/bbb.90357; Deeni YY, 2002, J ETHNOPHARMACOL, V83, P235, DOI 10.1016/S0378-8741(02)00244-1; Dong Q, 2011, PHYTOMEDICINE, V18, P309, DOI 10.1016/j.phymed.2010.06.008; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Fabre C, 1998, BIOCHEM J, V329, P551, DOI 10.1042/bj3290551; Fang EF, 2012, CANCER PREV RES, V5, P109, DOI 10.1158/1940-6207.CAPR-11-0203; Fang EF, 2011, ARCH TOXICOL, V85, P1551, DOI 10.1007/s00204-011-0698-x; Ghosh D, 2007, IMMUNOBIOLOGY, V212, P589, DOI 10.1016/j.imbio.2007.03.005; Haraguchi T, 2006, BIOSCI BIOTECH BIOCH, V70, P2222, DOI 10.1271/bbb.60156; Huang L, 2008, IMMUNOL LETT, V121, P148, DOI 10.1016/j.imlet.2008.10.004; Kamemura K, 1996, BIOSCI BIOTECH BIOCH, V60, P608, DOI 10.1271/bbb.60.608; KOIKE T, 1995, J BIOCHEM-TOKYO, V118, P1205, DOI 10.1093/oxfordjournals.jbchem.a125008; Kovalchuk N. V., 2006, Ukrainskii Biokhimicheskii Zhurnal, V78, P130; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lam SK, 2010, BIOSCIENCE REP, V30, P307, DOI 10.1042/BSR20090059; Lam SK, 2009, BIOSCIENCE REP, V29, P293, DOI 10.1042/BSR20080110; Lei HY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-10; Leung EHW, 2008, J PEPT SCI, V14, P349, DOI 10.1002/psc.946; Lin P, 2008, ACTA BIOCH BIOPH SIN, V40, P1029, DOI 10.1111/j.1745-7270.2008.00488.x; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Liu B, 2009, AUTOPHAGY, V5, P253, DOI 10.4161/auto.5.2.7561; Mengs U, 1999, Wien Med Wochenschr, V149, P262; Nakagawa R, 1996, BIOSCI BIOTECH BIOCH, V60, P259, DOI 10.1271/bbb.60.259; OHTANI K, 1980, J BIOCHEM, V87, P407, DOI 10.1093/oxfordjournals.jbchem.a132761; Peumans WJ, 2001, ADV EXP MED BIOL, V491, P27; Rodriguez-Juan C, 2000, CYTOKINE, V12, P1284, DOI 10.1006/cyto.1999.0731; Seelentag WKF, 1998, CANCER RES, V58, P5559; SERAFINICESSI F, 1979, BIOCHEM J, V183, P381, DOI 10.1042/bj1830381; Sharma A, 2010, PROTEIN PEPTIDE LETT, V17, P221, DOI 10.2174/092986610790226067; Silva JA, 2001, J PROTEIN CHEM, V20, P1, DOI 10.1023/A:1011053002001; Subramanyam S, 2008, PLANT PHYSIOL, V147, P1412, DOI 10.1104/pp.108.116145; Valadez-Vega C, 2011, MOLECULES, V16, P2107, DOI 10.3390/molecules16032107; Wong JH, 2010, J SCI FOOD AGR, V90, P70, DOI 10.1002/jsfa.3782; Xu ZT, 2011, AM J CHINESE MED, V39, P579, DOI 10.1142/S0192415X11009044; Yagi F, 2002, EUR J BIOCHEM, V269, P4335, DOI 10.1046/j.1432-1033.2002.03127.x; Yan QJ, 2009, PHYTOMEDICINE, V16, P586, DOI 10.1016/j.phymed.2008.12.024; Yang Y, 2011, PHYTOMEDICINE, V18, P748, DOI 10.1016/j.phymed.2010.11.001	45	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38961	10.1371/journal.pone.0038961	http://dx.doi.org/10.1371/journal.pone.0038961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720002	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800032
J	Morrey, JD; Siddharthan, V; Wang, H; Hall, JO				Morrey, John D.; Siddharthan, Venkatraman; Wang, Hong; Hall, Jeffery O.			Respiratory Insufficiency Correlated Strongly with Mortality of Rodents Infected with West Nile Virus	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; EASTERN EQUINE ENCEPHALITIS; ACUTE FLACCID PARALYSIS; HAMSTER MODEL; UNITED-STATES; BRAIN; MICE; OUTCOMES; PERMEABILITY; NEURONS	West Nile virus (WNV) disease can be fatal for high-risk patients. Since WNV or its antigens have been identified in multiple anatomical locations of the central nervous system of persons or rodent models, one cannot know where to investigate the actual mechanism of mortality without careful studies in animal models. In this study, depressed respiratory functions measured by plethysmography correlated strongly with mortality. This respiratory distress, as well as reduced oxygen saturation, occurred beginning as early as 4 days before mortality. Affected medullary respiratory control cells may have contributed to the animals' respiratory insufficiency, because WNV antigen staining was present in neurons located in the ventrolateral medulla. Starvation or dehydration would be irrelevant in people, but could cause death in rodents due to lethargy or loss of appetite. Animal experiments were performed to exclude this possibility. Plasma ketones were increased in moribund infected hamsters, but late-stage starvation markers were not apparent. Moreover, daily subcutaneous administration of 5% dextrose in physiological saline solution did not improve survival or other disease signs. Therefore, infected hamsters did not die from starvation or dehydration. No cerebral edema was apparent in WNV- or sham-infected hamsters as determined by comparing wet-to-total weight ratios of brains, or by evaluating blood-brain-barrier permeability using Evans blue dye penetration into brains. Limited vasculitis was present in the right atrium of the heart of infected hamsters, but abnormal electrocardiograms for several days leading up to mortality did not occur. Since respiratory insufficiency was strongly correlated with mortality more than any other pathological parameter, it is the likely cause of death in rodents. These animal data and a poor prognosis for persons with respiratory insufficiency support the hypothesis that neurological lesions affecting respiratory function may be the primary cause of human WNV-induced death.	[Morrey, John D.; Siddharthan, Venkatraman; Wang, Hong; Hall, Jeffery O.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Morrey, JD (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	john.morrey@usu.edu			Rocky Mountain Regional Centers of Excellence, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [U54 AI-065357]; Virology Branch, NIAID, NIH [HHSN272201000039I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Centers of Excellence, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Virology Branch, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U54 AI-065357 Rocky Mountain Regional Centers of Excellence, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) by supplying labor, supplies, and instrumentation, and HHSN272201000039I Virology Branch, NIAID, NIH by supplying essential instrumentation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agamanolis DP, 2003, ANN NEUROL, V54, P547, DOI 10.1002/ana.10731; Bagic A, 2007, EPILEPTIC DISORD, V9, P98; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Berdanier, 2000, ADV NUTR MACRONUTRIE; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Doron SI, 2003, CLIN INFECT DIS, V37, pE74, DOI 10.1086/377177; Fratkin JD, 2004, ARCH PATHOL LAB MED, V128, P533; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; Getts DR, 2007, J NEUROCHEM, V103, P1019, DOI 10.1111/j.1471-4159.2007.04798.x; Gowen BB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-240; Groeben H, 2003, BRIT J ANAESTH, V91, P541, DOI 10.1093/bja/aeg222; Hoffer LJ, 2006, MODERN NUTR HLTH DIS, P730; Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341; Lanciotti RS, 2001, J CLIN MICROBIOL, V39, P4506, DOI 10.1128/JCM.39.12.4506-4513.2001; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Leis A Arturo, 2005, Curr Treat Options Neurol, V7, P15, DOI 10.1007/s11940-005-0002-6; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mandel DA, 2006, J PHYSIOL-LONDON, V572, P881, DOI 10.1113/jphysiol.2005.103622; Mongue-Din H, 2009, AM J PHYSIOL-REG I, V296, pR610, DOI 10.1152/ajpregu.90376.2008; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; Morrey JD, 2008, J NEUROVIROL, V14, P152, DOI 10.1080/13550280801958930; Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0; Morrey JD, 2007, ANTIMICROB AGENTS CH, V51, P2396, DOI 10.1128/AAC.00147-07; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Morrey JD, 2010, J NEUROVIROL, V16, P318, DOI 10.3109/13550284.2010.501847; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Paessler S, 2004, J INFECT DIS, V189, P2072, DOI 10.1086/383246; Saad M, 2005, J INFECTION, V51, P120, DOI 10.1016/j.jinf.2004.10.005; Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047; Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281; Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Shpall AI, 2003, UROLOGY, V61, DOI 10.1016/S0090-4295(03)00119-5; Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09; SIDWELL RW, 1992, ANTIMICROB AGENTS CH, V36, P473, DOI 10.1128/AAC.36.2.473; Smee DF, 2010, ANTIVIR RES, V88, P38, DOI 10.1016/j.antiviral.2010.07.003; Smeraski CA, 2011, ANTIVIR RES, V91, P43, DOI 10.1016/j.antiviral.2011.04.011; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019575; Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Yudkoff M, 2001, J NEUROSCI RES, V66, P272, DOI 10.1002/jnr.1221	44	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38672	10.1371/journal.pone.0038672	http://dx.doi.org/10.1371/journal.pone.0038672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719920	gold, Green Published			2022-12-27	WOS:000305347800012
J	Barros, LC; Santos, U; Zanuncio, JC; Dergam, JA				Barros, Lucas C.; Santos, Udson; Zanuncio, Jose C.; Dergam, Jorge A.			Plagioscion squamosissimus (Sciaenidae) and Parachromis managuensis (Cichlidae): A Threat to Native Fishes of the Doce River in Minas Gerais, Brazil	PLOS ONE			English	Article							FRESH-WATER FISH; CURRENT KNOWLEDGE; TELEOSTEI; IMPACTS	The middle section of the lake basin of the Doce River in Minas Gerais State, Brazil is plagued by grave environmental problems, including the introduction of non-native fish, which reduces the biodiversity of this region. This study reports the presence of two newly-detected non-native species in the Doce River Basin. Sampling efforts included gill nets with mesh size of 3 to 12 mm (measured diagonally) and trawling nets, both of which were used in independent field campaigns in 2002 and 2011. The two new invasive Perciform fishes, Plagioscion squamosissimus (Heckel 1840) and Parachromis managuensis (Gunther 1867) were collected in Caratinga and Rio Doce municipalities. These records and other reports on non-native fishes suggest favorable environmental conditions for the establishment of invasive species in this drainage. These invasive species have behavior and diet observed in other wide distribution exotic fish of Rio Doce Basin representing a threat to the 77 native fishes of this region, 37 of which are endangered.	[Barros, Lucas C.; Santos, Udson; Zanuncio, Jose C.; Dergam, Jorge A.] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil; [Santos, Udson] Univ Fed Ouro Preto, Dept Biodivers Evolucao & Meio Ambiente, Ouro Preto, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Ouro Preto	Barros, LC (corresponding author), Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil.	udsonsan@gmail.com	Dergam, Jorge/B-1522-2013; barros, lucas/GXG-6687-2022	Dergam, Jorge/0000-0003-1395-1377; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PONE-D-12-01684R1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work (PONE-D-12-01684R1) was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CBM, 2007, REV-METHODS TECHNOL, V6, P291, DOI 10.1007/978-1-4020-6148-6_16; Barbosa JM, 2006, REV BRAS ENG PESCA, V1, P61; Bennemann Sirlei T., 2006, Iheringia, Sér. Zool., V96, P115, DOI 10.1590/S0073-47212006000100020; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; CLOUT M, 2004, ALIENS, V13, P3; CONKEL D, 1993, CICHLIDS N CENTRAL A; De Klemm C, 1996, INTRO NONNATIVE ORGA; Dergam JA, 2002, GENET MOL BIOL, V25, P379, DOI 10.1590/S1415-47572002000400005; Drummond GM, 2005, BIODIVERSIDADE MINAS, V2th; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Goudswaard PC, 2002, J FISH BIOL, V60, P838, DOI [10.1006/jfbi.2002.1888, 10.1111/j.1095-8649.2002.tb02413.x]; Gozlan RE, 2012, FISHERIES MANAG ECOL, V19, P89, DOI 10.1111/j.1365-2400.2012.00853.x; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Groom M.J., 2006, PRINCIPLES CONSERVAT; Hall S.R., 2000, Aquatic Ecosystem Health & Management, V3, P105, DOI 10.1080/14634980008656995; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Latini Anderson O., 2004, Lundiana, V5, P135; Latini AO, 2004, FISHERIES MANAG ECOL, V11, P71, DOI 10.1046/j.1365-2400.2003.00372.x; Lima FP, 2010, INTERCIENCIA, V35, P84; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Makrakis MC, 2008, J FISH BIOL, V72, P1690, DOI 10.1111/j.1095-8649.2008.01845.x; Martins CS, 1998, BIODIVERSIDADE MINAS, P44; *MMA SBF, 2000, AV AC PRIOR CONS BIO; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Myers JH, 2000, TREE, V15, P16; Paiva SR, 2006, HYDROBIOLOGIA, V560, P393, DOI 10.1007/s10750-005-9415-1; Pinto-Coelho RM, 2008, BRAZ J BIOL, V68, P1025, DOI 10.1590/S1519-69842008000500010; Reis R.E., 2003, CHECK LIST FISHES S; Ribeiro F, 2012, FISHERIES MANAG ECOL, V19, P142, DOI 10.1111/j.1365-2400.2011.00842.x; Rodriguez JP, 2001, BIODIVERS CONSERV, V10, P1983, DOI 10.1023/A:1013151722557; Rosa RS, 2005, LISTA FAUNA BRASILEI, P65; Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x; Vieira F., 2006, ICTIOFAUNA RIO SANTO; vonSperling M, 1994, ECOLOGY HUMAN IMPACT, P77; Wolter C, 2010, J APPL ICHTHYOL, V26, P19, DOI 10.1111/j.1439-0426.2010.01505.x; Ziller S. R, 2007, MODELO DESENVOLVIMEN	36	35	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39138	10.1371/journal.pone.0039138	http://dx.doi.org/10.1371/journal.pone.0039138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720053	gold, Green Published			2022-12-27	WOS:000305341900086
J	Callens, M; Tops, W; Brysbaert, M				Callens, Maaike; Tops, Wim; Brysbaert, Marc			Cognitive Profile of Students Who Enter Higher Education with an Indication of Dyslexia	PLOS ONE			English	Article							POSTSECONDARY STUDENTS; DEVELOPMENTAL DYSLEXIA; CHILDREN; ADULTS; SKILLS; DISABILITIES; METAANALYSIS; ACQUISITION; PREVALENCE; DIAGNOSES	For languages other than English there is a lack of empirical evidence about the cognitive profile of students entering higher education with a diagnosis of dyslexia. To obtain such evidence, we compared a group of 100 Dutch-speaking students diagnosed with dyslexia with a control group of 100 students without learning disabilities. Our study showed selective deficits in reading and writing (effect sizes for accuracy between d = 1 and d = 2), arithmetic (d approximate to 1), and phonological processing (d>0.7). Except for spelling, these deficits were larger for speed related measures than for accuracy related measures. Students with dyslexia also performed slightly inferior on the KAIT tests of crystallized intelligence, due to the retrieval of verbal information from long-term memory. No significant differences were observed in the KAIT tests of fluid intelligence. The profile we obtained agrees with a recent meta-analysis of English findings suggesting that it generalizes to all alphabetic languages. Implications for special arrangements for students with dyslexia in higher education are outlined.	[Callens, Maaike; Tops, Wim; Brysbaert, Marc] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Callens, M (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	maaike.callens@ugent.be	Brysbaert, Marc/A-3910-2011	Brysbaert, Marc/0000-0002-3645-3189; Tops, Wim/0000-0002-7889-8610				Borgwaldt S, 2004, AUST J PSYCHOL, V56, P106; Brus B, 1991, MINUUT TEST VORM A B; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Brysbaert M., 2011, BASIC STAT PSYCHOL; Campbell JID, 2002, BEHAV RES METH INS C, V34, P332, DOI 10.3758/BF03195460; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Cotton SM, 2005, DYSLEXIA, V11, P186, DOI 10.1002/dys.298; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/00131640121971374; De Pessemier P, 2009, TEST GEVORDERD LEZEN; De Smedt B, 2010, NEUROPSYCHOLOGIA, V48, P3973, DOI 10.1016/j.neuropsychologia.2010.10.018; De Vos T., 1992, TEMPO TEST REKENEN; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dekker PH, 2007, ONTWIKKELING VIJF NI; Dekker R, 2004, KAUFMAN ADOLESCENT A; Dekker R, 2003, DVMH DIFFERENTIELE V; Desoete A, 2002, LEARN DISABILITY Q, V25, P123, DOI 10.2307/1511279; Everatt J, 1997, PERCEPTION, V26, P1330; Farmer M, 2002, DYSLEXIA INCLUSION A; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FELTON RH, 1990, BRAIN LANG, V39, P485, DOI 10.1016/0093-934X(90)90157-C; Field A, 2013, DISCOVERING STAT USI; Gauderis K, 2004, THESIS U COLL ARTEVE; Ghesquiere P, 1998, THESIS U LEUVEN LEUV; Gobel SM, 2010, Q J EXP PSYCHOL, V63, P1361, DOI 10.1080/17470210903359206; Haager D., 2007, EVIDENCE BASED READI; Hadjikakou K, 2008, HIGH EDUC, V55, P103, DOI 10.1007/s10734-007-9070-8; Hanley JR, 2004, Q J EXP PSYCHOL-A, V57, P1393, DOI 10.1080/02724980343000819; Hatcher J, 2002, BRIT J EDUC PSYCHOL, V72, P119, DOI 10.1348/000709902158801; Henneman K, 2004, PROTOCOL DYSLEXIE VO; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; Kleijen R, 2008, TOETSEN INTERVENTIES; Kleijnen R., 2006, PROTOCOL DYSLEXIE HO; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; LEFLY DL, 1991, ANN DYSLEXIA, V41, P143, DOI 10.1007/BF02648083; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; Lovett BJ, 2010, J PSYCHOEDUC ASSESS, V28, P91, DOI 10.1177/0734282909341019; Madriaga M, 2010, STUD HIGH EDUC, V35, P647, DOI 10.1080/03075070903222633; Pieters S, 2012, CHILD CARE HLTH DEV, V38, P139, DOI 10.1111/j.1365-2214.2011.01225.x; Ransby MJ, 2003, J LEARN DISABIL-US, V36, P538, DOI 10.1177/00222194030360060501; Reid AA, 2007, DYSLEXIA, V13, P1, DOI 10.1002/dys.321; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Sharpe D, 1997, CLIN PSYCHOL REV, V17, P881, DOI 10.1016/S0272-7358(97)00056-1; Snowling M., 2000, DYSLEXIA; Sparks RL, 2009, J LEARN DISABIL-US, V42, P494, DOI 10.1177/0022219409338746; Sparks RL, 2009, J LEARN DISABIL-US, V42, P230, DOI 10.1177/0022219408331040; Stichting Dyslexie Nederland, 2008, DIAGN DYSL BROCH STI; Stone GO, 1997, J MEM LANG, V36, P337, DOI 10.1006/jmla.1996.2487; Swanson HL, 2009, REV EDUC RES, V79, P1362, DOI 10.3102/0034654309350931; Szenkovits G, 2005, DYSLEXIA, V11, P253, DOI 10.1002/dys.308; Tops W, 2012, ANN DYSLEXI IN PRESS; Trainin G, 2005, LEARN DISABILITY Q, V28, P261, DOI 10.2307/4126965; van den Bos K, 1999, KLEPEL VORM A B TEST; Van den Bosch A., 1994, J QUANT LINGUIST, V1, P178, DOI [10.1080/09296179408590015, DOI 10.1080/09296179408590015]; Van der Leij A, 2012, INTERACTIEV IN PRESS; Vanderswalmen R, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P367, DOI 10.1007/978-1-4419-6546-2_17; Vaughn S., 2003, LEARNING DISABILITIE, V18, P137, DOI [10.1111/1540-5826.00070, DOI 10.1111/1540-5826.00070]; Wechsler D, 2001, WAIS 3 NEDERLANDSTAL; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wolf LE, 2008, NEUROPSYCHOLOGISTS H; Wolff U, 2009, INT J DISABIL DEV ED, V56, P73, DOI 10.1080/10349120802682083; Yoshimasu K, 2010, PEDIATRICS, V126, pE788, DOI 10.1542/peds.2010-1187; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	64	69	69	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38081	10.1371/journal.pone.0038081	http://dx.doi.org/10.1371/journal.pone.0038081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719864	gold, Green Published			2022-12-27	WOS:000305341900018
J	Nischang, M; Sutmuller, R; Gers-Huber, G; Audige, A; Li, D; Rochat, MA; Baenziger, S; Hofer, U; Schlaepfer, E; Regenass, S; Amssoms, K; Stoops, B; Van Cauwenberge, A; Boden, D; Kraus, G; Speck, RF				Nischang, Marc; Sutmuller, Roger; Gers-Huber, Gustavo; Audige, Annette; Li, Duo; Rochat, Mary-Aude; Baenziger, Stefan; Hofer, Ursula; Schlaepfer, Erika; Regenass, Stephan; Amssoms, Katie; Stoops, Bart; Van Cauwenberge, Anja; Boden, Daniel; Kraus, Guenter; Speck, Roberto F.			Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting AntiRetroviral Drugs for Treating HIV-1	PLOS ONE			English	Article							SCID-HU MOUSE; REVERSE-TRANSCRIPTASE; IN-VIVO; RAG2(-/-)GAMMA(-/-)(C) MICE; T-CELLS; VIRUS; MODEL; RILPIVIRINE; THERAPY; PHARMACOKINETICS	Background: Humanized mice generate a lymphoid system of human origin subsequent to transplantation of human CD34+ cells and thus are highly susceptible to HIV infection. Here we examined the efficacy of antiretroviral treatment (ART) when added to food pellets, and of long-acting (LA) antiretroviral compounds, either as monotherapy or in combination. These studies shall be inspiring for establishing a gold standard of ART, which is easy to administer and well supported by the mice, and for subsequent studies such as latency. Furthermore, they should disclose whether viral breakthrough and emergence of resistance occurs similar as in HIV-infected patients when ART is insufficient. Methods/Principal Findings: NOD/shi-scid/ccnull (NOG) mice were used in all experimentations. We first performed pharmacokinetic studies of the drugs used, either added to food pellets (AZT, TDF, 3TC, RTV) or in a LA formulation that permitted once weekly subcutaneous administration (TMC278: non-nucleoside reverse transcriptase inhibitor, TMC181: protease inhibitor). A combination of 3TC, TDF and TMC278-LA or 3TC, TDF, TMC278-LA and TMC181-LA suppressed the viral load to undetectable levels in 15/19 (79%) and 14/14 (100%) mice, respectively. In successfully treated mice, subsequent monotherapy with TMC278-LA resulted in viral breakthrough; in contrast, the two LA compounds together prevented viral breakthrough. Resistance mutations matched the mutations most commonly observed in HIV patients failing therapy. Importantly, viral rebound after interruption of ART, presence of HIV DNA in successfully treated mice and in vitro reactivation of early HIV transcripts point to an existing latent HIV reservoir. Conclusions/Significance: This report is a unique description of multiple aspects of HIV infection in humanized mice that comprised efficacy testing of various treatment regimens, including LA compounds, resistance mutation analysis as well as viral rebound after treatment interruption. Humanized mice will be highly valuable for exploring the antiviral potency of new compounds or compounds targeting the latent HIV reservoir.	[Nischang, Marc; Gers-Huber, Gustavo; Audige, Annette; Li, Duo; Rochat, Mary-Aude; Baenziger, Stefan; Hofer, Ursula; Schlaepfer, Erika; Speck, Roberto F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Sutmuller, Roger; Amssoms, Katie; Stoops, Bart; Van Cauwenberge, Anja; Boden, Daniel; Kraus, Guenter] Tibotec BVBA, Beerse, Belgium	University of Zurich; University Zurich Hospital; Johnson & Johnson	Nischang, M (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	roberto.speck@usz.ch	Speck, Roberto F/O-2433-2016	Rochat, Mary-Aude/0000-0003-3414-1330; Speck, Roberto/0000-0002-8453-1137	Swiss National Science Foundation; Flemish agency for Innovation by Science and Technology (IWT), Belgium; Tibotec BVBA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Flemish agency for Innovation by Science and Technology (IWT), Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Tibotec BVBA	This work was supported by the Swiss National Science Foundation and by the Flemish agency for Innovation by Science and Technology (IWT), Belgium. This work is a collaboration between the University of Zurich and Tibotec BVBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The following authors are employees from Tibotec BVBA, Belgium: KA, BS, AvC, GK, DB and RS. The laboratory from RFS has been financially supported by Tibotec BVBA; in addition, Tibotec BVBA provided reagents to the laboratory of RFS and performed a number of assays in the context of the collaboration between the laboratory of RFS and Tibotec BVBA. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data materials.	Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Baert L, 2009, EUR J PHARM BIOPHARM, V72, P502, DOI 10.1016/j.ejpb.2009.03.006; Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Bonyhadi ML, 1997, MOL MED TODAY, V3, P246, DOI 10.1016/S1357-4310(97)01046-0; Camacho Ricardo, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS3, DOI 10.1097/01.COH.0000410239.88517.00; Chittick GE, 2006, ANTIMICROB AGENTS CH, V50, P1304, DOI 10.1128/AAC.50.4.1304-1310.2006; Choudhary SK, 2012, J VIROL, V86, P114, DOI 10.1128/JVI.05590-11; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Christopherson C, 2000, J CLIN MICROBIOL, V38, P630, DOI 10.1128/JCM.38.2.630-634.2000; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Cordery DV, 2010, ANTIVIR THER, V15, P1035, DOI 10.3851/IMP1647; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Fletcher CV, 2000, AIDS, V14, P2137, DOI 10.1097/00002030-200009290-00010; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Goldstein H, 1996, Semin Immunol, V8, P223, DOI 10.1006/smim.1996.0028; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Kaiser P, 2007, J VIROL, V81, P9693, DOI 10.1128/JVI.00492-07; Manrique A, 2007, J VIROL, V81, P8793, DOI 10.1128/JVI.00598-07; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miller CD, 2011, DRUG TODAY, V47, P5, DOI 10.1358/dot.2011.47.1.1583188; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sango K, 2010, AIDS RES HUM RETROV, V26, P735, DOI 10.1089/aid.2009.0136; Schrijvers R, 2011, LANCET, V378, P201, DOI 10.1016/S0140-6736(11)60992-6; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Taylor S, 2007, AIDS, V21, P1673, DOI 10.1097/QAD.0b013e3281c61394; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van 't Klooster G, 2010, ANTIMICROB AGENTS CH, V54, P2042, DOI 10.1128/AAC.01529-09; Vandamme AM, 2011, AIDS REV, V13, P77; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; YV T. Pattery, 2012, INTERVIROLOGY, P138; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	43	53	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38853	10.1371/journal.pone.0038853	http://dx.doi.org/10.1371/journal.pone.0038853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719966	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000305341900056
J	Rajaei, K; Khaligh-Razavi, SM; Ghodrati, M; Ebrahimpour, R; Abadi, MESA				Rajaei, Karim; Khaligh-Razavi, Seyed-Mahdi; Ghodrati, Masoud; Ebrahimpour, Reza; Abadi, Mohammad Ebrahim Shiri Ahmad			A Stable Biologically Motivated Learning Mechanism for Visual Feature Extraction to Handle Facial Categorization	PLOS ONE			English	Article							RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; RECOGNITION; CORTEX; NEOCOGNITRON; FEEDBACK; CLASSIFICATION; CIRCUITS; BRAIN; MODEL	The brain mechanism of extracting visual features for recognizing various objects has consistently been a controversial issue in computational models of object recognition. To extract visual features, we introduce a new, biologically motivated model for facial categorization, which is an extension of the Hubel and Wiesel simple-to-complex cell hierarchy. To address the synaptic stability versus plasticity dilemma, we apply the Adaptive Resonance Theory (ART) for extracting informative intermediate level visual features during the learning process, which also makes this model stable against the destruction of previously learned information while learning new information. Such a mechanism has been suggested to be embedded within known laminar microcircuits of the cerebral cortex. To reveal the strength of the proposed visual feature learning mechanism, we show that when we use this mechanism in the training process of a well-known biologically motivated object recognition model (the HMAX model), it performs better than the HMAX model in face/non-face classification tasks. Furthermore, we demonstrate that our proposed mechanism is capable of following similar trends in performance as humans in a psychophysical experiment using a face versus non-face rapid categorization task.	[Rajaei, Karim; Abadi, Mohammad Ebrahim Shiri Ahmad] Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran; [Rajaei, Karim; Khaligh-Razavi, Seyed-Mahdi; Ghodrati, Masoud; Ebrahimpour, Reza] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi] Univ Tehran, Dept Math Stat & Comp Sci, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England; [Ghodrati, Masoud] Shahed Univ, Fac Engn, Dept Biomed Engn, Tehran, Iran; [Ebrahimpour, Reza] Shahid Rajaee Teacher Training Univ, Dept Elect & Comp Engn, Brain & Intelligent Syst Res Lab BISLab, Tehran, Iran	Amirkabir University of Technology; University of Tehran; University of Cambridge; Shahed University; Shahid Rajaee Teacher Training University (SRTTU)	Rajaei, K (corresponding author), Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran.	ebrahimpour@ipm.ir	Ebrahimpour, Reza/A-9721-2009; Ebrahimpour, Reza/AAH-8531-2019	Ebrahimpour, Reza/0000-0002-7013-8078; Ghodrati, Masoud/0000-0002-4006-2578; Khaligh-Razavi, Seyed-Mahdi/0000-0002-5700-1704	MRC [MC_U105597120] Funding Source: UKRI; Medical Research Council [MC_U105597120] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Akhbardeh A, 2005, 2005 IEEE INTERNATIONAL WORKSHOP ON INTELLIGENT SIGNAL PROCESSING (WISP), P149; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Anton-Rodriguez M, 2009, NEUROCOMPUTING, V72, P3713, DOI 10.1016/j.neucom.2009.06.007; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bullier J, 2001, PROG BRAIN RES, V134, P193; Carpenter G. A., 2004, Proceedings. 33rd Applied Imagery Pattern Recognition Workshop, P61; Carpenter G. A., 1991, PATTERN RECOGNITION; CARPENTER GA, 1992, IEEE T NEURAL NETWOR, V3, P698, DOI 10.1109/72.159059; CARPENTER GA, 1987, COMPUT VISION GRAPH, V37, P54, DOI 10.1016/S0734-189X(87)80014-2; Fergus R, 2003, PROC CVPR IEEE, P264; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FUKUSHIMA K, 1988, NEURAL NETWORKS, V1, P119, DOI 10.1016/0893-6080(88)90014-7; Fukushima K, 2003, NEUROCOMPUTING, V51, P161, DOI 10.1016/S0925-2312(02)00614-8; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Ghodrati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032357; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; GROSSBERG S, 1986, PSYCHOL REV, V93, P46, DOI 10.1037/0033-295X.93.1.46; GROSSBERG S, 1995, AM SCI, V83, P438; GROSSBERG S, 1976, BIOL CYBERN, V23, P187; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Grossberg S, 2008, BRAIN RES, V1218, P278, DOI 10.1016/j.brainres.2008.04.024; Grossberg Stephen, 2003, Behav Cogn Neurosci Rev, V2, P47, DOI 10.1177/1534582303002001003; Grossberg S, 2007, PROG BRAIN RES, V165, P79, DOI 10.1016/S0079-6123(06)65006-1; Huang Y, 2011, IEEE T SYSTEMS MAN B; Hubel D. H., 1965, J NEUROPHYSIOLOGY; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kadiran S., 1993, Proceedings 1993 The First New Zealand International Two-Stream Conference on Artificial Neural Networks and Expert Systems, P341, DOI 10.1109/ANNES.1993.323007; Kleiner M, 2007, PERCEPTION, V36, P14; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kusiak A, 1991, GT ART USING NEURAL; LeCun Y., 2003, CONVOLUTIONAL NETWOR, P276; Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012; Liao IE, 2008, INT SYST DES APPL 20, V1, P318; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Serre T, 2005, PROC CVPR IEEE, P994; Serre T., 2005, THEORY OBJECT RECOGN; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Uysal M, 2006, IEEE IMAGE PROC, P2913, DOI 10.1109/ICIP.2006.313128; Weber M, 2000, LECT NOTES COMPUT SC, V1842, P18; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Woodbeck Kris, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563091; Zikan K., 1991, IJCNN-91-Seattle: International Joint Conference on Neural Networks (Cat. No.91CH3049-4), DOI 10.1109/IJCNN.1991.155600	54	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38478	10.1371/journal.pone.0038478	http://dx.doi.org/10.1371/journal.pone.0038478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719892	Green Published, gold			2022-12-27	WOS:000305341900030
J	Summers, EL; Meindl, K; Uson, I; Mitra, AK; Radjainia, M; Colangeli, R; Alland, D; Arcus, VL				Summers, Emma L.; Meindl, Kathrin; Uson, Isabel; Mitra, Alok K.; Radjainia, Mazdak; Colangeli, Roberto; Alland, David; Arcus, Vickery L.			The Structure of the Oligomerization Domain of Lsr2 from Mycobacterium tuberculosis Reveals a Mechanism for Chromosome Organization and Protection	PLOS ONE			English	Article							HISTONE-LIKE PROTEIN; NUCLEOID-ASSOCIATED PROTEINS; DNA; SMEGMATIS; LEPRAE; RESPONSES; SOFTWARE; GENOMES; GENE	Lsr2 is a small DNA-binding protein present in mycobacteria and related actinobacteria that regulates gene expression and influences the organization of bacterial chromatin. Lsr2 is a dimer that binds to AT-rich regions of chromosomal DNA and physically protects DNA from damage by reactive oxygen intermediates (ROI). A recent structure of the C-terminal DNA-binding domain of Lsr2 provides a rationale for its interaction with the minor groove of DNA, its preference for AT-rich tracts, and its similarity to other bacterial nucleoid-associated DNA-binding domains. In contrast, the details of Lsr2 dimerization (and oligomerization) via its N-terminal domain, and the mechanism of Lsr2-mediated chromosomal cross-linking and protection is unknown. We have solved the structure of the N-terminal domain of Lsr2 (N-Lsr2) at 1.73 angstrom resolution using crystallographic ab initio approaches. The structure shows an intimate dimer of two beta-beta-a motifs with no close homologues in the structural databases. The organization of individual N-Lsr2 dimers in the crystal also reveals a mechanism for oligomerization. Proteolytic removal of three N-terminal residues from Lsr2 results in the formation of an anti-parallel beta-sheet between neighboring molecules and the formation of linear chains of N-Lsr2. Oligomerization can be artificially induced using low concentrations of trypsin and the arrangement of N-Lsr2 into long chains is observed in both monoclinic and hexagonal crystallographic space groups. In solution, oligomerization of N-Lsr2 is also observed following treatment with trypsin. A change in chromosomal topology after the addition of trypsin to full-length Lsr2-DNA complexes and protection of DNA towards DNAse digestion can be observed using electron microscopy and electrophoresis. These results suggest a mechanism for oligomerization of Lsr2 via protease-activation leading to chromosome compaction and protection, and concomitant down-regulation of large numbers of genes. This mechanism is likely to be relevant under conditions of stress where cellular proteases are known to be upregulated.	[Summers, Emma L.; Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Meindl, Kathrin] Inst Biol Mol Barcelona, Barcelona, Spain; [Uson, Isabel] Inst Biol Mol Barcelona, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Mitra, Alok K.; Radjainia, Mazdak] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Colangeli, Roberto; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Div Infect Dis, Dept Med, Newark, NJ 07103 USA; [Colangeli, Roberto; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Emerging Pathogens, Dept Med, Newark, NJ 07103 USA	University of Waikato; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; University of Auckland; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Summers, EL (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton, New Zealand.	varcus@waikato.ac.nz	Meindl, Kathrin/O-9343-2015; Mitra, Alok/P-7800-2016	Meindl, Kathrin/0000-0001-6626-0428; ROBERTO, COLANGELI/0000-0003-3263-7404; Mitra, Alok/0000-0003-0891-5697	Biomedical Strategic Initiative at the University of Waikato; University of Waikato Doctoral Scholarship Award; Spanish Ministerio de Ciencia e Innovacion (MICINN); Generalitat de Catalunya [BIO2009-10576, IDC-20101173, 2009SGR-1036]; Deutsche Forschungsgemeinschaft [ME 3679/1-1]; "Juan de la Cierva" MICINN (MICINN-JDC) Program; ICREA Funding Source: Custom	Biomedical Strategic Initiative at the University of Waikato; University of Waikato Doctoral Scholarship Award; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); "Juan de la Cierva" MICINN (MICINN-JDC) Program; ICREA(ICREA)	This work was supported by the Biomedical Strategic Initiative at the University of Waikato. ELS was supported by a University of Waikato Doctoral Scholarship Award. IU is thankful to the Spanish Ministerio de Ciencia e Innovacion (MICINN) and Generalitat de Catalunya for financial support (Grant BIO2009-10576; IDC-20101173; 2009SGR-1036). KM thanks the Deutsche Forschungsgemeinschaft (ME 3679/1-1) and "Juan de la Cierva" MICINN (MICINN-JDC) Program for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Arora K, 2008, J BACTERIOL, V190, P4291, DOI 10.1128/JB.00023-08; Becker NA, 2007, NUCLEIC ACIDS RES, V35, P3988, DOI 10.1093/nar/gkm419; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Chen JM, 2008, NUCLEIC ACIDS RES, V36, P2123, DOI 10.1093/nar/gkm1162; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gordon BRG, 2008, J BACTERIOL, V190, P7052, DOI 10.1128/JB.00733-08; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P18741, DOI 10.1073/pnas.1014494107; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; LAAL S, 1991, P NATL ACAD SCI USA, V88, P1054, DOI 10.1073/pnas.88.3.1054; Lee BH, 1998, MOL GEN GENET, V260, P475, DOI 10.1007/s004380050919; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maurer S, 2009, J MOL BIOL, V387, P1261, DOI 10.1016/j.jmb.2009.02.050; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oftung F, 2000, FEMS IMMUNOL MED MIC, V27, P87, DOI 10.1111/j.1574-695X.2000.tb01416.x; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Ribeiro-Guimaraes ML, 2007, MICROB PATHOGENESIS, V43, P173, DOI 10.1016/j.micpath.2007.05.010; Rodriguez D, 2012, ACTA CRYSTALLOGR D, V68, P336, DOI 10.1107/S0907444911056071; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; Sharadamma N, 2010, NUCLEIC ACIDS RES, V38, P3555, DOI 10.1093/nar/gkq064; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SINGH S, 1994, INFECT IMMUN, V62, P5702, DOI 10.1128/IAI.62.12.5702-5705.1994; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38542	10.1371/journal.pone.0038542	http://dx.doi.org/10.1371/journal.pone.0038542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719899	Green Published, gold			2022-12-27	WOS:000305341900034
J	Theriault, ME; Pare, ME; Maltais, F; Debigare, R				Theriault, Marie-Eve; Pare, Marie-Eve; Maltais, Francois; Debigare, Richard			Satellite Cells Senescence in Limb Muscle of Severe Patients with COPD	PLOS ONE			English	Article							TELOMERE LENGTH; SKELETAL-MUSCLE; OXIDATIVE STRESS; UBIQUITIN; WEAKNESS; REGENERATION; PERFORMANCE; LIMITATION; CAPACITY	Rationale: The maintenance of peripheral muscle mass may be compromised in chronic obstructive pulmonary disease (COPD) due to premature cellular senescence and exhaustion of the regenerative potential of the muscles. Methods: Vastus lateralis biopsies were obtained from patients with COPD (n = 16) and healthy subjects (n = 7). Satellite cell number and the proportion of central nuclei, as a marker of muscle regenerative events, were assessed on cryosections. Telomere lengths, used as a marker of cellular senescence, were determined using Southern blot analyses. Results: Central nuclei proportion was significantly higher in patients with COPD with a preserved muscle mass compared to controls and patients with COPD with muscle atrophy (p<0.001). In COPD, maximal telomere length was significantly decreased compared to controls (p<0.05). Similarly, minimal telomere length was significantly reduced in GOLD III-IV patients with muscle atrophy compared to controls (p<0.005). Minimal, mean and maximum telomere lengths correlated with mid-thigh muscle cross-sectional area (MTCSA) (R = 0.523, p = 0.005; R = 0.435, p = 0.019 and R = 0.491, p = 0.009, respectively). Conclusions: Evidence of increased regenerative events was seen in GOLD III-IV patients with preserved muscle mass. Shortening of telomeres in GOLD III-IV patients with muscle atrophy is consistent with an increased number of senescent satellite cells and an exhausted muscle regenerative capacity, compromising the maintenance of muscle mass in these individuals.	[Theriault, Marie-Eve; Pare, Marie-Eve; Maltais, Francois; Debigare, Richard] Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University	Theriault, ME (corresponding author), Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Richard.Debigare@rea.ulaval.ca			Canadian Lung Association; Reseau en Sante Respiratoire du Fond de la recherche en Sante du Quebec (FRSQ)	Canadian Lung Association; Reseau en Sante Respiratoire du Fond de la recherche en Sante du Quebec (FRSQ)	This work has been supported by an operating grant from the Canadian Lung Association. MET is supported by a scholarship from Reseau en Sante Respiratoire du Fond de la recherche en Sante du Quebec (FRSQ). RD is a research scholar of the FRSQ. FM holds a (GlaxoSmithKline/Canadian Institutes of Health Research) Research Chair on COPD at Universite Laval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; [Anonymous], GLOB STRAT DIAGN MAN; Baird DM, 2008, EXP GERONTOL, V43, P15, DOI 10.1016/j.exger.2007.10.002; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; BLOMSTRAND E, 1984, ACTA PHYSIOL SCAND, V122, P545, DOI 10.1111/j.1748-1716.1984.tb07543.x; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; Cattan V, 2008, FREE RADICAL BIO MED, V44, P1592, DOI 10.1016/j.freeradbiomed.2008.01.007; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC; Couillard A, 2002, EUR RESPIR J, V20, P1123, DOI 10.1183/09031936.02.00014302; Debigare R, 2003, CHEST, V124, P83, DOI 10.1378/chest.124.1.83; Debigare R, 2008, J APPL PHYSIOL, V105, P751, DOI 10.1152/japplphysiol.90336.2008a; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; Decramer M, 1996, AM J RESP CRIT CARE, V153, P1958, DOI 10.1164/ajrccm.153.6.8665061; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Eliason G, 2009, SCAND J MED SCI SPOR, V19, P865, DOI 10.1111/j.1600-0838.2008.00858.x; Gosker HR, 2003, EUR RESPIR J, V22, P280, DOI 10.1183/09031936.03.00012803; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HEYMSFIELD SB, 1994, JPEN-PARENTER ENTER, V18, P91, DOI 10.1177/014860719401800291; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Kim HC, 2010, TUBERC RESPIR DIS, V68, P125, DOI 10.4046/trd.2010.68.3.125; Lansdorp PM, 2005, TRENDS BIOCHEM SCI, V30, P388, DOI 10.1016/j.tibs.2005.05.004; Lindstrom M, 2009, HISTOCHEM CELL BIOL; LLovera M, 1998, INT J MOL MED, V2, P69; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829; Mui TSY, 2009, J AM GERIATR SOC, V57, P2372, DOI 10.1111/j.1532-5415.2009.02589.x; O'Connor MS, 2009, BIOTECHNOL PROG; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Partridge TA, 2002, GENE THER, V9, P752, DOI 10.1038/sj.gt.3301764; Ponsot E, 2008, ELECTROPHORESIS, V29, P542, DOI 10.1002/elps.200700290; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabinovich RA, 2001, AM J RESP CRIT CARE, V164, P1114, DOI 10.1164/ajrccm.164.7.2103065; Rahman I, 1997, THORAX, V52, P565, DOI 10.1136/thx.52.6.565; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; SNOW MH, 1978, CELL TISSUE RES, V186, P535; TIAO G, 1994, J CLIN INVEST, V94, P2255, DOI 10.1172/JCI117588; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Van Helvoort HAC, 2006, MED SCI SPORT EXER, V38, P1543, DOI 10.1249/01.mss.0000228331.13123.53; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289	54	42	43	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39124	10.1371/journal.pone.0039124	http://dx.doi.org/10.1371/journal.pone.0039124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720047	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900083
J	Wang, P; Lei, JP; Li, MH; Yu, FH				Wang, Pu; Lei, Jing-Pin; Li, Mai-He; Yu, Fei-Hai			Spatial Heterogeneity in Light Supply Affects Intraspecific Competition of a Stoloniferous Clonal Plant	PLOS ONE			English	Article							SOIL NUTRIENT HETEROGENEITY; PHYSIOLOGICAL INTEGRATION; FRAGARIA-CHILOENSIS; ENVIRONMENTAL HETEROGENEITY; ROOT PROLIFERATION; HERB; GROWTH; PLASTICITY; PATTERN; AVAILABILITY	Spatial heterogeneity in light supply is common in nature. Many studies have examined the effects of heterogeneous light supply on growth, morphology, physiology and biomass allocation of clonal plants, but few have tested those effects on intraspecific competition. In a greenhouse experiment, we grew one (no competition) or nine ramets (with intraspecific competition) of a stoloniferous clonal plant, Duchesnea indica, in three homogeneous light conditions (high, medium and low light intensity) and two heterogeneous ones differing in patch size (large and small patch treatments). The total light in the two heterogeneous treatments was the same as that in the homogeneous medium light treatment. Both decreasing light intensity and intraspecific competition significantly decreased the growth (biomass, number of ramets and total stolon length) of D. indica. As compared with the homogeneous medium light treatment, the large patch treatment significantly increased the growth of D. indica without intraspecific competition. However, the growth of D. indica with competition did not differ among the homogeneous medium light, the large and the small patch treatments. Consequently, light heterogeneity significantly increased intraspecific competition intensity, as measured by the decreased log response ratio. These results suggest that spatial heterogeneity in light supply can alter intraspecific interactions of clonal plants.	[Wang, Pu; Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Lei, Jing-Pin] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China; [Li, Mai-He] Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland	Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Wang, P (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	feihaiyu@bjfu.edu.cn	Li, Mai-He/L-6390-2013; Yu, Fei-Hai/O-9395-2016; Wang, Pu/D-4111-2013	Li, Mai-He/0000-0002-7029-2841; Yu, Fei-Hai/0000-0001-5007-1745; 	Fundamental Research Funds for the Central Universities [JC2011-4]; National Science Foundation of China [31070371]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (Grant JC2011-4) and the National Science Foundation of China (Grant 31070371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 1999, PLANT ECOL, V141, P99, DOI 10.1023/A:1009823015170; [Anonymous], 1994, INVONOGRAPHIA CORMOP, P278; Baldocchi Dennis, 1994, P21; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; Bliss KM, 2002, NEW PHYTOL, V154, P409, DOI 10.1046/j.1469-8137.2002.00389.x; Chen JS, 2006, PLANT ECOL, V183, P147, DOI 10.1007/s11258-005-9013-3; Chen JS, 2004, FLORA, V199, P342, DOI 10.1078/0367-2530-00162; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; Day KJ, 2003, J ECOL, V91, P541, DOI 10.1046/j.1365-2745.2003.00799.x; Day KJ, 2003, J ECOL, V91, P305, DOI 10.1046/j.1365-2745.2003.00763.x; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; Dong M, 2000, ACTA BOT SIN, V42, P518; Du J, 2009, ANN BOT-LONDON, V104, P335, DOI 10.1093/aob/mcp130; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; Hutchings M.J., 2000, ECOLOGICAL CONSEQUEN, P91; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; James JJ, 2007, OECOLOGIA, V152, P721, DOI 10.1007/s00442-007-0685-3; Janecek S, 2008, EVOL ECOL, V22, P325, DOI 10.1007/s10682-007-9203-7; Littschwager J, 2010, PLANT SOIL, V331, P105, DOI 10.1007/s11104-009-0236-2; Maestre FT, 2007, ECOLOGY, V88, P501, DOI 10.1890/06-0421; Naruhashi Naohiro, 1996, Plant Species Biology, V11, P173, DOI 10.1111/j.1442-1984.1996.tb00143.x; Rajaniemi TK, 2007, OECOLOGIA, V153, P145, DOI 10.1007/s00442-007-0706-2; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; Roiloa SR, 2007, ENVIRON EXP BOT, V61, P1, DOI 10.1016/j.envexpbot.2007.02.006; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; TOMASKO DA, 1989, MAR ECOL PROG SER, V54, P299, DOI 10.3354/meps054299; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; van Kleunen M, 2001, OIKOS, V94, P515, DOI 10.1034/j.1600-0706.2001.940313.x; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025401; Wijesinghe DK, 1997, J ECOL, V85, P17, DOI 10.2307/2960624; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Wijesinghe DK, 2005, J ECOL, V93, P99, DOI 10.1111/j.0022-0477.2004.00934.x; Wijesinghe DK, 1996, OIKOS, V77, P137, DOI 10.2307/3545593; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314	49	25	28	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39105	10.1371/journal.pone.0039105	http://dx.doi.org/10.1371/journal.pone.0039105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720041	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900081
J	Ciriello, G; Mina, M; Guzzi, PH; Cannataro, M; Guerra, C				Ciriello, Giovanni; Mina, Marco; Guzzi, Pietro H.; Cannataro, Mario; Guerra, Concettina			AlignNemo: A Local Network Alignment Method to Integrate Homology and Topology	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; YEAST; DATABASE; SIMILARITY; BIOLOGY	Local network alignment is an important component of the analysis of protein-protein interaction networks that may lead to the identification of evolutionary related complexes. We present AlignNemo, a new algorithm that, given the networks of two organisms, uncovers subnetworks of proteins that relate in biological function and topology of interactions. The discovered conserved subnetworks have a general topology and need not to correspond to specific interaction patterns, so that they more closely fit the models of functional complexes proposed in the literature. The algorithm is able to handle sparse interaction data with an expansion process that at each step explores the local topology of the networks beyond the proteins directly interacting with the current solution. To assess the performance of AlignNemo, we ran a series of benchmarks using statistical measures as well as biological knowledge. Based on reference datasets of protein complexes, AlignNemo shows better performance than other methods in terms of both precision and recall. We show our solutions to be biologically sound using the concept of semantic similarity applied to Gene Ontology vocabularies. The binaries of AlignNemo and supplementary details about the algorithms and the experiments are available at: sourceforge.net/p/alignnemo.	[Ciriello, Giovanni; Mina, Marco; Guerra, Concettina] Univ Padua, Dept Informat Engn, Padua, Italy; [Guzzi, Pietro H.; Cannataro, Mario] Magna Graecia Univ Catanzaro, Dept Surg & Med Sci, Germaneto, Italy; [Guerra, Concettina] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA	University of Padua; Magna Graecia University of Catanzaro; University System of Georgia; Georgia Institute of Technology	Ciriello, G (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Dept, 1275 York Ave, New York, NY 10021 USA.	ciriello@cbio.mskcc.org; guerra@dei.unipd.it	Cannataro, Mario/B-1503-2012; Guzzi, Pietro Hiram/AAF-4094-2020	Cannataro, Mario/0000-0003-1502-2387; Ciriello, Giovanni/0000-0003-2021-8683; Mina, Marco/0000-0002-4186-8995	CARIPARO project "Systems Biology approaches to infer gene and protein time-series expression data"	CARIPARO project "Systems Biology approaches to infer gene and protein time-series expression data"	This work was funded in part by the CARIPARO project "Systems Biology approaches to infer gene and protein time-series expression data". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ORTH RES GERST LAB; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cootes AP, 2007, J MOL BIOL, V369, P1126, DOI 10.1016/j.jmb.2007.03.013; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Deng Minghua, 2003, Pac Symp Biocomput, P140; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Faria D, 2007, U LISBON TECHNICAL R; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; Flannick J, 2009, J COMPUT BIOL, V16, P1001, DOI 10.1089/cmb.2009.0099; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Kalaev M, 2008, LECT N BIOINFORMAT, V4955, P246; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kiemer Lars, 2007, Trends Biotechnol, V25, P448, DOI 10.1016/j.tibtech.2007.08.002; Koyuturk M, 2006, J COMPUT BIOL, V13, P182, DOI 10.1089/cmb.2006.13.182; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pache RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031220; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singh Rohit, 2008, Pac Symp Biocomput, P303; Singh R, 2007, LECT NOTES COMPUT SC, V4453, P16; Tian WH, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P99; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	35	74	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38107	10.1371/journal.pone.0038107	http://dx.doi.org/10.1371/journal.pone.0038107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719866	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000012
J	Chong, URW; Abdul-Rahman, PS; Abdul-Aziz, A; Hashim, OH; Junit, SM				Chong, Ursula Rho Wan; Abdul-Rahman, Puteri Shafinaz; Abdul-Aziz, Azlina; Hashim, Onn Haji; Junit, Sarni Mat			Tamarindus indica Extract Alters Release of Alpha Enolase, Apolipoprotein A-I, Transthyretin and Rab GDP Dissociation Inhibitor Beta from HepG2 Cells	PLOS ONE			English	Article							CHOLESTEROL TRANSPORT; BINDING-PROTEIN; APOA-I; GTPASES; L.; HAMSTERS; PULP	Background: The plasma cholesterol and triacylglycerol lowering effects of Tamarindus indica extract have been previously described. We have also shown that the methanol extract of T. indica fruit pulp altered the expression of lipid-associated genes including ABCG5 and APOAI in HepG2 cells. In the present study, effects of the same extract on the release of proteins from the cells were investigated using the proteomics approach. Methodology/Principal Findings: When culture media of HepG2 cells grown in the absence and presence of the methanol extract of T. indica fruit pulp were subjected to 2-dimensional gel electrophoresis, the expression of seven proteins was found to be significantly different (p<0.03125). Five of the spots were subsequently identified as alpha enolase (ENO1), transthyretin (TTR), apolipoprotein A-I (ApoA-I; two isoforms), and rab GDP dissociation inhibitor beta (GDI-2). A functional network of lipid metabolism, molecular transport and small molecule biochemistry that interconnects the three latter proteins with the interactomes was identified using the Ingenuity Pathways Analysis software. Conclusion/Significance: The methanol extract of T. indica fruit pulp altered the release of ENO1, ApoA-I, TTR and GDI-2 from HepG2 cells. Our results provide support on the effect of T. indica extract on cellular lipid metabolism, particularly that of cholesterol.	[Chong, Ursula Rho Wan; Abdul-Rahman, Puteri Shafinaz; Abdul-Aziz, Azlina; Hashim, Onn Haji; Junit, Sarni Mat] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Abdul-Rahman, Puteri Shafinaz; Abdul-Aziz, Azlina; Hashim, Onn Haji; Junit, Sarni Mat] Univ Malaya, Fac Med, Med Biotechnol Lab, Ctr Prote Res, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chong, URW (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	sarni@um.edu.my	Hashim, Onn H/B-9459-2010; Rahman, Puteri Shafinaz Akmar Binti Abdul/B-9511-2010; mat-junit, sarni/J-5838-2015; AZIZ, AZLINA ABDUL/B-8303-2010; MAT-JUNIT, SARNI/GXW-0277-2022	Hashim, Onn H/0000-0002-0196-6793; Rahman, Puteri Shafinaz Akmar Binti Abdul/0000-0002-1818-4552; AZIZ, AZLINA ABDUL/0000-0002-9210-5066; Mat Junit, Sarni/0000-0002-9813-452X	Ministry of Higher Education, Malaysia [H-20001-00-E000009]; University of Malaya [RG014-09AFR]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); University of Malaya(Universiti Malaya)	The present study was funded by the Ministry of Higher Education, Malaysia (H-20001-00-E000009) and the University of Malaya Research Grant (RG014-09AFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; ALESHIRE SL, 1983, J HISTOCHEM CYTOCHEM, V31, P608, DOI 10.1177/31.5.6341455; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibitha B, 2002, INDIAN J MICROBIOL, V42, P361; Bottoni P, 2009, BBA-PROTEINS PROTEOM, V1794, P615, DOI 10.1016/j.bbapap.2009.01.006; Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094; Chisholm JW, 2002, J LIPID RES, V43, P36; HAGEN GA, 1974, ENDOCRINOLOGY, V95, P1398, DOI 10.1210/endo-95-5-1398; Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Iftekhar A S M Maruf, 2006, Pak J Pharm Sci, V19, P125; Jiao R, 2010, J NUTR BIOCHEM, V21, P1134, DOI 10.1016/j.jnutbio.2009.10.007; John J, 2004, ALLELOPATHY J, V14, P43; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Liz MA, 2007, J LIPID RES, V48, P2385, DOI 10.1194/jlr.M700158-JLR200; Martinello F, 2006, FOOD CHEM TOXICOL, V44, P810, DOI 10.1016/j.fct.2005.10.011; Metwali M. R., 2003, Egyptian Journal of Microbiology, V38, P105; Ohnsorg PM, 2011, J BIOL CHEM, V286, P7744, DOI 10.1074/jbc.M110.193524; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; RAZ A, 1969, J BIOL CHEM, V244, P3230; Razali N, 2010, GENES NUTR, V5, P331, DOI 10.1007/s12263-010-0187-5; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Stenmark H, 2001, GENOME BIOL, V2; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Sudjaroen Y, 2005, FOOD CHEM TOXICOL, V43, P1673, DOI 10.1016/j.fct.2005.05.013; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	28	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39476	10.1371/journal.pone.0039476	http://dx.doi.org/10.1371/journal.pone.0039476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724021	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700084
J	Becker, K; Eder, M; Ranft, A; von Meyer, L; Zieglgansberger, W; Kochs, E; Dodt, HU				Becker, Klaus; Eder, Matthias; Ranft, Andreas; von Meyer, Ludwig; Zieglgaensberger, Walter; Kochs, Eberhard; Dodt, Hans-Ulrich			Low Dose Isoflurane Exerts Opposing Effects on Neuronal Network Excitability in Neocortex and Hippocampus	PLOS ONE			English	Article							INTRINSIC OPTICAL SIGNALS; IN-VITRO; GENERAL-ANESTHESIA; PYRAMIDAL NEURONS; HALOTHANE; MECHANISMS; INDUCTION; SLICES; VIDEOMICROSCOPY; INTERNEURONS	The anesthetic excitement phase occurring during induction of anesthesia with volatile anesthetics is a well-known phenomenon in clinical practice. However, the physiological mechanisms underlying anesthetic-induced excitation are still unclear. Here we provide evidence from in vitro experiments performed on rat brain slices that the general anesthetic isoflurane at a concentration of about 0.1 mM can enhance neuronal network excitability in the hippocampus, while simultaneously reducing it in the neocortex. In contrast, isoflurane tissue concentrations above 0.3 mM expectedly caused a pronounced reduction in both brain regions. Neuronal network excitability was assessed by combining simultaneous multisite stimulation via a multielectrode array with recording intrinsic optical signals as a measure of neuronal population activity.	[Becker, Klaus; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria; [Becker, Klaus; Dodt, Hans-Ulrich] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Eder, Matthias; Zieglgaensberger, Walter] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Ranft, Andreas; Kochs, Eberhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80804 Munich, Germany; [von Meyer, Ludwig] Univ Munich, Inst Forens Med, Munich, Germany	Technische Universitat Wien; Medical University of Vienna; Max Planck Society; Technical University of Munich; University of Munich	Becker, K (corresponding author), Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria.	klaus.becker@meduniwien.ac.at		Eder, Matthias/0000-0002-2579-2628; Becker, Klaus/0000-0002-2406-0476				Antkowiak B, 2002, BRIT J ANAESTH, V89, P102, DOI 10.1093/bja/aef154; Becker K, 2005, NEUROREPORT, V16, P993, DOI 10.1097/00001756-200506210-00022; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cerne R, 2002, NEUROSCI LETT, V317, P147, DOI 10.1016/S0304-3940(01)02453-3; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Dodt HU, 1996, NEUROREPORT, V7, P1553, DOI 10.1097/00001756-199607080-00004; Eder M, 2003, J NEUROSCI, V23, P6660; FISHER DM, 1985, ANESTHESIOLOGY, V63, P647, DOI 10.1097/00000542-198512000-00015; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; GUEDEL, 1920, AM J SURG, V34, P53; Hall JE, 1997, BRIT J ANAESTH, V79, P285, DOI 10.1093/bja/79.3.285; HOLTHOFF K, 1994, NEUROSCI LETT, V180, P227, DOI 10.1016/0304-3940(94)90526-6; Ma JY, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0004.2002; MACIVER MB, 1988, BRIT J ANAESTH, V60, P680, DOI 10.1093/bja/60.6.680; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; MARTIN JT, 1959, ANESTHESIOLOGY, V20, P359, DOI 10.1097/00000542-195905000-00017; Nishikawa K, 2001, ANESTHESIOLOGY, V94, P340, DOI 10.1097/00000542-200102000-00025; Nishikawa K, 2000, J NEUROSCI, V20, P5915, DOI 10.1523/JNEUROSCI.20-16-05915.2000; Peixoto NLV, 2001, NEUROSCI LETT, V299, P89, DOI 10.1016/S0304-3940(01)01501-4; PEROUANSKY M, 1995, ANESTHESIOLOGY, V83, P109, DOI 10.1097/00000542-199507000-00014; Ranft A, 2004, EUR J NEUROSCI, V20, P1276, DOI 10.1111/j.1460-9568.2004.03603.x; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; Sloan MH, 1996, ANESTH ANALG, V82, P528, DOI 10.1097/00000539-199603000-00018; Wakasugi M, 1999, ANESTH ANALG, V88, P676, DOI 10.1097/00000539-199903000-00039; WREN WS, 1985, ANAESTHESIA, V40, P315; Zschokke S, 1995, KLIN ELEKTROENZEPHAL	26	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39346	10.1371/journal.pone.0039346	http://dx.doi.org/10.1371/journal.pone.0039346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723999	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300135
J	Chen, DY; Wang, CY; Wen, MS; Lee, TH; Chu, Y; Hsieh, MJ; Chang, SH; Lee, CH; Wang, JL; Chen, CC; Lu, LS; Lee, MT; Yeh, SJ; Lin, FC; Hsieh, IC				Chen, Dong-Yi; Wang, Chao-Yung; Wen, Ming-Shien; Lee, Tsong-Hai; Chu, Yen; Hsieh, Ming-Jer; Chang, Shang-Hung; Lee, Cheng-Hung; Wang, Jian-Liang; Chen, Chun-Chi; Lu, Laing-Suei; Lee, Ming-Ta; Yeh, San-Jou; Lin, Fun-Chiung; Hsieh, I-Chang			Paraoxonase-1 Is Not a Major Determinant of Stent Thrombosis in a Taiwanese Population	PLOS ONE			English	Article							OF-FUNCTION POLYMORPHISM; PERCUTANEOUS CORONARY INTERVENTION; CLOPIDOGREL RESPONSIVENESS; RESPONSE VARIABILITY; PLATELET REACTIVITY; SEQUENCE VARIATIONS; CLINICAL-EFFICACY; GENE VARIANTS; CYP2C19; ASSOCIATION	Background: Clopidogrel is a prodrug that undergoes in vivo bioactivation to show its antiplatelet effects. Recent studies have shown that cytochrome P450 (CYP), ATP-binding cassette transporters (ABCB1), and paraoxonase-1 (PON1) play crucial roles in clopidogrel bioactivation. Here, we aim to determine the effects of genetic polymorphisms of CYP (CYP 2C19*2, CYP 2C19*3, and CYP 2C19*17), ABCB1 (ABCB1 3435C > T, ABCB1 129T > C, and ABCB1 2677G > T/A), and PON1 (PON1 Q192R, PON1 L55M, and PON1 108C > T) on the development of stent thrombosis (ST) in patients receiving clopidogrel after percutaneous coronary intervention (PCI). Methods and Results: We evaluated the incidence of ST (0.64%) in 4964 patients who were recruited in the CAPTAIN registry (Cardiovascular Atherosclerosis and Percutaneous TrAnsluminal INterventions). The presence of genetic polymorphisms was assessed in 20 subjects who developed ST after aspirin and clopidogrel therapy and in 40 age- and sex-matched control subjects who did not develop ST, which was documented after 9 months of angiographic follow-up. ST was acute in 5 subjects, subacute in 7, late in 7, and very late in 1. The presence of CYP 2C19*2 allele was significantly associated with ST (adjusted odds ratio [ORadj]: 4.20, 95% confidence interval [CI], 1.263-9.544; P=0.031). However, genetic variations in PON1 and ABCB1 showed no significant association with ST. Conclusion: We conclude that in a Taiwanese population, PON1 Q192R genotype is not associated with ST development after PCI. However, the presence of CYP 2C19*2 allele is a risk factor for ST development after PCI.	[Chen, Dong-Yi; Wang, Chao-Yung; Wen, Ming-Shien; Hsieh, Ming-Jer; Chang, Shang-Hung; Lee, Cheng-Hung; Wang, Jian-Liang; Chen, Chun-Chi; Yeh, San-Jou; Lin, Fun-Chiung; Hsieh, I-Chang] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med,Sect Cardiol 2, Tao Yuan, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Tao Yuan, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Stroke Ctr, Tao Yuan, Taiwan; [Chu, Yen] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Tao Yuan, Taiwan; [Lu, Laing-Suei; Lee, Ming-Ta] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan	Chen, DY (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med,Sect Cardiol 2, Tao Yuan, Taiwan.	ocean.laboratory@me.com	Hsieh, Ming-Jer/M-1340-2013; Wang, Chao-Yung/ABA-6757-2021	Hsieh, Ming-Jer/0000-0002-0148-8357; Wang, Chao-Yung/0000-0003-1546-7298; Chang, Shang-hung/0000-0003-0462-2344; Chu, Yen/0000-0002-7712-8331	National Health Research Institute [NHRI-EX100-9925SC]; National Science Council [98-2314-B-182A-082-MY3]; Chang Gung Memorial Hospital [CMRPG391861, CMRPG3A1071]; NRPB [101TM1033]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); NRPB	This work was supported by grants to Chao-Yung Wang from the National Health Research Institute (NHRI-EX100-9925SC), the National Science Council (98-2314-B-182A-082-MY3) and the Chang Gung Memorial Hospital (CMRPG391861) and to Ming-Shien Wen from NRPB (101TM1033) and the Chang Gung Memorial Hospital (CMRPG3A1071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Aynacioglu AS, 2000, INT J CARDIOL, V74, P33, DOI 10.1016/S0167-5273(00)00242-4; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Hulot JS, 2011, CIRC-CARDIOVASC INTE, V4, P422, DOI 10.1161/CIRCINTERVENTIONS.111.963025; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Lewis JP, 2011, CLIN PHARMACOL THER, V90, P568, DOI 10.1038/clpt.2011.194; Li WF, 2006, ENVIRON HEALTH PERSP, V114, P1233, DOI 10.1289/ehp.9163; Luo Y, 2011, J INT MED RES, V39, P2012, DOI 10.1177/147323001103900548; Mangiacapra F, 2010, BIOMARK MED, V4, P421, DOI [10.2217/bmm.10.56, 10.2217/BMM.10.56]; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; O'Donoghue M, 2006, CIRCULATION, V114, pE600, DOI 10.1161/CIRCULATIONAHA.106.643171; Oliveira SA, 2004, INT J CARDIOL, V94, P73, DOI 10.1016/j.ijcard.2003.05.011; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Shi Y, 2011, FORENSIC SCI INT, V207, P183, DOI 10.1016/j.forsciint.2010.10.004; Shin BS, 2009, J KOREAN MED SCI, V24, P561, DOI 10.3346/jkms.2009.24.4.561; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Simon T, 2011, CLIN PHARMACOL THER, V90, P561, DOI 10.1038/clpt.2011.193; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Trenk D, 2011, CIRC CARDIOVASC GENE; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x; Wang HH, 2009, PHARMACOGENOMICS, V10, P359, DOI 10.2217/14622416.10.3.359; Wang X, 2002, ARTERIOSCLER THROMB, V23, P328; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zabalza M, 2012, HEART, V98, P100, DOI 10.1136/hrt.2011.227652	37	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39178	10.1371/journal.pone.0039178	http://dx.doi.org/10.1371/journal.pone.0039178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723959	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300112
J	Chen, Z; Gallie, DR				Chen, Zhong; Gallie, Daniel R.			Induction of Monozygotic Twinning by Ascorbic Acid in Tobacco	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; QUIESCENT CENTER; DEHYDROASCORBATE REDUCTASE; WALL MICROTUBULES; GENE-EXPRESSION; CELL-CYCLE; VITAMIN-C; CAMV 35S; POLLEN; MUTANT	Embryo development in plants initiates following the transverse division of a zygote into an apical, proembryo cell and a basal cell that gives rise to the suspensor. Although mutants affected in embryo development through changes in cell division have been described, little is known about the control of the first zygotic division that gives rise to the proembryo. Ascorbic acid (Asc) promotes cell division by inducing G(1) to S progression but its role in embryo development has not been examined. In this study, we show that the level of dehydroascorbate reductase (DHAR) expression, which recycles Asc and regulates Asc pool size, affects the rate of monozygotic twinning and polycotyly. DHAR-induced twinning resulted from altered cell polarity and longitudinal instead of transverse cell division that generated embryos of equal size. Direct injection of Asc into ovaries phenocopied DHAR-induced twinning. Twinning induced by Asc was developmentally limited to the first two days after pollination whereas polycotyly was induced when the level of Asc was elevated just prior to cotyledon initiation. This work describes the first example of gene-directed monozygotic twinning and shows that Asc regulates cell polarity during embryo development.	[Chen, Zhong; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Chen, Z (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			University of California Agricultural Experiment Station	University of California Agricultural Experiment Station(University of California System)	The research was supported by the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGONI O, 1994, J BIOENERG BIOMEMBR, V26, P407, DOI 10.1007/BF00762782; ARRIGONI O, 1989, CARYOLOGIA, V42, P213, DOI 10.1080/00087114.1989.10796967; Arrigoni O, 2000, J PLANT PHYSIOL, V157, P481, DOI 10.1016/S0176-1617(00)80102-9; Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1987, PHOTOINHIBITION, P227; Asada K, 1994, PHOTOINHIBITION PHOT, P129; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bicknell RA, 2004, PLANT CELL, V16, pS228, DOI 10.1105/tpc.017921; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Chen Z, 2005, PLANT PHYSIOL, V138, P1673, DOI 10.1104/pp.105.062000; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; CITTERIO S, 1994, PHYSIOL PLANTARUM, V92, P601; Clowes F. A. L., 1975, The development and function of roots (Third Cabot Symposium)., P3; Conner AJ, 1999, J EXP BOT, V50, P1471, DOI 10.1093/jexbot/50.338.1471; Coulter JM, 1903, MORPHOLOGY ANGIOSPER, P212; Davies M./ B., 1991, VITAMIN C ITS CHEM B; de Mesa MC, 2004, PLANT CELL REP, V23, P32, DOI 10.1007/s00299-004-0776-0; Eskling M, 1997, PHYSIOL PLANTARUM, V100, P806, DOI 10.1034/j.1399-3054.1997.1000407.x; Faure JE, 2002, PLANT J, V30, P481, DOI 10.1046/j.1365-313X.2002.01305.x; Fernando DD, 2000, PLANT CELL REP, V19, P224, DOI 10.1007/s002990050003; Franceschi VR, 2002, PLANT PHYSIOL, V130, P649, DOI 10.1104/pp.007062; GURDON JB, 1992, CELL, V68, P185, DOI 10.1016/0092-8674(92)90465-O; Haberlandt G, 1913, SITZBER K PREUSS AKA, P318; Horemans N, 1997, PLANT PHYSIOL, V114, P1247, DOI 10.1104/pp.114.4.1247; Horemans N, 2000, TRENDS PLANT SCI, V5, P263, DOI 10.1016/S1360-1385(00)01649-6; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P85; INNOCENTI AM, 1990, NEW PHYTOL, V114, P507, DOI 10.1111/j.1469-8137.1990.tb00418.x; Kato N, 1999, PHYSIOL PLANTARUM, V105, P321, DOI 10.1034/j.1399-3054.1999.105218.x; KERK NM, 1995, DEVELOPMENT, V121, P2825; KIRK MM, 1993, J CELL BIOL, V123, P191, DOI 10.1083/jcb.123.1.191; LISO R, 1984, EXP CELL RES, V150, P314, DOI 10.1016/0014-4827(84)90574-3; LISO R, 1988, NEW PHYTOL, V110, P469, DOI 10.1111/j.1469-8137.1988.tb00284.x; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; ODELL JT, 1994, PLANT PHYSIOL, V106, P447, DOI 10.1104/pp.106.2.447; Paciolla C, 2001, PLANT CELL PHYSIOL, V42, P857, DOI 10.1093/pcp/pce113; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Potters G, 2000, PLANT PHYSIOL, V124, P17, DOI 10.1104/pp.124.1.17; RAUTENKRANZ AAF, 1994, PLANT PHYSIOL, V106, P187, DOI 10.1104/pp.106.1.187; SCHWARTZ BW, 1994, DEVELOPMENT, V120, P3235; SHIBAOKA H, 1974, PLANT CELL PHYSIOL, V15, P255; SHIBAOKA H, 1977, BOT MAG TOKYO, V90, P317, DOI 10.1007/BF02489344; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; SMITH JJ, 1992, PHYTOCHEMISTRY, V31, P1485, DOI 10.1016/0031-9422(92)83092-D; Sunilkumar G, 2002, PLANT MOL BIOL, V50, P463, DOI 10.1023/A:1019832123444; Tabata K, 2001, PLANT J, V27, P139, DOI 10.1046/j.1365-313x.2001.01074.x; Tian HQ, 2005, SEX PLANT REPROD, V17, P243, DOI 10.1007/s00497-004-0233-9; Tisserat B, 1979, HORTIC REV, V1, p1B78; TWELL D, 1989, PLANT PHYSIOL, V91, P1270, DOI 10.1104/pp.91.4.1270; Uwer U, 1998, PLANT CELL, V10, P1277, DOI 10.1105/tpc.10.8.1277; van Overbeek J, 1941, SCIENCE, V94, P350, DOI 10.1126/science.94.2441.350; VERNON DM, 1994, DEV BIOL, V165, P566, DOI 10.1006/dbio.1994.1276; Vernon DM, 2001, AM J BOT, V88, P570, DOI 10.2307/2657055; WEERDENBURG C, 1986, CELL MOTIL CYTOSKEL, V6, P469, DOI 10.1002/cm.970060505; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wick SM, 1991, CURR OPIN CELL BIOL, V3, P253, DOI 10.1016/0955-0674(91)90149-S; Wilkinson JE, 1997, J EXP BOT, V48, P265, DOI 10.1093/jxb/48.2.265; YADEGARI R, 1994, PLANT CELL, V6, P1713, DOI 10.1105/tpc.6.12.1713; Young TE, 2004, PLANT J, V38, P910, DOI 10.1111/j.1365-313X.2004.02093.x; Zhang JZ, 1997, P NATL ACAD SCI USA, V94, P7349, DOI 10.1073/pnas.94.14.7349	67	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39147	10.1371/journal.pone.0039147	http://dx.doi.org/10.1371/journal.pone.0039147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723952	Green Published, gold			2022-12-27	WOS:000305583300106
J	Dzamko, N; Inesta-Vaquera, F; Zhang, JZ; Xie, CS; Cai, HB; Arthur, S; Tan, L; Choi, H; Gray, N; Cohen, P; Pedrioli, P; Clark, K; Alessi, DR				Dzamko, Nicolas; Inesta-Vaquera, Francisco; Zhang, Jiazhen; Xie, Chengsong; Cai, Huaibin; Arthur, Simon; Tan, Li; Choi, Hwanguen; Gray, Nathanael; Cohen, Philip; Pedrioli, Patrick; Clark, Kristopher; Alessi, Dario R.			The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; CYTOPLASMIC LOCALIZATION; CROHNS-DISEASE; 14-3-3 BINDING; CROSS-TALK; MUTATIONS; AUTOPHAGY; ALPHA; INFLAMMATION	Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. LRRK2 is highly expressed in immune cells and recent work points towards a link between LRRK2 and innate immunity. Here we demonstrate that stimulation of the Toll-Like Receptor (TLR) pathway by MyD88-dependent agonists in bone marrow-derived macrophages (BMDMs) or RAW264.7 macrophages induces marked phosphorylation of LRRK2 at Ser910 and Ser935, the phosphorylation sites that regulate the binding of 14-3-3 to LRRK2. Phosphorylation of these residues is prevented by knock-out of MyD88 in BMDMs, but not the alternative TLR adaptor protein TRIF. Utilising both pharmacological inhibitors, including a new TAK1 inhibitor, NG25, and genetic models, we provide evidence that both the canonical (IKK alpha and IKK beta) and IKK-related (IKK epsilon and TBK1) kinases mediate TLR agonist induced phosphorylation of LRRK2 in vivo. Moreover, all four IKK members directly phosphorylate LRRK2 at Ser910 and Ser935 in vitro. Consistent with previous work describing Ser910 and Ser935 as pharmacodynamic biomarkers of LRRK2 activity, we find that the TLR independent basal phosphorylation of LRRK2 at Ser910 and Ser935 is abolished following treatment of macrophages with LRRK2 kinase inhibitors. However, the increased phosphorylation of Ser910 and Ser935 induced by activation of the MyD88 pathway is insensitive to LRRK2 kinase inhibitors. Finally, employing LRRK2-deficient BMDMs, we present data indicating that LRRK2 does not play a major role in regulating the secretion of inflammatory cytokines induced by activation of the MyD88 pathway. Our findings provide the first direct link between LRRK2 and the IKKs that mediate many immune responses. Further work is required to uncover the physiological roles that phosphorylation of LRRK2 by IKKs play in controlling macrophage biology and to determine how phosphorylation of LRRK2 by IKKs impacts upon the use of Ser910 and Ser935 as pharmacodynamic biomarkers.	[Dzamko, Nicolas; Inesta-Vaquera, Francisco; Zhang, Jiazhen; Arthur, Simon; Cohen, Philip; Clark, Kristopher; Alessi, Dario R.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Xie, Chengsong; Cai, Huaibin] NIMH, Transgen Sect, Neurogenet Lab, Natl Inst Aging,Natl Inst Hlth, Bethesda, MD 20892 USA; [Tan, Li; Choi, Hwanguen; Gray, Nathanael] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Tan, Li; Choi, Hwanguen; Gray, Nathanael] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pedrioli, Patrick] Univ Dundee, Coll Life Sci, Scottish Inst Life Sci, Dundee, Scotland	University of Dundee; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); NIH National Institute on Aging (NIA); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Dundee	Dzamko, N (corresponding author), Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dow St, Dundee, Scotland.	n.dzamko@neura.edu.au; d.r.alessi@dundee.ac.uk	Cai, Huaibin/H-3359-2013; Dzamko, Nicolas/AAD-6922-2019; Arthur, J. Simon/B-8058-2010	Cai, Huaibin/0000-0002-8596-6108; Arthur, J. Simon/0000-0002-8135-1958; Alessi, Dario/0000-0002-2140-9185; Tan, Li/0000-0002-1199-9046; Dzamko, Nicolas/0000-0002-9121-0294	Medical Research Council; Wellcome Trust UK Parkinsona(TM)s Disease Consortium; Michael J Fox Foundation; National Institute on Aging; NIH [1ZIAAG000944-04]; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Janssen Pharmaceutica; Merck KgaA; Pfizer; Medical Research Council [MC_EX_G0800765, MC_U127084348, G1100713, G0700656, MC_G1000735, MC_U127070193] Funding Source: researchfish; MRC [MC_G1000735, MC_U127070193, G0700656, MC_EX_G0800765, G1100713, MC_U127084348] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000944, ZIAAG000928, ZIAAG000945] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust UK Parkinsona(TM)s Disease Consortium(Wellcome Trust); Michael J Fox Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KgaA; Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Medical Research Council (DRA, PC and SA), Wellcome Trust UK Parkinsona(sic)(TM) s Disease Consortium (DRA), Michael J Fox Foundation (DRA), the Intramural Research Program of National Institute on Aging, NIH (1ZIAAG000944-04 to HC). We also thank the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Janssen Pharmaceutica; Merck KgaA and Pfizer) for financial support. I can also confirm that the funders listed above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Collins LM, 2012, NEUROPHARMACOLOGY; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Doggett EA, 2011, J NEUROCHEM; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Galluzzi L, 2011, EMBO J, V30, P3213, DOI 10.1038/emboj.2011.244; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Ling ZD, 2006, EXP NEUROL, V199, P499, DOI 10.1016/j.expneurol.2006.01.010; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Pauls E, 2011, J BIOL CHEM; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Tong Y, 2010, P NATL ACAD SCI US; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Vancraenenbroeck R, 2012, BBA-PROTEINS PROTEOM, V1824, P450, DOI 10.1016/j.bbapap.2011.12.009; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Weischenfeldt J, 2008, CSH PROTOC, V2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	62	155	155	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39132	10.1371/journal.pone.0039132	http://dx.doi.org/10.1371/journal.pone.0039132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723946	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300099
J	Ramirez-Alvarado, M; Ward, CJ; Huang, BQ; Gong, X; Hogan, MC; Madden, BJ; Charlesworth, MC; Leung, N				Ramirez-Alvarado, Marina; Ward, Christopher J.; Huang, Bing Q.; Gong, Xun; Hogan, Marie C.; Madden, Benjamin J.; Charlesworth, M. Cristine; Leung, Nelson			Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)	PLOS ONE			English	Article							SYSTEMIC AMYLOIDOSIS; STATISTICAL-MODEL; CAST NEPHROPATHY; PROTEINS; PROTEOMICS; KIDNEY; CELLS; IDENTIFICATION; ASSOCIATION; ACCURACY	Renal involvement is a frequent consequence of plasma cell dyscrasias. The most common entities are light chain amyloidosis, monoclonal immunoglobulin deposition disease and myeloma cast nephropathy. Despite a common origin, each condition has its own unique histologic and pathophysiologic characteristic which requires a renal biopsy to distinguish. Recent studies have shown urinary exosomes containing kidney-derived membrane and cytosolic proteins that can be used to probe the proteomics of the entire urinary system from the glomerulus to the bladder. In this study, we analyzed urine exosomes to determine the differences between exosomes from patients with light chain amyloidosis, multiple myeloma, monoclonal gammopathy of undetermined significance, and non-paraproteinemia related kidney disease controls. In patients with light chain amyloidosis, multiple myeloma and monoclonal gammopathy of undetermined significance, immunoreactive proteins corresponding to monomeric light chains were found in exosomes by western blot. In all of the amyloidosis samples with active disease, high molecular weight immunoreactive species corresponding to a decamer were found which were not found in exosomes from the other diseases or in amyloidosis exosomes from patients in remission. Few or no light chains monomeric bands were found in non-paraproteinemia related kidney disease controls. Our results showed that urinary exosomes may have tremendous potential in furthering our understanding of the pathophysiology and diagnosis of plasma cell dyscrasia related kidney diseases.	[Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ward, Christopher J.; Hogan, Marie C.; Leung, Nelson] Mayo Clin, Coll Med, Div Nephrol & Hypertens, Rochester, MN USA; [Huang, Bing Q.] Mayo Clin Rochester, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Gong, Xun] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Madden, Benjamin J.; Charlesworth, M. Cristine] Mayo Clin, Coll Med, Mayo Prote Res Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu; leung.nelson@mayo.edu		Leung, Nelson/0000-0002-5651-1411; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Gong, Xun/0000-0003-4168-2768	National Institutes of Health (NIH) [GM071514, CA111345]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA111345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM071514, NIH CA111345 (MR-A) (http://www.nih.gov/), the generous support of patients with light chain amyloidosis and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Comenzo RL, 2009, BLOOD, V114, P3147, DOI 10.1182/blood-2009-04-202879; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gonzales P, 2008, NEPHROL DIAL TRANSPL, V23, P1799, DOI 10.1093/ndt/gfn058; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hoorn EJ, 2005, NEPHROLOGY, V10, P283, DOI 10.1111/j.1440-1797.2005.00387.x; IVANYI B, 1990, ARCH PATHOL LAB MED, V114, P986; Keeling J, 2004, LAB INVEST, V84, P1322, DOI 10.1038/labinvest.3700161; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knepper MA, 2007, KIDNEY INT, V72, P1043, DOI 10.1038/sj.ki.5002510; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Leung N, 2008, KIDNEY INT, V73, P1282, DOI 10.1038/ki.2008.108; Leung N, 2007, AM J KIDNEY DIS, V50, P155, DOI 10.1053/j.ajkd.2007.05.007; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Soares SM, 2008, AM J KIDNEY DIS, V52, P1079, DOI 10.1053/j.ajkd.2008.05.022; SOLOMON A, 1991, NEW ENGL J MED, V324, P1845, DOI 10.1056/NEJM199106273242603; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; WINEARLS CG, 1995, KIDNEY INT, V48, P1347, DOI 10.1038/ki.1995.421; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874	30	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38061	10.1371/journal.pone.0038061	http://dx.doi.org/10.1371/journal.pone.0038061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723846	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300020
J	Buijsse, B; Lee, DH; Steffen, L; Erickson, RR; Luepker, RV; Jacobs, DR; Holtzman, JL				Buijsse, Brian; Lee, Duk-Hee; Steffen, Lyn; Erickson, Richard R.; Luepker, Russell V.; Jacobs, David R., Jr.; Holtzman, Jordan L.			Low Serum Glutathione Peroxidase Activity Is Associated with Increased Cardiovascular Mortality in Individuals with Low HDLc's	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN-PLASMA; LIPID PEROXIDES; RISK-FACTORS; TRENDS; PURIFICATION; CHOLESTEROL; DISEASE; STROKE	Background: Since oxidized LDL is thought to initiate atherosclerosis and the serum glutathione peroxidase (GPx3) reduces oxidized lipids, we investigated whether high GPx3 activity reduces cardiovascular disease (CVD) mortality. Methods: We determined GPx3 in stored samples from the Minnesota Heart Survey of 130 participants who after 5 to 12 years of follow-up had died of CVD and 240 controls. Participants were 26 to 85 years old and predominantly white. In a nested case-control, study we performed logistic regressions to calculate odds ratios (OR) adjusted for age, sex, baseline year, body mass index, smoking, alcohol intake, physical activity, total and HDL cholesterols, systolic blood pressure, serum glucose and gamma glutamyltransferase (GTT) activity. The referent was the quartile with the highest GPx3 activity (quartile 4). Results: OR's for CVD mortality for increasing quartiles of GPx3 were 2.37, 2.14, 1.83 and 1.00 (P for trend 0.02). This inverse correlation was confined to those with HDLc's below the median (P for interaction, 0.006). The OR's for increasing quartiles of GPx3 in this group were 6.08, 5.00, 3.64 and 1.00 (P for trend, 0.002). Conclusions: Individuals with both low HDLc and GPx3 activity are at markedly increased risk for death from CVD.	[Buijsse, Brian; Lee, Duk-Hee; Steffen, Lyn; Luepker, Russell V.; Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Buijsse, Brian] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Erickson, Richard R.; Holtzman, Jordan L.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Holtzman, Jordan L.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Holtzman, Jordan L.] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN USA; [Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Div Prevent Med, Taegu, South Korea; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	University of Minnesota System; University of Minnesota Twin Cities; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Kyungpook National University; University of Oslo	Buijsse, B (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	holtz003@umn.edu		Buijsse, Brian/0000-0003-0026-9360; Jacobs, David/0000-0002-7232-0543; Steffen, Lyn M/0000-0002-4053-6729				Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Bierl C, 2004, J BIOL CHEM, V279, P26839, DOI 10.1074/jbc.M401907200; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bowman Thomas S., 2008, P25, DOI 10.1007/978-0-387-72347-1_3; Chen NQ, 2000, J LAB CLIN MED, V136, P58, DOI 10.1067/mlc.2000.107692; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Dogru-Abbasoglu S, 1999, CLIN BIOCHEM, V32, P671, DOI 10.1016/S0009-9120(99)00076-4; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Espinola-Klein C, 2007, AM J CARDIOL, V99, P808, DOI 10.1016/j.amjcard.2006.10.041; Holtzman Jordan L, 2002, Clin Lab, V48, P129; Holtzman Jordan L., 2008, P213; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Lee D-H, EUR J CARDIOVASC PRE, V16, P16; Luepker RV, 2006, AM J MED, V119, P42, DOI 10.1016/j.amjmed.2005.08.051; LUEPKER RV, 1985, J CHRON DIS, V38, P671, DOI 10.1016/0021-9681(85)90021-9; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; MCMURRAY J, 1992, BRIT HEART J, V68, P454; Morrison JA, 1999, CIRCULATION, V100, P2244, DOI 10.1161/01.CIR.100.22.2244; National Heart Lung and Blood Institute, 1974, MAN LAB OP LIP RES C, V1, P75; OEN LH, 1992, INT J CLIN PHARM TH, V30, P77; PORTER M, 1992, CLIN SCI, V83, P343, DOI 10.1042/cs0830343; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; Upchurch GR, 1997, J BIOL CHEM, V272, P17012, DOI 10.1074/jbc.272.27.17012; Voetsch B, 2007, STROKE, V38, P41, DOI 10.1161/01.STR.0000252027.53766.2b; WARNICK GR, 1982, CLIN CHEM, V28, P1379	28	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38901	10.1371/journal.pone.0038901	http://dx.doi.org/10.1371/journal.pone.0038901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719980	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000028
J	Otsuka, T; Goto, M; Kawai, M; Togo, Y; Sato, K; Katoh, K; Furuse, M; Yasuo, S				Otsuka, Tsuyoshi; Goto, Mariko; Kawai, Misato; Togo, Yuki; Sato, Katsuyoshi; Katoh, Kazuo; Furuse, Mitsuhiro; Yasuo, Shinobu			Photoperiod Regulates Corticosterone Rhythms by Altered Adrenal Sensitivity via Melatonin-Independent Mechanisms in Fischer 344 Rats and C57BL/6J Mice	PLOS ONE			English	Article							GENE-EXPRESSION; ADRENOCORTICOTROPIC HORMONE; SIGNAL-TRANSDUCTION; CIRCADIAN-RHYTHM; ACTH; PLASMA; GLAND; RESPONSIVENESS; INNERVATION; RECEPTORS	Most species living in temperate zones adapt their physiology and behavior to seasonal changes in the environment by using the photoperiod as a primary cue. The mechanisms underlying photoperiodic regulation of stress-related functions are not well understood. In this study, we analyzed the effects of photoperiod on the hypothalamic-pituitary-adrenal axis in photoperiod-sensitive Fischer 344 rats. We first examined how photoperiod affects diurnal variations in plasma concentrations of adrenocorticotropic hormone (ACTH) and corticosterone. ACTH levels did not exhibit diurnal variations under long-and short-day conditions. On the other hand, corticosterone levels exhibited a clear rhythm under short-day condition with a peak during dark phase. This peak was not observed under long-day condition in which a significant rhythm was not detected. To analyze the mechanisms responsible for the photoperiodic regulation of corticosterone rhythms, ACTH was intraperitoneally injected at the onset of the light or dark phase in dexamethasone-treated rats maintained under long-and short-day conditions. ACTH induced higher corticosterone levels in rats examined at dark onset under short-day condition than those maintained under long-day condition. Next, we asked whether melatonin signals are involved in photoperiodic regulation of corticosterone rhythms, and rats were intraperitoneally injected with melatonin at late afternoon under long-day condition for 3 weeks. However, melatonin injections did not affect the corticosterone rhythms. In addition, photoperiodic changes in the amplitude of corticosterone rhythms were also observed in melatonin-deficient C57BL/6J mice, in which expression profiles of several clock genes and steroidgenesis genes in adrenal gland were modified by the photoperiod. Our data suggest that photoperiod regulates corticosterone rhythms by altered adrenal sensitivity through melatonin-independent mechanisms that may involve the adrenal clock.	[Otsuka, Tsuyoshi; Goto, Mariko; Kawai, Misato; Togo, Yuki; Furuse, Mitsuhiro; Yasuo, Shinobu] Kyushu Univ, Fac Agr, Lab Regulat Metab & Behav, Fukuoka 812, Japan; [Sato, Katsuyoshi; Katoh, Kazuo] Tohoku Univ, Fac Agr, Dept Anim Physiol, Sendai, Miyagi, Japan	Kyushu University; Tohoku University	Otsuka, T (corresponding author), Kyushu Univ, Fac Agr, Lab Regulat Metab & Behav, Fukuoka 812, Japan.	syasuo@brs.kyushu-u.ac.jp		Furuse, Mitsuhiro/0000-0002-7474-1165	Japanese Society for the Promotion of Science [22880026, 23248046]; Takeda Science Foundation; Sumitomo Foundation; Kyushu University; Grants-in-Aid for Scientific Research [24650490] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Research Activity Start-up to SY (No. 22880026) and in part by Grants-in Aid for Scientific Research (A) to MF (No. 23248046) from the Japanese Society for the Promotion of Science. This work was also supported by Life Science Research Grant from Takeda Science Foundation, Grant for Basic Science Research Projects from the Sumitomo Foundation, Kyushu University Interdisciplinary Program in Education and Projects in Research to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRAT Z, 1993, COMP BIOCHEM PHYS A, V104, P29, DOI 10.1016/0300-9629(93)90004-N; Arendt J., 1995, MELATONIN MAMMALIAN; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Ciarleglio CM, 2011, NEUROSCIENCE, V197, P8, DOI 10.1016/j.neuroscience.2011.09.036; DALLMAN MF, 1978, AM J PHYSIOL, V235, pR210, DOI 10.1152/ajpregu.1978.235.5.R210; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Demas GE, 2002, J NEUROENDOCRINOL, V14, P29, DOI 10.1046/j.0007-1331.2001.00736.x; EBIHARA S, 1986, SCIENCE, V231, P491, DOI 10.1126/science.3941912; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; ENGELAND WC, 1977, ENDOCRINOLOGY, V100, P138, DOI 10.1210/endo-100-1-138; Han ES, 1998, J NUTR, V128, P1415, DOI 10.1093/jn/128.9.1415; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Heideman PD, 1997, BIOL REPROD, V57, P134, DOI 10.1095/biolreprod57.1.134; HERMAN JP, 1993, MOL CELL NEUROSCI, V4, P181, DOI 10.1006/mcne.1993.1022; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; KANEKO M, 1981, ENDOCRINOLOGY, V109, P70, DOI 10.1210/endo-109-1-70; Katoh K, 2005, J ENDOCRINOL, V187, P249, DOI 10.1677/joe.1.06206; Lance SJ, 1998, BRAIN RES, V780, P342, DOI 10.1016/S0006-8993(97)01302-4; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; MEIER AH, 1976, ENDOCRINOLOGY, V98, P1475, DOI 10.1210/endo-98-6-1475; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nexon L, 2011, EUR J NEUROSCI, V33, P1308, DOI 10.1111/j.1460-9568.2010.07586.x; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; OTTENWELLER JE, 1987, AM J PHYSIOL, V253, pR321, DOI 10.1152/ajpregu.1987.253.2.R321; Pyter LM, 2007, ENDOCRINOLOGY, V148, P3402, DOI 10.1210/en.2006-1432; Reiter R J, 1980, Endocr Rev, V1, P109; Richter HG, 2008, ENDOCRINOLOGY, V149, P995, DOI 10.1210/en.2007-1009; Ronchi E, 1998, BRAIN RES, V780, P348, DOI 10.1016/S0006-8993(97)01303-6; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; Sage D, 2002, AM J PHYSIOL-ENDOC M, V282, pE458, DOI 10.1152/ajpendo.00287.2001; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Ulrich-Lai YM, 2006, AM J PHYSIOL-REG I, V290, pR1128, DOI 10.1152/ajpregu.00042.2003; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2007, AM J PHYSIOL-REG I, V292, pR1315, DOI 10.1152/ajpregu.00396.2006; Yasuo S, 2009, J NEUROSCI, V29, P2885, DOI 10.1523/JNEUROSCI.0145-09.2009; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	42	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39090	10.1371/journal.pone.0039090	http://dx.doi.org/10.1371/journal.pone.0039090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720039	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000039
J	Shi, SP; Qiu, JD; Sun, XY; Suo, SB; Huang, SY; Liang, RP				Shi, Shao-Ping; Qiu, Jian-Ding; Sun, Xing-Yu; Suo, Sheng-Bao; Huang, Shu-Yun; Liang, Ru-Ping			PMeS: Prediction of Methylation Sites Based on Enhanced Feature Encoding Scheme	PLOS ONE			English	Article							PROTEIN ARGININE METHYLATION; POSTTRANSLATIONAL MODIFICATIONS; HISTONE; IDENTIFICATION; ACCESSIBILITY; SPECIFICITY; EXPRESSION; SULFATION; SEQUENCE; MODELS	Protein methylation is predominantly found on lysine and arginine residues, and carries many important biological functions, including gene regulation and signal transduction. Given their important involvement in gene expression, protein methylation and their regulatory enzymes are implicated in a variety of human disease states such as cancer, coronary heart disease and neurodegenerative disorders. Thus, identification of methylation sites can be very helpful for the drug designs of various related diseases. In this study, we developed a method called PMeS to improve the prediction of protein methylation sites based on an enhanced feature encoding scheme and support vector machine. The enhanced feature encoding scheme was composed of the sparse property coding, normalized van der Waals volume, position weight amino acid composition and accessible surface area. The PMeS achieved a promising performance with a sensitivity of 92.45%, a specificity of 93.18%, an accuracy of 92.82% and a Matthew's correlation coefficient of 85.69% for arginine as well as a sensitivity of 84.38%, a specificity of 93.94%, an accuracy of 89.16% and a Matthew's correlation coefficient of 78.68% for lysine in 10-fold cross validation. Compared with other existing methods, the PMeS provides better predictive performance and greater robustness. It can be anticipated that the PMeS might be useful to guide future experiments needed to identify potential methylation sites in proteins of interest. The online service is available at http://bioinfo.ncu.edu.cn/inquiries_PMeS.aspx.	[Shi, Shao-Ping; Qiu, Jian-Ding; Sun, Xing-Yu; Suo, Sheng-Bao; Huang, Shu-Yun; Liang, Ru-Ping] Nanchang Univ, Dept Chem, Nanchang, Peoples R China; [Shi, Shao-Ping] Nanchang Univ, Dept Math, Nanchang, Peoples R China	Nanchang University; Nanchang University	Shi, SP (corresponding author), Nanchang Univ, Dept Chem, Nanchang, Peoples R China.	jdqiu@ncu.edu.cn	Qiu, Jianding/A-2259-2012; Shi, Shaoping/AAV-9122-2020	Qiu, Jianding/0000-0002-6793-9499; Shi, Shaoping/0000-0003-0045-868X	National Natural Science Foundation of China [21175064, 21163014, 21065006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (21175064, 21163014 and 21065006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen H, 2006, NUCLEIC ACIDS RES, V34, pW249, DOI 10.1093/nar/gkl233; Chen X, 2006, BASIC RES CARDIOL, V101, P346, DOI 10.1007/s00395-006-0592-5; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daily KM, 2005, PROCEEDINGS OF THE 2005 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P475; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Dong LH, 2006, J BIOMOL STRUCT DYN, V24, P239; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Hu LL, 2011, BIOPOLYMERS, V95, P763, DOI 10.1002/bip.21645; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Lapko VN, 2005, PROTEIN SCI, V14, P45, DOI 10.1110/ps.04738505; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mastronardi FG, 2006, J NEUROSCI, V26, P11387, DOI 10.1523/JNEUROSCI.3349-06.2006; Nanni L, 2011, EXPERT SYST APPL, V38, P3185, DOI 10.1016/j.eswa.2010.09.005; Niu S, 2010, J PROTEOME RES, V9, P6490, DOI 10.1021/pr1007152; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Plewczynski D, 2005, BIOINFORMATICS, V21, P2525, DOI 10.1093/bioinformatics/bti333; Predel R, 1999, EUR J BIOCHEM, V263, P552, DOI 10.1046/j.1432-1327.1999.00532.x; Rognvaldsson T, 2007, EXPERT REV MOL DIAGN, V7, P435, DOI 10.1586/14737159.7.4.435; Rognvaldsson T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-149; Rudbeck ME, 2012, J PHYS CHEM B, V116, P2751, DOI 10.1021/jp206414d; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Snijders APL, 2010, J AM SOC MASS SPECTR, V21, P88, DOI 10.1016/j.jasms.2009.09.010; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Suzuki A, 2007, ANN NY ACAD SCI, V1108, P323, DOI 10.1196/annals.1422.034; Teyssier C, 2010, TRENDS ENDOCRIN MET, V21, P181, DOI 10.1016/j.tem.2009.11.002; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Xu JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-8; Zhang ZH, 2006, FEBS LETT, V580, P6169, DOI 10.1016/j.febslet.2006.10.017	49	69	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38772	10.1371/journal.pone.0038772	http://dx.doi.org/10.1371/journal.pone.0038772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719939	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000023
J	Shriner, SA; VanDalen, KK; Mooers, NL; Ellis, JW; Sullivan, HJ; Root, JJ; Pelzel, AM; Franklin, AB				Shriner, Susan A.; VanDalen, Kaci K.; Mooers, Nicole L.; Ellis, Jeremy W.; Sullivan, Heather J.; Root, J. Jeffrey; Pelzel, Angela M.; Franklin, Alan B.			Low-Pathogenic Avian Influenza Viruses in Wild House Mice	PLOS ONE			English	Article							A H5N1 VIRUS; MX1 GENE; INFECTION; TRANSMISSION; OUTBREAK; POULTRY; FERRETS; REPLICATION; PNEUMONIA; LETHALITY	Background: Avian influenza viruses are known to productively infect a number of mammal species, several of which are commonly found on or near poultry and gamebird farms. While control of rodent species is often used to limit avian influenza virus transmission within and among outbreak sites, few studies have investigated the potential role of these species in outbreak dynamics. Methodology/Principal Findings: We trapped and sampled synanthropic mammals on a gamebird farm in Idaho, USA that had recently experienced a low pathogenic avian influenza outbreak. Six of six house mice (Mus musculus) caught on the outbreak farm were presumptively positive for antibodies to type A influenza. Consequently, we experimentally infected groups of naive wild-caught house mice with five different low pathogenic avian influenza viruses that included three viruses derived from wild birds and two viruses derived from chickens. Virus replication was efficient in house mice inoculated with viruses derived from wild birds and more moderate for chicken-derived viruses. Mean titers (EID50 equivalents/mL) across all lung samples from seven days of sampling (three mice/day) ranged from 10(3.89) (H3N6) to 10(5.06) (H4N6) for the wild bird viruses and 10(2.08) (H6N2) to 10(2.85) (H4N8) for the chicken-derived viruses. Interestingly, multiple regression models indicated differential replication between sexes, with significantly (p<0.05) higher concentrations of avian influenza RNA found in females compared with males. Conclusions/Significance: Avian influenza viruses replicated efficiently in wild-caught house mice without adaptation, indicating mice may be a risk pathway for movement of avian influenza viruses on poultry and gamebird farms. Differential virus replication between males and females warrants further investigation to determine the generality of this result in avian influenza disease dynamics.	[Shriner, Susan A.; VanDalen, Kaci K.; Mooers, Nicole L.; Ellis, Jeremy W.; Sullivan, Heather J.; Root, J. Jeffrey; Pelzel, Angela M.; Franklin, Alan B.] USDA Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Agriculture (USDA)	Shriner, SA (corresponding author), USDA Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA.	Susan.A.Shriner@aphis.usda.gov		Shriner, Susan/0000-0003-0349-7182; Ellis, Jeremy/0000-0003-4512-0906; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-25; Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; [Anonymous], 2010, R LANG ENV STAT COMP; Baek YH, 2010, VIRUS RES, V150, P119, DOI 10.1016/j.virusres.2010.03.002; Bailey CF, 1983, EXPT INFECT RACCOON; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; BERG M, 1990, ARCH VIROL, V113, P61, DOI 10.1007/BF01318353; BRUGH M, 1992, AVIAN DIS, V36, P968, DOI 10.2307/1591557; BRUGH M, 1986, AVIAN DIS, V30, P672, DOI 10.2307/1590566; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler D, 2006, NATURE, V439, P773, DOI 10.1038/439773a; Cardona CJ, 2005, THREAT PANDEMIC INFL, P243; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; CHU CM, 1951, J GEN MICROBIOL, V5, P739, DOI 10.1099/00221287-5-4-739; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; GERACI JR, 1982, SCIENCE, V215, P1129; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Hall JS, 2008, EMERG INFECT DIS, V14, P1842, DOI 10.3201/eid1412.071371; HALLER O, 1987, J INTERFERON RES, V7, P647, DOI 10.1089/jir.1987.7.647; Henzler DJ, 2003, AVIAN DIS, V47, P1022, DOI 10.1637/0005-2086-47.s3.1022; HINSHAW VS, 1984, J VIROL, V51, P863, DOI 10.1128/JVI.51.3.863-865.1984; HINSHAW VS, 1986, J VIROL, V58, P655, DOI 10.1128/JVI.58.2.655-656.1986; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Jin HK, 1998, BIOCHEM GENET, V36, P311, DOI 10.1023/A:1018741312058; JOHNSON DC, 1977, AVIAN DIS, V21, P167, DOI 10.2307/1589337; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1132, DOI 10.3201/eid1407.071468; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; KLINGEBORN B, 1985, ARCH VIROL, V86, P347, DOI 10.1007/BF01309839; Klopfleisch R, 2007, J COMP PATHOL, V137, P155, DOI 10.1016/j.jcpa.2007.06.001; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kuiken T, 2006, NATURE, V440, P741, DOI 10.1038/440741a; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Leschnik M, 2007, EMERG INFECT DIS, V13, P243, DOI 10.3201/eid1302.060608; MAROIS P, 1971, CAN J COMPARAT MED, V35, P71; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; NETTLES VF, 1985, AVIAN DIS, V29, P733, DOI 10.2307/1590665; Ninomiya A, 2002, VET MICROBIOL, V88, P107, DOI 10.1016/S0378-1135(02)00105-0; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Pocock MJO, 2004, J ANIM ECOL, V73, P878, DOI 10.1111/j.0021-8790.2004.00863.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Reperant LA, 2008, EMERG INFECT DIS, V14, P1835, DOI 10.3201/eid1412.080470; Rigoni M, 2010, VET RES, V41, DOI 10.1051/vetres/2010038; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Roberton SI, 2006, P ROY SOC B-BIOL SCI, V273, P1729, DOI 10.1098/rspb.2006.3549; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Shortridge KF, 2000, VET MICROBIOL, V74, P141, DOI 10.1016/S0378-1135(00)00174-7; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Subbarao K, 2000, CELL MOL LIFE SCI, V57, P1770, DOI 10.1007/PL00000657; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; U.S. Interagency Working Group, 2006, EARL DET SYST HIGHL; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; Vandalen KK, 2009, MAMMAL REV, V39, P167, DOI 10.1111/j.1365-2907.2009.00144.x; WILLIAMS K, 1977, J HYG-CAMBRIDGE, V79, P249, DOI 10.1017/S0022172400053067; Yee KS, 2009, VIROLOGY, V394, P19, DOI 10.1016/j.virol.2009.08.017; Yingst SL, 2006, EMERG INFECT DIS, V12, P1295, DOI 10.3201/eid1708.060264; [No title captured]	68	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39206	10.1371/journal.pone.0039206	http://dx.doi.org/10.1371/journal.pone.0039206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720076	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000050
J	Oellrich, A; Hoehndorf, R; Gkoutos, GV; Rebholz-Schuhmann, D				Oellrich, Anika; Hoehndorf, Robert; Gkoutos, Georgios V.; Rebholz-Schuhmann, Dietrich			Improving Disease Gene Prioritization by Comparing the Semantic Similarity of Phenotypes in Mice with Those of Human Diseases	PLOS ONE			English	Article							HESX1 MUTATIONS; GENOME-WIDE; ONTOLOGY; DATABASE; RESOURCE; INTEROPERABILITY; DYSPLASIA; MODEL; GDF6	Despite considerable progress in understanding the molecular origins of hereditary human diseases, the molecular basis of several thousand genetic diseases still remains unknown. High-throughput phenotype studies are underway to systematically assess the phenotype outcome of targeted mutations in model organisms. Thus, comparing the similarity between experimentally identified phenotypes and the phenotypes associated with human diseases can be used to suggest causal genes underlying a disease. In this manuscript, we present a method for disease gene prioritization based on comparing phenotypes of mouse models with those of human diseases. For this purpose, either human disease phenotypes are "translated" into a mouse-based representation (using the Mammalian Phenotype Ontology), or mouse phenotypes are "translated" into a human-based representation (using the Human Phenotype Ontology). We apply a measure of semantic similarity and rank experimentally identified phenotypes in mice with respect to their phenotypic similarity to human diseases. Our method is evaluated on manually curated and experimentally verified gene-disease associations for human and for mouse. We evaluate our approach using a Receiver Operating Characteristic (ROC) analysis and obtain an area under the ROC curve of up to. Furthermore, we are able to confirm previous results that the Vax1 gene is involved in Septo-Optic Dysplasia and suggest Gdf6 and Marcks as further potential candidates. Our method significantly outperforms previous phenotype-based approaches of prioritizing gene-disease associations. To enable the adaption of our method to the analysis of other phenotype data, our software and prioritization results are freely available under a BSD licence at http://code.google.com/p/phenomeblast/wiki/CAMP. Furthermore, our method has been integrated in PhenomeNET and the results can be explored using the PhenomeBrowser at http://phenomebrowser.net.	[Oellrich, Anika; Rebholz-Schuhmann, Dietrich] European Bioinformat Inst, Hinxton, England; [Hoehndorf, Robert; Gkoutos, Georgios V.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	European Molecular Biology Laboratory (EMBL); University of Cambridge	Oellrich, A (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, England.	anika@ebi.ac.uk	Hoehndorf, Robert/H-6127-2019; Gkoutos, Georgios/AAS-9936-2020; Hoehndorf, Robert/A-9943-2011	Hoehndorf, Robert/0000-0001-8149-5890; Gkoutos, Georgios/0000-0002-2061-091X; Hoehndorf, Robert/0000-0001-8149-5890; Rebholz-Schuhmann, Dietrich/0000-0002-1018-0370	European Bioinformatics Institute; European Commission [248502]; BBSRC (Biotechnology and Biological Sciences Research Council) [BBG0043581]	European Bioinformatics Institute; European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AO and DRS are funded by the European Bioinformatics Institute. Funding for RH was provided by the European Commission, 7th Framework Programme, RICORDO project, grant number 248502. Funding for GVG was provided by BBSRC (Biotechnology and Biological Sciences Research Council) grant BBG0043581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Amberger J., 2011, HUM MUTAT; [Anonymous], 2010, NATURE, V465, P526, DOI 10.1038/465526a; Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Bharti K, 2011, DEVELOPMENT, V138, P873, DOI 10.1242/dev.056465; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Chen CK, 2012, HUMAN MUTATION; Collins FS, 2007, CELL, V129, P235, DOI 10.1016/j.cell.2007.04.007; Cruz IF, 2009, AGREEMENTMAKER EFFIC, P1; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Degtyarenko K, 2007, NUCL ACIDS RES; Drysdale R, 2001, Brief Bioinform, V2, P68, DOI 10.1093/bib/2.1.68; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Espinosa O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019693; Euzenat J., 2007, ONTOLOGY MATCHING; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Ghazvinian Amir, 2009, AMIA Annu Symp Proc, V2009, P198; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Gkoutos GV, 2009, IEEE ENG MED BIO, P7069, DOI 10.1109/IEMBS.2009.5333362; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Gruber T. R, 1995, INT J HUMAN COMPUTER, V43; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Hoehndorf R, 2011, BIOINFORMATICS, V27, P1001, DOI 10.1093/bioinformatics/btr058; Hoehndorf R, 2010, BIOINFORMATICS, V26, P3112, DOI 10.1093/bioinformatics/btq578; Kazakov Y, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P2040; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Sardana D, 2010, NUCL ACIDS RES; Schindelman G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-32; Schofield PN, 2004, RADIAT PROT DOSIM, V112, P525, DOI 10.1093/rpd/nch101; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Thomas PQ, 2001, HUM MOL GENET, V10, P39, DOI 10.1093/hmg/10.1.39; TRANCHEVENT LC, 2010, BRIEFINGS BIOINFORMA; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Weinreich S S, 2008, Ned Tijdschr Geneeskd, V152, P518; Xu T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-472	50	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38937	10.1371/journal.pone.0038937	http://dx.doi.org/10.1371/journal.pone.0038937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719993	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800028
J	Khademi, H; Radmard, AR; Malekzadeh, F; Kamangar, F; Nasseri-Moghaddam, S; Johansson, M; Byrnes, G; Brennan, P; Malekzadeh, R				Khademi, Hooman; Radmard, Amir-Reza; Malekzadeh, Fatemeh; Kamangar, Farin; Nasseri-Moghaddam, Siavosh; Johansson, Mattias; Byrnes, Graham; Brennan, Paul; Malekzadeh, Reza			Diagnostic Accuracy of Age and Alarm Symptoms for Upper GI Malignancy in Patients with Dyspepsia in a GI Clinic: A 7-Year Cross-Sectional Study	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; UPPER GASTROINTESTINAL MALIGNANCY; UNINVESTIGATED DYSPEPSIA; ENDOSCOPIC FINDINGS; PREDICTIVE MODELS; CANCER REGISTRY; GASTRIC-CANCER; MANAGEMENT; PREVALENCE; FEATURES	Objectives: We investigated whether using demographic characteristics and alarm symptoms can accurately predict cancer in patients with dyspepsia in Iran, where upper GI cancers and H. pylori infection are common. Methods: All consecutive patients referred to a tertiary gastroenterology clinic in Tehran, Iran, from 2002 to 2009 were invited to participate in this study. Each patient completed a standard questionnaire and underwent upper gastrointestinal endoscopy. Alarm symptoms included in the questionnaire were weight loss, dysphagia, GI bleeding, and persistent vomiting. We used logistic regression models to estimate the diagnostic value of each variable in combination with other ones, and to develop a risk-prediction model. Results: A total of 2,847 patients with dyspepsia participated in this study, of whom 87 (3.1%) had upper GI malignancy. Patients reporting at least one of the alarm symptoms constituted 66.7% of cancer patients compared to 38.9% in patients without cancer (p<0.001). Esophageal or gastric cancers in patients with dyspepsia was associated with older age, being male, and symptoms of weight loss and vomiting. Each single predictor had low sensitivity and specificity. Using a combination of age, alarm symptoms, and smoking, we built a risk-prediction model that distinguished between high-risk and low-risk individuals with an area under the ROC curve of 0.85 and acceptable calibration. Conclusions: None of the predictors demonstrated high diagnostic accuracy. While our risk-prediction model had reasonable accuracy, some cancer cases would have remained undiagnosed. Therefore, where available, low cost endoscopy may be preferable for dyspeptic older patient or those with history of weight loss.	[Khademi, Hooman; Radmard, Amir-Reza; Malekzadeh, Fatemeh; Kamangar, Farin; Nasseri-Moghaddam, Siavosh; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Univ Tehran, Tehran, Iran; [Khademi, Hooman; Johansson, Mattias; Byrnes, Graham; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA	Tehran University of Medical Sciences; University of Tehran; World Health Organization; International Agency for Research on Cancer (IARC); Morgan State University	Khademi, H (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Univ Tehran, Tehran, Iran.	malek@ams.ac.ir	Johansson, Mattias/ABF-3365-2020; Khademi, Hooman/AAZ-8798-2020; Malekzadeh, Reza/U-1382-2017	Malekzadeh, Reza/0000-0002-9820-6335; Byrnes, Graham/0000-0003-3893-7539; Malekzadeh, Reza/0000-0003-1043-3814; Johansson, Mattias/0000-0002-3116-5081				Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020; [Anonymous], 1998, Gastroenterology, V114, P579; Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; AXON ATR, 1995, BMJ-BRIT MED J, V310, P853, DOI 10.1136/bmj.310.6983.853; Ayoola EA, 1996, HEPATO-GASTROENTEROL, V43, P409; Babaei M, 2010, ASIAN PAC J CANCER P, V11, P595; Bai Y, 2010, GUT, V59, P722, DOI 10.1136/gut.2009.192401; Barazandeh Farhad, 2012, Middle East J Dig Dis, V4, P90; BARBARA L, 1989, DIGEST DIS SCI, V34, P1272, DOI 10.1007/BF01537277; Barkun AN, 2010, CAN J GASTROENTEROL, V24, P489, DOI 10.1155/2010/379583; Bazaldua OV, 1999, AM FAM PHYSICIAN, V60, P1773; Bramble MG, 2000, GUT, V46, P464, DOI 10.1136/gut.46.4.464; Bytzer P, 2001, ANN INTERN MED, V134, P815, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00004; Chen LQ, 1999, DIS ESOPHAGUS, V12, P161; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Delaney B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001961.pub2; Delaney BC, 2000, LANCET, V356, P1965, DOI 10.1016/S0140-6736(00)03308-0; Derakhshan MH, 2004, GUT, V53, P1262, DOI 10.1136/gut.2003.035857; Dickerson LM, 2004, AM FAM PHYSICIAN, V70, P107; Eisen GM, 2001, GASTROINTEST ENDOSC, V54, P815, DOI 10.1016/S0016-5107(01)70083-1; El-Serag HB, 2004, ALIMENT PHARM THER, V19, P643, DOI 10.1111/j.1365-2036.2004.01897.x; Fisher RS, 1998, NEW ENGL J MED, V339, P1376, DOI 10.1056/NEJM199811053391907; Ford AC, 2005, GASTROENTEROLOGY, V128, P1838, DOI 10.1053/j.gastro.2005.03.004; Ford AC, 2008, DIGEST DIS, V26, P225, DOI 10.1159/000121351; Ford AC, 2010, HELICOBACTER, V15, P1, DOI [10.1111/j.1523-5378.2010.00779.x, 10.1111/j.1523-5378.2011.00874.x]; Fransen GAJ, 2004, ALIMENT PHARM THERAP, V20, P1045, DOI 10.1111/j.1365-2036.2004.02251.x; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; HALLISSEY MT, 1990, BRIT MED J, V301, P513, DOI 10.1136/bmj.301.6751.513; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; HEIKKINEN M, 1995, SCAND J GASTROENTERO, V30, P519, DOI 10.3109/00365529509089783; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; Kolahdoozan S, 2010, ARCH IRAN MED, V13, P143; Malekzadeh R, 2004, J CLIN PATHOL, V57, P37, DOI 10.1136/jcp.57.1.37; Malekzadeh R, 2009, ARCH IRAN MED, V12, P576; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; MANSI C, 1990, DIGEST DIS SCI, V35, P1452, DOI 10.1007/BF01540561; Moayyedi P, 2002, GUT, V50, P10, DOI 10.1136/gut.50.suppl_4.iv10; Moayyedi P, 1999, AM J GASTROENTEROL, V94, P3122, DOI 10.1111/j.1572-0241.1999.01502.x; Mohagheghi MA, 2009, ARCH IRAN MED, V12, P15; Nasseri-Moghaddam S, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-42; National Institute for Health and Clinical Excellence, 2004, DYSP MAN DYSP AD PRI, P17; Numans ME, 2001, SCAND J GASTROENTERO, V36, P437, DOI 10.1080/003655201300051379; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Sadjadi Alireza, 2005, Asian Pac J Cancer Prev, V6, P359; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schroeder BM, 2003, AM FAM PHYSICIAN, V68, P1215; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P233, DOI 10.1016/S0016-5085(99)70573-1; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; TALLEY NJ, 1993, AM FAM PHYSICIAN, V47, P1407; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; Thomson ABR, 2003, ALIMENT PHARM THER, V17, P1481, DOI 10.1046/j.1365-2036.2003.01646.x; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Vakil N, 2009, CLIN GASTROENTEROL H, V7, P756, DOI 10.1016/j.cgh.2009.03.031; van Zanten SJOV, 2000, CAN MED ASSOC J, V162, pS3; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Voutilainen M, 2005, DIGEST LIVER DIS, V37, P526, DOI 10.1016/j.dld.2005.01.012; Wallace MB, 2001, GUT, V49, P29, DOI 10.1136/gut.49.1.29	64	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39173	10.1371/journal.pone.0039173	http://dx.doi.org/10.1371/journal.pone.0039173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720064	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900089
J	Thielman, N; Ostermann, J; Whetten, K; Whetten, R; O'Donnell, K				Thielman, Nathan; Ostermann, Jan; Whetten, Kathryn; Whetten, Rachel; O'Donnell, Karen		Positive Outcomes Orphans POFO Res	Correlates of Poor Health among Orphans and Abandoned Children in Less Wealthy Countries: The Importance of Caregiver Health	PLOS ONE			English	Article							QUALITY-OF-LIFE; HIV-INFECTION; VULNERABLE CHILDREN; LOW-INCOME; MORTALITY; RISK; AIDS; SURVIVAL; IMPACT; FOOD	Background: More than 153 million children worldwide have been orphaned by the loss of one or both parents, and millions more have been abandoned. We investigated relationships between the health of orphaned and abandoned children (OAC) and child, caregiver, and household characteristics among randomly selected OAC in five countries. Methodology: Using a two-stage random sampling strategy in 6 study areas in Cambodia, Ethiopia, India, Kenya, and Tanzania, the Positive Outcomes for Orphans (POFO) study identified 1,480 community-living OAC ages 6 to 12. Detailed interviews were conducted with 1,305 primary caregivers at baseline and after 6 and 12 months. Multivariable logistic regression models describe associations between the characteristics of children, caregivers, and households and child health outcomes: fair or poor child health; fever, cough, or diarrhea within the past two weeks; illness in the past 6 months; and fair or poor health on at least two assessments. Principal Findings: Across the six study areas, 23% of OAC were reported to be in fair or poor health; 19%, 18%, and 2% had fever, cough, or diarrhea, respectively, within the past two weeks; 55% had illnesses within the past 6 months; and 23% were in fair or poor health on at least two assessments. Female gender, suspected HIV infection, experiences of potentially traumatic events, including the loss of both parents, urban residence, eating fewer than 3 meals per day, and low caregiver involvement were associated with poorer child health outcomes. Particularly strong associations were observed between child health measures and the health of their primary caregivers. Conclusions: Poor caregiver health is a strong signal for poor health of OAC. Strategies to support OAC should target the caregiver-child dyad. Steps to ensure food security, foster gender equality, and prevent and treat traumatic events are needed.	[Thielman, Nathan; Ostermann, Jan; Whetten, Kathryn; Whetten, Rachel; O'Donnell, Karen] Duke Univ, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC 27706 USA; [Thielman, Nathan] Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC USA; [O'Donnell, Karen] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [O'Donnell, Karen] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [O'Donnell, Karen] Duke Univ, Ctr Child & Family Hlth, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Thielman, N (corresponding author), Duke Univ, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC 27706 USA.	n.thielman@duke.edu	Whetten, Kathryn/C-8572-2009; Ostermann, Jan/GQB-4743-2022; Thielman, Nathan/R-5142-2019	Whetten, Kathryn/0000-0002-4841-7695; Thielman, Nathan/0000-0001-8152-2879; Ostermann, Jan/0000-0002-8236-9500; Masnick, Max/0000-0001-6299-6251; Agala, Chris B/0000-0001-7157-814X	National Institute of Child Health and Development (NICHD) [5R01HD046345-04]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [5R01HD046345]; ACE Africa, Bungoma, Kenya; Homeland Meahto Phum Ko'Mah in Battambang, Cambodia; KIWAKKUKI, TAWREF; Kilimanjaro Christian Medical Centre in Moshi, Tanzania; SaveLives Ethiopia and Save the Vulnerables Organization; Addis Ababa, Ethiopia; Sahara Centre for Rehabilitation and Residential Care in Delhi, India; Sahara Centre for Rehabilitation and Residential Care in Hyderabad, India; Sahara Centre for Rehabilitation and Residential Care in Nagaland, India; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046345] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ACE Africa, Bungoma, Kenya; Homeland Meahto Phum Ko'Mah in Battambang, Cambodia; KIWAKKUKI, TAWREF; Kilimanjaro Christian Medical Centre in Moshi, Tanzania; SaveLives Ethiopia and Save the Vulnerables Organization; Addis Ababa, Ethiopia; Sahara Centre for Rehabilitation and Residential Care in Delhi, India; Sahara Centre for Rehabilitation and Residential Care in Hyderabad, India; Sahara Centre for Rehabilitation and Residential Care in Nagaland, India; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Development (NICHD), grant No. 5R01HD046345-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project described was supported by grant # 5R01HD046345 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.; We thank all the children and caregivers who participated in this study. We appreciate the support that has been provided by the partner organizations: ACE Africa, Bungoma, Kenya; Homeland Meahto Phum Ko'Mah in Battambang, Cambodia; KIWAKKUKI, TAWREF, and the Kilimanjaro Christian Medical Centre in Moshi, Tanzania; SaveLives Ethiopia and Save the Vulnerables Organization, Addis Ababa, Ethiopia; and Sahara Centre for Rehabilitation and Residential Care in Delhi, Hyderabad and Nagaland, India. We thank Lynn Messer and Brian Pence for offering critical reviews and input into early drafts of this manuscript.	Agnihotri K, 2010, J PSYCHOSOM RES, V69, P525, DOI 10.1016/j.jpsychores.2010.03.011; Ainsworth M, 2000, IMPACT ADULT DEATHS; Benson T, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P87; Birdthistle IJ, 2008, AIDS, V22, P759, DOI 10.1097/QAD.0b013e3282f4cac7; Caballero B, 2002, ANN NUTR METAB, V46, P3, DOI 10.1159/000066400; CHEN LC, 1981, POPUL DEV REV, V7, P55, DOI 10.2307/1972764; Cook JT, 2004, J NUTR, V134, P1432; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; Desilva MB, 2008, VULNERABLE CHILD YOU, V3, P102, DOI 10.1080/17450120701868411; Dunbar MS, 2010, J PREV INTERV COMMUN, V38, P147, DOI 10.1080/10852351003640849; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Galiano A., 2008, HLTH SHOCKS HOUSEHOL; Glaziou P, 2009, CLIN CHEST MED, V30, P621, DOI 10.1016/j.ccm.2009.08.017; Gregson S, 2005, AIDS CARE, V17, P785, DOI 10.1080/09540120500258029; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; HILL K, 1995, POPUL DEV REV, V21, P127, DOI 10.2307/2137416; Hosegood V, 2007, POP STUD-J DEMOG, V61, P327, DOI 10.1080/00324720701524292; Hussain A, 1999, TROP MED INT HEALTH, V4, P758, DOI 10.1046/j.1365-3156.1999.00485.x; Joslin D, 2002, AIDS CARE, V14, P619, DOI 10.1080/0954012021000005443; Kamali A, 1996, AIDS CARE, V8, P509, DOI 10.1080/09540129650125470; Katz J, 2003, B WORLD HEALTH ORGAN, V81, P717; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Kuo C, 2011, AIDS CARE, V23, P1128, DOI 10.1080/09540121.2011.554527; Lefante JJ, 2005, QUAL LIFE RES, V14, P665, DOI 10.1007/s11136-004-0784-0; Lindblade KA, 2003, TROP MED INT HEALTH, V8, P67, DOI 10.1046/j.1365-3156.2003.00987.x; Littrell M, 2011, AIDS CARE, V23, P1551, DOI 10.1080/09540121.2011.582079; Mason JB, 2005, PUBLIC HEALTH NUTR, V8, P551, DOI 10.1079/PHN2005726; Messer LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-504; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Nakiyingi JS, 2003, AIDS, V17, P1827, DOI 10.1097/00002030-200308150-00012; O'Donnell K, CHILD STATUS INDEX T; O'Donnell K, 2012, AIDS BEHAV, V16, P480, DOI 10.1007/s10461-011-9940-z; Panpanich R, 1999, ANN TROP PAEDIATR, V19, P279, DOI 10.1080/02724939992374; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Pianta R.C., 1996, MANUAL SCORING GUIDE; POFO Study Team, 2010, POS OUTC ORPH POFO S; Racine EF, 2009, PUBLIC HEALTH NUTR, V12, P1443, DOI 10.1017/S1368980008004229; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Rousham EK, 1996, EUR J CLIN NUTR, V50, P560; Sarker M, 2005, TROP MED INT HEALTH, V10, P210, DOI 10.1111/j.1365-3156.2004.01377.x; Senefeld S., 2009, ORPHANS VULNERABLE C; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Stover J, 2007, HEALTH POLICY PLANN, V22, P21, DOI 10.1093/heapol/czl033; Taha TET, 1996, AIDS, V10, P111, DOI 10.1097/00002030-199601000-00021; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Trapp EM, 2004, ANN M POP ASS AM 1A3; UNAIDS, 2010, GLOB REP UNAIDS REP; UNICEF, 2011, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; Urassa M, 2001, AIDS, V15, P2017, DOI 10.1097/00002030-200110190-00015; Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779; Whetten K, 2011, J TRAUMA STRESS, V24, P174, DOI 10.1002/jts.20625; Whetten K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008169; Whetten R, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-1; World Bank, 2008, CHILD NEEDS ASS CNA; World Health Organization, 2011, WORLD HLTH STAT 2011; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	59	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38109	10.1371/journal.pone.0038109	http://dx.doi.org/10.1371/journal.pone.0038109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719867	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900020
J	Ahn, JH				Ahn, Jung Ho			ccTSA: A Coverage-Centric Threaded Sequence Assembler	PLOS ONE			English	Article								De novo sequencing, a process to find the whole genome or the regions of a species without references, requires much higher computational power compared to mapped sequencing with references. The advent and continuous evolution of next-generation sequencing technologies further stress the demands of high-throughput processing of myriads of short DNA fragments. Recently announced sequence assemblers, such as Velvet, SOAPdenovo, and ABySS, all exploit parallelism to meet these computational demands since contemporary computer systems primarily rely on scaling the number of computing cores to improve performance. However, most of them are not tailored to exploit the full potential of these systems, leading to suboptimal performance. In this paper, we present ccTSA, a parallel sequence assembler that utilizes coverage to prune k-mers, find preferred edges, and resolve conflicts in preferred edges between k-mers. We minimize computation dependencies between threads to effectively parallelize k-mer processing. We also judiciously allocate and reuse memory space in order to lower memory usage and further improve sequencing speed. The results of ccTSA are compelling such that it runs several times faster than other assemblers while providing comparable quality values such as N50.	Seoul Natl Univ, Dept Intelligent Convergence Syst, Seoul, South Korea	Seoul National University (SNU)	Ahn, JH (corresponding author), Seoul Natl Univ, Dept Intelligent Convergence Syst, Seoul, South Korea.	gajh@snu.ac.kr	Ahn, Jung Ho/D-1298-2013	Ahn, Jung Ho/0000-0003-1733-1394	Seoul National University	Seoul National University	This work was supported by the Seoul National University Brain Fusion Program Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berger ED, 2002, ACM SIGPLAN NOTICES, V37, P1, DOI 10.1145/583854.582421; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Culler D., 1998, PARALLEL COMPUTER AR; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hennessy John L., 2011, COMPUTER ARCHITECTUR; Jackson BG, 2010, 24 IEEE INT PAR DIST, DOI [10.1109/IPDPS.2010.5470397, DOI 10.1109/IPDPS.2010.5470397]; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39232	10.1371/journal.pone.0039232	http://dx.doi.org/10.1371/journal.pone.0039232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723971	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700056
J	Bai, Y; Yang, WW; Yang, HX; Liao, QP; Ye, G; Fu, GD; Ji, L; Xu, P; Wang, H; Li, YX; Peng, C; Wang, YL				Bai, Yang; Yang, Weiwei; Yang, Hui-xia; Liao, Qinping; Ye, Gang; Fu, Guodong; Ji, Lei; Xu, Peng; Wang, Hao; Li, Yu-xia; Peng, Chun; Wang, Yan-ling			Downregulated miR-195 Detected in Preeclamptic Placenta Affects Trophoblast Cell Invasion via Modulating ActRIIA Expression	PLOS ONE			English	Article							SUPPRESSES TUMORIGENICITY; HEPATOCELLULAR-CARCINOMA; PROMOTES APOPTOSIS; ACTIVIN RECEPTORS; MICRORNA; PROLIFERATION; TARGET; PROFILE; GENES; LET-7	Background: Preeclampsia (PE) is a pregnancy-specific syndrome manifested by on-set of hypertension and proteinuria after 20 weeks of gestation. Abnormal placenta development has been generally accepted as initial cause of the disorder. Recently, miR-195 was found to be down-regulated in preeclamptic placentas compared with normal pregnant ones, indicating possible association of this small molecule with placental pathology of preeclampsia. By far the function of miR-195 in the development of placenta remains unknown. Methodology/Principal Findings: Bioinformatic assay predicted ActRIIA as one of the targets for miR-195. By using Real-time PCR, Western blotting and Dual Luciferase Assay, we validated that ActRIIA was the direct target of miR-195 in human trophoblast cells. Transwell insert invasion assay showed that miR-195 could promote cell invasion in trophoblast cell line, HTR8/SVneo cells, and the effect could be abrogated by overexpressed ActRIIA. In preeclamptic placenta tissues, pri-miR-195 and mature miR-195 expressions were down-regulated, whereas ActRIIA level appeared to be increased when compared with that in gestational-week-matched normal placentas. Conclusions/Significance: This is the first report on the function of miR-195 in human placental trophoblast cells which reveals an invasion-promoting effect of the small RNA via repressing ActRIIA. Aberrant expression of miR-195 may contribute to the occurrence of preeclampsia through interfering with Activin/Nodal signaling mediated by ActRIIA in human placenta.	[Bai, Yang; Yang, Weiwei; Ji, Lei; Xu, Peng; Wang, Hao; Li, Yu-xia; Wang, Yan-ling] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yang, Hui-xia; Liao, Qinping] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Ye, Gang; Fu, Guodong; Peng, Chun] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Bai, Yang; Yang, Weiwei; Xu, Peng; Wang, Hao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University; York University - Canada; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, Y (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	cpeng@yorku.ca; wangyl@ioz.ac.cn	Fu, Guodong/AGF-1991-2022; Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X; Yang, Huixia/0000-0001-8954-2102; YANG, HUIXIA/0000-0001-9913-2721	Chinese National Special Fund for Basic Research Project [2011CB944400]; National Natural Sciences Foundation [81025004, 3081120430]; Canadian Institutes of Health Research [CCI-92222, MOP-81370]	Chinese National Special Fund for Basic Research Project; National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Chinese National Special Fund for Basic Research Project (2011CB944400) (URL: http://www.973.gov.cn/English/Index.aspx), the National Natural Sciences Foundation (81025004 and 3081120430) (URL: http://www.nsfc.gov.cn/english/07fd/07.html), and Canadian Institutes of Health Research grants CCI-92222 and MOP-81370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bandera CA, 1998, ONCOGENE, V16, P3455, DOI 10.1038/sj.onc.1201901; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calame K, 2007, IMMUNITY, V27, P825, DOI 10.1016/j.immuni.2007.11.010; Caniggia I, 1997, ENDOCRINOLOGY, V138, P3976, DOI 10.1210/en.138.9.3976; Chelbi ST, 2008, MOL CELL ENDOCRINOL, V282, P120, DOI 10.1016/j.mce.2007.11.022; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Enquobahrie DA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.004; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu J, 2009, MOL ENDOCRINOL, V23, P1014, DOI 10.1210/me.2008-0451; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Ma GT, 2001, DEV BIOL, V236, P124, DOI 10.1006/dbio.2001.0334; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Schneider-Kolsky ME, 2002, PLACENTA, V23, P294, DOI 10.1053/plac.2002.0787; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216; Zhang YQ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.057; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	39	71	82	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38875	10.1371/journal.pone.0038875	http://dx.doi.org/10.1371/journal.pone.0038875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723898	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700035
J	Awasthi, N; Zhang, CH; Ruan, W; Schwarz, MA; Schwarz, RE				Awasthi, Niranjan; Zhang, Changhua; Ruan, Winston; Schwarz, Margaret A.; Schwarz, Roderich E.			Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer	PLOS ONE			English	Article							ACTIVATING POLYPEPTIDE-II; ENDOTHELIAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; CLINICAL-TRIALS; ANTITUMOR-ACTIVITY; TUMOR-GROWTH; PHASE-II; IN-VITRO; EMAP II; GEMCITABINE	Gemcitabine (Gem) has limited clinical benefits in pancreatic ductal adenocarcinoma (PDAC). The present study investigated combinations of gemcitabine with antiangiogenic agents of various mechanisms for PDAC, including bevacizumab (Bev), sunitinib (Su) and EMAP II. Cell proliferation and protein expression were analyzed by WST-1 assay and Western blotting. In vivo experiments were performed via murine xenografts. Inhibition of in vitro proliferation of AsPC-1 PDAC cells by gemcitabine (10 mu M), bevacizumab (1 mg/ml), sunitinib (10 mu M) and EMAP (10 mu M) was 35, 22, 81 and 6 percent; combination of gemcitabine with bevacizumab, sunitinib or EMAP had no additive effects. In endothelial HUVECs, gemcitabine, bevacizumab, sunitinib and EMAP caused 70, 41, 86 and 67 percent inhibition, while combination of gemcitabine with bevacizumab, sunitinib or EMAP had additive effects. In WI-38 fibroblasts, gemcitabine, bevacizumab, sunitinib and EMAP caused 79, 58, 80 and 29 percent inhibition, with additive effects in combination as well. Net in vivo tumor growth inhibition in gemcitabine, bevacizumab, sunitinib and EMAP monotherapy was 43, 38, 94 and 46 percent; dual combinations of Gem+Bev, Gem+Su and Gem+EMAP led to 69, 99 and 64 percent inhibition. Combinations of more than one antiangiogenic agent with gemcitabine were generally more effective but not superior to Gem+Su. Intratumoral proliferation, apoptosis and microvessel density findings correlated with tumor growth inhibition data. Median animal survival was increased by gemcitabine (26 days) but not by bevacizumab, sunitinib or EMAP monotherapy compared to controls (19 days). Gemcitabine combinations with bevacizumab, sunitinib or EMAP improved survival to similar extent (36 or 37 days). Combinations of gemcitabine with Bev+EMAP (43 days) or with Bev+Su+EMAP (46 days) led to the maximum survival benefit observed. Combination of antiangiogenic agents improves gemcitabine response, with sunitinib inducing the strongest effect. These findings demonstrate advantages of combining multi-targeting agents with standard gemcitabine therapy for PDAC.	[Awasthi, Niranjan; Zhang, Changhua; Ruan, Winston; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Schwarz, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Awasthi, Niranjan; Zhang, Changhua; Ruan, Winston; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Awasthi, N (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA.	Roderich.Schwarz@utsouthwestern.edu						Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Awasthi N, 2011, HPB, V13, P597, DOI 10.1111/j.1477-2574.2011.00333.x; Awasthi N, 2011, CANCER CHEMOTH PHARM, V68, P571, DOI 10.1007/s00280-010-1514-7; Awasthi N, 2009, LAB INVEST, V89, P38, DOI 10.1038/labinvest.2008.106; Berger AC, 2000, MICROVASC RES, V60, P70, DOI 10.1006/mvre.2000.2249; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; Bramhall SR, 2002, BRIT J CANCER, V87, P161, DOI 10.1038/sj.bjc.6600446; Brennan MF, 2004, SURG ONCOL CLIN N AM, V13, pvii; Brennan Murray F, 2004, Surg Oncol Clin N Am, V13, P555; Cabebe E, 2007, EXPERT OPIN INV DRUG, V16, P467, DOI 10.1517/13543784.16.4.467; Cao HST, 2010, MOL CANCER THER, V9, P2068, DOI 10.1158/1535-7163.MCT-10-0201; Chang YT, 2008, PANCREAS, V37, P145, DOI 10.1097/MPA.0b013e318164548a; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Costa R, 2009, J CELL BIOCHEM, V108, P1410, DOI 10.1002/jcb.22378; Crippa L, 2008, CANCER RES, V68, P1154, DOI 10.1158/0008-5472.CAN-07-2085; Cuneo KC, 2008, INT J RADIAT ONCOL, V71, P873, DOI 10.1016/j.ijrobp.2008.02.062; Dragovich T, 2008, AM J CLIN ONCOL-CANC, V31, P157, DOI 10.1097/COC.0b013e31815878c9; Fujimoto K, 1998, EUR J CANCER, V34, P1439, DOI 10.1016/S0959-8049(98)00069-0; Garcea G, 2004, EUR J CANCER, V40, P1302, DOI 10.1016/j.ejca.2004.02.015; Hayes AJ, 2000, WESTERN J MED, V172, P39, DOI 10.1136/ewjm.172.1.39; Itakura J, 2000, INT J CANCER, V85, P27; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Ko AH, 2008, INVEST NEW DRUG, V26, P463, DOI 10.1007/s10637-008-9127-2; KONNO H, 1995, INT J CANCER, V61, P268, DOI 10.1002/ijc.2910610221; Korc M, 2003, Mol Cancer, V2, P8, DOI 10.1186/1476-4598-2-8; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Laquente B, 2008, MOL CANCER THER, V7, P638, DOI 10.1158/1535-7163.MCT-07-2122; Lee JJ, 2007, J BIOPHARM STAT, V17, P461, DOI 10.1080/10543400701199593; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Luo JY, 2001, INT J CANCER, V92, P361, DOI 10.1002/ijc.1202; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Ogawa T, 2002, CANCER GENE THER, V9, P633, DOI 10.1038/sj.cgt.7700478; Reni M, 2005, LANCET ONCOL, V6, P369, DOI 10.1016/S1470-2045(05)70175-3; Reznikov A. G., 2007, Experimental Oncology, V29, P267; Rosewicz S, 1997, LANCET, V349, P485; Satoh H, 1998, ACTA ONCOL, V37, P85, DOI 10.1080/028418698423221; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Schwarz MA, 2005, EXP CELL RES, V311, P229, DOI 10.1016/j.yexcr.2005.09.008; Schwarz MA, 2000, MECH DEVELOP, V95, P123, DOI 10.1016/S0925-4773(00)00361-0; Schwarz RE, 2004, J SURG RES, V120, P64, DOI 10.1016/j.jss.2003.10.005; Schwarz RE, 1999, SURGERY, V126, P562, DOI 10.1016/S0039-6060(99)70099-1; Schwarz RE, 2010, CANCER BIOL THER, V9, P632, DOI 10.4161/cbt.9.8.11265; Schwarz RE, 2010, ANN SURG ONCOL, V17, P1442, DOI 10.1245/s10434-009-0879-5; Schwarz RE, 2009, SURGERY, V146, P241, DOI 10.1016/j.surg.2009.04.015; Seandel M, 2006, CLIN CANCER RES, V12, P6203, DOI 10.1158/1078-0432.CCR-06-1292; Wilkowski R, 2006, J PANCREAS, V7, P34; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220; Zhang HP, 2011, J RADIAT RES, V52, P1, DOI 10.1269/jrr.10013	56	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38477	10.1371/journal.pone.0038477	http://dx.doi.org/10.1371/journal.pone.0038477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723862	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300029
J	Corsetti, JP; Bakker, SJL; Sparks, CE; Dullaart, RPF				Corsetti, James P.; Bakker, Stephan J. L.; Sparks, Charles E.; Dullaart, Robin P. F.			Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; RECEPTOR-BINDING ACTIVITY; ISCHEMIC-HEART-DISEASE; ENDOTHELIAL LIPASE; HUMAN-PLASMA; LPA-I; POSTINFARCTION PATIENTS; ANTIOXIDANT PROPERTIES; APOA-II	Background: In a previous report by our group, high levels of apolipoprotein E (apoE) were demonstrated to be associated with risk of incident cardiovascular disease in women with high levels of C-reactive protein (CRP) in the setting of both low (designated as HR1 subjects) and high (designated as HR2 subjects) levels of high-density lipoprotein cholesterol (HDL-C). To assess whether apolipoprotein A-II (apoA-II) plays a role in apoE-associated risk in the two female groups. Methodology/Principal: Outcome event mapping, a graphical data exploratory tool; Cox proportional hazards multivariable regression; and curve-fitting modeling were used to examine apoA-II influence on apoE-associated risk focusing on HDL particles with apolipoprotein A-I (apoA-I) without apoA-II (LpA-I) and HDL particles with both apoA-I and apoA-II (LpA-I:A-II). Results of outcome mappings as a function of apoE levels and the ratio of apoA-II to apoA-I revealed within each of the two populations, a high-risk subgroup characterized in each situation by high levels of apoE and additionally: in HR1, by a low value of the apoA-II/apoA-I ratio; and in HR2, by a moderate value of the apoA-II/apoA-I ratio. Furthermore, derived estimates of LpA-I and LpA-I:A-II levels revealed for high-risk versus remaining subjects: in HR1, higher levels of LpA-I and lower levels of LpA-I:A-II; and in HR2 the reverse, lower levels of LpA-I and higher levels of LpA-I:A-II. Results of multivariable risk modeling as a function of LpA-I and LpA-I:A-II (dichotomized as highest quartile versus combined three lower quartiles) revealed association of risk only for high levels of LpA-I:A-II in the HR2 subgroup (hazard ratio 5.31, 95% CI 1.12-25.17, p = 0.036). Furthermore, high LpA-I: A-II levels interacted with high apoE levels in establishing subgroup risk. Conclusions/Significance: We conclude that apoA-II plays a significant role in apoE-associated risk of incident CVD in women with high levels of HDL-C and CRP.	[Corsetti, James P.; Sparks, Charles E.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14627 USA; [Bakker, Stephan J. L.] Univ Groningen, Dept Nephrol, Groningen, Netherlands; [Bakker, Stephan J. L.; Dullaart, Robin P. F.] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Dullaart, Robin P. F.] Univ Groningen, Dept Endocrinol, Groningen, Netherlands	University of Rochester; University of Groningen; University of Groningen; University of Groningen	Corsetti, JP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14627 USA.	James_Corsetti@urmc.rochester.edu	Bakker, Stephan J. L./J-4023-2015	Bakker, Stephan J. L./0000-0003-3356-6791	Netherlands Heart Foundation [2001.005]	Netherlands Heart Foundation(Netherlands Heart Foundation)	Grant 2001.005 (Netherlands Heart Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, CIRCULATION, V101, P1907, DOI 10.1161/01.CIR.101.16.1907; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Asztalos BF, 2006, ATHEROSCLEROSIS, V188, P59, DOI 10.1016/j.atherosclerosis.2005.10.018; ATMEH RF, 1990, J LIPID RES, V31, P1771; ATMEH RF, 1983, BIOCHIM BIOPHYS ACTA, V751, P175, DOI 10.1016/0005-2760(83)90172-8; BEKAERT ED, 1992, BIOCHIM BIOPHYS ACTA, V1126, P105, DOI 10.1016/0005-2760(92)90223-I; Birjmohun RS, 2007, CIRCULATION, V116, P2029, DOI 10.1161/CIRCULATIONAHA.107.704031; Bittner V, 2000, AM HEART J, V139, P288, DOI 10.1067/mhj.2000.101224; Blanco-Vaca F, 2001, J LIPID RES, V42, P1727; Boisfer E, 2002, J LIPID RES, V43, P732; Borggreve SE, 2006, J CLIN ENDOCR METAB, V91, P3382, DOI 10.1210/jc.2005-2322; Broedl UC, 2004, TRENDS CARDIOVAS MED, V14, P202, DOI 10.1016/j.tcm.2004.03.003; Brousseau ME, 2009, J LIPID RES, V50, P1456, DOI 10.1194/jlr.P800037-JLR200; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; Corsetti JP, 2008, ATHEROSCLEROSIS, V196, P461, DOI 10.1016/j.atherosclerosis.2006.12.007; Corsetti JP, 2011, ATHEROSCLEROSIS, V214, P373, DOI 10.1016/j.atherosclerosis.2010.11.029; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Corsetti JP, 2010, EUR J CLIN INVEST, V40, P483, DOI 10.1111/j.1365-2362.2010.02287.x; Corsetti JP, 2005, ATHEROSCLEROSIS, V183, P293, DOI 10.1016/j.atherosclerosis.2005.03.046; Corsetti JP, 2012, METABOLISM IN PRESS; de Backer G, 1998, ATHEROSCLEROSIS, V137, pS1, DOI 10.1016/S0021-9150(97)00310-9; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Dugue-Pujol S, 2006, J LIPID RES, V47, P2631, DOI 10.1194/jlr.M600112-JLR200; Durbin DM, 1997, J BIOL CHEM, V272, P31333, DOI 10.1074/jbc.272.50.31333; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Gnasso A, 2002, ATHEROSCLEROSIS, V164, P289, DOI 10.1016/S0021-9150(02)00070-9; Grundy SM, 1999, J LIPID RES, V40, P229; Hedrick CC, 2001, J LIPID RES, V42, P563; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; INNERARITY TL, 1978, J BIOL CHEM, V253, P6289; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Julve J, 2010, ARTERIOSCL THROM VAS, V30, P232, DOI 10.1161/ATVBAHA.109.198226; Kalopissis AD, 2003, CURR OPIN LIPIDOL, V14, P165, DOI 10.1097/00041433-200304000-00008; Kazlauskaite R, 2010, J CLIN LIPIDOL, V4, P113, DOI 10.1016/j.jacl.2010.01.006; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; LEROY A, 1993, J BIOL CHEM, V268, P4798; Ma K, 2003, P NATL ACAD SCI USA, V100, P2748, DOI 10.1073/pnas.0438039100; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martin-Campos JM, 2004, CURR OPIN LIPIDOL, V15, P247, DOI 10.1097/01.mol.0000130087.23887.97; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; NORFELDT PIP, 1981, EUR J BIOCHEM, V118, P1, DOI 10.1111/j.1432-1033.1981.tb05478.x; OHTA T, 1988, J LIPID RES, V29, P721; Onat A, 2011, METABOLISM, V60, P499, DOI 10.1016/j.metabol.2010.04.018; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; PUCHOIS P, 1987, ATHEROSCLEROSIS, V68, P35, DOI 10.1016/0021-9150(87)90091-8; Ragbir S, 2010, CURR ATHEROSCLER REP, V12, P343, DOI 10.1007/s11883-010-0091-x; Ribas V, 2004, CIRC RES, V95, P789, DOI 10.1161/01.RES.0000146031.94850.5f; Ruel IL, 2004, J LIPID RES, V45, P1528, DOI 10.1194/jlr.M400090-JLR200; Scanu AM, 2008, FASEB J, V22, P4044, DOI 10.1096/fj.08-117150; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shimoni N, 2003, ISR MED ASSOC J, V5, P702; Sich D, 1998, ATHEROSCLEROSIS, V138, P351, DOI 10.1016/S0021-9150(98)00030-6; Sviridov D, 2008, J ATHEROSCLER THROMB, V15, P52, DOI 10.5551/jat.E571; SYVANNE M, 1995, CIRCULATION, V92, P364, DOI 10.1161/01.CIR.92.3.364; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Thompson PA, 2008, INNATE IMMUN-LONDON, V14, P365, DOI 10.1177/1753425908099171; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; von Eckardstein A, 1999, CIRCULATION, V99, P1925; WEISGRABER KH, 1991, J BIOL CHEM, V266, P12029; Wroblewska M, 2010, BBA-MOL CELL BIOL L, V1801, P1323, DOI 10.1016/j.bbalip.2010.08.005	64	47	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39110	10.1371/journal.pone.0039110	http://dx.doi.org/10.1371/journal.pone.0039110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723940	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300095
J	Liu, L; Zeng, LL; Li, YM; Ma, QM; Li, BJ; Shen, H; Hu, DW				Liu, Li; Zeng, Ling-Li; Li, Yaming; Ma, Qiongmin; Li, Baojuan; Shen, Hui; Hu, Dewen			Altered Cerebellar Functional Connectivity with Intrinsic Connectivity Networks in Adults with Major Depressive Disorder	PLOS ONE			English	Article							DEFAULT MODE; CINGULATE CORTEX; BRAIN; MRI; CIRCUITS; DISTINCT; EMOTION; MOTION; FMRI	Background: Numerous studies have demonstrated the higher-order functions of the cerebellum, including emotion regulation and cognitive processing, and have indicated that the cerebellum should therefore be included in the pathophysiological models of major depressive disorder. The aim of this study was to compare the resting-state functional connectivity of the cerebellum in adults with major depression and healthy controls. Methods: Twenty adults with major depression and 20 gender-,age-, and education-matched controls were investigated using seed-based resting-state functional connectivity magnetic resonance imaging. Results: Compared with the controls, depressed patients showed significantly increased functional connectivity between the cerebellum and the temporal poles. However, significantly reduced cerebellar functional connectivity was observed in the patient group in relation to both the default-mode network, mainly including the ventromedial prefrontal cortex and the posterior cingulate cortex/precuneus, and the executive control network, mainly including the superior frontal cortex and orbitofrontal cortex. Moreover, the Hamilton Depression Rating Scale score was negatively correlated with the functional connectivity between the bilateral Lobule VIIb and the right superior frontal gyrus in depressed patients. Conclusions: This study demonstrated increased cerebellar coupling with the temporal poles and reduced coupling with the regions in the default-mode and executive control networks in adults with major depression. These differences between patients and controls could be associated with the emotional disturbances and cognitive control function deficits that accompany major depression. Aberrant cerebellar connectivity during major depression may also imply a substantial role for the cerebellum in the pathophysiological models of depression.	[Liu, Li] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Zeng, Ling-Li; Ma, Qiongmin; Li, Baojuan; Shen, Hui; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Li, Yaming] China Med Univ, Affiliated Hosp 1, Dept Nucl Med, Shenyang, Liaoning, Peoples R China	China Medical University; National University of Defense Technology - China; China Medical University	Liu, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China.	lllyy2003@163.com	Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020	Zeng, Ling-Li/0000-0002-0515-256X	National Basic Research Program of China [2011CB707802]; National Science Foundation of China [60835005, 61003202]; Hunan Provincial Innovation Foundation [CX2011B015]; Graduate Innovation Fund of National University of Defense Technology [B110304]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation; Graduate Innovation Fund of National University of Defense Technology	This work was supported by the National Basic Research Program of China (Grant No 2011CB707802), National Science Foundation of China (Grant No 60835005, 61003202). Hunan Provincial Innovation Foundation (Grant No CX2011B015); Graduate Innovation Fund of National University of Defense Technology (Grant No B110304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alalade E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020035; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; APA, 2000, DIAGN STAT MAN MENT; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett C.M., 2010, J SERENDIPITOUS UNEX, V1, P1, DOI [DOI 10.1016/S1053-8119(09)71202-9, 10.1016/S1053-8119(09)71202-9]; Buckner RL, 2010, P NATL ACAD SCI USA, V107, P10769, DOI 10.1073/pnas.1005987107; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desmond JE, 2010, BEHAV NEUROL, V23, P1, DOI 10.3233/BEN-2010-0272; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; Dolan RJ, 1998, BRAIN, V121, P545, DOI 10.1093/brain/121.4.545; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; First M.B., 2016, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hu DW, 2008, CEREBELLUM, V7, P304, DOI 10.1007/s12311-008-0031-2; Jiang AP, 1995, HUM BRAIN MAPP, V3, P224, DOI 10.1002/hbm.460030306; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Liu YD, 2008, IEEE J-STSP, V2, P870, DOI 10.1109/JSTSP.2008.2008495; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Naismith SL, 2010, J AFFECT DISORDERS, V125, P256, DOI 10.1016/j.jad.2010.02.114; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Timmann D, 2010, CORTEX, V46, P845, DOI 10.1016/j.cortex.2009.06.009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vasic N, 2009, PSYCHOL MED, V39, P977, DOI 10.1017/S0033291708004443; Walter H, 2007, NEUROIMAGE, V35, P1551, DOI 10.1016/j.neuroimage.2007.01.041; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	59	81	85	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39516	10.1371/journal.pone.0039516	http://dx.doi.org/10.1371/journal.pone.0039516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724025	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300143
J	Mata, R; Hau, R; Papassotiropoulos, A; Hertwig, R				Mata, Rui; Hau, Robin; Papassotiropoulos, Andreas; Hertwig, Ralph			DAT1 Polymorphism Is Associated with Risk Taking in the Balloon Analogue Risk Task (BART)	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; VARIABLE NUMBER; PERSONALITY-TRAIT; VNTR POLYMORPHISM; IMAGING GENETICS; AVAILABILITY; IMPULSIVITY; PROPENSITY; GENOTYPE; BRAIN	Twin-studies suggest that a significant portion of individual differences in the propensity to take risks resides in people's genetic make-up and there is evidence that variability in dopaminergic systems relates to individual differences in risky choice. We examined the link between risk taking in a risk taking task (the Balloon Analogue Risk Task, BART) and a variable number tandem repeat (VNTR) polymorphism in the 3'UTR of the dopamine transporter gene (SLC6A3/DAT1). Behavior in BART is known to be associated with activity in striatal reward-processing regions, and DAT1 is assumed to modulate striatal dopamine levels. We find that carriers of DAT1 alleles, which presumably result in lower striatal dopamine availability, showed more risk taking, relative to carriers of the alleles associated with higher striatal dopamine availability. Our analyses suggest that the mechanism underlying this association is diminished sensitivity to rewards among those who take more risks. Overall, our results support the notion that a behavioral genetic approach can be helpful in uncovering the basis of individual differences in risk taking.	[Mata, Rui; Hau, Robin; Hertwig, Ralph] Univ Basel, Dept Psychol, Ctr Cognit & Decis Sci, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Univ Psychiat Clin, Div Mol Neurosci, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, Basel, Switzerland; [Hertwig, Ralph] Max Planck Inst Human Dev, Berlin, Germany	University of Basel; University of Basel; University of Basel; University of Basel; Max Planck Society	Mata, R (corresponding author), Univ Basel, Dept Psychol, Ctr Cognit & Decis Sci, Basel, Switzerland.	rui.mata@unibas.ch	Hertwig, Ralph/B-3468-2015; Mata, Rui/K-8138-2015	Hertwig, Ralph/0000-0002-9908-9556; Mata, Rui/0000-0002-1679-906X; Papassotiropoulos, Andreas/0000-0002-2210-9651	Swiss National Science Foundation [100014-126558]; Swiss National Science Foundation Sinergia [CRSIK0_122691, CRSI33_130080]; European Union [HEALTH-F4-2009-242257]; National Center for Competence in Research synapsy	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); European Union(European Commission); National Center for Competence in Research synapsy	This work was funded by a grant from the Swiss National Science Foundation to Ralph Hertwig (100014-126558), the Swiss National Science Foundation Sinergia grants (CRSIK0_122691, CRSI33_130080), the 7th framework programme of the European Union (ADAMS project, HEALTH-F4-2009-242257), and the National Center for Competence in Research synapsy (www.nccr-synapsy.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 2009, TWIN RES HUM GENET, V12, P366, DOI 10.1375/twin.12.4.366; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bedard AC, 2010, NEUROIMAGE, V53, P935, DOI 10.1016/j.neuroimage.2009.12.041; Bishara AJ, 2009, J BEHAV DECIS MAKING, V22, P435, DOI 10.1002/bdm.641; Bornovalova MA, 2005, EXP CLIN PSYCHOPHARM, V13, P311, DOI 10.1037/1064-1297.13.4.311; Bornovalova MA, 2009, PHARMACOL BIOCHEM BE, V93, P258, DOI 10.1016/j.pbb.2008.10.023; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; BYERLEY W, 1993, HUM MOL GENET, V2, P335, DOI 10.1093/hmg/2.3.335; Cesarini D, 2011, MANAGEMENT SCI; Cesarini D, 2010, J FINANC, V65, P1725, DOI 10.1111/j.1540-6261.2010.01592.x; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Durston S, 2010, NEUROIMAGE, V53, P832, DOI 10.1016/j.neuroimage.2010.02.071; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fein G, 2008, DRUG ALCOHOL DEPEN, V92, P141, DOI 10.1016/j.drugalcdep.2007.07.017; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Guo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009352; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Jaber M, 1997, MOVEMENT DISORD, V12, P629, DOI 10.1002/mds.870120502; Jacobsen LK, 2000, AM J PSYCHIAT, V157, P1700, DOI 10.1176/appi.ajp.157.10.1700; Jentsch JD, 2010, NEUROPSYCHOPHARMACOL, V35, P1797, DOI 10.1038/npp.2010.47; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lighthall N. R., 2011, SOCIAL COGNITIVE AFF, DOI 10.1093/scan/nsr026; Lynch DR, 2003, MOVEMENT DISORD, V18, P804, DOI 10.1002/mds.10430; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Mitchell RJ, 2000, HUM BIOL, V72, P295; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82; Pleskac TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P555, DOI 10.1037/a0014245; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Rao HY, 2010, MOVEMENT DISORD, V25, P1660, DOI 10.1002/mds.23147; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Simon JR, 2011, BEHAV BRAIN RES, V216, P452, DOI 10.1016/j.bbr.2010.08.043; Simonson I, 2011, J CONSUM RES, V37, P951, DOI 10.1086/657022; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104; Zhong SF, 2012, NEUROIMAGE, V59, P540, DOI 10.1016/j.neuroimage.2011.07.031; Zhong SF, 2009, TWIN RES HUM GENET, V12, P103, DOI 10.1375/twin.12.1.103; Zyphur MJ, 2009, J BEHAV DECIS MAKING, V22, P367, DOI 10.1002/bdm.643	58	43	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39135	10.1371/journal.pone.0039135	http://dx.doi.org/10.1371/journal.pone.0039135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723947	gold, Green Published			2022-12-27	WOS:000305583300100
J	Moreira, F; Silva, JP; Estanque, B; Palmeirim, JM; Lecoq, M; Pinto, M; Leitao, D; Alonso, I; Pedroso, R; Santos, E; Catry, T; Silva, P; Henriques, I; Delgado, A				Moreira, Francisco; Silva, Joao P.; Estanque, Beatriz; Palmeirim, Jorge M.; Lecoq, Miguel; Pinto, Marcia; Leitao, Domingos; Alonso, Ivan; Pedroso, Rui; Santos, Eduardo; Catry, Teresa; Silva, Patricia; Henriques, Ines; Delgado, Ana			Mosaic-Level Inference of the Impact of Land Cover Changes in Agricultural Landscapes on Biodiversity: A Case-Study with a Threatened Grassland Bird	PLOS ONE			English	Article							BUSTARD TETRAX-TETRAX; HABITAT SELECTION; STEPPE BIRDS; POPULATION; DENSITIES; INTENSIFICATION; HETEROGENEITY	Changes in land useland cover are a major driver of biodiversity change in the Mediterranean region. Understanding how animal populations respond to these landscape changes often requires using landscape mosaics as the unit of investigation, but few previous studies have measured both response and explanatory variables at the land mosaic level. Here, we used a "whole-landscape'' approach to assess the influence of regional variation in the land cover composition of 81 farmland mosaics (mean area of 2900 ha) on the population density of a threatened bird, the little bustard (Tetrax tetrax), in southern Portugal. Results showed that ca. 50% of the regional variability in the density of little bustards could be explained by three variables summarising the land cover composition and diversity in the studied mosaics. Little bustard breeding males attained higher population density in land mosaics with a low land cover diversity, with less forests, and dominated by grasslands. Land mosaic composition gradients showed that agricultural intensification was not reflected in a loss of land cover diversity, as in many other regions of Europe. On the contrary, it led to the introduction of new land cover types in homogenous farmland, which increased land cover diversity but reduced overall landscape suitability for the species. Based on these results, the impact of recent land cover changes in Europe on the little bustard populations is evaluated.	[Moreira, Francisco; Silva, Joao P.; Henriques, Ines; Delgado, Ana] Univ Tecn Lisboa, Inst Agron, Ctr Appl Ecol Prof Baeta Neves, Lisbon, Portugal; [Silva, Joao P.; Estanque, Beatriz; Palmeirim, Jorge M.] Univ Lisbon, Ctr Environm Biol, Fac Sci, P-1699 Lisbon, Portugal; [Silva, Joao P.; Pinto, Marcia; Alonso, Ivan; Pedroso, Rui; Santos, Eduardo; Catry, Teresa] Inst Nat Conservat & Biodivers, Lisbon, Portugal; [Lecoq, Miguel; Leitao, Domingos; Silva, Patricia] SPEA Soc Protect & Study Birds, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Moreira, F (corresponding author), Univ Tecn Lisboa, Inst Agron, Ctr Appl Ecol Prof Baeta Neves, Lisbon, Portugal.	fmoreira@isa.utl.pt	Catry, Teresa/A-8082-2012; Palmeirim, Jorge M/A-1323-2014; Moreira, Francisco/B-2873-2008; Granadeiro, José Pedro/E-8060-2011; Silva, João P/L-6745-2013	Catry, Teresa/0000-0003-4047-9995; Palmeirim, Jorge M/0000-0003-4734-8162; Moreira, Francisco/0000-0003-4393-8018; Granadeiro, José Pedro/0000-0002-7207-3474; Silva, João P/0000-0002-1956-5779; Delgado, ana/0000-0002-0275-8734	Conservation of the little bustard in Alentejo [LIFE02NAT/P/8476]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/28805/2006]	Conservation of the little bustard in Alentejo; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Field work between 2004 and 2006 was financed by Project LIFE02NAT/P/8476: Conservation of the little bustard in Alentejo. JPS was partly supported by grant SFRH/BD/28805/2006 from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi A, 2011, IBIS, V153, P875, DOI 10.1111/j.1474-919X.2011.01169.x; Batari A, 2011, FRONTIERS ECOLOGY EN, V9, P182; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Campos B, 1996, CONSERVACION AVES ES, P201; Costa LT, 2003, ZONAS IMPORTANTES AY; De Juana Eduardo, 1996, Ardeola, V43, P157; Delgado A, 2000, AGR ECOSYST ENVIRON, V78, P65, DOI 10.1016/S0167-8809(99)00114-0; Delgado A, 2010, IBIS, V152, P633, DOI 10.1111/j.1474-919X.2010.01026.x; EEA, 2007, CORINE LAND COV 2006; Feranec J, 2010, APPL GEOGR, V30, P19, DOI 10.1016/j.apgeog.2009.07.003; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Freire S, 2005, P GIS PLAN 2005 2 IN; Garcia de la Morena E. L., 2006, SISON COMUN ESPANA; Garcia J, 2007, BIOL CONSERV, V137, P45, DOI 10.1016/j.biocon.2007.01.013; Goriup P, 1994, BIRDS EUROPE THEIR C, P236; Heymann Y., 1994, CORINE LAND COVER TE; Hill J, 2008, GLOBAL PLANET CHANGE, V64, P146, DOI 10.1016/j.gloplacha.2008.10.005; Inigo A, 2010, LITTLE BUSTARD TETRA; Jiguet F, 2001, BEHAV PROCESS, V55, P107, DOI 10.1016/S0376-6357(01)00173-5; Jiguet F, 2006, AM NAT, V168, P758, DOI 10.1086/508808; Jolivet Christophe, 2007, Ornithos, V14, P80; Legendre P., 2012, NUMERICAL ECOLOGY; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; MARTINEZ C, 1994, BIOL CONSERV, V67, P125, DOI 10.1016/0006-3207(94)90357-3; Martinez C, 2000, ARDEOLA, V49, P301; Morales MB, 2008, ACTA OECOL, V34, P345, DOI 10.1016/j.actao.2008.06.009; Morales MB, 2006, REV ECOL-TERRE VIE, V61, P261; Morales MB, 2005, ANIM CONSERV, V8, P167, DOI 10.1017/S1367943005001988; Moreira F, 1999, BIRD STUDY, V46, P309, DOI 10.1080/00063659909461144; Moreira F, 2007, LANDSCAPE ECOL, V22, P1461, DOI 10.1007/s10980-007-9125-3; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moreira Francisco, 2007, Airo, V17, P5; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2020, R LANG ENV STAT COMP; Radford JQ, 2007, J APPL ECOL, V44, P737, DOI 10.1111/j.1365-2664.2007.01327.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salamolard M, 1999, BIRD STUDY, V46, P25, DOI 10.1080/00063659909461112; Santangeli A, 2011, EUR J WILDLIFE RES, V57, P805, DOI 10.1007/s10344-011-0492-3; Silva JP, 2007, BIOL CONSERV, V139, P186, DOI 10.1016/j.biocon.2007.06.013; Silva JP, 2010, BIOL CONSERV, V143, P2553, DOI 10.1016/j.biocon.2010.06.023; Silva JP, 2004, BIOL CONSERV, V117, P521, DOI 10.1016/j.biocon.2003.09.001; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Suarez Francisco, 1997, P297; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vila M, 2003, GLOBAL CHANGE BIOL, V9, P1234, DOI 10.1046/j.1365-2486.2003.00652.x; Wolff A, 2001, J APPL ECOL, V38, P963, DOI 10.1046/j.1365-2664.2001.00651.x; Zuur Alain F., 2009, P1	52	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38876	10.1371/journal.pone.0038876	http://dx.doi.org/10.1371/journal.pone.0038876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723899	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300063
J	Pavlenok, M; Derrington, IM; Gundlach, JH; Niederweis, M				Pavlenok, Mikhail; Derrington, Ian M.; Gundlach, Jens H.; Niederweis, Michael			MspA Nanopores from Subunit Dimers	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; MYCOBACTERIUM-SMEGMATIS; ESCHERICHIA-COLI; OUTER-MEMBRANE; PORIN MSPA; BETA-BARREL; LINKER PEPTIDES; MOLECULAR-BASIS; ANTHRAX TOXIN; CELL-WALL	Mycobacterium smegmatis porin A (MspA) forms an octameric channel and represents the founding member of a new family of pore proteins. Control of subunit stoichiometry is important to tailor MspA for nanotechnological applications. In this study, two MspA monomers were connected by linkers ranging from 17 to 62 amino acids in length. The oligomeric pore proteins were purified from M. smegmatis and were shown to form functional channels in lipid bilayer experiments. These results indicated that the peptide linkers did not prohibit correct folding and localization of MspA. However, expression levels were reduced by 10-fold compared to wild-type MspA. MspA is ideal for nanopore sequencing due to its unique pore geometry and its robustness. To assess the usefulness of MspA made from dimeric subunits for DNA sequencing, we linked two M1-MspA monomers, whose constriction zones were modified to enable DNA translocation. Lipid bilayer experiments demonstrated that this construct also formed functional channels. Voltage gating of MspA pores made from M1 monomers and M1-M1 dimers was identical indicating similar structural and dynamic channel properties. Glucose uptake in M. smegmatis cells lacking porins was restored by expressing the dimeric mspA M1 gene indicating correct folding and localization of M1-M1 pores in their native membrane. Single-stranded DNA hairpins produced identical ionic current blockades in pores made from monomers and subunit dimers demonstrating that M1-M1 pores are suitable for DNA sequencing. This study provides the proof of principle that production of single-chain MspA pores in M. smegmatis is feasible and paves the way for generating MspA pores with altered stoichiometries. Subunit dimers enable better control of the chemical and physical properties of the constriction zone of MspA. This approach will be valuable both in understanding transport across the outer membrane in mycobacteria and in tailoring MspA for nanopore sequencing of DNA.	[Pavlenok, Mikhail; Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Derrington, Ian M.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle	Pavlenok, M (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	mnieder@uab.edu		Niederweis, Michael/0000-0003-4068-8092; Gundlach, Jens Horst/0000-0002-0773-8038	United States National Institutes of Health, National Human Genome Research Institute [R21HG004145, R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004145, R01HG005115] Funding Source: NIH RePORTER	United States National Institutes of Health, National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the United States National Institutes of Health, National Human Genome Research Institute $1000 Genome Program Grants R21HG004145 and R01HG005115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFTHAN K, 1995, PROTEIN ENG, V8, P725, DOI 10.1093/protein/8.7.725; Bainbridge G, 1998, FEBS LETT, V431, P305, DOI 10.1016/S0014-5793(98)00761-3; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bi WL, 1997, NUCLEIC ACIDS RES, V25, P2949, DOI 10.1093/nar/25.14.2949; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; DELAVEGA AL, 1995, EMBO J, V14, P6058, DOI 10.1002/j.1460-2075.1995.tb00294.x; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Duret G, 2007, CHANNELS, V1, P70, DOI 10.4161/chan.3983; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; Engelhardt H, 2002, J BIOL CHEM, V277, P37567, DOI 10.1074/jbc.M206983200; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hammerstein AF, 2011, J BIOL CHEM, V286, P14324, DOI 10.1074/jbc.M111.218164; Heinz C, 2000, ANAL BIOCHEM, V285, P113, DOI 10.1006/abio.2000.4728; Heinz C, 2003, J CHROMATOGR B, V790, P337, DOI 10.1016/S1570-0232(03)00130-2; Heinz Christian, 2003, Methods Mol Biol, V228, P139, DOI 10.1385/1-59259-400-X:139; Huff J, 2009, J BIOL CHEM, V284, P10223, DOI 10.1074/jbc.M808599200; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Iyer R, 1997, J BIOL CHEM, V272, P18595, DOI 10.1074/jbc.272.30.18595; Kavoosi M, 2007, BIOTECHNOL BIOENG, V98, P599, DOI 10.1002/bit.21396; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Liu NZ, 1998, PROTEIN ENG, V11, P797, DOI 10.1093/protein/11.9.797; Mahfoud M, 2006, J BIOL CHEM, V281, P5908, DOI 10.1074/jbc.M511642200; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Robertson KM, 2002, BIOCHEM CELL BIOL, V80, P517, DOI 10.1139/O02-145; Rotem D, 2012, J AM CHEM SOC, V134, P2781, DOI 10.1021/ja2105653; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Tang Y, 1996, J BIOL CHEM, V271, P15682, DOI 10.1074/jbc.271.26.15682; Worner M, 2007, SMALL, V3, P1084, DOI 10.1002/smll.200600559	40	11	27	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38726	10.1371/journal.pone.0038726	http://dx.doi.org/10.1371/journal.pone.0038726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719928	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300043
J	Verhoeven, KJF; van Gurp, TP				Verhoeven, Koen J. F.; van Gurp, Thomas P.			Transgenerational Effects of Stress Exposure on Offspring Phenotypes in Apomictic Dandelion	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRICHOME DENSITY; PLASTICITY; RESPONSES; PLANTS; METHYLATION; HERBIVORY; CONSEQUENCES; INHERITANCE; MECHANISMS	Heritable epigenetic modulation of gene expression is a candidate mechanism to explain parental environmental effects on offspring phenotypes, but current evidence for environment-induced epigenetic changes that persist in offspring generations is scarce. In apomictic dandelions, exposure to various stresses was previously shown to heritably alter DNA methylation patterns. In this study we explore whether these induced changes are accompanied by heritable effects on offspring phenotypes. We observed effects of parental jasmonic acid treatment on offspring specific leaf area and on offspring interaction with a generalist herbivore; and of parental nutrient stress on offspring root-shoot biomass ratio, tissue P-content and leaf morphology. Some of the effects appeared to enhance offspring ability to cope with the same stresses that their parents experienced. Effects differed between apomictic genotypes and were not always consistently observed between different experiments, especially in the case of parental nutrient stress. While this context-dependency of the effects remains to be further clarified, the total set of results provides evidence for the existence of transgenerational effects in apomictic dandelions. Zebularine treatment affected the within-generation response to nutrient stress, pointing at a role of DNA methylation in phenotypic plasticity to nutrient environments. This study shows that stress exposure in apomictic dandelions can cause transgenerational phenotypic effects, in addition to previously demonstrated transgenerational DNA methylation effects.	[Verhoeven, Koen J. F.; van Gurp, Thomas P.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Verhoeven, KJF (corresponding author), Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	k.verhoeven@nioo.knaw.nl	Verhoeven, Koen JF/C-9920-2010; van Gurp, Thomas/B-4311-2012; KNAW, NIOO-KNAW/A-4320-2012	Verhoeven, Koen JF/0000-0003-3002-4102; van Gurp, Thomas/0000-0001-5622-2217; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research (NWO-VIDI) [864.10.008]	Netherlands Organisation for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	The study was supported by the Netherlands Organisation for Scientific Research (NWO-VIDI grant 864.10.008). NWO website: http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Baubec T, 2009, PLANT J, V57, P542, DOI 10.1111/j.1365-313X.2008.03699.x; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; de Kovel CGF, 1999, PLANT BIOLOGY, V1, P541, DOI 10.1055/s-2007-978550; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 1996, MATERNAL ENV EFFECTS; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Galloway LF, 2001, ECOLOGY, V82, P2781, DOI 10.1890/0012-9658(2001)082[2781:PEEOLH]2.0.CO;2; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Houba VJG, 2004, PLANT ANAL PROCEDURE; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Latzel V, 2009, OIKOS, V118, P1669, DOI 10.1111/j.1600-0706.2009.17767.x; MIAO SL, 1991, ECOLOGY, V72, P1634, DOI 10.2307/1940963; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Munir J, 2001, AM J BOT, V88, P1240, DOI 10.2307/3558335; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Richards CL, 2011, NEW PHYTOL, V191, P7, DOI 10.1111/j.1469-8137.2011.03761.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; SCHMID B, 1994, EVOLUTION, V48, P1525, DOI 10.1111/j.1558-5646.1994.tb02194.x; SCHMITT J, 1992, AM NAT, V139, P451, DOI 10.1086/285338; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Shea N, 2011, J EVOLUTION BIOL, V24, P1178, DOI 10.1111/j.1420-9101.2011.02235.x; Sultan SE, 1996, ECOLOGY, V77, P1791, DOI 10.2307/2265784; Van Dijk PJ, 1999, HEREDITY, V83, P715, DOI 10.1038/sj.hdy.6886200; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; WILSON JB, 1988, ANN BOT-LONDON, V61, P433, DOI 10.1093/oxfordjournals.aob.a087575	44	83	88	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38605	10.1371/journal.pone.0038605	http://dx.doi.org/10.1371/journal.pone.0038605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723869	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300033
J	Vong, L; Ferraz, JGP; Dufton, N; Panaccione, R; Beck, PL; Sherman, PM; Perretti, M; Wallace, JL				Vong, Linda; Ferraz, Jose G. P.; Dufton, Neil; Panaccione, Remo; Beck, Paul L.; Sherman, Philip M.; Perretti, Mauro; Wallace, John L.			Up-Regulation of Annexin-A1 and Lipoxin A(4) in Individuals with Ulcerative Colitis May Promote Mucosal Homeostasis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FORMYL-PEPTIDE RECEPTORS; APOPTOTIC NEUTROPHILS; PROSTAGLANDIN D-2; CUTTING EDGE; IN-VITRO; RESOLUTION; MACROPHAGES; IDENTIFICATION; ANALOGS	Background: One of the characteristics of an active episode of ulcerative colitis (UC) is the intense mucosal infiltration of leukocytes. The pro-resolution mediators Annexin-A1 (AnxA1) and lipoxin A(4) (LXA(4)) exert counter-regulatory effects on leukocyte recruitment, however to date, the dual/cumulative effects of these formyl peptide receptor-2 (FPR2/ALX) agonists in the context of human intestinal diseases are unclear. To define the contribution of these mediators, we measured their expression in biopsies from individuals with UC. Methods: Colonic mucosal biopsies were collected from two broad patient groups: healthy volunteers without ('Ctrl' n=20) or with a prior history of UC ('hx of UC' n=5); individuals with UC experiencing active disease ('active' n=8), or in medically-induced remission ('remission' n=16). We assessed the mucosal expression of LXA(4), AnxA1, and the FPR2/ALX receptor in each patient group using a combination of fluorescence microscopy, biochemical and molecular analyses. Results: Mucosal expression of LXA(4) was elevated exclusively in biopsies from individuals in remission (3-fold, P < 0.05 vs. Ctrl). Moreover, in this same group we observed an upregulation of AnxA1 protein expression (2.5-fold increase vs. Ctrl, P <.01), concurrent with an increased level of macrophage infiltration, and an elevation in FPR2/ALX mRNA (7-fold increase vs. Ctrl, P <.05). Importantly, AnxA1 expression was not limited to cells infiltrating the lamina propria but was also detected in epithelial cells lining the intestinal crypts. Conclusions: Our results demonstrate a specific up-regulation of this pro-resolution circuit in individuals in remission from UC, and suggest a significant role for LXA(4) and AnxA1 in promoting mucosal homeostasis.	[Vong, Linda; Sherman, Philip M.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Dufton, Neil; Wallace, John L.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Ferraz, Jose G. P.; Panaccione, Remo; Beck, Paul L.] Univ Calgary, Div Gastroenterol, Calgary, AB, Canada; [Perretti, Mauro] Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, Ctr Biochem Pharmacol, London EC1M 6BQ, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Calgary; University of London; Queen Mary University London	Vong, L (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	linda.vong@sickkids.ca	Dufton, Neil P/AAI-9571-2020; Wallace, John/AAL-3763-2021; Panaccione, Remo/ABC-1140-2021	Dufton, Neil P/0000-0002-6283-9210; Panaccione, Remo/0000-0002-5247-940X; Sherman, Philip/0000-0002-4733-6690	Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research; Canada Research Chair in Gastrointestinal Disease	Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Gastrointestinal Disease	This research was supported by a grant-in-aid from the Crohn's and Colitis Foundation of Canada (to J.G.P.F. and J.L.W.; http://www.ccfc.ca/site/c.ajIRK4NLLhJ0E/b.6319851/k.BDBF/Home.htm) and a grant from the Canadian Institutes of Health Research (to J.L.W; http://www.cihr-irsc.gc.ca/e/193.html). P.M.S is the recipient of a Canada Research Chair in Gastrointestinal Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bandeira-Melo C, 2000, J IMMUNOL, V164, P2267, DOI 10.4049/jimmunol.164.5.2267; Brancaleone V, 2011, J IMMUNOL; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Chavez-Pina AE, 2008, BRIT J PHARMACOL, V155, P857, DOI 10.1038/bjp.2008.316; Clish CB, 2000, ANN NY ACAD SCI, V905, P274; COLGAN SP, 1993, J CLIN INVEST, V92, P75, DOI 10.1172/JCI116601; CROXTALL JD, 1993, INT J CANCER, V54, P153, DOI 10.1002/ijc.2910540124; Croxtall JD, 1998, BRIT J PHARMACOL, V123, P975, DOI 10.1038/sj.bjp.0701679; der Weid PY, 2004, CIRCULATION, V110, P1320; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; EDENIUS C, 1990, FEBS LETT, V272, P25, DOI 10.1016/0014-5793(90)80440-T; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; Fiorucci S, 2004, P NATL ACAD SCI USA, V101, P15736, DOI 10.1073/pnas.0404722101; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Goh J, 2001, J IMMUNOL, V167, P2772, DOI 10.4049/jimmunol.167.5.2772; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; Gronert K, 1998, J EXP MED, V187, P1285, DOI 10.1084/jem.187.8.1285; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; LEE TH, 1990, AM REV RESPIR DIS, V141, P1453, DOI 10.1164/ajrccm/141.6.1453; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; MANCUSO F, 1995, J IMMUNOL, V155, P377; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Nusrat A, 1997, GASTROENTEROLOGY, V113, P1489, DOI 10.1053/gast.1997.v113.pm9352851; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; RUGTVEIT J, 1995, GUT, V37, P367, DOI 10.1136/gut.37.3.367; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Souza MHLP, 2003, AM J PHYSIOL-GASTR L, V285, pG54, DOI 10.1152/ajpgi.00525.2002; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Vergnolle N, 2004, INFLAMM BOWEL DIS, V10, P584, DOI 10.1097/00054725-200409000-00013; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	54	66	69	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39244	10.1371/journal.pone.0039244	http://dx.doi.org/10.1371/journal.pone.0039244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723974	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300121
J	Chen, SY; Yao, LH; Cunningham, TJ				Chen, Shuyan; Yao, Lihua; Cunningham, Timothy J.			Secreted Phospholipase A2 Involvement in Neurodegeneration: Differential Testing of Prosurvival and Anti-Inflammatory Effects of Enzyme Inhibition	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; CELL-LINE; HL-60 CELLS; IN-VITRO; KAPPA-B; A(2); BRAIN; MACROPHAGES	There is increased interest in the contribution of secreted phospholipase A2 (sPLA2) enzymes to neurodegenerative diseases. Systemic treatment with the nonapeptide CHEC-9, a broad spectrum uncompetitive inhibitor of sPLA2, has been shown previously to inhibit neuron death and aspects of the inflammatory response in several models of neurodegeneration. A persistent question in studies of sPLA2 inhibitors, as for several other anti-inflammatory and neuroprotective compounds, is whether the cell protection is direct or due to slowing of the toxic aspects of the inflammatory response. To further explore this issue, we developed assays using SY5Y (neuronal cells) and HL-60 (monocytes) cell lines and examined the effects of sPLA2 inhibition on these homogeneous cell types in vitro. We found that the peptide inhibited sPLA2 enzyme activity in both SY5Y and HL-60 cultures. This inhibition provided direct protection to SY5Y neuronal cells and their processes in response to several forms of stress including exposure to conditioned medium from HL-60 cells. In cultures of HL-60 cells, sPLA2 inhibition had no effect on survival of the cells but attenuated their differentiation into macrophages, with regard to process development, phagocytic ability, and the expression of differentiation marker CD36, as well as the secretion of proinflammatory cytokines TNF-alpha and IL-6. These results suggest that sPLA2 enzyme activity organizes a cascade of changes comprising both cell degeneration and inflammation, processes that could theoretically operate independently during neurodegenerative conditions. The effectiveness of sPLA2 inhibitor CHEC-9 may be due to its ability to affect both processes in isolation. Testing potential anti-inflammatory/neuroprotective compounds with these human cell lines and their conditioned media may provide a useful screening tool prior to in vivo therapeutic applications.	[Chen, Shuyan; Yao, Lihua; Cunningham, Timothy J.] Drexel Univ, Dept Anat & Neurobiol, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Chen, SY (corresponding author), Drexel Univ, Dept Anat & Neurobiol, Coll Med, Philadelphia, PA 19104 USA.	tcunning@drexelmed.edu			Pennsylvania Department of Health, Commonwealth Universal Research Enhancement Program	Pennsylvania Department of Health, Commonwealth Universal Research Enhancement Program	This work was supported by Pennsylvania Department of Health, Commonwealth Universal Research Enhancement Program (http://www.portal.state.pa.us/portal/server.pt/community/health_research_program_cure/14189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; ASAOKA Y, 1993, P NATL ACAD SCI USA, V90, P716, DOI 10.1073/pnas.90.2.716; ASAOKA Y, 1993, P NATL ACAD SCI USA, V90, P4917, DOI 10.1073/pnas.90.11.4917; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Boyanovsky BB, 2010, CYTOKINE, V50, P50, DOI 10.1016/j.cyto.2009.12.009; Chakraborti S, 2003, CELL SIGNAL, V15, P637, DOI 10.1016/S0898-6568(02)00144-4; Chen S, 2008, SOC NEUR ABS, V38, P1465; COLLINS SJ, 1987, BLOOD, V70, P1233; Corke C, 2001, Crit Care Resusc, V3, P244; Cunningham T, 2009, OPEN ENZYME IN PRESS; Cunningham TJ, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-26; Cunningham TJ, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-25; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2004, J NEUROTRAUM, V21, P1683, DOI 10.1089/0897715042441792; Cunningham TJ, 2002, EXP NEUROL, V177, P32, DOI 10.1006/exnr.2002.7979; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Guy B, 2000, CLIN DIAGN LAB IMMUN, V7, P314, DOI 10.1128/CDLI.7.2.314-317.2000; HALL RE, 1983, CELL IMMUNOL, V76, P58, DOI 10.1016/0008-8749(83)90348-9; Hoda MN, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-21; Ibeas E, 2009, CARDIOVASC RES, V81, P54, DOI 10.1093/cvr/cvn234; Jensen MD, 2009, NEUROCHEM INT, V55, P362, DOI 10.1016/j.neuint.2009.04.002; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Kury P, 2004, FASEB J, V18, P398, DOI 10.1096/fj.04-1777fje; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Lucena A, 2008, SOC NEUR ABS, V38, P966; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Meyer MC, 2005, CURR PHARM DESIGN, V11, P1301, DOI 10.2174/1381612053507521; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Nakada-Tsukui K, 1999, J LEUKOCYTE BIOL, V66, P968, DOI 10.1002/jlb.66.6.968; NAKAHARA I, 1992, J NEUROSURG, V76, P244, DOI 10.3171/jns.1992.76.2.0244; Nanda BL, 2007, CURR TOP MED CHEM, V7, P765, DOI 10.2174/156802607780487623; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Thommesen L, 1998, J IMMUNOL, V161, P3421; Titsworth WL, 2008, CNS NEUROL DISORD-DR, V7, P254, DOI 10.2174/187152708784936671; Westley AM, 1996, J BIOL CHEM, V271, P5347, DOI 10.1074/jbc.271.10.5347; Xi D, 2011, NEUROPSYCHOPHARMACOL; Xi D, 2009, INT J NEUROPSYCHOPH, V12, P1395, DOI 10.1017/S146114570900042X; Xie B, 1998, J BIOL CHEM, V273, P11583, DOI 10.1074/jbc.273.19.11583	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39257	10.1371/journal.pone.0039257	http://dx.doi.org/10.1371/journal.pone.0039257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720084	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000053
J	Bruning-Richardson, A; Bond, J; Alsiary, R; Richardson, J; Cairns, DA; McCormac, L; Hutson, R; Burns, PA; Wilkinson, N; Hall, GD; Morrison, EE; Bell, SM				Bruening-Richardson, Anke; Bond, Jaqueline; Alsiary, Rawiah; Richardson, Julie; Cairns, David A.; McCormac, Luci; Hutson, Richard; Burns, Philip A.; Wilkinson, Nafisa; Hall, Geoff D.; Morrison, Ewan E.; Bell, Sandra M.			NuMA Overexpression in Epithelial Ovarian Cancer	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; MITOTIC APPARATUS; NUCLEAR-MATRIX; PROTEIN; EXPRESSION; PATHOGENESIS; SEGREGATION; ANEUPLOIDY; PATTERNS; PATHWAY	Highly aneuploid tumours are common in epithelial ovarian cancers (EOC). We investigated whether NuMA expression was associated with this phenomenon. NuMA protein levels in normal and tumour tissues, ovarian cell lines and primary cultures of malignant cells derived from ovarian ascitic fluids were analysed by Affymetrix microarray analysis, immunoblotting, immunohistochemistry (IHC) and immunofluorescence (IF), with results correlated to associated clinical data. Aneuploidy status in primary cultures was determined by FACS analysis. Affymetrix microarray data indicated that NuMA was overexpressed in tumour tissue, primary cultures and cell lines compared to normal ovarian tissue. IHC revealed low to weak NuMA expression in normal tissues. Expression was upregulated in tumours, with a significant association with disease stage in mucinous EOC subtypes (p = 0.009), lymph node involvement (p = 0.03) and patient age (p = 0.04). Additional discontinuous data analysis revealed that high NuMA levels in tumours decreased with grade (p = 0.02) but increased with disease stage (p = 0.04) in serous EOC. NuMA expression decreased in late disease stage 4 endometrioid EOCs. High NuMA levels decreased with increased tumour invasion in all subtypes (p = 0.03). IF of primary cultures revealed that high NuMA levels at mitotic spindle poles were significantly associated with a decreased proportion of cells in cytokinesis (p = 0.05), increased binucleation (p = 0.021) and multinucleation (p = 0.007), and aneuploidy (p = 0.008). NuMA is highly expressed in EOC tumours and high NuMA levels correlate with increases in mitotic defects and aneuploidy in primary cultures.	[Bruening-Richardson, Anke; Bond, Jaqueline; Alsiary, Rawiah; Richardson, Julie; Morrison, Ewan E.; Bell, Sandra M.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Cairns, David A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Oncol & Clin Res, Leeds, W Yorkshire, England; [McCormac, Luci; Burns, Philip A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Pathol & Tumour Biol, Leeds, W Yorkshire, England; [Hutson, Richard; Wilkinson, Nafisa; Hall, Geoff D.] St Jamess Inst Oncol, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital	Bruning-Richardson, A (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England.	bgyar@leeds.ac.uk	Cairns, David/A-6577-2009; Hall, Geoff D/A-1717-2010	Cairns, David/0000-0002-2338-0179; Hall, Geoff D/0000-0002-8864-5932; Bell, Sandra/0000-0002-3022-9864; Bruning-Richardson, Anke/0000-0002-9862-9805	Yorkshire Cancer Research [L328]; University of Leeds; Breast Cancer Campaign [2007NovPR53]; Saudi Arabian Ministry of Higher Education; UK Medical Research Council [G0802416]; Oncolytics Biotech Inc, (Calgary, Canada); Leeds Teaching Hospitals NHS Trust; Cancer Research UK; Wellbeing of Women; MRC [G0802416] Funding Source: UKRI; Medical Research Council [G0802416] Funding Source: researchfish	Yorkshire Cancer Research; University of Leeds; Breast Cancer Campaign; Saudi Arabian Ministry of Higher Education; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oncolytics Biotech Inc, (Calgary, Canada); Leeds Teaching Hospitals NHS Trust; Cancer Research UK(Cancer Research UK); Wellbeing of Women(Wellbeing of Women (WoW)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work and Dr. Bruning-Richardson were funded by Yorkshire Cancer Research [L328]. The University of Leeds supports Dr. Bond, Dr. Burns, Dr. Hall and Dr. Morrison. Dr. Bell is supported by the Breast Cancer Campaign [2007NovPR53], Dr. Alsiary by a scholarship from the Saudi Arabian Ministry of Higher Education, Dr. Cairns by the UK Medical Research Council [G0802416], Dr. McCormac by Oncolytics Biotech Inc, (Calgary, Canada) and Dr. Wilkinson and Dr. Hutson by Leeds Teaching Hospitals NHS Trust. Dr. Bond, Dr. Burns, Dr. Wilkinson, Dr. Morrison and Dr. Bell hold funding from Yorkshire Cancer Research, GDH from Cancer Research UK, and Dr. Burns and Dr. Wilkinson from Wellbeing of Women. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad PC, 2007, MOL BIOL CELL, V18, P348, DOI 10.1091/mbc.E06-06-0551; Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bayani J, 2008, NEOPLASIA, V10, P1057, DOI 10.1593/neo.08584; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Bruning-Richardson A, 2011, BRIT J CANCER, V104, P1602, DOI 10.1038/bjc.2011.117; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Dynlacht JR, 2000, RADIAT RES, V154, P515, DOI 10.1667/0033-7587(2000)154[0515:DPODFA]2.0.CO;2; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Harborth J, 1999, CRIT REV EUKAR GENE, V9, P319, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.160; Hoglund M, 2003, CANCER RES, V63, P3378; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Lassus H, 2011, GYNECOL ONCOL, V120, P11, DOI 10.1016/j.ygyno.2010.09.003; LYDERSEN BK, 1980, CELL, V22, P489, DOI 10.1016/0092-8674(80)90359-1; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Ota J, 2003, ONCOGENE, V22, P5720, DOI 10.1038/sj.onc.1206855; Parrella P, 2003, MODERN PATHOL, V16, P636, DOI 10.1097/01.MP.0000076979.28106.ED; Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039; Pothuri B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010358; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; SPARKS CA, 1993, GENOMICS, V17, P222, DOI 10.1006/geno.1993.1307; Taimen P, 2000, EXP CELL RES, V256, P140, DOI 10.1006/excr.2000.4799; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Whitehurst AW, 2010, CANCER RES, V70, P7652, DOI 10.1158/0008-5472.CAN-10-0840; ZENG CQ, 1994, CELL MOTIL CYTOSKEL, V29, P167, DOI 10.1002/cm.970290208	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38945	10.1371/journal.pone.0038945	http://dx.doi.org/10.1371/journal.pone.0038945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719996	Green Published, Green Accepted, gold			2022-12-27	WOS:000305347800030
J	Maly, IV				Maly, Ivan V.			Equilibria of Idealized Confined Astral Microtubules and Coupled Spindle Poles	PLOS ONE			English	Article							CELL-DIVISION; CAENORHABDITIS-ELEGANS; DYNAMIC INSTABILITY; EMBRYOS; ORIENTATION; FORCE; POLARITY; MODEL	Positioning of the mitotic spindle through the interaction of astral microtubules with the cell boundary often determines whether the cell division will be symmetric or asymmetric. This process plays a crucial role in development. In this paper, a numerical model is presented that deals with the force exerted on the spindle by astral microtubules that are bent by virtue of their confinement within the cell boundary. It is found that depending on parameters, the symmetric position of the spindle can be stable or unstable. Asymmetric stable equilibria also exist, and two or more stable positions can exist simultaneously. The theory poses new types of questions for experimental research. Regarding the cases of symmetric spindle positioning, it is necessary to ask whether the microtubule parameters are controlled by the cell so that the bending mechanics favors symmetry. If they are not, then it is necessary to ask what forces external to the microtubule cytoskeleton counteract the bending effects sufficiently to actively establish symmetry. Conversely, regarding the cases with asymmetry, it is now necessary to investigate whether the cell controls the microtubule parameters so that the bending favors asymmetry apart from any forces that are external to the microtubule cytoskeleton.	Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maly, IV (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	ivanvmaly@gmail.com						[Anonymous], 1987, LINEAR AGGREGATION T; Arkhipov SN, 2006, PHYS BIOL, V3, P209, DOI 10.1088/1478-3975/3/3/006; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; Baratt A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003861; BJERKNES M, 1986, SCIENCE, V234, P1413, DOI 10.1126/science.3787253; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Bray D., 2001, CELL MOVEMENTS; Cytrynbaum EN, 2003, BIOPHYS J, V84, P757, DOI 10.1016/S0006-3495(03)74895-4; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Gu B, 2009, ACTA MECH, V207, P195, DOI 10.1007/s00707-008-0121-8; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Holy TE, 1997, PHYS ASPECTS ASSEMBL; Howard J., 2001, MECH MOTOR PROTEINS; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kim MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000260; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Lillie FR, 1901, J MORPHOL, V17, P227, DOI 10.1002/jmor.1050170204; Maly VI, 2010, BIOPHYS J, V99, P2831, DOI 10.1016/j.bpj.2010.09.017; McCarthy EK, 2006, CURR OPIN CELL BIOL, V18, P79, DOI 10.1016/j.ceb.2005.12.006; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Rubinstein B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016005; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Segal M, 2000, MOL BIOL CELL, V11, P3689, DOI 10.1091/mbc.11.11.3689; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SYMES K, 1992, DEV BIOL, V150, P203, DOI 10.1016/0012-1606(92)90019-D; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; WADSWORTH P, 1986, J CELL BIOL, V102, P1032, DOI 10.1083/jcb.102.3.1032; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WHITTAKER JR, 1980, J EMBRYOL EXP MORPH, V55, P343	35	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38921	10.1371/journal.pone.0038921	http://dx.doi.org/10.1371/journal.pone.0038921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719988	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305347800027
J	Garcia-Amado, M; Prensa, L				Garcia-Amado, Maria; Prensa, Lucia			Stereological Analysis of Neuron, Glial and Endothelial Cell Numbers in the Human Amygdaloid Complex	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; 5 SUBCORTICAL REGIONS; TISSUE SHRINKAGE; IMMUNOREACTIVE CELLS; ALZHEIMERS-DISEASE; LATERAL VENTRICLE; CHEMICAL ANATOMY; BIPOLAR DISORDER; THALAMIC NUCLEUS; HUMAN-BRAIN	Cell number alterations in the amygdaloid complex (AC) might coincide with neurological and psychiatric pathologies with anxiety imbalances as well as with changes in brain functionality during aging. This stereological study focused on estimating, in samples from 7 control individuals aged 20 to 75 years old, the number and density of neurons, glia and endothelial cells in the entire AC and in its 5 nuclear groups (including the basolateral (BL), corticomedial and central groups), 5 nuclei and 13 nuclear subdivisions. The volume and total cell number in these territories were determined on Nissl-stained sections with the Cavalieri principle and the optical fractionator. The AC mean volume was 956 mm(3) and mean cell numbers (x10(6)) were: 15.3 neurons, 60 glial cells and 16.8 endothelial cells. The numbers of endothelial cells and neurons were similar in each AC region and were one fourth the number of glial cells. Analysis of the influence of the individuals' age at death on volume, cell number and density in each of these 24 AC regions suggested that aging does not affect regional size or the amount of glial cells, but that neuron and endothelial cell numbers respectively tended to decrease and increase in territories such as AC or BL. These accurate stereological measures of volume and total cell numbers and densities in the AC of control individuals could serve as appropriate reference values to evaluate subtle alterations in this structure in pathological conditions.	[Garcia-Amado, Maria; Prensa, Lucia] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid	Garcia-Amado, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	lucia.prensa@uam.es	; Garcia-Amado Sancho, Maria/K-2705-2014	Prensa Sepulveda, Lucia/0000-0003-2217-3271; Garcia-Amado Sancho, Maria/0000-0001-6778-5680	Spanish Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PI070199]; Fundacion Eugenio Rodriguez Pascual; Universidad Autonoma de Madrid [FPI2009]	Spanish Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III; Fundacion Eugenio Rodriguez Pascual; Universidad Autonoma de Madrid	The project was supported by Grants from the Spanish Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (PI070199)(http://www.isciii.es/) and the Fundacion Eugenio Rodriguez Pascual (http://www. fundacioneugeniorodriguezpascual.es/), and a predoctoral fellowship from the Universidad Autonoma de Madrid (FPI2009) (www.uam.es) to Maria Garcia-Amado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 1999, J MICROSC-OXFORD, V196, P69; Asllani I, 2009, HUM BRAIN MAPP, V30, P2927, DOI 10.1002/hbm.20719; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Bermejo PE, 2003, J COMP NEUROL, V463, P419, DOI 10.1002/cne.10747; Berretta S, 2007, BIOL PSYCHIAT, V62, P884, DOI 10.1016/j.biopsych.2007.04.023; Bezchlibnyk YB, 2007, J PSYCHIATR NEUROSCI, V32, P203; BOONSTRA H, 1983, VIRCHOWS ARCH A, V402, P195, DOI 10.1007/BF00695061; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Carlo CN, 2010, J COMP NEUROL, V518, P1176, DOI 10.1002/cne.22264; Chance SA, 2002, BRIT J PSYCHIAT, V180, P331, DOI 10.1192/bjp.180.4.331; deCampo DM, 2012, NEUROSCI BIOBEHAV R, V36, P520, DOI 10.1016/j.neubiorev.2011.08.007; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Dorph-Petersen KA, 2009, ACTA NEUROPATHOL, V117, P369, DOI 10.1007/s00401-008-0410-2; Gallyas F, 1979, Neurol Res, V1, P203; Gardella D, 2003, J NEUROSCI METH, V124, P45, DOI 10.1016/S0165-0270(02)00363-1; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hajek T, 2009, J AFFECT DISORDERS, V115, P395, DOI 10.1016/j.jad.2008.10.007; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hatton WJ, 1999, J COMP NEUROL, V409, P169; HAUG H, 1984, J HIRNFORSCH, V25, P353; HECKERS S, 1990, ARCH GEN PSYCHIAT, V47, P1016; Hof PR, 2001, TRENDS NEUROSCI, V24, P377, DOI 10.1016/S0166-2236(00)01834-8; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Kreczmanski P, 2007, BRAIN, V130, P678, DOI 10.1093/brain/awl386; Kreczmanski P, 2009, ACTA NEUROPATHOL, V117, P409, DOI 10.1007/s00401-009-0482-7; KUSHNER PD, 1991, J NEUROPATH EXP NEUR, V50, P263, DOI 10.1097/00005072-199105000-00008; LaManna JC, 2004, J EXP BIOL, V207, P3163, DOI 10.1242/jeb.00976; LEHERICY S, 1994, AM J NEURORADIOL, V15, P929; Mai JK, 2004, ATLAS HUMAN BRAIN; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mu QW, 1999, AM J NEURORADIOL, V20, P207; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; Nissl F, 1913, ARCH PSYCHIAT NERVEN, V52, P867, DOI 10.1007/BF02160485; PAKKENBERG B, 1990, ARCH GEN PSYCHIAT, V47, P1023; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Prensa L, 2003, J COMP NEUROL, V460, P345, DOI 10.1002/cne.10627; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Rubinow MJ, 2009, NEUROBIOL AGING, V30, P137, DOI 10.1016/j.neurobiolaging.2007.05.006; Rubinow MJ, 2009, BEHAV BRAIN RES, V198, P263, DOI 10.1016/j.bbr.2008.11.024; Rubinow MJ, 2009, J COMP NEUROL, V512, P717, DOI 10.1002/cne.21924; Schumann CM, 2005, J COMP NEUROL, V491, P320, DOI 10.1002/cne.20704; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Sherwood CC, 2006, P NATL ACAD SCI USA, V103, P13606, DOI 10.1073/pnas.0605843103; SIMS KS, 1990, NEUROSCIENCE, V36, P449, DOI 10.1016/0306-4522(90)90440-F; SORVARI H, 1995, J COMP NEUROL, V360, P185, DOI 10.1002/cne.903600202; St Jacques P, 2009, NEUROBIOL AGING, V31, P315; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Uroz V, 2004, SYNAPSE, V51, P173, DOI 10.1002/syn.10298; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Yachnis AT, 2000, J NEUROPATH EXP NEUR, V59, P113, DOI 10.1093/jnen/59.2.113; Zhang XM, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.017.2009	58	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38692	10.1371/journal.pone.0038692	http://dx.doi.org/10.1371/journal.pone.0038692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719923	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900042
J	Xing, DQ; Oparil, S; Yu, H; Gong, KZ; Feng, WG; Black, J; Chen, YF; Nozell, S				Xing, Dongqi; Oparil, Suzanne; Yu, Hao; Gong, Kaizheng; Feng, Wenguang; Black, Jonathan; Chen, Yiu-Fai; Nozell, Susan			Estrogen Modulates NF kappa B Signaling by Enhancing I kappa B alpha Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-beta	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RAT CAROTID ARTERIES; INJURED ARTERIES; ADHESION MOLECULE-1; NEOINTIMA FORMATION; DNA-BINDING; EXPRESSION; ACTIVATION; TRANSCRIPTION; ATHEROSCLEROSIS	Background: NF kappa B signaling is critical for expression of genes involved in the vascular injury response. We have shown that estrogen (17 beta-estradiol, E2) inhibits expression of these genes in an estrogen receptor (ER)-dependent manner in injured rat carotid arteries and in tumor necrosis factor (TNF)-alpha treated rat aortic smooth muscle cells (RASMCs). This study tested whether E2 inhibits NF kappa B signaling in RASMCs and defined the mechanisms. Methodology/Principal Findings: TNF-alpha treated RASMCs demonstrated rapid degradation of I kappa B alpha (10-30 min), followed by dramatic increases in I kappa B alpha mRNA and protein synthesis (40-60 min). E2 enhanced TNF-alpha induced I kappa B alpha synthesis without affecting I kappa B alpha degradation. Chromatin immunoprecipitation (ChIP) assays revealed that E2 pretreatment both enhanced TNF-alpha induced binding of NF kappa B p65 to the I kappa B alpha promoter and suppressed TNF-alpha induced binding of NF kappa B p65 to and reduced the levels of acetylated histone 3 at promoters of monocyte chemotactic protein (MCP)-1 and cytokine-induced neutrophil chemoattractant (CINC)-2 beta genes. ChIP analyses also demonstrated that ER beta can be recruited to the promoters of MCP-1 and CINC-2 beta during co-treatment with TNF-alpha and E2. Conclusions: These data demonstrate that E2 inhibits inflammation in RASMCs by two distinct mechanisms: promoting new synthesis of I kappa B alpha, thus accelerating a negative feedback loop in NF kappa B signaling, and directly inhibiting binding of NF kappa B to the promoters of inflammatory genes. This first demonstration of multifaceted modulation of NF kappa B signaling by E2 may represent a novel mechanism by which E2 protects the vasculature against inflammatory injury.	[Xing, Dongqi; Oparil, Suzanne; Gong, Kaizheng; Feng, Wenguang; Black, Jonathan; Chen, Yiu-Fai] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA; [Yu, Hao; Nozell, Susan] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Gong, Kaizheng] Yangzhou Univ, Clin Med Sch 2, Dept Cardiol, Yangzhou, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Yangzhou University	Xing, DQ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA.	dqxing@uab.edu		Black, Jonathan/0000-0002-0328-5537	National Heart, Lung, and Blood Institute [HL07457, HL75211, HL087980, HL080017, HL044195]; American Heart Association Greater Southeast Affiliate [09BGIA2250367]; UAB Diabetes Research and Training Center [P60 DK-079626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044195, T35HL007473, R01HL075211, R01HL087980, T32HL007457, R01HL080017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Greater Southeast Affiliate(American Heart Association); UAB Diabetes Research and Training Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung, and Blood Institute grants HL07457, HL75211, HL087980 (to S.O.); HL080017, HL044195 (to Y.F.C.), American Heart Association Greater Southeast Affiliate grant 09BGIA2250367 and UAB Diabetes Research and Training Center P60 DK-079626 (to D.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir S, 2000, CIRCULATION, V101, P2342, DOI 10.1161/01.CIR.101.20.2342; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; Cerillo G, 1998, J STEROID BIOCHEM, V67, P79, DOI 10.1016/S0960-0760(98)00078-8; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Evans MJ, 2002, ENDOCRINOLOGY, V143, P2559, DOI 10.1210/en.143.7.2559; Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kalaitzidis D, 2004, ONCOGENE, V23, P7580, DOI 10.1038/sj.onc.1207912; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Landry DB, 1997, AM J PATHOL, V151, P1085; Li GH, 2002, CIRCULATION, V106, P854, DOI 10.1161/01.CIR.0000024113.26985.CC; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; Liu H, 2005, CYTOKINE, V31, P251, DOI 10.1016/j.cyto.2004.12.008; McMurray RW, 2001, CYTOKINE, V14, P324, DOI 10.1006/cyto.2001.0900; Miller AP, 2007, MENOPAUSE, V14, P251, DOI 10.1097/01.gme.0000235366.39726.f6; Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Nozell S, 2006, J IMMUNOL, V177, P822, DOI 10.4049/jimmunol.177.2.822; Ohtsuka T, 1996, J BIOL CHEM, V271, P1651, DOI 10.1074/jbc.271.3.1651; Okamoto E, 2001, CIRCULATION, V104, P2228, DOI 10.1161/hc4301.097195; Oparil S, 1999, CARDIOVASC RES, V44, P608, DOI 10.1016/S0008-6363(99)00240-0; Oparil S, 1997, CIRCULATION, V95, P1301; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rupec RA, 1999, IMMUNOGENETICS, V49, P395, DOI 10.1007/s002510050512; Ruusalepp A, 2006, CARDIOVASC DRUG THER, V20, P103, DOI 10.1007/s10557-006-6755-7; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Speir E, 2000, CIRCULATION, V102, P2990; STEIN B, 1995, MOL CELL BIOL, V15, P4971; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun WH, 1998, BIOCHEM BIOPH RES CO, V244, P691, DOI 10.1006/bbrc.1998.8324; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Wang XL, 2009, MOL IMMUNOL, V46, P2413, DOI 10.1016/j.molimm.2009.04.014; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Xing DQ, 2007, AM J PHYSIOL-HEART C, V292, pH2607, DOI 10.1152/ajpheart.01107.2006; Xing DQ, 2004, CIRCULATION, V109, P234, DOI 10.1161/01.CIR.0000105700.95607.49; Xing L, 2007, ANTIOXID REDOX SIGN, V9, P1979, DOI 10.1089/ars.2007.1921	55	81	82	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e36890	10.1371/journal.pone.0036890	http://dx.doi.org/10.1371/journal.pone.0036890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723832	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700002
J	Yuan, LZ; Tang, JH; Wang, XP; Li, CH				Yuan, Liuzheng; Tang, Jihua; Wang, Xiuping; Li, Chaohai			QTL Analysis of Shading Sensitive Related Traits in Maize under Two Shading Treatments	PLOS ONE			English	Article							ANTHESIS-SILKING INTERVAL; ZEA-MAYS L; PLANT HEIGHT; KERNEL NUMBER; MOLECULAR MARKERS; DROUGHT TOLERANCE; DIFFERENT TESTERS; WATER-DEFICIT; LOCI; IDENTIFICATION	During maize development and reproduction, shading stress is an important abiotic factor influencing grain yield. To elucidate the genetic basis of shading stress in maize, an F-2:3 population derived from two inbred lines, Zhong72 and 502, was used to evaluate the performance of six traits under shading treatment and full-light treatment at two locations. The results showed that shading treatment significantly decreased plant height and ear height, reduced stem diameter, delayed day-to-tassel (DTT) and day-to-silk (DTS), and increased anthesis-silking interval (ASI). Forty-three different QTLs were identified for the six measured traits under shading and full light treatment at two locations, including seven QTL for plant height, nine QTL for ear height, six QTL for stem diameter, seven QTL for day-to-tassel, six QTL for day-to-silk, and eight QTL for ASI. Interestingly, three QTLs, qPH4, qEH4a, and qDTT1b were detected under full sunlight and shading treatment at two locations simultaneously, these QTL could be used for selecting elite hybrids with high tolerance to shading and high plant density. And the two QTL, qPH10 and qDTS1a, were only detected under shading treatment at two locations, should be quit for selecting insensitive inbred line in maize breeding procedure by using MAS method.	[Yuan, Liuzheng; Tang, Jihua; Wang, Xiuping; Li, Chaohai] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China	Henan Agricultural University	Yuan, LZ (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China.	lichaohai2005@yahoo.com.cn			National Maize Industrial Technology RD system [NYCYTX-2]	National Maize Industrial Technology RD system	This work was supported by National Maize Industrial Technology R&D system (No.: NYCYTX-2). (http://www.moa.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLER BSB, 1991, CROP SCI, V31, P267, DOI 10.2135/cropsci1991.0011183X003100020006x; Agrama HAS, 1996, EUPHYTICA, V91, P89, DOI 10.1007/BF00035278; Andrade FH, 1999, CROP SCI, V39, P453, DOI 10.2135/cropsci1999.0011183X0039000200026x; BEAVIS WD, 1991, THEOR APPL GENET, V83, P141, DOI 10.1007/BF00226242; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; Doust AN, 2007, CURR OPIN PLANT BIOL, V10, P21, DOI 10.1016/j.pbi.2006.11.015; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; EARLEY EB, 1966, CROP SCI, V6, P1, DOI 10.2135/cropsci1966.0011183X000600010001x; EARLY EB, 1967, CROP SCI, V7, P151, DOI 10.2135/cropsci1967.0011183X000700020018x; Edmeades GO, 2000, CSSA SPEC PUBL, P43; Fournier C, 2000, ANN BOT-LONDON, V86, P1127, DOI 10.1006/anbo.2000.1280; GERAKIS PA, 1980, AGR METEOROL, V21, P129, DOI 10.1016/0002-1571(80)90059-X; HASHEMIDEZFOULI A, 1992, AGRON J, V84, P547, DOI 10.2134/agronj1992.00021962008400040001x; Hebert Y, 2001, CROP SCI, V41, P363, DOI 10.2135/cropsci2001.412363x; KARLEN DL, 1985, AGRON J, V77, P393, DOI 10.2134/agronj1985.00021962007700030010x; Khairallah MM, 1998, PLANT BREEDING, V117, P309, DOI 10.1111/j.1439-0523.1998.tb01947.x; KINIRY JR, 1985, AGRON J, V77, P711, DOI 10.2134/agronj1985.00021962007700050012x; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; Kozumplik V, 1996, MAYDICA, V41, P211; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liu WD, 2009, CROP SCI, V49, P1817, DOI 10.2135/cropsci2008.07.0423; Lubberstedt T, 1997, CROP SCI, V37, P921, DOI 10.2135/cropsci1997.0011183X003700030037x; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; Melchinger AE, 1998, GENETICS, V149, P383; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; MOSS DALE N., 1961, CROP SCI, V1, P416, DOI 10.2135/cropsci1961.0011183X000100060009x; Rebai A, 1997, THEOR APPL GENET, V95, P451, DOI 10.1007/s001220050582; REED AJ, 1988, CROP SCI, V28, P819, DOI 10.2135/cropsci1988.0011183X002800050020x; Ribaut JM, 1996, THEOR APPL GENET, V92, P905, DOI 10.1007/BF00221905; Salah HBH, 1996, J EXP BOT, V47, P1689, DOI 10.1093/jxb/47.11.1689; SCHMIDT WH, 1967, CROP SCI, V7, P137, DOI 10.2135/cropsci1967.0011183X000700020013x; SCHON CC, 1994, CROP SCI, V34, P378, DOI 10.2135/cropsci1994.0011183X003400020014x; SCHOPER JB, 1982, CROP SCI, V22, P1184, DOI 10.2135/cropsci1982.0011183X002200060023x; SETTER TL, 1989, ANN BOT-LONDON, V64, P481, DOI 10.1093/oxfordjournals.aob.a087867; Setter TL, 2001, CROP SCI, V41, P1530, DOI 10.2135/cropsci2001.4151530x; SINGH BK, 1984, AUST J PLANT PHYSIOL, V11, P151, DOI 10.1071/PP9840151; STINSON HARRY T., 1960, AGRON JOUR, V52, P482; STRUIK PC, 1983, NETH J AGR SCI, V31, P101; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; TOLLENAAR M, 1978, AGRON J, V70, P219, DOI 10.2134/agronj1978.00021962007000020003x; Tollenaar M., 1977, Maydica, V22, P49; VELDBOOM LR, 1994, THEOR APPL GENET, V88, P7, DOI 10.1007/BF00222387; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; WARD DA, 1986, PLANT CELL ENVIRON, V9, P261, DOI 10.1111/j.1365-3040.1986.tb01738.x; Welcker C, 2007, J EXP BOT, V58, P339, DOI 10.1093/jxb/erl227; Yuan LiuZheng, 2008, Journal of Maize Sciences, V16, P19; ZENG ZB, 1994, GENETICS, V136, P1457	49	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38696	10.1371/journal.pone.0038696	http://dx.doi.org/10.1371/journal.pone.0038696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723877	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700022
J	Belluzzi, E; Bisaglia, M; Lazzarini, E; Tabares, LC; Beltramini, M; Bubacco, L				Belluzzi, Elisa; Bisaglia, Marco; Lazzarini, Elisabetta; Tabares, Leandro C.; Beltramini, Mariano; Bubacco, Luigi			Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease	PLOS ONE			English	Article							HIGH-FIELD EPR; MANGANESE SUPEROXIDE DISMUTASES; RAT-BRAIN MITOCHONDRIA; ALPHA-SYNUCLEIN; TYROSINE-HYDROXYLASE; OXIDATIVE PATHWAYS; PATHOGENESIS; CATECHOLAMINES; IDENTIFICATION; NEUROTOXICITY	Mitochondrial dysfunction and oxidative stress are considered central in dopaminergic neurodegeneration in Parkinson's disease (PD). Oxidative stress occurs when the endogenous antioxidant systems are overcome by the generation of reactive oxygen species (ROS). A plausible source of oxidative stress, which could account for the selective degeneration of dopaminergic neurons, is the redox chemistry of dopamine (DA) and leads to the formation of ROS and reactive dopamine-quinones (DAQs). Superoxide dismutase 2 (SOD2) is a mitochondrial enzyme that converts superoxide radicals to molecular oxygen and hydrogen peroxide, providing a first line of defense against ROS. We investigated the possible interplay between DA and SOD2 in the pathogenesis of PD using enzymatic essays, site-specific mutagenesis, and optical and high-field-cw-EPR spectroscopies. Using radioactive DA, we demonstrated that SOD2 is a target of DAQs. Exposure to micromolar DAQ concentrations induces a loss of up to 50% of SOD2 enzymatic activity in a dose-dependent manner, which is correlated to the concomitant formation of protein aggregates, while the coordination geometry of the active site appears unaffected by DAQ modifications. Our findings support a model in which DAQ-mediated SOD2 inactivation increases mitochondrial ROS production, suggesting a link between oxidative stress and mitochondrial dysfunction.	[Belluzzi, Elisa; Bisaglia, Marco; Lazzarini, Elisabetta; Beltramini, Mariano; Bubacco, Luigi] Univ Padua, Dept Biol, Padua, Italy; [Tabares, Leandro C.] CEA, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanismes, Gif Sur Yvette, France	University of Padua; CEA; UDICE-French Research Universities; Universite Paris Saclay	Belluzzi, E (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	mariano.beltramini@unipd.it; luigi.bubacco@unipd.it	Belluzzi, Elisa/K-4622-2016; Bubacco, Luigi/B-5602-2012; Tabares, Leandro C/A-6368-2009	Belluzzi, Elisa/0000-0003-1129-2574; Bubacco, Luigi/0000-0001-7927-9208; Tabares, Leandro C/0000-0002-8906-6430	Italian Ministry of Education, University and Research [PRIN2008-5SYP79]; University of Padova [PRAT2010-CPDA103503]; Bruno Kessler Foundation	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova; Bruno Kessler Foundation	This work was supported by grants from the Italian Ministry of Education, University and Research (PRIN2008-5SYP79), the University of Padova (PRAT2010-CPDA103503) and the Bruno Kessler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Attar F, 2006, APPL BIOCHEM MICRO+, V42, P101, DOI 10.1134/S0003683806010169; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Bisaglia M, 2010, BBA-MOL BASIS DIS, V1802, P699, DOI 10.1016/j.bbadis.2010.06.006; Bisaglia M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-41; Bisaglia M, 2010, BIOCHEM BIOPH RES CO, V394, P424, DOI 10.1016/j.bbrc.2010.03.044; BURGHAUS O, 1993, J PHYS CHEM-US, V97, P7639, DOI 10.1021/j100131a037; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Girotto S, 2012, J BIOL CHEM IN PRESS; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Greggio E, 2005, J NEUROCHEM, V93, P246, DOI 10.1111/j.1471-4159.2005.03019.x; Hastings TG, 2009, J BIOENERG BIOMEMBR, V41, P469, DOI 10.1007/s10863-009-9257-z; HASTINGS TG, 1994, J NEUROCHEM, V63, P1126; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuhn DM, 1999, J NEUROCHEM, V73, P1309, DOI 10.1046/j.1471-4159.1999.0731309.x; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; PAZ MA, 1991, J BIOL CHEM, V266, P689; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Tabares LC, 2006, BIOCHEMISTRY-US, V45, P1919, DOI 10.1021/bi051947m; Tabares LC, 2007, BIOCHEMISTRY-US, V46, P9320, DOI 10.1021/bi700438j; Tabares LC, 2010, BBA-PROTEINS PROTEOM, V1804, P308, DOI 10.1016/j.bbapap.2009.09.027; TSE DCS, 1976, J MED CHEM, V19, P37, DOI 10.1021/jm00223a008; Un S, 2004, J AM CHEM SOC, V126, P2720, DOI 10.1021/ja036503x; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; Un S, 2001, J AM CHEM SOC, V123, P10123, DOI 10.1021/ja016258m; Van Laar VS, 2008, NEUROBIOL DIS, V29, P477, DOI 10.1016/j.nbd.2007.11.007; Van Laar VS, 2009, NEUROBIOL DIS, V34, P487, DOI 10.1016/j.nbd.2009.03.004; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023	40	49	49	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38026	10.1371/journal.pone.0038026	http://dx.doi.org/10.1371/journal.pone.0038026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723845	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300019
J	Cosson, P; Schurdi-Levraud, V; Le, QH; Sicard, O; Caballero, M; Roux, F; Le Gall, O; Candresse, T; Revers, F				Cosson, Patrick; Schurdi-Levraud, Valerie; Le, Quang Hien; Sicard, Ophelie; Caballero, Melodie; Roux, Fabrice; Le Gall, Olivier; Candresse, Thierry; Revers, Frederic			The RTM Resistance to Potyviruses in Arabidopsis thaliana: Natural Variation of the RTM Genes and Evidence for the Implication of Additional Genes	PLOS ONE			English	Article							LONG-DISTANCE MOVEMENT; LETTUCE-MOSAIC-VIRUS; TOBACCO ETCH VIRUS; PLANT-RESISTANCE; DUPLICATED GENES; TERMINAL REGION; COMPLEX TRAITS; RESTRICTION; REPLICATION; EXPRESSION	Background: The non conventional RTM (Restricted Tobacco etch virus Movement) resistance which restricts long distance movement of some plant viruses in Arabidopsis thaliana is still poorly understood. Though at least three RTM genes have been identified, their precise role(s) in the process as well as whether other genes are involved needs to be elucidated. Methodology/Principal Findings: In this study, the natural variation of the RTM genes was analysed at the amino acid level in relation with their functionality to restrict the long distance movement of Lettuce mosaic potyvirus (LMV). We identified non-functional RTM alleles in LMV-susceptible Arabidopsis accessions as well as some of the mutations leading to the non-functionality of the RTM proteins. Our data also indicate that more than 40% of the resistant accessions to LMV are controlled by the RTM genes. In addition, two new RTM loci were genetically identified. Conclusions/Significance: Our results show that the RTM resistance seems to be a complex biological process which would involves at least five different proteins. The next challenges will be to understand how the different RTM protein domains are involved in the resistance mechanism and to characterise the new RTM genes for a better understanding of the blocking of the long distance transport of plant viruses.	[Cosson, Patrick; Schurdi-Levraud, Valerie; Le, Quang Hien; Sicard, Ophelie; Caballero, Melodie; Le Gall, Olivier; Candresse, Thierry; Revers, Frederic] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Cosson, Patrick; Schurdi-Levraud, Valerie; Caballero, Melodie; Le Gall, Olivier; Candresse, Thierry; Revers, Frederic] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Roux, Fabrice] Univ Sci & Technol Lille 1, Lab Genet & Evolut Populat Vegetales, FRE CNRS 3268, Villeneuve Dascq, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Universite de Lille - ISITE; Universite de Lille	Cosson, P (corresponding author), INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France.	revers@bordeaux.inra.fr	Revers, Frederic/A-9732-2009; Schurdi-Levraud, Valerie/P-5508-2019; Le Gall, Olivier/C-4820-2011	Revers, Frederic/0000-0002-6167-192X; Schurdi-Levraud, Valerie/0000-0001-5519-5800; Le Gall, Olivier/0000-0002-8547-6061; Fabrice, Roux/0000-0001-8059-5638; Candresse, Thierry/0000-0001-9757-1835	INRA's 'Jeune Equipe' program; Etablissement Public Regional Aquitaine [20000307004]; French Research Ministry; INRA (Plant Health and Plant Genetics divisions); Aquitaine regional council	INRA's 'Jeune Equipe' program; Etablissement Public Regional Aquitaine; French Research Ministry(Ministry of Research, France); INRA (Plant Health and Plant Genetics divisions); Aquitaine regional council(Region Nouvelle-Aquitaine)	This work was supported by grants from INRA's 'Jeune Equipe' program, from the Etablissement Public Regional Aquitaine (contract number 20000307004). QHL was supported by a "Haignere'' post-doctoral grant from the French Research Ministry. OS was funded by a Ph.D. fellowship from INRA (Plant Health and Plant Genetics divisions) and the Aquitaine regional council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carrington JC, 1998, CURR OPIN PLANT BIOL, V1, P336, DOI 10.1016/1369-5266(88)80056-6; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; Chisholm ST, 2001, PLANT PHYSIOL, V127, P1667, DOI 10.1104/pp.010479; Cosson P, 2010, PLANT PHYSIOL, V154, P222, DOI 10.1104/pp.110.155754; Decroocq V, 2006, MOL PLANT MICROBE IN, V19, P541, DOI 10.1094/MPMI-19-0541; Decroocq V, 2009, MOL PLANT MICROBE IN, V22, P1302, DOI 10.1094/MPMI-22-10-1302; Diaz-Pendon JA, 2004, MOL PLANT PATHOL, V5, P223, DOI [10.1111/j.1364-3703.2004.00223.x, 10.1111/J.1364-3703.2004.00223.X]; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Holub EB, 1997, ADV BOT RES, V24, P227; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ishibashi K, 2007, P NATL ACAD SCI USA, V104, P13833, DOI 10.1073/pnas.0703203104; Ishibashi K, 2010, MOL PLANT MICROBE IN, V23, P1413, DOI 10.1094/MPMI-04-10-0102; Jeyaprakash AA, 2002, J MOL BIOL, V321, P637, DOI 10.1016/S0022-2836(02)00674-5; Krause-Sakate R, 2002, PHYTOPATHOLOGY, V92, P563, DOI 10.1094/PHYTO.2002.92.5.563; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Mahajan SK, 1998, PLANT J, V14, P177, DOI 10.1046/j.1365-313X.1998.00105.x; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Maule AJ, 2007, MOL PLANT PATHOL, V8, P223, DOI 10.1111/J.1364-3703.2007.00386.X; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Revers F, 2003, MOL PLANT MICROBE IN, V16, P608, DOI 10.1094/MPMI.2003.16.7.608; Revers F, 1999, ARCH VIROL, V144, P1619, DOI 10.1007/s007050050615; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang S., 2011, WINDOWS QTL CARTOGRA; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006; Whitham SA, 2000, PLANT CELL, V12, P569, DOI 10.1105/tpc.12.4.569; Xiang Y, 2011, J EXP BOT, V62, P5471, DOI 10.1093/jxb/err226; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	51	34	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39169	10.1371/journal.pone.0039169	http://dx.doi.org/10.1371/journal.pone.0039169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723957	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300111
J	Dainat, J; Paganini, J; Pontarotti, P; Gouret, P				Dainat, Jacques; Paganini, Julien; Pontarotti, Pierre; Gouret, Philippe			GLADX: An Automated Approach to Analyze the Lineage-Specific Loss and Pseudogenization of Genes	PLOS ONE			English	Article							UNITARY PSEUDOGENES; URATE OXIDASE; IDENTIFICATION; GENOME; DIVERGENCE; PATTERNS; SEQUENCE; MUTATION; SEARCH; HUMANS	A well-established ancestral gene can usually be found, in one or multiple copies, in different descendant species. Sometimes during the course of evolution, all the representatives of a well-established ancestral gene disappear in specific lineages; such gene losses may occur in the genome by deletion of a DNA fragment or by pseudogenization. The loss of an entire gene family in a given lineage may reflect an important phenomenon, and could be due either to adaptation, or to a relaxation of selection that leads to neutral evolution. Therefore, the lineage-specific gene loss analyses are important to improve the understanding of the evolutionary history of genes and genomes. In order to perform this kind of study from the increasing number of complete genome sequences available, we developed a unique new software module called GLADX in the DAGOBAH framework, based on a comparative genomic approach. The software is able to automatically detect, for all the species of a phylum, the presence/absence of a representative of a well-established ancestral gene, and by systematic steps of re-annotation, confirm losses, detect and analyze pseudogenes and find novel genes. The approach is based on the use of highly reliable gene phylogenies, of protein predictions and on the analysis of genomic mutations. All the evidence associated to evolutionary approach provides accurate information for building an overall view of the evolution of a given gene in a selected phylum. The reliability of GLADX has been successfully tested on a benchmark analysis of 14 reported cases. It is the first tool that is able to fully automatically study the lineage-specific losses and pseudogenizations. GLADX is available at http://ioda.univ-provence.fr/IodaSite/gladx/.	[Dainat, Jacques; Paganini, Julien; Pontarotti, Pierre; Gouret, Philippe] Aix Marseille Univ, Lab Anal, Probabilites LATP, CNRS,Equipe Evolut Biol & Modelisat,UMR 7353, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Dainat, J (corresponding author), Aix Marseille Univ, Lab Anal, Probabilites LATP, CNRS,Equipe Evolut Biol & Modelisat,UMR 7353, Marseille, France.	jacques.dainat@gmail.com	, pontarotti/ABB-1753-2021	Pierre, Pontarotti/0000-0001-7202-3648; Dainat, Jacques/0000-0002-6629-0173	French Ministry of Research; French National Research Agency [ANR-07-BLAN-0054]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French National Research Agency(French National Research Agency (ANR))	JD was funded by a PhD fellowship from the French Ministry of Research. This work was supported by the French National Research Agency [EvolHHupro: ANR-07-BLAN-0054]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Brawand D, 2008, PLOS BIOL, V6, P507, DOI 10.1371/journal.pbio.0060063; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Eulenstein O, 1997, MATH HIERARCHIES BIO, P71; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Freimuth RR, 2004, PHARMACOGENOMICS J, V4, P54, DOI 10.1038/sj.tpj.6500223; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Gouret P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-198; Gouret P, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P71, DOI 10.1007/978-3-642-20763-1_5; Gouret P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-298; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; Hughes AL, 2004, J MOL EVOL, V59, P827, DOI 10.1007/s00239-004-0115-7; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kuraku S, 2011, GENOME BIOL EVOL, P1; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mitchell A, 2005, J MOL EVOL, V61, P795, DOI 10.1007/s00239-004-0235-0; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Paganini J, 2012, EVOLUTIONAR IN PRESS; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANKOFF D, 1975, MATH PROGRAM, V9, P240, DOI 10.1007/BF01681346; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38792	10.1371/journal.pone.0038792	http://dx.doi.org/10.1371/journal.pone.0038792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723889	Green Published, gold			2022-12-27	WOS:000305583300050
J	McKnite, AM; Perez-Munoz, ME; Lu, L; Williams, EG; Brewer, S; Andreux, PA; Bastiaansen, JWM; Wang, XS; Kachman, SD; Auwerx, J; Williams, RW; Benson, AK; Peterson, DA; Ciobanu, DC				McKnite, Autumn M.; Perez-Munoz, Maria Elisa; Lu, Lu; Williams, Evan G.; Brewer, Simon; Andreux, Penelope A.; Bastiaansen, John W. M.; Wang, Xusheng; Kachman, Stephen D.; Auwerx, Johan; Williams, Robert W.; Benson, Andrew K.; Peterson, Daniel A.; Ciobanu, Daniel C.			Murine Gut Microbiota Is Defined by Host Genetics and Modulates Variation of Metabolic Traits	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GENOME-WIDE ASSOCIATION; INBRED MOUSE STRAINS; INNATE IMMUNITY; INDUCED OBESITY; MICE; DIET; EXPRESSION; WEIGHT; LOCI	The gastrointestinal tract harbors a complex and diverse microbiota that has an important role in host metabolism. Microbial diversity is influenced by a combination of environmental and host genetic factors and is associated with several polygenic diseases. In this study we combined next-generation sequencing, genetic mapping, and a set of physiological traits of the BXD mouse population to explore genetic factors that explain differences in gut microbiota and its impact on metabolic traits. Molecular profiling of the gut microbiota revealed important quantitative differences in microbial composition among BXD strains. These differences in gut microbial composition are influenced by host-genetics, which is complex and involves many loci. Linkage analysis defined Quantitative Trait Loci (QTLs) restricted to a particular taxon, branch or that influenced the variation of taxa across phyla. Gene expression within the gastrointestinal tract and sequence analysis of the parental genomes in the QTL regions uncovered candidate genes with potential to alter gut immunological profiles and impact the balance between gut microbial communities. A QTL region on Chr 4 that overlaps several interferon genes modulates the population of Bacteroides, and potentially Bacteroidetes and Firmicutes-the predominant BXD gut phyla. Irak4, a signaling molecule in the Toll-like receptor pathways is a candidate for the QTL on Chr15 that modulates Rikenellaceae, whereas Tgfb3, a cytokine modulating the barrier function of the intestine and tolerance to commensal bacteria, overlaps a QTL on Chr 12 that influence Prevotellaceae. Relationships between gut microflora, morphological and metabolic traits were uncovered, some potentially a result of common genetic sources of variation.	[McKnite, Autumn M.; Ciobanu, Daniel C.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA; [Perez-Munoz, Maria Elisa; Benson, Andrew K.; Peterson, Daniel A.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Williams, Evan G.; Andreux, Penelope A.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Brewer, Simon] Univ Utah, Dept Geog, Salt Lake City, UT USA; [Bastiaansen, John W. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Kachman, Stephen D.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Peterson, Daniel A.] Johns Hopkins Univ Sch Med, Dept Pathol, Baltimore, MD USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Tennessee System; University of Tennessee Health Science Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Utah System of Higher Education; University of Utah; Wageningen University & Research; University of Nebraska System; University of Nebraska Lincoln; Johns Hopkins University	McKnite, AM (corresponding author), Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA.	dciobanu2@unl.edu	Williams, Evan/M-7539-2017; Bastiaansen, John WM/A-5733-2010; Auwerx, Johan/ABE-9307-2021; Williams, Robert W./H-8789-2016	Williams, Evan/0000-0002-9746-376X; Bastiaansen, John WM/0000-0002-6562-176X; McKnite, Autumn/0000-0001-7985-2991; Benson, Andrew/0000-0001-6330-0252; Auwerx, Johan/0000-0002-5065-5393; Kachman, Stephen/0000-0003-0506-513X; Williams, Robert W./0000-0001-8924-4447; Brewer, Simon/0000-0002-6810-1911	Office of Research of the University of Nebraska-Lincoln; Nebraska Tobacco Settlement Biomedical Research Development Funds; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; European Research Council Ideas Programme [ERC-2008-AdG23118]; NIAAA [U01AA013499, U01AA014425, P20-DA 21131]; NIDA; UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499, U01AA014425, U01AA016662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	Office of Research of the University of Nebraska-Lincoln; Nebraska Tobacco Settlement Biomedical Research Development Funds; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council Ideas Programme; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Layman Award from the Office of Research of the University of Nebraska-Lincoln, the Nebraska Tobacco Settlement Biomedical Research Development Funds, the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, the European Research Council Ideas Programme (Sirtuins; ERC-2008-AdG23118), NIAAA (U01AA013499, U01AA014425), NIDA and NIAAA (P20-DA 21131), and the UT Center for Integrative and Translational Genomics. The Nebraska Tobacco Settlement Biomedical. Research Development Funds is not a profit making body and there are no commercial connections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Barbosa T, 2010, WIRES SYST BIOL MED, V2, P80, DOI 10.1002/wsbm.48; Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bird AR, 2000, J NUTR, V130, P1780, DOI 10.1093/jn/130.7.1780; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; Geisert EE, 2009, MOL VIS, V15, P1730; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; LANDER ES, 1989, GENETICS, V121, P185; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Macfarlane GT, 1997, CARBOHYDRATE FERMENT; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Meijerink E, 2000, IMMUNOGENETICS, V52, P129, DOI 10.1007/s002510000263; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Niu X, 2011, ANIMAL GENETICS; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; PLANCHON SM, 1994, J IMMUNOL, V153, P5730; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; Scarpellini E, 2010, INTERN EMERG MED, V5, pS53, DOI 10.1007/s11739-010-0450-1; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Stylianou IM, 2006, MAMM GENOME, V17, P22, DOI 10.1007/s00335-005-0091-2; Suhir H, 2010, CLIN REV ALLERG IMMU, V38, P11, DOI 10.1007/s12016-009-8135-0; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tortoriello DV, 2004, ENDOCRINOLOGY, V145, P1238, DOI 10.1210/en.2003-1406; Tsang SL, 2007, CYTOKINE, V37, P138, DOI 10.1016/j.cyto.2007.03.002; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VERNAY M, 1987, BRIT J NUTR, V57, P371, DOI 10.1079/BJN19870045; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Williams RW, 2001, GENOME BIOL, V2; WOLEVER TMS, 1989, AM J GASTROENTEROL, V84, P1027; Yang H, 2011, NAT GENET; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006	71	149	156	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39191	10.1371/journal.pone.0039191	http://dx.doi.org/10.1371/journal.pone.0039191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723961	Green Published, gold			2022-12-27	WOS:000305583300114
J	Pante, E; France, SC; Couloux, A; Cruaud, C; McFadden, CS; Samadi, S; Watling, L				Pante, Eric; France, Scott C.; Couloux, Arnaud; Cruaud, Corinne; McFadden, Catherine S.; Samadi, Sarah; Watling, Les			Deep-Sea Origin and In-Situ Diversification of Chrysogorgiid Octocorals	PLOS ONE			English	Article							RIBOSOMAL-RNA; MITOCHONDRIAL GENOME; PHENOTYPIC PLASTICITY; PHYLOGENETIC ANALYSES; DNA-SEQUENCES; ANTHOZOA; CNIDARIA; CORALS; GENUS; ALIGNMENT	The diversity, ubiquity and prevalence in deep waters of the octocoral family Chrysogorgiidae Verrill, 1883 make it noteworthy as a model system to study radiation and diversification in the deep sea. Here we provide the first comprehensive phylogenetic analysis of the Chrysogorgiidae, and compare phylogeny and depth distribution. Phylogenetic relationships among 10 of 14 currently-described Chrysogorgiidae genera were inferred based on mitochondrial (mtMutS, cox1) and nuclear (18S) markers. Bathymetric distribution was estimated from multiple sources, including museum records, a literature review, and our own sampling records (985 stations, 2345 specimens). Genetic analyses suggest that the Chrysogorgiidae as currently described is a polyphyletic family. Shallow-water genera, and two of eight deep-water genera, appear more closely related to other octocoral families than to the remainder of the monophyletic, deep-water chrysogorgiid genera. Monophyletic chrysogorgiids are composed of strictly (Iridogorgia Verrill, 1883, Metallogorgia Versluys, 1902, Radicipes Stearns, 1883, Pseudochrysogorgia Pante & France, 2010) and predominantly (Chrysogorgia Duchassaing & Michelotti, 1864) deep-sea genera that diversified in situ. This group is sister to gold corals (Primnoidae Milne Edwards, 1857) and deep-sea bamboo corals (Keratoisidinae Gray, 1870), whose diversity also peaks in the deep sea. Nine species of Chrysogorgia that were described from depths shallower than 200 m, and mtMutS haplotypes sequenced from specimens sampled as shallow as 101 m, suggest a shallow-water emergence of some Chrysogorgia species.	[Pante, Eric; France, Scott C.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Couloux, Arnaud; Cruaud, Corinne] Ctr Natl Sequencage, GENOSCOPE, Evry, France; [McFadden, Catherine S.] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [Samadi, Sarah] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR UPMC IRD MNHN CNRS UR IRD 148 7138, F-75231 Paris, France; [Watling, Les] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Watling, Les] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	University of Louisiana Lafayette; Claremont Colleges; Harvey Mudd College; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Hawaii System; University of Hawaii Manoa; University of Maine System; University of Maine Orono	Pante, E (corresponding author), Univ La Rochelle, CNRS, UMR 7266, La Rochelle, France.	pante.eric@gmail.com	Pante, Eric/C-4230-2011; samadi, sarah/G-5011-2010	Pante, Eric/0000-0001-7680-2112; samadi, sarah/0000-0003-0725-9368; France, Scott/0000-0002-2114-5968; Cruaud, Corinne/0000-0002-4752-7278; Couloux, Arnaud/0000-0003-2356-0062	National Science Foundation (NSF) [OCE-0624601, EF-0531570, EF-0531779]; National Oceanic and Atmospheric Administration (NOAA)/National Marine Fisheries Service Auke Bay Laboratory [NFFS7400-5-00022]; NOAA [NA05OAR4301001, NA66RU0186]; NOAA-OER [NA05OAR4601061, NA03OAR4600116, NA08OAR4600756]; French National Agency for Research (ANR); Sigma Xi [GIAR G20061021830514629]; American Museum of Natural History; University of Louisiana at Lafayette Graduate Student Organization; New Zealand Foundation for Research, Science and Technology; New Zealand Ministry of Fisheries; Australian National Oceans Office; NOAA-OE; Woods Hole Oceanographic Institution; Scripps Institution of Oceanography; University of Hawaii; Consortium National de Recherche en Genomique; Service de Systematique Moleculaire; Museum national d'Histoire naturelle (MNHN) (CNRS) [UMS 2700]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Oceanic and Atmospheric Administration (NOAA)/National Marine Fisheries Service Auke Bay Laboratory; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA-OER; French National Agency for Research (ANR)(French National Research Agency (ANR)); Sigma Xi; American Museum of Natural History; University of Louisiana at Lafayette Graduate Student Organization; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Ministry of Fisheries; Australian National Oceans Office; NOAA-OE; Woods Hole Oceanographic Institution; Scripps Institution of Oceanography(University of California System); University of Hawaii; Consortium National de Recherche en Genomique(General Electric); Service de Systematique Moleculaire; Museum national d'Histoire naturelle (MNHN) (CNRS)	Support for this research was provided by funding to SCF from National Science Foundation's (NSF) Ocean Sciences Division-Biological Oceanography Program (OCE-0624601; http://www.nsf.gov/funding/pgm_ summ.jsp?pims_ id = 11696), National Oceanic and Atmospheric Administration (NOAA)/National Marine Fisheries Service Auke Bay Laboratory (NFFS7400-5-00022; http://www.afsc.noaa.gov/abl/), NOAA's National Undersea Research Program (NA05OAR4301001, NA66RU0186), NOAA-OER (NA05OAR4601061, NA03OAR4600116, NA08OAR4600756; http://explore.noaa.gov/), and NSF's "Assembling the Cnidarian Tree of Life" (sub-contract on EF-0531570 to CSM and EF-0531779 to Paulyn Cartwright; http://www.nsf.gov/funding/pgm_ summ.jsp?pims_ id = 5129& org = DEB& from = home); to Philippe Grandcolas from the French National Agency for Research (ANR Bioneocal; http://www.agence-nationalerecherche.fr/); to EGP from Sigma Xi (GIAR G20061021830514629; http://www.sigmaxi.org/programs/giar/), the American Museum of Natural History (Lerner Gray Fund; http://rggs.amnh.org/pages/academics_ and_ research/fellowship_ and_ grant_ opportunities), and the University of Louisiana at Lafayette Graduate Student Organization. Specimens from New Zealand were provided by the National Institute of Water and Atmospheric (NIWA) Research Invertebrate Collection, and were collected during voyages undertaken by the NIWA (www.niwa.co.nz) with funding from the New Zealand Foundation for Research, Science and Technology (www.msi.govt.nz), with additional funding from the New Zealand Ministry of Fisheries (www.fish.govt.nz) and the Australian National Oceans Office (voyage TAN0308), as well as NOAA-OE (http://explore.noaa.gov/), Woods Hole Oceanographic Institution (www.whoi.edu), Scripps Institution of Oceanography (sio.ucsd.edu), and the University of Hawaii (www.hawaii.edu) (voyage RENEWZ I-NEW ZEEPS). This work was supported by the "Consortium National de Recherche en Genomique," and the "Service de Systematique Moleculaire" of the Museum national d'Histoire naturelle (MNHN) (CNRS UMS 2700; http://www.genoscope.cns.fr/spip/). It is part of the agreement n. 2005/67 between the Genoscope and the MNHN on the project "Macrophylogeny of life" directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Aurivillius M, 1931, KUNGLIGA SVENSKA VET, V9, P1; BAYER F M, 1979, Proceedings of the Biological Society of Washington, V92, P876; Bayer F. M., 1956, P166; BAYER F M, 1974, Micronesica, V10, P257; BAYER FM, 1988, P BIOL SOC WASH, V101, P257; Bayer Frederick M., 1994, Senckenbergiana Biologica, V74, P21; BAYER FREDERICK M., 1955, PROC U S NATL MUS, V105, P207; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Berntson EA, 2001, MAR BIOL, V138, P235, DOI 10.1007/s002270000457; Bilewitch JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-228; BOUCHET P, 2008, TROPICAL DEEP SEA BE, V0025, P00009; Brugler MR, 2008, J MOL EVOL, V67, P125, DOI 10.1007/s00239-008-9116-2; Cairns SD, 2002, P BIOL SOC WASH, V115, P217; Cairns SD, 2001, P BIOL SOC WASH, V114, P746; Cairns Stephen D., 2009, Smithsonian Contributions to Zoology, P1; Cairns Stephen D., 2007, Proceedings of the California Academy of Sciences, V58, P511; Calderon I, 2006, J EXP MAR BIOL ECOL, V336, P184, DOI 10.1016/j.jembe.2006.05.006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Concepcion GT, 2008, CORAL REEFS, V27, P323, DOI 10.1007/s00338-007-0323-x; de Pourtales LF, 1868, B MUS COMP ZOOL HARV, V1, P121; DEICHMANN ELISABETH, 1936, MEM MUS COMP ZOOL, V53, P1; Duenas LF, 2009, MAR ECOL PROG SER, V397, P11, DOI 10.3354/meps08307; Fabricius K., 2001, SOFT CORALS SEA FANS; France SC, 2002, HYDROBIOLOGIA, V471, P149, DOI 10.1023/A:1016517724749; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; France SC, 2007, B MAR SCI, V81, P323; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; Grasshoff M, 1995, P 6 INT C COEL BIOL, P195; Grasshoff M, 1985, PEUPLEMENTS PROFONDS, P299; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heifetz J, 2005, FISH OCEANOGR, V14, P131, DOI 10.1111/j.1365-2419.2005.00371.x; Herrera S, 2010, MOL PHYLOGENET EVOL, V55, P123, DOI 10.1016/j.ympev.2009.12.007; HESSLER RR, 1975, MAR BIOL, V32, P155, DOI 10.1007/BF00388508; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KUSSAKIN OG, 1973, MAR BIOL, V23, P19, DOI 10.1007/BF00394108; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Madsen F. J., 1944, Danish Ingolf-Expedition, V5, P1; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; McFadden CS, 2004, MAR BIOTECHNOL, V6, P516, DOI 10.1007/s10126-002-0102-1; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; Miller M, 2011, 20090804 CIPRES; Nutting C, 1910, SIBOGA EXPEDITIE MON; Nutting C C., 1912, P US NATL MUS, V43, P1, DOI DOI 10.5479/SI.00963801.43-1923.1; Nutting Charles C., 1908, Proceedings of the United States National Museum Smithsonian Institution Washington, V34; Pante E, 2011, J MARINE BIOL ASS UK; Pante E, 2010, ZOOSYSTEMA, V32, P595, DOI 10.5252/z2010n4a4; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasternak F.A., 1981, P40; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; R Development Core Team, 2012, R LANG ENV STAT COMP; Sanchez JA, 2003, MOL PHYLOGENET EVOL, V29, P31, DOI 10.1016/S1055-7903(03)00090-3; Sanchez JA, 2003, MAR BIOL, V142, P975, DOI 10.1007/s00227-003-1018-7; Sanchez JA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-122; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Strychar KB, 2005, ERLANGEN EARTH C SER, P679, DOI 10.1007/3-540-27673-4_34; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Thomson JA, 1906, ACCOUNT ALCYONARIA 1; Verrill A, 1883, B MUSEUM COMP ZOOLOG, V11; Versluys J., 1902, MONOGRAPHIE SIBOGA E, V1; Wating L, 2011, ADV MAR BIOL, V60, P41, DOI 10.1016/B978-0-12-385529-9.00002-0; Watling L, 2007, J MAR BIOL ASSOC UK, V87, P393, DOI 10.1017/S002531540705535X; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; West JM, 1997, BIOL BULL, V192, P279, DOI 10.2307/1542721; WEST JM, 1993, MAR ECOL PROG SER, V94, P61, DOI 10.3354/meps094061; Wright E. P., 1889, Report of the Scientific Results Voyage HMS 'Challenger' Zool, Vxxxi, pUnpaginated; Young CM, 1997, MAR ECOL PROG SER, V154, P197, DOI 10.3354/meps154197	75	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38357	10.1371/journal.pone.0038357	http://dx.doi.org/10.1371/journal.pone.0038357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723855	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300025
J	Vogel, V; Falquet, L; Calderon-Copete, SP; Basset, P; Blanc, DS				Vogel, Valerie; Falquet, Laurent; Calderon-Copete, Sandra P.; Basset, Patrick; Blanc, Dominique S.			Short Term Evolution of a Highly Transmissible Methicillin-Resistant Staphylococcus aureus Clone (ST228) in a Tertiary Care Hospital	PLOS ONE			English	Article							GEOGRAPHIC AREA; SEQUENCE; VIRULENCE; ALIGNMENT; INSIGHTS; STRAINS; MRSA; EPIDEMIOLOGY; ALGORITHM; GENOMICS	Staphylococcus aureus is recognized as one of the major human pathogens and is by far one of the most common nosocomial organisms. The genetic basis for the emergence of highly epidemic strains remains mysterious. Studying the microevolution of the different clones of S. aureus is essential for identifying the forces driving pathogen emergence and spread. The aim of the present study was to determine the genetic changes characterizing a lineage belonging to the South German clone (ST228) that spread over ten years in a tertiary care hospital in Switzerland. For this reason, we compared the whole genome of eight isolates recovered between 2001 and 2008 at the Lausanne hospital. The genetic comparison of these isolates revealed that their genomes are extremely closely related. Yet, a few more important genetic changes, such as the replacement of a plasmid, the loss of large fragments of DNA, or the insertion of transposases, were observed. These transfers of mobile genetic elements shaped the evolution of the ST228 lineage that spread within the Lausanne hospital. Nevertheless, although the strains analyzed differed in their dynamics, we have not been able to link a particular genetic element with spreading success. Finally, the present study showed that new sequencing technologies improve considerably the quality and quantity of information obtained for a single strain; but this information is still difficult to interpret and important investments are required for the technology to become accessible for routine investigations.	[Vogel, Valerie; Basset, Patrick; Blanc, Dominique S.] Univ Lausanne Hosp, Serv Hosp Prevent Med, Lausanne, Switzerland; [Falquet, Laurent; Calderon-Copete, Sandra P.; Basset, Patrick] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics	Vogel, V (corresponding author), Univ Lausanne Hosp, Serv Hosp Prevent Med, Lausanne, Switzerland.	valerie.vogel@gmail.com	Basset, Patrick/C-6232-2013; Falquet, Laurent/C-2541-2013	Basset, Patrick/0000-0002-2924-4821; Falquet, Laurent/0000-0001-8102-7579; Blanc, Dominique/0000-0002-0324-8437	Swiss National Foundation for Research [3100A0-113346]	Swiss National Foundation for Research(Swiss National Science Foundation (SNSF))	This work was supported by a grant # 3100A0-113346 of the Swiss National Foundation for Research. The SIB Swiss Institute of Bioinformatics is an independent non-profit foundation recognised of public utility. More details on the SIB are available at http://www.isb-sib.ch/aboutsib/organisation.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Aziz RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000713; Backman C, 2011, AM J INFECT CONTROL, V39, P368, DOI 10.1016/j.ajic.2010.07.017; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blanc DS, 2007, J CLIN MICROBIOL, V45, P3729, DOI 10.1128/JCM.00511-07; Blanc DS, 1999, CLIN INFECT DIS, V29, P1512, DOI 10.1086/313522; Blanc DS, 2001, J CLIN MICROBIOL, V39, P2287, DOI 10.1128/JCM.39.6.2287-2290.2001; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Calderon-Copete SP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S7; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson RW, 2011, TRENDS GENET, V27, P32, DOI 10.1016/j.tig.2010.10.001; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kuhn G, 2007, J CLIN MICROBIOL, V45, P54, DOI 10.1128/JCM.01457-06; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazarevic V, 2011, FUTURE MICROBIOL, V6, P513, DOI [10.2217/FMB.11.38, 10.2217/fmb.11.38]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Massouras A, 2010, NAT METHODS, V7, P485, DOI [10.1038/nmeth.f.308, 10.1038/NMETH.f.308]; Mato R, 2004, MICROB DRUG RESIST, V10, P106, DOI 10.1089/1076629041310109; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Wannet WJB, 2004, J CLIN MICROBIOL, V42, P3077, DOI 10.1128/JCM.42.7.3077-3082.2004; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Witte Wolfgang, 1997, Clin Microbiol Infect, V3, P414, DOI 10.1111/j.1469-0691.1997.tb00277.x; Woodford N, 2005, CLIN MICROBIOL INFEC, V11, P2, DOI 10.1111/j.1469-0691.2005.01140.x	51	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38969	10.1371/journal.pone.0038969	http://dx.doi.org/10.1371/journal.pone.0038969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22720005	gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300072
J	Miura, S; Kiya, Y; Hanzawa, H; Nakao, N; Fujino, M; Imaizumi, S; Matsuo, Y; Yanagisawa, H; Koike, H; Komuro, I; Karnik, SS; Saku, K				Miura, Shin-ichiro; Kiya, Yoshihiro; Hanzawa, Hiroyuki; Nakao, Naoki; Fujino, Masahiro; Imaizumi, Satoshi; Matsuo, Yoshino; Yanagisawa, Hiroaki; Koike, Hiroyuki; Komuro, Issei; Karnik, Sadashiva S.; Saku, Keijiro			Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; ALPHA(1B)-ADRENERGIC RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; AT(1) RECEPTOR; ACTIVATION; STATE; ADRENOCEPTOR; MECHANISM	Small differences in the chemical structures of ligands can be responsible for agonism, neutral antagonism or inverse agonism toward a G-protein-coupled receptor (GPCR). Although each ligand may stabilize the receptor conformation in a different way, little is known about the precise conformational differences. We synthesized the angiotensin II type 1 receptor blocker (ARB) olmesartan, R239470 and R794847, which induced inverse agonism, antagonism and agonism, respectively, and then investigated the ligand-specific changes in the receptor conformation with respect to stabilization around transmembrane (TM)3. The results of substituted cysteine accessibility mapping studies support the novel concept that ligand-induced changes in the conformation of TM3 play a role in stabilizing GPCR. Although the agonist-, neutral antagonist and inverse agonist-binding sites in the AT(1) receptor are similar, each ligand induced specific conformational changes in TM3. In addition, all of the experimental data were obtained with functional receptors in a native membrane environment (in situ).	[Miura, Shin-ichiro; Kiya, Yoshihiro; Fujino, Masahiro; Imaizumi, Satoshi; Matsuo, Yoshino; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan; [Miura, Shin-ichiro; Karnik, Sadashiva S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH USA; [Hanzawa, Hiroyuki; Nakao, Naoki; Yanagisawa, Hiroaki; Koike, Hiroyuki] Daiichi Sankyo Co Ltd, Div Res & Dev, Tokyo, Japan; [Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan	Fukuoka University; Cleveland Clinic Foundation; Daiichi Sankyo Company Limited; Osaka University	Miura, S (corresponding author), Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan.	miuras@cis.fukuoka-u.ac.jp	Imaizumi, Satoshi/AHB-5318-2022; Saku, Keijiro/HGB-6168-2022; Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	Ministry of Education, Culture, Sports, Science and Technology, Japan [21591065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a Grant-in-Aid for Scientific Research (21591065) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Chen SH, 2002, BIOCHEMISTRY-US, V41, P588, DOI 10.1021/bi011868k; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rossier O, 1999, MOL PHARMACOL, V56, P858, DOI 10.1124/mol.56.5.858; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schneider EH, 2010, J PHARMACOL EXP THER, V334, P513, DOI 10.1124/jpet.110.165977; Schneider G, 2005, NAT REV DRUG DISCOV, V4, P649, DOI 10.1038/nrd1799; Soudijn W, 2005, MED RES REV, V25, P398, DOI 10.1002/med.20031; Wang RX, 2000, J MOL MODEL, V6, P498, DOI 10.1007/s0089400060498; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157	29	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e37974	10.1371/journal.pone.0037974	http://dx.doi.org/10.1371/journal.pone.0037974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719858	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800003
J	Qi, YL; Operario, DJ; Georas, SN; Mosmann, TR				Qi, Yilin; Operario, Darwin J.; Georas, Steve N.; Mosmann, Tim R.			The Acute Environment, Rather than T Cell Subset Pre-Commitment, Regulates Expression of the Human T Cell Cytokine Amphiregulin	PLOS ONE			English	Article							GAMMA-SECRETING CELLS; GROWTH-FACTOR-BETA; HUMAN MAST-CELLS; IFN-GAMMA; GENE-EXPRESSION; CHEMOKINE RECEPTORS; PROSTAGLANDIN E-2; EPITHELIAL-CELLS; DISTINCT ROLES; HELPER TYPE-1	Cytokine expression patterns of T cells can be regulated by pre-commitment to stable effector phenotypes, further modification of moderately stable phenotypes, and quantitative changes in cytokine production in response to acute signals. We showed previously that the epidermal growth factor family member Amphiregulin is expressed by T cell receptor-activated mouse CD4 T cells, particularly Th2 cells, and helps eliminate helminth infection. Here we report a detailed analysis of the regulation of Amphiregulin expression by human T cell subsets. Signaling through the T cell receptor induced Amphiregulin expression by most or all T cell subsets in human peripheral blood, including naive and memory CD4 and CD8 T cells, Th1 and Th2 in vitro T cell lines, and subsets of memory CD4 T cells expressing several different chemokine receptors and cytokines. In these different T cell types, Amphiregulin synthesis was inhibited by an antagonist of protein kinase A, a downstream component of the cAMP signaling pathway, and enhanced by ligands that increased cAMP or directly activated protein kinase A. Prostaglandin E2 and adenosine, natural ligands that stimulate adenylyl cyclase activity, also enhanced Amphiregulin synthesis while reducing synthesis of most other cytokines. Thus, in contrast to mouse T cells, Amphiregulin synthesis by human T cells is regulated more by acute signals than pre-commitment of T cells to a particular cytokine pattern. This may be appropriate for a cytokine more involved in repair than attack functions during most inflammatory responses.	[Qi, Yilin; Operario, Darwin J.; Mosmann, Tim R.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Georas, Steve N.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Qi, YL (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu			NIH [AI054953]; American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI054953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH AI054953 and American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2004, J IMMUNOL, V173, P4847, DOI 10.4049/jimmunol.173.8.4847; Alam MS, 2009, MUCOSAL IMMUNOL, V2, P232, DOI 10.1038/mi.2009.4; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Berquin IM, 2001, ONCOGENE, V20, P4019, DOI 10.1038/sj.onc.1204537; BETZ M, 1991, J IMMUNOL, V146, P108; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Borger P, 1998, J ALLERGY CLIN IMMUN, V101, P231, DOI 10.1016/S0091-6749(98)70388-4; Borger P, 1996, BLOOD, V87, P691, DOI 10.1182/blood.V87.2.691.bloodjournal872691; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Johansson CC, 2004, AIDS, V18, P171, DOI 10.1097/00002030-200401230-00005; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; LEDBETTER JA, 1986, J IMMUNOL, V137, P3299; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Matsumoto K, 2009, INT ARCH ALLERGY IMM, V149, P39, DOI 10.1159/000210652; MINAKUCHI R, 1990, J IMMUNOL, V145, P2616; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okano M, 2006, IMMUNOLOGY, V118, P343, DOI 10.1111/j.1365-2567.2006.02376.x; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; PALIOGIANNI F, 1993, J EXP MED, V178, P1813, DOI 10.1084/jem.178.5.1813; Qi Y, 2010, J ALLERGY CLIN IMMUN; Quast S, 2005, CELL IMMUNOL, V237, P28, DOI 10.1016/j.cellimm.2005.09.002; Riese DJ, 1996, J BIOL CHEM, V271, P20047, DOI 10.1074/jbc.271.33.20047; SAD S, 1994, J IMMUNOL, V153, P3514; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; WALKER C, 1983, J IMMUNOL, V130, P1770; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	50	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39072	10.1371/journal.pone.0039072	http://dx.doi.org/10.1371/journal.pone.0039072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720031	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347800041
J	Akhtar, S; Yousif, MHM; Chandrasekhar, B; Benter, IF				Akhtar, Saghir; Yousif, Mariam H. M.; Chandrasekhar, Bindu; Benter, Ibrahim F.			Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; CARDIAC DEVELOPMENT; VENTRICULAR MYOCYTES; VASCULAR DYSFUNCTION; NEUREGULIN RECEPTOR; PROTEIN-KINASE; MESSENGER-RNA; HUMAN CANCER	This study characterized the effects of diabetes and/or ischemia on epidermal growth factor receptor, EGFR, and/or erbB2 signaling pathways on cardiac function. Isolated heart perfusion model of global ischemia was used to study the effect of chronic inhibition or acute activation of EGFR/erbB2 signaling on cardiac function in a rat model of type-1 diabetes. Induction of diabetes with streptozotocin impaired recovery of cardiac function (cardiac contractility and hemodynamics) following 40 minutes of global ischemia in isolated hearts. Chronic treatment with AG825 or AG1478, selective inhibitors of erbB2 and EGFR respectively, did not affect hyperglycemia but led to an exacerbation whereas acute administration of the EGFR ligand, epidermal growth factor (EGF), led to an improvement in cardiac recovery in diabetic hearts. Diabetes led to attenuated dimerization and phosphorylation of cardiac erbB2 and EGFR receptors that was associated with reduced signaling via extracellular-signal-regulated kinase 1/2 (ERK1/2), p38 mitogen activated protein (MAP) kinase and AKT (protein kinase B). Ischemia was also associated with reduced cardiac signaling via these molecules whereas EGF-treatment opposed diabetes and/or ischemia induced changes in ERK1/2, p38 MAP kinase, and AKT-FOXO signaling. Losartan treatment improved cardiac function in diabetes but also impaired EGFR phosphorylation in diabetic heart. Co-administration of EGF rescued Losartan-mediated reduction in EGFR phosphorylation and significantly improved cardiac recovery more than with either agent alone. EGFR/erbB2 signaling is an important cardiac survival pathway whose activation, particularly in diabetes, ischemia or following treatment with drugs that inhibit this cascade, significantly improves cardiac function. These findings may have clinical relevance particularly in the treatment of diabetes-induced cardiac dysfunction.	[Akhtar, Saghir; Yousif, Mariam H. M.; Chandrasekhar, Bindu; Benter, Ibrahim F.] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Kuwait, Kuwait	Kuwait University	Akhtar, S (corresponding author), Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Kuwait, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Yousif, Mariam/0000-0002-6464-031X; Akhtar, Saghir/0000-0003-3177-946X	Kuwait University [MR02/09]	Kuwait University	This research was funded by a Kuwait University grant (MR02/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Barrick CJ, 2008, TOXICOL APPL PHARM, V228, P315, DOI 10.1016/j.taap.2007.12.012; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Benter IF, 2009, VASC PHARMACOL, V51, P236, DOI 10.1016/j.vph.2009.06.008; Benter IF, 2005, MOL CELL BIOCHEM, V268, P175, DOI 10.1007/s11010-005-3895-1; Benter IF, 2005, J VASC RES, V42, P284, DOI 10.1159/000085904; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Coulson JM, 1996, MOL PHARMACOL, V50, P314; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Ewer MS, 1999, SEMIN ONCOL, V26, P96; Fisman EZ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-38; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lorita J, 2009, GROWTH FACTORS, V27, P203, DOI 10.1080/08977190902913731; McKeage K, 2002, DRUGS, V62, P209, DOI 10.2165/00003495-200262010-00008; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Pareja M, 2003, AM J PHYSIOL-REG I, V285, pR455, DOI 10.1152/ajpregu.00588.2002; Patel R, 2012, CURR PHARM IN PRESS; Petch AK, 2003, BIOCHEM PHARMACOL, V66, P819, DOI 10.1016/S0006-2952(03)00407-6; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Sanchez-Soria P, 2010, SEMIN CELL DEV BIOL, V21, P929, DOI 10.1016/j.semcdb.2010.09.011; Sawyer DB, 2011, J MOL CELL CARDIOL, V51, P501, DOI 10.1016/j.yjmcc.2011.06.016; Schneider JW, 2001, SEMIN ONCOL, V28, P18, DOI 10.1053/sonc.2001.28546; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Spector NL, 2007, P NATL ACAD SCI USA, V104, P10607, DOI 10.1073/pnas.0701286104; Srinivasan R, 1998, J PATHOL, V185, P236, DOI 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; Watanabe K, 2010, CURR CARDIOL REV, V6, P280, DOI 10.2174/157340310793566145; Williams-Pritchard G, 2011, AM J PHYSIOL-HEART C, V300, pH2161, DOI 10.1152/ajpheart.00639.2010; Zhao YY, 1999, CIRC RES, V84, P1380; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	40	56	57	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39066	10.1371/journal.pone.0039066	http://dx.doi.org/10.1371/journal.pone.0039066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720029	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900078
J	Ehlgen, F; Pham, JS; de Koning-Ward, T; Cowman, AF; Ralph, SA				Ehlgen, Florian; Pham, James S.; de Koning-Ward, Tania; Cowman, Alan F.; Ralph, Stuart A.			Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN PFCRT; DYNAMIN-LIKE PROTEIN; MALARIA PARASITE; DIGESTIVE-VACUOLE; ENDOPLASMIC-RETICULUM; GUANINE-NUCLEOTIDE; HEMOGLOBIN UPTAKE; DRUG-RESISTANCE; MAURERS CLEFTS; BREFELDIN-A	Haemoglobin degradation during the erythrocytic life stages is the major function of the food vacuole (FV) of Plasmodium falciparum and the target of several anti-malarial drugs that interfere with this metabolic pathway, killing the parasite. Two multi-spanning food vacuole membrane proteins are known, the multidrug resistance protein 1 (PfMDR1) and Chloroquine Resistance Transporter (PfCRT). Both modulate resistance to drugs that act in the food vacuole. To investigate the formation and behaviour of the food vacuole membrane we have generated inducible GFP fusions of chloroquine sensitive and resistant forms of the PfCRT protein. The inducible expression system allowed us to follow newly-induced fusion proteins, and corroborated a previous report of a direct trafficking route from the ER/Golgi to the food vacuole membrane. These parasites also allowed the definition of a food vacuole compartment in ring stage parasites well before haemozoin crystals were apparent, as well as the elucidation of secondary PfCRT-labelled compartments adjacent to the food vacuole in late stage parasites. We demonstrated that in addition to previously demonstrated Brefeldin A sensitivity, the trafficking of PfCRT is disrupted by Dynasore, a non competitive inhibitor of dynamin-mediated vesicle formation. Chloroquine sensitivity was not altered in parasites over-expressing chloroquine resistant or sensitive forms of the PfCRT fused to GFP, suggesting that the PfCRT does not mediate chloroquine transport as a GFP fusion protein.	[Ehlgen, Florian; Pham, James S.; Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [de Koning-Ward, Tania] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia	University of Melbourne; Deakin University; Walter & Eliza Hall Institute	Ehlgen, F (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.	saralph@unimelb.edu.au	Cowman, Alan F/C-7642-2013; de Koning-Ward, Tania F/N-3572-2017; Ralph, Stuart/C-8590-2014	Cowman, Alan F/0000-0001-5145-9004; de Koning-Ward, Tania F/0000-0001-5810-8063; Ralph, Stuart/0000-0003-0114-7808	Australian Research Council; University of Melbourne postgraduate scholarship; Australian Postgraduate Award; Australian Research Council Future fellowship [FT0990350]; National Health and Medical Research Council	Australian Research Council(Australian Research Council); University of Melbourne postgraduate scholarship; Australian Postgraduate Award(Australian Government); Australian Research Council Future fellowship(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by research from the National Health and Medical Research Council, Australia (http://www.nhmrc.gov.au/), and the Australian Research Council (http://www.arc.gov.au/). FE was supported by a University of Melbourne postgraduate scholarship, JSP is supported by an Australian Postgraduate Award. SAR is supported by an Australian Research Council Future fellowship FT0990350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Charneau S, 2007, MICROBES INFECT, V9, P797, DOI 10.1016/j.micinf.2007.02.020; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Egan TJ, 2008, J INORG BIOCHEM, V102, P1288, DOI 10.1016/j.jinorgbio.2007.12.004; Elliott DA, 2008, P NATL ACAD SCI USA, V105, P2463, DOI 10.1073/pnas.0711067105; Famin O, 2003, PARASITE, V10, P39, DOI 10.1051/parasite/2003101p39; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4; FITCH CD, 1986, PARASITOL TODAY, V2, P330, DOI 10.1016/0169-4758(86)90051-7; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Hanssen E, 2012, J STRUCT BIOL, V177, P224, DOI 10.1016/j.jsb.2011.09.003; Hanssen E, 2011, J STRUCT BIOL, V173, P161, DOI 10.1016/j.jsb.2010.08.013; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson KE, 2012, INT J PARASITOL, V42, P177, DOI 10.1016/j.ijpara.2011.11.008; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Li HL, 2004, BIOCHEM BIOPH RES CO, V320, P664, DOI 10.1016/j.bbrc.2004.06.010; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; MACHAMER CE, 1993, MOL BIOL CELL, V4, P695, DOI 10.1091/mbc.4.7.695; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MACOMBER PB, 1966, SCIENCE, V152, P1374, DOI 10.1126/science.152.3727.1374; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Muriel MP, 2009, J NEUROCHEM, V110, P1607, DOI 10.1111/j.1471-4159.2009.06258.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; RUDZINSKA MA, 1965, J PROTOZOOL, V12, P563, DOI 10.1111/j.1550-7408.1965.tb03256.x; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wong RPM, 2012, ANTIMICROB AGENTS CH, V56, P2814, DOI 10.1128/AAC.05076-11; Wong RPM, 2011, ANTIMICROB AGENTS CH, V55, P1194, DOI 10.1128/AAC.01312-10; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Zhou HC, 2009, CHINESE MED J-PEKING, V122, P1686, DOI 10.3760/cma.j.issn.0366-6999.2009.14.015	83	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38781	10.1371/journal.pone.0038781	http://dx.doi.org/10.1371/journal.pone.0038781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719945	Green Published, gold			2022-12-27	WOS:000305341900051
J	Li, X; Jadlowiec, C; Guo, YY; Protack, CD; Ziegler, KR; Lv, W; Yang, CZ; Shu, C; Dardik, A				Li, Xin; Jadlowiec, Caroline; Guo, Yuanyuan; Protack, Clinton D.; Ziegler, Kenneth R.; Lv, Wei; Yang, Chenzi; Shu, Chang; Dardik, Alan			Pericardial Patch Angioplasty Heals via an Ephrin-B2 and CD34 Positive Cell Mediated Mechanism	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; VEIN GRAFT ADAPTATION; CAROTID-ENDARTERECTOMY; ANGIOGENESIS; RESTENOSIS; RECEPTORS; IDENTITY; LIGANDS; LIMB	Objective: Pericardial patches are commonly used in vascular surgery to close arteriotomies. The mechanism of early healing after patch implantation is still not well defined. We used a rat aortic patch model to assess pericardial patch healing and examined Ephrin-B2, a marker of arterial identity, expression within the post-implantation patch. We also determined whether endothelial progenitor cells (EPC) are associated with early patch healing in the arterial environment. Methods: Wistar rats (200-250 grams) underwent infrarenal aortic arteriotomy and then closure via bovine or porcine pericardial patch angioplasty. Control groups included subcutaneously implanted patches. Patches were harvested at 0-30 days and analyzed by histology, immunohistochemistry, immunofluorescence and Western blot as well as quantitative PCR. Results: Prior to implantation, pericardial patches are largely composed of collagen and are acellular. Following arterial implantation, increasing numbers of CD68-positive cells as well as Ephrin-B2 and CD34 dual-positive cells are found within both bovine and porcine pericardial patches, whereas the infiltrating cells are negative for vWF and a-actin. Porcine patches have a luminal monolayer of cells at day 7, compared to bovine patches that have fewer luminal cells. Subcutaneously implanted patches do not attract Ephrin-B2/CD34-positive cells. By day 30, both bovine and porcine pericardial patches develop a neointima that contains Ephrin-B2, CD34, and VEGFR2-positive cells. Conclusion: Both CD68-positive and Ephrin-B2 and CD34 dual-positive cells infiltrate the pericardial patch early after implantation. Arteriotomy closure via pericardial patch angioplasty shows patch adaptation to the arterial environment that may involve a foreign body response as well as localization of EPC. Arterial remodeling of pericardial patches support endothelialization and may represent a paradigm of healing of scaffolds used for tissue engineering.	[Li, Xin; Jadlowiec, Caroline; Guo, Yuanyuan; Protack, Clinton D.; Ziegler, Kenneth R.; Lv, Wei; Yang, Chenzi; Dardik, Alan] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Li, Xin; Jadlowiec, Caroline; Guo, Yuanyuan; Protack, Clinton D.; Ziegler, Kenneth R.; Lv, Wei; Yang, Chenzi; Dardik, Alan] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT USA; [Li, Xin; Guo, Yuanyuan; Yang, Chenzi; Shu, Chang] Cent S Univ, Xiangya Hosp 2, Dept Vasc Surg, Changsha, Hunan, Peoples R China; [Lv, Wei] Shandong Univ, Sch Med, Dept Vasc Surg, Jinan 250100, Shandong, Peoples R China; [Dardik, Alan] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA	Yale University; Yale University; Central South University; Shandong University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Li, X (corresponding author), Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA.	alan.dardik@yale.edu	Ziegler, Kenneth/Z-1197-2019	Dardik, Alan/0000-0001-5022-7367; Ziegler, Kenneth/0000-0003-4568-8817	National Institute of Health [R01-HL095498-01]; American Vascular Association William J. von Liebig Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095498] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Vascular Association William J. von Liebig Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health (R01-HL095498-01 to AD); the American Vascular Association William J. von Liebig Award; as well as with the resources and the use of facilities at the Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bond R, 2004, J VASC SURG, V40, P1126, DOI 10.1016/j.jvs.2004.08.048; Bond R, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000160.PUB2; Braun J, 2011, ARTERIOSCL THROM VAS, V31, P297, DOI 10.1161/ATVBAHA.110.217646; Burt RK, BONE MARROW TRANSPLA, V45, P111; Dardik A, 2011, REGENERATIVE MEDICINE USING PREGNANCY-SPECIFIC BIOLOGICAL SUBSTANCES, P189, DOI 10.1007/978-1-84882-718-9_19; DARDIK H, 1988, J VASC SURG, V7, P336, DOI 10.1067/mva.1988.avs0070336; Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Hristov M, 2008, PHARMACOL RES, V58, P148, DOI 10.1016/j.phrs.2008.07.008; Inoue T, 2007, CIRCULATION, V115, P553, DOI 10.1161/CIRCULATIONAHA.106.621714; Kim GE, 2001, CARDIOVASC SURG, V9, P458, DOI 10.1016/S0967-2109(01)00042-4; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kondo Y, 2011, J SURG RES, V171, pE149, DOI 10.1016/j.jss.2011.06.036; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Li X, 2011, ANN VASC SURG; Magri D, 2007, VASCULAR, V15, P384, DOI 10.2310/6670.2007.00058; Matsagas MI, 2006, ANN VASC SURG, V20, P614, DOI 10.1007/s10016-006-9102-3; Muto A, 2011, J EXP MED, V208, P561, DOI 10.1084/jem.20101854; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Muto A, 2009, J VASC SURG, V50, P206, DOI 10.1016/j.jvs.2009.01.062; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; SHORE DF, 1983, J CARDIOVASC SURG, V24, P132; Siddique Aurangzeb, 2010, J Angiogenes Res, V2, P6, DOI 10.1186/2040-2384-2-6; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Umashankar PR, 2011, J BIOMED MATER RES A, V97A, P311, DOI 10.1002/jbm.a.33061; Wei HJ, 2010, CHIN J TRAUMATOL, V13, P316, DOI 10.3760/cma.j.issn.1008-1275.2010.05.013	32	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38844	10.1371/journal.pone.0038844	http://dx.doi.org/10.1371/journal.pone.0038844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719962	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900053
J	Zhang, Z; Zhou, LH; Yang, XW; Wang, YC; Zhang, P; Hou, LH; Hu, XB; Xing, Y; Liu, YF; Li, W; Han, H				Zhang, Zhuo; Zhou, Lanhua; Yang, Xinwei; Wang, Yaochun; Zhang, Ping; Hou, Lihong; Hu, Xinbin; Xing, Ying; Liu, Yufeng; Li, Wei; Han, Hua			Notch-RBP-J-Independent Marginal Zone B Cell Development in IgH Transgenic Mice with V-H Derived from a Natural Polyreactive Antibody	PLOS ONE			English	Article							POSITIVE SELECTION; LYMPHOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; FATE DECISION; IN-VIVO; KAPPA-B; RECEPTOR; MOUSE; BAFF; PROLIFERATION	Both the B cell antigen receptor (BCR) signaling and Notch signaling pathway play important roles in marginal zone (MZ) B cell development; however, if and how these two signaling pathways engage in crosstalk with each other remain unclear. In the present study, IgH transgenic mice (TgV(H)3B4) were crossed with mice with Notch downstream transcription factor RBP-J floxed alleles (RBP-J(f/f)) and Mx-Cre transgene. Subsequently, MZ B cell development was analyzed in 3B4/Cre/RBP-J(f/f) mice that expressed the transgenic 3B4 IgH and exhibited a deficiency in Notch signaling in B cells upon poly (I:C) injection. We observed that MZ B cell numbers were severely reduced, but still detectable in 3B4/Cre/RBP-J(f/f) mice, in contrast to increased numbers of MZ B cells in TgVH3B4 mice and almost no MZ B cells in Cre/RBP-J(f/f) mice. The majority of the MZ B cells in the 3B4/Cre/RBP-J(f/f) mice had the same antigen specificity with that of 3B4 antibody, indicating that a particular BCR specificity might direct MZ B cell development in the absence of Notch signaling. The number of MZ B precursor (MZP) cells was reduced sharply in 3B4/Cre/RBP-J(f/f) mice, and the number of transitional stage 1 and transitional stage 2 cells did not change that much, indicating that the interaction between BCR and Notch signaling likely occurred during the T2-MZP stage. Based on the transgenic mouse model, our data indicate that MZ B cells with certain BCR specificity can develop in a Notch-RBP-J independent manner.	[Zhang, Zhuo; Zhou, Lanhua; Xing, Ying; Liu, Yufeng; Li, Wei; Han, Hua] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Yang, Xinwei; Wang, Yaochun; Zhang, Ping; Hou, Lihong; Hu, Xinbin; Xing, Ying; Li, Wei; Han, Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Zhang, Zhuo] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Peoples R China; [Zhou, Lanhua] Air Force, Inst Aviat Med, Affiliated Hosp, Dept Dermatol, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force General Hospital PLA	Zhang, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China.	liwei1@fmmu.edu.cn; huahan@fmmu.edu.cn	Hu, XB/U-8501-2019		National Natural Science Foundation of China [30771949, 31070793, 30872299, 30972641]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30771949 and 31070793 for W. Li; 30872299 and 30972641 for Y.F. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Artavanis T, 1995, SCIENCE, V268, P225; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; He F, 2009, LEUKEMIA RES, V33, P798, DOI 10.1016/j.leukres.2008.09.016; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Li W, 2007, CELL MICROBIOL, V9, P306, DOI 10.1111/j.1462-5822.2006.00786.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Roark JH, 1998, J IMMUNOL, V160, P3121; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Srivastava B, 2005, SEMIN IMMUNOL, V17, P175, DOI 10.1016/j.smim.2005.02.008; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas M, 2007, BLOOD, V109, P3342, DOI 10.1182/blood-2006-09-046698; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Wang HS, 2004, CURR OPIN IMMUNOL, V16, P246, DOI 10.1016/j.coi.2004.01.006; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Xing Y, 2009, MOL IMMUNOL, V46, P1120, DOI 10.1016/j.molimm.2008.10.031	44	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38894	10.1371/journal.pone.0038894	http://dx.doi.org/10.1371/journal.pone.0038894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719978	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900061
J	Bond, JE; Hendrixson, BE; Hamilton, CA; Hedin, M				Bond, Jason E.; Hendrixson, Brent E.; Hamilton, Chris A.; Hedin, Marshal			A Reconsideration of the Classification of the Spider Infraorder Mygalomorphae (Arachnida: Araneae) Based on Three Nuclear Genes and Morphology	PLOS ONE			English	Article							TRAPDOOR SPIDERS; PHYLOGENY; ANTRODIAETIDAE; INFERENCE; BIOGEOGRAPHY; SYSTEMATICS; DIVERGENCE; EVOLUTION; EFFICACY; PROGRAM	Background: The infraorder Mygalomorphae (i.e., trapdoor spiders, tarantulas, funnel web spiders, etc.) is one of three main lineages of spiders. Comprising 15 families, 325 genera, and over 2,600 species, the group is a diverse assemblage that has retained a number of features considered primitive for spiders. Despite an evolutionary history dating back to the lower Triassic, the group has received comparatively little attention with respect to its phylogeny and higher classification. The few phylogenies published all share the common thread that a stable classification scheme for the group remains unresolved. Methods and Findings: We report here a reevaluation of mygalomorph phylogeny using the rRNA genes 18S and 28S, the nuclear protein-coding gene EF-1 gamma, and a morphological character matrix. Taxon sampling includes members of all 15 families representing 58 genera. The following results are supported in our phylogenetic analyses of the data: (1) the Atypoidea (i.e., antrodiaetids, atypids, and mecicobothriids) is a monophyletic group sister to all other mygalomorphs; and (2) the families Mecicobothriidae, Hexathelidae, Cyrtaucheniidae, Nemesiidae, Ctenizidae, and Dipluridae are not monophyletic. The Microstigmatidae is likely to be subsumed into Nemesiidae. Nearly half of all mygalomorph families require reevaluation of generic composition and placement. The polyphyletic family Cyrtaucheniidae is most problematic, representing no fewer than four unrelated lineages. Conclusions: Based on these analyses we propose the following nomenclatural changes: (1) the establishment of the family Euctenizidae (NEW RANK); (2) establishment of the subfamily Apomastinae within the Euctenizidae; and (3) the transfer of the cyrtaucheniid genus Kiama to Nemesiidae. Additional changes include relimitation of Domiothelina and Theraphosoidea, and the establishment of the Euctenizoidina clade (Idiopidae + Euctenizidae). In addition to these changes, we propose a "road map" for future sampling across the infraorder with the aim of solving many remaining questions that hinder mygalomorph systematics.	[Bond, Jason E.; Hamilton, Chris A.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Bond, Jason E.; Hamilton, Chris A.] Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA; [Hendrixson, Brent E.] Millsaps Coll, Dept Biol, Jackson, MS 39210 USA; [Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Millsaps College; California State University System; San Diego State University	Bond, JE (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	jbond@auburn.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 0108575, DEB 0236020]; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Science Foundation grants DEB 0108575 (to JEB and MH) and DEB 0236020 (to JEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Bond JE, 2006, MOL PHYLOGENET EVOL, V41, P70, DOI 10.1016/j.ympev.2006.04.026; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2006, INVERTEBR SYST, V20, P1, DOI 10.1071/IS05041; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; Chamberlin Ralph V., 1945, ANN ENT SOC AMERICA, V38, P549; Coddington JA, 2004, ASSEMBLING THE TREE OF LIFE, P296; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; COYLE F A, 1986, P269; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eskov K., 1990, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V178, P325; Fourie R, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.95.745; Gallon Richard C., 2002, Bulletin of the British Arachnological Society, V12, P201; Gertsch W.J., 1980, AM MUS NOVIT, V2704, P1; Gertsch W.J., 1979, AM MUS NOVIT, V2687, P1; Goloboff P.A., 1993, American Museum Novitates, P1; Griswold Charles E., 2001, Occasional Papers California Academy of Sciences, V151, P1; Hamilton CA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020156, 10.1371/journal.pone.0026207]; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2011, ZOOTAXA, P55; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Hendrixson BE, 2009, MOL PHYLOGENET EVOL, V53, P300, DOI 10.1016/j.ympev.2009.06.001; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kraus O., 1974, Abhandlungen Verh naturw Ver Hamburg, VNo. 17, P85; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddison W., 2018, MESQUITE MODULAR SYS; Miller JA, 1996, J ARACHNOL, V24, P201; Platnick NI, WORLD SPIDER CATALOG; Rash LD, 2000, BRIT J PHARMACOL, V130, P1817, DOI 10.1038/sj.bjp.0703494; Raven R.J., 1980, Bulletin of the British Arachnological Society, V5, P43; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; RAVEN RJ, 1980, J ARACHNOL, V8, P251; Raven RJ, 2008, RAFFLES B ZOOL, V56, P29; Reichling Steven B., 1997, Bulletin of the British Arachnological Society, V10, P337; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025355; Selden PA, 2010, BIOL REV, V85, P171, DOI 10.1111/j.1469-185X.2009.00099.x; Selden PA, 2009, AFR INVERTEBR, V50, P105, DOI 10.5733/afin.050.0103; Simon E., 1892, Histoire naturelle des araignees, V1, P1; Simon Eugene, 1903, P669; Smith Chas. Piper, 1908, Annals of the Entomological Society of America, V1; Stamatakis A, 2005, CONCURR COMP-PRACT E, V17, P1705, DOI 10.1002/cpe.954; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x	47	89	95	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38753	10.1371/journal.pone.0038753	http://dx.doi.org/10.1371/journal.pone.0038753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723885	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700028
J	Fan, J; McLeod, CB; Koehoorn, M				Fan, Jonathan; McLeod, Christopher B.; Koehoorn, Mieke			Descriptive Epidemiology of Serious Work-Related Injuries in British Columbia, Canada	PLOS ONE			English	Article							NONFATAL OCCUPATIONAL INJURIES; AGE-RELATED DIFFERENCES; UNITED-STATES; OLDER-ADULTS; EMERGENCY-DEPARTMENTS; GENDER-DIFFERENCES; FALLS; COMPENSATION; HEALTH; FRACTURES	Objective: This study examined the rates and distribution of serious work-related injuries by demographic, work and injury characteristics in British Columbia, Canada from 2002-2008, using population-based data. Methods: Claims for workers with a serious injury were extracted from workers' compensation data. Serious injuries were defined by long duration, high cost, serious medical diagnosis, or fatality. Workforce estimates were used to calculate stratum-specific rates. Rate-ratios (RR) and 95% CIs were calculated using negative binomial regression for the comparison of rates, adjusting for gender, age and occupation. Results: Women had a lower overall serious injury rate compared to men (RR: 0.93, 95% CI: 0.87-0.99). The 35-44 age group had the highest overall rate compared to the youngest age group. The rate for severe strains/sprains was similarly high for men and women in the 35-44 age group, although there was a differential pattern by gender for other injury types: the rate of fracture was similar across age groups for men, but increased with age for women (RR: 2.7, 95% CI: 2.2-3.3); and the rate of severe falls increased with age for men and women, with a larger three-fold increase for older women (men: RR: 1.8, 95% CI: 1.7-2.1; women: RR: 3.2, 95% CI: 2.7-3.7). Conclusions: The risk of serious injuries is higher among specific age groups with different patterns emerging for men and women. Variations persisted within similar injury types and occupation groups in our adjusted models. These results provide evidence for the burden of serious injuries and a basis for future analytic research. Given projected demographic shifts and increasing workforce participation of older workers, intervention programs should be carefully implemented with consideration to demographic groups at risk for serious injuries in the workplace.	[McLeod, Christopher B.; Koehoorn, Mieke] Univ British Columbia, Sch Populat & Publ Hlth, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [McLeod, Christopher B.] Univ British Columbia, Coll Interdisciplinary Studies, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Fan, J (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada.	jfan@chspr.ubc.ca	McLeod, Christopher B/D-7767-2012	McLeod, Christopher/0000-0001-9268-3694	WorkSafeBC (the Workers' Compensation Board of British Columbia); Michael Smith Foundation for Health Research; Social Sciences and Humanities Research Council of Canada	WorkSafeBC (the Workers' Compensation Board of British Columbia); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was funded by WorkSafeBC (the Workers' Compensation Board of British Columbia; http://www.worksafebc.com), through the Partnership for Work, Health and Safety. M Koehoorn was supported in-part by a Michael Smith Foundation for Health Research Senior Scholar Award (http://www.msfhr.org). CB McLeod was supported in-part by a post-doctoral fellowship from the Social Sciences and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. The administrative data on workers' compensation claims used for this study was collected and controlled by WorkSafeBC, and access to this data was provided under a data access agreement between the University of British Columbia and WorkSafeBC governing the privacy and confidentiality conditions for use of the data for research purposes.	Alamgir H, 2006, OCCUP ENVIRON MED, V63, P290, DOI 10.1136/oem.2005.026047; Alamgir H, 2011, OCCUP MED-OXFORD, V61, P234, DOI 10.1093/occmed/kqr025; Association of Workers' Compensation Boards of Canada, 2010, NUMB ACC TIM LOSS IN; Breslin C, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e10; Breslin FC, 2005, AM J IND MED, V48, P50, DOI 10.1002/ajim.20185; Cherry N, 2005, OCCUP MED-OXFORD, V55, P292, DOI 10.1093/occmed/kqi118; Choi BCK, 1996, J OCCUP ENVIRON MED, V38, P379, DOI 10.1097/00043764-199604000-00016; Crawford JO, 2010, OCCUP MED-OXFORD, V60, P184, DOI 10.1093/occmed/kqq028; Eng A, 2011, OCCUP ENVIRON MED, V68, P888, DOI 10.1136/oem.2010.064097; Ferrao V, 2007, PARTICIPATION OLDER; Grandjean Cynthia K, 2006, Nurs Health Sci, V8, P103, DOI 10.1111/j.1442-2018.2006.00260.x; Hu GQ, 2010, INJURY PREV, V16, P26, DOI 10.1136/ip.2009.023481; Islam SS, 2001, J OCCUP ENVIRON MED, V43, P140, DOI 10.1097/00043764-200102000-00013; Jacoby SF, 2006, J NURS SCHOLARSHIP, V38, P133, DOI 10.1111/j.1547-5069.2006.00090.x; Kemmlert K, 2001, APPL ERGON, V32, P149, DOI 10.1016/S0003-6870(00)00051-X; Layne L, 1997, J OCCUP ENVIRON MED, V29, P855; Layne LA, 2004, AM J IND MED, V46, P32, DOI 10.1002/ajim.20038; Liberty Mutual Research Institute for Safety, 2011, 2010 LIB MUT WORKPL; Martel L, 2007, RAPID AGING WORKING; MITCHELL OS, 1988, MON LABOR REV, V111, P8; Orces CH, 2011, INJURY PREV, V17, P33, DOI 10.1136/ip.2010.026799; Paulozzi LJ, 2006, J SAFETY RES, V37, P277, DOI 10.1016/j.jsr.2006.02.004; Rosenman KD, 2000, J OCCUP ENVIRON MED, V42, P25, DOI 10.1097/00043764-200001000-00008; Salminen S, 2004, J SAFETY RES, V35, P513, DOI 10.1016/j.jsr.2004.08.005; Shannon HS, 2002, AM J IND MED, V42, P467, DOI 10.1002/ajim.10142; StataCorp, 2008, STAT STAT SOFTW REL; [Statistics Canada Statistics Canada Labour Statistics Division], 2011, GUID LAB FORC SURV; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; The Health and Safety Executive, 2011, STAT 2009 2010; TheHealth & SafetyExecutive, 2010, SLIPS TRIPS FALLS CO; United States Department of Labor, 2011, FAT OCC INJ NONF OCC; WorkSafeBC, 2010, STAT 2009; WorkSafeBC, 2011, 2010 ANN REP 2011 20; World Health Organization, 2007, GLOB REP FALLS PREV; Wuellner Sara E., 2011, Morbidity and Mortality Weekly Report, V60, P503	37	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38750	10.1371/journal.pone.0038750	http://dx.doi.org/10.1371/journal.pone.0038750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723884	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700027
J	O'Brien, RM				O'Brien, Robert M.			Visualizing Rank Deficient Models: A Row Equation Geometry of Rank Deficient Matrices and Constrained-Regression	PLOS ONE			English	Article							COHORT ANALYSIS; PERIOD; AGE; ESTIMATORS	Situations often arise in which the matrix of independent variables is not of full column rank. That is, there are one or more linear dependencies among the independent variables. This paper covers in detail the situation in which the rank is one less than full column rank and extends this coverage to include cases of even greater rank deficiency. The emphasis is on the row geometry of the solutions based on the normal equations. The author shows geometrically how constrained-regression/generalized-inverses work in this situation to provide a solution in the face of rank deficiency.	Univ Oregon, Dept Sociol, Eugene, OR 97403 USA	University of Oregon	O'Brien, RM (corresponding author), Univ Oregon, Dept Sociol, Eugene, OR 97403 USA.	bobrien@uoregon.edu						Amir-Moez AR, 1970, MATH MAG, V43, P33; Andruchow E, 2005, MATH NACHR, V278, P756, DOI 10.1002/mana.200310270; BLALOCK HM, 1967, AM SOCIOL REV, V32, P790, DOI 10.2307/2092026; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Dietz T, 2009, INTRO SOCIAL STAT LO; Duncan O. D., 1966, SOCIAL STRUCTURE MOB, P51; Glenn Norval D., 2005, COHORT ANAL; Holford TR, 2006, STAT MED, V25, P977, DOI 10.1002/sim.2253; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; Kendall MG, 1961, COURSE GEOMETRY N DI; Keyser CJ, 1902, B AM MATH SOC, V10, P324; KRUSKAL W, 1975, J ROY STAT SOC B MET, V37, P272; Kuang D, 2008, BIOMETRIKA, V95, P979, DOI 10.1093/biomet/asn026; MASON KO, 1973, AM SOCIOL REV, V38, P242, DOI 10.2307/2094398; MAZUMDAR S, 1980, AM STAT, V34, P103, DOI 10.2307/2684114; O'Brien RM, 2011, AM SOC ASS M LAS VEG; O'Brien RM, 2011, SOCIOL METHOD RES, V40, P467, DOI 10.1177/0049124111415369; O'Brien RM, 2011, SOCIOL METHOD RES, V40, P419, DOI 10.1177/0049124111415367; Press W. H., 1992, ART SCI COMPUTING; SAS Institute Inc., 2011, SAS SOFTW; StataCorp, 2011, STAT STAT SOFTW REL, P173; Strang G., 2009, INTRO LINEAR ALGEBRA; Tarone RE, 1996, AM J EPIDEMIOL, V143, P85; Yang Y, 2008, AM J SOCIOL, V113, P1697, DOI 10.1086/587154	24	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38923	10.1371/journal.pone.0038923	http://dx.doi.org/10.1371/journal.pone.0038923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723906	Green Published, gold			2022-12-27	WOS:000305652700040
J	Crane, MJ; Gaddi, PJ; Salazar-Mather, TP				Crane, Meredith J.; Gaddi, Pamela J.; Salazar-Mather, Thais P.			UNC93B1 Mediates Innate Inflammation and Antiviral Defense in the Liver during Acute Murine Cytomegalovirus Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; IFN-ALPHA-BETA; PATTERN-RECOGNITION RECEPTORS; PLASMACYTOID DENDRITIC CELLS; NATURAL-KILLER; CYTOKINE RESPONSES; IMMUNE-RESPONSES; VIRAL-INFECTIONS; CUTTING EDGE; STRANDED-RNA	Antiviral defense in the liver during acute infection with the hepatotropic virus murine cytomegalovirus (MCMV) involves complex cytokine and cellular interactions. However, the mechanism of viral sensing in the liver that promotes these cytokine and cellular responses has remained unclear. Studies here were undertaken to investigate the role of nucleic acid-sensing Toll-like receptors (TLRs) in initiating antiviral immunity in the liver during infection with MCMV. We examined the host response of UNC93B1 mutant mice, which do not signal properly through TLR3, TLR7 and TLR9, to acute MCMV infection to determine whether liver antiviral defense depends on signaling through these molecules. Infection of UNC93B1 mutant mice revealed reduced production of systemic and liver proinflammatory cytokines including IFN-alpha, IFN-gamma, IL-12 and TNF-alpha when compared to wild-type. UNC93B1 deficiency also contributed to a transient hepatitis later in acute infection, evidenced by augmented liver pathology and elevated systemic alanine aminotransferase levels. Moreover, viral clearance was impaired in UNC93B1 mutant mice, despite intact virus-specific CD8+ T cell responses in the liver. Altogether, these results suggest a combined role for nucleic acid-sensing TLRs in promoting early liver antiviral defense during MCMV infection.	[Crane, Meredith J.; Gaddi, Pamela J.; Salazar-Mather, Thais P.] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Brown University	Crane, MJ (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Thais_Mather@brown.edu			Centers for Disease Control and Prevention [1R36PS001439-01]; National Institutes of Health [CA102708, AA018772]; Department of Education Predoctoral Training [P200A000117]; NATIONAL CANCER INSTITUTE [R01CA102708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [R36PS001439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018772] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education Predoctoral Training; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Centers for Disease Control and Prevention Grant 1R36PS001439-01 (to MJC), and in part by National Institutes of Health Grants CA102708 and AA018772 (to TPS-M) and Department of Education Predoctoral Training Grant P200A000117 (to MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Cavanaugh VJ, 2003, J VIROL, V77, P1703, DOI 10.1128/JVI.77.3.1703-1717.2003; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; DeFilippis VR, 2010, J VIROL, V84, P8913, DOI 10.1128/JVI.00169-10; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Finberg RW, 2009, IMMUNITY, V30, P173, DOI 10.1016/j.immuni.2009.02.001; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Held KS, 2008, VIRAL IMMUNOL, V21, P173, DOI 10.1089/vim.2008.0014; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Hokeness-Antonelli KL, 2007, J IMMUNOL, V179, P6176, DOI 10.4049/jimmunol.179.9.6176; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; John B, 2002, J IMMUNOL, V169, P2545, DOI 10.4049/jimmunol.169.5.2545; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mitrovic M, 2012, J VIROL, V86, P2165, DOI 10.1128/JVI.06042-11; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; OLVER SD, 1994, CLIN EXP IMMUNOL, V98, P375; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Orange JS, 1996, J IMMUNOL, V156, P4746; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Salazar-Mather TP, 2006, CURR TOP MICROBIOL, V303, P29, DOI 10.1007/978-3-540-33397-5_2; Salazar-Mather TP, 2000, J CLIN INVEST, V105, P985, DOI 10.1172/JCI9232; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Su HC, 2001, AID IMMU3048 62 3 0; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Trgovcich J, 2000, ARCH VIROL, V145, P2601, DOI 10.1007/s007050070010; Wick MJ, 2002, CRIT REV IMMUNOL, V22, P47; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zucchini N, 2008, INT IMMUNOL, V20, P45, DOI 10.1093/intimm/dxm119; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	62	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39161	10.1371/journal.pone.0039161	http://dx.doi.org/10.1371/journal.pone.0039161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723955	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300109
J	Fang, KN; Shia, BC; Ma, SG				Fang, Kuangnan; Shia, BenChang; Ma, Shuangge			Health Insurance Coverage and Impact: A Survey in Three Cities in China	PLOS ONE			English	Article							COOPERATIVE MEDICAL SCHEME; OUT-OF-POCKET; RURAL CHINA; CARE; EXPENDITURE	Background: China has one of the world's largest health insurance systems, composed of government-run basic health insurance and commercial health insurance. The basic health insurance has undergone system-wide reform in recent years. Meanwhile, there is also significant development in the commercial health insurance sector. A phone call survey was conducted in three major cities in China in July and August, 2011. The goal was to provide an updated description of the effect of health insurance on the population covered. Of special interest were insurance coverage, gross and out-of-pocket medical cost and coping strategies. Results: Records on 5,097 households were collected. Analysis showed that smaller households, higher income, lower expense, presence of at least one inpatient treatment and living in rural areas were significantly associated with a lower overall coverage rate. In the separate analysis of basic and commercial health insurance, similar factors were found to have significant associations. Higher income, presence of chronic disease, presence of inpatient treatment, higher coverage rates and living in urban areas were significantly associated with higher gross medical cost. A similar set of factors were significantly associated with higher out-of-pocket cost. Households with lower income, inpatient treatment, higher commercial insurance coverage, and living in rural areas were significantly more likely to pursue coping strategies other than salary. Conclusions: The surveyed cities and surrounding rural areas had socioeconomic status far above China's average. However, there was still a need to further improve coverage. Even for households with coverage, there was considerable out-of-pocket medical cost, particularly for households with inpatient treatments and/or chronic diseases. A small percentage of households were unable to self-finance out-of-pocket medical cost. Such observations suggest possible targets for further improving the health insurance system.	[Fang, Kuangnan; Shia, BenChang; Ma, Shuangge] Xiamen Univ, Dept Stat, Sch Econ, Xiamen, Peoples R China; [Shia, BenChang] FuJen Catholic Univ, Dept Stat & Informat Sci, New Taipei City, Peoples R China; [Ma, Shuangge] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Xiamen University; Yale University	Fang, KN (corresponding author), Xiamen Univ, Dept Stat, Sch Econ, Xiamen, Peoples R China.	shuangge.ma@yale.edu			Fundamental Research Funds for the Central Universities [2010221040]; Fujian Social Science Funds from China [2011C042]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fujian Social Science Funds from China	This study was partly supported by Fundamental Research Funds for the Central Universities (2010221040) and Fujian Social Science Funds (2011C042) from China. The funding agencies had no role in the design, collection, analysis, or interpretation of data, or in writing the paper.	Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Dong KY, 2009, CHINA ECON REV, V20, P591, DOI 10.1016/j.chieco.2009.05.011; IBM, 2006, HEALTHC CHIN GREAT A; Jiang QC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-50; Nguyen KT, 2012, SOC SCI MED, V74, P724, DOI 10.1016/j.socscimed.2011.10.027; Lei XY, 2009, HEALTH ECON, V18, pS25, DOI 10.1002/hec.1501; Liu YL, 2002, HEALTH POLICY, V60, P133, DOI 10.1016/S0168-8510(01)00207-X; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Morrison J, 2008, FIELD NOTE PERSPECTI, V10, P141; Qiu PY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-520; Roger JP, 2007, AM J PUBLIC HEALTH, V97, P804, DOI 10.2105/AJPH.2005.080184; Sun XY, 2009, HEALTH ECON, V18, P103, DOI 10.1002/hec.1346; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wagstaff A, 2008, J HEALTH ECON, V27, P990, DOI 10.1016/j.jhealeco.2008.02.002; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wang H, 2006, SOC SCI MED, V63, P1236, DOI 10.1016/j.socscimed.2006.03.008; Wang T, 2009, CHINA TAKES STAB UNI; Xiao SB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-695; Xinhua Net, 2011, CHIN MAINL POP GROWS; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-37; You X, 2011, APPL HEALTH ECON HEA, V9, P39, DOI 10.2165/11530730-000000000-00000; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012; Zhang L, 2011, CHINAS BASIC MED INS; Zhang Y, 2011, INT P ECON DEV RES, V5, P356	26	31	33	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39157	10.1371/journal.pone.0039157	http://dx.doi.org/10.1371/journal.pone.0039157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22723954	Green Published, gold			2022-12-27	WOS:000305583300108
J	Yao, J; He, XY; Wang, AZ; Chen, W; Li, XY; Lewis, BJ; Lv, XT				Yao, Jing; He, Xingyuan; Wang, Anzhi; Chen, Wei; Li, Xiaoyu; Lewis, Bernard J.; Lv, Xiaotao			Influence of Forest Management Regimes on Forest Dynamics in the Upstream Region of the Hun River in Northeastern China	PLOS ONE			English	Article							GREAT XINGAN MOUNTAINS; SEED DISPERSAL; SPECIES-DIVERSITY; PINUS-KORAIENSIS; LANDSCAPE MODEL; PLANT DIVERSITY; FIRE REGIMES; RESTORATION; SIMULATION; SUCCESSION	Balancing forest harvesting and restoration is critical for forest ecosystem management. In this study, we used LANDIS, a spatially explicit forest landscape model, to evaluate the effects of 21 alternative forest management initiatives which were drafted for forests in the upstream region of the Hun River in northeastern China. These management initiatives included a wide range of planting and harvest intensities for Pinus koraiensis, the historically dominant tree species in the region. Multivariate analysis of variance, Shannon's Diversity Index, and planting efficiency (which indicates how many cells of the target species at the final year benefit from per-cell of the planting trees) estimates were used as indicators to analyze the effects of planting and harvesting regimes on forests in the region. The results showed that the following: (1) Increased planting intensity, although augmenting the coverage of P. koraiensis, was accompanied by decreases in planting efficiency and forest diversity. (2) While selective harvesting could increase forest diversity, the abrupt increase of early succession species accompanying this method merits attention. (3) Stimulating rapid forest succession may not be a good management strategy, since the climax species would crowd out other species which are likely more adapted to future climatic conditions in the long run. In light of the above, we suggest a combination of 30% planting intensity with selective harvesting of 50% and 70% of primary and secondary timber species, respectively, as the most effective management regime in this area. In the long run this would accelerate the ultimate dominance of P. koraiensis in the forest via a more effective rate of planting, while maintaining a higher degree of forest diversity. These results are particularly useful for forest managers constrained by limited financial and labor resources who must deal with conflicts between forest harvesting and restoration.	[Yao, Jing; He, Xingyuan; Wang, Anzhi; Chen, Wei; Li, Xiaoyu; Lewis, Bernard J.; Lv, Xiaotao] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yao, Jing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yao, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	avril_y@foxmail.com; hexy@iae.ac.cn	Lu (ü), Xiao-Tao/B-3905-2008	Lu (ü), Xiao-Tao/0000-0001-5571-1895	National Forestry Public Benefit Research Foundation of China [200804001]; National Natural Science Foundation of China [40971272]	National Forestry Public Benefit Research Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financed by the National Forestry Public Benefit Research Foundation of China (No. 200804001) and the National Natural Science Foundation of China (No. 40971272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HD, 2010, CAN J FOREST RES, V40, P716, DOI 10.1139/X10-029; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Bent GC, 2001, FOREST ECOL MANAG, V143, P115, DOI 10.1016/S0378-1127(00)00511-9; Berry NJ, 2008, LANDSCAPE ECOL, V23, P915, DOI 10.1007/s10980-008-9248-1; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bhatti JS, 2000, FOREST ECOL MANAG, V138, P413, DOI 10.1016/S0378-1127(00)00427-8; Bonell M, 2010, J HYDROL, V391, P49, DOI 10.1016/j.jhydrol.2010.07.004; Bu R, 2008, FOREST ECOL MANAG, V254, P407, DOI 10.1016/j.foreco.2007.09.080; Cairns DM, 2008, LANDSCAPE ECOL, V23, P403, DOI 10.1007/s10980-008-9198-7; Carlson M, 2010, FOREST CHRON, V86, P434, DOI 10.5558/tfc86434-4; Chang Y, 2008, FOREST ECOL MANAG, V254, P445, DOI 10.1016/j.foreco.2007.04.050; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Chen XW, 2003, FOREST ECOL MANAG, V177, P503, DOI 10.1016/S0378-1127(02)00455-3; Donath TW, 2003, APPL VEG SCI, V6, P13, DOI 10.1111/j.1654-109X.2003.tb00560.x; Duncan RS, 2003, FOREST ECOL MANAG, V173, P235, DOI 10.1016/S0378-1127(02)00009-9; Elliott KJ, 2005, FOREST ECOL MANAG, V211, P296, DOI 10.1016/j.foreco.2005.02.064; Feyrer LJ, 2011, HYDROBIOLOGIA, V678, P37, DOI 10.1007/s10750-011-0816-z; Franklin J, 2005, ECOSYSTEMS, V8, P885, DOI 10.1007/s10021-005-0017-6; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Hall SJ, 2008, WETLANDS, V28, P776, DOI 10.1672/07-231.1; Hao Z., 2001, CHINESE J APPL ECOLO, V12, P653; He HS, 1999, ECOL MODEL, V119, P1, DOI 10.1016/S0304-3800(99)00041-1; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; He HS, 2002, ECOL MODEL, V156, P153, DOI 10.1016/S0304-3800(02)00104-7; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; He J, 2009, FOREST ECOL MANAG, V257, P2010, DOI 10.1016/j.foreco.2009.01.041; Leng WF, 2008, FOREST ECOL MANAG, V254, P420, DOI 10.1016/j.foreco.2007.08.031; Li J, 2003, ACTA ECOLOGICA SINIC, P23; Li JingWen, 2005, Scientia Silvae Sinicae, V41, P72; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Liu GH, 2001, J NATURAL RESOURCES, V16, P71; Mehta S, 2004, ECOL MODEL, V180, P73, DOI 10.1016/j.ecolmodel.2004.01.019; Mladenoff DJ, 2004, ECOL MODEL, V180, P7, DOI 10.1016/j.ecolmodel.2004.03.016; Moss EH, 1937, BOT GAZ, V99, P529; Pietsch SA, 2002, FOREST ECOL MANAG, V159, P111, DOI 10.1016/S0378-1127(01)00714-9; Ravenscroft C, 2010, ECOL APPL, V20, P327, DOI 10.1890/08-1698.1; Schumann ME, 2003, FOREST ECOL MANAG, V176, P543, DOI 10.1016/S0378-1127(02)00233-5; Shin JH, 2004, FOREST ECOL MANAG, V201, P43, DOI 10.1016/j.foreco.2004.06.020; Shinneman DJ, 2010, FOREST ECOL MANAG, V259, P446, DOI 10.1016/j.foreco.2009.10.042; Steenberg JWN, 2011, FOREST ECOL MANAG, V262, P2316, DOI 10.1016/j.foreco.2011.08.027; TAUSCH RJ, 1993, J RANGE MANAGE, V46, P439, DOI 10.2307/4002664; van Loon AH, 2011, BIOL CONSERV, V144, P1025, DOI 10.1016/j.biocon.2010.12.021; Wang J, 2010, FORESTRY SCI TECHNOL, V35, P10; Wang XG, 2006, FOREST ECOL MANAG, V225, P82, DOI 10.1016/j.foreco.2005.12.029; Weiss G, 2004, FOREST ECOL MANAG, V195, P1, DOI 10.1016/j.foreco.2004.03.019; Will R, 2010, FOREST SCI, V56, P437; Wu Jing-Lian, 2009, Yingyong Shengtai Xuebao, V20, P235; Xu CG, 2004, ECOL MODEL, V180, P57, DOI 10.1016/j.ecolmodel.2004.01.018; Xu C, 2009, GLOBAL CHANGE BIOL, V15, P116, DOI 10.1111/j.1365-2486.2008.01705.x; Yosi CK, 2011, FOREST ECOL MANAG, V262, P895, DOI 10.1016/j.foreco.2011.06.007; Youngblood A, 2006, FOREST ECOL MANAG, V234, P143, DOI 10.1016/j.foreco.2006.06.033; Yu M, 2011, ANN BOT-LONDON, V108, P885, DOI 10.1093/aob/mcr218; Yu XiaoMei, 2009, Journal of Northeast Forestry University, V37, P18; Yu XM, 2009, J NE FORESTRY U, V37, P53; Zerbe S, 2002, FOREST ECOL MANAG, V167, P27, DOI 10.1016/S0378-1127(01)00686-7; Zhang Jian, 2007, Yingyong Shengtai Xuebao, V18, P1681; Zhao DS, 2007, CHINESE GEOGR SCI, V17, P317, DOI 10.1007/s11769-007-0317-1; Zhu Jiao-jun, 2008, Yingyong Shengtai Xuebao, V19, P695	59	4	4	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39058	10.1371/journal.pone.0039058	http://dx.doi.org/10.1371/journal.pone.0039058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723930	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300088
J	Chisti, MJ; Ahmed, T; Ashraf, H; Faruque, ASG; Bardhan, PK; Dey, SK; Huq, S; Das, SK; Salam, MA				Chisti, Mohammod J.; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, A. S. G.; Bardhan, Pradip K.; Dey, Sanjoy Kumer; Huq, Sayeeda; Das, Sumon Kumar; Salam, Mohammed A.			Clinical Predictors and Outcome of Metabolic Acidosis in Under-Five Children Admitted to an Urban Hospital in Bangladesh with Diarrhea and Pneumonia	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK; DEHYDRATION; MANAGEMENT; MORTALITY; INFANTS; MALNUTRITION; FEATURES; SEPSIS	Background: Clinical features of metabolic acidosis and pneumonia frequently overlap in young diarrheal children, resulting in differentiation from each other very difficult. However, there is no published data on the predictors of metabolic acidosis in diarrheal children also having pneumonia. Our objective was to evaluate clinical predictors of metabolic acidosis in under-five diarrheal children with radiological pneumonia, and their outcome. Methods: We prospectively enrolled all under-five children (n = 164) admitted to the Special Care Ward (SCW) of the Dhaka Hospital of icddr, b between September and December 2007 with diarrhea and radiological pneumonia who also had their total serum carbon-dioxide estimated. We compared the clinical features and outcome of children with radiological pneumonia and diarrhea with (n = 98) and without metabolic acidosis (n = 66). Results: Children with metabolic acidosis more often had higher case-fatality (16% vs. 5%, p = 0.039) compared to those without metabolic acidosis on admission. In logistic regression analysis, after adjusting for potential confounders such as age of the patient, fever on admission, and severe wasting, the independent predictors of metabolic acidosis in under-five diarrheal children having pneumonia were clinical dehydration (OR 3.57, 95% CI 1.62-7.89, p = 0.002), and low systolic blood pressure even after full rehydration (OR 1.02, 95% CI 1.01-1.04, p = 0.005). Proportions of children with cough, respiratory rate/minute, lower chest wall indrawing, nasal flaring, head nodding, grunting respiration, and cyanosis were comparable (p>0.05) among the groups. Conclusion and Significance: Under-five diarrheal children with radiological pneumonia having metabolic acidosis had frequent fatal outcome than those without acidosis. Clinical dehydration and persistent systolic hypotension even after adequate rehydration were independent clinical predictors of metabolic acidosis among the children. However, metabolic acidosis in young diarrheal children had no impact on the diagnostic clinical features of radiological pneumonia which underscores the importance of early initiation of appropriate antibiotics to combat morbidity and deaths in such population.	[Chisti, Mohammod J.; Bardhan, Pradip K.] Bangladesh icddr b, Int Ctr Diarhoeal Dis Res, CS, Dhaka, Bangladesh; [Chisti, Mohammod J.; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, A. S. G.; Bardhan, Pradip K.; Huq, Sayeeda; Das, Sumon Kumar] Icddr b, CNFS, Dhaka, Bangladesh; [Dey, Sanjoy Kumer] BSMMU, Dept Neonatol, Dhaka, Bangladesh; [Salam, Mohammed A.] Icddr b, RAS, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); Bangabandhu Sheikh Mujib Medical University (BSMMU); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Bangladesh icddr b, Int Ctr Diarhoeal Dis Res, CS, Dhaka, Bangladesh.	chisti@icddrb.org	Das, Sumon Kumar/AAD-1551-2019; Das, Sumon Kumar/T-6384-2019; Chisti, Mohammod J/A-7216-2018; Dey, Sanjoy Kumer/AAN-6937-2020		Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR) [Gr-00233]	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR)	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SM, 1986, SCAND J INFECT DIS, V18, P65, DOI 10.3109/00365548609032308; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chisti MJ, 2011, ANN TROP PAEDIATR, V31, P311, DOI 10.1179/1465328111Y.0000000033; Chisti MJ, 2010, ANN TROP PAEDIATR, V30, P311, DOI 10.1179/146532810X12858955921230; Chisti MJ, 2012, TROP MED INT HLTH; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; Chisti MJ, 2010, TROP MED INT HEALTH, V15, P1322, DOI 10.1111/j.1365-3156.2010.02619.x; Chisti MJ, 2010, PEDIATR CRIT CARE ME, V11, P92, DOI 10.1097/PCC.0b013e3181b063e1; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Ebrahim GJ, 2011, J TROP PEDIATRICS, V57, P77, DOI 10.1093/tropej/fmr022; Greenbaum LA, 2012, NELSON TXB PAEDIAT, P267; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; NATHOO KJ, 1987, CENT AFR J MED, V33, P200; RICHARDS L, 1993, PEDIATR INFECT DIS J, V12, P5, DOI 10.1097/00006454-199301000-00003; Said M, 1980, Paediatr Indones, V20, P68; Salam MA, 2002, SAN DIEG CA 42 INT C; Suskind DMK, 1990, MALNOURISHED CHILD; Vega RM, 1997, PEDIATR EMERG CARE, V13, P179, DOI 10.1097/00006565-199706000-00001; WANG F, 1986, NEW ENGL J MED, V315, P1591, DOI 10.1056/NEJM198612183152506; World Health Organization, 1990, AC RESP INF CHILDR C; World Health Organization, 1999, MAN SEV MALN MAN PHY	26	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39164	10.1371/journal.pone.0039164	http://dx.doi.org/10.1371/journal.pone.0039164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720060	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000045
J	Suchodolski, JS; Dowd, SE; Wilke, V; Steiner, JM; Jergens, AE				Suchodolski, Jan S.; Dowd, Scot E.; Wilke, Vicky; Steiner, Joerg M.; Jergens, Albert E.			16S rRNA Gene Pyrosequencing Reveals Bacterial Dysbiosis in the Duodenum of Dogs with Idiopathic Inflammatory Bowel Disease	PLOS ONE			English	Article							MOLECULAR-PHYLOGENETIC CHARACTERIZATION; TOLL-LIKE RECEPTORS; SMALL-INTESTINE; CHRONIC ENTEROPATHIES; FECAL BACTERIAL; GUT MICROBIOTA; HEALTHY DOGS; ASSOCIATION; COMMUNITIES; POPULATIONS	Background: Canine idiopathic inflammatory bowel disease (IBD) is believed to be caused by a complex interaction of genetic, immunologic, and microbial factors. While mucosa-associated bacteria have been implicated in the pathogenesis of canine IBD, detailed studies investigating the enteric microbiota using deep sequencing techniques are lacking. The objective of this study was to evaluate mucosa-adherent microbiota in the duodenum of dogs with spontaneous idiopathic IBD using 16 S rRNA gene pyrosequencing. Methodology/Principal Findings: Biopsy samples of small intestinal mucosa were collected endoscopically from healthy dogs (n = 6) and dogs with moderate IBD (n = 7) or severe IBD (n = 7) as assessed by a clinical disease activity index. Total RNA was extracted from biopsy specimens and 454-pyrosequencing of the 16 S rRNA gene was performed on aliquots of cDNA from each dog. Intestinal inflammation was associated with significant differences in the composition of the intestinal microbiota when compared to healthy dogs. PCoA plots based on the unweighted UniFrac distance metric indicated clustering of samples between healthy dogs and dogs with IBD (ANOSIM, p<0.001). Proportions of Fusobacteria (p = 0.010), Bacteroidaceae (p = 0.015), Prevotellaceae (p = 0.022), and Clostridiales (p = 0.019) were significantly more abundant in healthy dogs. In contrast, specific bacterial genera within Proteobacteria, including Diaphorobacter (p = 0.044) and Acinetobacter (p = 0.040), were either more abundant or more frequently identified in IBD dogs. Conclusions/Significance: In conclusion, dogs with spontaneous IBD exhibit alterations in microbial groups, which bear resemblance to dysbiosis reported in humans with chronic intestinal inflammation. These bacterial groups may serve as useful targets for monitoring intestinal inflammation.	[Suchodolski, Jan S.; Steiner, Joerg M.] Texas A&M Univ, Gastrointestinal Lab, Dept Small Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Wilke, Vicky] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Jergens, Albert E.] Iowa State Univ, Coll Vet Med, Ames, IA USA	Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University	Suchodolski, JS (corresponding author), Texas A&M Univ, Gastrointestinal Lab, Dept Small Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	jsuchodolski@cvm.tamu.edu	Dowd, Scot E/M-5386-2017; Fiumefreddo, Andrea/T-2977-2019	Dowd, Scot E/0000-0002-6296-1427; Suchodolski, Jan/0000-0002-2176-6932	American Kennel Club Canine Health Foundation	American Kennel Club Canine Health Foundation	This study was funded by a grant from the American Kennel Club Canine Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BATT RM, 1992, AM J VET RES, V53, P1935; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNO Y, 1992, J VET MED SCI, V54, P703, DOI 10.1292/jvms.54.703; Buddington RK, 2003, AM J VET RES, V64, P646, DOI 10.2460/ajvr.2003.64.646; Burgener IA, 2008, J VET INTERN MED, V22, P553, DOI 10.1111/j.1939-1676.2008.0093.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Craven M, 2004, J SMALL ANIM PRACT, V45, P336, DOI 10.1111/j.1748-5827.2004.tb00245.x; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Khan ST, 2002, J GEN APPL MICROBIOL, V48, P299; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Simpson KW, 2011, VET CLIN N AM-SMALL, V41, P381, DOI 10.1016/j.cvsm.2011.02.003; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Suchodolski JS, 2008, VET MICROBIOL, V132, P379, DOI 10.1016/j.vetmic.2008.05.017; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Washabau RJ, 2010, J VET INTERN MED, V24, P10, DOI 10.1111/j.1939-1676.2009.0443.x; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x	36	143	144	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39333	10.1371/journal.pone.0039333	http://dx.doi.org/10.1371/journal.pone.0039333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720094	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000059
J	Bender, S; Resch, F; Klein, C; Renner, T; Fallgatter, AJ; Weisbrod, M; Romanos, M				Bender, Stephan; Resch, Franz; Klein, Christoph; Renner, Tobias; Fallgatter, Andreas J.; Weisbrod, Matthias; Romanos, Marcel			Influence of Stimulant Medication and Response Speed on Lateralization of Movement-Related Potentials in Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; CONTINGENT NEGATIVE-VARIATION; CONTINUOUS PERFORMANCE-TEST; SLOW CORTICAL POTENTIALS; ANTICIPATORY MECHANISMS; MOTOR PREPARATION; TIC DISORDER; CHILDREN; ADHD; METHYLPHENIDATE	Background: Hyperactivity is one of the core symptoms in attention deficit hyperactivity disorder (ADHD). However, it remains unclear in which way the motor system itself and its development are affected by the disorder. Movement-related potentials (MRP) can separate different stages of movement execution, from the programming of a movement to motor post-processing and memory traces. Pre-movement MRP are absent or positive during early childhood and display a developmental increase of negativity. Methods: We examined the influences of response-speed, an indicator of the level of attention, and stimulant medication on lateralized MRP in 16 children with combined type ADHD compared to 20 matched healthy controls. Results: We detected a significantly diminished lateralisation of MRP over the pre-motor and primary motor cortex during movement execution (initial motor potential peak, iMP) in patients with ADHD. Fast reactions (indicating increased visuo-motor attention) led to increased lateralized negativity during movement execution only in healthy controls, while in children with ADHD faster reaction times were associated with more positive amplitudes. Even though stimulant medication had some effect on attenuating group differences in lateralized MRP, this effect was insufficient to normalize lateralized iMP amplitudes. Conclusions: A reduced focal (lateralized) motor cortex activation during the command to muscle contraction points towards an immature motor system and a maturation delay of the (pre-) motor cortex in children with ADHD. A delayed maturation of the neuronal circuitry, which involves primary motor cortex, may contribute to ADHD pathophysiology.	[Bender, Stephan] Tech Univ Dresden, Child & Adolscent Psychiat Hosp, Sect Clin Neurophysiol & Multimodal NeuroImaging, Dresden, Germany; [Resch, Franz] Heidelberg Univ, Dept Child & Adolescent Psychiat, Heidelberg, Germany; [Klein, Christoph] Univ Bangor, Sch Psychol, Bangor, Gwynedd, Wales; [Renner, Tobias; Romanos, Marcel] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Wurzburg, Germany; [Fallgatter, Andreas J.] Univ Tubingen, Dept Psychiat, Tubingen, Germany; [Weisbrod, Matthias] Heidelberg Univ, Hosp Psychiat, Sect Expt Psychopathol, Heidelberg, Germany; [Weisbrod, Matthias] Hosp Psychiat, SRH, Karlsbad, Germany; [Romanos, Marcel] Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany	Technische Universitat Dresden; Ruprecht Karls University Heidelberg; Bangor University; University of Wurzburg; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; University of Munich	Bender, S (corresponding author), Tech Univ Dresden, Child & Adolscent Psychiat Hosp, Sect Clin Neurophysiol & Multimodal NeuroImaging, Dresden, Germany.	Stephan.Bender@uniklinikum-dresden.de	Bender, Stephan/AAT-1266-2021; Romanos, Marcel/D-7695-2017; Renner, Tobias J/I-2120-2013	Romanos, Marcel/0000-0001-7628-8299; 	Deutsche Forschungsgemeinschaft [KFO 125]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was performed within the framework of the Clinical Research Program Attention Deficit Hyperactivity Disorder (KFO 125), supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMABILE G, 1986, ELECTROEN CLIN NEURO, V64, P521, DOI 10.1016/0013-4694(86)90189-6; Banaschewski T, 2008, BIOL PSYCHOL, V77, P53, DOI 10.1016/j.biopsycho.2007.09.003; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; Bender S, 2005, ANN NEUROL, V58, P58, DOI 10.1002/ana.20521; Bender S, PLOS ONE IN PRESS; Bender S, 2007, PAIN, V127, P221, DOI 10.1016/j.pain.2006.08.017; Bender S, 2006, NEUROIMAGE, V32, P333, DOI 10.1016/j.neuroimage.2006.03.009; Bender S, 2010, CLIN NEUROPHYSIOL, V121, P2044, DOI 10.1016/j.clinph.2010.05.008; Bruckmann S, BRAIN IN PRESS; Buchmann J, 2007, BIOL PSYCHIAT, V62, P963, DOI 10.1016/j.biopsych.2007.05.010; CHIARENZA GA, 1983, ELECTROEN CLIN NEURO, V56, P373, DOI 10.1016/0013-4694(83)90263-8; Doehnert M, 2010, BIOL PSYCHIAT, V67, P608, DOI 10.1016/j.biopsych.2009.07.038; Epstein JN, 2010, J INT NEUROPSYCH SOC, V16, P138, DOI 10.1017/S1355617709991111; Fallgatter AJ, 1997, BRAIN TOPOGR, V9, P295, DOI 10.1007/BF01464484; Fallgatter AJ, 2004, CLIN NEUROPHYSIOL, V115, P973, DOI 10.1016/j.clinph.2003.11.036; Fernandez A, 2009, BIOL PSYCHIAT, V65, P571, DOI 10.1016/j.biopsych.2008.10.046; Hallett M, 1994, Electromyogr Clin Neurophysiol, V34, P5; Heinrich H, 2004, BIOL PSYCHIAT, V55, P772, DOI 10.1016/j.biopsych.2003.11.013; Hennighausen K, 2000, Z KINDER JUG-PSYCH, V28, P239, DOI 10.1024//1422-4917.28.4.239; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Klein C, 1996, PSYCHOPHYSIOLOGY, V33, P426, DOI 10.1111/j.1469-8986.1996.tb01068.x; Klein C, 1998, PSYCHOPHYSIOLOGY, V35, P272, DOI 10.1017/S0048577298961212; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Kratz O, 2011, INT J PSYCHOPHYSIOL, V81, P82, DOI 10.1016/j.ijpsycho.2011.05.008; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P199, DOI 10.1111/1469-7610.00711; Linssen AM, 2011, PSYCHOPHARMACOLOGY B; Linssen AMW, 2011, PSYCHOPHARMACOLOGY, V218, P533, DOI 10.1007/s00213-011-2345-x; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469-8986.2004.00150.x; Moll GH, 2001, ANN NEUROL, V49, P393, DOI 10.1002/ana.77; Mordkoff JT, 2001, PSYCHOPHYSIOLOGY, V38, P777, DOI 10.1017/S0048577201000464; Mostofsky SH, 2006, BIOL PSYCHIAT, V59, P48, DOI 10.1016/j.biopsych.2005.06.011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OTTO D, 1984, ANN NY ACAD SCI, V425, P377, DOI 10.1111/j.1749-6632.1984.tb23559.x; Perchet C, 2005, CLIN NEUROPHYSIOL, V116, P1906, DOI 10.1016/j.clinph.2005.03.022; Perchet C, 2001, BIOL PSYCHIAT, V50, P44, DOI 10.1016/S0006-3223(00)01119-7; Praamstra P, 1999, COGNITIVE BRAIN RES, V8, P77, DOI 10.1016/S0926-6410(99)00008-7; Rammsayer T, 2006, PSYCHOPHARMACOLOGY, V187, P36, DOI 10.1007/s00213-006-0400-9; Richter MM, 2007, NEUROSCI LETT, V419, P137, DOI 10.1016/j.neulet.2007.04.024; Rothenberger A., 1986, CEREB PSYCHOPHYSIOL, V38, P496; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Seifert J, 2003, J NEURAL TRANSM, V110, P821, DOI 10.1007/s00702-003-0818-8; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2009, CURR PSYCHIAT REP, V11, P393, DOI 10.1007/s11920-009-0059-0; SOMMER W, 1994, PSYCHOPHYSIOLOGY, V31, P503, DOI 10.1111/j.1469-8986.1994.tb01054.x; Spencer SV, 2009, J ABNORM CHILD PSYCH, V37, P805, DOI 10.1007/s10802-009-9316-2; Steger J, 2000, CLIN NEUROPHYSIOL, V111, P1141, DOI 10.1016/S1388-2457(00)00311-4; Thiemann U, 2011, NEUROIMAGE; van Turennout M, 1998, SCIENCE, V280, P572, DOI 10.1126/science.280.5363.572; Verleger R, 1999, CLIN NEUROPHYSIOL, V110, P1175, DOI 10.1016/S1388-2457(99)00023-1; WARREN C, 1984, ANN NY ACAD SCI, V425, P489, DOI 10.1111/j.1749-6632.1984.tb23572.x; Wascher E, 1997, BRAIN, V120, P1355, DOI 10.1093/brain/120.8.1355; Werner J, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-38; Yordanova J, 1997, BIOL PSYCHIAT, V41, P585, DOI 10.1016/S0006-3223(96)00096-0; Zillessen KE, 2001, CLIN NEUROPHYSIOL, V112, P1166, DOI 10.1016/S1388-2457(01)00535-1	57	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39012	10.1371/journal.pone.0039012	http://dx.doi.org/10.1371/journal.pone.0039012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720017	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800037
J	Hebestreit, K; Grottrup, S; Emden, D; Veerkamp, J; Ruckert, C; Klein, HU; Muller-Tidow, C; Dugas, M				Hebestreit, Katja; Groettrup, Soeren; Emden, Daniel; Veerkamp, Jannis; Ruckert, Christian; Klein, Hans-Ulrich; Mueller-Tidow, Carsten; Dugas, Martin			Leukemia Gene Atlas - A Public Platform for Integrative Exploration of Genome-Wide Molecular Data	PLOS ONE			English	Article							CANCER; HEMATOPOIESIS; MUTATIONS; PATHWAYS; ONCOLOGY; RUNX1	Leukemias are exceptionally well studied at the molecular level and a wealth of high-throughput data has been published. But further utilization of these data by researchers is severely hampered by the lack of accessible integrative tools for viewing and analysis. We developed the Leukemia Gene Atlas (LGA) as a public platform designed to support research and analysis of diverse genomic data published in the field of leukemia. With respect to leukemia research, the LGA is a unique resource with comprehensive search and browse functions. It provides extensive analysis and visualization tools for various types of molecular data. Currently, its database contains data from more than 5,800 leukemia and hematopoiesis samples generated by microarray gene expression, DNA methylation, SNP and next generation sequencing analyses. The LGA allows easy retrieval of large published data sets and thus helps to avoid redundant investigations. It is accessible at www.leukemia-gene-atlas.org.	[Hebestreit, Katja; Groettrup, Soeren; Emden, Daniel; Veerkamp, Jannis; Ruckert, Christian; Klein, Hans-Ulrich; Dugas, Martin] Univ Munster, Inst Med Informat, Munster, Germany; [Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol & Oncol, Munster, Germany	University of Munster; University of Munster	Hebestreit, K (corresponding author), Univ Munster, Inst Med Informat, Munster, Germany.	dugas@uni-muenster.de	Klein, Hans-Ulrich/O-5118-2019; Klein, Hans-Ulrich/A-7801-2013; Hebestreit, Katja/A-7906-2013; Dugas, Martin/F-5454-2011; Ruckert, Christian/A-8732-2013; Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014	Klein, Hans-Ulrich/0000-0002-6382-9428; Klein, Hans-Ulrich/0000-0002-6382-9428; Ruckert, Christian/0000-0001-9915-1287; Müller-Tidow, Carsten/0000-0002-7166-5232; 	Jose Carreras Foundation [DJCLS 09/04]; COST Action [BM0801]	Jose Carreras Foundation; COST Action(European Cooperation in Science and Technology (COST))	The Leukemia Gene Atlas is supported by the Jose Carreras Foundation (DJCLS 09/04) and COST Action BM0801 Translating genomic and epigenetic studies of MDS and AML (EuGESMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluteau D, 2011, BLOOD, V118, P6310, DOI 10.1182/blood-2010-12-325555; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cronin M, 2011, BIOMARK MED, V5, P293, DOI [10.2217/BMM.11.37, 10.2217/bmm.11.37]; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gadaleta E, 2011, BRIEF BIOINFORM, V12, P52, DOI 10.1093/bib/bbq010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Huret JL, 2001, NUCLEIC ACIDS RES, V29, P303, DOI 10.1093/nar/29.1.303; Klein HU, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-422; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Neff T, 2009, LEUKEMIA, V23, P1243, DOI 10.1038/leu.2009.40; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Theilgaard-Monch K, 2011, LEUKEMIA, V25, P909, DOI 10.1038/leu.2011.48; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299	24	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39148	10.1371/journal.pone.0039148	http://dx.doi.org/10.1371/journal.pone.0039148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720055	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347800047
J	Mitra, S; Mazumder-Indra, D; Mondal, RK; Basu, PS; Roy, A; Roychoudhury, S; Panda, CK				Mitra, Sraboni; Mazumder-Indra, Dipanjana; Mondal, Ranajit K.; Basu, Partha S.; Roy, Anup; Roychoudhury, Susanta; Panda, Chinmay K.			Inactivation of SLIT2-ROBO1/2 Pathway in Premalignant Lesions of Uterine Cervix: Clinical and Prognostic Significances	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; FREQUENT EPIGENETIC INACTIVATION; SQUAMOUS-CELL CARCINOMA; SLIT-ROBO PATHWAY; BREAST-CANCER; POOR-PROGNOSIS; HUMAN HOMOLOG; BETA-CATENIN; LUNG-CANCER; METHYLATION	The SLIT2-ROBO1/2 pathways control diverse biological processes, including growth regulation. To understand the role of SLIT2 and ROBO1/2 in cervical carcinogenesis, firstly their RNA expression profiles were screened in 21 primary uterine cervical carcinoma (CACX) samples and two CACX cell lines. Highly reduced expressions of these genes were evident. Concomitant alterations [deletion/methylation] of the genes were then analyzed in 23 cervical intraepithelial neoplasia (CIN) and 110 CACX samples. In CIN, SLIT2 was deleted in 22% samples compared to 9% for ROBO1 and none for ROBO2, whereas comparable methylation was observed for both SLIT2 (30%) and ROBO1 (22%) followed by ROBO2 (9%). In CACX, alteration of the genes were in the following order: Deletion: ROBO1 (48%) > SLIT2 (35%) > ROBO2 (33%), Methylation: SLIT2 (34%) > ROBO1 (29%) > ROBO2 (26%). Overall alterations of SLIT2 and/or ROBO1 (44%) and SLIT2 and/or ROBO2 (39%) were high in CIN followed by significant increase in stage I/II tumors, suggesting deregulation of these interactions in premalignant lesions and early invasive tumors. Immunohistochemical analysis of SLIT2 and ROBO1/2 in CACX also showed reduced expression concordant with molecular alterations. Alteration of all these genes predicted poor patient outcome. Multiparous (>= 5) women with altered SLIT2 and ROBO1 along with advanced tumor stage (III/IV) and early sexual debut (<19 years) had worst prognosis. Our data suggests the importance of abrogation of SLIT2-ROBO1 and SLIT2-ROBO2 interactions in the initiation and progression of CACX and also for early diagnosis and prognosis of the disease.	[Mitra, Sraboni; Mazumder-Indra, Dipanjana; Panda, Chinmay K.] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, West Bengal, India; [Mondal, Ranajit K.; Basu, Partha S.] Chittaranjan Natl Canc Inst, Dept Gynaecol Oncol, Kolkata, West Bengal, India; [Roy, Anup] N Bengal Med Coll, Siliguri, West Bengal, India; [Roychoudhury, Susanta] Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, West Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Mitra, S (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ckpanda.cnci@gmail.com	Roychoudhury, Susanta/AAD-7946-2021		Council for Scientific and Industrial Research (CSIR), Government of India [27 (0111)/00/EMR-II]; Department of Science and Technology (DST), Government of India [SR/SO/HS-116/2007(G)]; CSIR funded Senior Research Fellowship [CSIR-SRF(Ext)] [09/030(0064)/2011EMR-I]; CSIR funded Junior Research Fellowship through the National Eligibility Test [CSIR-JRF/NET] Fellowship [9/30(44)/2005-EMR-I]; CSIR-Project [IAP-001]	Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR funded Senior Research Fellowship [CSIR-SRF(Ext)]; CSIR funded Junior Research Fellowship through the National Eligibility Test [CSIR-JRF/NET] Fellowship; CSIR-Project(Council of Scientific & Industrial Research (CSIR) - India)	Financial support for this work was provided by grants: [no. 27 (0111)/00/EMR-II] from Council for Scientific and Industrial Research (CSIR), Government of India and [SR/SO/HS-116/2007(G)] from the Department of Science and Technology (DST), Government of India to Dr. Panda, CSIR funded Senior Research Fellowship [CSIR-SRF(Ext)] grant no:[09/030(0064)/2011EMR-I] to Ms Sraboni Mitra, CSIR funded Junior Research Fellowship selected through the National Eligibility Test [CSIR-JRF/NET] Fellowship grant no: [9/30(44)/2005-EMR-I] to Ms. Mazumder-Indra and CSIR-Project (IAP-001) to Dr. Roychoudhury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2000, BRIT J CANCER, V83, P1659, DOI 10.1054/bjoc.2000.1509; Angeloni D, 2006, GENE CHROMOSOME CANC, V45, P676, DOI 10.1002/gcc.20332; Astuti D, 2004, BRIT J CANCER, V90, P515, DOI 10.1038/sj.bjc.6601447; Atkin NB, 1997, CANCER GENET CYTOGEN, V95, P33, DOI 10.1016/S0165-4608(97)83452-8; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Dasgupta S, 2002, ORAL ONCOL, V38, P6, DOI 10.1016/S1368-8375(00)00131-7; Dickinson RE, 2010, REPRODUCTION, V139, P697, DOI 10.1530/REP-10-0017; Dunwell TL, 2009, EPIGENETICS-US, V4, P265, DOI 10.4161/epi.9137; Ghosh S, 2009, HUM GENET, V125, P189, DOI 10.1007/s00439-008-0610-9; Hampton GM, 1996, P NATL ACAD SCI USA, V93, P6704, DOI 10.1073/pnas.93.13.6704; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Ichimura K, 2000, CANCER RES, V60, P417; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Lazo PA, 1999, BRIT J CANCER, V80, P2008, DOI 10.1038/sj.bjc.6690635; Li LC, 2004, BIOCHEM BIOPH RES CO, V321, P455, DOI 10.1016/j.bbrc.2004.06.164; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loginov V I, 2004, Mol Biol (Mosk), V38, P654; Martinez A, 2000, J CLIN PATHOL-MOL PA, V53, P137, DOI 10.1136/mp.53.3.137; Martinez A, 2001, J CLIN PATHOL-MOL PA, V54, P300, DOI 10.1136/mp.54.5.300; Mitra S, 2010, MOL CARCINOGEN, V49, P935, DOI 10.1002/mc.20671; Murthy N. S., 1999, Indian Journal of Cancer, V36, P154; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Perrone F, 2006, CLIN CANCER RES, V12, P6643, DOI 10.1158/1078-0432.CCR-06-1759; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Sambrook J., 2002, MOL CLONING LAB MANU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen U, 2002, INT J CANCER, V100, P86, DOI 10.1002/ijc.10446; Singh RK, 2007, HUM GENET, V122, P71, DOI 10.1007/s00439-007-0375-6; Singh RK, 2005, J CANCER RES CLIN, V131, P395, DOI 10.1007/s00432-004-0655-7; SLATTERY ML, 1989, AM J EPIDEMIOL, V130, P248, DOI 10.1093/oxfordjournals.aje.a115331; Sundaresan V, 1998, ONCOGENE, V17, P1723, DOI 10.1038/sj.onc.1202103; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Yiin JJ, 2009, NEURO-ONCOLOGY, V11, P779, DOI 10.1215/15228517-2008-017; Yuasa Y, 2005, CARCINOGENESIS, V26, P193, DOI 10.1093/carcin/bgh304; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zheng Dan, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P198; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	45	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38342	10.1371/journal.pone.0038342	http://dx.doi.org/10.1371/journal.pone.0038342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719878	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341900024
J	Motter, AL; Ahern, GP				Motter, Arianne L.; Ahern, Gerard P.			TRPA1 Is a Polyunsaturated Fatty Acid Sensor in Mammals	PLOS ONE			English	Article							ION-CHANNEL TRPA1; IRRITANT RECEPTOR TRPA1; COVALENT MODIFICATION; DIRECT ACTIVATION; CALCIUM-IONS; SECRETION; CELLS; PAIN; INFLAMMATION; NOCICEPTION	Fatty acids can act as important signaling molecules regulating diverse physiological processes. Our understanding, however, of fatty acid signaling mechanisms and receptor targets remains incomplete. Here we show that Transient Receptor Potential Ankyrin 1 (TRPA1), a cation channel expressed in sensory neurons and gut tissues, functions as a sensor of polyunsaturated fatty acids (PUFAs) in vitro and in vivo. PUFAs, containing at least 18 carbon atoms and three unsaturated bonds, activate TRPA1 to excite primary sensory neurons and enteroendocrine cells. Moreover, behavioral aversion to PUFAs is absent in TRPA1-null mice. Further, sustained or repeated agonism with PUFAs leads to TRPA1 desensitization. PUFAs activate TRPA1 non-covalently and independently of known ligand binding domains located in the N-terminus and 5th transmembrane region. PUFA sensitivity is restricted to mammalian (rodent and human) TRPA1 channels, as the drosophila and zebrafish TRPA1 orthologs do not respond to DHA. We propose that PUFA-sensing by mammalian TRPA1 may regulate pain and gastrointestinal functions.	[Motter, Arianne L.; Ahern, Gerard P.] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20057 USA	Georgetown University	Motter, AL (corresponding author), Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20057 USA.	gpa3@georgetown.edu			National Institute of Neurological Disorders and Stroke; American Recovery and Reinvestment Act	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Recovery and Reinvestment Act	This work was supported by grants from National Institute of Neurological Disorders and Stroke and the American Recovery and Reinvestment Act 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Boesmans W, 2011, BRIT J PHARMACOL, V162, P18, DOI 10.1111/j.1476-5381.2010.01009.x; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Cattaruzza F, 2010, AM J PHYSIOL-GASTR L, V298, pG81, DOI 10.1152/ajpgi.00221.2009; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; CLANDININ MT, 1989, ACTA PAEDIATR SCAND, P63; Cordero-Morales JF, 2011, P NATL ACAD SCI US; CRAWFORD MA, 1989, J INTERN MED, V225, P159, DOI 10.1111/j.1365-2796.1989.tb01450.x; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Doihara H, 2009, N-S ARCH PHARMACOL, V380, P353, DOI 10.1007/s00210-009-0435-7; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; GONZALEZ MJ, 1992, J NUTR, V122, P2190, DOI 10.1093/jn/122.11.2190; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kondo T, 2009, GUT, V58, P1342, DOI 10.1136/gut.2008.175901; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; Lindquist S, 2010, CURR OPIN CLIN NUTR, V13, P314, DOI 10.1097/MCO.0b013e328337bbf0; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Poole DP, 2011, GASTROENTEROLOGY; Purhonen AK, 2008, FEBS LETT, V582, P229, DOI 10.1016/j.febslet.2007.12.005; Refsgaard HHF, 2000, J AGR FOOD CHEM, V48, P3280, DOI 10.1021/jf000021c; Sculptoreanu A, 2010, J PHARMACOL EXP THER, V333, P883, DOI 10.1124/jpet.109.163154; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; Spiller RC, 2001, CURR OPIN GASTROEN, V17, P99, DOI 10.1097/00001574-200103000-00001; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	58	51	53	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38439	10.1371/journal.pone.0038439	http://dx.doi.org/10.1371/journal.pone.0038439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723860	gold, Green Submitted, Green Published			2022-12-27	WOS:000305652700016
J	dos Santos, VA; Chatkin, JM; Bau, CHD; Paixao-Cortes, VR; Sun, Y; Zamel, N; Siminovitch, K				dos Santos, Vanessa Argondizo; Chatkin, Jose Miguel; Dotto Bau, Claiton Henrique; Paixao-Cortes, Vanessa Rodrigues; Sun, Ye; Zamel, Noe; Siminovitch, Katherine			Glutamate and Synaptic Plasticity Systems and Smoking Behavior: Results from a Genetic Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LOCI; TRANSMISSION; METAANALYSIS; POPULATIONS; INITIATION; ADDICTION; RECEPTORS; CESSATION	Smoking behavior is a multifactorial phenotype with significant heritability. Identifying the specific loci that influence smoking behavior could provide important etiological insights and facilitate the development of treatments to further reduce smoking related mortality. Although several studies pointed to different candidate genes for smoking, there is still a need for replication especially in samples from different countries. In the present study, we investigated whether 21 positive signals for smoking behavior from these studies are replicated in a sample of 531 blood donors from the Brazilian population. The polymorphisms were chosen based on their representativeness of different candidate biologic systems, strength of previous evidence, location and allele frequencies. By genotyping with the Sequenom MassARRAY iPLEX platform and subsequent statistical analysis using Plink software, we show that two of the SNPs studied, in the SLC1A2 (rs1083658) and ACTN1 (rs2268983) genes, were associated with smoking behavior in our study population. These genes are involved in crucial aspects of nicotine dependence, glutamate system and synaptic plasticity, and as such, are biologically plausible candidates that merit further molecular analyses so as to clarify their potential role in smoking behavior.	[dos Santos, Vanessa Argondizo; Chatkin, Jose Miguel] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil; [Dotto Bau, Claiton Henrique; Paixao-Cortes, Vanessa Rodrigues] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Sun, Ye; Zamel, Noe; Siminovitch, Katherine] Univ Toronto, Dept Med, Toronto, ON, Canada; [Sun, Ye; Siminovitch, Katherine] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Sun, Ye; Siminovitch, Katherine] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Sun, Ye; Siminovitch, Katherine] Samuel Lunenfeld & Toronto Gen Hosp Res Inst, Toronto, ON, Canada	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	dos Santos, VA (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.	jmchatkin@pucrs.br	Paixão-Côrtes, Vanessa R/H-3564-2011; Chatkin, Jose M/Q-3925-2016; Sun, Ye/B-9814-2017; Siminovitch, Katherine/K-1475-2013; Bau, Claiton Henrique Dotto/C-9980-2013	Paixão-Côrtes, Vanessa R/0000-0003-2677-0903; Chatkin, Jose M/0000-0002-4343-025X; Bau, Claiton Henrique Dotto/0000-0001-5644-3845	Ontario Research Excellence Fund [ORF RE-01-061]; Canada Research Chair; Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Fundacao de Auxilio a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Ontario Research Excellence Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Auxilio a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Programa de Apoio a Nucleos de Excelencia (PRONEX)	This study was supported by an Ontario Research Excellence Fund grant (ORF RE-01-061) to KAS. KAS holds the Sherman Family Chair in Genomic Medicine and is also supported by a Canada Research Chair. The Brazilian authors (VAS, JMC, CHDB) received funding from the agencies Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Fundacao de Auxilio a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Programa de Apoio a Nucleos de Excelencia (PRONEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2010, NAT GENET, V42, P366, DOI 10.1038/ng0510-366; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Beuten J, 2006, NEUROPSYCHOPHARMACOL, V31, P675, DOI 10.1038/sj.npp.1300997; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P342; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Flatscher-Bader T, 2008, HUM MOL GENET, V17, P38, DOI 10.1093/hmg/ddm283; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; Jackson A, 2009, NEUROPSYCHOPHARMACOL, V34, P257, DOI 10.1038/npp.2008.50; Lang UE, 2007, PSYCHOPHARMACOLOGY, V190, P433, DOI 10.1007/s00213-006-0647-1; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Liechti ME, 2008, CNS DRUGS, V22, P705, DOI 10.2165/00023210-200822090-00001; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu QR, 2005, P NATL ACAD SCI USA, V102, P11864, DOI 10.1073/pnas.0500329102; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; Nesic J, 2011, PSYCHOPHARMACOLOGY, V216, P29, DOI 10.1007/s00213-011-2189-4; Novak G, 2010, ANN HUM GENET, V74, P291, DOI 10.1111/j.1469-1809.2010.00578.x; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Takahashi M, 1997, J EXP BIOL, V200, P401; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Vink JM, 2004, PHARMACOGENOMICS J, V4, P274, DOI 10.1038/sj.tpj.6500255; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Wipfli H, 2009, CLIN PHARMACOL THER, V86, P263, DOI 10.1038/clpt.2009.93	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38666	10.1371/journal.pone.0038666	http://dx.doi.org/10.1371/journal.pone.0038666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719919	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300040
J	Ma, YJ; Liu, DX				Ma, Yongjie; Liu, Dexi			Activation of Pregnane X Receptor by Pregnenolone 16 alpha-carbonitrile Prevents High-Fat Diet-Induced Obesity in AKR/J Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; NUCLEAR RECEPTOR; INSULIN-RESISTANCE; MOUSE STRAINS; PPAR-GAMMA; CROSS-TALK; METABOLISM; PXR; EXPRESSION; GENE	Pregnane X receptor (PXR) is known to function as a xenobiotic sensor to regulate xenobiotic metabolism through selective transcription of genes responsible for maintaining physiological homeostasis. Here we report that the activation of PXR by pregnenolone 16 alpha-carbonitrile (PCN) in AKR/J mice can prevent the development of high-fat diet-induced obesity and insulin resistance. The beneficial effects of PCN treatment are seen with reduced lipogenesis and gluconeogenesis in the liver, and lack of hepatic accumulation of lipid and lipid storage in the adipose tissues. RT-PCR analysis of genes involved in gluconeogenesis, lipid metabolism and energy homeostasis reveal that PCN treatment on high-fat diet-fed mice reduces expression in the liver of G6Pase, Pepck, Cyp7a1, Cd36, L-Fabp, Srebp, and Fas genes and slightly enhances expression of Cyp27a1 and Abca1 genes. RT-PCR analysis of genes involved in adipocyte differentiation and lipid metabolism in white adipose tissue show that PCN treatment reduces expression of Ppar gamma 2, Acc1, Cd36, but increases expression of Cpt1b and Ppar alpha genes in mice fed with high-fat diet. Similarly, PCN treatment of animals on high-fat diet increases expression in brown adipose tissue of Ppar alpha, Hsl, Cpt1b, and Cd36 genes, but reduces expression of Acc1 and Scd-1 genes. PXR activation by PCN in high-fat diet fed mice also increases expression of genes involved in thermogenesis in brown adipose tissue including Dio2, Pgc-1 alpha, Pgc-1 beta, Cidea, and Ucp-3. These results verify the important function of PXR in lipid and energy metabolism and suggest that PXR represents a novel therapeutic target for prevention and treatment of obesity and insulin resistance.	[Ma, Yongjie; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Ma, YJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	dliu@uga.edu	MA, YONGJIE/O-3861-2015		NIH [RO1EB007357, RO1HL098295]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work is supported in part by NIH Grants (RO1EB007357, RO1HL098295]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; EIRIS JM, 1995, NEUROLOGY, V45, P1155, DOI 10.1212/WNL.45.6.1155; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; He JH, 2011, GASTROENTEROLOGY, V140, P2095, DOI 10.1053/j.gastro.2011.02.055; HIMMSHAGEN J, 1985, ANNU REV NUTR, V5, P69, DOI 10.1146/annurev.nu.05.070185.000441; Hossain P, 2007, NEW ENGL J MED, V356, P973; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; KHOGALI AM, 1974, TUBERCLE, V55, P231, DOI 10.1016/0041-3879(74)90050-6; Kim Y, 2010, BIOTECHNOL J, V5, P99, DOI 10.1002/biot.200900228; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Li TG, 2005, AM J PHYSIOL-GASTR L, V288, pG74, DOI 10.1152/ajpgi.00258.2004; Montminy M, 2004, NATURE, V432, P958, DOI 10.1038/432958a; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	39	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38734	10.1371/journal.pone.0038734	http://dx.doi.org/10.1371/journal.pone.0038734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723881	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300045
J	Roland, MCP; Friis, CM; Voldner, N; Godang, K; Bollerslev, J; Haugen, G; Henriksen, T				Roland, Marie Cecilie Paasche; Friis, Camilla M.; Voldner, Nanna; Godang, Kristin; Bollerslev, Jens; Haugen, Guttorm; Henriksen, Tore			Fetal Growth versus Birthweight: The Role of Placenta versus Other Determinants	PLOS ONE			English	Article							MACROSOMIA; OVERWEIGHT; NUTRITION; COHORT; SIZE; RISK	Introduction: Birthweight is used as an indicator of intrauterine growth, and determinants of birthweight are widely studied. Less is known about determinants of deviating patterns of growth in utero. We aimed to study the effects of maternal characteristics on both birthweight and fetal growth in third trimester and introduce placental weight as a possible determinant of both birthweight and fetal growth in third trimester. Methods: The STORK study is a prospective cohort study including 1031 healthy pregnant women of Scandinavian heritage with singleton pregnancies. Maternal determinants (age, parity, body mass index (BMI), gestational weight gain and fasting plasma glucose) of birthweight and fetal growth estimated by biometric ultrasound measures were explored by linear regression models. Two models were fitted, one with only maternal characteristics and one which included placental weight. Results: Placental weight was a significant determinant of birthweight. Parity, BMI, weight gain and fasting glucose remained significant when adjusted for placental weight. Introducing placental weight as a covariate reduced the effect estimate of the other variables in the model by 62% for BMI, 40% for weight gain, 33% for glucose and 22% for parity. Determinants of fetal growth were parity, BMI and weight gain, but not fasting glucose. Placental weight was significant as an independent variable. Parity, BMI and weight gain remained significant when adjusted for placental weight. Introducing placental weight reduced the effect of BMI on fetal growth by 23%, weight gain by 14% and parity by 17%. Conclusion: In conclusion, we find that placental weight is an important determinant of both birthweight and fetal growth. Our findings indicate that placental weight markedly modifies the effect of maternal determinants of both birthweight and fetal growth. The differential effect of third trimester glucose on birthweight and growth parameters illustrates that birthweight and fetal growth are not identical entities.	[Roland, Marie Cecilie Paasche; Friis, Camilla M.; Voldner, Nanna; Haugen, Guttorm; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Dept Specialized Endocrinol, Oslo, Norway; [Bollerslev, Jens; Haugen, Guttorm; Henriksen, Tore] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Roland, MCP (corresponding author), Oslo Univ Hosp, Dept Obstet, Oslo, Norway.	mcpaasche@hotmail.com			University of Oslo; Thematic research: Perinatal nutrition; Oslo University Hospital, Department of Obstetrics; Norwegian Health Association; Norwegian Extrafoundation for Health and Rehabilitation	University of Oslo; Thematic research: Perinatal nutrition; Oslo University Hospital, Department of Obstetrics; Norwegian Health Association; Norwegian Extrafoundation for Health and Rehabilitation	This project has been financially supported by: University of Oslo; Thematic research: Perinatal nutrition. Oslo University Hospital, Department of Obstetrics. The Norwegian Health Association. The Norwegian Extrafoundation for Health and Rehabilitation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Baptiste-Roberts Kesha, 2008, BMC Pregnancy Childbirth, V8, P44, DOI 10.1186/1471-2393-8-44; Barker DJP, 1997, CLIN OBSTET GYNECOL, V40, P853, DOI 10.1097/00003081-199712000-00019; Baumann MU, 2002, ENDOCRINE, V19, P13, DOI 10.1385/ENDO:19:1:13; Cetin I, 2005, ACTA PAEDIATR, V94, P7, DOI 10.1080/08035320510043709; COMBS CA, 1993, OBSTET GYNECOL, V82, P365; Dietz PM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.051; Dietz PM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.045; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Friis CM, 2010, J DEV ORIG HLTH DIS, V1, P310, DOI 10.1017/S204017441000036X; Froslie KF, 2011, CLIN BIOCHEM, V44, P1483, DOI 10.1016/j.clinbiochem.2011.08.1150; GARROW JS, 1971, J OBSTET GYN BR COMM, V78, P22; Hafner E, 2000, ULTRASOUND OBST GYN, V16, P625, DOI 10.1046/j.1469-0705.2000.00290.x; Haggarty P, 2010, ANNU REV NUTR, V30, P237, DOI 10.1146/annurev.nutr.012809.104742; Jansson T, 2001, PEDIATR RES, V49, P141, DOI 10.1203/00006450-200102000-00003; Johnsen SL, 2006, ACTA OBSTET GYN SCAN, V85, P286, DOI 10.1080/00016340600569133; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Leary SD, 2003, PLACENTA, V24, P276, DOI 10.1053/plac.2002.0888; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; MOLTENI RA, 1984, SEMIN PERINATOL, V8, P94; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; PEDERSEN J, 1952, Nord Med, V47, P1049; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Schaefer-Graf UM, 2003, DIABETES CARE, V26, P193, DOI 10.2337/diacare.26.1.193; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stettler N, 2000, AM J CLIN NUTR, V72, P378; Thame M, 2004, EUR J CLIN NUTR, V58, P894, DOI 10.1038/sj.ejcn.1601909; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Voldner N, 2010, J MATERN-FETAL NEO M, V23, P74, DOI 10.3109/14767050903121472; Voldner N, 2009, ACTA OBSTET GYN SCAN, V88, P550, DOI 10.1080/00016340902818162; 2010, BJOG INT J OBSTET GY, V117, P575	34	102	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39324	10.1371/journal.pone.0039324	http://dx.doi.org/10.1371/journal.pone.0039324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723995	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300132
J	Roy, A; Ghosh, A; Jana, A; Liu, XJ; Brahmachari, S; Gendelman, HE; Pahan, K				Roy, Avik; Ghosh, Anamitra; Jana, Arundhati; Liu, Xiaojuan; Brahmachari, Saurav; Gendelman, Howard E.; Pahan, Kalipada			Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HISTONE DEACETYLASE INHIBITORS; NF-KAPPA-B; PRIMARY ASTROCYTES; NADPH OXIDASE; UP-REGULATION; NEUTRAL SPHINGOMYELINASE; OXIDATIVE STRESS; ACTIVATION; INDUCTION	Neuroinflammation and oxidative stress underlie the pathogenesis of various neurodegenerative disorders. Here we demonstrate that sodium phenylbutyrate (NaPB), an FDA-approved therapy for reducing plasma ammonia and glutamine in urea cycle disorders, can suppress both proinflammatory molecules and reactive oxygen species (ROS) in activated glial cells. Interestingly, NaPB also decreased the level of cholesterol but involved only intermediates, not the end product of cholesterol biosynthesis pathway for these functions. While inhibitors of both geranylgeranyl transferase (GGTI) and farnesyl transferase (FTI) inhibited the activation of NF-kappa B, inhibitor of GGTI, but not FTI, suppressed the production of ROS. Accordingly, a dominant-negative mutant of p21(rac), but not p21(ras), attenuated the production of ROS from activated microglia. Inhibition of both p21(ras) and p21(rac) activation by NaPB in microglial cells suggests that NaPB exerts anti-inflammatory and antioxidative effects via inhibition of these small G proteins. Consistently, we found activation of both p21(ras) and p21(rac) in vivo in the substantia nigra of acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Oral administration of NaPB reduced nigral activation of p21(ras) and p21(rac), protected nigral reduced glutathione, attenuated nigral activation of NF-kappa B, inhibited nigral expression of proinflammatory molecules, and suppressed nigral activation of glial cells. These findings paralleled dopaminergic neuronal protection, normalized striatal neurotransmitters, and improved motor functions in MPTP-intoxicated mice. Consistently, FTI and GGTI also protected nigrostriata in MPTP-intoxicated mice. Furthermore, NaPB also halted the disease progression in a chronic MPTP mouse model. These results identify novel mode of action of NaPB and suggest that NaPB may be of therapeutic benefit for neurodegenerative disorders.	[Roy, Avik; Ghosh, Anamitra; Jana, Arundhati; Brahmachari, Saurav; Pahan, Kalipada] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Liu, Xiaojuan; Pahan, Kalipada] Univ Nebraska, Med Ctr, Coll Dent, Sect Neurosci, Lincoln, NE 68583 USA; [Gendelman, Howard E.] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Rush University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Roy, A (corresponding author), Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu	Ghosh, Anamitra/C-5118-2015; Gendelman, Howard E/G-8242-2012	Ghosh, Anamitra/0000-0001-9740-2070	National Institutes of Health [NS48923, NS64564, NS71479]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064564, R21NS071479, R21NS048923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the National Institutes of Health (NS48923, NS64564 and NS71479). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; GIULIAN D, 1986, J NEUROSCI, V6, P2163; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; Jana A, 2004, J NEUROSCI, V24, P9531, DOI 10.1523/JNEUROSCI.3085-04.2004; Jana M, 2005, FREE RADICAL BIO MED, V38, P655, DOI 10.1016/j.freeradbiomed.2004.11.021; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; Lahaie-Collins V, 2008, OXID MED CELL LONGEV, V1, P54, DOI 10.4161/oxim.1.1.6958; Liu XJ, 2002, J BIOL CHEM, V277, P39312, DOI 10.1074/jbc.M205107200; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; OURESHI GA, 1995, NEUROREPORT, V6, P1642, DOI 10.1097/00001756-199508000-00013; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Pahan K, 2000, J NEUROCHEM, V74, P2288, DOI 10.1046/j.1471-4159.2000.0742288.x; Phuphanich S, 2005, NEURO-ONCOLOGY, V7, P177, DOI 10.1215/S1152851704000183; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saha RN, 2006, NEUROCHEM INT, V49, P154, DOI 10.1016/j.neuint.2006.04.007; THIBAULT A, 1994, CANCER RES, V54, P1690; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje; Zhang X, 2012, MOL NEURODEGENER S1, V7, pS24; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029	50	77	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38113	10.1371/journal.pone.0038113	http://dx.doi.org/10.1371/journal.pone.0038113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723850	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300021
J	Soderberg, CAG; Lambert, W; Kjellstrom, S; Wiegandt, A; Wulff, RP; Mansson, C; Rutsdottir, G; Emanuelsson, C				Soderberg, Christopher A. G.; Lambert, Wietske; Kjellstrom, Sven; Wiegandt, Alena; Wulff, Ragna Peterson; Mansson, Cecilia; Rutsdottir, Gudrun; Emanuelsson, Cecilia			Detection of Crosslinks within and between Proteins by LC-MALDI-TOFTOF and the Software FINDX to Reduce the MSMS-Data to Acquire for Validation	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MASS-SPECTROMETRY; PEPTIDES; IDENTIFICATION; COMPLEXES; MODEL; TOOL	Lysine-specific chemical crosslinking in combination with mass spectrometry is emerging as a tool for the structural characterization of protein complexes and protein-protein interactions. After tryptic digestion of crosslinked proteins there are thousands of peptides amenable to MSMS, of which only very few are crosslinked peptides of interest. Here we describe how the advantage offered by off-line LC-MALDI-TOF/TOF mass spectrometry is exploited in a two-step workflow to focus the MSMS-acquisition on crosslinks mainly. In a first step, MS-data are acquired and all the peak list files from the LC-separated fractions are merged by the FINDX software and screened for presence of crosslinks which are recognized as isotope-labeled doublet peaks. Information on the isotope doublet peak mass and intensity can be used as search constraints to reduce the number of false positives that match randomly to the observed peak masses. Based on the MS-data a precursor ion inclusion list is generated and used in a second step, where a restricted number of MSMS-spectra are acquired for crosslink validation. The decoupling of MS and MSMS and the peptide sorting with FINDX based on MS-data has the advantage that MSMS can be restricted to and focused on crosslinks of Type 2, which are of highest biological interest but often lowest in abundance. The LC-MALDI-TOF/TOF workflow here described is applicable to protein multisubunit complexes and using N-14/N-15 mixed isotope strategy for the detection of inter-protein crosslinks within protein oligomers.	[Soderberg, Christopher A. G.; Lambert, Wietske; Kjellstrom, Sven; Wiegandt, Alena; Wulff, Ragna Peterson; Mansson, Cecilia; Rutsdottir, Gudrun; Emanuelsson, Cecilia] Lund Univ, Inst Chem & Chem Engn, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden	Lund University	Soderberg, CAG (corresponding author), Lund Univ, Inst Chem & Chem Engn, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	Cecilia.Emanuelsson@biochemistry.lu.se	Söderberg, Christopher/E-1819-2013	Kjellstrom, Sven/0000-0003-4646-5279	Carl Tryggers Foundation [CTS 09:96]	Carl Tryggers Foundation	Funding for the study was provided by the Carl Tryggers Foundation (CTS 09:96). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrman E, 2007, PROTEIN SCI, V16, P1464, DOI 10.1110/ps.072831607; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Lambert W, 2011, PROTEIN SCI, V20, P291, DOI 10.1002/pro.560; Lambert W, 2011, PROTEIN SCI, V20, P1682, DOI 10.1002/pro.699; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Mayne SLN, 2011, BRIEF BIOINFORM, V12, P660, DOI 10.1093/bib/bbq087; Muller DR, 2001, ANAL CHEM, V73, P1927, DOI 10.1021/ac001379a; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Painter AJ, 2008, CHEM BIOL, V15, P246, DOI 10.1016/j.chembiol.2008.01.009; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Petrotchenko EV, 2010, MASS SPECTROM REV, V29, P862, DOI 10.1002/mas.20293; Rasmussen MI, 2011, J PROTEOMICS, V74, P1871, DOI 10.1016/j.jprot.2011.04.019; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Singh P, 2010, ANAL CHEM, V82, P2636, DOI 10.1021/ac1000724; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Stengel F, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.R111.014027; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Taverner T, 2002, J BIOL CHEM, V277, P46487, DOI 10.1074/jbc.M207370200; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Zhang RJ, 2001, ANAL CHEM, V73, P5142, DOI 10.1021/ac010583a	27	19	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38927	10.1371/journal.pone.0038927	http://dx.doi.org/10.1371/journal.pone.0038927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723907	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300067
J	Vindras, P; Desmurget, M; Baraduc, P				Vindras, Philippe; Desmurget, Michel; Baraduc, Pierre			When One Size Does Not Fit All: A Simple Statistical Method to Deal with Across-Individual Variations of Effects	PLOS ONE			English	Article							CONJUNCTION; PERFORMANCE; BIOLOGY; POINTS; VALUES; SAMPLE; FMRI	In science, it is a common experience to discover that although the investigated effect is very clear in some individuals, statistical tests are not significant because the effect is null or even opposite in other individuals. Indeed, t-tests, Anovas and linear regressions compare the average effect with respect to its inter-individual variability, so that they can fail to evidence a factor that has a high effect in many individuals (with respect to the intra-individual variability). In such paradoxical situations, statistical tools are at odds with the researcher's aim to uncover any factor that affects individual behavior, and not only those with stereotypical effects. In order to go beyond the reductive and sometimes illusory description of the average behavior, we propose a simple statistical method: applying a Kolmogorov-Smirnov test to assess whether the distribution of p-values provided by individual tests is significantly biased towards zero. Using Monte-Carlo studies, we assess the power of this two-step procedure with respect to RM Anova and multilevel mixed-effect analyses, and probe its robustness when individual data violate the assumption of normality and homoscedasticity. We find that the method is powerful and robust even with small sample sizes for which multilevel methods reach their limits. In contrast to existing methods for combining p-values, the Kolmogorov-Smirnov test has unique resistance to outlier individuals: it cannot yield significance based on a high effect in one or two exceptional individuals, which allows drawing valid population inferences. The simplicity and ease of use of our method facilitates the identification of factors that would otherwise be overlooked because they affect individual behavior in significant but variable ways, and its power and reliability with small sample sizes (<30-50 individuals) suggest it as a tool of choice in exploratory studies.	[Vindras, Philippe; Desmurget, Michel; Baraduc, Pierre] CNRS, UMR 5229, Cognit Neurosci Ctr, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Vindras, P (corresponding author), CNRS, UMR 5229, Cognit Neurosci Ctr, Bron, France.	philippe.vindras@isc.cnrs.fr	Desmurget, Michel/L-2401-2017		ANR [ANR05-JCJC013]; CNRS	ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This research was funded by the ANR (grant ANR05-JCJC013) and the CNRS (PEPII 2011 grant) to P.B The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Benjamini Y, 2008, BIOMETRICS, V64, P1215, DOI 10.1111/j.1541-0420.2007.00984.x; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Browne WJ, 2006, BAYESIAN ANAL, V1, P473, DOI 10.1214/06-BA117; Browne WJ, 2000, COMPUTATION STAT, V15, P391, DOI 10.1007/s001800000041; EDGINGTON ES, 1972, J PSYCHOL, V80, P351, DOI 10.1080/00223980.1972.9924813; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Heathcote A, 2002, PSYCHON B REV, V9, P394, DOI 10.3758/BF03196299; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; HOCKLEY WE, 1984, J EXP PSYCHOL LEARN, V10, P598, DOI 10.1037/0278-7393.10.4.598; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; Lazar NA, 2002, NEUROIMAGE, V16, P538, DOI 10.1006/nimg.2002.1107; Loughin TM, 2004, COMPUT STAT DATA AN, V47, P467, DOI 10.1016/j.csda.2003.11.020; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maxwell S. E., 2004, DESIGNING EXPT ANAL; McNamee RL, 2004, NEUROIMAGE, V22, P920, DOI 10.1016/j.neuroimage.2004.02.016; MILLER LH, 1956, J AM STAT ASSOC, V51, P111, DOI 10.2307/2280807; Myerson J, 2007, J EXP ANAL BEHAV, V88, P319, DOI 10.1901/jeab.2007.88-319; Paccagnella O, 2011, METHODOLOGY-EUR, V7, P111, DOI 10.1027/1614-2241/a000029; Pearson K, 1933, BIOMETRIKA, V25, P379, DOI 10.1093/biomet/25.3-4.379; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; SIEGEL S., 1956, NONPARAMETRIC STAT B; Snijders T, 1999, MULTILEVEL ANAL; Stouffer S. A., 1949, AM SOLDIER, V1; Van Zandt T, 2000, PSYCHON B REV, V7, P424, DOI 10.3758/BF03214357; Vindras P, 2005, J NEUROPHYSIOL, V94, P1212, DOI 10.1152/jn.01295.2004; Vogel EK, 2008, CURR DIR PSYCHOL SCI, V17, P171, DOI 10.1111/j.1467-8721.2008.00569.x; Wilcox RR, 1998, AM PSYCHOL, V53, P300, DOI 10.1037/0003-066X.53.3.300; WILKINSON B, 1951, PSYCHOL BULL, V48, P156, DOI 10.1037/h0059111; Wilmer JB, 2008, SPATIAL VISION, V21, P561, DOI 10.1163/156856808786451408; Won SH, 2009, STAT MED, V28, P1537, DOI 10.1002/sim.3569; Worsley KJ, 2000, STAT PROBABIL LETT, V47, P135, DOI 10.1016/S0167-7152(99)00149-2	41	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39059	10.1371/journal.pone.0039059	http://dx.doi.org/10.1371/journal.pone.0039059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723931	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300089
J	Inostroza, M; Cid, E; de la Prida, LM; Sandi, C				Inostroza, Marion; Cid, Elena; Menendez de la Prida, Liset; Sandi, Carmen			Different Emotional Disturbances in Two Experimental Models of Temporal Lobe Epilepsy in Rats	PLOS ONE			English	Article							KAINIC ACID; STATUS EPILEPTICUS; SEIZURES; DEPRESSION; ANXIETY; PILOCARPINE; BEHAVIOR; INJURY; IMPAIRMENT; ACTIVATION	Affective symptoms such as anxiety and depression are frequently observed in patients with epilepsy. The mechanisms of comorbidity of epilepsy and affective disorders, however, remain unclear. Diverse models are traditionally used in epilepsy research, including the status epilepticus (SE) model in rats, which are aimed at generating chronic epileptic animals; however, the implications of different SE models and rat strains in emotional behaviors has not been reported. To address this issue, we examined the emotional sequelae of two SE models of temporal lobe epilepsy (TLE) - the lithium-pilocarpine (LIP) model and the kainic acid (KA) model - in two different rat strains (Wistar and Sprague-Dawley), which differ significantly in the pattern and extent of TLE-associated brain lesions. We found differences between LIP-and KA-treated animals in tests for depression-like and anxiety-like behaviors, as well as differences in plasma corticosterone levels. Whereas only LIP-treated rats displayed increased motivation to consume saccharin, both SE models led to reduced motivation for social contact, with LIP-treated animals being particularly affected. Evaluation of behavior in the open field test indicated very low levels of anxiety in LIP-treated rats and a mild decrease in KA-treated rats compared to controls. After exposure to a battery of behavioral tests, plasma corticosterone levels were increased only in LIP-treated animals. This hyperactivity in the hypothalamus-pituitary-adrenocortical (HPA) axis was highly correlated with performance in the open field test and the social interaction test, suggesting that comorbidity of epilepsy and emotional behaviors might also be related to other factors such as HPA axis function. Our results indicate that altered emotional behaviors are not inherent to the epileptic condition in experimental TLE; instead, they likely reflect alterations in anxiety levels related to model-dependent dysregulation of the HPA axis.	[Inostroza, Marion; Cid, Elena; Menendez de la Prida, Liset] CSIC, Inst Cajal, Madrid, Spain; [Inostroza, Marion] Univ Chile, Dept Psicol, Santiago, Chile; [Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad de Chile; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Inostroza, M (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany.	carmen.sandi@epfl.ch	de la Prida, Liset M/O-1342-2013; Cid, Elena/N-5072-2014; Inostroza, Marion/R-9394-2018	de la Prida, Liset M/0000-0002-0160-6472; Sandi, Carmen/0000-0001-7713-8321; Cid, Elena/0000-0003-4852-595X; Inostroza, Marion/0000-0003-3483-1905	EU [201600]	EU(European Commission)	This work was supported by a FP7 EU grant (MemStick, No 201600; http://cordis.europa.eu/fp7/home_en.html) to CS and LMP. MI was a PhD student fellow from CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica; www.conicyt.cl), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2004, BRAIN RES, V1024, P44, DOI 10.1016/j.brainres.2004.06.074; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; Cardoso A, 2011, BEHAV BRAIN RES, V225, P538, DOI 10.1016/j.bbr.2011.07.057; Cardoso A, 2009, EPILEPSY BEHAV, V14, P293, DOI 10.1016/j.yebeh.2008.11.004; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; DANIELS WMU, 1990, NEUROCHEM RES, V15, P495, DOI 10.1007/BF00966206; Del Rio JA, 2002, PROG BRAIN RES, V135, P149; Detour J, 2005, EPILEPSIA, V46, P499, DOI 10.1111/j.0013-9580.2005.38704.x; dos Santos NF, 2000, BRAIN RES REV, V32, P269, DOI 10.1016/S0165-0173(99)00089-2; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; GALLAGHER BB, 1987, YALE J BIOL MED, V60, P93; Hannesson DK, 2001, J NEUROSCI, V21, P4443, DOI 10.1523/JNEUROSCI.21-12-04443.2001; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hort J, 2000, BEHAV BRAIN RES, V112, P77, DOI 10.1016/S0166-4328(00)00163-7; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Kanner AM, 2007, EPILEPSIA, V48, P20, DOI 10.1111/j.1528-1167.2007.01395.x; Kondziella D, 2007, J NEUROCHEM, V103, P2136, DOI 10.1111/j.1471-4159.2007.04926.x; Kubova H, 2004, EUR J NEUROSCI, V19, P3255, DOI 10.1111/j.0953-816X.2004.03410.x; Lai MC, 2006, EPILEPSY RES, V68, P123, DOI 10.1016/j.eplepsyres.2005.10.005; Landgraf R, 2003, STRESS, V6, P111, DOI 10.1080/1025389031000104193; Loscher W, 1998, EXP NEUROL, V154, P551, DOI 10.1006/exnr.1998.6948; Marin JCM, 2008, EPILEPSY BEHAV, V13, P43, DOI 10.1016/j.yebeh.2008.03.004; Marquez C, 2006, BEHAV BRAIN RES, V168, P13, DOI 10.1016/j.bbr.2005.10.004; Mazarati A, 2008, BRAIN, V131, P2071, DOI 10.1093/brain/awn117; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; MELLANBY J, 1981, J NEUROL NEUROSUR PS, V44, P1084, DOI 10.1136/jnnp.44.12.1084; Motte J, 1998, BRAIN RES, V793, P61, DOI 10.1016/S0006-8993(98)00135-8; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Piazzini A, 2001, EPILEPSY BEHAV, V2, P481, DOI 10.1006/ebeh.2001.0247; Pineda E, 2010, EPILEPSIA, V51, P110, DOI 10.1111/j.1528-1167.2010.02623.x; PUCILOWSKI O, 1993, BRAIN RES BULL, V32, P471, DOI 10.1016/0361-9230(93)90293-K; Racine RJ, 2003, NEUROPHARMACOLOGY, V45, P918, DOI 10.1016/S0028-3908(03)00252-1; Romeas T, 2009, PSYCHOPHARMACOLOGY, V205, P293, DOI 10.1007/s00213-009-1539-y; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Sandi C, 2007, NEURAL PLAST, DOI [10.1155/2077/78970, DOI 10.1155/2077/78970]; Sayin U, 2004, EPILEPSIA, V45, P1539, DOI 10.1111/j.0013-9580.2004.54903.x; Shaw FZ, 2009, NEUROSCIENCE, V160, P382, DOI 10.1016/j.neuroscience.2009.02.053; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; SZAFARCZYK A, 1986, EXP NEUROL, V92, P583, DOI 10.1016/0014-4886(86)90300-6; Tchekalarova J, 2011, EPILEPSY BEHAV, V20, P277, DOI 10.1016/j.yebeh.2010.12.021; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Wintink AJ, 2003, BEHAV NEUROSCI, V117, P632, DOI 10.1037/0735-7044.117.3.632; Xu B, 2004, EUR J NEUROSCI, V20, P403, DOI 10.1111/j.1460-9568.2004.03489.x; Yu S, 2008, J STEROID BIOCHEM, V108, P300, DOI 10.1016/j.jsbmb.2007.09.014; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	51	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38959	10.1371/journal.pone.0038959	http://dx.doi.org/10.1371/journal.pone.0038959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720001	Green Published, gold			2022-12-27	WOS:000305350000031
J	Kim, HS; Woo, JS; Joo, HJ; Moon, WK				Kim, Hoe Suk; Woo, Ji Soo; Joo, Hyun Jung; Moon, Woo Kyung			Cardiac Transcription Factor Nkx2.5 Is Downregulated under Excessive O-GlcNAcylation Condition	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; CELL-DEATH; HEART; PROTEINS; PHOSPHORYLATION; GLYCOSYLATION; CSX/NKX2.5; NUCLEAR; P53	Post-translational modification of proteins with O-linked N-acetylglucosamine (O-GlcNAc) is linked the development of diabetic cardiomyopathy. We investigated whether Nkx2.5 protein, a cardiac transcription factor, is regulated by O-GlcNAc. Recombinant Nkx2.5 (myc-Nkx2.5) proteins were reduced by treatment with the O-GlcNAcase inhibitors STZ and O-(2-acetamido-2-deoxy-D-glucopyroanosylidene)-amino-N-phenylcarbamate; PUGNAC) as well as the overexpression of recombinant O-GlcNAc transferase (OGT-flag). Co-immunoprecipitation analysis revealed that myc-Nkx2.5 and OGT-flag proteins interacted and myc-Nkx2.5 proteins were modified by O-GlcNAc. In addition, Nkx2.5 proteins were reduced in the heart tissue of streptozotocin (STZ)-induced diabetic mice and O-GlcNAc modification of Nkx2.5 protein increased in diabetic heart tissue compared with non-diabetic heart. Thus, excessive O-GlcNAcylation causes downregulation of Nkx2.5, which may be an underlying contributing factor for the development of diabetic cardiomyopathy.	[Kim, Hoe Suk; Woo, Ji Soo; Moon, Woo Kyung] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Kim, Hoe Suk; Woo, Ji Soo; Joo, Hyun Jung; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Joo, Hyun Jung; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, HS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	moonwk@snu.ac.kr	Moon, Woo Kyung/J-2755-2012		National Research Foundation of Korea Grant; Korean Government [KRF-2006-311-C00399]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0003657, 2011-0004322]	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Government(Korean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant funded by the Korean Government (KRF-2006-311-C00399) and supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0003657, 2011-0004322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 1996, GLYCOBIOLOGY, V6, P711, DOI 10.1093/glycob/6.7.711; Hidaka K, 2003, FASEB J, V17, P740, DOI 10.1096/fj.02-0104fje; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Kim HS, 2006, FEBS LETT, V580, P2311, DOI 10.1016/j.febslet.2006.03.043; Kohda Y, 2009, J PHARMACOL SCI, V111, P446, DOI 10.1254/jphs.09236SC; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; LINTS TJ, 1993, DEVELOPMENT, V119, P419; McNulty PH, 2007, AM J PHYSIOL-CELL PH, V292, pC1243, DOI 10.1152/ajpcell.00521.2006; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	23	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38053	10.1371/journal.pone.0038053	http://dx.doi.org/10.1371/journal.pone.0038053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719862	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350000011
J	Liu, Y; Dang, HX; Li, D; Pang, W; Hammock, BD; Zhu, Y				Liu, Yan; Dang, Huaixin; Li, Dan; Pang, Wei; Hammock, Bruce D.; Zhu, Yi			Inhibition of Soluble Epoxide Hydrolase Attenuates High-Fat-Diet-Induced Hepatic Steatosis by Reduced Systemic Inflammatory Status in Mice	PLOS ONE			English	Article							BLOOD-PRESSURE REGULATION; HUMAN CYTOCHROMES P450; ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIVER-DISEASE; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; TNF-ALPHA; IN-VIVO; OBESITY	Non-alcoholic fatty liver disease is associated with obesity and considered an inflammatory disease. Soluble epoxide hydrolase (sEH) is a major enzyme hydrolyzing epoxyeicosatrienoic acids and attenuates their cardiovascular protective and anti-inflammatory effects. We examined whether sEH inhibition can protect against high-fat (HF)-diet-induced fatty liver in mice and the underlying mechanism. Compared with wild-type littermates, sEH-null mice showed lower diet-induced lipid accumulation in liver, as seen by Oil-red O staining and triglycerides levels. We studied the effect of sEH inhibition on diet-induced fatty liver by feeding C57BL/6 mice an HF diet for 8 weeks (short-term) or 16 weeks (long-term) and administering t-AUCB, a selective sEH inhibitor. sEH inhibition had no effect on the HF-diet-increased body and adipose tissue weight or impaired glucose tolerance but alleviated the diet-induced hepatic steatosis. Adenovirus-mediated overexpression of sEH in liver increased the level of triglycerides in liver and the hepatic inflammatory response. Surprisingly, the induced expression of sEH in liver occurred only with the long-term but not short-term HF diet, which suggests a secondary effect of HF diet on regulating sEH expression. Furthermore, sEH inhibition attenuated the HF-diet-induced increase in plasma levels of proinflammatory cytokines and their mRNA upregulation in adipose tissue, which was accompanied by increased macrophage infiltration. Therefore, sEH inhibition could alleviate HF-diet-induced hepatic steatosis, which might involve its anti-inflammatory effect in adipose tissue and direct inhibition in liver. sEH may be a therapeutic target for HF-diet-induced hepatic steatosis in inhibiting systemic inflammation.	[Liu, Yan; Dang, Huaixin; Li, Dan; Pang, Wei; Zhu, Yi] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Educ Minist, Beijing 100871, Peoples R China; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA	Peking University; University of California System; University of California Davis; University of California System; University of California Davis	Liu, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Educ Minist, Beijing 100871, Peoples R China.	zhuyi@hsc.pku.edu.cn	Li, Dan/B-6565-2018		Major National Basic Research Grant of China [2010BC912504]; National Natural Science Foundation of China [81130002, 30971063, 81121061]; "111" plan of China	Major National Basic Research Grant of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" plan of China(Ministry of Education, China - 111 Project)	This work was supported in part by grants from the Major National Basic Research Grant of China [No. 2010BC912504], and the National Natural Science Foundation of China [81130002, 30971063, 81121061], the "111" plan of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; Ai D, 2009, P NATL ACAD SCI USA, V106, P564, DOI 10.1073/pnas.0811022106; Busch L, 2009, INFLAMM RES, V58, P423, DOI 10.1007/s00011-009-0008-8; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P967, DOI 10.1111/j.1440-1746.2007.04995.x; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; De Taeye BM, 2009, OBESITY SILVER SPRIN, V18, P489; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Endo M, 2007, EXP BIOL MED, V232, P614; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Fishbein MH, 2006, J PEDIATR GASTR NUTR, V42, P83; Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Iyer A, 2012, EXP DIABETES RES, DOI 10.1155/2012/758614; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Liu JY, 2009, BRIT J PHARMACOL, V156, P284, DOI 10.1111/j.1476-5381.2008.00009.x; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Pantanetti P, 2004, CLIN EXP HYPERTENS, V26, P387, DOI 10.1081/CEH-120034142; Sato K, 2004, J HUM GENET, V49, P29, DOI 10.1007/s10038-003-0103-6; Scarborough PE, 1999, DRUG METAB REV, V31, P205, DOI 10.1081/DMR-100101915; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf NM, 2006, ANAL BIOCHEM, V355, P71, DOI 10.1016/j.ab.2006.04.045; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Zhang LN, 2009, ARTERIOSCL THROM VAS, V29, P1265, DOI 10.1161/ATVBAHA.109.186064	41	85	89	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39165	10.1371/journal.pone.0039165	http://dx.doi.org/10.1371/journal.pone.0039165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720061	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800049
J	Yen, ML; Hsu, PN; Liao, HJ; Lee, BH; Tsai, HF				Yen, Men-Luh; Hsu, Ping-Ning; Liao, Hsiu-Jung; Lee, Be-Hang; Tsai, Hwei-Fang			TRAF-6 Dependent Signaling Pathway Is Essential for TNF-Related Apoptosis-Inducing Ligand (TRAIL) Induces Osteoclast Differentiation	PLOS ONE			English	Article							LYMPH-NODE ORGANOGENESIS; ACTIVATED PROTEIN-KINASE; LINEAGE PRECURSOR CELLS; NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; RANKL; RECEPTOR; BONE; AXIS; OSTEOPROTEGERIN	Human osteoclast formation from mononuclear phagocyte precursors involves interactions between tumor necrosis factor (TNF) ligand superfamily members and their receptors. Recent evidence indicates that in addition to triggering apoptosis, the TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation. To understand TRAIL-mediated signal transduction mechanism in osteoclastogenesis, we demonstrated that TRAIL induces osteoclast differentiation via a Tumor necrosis factor receptor-associated factor 6 (TRAF-6)-dependent signaling pathway. TRAIL-induced osteoclast differentiation was significantly inhibited by treatment with TRAF-6 siRNA and TRAF6 decoy peptides in both human monocytes and murine RAW264.7 macrophage cell lines, as evaluated in terms of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells and bone resorption activity. Moreover, TRAIL-induced osteoclast differentiation was also abolished in TRAF6 knockout bone marrow macrophages. In addition to induction of NFATc1, treatment of TRAIL also induced ubiquitination of TRAF6 in osteoclast differentiation. Thus, our data demonstrate that TRAIL induces osteoclastic differentiation via a TRAF-6 dependent signaling pathway. This study suggests TRAF6-dependent signaling may be a central pathway in osteoclast differentiation, and that TNF superfamily molecules other than RANKL may modify RANK signaling by interaction with TRAF6-associated signaling.	[Yen, Men-Luh] Natl Taiwan Univ, Coll Med, Dept Gen Med, Taipei 10764, Taiwan; [Yen, Men-Luh] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Hsu, Ping-Ning; Liao, Hsiu-Jung; Lee, Be-Hang] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Hsu, Ping-Ning] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Taipei, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Yen, ML (corresponding author), Natl Taiwan Univ, Coll Med, Dept Gen Med, Taipei 10764, Taiwan.	hftsai8635@yahoo.com.tw		HSU, PING-NING/0000-0003-4479-3391; YEN, MEN-LUH/0000-0003-3800-3664	National Science Council, Taiwan [NSC096-2811-B-002-043, NSC98-3112-B-002-047, NSC98-2320-B-002-049-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC096-2811-B-002-043, NSC98-3112-B-002-047, and NSC98-2320-B-002-049-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cheng X, 2003, IMMUNOL RES, V27, P287, DOI 10.1385/IR:27:2-3:287; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Walsh MC, 2003, CYTOKINE GROWTH F R, V14, P251, DOI 10.1016/S1359-6101(03)00027-3; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yang CR, 2004, CELL DEATH DIFFER, V11, pS97, DOI 10.1038/sj.cdd.4401403; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yen ML, 2008, MOL IMMUNOL, V45, P2205, DOI 10.1016/j.molimm.2007.12.003	36	39	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38048	10.1371/journal.pone.0038048	http://dx.doi.org/10.1371/journal.pone.0038048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719861	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347800004
J	Dammanahalli, KJ; Stevens, S; Terkeltaub, R				Dammanahalli, K. Jagadeesha; Stevens, Stephanie; Terkeltaub, Robert			Vanin-1 Pantetheinase Drives Smooth Muscle Cell Activation in Post-Arterial Injury Neointimal Hyperplasia	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASES; GROWTH-FACTOR; PPAR-GAMMA; TRANSCRIPTION FACTOR; NAD(P)H OXIDASE; MMP-9 ACTIVITY; IN-VITRO; EXPRESSION; RECEPTOR	The pantetheinase vanin-1 generates cysteamine, which inhibits reduced glutathione (GSH) synthesis. Vanin-1 promotes inflammation and tissue injury partly by inducing oxidative stress, and partly by peroxisome proliferator-activated receptor gamma (PPAR gamma) expression. Vascular smooth muscle cells (SMCs) contribute to neointimal hyperplasia in response to injury, by multiple mechanisms including modulation of oxidative stress and PPAR gamma. Therefore, we tested the hypothesis that vanin-1 drives SMC activation and neointimal hyperplasia. We studied reactive oxygen species (ROS) generation and functional responses to platelet-derived growth factor (PDGF) and the pro-oxidant diamide in cultured mouse aortic SMCs, and also assessed neointima formation after carotid artery ligation in vanin-1 deficiency. Vnn1(-/-) SMCs demonstrated decreased oxidative stress, proliferation, migration, and matrix metalloproteinase 9 (MMP-9) activity in response to PDGF and/or diamide, with the effects on proliferation linked, in these studies, to both increased GSH levels and PPAR gamma expression. Vnn1(-/-) mice displayed markedly decreased neointima formation in response to carotid artery ligation, including decreased intima: media ratio and cross-sectional area of the neointima. We conclude that vanin-1, via dual modulation of GSH and PPAR gamma, critically regulates the activation of cultured SMCs and development of neointimal hyperplasia in response to carotid artery ligation. Vanin-1 is a novel potential therapeutic target for neointimal hyperplasia following revascularization.	[Dammanahalli, K. Jagadeesha] Univ Calif San Diego, San Diego VA Healthcare Syst, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Dammanahalli, KJ (corresponding author), Univ Calif San Diego, San Diego VA Healthcare Syst, San Diego, CA 92103 USA.	rterkeltaub@ucsd.edu			Veterans Affairs Research Service; NIH [HL077360, HL087252]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077360, R01HL087252] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Veterans Affairs Research Service and NIH (HL077360, HL087252) awards to Robert Terkeltaub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Berry C, 2001, CURR OPIN NEPHROL HY, V10, P247, DOI 10.1097/00041552-200103000-00014; Bhanoori M, 2003, ONCOGENE, V22, P117, DOI 10.1038/sj.onc.1206065; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Bruemmer D, 2003, AM J MED, V115, P87, DOI 10.1016/j.amjmed.2003.09.014; Chinetti G, 2001, Z Kardiol, V90 Suppl 3, P125; Ciudin A, 2012, CURR TOP MED CHEM, V12, P585, DOI 10.2174/156802612799436632; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; Doenhoff MJ, 2002, PARASITOLOGY, V125, P415, DOI 10.1017/S0031182002002275; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Feng WG, 2010, HYPERTENSION, V55, P1381, DOI 10.1161/HYPERTENSIONAHA.110.150995; Ferguson HE, 2006, AM J PHYSIOL-LUNG C, V291, pL19; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Garat CV, 2006, MOL CELL BIOL, V26, P4934, DOI 10.1128/MCB.02477-05; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; Goetze S, 2001, J CARDIOVASC PHARM, V38, P909, DOI 10.1097/00005344-200112000-00013; Gong KW, 1996, J VASC RES, V33, P42, DOI 10.1159/000159130; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gurjar MV, 1999, ARTERIOSCL THROM VAS, V19, P2871, DOI 10.1161/01.ATV.19.12.2871; Hattori Y, 2000, BIOCHEM BIOPH RES CO, V273, P1144, DOI 10.1006/bbrc.2000.3084; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hsueh WA, 2001, DIABETES CARE, V24, P392, DOI 10.2337/diacare.24.2.392; HultgardhNilsson A, 1996, CIRC RES, V78, P589, DOI 10.1161/01.RES.78.4.589; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Johnson KA, 2008, AM J PATHOL, V172, P440, DOI 10.2353/ajpath.2008.070753; Kaskow BJ, 2012, BIOCHEM BIOPH RES CO, V417, P653, DOI 10.1016/j.bbrc.2011.11.099; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Martin F, 2001, IMMUNOGENETICS, V53, P296, DOI 10.1007/s002510100327; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Ruan BH, 2010, ANAL BIOCHEM, V399, P284, DOI 10.1016/j.ab.2009.12.010; Saghaei F, 2010, EXP TOXICOL PATHOL; Shi Y, 2001, ARTERIOSCL THROM VAS, V21, P739, DOI 10.1161/01.ATV.21.5.739; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Zhang B, 2011, BLOOD, V117, P4569, DOI 10.1182/blood-2010-09-304931	43	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39106	10.1371/journal.pone.0039106	http://dx.doi.org/10.1371/journal.pone.0039106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720042	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900082
J	Ou, FR; Li, K; Gao, Q; Liu, D; Li, JH; Hu, LW; Wu, X; Edmiston, EK; Liu, Y				Ou, Fengrong; Li, Kai; Gao, Qian; Liu, Dan; Li, Jinghai; Hu, Liwen; Wu, Xian; Edmiston, E. Kale; Liu, Yang			An Urban Neo-Poverty Population-Based Quality of Life and Related Social Characteristics Investigation from Northeast China	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; GENERAL-POPULATION; ECONOMIC-GROWTH; HEALTH-STATUS; SF-36; QOL; CANCER	Objective: To investigate quality of life (QOL) and related characteristics among an urban neo-poverty population in northeast China, and to compare this population with a traditional poverty cohort. Design: The research was a cross-sectional survey executed from June 2005 to October 2007, with a sample of 2940 individuals ages 36 to 55 in three different industrial cities of northeast China. Data were collected on QOL status and sociodemographic characteristics. QOL was assessed using the 36-item Short Form Health Survey (Chinese version). Multiple regression analysis was employed to analyze association between sociodemographic variables and QOL. Results: The scores for QOL in the neo-poverty group were higher than those in the traditional poverty group, but lower than those in the general population. When the neo-poverty population was divided into two subgroups by age, 36-45 years and 46-55 years, the differences in QOL scores were not significant. However, there were significant differences in several dimensions between two subgroups according to unemployment time (<5 years and >5 years). Additionally, stepwise regression analysis indicated that disease burden, including disease and medical expenditures, was a common risk factor for declining QOL in the neo-poverty group. Conclusions: Despite some limitations, this study provides initial evidence that the QOL of the urban neo-poverty population lies between that of the general population and traditional poverty. QOL of the neo-poverty group approached QOL of the traditional poverty group with increased unemployment years. In addition to decreased income, disease burden is the most important factor influencing QOL status in urban neo-poverty.	[Ou, Fengrong; Li, Kai; Wu, Xian] China Med Univ, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Gao, Qian; Hu, Liwen; Liu, Yang] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Liu, Dan] Liaoning Canc Hosp & Inst, Shenyang, Liaoning, Peoples R China; [Li, Jinghai] Tianjin Tanggu Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Edmiston, E. Kale] Vanderbilt Univ, Vanderbilt Brain Inst, Grad Program Neurosci, Nashville, TN USA	China Medical University; China Medical University; Tianjin Center for Disease Control & Prevention; Vanderbilt University	Ou, FR (corresponding author), China Med Univ, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.	cmuliuyang@yahoo.com	Hu, Liwen/AAQ-2735-2020	Edmiston, E Kale/0000-0002-3548-6026	National Natural Science Foundation of China [70503029]; Liaoning Province Science and Technology Program [2009225010-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Province Science and Technology Program	This study was supported by the National Natural Science Foundation of China (70503029) http://www.nsfc.gov.cn/Portal0/default152.htm and Liaoning Province Science and Technology Program (2009225010-11) http://kjjh.lninfo.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2002, J HEALTH POPUL NUTR, V20, P334; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Brouwer WBF, 2005, PHARMACOECONOMICS, V23, P209, DOI 10.2165/00019053-200523030-00002; Chen BZ, 2000, CHINA ECON REV, V11, P1, DOI 10.1016/S1043-951X(99)00014-0; Demiral Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-247; Ferrer RL, 2004, J EPIDEMIOL COMMUN H, V58, P381, DOI 10.1136/jech.2002.003251; Figueira HA, 2009, ARCH GERONTOL GERIAT, V49, P368, DOI 10.1016/j.archger.2008.11.017; Fiz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018440; Flatau P., 2000, AUST ECON REV, V33, P161, DOI DOI 10.1111/1467-8462.00145; Ghislandi S, 2002, Eur J Health Econ, V3, P125, DOI 10.1007/s10198-002-0105-x; Gore JL, 2005, J UROLOGY, V173, P1323, DOI 10.1097/01.ju.0000152312.28002.ad; Hao C, 2006, CHINA ECON REV, V17, P347, DOI 10.1016/j.chieco.2006.01.001; Hikosaka M, 2011, AURIS NASUS LARYNX, V38, P730, DOI 10.1016/j.anl.2011.02.004; Imataki Osamu, 2010, Gan To Kagaku Ryoho, V37, P847; Ishida Y, 2011, INT J HEMATOL, V93, P633, DOI 10.1007/s12185-011-0843-6; Kobayashi K, 2008, PSYCHO-ONCOLOGY, V17, P606, DOI 10.1002/pon.1278; Lim WY, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-184; Lin CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021841; LIN JYF, 1992, AM ECON REV, V82, P34; Lubetkin EI, 2004, QUAL LIFE RES, V13, P1459, DOI 10.1023/B:QURE.0000040793.40831.72; Lubetkin EI, 2003, AM J PREV MED, V24, P354, DOI 10.1016/S0749-3797(03)00017-5; Lubetkin EI, 2003, MED CARE, V41, P447, DOI 10.1097/00005650-200304000-00001; Ou F, 2008, CHIN J PUBLIC HLTH, V24, P1442; Pappa E, 2009, INT J PUBLIC HEALTH, V54, P241, DOI 10.1007/s00038-009-8057-x; Rose MS, 1999, J CLIN EPIDEMIOL, V52, P405, DOI 10.1016/S0895-4356(99)00014-1; Saarni SI, 2007, J CLIN EPIDEMIOL, V60, P1288, DOI 10.1016/j.jclinepi.2007.03.004; Terreehorst I, 2004, CLIN EXP ALLERGY, V34, P1673, DOI 10.1111/j.1365-2222.2004.02096.x; Tong X, 2000, SOCIOLOGY PERSPECTIV, V4, P42; Tong X, 1993, SOCIAL SCI CHINA, V3; Wang H, 2001, CHIN J PREV MED, V35, P428; Wang R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-292; Ware J., 1993, SF 36 HLTH SURVEY MA; Weng Q, 2010, J LIAONING TU, V12, P506; West CP, 2011, JAMA-J AM MED ASSOC, V306, P952, DOI 10.1001/jama.2011.1247; WHO, 1998, POV HLTH AL SECT PRO; *WHO CONS OB, 1998, PREV MAN GLOB EP REP, P1; Wilton R, 2004, SOC SCI MED, V58, P25, DOI 10.1016/S0277-9536(03)00148-5; Xing J, 2007, CHIN J PUBLIC HLTH, V23, P1384; Yang H, 2006, J HIGH ALTITUDE MED, V16, P51; Yang TZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030521, 10.1371/journal.pone.0048971]; Zhou XG, 2000, AM J SOCIOL, V105, P1135, DOI 10.1086/210401	41	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38861	10.1371/journal.pone.0038861	http://dx.doi.org/10.1371/journal.pone.0038861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719968	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341900057
J	Wan, ZT; Lu, YM; Liao, QJ; Wu, Y; Chen, XL				Wan, Zhitao; Lu, Yimei; Liao, Qingjiao; Wu, Yang; Chen, Xulin			Fangchinoline Inhibits Human Immunodeficiency Virus Type 1 Replication by Interfering with gp160 Proteolytic Processing	PLOS ONE			English	Article							ANTI-HIV ACTIVITY; ENVELOPE GLYCOPROTEINS; ANTIRETROVIRAL THERAPY; SYNCYTIUM FORMATION; CLEAVAGE SEQUENCE; BETULINIC ACID; PEPTIDE; INFECTION; PRECURSOR; FURIN	The introduction of highly active antiretroviral therapy has led to a significant reduction in the morbidity and mortality of acquired immunodeficiency syndrome patients. However, the emergence of drug resistance has resulted in the failure of treatments in large numbers of patients and thus necessitates the development of new classes of anti-HIV drugs. In this study, more than 200 plant-derived small-molecule compounds were evaluated in a cell-based HIV-1 antiviral screen, resulting in the identification of a novel HIV-1 inhibitor (fangchinoline). Fangchinoline, a bisbenzylisoquinoline alkaloid isolated from Radix Stephaniae tetrandrae, exhibited antiviral activity against HIV-1 laboratory strains NL4-3, LAI and BaL in MT-4 and PM1 cells with a 50% effective concentration ranging from 0.8 to 1.7 mu M. Mechanism-of-action studies showed that fangchinoline did not exhibit measurable antiviral activity in TZM-b1 cells but did inhibit the production of infectious virions in HIV-1 cDNA transfected 293T cells, which suggests that the compound targets a late event in infection cycle. Furthermore, the antiviral effect of fangchinoline seems to be HIV-1 envelope-dependent, as the production of infectious HIV-1 particles packaged with a heterologous envelope, the vesicular stomatitis virus G glycoprotein, was unaffected by fangchinoline. Western blot analysis of HIV envelope proteins expressed in transfected 293T cells and in isolated virions showed that fangchinoline inhibited HIV-1 gp160 processing, resulting in reduced envelope glycoprotein incorporation into nascent virions. Collectively, our results demonstrate that fangchinoline inhibits HIV-1 replication by interfering with gp160 proteolytic processing. Fangchinoline may serve as a starting point for developing a new HIV-1 therapeutic approach.	[Wan, Zhitao; Lu, Yimei; Liao, Qingjiao; Wu, Yang; Chen, Xulin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wan, ZT (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenxl@wh.iov.cn			Important National Science & Technology Specific Projects [2009ZX09301-014, 2008ZX10001-002]	Important National Science & Technology Specific Projects	This work was jointly funded by the Important National Science & Technology Specific Projects 2009ZX09301-014 and 2008ZX10001-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Aiken C, 2005, TRENDS MOL MED, V11, P31, DOI 10.1016/j.molmed.2004.11.001; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Barbouche R, 2000, VIROLOGY, V273, P169, DOI 10.1006/viro.2000.0368; Barbouche R, 1998, VIROLOGY, V247, P137, DOI 10.1006/viro.1998.9239; Blair WS, 2007, ANTIMICROB AGENTS CH, V51, P3554, DOI 10.1128/AAC.00643-07; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Blair WS, 2009, ANTIMICROB AGENTS CH, V53, P5080, DOI 10.1128/AAC.00759-09; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; DEWAR RL, 1989, J VIROL, V63, P2452, DOI 10.1128/JVI.63.6.2452-2456.1989; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; GRUTERS RA, 1987, NATURE, V330, P74, DOI 10.1038/330074a0; Jiang Y, 2011, CURR MED CHEM, V18, P16, DOI 10.2174/092986711793979751; Jose ES, 1997, VIROLOGY, V239, P303, DOI 10.1006/viro.1997.8872; Kibler KV, 2004, J BIOL CHEM, V279, P49055, DOI 10.1074/jbc.M403394200; Kim HS, 1997, J ETHNOPHARMACOL, V58, P117, DOI 10.1016/S0378-8741(97)00092-5; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Miyake A, 2010, MICROBES INFECT, V12, P400, DOI 10.1016/j.micinf.2010.02.004; Montessori V, 2004, CAN MED ASSOC J, V170, P229; MOULARD M, 1994, FEBS LETT, V338, P281, DOI 10.1016/0014-5793(94)80284-X; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; PAL R, 1989, P NATL ACAD SCI USA, V86, P3384, DOI 10.1073/pnas.86.9.3384; PAL R, 1988, P NATL ACAD SCI USA, V85, P9283, DOI 10.1073/pnas.85.23.9283; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Sabatier JM, 1996, VIROLOGY, V223, P406, DOI 10.1006/viro.1996.0496; Saklani A, 2008, DRUG DISCOV TODAY, V13, P161, DOI 10.1016/j.drudis.2007.10.010; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vlietinck AJ, 1998, PLANTA MED, V64, P97, DOI 10.1055/s-2006-957384; WALKER BD, 1987, P NATL ACAD SCI USA, V84, P8120, DOI 10.1073/pnas.84.22.8120; Wan H, 2010, J CLIN MICROBIOL, V48, P2186, DOI 10.1128/JCM.02034-09	35	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39225	10.1371/journal.pone.0039225	http://dx.doi.org/10.1371/journal.pone.0039225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720080	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900091
J	Kascakova, S; Maigre, L; Chevalier, J; Refregiers, M; Pages, JM				Kascakova, Slavka; Maigre, Laure; Chevalier, Jacqueline; Refregiers, Matthieu; Pages, Jean-Marie			Antibiotic Transport in Resistant Bacteria: Synchrotron UV Fluorescence Microscopy to Determine Antibiotic Accumulation with Single Cell Resolution	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; EFFLUX PUMP; ANTIMICROBIAL RESISTANCE; DRUG-RESISTANCE; ACTIVE EFFLUX; CIPROFLOXACIN; NORFLOXACIN; SERUM; PORIN	A molecular definition of the mechanism conferring bacterial multidrug resistance is clinically crucial and today methods for quantitative determination of the uptake of antimicrobial agents with single cell resolution are missing. Using the naturally occurring fluorescence of antibacterial agents after deep ultraviolet (DUV) excitation, we developed a method to non-invasively monitor the quinolones uptake in single bacteria. Our approach is based on a DUV fluorescence microscope coupled to a synchrotron beamline providing tuneable excitation from 200 to 600 nm. A full spectrum was acquired at each pixel of the image, to study the DUV excited fluorescence emitted from quinolones within single bacteria. Measuring spectra allowed us to separate the antibiotic fluorescence from the autofluorescence contribution. By performing spectroscopic analysis, the quantification of the antibiotic signal was possible. To our knowledge, this is the first time that the intracellular accumulation of a clinical antibitiotic could be determined and discussed in relation with the level of drug susceptibility for a multiresistant strain. This method is especially important to follow the behavior of quinolone molecules at individual cell level, to quantify the intracellular concentration of the antibiotic and develop new strategies to combat the dissemination of MDR-bacteria. In addition, this original approach also indicates the heterogeneity of bacterial population when the same strain is under environmental stress like antibiotic attack.	[Kascakova, Slavka; Refregiers, Matthieu] Synchrotron Soleil, DISCO Beamline, St Aubin, France; [Maigre, Laure; Chevalier, Jacqueline; Pages, Jean-Marie] Aix Marseille Univ, UMR MD1, IRBA, Fac Med & Pharm, Marseille, France	SOLEIL Synchrotron; UDICE-French Research Universities; Aix-Marseille Universite	Kascakova, S (corresponding author), Synchrotron Soleil, DISCO Beamline, St Aubin, France.	Jean-Marie.PAGES@univ-amu.fr	Réfrégiers, Matthieu/A-4249-2011; Kascakova, Slavka/V-1844-2018; Réfrégiers, Matthieu/AAE-2075-2022; PAGES, jean-marie/F-2555-2013	Réfrégiers, Matthieu/0000-0002-3281-2308; PAGES, jean-marie/0000-0001-7092-7977	Aix-Marseille Universite, Service de Sante des Armees; SOLEIL [N0 9909 0101, N0 2010 0674, N0 2010 0054]; ANR METABACT [ANR2010 BLAN 725]	Aix-Marseille Universite, Service de Sante des Armees; SOLEIL; ANR METABACT(French National Research Agency (ANR))	The authors are grateful to the SOLEIL for general facilities placed at the authors' disposure. This research was supported by Aix-Marseille Universite, Service de Sante des Armees, the SOLEIL (program N0 9909 0101; N0 2010 0674; N0 2010 0054) and by the ANR METABACT (ANR2010 BLAN 725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral Leonard, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P61; Ankomah P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002487; Batard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019440; BEDARD J, 1987, ANTIMICROB AGENTS CH, V31, P1348, DOI 10.1128/AAC.31.9.1348; Blot S, 2007, CURR OPIN INFECT DIS, V20, P391, DOI 10.1097/QCO.0b013e32818be6f7; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; CHAPMAN JS, 1988, ANTIMICROB AGENTS CH, V32, P438, DOI 10.1128/AAC.32.4.438; CHAPMAN JS, 1989, ANTIMICROB AGENTS CH, V33, P27, DOI 10.1128/AAC.33.1.27; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Dorr T, 2010, PLOS BIOL, DOI [10.1371/journal.-pbio.1000317, DOI 10.1371/JOURNAL.-PBIO.1000317]; Dupont M, 2007, ANTIMICROB AGENTS CH, V51, P3190, DOI 10.1128/AAC.01481-06; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Gandhi TN, 2010, CRIT CARE MED, V38, pS315, DOI 10.1097/CCM.0b013e3181e6a2a4; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; HIRAI K, 1987, ANTIMICROB AGENTS CH, V31, P582, DOI 10.1128/AAC.31.4.582; HIRAI K, 1986, ANTIMICROB AGENTS CH, V29, P535, DOI 10.1128/AAC.29.3.535; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; JOOS B, 1985, ANTIMICROB AGENTS CH, V27, P353, DOI 10.1128/AAC.27.3.353; Kirkpatrick ND, 2005, PHOTOCHEM PHOTOBIOL, V81, P125, DOI 10.1562/2004-08-09-RA-267.1; Kouyos RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001334; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; MORTON SJ, 1986, ANTIMICROB AGENTS CH, V30, P325, DOI 10.1128/AAC.30.2.325; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Pages JM, 2011, CURR MED CHEM, V18, P2969, DOI 10.2174/092986711796150469; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Piddock LJV, 2000, J ANTIMICROB CHEMOTH, V45, P159, DOI 10.1093/jac/45.2.159; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Ricci V, 2000, ANTIMICROB AGENTS CH, V44, P2361, DOI 10.1128/AAC.44.9.2361-2366.2000; Rice Louis B, 2007, Cleve Clin J Med, V74 Suppl 4, pS12; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Wernli D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001022; Zeller V, 1997, ANTIMICROB AGENTS CH, V41, P1973, DOI 10.1128/AAC.41.9.1973; ZENILMAN JM, 1986, ANTIMICROB AGENTS CH, V30, P877, DOI 10.1128/AAC.30.6.877	45	46	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38624	10.1371/journal.pone.0038624	http://dx.doi.org/10.1371/journal.pone.0038624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719907	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000037
J	Tenbusch, M; Ignatius, R; Nchinda, G; Trumpfheller, C; Salazar, AM; Topfer, K; Sauermann, U; Wagner, R; Hannaman, D; Tenner-Racz, K; Racz, P; Stahl-Hennig, C; Uberla, K				Tenbusch, Matthias; Ignatius, Ralf; Nchinda, Godwin; Trumpfheller, Christine; Salazar, Andres M.; Toepfer, Katharina; Sauermann, Ulrike; Wagner, Ralf; Hannaman, Drew; Tenner-Racz, Klara; Racz, Paul; Stahl-Hennig, Christiane; Ueberla, Klaus			Immunogenicity of DNA Vaccines Encoding Simian Immunodeficiency Virus Antigen Targeted to Dendritic Cells in Rhesus Macaques	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; IMMUNE-RESPONSES; T-CELLS; NONHUMAN-PRIMATES; HIV GAG; DEC-205 RECEPTOR; SURVIVAL-TIME; PLASMID DNA; PROTEIN; VACCINATION	Background: Targeting antigens encoded by DNA vaccines to dendritic cells (DCs) in the presence of adjuvants enhances their immunogenicity and efficacy in mice. Methodology/Principal Findings: To explore the immunogenicity of this approach in non-human primates, we generated a single chain antibody to the antigen uptake receptor DEC-205 expressed on rhesus macaque DCs. DNA vaccines encoding this single chain antibody fused to the SIV capsid protein were delivered to six monkeys each by either intramuscular electroporation or conventional intramuscular injection co-injected or not with poly ICLC, a stabilized poly I: C analogue, as adjuvant. Antibodies to capsid were induced by the DC-targeting and non-targeting control DNA delivered by electroporation while conventional DNA immunization at a 10-fold higher dose of DNA failed to induce detectable humoral immune responses. Substantial cellular immune responses were also observed after DNA electroporation of both DNAs, but stronger responses were induced by the non-targeting vaccine. Conventional immunization with the DC-targeting DNA at a 10-fold higher dose did not give rise to substantial cellular immune responses, neither when co-injected with poly ICLC. Conclusions/Significance: The study confirms the potent immunogenicity of DNA vaccines delivered by electroporation. Targeting the DNA via a single chain antibody to DEC-205 expressed by DCs, however, does not improve the immunogenicity of the antigens in non-human primates.	[Tenbusch, Matthias; Ueberla, Klaus] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany; [Ignatius, Ralf] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Nchinda, Godwin; Trumpfheller, Christine] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Toepfer, Katharina; Sauermann, Ulrike; Stahl-Hennig, Christiane] German Primate Ctr, Unit Infect Models, Gottingen, Germany; [Wagner, Ralf] Geneart, Regensburg, Germany; [Hannaman, Drew] Ichor Med Syst, San Diego, CA USA; [Tenner-Racz, Klara; Racz, Paul] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; Deutsches Primatenzentrum (DPZ); Bernhard Nocht Institut fur Tropenmedizin	Tenbusch, M (corresponding author), Ruhr Univ Bochum, Dept Mol & Med Virol, Univ Str 150, Bochum, Germany.	klaus.ueberla@rub.de			Wilhelm Sander Foundation [2004.107.2]; European Commission [LSHP-CT-2005-018685]; H.W. & J. Hector Foundation; Bill and Melinda Gates GHRC-CAVD Project; EC FP7 program	Wilhelm Sander Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); H.W. & J. Hector Foundation; Bill and Melinda Gates GHRC-CAVD Project; EC FP7 program(European Commission)	This work was supported by grants from the Wilhelm Sander Foundation (2004.107.2), the European Commission FP6 program (DEC-VAC, LSHP-CT-2005-018685 and Europrise Network of Excellence), the H.W. & J. Hector Foundation. In addition, the Centre for AIDS Reagents, NIBSC HPA UK, from which we obtained reference reagents, was funded by the EC FP7 program (Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies) and the Bill and Melinda Gates GHRC-CAVD Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Capone S, 2006, J IMMUNOL, V177, P7462, DOI 10.4049/jimmunol.177.10.7462; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; Do Y, 2010, EUR J IMMUNOL, V40, P2791, DOI 10.1002/eji.201040511; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Grossmann C, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-43; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Hirao LA, 2010, MOL THER, V18, P1568, DOI 10.1038/mt.2010.112; Jasny E, 2008, J IMMUNOL, V180, P6629, DOI 10.4049/jimmunol.180.10.6629; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Liu JY, 2008, J VIROL, V82, P5643, DOI 10.1128/JVI.02564-07; Livingston BD, 2010, VACCINE, V28, P1056, DOI 10.1016/j.vaccine.2009.10.111; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Mehlhop E, 2002, J IMMUNOL METHODS, V260, P219, DOI 10.1016/S0022-1759(01)00544-0; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Park SH, 2008, J IMMUNOL METHODS, V331, P27, DOI 10.1016/j.jim.2007.10.012; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Stahl-Hennig C, 2007, J VIROL, V81, P13180, DOI 10.1128/JVI.01400-07; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Stolte-Leeb N, 2006, VIRAL IMMUNOL, V19, P448, DOI 10.1089/vim.2006.19.448; Suh YS, 2006, VACCINE, V24, P1811, DOI 10.1016/j.vaccine.2005.10.026; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105	42	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39038	10.1371/journal.pone.0039038	http://dx.doi.org/10.1371/journal.pone.0039038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720025	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000063
J	Albanese, E; Lombardo, FL; Dangour, AD; Guerra, M; Acosta, D; Huang, YQ; Jacob, KS; Rodriguez, JDL; Salas, A; Schonborn, C; Sosa, AL; Williams, J; Prince, MJ; Ferri, CP				Albanese, Emiliano; Lombardo, Flavia L.; Dangour, Alan D.; Guerra, Mariella; Acosta, Daisy; Huang, Yueqin; Jacob, K. S.; Llibre Rodriguez, Juan de Jesus; Salas, Aquiles; Schoenborn, Claudia; Luisa Sosa, Ana; Williams, Joseph; Prince, Martin J.; Ferri, Cleusa P.			No Association between Fish Intake and Depression in over 15,000 Older Adults from Seven Low and Middle Income Countries-The 10/66 Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LATE-LIFE DEPRESSION; POPULATION-BASED COHORT; GERIATRIC MENTAL STATE; CROSS-SECTIONAL SURVEY; EURO-D SCALE; LATIN-AMERICA; DIETARY FISH; RISK-FACTORS; POSTPARTUM DEPRESSION	Background: Evidence on the association between fish consumption and depression is inconsistent and virtually nonexistent from low-and middle-income countries. Using a standard protocol, we aim to assess the association of fish consumption and late-life depression in seven low-and middle-income countries. Methodology/Findings: We used cross-sectional data from the 10/66 cohort study and applied two diagnostic criteria for late-life depression to assess the association between categories of weekly fish consumption and depression according to ICD-10 and the EURO-D depression symptoms scale scores, adjusting for relevant confounders. All-catchment area surveys were carried out in Cuba, Dominican Republic, Venezuela, Peru, Mexico, China, and India, and over 15,000 community-dwelling older adults (65+) were sampled. Using Poisson models the adjusted association between categories of fish consumption and ICD-10 depression was positive in India (p for trend = 0.001), inverse in Peru (p = 0.025), and not significant in all other countries. We found a linear inverse association between fish consumption categories and EURO-D scores only in Cuba (p for trend = 0.039) and China (p<0.001); associations were not significant in all other countries. Between-country heterogeneity was marked for both ICD-10 (I-2>61%) and EURO-D criteria (I-2>66%). Conclusions: The associations of fish consumption with depression in large samples of older adults varied markedly across countries and by depression diagnosis and were explained by socio-demographic and lifestyle variables. Experimental studies in these settings are needed to confirm our findings.	[Albanese, Emiliano; Schoenborn, Claudia; Prince, Martin J.; Ferri, Cleusa P.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Lombardo, Flavia L.] Italian Natl Inst Hlth, Dept Epidemiol, Rome, Italy; [Dangour, Alan D.] London Sch Hyg & Trop Med, Dept Nutr & Publ Hlth Intervent Res, London WC1, England; [Guerra, Mariella] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Acosta, Daisy] UNPHU, Dept Internal Med, Santo Domingo, Dominican Rep; [Huang, Yueqin] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Llibre Rodriguez, Juan de Jesus] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Salas, Aquiles] Cent Univ Venezuela, Fac Med, Caracas, Venezuela; [Luisa Sosa, Ana] Natl Inst Neurol & Neurosurg Mexico, Mexico City, DF, Mexico; [Williams, Joseph] Inst Community Hlth, Madras, Tamil Nadu, India	University of London; King's College London; Istituto Superiore di Sanita (ISS); University of London; London School of Hygiene & Tropical Medicine; Universidad Nacional Pedro Henriquez Urena; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Central Venezuela	Albanese, E (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	emiliano.albanese@nih.gov	Rodriguez, Juan J Llibre/D-2380-2010; Ferri, Cleusa Pinheiro/B-2922-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Lombardo, Flavia/AAA-9723-2021; Prince, Martin J/A-9170-2010	Rodriguez, Juan J Llibre/0000-0002-8215-3160; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prince, Martin J/0000-0003-1379-7146; Guerra, Mariella/0000-0001-8923-349X; Lombardo, Flavia Lucia/0000-0001-6183-0735; Dangour, Alan/0000-0001-6908-1273; Schonborn, Claudia/0000-0002-4524-7192	Wellcome Trust (UK) [GR066133]; World Health Organization (WHO); U.S. Alzheimer's Association [IIRG-04-1286]; Fondo Nacional de Ciencia Y Tecnologia; Consejo de Desarollo Cientifico Y Humanistico; Universidad Central de Venezuela (Venezuela); Rockerfeller Foundation; Alzheimer's Disease International (ADI); GaxoSmithKline; Novartis; Lundbeck; Pfizer; Eisai; Intramural Research Program of the National Institute on Aging, National Institutes of Health	Wellcome Trust (UK)(Wellcome Trust); World Health Organization (WHO)(World Health Organization); U.S. Alzheimer's Association(Alzheimer's Association); Fondo Nacional de Ciencia Y Tecnologia; Consejo de Desarollo Cientifico Y Humanistico; Universidad Central de Venezuela (Venezuela); Rockerfeller Foundation; Alzheimer's Disease International (ADI); GaxoSmithKline; Novartis(Novartis); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Eisai(Eisai Co Ltd); Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The 10/66 Dementia Research Group population-based surveys were funded by the Wellcome Trust (UK) (GR066133); the World Health Organization (WHO); the U.S. Alzheimer's Association (IIRG-04-1286); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). The Rockerfeller Foundation supported a dissemination meeting in their Bellagio Centre. Alzheimer's Disease International (ADI) has provided support for networking and infrastructure. The 10/66 Dementia Research Group works closely with ADI, which is a non-profit federation of 77 Alzheimer associations around the world. ADI is committed to strengthening Alzheimer associations worldwide, raising awareness regarding dementia and Alzheimer's disease, and advocating for more and better services for people with dementia and their caregivers. ADI is supported in part by grants from GaxoSmithKline, Novartis, Lundbeck, Pfizer, and Eisai. Dr. Emiliano Albanese is supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese E, 2009, AM J CLIN NUTR, V90, P392, DOI 10.3945/ajcn.2009.27580; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Appleton KM, 2007, SOC PSYCH PSYCH EPID, V42, P100, DOI 10.1007/s00127-006-0142-3; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Barberger-Gateau P, 2005, EUR J CLIN NUTR, V59, P817, DOI 10.1038/sj.ejcn.1602145; BEEKMAN ATF, 1995, SOC PSYCH PSYCH EPID, V30, P32, DOI 10.1007/BF00784432; Beekman ATF, 1995, J AFFECT DISORDERS, V36, P65, DOI 10.1016/0165-0327(95)00061-5; Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002; BROE GA, 1976, J NEUROL NEUROSUR PS, V39, P362, DOI 10.1136/jnnp.39.4.362; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Burdge GC, 2003, BRIT J NUTR, V90, P311, DOI 10.1079/BJN2003901; Calder PC, 2003, NUTRITION, V19, P472, DOI 10.1016/S0899-9007(02)01042-0; Castro-Costa E, 2007, BRIT J PSYCHIAT, V191, P393, DOI 10.1192/bjp.bp.107.036772; Castro-Costa E, 2008, INT J METH PSYCH RES, V17, P12, DOI 10.1002/mpr.236; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Colangelo LA, 2009, NUTRITION, V25, P1011, DOI 10.1016/j.nut.2008.12.008; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Covault J, 2004, AM J MED GENET B, V127B, P42, DOI 10.1002/ajmg.b.20156; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; *DUK U, 1978, MULT FUNCT ASS OARS; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Grenyer BFS, 2007, PROG NEURO-PSYCHOPH, V31, P1393, DOI 10.1016/j.pnpbp.2007.06.004; Guerra M, 2009, BRIT J PSYCHIAT, V195, P510, DOI 10.1192/bjp.bp.109.064055; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hakkarainen R, 2004, AM J PSYCHIAT, V161, P567, DOI 10.1176/appi.ajp.161.3.567; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofler M, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-11; Hostenkamp G, 2009, PUBLIC HEALTH NUTR, P1; Jacka E, 2004, NUTR NEUROSCI, V7, P101, DOI 10.1080/10284150410001710438; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Sosa AL, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-48; MACLURE M, 1992, AM J EPIDEMIOL, V135, P96; Margetts B, 1997, DESIGN COCEPTS NUTR; MENDLEWICZ J, 1976, J GERONTOL, V31, P300; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Miyake Y, 2006, PSYCHOL MED, V36, P1727, DOI 10.1017/S0033291706008701; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Noaghiul S, 2003, AM J PSYCHIAT, V160, P2222, DOI 10.1176/appi.ajp.160.12.2222; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Peet M, 2004, BRIT J PSYCHIAT, V184, P404, DOI 10.1192/bjp.184.5.404; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Prince M, 2004, BRIT J PSYCHIAT, V185, P429, DOI 10.1192/bjp.185.5.429; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Reynolds CF, 1999, PSYCHIAT SERV, V50, P1167, DOI 10.1176/ps.50.9.1167; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Suominen-Taipale AL, 2010, INT J EPIDEMIOL, V39, P494, DOI 10.1093/ije/dyp386; Suzuki S, 2004, BRIT J CANCER, V90, P787, DOI 10.1038/sj.bjc.6601621; Tanskanen A, 2001, PSYCHIATR SERV, V52, P529, DOI 10.1176/appi.ps.52.4.529; Tanskanen A, 2001, ARCH GEN PSYCHIAT, V58, P512, DOI 10.1001/archpsyc.58.5.512; Tiemeier H, 2003, EUR J EPIDEMIOL, V18, P745; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Tracy M, 2008, ANN EPIDEMIOL, V18, P447, DOI 10.1016/j.annepidem.2007.12.004; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Virtanen JK, 2008, AM J CLIN NUTR, V88, P1618, DOI 10.3945/ajcn.2007.25816; Visioli F, 2003, LIPIDS, V38, P415, DOI 10.1007/s11745-003-1077-x; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; *WHO, 1987, 10 REV INT CLASS DIS; WHO, 2008, MHGAP MENTAL HLTH GA; Whyte EM, 2006, INT J GERIATR PSYCH, V21, P746, DOI 10.1002/gps.1555; Yao JK, 2003, PROSTAG LEUKOTR ESS, V69, P429, DOI 10.1016/j.plefa.2003.08.015	74	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38879	10.1371/journal.pone.0038879	http://dx.doi.org/10.1371/journal.pone.0038879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723900	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700036
J	Kumari, S; Mehta, SL; Li, PA				Kumari, Santosh; Mehta, Suresh L.; Li, P. Andy			Glutamate Induces Mitochondrial Dynamic Imbalance and Autophagy Activation: Preventive Effects of Selenium	PLOS ONE			English	Article							NEURONAL CELL-DEATH; OXIDATIVE STRESS; PARKINSONS-DISEASE; FISSION; ISCHEMIA; FUSION; RAT; PROTECTS; INJURY; OVEREXPRESSION	Glutamate-induced cytotoxicity is partially mediated by enhanced oxidative stress. The objectives of the present study are to determine the effects of glutamate on mitochondrial membrane potential, oxygen consumption, mitochondrial dynamics and autophagy regulating factors and to explore the protective effects of selenium against glutamate cytotoxicity in murine neuronal HT22 cells. Our results demonstrated that glutamate resulted in cell death in a dose-dependent manner and supplementation of 100 nM sodium selenite prevented the detrimental effects of glutamate on cell survival. The glutamate induced cytotoxicity was associated with mitochondrial hyperpolarization, increased ROS production and enhanced oxygen consumption. Selenium reversed these alterations. Furthermore, glutamate increased the levels of mitochondrial fission protein markers pDrp1 and Fis1 and caused increase in mitochondrial fragmentation. Selenium corrected the glutamate-caused mitochondrial dynamic imbalance and reduced the number of cells with fragmented mitochondria. Finally, glutamate activated autophagy markers Beclin 1 and LC3-II, while selenium prevented the activation. These results suggest that glutamate targets the mitochondria and selenium supplementation within physiological concentration is capable of preventing the detrimental effects of glutamate on the mitochondria. Therefore, adequate selenium supplementation may be an efficient strategy to prevent the detrimental glutamate toxicity and further studies are warranted to define the therapeutic potentials of selenium in animal disease models and in human.	[Kumari, Santosh] N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst, Durham, NC USA; N Carolina Cent Univ, Technol Enterprise, Durham, NC USA	University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina Central University	Kumari, S (corresponding author), N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst, Durham, NC USA.	pli@nccu.edu		/0000-0002-5634-5230	National Institute of Health [7R01DK075476]; Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075476] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from National Institute of Health to PAL (7R01DK075476). The Biomanufacturing Research Institute and Technology Enterprise is partially funded by the Golden Leaf Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Ansari MA, 2004, BIOL TRACE ELEM RES, V101, P73, DOI 10.1385/BTER:101:1:73; Ben Jilani KE, 2007, INT J BIOL SCI, V3, P198; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Blandini F, 1996, FUNCT NEUROL, V11, P3; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Gupta R, 2003, PHARMACOL RES, V48, P209, DOI 10.1016/S1043-6618(03)00102-6; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Islam F, 2002, BIOL TRACE ELEM RES, V90, P203, DOI 10.1385/BTER:90:1-3:203; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim H, 2009, BIOCHEM BIOPH RES CO, V388, P339, DOI 10.1016/j.bbrc.2009.08.007; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Mendelev N, 2011, MITOCHONDRION, V11, P76, DOI 10.1016/j.mito.2010.07.007; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Ouyang YB, 2002, FREE RADICAL BIO MED, V33, P544, DOI 10.1016/S0891-5849(02)00912-7; Panee J, 2007, INT J BIOL SCI, V3, P335; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Sagara Y, 2002, J BIOL CHEM, V277, P36204, DOI 10.1074/jbc.M203895200; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Tirosh O, 2007, NUTRITION, V23, P878, DOI 10.1016/j.nut.2007.08.019; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Venardos K, 2004, J TRACE ELEM MED BIO, V18, P81, DOI 10.1016/j.jtemb.2004.01.001; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zafar KS, 2003, J NEUROCHEM, V84, P438, DOI 10.1046/j.1471-4159.2003.01531.x	41	93	98	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39382	10.1371/journal.pone.0039382	http://dx.doi.org/10.1371/journal.pone.0039382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724008	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700073
J	Morandi, B; Mortara, L; Chiossone, L; Accolla, RS; Mingari, MC; Moretta, L; Moretta, A; Ferlazzo, G				Morandi, Barbara; Mortara, Lorenzo; Chiossone, Laura; Accolla, Roberto S.; Mingari, Maria Cristina; Moretta, Lorenzo; Moretta, Alessandro; Ferlazzo, Guido			Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response	PLOS ONE			English	Article							NK CELL; MAMMARY ADENOCARCINOMA; CROSS-TALK; IFN-GAMMA; IN-VIVO; RECEPTORS; INNATE; TISSUES; POLARIZATION; EXPRESSION	Over the last decade, several studies have extensively reported that activated natural killer (NK) cells can kill autologous immature dendritic cells (DCs) in vitro, whereas they spare fully activated DCs. This led to the proposal that activated NK cells might select a more immunogenic subset of DCs during a protective immune response. However, there is no demonstration that autologous DC killing by NK cells is an event occurring in vivo and, consequently, the functional relevance of this killing remains elusive. Here we report that a significant decrease of CD11c(+) DCs was observed in draining lymph nodes of mice inoculated with MHC-devoid cells as NK cell targets able to induce NK cell activation. This in vivo DC editing by NK cells was perforin-dependent and it was functionally relevant, since residual lymph node DCs displayed an improved capability to induce T cell proliferation. In addition, in a model of anti-cancer vaccination, the administration of MHC-devoid cells together with tumor cells increased the number of tumor-specific CTLs and resulted in a significant increase in survival of mice upon challenge with a lethal dose of tumor cells. Depletion of NK cells or the use of perforin knockout mice strongly decreased the tumor-specific CTL expansion and its protective role against tumor cell challenge. As a whole, our data support the hypothesis that NK cell-mediated DC killing takes place in vivo and is able to promote expansion of cancer-specific CTLs. Our results also indicate that cancer vaccines could be improved by strategies aimed at activating NK cells.	[Morandi, Barbara; Mingari, Maria Cristina; Moretta, Alessandro] Univ Genoa, Dept Expt Med, Genoa, Italy; [Mortara, Lorenzo] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Chiossone, Laura; Moretta, Lorenzo] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Accolla, Roberto S.] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Mingari, Maria Cristina] San Martino IST Ist Nazl Ric Canc, Ist Ricovero & Cura Carattere Sci AOU, Genoa, Italy; [Ferlazzo, Guido] Univ Messina, Dept Human Pathol, Messina, Italy	University of Genoa; University of Insubria; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Insubria; University of Genoa; IRCCS AOU San Martino IST; University of Messina	Morandi, B (corresponding author), Univ Genoa, Dept Expt Med, Genoa, Italy.	guido.ferlazzo@unime.it	Moretta, Lorenzo/AAA-7239-2020; Mingari, Maria Cristina/AAB-1315-2019; Chiossone, Laura/D-3062-2011	Moretta, Lorenzo/0000-0003-4658-1747; Chiossone, Laura/0000-0002-9097-5869; Ferlazzo, Guido/0000-0002-3874-8554; Accolla, Roberto/0000-0003-2493-7378	Associazione Italiana Ricerca sul Cancro [IG5624, IG11650, IG 8862]; Ministero Italiano della Salute - Programma Strategico Ricerca Oncologica; Fondazione Cariplo [2008-2230]; Ministero Italiano dell' Istruzione, Universita', Ricerca, - Progetto Rilevanza Nazionale [2008-WXF7KK]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute - Programma Strategico Ricerca Oncologica; Fondazione Cariplo(Fondazione Cariplo); Ministero Italiano dell' Istruzione, Universita', Ricerca, - Progetto Rilevanza Nazionale	This work has been supported by Associazione Italiana Ricerca sul Cancro http://www.airc.it) IG5624 and IG11650 to GF and IG 8862 to RSA; by Ministero Italiano della Salute - Programma Strategico Ricerca Oncologica (http://www.ministerosalute.it/) to GF; by Fondazione Cariplo 2008-2230 (www.fondazionecariplo.it) and by Ministero Italiano dell' Istruzione, Universita', Ricerca, - Progetto Rilevanza Nazionale (http://prin.miur.it/) 2008-WXF7KK to RSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Alter G, 2010, J CLIN INVEST, V120, P1905, DOI 10.1172/JCI40913; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Ferlazzo G, 2005, IMMUNOL LETT, V101, P12, DOI 10.1016/j.imlet.2005.04.015; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Laffont S, 2008, BLOOD, V112, P661, DOI 10.1182/blood-2007-10-120089; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mailliard RB, 2005, J EXP MED, V202, P941, DOI 10.1084/hem.20050128; Marcenaro E, 2009, BLOOD, V114, P4108, DOI 10.1182/blood-2009-05-222265; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Melki MT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000862; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Morandi B, 2006, EUR J IMMUNOL, V36, P2394, DOI 10.1002/eji.200636290; Moretta A, 2005, TRENDS IMMUNOL, V26, P668, DOI 10.1016/j.it.2005.09.008; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; MORETTA L, 1992, IMMUNOL TODAY, V13, P300, DOI 10.1016/0167-5699(92)90042-6; MORETTA L, 1994, ADV IMMUNOL, V55, P341; Mortara L, 2006, CLIN CANCER RES, V12, P3435, DOI 10.1158/1078-0432.CCR-06-0165; NANNI P, 1983, CLIN EXP METASTAS, V1, P373, DOI 10.1007/BF00121199; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Persson CM, 2008, SCAND J IMMUNOL, V67, P30, DOI 10.1111/j.1365-3083.2007.02034.x; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Romagnani C, 2010, BLOOD1, V16, P1299; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145	43	82	85	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39170	10.1371/journal.pone.0039170	http://dx.doi.org/10.1371/journal.pone.0039170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723958	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700051
J	Prohaska, TA; Wahlmuller, FC; Furtmuller, M; Geiger, M				Prohaska, Thomas A.; Wahlmueller, Felix C.; Furtmueller, Margareta; Geiger, Margarethe			Interaction of Protein C Inhibitor with the Type II Transmembrane Serine Protease Enteropeptidase	PLOS ONE			English	Article							HEPARIN-BINDING; TISSUE KALLIKREIN; CELL MIGRATION; HUMAN-PLASMA; SERPIN; EXPRESSION; PCI; PANCREATITIS; TRYPSIN; KERATINOCYTES	The serine protease inhibitor protein C inhibitor (PCI) is expressed in many human tissues and exhibits broad protease reactivity. PCI binds glycosaminoglycans and certain phospholipids, which modulate its inhibitory activity. Enteropeptidase (EP) is a type II transmembrane serine protease mainly found on the brush border membrane of epithelial cells in the duodenum, where it activates trypsinogen to initiate the digestion of food proteins. Some active EP is also present in duodenal fluid and has been made responsible for causing pancreatitis in case of duodeno-pancreatic reflux. Together with its substrate trypsinogen, EP is furthermore present in the epidermis and in some cancer cells. In this report, we show that PCI inhibited EP with an apparent 2nd order rate constant of 4.48x10(4) M-1 s(-1). Low molecular weight (LMWH) and unfractionated heparin (UFH) slightly reduced the inhibitory effect of PCI. The SI (stoichiometry of inhibition) value for the inhibition of EP by PCI was 10.8 in the absence and 17.9 in the presence of UFH (10 U/ml). By inhibiting trypsin, chymotrypsin, and additionally EP, PCI might play a role in the protection of the pancreas from autodigestion. Furthermore the interaction of PCI with EP may influence the regulation of epithelial differentiation.	[Prohaska, Thomas A.; Wahlmueller, Felix C.; Furtmueller, Margareta; Geiger, Margarethe] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Prohaska, TA (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Geiger, Margarethe/0000-0003-2021-5319; Prohaska, Thomas/0000-0002-1406-692X; Furtmuller, Margareta/0000-0002-2572-6401	FWF-Austrian Science Fund [P20248-B09, P22160-B09, P20386-B09]; Austrian Science Fund (FWF) [P 20386, P 22792] Funding Source: researchfish	FWF-Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the FWF-Austrian Science Fund grant P20248-B09 to MG, grant P22160-B09 to MG, and grant P20386-B09 to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2007, INT J CANCER, V121, P955, DOI 10.1002/ijc.22773; Bijsmans ITGW, 2011, MODERN PATHOL, V24, P463, DOI 10.1038/modpathol.2010.214; Cao Y, 2003, PROSTATE, V57, P196, DOI 10.1002/pros.10296; COOPER ST, 1995, BBA-PROTEIN STRUCT M, V1246, P29, DOI 10.1016/0167-4838(94)00185-J; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; ECKE S, 1992, J BIOL CHEM, V267, P7048; Ecke S, 1997, EUR J BIOCHEM, V248, P475, DOI 10.1111/j.1432-1033.1997.00475.x; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; ESPANA F, 1993, THROMB HAEMOSTASIS, V70, P989; FERNANDEZDELCASTILLO C, 1994, SURGERY, V116, P497; FONSECA P, 1982, BIOPHYS J, V37, P44, DOI 10.1016/S0006-3495(82)84590-6; Fortenberry YM, 2010, BBA-GEN SUBJECTS, V1800, P580, DOI 10.1016/j.bbagen.2010.03.003; GEIGER M, 1989, BLOOD, V74, P722; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hayashi T, 2004, J THROMB HAEMOST, V2, P949, DOI 10.1111/j.1538-7836.2004.00733.x; HERMANS JM, 1993, BIOCHEM J, V295, P239, DOI 10.1042/bj2950239; HERMANS JM, 1994, BIOCHEMISTRY-US, V33, P5440, DOI 10.1021/bi00184a012; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huntington J, 2009, CELL MOL LIFE SCI, V66, P113, DOI 10.1007/s00018-008-8371-0; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Imamura T, 2003, AM J PHYSIOL-GASTR L, V285, pG1235, DOI 10.1152/ajpgi.00198.2003; KOIVUNEN E, 1991, CANCER RES, V51, P2107; Krebs M, 1999, J INVEST DERMATOL, V113, P32, DOI 10.1046/j.1523-1747.1999.00644.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; Li W, 2008, J BIOL CHEM, V283, P36039, DOI 10.1074/jbc.M805974200; Lu DS, 1997, J BIOL CHEM, V272, P31293, DOI 10.1074/jbc.272.50.31293; Lukkonen A, 2000, INT J CANCER, V86, P577, DOI 10.1002/(SICI)1097-0215(20000515)86:4<577::AID-IJC21>3.3.CO;2-A; Luo LY, 2006, BIOL CHEM, V387, P813, DOI 10.1515/BC.2006.103; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; MATSUSHIMA M, 1994, J BIOL CHEM, V269, P19976; McCutcheon AD, 2000, ARCH SURG-CHICAGO, V135, P278, DOI 10.1001/archsurg.135.3.278; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Mona B, 2010, FERTIL STERIL, V93, P277, DOI 10.1016/j.fertnstert.2009.07.984; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Radtke KP, 1996, INT S CHEM BIOL SERP, P123; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Schechter NM, 2004, METHODS, V32, P159, DOI 10.1016/S1046-2023(03)00207-X; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Suzuki K, 2008, J THROMB HAEMOST, V6, P2017, DOI 10.1111/j.1538-7836.2008.03181.x; SUZUKI K, 1983, J BIOL CHEM, V258, P163; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Vilen ST, 2008, EXP CELL RES, V314, P914, DOI 10.1016/j.yexcr.2007.10.025; Vonlaufen A, 2008, J GASTROEN HEPATOL, V23, P1339, DOI 10.1111/j.1440-1746.2008.05520.x; Wakita T, 2004, INT J CANCER, V108, P516, DOI 10.1002/ijc.11594; ZechmeisterMachhart M, 1996, IMMUNOPHARMACOLOGY, V32, P96, DOI 10.1016/0162-3109(95)00062-3; Zhang C, 2007, ACTA HISTOCHEM, V109, P461, DOI 10.1016/j.acthis.2007.04.007; Zheng X Long, 2009, Front Biosci (Elite Ed), V1, P242; ZHENG XL, 1994, AM J PHYSIOL, V267, pC466, DOI 10.1152/ajpcell.1994.267.2.C466	56	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39262	10.1371/journal.pone.0039262	http://dx.doi.org/10.1371/journal.pone.0039262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723979	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700061
J	Cohen, N; Margalit, R; Pevsner-Fischer, M; Yona, S; Jung, S; Eisenbach, L; Cohen, IR				Cohen, Noam; Margalit, Raanan; Pevsner-Fischer, Meirav; Yona, Simon; Jung, Steffen; Eisenbach, Lea; Cohen, Irun R.			Mouse Dendritic Cells Pulsed with Capsular Polysaccharide Induce Resistance to Lethal Pneumococcal Challenge: Roles of T Cells and B Cells	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; VIRULENCE FACTORS; IMMUNE-RESPONSES; MICE; PATHWAY; GAMMA; IMMUNIZATION; PATHOGENESIS; MACROPHAGES	Mice are exceedingly sensitive to intra-peritoneal (IP) challenge with some virulent pneumococci (LD50=1 bacterium). To investigate how peripheral contact with bacterial capsular polysaccharide (PS) antigen can induce resistance, we pulsed bone marrow dendritic cells (BMDC) of C57BL/6 mice with type 4 or type 3 PS, injected the BMDC intra-foot pad (IFP) and challenged the mice IP with supra-lethal doses of pneumococci. We examined the responses of T cells and B cells in the draining popliteal lymph node and measured the effects on the bacteria in the peritoneum and blood. We now report that: 1) The PS co-localized with MHC molecules on the BMDC surface; 2) PS-specific T and B cell proliferation and IFN gamma secretion was detected in the draining popliteal lymph nodes on day 4; 3) Type-specific resistance to lethal IP challenge was manifested only after day 5; 4) Type-specific IgM and IgG antibodies were detected in the sera of only some of the mice, but B cells were essential for resistance; 5) Control mice vaccinated with a single injection of soluble PS did not develop a response in the draining popliteal lymph node and were not protected; 6) Mice injected with unpulsed BMDC also did not resist challenge: In unprotected mice, pneumococci entered the blood shortly after IP inoculation and multiplied exponentially in both blood and peritoneum killing the mice within 20 hours. Mice vaccinated with PS-pulsed BMDC trapped the bacteria in the peritoneum. The trapped bacteria proliferated exponentially IP, but died suddenly at 1820 hours. Thus, a single injection of PS antigen associated with intact BMDC is a more effective vaccine than the soluble PS alone. This model system provides a platform for studying novel aspects of PS-targeted vaccination.	[Cohen, Noam; Margalit, Raanan; Pevsner-Fischer, Meirav; Yona, Simon; Jung, Steffen; Eisenbach, Lea; Cohen, Irun R.] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Cohen, N (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	irun.cohen@weizmann.ac.il	Yona, Simon/ABE-6572-2020; Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; Eisenbach, Lea R/0000-0002-4816-1968; Yona, Simon/0000-0002-3984-2008	Center for the Study of Emerging Diseases	Center for the Study of Emerging Diseases	The financial support for this study was obtained from the Center for the Study of Emerging Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; Amir-Kroll H, 2003, J IMMUNOL, V170, P6165, DOI 10.4049/jimmunol.170.12.6165; BROWN EJ, 1983, REV INFECT DIS, V5, pS797; Calbo E, 2011, CURR OPIN INFECT DIS, V24, P241, DOI 10.1097/QCO.0b013e3283463e45; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Cohen N, 2008, J IMMUNOL, V180, P2409, DOI 10.4049/jimmunol.180.4.2409; Dallaire F, 2001, J INFECT DIS, V184, P292, DOI 10.1086/322021; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Garcia E, 1997, FEMS MICROBIOL LETT, V149, P1; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HILLEMAN MR, 1978, B WORLD HEALTH ORGAN, V56, P371; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lai ZZ, 2009, VACCINE, V27, P3137, DOI 10.1016/j.vaccine.2009.03.064; Meltzer U, 2006, INFECT IMMUN, V74, P1890, DOI 10.1128/IAI.74.3.1890-1895.2006; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muthukkumar S, 2004, VACCINE, V22, P1290, DOI 10.1016/j.vaccine.2003.08.047; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; Saeki H, 1999, J IMMUNOL, V162, P2472; SCHIFFMAN G, 1983, P SOC EXP BIOL MED, V174, P309; Schweitzer AN, 1997, J IMMUNOL, V158, P2713; Selman S, 2000, Manag Care, V9, P49; SELMAN S, 2000, MANAG CARE, V9, P54; SELMAN S, 2000, MANAG CARE, V9, P56; SMIT P, 1977, JAMA-J AM MED ASSOC, V238, P2613, DOI 10.1001/jama.238.24.2613; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stephen TL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030032; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tuomanen EI, 1997, PEDIATR RES, V42, P253, DOI 10.1203/00006450-199709000-00001; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; WATSON DA, 1995, EUR J CLIN MICROBIOL, V14, P479, DOI 10.1007/BF02113425; Yanez DM, 1999, INFECT IMMUN, V67, P446	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39193	10.1371/journal.pone.0039193	http://dx.doi.org/10.1371/journal.pone.0039193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723962	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300115
J	Krauser, J; Walles, M; Wolf, T; Graf, D; Swart, P				Krauser, Joel; Walles, Markus; Wolf, Thierry; Graf, Daniel; Swart, Piet			A Unique Automation Platform for Measuring Low Level Radioactivity in Metabolite Identification Studies	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIOLABELED DRUG METABOLITES; COMPLEX BIOLOGICAL SAMPLES; VALIDATION	Generation and interpretation of biotransformation data on drugs, i.e. identification of physiologically relevant metabolites, defining metabolic pathways and elucidation of metabolite structures, have become increasingly important to the drug development process. Profiling using C-14 or H-3 radiolabel is defined as the chromatographic separation and quantification of drug-related material in a given biological sample derived from an in vitro, preclinical in vivo or clinical study. Metabolite profiling is a very time intensive activity, particularly for preclinical in vivo or clinical studies which have defined limitations on radiation burden and exposure levels. A clear gap exists for certain studies which do not require specialized high volume automation technologies, yet these studies would still clearly benefit from automation. Use of radiolabeled compounds in preclinical and clinical ADME studies, specifically for metabolite profiling and identification are a very good example. The current lack of automation for measuring low level radioactivity in metabolite profiling requires substantial capacity, personal attention and resources from laboratory scientists. To help address these challenges and improve efficiency, we have innovated, developed and implemented a novel and flexible automation platform that integrates a robotic plate handling platform, HPLC or UPLC system, mass spectrometer and an automated fraction collector.	[Krauser, Joel] Novartis Pharma AG, DMPK Isotope Labs, Basel, Switzerland; [Walles, Markus; Wolf, Thierry; Graf, Daniel; Swart, Piet] Novartis Pharma AG, DMPK Biotransformat Labs, Basel, Switzerland	Novartis; Novartis	Krauser, J (corresponding author), Novartis Pharma AG, DMPK Isotope Labs, Basel, Switzerland.	joel.krauser@novartis.com						Athersuch TJ, 2008, J PHARMACEUT BIOMED, V48, P151, DOI 10.1016/j.jpba.2008.05.003; Bateman KP, 2007, RAPID COMMUN MASS SP, V21, P1485, DOI 10.1002/rcm.2996; Bruin GJ, 2006, J CHROMATOGR A, V1133, P184, DOI 10.1016/j.chroma.2006.08.020; Cuyckens F, 2008, J CHROMATOGR A, V1209, P128, DOI 10.1016/j.chroma.2008.09.002; Dear GJ, 2008, J CHROMATOGR B, V868, P49, DOI 10.1016/j.jchromb.2008.04.013; Dear GJ, 2006, J CHROMATOGR B, V844, P96, DOI 10.1016/j.jchromb.2006.07.041; FDA, 2011, FDA MIST GUID; ICH, 2011, ICH M3 R2 GUID; ICRP, 2007, REC INT COMM RAD PRO; Tiller PR, 2008, RAPID COMMUN MASS SP, V22, P1053, DOI 10.1002/rcm.3472; Zhu MS, 2005, J PHARMACEUT BIOMED, V39, P233, DOI 10.1016/j.jpba.2005.03.012	11	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39070	10.1371/journal.pone.0039070	http://dx.doi.org/10.1371/journal.pone.0039070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723932	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300090
J	Orenstein, JM; Shulman, ST; Fox, LM; Baker, SC; Takahashi, M; Bhatti, TR; Russo, PA; Mierau, GW; de Chadarevian, JP; Perlman, EJ; Trevenen, C; Rotta, AT; Kalelkar, MB; Rowley, AH				Orenstein, Jan Marc; Shulman, Stanford T.; Fox, Linda M.; Baker, Susan C.; Takahashi, Masato; Bhatti, Tricia R.; Russo, Pierre A.; Mierau, Gary W.; de Chadarevian, Jean Pierre; Perlman, Elizabeth J.; Trevenen, Cynthia; Rotta, Alexandre T.; Kalelkar, Mitra B.; Rowley, Anne H.			Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study	PLOS ONE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; INFANTILE PERIARTERITIS-NODOSA; CYTOPLASMIC INCLUSION-BODIES; CORONARY-ARTERY LESIONS; INTRAVASCULAR ULTRASOUND; ADVENTITIAL FIBROBLASTS; YOUNG-ADULTS; ANEURYSMS; LONG; PATHOLOGY	Background: Kawasaki disease is recognized as the most common cause of acquired heart disease in children in the developed world. Clinical, epidemiologic, and pathologic evidence supports an infectious agent, likely entering through the lung. Pathologic studies proposing an acute coronary arteritis followed by healing fail to account for the complex vasculopathy and clinical course. Methodology/Principal Findings: Specimens from 32 autopsies, 8 cardiac transplants, and an excised coronary aneurysm were studied by light (n = 41) and transmission electron microscopy (n = 7). Three characteristic vasculopathic processes were identified in coronary (CA) and non-coronary arteries: acute self-limited necrotizing arteritis (NA), subacute/chronic (SA/C) vasculitis, and luminal myofibroblastic proliferation (LMP). NA is a synchronous neutrophilic process of the endothelium, beginning and ending within the first two weeks of fever onset, and progressively destroying the wall into the adventitia causing saccular aneurysms, which can thrombose or rupture. SA/C vasculitis is an asynchronous process that can commence within the first two weeks onward, starting in the adventitia/perivascular tissue and variably inflaming/damaging the wall during progression to the lumen. Besides fusiform and saccular aneurysms that can thrombose, SA/C vasculitis likely causes the transition of medial and adventitial smooth muscle cells (SMC) into classic myofibroblasts, which combined with their matrix products and inflammation create progressive stenosing luminal lesions (SA/C-LMP). Remote LMP apparently results from circulating factors. Veins, pulmonary arteries, and aorta can develop subclinical SA/C vasculitis and SA/C-LMP, but not NA. The earliest death (day 10) had both CA SA/C vasculitis and SA/C-LMP, and an "eosinophilic-type'' myocarditis. Conclusions/Significance: NA is the only self-limiting process of the three, is responsible for the earliest morbidity/mortality, and is consistent with acute viral infection. SA/C vasculitis can begin as early as NA, but can occur/persist for months to years; LMP causes progressive arterial stenosis and thrombosis and is composed of unique SMC-derived pathologic myofibroblasts.	[Orenstein, Jan Marc] George Washington Univ, Sch Med, Dept Pathol, Washington, DC 20052 USA; [Shulman, Stanford T.; Rowley, Anne H.] Northwestern Univ, Childrens Mem Hosp, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA; [Perlman, Elizabeth J.] Northwestern Univ, Childrens Mem Hosp, Dept Pathol, Feinberg Sch Med, Chicago, IL 60614 USA; [Rowley, Anne H.] Northwestern Univ, Childrens Mem Hosp, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60614 USA; [Fox, Linda M.] Loyola Univ, Stritch Sch Med, Dept Pathol, Maywood, IL 60153 USA; [Baker, Susan C.] Loyola Univ, Stritch Sch Med, Dept Microbiol Immunol, Maywood, IL 60153 USA; [Takahashi, Masato] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Sch Med, Los Angeles, CA 90089 USA; [Bhatti, Tricia R.; Russo, Pierre A.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mierau, Gary W.] Childrens Hosp Colorado, Dept Pathol, Aurora, CO USA; [de Chadarevian, Jean Pierre] Drexel Univ, St Christophers Hosp Children, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Trevenen, Cynthia] Alberta Childrens Prov Gen Hosp, Dept Pathol & Lab Med, Calgary, AB, Canada; [Rotta, Alexandre T.] Indiana Univ Hlth, Dept Pediat, Riley Hosp Children, Indianapolis, IN USA; [Kalelkar, Mitra B.] Cook Cty Inst Forens Med, Off Med Examiner, Chicago, IL USA	George Washington University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Loyola University Chicago; Children's Hospital Los Angeles; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Colorado; Drexel University; Alberta Childrens Hospital; University of Calgary; Indiana University System; James Whitcomb Riley Hospital Children	Orenstein, JM (corresponding author), George Washington Univ, Sch Med, Dept Pathol, Washington, DC 20052 USA.	jmo@gwu.edu		Rowley, Anne/0000-0003-4695-6676; Rotta, Alexandre/0000-0002-4406-2276; Perlman, Elizabeth/0000-0001-6853-6221	National Institutes of Health [R01HL63771, R21HL109955, R21HL089526]; Max Goldenberg Foundation; Children's Memorial Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109955, R01HL063771, R21HL089526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Goldenberg Foundation; Children's Memorial Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health grant R01HL63771, R21HL109955, R21HL089526, the Max Goldenberg Foundation, and the Kawasaki Disease Fund of the Children's Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO S, 1980, ACTA PATHOL JAPON, V30, P681; AMANO S, 1979, JPN CIRC J, V43, P633, DOI 10.1253/jcj.43.633; Ashrafi AH, 2007, PEDIATR DEVEL PATHOL, V10, P491, DOI 10.2350/06-10-0172.1; Barbaro G, 2003, RHEUMATOLOGY, V42, P1427, DOI 10.1093/rheumatology/keg365; Blanchard JN, 2003, CLIN INFECT DIS, V36, P105, DOI 10.1086/345465; Brenner JL, 2000, CAN J CARDIOL, V16, P1017; Burke AP, 1998, PEDIATRICS, V101, P108, DOI 10.1542/peds.101.1.108; Burns JC, 2008, J PEDIATR-US, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; Checchia PA, 2001, PEDIATR CARDIOL, V22, P102, DOI 10.1007/s002460010170; Checchia PA, 1997, PEDIATRICS, V100, P695, DOI 10.1542/peds.100.4.695; de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X; Fleenor BS, 2009, AM J PHYSIOL-HEART C, V296, pH1532, DOI 10.1152/ajpheart.00566.2008; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; FUJIWARA H, 1978, PEDIATRICS, V61, P100; FUJIWARA T, 1988, CIRCULATION, V78, P345, DOI 10.1161/01.CIR.78.2.345; Fukushige J, 1996, PEDIATR CARDIOL, V17, P71, DOI 10.1007/BF02505086; FURUSHO K, 1984, LANCET, V2, P1055; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Han RK, 2000, ARCH PEDIAT ADOL MED, V154, P694, DOI 10.1001/archpedi.154.7.694; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hunsaker Donna M, 2003, J Ky Med Assoc, V101, P233; Iemura M, 2000, HEART, V83, P307, DOI 10.1136/heart.83.3.307; Ishii M, 2001, PEDIATR INT, V43, P211, DOI 10.1046/j.1442-200x.2001.01373.x; JOHNSON DE, 1989, J HEART TRANSPLANT, V8, P349; Johnson RM, 2001, CLIN INFECT DIS, V32, P1628, DOI 10.1086/320523; JOSHI V V, 1987, Pediatric Pathology, V7, P261; Kawasaki T, 1967, Arerugi, V16, P178; Kobayashi T, 1998, CIRCULATION, V98, P92, DOI 10.1161/01.CIR.98.1.92; Landing B H, 1987, Am J Cardiovasc Pathol, V1, P218; LANDING BH, 1977, PEDIATRICS, V59, P651; Levy DM, 2005, J RHEUMATOL, V32, P928; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Manlhiot C, 2010, PEDIATR CARDIOL, V31, P242, DOI 10.1007/s00246-009-9599-7; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mitani Y, 2009, CIRCULATION, V119, P2829, DOI 10.1161/CIRCULATIONAHA.108.818609; Moran AM, 2000, AM HEART J, V139, P217, DOI 10.1016/S0002-8703(00)90229-1; Nakamura Y, 2010, J EPIDEMIOL; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; NEWBURGER JW, 1989, CIRCULATION, V79, P1237, DOI 10.1161/01.CIR.79.6.1237; Porneuf M, 1996, INT J DERMATOL, V35, P292, DOI 10.1111/j.1365-4362.1996.tb03007.x; Rowley AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001582; Rowley AH, 2008, NAT REV MICROBIOL, V6, P394, DOI 10.1038/nrmicro1853; Rowley AH, 2011, J INFECT DIS, V203, P1021, DOI 10.1093/infdis/jiq136; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; SASAGURI Y, 1982, J PEDIATR-US, V100, P225, DOI 10.1016/S0022-3476(82)80639-2; Senzaki H, 2008, CIRCULATION, V118, P2763, DOI 10.1161/CIRCULATIONAHA.107.749515; Siow RCM, 2003, CARDIOVASC RES, V59, P212, DOI 10.1016/S0008-6363(03)00292-X; Stankovic K, 2007, J INFECTION, V55, P488, DOI 10.1016/j.jinf.2007.09.005; SUNDEL RP, 1993, J PEDIATR-US, V123, P657, DOI 10.1016/S0022-3476(05)80972-2; Suzuki A, 2000, JPN HEART J, V41, P245; Suzuki A, 2000, CIRCULATION, V101, P2935, DOI 10.1161/01.CIR.101.25.2935; Takahashi K, 2001, PEDIATR CARDIOL, V22, P138, DOI 10.1007/s002460010180; Takahashi K, 2007, PATHOLOGY CASE REV, V12, P193; Takahashi Kei, 2010, Ann Vasc Dis, V3, P173, DOI 10.3400/avd.sasvp01003; TAKAHASHI M, 1989, CIRCULATION, V79, P1398, DOI 10.1161/01.CIR.79.6.1398; TAKAHASHI M, 1987, CIRCULATION, V75, P387, DOI 10.1161/01.CIR.75.2.387; TANAKA N, 1976, ARCH PATHOL LAB MED, V100, P81; Terashima M, 2002, CIRCULATION, V106, P887, DOI 10.1161/01.CIR.0000030708.86783.92; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tsuda E, 2002, PEDIATR CARDIOL, V23, P9, DOI 10.1007/s00246-001-0004-4; VIRMANI R, 1986, HUM PATHOL, V17, P575, DOI 10.1016/S0046-8177(86)80129-0; Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78; YOGANATHAN K, 1995, J INFECTION, V30, P165, DOI 10.1016/S0163-4453(95)80014-X; YUTANI C, 1981, ARCH PATHOL LAB MED, V105, P470; Zalewski A, 2002, CIRC RES, V91, P652, DOI 10.1161/01.RES.0000038996.97287.9A	68	202	212	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38998	10.1371/journal.pone.0038998	http://dx.doi.org/10.1371/journal.pone.0038998			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723916	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300078
J	Zhao, YY; Li, YP; Lou, GY; Zhao, L; Xu, ZZ; Zhang, Y; He, FT				Zhao, Yuanyin; Li, Yuping; Lou, Guiyu; Zhao, Li; Xu, Zhizhen; Zhang, Yan; He, Fengtian			MiR-137 Targets Estrogen-Related Receptor Alpha and Impairs the Proliferative and Migratory Capacity of Breast Cancer Cells	PLOS ONE			English	Article							INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ERR-ALPHA; GENE-EXPRESSION; MICRORNA TARGETS; ORPHAN RECEPTOR; IDENTIFICATION; GROWTH; RNAS; COACTIVATOR-1-ALPHA; DIFFERENTIATION	ERR alpha is an orphan nuclear receptor emerging as a novel biomarker of breast cancer. Over-expression of ERR alpha in breast tumor is considered as a prognostic factor of poor clinical outcome. The mechanisms underlying the dysexpression of this nuclear receptor, however, are poorly understood. MicroRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play important roles in tumor initiation and progression. In the present study, we have identified that the expression of ERR alpha is regulated by miR-137, a potential tumor suppressor microRNA. The bioinformatics search revealed two putative and highly conserved target-sites for miR-137 located within the ERR alpha 3'UTR at nt 480-486 and nt 596-602 respectively. Luciferase-reporter assay demonstrated that the two predicted target sites were authentically functional. They mediated the repression of reporter gene expression induced by miR-137 in an additive manner. Moreover, ectopic expression of miR-137 down-regulated ERR alpha expression at both protein level and mRNA level, and the miR-137 induced ERR alpha-knockdown contributed to the impaired proliferative and migratory capacity of breast cancer cells. Furthermore, transfection with miR-137mimics suppressed at least two downstream target genes of ERR alpha-CCNE1 and WNT11, which are important effectors of ERR alpha implicated in tumor proliferation and migration. Taken together, our results establish a role of miR-137 in negatively regulating ERR alpha expression and breast cancer cell proliferation and migration. They suggest that manipulating the expression level of ERR alpha by microRNAs has the potential to influence breast cancer progression.	[Zhao, Yuanyin; Li, Yuping; Lou, Guiyu; Zhao, Li; Xu, Zhizhen; Zhang, Yan; He, Fengtian] Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Army Medical University	Zhao, YY (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing, Peoples R China.	yupingli1999@yahoo.com; hefengtian06@yahoo.com.cn	Li, Yuping/J-3138-2018; He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	National Natural Science Foundation of China [30800638, 81072155]; Natural Science Foundation of Chongqing [CSTC2008BB5019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work was funded by grants from National Natural Science Foundation of China (No. 30800638; No. 81072155) and Natural Science Foundation of Chongqing (No. CSTC2008BB5019) to YPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ariazi EA, 2002, CANCER RES, V62, P6510; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bieche I, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-37; Busch BB, 2004, J MED CHEM, V47, P5593, DOI 10.1021/jm049334f; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chen QJ, 2011, DIGEST DIS SCI, V56, P2009, DOI 10.1007/s10620-010-1536-3; Chen XY, 2011, INVEST OPHTH VIS SCI, V52, P1193, DOI 10.1167/iovs.10-5272; Chisamore MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005624; Chisarnore MJ, 2009, MOL CANCER THER, V8, P672, DOI 10.1158/1535-7163.MCT-08-1028; Deblois G, 2011, BBA-MOL BASIS DIS, V1812, P1032, DOI 10.1016/j.bbadis.2010.12.009; Deblois G, 2010, CANCER RES, V70, P10277, DOI 10.1158/0008-5472.CAN-10-2840; Deblois G, 2009, CANCER RES, V69, P6149, DOI 10.1158/0008-5472.CAN-09-1251; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jahanzeb M, 2008, CLIN BREAST CANCER, V8, P324, DOI 10.3816/CBC.2008.n.037; Jarzabek K, 2009, J STEROID BIOCHEM, V113, P127, DOI 10.1016/j.jsbmb.2008.12.005; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kirikoshi H, 2001, INT J MOL MED, V8, P651; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; LAW ML, 1987, P NATL ACAD SCI USA, V84, P2877, DOI 10.1073/pnas.84.9.2877; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu DX, 2003, ENDOCRINOLOGY, V144, P4894, DOI 10.1210/en.2003-0432; Liu M, 2011, INT J CANCER, V128, P1269, DOI 10.1002/ijc.25452; Moelans CB, 2010, MODERN PATHOL, V23, P1029, DOI 10.1038/modpathol.2010.84; O'Day E, 2011, BREAST CANCER RES, V12, P201; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Seely J, 2005, ENDOCRINOLOGY, V146, P3605, DOI 10.1210/en.2004-1619; Sieuwerts AM, 2006, CLIN CANCER RES, V12, P3319, DOI 10.1158/1078-0432.CCR-06-0225; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Uysal-Onganer P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-55; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Yang C, 1999, CANCER RES, V59, P4519; Yang C, 1998, CANCER RES, V58, P5695	57	97	107	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39102	10.1371/journal.pone.0039102	http://dx.doi.org/10.1371/journal.pone.0039102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723937	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300092
J	Yamamoto, E; Kataoka, K; Dong, YF; Koibuchi, N; Toyama, K; Sueta, D; Katayama, T; Yasuda, O; Ogawa, H; Kim-Mitsuyama, S				Yamamoto, Eiichiro; Kataoka, Keiichiro; Dong, Yi-Fei; Koibuchi, Nobutaka; Toyama, Kensuke; Sueta, Daisuke; Katayama, Tetsuji; Yasuda, Osamu; Ogawa, Hisao; Kim-Mitsuyama, Shokei			Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats	PLOS ONE			English	Article							MECHANISMS; SENSITIVITY; PRESSURE; DISEASE; INJURY	The combination therapy of an angiotensin receptor blocker (ARB) with a calcium channel blocker (CCB) or with a diuretic is favorably recommended for the treatment of hypertension. However, the difference between these two combination therapies is unclear. The present work was undertaken to examine the possible difference between the two combination therapies in vascular protection. Salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP) were divided into 6 groups, and they were orally administered (1) vehicle, (2) olmesartan, an ARB, (3) azelnidipine, a CCB, (4) hydrochlorothiazide, a diuretic, (5) olmesartan combined with azelnidipine, or (6) olmesartan combined with hydrochlorothiazide. Olmesartan combined with either azelnidipine or hydrochlorothiazide ameliorated vascular endothelial dysfunction and remodeling in SHRSP more than did monotherapy with either agent. However, despite a comparable blood pressure lowering effect between the two treatments, azelnidipine enhanced the amelioration of vascular endothelial dysfunction and remodeling by olmesartan to a greater extent than did hydrochlorothiazide in salt-loaded SHRSP. The increased enhancement by azelnidipine of olmesartan-induced vascular protection than by hydrochlorothiazide was associated with a greater amelioration of vascular nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation, superoxide, mitogen-activated protein kinase activation, and with a greater activation of the Akt/endothelial nitric oxide synthase (eNOS) pathway. These results provided the first evidence that a CCB potentiates the vascular protective effects of an ARB in salt-sensitive hypertension, compared with a diuretic, and provided a novel rationale explaining the benefit of the combination therapy with an ARB and a CCB.	[Yamamoto, Eiichiro; Kataoka, Keiichiro; Dong, Yi-Fei; Koibuchi, Nobutaka; Toyama, Kensuke; Sueta, Daisuke; Katayama, Tetsuji; Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan; [Yamamoto, Eiichiro; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Dong, Yi-Fei] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang, Peoples R China; [Yasuda, Osamu] Kumamoto Univ Hosp, Dept Cardiovasc Clin & Translat Res, Kumamoto, Japan	Kumamoto University; Kumamoto University; Nanchang University; Kumamoto University	Yamamoto, E (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan.	kimmitsu@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [23390058]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (23390058). http://www.mext.go.jp/english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Force T, 1996, CIRC RES, V78, P947, DOI 10.1161/01.RES.78.6.947; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nakamura T, 2008, HYPERTENSION, V51, P296, DOI 10.1161/HYPERTENSIONAHA.107.099044; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Yamamoto E, 2007, ARTERIOSCL THROM VAS, V27, P2569, DOI 10.1161/ATVBAHA.107.153692; Yamamoto E, 2007, HYPERTENSION, V50, P657, DOI 10.1161/HYPERTENSIONAHA.107.095315	17	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39162	10.1371/journal.pone.0039162	http://dx.doi.org/10.1371/journal.pone.0039162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720058	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800048
J	Gupta, G; Qin, HN; Song, JX				Gupta, Garvita; Qin, Haina; Song, Jianxing			Intrinsically Unstructured Domain 3 of Hepatitis C Virus NS5A Forms a "Fuzzy Complex" with VAPB-MSP Domain Which Carries ALS-Causing Mutations	PLOS ONE			English	Article							OXYSTEROL-BINDING-PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; RNA REPLICATION COMPLEX; NONSTRUCTURAL PROTEINS; ENDOPLASMIC-RETICULUM; DISORDERED PROTEIN; CRYSTAL-STRUCTURE; NMR; IDENTIFICATION; MEMBRANE	Hepatitis C virus (HCV) affects nearly 200 million people worldwide and is a leading factor for serious chronic liver diseases. For replicating HCV genome, the membrane-associated replication machinery needs to be formed by both HCV nonstructural proteins including NS5A and human host factors. Recently NS5A has been identified to bind ER-anchored human VAP proteins and consequently this interaction may serve as a novel target for design of anti-HCV drugs. So far no biophysical characterization of this interaction has been reported. Here, we dissected the 243-residue VAPB into 4 and 447-residue NS5A into 10 fragments, followed by CD and NMR characterization of their structural properties. Subsequently, binding interactions between these fragments have been extensively assessed by NMR HSQC titration which is very powerful in detecting even very weak binding. The studies lead to three important findings: 1). a "fuzzy complex" is formed between the intrinsically-unstructured third domain (D3) of NS5A and the well-structured MSP domain of VAPB, with an average dissociation constant (Kd) of similar to 5 mu M. 2). The binding-important residues on both NS5A-D3 and VAPB-MSP have been successfully mapped out, which provided experimental constraints for constructing the complex structure. In the complex, unstructured D3 binds to three surface pockets on one side of the MSP structure. Interestingly, two ALS-causing mutations T46I and P56S are also located on the D3-MSP interface. Moreover, NS5A-D3, FFAT-containing proteins and EphA4 appear to have overlapped binding interfaces on the MSP domain. 3). NS5A-D3 has been experimentally confirmed to competes with EphA4 in binding to the MSP domain, and T46I mutation of MSP dramatically abolishes its binding ability to D3. Our study not only provides essential foundation for further deciphering structure and function of the HCV replication machinery, but may also shed light on rationalizing a recent observation that a chronic HCV patient surprisingly developed ALS-like syndrome.	[Gupta, Garvita; Qin, Haina; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	bchsj@nus.edu.sg	Song, Jianxing/H-8026-2012; Qin, Haina/AAB-7486-2020	Song, Jianxing/0000-0003-0224-6322; Haina, Qin/0000-0002-9175-8014	Ministry of Education (MOE) of Singapore Tier 2 Grant [MOE2011-T2-1-096]; National Medical Research Council (NMRC) grant [R154-000-454-213]	Ministry of Education (MOE) of Singapore Tier 2 Grant; National Medical Research Council (NMRC) grant	This study is supported by Ministry of Education (MOE) of Singapore Tier 2 Grant MOE2011-T2-1-096 and National Medical Research Council (NMRC) grant R154-000-454-213 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Akhvlediani T, 2009, Georgian Med News, P70; Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Asselah T, 2011, J HEPATOL, V54, P1069, DOI 10.1016/j.jhep.2010.11.033; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Bastos AF, 2011, NEUROL INT, V3, P12, DOI 10.4081/ni.2011.e4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Hardy RW, 2003, J VIROL, V77, P2029, DOI 10.1128/JVI.77.3.2029-2037.2003; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lim SP, 2001, VIRUS GENES, V23, P89, DOI 10.1023/A:1011143731677; Liu JX, 2008, BIOCHEM BIOPH RES CO, V366, P585, DOI 10.1016/j.bbrc.2007.12.022; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Lohmann V, 1996, J HEPATOL, V24, P11; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Miao LL, 2011, FEBS LETT, V585, P3126, DOI 10.1016/j.febslet.2011.08.048; Moriishi Kohji, 2003, Antiviral Chemistry & Chemotherapy, V14, P285; Nachreiner T, 2010, BIOCHEM BIOPH RES CO, V394, P703, DOI 10.1016/j.bbrc.2010.03.055; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Qin HN, 2008, BIOCHEMISTRY-US, V47, P13647, DOI 10.1021/bi8017976; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Rice Charles M, 2011, Top Antivir Med, V19, P117; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022; Song JX, 2001, J BIOL CHEM, V276, P41205, DOI 10.1074/jbc.M103449200; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yamasaki LHT, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-14; Yang G, 2004, J VIROL, V78, P10202, DOI 10.1128/JVI.78.18.10202-10205.2004; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	84	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39261	10.1371/journal.pone.0039261	http://dx.doi.org/10.1371/journal.pone.0039261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720086	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900092
J	Jones, COH; Wasunna, B; Sudoi, R; Githinji, S; Snow, RW; Zurovac, D				Jones, Caroline O. H.; Wasunna, Beatrice; Sudoi, Raymond; Githinji, Sophie; Snow, Robert W.; Zurovac, Dejan			"Even if You Know Everything You Can Forget": Health Worker Perceptions of Mobile Phone Text-Messaging to Improve Malaria Case-Management in Kenya	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; LUMEFANTRINE TREATMENT POLICY; ARTEMETHER-LUMEFANTRINE; CLINICAL MANAGEMENT; GUIDELINES; PERFORMANCE; ADHERENCE; IMPLEMENTATION; MINDLINES; TANZANIA	This paper presents the results of a qualitative study to investigate the perceptions and experiences of health workers involved in a a cluster-randomized controlled trial of a novel intervention to improve health worker malaria case-management in 107 government health facilities in Kenya. The intervention involved sending text-messages about paediatric outpatient malaria case-management accompanied by "motivating" quotes to health workers' mobile phones. Ten malaria messages were developed reflecting recommendations from the Kenyan national guidelines. Two messages were delivered per day for 5 working days and the process was repeated for 26 weeks (May to October 2009). The accompanying quotes were unique to each message. The intervention was delivered to 119 health workers and there were significant improvements in correct artemether-lumefantrine (AL) management both immediately after the intervention (November 2009) and 6 months later (May 2010). In-depth interviews with 24 health workers were undertaken to investigate the possible drivers of this change. The results suggest high acceptance of all components of the intervention, with the active delivery of information in an on the job setting, the ready availability of new and stored text messages and the perception of being kept 'up to date' as important factors influencing practice. Applying the construct of stages of change we infer that in this intervention the SMS messages were operating primarily at the action and maintenance stages of behaviour change achieving their effect by creating an enabling environment and providing a prompt to action for the implementation of case management practices that had already been accepted as the clinical norm by the health workers. Future trials testing the effectiveness of SMS reminders in creating an enabling environment for the establishment of new norms in clinical practice as well as in providing a prompt to action for the implementation of the new case-management guidelines are justified.	[Jones, Caroline O. H.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Jones, Caroline O. H.; Snow, Robert W.; Zurovac, Dejan] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Jones, Caroline O. H.] Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX3 7LF, England; [Wasunna, Beatrice; Sudoi, Raymond; Githinji, Sophie; Snow, Robert W.; Zurovac, Dejan] KEMRI Wellcome Trust Res Programme, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; [Zurovac, Dejan] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA	University of Oxford; University of Oxford; Boston University	Jones, COH (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	cjones@kilifi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust, UK [084253]; Wellcome Trust [084253, 079080, 092654/Z/10/A]	Wellcome Trust, UK(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust, UK (#084253). Dr. Snow is supported by the Wellcome Trust as Principal Research Fellow [#079080] which also supports Dr. Githinji. Dr. Zurovac and Dr. Sudoi are supported by the Welcome Trust project grant [#084253]. All authors acknowledge support from the Wellcome Trust core grant [#092654/Z/10/A]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2005, HEALTH EDUC RES, V20, P237, DOI 10.1093/her/cyg105; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chilvers R, 2002, BRIT J PSYCHIAT, V181, P99; Chinkhumba J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-209; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; DeRenzi B, 2012, INT C INF COMM TECHN; Felch WC, 1997, JAMA-J AM MED ASSOC, V277, P155, DOI 10.1001/jama.277.2.155; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hayward RSA, 1996, J GEN INTERN MED, V11, P176, DOI 10.1007/BF02600272; Kyabayinze D, 2010, MALARIA J, V9, pP18; Moulding NT, 1999, QUAL HEALTH CARE, V8, P177, DOI 10.1136/qshc.8.3.177; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; QSR International, 2010, NVIVO; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Robertson R., 2006, INTERVENTIONS CHANGE; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2010, 1 GLOB S HLTH SYST R; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Sutton S, 2000, PSYCHOL HEALTH, V15, P163, DOI 10.1080/08870440008400298; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Treatman D, 2012, STRENGTHENING COMMUN; Uzochukwu BSC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014627; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; World Health Organization, 2010, MAL TREATM GUID; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	37	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38636	10.1371/journal.pone.0038636	http://dx.doi.org/10.1371/journal.pone.0038636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719911	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900039
J	Kumar, A; Majid, M; Kunisch, R; Rani, PS; Qureshi, IA; Lewin, A; Hasnain, SE; Ahmed, N				Kumar, Ashutosh; Majid, Mohammad; Kunisch, Ralph; Rani, Pittu Sandhya; Qureshi, Insaf A.; Lewin, Astrid; Hasnain, Seyed E.; Ahmed, Niyaz			Mycobacterium tuberculosis DosR Regulon Gene Rv0079 Encodes a Putative, 'Dormancy Associated Translation Inhibitor (DATIN)'	PLOS ONE			English	Article							CONSENSUS PREDICTION; PROTEIN; PERSISTENCE; TOPOLOGY; DOCKING; LATENCY; SERVER; BCG	Mycobacterium tuberculosis is a major human pathogen that has evolved survival mechanisms to persist in an immune-competent host under a dormant condition. The regulation of M. tuberculosis metabolism during latent infection is not clearly known. The dormancy survival regulon (DosR regulon) is chiefly responsible for encoding dormancy related functions of M. tuberculosis. We describe functional characterization of an important gene of DosR regulon, Rv0079, which appears to be involved in the regulation of translation through the interaction of its product with bacterial ribosomal subunits. The protein encoded by Rv0079, possibly, has an inhibitory role with respect to protein synthesis, as revealed by our experiments. We performed computational modelling and docking simulation studies involving the protein encoded by Rv0079 followed by in vitro translation and growth curve analysis experiments, involving recombinant E. coli and Bacille Calmette Guerin (BCG) strains that overexpressed Rv0079. Our observations concerning the interaction of the protein with the ribosomes are supportive of its role in regulation/inhibition of translation. We propose that the protein encoded by locus Rv0079 is a 'dormancy associated translation inhibitor' or DATIN.	[Kumar, Ashutosh; Majid, Mohammad; Rani, Pittu Sandhya; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Kunisch, Ralph; Lewin, Astrid] Robert Koch Inst, Berlin, Germany; [Hasnain, Seyed E.] Indian Inst Technol, Sch Biol Sci, New Delhi, India; [Hasnain, Seyed E.] Inst Life Sci, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] King Saud Univ, Riyadh, Saudi Arabia; [Ahmed, Niyaz] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia	University of Hyderabad; Robert Koch Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; King Saud University; Universiti Malaya	Kumar, A (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.	ahmed.nizi@gmail.com	Qureshi, Insaf Ahmed/W-1957-2019	Qureshi, Insaf Ahmed/0000-0001-7720-7067; Hasnain, Seyed/0000-0002-2967-0791	Centre of Excellence Grant from the Department of Biotechnology of the Indian Government [BT/01/C0E/07/02]; German Research Foundation (DFG); international research training group (IRTG) [GRK1673 (Berlin-Hyderabad)]; University of Malaya High Impact Research (HIR) [UM.C/625/1HIR/MOHE/CHAN-02]; University of Malaya (HIRG) [UM.C/625/1/HIR/MOHE/CHAN-02 [A000002-5000 1]]	Centre of Excellence Grant from the Department of Biotechnology of the Indian Government; German Research Foundation (DFG)(German Research Foundation (DFG)); international research training group (IRTG); University of Malaya High Impact Research (HIR); University of Malaya (HIRG)	This work was primarily supported by a Centre of Excellence Grant from the Department of Biotechnology of the Indian Government entitled 'Multidisciplinary approaches aimed at interventions against Mycobacterium tuberculosis' [BT/01/C0E/07/02] to NA (component B2b). The authors would like to also acknowledge support from the German Research Foundation (DFG) sponsored international research training group (IRTG) entitled 'Internationales Graduiertenkolleg - functional molecular infection epidemiology - GRK1673 (Berlin-Hyderabad)' of which NA is a speaker, and partial support through the University of Malaya High Impact Research (HIR) grant (Ref. UM.C/625/1HIR/MOHE/CHAN-02). SEH is a J. C. Bose National Fellow (India) and a Robert Koch Fellow of the Robert Koch Institute, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Elisabeth Kamal for excellent technical assistance and Sven Maurischat for providing materials and help. We acknowledge support from University of Malaya (HIRG, reference UM.C/625/1/HIR/MOHE/CHAN-02 [A000002-5000 1]) - Molecular Genetics. We would like to convey our acknowledgement of help received from Syed Asif Hasan and Priyadarshini Yerra in carrying out additional confirmatory growth curve experiments involving DATIN and Hsp65.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; El-Sharoud Walid M., 2004, Science Progress, V87, P137, DOI 10.3184/003685004783238517; Flores Valdez MA, 2010, TUBERCULOSIS EDINB, V90, P197, DOI DOI 10.1016/J.TUBE.2010.04.001; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mishra S, 2009, J BIOMOL STRUCT DYN, V27, P283, DOI 10.1080/07391102.2009.10507316; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sharbati-Tehrani S, 2004, INT J MED MICROBIOL, V294, P235, DOI 10.1016/j.ijmm.2004.02.001; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	28	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38709	10.1371/journal.pone.0038709	http://dx.doi.org/10.1371/journal.pone.0038709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719925	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900043
J	Langevin, C; Blanco, M; Martin, SAM; Jouneau, L; Bernardet, JF; Houel, A; Lunazzi, A; Duchaud, E; Michel, C; Quillet, E; Boudinot, P				Langevin, Christelle; Blanco, Mar; Martin, Samuel A. M.; Jouneau, Luc; Bernardet, Jean-Francois; Houel, Armel; Lunazzi, Aurelie; Duchaud, Eric; Michel, Christian; Quillet, Edwige; Boudinot, Pierre			Transcriptional Responses of Resistant and Susceptible Fish Clones to the Bacterial Pathogen Flavobacterium psychrophilum	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; INNATE IMMUNE-RESPONSE; RAINBOW-TROUT; EXPERIMENTAL-INFECTION; INTRAOVUM INFECTION; PURIFICATION; COMPLEMENT; WALBAUM; DISEASE; METALLOPROTEASE	Flavobacterium psychrophilum is a bacterial species that represents one of the most important pathogens for aquaculture worldwide, especially for salmonids. To gain insights into the genetic basis of the natural resistance to F. psychrophilum, we selected homozygous clones of rainbow trout with contrasted susceptibility to the infection. We compared the transcriptional response to the bacteria in the pronephros of a susceptible and a resistant line by micro-array analysis five days after infection. While the basal transcriptome of healthy fish was significantly different in the resistant and susceptible lines, the transcriptome modifications induced by the bacteria involved essentially the same genes and pathways. The response to F. psychrophilum involved antimicrobial peptides, complement, and a number of enzymes and chemokines. The matrix metalloproteases mmp9 and mmp13 were among the most highly induced genes in both genetic backgrounds. Key genes of both pro- and anti-inflammatory response such as IL1 and IL10, were up-regulated with a greater magnitude in susceptible animals where the bacterial load was also much higher. While higher resistance to F. psychrophilum does not seem to be based on extensive differences in the orientation of the immune response, several genes including complement C3 showed stronger induction in the resistant fish. They may be important for the variation of susceptibility to the infection.	[Quillet, Edwige] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Langevin, Christelle; Jouneau, Luc; Bernardet, Jean-Francois; Houel, Armel; Lunazzi, Aurelie; Duchaud, Eric; Michel, Christian; Boudinot, Pierre] INRA, Mol Virol & Immunol, Domaine Vilvert, Jouy En Josas, France; [Blanco, Mar] Univ Complutense, Fac Vet Sci, Dept Anim Hlth, E-28040 Madrid, Spain; [Martin, Samuel A. M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Complutense University of Madrid; University of Aberdeen	Langevin, C (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	Pierre.Boudinot@jouy.inra.fr	Jouneau, Luc/AAC-4711-2020; Martin, Samuel A/K-5396-2012; boudinot, pierre/L-4246-2016	boudinot, pierre/0000-0002-7490-9677; Langevin, Christelle/0000-0002-6013-4460; Martin, Samuel/0000-0003-0289-6317; BLANCO, MARIA DEL MAR/0000-0003-4335-4346	Institut National Recherche Agronomique; Agence Nationale de la Recherche [ANR-513 07-GANI-002]	Institut National Recherche Agronomique; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work has been supported by Institut National Recherche Agronomique and the Agence Nationale de la Recherche (ANR-513 07-GANI-002 FLAVORES project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardet J.F., 1988, Bulletin of the European Association of Fish Pathologists, V8, P104; Bernardet J.F., 2011, BERGEYS MANUAL SYSTE, V4, P112; Bernardet J.-F., 2006, PROKARYOTES, P481, DOI [10.1007/0-387-30747-8_17, DOI 10.1007/0-387-30747-8_17]; Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006&lt;0224:EDOPFS&gt;2.3.CO;2; Casel Pierrot, 2009, BMC Proc, V3 Suppl 4, pS3, DOI 10.1186/1753-6561-3-S4-S3; Cipriano RC, 2005, J AQUAT ANIM HEALTH, V17, P275, DOI 10.1577/H05-003.1; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Dalsgaard I., 1993, Annual Review of Fish Diseases, V3, P127, DOI 10.1016/0959-8030(93)90032-7; Decostere A, 2001, J FISH DIS, V24, P481, DOI 10.1046/j.1365-2761.2001.00322.x; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Ekman E, 2003, J FISH DIS, V26, P529, DOI 10.1046/j.1365-2761.2003.00487.x; Faruk MAR, 2000, THESIS U STIRLING ST; Garcia C, 2000, DIS AQUAT ORGAN, V42, P191, DOI 10.3354/dao042191; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Hadidi S, 2008, J IMMUNOL, V180, P4156, DOI 10.4049/jimmunol.180.6.4156; Holt R. A., 1993, P3; Holt RA, 1988, THESIS OREGON STATE; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Koller G, 2009, CURR PHARM DESIGN, V15, P2272, DOI 10.2174/138161209788682361; Kondo M, 2002, MICROBES INFECT, V4, P279, DOI 10.1016/S1286-4579(02)01539-3; Kumagai A, 2010, FISH PATHOL, V45, P115, DOI 10.3147/jsfp.45.115; Kumagai A, 2010, FISH PATHOL, V45, P31, DOI 10.3147/jsfp.45.31; LEHMANN J, 1991, DIS AQUAT ORGAN, V10, P217, DOI 10.3354/dao010217; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Merle C, 2003, J APPL MICROBIOL, V94, P1120, DOI 10.1046/j.1365-2672.2003.01946.x; Moller JD, 2005, J FISH DIS, V28, P391, DOI 10.1111/j.1365-2761.2005.00639.x; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Nematollahi A, 2003, DIS AQUAT ORGAN, V55, P101, DOI 10.3354/dao055101; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x; Ostland VE, 1997, J FISH DIS, V20, P443, DOI 10.1046/j.1365-2761.1997.00323.x; Ostland VE, 1999, J FISH DIS, V22, P351, DOI 10.1046/j.1365-2761.1999.00181.x; Otis EJ, 1984, THESIS U RHODE ISLAN; Overturf K, 2006, J FISH DIS, V29, P215, DOI 10.1111/j.1365-2761.2006.00707.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell MK, 2011, FISH SHELLFISH IMMUN, V30, P84, DOI 10.1016/j.fsi.2010.09.007; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; Rahman MH, 2002, FISH SHELLFISH IMMUN, V12, P169, DOI 10.1006/fsim.2001.0362; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ramadoss P, 2010, J BIOL CHEM, V285, P16453, DOI 10.1074/jbc.M109.066936; Rangdale RE, 1999, VET REC, V144, P251; Salem M, 2008, J FISH BIOL, V72, P2187, DOI 10.1111/j.1095-8649.2008.01860.x; Secades P, 2003, FEMS MICROBIOL LETT, V226, P273, DOI 10.1016/S0378-1097(03)00599-8; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Sundell K, 2011, J FISH DIS, V34, P373, DOI 10.1111/j.1365-2761.2011.01250.x; Sunyer JO, 1996, P NATL ACAD SCI USA, V93, P8546, DOI 10.1073/pnas.93.16.8546; Tacchi L, 2011, PHYSIOL GENOMICS, V43, P1241, DOI 10.1152/physiolgenomics.00086.2011; Tanaka Y, 2012, MOD RHEUMATOL, V22, P128, DOI 10.1007/s10165-011-0475-y; Vatsos IN, 2001, LETT APPL MICROBIOL, V33, P178, DOI 10.1046/j.1472-765x.2001.00980.x; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Wiklund T, 2002, FISH SHELLFISH IMMUN, V12, P141, DOI 10.1006/fsim.2001.0360	54	37	37	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39126	10.1371/journal.pone.0039126	http://dx.doi.org/10.1371/journal.pone.0039126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720048	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900084
J	Malik-Kale, P; Winfree, S; Steele-Mortimer, O				Malik-Kale, Preeti; Winfree, Seth; Steele-Mortimer, Olivia			The Bimodal Lifestyle of Intracellular Salmonella in Epithelial Cells: Replication in the Cytosol Obscures Defects in Vacuolar Replication	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; PATHOGENICITY ISLAND 2; MURINE MACROPHAGES; EFFECTOR PROTEINS; HOST-CELLS; INFECTION; SURVIVAL; SIFA	Salmonella enterica serovar Typhimurium invades and proliferates within epithelial cells. Intracellular bacteria replicate within a membrane bound vacuole known as the Salmonella containing vacuole. However, this bacterium can also replicate efficiently in the cytosol of epithelial cells and net intracellular growth is a product of both vacuolar and cytosolic replication. Here we have used semi-quantitative single-cell analyses to investigate the contribution of each of these replicative niches to intracellular proliferation in cultured epithelial cells. We show that cytosolic replication can account for the majority of net replication even though it occurs in less than 20% of infected cells. Consequently, assays for net growth in a population of infected cells, for example by recovery of colony forming units, are not good indicators of vacuolar proliferation. We also show that the Salmonella Type III Secretion System 2, which is required for SCV biogenesis, is not required for cytosolic replication. Altogether this study illustrates the value of single cell analyses when studying intracellular pathogens.	[Malik-Kale, Preeti; Winfree, Seth; Steele-Mortimer, Olivia] Natl Inst Allergy & Infect Dis, Salmonella Host Cell Interact Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Malik-Kale, P (corresponding author), Natl Inst Allergy & Infect Dis, Salmonella Host Cell Interact Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA.	omortimer@niaid.nih.gov		Winfree, Seth/0000-0002-2396-5871	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000909] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was entirely supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Brumell JH, 2001, TRAFFIC, V2, P643, DOI 10.1034/j.1600-0854.2001.20907.x; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Buckner MMC, 2011, VIRULENCE, V2, P208, DOI 10.4161/viru.2.3.15894; Bujny MV, 2008, J CELL SCI, V121, P2027, DOI 10.1242/jcs.018432; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coombes BK, 2003, MICROBES INFECT, V5, P561, DOI 10.1016/S1286-4579(03)00094-7; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Guignot J, 2008, MICROB PATHOGENESIS, V45, P415, DOI 10.1016/j.micpath.2008.09.007; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Knodler LA, 2003, MOL MICROBIOL, V49, P685, DOI 10.1046/j.1365-2958.2003.03598.x; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Marlovits TC, 2010, CURR OPIN MICROBIOL, V13, P47, DOI 10.1016/j.mib.2009.11.001; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002	36	86	86	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38732	10.1371/journal.pone.0038732	http://dx.doi.org/10.1371/journal.pone.0038732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719929	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900044
J	Raina, SA; Tsai, J; Samso, M; Fessenden, JD				Raina, Shweta A.; Tsai, Jeffrey; Samso, Montserrat; Fessenden, James D.			FRET-Based Localization of Fluorescent Protein Insertions Within the Ryanodine Receptor Type 1	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MUTATION HOT-SPOT; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; SITE; DOMAIN; CHANNEL; COMPLEX; LIGAND; REGION	Fluorescent protein (FP) insertions have often been used to localize primary structure elements in mid-resolution 3D cryo electron microscopic (EM) maps of large protein complexes. However, little is known as to the precise spatial relationship between the location of the fused FP and its insertion site within a larger protein. To gain insights into these structural considerations, Forster resonance energy transfer (FRET) measurements were used to localize green fluorescent protein (GFP) insertions within the ryanodine receptor type 1 (RyR1), a large intracellular Ca2+ release channel that plays a key role in skeletal muscle excitation contraction coupling. A series of full-length His-tagged GFP-RyR1 fusion constructs were created, expressed in human embryonic kidney (HEK)-293T cells and then complexed with Cy3NTA, a His-tag specific FRET acceptor. FRET efficiency values measured from each GFP donor to Cy3NTA bound to each His tag acceptor site were converted into intermolecular distances and the positions of each inserted GFP were then triangulated relative to a previously published X-ray crystal structure of a 559 amino acid RyR1 fragment. We observed that the chromophoric centers of fluorescent proteins inserted into RyR1 can be located as far as 45 angstrom from their insertion sites and that the fused proteins can also be located in internal cavities within RyR1. These findings should prove useful in interpreting structural results obtained in cryo EM maps using fusions of small fluorescent proteins. More accurate point-to-point distance information may be obtained using complementary orthogonal labeling systems that rely on fluorescent probes that bind directly to amino acid side chains.	[Raina, Shweta A.; Tsai, Jeffrey; Fessenden, James D.] Boston Biomed Res Inst, Watertown, MA USA; [Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Boston Biomedical Research Institute; Virginia Commonwealth University	Raina, SA (corresponding author), Boston Biomed Res Inst, Watertown, MA USA.	jfessenden@partners.org		Samso, Montserrat/0000-0002-2788-3283	NIH [R21ARO56406, 1R01AR059124]; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	JDF was supported by NIH grants R21ARO56406 and 1R01AR059124. MS acknowledges Virginia Commonwealth University start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Conway JF, 2010, J MOL BIOL, V397, P575, DOI 10.1016/j.jmb.2010.01.043; Fessenden JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007338; Fessenden JD, 2003, J BIOL CHEM, V278, P28727, DOI 10.1074/jbc.M303821200; Guignet EG, 2004, NAT BIOTECHNOL, V22, P440, DOI 10.1038/nbt954; John CM, 2007, EMBO J, V26, P3296, DOI 10.1038/sj.emboj.7601775; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Lorenzon NM, 2001, ARCH BIOCHEM BIOPHYS, V388, P13, DOI 10.1006/abbi.2000.2263; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Toropova K, 2011, J VIROL, V85, P7513, DOI 10.1128/JVI.00837-11; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhong X, 2012, BIOPH SOC M	31	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38594	10.1371/journal.pone.0038594	http://dx.doi.org/10.1371/journal.pone.0038594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719904	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900036
J	Chen, X; Pan, LQ; Naranmandura, H; Zeng, S; Chen, SQ				Chen, Xuan; Pan, Li Qiang; Naranmandura, Hua; Zeng, Su; Chen, Shu Qing			Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6	PLOS ONE			English	Article							ANTLEY-BIXLER-SYNDROME; MUTANT P450 OXIDOREDUCTASE; GENETIC-VARIATION; DISORDERED STEROIDOGENESIS; NADPH-P450 OXIDOREDUCTASE; HEME OXYGENASE; IN-VITRO; REDUCTASE; MUTATIONS; SYSTEM	Cytochrome P450 oxidoreductase (POR) is known as the sole electron donor in the metabolism of drugs by cytochrome P450 (CYP) enzymes in human. However, little is known about the effect of polymorphic variants of POR on drug metabolic activities of CYP3A4 and CYP2B6. In order to better understand the mechanism of the activity of CYPs affected by polymorphic variants of POR, six full-length mutants of POR (e.g., Y181D, A287P, K49N, A115V, S244C and G413S) were designed and then co-expressed with CYP3A4 and CYP2B6 in the baculovirus-Sf9 insect cells to determine their kinetic parameters. Surprisingly, both mutants, Y181D and A287P in POR completely inhibited the CYP3A4 activity with testosterone, while the catalytic activity of CYP2B6 with bupropion was reduced to approximately similar to 70% of wild-type activity by Y181D and A287P mutations. In addition, the mutant K49N of POR increased the CLint (Vmax/Km) of CYP3A4 up to more than 31% of wild-type, while it reduced the catalytic efficiency of CYP2B6 to 74% of wild-type. Moreover, CLint values of CYP3A4-POR (A115V, G413S) were increased up to 36% and 65% of wild-type respectively. However, there were no appreciable effects observed by the remaining two mutants of POR (i.e., A115V and G413S) on activities of CYP2B6. In conclusion, the extent to which the catalytic activities of CYP were altered did not only depend on the specific POR mutations but also on the isoforms of different CYP redox partners. Thereby, we proposed that the POR-mutant patients should be carefully monitored for the activity of CYP3A4 and CYP2B6 on the prescribed medication.	[Chen, Xuan; Pan, Li Qiang; Naranmandura, Hua; Chen, Shu Qing] Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310003, Zhejiang, Peoples R China; [Zeng, Su] Zhejiang Univ, Coll Pharmaceut Sci, Dept Drug Metab & Pharmaceut Anal, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, X (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310003, Zhejiang, Peoples R China.	narenman@zju.edu.cn; chenshuqing@zju.edu.cn	Naranmandura, Hua/C-6499-2015	Naranmandura, Hua/0000-0003-0799-2340; Chen, Shuqing/0000-0002-0792-3735	National Natural Science Foundation of China [81001477]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China [2012ZX09506001-004]; Zhejiang Provincial Natural Science Foundation of China [R2110231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors wish to acknowledge the National Natural Science Foundation of China (No. 81001477), National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China (No. 2012ZX09506001-004) and Zhejiang Provincial Natural Science Foundation of China (No. R2110231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; Agrawal V, 2010, PHARMACOGENET GENOM, V20, P611, DOI 10.1097/FPC.0b013e32833e0cb5; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; BLACK SD, 1982, J BIOL CHEM, V257, P5929; Bonina TA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P357, DOI 10.1007/s10541-005-0122-3; Dhir V, 2007, MOL ENDOCRINOL, V21, P1958, DOI 10.1210/me.2007-0066; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fluck CE, 2007, FUND CLIN PHARMACOL, V21, P399, DOI 10.1111/j.1472-8206.2007.00520.x; Fluck CE, 2010, BIOCHEM BIOPH RES CO, V401, P149, DOI 10.1016/j.bbrc.2010.09.035; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Guengerich FP, 2004, DRUG METAB REV, V36, P159, DOI 10.1081/DMR-120033996; Han JF, 2006, TOXICOL SCI, V91, P42, DOI 10.1093/toxsci/kfj139; Hart SN, 2008, EXPERT OPIN DRUG MET, V4, P439, DOI [10.1517/17425255.4.4.439, 10.1517/17425255.4.4.439 ]; Hart SN, 2007, DRUG METAB PHARMACOK, V22, P322, DOI 10.2133/dmpk.22.322; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; ILAN Z, 1981, J BIOL CHEM, V256, P66; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kranendonk M, 2008, ARCH BIOCHEM BIOPHYS, V475, P93, DOI 10.1016/j.abb.2008.04.014; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428; Miller WL, 2009, MOL CELL ENDOCRINOL, V300, P180, DOI 10.1016/j.mce.2008.09.017; Miller WL, 2011, MOL CELL ENDOCRINOL, P174; Moutinho D, 2012, DRUG METAB DISPOS, DOI [10.1124/dmd.1111.042820, DOI 10.1124/DMD.1111.042820]; Moutinho D, 2012, DRUG METAB DISPOS, V40, P754, DOI 10.1124/dmd.111.042820; OMURA T, 1964, J BIOL CHEM, V239, P2370; Oneda B, 2009, PHARMACOGENET GENOM, V19, P877, DOI 10.1097/FPC.0b013e32833225e7; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Panda SP, 2006, J BIOL CHEM, V281, P34246, DOI 10.1074/jbc.M601041200; Pandey AV, 2007, MOL ENDOCRINOL, V21, P2579, DOI 10.1210/me.2007-0245; Pandey AV, 2010, BIOCHEM BIOPH RES CO, V400, P374, DOI 10.1016/j.bbrc.2010.08.072; Sandee D, 2010, PHARMACOGENET GENOM, V20, P677, DOI 10.1097/FPC.0b013e32833f4f9b; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Sim SC, 2009, PHARMACOGENET GENOM, V19, P565, DOI 10.1097/FPC.0b013e32832af5b7; Wang HN, 2011, BIOCHEM PHARMACOL, V82, P1757, DOI 10.1016/j.bcp.2011.08.004; Wang RW, 1997, DRUG METAB DISPOS, V25, P502; Wang SL, 2007, DRUG METAB DISPOS, V35, P176, DOI 10.1124/dmd.106.011056; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhang HM, 2011, J PHARMACOL EXP THER, V338, P803, DOI 10.1124/jpet.111.183111; Zhang XL, 2011, DRUG METAB DISPOS, V39, P1433, DOI 10.1124/dmd.111.038836; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	48	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38495	10.1371/journal.pone.0038495	http://dx.doi.org/10.1371/journal.pone.0038495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719896	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340000026
J	Kanga, S; Bernard, D; Mager-Heckel, AM; Erpapazoglou, Z; Mattiroli, F; Sixma, TK; Leon, S; Urban-Grimal, D; Tarassov, I; Haguenauer-Tsapis, R				Kanga, Sophie; Bernard, Delphine; Mager-Heckel, Anne-Marie; Erpapazoglou, Zoi; Mattiroli, Francesca; Sixma, Titia K.; Leon, Sebastien; Urban-Grimal, Daniele; Tarassov, Ivan; Haguenauer-Tsapis, Rosine			A Deubiquitylating Complex Required for Neosynthesis of a Yeast Mitochondrial ATP Synthase Subunit	PLOS ONE			English	Article							TRANSFER-RNA IMPORT; DEUBIQUITINATING ENZYME; SACCHAROMYCES-CEREVISIAE; PROTEIN; UBIQUITIN; DEGRADATION; REGULATOR; VERSATILE; TURNOVER; DEFECTS	The ubiquitin system is known to be involved in maintaining the integrity of mitochondria, but little is known about the role of deubiquitylating (DUB) enzymes in such functions. Budding yeast cells deleted for UBP13 and its close homolog UBP9 displayed a high incidence of petite colonies and slow respiratory growth at 37 degrees C. Both Ubp9 and Ubp13 interacted directly with Duf1 (DUB-associated factor 1), a WD40 motif-containing protein. Duf1 activates the DUB activity of recombinant Ubp9 and Ubp13 in vitro and deletion of DUF1 resulted in the same respiratory phenotype as the deletion of both UBP9 and UBP13. We show that the mitochondrial defects of these mutants resulted from a strong decrease at 37 degrees C in the de novo biosynthesis of Atp9, a membrane-bound component of ATP synthase encoded by mitochondrial DNA. The defect appears at the level of ATP9 mRNA translation, while its maturation remained unchanged in the mutants. This study describes a new role of the ubiquitin system in mitochondrial biogenesis.	[Kanga, Sophie; Bernard, Delphine; Erpapazoglou, Zoi; Leon, Sebastien; Urban-Grimal, Daniele; Haguenauer-Tsapis, Rosine] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR7592, Paris, France; [Mattiroli, Francesca; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands; [Mager-Heckel, Anne-Marie; Tarassov, Ivan] Univ Strasbourg, CNRS, UMR Genet Mol Genom Microbiol GMGM 7156, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Netherlands Cancer Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kanga, S (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR7592, Paris, France.	haguenauer.rosine@ijm.univ-paris-diderot.fr	Mattiroli, Francesca/AAT-1489-2020; Erpapazoglou, Zoi/X-8497-2019; LEON, Sebastien/A-5441-2008	Mattiroli, Francesca/0000-0002-1574-7217; LEON, Sebastien/0000-0002-2536-8595; Tarassov, Ivan/0000-0001-8763-6703; Bernard, Delphine/0000-0002-9439-5482; Sixma, Titia K/0000-0001-6180-0632	Centre National de la Recherche Scientifique (CNRS), Paris 6-Denis Diderot University; Centre National de la Recherche Scientifique (CNRS), Paris 7-Denis Diderot University; Association pour la Recherche contre le Cancer (ARC) [3298]; Ligue Nationale Contre le Cancer (Comite de Paris) [RS09/75-26]; French Ministry of Research (ACI BCMS) (RHT's lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (RHT lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (TS lab); FRM (Fondation pour la Recherche Medicale); ANR (Agence Nationale de la Recherche); National Program "Investissements d'Avenir" (LabEx "MitoCross); French Ministry of Research; Ligue Nationale Contre le Cancer; Pierre et Marie Curie University; UBIREGULATORS network; RUBICON network	Centre National de la Recherche Scientifique (CNRS), Paris 6-Denis Diderot University; Centre National de la Recherche Scientifique (CNRS), Paris 7-Denis Diderot University; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Ligue Nationale Contre le Cancer (Comite de Paris); French Ministry of Research (ACI BCMS) (RHT's lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (RHT lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (TS lab); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); National Program "Investissements d'Avenir" (LabEx "MitoCross)(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Pierre et Marie Curie University; UBIREGULATORS network; RUBICON network	This work was supported by the Centre National de la Recherche Scientifique (CNRS), Paris 6 and Paris 7-Denis Diderot Universities, and by grants from the Association pour la Recherche contre le Cancer (ARC, grant 3298), the Ligue Nationale Contre le Cancer (Comite de Paris, grant RS09/75-26), the French Ministry of Research (ACI BCMS) (RHT's lab), the EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (RHT and TS labs), and by Agence Nationale de la Recherche (ANR). AMMG and IT were supported by the FRM (Fondation pour la Recherche Medicale), the ANR (Agence Nationale de la Recherche) and the National Program "Investissements d'Avenir" (LabEx "MitoCross). SK was supported by the French Ministry of Research and the Ligue Nationale Contre le Cancer. DB was supported by Pierre et Marie Curie University. ZE received fellowships from the UBIREGULATORS and RUBICON networks. FM received a fellowship from the UBIREGULATORS network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kinner A, 2003, FEBS LETT, V549, P135, DOI 10.1016/S0014-5793(03)00801-9; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lockington RA, 2002, MOL MICROBIOL, V43, P1173, DOI 10.1046/j.1365-2958.2002.02811.x; Lockington RA, 2001, MOL MICROBIOL, V40, P1311, DOI 10.1046/j.1365-2958.2001.02474.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malc E, 2009, MUTAT RES-FUND MOL M, V669, P95, DOI 10.1016/j.mrfmmm.2009.05.008; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; RICHTERRUOFF B, 1994, FEBS LETT, V354, P50, DOI 10.1016/0014-5793(94)01085-4; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zoladek T, 1997, GENETICS, V145, P595	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38071	10.1371/journal.pone.0038071	http://dx.doi.org/10.1371/journal.pone.0038071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723847	Green Published, gold			2022-12-27	WOS:000305652700009
J	Matragrano, LL; Beaulieu, M; Phillip, JO; Rae, AI; Sanford, SE; Sockman, KW; Maney, DL				Matragrano, Lisa L.; Beaulieu, Michael; Phillip, Jessica O.; Rae, Ali I.; Sanford, Sara E.; Sockman, Keith W.; Maney, Donna L.			Rapid Effects of Hearing Song on Catecholaminergic Activity in the Songbird Auditory Pathway	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE PHOSPHORYLATION; WHITE-THROATED SPARROWS; ESTRADIOL-DEPENDENT MODULATION; SEASONALLY BREEDING SONGBIRD; FEMALE EUROPEAN STARLINGS; MALE COURTSHIP SONG; MALE ZEBRA FINCHES; LOCUS-COERULEUS; DOPAMINE RELEASE; GENE-EXPRESSION	Catecholaminergic (CA) neurons innervate sensory areas and affect the processing of sensory signals. For example, in birds, CA fibers innervate the auditory pathway at each level, including the midbrain, thalamus, and forebrain. We have shown previously that in female European starlings, CA activity in the auditory forebrain can be enhanced by exposure to attractive male song for one week. It is not known, however, whether hearing song can initiate that activity more rapidly. Here, we exposed estrogen-primed, female white-throated sparrows to conspecific male song and looked for evidence of rapid synthesis of catecholamines in auditory areas. In one hemisphere of the brain, we used immunohistochemistry to detect the phosphorylation of tyrosine hydroxylase (TH), a rate-limiting enzyme in the CA synthetic pathway. We found that immunoreactivity for TH phosphorylated at serine 40 increased dramatically in the auditory forebrain, but not the auditory thalamus and midbrain, after 15 min of song exposure. In the other hemisphere, we used high pressure liquid chromatography to measure catecholamines and their metabolites. We found that two dopamine metabolites, dihydroxyphenylacetic acid and homovanillic acid, increased in the auditory forebrain but not the auditory midbrain after 30 min of exposure to conspecific song. Our results are consistent with the hypothesis that exposure to a behaviorally relevant auditory stimulus rapidly induces CA activity, which may play a role in auditory responses.	[Matragrano, Lisa L.; Phillip, Jessica O.; Rae, Ali I.; Sanford, Sara E.; Maney, Donna L.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Beaulieu, Michael; Sockman, Keith W.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Sockman, Keith W.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA	Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matragrano, LL (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	dmaney@emory.edu	Maney, Donna L/G-3706-2011; Beaulieu, Michaël/A-5261-2011	Maney, Donna L/0000-0002-1006-2358; Beaulieu, Michaël/0000-0002-9948-269X	NINDS [R01 NS055125]; NSF [IBN-0346984]; Center for Behavioral Neuroscience [IBN-9876754]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055125] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); Center for Behavioral Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NINDS R01 NS055125 to KWS (www.ninds.nih.gov), NSF IBN-0346984 to DLM (www.nsf.gov), and the Center for Behavioral Neuroscience IBN-9876754 (www.cbn-atl.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Amin N, 2010, J NEUROPHYSIOL, V104, P784, DOI 10.1152/jn.00128.2010; Appeltants D, 2005, BEHAV PROCESS, V69, P331, DOI 10.1016/j.beproc.2005.01.010; Appeltants D, 2002, NEUROREPORT, V13, P649, DOI 10.1097/00001756-200204160-00023; Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; Appeltants D, 2001, CELL TISSUE RES, V304, P237, DOI 10.1007/s004410100360; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Avey MT, 2005, BEHAV BRAIN RES, V165, P247, DOI 10.1016/j.bbr.2005.07.002; BAILHACHE T, 1993, J COMP NEUROL, V329, P230, DOI 10.1002/cne.903290206; Balthazart J, 1996, BELG J ZOOL, V126, P65; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BEAUDET A, 1978, NEUROSCIENCE, V3, P851, DOI 10.1016/0306-4522(78)90115-X; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bharati IS, 2006, NEUROSCIENCE, V143, P661, DOI 10.1016/j.neuroscience.2006.08.046; BOTTJER SW, 1993, J NEUROBIOL, V24, P51, DOI 10.1002/neu.480240105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN EE, 1991, J NEUROCHEM, V57, P701, DOI 10.1111/j.1471-4159.1991.tb03802.x; Cardin JA, 2004, J NEUROSCI, V24, P7745, DOI 10.1523/JNEUROSCI.1951-04.2004; Castelino CB, 2010, J CHEM NEUROANAT, V39, P96, DOI 10.1016/j.jchemneu.2009.08.003; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; COMMISSIONG JW, 1985, BIOCHEM PHARMACOL, V34, P1127, DOI 10.1016/0006-2952(85)90484-8; Cransac H, 1998, HEARING RES, V118, P151, DOI 10.1016/S0378-5955(98)00031-8; Curtis AL, 2012, NEUROPHARMACOLOGY, V62, P1737, DOI 10.1016/j.neuropharm.2011.11.020; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Falls J.B., 1994, Birds of North America, V128, P1; Fujisawa H, 2005, BIOCHEM BIOPH RES CO, V338, P271, DOI 10.1016/j.bbrc.2005.07.183; Gale SD, 2010, J NEUROSCI, V30, P1027, DOI 10.1523/JNEUROSCI.3585-09.2010; Gammie SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001974; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Goodson JL, 2009, P NATL ACAD SCI USA, V106, P8737, DOI 10.1073/pnas.0811821106; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRESCH PJ, 1994, J NEUROCHEM, V63, P575; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hurley LM, 2011, HEARING RES, V279, P74, DOI 10.1016/j.heares.2010.12.015; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; KARTEN HARVEY J., 1967, BRAIN RES, V6, P409, DOI 10.1016/0006-8993(67)90055-8; KILTS CD, 1981, J CHROMATOGR, V225, P347, DOI 10.1016/S0378-4347(00)80283-2; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lake JI, 2008, GEN COMP ENDOCR, V156, P426, DOI 10.1016/j.ygcen.2007.12.009; LeBlanc MM, 2007, BRAIN RES, V1171, P93, DOI 10.1016/j.brainres.2007.06.086; Leviel V, 2001, NEUROCHEM INT, V38, P83, DOI 10.1016/S0197-0186(00)00076-0; Logerot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020686; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; Maney DL, 2003, J NEUROBIOL, V56, P163, DOI 10.1002/neu.10227; Maney DL, 2005, HORM BEHAV, V48, P196, DOI 10.1016/j.yhbeh.2005.03.004; Maney DL, 2003, J COMP PHYSIOL A, V189, P667, DOI 10.1007/s00359-003-0441-z; Maney DL, 2001, NEUROSCI LETT, V311, P189, DOI 10.1016/S0304-3940(01)02157-7; Maney DL, 2008, J COMP NEUROL, V511, P173, DOI 10.1002/cne.21830; Maney DL, 2007, ENDOCRINOLOGY, V148, P5614, DOI 10.1210/en.2007-0879; Maney DL, 2011, FRONT NEUROENDOCRIN, V32, P287, DOI 10.1016/j.yfrne.2010.12.002; Maney DL, 2009, HORM BEHAV, V55, P113, DOI 10.1016/j.yhbeh.2008.09.002; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; Matragrano LL, 2012, BEHAV NEUROSCI, V126, P110, DOI 10.1037/a0025586; Matragrano LL, 2011, EUR J NEUROSCI, V34, P416, DOI 10.1111/j.1460-9568.2011.07751.x; Metzger M, 1996, J COMP NEUROL, V376, P1, DOI 10.1002/(SICI)1096-9861(19961202)376:1<1::AID-CNE1>3.0.CO;2-7; Miranda JA, 2009, HEARING RES, V252, P21, DOI 10.1016/j.heares.2009.04.014; MOONS L, 1994, J COMP NEUROL, V346, P97, DOI 10.1002/cne.903460107; MOORE KE, 1986, ANN NY ACAD SCI, V473, P303; MOORE MC, 1983, J ZOOL, V199, P137, DOI 10.1111/j.1469-7998.1983.tb02085.x; Niu XZ, 2002, HEARING RES, V174, P124, DOI 10.1016/S0378-5955(02)00646-9; Nordeen EJ, 2009, EUR J NEUROSCI, V30, P662, DOI 10.1111/j.1460-9568.2009.06849.x; Olsson C, 2008, J COMP NEUROL, V508, P756, DOI 10.1002/cne.21705; Ong LK, 2011, NEUROSCIENCE, V192, P20, DOI 10.1016/j.neuroscience.2011.06.087; Ong LK, 2011, NEUROCHEM RES, V36, P27, DOI 10.1007/s11064-010-0255-7; Pawlisch BA, 2011, NEUROSCI LETT, V496, P20, DOI 10.1016/j.neulet.2011.03.078; Pawlisch BA, 2010, BRAIN RES, V1353, P113, DOI 10.1016/j.brainres.2010.07.003; Phan ML, 2010, P NATL ACAD SCI USA, V107, P2301, DOI 10.1073/pnas.0900091107; Pinaud R, 2008, J BIOSCIENCES, V33, P145, DOI 10.1007/s12038-008-0030-y; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; READER TA, 1979, BRAIN RES, V160, P217, DOI 10.1016/0006-8993(79)90420-7; Reiner A., 1994, P135; Riters LV, 2007, GEN COMP ENDOCR, V154, P137, DOI 10.1016/j.ygcen.2007.05.029; Riters LV, 2007, BRAIN RES, V1149, P127, DOI 10.1016/j.brainres.2007.02.059; Roberts TF, 2001, J COMP NEUROL, V429, P436, DOI 10.1002/1096-9861(20010115)429:3<436::AID-CNE6>3.0.CO;2-H; ROBINSON PJ, 1985, J NEUROCHEM, V44, P338, DOI 10.1111/j.1471-4159.1985.tb05422.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Sanford SE, 2010, DEV NEUROBIOL, V70, P73, DOI 10.1002/dneu.20757; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SHANK MAX C., 1959, AUK, V76, P44; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SOARESDASILVA P, 1987, J PHARM PHARMACOL, V39, P127, DOI 10.1111/j.2042-7158.1987.tb06958.x; SOARESDASILVA P, 1990, NEUROPHARMACOLOGY, V29, P869, DOI 10.1016/0028-3908(90)90135-E; Sockman KW, 2008, DEV NEUROBIOL, V68, P656, DOI 10.1002/dneu.20611; Sockman KW, 2002, P ROY SOC B-BIOL SCI, V269, P2479, DOI 10.1098/rspb.2002.2180; Soha JA, 1996, J NEUROBIOL, V29, P473, DOI 10.1002/(SICI)1097-4695(199604)29:4<473::AID-NEU5>3.0.CO;2-5; Stark H, 1997, J NEUROCHEM, V68, P691; Tremere LA, 2009, J NEUROSCI, V29, P5949, DOI 10.1523/JNEUROSCI.0774-09.2009; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vyas A, 2008, BEHAV NEUROSCI, V122, P1148, DOI 10.1037/0735-7044.122.5.1148; WOLFSON A, 1958, J EXP ZOOL, V139, P349, DOI 10.1002/jez.1401390207; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Xu ZQ, 1998, NEUROSCIENCE, V82, P727; Zeng SJ, 2007, BRAIN BEHAV EVOLUT, V70, P1, DOI 10.1159/000101066; ZETTERSTROM T, 1988, EUR J PHARMACOL, V148, P327, DOI 10.1016/0014-2999(88)90110-0	99	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39388	10.1371/journal.pone.0039388	http://dx.doi.org/10.1371/journal.pone.0039388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724011	gold, Green Published			2022-12-27	WOS:000305652700076
J	London, JM; Hoef, JMV; Jeffries, SJ; Lance, MM; Boveng, PL				London, Josh M.; Hoef, Jay M. Ver; Jeffries, Steven J.; Lance, Monique M.; Boveng, Peter L.			Haul-Out Behavior of Harbor Seals (Phoca vitulina) in Hood Canal, Washington	PLOS ONE			English	Article							RICHARDSI; PATTERNS; ALASKA; CALIFORNIA; ABUNDANCE; OREGON; DISTURBANCE; TRENDS; ISLAND; SITE	The goal of this study was to model haul-out behavior of harbor seals (Phoca vitulina) in the Hood Canal region of Washington State with respect to changes in physiological, environmental, and temporal covariates. Previous research has provided a solid understanding of seal haul-out behavior. Here, we expand on that work using a generalized linear mixed model (GLMM) with temporal autocorrelation and a large dataset. Our dataset included behavioral haul-out records from archival and VHF radio tag deployments on 25 individual seals representing 61,430 seal hours. A novel application for increased computational efficiency allowed us to examine this large dataset with a GLMM that appropriately accounts for temporal autocorellation. We found significant relationships with the covariates hour of day, day of year, minutes from high tide and year. Additionally, there was a significant effect of the interaction term hour of day : day of year. This interaction term demonstrated that seals are more likely to haul out during nighttime hours in August and September, but then switch to predominantly daylight haul-out patterns in October and November. We attribute this change in behavior to an effect of human disturbance levels. This study also examined a unique ecological event to determine the role of increased killer whale (Orcinus orca) predation on haul-out behavior. In 2003 and 2005 these harbor seals were exposed to unprecedented levels of killer whale predation and results show an overall increase in haul-out probability after exposure to killer whales. The outcome of this study will be integral to understanding any changes in population abundance as a result of increased killer whale predation.	[London, Josh M.; Hoef, Jay M. Ver; Boveng, Peter L.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Jeffries, Steven J.; Lance, Monique M.] Washington Dept Fish & Wildlife, Tacoma, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Washington Department of Fish & Wildlife (WDFW)	London, JM (corresponding author), NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	josh.london@noaa.gov	Ver Hoef, Jay/C-8577-2017	Ver Hoef, Jay/0000-0003-4302-6895; London, Josh/0000-0002-3647-5046	Washington Department of Fish and Wildlife; Washington Cooperative Fish and Wildlife Research Unit; Alaska Fisheries Science Center's National Marine Mammal Laboratory; United States Marine Mammal Commission; Pacific States Marine Fisheries Commission; Northwest Fisheries Science Center	Washington Department of Fish and Wildlife; Washington Cooperative Fish and Wildlife Research Unit; Alaska Fisheries Science Center's National Marine Mammal Laboratory; United States Marine Mammal Commission; Pacific States Marine Fisheries Commission; Northwest Fisheries Science Center	The authors would like to acknowledge the support from the Washington Department of Fish and Wildlife, the Washington Cooperative Fish and Wildlife Research Unit and the Alaska Fisheries Science Center's National Marine Mammal Laboratory. The field component of the project benefited greatly from the contributions of B. Murphie, S. Murphie, D. Lambourn, A. Galloway and other members of the capture crew. Special consideration goes to G. VanBlaricom for his advice and support as the primary author's graduate advisor. M. Simpkins and J. Laake provided valuable feedback during the analysis and manuscript preparation.; The authors would like to acknowledge the financial and logistical support from the Washington Department of Fish and Wildlife, the Washington Cooperative Fish and Wildlife Research Unit and the Alaska Fisheries Science Center's National Marine Mammal Laboratory. Signicant funding was also provided by the United States Marine Mammal Commission, the Pacific States Marine Fisheries Commission and the Northwest Fisheries Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SG, 1984, FISH B-NOAA, V82, P493; Bengtson JL, 2005, POLAR BIOL, V28, P833, DOI 10.1007/s00300-005-0009-1; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Brown RE, 2005, MAR MAMMAL SCI, V21, P657, DOI 10.1111/j.1748-7692.2005.tb01258.x; BROWN RF, 1983, FISH B-NOAA, V81, P291; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Calambokidis J.A., 1979, Murrelet, V60, P110, DOI 10.2307/3534278; Daniel RG, 2003, MAR MAMMAL SCI, V19, P128, DOI 10.1111/j.1748-7692.2003.tb01097.x; DASILVA J, 1988, ANIM BEHAV, V36, P1309, DOI 10.1016/S0003-3472(88)80199-4; EVERITT R D, 1980, Northwest Science, V54, P281; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Grigg EK, 2002, CALIF FISH GAME, V88, P15; Hayes SA, 2004, MAR MAMMAL SCI, V20, P639, DOI 10.1111/j.1748-7692.2004.tb01184.x; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; London JM, 2006, THESIS U WASHINGTON; McCullagh P, 1989, GEN LINEAR MODELS; Nordstrom CA, 2002, MAR MAMMAL SCI, V18, P194, DOI 10.1111/j.1748-7692.2002.tb01028.x; PAULI B D, 1987, Aquatic Mammals, V13, P93; Reder S, 2003, POLAR BIOL, V27, P6, DOI 10.1007/s00300-003-0557-1; SCHNEIDER DC, 1983, J MAMMAL, V64, P518, DOI 10.2307/1380370; Simpkins MA, 2003, MAR MAMMAL SCI, V19, P791, DOI 10.1111/j.1748-7692.2003.tb01130.x; STEWART B S, 1984, Bulletin Southern California Academy of Sciences, V83, P121; SULLIVAN RM, 1981, J MAMMAL, V62, P825, DOI 10.2307/1380606; Suryan RM, 1999, FISH B-NOAA, V97, P332; Team RDC, 2006, R LANG ENV STAT COMP; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; THOMPSON PM, 1989, J ZOOL, V217, P281, DOI 10.1111/j.1469-7998.1989.tb02488.x; Ver Hoef Jay M., 2001, P214; Ver Hoef JM, 2010, COMPUTATION STAT, V25, P39; Watts P, 1996, J ZOOL, V240, P175, DOI 10.1111/j.1469-7998.1996.tb05494.x; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; YOCHEM PK, 1987, MAR MAMMAL SCI, V3, P323, DOI 10.1111/j.1748-7692.1987.tb00319.x	37	32	32	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							38180	10.1371/journal.pone.0038180	http://dx.doi.org/10.1371/journal.pone.0038180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723851	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300022
J	Mistri, M; Tamhankar, PM; Sheth, F; Sanghavi, D; Kondurkar, P; Patil, S; Idicula-Thomas, S; Gupta, S; Sheth, J				Mistri, Mehul; Tamhankar, Parag M.; Sheth, Frenny; Sanghavi, Daksha; Kondurkar, Pratima; Patil, Swapnil; Idicula-Thomas, Susan; Gupta, Sarita; Sheth, Jayesh			Identification of Novel Mutations in HEXA Gene in Children Affected with Tay Sachs Disease from India	PLOS ONE			English	Article							BETA-HEXOSAMINIDASE; 2ND; POPULATION; JEWISH; ALLELE	Tay Sachs disease (TSD) is a neurodegenerative disorder due to beta-hexosaminidase A deficiency caused by mutations in the HEXA gene. The mutations leading to Tay Sachs disease in India are yet unknown. We aimed to determine mutations leading to TSD in India by complete sequencing of the HEXA gene. The clinical inclusion criteria included neuroregression, seizures, exaggerated startle reflex, macrocephaly, cherry red spot on fundus examination and spasticity. Neuroimaging criteria included thalamic hyperdensities on CT scan/T1W images of MRI of the brain. Biochemical criteria included deficiency of hexosaminidase A (less than 2% of total hexosaminidase activity for infantile patients). Total leukocyte hexosaminidase activity was assayed by 4-methylumbelliferyl-N-acetyl-beta-D-glucosamine lysis and hexosaminidase A activity was assayed by heat inactivation method and 4-methylumbelliferyl-N-acetyl-beta-D-glucosamine-6-sulphate lysis method. The exons and exon-intron boundaries of the HEXA gene were bidirectionally sequenced using an automated sequencer. Mutations were confirmed in parents and looked up in public databases. In silico analysis for mutations was carried out using SIFT, Polyphen2, MutationT@ster and Accelrys Discovery Studio softwares. Fifteen families were included in the study. We identified six novel missense mutations, c.340 G>A (p.E114K), c.964 G>A (p.D322N), c.964 G>T (p.D322Y), c.1178C>G (p.R393P) and c.1385A>T (p.E462V), c.1432 G>A (p.G478R) and two previously reported mutations. c.1277_1278insTATC and c.508C>T (p.R170W). The mutation p.E462V was found in six unrelated families from Gujarat indicating a founder effect. A previously known splice site mutation c.805+1 G>C and another intronic mutation c.672+ 30 T>G of unknown significance were also identified. Mutations could not be identified in one family. We conclude that TSD patients from Gujarat should be screened for the common mutation p.E462V.	[Mistri, Mehul; Sheth, Frenny; Sheth, Jayesh] FRIGE Inst Human Genet, Ahmadabad, Gujarat, India; [Tamhankar, Parag M.; Sanghavi, Daksha; Kondurkar, Pratima] Natl Inst Res Reprod Hlth, ICMR Genet Res Ctr, Bombay, Maharashtra, India; [Patil, Swapnil; Idicula-Thomas, Susan] Natl Inst Res Reprod Hlth, Biomed Informat Ctr, Bombay, Maharashtra, India; [Gupta, Sarita] MS Univ, Dept Biochem, Vadodara, Gujarat, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Maharaja Sayajirao University Baroda	Mistri, M (corresponding author), FRIGE Inst Human Genet, Ahmadabad, Gujarat, India.	tamhankarp@nirrh.res.in; jshethad1@gmail.com	Mistri, Mehul/X-8097-2019; Sheth, Jayesh J./L-9966-2013	Mistri, Mehul/0000-0003-1872-291X; 	Indian council of medical research (ICMR) [BMS: 54/2010]	Indian council of medical research (ICMR)(Indian Council of Medical Research (ICMR))	The work at FRIGE was supported by grant from Indian council of medical research (ICMR), project no BMS: 54/2010. The work at Genetic Research Center, NIRRH (National Institute for Research in Reproductive Health) was supported by intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akerman B, 1991, AM J HUM GENET, V49, P1041; AKLI S, 1993, HUM MOL GENET, V2, P61, DOI 10.1093/hmg/2.1.61; AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; CAO Z, 1993, AM J HUM GENET, V53, P1198; Fernandes JA, 2004, ARCH NEUROL-CHICAGO, V61, P1466, DOI 10.1001/archneur.61.9.1466; Fernandes Maria, 1992, Human Molecular Genetics, V1, P759, DOI 10.1093/hmg/1.9.759; Gravel RA, 1995, METABOLIC MOL BASES, P3827; Haghighi A, 2011, J HUM GENET, V56, P682, DOI 10.1038/jhg.2011.78; HECHTMAN P, 1992, HUM GENET, V90, P402, DOI 10.1007/BF00220467; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; Kaback M M, 1999, GENEREVIEWS, P1993; KAPLAN F, 1991, J INHERIT METAB DIS, V14, P707, DOI 10.1007/BF01799939; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Matsuzawa F, 2003, J HUM GENET, V48, P582, DOI 10.1007/s10038-003-0082-7; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; Nalini A, 2004, J CHILD NEUROL, V19, P447, DOI 10.1177/088307380401900610; Ohno K, 2008, MOL GENET METAB, V94, P2; Ozkara HA, 1998, MOL GENET METAB, V65, P250, DOI 10.1006/mgme.1998.2742; RIBEIRO MG, 1995, BBA-MOL BASIS DIS, V1270, P44, DOI 10.1016/0925-4439(94)00070-7; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Stockley Tracy L, 2003, Methods Mol Biol, V217, P131; Tanaka A, 1999, J HUM GENET, V44, P91, DOI 10.1007/s100380050116; TRIGGSRAINE B, 1995, AM J HUM GENET, V56, P870; Wendeler M, 2009, GLYCOCONJUGATE J, V26, P945, DOI 10.1007/s10719-008-9137-5	28	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39122	10.1371/journal.pone.0039122	http://dx.doi.org/10.1371/journal.pone.0039122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723944	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300097
J	Sun, Y; Li, H; Yang, MF; Shu, W; Sun, MJ; Xu, Y				Sun, Ying; Li, Hui; Yang, Mi-Fang; Shu, Wei; Sun, Meng-Jun; Xu, Yan			Effects of Aging on Endotoxin Tolerance Induced by Lipopolysaccharides Derived from Porphyromonas gingivalis and Escherichia coli	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NEGATIVE REGULATION; CYTOKINE PRODUCTION; IMMUNE-SYSTEM; TNF-ALPHA; INNATE; ACTIVATION; CELLS; LPS; PERIODONTITIS	Background: Periodontitis is a bacterially induced chronic inflammatory disease. Exposure of the host to periodontal pathogens and their virulence factors induces a state of hyporesponsiveness to subsequent stimulations, termed endotoxin tolerance. Aging has a profound effect on immune response to bacteria challenge. The aim of this study was to explore the effects of aging on endotoxin tolerance induced by Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide (LPS) and Escherichia coli (E. coli) LPS in murine peritoneal macrophages. Methodology/Principal Findings: We studied the cytokine production (TNF-alpha and IL-10) and Toll-like receptor 2, 4 (TLR2, 4) gene and protein expressions in peritoneal macrophages from young (2-month-old) and middle-aged (12-month-old) ICR mice following single or repeated P. gingivalis LPS or E. coli LPS stimulation. Pretreatment of peritoneal macrophages with P. gingivalis LPS or E. coli LPS resulted in a reduction in TNF-alpha production and an increase in IL-10 production upon secondary stimulation (p < 0.05), and the markedly lower levels of TNF-alpha and higher levels of IL-10 were observed in macrophages from young mice compared with those from middle-aged mice (p < 0.05). In addition, LPS restimulations also led to the significantly lower expression levels of TLR2, 4 mRNA and protein in macrophages from young mice (p < 0.05). Conclusions/Significance: Repeated LPS stimulations triggered endotoxin tolerance in peritoneal macrophages and the ability to develop tolerance in young mice was more excellent. The impaired ability to develop endotoxin tolerance resulted from aging might be related to TLR2, 4 and might lead to the incontrollable periodontal inflammation in older adults.	[Sun, Ying; Li, Hui; Yang, Mi-Fang; Sun, Meng-Jun; Xu, Yan] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Sun, Ying; Li, Hui; Shu, Wei; Sun, Meng-Jun; Xu, Yan] Nanjing Med Univ, Dept Periodontol, Stomatol Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, Y (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	yanxu@njmu.edu.cn		Sun, Ying/0000-0003-3996-9946	National Natural Science Foundation of China [81000444]; Natural Science Foundation of Jiangsu Province [BK2008363]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China through Project 81000444 (https://isis.nsfc.gov.cn), the Natural Science Foundation of Jiangsu Province through Project BK2008363 (http://www.jskjjh.gov.cn/) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTIZ ME, 1995, CRIT CARE MED, V23, P9, DOI 10.1097/00003246-199501000-00006; Barksby HE, 2009, CLIN EXP IMMUNOL, V156, P479, DOI 10.1111/j.1365-2249.2009.03920.x; BECK JD, 1984, COMMUNITY DENT ORAL, V12, P17, DOI 10.1111/j.1600-0528.1984.tb01403.x; Ben-Othman R, 2009, MOL IMMUNOL, V46, P3438, DOI 10.1016/j.molimm.2009.05.337; Biswas SK, 2007, INT J BIOCHEM CELL B, V39, P1582, DOI 10.1016/j.biocel.2007.04.021; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; Braga RRR, 2010, ANAEROBE, V16, P234, DOI 10.1016/j.anaerobe.2010.02.007; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Cardoso CR, 2008, J LEUKOCYTE BIOL, V84, P311, DOI 10.1189/jlb.0108014; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Chelvarajan RL, 2006, J LEUKOCYTE BIOL, V79, P1314, DOI 10.1189/jlb.0106024; Silva Paulo Tadeu da, 2008, Braz. Dent. J., V19, P228, DOI 10.1590/S0103-64402008000300010; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Desai A, 2010, J LEUKOCYTE BIOL, V87, P1001, DOI 10.1189/jlb.0809542; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Gaddis DE, 2009, MOL IMMUNOL, V46, P2493, DOI 10.1016/j.molimm.2009.05.022; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Gelani V, 2009, J PERIODONTOL, V80, P2010, DOI 10.1902/jop.2009.090198; Goldstein DR, 2010, VIRULENCE, V1, P295, DOI 10.4161/viru.1.4.12009; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Gutierrez-Venegas G, 2006, LIFE SCI, V78, P2577, DOI 10.1016/j.lfs.2005.10.033; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Kim HG, 2008, J IMMUNOL, V180, P2553, DOI 10.4049/jimmunol.180.4.2553; Komiya Ito Akiyo, 2010, Bull Tokyo Dent Coll, V51, P139; Krustrup U, 2006, ACTA ODONTOL SCAND, V64, P65, DOI 10.1080/00016350500377859; Lehner MD, 2001, INFECT IMMUN, V69, P463, DOI 10.1128/IAI.69.1.463-471.2001; Liu QY, 2011, IMMUNOBIOLOGY, V216, P47, DOI 10.1016/j.imbio.2010.03.005; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Mahbub Shegufta, 2011, Current Immunology Reviews, V7, P104, DOI 10.2174/157339511794474181; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Murciano C, 2007, FEMS IMMUNOL MED MIC, V51, P327, DOI 10.1111/j.1574-695X.2007.00309.x; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Parker LC, 2005, J LEUKOCYTE BIOL, V78, P1301, DOI 10.1189/jlb.0405236; Perkins DJ, 2010, MBIO, V1, DOI 10.1128/mBio.00239-10; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Qu J, 2003, SCAND J IMMUNOL, V58, P613, DOI 10.1111/j.1365-3083.2003.01339.x; Roberts HC, 2008, EUR J ORAL SCI, V116, P207, DOI 10.1111/j.1600-0722.2008.00535.x; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schroder M, 2003, J IMMUNOL, V170, P5260, DOI 10.4049/jimmunol.170.10.5260; Sun Y, 2010, ORAL DIS, V16, P343, DOI 10.1111/j.1601-0825.2009.01630.x; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Suzuki T, 2004, INFECT IMMUN, V72, P1856, DOI 10.1128/IAI.72.4.1856-1865.2004; Teng YTA, 2006, J DENT RES, V85, P198, DOI 10.1177/154405910608500301; Tesar BM, 2006, AGING CELL, V5, P473, DOI 10.1111/j.1474-9726.2006.00245.x; Wang JH, 2002, J BIOL CHEM, V277, P36068, DOI 10.1074/jbc.M205584200; Yang Q, 2011, MATH BIOSCI, V232, P151, DOI 10.1016/j.mbs.2011.05.005; Yoshimura A, 1997, J PERIODONTAL RES, V32, P279, DOI 10.1111/j.1600-0765.1997.tb00535.x; Zhang J, 2009, ACTA PHARMACOL SIN, V30, P582, DOI 10.1038/aps.2009.34	53	28	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39224	10.1371/journal.pone.0039224	http://dx.doi.org/10.1371/journal.pone.0039224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723968	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300117
J	Toomey, JS; Bhatia, S; Moon, LT; Orchard, EA; Tainter, KH; Lokitz, SJ; Terry, T; Mathis, JM; Penman, AD				Toomey, James S.; Bhatia, Shilpa; Moon, La'Wanda T.; Orchard, Elysse A.; Tainter, Kerrie H.; Lokitz, Stephen J.; Terry, Tracee; Mathis, J. Michael; Penman, Andrew D.			PET Imaging a MPTP-Induced Mouse Model of Parkinson's Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [F-18]-DTBZ (AV-133)	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER; POSITRON-EMISSION-TOMOGRAPHY; BETA-CELL MASS; IN-VIVO; DOPAMINE DEPLETION; ANIMAL-MODELS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; TYROSINE-HYDROXYLASE; MICE; F-18-FP-(+)-DTBZ	Parkinson's disease (PD) is characterized by the loss of dopamine-producing neurons in the nigrostriatal system. Numerous researchers in the past have attempted to track the progression of dopaminergic depletion in PD. We applied a quantitative non-invasive PET imaging technique to follow this degeneration process in an MPTP-induced mouse model of PD. The VMAT2 ligand F-18-DTBZ (AV-133) was used as a radioactive tracer in our imaging experiments to monitor the changes of the dopaminergic system. Intraperitoneal administrations of MPTP (a neurotoxin) were delivered to mice at regular intervals to induce lesions consistent with PD. Our results indicate a significant decline in the levels of striatal dopamine and its metabolites (DOPAC and HVA) following MPTP treatment as determined by HPLC method. Images obtained by positron emission tomography revealed uptake of F-18-DTBZ analog in the mouse striatum. However, reduction in radioligand binding was evident in the striatum of MPTP lesioned animals as compared with the control group. Immunohistochemical analysis further confirmed PET imaging results and indicated the progressive loss of dopaminergic neurons in treated animals compared with the control counterparts. In conclusion, our findings suggest that MPTP induced PD in mouse model is appropriate to follow the degeneration of dopaminergic system and that F-18-DTBZ analog is a potentially sensitive radiotracer that can used to diagnose changes associated with PD by PET imaging modality.	[Toomey, James S.; Moon, La'Wanda T.; Penman, Andrew D.] So Res Inst, Birmingham, AL 35255 USA; [Orchard, Elysse A.; Terry, Tracee] Louisiana State Univ, Hlth Sci Ctr, Dept Anim Resources, Shreveport, LA 71105 USA; [Bhatia, Shilpa; Mathis, J. Michael] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Orchard, Elysse A.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Bhatia, Shilpa; Terry, Tracee; Mathis, J. Michael] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Shreveport, LA 71105 USA; [Bhatia, Shilpa; Mathis, J. Michael] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Tainter, Kerrie H.; Lokitz, Stephen J.] Biomed Res Inst NW Louisiana, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Toomey, JS (corresponding author), So Res Inst, Birmingham, AL 35255 USA.	jmathi@lsuhsc.edu	Mathis, J. Michael/J-1379-2018	Mathis, J. Michael/0000-0001-5528-5195	Louisiana Gene Therapy Research Consortium; Biomedical Research Institute of Northwest Louisiana	Louisiana Gene Therapy Research Consortium; Biomedical Research Institute of Northwest Louisiana	This work was supported by the Louisiana Gene Therapy Research Consortium and the Biomedical Research Institute of Northwest Louisiana. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Balkowiec-Iskra E, 2007, INFLAMM RES, V56, P311, DOI 10.1007/s00011-007-6128-0; Blesa J, 2010, NEUROBIOL DIS, V38, P456, DOI 10.1016/j.nbd.2010.03.006; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; DONZANTI BA, 1988, PHARMACOL BIOCHEM BE, V30, P795, DOI 10.1016/0091-3057(88)90102-5; Eriksson O, 2010, NUCL MED BIOL, V37, P357, DOI 10.1016/j.nucmedbio.2009.12.004; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frey KA, 2001, ADV NEUROL, V86, P237; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; Harris PE, 2008, J MOL MED, V86, P5, DOI 10.1007/s00109-007-0242-x; Hattori N, 2007, NEUROPATHOLOGY, V27, P479, DOI 10.1111/j.1440-1789.2007.00842.x; Heise CE, 2005, ANAT EMBRYOL, V210, P287, DOI 10.1007/s00429-005-0053-1; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; Honer M, 2006, NUCL MED BIOL, V33, P607, DOI 10.1016/j.nucmedbio.2006.04.005; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Jakowec MW, 2004, J NEUROSCI RES, V76, P539, DOI 10.1002/jnr.20114; Kung MP, 2008, J NUCL MED, V49, P1171, DOI 10.2967/jnumed.108.051680; Kung MP, 2007, NUCL MED BIOL, V34, P239, DOI 10.1016/j.nucmedbio.2006.12.005; Lin KJ, 2010, J NUCL MED, V51, P1480, DOI 10.2967/jnumed.110.078196; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Okamura N, 2010, J NUCL MED, V51, P223, DOI 10.2967/jnumed.109.070094; Partridge M, 2006, NUCL INSTRUM METH A, V568, P933, DOI 10.1016/j.nima.2006.09.035; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Simpson NR, 2006, NUCL MED BIOL, V33, P855, DOI 10.1016/j.nucmedbio.2006.07.002; Singhal T, 2011, MOL IMAGING BIOL, V13, P973, DOI 10.1007/s11307-010-0406-x; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Taylor TN, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/124165; Tsao HH, 2011, NUCL MED BIOL, V38, P1029, DOI 10.1016/j.nucmedbio.2011.03.006; Veluthakal R, 2010, CURR PHARM DESIGN, V16, P1568, DOI 10.2174/138161210791164180; Vergo S, 2007, BRAIN RES, V1185, P18, DOI 10.1016/j.brainres.2007.09.028; Wang JL, 2010, NUCL MED BIOL, V37, P479, DOI 10.1016/j.nucmedbio.2010.01.006; Youdim MBH, 2007, J NEURAL TRANSM, V114, P205, DOI 10.1007/s00702-006-0499-1; Zhu L, 2010, NUCL MED BIOL, V37, P133, DOI 10.1016/j.nucmedbio.2009.10.005	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39041	10.1371/journal.pone.0039041	http://dx.doi.org/10.1371/journal.pone.0039041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723923	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300081
J	Oppliger, LV; Correa, JA; Engelen, AH; Tellier, F; Vieira, V; Faugeron, S; Valero, M; Gomez, G; Destombe, C				Valeria Oppliger, L.; Correa, Juan A.; Engelen, Aschwin H.; Tellier, Florence; Vieira, Vasco; Faugeron, Sylvain; Valero, Myriam; Gomez, Gonzalo; Destombe, Christophe			Temperature Effects on Gametophyte Life-History Traits and Geographic Distribution of Two Cryptic Kelp Species	PLOS ONE			English	Article							RANGE; PHAEOPHYCEAE; LAMINARIALES; GROWTH; BOUNDARIES; SURVIVAL; SEAWEEDS; REPRODUCTION; POPULATIONS; ALARIACEAE	A major determinant of the geographic distribution of a species is expected to be its physiological response to changing abiotic variables over its range. The range of a species often corresponds to the geographic extent of temperature regimes the organism can physiologically tolerate. Many species have very distinct life history stages that may exhibit different responses to environmental factors. In this study we emphasized the critical role of the haploid microscopic stage (gametophyte) of the life cycle to explain the difference of edge distribution of two related kelp species. Lessonia nigrescens was recently identified as two cryptic species occurring in parapatry along the Chilean coast: one located north and the other south of a biogeographic boundary at latitude 29-30 degrees S. Six life history traits from microscopic stages were identified and estimated under five treatments of temperature in eight locations distributed along the Chilean coast in order to (1) estimate the role of temperature in the present distribution of the two cryptic L. nigrescens species, (2) compare marginal populations to central populations of the two cryptic species. In addition, we created a periodic matrix model to estimate the population growth rate (lambda) at the five temperature treatments. Differential tolerance to temperature was demonstrated between the two species, with the gametophytes of the Northern species being more tolerant to higher temperatures than gametophytes from the south. Second, the two species exhibited different life history strategies with a shorter haploid phase in the Northern species contrasted with considerable vegetative growth in the Southern species haploid stage. These results provide strong ecological evidence for the differentiation process of the two cryptic species and show local adaptation of the life cycle at the range limits of the distribution. Ecological and evolutionary implications of these findings are discussed.	[Valeria Oppliger, L.; Correa, Juan A.; Faugeron, Sylvain; Gomez, Gonzalo] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [Valeria Oppliger, L.; Valero, Myriam; Destombe, Christophe] BEDIM, UPMC Stn Biol Roscoff, Equipe Biol Evolut & Divers Marine, UMR 7144, Roscoff, France; [Valeria Oppliger, L.; Valero, Myriam; Destombe, Christophe] BEDIM, Equipe Biol Evolut & Divers Marine, CNRS Stn Biol Roscoff, UMR 7144, Roscoff, France; [Engelen, Aschwin H.; Vieira, Vasco] Univ Algarve, Ctr Marine Sci CCMAR, CIMAR Lab Associado, Faro, Portugal; [Tellier, Florence] Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universidade do Algarve; Universidad Catolica de la Santisima Concepcion	Oppliger, LV (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Adv Studies Ecol & Biodivers, Alameda 340, Santiago, Chile.	destombe@sb-roscoff.fr	Valero, Myriam/C-7550-2011; Gomez, Gonzalo I/N-6443-2019; Destombe, Christophe/G-5317-2012; Tellier, Florence/E-1380-2015; Valero, Myriam/M-6052-2019; Teliler, Florence/Y-9505-2019; Engelen, Aschwin H/M-3432-2013	Valero, Myriam/0000-0002-9000-1423; Gomez, Gonzalo I/0000-0001-7761-8675; Tellier, Florence/0000-0002-9436-0095; Valero, Myriam/0000-0002-9000-1423; Teliler, Florence/0000-0002-9436-0095; Engelen, Aschwin H/0000-0002-9579-9606; Faugeron, Sylvain/0000-0001-7258-5229; Destombe, Christophe/0000-0001-5656-9659; Vieira, Vasco/0000-0001-9858-6254	CONICYT-FRENCH EMBASSADY; French Ministry of Education and Research; College Doctoral Franco-Chilien; "ARCUS'' of the French Ministry of Foreign Affairs; FCT-CNRS; FCT scholarships [SFRH/BPD/7153/2001, SFRH/BPD/63703/2009]	CONICYT-FRENCH EMBASSADY; French Ministry of Education and Research; College Doctoral Franco-Chilien; "ARCUS'' of the French Ministry of Foreign Affairs; FCT-CNRS(Centre National de la Recherche Scientifique (CNRS)Portuguese Foundation for Science and Technology); FCT scholarships(Portuguese Foundation for Science and Technology)	Support from the following programs is acknowledged: CONICYT-FRENCH EMBASSADY (PhD grant to LVO), French Ministry of Education and Research (PhD grant to FT), "College Doctoral Franco-Chilien'', "ARCUS'' of the French Ministry of Foreign Affairs and FCT-CNRS collaborative funding. This study is part of the research programs FONDAP 1501-0001 6 Program 7, ANR ECOKELP (ANR BDIV 012), Pole Mer Bretagne, FONDECYT 1060493, Laboratoire International Associe "Dispersal and Adaptation of Marine Species" (LIA DIAMS), and FCT scholarships SFRH/BPD/7153/2001 and SFRH/BPD/63703/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R, 2011, J PHYCOL, V47, P451, DOI 10.1111/j.1529-8817.2011.00986.x; AVILA M, 1985, Revista Chilena de Historia Natural, V58, P71; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BOLTON JJ, 1987, MAR BIOL, V96, P293, DOI 10.1007/BF00427029; BOLTON JJ, 1983, MAR BIOL, V73, P131, DOI 10.1007/BF00406880; BOLTON JJ, 1985, MAR BIOL, V87, P131, DOI 10.1007/BF00539420; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P199, DOI 10.1007/BF02366043; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; Caswell, 2000, MATRIX POPULATION MO; CASWELL H, 1994, ECOLOGY, V75, P1299, DOI 10.2307/1937455; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Darwin C, 1859, ORIGINS SPECIES MEAN; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; Dennis R. L., 1993, BUTTERFLIES CLIMATE; Destombe C, 2011, CAH BIOL MAR, V52, P385; DIECK IT, 1993, MAR ECOL PROG SER, V100, P253; DIECK IT, 1992, PHYCOLOGIA, V31, P147, DOI 10.2216/i0031-8884-31-2-147.1; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Engelen A, 2009, J ECOL, V97, P675, DOI 10.1111/j.1365-2745.2009.01501.x; GERARD VA, 1988, MAR BIOL, V97, P575, DOI 10.1007/BF00391054; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Hautekeete NC, 2009, ACTA OECOL, V35, P104, DOI 10.1016/j.actao.2008.08.004; Hautekeete NC, 2002, J ECOL, V90, P508, DOI 10.1046/j.1365-2745.2002.00688.x; HERSTEINSSON P, 1992, OIKOS, V64, P505, DOI 10.2307/3545168; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hill MO, 2002, J APPL ECOL, V39, P708, DOI 10.1046/j.1365-2664.2002.00746.x; HOFFMANN AJ, 1982, J EXP MAR BIOL ECOL, V60, P77, DOI 10.1016/0022-0981(81)90182-9; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; Jahns H. M., 1995, ALGAE INTRO PHYCOLOG; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; LUNING K, 1978, Z PFLANZENPHYSIOL, V89, P333; Luning K, 1990, SEAWEEDS THEIR ENV B; Martinez EA, 2003, J PHYCOL, V39, P504, DOI 10.1046/j.1529-8817.2003.02191.x; Martinez Enrique A., 1999, Pacific Science, V53, P74; Matson PG, 2007, MAR BIOL, V151, P1941, DOI 10.1007/s00227-007-0630-3; Mills LS, 1999, CONSERV BIOL, V13, P815, DOI 10.1046/j.1523-1739.1999.98232.x; Muller R, 2008, CLIM RES, V37, P203, DOI 10.3354/cr00762; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Munoz V, 2004, REV CHIL HIST NAT, V77, P639; Oppliger LV, 2011, J PHYCOL, V47, P5, DOI 10.1111/j.1529-8817.2010.00930.x; Perry AL, 2005, SCIENCE, V308, p1837a; PETERS AF, 1993, MAR BIOL, V115, P143, DOI 10.1007/BF00349396; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sauvageau C, 1918, MEM ACAD SCI I FR, V56, P1; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sokal RR, 1995, BIOMETRY; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; TILLBOTTRAUD I, 1990, J EVOLUTION BIOL, V3, P205, DOI 10.1046/j.1420-9101.1990.3030205.x; Van Kleunen M, 2007, CONSERV BIOL, V21, P1537, DOI 10.1111/j.1523-1739.2007.00765.x; Viejo RM, 2011, ECOGRAPHY, V34, P75, DOI 10.1111/j.1600-0587.2010.06365.x; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060; YOUNG TP, 1981, AM NAT, V118, P27, DOI 10.1086/283798	65	43	43	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39289	10.1371/journal.pone.0039289	http://dx.doi.org/10.1371/journal.pone.0039289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723987	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300128
J	Xiao, W; Bao, ZX; Zhang, CY; Zhang, XY; Shi, LJ; Zhou, ZT; Jiang, WW				Xiao, Wen; Bao, Zhe-Xuan; Zhang, Chen-Yang; Zhang, Xiao-Yun; Shi, Lin-Jun; Zhou, Zeng-Tong; Jiang, Wei-Wen			Upregulation of miR-31*Is Negatively Associated with Recurrent/Newly Formed Oral Leukoplakia	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; IN-SITU HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; NASOPHARYNGEAL CARCINOMA; 11Q13 AMPLIFICATION; GENE AMPLIFICATION; EPITHELIAL-CELLS; THYROID-CANCER; MICRORNA; EXPRESSION	Background: Oral leukoplakia (OLK) is a potentially malignant disorder of the oral cavity. However, the underlying mechanism of OLK is still unclear. In this study, we explore possible miRNAs involved in OLK. Methodology/Principal Findings: Using miRNA microarrays, we profiled miRNA expression in OLK and malignantly transformed OLK (mtOLK) tissue samples. The upregulation of miR-31*, miR-142-5p, miR-33a, miR-1259, miR-146b-5p, miR-886-3p, miR-886-5p, miR-519d, and miR-301a along with the downregulation of miR-572, miR-611, miR-602, miR-675, miR-585, miR-623, miR-637, and miR-1184 in mtOLK were new observations. Fluorescence in situ hybridization (FISH) analyses confirmed that miR-31* is highly expressed in mtOLK. There was a significant difference between the FISH score (p<0.05) in patients with or without recurrent/newly formed OLK. Functional analyses demonstrated that a miR-31* inhibitor decreased apoptosis in the Leuk-1, which is an immortalized oral epithelial cell line spontaneously derived from an oral leukoplakia lesion. miR-31* regulated apoptosis, cell proliferation, migration, and invasion in the HOIEC, which is a HPV E6/E7-immortalized oral epithelial cell line. Furthermore, miR-31* modulated the biological functions of apoptosis, cell proliferation, cell cycle, migration, and invasion in the oral squamous cell carcinoma cell line, Cal-27. Using bioinformatic analyses and dual luciferase reporter assays, we determined that the 3' untranslated region of fibroblast growth factor 3 (FGF3) is the target of miR-31*. Expression of FGF3 was downregulated or upregulated in the presence of a miR-31* mimic or inhibitor, respectively. Conclusions/Significance: Upregulation of miR-31* is negatively associated with recurrent/newly formed OLK. MiR-31* may exert similar but distinguishable effects on biological function in oral cells with different malignant potential. FGF3 is the target of miR-31*. miR-31* may play an important role during OLK progression through regulating FGF3. MiRNA* strands may also have prominent roles in oral carcinogenesis.	[Xiao, Wen; Bao, Zhe-Xuan; Zhang, Chen-Yang; Zhang, Xiao-Yun; Shi, Lin-Jun; Zhou, Zeng-Tong; Jiang, Wei-Wen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral Mucosal Dis,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xiao, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral Mucosal Dis,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	wwjiang33@hotmail.com			Science and Technology Commission of Shanghai [07PJ14067, 08DZ2271100]; Shanghai Leading Academic Discipline Project [S30206]; National and Natural Foundation of China [30872887]	Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National and Natural Foundation of China	This work was supported by Science and Technology Commission of Shanghai (www.stcsm.gov.cn) Grants No. 07PJ14067 and 08DZ2271100, Shanghai Leading Academic Discipline Project No. S30206, and National and Natural Foundation of China (www.nsfc.gov.cn) Grant No. 30872887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axell T, 1996, J ORAL PATHOL MED, V25, P49, DOI 10.1111/j.1600-0714.1996.tb00191.x; BENHARROCH D, 1990, ISRAEL J MED SCI, V26, P212; Califano J, 1996, CANCER RES, V56, P2488; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen CZ, 2005, NEW ENGLAND J MED, P353; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Chua SS, 2002, ONCOGENE, V21, P1899, DOI 10.1038/sj.onc.1205096; DICKSON C, 1990, J CELL SCI, P87; ESTELLER M, 1995, CANCER-AM CANCER SOC, V75, P2139, DOI 10.1002/1097-0142(19950415)75:8<2139::AID-CNCR2820750817>3.0.CO;2-6; Fan CS, 2000, HUM PATHOL, V31, P169, DOI 10.1016/S0046-8177(00)80216-6; Freier K, 2006, GENE CHROMOSOME CANC, V45, P118, DOI 10.1002/gcc.20270; Fujii T, 2005, DIAGN MOL PATHOL, V14, P103, DOI 10.1097/01.pas.0000162755.84026.9f; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Habbe N, 2009, MICRORNA MIR 155 IS, P1; Hajitou A, 1998, ONCOGENE, V17, P2059, DOI 10.1038/sj.onc.1202126; Hollmann CA, 2001, ONCOGENE, V20, P7645, DOI 10.1038/sj.onc.1204980; Hu L, 2007, CANCER LETT, V252, P36, DOI 10.1016/j.canlet.2006.12.003; Hu Y, 2011, INT J CANC; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KRAMER I R H, 1978, Oral Surgery Oral Medicine Oral Pathology, V46, P518; LESE CM, 1995, GENE CHROMOSOME CANC, V12, P288, DOI 10.1002/gcc.2870120409; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Sdek P, 2006, INT J ORAL MAX SURG, V35, P653, DOI 10.1016/j.ijom.2006.01.017; Seki A, 2000, INT J ONCOL, V17, P103; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; Shuster MI, 2000, GENE CHROMOSOME CANC, V28, P153, DOI 10.1002/(SICI)1098-2264(200006)28:2<153::AID-GCC4>3.0.CO;2-9; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sobin, 2009, UICC TNM CLASSIFICAT; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; van der Hem PS, 2005, ORAL ONCOL, V41, P31, DOI 10.1016/j.oraloncology.2004.06.010; VINDELOV LL, 1983, CYTOMETRY, V3, P328, DOI 10.1002/cyto.990030504; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; William WN, 2009, CANCER PREV RES, V2, P22, DOI 10.1158/1940-6207.CAPR-08-0100; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xu CF, 2009, OMICS, V13, P513, DOI 10.1089/omi.2009.0035; Xu J, 1996, GENE CHROMOSOME CANC, V17, P172, DOI 10.1002/(SICI)1098-2264(199611)17:3<172::AID-GCC5>3.0.CO;2-1; Yu JW, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-55; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhong LP, 2008, ARCH ORAL BIOL, V53, P443, DOI 10.1016/j.archoralbio.2007.12.002	50	45	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38648	10.1371/journal.pone.0038648	http://dx.doi.org/10.1371/journal.pone.0038648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719913	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300037
J	Yu, ZG; Jia, CX; Liu, LY; Geng, CZ; Tang, JH; Zhang, J; Zhang, Q; Li, YY; Ma, ZB				Yu, Zhi-Gang; Jia, Cun-Xian; Liu, Li-Yuan; Geng, Cui-Zhi; Tang, Jin-Hai; Zhang, Jin; Zhang, Qiang; Li, Yu-Yang; Ma, Zhong-Bing			The Prevalence and Correlates of Breast Cancer among Women in Eastern China	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; RISK-FACTORS; DIABETES-MELLITUS; INDUCED-ABORTION; YOUNG-WOMEN; COHORT; METAANALYSIS; ASSOCIATION; ESTROGEN; OBESITY	The purpose was to investigate the prevalence rate, characteristics and related factors of breast cancer among women in Eastern China. A total of 122,058 female subjects completed the study, with 320 confirmed cases of breast cancer (crude prevalence: 262.5/100,000; standardized prevalence: 207.7/100,000). Among all of the identified breast cancer cases, 91.6% were diagnosed after the age of 35 and 60.0% were diagnosed before menopause. The odds ratios (95% confidence interval) of those breast cancer risk factors as selected through multivariate logistic regression were as follows: 5.438 (1.553-19.004) for family history of breast cancer, 3.556 (1.880-6.728) for high behavior intervention score, 3.556 (0.904-13.994) for history of diabetes, 3.357 (1.131-9.969) for history of benign breast tumors, 2.196 (1.355-3.556) for poor overall life satisfaction, 1.826 (0.995-3.350) for premenopause of breast cancer, 1.528 (1.083-2.155) for high BMI index, 1.500 (0.920-2.446) for poor financial status, 1.497 (1.014-2.211) for multiple miscarriages/abortions, and 1.231 (0.972-1.559) for infrequent consumption of garlic (frequent garlic consumption is a protective factor). There were significantly more cases of breast cancer diagnosed prior to menopause than after menopause, and most of the patients were diagnosed after the age of 35. These findings suggest that attention should be focused on the incidence of breast cancer among premenopausal women older than 35.	[Yu, Zhi-Gang; Zhang, Qiang; Li, Yu-Yang; Ma, Zhong-Bing] Shandong Univ, Dept Breast Dis, Hosp 2, Jinan 250100, Peoples R China; [Jia, Cun-Xian; Liu, Li-Yuan] Shandong Univ, Inst Epidemiol, Sch Publ Hlth, Jinan 250100, Peoples R China; [Jia, Cun-Xian] SUNY Buffalo, Dept Sociol, Buffalo, NY 14260 USA; [Geng, Cui-Zhi] Hebei Med Univ, Dept Breast Dis, Hosp 4, Shijiazhuang, Peoples R China; [Tang, Jin-Hai] Jiangsu Canc Hosp, Dept Breast Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Jin] Tianjin Canc Hosp, Dept Breast Dis, Tianjin, Peoples R China	Shandong University; Shandong University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hebei Medical University; Nanjing Medical University; Tianjin Medical University	Yu, ZG (corresponding author), Shandong Univ, Dept Breast Dis, Hosp 2, Jinan 250100, Peoples R China.	yuzgsd@yeah.net	YU, ZHIGANG/AAA-4679-2022	liu, liyuan/0000-0002-9862-7471	Novartis China; Ministry of Health of the People's Republic of China [07090122]	Novartis China(Novartis); Ministry of Health of the People's Republic of China	At the outset the programme was sponsored by Novartis China. The study sponsors played no role in any aspect of the study design; in the collection, analysis, and interpretation of data; or in the development of the manuscript. The authors would also like to thank all survey participants for their involvement, as well as the members of the Centres of Disease Control and Prevention and the Family Planning Departments of Shandong, Hebei, JiangSu, and Tianjin Hospitals for their collaboration and cooperation.; This study was granted funding from the minister-affiliated hospital key project of the Ministry of Health of the People's Republic of China (NO: 07090122). At the outset the programme was sponsored by Novartis China. The study sponsors played no role in any aspect of the study design; in the collection, analysis, and interpretation of data; or in the development of the manuscript.	Alokail MS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-33; [Anonymous], WHO GLOB BURD DIS 20; Brewster DH, 2005, J EPIDEMIOL COMMUN H, V59, P283, DOI 10.1136/jech.2004.026393; Brind J, 1996, J EPIDEMIOL COMMUN H, V50, P481, DOI 10.1136/jech.50.5.481; Chen WY, 2004, CANCER, V101, P1490, DOI 10.1002/cncr.20499; COLE P, 1978, AM J EPIDEMIOL, V108, P112, DOI 10.1093/oxfordjournals.aje.a112594; Collaborative Group on Hormonal Factors in Breast Cancer, 2011, LANCET, V358, P1389; Couzin J, 2003, SCIENCE, V299, P1498; Daling JR, 2003, CANCER EPIDEM BIOMAR, V12, P1175; [方亚 Fang Ya], 2009, [中国卫生统计, Chinese Journal of Health Statistics], V26, P241; Feigelson HS, 2004, CANCER EPIDEM BIOMAR, V13, P220, DOI 10.1158/1055-9965.EPI-03-0301; GAJALAKSHMI CK, 1991, ACTA ONCOL, V30, P569, DOI 10.3109/02841869109092419; Han Ding-fen, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P256; Hao YY, 2005, ENDEMIC DIS B, V20, P38; Horn-Ross PL, 2004, CANCER EPIDEM BIOMAR, V13, P405; Horner MJ, 2009, SEER CANC STAT REV 1; La Vecchia C, 2011, ONCOLOGIST, V16, P726, DOI 10.1634/theoncologist.2011-0050; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Li HJ, 2007, CHIN RURAL HLTH SERV, V7, P556; Li J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-364; Liao SC, 2010, ASIAN PAC J CANCER P, V11, P933; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Michels KB, 2007, ARCH INTERN MED, V167, P814, DOI 10.1001/archinte.167.8.814; Papadimitriou Konstantinos, 2010, J Thorac Dis, V2, P160, DOI 10.3978/j.issn.2072-1439.2010.02.03.8; Pike MC, 2002, CANCER EPIDEM BIOMAR, V11, P795; PIKE MC, 1981, BRIT J CANCER, V43, P72, DOI 10.1038/bjc.1981.10; *SOC AC, 2005, BREAST CANC FACTS FI; Tao HL, 2009, CHIN ONCOL, V18, P446; Vachon CM, 2002, CANCER EPIDEM BIOMAR, V11, P1382; Valerie B, 2002, LANCET, V360, P187; WANG QJ, 2000, CHIN J EPIDEMIOL, V21, P216; Xu Yali, 2010, J Thorac Dis, V2, P171, DOI 10.3978/j.issn.2072-1439.2010.02.03.9; Yang DH, 2012, GLAND SURG, V1, P33, DOI [10.3978/j.issn.2227-684X.2012.04.01, 10.3978/j.issn.2227-684X.2012.04.07]; Zheng W, 2001, CANCER EPIDEM BIOMAR, V10, P89; BREAST CANC STAT INC	36	30	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37784	10.1371/journal.pone.0037784	http://dx.doi.org/10.1371/journal.pone.0037784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723840	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300012
J	Brettschneider, J; Toledo, JB; Van Deerlin, VM; Elman, L; McCluskey, L; Lee, VMY; Trojanowski, JQ				Brettschneider, Johannes; Toledo, Jon B.; Van Deerlin, Vivianna M.; Elman, Lauren; McCluskey, Leo; Lee, Virginia M. -Y.; Trojanowski, John Q.			Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; HEXANUCLEOTIDE REPEAT EXPANSION; WEIGHT NEUROFILAMENT PROTEIN; WILD-TYPE MICROGLIA; SPINAL-CORD TISSUE; TDP-43 PROTEINOPATHIES; MOUSE MODEL; SUPEROXIDE-DISMUTASE; BINDING PROTEIN; FAMILIAL ALS	Background/Aims: We evaluated clinicopathological correlates of upper motor neuron (UMN) damage in amyotrophic lateral sclerosis (ALS), and analyzed if the presence of the C9ORF72 repeat expansion was associated with alterations in microglial inflammatory activity. Methods: Microglial pathology was assessed by IHC with 2 different antibodies (CD68, Iba1), myelin loss by Kluver-Barrera staining and myelin basic protein (MBP) IHC, and axonal loss by neurofilament protein (TA51) IHC, performed on 59 autopsy cases of ALS including 9 cases with C9ORF72 repeat expansion. Results: Microglial pathology as depicted by CD68 and Iba1 was significantly more extensive in the corticospinal tract (CST) of ALS cases with a rapid progression of disease. Cases with C9ORF72 repeat expansion showed more extensive microglial pathology in the medulla and motor cortex which persisted after adjusting for disease duration in a logistic regression model. Higher scores on the clinical UMN scale correlated with increasing microglial pathology in the cervical CST. TDP-43 pathology was more extensive in the motor cortex of cases with rapid progression of disease. Conclusions: This study demonstrates that microglial pathology in the CST of ALS correlates with disease progression and is linked to severity of UMN deficits.	[Brettschneider, Johannes; Toledo, Jon B.; Lee, Virginia M. -Y.; Trojanowski, John Q.] Univ Penn, Sch Med, CNDR, Philadelphia, PA 19104 USA; [Toledo, Jon B.; Van Deerlin, Vivianna M.; Lee, Virginia M. -Y.; Trojanowski, John Q.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Elman, Lauren; McCluskey, Leo] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Brettschneider, Johannes] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Ulm University	Brettschneider, J (corresponding author), Univ Penn, Sch Med, CNDR, Philadelphia, PA 19104 USA.	Johannes.brettschneider@uni-ulm.de		Toledo, Jon/0000-0003-4366-9268	NIH [AG033101, AG17586, AG10124, AG32953]; Koller Family Foundation; Deutsche Forschungsgemeinschaft DFG [AOBJ586910]; Fundacion Alfonso Martin Escudero; NATIONAL INSTITUTE ON AGING [P01AG017586, P30AG010124, K08AG033101, P01AG032953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koller Family Foundation; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Fundacion Alfonso Martin Escudero; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIH (AG033101, AG17586, AG10124, AG32953), and the Koller Family Foundation. VMYL is the John H. Ware, 3rd, Professor of Alzheimer's Disease Research. JQT is the William Maul Measey-Truman G. Schnabel, Jr., Professor of Geriatric Medicine and Gerontology. JB is supported by a grant of the Deutsche Forschungsgemeinschaft DFG (AOBJ586910). JBT is supported by a grant of the Fundacion Alfonso Martin Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Arnold SE, 2000, NEUROBIOL AGING, V21, P913, DOI 10.1016/S0197-4580(00)00173-1; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bigio EH, 2011, ACTA NEUROPATHOL, V122, P653, DOI 10.1007/s00401-011-0919-7; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brettschneider J, 2012, ACTA NEUROPATHOL; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; FAMBROUGH DM, 1988, J CELL BIOL, V106, P61, DOI 10.1083/jcb.106.1.61; Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; HICKEY WF, 1983, J HISTOCHEM CYTOCHEM, V31, P1126, DOI 10.1177/31.9.6193166; HOLNESS CL, 1993, BLOOD, V81, P1607; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Ince PG, 2003, NEUROLOGY, V60, P1252, DOI 10.1212/01.WNL.0000058901.75728.4E; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; ITOH T, 1992, ACTA NEUROPATHOL, V83, P240, DOI 10.1007/BF00296785; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Lasiene J, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/718987; Lloyd CM, 2000, BRAIN, V123, P2289, DOI 10.1093/brain/123.11.2289; McGeer EG, 2005, BIODRUGS, V19, P31, DOI 10.2165/00063030-200519010-00004; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mosley RL, 2010, EXP NEUROL, V222, P1, DOI 10.1016/j.expneurol.2009.12.018; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Ohsawa K, 2000, J CELL SCI, V113, P3073; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Pena EA, 2006, J AM STAT ASSOC, V101, P341, DOI 10.1198/016214505000000637; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Smith RA, 2004, AMYOTROPH LATERAL SC, V5, P99, DOI 10.1080/17434470410020058; SOBUE G, 1990, ACTA NEUROPATHOL, V79, P402, DOI 10.1007/BF00308716; Stewart H., 2012, ACTA NEUROPATHOL; Troakes C, 2011, NEUROPATHOLOGY; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Van Damme P, 2007, P NATL ACAD SCI USA, V104, P14825, DOI 10.1073/pnas.0705046104; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	68	150	154	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39216	10.1371/journal.pone.0039216	http://dx.doi.org/10.1371/journal.pone.0039216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720079	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800058
J	Marangolo, P; Cipollari, S; Fiori, V; Razzano, C; Caltagirone, C				Marangolo, Paola; Cipollari, Susanna; Fiori, Valentina; Razzano, Carmela; Caltagirone, Carlo			Walking but Not Barking Improves Verb Recovery: Implications for Action Observation Treatment in Aphasia Rehabilitation	PLOS ONE			English	Article							PREMOTOR CORTEX; MIRROR NEURONS; MOTOR; INTENSITY; RETRIEVAL; LANGUAGE; GESTURE; SPEECH; MOTION; WORDS	Recent studies have shown that action observation treatment without concomitant verbal cue has a positive impact on the recovery of verb retrieval deficits in aphasic patients. In agreement with an embodied cognition viewpoint, a hypothesis has been advanced that gestures and language form a single communication system and words whose retrieval is facilitated by gestures are semantically represented through sensory-motor features. However, it is still an open question as to what extent this treatment approach works. Results from the recovery of motor deficits have suggested that action observation promotes motor recovery only for actions that are part of the motor repertoire of the observer. The aim of the present experiment was to further investigate the role of action observation treatment in verb recovery. In particular, we contrasted the effects induced by observing human actions (e.g. dancing, kicking, pointing, eating) versus non human actions (e. g. barking, printing). Seven chronic aphasic patients with a selective deficit in verb retrieval underwent an intensive rehabilitation training that included five daily sessions over two consecutive weeks. Each subject was asked to carefully observe 115 video-clips of actions, one at a time and, after observing them, they had to produce the corresponding verb. Two groups of actions were randomly presented: humans versus nonhuman actions. In all patients, significant improvement in verb retrieval was found only by observing video-clips of human actions. Moreover, follow-up testing revealed long-term verb recovery that was still present two months after the two treatments had ended. In support of the multimodal concept representation's proposal, we suggest that just the observation of actions pertaining to the human motor repertoire is an effective rehabilitation approach for verb recovery.	[Marangolo, Paola] Univ Politecn Marche, Fac Med, Ancona, Italy; [Marangolo, Paola; Cipollari, Susanna; Fiori, Valentina; Razzano, Carmela; Caltagirone, Carlo] IRCCS Fdn Santa Lucia, Rome, Italy; [Caltagirone, Carlo] Univ Roma, Rome, Italy	Marche Polytechnic University; IRCCS Santa Lucia; Sapienza University Rome; University of Rome Tor Vergata	Marangolo, P (corresponding author), Univ Politecn Marche, Fac Med, Ancona, Italy.	p.marangolo@univpm.it	Caltagirone, Carlo/B-4930-2013	fiori, valentina/0000-0002-3468-221X; MARANGOLO, Paola/0000-0002-1516-9832				Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bellelli G, 2010, ARCH PHYS MED REHAB, V91, P1489, DOI 10.1016/j.apmr.2010.07.013; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Binkofski F, 2006, J PHYSIOL-PARIS, V99, P396, DOI 10.1016/j.jphysparis.2006.03.005; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2011, MOVEMENT DISORD, V26, P1963, DOI 10.1002/mds.23745; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Chaminade T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011577; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Della Sala S, 2004, J NEUROL NEUROSUR PS, V75, P196; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; DERENZI E, 1980, ARCH NEUROL-CHICAGO, V37, P6, DOI 10.1001/archneur.1980.00500500036003; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Franceschini M, 2010, EUR J PHYS REHAB MED, V46, P517; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Hadar U, 1998, BRAIN LANG, V62, P107, DOI 10.1006/brln.1997.1890; HANLON RE, 1990, BRAIN LANG, V38, P298, DOI 10.1016/0093-934X(90)90116-X; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Hornby TG, 2011, TOP STROKE REHABIL, V18, P293, DOI 10.1310/tsr1804-293; Krauss R., 2000, LANGUAGE GESTURE WIN, P228; Krauss RobertM., 1999, GESTURE SPEECH SIGN, P93, DOI [10.1093/acprof:oso/9780198524519.003.0006, DOI 10.1093/ACPROF:OSO/9780198524519.003.0006]; Marangolo P, 2010, NEUROPSYCHOLOGIA, V48, P3824, DOI 10.1016/j.neuropsychologia.2010.09.025; Martin A. C, 2000, NEW COGNITIVE NEUROS, P1023; Miceli G., 1994, BATTERIA LANALISI DE; Miura N, 2010, SOC NEUROSCI-UK, V5, P40, DOI 10.1080/17470910903083256; Moore JL, 2010, STROKE, V41, P129, DOI 10.1161/STROKEAHA.109.563247; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pashek G, 1998, BRAIN LANG, V65, P177; Pashek GV, 1997, J COMMUN DISORD, V30, P349, DOI 10.1016/S0021-9924(96)00079-2; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Raymer AM, 2006, J INT NEUROPSYCH SOC, V12, P867, DOI 10.1017/S1355617706061042; Richards K, 2002, J REHABIL RES DEV, V39, P445; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rodriguez AD, 2006, APHASIOLOGY, V20, P286, DOI 10.1080/02687030500474898; Rose M, 2002, APHASIOLOGY, V16, P1001, DOI 10.1080/02687030143000825; Shimada S, 2010, BRAIN COGNITION, V72, P394, DOI 10.1016/j.bandc.2009.11.005; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005	40	33	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38610	10.1371/journal.pone.0038610	http://dx.doi.org/10.1371/journal.pone.0038610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719906	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900037
J	Thomas, P; Matuschek, H; Grima, R				Thomas, Philipp; Matuschek, Hannes; Grima, Ramon			intrinsic Noise Analyzer: A Software Package for the Exploration of Stochastic Biochemical Kinetics Using the System Size Expansion	PLOS ONE			English	Article							CIRCADIAN CLOCK; SIMULATION; NETWORKS; FLUCTUATIONS; OSCILLATIONS; METABOLISM; DYNAMICS; LIBRARY; RHYTHMS; MODEL	The accepted stochastic descriptions of biochemical dynamics under well-mixed conditions are given by the Chemical Master Equation and the Stochastic Simulation Algorithm, which are equivalent. The latter is a Monte-Carlo method, which, despite enjoying broad availability in a large number of existing software packages, is computationally expensive due to the huge amounts of ensemble averaging required for obtaining accurate statistical information. The former is a set of coupled differential-difference equations for the probability of the system being in any one of the possible mesoscopic states; these equations are typically computationally intractable because of the inherently large state space. Here we introduce the software package intrinsic Noise Analyzer (iNA), which allows for systematic analysis of stochastic biochemical kinetics by means of van Kampen's system size expansion of the Chemical Master Equation. iNA is platform independent and supports the popular SBML format natively. The present implementation is the first to adopt a complementary approach that combines state-of-the-art analysis tools using the computer algebra system Ginac with traditional methods of stochastic simulation. iNA integrates two approximation methods based on the system size expansion, the Linear Noise Approximation and effective mesoscopic rate equations, which to-date have not been available to non-expert users, into an easy-to-use graphical user interface. In particular, the present methods allow for quick approximate analysis of time-dependent mean concentrations, variances, covariances and correlations coefficients, which typically outperforms stochastic simulations. These analytical tools are complemented by automated multi-core stochastic simulations with direct statistical evaluation and visualization. We showcase iNA's performance by using it to explore the stochastic properties of cooperative and non-cooperative enzyme kinetics and a gene network associated with circadian rhythms. The software iNA is freely available as executable binaries for Linux, MacOSX and Microsoft Windows, as well as the full source code under an open source license.	[Thomas, Philipp; Grima, Ramon] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Thomas, Philipp; Grima, Ramon] Univ Edinburgh, SynthSys Edinburgh, Edinburgh, Midlothian, Scotland; [Thomas, Philipp] Humboldt Univ, Dept Phys, Berlin, Germany; [Matuschek, Hannes] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany	University of Edinburgh; University of Edinburgh; Humboldt University of Berlin; University of Potsdam	Thomas, P (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Ramon.Grima@ed.ac.uk		Thomas, Philipp/0000-0003-4919-8452; Grima, Ramon/0000-0002-1266-8169	SULSA (Scottish Universities Life Sciences Alliance); SynthSys Edinburgh	SULSA (Scottish Universities Life Sciences Alliance); SynthSys Edinburgh	The work was funded by SULSA (Scottish Universities Life Sciences Alliance) http://www.sulsa.ac.uk/ and by SynthSys Edinburgh http://www.csbe.ed.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-24; Aho A.V., 2007, COMPILERS PRINCIPLES; Ander M., 2004, Systems Biology, V1, P129, DOI 10.1049/sb:20045017; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bauer C, 2002, J SYMB COMPUT, V33, P1, DOI 10.1006/jsco.2001.0494; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; Caulfield E, 2010, BIOINFORMATICS, V26, P426, DOI 10.1093/bioinformatics/btp662; Davis KL, 2006, FEBS J, V273, P84, DOI 10.1111/j.1742-4658.2005.05043.x; de Ronde WH, 2009, IET SYST BIOL, V3, P429, DOI 10.1049/iet-syb.2008.0167; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Fehlberg E, 1969, 315 NASA; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gardiner C.W., 2007, HDB STOCHASTIC METHO; Gillespie CS, 2009, IET SYST BIOL, V3, P52, DOI 10.1049/iet-syb:20070031; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3253798; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218103; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Grima R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-101; Guennebaud G., 2010, EIGEN V3; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Hayot F, 2004, PHYS BIOL, V1, P205, DOI 10.1088/1478-3967/1/4/002; Hespanha J, 2008, 2008 3RD INTERNATIONAL SYMPOSIUM ON COMMUNICATIONS, CONTROL AND SIGNAL PROCESSING, VOLS 1-3, P142, DOI 10.1109/ISCCSP.2008.4537208; Higham DJ, 2008, SIAM REV, V50, P347, DOI 10.1137/060666457; Hucka M., 2004, Systems Biology, V1, P41, DOI 10.1049/sb:20045008; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Liu Q., 2010, JISUANJI YINGYONG YU, V27, P212; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; LODOLA A, 1978, BIOCHEM J, V175, P987, DOI 10.1042/bj1750987; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Machne R, 2006, BIOINFORMATICS, V22, P1406, DOI 10.1093/bioinformatics/btl086; MAUCH S., 2009, CAIN STOCHASTIC SIMU; Mauch S, 2011, IEEE ACM T COMPUT BI, V8, P27, DOI 10.1109/TCBB.2009.47; McKane AJ, 2007, J STAT PHYS, V128, P165, DOI 10.1007/s10955-006-9221-9; MCQUARRI.DA, 1967, J APPL PROBAB, V4, P413, DOI 10.2307/3212214; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Olivier BG, 2005, BIOINFORMATICS, V21, P560, DOI 10.1093/bioinformatics/bti046; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Ramaswamy R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1775; Ramaswamy R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00154; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Nicolas R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-79; Sanft KR, 2011, BIOINFORMATICS, V27, P2457, DOI 10.1093/bioinformatics/btr401; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shou MG, 1999, BIOCHEM J, V340, P845, DOI 10.1042/0264-6021:3400845; Tam ZY, 2010, BIOPHYS J, V99, P3155, DOI 10.1016/j.bpj.2010.09.041; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas P, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3505552; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; Tyson J.J., 2002, INTERD APPL, P230, DOI 10.1007/978-0-387-22459-6_9; Vallabhajosyula RR, 2006, BIOINFORMATICS, V22, P346, DOI 10.1093/bioinformatics/bti800; Van Kampen NG., 1976, ADV CHEM PHYS, V34, P245, DOI DOI 10.1002/9780470142530.CH5); van Zon JS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2137716; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Westermark PO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000580	77	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38518	10.1371/journal.pone.0038518	http://dx.doi.org/10.1371/journal.pone.0038518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22723865	Green Published, gold			2022-12-27	WOS:000305340000028
J	McCambridge, J; de Bruin, M; Witton, J				McCambridge, Jim; de Bruin, Marijn; Witton, John			The Effects of Demand Characteristics on Research Participant Behaviours in Non-Laboratory Settings: A Systematic Review	PLOS ONE			English	Review							SELF-REPORT; VALIDITY; BIAS	Background: The concept of demand characteristics, which involves research participants being aware of what the researcher is investigating, is well known and widely used within psychology, particularly in laboratory-based studies. Studies of this phenomenon may make a useful contribution to broader consideration of the effects of taking part in research on participant behaviour. This systematic review seeks to summarise data from studies of the effects of demand characteristics on participant behaviours in non-laboratory settings. Methodology/Principal Findings: Electronic databases were searched to identify eligible studies. These had to be purposely designed to evaluate possible effects of demand characteristics on at least one behavioural outcome under the autonomous control of the participants and use longitudinal study designs. Only 7 studies were included, 6 providing observational data and 1 experimental study, with 5 studies involving examination of possible effects on health behaviours. Although studies provided some evidence of effects of demand characteristics on participant behaviour, heterogeneous operationalisation of the construct, the limited number of studies and poor quality of study designs made synthesis and interpretation of study findings challenging. Conclusions/Significance: Although widely accepted as important in psychology, there have been few dedicated studies of the effects of demand characteristics on research participant behaviours outside laboratory settings. This body of literature does not currently contribute to the wider study of research participation effects. A systematic review of data from laboratory-based studies is needed, as are high-quality primary studies in non-laboratory settings. We suggest that unqualified use of the term demand characteristics should be abandoned.	[McCambridge, Jim] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [de Bruin, Marijn] Wageningen Univ, Dept Commun Sci, Wageningen, Netherlands; [Witton, John] Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; Wageningen University & Research; University of London; King's College London	McCambridge, J (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England.	Jim.McCambridge@lshtm.ac.uk	de Bruin, Marijn/X-8418-2018	de Bruin, Marijn/0000-0003-3100-6803; McCambridge, Jim/0000-0002-5461-7001	Wellcome Trust [WT086516MA]	Wellcome Trust(Wellcome Trust)	No specific project funding was received for this study, which was undertaken as part of a programme of work funded by a career award to the first author from the Wellcome Trust, http://www.wellcome.ac.uk/index.(WT086516MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR JG, 1984, J APPL PSYCHOL, V69, P334, DOI 10.1037/0021-9010.69.2.334; ADAIR JG, 1972, CAN J BEH SCI, V4, P238, DOI 10.1037/h0082309; Anderson T, 1996, J CONSULT CLIN PSYCH, V64, P776, DOI 10.1037/0022-006X.64.4.776; Armitage CJ, 2009, HEALTH PSYCHOL, V28, P545, DOI 10.1037/a0015984; BERKOWITZ L, 1986, MOTIV EMOTION, V10, P337, DOI 10.1007/BF00992108; Chapman J, 2010, PSYCHOL HEALTH, V25, P365, DOI 10.1080/08870440802642148; Chapman J, 2009, PSYCHOL HEALTH, V24, P317, DOI 10.1080/08870440701864538; Conner M, 2011, HEALTH PSYCHOL, V30, P300, DOI 10.1037/a0023036; Davies JB, 1996, PSYCHOL HEALTH, V11, P291, DOI 10.1080/08870449608400258; DELAMATER AM, 1988, J APPL SOC PSYCHOL, V18, P491, DOI 10.1111/j.1559-1816.1988.tb00031.x; Faith MS, 1998, OBES RES, V6, P134, DOI 10.1002/j.1550-8528.1998.tb00327.x; HORVATH P, 1984, J CONSULT CLIN PSYCH, V52, P616; Kanter JW, 2004, COGNITIVE THER RES, V28, P229, DOI 10.1023/B:COTR.0000021542.40547.15; Kiley D, 1974, J COMMUNITY PSYCHOL, V2, P242, DOI DOI 10.1002/(ISSN)1520-6629; Kypri K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-42; Laney C, 2008, PSYCHOL RES-PSYCH FO, V72, P362, DOI 10.1007/s00426-007-0122-6; Lewis MA, 2007, J STUD ALCOHOL DRUGS, V68, P228, DOI 10.15288/jsad.2007.68.228; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mccambridge J, 2007, DRUG ALCOHOL REV, V26, P463, DOI 10.1080/09595230701494366; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025223; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; MCNAMARA K, 1986, J COUNS PSYCHOL, V33, P23, DOI 10.1037/0022-0167.33.1.23; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; MOOS RH, 1967, ARCH GEN PSYCHIAT, V17, P75; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; ORNE MT, 1959, J ABNORM SOC PSYCH, V58, P277, DOI 10.1037/h0046128; Orne MT, 2000, ENCY PSYCHOL, P469; ROSEN NA, 1970, J APPL PSYCHOL, V54, P163, DOI 10.1037/h0029053; Timko C, 2000, J SUBST ABUSE, V12, P387, DOI 10.1016/S0899-3289(01)00056-6; WEBER SJ, 1972, PSYCHOL BULL, V77, P273, DOI 10.1037/h0032351; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Williams RJ, 2005, SUBST USE MISUSE, V40, P299, DOI 10.1081/JA-200049327; Williamson A, 2007, NEUROTOXICOLOGY, V28, P227, DOI 10.1016/j.neuro.2006.03.009	33	124	127	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39116	10.1371/journal.pone.0039116	http://dx.doi.org/10.1371/journal.pone.0039116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723942	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305652700050
J	Papakrivos, J; Sa, JM; Wellems, TE				Papakrivos, Janni; Sa, Juliana M.; Wellems, Thomas E.			Functional Characterization of the Plasmodium falciparum Chloroquine-Resistance Transporter (PfCRT) in Transformed Dictyostelium discoideum Vesicles	PLOS ONE			English	Article							ANTIMALARIAL-DRUG RESISTANCE; TRANSMEMBRANE PROTEIN PFCRT; MALARIA PARASITES; DIGESTIVE VACUOLE; FERRIPROTOPORPHYRIN-IX; REVERSING AGENTS; MUTATIONS; MECHANISM; PH; SUSCEPTIBILITY	Background: Chloroquine (CQ)-resistant Plasmodium falciparum malaria has been a global health catastrophe, yet much about the CQ resistance (CQR) mechanism remains unclear. Hallmarks of the CQR phenotype include reduced accumulation of protonated CQ as a weak base in the digestive vacuole of the erythrocyte-stage parasite, and chemosensitization of CQ-resistant (but not CQ-sensitive) P. falciparum by agents such as verapamil. Mutations in the P. falciparum CQR transporter (PfCRT) confer CQR; particularly important among these mutations is the charge-loss substitution K -> T at position 76. Dictyostelium discoideum transformed with mutant PfCRT expresses key features of CQR including reduced drug accumulation and verapamil chemosensitization. Methodology and Findings: We describe the isolation and characterization of PfCRT-transformed, hematin-free vesicles from D. discoideum cells. These vesicles permit assessments of drug accumulation, pH, and membrane potential that are difficult or impossible with hematin-containing digestive vacuoles from P. falciparum-infected erythrocytes. Mutant PfCRT-transformed D. discoideum vesicles show features of the CQR phenotype, and manipulations of vesicle membrane potential by agents including ionophores produce large changes of CQ accumulation that are dissociated from vesicular pH. PfCRT in its native or mutant form blunts the ability of valinomycin to reduce CQ accumulation in transformed vesicles and decreases the ability of K+ to reverse membrane potential hyperpolarization caused by valinomycin treatment. Conclusion: Isolated vesicles from mutant-PfCRT-transformed D. discoideum exhibit features of the CQR phenotype, consistent with evidence that the drug resistance mechanism operates at the P. falciparum digestive vacuole membrane in malaria. Membrane potential apart from pH has a major effect on the PfCRT-mediated CQR phenotype of D. discoideum vesicles. These results support a model of PfCRT as an electrochemical potential-driven transporter in the drug/metabolite superfamily that (appropriately mutated) acts as a saturable simple carrier for the facilitated diffusion of protonated CQ.	[Papakrivos, Janni; Sa, Juliana M.; Wellems, Thomas E.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Papakrivos, J (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twellems@niaid.nih.gov			NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000483] Funding Source: NIH RePORTER	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOBENSON M, 1986, CELL IMMUNOL, V103, P417, DOI 10.1016/0008-8749(86)90101-2; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; AUBRY L, 1993, J CELL SCI, V105, P861; Bala S, 2001, BBA-BIOMEMBRANES, V1510, P258, DOI 10.1016/S0005-2736(00)00357-6; Baro NK, 2011, BIOCHEMISTRY-US, V50, P6701, DOI 10.1021/bi200922g; BITONTI AJ, 1988, SCIENCE, V242, P1301, DOI 10.1126/science.3057629; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; Bray PG, 2005, BIOCHEM PHARMACOL, V70, P1158, DOI 10.1016/j.bcp.2005.07.021; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; DAVIES L, 1993, CELL, V75, P321, DOI 10.1016/0092-8674(93)80073-N; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; FERRARI V, 1987, J PHARM SCI, V76, P554, DOI 10.1002/jps.2600760714; FERRARI V, 1990, BIOCHEM PHARMACOL, V39, P753, DOI 10.1016/0006-2952(90)90155-E; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1970, SCIENCE, V169, P289, DOI 10.1126/science.169.3942.289; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Flaadt H, 2000, J BIOSCIENCES, V25, P243, DOI 10.1007/BF02703931; GINSBURG H, 1990, PARASITOL TODAY, V6, P334, DOI 10.1016/0169-4758(90)90178-7; Jenne N, 1998, J CELL SCI, V111, P61; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Mehlotra RK, 2001, P NATL ACAD SCI USA, V98, P12689, DOI 10.1073/pnas.221440898; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Nessler S, 2004, J BIOL CHEM, V279, P39438, DOI 10.1074/jbc.M404671200; NILSEN A, 1988, EXP LUNG RES, V14, P197, DOI 10.3109/01902148809115124; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Paguio MF, 2009, BIOCHEMISTRY-US, V48, P9482, DOI 10.1021/bi901035j; PETERS W, 1989, LANCET, V2, P334, DOI 10.1016/S0140-6736(89)90522-9; Rasoanaivo P, 1996, CURR MED CHEM, V3, P1; Roepe PD, 2011, BIOCHEMISTRY-US, V50, P163, DOI 10.1021/bi101638n; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; Summers RL, 2010, VIRULENCE, V1, P304, DOI 10.4161/viru.1.4.12012; Temesvari LA, 1996, J CELL SCI, V109, P1479; THAYER WS, 1975, J BIOL CHEM, V250, P5336; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Ursing J, 2008, TRENDS PARASITOL, V24, P49, DOI 10.1016/j.pt.2007.11.002; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Warhurst DC, 2002, LANCET, V360, P1527, DOI 10.1016/S0140-6736(02)11577-7; YAYON A, 1985, P NATL ACAD SCI USA, V82, P2784, DOI 10.1073/pnas.82.9.2784; Zhang HB, 2004, BIOCHEMISTRY-US, V43, P8290, DOI 10.1021/bi049137i	56	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39569	10.1371/journal.pone.0039569	http://dx.doi.org/10.1371/journal.pone.0039569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724026	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700087
J	Surls, J; Nazarov-Stoica, C; Kehl, M; Olsen, C; Casares, S; Brumeanu, TD				Surls, Jacqueline; Nazarov-Stoica, Cristina; Kehl, Margaret; Olsen, Cara; Casares, Sofia; Brumeanu, Teodor-D.			Increased Membrane Cholesterol in Lymphocytes Diverts T-Cells toward an Inflammatory Response	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTORS; LIPID-RAFTS; PLASMA-MEMBRANE; INTERLEUKIN-2 RECEPTOR; CELLULAR CHOLESTEROL; SIGNAL-TRANSDUCTION; DOWN-REGULATION; TH2 CELLS; ACTIVATION; MICRODOMAINS	Cell signaling for T-cell growth, differentiation, and apoptosis is initiated in the cholesterol-rich microdomains of the plasma membrane known as lipid rafts. Herein, we investigated whether enrichment of membrane cholesterol in lipid rafts affects antigen-specific CD4 T-helper cell functions. Enrichment of membrane cholesterol by 40-50% following squalene administration in mice was paralleled by an increased number of resting CD4 T helper cells in periphery. We also observed sensitization of the Th1 differentiation machinery through co-localization of IL-2R alpha, IL-4R alpha, and IL-12R beta 2 subunits with GM1 positive lipid rafts, and increased STAT-4 and STAT-5 phosphorylation following membrane cholesterol enrichment. Antigen stimulation or CD3/CD28 polyclonal stimulation of membrane cholesterol-enriched, resting CD4 T-cells followed a path of Th1 differentiation, which was more vigorous in the presence of increased IL-12 secretion by APCs enriched in membrane cholesterol. Enrichment of membrane cholesterol in antigen-specific, autoimmune Th1 cells fostered their organ-specific reactivity, as confirmed in an autoimmune mouse model for diabetes. However, membrane cholesterol enrichment in CD4(+) Foxp3(+) T-reg cells did not alter their suppressogenic function. These findings revealed a differential regulatory effect of membrane cholesterol on the function of CD4 T-cell subsets. This first suggests that membrane cholesterol could be a new therapeutic target to modulate the immune functions, and second that increased membrane cholesterol in various physiopathological conditions may bias the immune system toward an inflammatory Th1 type response.	[Surls, Jacqueline; Nazarov-Stoica, Cristina; Kehl, Margaret; Olsen, Cara; Casares, Sofia; Brumeanu, Teodor-D.] Uniformed Serv Univ Hlth Sci, Dept Med, Div Immunol, Bethesda, MD 20814 USA; [Surls, Jacqueline; Nazarov-Stoica, Cristina; Kehl, Margaret; Olsen, Cara; Casares, Sofia; Brumeanu, Teodor-D.] Uniformed Serv Univ Hlth Sci, Biostat Counseling Ctr, Bethesda, MD 20814 USA; [Casares, Sofia] USN, Infect Dis Directorate, Malaria Program, Med Res Ctr, Silver Spring, MD USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Navy	Surls, J (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Div Immunol, Room A3060, Bethesda, MD 20814 USA.	tbrumeanu@usuhs.edu	Brumeanu, Teodor/AAB-1965-2020		Uniformed Services University of Health Sciences (USUHS) [RO83-ZK]	Uniformed Services University of Health Sciences (USUHS)	This work was supported (grant # RO83-ZK) by the Uniformed Services University of Health Sciences (USUHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Bot A, 1998, J IMMUNOL, V160, P4500; Brumeanu TD, 2006, CLIN IMMUNOL, V119, P1, DOI 10.1016/j.clim.2005.11.007; Brumeanu TD, 2007, MOL IMMUNOL, V44, P530, DOI 10.1016/j.molimm.2006.02.008; Canda-Sanchez A, 2009, J MEMBRANE BIOL, V227, P1, DOI 10.1007/s00232-008-9127-3; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CANTRELL DA, 1988, IMMUNOLOGY, V65, P343; Casares S, 1997, PROTEIN ENG, V10, P1295, DOI 10.1093/protein/10.11.1295; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CUTHBERT JA, 1986, J BIOL CHEM, V261, P3620; CUTHBERT JA, 1987, INT J TISSUE REACT, V9, P447; CUTHBERT JA, 1987, J BIOL CHEM, V262, P7808; de Mello Coelho V, 2004, BMC IMMUNOL, V5, P2; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Ebert PJR, 2000, J IMMUNOL, V165, P5435, DOI 10.4049/jimmunol.165.10.5435; EIDINOFF ML, 1958, J CLIN INVEST, V37, P655, DOI 10.1172/JCI103650; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Fisson S, 2006, EUR J IMMUNOL, V36, P817, DOI 10.1002/eji.200535445; Fulop T, 2005, DRUG AGING, V22, P589, DOI 10.2165/00002512-200522070-00005; Fulop T, 2001, MECH AGEING DEV, V122, P1413, DOI 10.1016/S0047-6374(01)00274-3; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Ghazizadeh R, 2011, AM J MED SCI, V341, P394, DOI 10.1097/MAJ.0b013e3181ff8eeb; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Goebel J, 2002, J LEUKOCYTE BIOL, V72, P199; Goldman F, 1996, BLOOD, V88, P4611, DOI 10.1182/blood.V88.12.4611.bloodjournal88124611; Gombos I, 2004, IMMUNOL LETT, V92, P117, DOI 10.1016/j.imlet.2003.11.022; Harikumar KG, 2005, J BIOL CHEM, V280, P2176, DOI 10.1074/jbc.M410385200; Hillyard DZ, 2004, ATHEROSCLEROSIS, V175, P305, DOI 10.1016/j.atherosclerosis.2004.03.018; HO YK, 1976, J CLIN INVEST, V58, P1465, DOI 10.1172/JCI108603; Horejsi V, 2005, MICROBES INFECT, V7, P310, DOI 10.1016/j.micinf.2004.12.004; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; LEHOUX JG, 1985, ENDOCRINOLOGY, V117, P1462, DOI 10.1210/endo-117-4-1462; Leitenberg D, 2001, SEMIN IMMUNOL, V13, P129, DOI 10.1006/smim.2000.0304; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li QR, 2005, TRANSPL P, V37, P2395, DOI 10.1016/j.transproceed.2005.03.115; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; LOUD AV, 1958, J BIOL CHEM, V233, P37; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Marmor MD, 2001, BLOOD, V98, P1489, DOI 10.1182/blood.V98.5.1489; Matko J, 2002, IMMUNOL LETT, V82, P3, DOI 10.1016/S0165-2478(02)00011-1; Matko J, 2002, EUR J BIOCHEM, V269, P1199, DOI 10.1046/j.0014-2956.2002.02759.x; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MULLER CP, 1984, CYTOMETRY, V5, P42, DOI 10.1002/cyto.990050108; MURAKOSHI M, 1992, INT J CANCER, V52, P950, DOI 10.1002/ijc.2910520620; Nazarov-Stoica C, 2009, J IMMUNOL, V182, P102, DOI 10.4049/jimmunol.182.1.102; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V311, P277, DOI 10.1006/abbi.1994.1238; Nguyen DH, 2004, MECH AGEING DEV, V125, P641, DOI 10.1016/j.mad.2004.08.002; Nix M, 2000, CELL DEATH DIFFER, V7, P413, DOI 10.1038/sj.cdd.4400666; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Rao CV, 1998, CARCINOGENESIS, V19, P287, DOI 10.1093/carcin/19.2.287; Rao R, 2004, CYTOKINE GROWTH F R, V15, P103, DOI 10.1016/j.cytogfr.2004.01.003; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Senthilkumar S, 2006, CLIN CHIM ACTA, V364, P335, DOI 10.1016/j.cca.2005.07.032; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Surls J, 2010, VACCINE, V28, P7319, DOI 10.1016/j.vaccine.2010.08.074; Tani-ichi S, 2005, INT IMMUNOL, V17, P749, DOI 10.1093/intimm/dxh257; Thomas S, 2004, ARCH IMMUNOL THER EX, V52, P215; Thomas S, 2003, J IMMUNOL METHODS, V275, P161, DOI 10.1016/S0022-1759(03)00014-0; TILVIS RS, 1983, LIPIDS, V18, P32, DOI 10.1007/BF02534687; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; VANDUUREN BL, 1976, JNCI-J NATL CANCER I, V56, P1237, DOI 10.1093/jnci/56.6.1237; Verhoeye FR, 1996, J LIPID RES, V37, P1377; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zeyda M, 2006, PROG LIPID RES, V45, P187, DOI 10.1016/j.plipres.2006.01.002; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	81	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38733	10.1371/journal.pone.0038733	http://dx.doi.org/10.1371/journal.pone.0038733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723880	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700024
J	Yang, G; Yang, L; Zhao, Z; Wang, JJ; Zhang, XB				Yang, Geng; Yang, Lu; Zhao, Zhe; Wang, Jiajia; Zhang, Xiaobo			Signature miRNAs Involved in the Innate Immunity of Invertebrates	PLOS ONE			English	Article							MIR-155; TRANSCRIPTION	The innate immune system, including the cell-based immunity (mainly apoptosis and phagocytosis) and the humoral immunity (such as pro-phenoloxidase system), is the first defense line of animals against the infection of pathogens in a nonspecific manner, which is fine regulated through the gene expression regulations. The microRNAs (miRNAs) are recognized as important regulators of gene expression. To date, however, a comprehensive view about the regulation of innate immunity by miRNAs is not available. To address this issue, the signature miRNAs involved in the innate immunity were characterized in this study. The phagocytosis, apoptosis and phenoloxidase (PO), a key enzyme in the pro-phenoloxidase system, of invertebrate shrimp were activated or inhibited, followed by the small RNA sequencing. The results showed that a total of 24 miRNAs took great effects on phagocytosis, apoptosis or the pro-phenoloxidase system, which were further confirmed by Northern blots. Among the 24 innate immunity-associated miRNAs, 21 miRNAs were conserved in animals, suggesting that these miRNAs might share the similar or the same functions in different species of animals. Based on degradome sequencing and prediction of target genes, it was found that the miRNAs might mediate the regulations of phagocytosis, apoptosis or pro-phenoloxidase system by targeting different genes. Therefore our study presented the first comprehensive view of the miRNAs associated with innate immunity, which would facilitate to reveal the molecular events in the regulation of innate immunity.	[Yang, Geng] Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Key Lab Conservat Biol Endangered Wildlife,Minist, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Yang, G (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Key Lab Conservat Biol Endangered Wildlife,Minist, Hangzhou 310003, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Yang, Lu/0000-0002-8338-1616	National Natural Science Foundation of China [30830084]; Hi-Tech Research and Development Program of China (863 program of China) [2010AA09Z403, 2011AA10A216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China (863 program of China)(National High Technology Research and Development Program of China)	This work was financially supported by National Natural Science Foundation of China (30830084) and Hi-Tech Research and Development Program of China (863 program of China) (2010AA09Z403, 2011AA10A216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejarano F, 2010, DEV BIOL, V338, P63, DOI 10.1016/j.ydbio.2009.11.025; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bracken CP, 2011, NUCLEIC ACIDS RES, V39, P5658, DOI 10.1093/nar/gkr110; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen M, 2010, IMMUNOL REV, V236, P11, DOI 10.1111/j.1600-065X.2010.00916.x; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Eleftherianos I, 2010, TRENDS MICROBIOL, V18, P552, DOI 10.1016/j.tim.2010.09.006; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Mortensen K, 2003, CELL MOL LIFE SCI, V60, P1007, DOI 10.1007/s00018-003-3022-x; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Sheedy FJ, 2011, NAT IMMUNOL, V11, P141; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	29	62	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39015	10.1371/journal.pone.0039015	http://dx.doi.org/10.1371/journal.pone.0039015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723921	gold, Green Published			2022-12-27	WOS:000305652700044
J	Hoshika, Y; Omasa, K; Paoletti, E				Hoshika, Yasutomo; Omasa, Kenji; Paoletti, Elena			Whole-Tree Water Use Efficiency Is Decreased by Ambient Ozone and Not Affected by O-3-Induced Stomatal Sluggishness	PLOS ONE			English	Article							ETHYLENEDIUREA EDU; AIR-POLLUTION; CLIMATE-CHANGE; GAS-EXCHANGE; PLANTS; FOREST; PHOTOSYNTHESIS; CONDUCTANCE; EXPOSURE; GROWTH	Steady-state and dynamic gas exchange responses to ozone visible injury were investigated in an ozone-sensitive poplar clone under field conditions. The results were translated into whole tree water loss and carbon assimilation by comparing trees exposed to ambient ozone and trees treated with the ozone-protectant ethylenediurea (EDU). Steady-state stomatal conductance and photosynthesis linearly decreased with increasing ozone visible injury. Dynamic responses simulated by severing of a leaf revealed that stomatal sluggishness increased until a threshold of 5% injury and was then fairly constant. Sluggishness resulted from longer time to respond to the closing signal and slower rate of closing. Changes in photosynthesis were driven by the dynamics of stomata. Whole-tree carbon assimilation and water loss were lower in trees exposed to ambient O-3 than in trees protected by EDU, both under steady-state and dynamic conditions. Although stomatal sluggishness is expected to increase water loss, lower stomatal conductance and premature leaf shedding of injured leaves aggravated O-3 effects on whole tree carbon gain, while compensating for water loss. On average, WUE of trees exposed to ambient ozone was 2-4% lower than that of EDU-protected control trees in September and 6-8% lower in October.	[Hoshika, Yasutomo; Omasa, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Paoletti, Elena] CNR, Inst Plant Protect, Florence, Italy	University of Tokyo; Consiglio Nazionale delle Ricerche (CNR)	Hoshika, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	e.paoletti@ipp.cnr.it	Paoletti, Elena/B-8974-2009; Paoletti, Elena/AAS-5316-2021; Hoshika, Yasutomo/AAA-9477-2020; Hoshika, Yasutomo/D-4441-2016	Paoletti, Elena/0000-0001-5324-7769; Paoletti, Elena/0000-0001-5324-7769; Hoshika, Yasutomo/0000-0002-5263-2945; Hoshika, Yasutomo/0000-0002-5263-2945	JSPS Fellowships for Young Scientists	JSPS Fellowships for Young Scientists	JSPS Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Cieslik S, 2009, PLANT BIOLOGY, V11, P24, DOI 10.1111/j.1438-8677.2009.00262.x; De Kok LJ, 1998, RESPONSES PLANT META; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Grulke NE, 2007, ENVIRON POLLUT, V146, P640, DOI 10.1016/j.envpol.2006.04.014; Grulke NE, 2007, NEW PHYTOL, V173, P100, DOI 10.1111/j.1469-8137.2006.01872.x; Heath RL, 2008, ENVIRON POLLUT, V155, P453, DOI 10.1016/j.envpol.2008.03.010; HEBER U, 1986, PLANTA, V167, P554, DOI 10.1007/BF00391232; Hoshika Y, 2013, ENVIRON EXP BOT, V88, P19, DOI 10.1016/j.envexpbot.2011.12.004; Huttunen S., 2004, P M FOR CHANG CLIM E, P85; Innes JL., 2001, OZONE BROADLEAVED SP; KERSTIENS G, 1989, NEW PHYTOL, V112, P13, DOI 10.1111/j.1469-8137.1989.tb00303.x; Koziol M. J., 1984, GASEOUS AIR POLLUTAN; Manning WJ, 2011, ENVIRON POLLUT, V159, P3283, DOI 10.1016/j.envpol.2011.07.005; Mansfield TA, 1998, ENVIRON POLLUT, V101, P1, DOI 10.1016/S0269-7491(98)00076-1; Marzuoli R, 2009, TREE PHYSIOL, V29, P67, DOI 10.1093/treephys/tpn012; McLaughlin SB, 2007, NEW PHYTOL, V174, P109, DOI 10.1111/j.1469-8137.2007.02018.x; Mills G, 2009, GLOBAL CHANGE BIOL, V15, P1522, DOI 10.1111/j.1365-2486.2008.01798.x; NIES, 1984, STUD EFF AIR POLL 1; NIES, 1984, STUD EFF AIR POLL 2; NIES (National Institute for Environmental Studies), 1980, STUD EFF AIR POLL PL; Novak K, 2005, ENVIRON POLLUT, V136, P33, DOI 10.1016/j.envpol.2004.12.018; Omasa K., 1979, Journal of Agricultural Meteorology, V35, P77, DOI 10.2480/agrmet.35.77; OMASA K, 1981, Environment Control in Biology, V19, P85; OMASA K, 1990, Journal of Agricultural Meteorology, V45, P251; Omasa K, 2002, AIR POLLUTION PLANT; Paoletti E, 2005, ENVIRON POLLUT, V137, P483, DOI 10.1016/j.envpol.2005.01.035; Paoletti E, 2007, ENVIRON POLLUT, V145, P869, DOI 10.1016/j.envpol.2006.05.005; Paoletti E, 2005, ENVIRON POLLUT, V134, P439, DOI 10.1016/j.envpol.2004.09.011; Paoletti E, 2011, IFOREST, V4, P66, DOI 10.3832/ifor0569-004; Paoletti E., 2007, CAB REV PERSPECTIVES, V2; Paoletti E, 2009, SCI TOTAL ENVIRON, V407, P1631, DOI 10.1016/j.scitotenv.2008.11.061; Paoletti E, 2007, ENVIRON POLLUT, V150, P85, DOI 10.1016/j.envpol.2007.06.037; Paoletti E, 2010, ENVIRON POLLUT, V158, P2664, DOI 10.1016/j.envpol.2010.04.024; Paoletti E, 2009, ENVIRON POLLUT, V157, P1453, DOI 10.1016/j.envpol.2008.09.021; Paoletti E, 2009, ENVIRON POLLUT, V157, P865, DOI 10.1016/j.envpol.2008.11.009; PELL EJ, 1992, NEW PHYTOL, V120, P397, DOI 10.1111/j.1469-8137.1992.tb01080.x; REICH PB, 1984, PLANT CELL ENVIRON, V7, P661, DOI 10.1111/1365-3040.ep11571645; REILING K, 1995, NEW PHYTOL, V129, P587, DOI 10.1111/j.1469-8137.1995.tb03026.x; Robinson MF, 1998, J EXP BOT, V49, P461, DOI 10.1093/jexbot/49.suppl_1.461; Samuel MA, 2005, J EXP BOT, V56, P2195, DOI 10.1093/jxb/eri219; Sandermann H., 1997, FOREST DECLINE OZONE; Schulte-Hostede S, 1987, AIR POLLUTION PLANT; Serengil Y, 2011, IFOREST, V4, P44, DOI 10.3832/ifor0566-004; TINGEY DT, 1976, ATMOS ENVIRON, V10, P969, DOI 10.1016/0004-6981(76)90204-3; TINOCOOJANGUREN C, 1993, OECOLOGIA, V94, P395, DOI 10.1007/BF00317115; Tuomainen J, 1997, PLANT J, V12, P1151, DOI 10.1046/j.1365-313X.1997.12051151.x; *UNECE, 2004, MAPP CRIT LEV VEG, pCH3; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; VOLZ A, 1988, NATURE, V332, P240, DOI 10.1038/332240a0; Wieser G., 2008, Italian Journal of Agronomy, V3, P35; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Wittig VE, 2009, GLOBAL CHANGE BIOL, V15, P396, DOI 10.1111/j.1365-2486.2008.01774.x; YUNUS M, 1996, PLANT RESPONSE AIR P; Zhang J., 2000, ENVIRON POLLUT, V113, P117	57	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39270	10.1371/journal.pone.0039270	http://dx.doi.org/10.1371/journal.pone.0039270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723982	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300123
J	Kallo, I; Mohacsik, P; Vida, B; Zeold, A; Bardoczi, Z; Zavacki, AM; Farkas, E; Kadar, A; Hrabovszky, E; Drigo, RAE; Dong, LP; Barna, L; Palkovits, M; Borsay, BA; Herczeg, L; Lechan, RM; Bianco, AC; Liposits, Z; Fekete, C; Gereben, B				Kallo, Imre; Mohacsik, Petra; Vida, Barbara; Zeoeld, Aniko; Bardoczi, Zsuzsanna; Zavacki, Ann Marie; Farkas, Erzsebet; Kadar, Andrea; Hrabovszky, Erik; Arrojo e Drigo, Rafael; Dong, Liping; Barna, Laszlo; Palkovits, Miklos; Borsay, Beata A.; Herczeg, Laszlo; Lechan, Ronald M.; Bianco, Antonio C.; Liposits, Zsolt; Fekete, Csaba; Gereben, Balazs			A Novel Pathway Regulates Thyroid Hormone Availability in Rat and Human Hypothalamic Neurosecretory Neurons	PLOS ONE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; GONADOTROPIN-RELEASING-HORMONE; MESSENGER-RIBONUCLEIC-ACID; MONOCARBOXYLATE TRANSPORTER-8; PSYCHOMOTOR RETARDATION; MEDIAN-EMINENCE; BRAIN; THYROTROPIN; SYSTEM; EXPRESSION	Hypothalamic neurosecretory systems are fundamental regulatory circuits influenced by thyroid hormone. Monocarboxylate-transporter-8 (MCT8)-mediated uptake of thyroid hormone followed by type 3 deiodinase (D3)-catalyzed inactivation represent limiting regulatory factors of neuronal T3 availability. In the present study we addressed the localization and subcellular distribution of D3 and MCT8 in neurosecretory neurons and addressed D3 function in their axons. Intense D3-immunoreactivity was observed in axon varicosities in the external zone of the rat median eminence and the neurohaemal zone of the human infundibulum containing axon terminals of hypophysiotropic parvocellular neurons. Immuno-electronmicroscopy localized D3 to dense-core vesicles in hypophysiotropic axon varicosities. N-STORM-superresolution-microscopy detected the active center containing C-terminus of D3 at the outer surface of these organelles. Double-labeling immunofluorescent confocal microscopy revealed that D3 is present in the majority of GnRH, CRH and GHRH axons but only in a minority of TRH axons, while absent from somatostatin-containing neurons. Bimolecular-Fluorescence-Complementation identified D3 homodimers, a prerequisite for D3 activity, in processes of GT1-7 cells. Furthermore, T3-inducible D3 catalytic activity was detected in the rat median eminence. Triple-labeling immunofluorescence and immuno-electronmicroscopy revealed the presence of MCT8 on the surface of the vast majority of all types of hypophysiotropic terminals. The presence of MCT8 was also demonstrated on the axon terminals in the neurohaemal zone of the human infundibulum. The unexpected role of hypophysiotropic axons in fine-tuned regulation of T3 availability in these cells via MCT8-mediated transport and D3-catalyzed inactivation may represent a novel regulatory core mechanism for metabolism, growth, stress and reproduction in rodents and humans.	[Kallo, Imre; Mohacsik, Petra; Vida, Barbara; Zeoeld, Aniko; Bardoczi, Zsuzsanna; Farkas, Erzsebet; Kadar, Andrea; Hrabovszky, Erik; Liposits, Zsolt; Fekete, Csaba; Gereben, Balazs] Hungarian Acad Sci, Dept Endocrine Neurobiol, Inst Expt Med, Budapest, Hungary; [Kallo, Imre; Liposits, Zsolt] Pazmany Peter Catholic Univ, Dept Neurosci, Fac Informat Technol, Budapest, Hungary; [Zavacki, Ann Marie] Brigham & Womens Hosp, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Zavacki, Ann Marie] Harvard Univ, Sch Med, Boston, MA USA; [Arrojo e Drigo, Rafael; Dong, Liping; Bianco, Antonio C.; Gereben, Balazs] Univ Miami, Div Endocrinol Diabet & Metab, Miller Sch Med Miami, Coral Gables, FL 33124 USA; [Barna, Laszlo] Hungarian Acad Sci, Inst Expt Med, Nikon Microscopy Ctr, Budapest, Hungary; [Palkovits, Miklos] Semmelweis Univ, Human Brain Tissue Bank, Budapest, Hungary; [Borsay, Beata A.; Herczeg, Laszlo] Univ Debrecen, Dept Forens Med, Fac Med, Debrecen, Hungary; [Lechan, Ronald M.; Fekete, Csaba] Tufts Med Ctr, Tupper Res Inst, Boston, MA USA; [Lechan, Ronald M.; Fekete, Csaba] Tufts Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Miami; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; University of Debrecen; Tufts Medical Center; Tufts Medical Center	Kallo, I (corresponding author), Hungarian Acad Sci, Dept Endocrine Neurobiol, Inst Expt Med, Budapest, Hungary.	gereben.balazs@koki.mta.hu	Palkovits, Miklos/F-2707-2013; Liposits, Zsolt/K-8145-2019; Kalló, Imre/C-6262-2016; Bianco, Antonio/AAK-6336-2020	Palkovits, Miklos/0000-0003-0578-0387; Kalló, Imre/0000-0003-3412-4100; Bianco, Antonio/0000-0001-7737-6813; Hrabovszky, Erik/0000-0001-6927-0015; Liposits, Zsolt/0000-0002-3508-2750; Fekete, Csaba/0000-0002-8206-562X; Barna, Laszlo/0000-0002-3856-5774; Arrojo e Drigo, Rafael/0000-0001-7712-013X	National Science Foundation of Hungary [OTKA K81226, K81845, K69127]; Medical Research Council [02-121/2009]; European Community [259772, 245009]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077148] Funding Source: NIH RePORTER	National Science Foundation of Hungary; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Science Foundation of Hungary (OTKA K81226, K81845, K69127), the Medical Research Council (ETT Grant 02-121/2009) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259772 and 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P4322, DOI 10.1210/jc.2004-2567; Araki O, 2003, ENDOCRINOLOGY, V144, P4459, DOI 10.1210/en.2003-0419; Baumgartner A, 1998, J NEUROCHEM, V71, P817; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bluet-Pajot MT, 1998, CELL MOL NEUROBIOL, V18, P101, DOI 10.1023/A:1022579327647; Callebaut I, 2003, J BIOL CHEM, V278, P36887, DOI 10.1074/jbc.M305725200; CECCATELLI S, 1992, NEUROENDOCRINOLOGY, V56, P694, DOI 10.1159/000126295; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; CROTEAU W, 1995, J BIOL CHEM, V270, P16569, DOI 10.1074/jbc.270.28.16569; Curcio-Morelli C, 2003, ENDOCRINOLOGY, V144, P937, DOI 10.1210/en.2002-220960; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; DAWSON A, 1993, J ENDOCRINOL, V139, P51, DOI 10.1677/joe.0.1390051; Dentice M, 2011, J ENDOCRINOL, V209, P273, DOI 10.1530/JOE-11-0002; Du JL, 2009, P NATL ACAD SCI USA, V106, P18890, DOI 10.1073/pnas.0910659106; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Fekete C, 2004, ENDOCRINOLOGY, V145, P1649, DOI 10.1210/en.2003-1439; Fekete C, 2007, FRONT NEUROENDOCRIN, V28, P97, DOI 10.1016/j.yfrne.2007.04.002; Freitas BCG, 2010, J CLIN INVEST, V120, P2206, DOI 10.1172/JCI41977; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Giustina A, 1995, EUR J ENDOCRINOL, V133, P646, DOI 10.1530/eje.0.1330646; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Heuer H, 2005, ENDOCRINOLOGY, V146, P1701, DOI 10.1210/en.2004-1179; Horvath TL, 1999, J NEUROSCI, V19, P10417; Hrabovszky E, 2005, EUR J NEUROSCI, V21, P2120, DOI 10.1111/j.1460-9568.2005.04076.x; Hrabovszky E, 2011, FRONTIERS ENDOCRINOL, P2; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Jansen HT, 1997, ENDOCRINOLOGY, V138, P5039, DOI 10.1210/en.138.11.5039; Johnson EO, 2005, EUR J ENDOCRINOL, V153, P177, DOI 10.1530/eje.1.01923; Kallo I, 2001, J NEUROENDOCRINOL, V13, P741, DOI 10.1046/j.1365-2826.2001.00708.x; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LECHAN RM, 1976, NATURE, V264, P463, DOI 10.1038/264463a0; Lechan RM, 2005, THYROID, V15, P883, DOI 10.1089/thy.2005.15.883; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lehman MN, 1997, BRAIN RES BULL, V44, P445, DOI 10.1016/S0361-9230(97)00225-6; LIPOSITS Z, 1984, NEUROSCIENCE, V13, P513, DOI 10.1016/0306-4522(84)90245-8; Mann DR, 2010, BRAIN RES, V1364, P175, DOI 10.1016/j.brainres.2010.09.082; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; Meldolesi J, 2004, TRENDS CELL BIOL, V14, P13, DOI 10.1016/j.tcb.2003.11.006; MERCHENTHALER I, 1984, CELL TISSUE RES, V237, P15; Mohacsik P, 2011, J THYROID R IN PRESS; Murphy M, 2011, J THYROID R IN PRESS; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; RETHELYI M, 1982, ACTA BIOL ACAD SCI H, V33, P289; RISKIND PN, 1987, BRAIN RES, V420, P194, DOI 10.1016/0006-8993(87)90260-5; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Sagar GDV, 2008, MOL ENDOCRINOL, V22, P1382, DOI 10.1210/me.2007-0490; Sanchez E, 2001, NEUROENDOCRINOLOGY, V74, P407, DOI 10.1159/000054707; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Tu HM, 1997, ENDOCRINOLOGY, V138, P3359, DOI 10.1210/en.138.8.3359; Tu HM, 1999, ENDOCRINOLOGY, V140, P784, DOI 10.1210/en.140.2.784; Visser WE, 2008, TRENDS ENDOCRIN MET, V19, P50, DOI 10.1016/j.tem.2007.11.003; WETSEL WC, 1991, ENDOCRINOLOGY, V129, P1584, DOI 10.1210/endo-129-3-1584; WIEGAND SJ, 1980, J COMP NEUROL, V192, P1, DOI 10.1002/cne.901920102; Williams GR, 2008, J NEUROENDOCRINOL, V20, P784, DOI 10.1111/j.1365-2826.2008.01733.x; Wittmann G, 2009, J COMP NEUROL, V517, P825, DOI 10.1002/cne.22180; Yoshimura T, 2010, ANIM SCI J, V81, P403, DOI 10.1111/j.1740-0929.2010.00777.x; Zeold A, 2006, J BIOL CHEM, V281, P31538, DOI 10.1074/jbc.M604728200	62	34	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37860	10.1371/journal.pone.0037860	http://dx.doi.org/10.1371/journal.pone.0037860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719854	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300015
J	Lu, Y; Li, XG; Wang, M; Li, X; Zhang, F; Li, Y; Zhang, M; Da, YW; Yu, J; Jia, JP				Lu, Yan; Li, Xingang; Wang, Min; Li, Xin; Zhang, Feng; Li, Yun; Zhang, Meng; Da, Yuwei; Yu, Jun; Jia, Jianping			A Novel Autosomal Dominant Inclusion Body Myopathy Linked to 7q22.1-31.1	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DISTAL MYOPATHY; FRONTOTEMPORAL DEMENTIA; RIMMED VACUOLES; PAGET-DISEASE; GENE; MAPS; DISORDER; MUTATION; MYOTILIN	We describe a novel autosomal dominant hereditary inclusion body myopathy (HIBM) that clinically mimics limb girdle muscular dystrophy in a Chinese family. We performed a detailed clinical assessment of 36 individuals spanning four generations. The age of onset ranged from the 30s to the 50s. Hip girdle, neck flexion and axial muscle weakness were involved at an early stage. This disease progressed slowly, and a shoulder girdle weakness appeared later in the disease course. Muscle biopsies showed necrotic, regenerating, and rimmed vacuolated fibers as well as congophilic inclusions in some of the fibers. Electron micrograph revealed cytoplasmic inclusions of 15-21 nm filaments. A genomewide scan and haplotype analyses were performed using an Illumina Linkage-12 DNA Analysis Kit (average spacing 0.58 cM), which traced the disease to a new locus on chromosome 7q22.1-31.1 with a maximum multi-point LOD score of 3.65. The critical locus for this unique disorder, which is currently referred to as hereditary inclusion body myopathy 4 (HIBM4), spans 8.78 Mb and contains 65 genes. This localization raises the possibility that one of the genes clustered within this region may be involved in this disorder.	[Lu, Yan; Wang, Min; Li, Yun; Da, Yuwei; Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Li, Xingang; Li, Xin; Zhang, Feng; Zhang, Meng; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Li, Xingang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, Y (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.	dayuwei100@hotmail.com; junyu@big.ac.cn		Li, Xingang/0000-0003-0252-154X; Jia, Jianping/0000-0003-4624-0336	"215" high-level personnel construction from Beijing Municipal Health Bureau, 215 Healthy and Technical Project [2009-3-58]	"215" high-level personnel construction from Beijing Municipal Health Bureau, 215 Healthy and Technical Project	Funding of this study is from "215" high-level personnel construction from Beijing Municipal Health Bureau, 215 Healthy and Technical Project (grant no. 2009-3-58). website: http://bjwsrc.org/hhr/new/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Argov Z, 2002, STRUCTURAL MOL BASIS, P274; Darin N, 1998, ANN NEUROL, V44, P242, DOI 10.1002/ana.410440215; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg I, 2001, EUR J HUM GENET, V9, P501, DOI 10.1038/sj.ejhg.5200665; GILCHRIST JM, 1988, NEUROLOGY, V38, P5, DOI 10.1212/WNL.38.1.5; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hackman P, 2011, NEUROMUSCULAR DISORD, V21, P338, DOI 10.1016/j.nmd.2011.02.008; Harms MB, 2012, ANN NEUROL, DOI 1002/ana.22683; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; HOROWITZ SH, 1994, MUSCLE NERVE, V17, P151, DOI 10.1002/mus.880170204; Jay CM, 2009, GENE REGUL SYST BIO, V3, P181; JONGEN PJH, 1995, NEUROMUSCULAR DISORD, V5, P31, DOI 10.1016/0960-8966(94)E0019-5; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Martinsson T, 1999, AM J HUM GENET, V64, P1420, DOI 10.1086/302375; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Motozaki Y, 2007, EUR J NEUROL, V14, pE14, DOI 10.1111/j.1468-1331.2007.01905.x; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Saavedra-Matiz CA, 2000, HUM HERED, V50, P166, DOI 10.1159/000022908; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; Sandell S, 2010, J NEUROL NEUROSUR PS, V81, P834, DOI 10.1136/jnnp.2009.192351; Starling A, 2004, EUR J HUM GENET, V12, P1033, DOI 10.1038/sj.ejhg.5201289; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009	28	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39288	10.1371/journal.pone.0039288	http://dx.doi.org/10.1371/journal.pone.0039288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723986	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300127
J	Martin-Lopez, B; Iniesta-Arandia, I; Garcia-Llorente, M; Palomo, I; Casado-Arzuaga, I; Del Amo, DG; Gomez-Baggethun, E; Oteros-Rozas, E; Palacios-Agundez, I; Willaarts, B; Gonzalez, JA; Santos-Martin, F; Onaindia, M; Lopez-Santiago, C; Montes, C				Martin-Lopez, Berta; Iniesta-Arandia, Irene; Garcia-Llorente, Marina; Palomo, Ignacio; Casado-Arzuaga, Izaskun; Garcia Del Amo, David; Gomez-Baggethun, Erik; Oteros-Rozas, Elisa; Palacios-Agundez, Igone; Willaarts, Barbara; Gonzalez, Jose A.; Santos-Martin, Fernando; Onaindia, Miren; Lopez-Santiago, Cesar; Montes, Carlos			Uncovering Ecosystem Service Bundles through Social Preferences	PLOS ONE			English	Article							PROTECTED AREAS; VALUATION; KNOWLEDGE; CONSERVATION; PERCEPTIONS; GENDER; BIODIVERSITY; DIVERSITY; TRENDS; VALUES	Ecosystem service assessments have increasingly been used to support environmental management policies, mainly based on biophysical and economic indicators. However, few studies have coped with the social-cultural dimension of ecosystem services, despite being considered a research priority. We examined how ecosystem service bundles and trade-offs emerge from diverging social preferences toward ecosystem services delivered by various types of ecosystems in Spain. We conducted 3,379 direct face-to-face questionnaires in eight different case study sites from 2007 to 2011. Overall, 90.5% of the sampled population recognized the ecosystem's capacity to deliver services. Formal studies, environmental behavior, and gender variables influenced the probability of people recognizing the ecosystem's capacity to provide services. The ecosystem services most frequently perceived by people were regulating services; of those, air purification held the greatest importance. However, statistical analysis showed that socio-cultural factors and the conservation management strategy of ecosystems (i.e., National Park, Natural Park, or a non-protected area) have an effect on social preferences toward ecosystem services. Ecosystem service trade-offs and bundles were identified by analyzing social preferences through multivariate analysis (redundancy analysis and hierarchical cluster analysis). We found a clear trade-off among provisioning services (and recreational hunting) versus regulating services and almost all cultural services. We identified three ecosystem service bundles associated with the conservation management strategy and the rural-urban gradient. We conclude that socio-cultural preferences toward ecosystem services can serve as a tool to identify relevant services for people, the factors underlying these social preferences, and emerging ecosystem service bundles and trade-offs.	[Martin-Lopez, Berta; Iniesta-Arandia, Irene; Garcia-Llorente, Marina; Palomo, Ignacio; Garcia Del Amo, David; Gomez-Baggethun, Erik; Oteros-Rozas, Elisa; Gonzalez, Jose A.; Santos-Martin, Fernando; Lopez-Santiago, Cesar; Montes, Carlos] Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, Madrid, Spain; [Iniesta-Arandia, Irene] Univ Almeria, Dept Plant Biol & Ecol, Almeria, Spain; [Casado-Arzuaga, Izaskun; Palacios-Agundez, Igone; Onaindia, Miren] Univ Pais Vasco UPV EHU, Plant Biol & Ecol Dept, Bizkaia, Spain; [Gomez-Baggethun, Erik] Univ Autonoma Barcelona, Inst Environm Sci & Technol, Fac Sci, Bellaterra, Spain; [Willaarts, Barbara] Univ Politecn Madrid, Res Ctr Management Agr & Environm Risks CEIGRAM, Madrid, Spain	Autonomous University of Madrid; Universidad de Almeria; University of Basque Country; Autonomous University of Barcelona; Universidad Politecnica de Madrid	Martin-Lopez, B (corresponding author), Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, Madrid, Spain.	berta.martin@uam.es	Montes, Carlos/M-1449-2014; López-Santiago, Cesar Agustin/P-7786-2019; Palacios-Agundez, Igone/L-5084-2014; González, José/K-1321-2014; Onaindia, Miren/L-7082-2014; López-Santiago, Cesar A./D-8528-2011; PALOMO, IGNACIO/D-4398-2014; Iniesta-Arandia, Irene/B-4528-2017; Garcia del Amo, David/GXM-6035-2022; Oteros-Rozas, Elisa/L-8633-2014; García-Llorente, Marina/L-3550-2014; Martin-Lopez, Berta/R-9397-2017; Llorente, Marina Garcia/P-1644-2017; GARCIA, MARINA/AAH-8893-2019	Montes, Carlos/0000-0001-9280-2083; López-Santiago, Cesar Agustin/0000-0003-3681-1529; Palacios-Agundez, Igone/0000-0001-9683-6977; González, José/0000-0001-5917-9314; Onaindia, Miren/0000-0003-1040-0131; López-Santiago, Cesar A./0000-0003-3681-1529; PALOMO, IGNACIO/0000-0002-4573-5989; Iniesta-Arandia, Irene/0000-0002-1304-3232; Oteros-Rozas, Elisa/0000-0003-4313-3041; García-Llorente, Marina/0000-0002-3527-9318; Martin-Lopez, Berta/0000-0003-2622-0135; Llorente, Marina Garcia/0000-0002-3527-9318; GARCIA, MARINA/0000-0002-3527-9318; Willaarts, Barbara Anna/0000-0001-6589-1543; Garcia del Amo, David/0000-0002-0598-5465; Santos Martin, Fernando/0000-0002-2301-5876	Department of Innovation, Science, and Enterprise of Andalusian Government [P08-RNM-03945]; Ministry of the Environment and Rural and Marine Affairs of Spain [018/2009, 079/RN08/02.1]; Department of Education, University and Research of the Basque Government [BFI09.231]; Environment Department of the Regional Government of Bizkaia; Biodiversity Foundation	Department of Innovation, Science, and Enterprise of Andalusian Government; Ministry of the Environment and Rural and Marine Affairs of Spain; Department of Education, University and Research of the Basque Government; Environment Department of the Regional Government of Bizkaia; Biodiversity Foundation	Funding for the Andalusian case studies came from the Department of Innovation, Science, and Enterprise of Andalusian Government (project P08-RNM-03945) and the Ministry of the Environment and Rural and Marine Affairs of Spain (project 018/2009). The study of the Conquense Drove Road was funded by the Ministry of the Environment and Rural and Marine Affairs of Spain (project #079/RN08/02.1). The Bilbao Metropolitan Greenbelt study was funded by the Department of Education, University and Research of the Basque Government through the doctoral grant received by I. Casado-Arzuaga (BFI09.231), and the Environment Department of the Regional Government of Bizkaia through the project "Millennium Ecosystem Assessment in Bizkaia.'' This paper was further supported by the Biodiversity Foundation through the Spanish Millennium Ecosystem Assessment project (http://www.ecomilenio.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbenyega O, 2009, LAND USE POLICY, V26, P551, DOI 10.1016/j.landusepol.2008.08.011; Anton C, 2010, BIODIVERS CONSERV, V19, P2979, DOI 10.1007/s10531-010-9853-6; Arnaez J, 2011, LAND DEGRAD DEV, V22, P537, DOI 10.1002/ldr.1032; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Blondel J, 2010, MEDITERRANEAN REGION; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; BROWN TC, 1984, LAND ECON, V60, P231, DOI 10.2307/3146184; Bryan BA, 2010, LANDSCAPE URBAN PLAN, V97, P111, DOI 10.1016/j.landurbplan.2010.05.002; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Burham K. P., 2002, MODEL SELECTION MULT; Butzer KW, 2005, J ARCHAEOL SCI, V32, P1773, DOI 10.1016/j.jas.2005.06.001; Calvet-Mir L, 2012, ECOL ECON, V74, P153, DOI 10.1016/j.ecolecon.2011.12.011; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Castro AJ, 2011, J ARID ENVIRON, V75, P1201, DOI 10.1016/j.jaridenv.2011.05.013; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Chiu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021837; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; de Groot R, 2006, LANDSCAPE URBAN PLAN, V75, P175, DOI 10.1016/j.landurbplan.2005.02.016; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dietz T, 2002, SOC SCI QUART, V83, P353, DOI 10.1111/1540-6237.00088; Fagerholm N, 2012, ECOL INDIC, V18, P421, DOI 10.1016/j.ecolind.2011.12.004; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Folke C, 1997, AMBIO, V26, P167; Folke C, 2006, CONSERV BIOL, V20, P686, DOI 10.1111/j.1523-1739.2006.00446.x; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Garcia-Llorente M, 2011, ECOL APPL, V21, P3083, DOI 10.1890/10-1744.1; Garcia-Llorente M, 2011, ENVIRON SCI POLICY, V14, P76, DOI 10.1016/j.envsci.2010.11.004; Gomez-Baggethun E, 2010, CONSERV BIOL, V24, P721, DOI 10.1111/j.1523-1739.2009.01401.x; Gonzalez C, 2009, ECOL SOC, V14; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Gutman P, 2007, ECOL ECON, V62, P383, DOI 10.1016/j.ecolecon.2007.02.027; Hartter J, 2010, SOC NATUR RESOUR, V23, P207, DOI 10.1080/08941920903360372; Iftekhar M. S., 2008, Wetlands Ecology and Management, V16, P119, DOI 10.1007/s11273-007-9060-8; Kim KS, 2007, TRANSPORT RES D-TR E, V12, P275, DOI 10.1016/j.trd.2007.03.002; Kroll F, 2012, LAND USE POLICY, V29, P521, DOI 10.1016/j.landusepol.2011.07.008; Kumar M, 2008, ECOL ECON, V64, P808, DOI 10.1016/j.ecolecon.2007.05.008; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; Lamarque P, 2011, CR BIOL, V334, P441, DOI 10.1016/j.crvi.2010.11.007; Lewan L, 2002, ECOL ECON, V42, P459, DOI 10.1016/S0921-8009(02)00127-1; Luck GW, 2009, BIOSCIENCE, V59, P223, DOI 10.1525/bio.2009.59.3.7; Martin-Lopez B, 2007, ENVIRON CONSERV, V34, P215, DOI 10.1017/S0376892907004067; Martin-Lopez B, 2011, ECOL ECON, V70, P1481, DOI 10.1016/j.ecolecon.2011.03.009; Martino D, 2008, ENVIRON MANAGE, V41, P654, DOI 10.1007/s00267-008-9069-7; McDonald R., 2009, J CONSERVAT PLANN, V5, P1; Menzel S, 2010, CONSERV BIOL, V24, P907, DOI 10.1111/j.1523-1739.2009.01347.x; Millennium Ecosystem Assessment (MA), 2005, EC HUM WELL SYNTH; Millennium Ecosystem Assessment of Spain, 2011, MILL EC ASS SPAIN EM; Ministerio de Medio Ambiente y Medio Rural y Marino, 2011, DIAGN LGUALD GEN MED; Observatorio de la Sostenibilidad en Espana, 2011, SOST ESP 2010; Paetzold A, 2010, ECOL COMPLEX, V7, P273, DOI 10.1016/j.ecocom.2009.11.003; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Pfeiffer Jeanine M., 2005, Journal of Ethnobiology, V25, P240, DOI 10.2993/0278-0771(2005)25[240:ACAEVI]2.0.CO;2; Phillipson J, 2009, J APPL ECOL, V46, P261, DOI 10.1111/j.1365-2664.2009.01625.x; Pilgrim S, 2007, ECOL APPL, V17, P1742, DOI 10.1890/06-1358.1; Pyke CR, 2007, ECOL SOC, V12; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reyes-Garcia V, 2010, ECON BOT, V64, P235, DOI 10.1007/s12231-010-9124-1; Rodriguez JP, 2006, ECOL SOC, V11; Ronnback P, 2007, ENVIRON CONSERV, V34, P313, DOI 10.1017/S0376892907004225; Schneiders A, 2012, ECOL INDIC, V21, P123, DOI 10.1016/j.ecolind.2011.06.021; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P1175, DOI 10.1007/s10531-009-9745-9; Tengo M, 2004, ECOL SOC, V9; The Economics of Ecosystems and Biodiversity (TEEB), 2010, EC EC BIOD EC EC FDN; Vihervaara P, 2010, AMBIO, V39, P314, DOI 10.1007/s13280-010-0048-x; Vilardy SP, 2011, HYDROLOG SCI J, V56, P1423, DOI 10.1080/02626667.2011.631497; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warren-Rhodes K, 2011, ENVIRON CONSERV, V38, P485, DOI 10.1017/S0376892911000373; Zelezny LC, 2000, J SOC ISSUES, V56, P443, DOI 10.1111/0022-4537.00177; Zhen L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015001	74	583	615	37	485	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38970	10.1371/journal.pone.0038970	http://dx.doi.org/10.1371/journal.pone.0038970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22720006	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305583300073
J	Na, YS; Yang, SJ; Kim, SM; Jung, KA; Moon, JH; Shin, JS; Yoon, DH; Hong, YS; Ryu, MH; Lee, JL; Lee, JS; Kim, TW				Na, Young-Soon; Yang, Soo-Jin; Kim, Seung-Mi; Jung, Kyung-Ah; Moon, Jai-Hee; Shin, Jae-Sik; Yoon, Dok Hyun; Hong, Yong Sang; Ryu, Min-Hee; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won			YM155 Induces EGFR Suppression in Pancreatic Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOLECULE SURVIVIN SUPPRESSANT; PROTEIN-KINASE; NUCLEAR TRANSLOCATION; INHIBITS APOPTOSIS; SIGNALING PATHWAYS; ANTITUMOR-ACTIVITY; TARGETED THERAPY; DRUG DISCOVERY; LUNG-CANCER	YM155, which inhibits the anti-apoptotic protein survivin, is known to exert anti-tumor effects in various cancers, including prostate and lung cancer. However, there are few reports describing the inhibitory effect of YM155 on human pancreatic cancers that highly express survivin. Here, we tested the effects of YM155 on a variety of cancer cell lines, including pancreatic cancer cells. We found that YM155 exerts an anti-proliferative effect in pancreatic cancer cells, inducing cell death through suppression of XIAP (X-linked inhibitor of apoptosis) as well as survivin without affecting the anti-apoptotic proteins Bcl-xL or Mcl-1. YM155 also inhibited tumor growth in vivo, reducing the size of pancreatic cancer cell line MIAPaCa-2 xenografts by 77.1% on day 31. Western blot analyses further showed that YM155 downregulated phosphoinoside 3-kinase (PI3K) expression and reduced the levels of phosphorylated (activated) extracellular signal-regulated kinase (ERK) and STAT3 (signal transducer and activator of transcription 3) in PANC-1 cells. Interestingly, we also found that YM155 downregulated the epidermal growth factor receptor (EGFR) in various cancer cell lines and induced the EGFR phosphorylation and ubiquitination of EGFR in PANC-1 cells. YM155 also modestly promoted the ubiquitination of survivin and XIAP. Therefore, YM155 acts through modulation of EGFR and survivin expression to subsequently reduce survival. We suggest that YM155 has potential as a therapeutic agent in the treatment of pancreatic cancer.	[Na, Young-Soon; Yang, Soo-Jin; Kim, Seung-Mi; Jung, Kyung-Ah; Moon, Jai-Hee; Shin, Jae-Sik; Hong, Yong Sang; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won] Asan Med Ctr, Inst Innovate Canc Res, Seoul, South Korea; [Yoon, Dok Hyun; Hong, Yong Sang; Ryu, Min-Hee; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Na, YS (corresponding author), Asan Med Ctr, Inst Innovate Canc Res, Seoul, South Korea.	twkimmd@amc.seoul.kr			Ministry of Health, Welfare, and Family Affairs, Republic of Korea [A062254]	Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea (A062254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bondar VM, 2002, MOL CANCER THER, V1, P989; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Iwasa T, 2010, BRIT J CANCER, V103, P36, DOI 10.1038/sj.bjc.6605713; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Kim HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005933; Kleespies A, 2006, DRUG RESIST UPDATE, V9, P1, DOI 10.1016/j.drup.2006.02.002; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lewis KD, 2011, INVEST NEW DRUG, V29, P161, DOI 10.1007/s10637-009-9333-6; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pangburn HA, 2010, CANCER PREV RES, V3, P560, DOI 10.1158/1940-6207.CAPR-09-0159; Qiao JG, 2004, WORLD J GASTROENTERO, V10, P2759, DOI 10.3748/wjg.v10.i18.2759; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Siddiqa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-129; Tang HK, 2011, BIOCHEM PHARMACOL, V82, P1066, DOI 10.1016/j.bcp.2011.07.064; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Xiong HQ, 2002, SEMIN ONCOL, V29, P31, DOI 10.1053/sonc.2002.35645; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001	41	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38625	10.1371/journal.pone.0038625	http://dx.doi.org/10.1371/journal.pone.0038625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723871	gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300035
J	Ekoff, M; Lyberg, K; Krajewska, M; Arvidsson, M; Rak, S; Reed, JC; Harvima, I; Nilsson, G				Ekoff, Maria; Lyberg, Katarina; Krajewska, Maryla; Arvidsson, Monica; Rak, Sabina; Reed, John C.; Harvima, Ilkka; Nilsson, Gunnar			Anti-Apoptotic Bfl-1 Is the Major Effector in Activation-Induced Human Mast Cell Survival	PLOS ONE			English	Article							IGE-RECEPTOR ACTIVATION; BCL-2 FAMILY-MEMBER; FC-GAMMA-RI; SELICICLIB CYC202; PROMOTES SURVIVAL; MULTIPLE-MYELOMA; DOWN-REGULATION; TNF-ALPHA; EXPRESSION; DEGRANULATION	Mast cells are best known for their role in allergic reactions, where aggregation of FceRI leads to the release of mast cell mediators causing allergic symptoms. The activation also induces a survival program in the cells, i.e., activation-induced mast cell survival. The aim of the present study was to investigate how the activation-induced survival is mediated. Cord blood-derived mast cells and the mast cell line LAD-2 were activated through FceRI crosslinking, with or without addition of chemicals that inhibit the activity or expression of selected Bcl-2 family members (ABT-737; roscovitine). Cell viability was assessed using staining and flow cytometry. The expression and function of Bcl-2 family members BFL-1 and MCL-1 were investigated using real-time quantitative PCR and siRNA treatment. The mast cell expression of Bfl-1 was investigated in skin biopsies. FceRI crosslinking promotes activation-induced survival of human mast cells and this is associated with an upregulation of the anti-apoptotic Bcl-2 family member Bfl-1. ABT-737 alone or in combination with roscovitine decreases viability of human mast cells although activation-induced survival is sustained, indicating a minor role for Bcl-X-L, Bcl-2, Bcl-w and Mcl-1. Reducing BFL-1 but not MCL-1 levels by siRNA inhibited activation-induced mast cell survival. We also demonstrate that mast cell expression of Bfl-1 is elevated in birch-pollen-provocated skin and in lesions of atopic dermatitis and psoriasis patients. Taken together, our results highlight Bfl-1 as a major effector in activation-induced human mast cell survival.	[Ekoff, Maria; Lyberg, Katarina; Nilsson, Gunnar] Karolinska Inst, Ctr Allergy Res, Dept Med, Stockholm, Sweden; [Krajewska, Maryla; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Arvidsson, Monica; Rak, Sabina] Sahlgrens Univ Hosp, Dept Resp Med & Allergol, Gothenburg, Sweden; [Harvima, Ilkka] Kuopio Univ Hosp, Dept Dermatol, SF-70210 Kuopio, Finland; [Harvima, Ilkka] Univ Eastern Finland, Kuopio, Finland	Karolinska Institutet; Sanford Burnham Prebys Medical Discovery Institute; Sahlgrenska University Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Ekoff, M (corresponding author), Karolinska Inst, Ctr Allergy Res, Dept Med, Stockholm, Sweden.	maria.ekoff@ki.se		Lyberg, Katarina/0000-0003-3507-7983; Nilsson, Gunnar/0000-0001-6795-5512	Swedish Research Council-Medicine; Centre for Allergy Research at Karolinska Institutet; Swedish Heart Lung Foundation; Ellen, Walter and Lennart Hesselmans foundation for scientific research; Ollie and Elof Ericsson's foundation; King Gustav V's 80-years foundation, Sweden; Kuopio University Hospital; Abbot, Finland	Swedish Research Council-Medicine(Swedish Research Council); Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Ellen, Walter and Lennart Hesselmans foundation for scientific research; Ollie and Elof Ericsson's foundation; King Gustav V's 80-years foundation, Sweden; Kuopio University Hospital; Abbot, Finland	This study was supported by grants from the Swedish Research Council-Medicine, the Centre for Allergy Research at Karolinska Institutet, the Swedish Heart Lung Foundation, the Swedish Cancer Society, Ellen, Walter and Lennart Hesselmans foundation for scientific research, Ollie and Elof Ericsson's foundation, King Gustav V's 80-years foundation, Sweden, Kuopio University Hospital and Abbot, Finland. The authors also acknowledge support from the COST Action BM1007 (Mast cells and basophils - targets for innovative therapies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann L, 1998, ARCH DERMATOL RES, V290, P353, DOI 10.1007/s004030050317; Alfredsson J, 2006, SCAND J IMMUNOL, V63, P1, DOI 10.1111/j.1365-3083.2006.01704.x; Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; BARKER JNWN, 1991, LANCET, V338, P227, DOI 10.1016/0140-6736(91)90357-U; Berent-Maoz B, 2008, ALLERGY, V63, P333, DOI 10.1111/j.1398-9995.2007.01598.x; Diaconu NC, 2007, CANCER IMMUNOL IMMUN, V56, P1407, DOI 10.1007/s00262-007-0290-7; DVORAK AM, 1987, CELL IMMUNOL, V105, P199, DOI 10.1016/0008-8749(87)90068-2; Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JCI24274; Galli SJ, 2000, CURR BIOL, V10, pR93, DOI 10.1016/S0960-9822(00)00322-5; Ishizaka T, 1984, MAST CELL ACTIVATION, P188; Karlberg M, 2008, J CLIN IMMUNOL, V28, P250, DOI 10.1007/s10875-007-9153-4; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kitaura J, 2004, J IMMUNOL, V173, P4317, DOI 10.4049/jimmunol.173.7.4317; KOBAYASI T, 1969, ACTA DERM-VENEREOL, V49, P369; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Moller C, 2003, CLIN EXP ALLERGY, V33, P1135, DOI 10.1046/j.1365-2222.2003.01728.x; Nilsson G, 1996, IMMUNOLOGY, V88, P308, DOI 10.1111/j.1365-2567.1996.tb00020.x; NILSSON G, 1999, INFLAMMATION BASIC P, P97; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ortiz-Ferron G, 2008, CELL RES, V18, P664, DOI 10.1038/cr.2008.54; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; SAITO H, 1995, INT ARCH ALLERGY IMM, V107, P63, DOI 10.1159/000236932; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Tkaczyk C, 2002, MOL IMMUNOL, V38, P1289, DOI 10.1016/S0161-5890(02)00077-9; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Xiang Z, 2006, ALLERGY, V61, P1040, DOI 10.1111/j.1398-9995.2006.01024.x; Xiang Z, 2001, J EXP MED, V194, P1561, DOI 10.1084/jem.194.11.1561; Yoshikawa H, 1999, J IMMUNOL, V162, P6162	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39117	10.1371/journal.pone.0039117	http://dx.doi.org/10.1371/journal.pone.0039117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720045	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000041
J	Faerch, K; Bergman, B; Perreault, L				Faerch, Kristine; Bergman, Bryan; Perreault, Leigh			Does Insulin Resistance Drive the Association between Hyperglycemia and Cardiovascular Risk?	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; ALL-CAUSE; MORTALITY; PIOGLITAZONE; EVENTS; COMPLICATIONS; PROGRESSION; PREVENTION; FRAMINGHAM	Background: Several studies have shown associations between hyperglycemia and risk of cardiovascular disease (CVD) and mortality, yet glucose-lowering treatment does little to mitigate this risk. We examined whether associations between hyperglycemia and CVD risk were explained by underlying insulin resistance. Methods: In 60 middle-aged individuals without diabetes we studied the associations of fasting plasma glucose, 2-hour post oral glucose tolerance test plasma glucose, insulin sensitivity as well as body fat percentage with CVD risk. Insulin sensitivity was measured as the glucose infusion rate during a euglycemic hyperinsulinemic clamp, body fat percentage was measured by dual X-ray absorptiometry, and CVD risk was estimated using the Framingham risk score. Associations of fasting plasma glucose, 2-hour plasma glucose, insulin sensitivity and body fat percentage with the Framingham risk score were assessed in linear regression models. Results: Both fasting and 2-hour plasma glucose levels were associated with higher Framingham risk score (fasting glucose: r(2) = 0.21; 2-hour glucose: r(2) = 0.24; P<0.001 for both), and insulin sensitivity with lower Framingham risk score (r(2) = 0.36; P<0.001). However, adjustment for insulin sensitivity and 2-hour glucose made the effect of fasting glucose non-significant (P = 0.060). Likewise, when adjusting for insulin sensitivity and fasting glucose, the association between 2-hour glucose and Framingham risk score disappeared (P = 0.143). In contrast, insulin sensitivity was still associated with Framingham risk score after adjusting for glucose levels (P<0.001). Body fat was not associated with Framingham risk score when taking insulin sensitivity into account (P = 0.550). Conclusion: The association between plasma glucose levels and CVD risk is mainly explained by insulin resistance, which raises the question of whether glucose lowering per se without changes in the processes that underlie hyperglycemia should be the sole clinical paradigm in the treatment of type 2 diabetes or its prevention.	[Faerch, Kristine] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Bergman, Bryan; Perreault, Leigh] Univ Colorado, Aurora, CO USA	Steno Diabetes Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Faerch, K (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.	krif@steno.dk	Bergman, Bryan/T-8055-2019	Faerch, Kristine/0000-0002-6127-0448; Bergman, Bryan/0000-0002-9561-1052	National Institutes of Health [DK064811, DK059739, RR00036]; Fonden til Laegevidenskabens Fremme; Novo Nordisk Foundation; Novo Nordisk A/S; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK064811, F32DK059739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonden til Laegevidenskabens Fremme; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk A/S(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Institutes of Health (DK064811, DK059739, RR00036) and Fonden til Laegevidenskabens Fremme funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors have read the journal's policy and have the following conflicts: KF is employed by Steno Diabetes Center A/S, a research hospital working in the Danish National Health Service and which is owned by Novo Nordisk A/S. Steno Diabetes Center A/S receives part of its core funding from unrestricted grants from the Novo Nordisk Foundation and Novo Nordisk A/S. K. F. owns shares in Novo Nordisk A/S. No other potential conflicts of interest relevant to this article were reported. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Chamnan P, 2009, DIABETOLOGIA, V52, P2001, DOI 10.1007/s00125-009-1454-0; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Faerch K, 2009, DIABETOLOGIA, V52, P1714, DOI 10.1007/s00125-009-1443-3; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goldberg RB, 2009, DIABETES CARE, V32, P726, DOI 10.2337/dc08-0494; Haffner SM, 2000, CIRCULATION, V101, P975, DOI 10.1161/01.CIR.101.9.975; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hills SA, 2004, DIABETOLOGIA, V47, P566, DOI 10.1007/s00125-004-1335-5; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kengne AP, 2010, DIABETOLOGIA, V53, P821, DOI 10.1007/s00125-010-1681-4; Kodama S, 2012, J ATHEROSCLER THROMB; Linton MF, 2003, AM J CARDIOL, V92, p19I, DOI 10.1016/S0002-9149(03)00505-8; Neiberg RH, 2012, OBESITY, V20, P2048, DOI 10.1038/oby.2012.33; Ning F, 2010, DIABETES CARE, V33, P2211, DOI 10.2337/dc09-2328; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Perreault L, 2004, J APPL PHYSIOL, V97, P1013, DOI 10.1152/japplphysiol.00186.2004; Perreault L, 2008, AM J PHYSIOL-ENDOC M, V295, pE428, DOI 10.1152/ajpendo.90354.2008; Ray KK, 2009, NAT REV ENDOCRINOL, V5, P302, DOI 10.1038/nrendo.2009.100; Reddigan JI, 2012, DIABETOLOGIA, V55, P632, DOI 10.1007/s00125-011-2374-3; Smith NL, 2002, ARCH INTERN MED, V162, P209, DOI 10.1001/archinte.162.2.209; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959	31	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39260	10.1371/journal.pone.0039260	http://dx.doi.org/10.1371/journal.pone.0039260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720085	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350000054
J	Hansen, S; Vulic, M; Min, JK; Yen, TJ; Schumacher, MA; Brennan, RG; Lewis, K				Hansen, Sonja; Vulic, Marin; Min, Jungki; Yen, Tien-Jui; Schumacher, Maria A.; Brennan, Richard G.; Lewis, Kim			Regulation of the Escherichia coli HipBA Toxin-Antitoxin System by Proteolysis	PLOS ONE			English	Article							BACTERIAL PERSISTENCE; MULTIDRUG TOLERANCE; CRYSTAL-STRUCTURE; STRESS-RESPONSE; INORGANIC POLYPHOSPHATE; PSEUDOMONAS-AERUGINOSA; DEPENDENT PROTEASE; AFFECTS LETHALITY; AFFECTS FREQUENCY; MUREIN SYNTHESIS	Bacterial populations produce antibiotic-tolerant persister cells. A number of recent studies point to the involvement of toxin/antitoxin (TA) modules in persister formation. hipBA is a type II TA module that codes for the HipB antitoxin and the HipA toxin. HipA is an EF-Tu kinase, which causes protein synthesis inhibition and dormancy upon phosphorylation of its substrate. Antitoxins are labile proteins that are degraded by one of the cytosolic ATP-dependent proteases. We followed the rate of HipB degradation in different protease deficient strains and found that HipB was stabilized in a lon(-) background. These findings were confirmed in an in vitro degradation assay, showing that Lon is the main protease responsible for HipB proteolysis. Moreover, we demonstrated that degradation of HipB is dependent on the presence of an unstructured carboxy-terminal stretch of HipB that encompasses the last 16 amino acid residues. Further, substitution of the conserved carboxy-terminal tryptophan of HipB to alanine or even the complete removal of this 16 residue fragment did not alter the affinity of HipB for hipBA operator DNA or for HipA indicating that the major role of this region of HipB is to control HipB degradation and hence HipA-mediated persistence.	[Hansen, Sonja; Vulic, Marin; Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA; [Min, Jungki; Yen, Tien-Jui; Schumacher, Maria A.; Brennan, Richard G.] Duke Univ, Sch Med, Dept Biochem, Durham, NC USA	Northeastern University; Duke University	Hansen, S (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Yen, Tien-Jui/AGF-8092-2022	Brennan, Richard/0000-0001-7647-485X; Min, Jungki/0000-0003-1860-3064	National Institutes of Health [R01 GM061162]; Robert A. Welch Foundation [G-0040]; MD Anderson Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); MD Anderson Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM061162 (to KL), the Robert A. Welch Foundation grant G-0040 (to RGB), and MD Anderson Fellowship (to MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; CHARETTE MF, 1981, P NATL ACAD SCI-BIOL, V78, P4728, DOI 10.1073/pnas.78.8.4728; Cherny I, 2007, BIOCHEMISTRY-US, V46, P12152, DOI 10.1021/bi701037e; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Evdokimov A, 2009, ACTA CRYSTALLOGR D, V65, P875, DOI 10.1107/S0907444909018800; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; HANSEN S, 2008, ANTIMICROB AGENTS CH; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Langklotz S, 2011, MOL MICROBIOL, V80, P1313, DOI 10.1111/j.1365-2958.2011.07646.x; Lewis K., 2010, ANN REV MICROBIOL; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maisonneuve E, 2011, P NATL ACAD SCI US; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; Ojangu EL, 2000, J BACTERIOL, V182, P6707, DOI 10.1128/JB.182.23.6707-6713.2000; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pruteanu M, 2007, J BACTERIOL, V189, P3017, DOI 10.1128/JB.01531-06; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	59	63	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39185	10.1371/journal.pone.0039185	http://dx.doi.org/10.1371/journal.pone.0039185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720069	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350000047
J	Haskelberg, H; Hoy, JF; Amin, J; Ebeling, PR; Emery, S; Carr, A				Haskelberg, Hila; Hoy, Jennifer F.; Amin, Janaki; Ebeling, Peter R.; Emery, Sean; Carr, Andrew		Steal Study Grp	Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine	PLOS ONE			English	Article							MINERAL DENSITY; ANTIRETROVIRAL THERAPY; BODY-COMPOSITION; NAIVE PATIENTS; MARKERS; OSTEOPOROSIS; WOMEN; RESORPTION; ADULTS; PREMENOPAUSAL	Background: Those receiving tenofovir/emtricitabine (TDF-FTC) had greater bone loss compared with abacavir/lamivudine (ABC-3TC) in a randomized simplification trial (STEAL study). Previous studies associated increased bone turnover and bone loss with initiation of antiretroviral treatment, however it is unclear whether change in bone mineral density (BMD) was a result of specific drugs, from immune reconstitution or from suppression of HIV replication. This analysis determined predictors of BMD change in the hip and spine by dual-energy x-ray absorptiometry in virologically suppressed participants through week 96. Methodology/Principal Findings: Bone turnover markers (BTMs) tested were: formation [bone alkaline phosphatase, procollagen type 1 N-terminal propeptide (P1NP)]; resorption (C-terminal cross-linking telopeptide of type 1 collagen [CTx]); and bone cytokine-signalling (osteoprotegerin, RANK ligand). Independent predictors of BMD change were determined using forward, stepwise, linear regression. BTM changes and fracture risk (FRAX (R)) at week 96 were compared by t-test. Baseline characteristics (n = 301) were: 98% male, mean age 45 years, current protease-inhibitor (PI) 23%, tenofovir/abacavir-naive 52%. Independent baseline predictors of greater hip and spine bone loss were TDF-FTC randomisation (p<0.013), lower fat mass (p-trend<0.009), lower P1NP (p = 0.015), and higher hip T score/spine BMD (p-trend<0.006). Baseline PI use was associated with greater spine bone loss (p = 0.004). TDF-FTC increased P1NP and CTx through Wk96 (p<0.01). Early changes in BTM did not predict bone loss at week 96. No significant between-group difference was found in fracture risk. Conclusions/Significance: Tenofovir/emtricitabine treatment, lower bone formation and lower fat mass predicted subsequent bone loss. There was no association between TDF-FTC and fracture risk.	[Haskelberg, Hila; Amin, Janaki; Emery, Sean] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Hoy, Jennifer F.] Monash Univ, Alfred Hosp, Infect Dis Unit, Melbourne, Vic 3181, Australia; [Ebeling, Peter R.] Univ Melbourne, N W Acad Ctr, Melbourne, Vic, Australia; [Carr, Andrew] St Vincents Hosp, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; St Vincents Hospital Sydney	Haskelberg, H (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	hhaskelberg@kirby.unsw.edu.au	Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019; Hoy, Jennifer/AAK-7968-2020	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Smith, David/0000-0002-9465-988X; Anderson, Jonathan/0000-0002-7316-428X; Hoy, Jennifer/0000-0002-6948-7086; Boyd, Mark/0000-0002-6848-3307; Ebeling, Peter/0000-0002-2921-3742; Giles, Michelle/0000-0003-3007-1822; Gordon, David/0000-0003-3276-9685; Medland, Nicholas Andrew/0000-0003-0403-8930; Woolley, Ian John/0000-0003-2928-1291; Post, Jeffrey/0000-0003-1475-9272; Amin, Janaki/0000-0003-2161-9366	Kirby Institute; Australian Government Department of Health and Ageing; GSK/ViiV Healthcare; Gilead Sciences; Merck; Janssen-Cilag; Abbott; BMS; Gilead; GSK; Tibotec; Viiv Healthcare; Pfizer; Bristol-Myers Squibb; Roche; Boehringer-Ingelheim	Kirby Institute; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); GSK/ViiV Healthcare; Gilead Sciences(Gilead Sciences); Merck(Merck & Company); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); GSK(GlaxoSmithKline); Tibotec; Viiv Healthcare; Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Boehringer-Ingelheim(Boehringer Ingelheim)	This work was supported by The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research) funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. Partial funding for the biomarker analysis was provided by GSK/ViiV Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; Co-author Sean Emery is a PLoS ONE Editorial Board member, Hila Haskelberg declares no conflict of interest. Jennifer Hoy's institution has received research funding from GlaxoSmithKline/ViiV Healthcare, Gilead Sciences and Merck; travel sponsorship from Gilead Sciences, Janssen-Cilag, and Merck; and has served on advisory boards for Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Janssen-Cilag, Merck and Roche. Janaki Amin declares no conflict of interest. Peter Ebeling's institution has received research funding from Merck; consultancy fees from Gilead Sciences and GlaxoSmithKline/ViiV Healthcare; and he has served on an advisory board for Merck. Sean Emery has either served on advisory boards; received travel grants, consultancy payments or honoraria from Abbott, BMS, Merck, Gilead, GSK, Tibotec, Viiv Healthcare, and Pfizer. Andrew Carr has received research funding from GlaxoSmithKline/ViiV Healthcare, and Merck; consultancy fees from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Merck and Roche; lecture and travel sponsorships from Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, and Merck; and has served on advisory boards for Abbott, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, Merck and Roche. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials. Partial funding for the biomarker analysis was provided by GSK/ViiV Healthcare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials. In the STEAL main study, subjects were randomised to receive either of the following study drugs in combination with the remainder of their existing ART (having ceased the NRTI component): KivexaTM: ABC 600 mg+3 TC 300 mg FDC once daily TruvadaTM: FTC 200 mg+TDF 300 mg FDC once daily There are no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products.	Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Aukrust P, 1999, J CLIN ENDOCR METAB, V84, P145, DOI 10.1210/jc.84.1.145; Bolland MJ, 2011, J CLIN ENDOCR METAB, V96, P2721, DOI 10.1210/jc.2011-0591; Borderi M, 2009, AIDS, V23, P1297, DOI 10.1097/QAD.0b013e32832ce85a; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Ding C, 2008, J CLIN ENDOCR METAB, V93, P1952, DOI 10.1210/jc.2007-2325; Dolan SE, 2007, JAIDS-J ACQ IMM DEF, V45, P161, DOI 10.1097/QAI.0b013e31804a7f4d; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; FRAX&REG;, WHO FRACT RISK ASS T; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Garnero P, 1996, J BONE MINER RES, V11, P1531; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V394, P48, DOI 10.1016/j.bbrc.2010.02.080; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V391, P1324, DOI 10.1016/j.bbrc.2009.12.039; Liu AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023688; Malizia AP, 2007, AIDS RES HUM RETROV, V23, P243, DOI 10.1089/aid.2006.0084; Mallon PWG, 2010, CURR OPIN INFECT DIS, V23, P1, DOI 10.1097/QCO.0b013e328334fe9a; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Meier C, 2005, J BONE MINER RES, V20, P579, DOI 10.1359/JBMR.041207; Mondy K, 2003, CLIN INFECT DIS, V36, P482, DOI 10.1086/367569; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; NOF, 2011, CLIN GUID PREV TREAT; Ofotokun I, 2011, 18 C RETR OPP INF CR; Piso RJ, 2011, JAIDS-J ACQ IMM DEF, V56, P320, DOI 10.1097/QAI.0b013e31820cf010; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; Schulte CMS, 2004, BLOOD, V103, P3635, DOI 10.1182/blood-2003-09-3081; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; van Vonderen MG, 2011, 18 C RETR OPP INF CR; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; World Health Organization (WHO), 2004, WHO SCI GROUP ASS OS; Yin MT, 2010, JAIDS-J ACQ IMM DEF, V53, P202, DOI 10.1097/QAI.0b013e3181bf6471; Yun AJ, 2004, MED HYPOTHESES, V63, P532, DOI 10.1016/S0306-9877(03)00326-8	33	81	81	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38377	10.1371/journal.pone.0038377	http://dx.doi.org/10.1371/journal.pone.0038377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719882	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000015
J	Liu, F; Lunsford, EP; Tong, JL; Ashitate, Y; Gibbs, SL; Yu, J; Choi, HS; Henske, EP; Frangioni, JV				Liu, Fangbing; Lunsford, Elaine P.; Tong, Jingli; Ashitate, Yoshitomo; Gibbs, Summer L.; Yu, Jane; Choi, Hak Soo; Henske, Elizabeth P.; Frangioni, John V.			Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex	PLOS ONE			English	Article							TUBEROUS SCLEROSIS; SMOOTH-MUSCLE; RENAL ANGIOMYOLIPOMA; NA+/I-SYMPORTER; MATRIX METALLOPROTEINASES; TSC2(+/-) MICE; TUMOR-CELLS; TSC2; MTOR; LAM	Background: TSC2-deficient cells can proliferate in the lungs, kidneys, and other organs causing devastating progressive multisystem disorders such as lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC). Preclinical models utilizing LAM patient-derived cells have been difficult to establish. We developed a novel animal model system to study the molecular mechanisms of TSC/LAM pathogenesis and tumorigenesis and provide a platform for drug testing. Methods and Findings: TSC2-deficient human cells, derived from the angiomyolipoma of a LAM patient, were engineered to co-express both sodium-iodide symporter (NIS) and green fluorescent protein (GFP). Cells were inoculated intraparenchymally, intravenously, or intratracheally into athymic NCr nu/nu mice and cells were tracked and quantified using single photon emission computed tomography (SPECT) and computed tomography (CT). Surprisingly, TSC2-deficient cells administered intratracheally resulted in rapid dissemination to lymph node basins throughout the body, and histopathological changes in the lung consistent with LAM. Estrogen was found to be permissive for tumor growth and dissemination. Rapamycin inhibited tumor growth, but tumors regrew after the drug treatment was withdrawn. Conclusions: We generated homogeneous NIS/GFP co-expressing TSC2-deficient, patient-derived cells that can proliferate and migrate in vivo after intratracheal instillation. Although the animal model we describe has some limitations, we demonstrate that systemic tumors formed from TSC2-deficient cells can be monitored and quantified noninvasively over time using SPECT/CT, thus providing a much needed model system for in vivo drug testing and mechanistic studies of TSC2-deficient cells and their related clinical syndromes.	[Liu, Fangbing; Ashitate, Yoshitomo; Gibbs, Summer L.; Choi, Hak Soo; Frangioni, John V.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA; [Tong, Jingli] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02115 USA; [Yu, Jane; Henske, Elizabeth P.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Yu, Jane; Henske, Elizabeth P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Frangioni, John V.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Liu, F (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA.	jfrangio@bidmc.harvard.edu	Choi, Hak Soo/C-9954-2011		United States National Institutes of Health (High-End Instrumentation Grant) [S10-RR-023010]; Ellison Foundation; Tuberous Sclerosis Alliance; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER	United States National Institutes of Health (High-End Instrumentation Grant); Ellison Foundation(Lawrence Ellison Foundation); Tuberous Sclerosis Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants to JVF from the United States National Institutes of Health (High-End Instrumentation Grant #S10-RR-023010), the Ellison Foundation, and the Tuberous Sclerosis Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Arbiser JL, 2001, AM J PATHOL, V159, P483, DOI 10.1016/S0002-9440(10)61720-8; Astrinidis A, 2005, ONCOGENE, V24, P7475, DOI 10.1038/sj.onc.1209090; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; CAPRON F, 1983, CANCER, V52, P851, DOI 10.1002/1097-0142(19830901)52:5<851::AID-CNCR2820520518>3.0.CO;2-M; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; CORNOG JL, 1966, CANCER-AM CANCER SOC, V19, P1909, DOI 10.1002/1097-0142(196612)19:12<1909::AID-CNCR2820191219>3.0.CO;2-R; CRAWFORD HC, 1994, INVAS METAST, V14, P234; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dadachova E, 2004, SEMIN NUCL MED, V34, P23, DOI 10.1053/j.semnuclmed.2003.09.004; Darling TN, 2010, LYMPHAT RES BIOL, V8, P59, DOI 10.1089/lrb.2009.0031; El-Hashemite N, 2005, CANCER RES, V65, P2474, DOI 10.1158/0008-5472.CAN-04-3840; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Finlay GA, 2009, MOL CANCER THER, V8, P1799, DOI 10.1158/1535-7163.MCT-09-0055; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Glasgow CG, 2008, ANN NY ACAD SCI, V1131, P206, DOI 10.1196/annals.1413.018; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Juvet SC, 2007, AM J RESP CELL MOL, V36, P398, DOI 10.1165/rcmb.2006-0372TR; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Krymskaya VP, 2003, CELL SIGNAL, V15, P729, DOI 10.1016/S0898-6568(03)00040-8; Kwiatkowski DJ, 2010, LYMPHAT RES BIOL, V8, P51, DOI 10.1089/lrb.2009.0013; Lacroix L, 2001, EUR J ENDOCRINOL, V144, P297, DOI 10.1530/eje.0.1440297; Lesma E, 2005, AM J PATHOL, V167, P1093, DOI 10.1016/S0002-9440(10)61198-4; Lesma E, 2009, AM J PATHOL, V174, P2150, DOI 10.2353/ajpath.2009.080799; Lesma E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003558; Marsee DK, 2004, CANCER GENE THER, V11, P121, DOI 10.1038/sj.cgt.7700661; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P267; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; Nurok M, 2010, LYMPHAT RES BIOL, V8, P81, DOI 10.1089/lrb.2009.0028; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Strizheva GD, 2001, AM J RESP CRIT CARE, V163, P253, DOI 10.1164/ajrccm.163.1.2005004; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Vayre L, 1999, EUR J ENDOCRINOL, V141, P382, DOI 10.1530/eje.0.1410382; Walker CL, 2003, GENE CHROMOSOME CANC, V38, P349, DOI 10.1002/gcc.10281; Wlodarski PK, 2008, INT J MOL MED, V21, P245; Woodrum C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-14; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu J, 2010, LYMPHAT RES BIOL, V8, P43, DOI 10.1089/lrb.2009.0020; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Zhe XN, 2004, J HISTOCHEM CYTOCHEM, V52, P1537, DOI 10.1369/jhc.4A6438.2004	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38589	10.1371/journal.pone.0038589	http://dx.doi.org/10.1371/journal.pone.0038589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719903	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000017
J	Bierne, H; Travier, L; Mahlakoiv, T; Tailleux, L; Subtil, A; Lebreton, A; Paliwal, A; Gicquel, B; Staeheli, P; Lecuit, M; Cossart, P				Bierne, Helene; Travier, Laetitia; Mahlakoiv, Tanel; Tailleux, Ludovic; Subtil, Agathe; Lebreton, Alice; Paliwal, Anupam; Gicquel, Brigitte; Staeheli, Peter; Lecuit, Marc; Cossart, Pascale			Activation of Type III Interferon Genes by Pathogenic Bacteria in Infected Epithelial Cells and Mouse Placenta	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS RHINOSINUSITIS; LISTERIA-MONOCYTOGENES; MYCOBACTERIUM-TUBERCULOSIS; LAMBDA-INTERFERONS; SHIGELLA-FLEXNERI; DENDRITIC CELLS; VIRUS-INFECTION; IN-VIVO; EXPRESSION; VIRULENCE	Bacterial infections trigger the expression of type I and II interferon genes but little is known about their effect on type III interferon (IFN-lambda) genes, whose products play important roles in epithelial innate immunity against viruses. Here, we studied the expression of IFN-lambda genes in cultured human epithelial cells infected with different pathogenic bacteria and in the mouse placenta infected with Listeria monocytogenes. We first showed that in intestinal LoVo cells, induction of IFN-lambda genes by L. monocytogenes required bacterial entry and increased further during the bacterial intracellular phase of infection. Other Gram-positive bacteria, Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis, also induced IFN-lambda genes when internalized by LoVo cells. In contrast, Gram-negative bacteria Salmonella enterica serovar Typhimurium, Shigella flexneri and Chlamydia trachomatis did not substantially induce IFN-lambda. We also found that IFN-lambda genes were up-regulated in A549 lung epithelial cells infected with Mycobacterium tuberculosis and in HepG2 hepatocytes and BeWo trophoblastic cells infected with L. monocytogenes. In a humanized mouse line permissive to fetoplacental listeriosis, IFN-lambda 2/lambda 3 mRNA levels were enhanced in placentas infected with L. monocytogenes. In addition, the feto-placental tissue was responsive to IFN-lambda 2. Together, these results suggest that IFN-lambda may be an important modulator of the immune response to Gram-positive intracellular bacteria in epithelial tissues.	[Bierne, Helene; Lebreton, Alice; Paliwal, Anupam; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France; [Bierne, Helene; Lebreton, Alice; Paliwal, Anupam; Cossart, Pascale] INSERM, U604, Paris, France; [Bierne, Helene; Lebreton, Alice; Paliwal, Anupam; Cossart, Pascale] INRA, USC2020, Paris, France; [Travier, Laetitia; Lecuit, Marc] Inst Pasteur, Grp Microorganismes & Barriere Hote, Paris, France; [Travier, Laetitia; Lecuit, Marc] INSERM, Avenir U604, Paris, France; [Mahlakoiv, Tanel; Staeheli, Peter] Univ Freiburg, Dept Virol, D-79106 Freiburg, Germany; [Mahlakoiv, Tanel] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Tailleux, Ludovic; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Subtil, Agathe] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France; [Lecuit, Marc] Univ Paris 05, Hop Necker Enfants Malades, Serv Malad Infect & Trop, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Freiburg; University of Freiburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bierne, H (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France.	hbierne@pasteur.fr	Lecuit, Marc/M-4126-2019; Lebreton, Alice/M-8764-2015; Subtil, Agathe/C-7464-2017; Lecuit, Marc/J-4073-2013	Lecuit, Marc/0000-0002-4491-1063; Lebreton, Alice/0000-0002-6643-902X; Subtil, Agathe/0000-0002-7481-4846; Lecuit, Marc/0000-0002-4491-1063; Mahlakoiv, Tanel/0000-0001-9059-0486; Bierne, Helene/0000-0002-0525-0848; Tailleux, Ludovic/0000-0003-3931-1052	Institut Pasteur; Institut National de la Recherche Agronomique (AO blanc, MICA); Institut National de la Sante et de la Recherche Medicale; French National Research Agency [ANR 11 BSV3 003 01, EPILIS]; ERA-NET (Listress); French Ligue Nationale Contre le Cancer [LNCC RS10/75-76]; La Fondation Le Roch-Les Mousquetaires; Deutsche Forschungsgemeinschaft [SFB 620]	Institut Pasteur(European Commission); Institut National de la Recherche Agronomique (AO blanc, MICA); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency(French National Research Agency (ANR)); ERA-NET (Listress); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); La Fondation Le Roch-Les Mousquetaires; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Institut Pasteur, Institut National de la Recherche Agronomique (AO blanc 2011, MICA), Institut National de la Sante et de la Recherche Medicale, the French National Research Agency (ANR 11 BSV3 003 01, EPILIS), ERA-NET (Listress), the French Ligue Nationale Contre le Cancer (LNCC RS10/75-76), La Fondation Le Roch-Les Mousquetaires, and the Deutsche Forschungsgemeinschaft (SFB 620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Gallagher G, 2010, J INTERF CYTOK RES, V30, P603, DOI 10.1089/jir.2010.0081; Hamon M, 2012, TRENDS MICR IN PRESS; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Hess BJ, 2003, J SURG RES, V114, P42, DOI 10.1016/S0022-4804(03)00314-7; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lebreton A, 2012, VIRULENCE, V3, P87, DOI 10.4161/viru.3.1.18531; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Li Xianglu, 2009, Int J Microbiol, V2009, P753278, DOI 10.1155/2009/753278; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Nagarajan UM, 2011, CRIT REV IMMUNOL, V31, P459, DOI 10.1615/CritRevImmunol.v31.i6.20; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; Pietila TE, 2010, J LEUKOCYTE BIOL, V88, P665, DOI 10.1189/jlb.1009651; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Steen HC, 2010, J INTERF CYTOK RES, V30, P597, DOI 10.1089/jir.2010.0058; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Wolk K, 2010, J INTERF CYTOK RES, V30, P617, DOI 10.1089/jir.2010.0064	60	70	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39080	10.1371/journal.pone.0039080	http://dx.doi.org/10.1371/journal.pone.0039080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720036	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800042
J	Kar, S; Kavdia, M				Kar, Saptarshi; Kavdia, Mahendra			Local Oxidative and Nitrosative Stress Increases in the Microcirculation during Leukocytes-Endothelial Cell Interactions	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-TYROSINE NITRATION; CREMASTER MUSCLE ARTERIOLES; COMPUTATIONAL MODEL; MICROVESSEL PERMEABILITY; SUPEROXIDE-DISMUTASE; HUMAN NEUTROPHILS; NADPH OXIDASE; VASCULAR-PERMEABILITY; ISCHEMIA-REPERFUSION	Leukocyte-endothelial cell interactions and leukocyte activation are important factors for vascular diseases including nephropathy, retinopathy and angiopathy. In addition, endothelial cell dysfunction is reported in vascular disease condition. Endothelial dysfunction is characterized by increased superoxide (O-2(center dot-)) production from endothelium and reduction in NO bioavailability. Experimental studies have suggested a possible role for leukocyte-endothelial cell interaction in the vessel NO and peroxynitrite levels and their role in vascular disorders in the arterial side of microcirculation. However, anti-adhesion therapies for preventing leukocyte-endothelial cell interaction related vascular disorders showed limited success. The endothelial dysfunction related changes in vessel NO and peroxynitrite levels, leukocyte-endothelial cell interaction and leukocyte activation are not completely understood in vascular disorders. The objective of this study was to investigate the role of endothelial dysfunction extent, leukocyte-endothelial interaction, leukocyte activation and superoxide dismutase therapy on the transport and interactions of NO, O-2(center dot-) and peroxynitrite in the microcirculation. We developed a biotransport model of NO, O-2(center dot-) and peroxynitrite in the arteriolar microcirculation and incorporated leukocytes-endothelial cell interactions. The concentration profiles of NO, O-2(center dot-) and peroxynitrite within blood vessel and leukocytes are presented at multiple levels of endothelial oxidative stress with leukocyte activation and increased superoxide dismutase accounted for in certain cases. The results showed that the maximum concentrations of NO decreased similar to 0.6 fold, O-2(center dot-) increased similar to 27 fold and peroxynitrite increased similar to 30 fold in the endothelial and smooth muscle region in severe oxidative stress condition as compared to that of normal physiologic conditions. The results show that the onset of endothelial oxidative stress can cause an increase in O-2(center dot-) and peroxynitrite concentration in the lumen. The increased O-2(center dot-) and peroxynitrite can cause leukocytes priming through peroxynitrite and leukocytes activation through secondary stimuli of O-2(center dot-) in bloodstream without endothelial interaction. This finding supports that leukocyte rolling/adhesion and activation are independent events.	[Kar, Saptarshi; Kavdia, Mahendra] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA	Wayne State University	Kar, S (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	s.kar@wayne.edu	Kar, Saptarshi/H-5166-2014	Kar, Saptarshi/0000-0002-3788-372X	National Institute of Health [NIH R01 HL084337]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084337] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institute of Health grant NIH R01 HL084337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Nabah YN, 2005, MICROCIRCULATION, V12, P443, DOI 10.1080/10739680590960962; Adrie C, 2000, AM J PHYSIOL-CELL PH, V279, pC452, DOI 10.1152/ajpcell.2000.279.2.C452; Akamine EH, 2006, J VASC RES, V43, P309, DOI 10.1159/000093196; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BELLAVITE P, 1988, FREE RADICAL BIO MED, V4, P225, DOI 10.1016/0891-5849(88)90044-5; Bertuglia S, 2003, AM J PHYSIOL-HEART C, V285, pH1064, DOI 10.1152/ajpheart.00124.2003; Buerk DG, 2003, FREE RADICAL BIO MED, V34, P1488, DOI 10.1016/S0891-5849(03)00178-3; Casillan AJ, 2003, J APPL PHYSIOL, V94, P2313, DOI 10.1152/japplphysiol.00047.2002; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Chen XW, 2006, J APPL PHYSIOL, V100, P482, DOI 10.1152/japplphysiol.00633.2005; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; COULTER NA, 1949, AM J PHYSIOL, V159, P401, DOI 10.1152/ajplegacy.1949.159.2.401; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Damiano ER, 1996, CIRC RES, V79, P1122, DOI 10.1161/01.RES.79.6.1122; Deonikar P, 2010, MICROVASC RES, V80, P464, DOI 10.1016/j.mvr.2010.09.004; Deonikar P, 2010, ANN BIOMED ENG, V38, P357, DOI 10.1007/s10439-009-9823-x; El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861; ELLSWORTH ML, 1988, MICROVASC RES, V35, P341, DOI 10.1016/0026-2862(88)90089-1; Feng L, 2011, J SURG RES, V166, P298, DOI 10.1016/j.jss.2009.04.005; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Frisbee JC, 2001, AM J PHYSIOL-HEART C, V281, pH1304, DOI 10.1152/ajpheart.2001.281.3.H1304; Fuhrman B, 2004, FREE RADICAL BIO MED, V37, P259, DOI 10.1016/j.freeradbiomed.2004.04.026; Gagnon C, 1998, FEBS LETT, V431, P107, DOI 10.1016/S0014-5793(98)00741-8; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Gujral JS, 2004, AM J PHYSIOL-GASTR L, V287, pG243, DOI 10.1152/ajpgi.00287.2003; Gupte S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011800; Hayashi T, 2007, BBA-MOL BASIS DIS, V1772, P364, DOI 10.1016/j.bbadis.2006.11.011; He PN, 2006, AM J PHYSIOL-HEART C, V291, pH591, DOI 10.1152/ajpheart.01228.2005; He PN, 2010, CARDIOVASC RES, V87, P281, DOI 10.1093/cvr/cvq140; Hink U, 2001, CIRC RES, V88, pE14; Huang J, 2008, J VASC SURG, V47, P599, DOI 10.1016/j.jvs.2007.11.006; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Jariyapongskul A, 2006, CLIN HEMORHEOL MICRO, V34, P283; Jebelovszki E, 2008, AM J PHYSIOL-HEART C, V294, pH2558, DOI 10.1152/ajpheart.01198.2007; Julius U, 2009, EXP CLIN ENDOCR DIAB, V117, P72, DOI 10.1055/s-2008-1078710; Kar S, 2011, FREE RADICAL BIO MED, V51, P1411, DOI 10.1016/j.freeradbiomed.2011.06.009; Kaul DK, 2004, AM J PHYSIOL-HEART C, V287, pH293, DOI 10.1152/ajpheart.01150.2003; Kavdia M, 2006, AM J PHYSIOL-HEART C, V290, pH716, DOI 10.1152/ajpheart.00776.2005; Kavdia M, 2004, J APPL PHYSIOL, V97, P293, DOI 10.1152/japplphysiol.00049.2004; Kavdia M, 2003, MICROVASC RES, V66, P49, DOI 10.1016/S0026-2862(03)00008-6; Kavdia M, 2002, AM J PHYSIOL-HEART C, V282, pH2245, DOI 10.1152/ajpheart.00972.2001; Kavdia M, 2006, ANTIOXID REDOX SIGN, V8, P1103, DOI 10.1089/ars.2006.8.1103; KUBES P, 1990, AM J PHYSIOL, V259, pG859, DOI 10.1152/ajpgi.1990.259.5.G859; Kubes P, 2001, NEWS PHYSIOL SCI, V16, P76; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; Liu PT, 1998, J PHARMACOL EXP THER, V284, P1139; Lu JJ, 2011, ANTIOXID REDOX SIGN, V15, P2301, DOI 10.1089/ars.2010.3792; Lyczkowski RW, 2009, ANN BIOMED ENG, V37, P1516, DOI 10.1007/s10439-009-9729-7; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Mastej K, 2008, ACTA DIABETOL, V45, P183, DOI 10.1007/s00592-008-0040-0; MUROHARA T, 1994, ARTERIOSCLER THROMB, V14, P1509, DOI 10.1161/01.ATV.14.9.1509; Nagaoka T, 2008, INVEST OPHTH VIS SCI, V49, P2053, DOI 10.1167/iovs.07-1387; Nalwaya N, 2004, J THEOR BIOL, V226, P409, DOI 10.1016/j.jtbi.2003.09.015; Nalwaya N, 2003, CHEM RES TOXICOL, V16, P920, DOI 10.1021/tx025664w; Okamoto E, 2001, CIRCULATION, V104, P2228, DOI 10.1161/hc4301.097195; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paolocci N, 2001, J MOL CELL CARDIOL, V33, P671, DOI 10.1006/jmcc.2000.1334; Pfeiffer S, 2002, FASEB J, V16, P1854, DOI 10.1096/fj.02-0953lte; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Potdar S, 2009, MICROVASC RES, V78, P191, DOI 10.1016/j.mvr.2009.04.001; Rohn TT, 1999, J LEUKOCYTE BIOL, V65, P59, DOI 10.1002/jlb.65.1.59; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; Segui J, 2005, INFLAMM BOWEL DIS, V11, P872, DOI 10.1097/01.MIB.0000183420.25186.7a; Steiner L, 1997, DIABETOLOGIA, V40, P150, DOI 10.1007/s001250050656; SUEMATSU M, 1994, AM J PHYSIOL, V266, pH2410, DOI 10.1152/ajpheart.1994.266.6.H2410; Sumagin R, 2008, AM J PHYSIOL-HEART C, V295, pH969, DOI 10.1152/ajpheart.00400.2008; Sumagin R, 2007, AM J PHYSIOL-HEART C, V293, pH2786, DOI 10.1152/ajpheart.00720.2007; Sumagin R, 2006, AM J PHYSIOL-HEART C, V291, pH2116, DOI 10.1152/ajpheart.00248.2006; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Thorlacius H, 1997, AM J PHYSIOL-HEART C, V272, pH1725, DOI 10.1152/ajpheart.1997.272.4.H1725; TINGBEALL HP, 1993, BLOOD, V81, P2774; Tsukimori K, 2005, HYPERTENSION, V46, P696, DOI 10.1161/01.HYP.0000184197.11226.71; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705; VEDDER NB, 1990, P NATL ACAD SCI USA, V87, P2643, DOI 10.1073/pnas.87.7.2643; Wang Q, 2000, J IMMUNOL, V164, P6487, DOI 10.4049/jimmunol.164.12.6487; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479; Yang H, 2009, ATHEROSCLEROSIS, V207, P51, DOI 10.1016/j.atherosclerosis.2009.03.052; Zeng M, 2002, AM J PHYSIOL-HEART C, V283, pH2420, DOI 10.1152/ajpheart.00787.2001; Zhang CH, 2006, J MOL CELL CARDIOL, V40, P247, DOI 10.1016/j.yjmcc.2005.11.010; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH1331, DOI 10.1152/ajpheart.00802.2004; ZIMMERLI W, 1986, J CLIN INVEST, V77, P925, DOI 10.1172/JCI112391; Zou MH, 2007, PROSTAG OTH LIPID M, V82, P119, DOI 10.1016/j.prostaglandins.2006.05.005	89	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38912	10.1371/journal.pone.0038912	http://dx.doi.org/10.1371/journal.pone.0038912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719984	gold, Green Submitted, Green Published			2022-12-27	WOS:000305347800026
J	Noblanc, A; Peltier, M; Damon-Soubeyrand, C; Kerchkove, N; Chabory, E; Vernet, P; Saez, F; Cadet, R; Janny, L; Pons-Rejraji, H; Conrad, M; Drevet, JR; Kocer, A				Noblanc, Anais; Peltier, Manon; Damon-Soubeyrand, Christelle; Kerchkove, Nicolas; Chabory, Eleonore; Vernet, Patrick; Saez, Fabrice; Cadet, Remi; Janny, Laurent; Pons-Rejraji, Hanae; Conrad, Marcus; Drevet, Joel R.; Kocer, Ayhan			Epididymis Response Partly Compensates for Spermatozoa Oxidative Defects in snGPx4 and GPx5 Double Mutant Mice	PLOS ONE			English	Article							SPERM DNA INTEGRITY; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; DAMAGE; THIOREDOXIN; FRAGMENTATION; SUPPRESSION; PROTAMINES; EXPRESSION; MECHANISM; ENZYMES	We report here that spermatozoa of mice lacking both the sperm nucleaus glutathione peroxidase 4 (snGPx4) and the epididymal glutathione peroxidase 5 (GPx5) activities display sperm nucleus structural abnormalities including delayed and defective nuclear compaction, nuclear instability and DNA damage. We show that to counteract the GPx activity losses, the epididymis of the double KO animals mounted an antioxydant response resulting in a strong increase in the global H2O2-scavenger activity especially in the cauda epididymis. Quantitative RT-PCR data show that together with the up-regulation of epididymal scavengers (of the thioredoxin/peroxiredoxin system as well as glutathione-S-transferases) the epididymis of double mutant animals increased the expression of several disulfide isomerases in an attempt to recover normal disulfide-bridging activity. Despite these compensatory mechanisms cauda-stored spermatozoa of double mutant animals show high levels of DNA oxidation, increased fragmentation and greater susceptibility to nuclear decondensation. Nevertheless, the enzymatic epididymal salvage response is sufficient to maintain full fertility of double KO males whatever their age, crossed with young WT female mice.	[Noblanc, Anais; Damon-Soubeyrand, Christelle; Kerchkove, Nicolas; Vernet, Patrick; Saez, Fabrice; Cadet, Remi; Janny, Laurent; Pons-Rejraji, Hanae; Drevet, Joel R.; Kocer, Ayhan] Clermont Univ, INSERM, CNRS, Genet Reprod & Dev Lab,UMR 6293,U1103, Aubiere, France; [Peltier, Manon] Inst Curie, Paris, France; [Chabory, Eleonore] Hop Porte Madeleine Orleans, Dept Obstet Gynecol, Lab Assistance Med Procreat, Orleans, France; [Janny, Laurent; Pons-Rejraji, Hanae] CHU Estaing, Clermont Ferrand, France; [Conrad, Marcus] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Munich, Germany; [Conrad, Marcus] German Ctr Neurodegenerat Dis, Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU Clermont Ferrand; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Noblanc, A (corresponding author), Clermont Univ, INSERM, CNRS, Genet Reprod & Dev Lab,UMR 6293,U1103, Aubiere, France.	joel.drevet@univ-bpclermont.fr	Kocer, Ayhan/N-7927-2014; VERNET, Patrick/F-1681-2018; Conrad, Marcus/E-8792-2015; Drevet, Joël/W-2692-2019; PONS, HANAE/X-8673-2019	VERNET, Patrick/0000-0003-0170-7545; Conrad, Marcus/0000-0003-1140-5612; Drevet, Joël/0000-0003-3077-6558; PONS, HANAE/0000-0002-9779-9693	CNRS; INSERM; French Ministry of Higher Education	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Higher Education	Institutional funding from the CNRS, the INSERM and The French Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Aoki VW, 2005, J ANDROL, V26, P741, DOI 10.2164/jandrol.05063; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Balhorn R, 2001, BIOCHEMISTRY-US, V30, P175; Bartoov B, 2003, FERTIL STERIL, V80, P1413, DOI 10.1016/j.fertnstert.2003.05.016; BEDFORD JM, 1974, J EXP ZOOL, V188, P137, DOI 10.1002/jez.1401880203; Berggren MI, 2001, ARCH BIOCHEM BIOPHYS, V392, P103, DOI 10.1006/abbi.2001.2435; Calvin H. I, 1971, Journal Reprod Fertil, VNo. 13, P65; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cocuzza Marcello, 2007, Int. braz j urol., V33, P603, DOI 10.1590/S1677-55382007000500002; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Fernandez JL, 2003, J ANDROL, V24, P59; Flohe L, 2011, ANTIOXID REDOX SIGN, V15, P763, DOI 10.1089/ars.2010.3397; Golan R, 1996, HUM REPROD, V11, P1457; Herbette S, 2002, EUR J BIOCHEM, V269, P2414, DOI 10.1046/j.1432-1033.2002.02905.x; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; HUANG HFS, 1984, J REPROD FERTIL, V70, P31, DOI 10.1530/jrf.0.0700031; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Kodama H, 1997, FERTIL STERIL, V68, P519, DOI 10.1016/S0015-0282(97)00236-7; Lee W, 2007, MOL VIS, V13, P1469; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; Marchesi DE, 2007, ARCH ANDROLOGY, V53, P239, DOI 10.1080/01485010701569858; Meseguer M, 2011, FERTIL STERIL, V95, P124, DOI 10.1016/j.fertnstert.2010.05.055; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Montiel EE, 2003, ARCH ANDROLOGY, V49, P95, DOI 10.1080/01485010390129296; Noblanc A, 2011, J ANDROL, V32, P641, DOI 10.2164/jandrol.110.012823; O'Brien J, 2005, UROLOGY, V65, P16, DOI 10.1016/j.urology.2004.07.015; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; Puglisi R, 2012, J CELL PHYSIOL, V227, P1420, DOI 10.1002/jcp.22857; Quan X, 2011, FEBS LETT, V585, P3436, DOI 10.1016/j.febslet.2011.09.035; Sakkas D, 2009, FERTIL STERIL, V93, P1027; Satake N, 2006, J EXP BIOL, V209, P1560, DOI 10.1242/jeb.02136; SELIGMAN J, 1994, J REPROD FERTIL, V101, P435; SHALGI R, 1989, BIOL REPROD, V40, P1037, DOI 10.1095/biolreprod40.5.1037; Simon L, 2011, REPROD BIOMED ONLINE, V23, P724, DOI 10.1016/j.rbmo.2011.08.010; Simon L, 2010, HUM REPROD, V25, P1594, DOI 10.1093/humrep/deq103; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Speyer BE, 2010, HUM REPROD, V25, P1609, DOI 10.1093/humrep/deq116; Tesarik J, 2004, HUM REPROD, V19, P611, DOI 10.1093/humrep/deh127; Tesarik J, 2006, REPROD BIOMED ONLINE, V12, P715, DOI 10.1016/S1472-6483(10)61083-8; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yeung CH, 2006, MOL CELL ENDOCRINOL, V250, P98, DOI 10.1016/j.mce.2005.12.030; Zini A, 2001, FERTIL STERIL, V75, P674, DOI 10.1016/S0015-0282(00)01796-9; Zini A, 2006, CURR OPIN UROL, V16, P428, DOI 10.1097/01.mou.0000250283.75484.dd; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	49	32	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38565	10.1371/journal.pone.0038565	http://dx.doi.org/10.1371/journal.pone.0038565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719900	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347800008
J	Xie, JY; Kiryluk, K; Wang, WM; Wang, ZH; Guo, SM; Shen, PY; Ren, H; Pan, XX; Chen, XN; Zhang, W; Li, X; Shi, H; Li, YF; Gharavi, AG; Chen, N				Xie, Jingyuan; Kiryluk, Krzysztof; Wang, Weiming; Wang, Zhaohui; Guo, Shanmai; Shen, Pingyan; Ren, Hong; Pan, Xiaoxia; Chen, Xiaonong; Zhang, Wen; Li, Xiao; Shi, Hao; Li, Yifu; Gharavi, Ali G.; Chen, Nan			Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; IMMUNOGLOBULIN-A NEPHROPATHY; TERM-FOLLOW-UP; NATURAL-HISTORY; ASSOCIATION; PROGNOSIS; CHINESE	IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this study, based on a large cohort of Chinese patients with IgAN, we aim to identify independent predictive factors associated with disease progression to ESRD. We collected retrospective clinical data and renal outcomes on 619 biopsy-diagnosed IgAN patients with a mean follow-up time of 41.3 months. In total, 67 individuals reached the study endpoint defined by occurrence of ESRD necessitating renal replacement therapy. In the fully adjusted Cox proportional hazards model, there were four baseline variables with a significant independent effect on the risk of ESRD. These included: eGFR [HR = 0.96(0.95-0.97)], serum albumin [HR = 0.47(0.32-0.68)], hemoglobin [HR = 0.79(0.72-0.88)], and SBP [HR = 1.02(1.00-1.03)]. Based on these observations, we developed a 4-variable equation of a clinical risk score for disease progression. Our risk score explained nearly 22% of the total variance in the primary outcome. Survival ROC curves revealed that the risk score provided improved prediction of ESRD at 24th, 60th and 120th month of follow-up compared to the three previously proposed risk scores. In summary, our data indicate that IgAN patients with higher systolic blood pressure, lower eGFR, hemoglobin, and albumin levels at baseline are at a greatest risk of progression to ESRD. The new progression risk score calculated based on these four baseline variables offers a simple clinical tool for risk stratification.	[Xie, Jingyuan; Wang, Weiming; Wang, Zhaohui; Guo, Shanmai; Shen, Pingyan; Ren, Hong; Pan, Xiaoxia; Chen, Xiaonong; Zhang, Wen; Li, Xiao; Shi, Hao; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China; [Xie, Jingyuan; Kiryluk, Krzysztof; Li, Yifu; Gharavi, Ali G.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY USA	Shanghai Jiao Tong University; Columbia University	Xie, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China.	ag2239@columbia.edu; cnrj100@126.com	xie, jing/GRY-1689-2022; Xie, Jingyuan/AAX-2708-2021	LI, YIFU/0000-0002-7077-7689	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517604]; National Natural Science Foundation of China [81000295]; Schrier Family Fellowship from the International Society of Nephrology (ISN); National Institutes of Health [K23DK090207]; Leading Academic Discipline Project of Shanghai Health Bureau [05III 001, 2003ZD002]; Shanghai Leading Academic Discipline Project [T0201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK090207] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Schrier Family Fellowship from the International Society of Nephrology (ISN); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leading Academic Discipline Project of Shanghai Health Bureau; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517604), the National Natural Science Foundation of China (No. 81000295). XJ is supported by the Schrier Family Fellowship from the International Society of Nephrology (ISN). KK is supported by the National Institutes of Health grant K23DK090207 (NIDDK). This work was also supported by the Leading Academic Discipline Project of Shanghai Health Bureau (05III 001 and 2003ZD002) and Shanghai Leading Academic Discipline Project (T0201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; DAMICO G, 1987, SEMIN NEPHROL, V7, P355; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Kaartinen K, 2008, NEPHROL DIAL TRANSPL, V23, P1285, DOI 10.1093/ndt/gfm782; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Leehey David J, 2005, BMC Nephrol, V6, P8, DOI 10.1186/1471-2369-6-8; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Li LS, 1996, KIDNEY INT, V49, P287, DOI 10.1038/ki.1996.41; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Lv JC, 2008, NEPHROLOGY, V13, P242, DOI 10.1111/j.1440-1797.2007.00898.x; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mackinnon B, 2008, NEPHRON CLIN PRACT, V109, pC148, DOI 10.1159/000145458; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; National Kidney Foundation, 2002, OFFICIAL J NATL KIDN, V39, pS1; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Staples AO, 2010, CLIN J AM SOC NEPHRO, V5, P2172, DOI 10.2215/CJN.07851109; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Therneau PGaT, 1994, BIOMETRIKA, V81, P11; Yokoyama H, 1997, DIABETOLOGIA, V40, P405, DOI 10.1007/s001250050694	38	86	104	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38904	10.1371/journal.pone.0038904	http://dx.doi.org/10.1371/journal.pone.0038904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719981	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800025
J	Lyon, C; Nehaniv, CL; Saunders, J				Lyon, Caroline; Nehaniv, Chrystopher L.; Saunders, Joe			Interactive Language Learning by Robots: The Transition from Babbling to Word Forms	PLOS ONE			English	Article							SOCIAL CONTINGENCY; SPEECH-PERCEPTION; ACQUISITION; INFANTS; DORSAL; SOUNDS; MEMORY	The advent of humanoid robots has enabled a new approach to investigating the acquisition of language, and we report on the development of robots able to acquire rudimentary linguistic skills. Our work focuses on early stages analogous to some characteristics of a human child of about 6 to 14 months, the transition from babbling to first word forms. We investigate one mechanism among many that may contribute to this process, a key factor being the sensitivity of learners to the statistical distribution of linguistic elements. As well as being necessary for learning word meanings, the acquisition of anchor word forms facilitates the segmentation of an acoustic stream through other mechanisms. In our experiments some salient one-syllable word forms are learnt by a humanoid robot in real-time interactions with naive participants. Words emerge from random syllabic babble through a learning process based on a dialogue between the robot and the human participant, whose speech is perceived by the robot as a stream of phonemes. Numerous ways of representing the speech as syllabic segments are possible. Furthermore, the pronunciation of many words in spontaneous speech is variable. However, in line with research elsewhere, we observe that salient content words are more likely than function words to have consistent canonical representations; thus their relative frequency increases, as does their influence on the learner. Variable pronunciation may contribute to early word form acquisition. The importance of contingent interaction in real-time between teacher and learner is reflected by a reinforcement process, with variable success. The examination of individual cases may be more informative than group results. Nevertheless, word forms are usually produced by the robot after a few minutes of dialogue, employing a simple, real-time, frequency dependent mechanism. This work shows the potential of human-robot interaction systems in studies of the dynamics of early language acquisition.	[Lyon, Caroline; Nehaniv, Chrystopher L.; Saunders, Joe] Univ Hertfordshire, Adapt Syst Res Grp, Hertford, England	University of Hertfordshire	Lyon, C (corresponding author), Univ Hertfordshire, Adapt Syst Res Grp, Hertford, England.	c.lyon@herts.ac.uk		Nehaniv, Chrystopher L./0000-0002-7807-1875	European Commission [FP7-214668]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by the European Commission under project grant FP7-214668 for ITALK: Integration and Transfer of Action and Language Knowledge in Robots. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, TALKING HEADS EXPT; [Anonymous], 1890, HISTORY; [Anonymous], 2009, 1 LANGUAGE ACQUISITI, DOI DOI 10.1017/CBO9780511806698; Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Bigelow AE, 2003, INFANCY, V4, P111, DOI 10.1207/S15327078IN0401_6; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Breazeal, 2002, DESIGNING SOCIABLE R; Brent M, BRENT CORPUS; Brent MR, 2001, COGNITION, V81, pB33, DOI 10.1016/S0010-0277(01)00122-6; Cairns P, 1997, COGNITIVE PSYCHOL, V33, P111, DOI 10.1006/cogp.1997.0649; Cangelosi A, 2010, IEEE T AUTON MENT DE, V2, P167, DOI 10.1109/TAMD.2010.2053034; Cangelosi A, 2010, PHYS LIFE REV, V7, P139, DOI 10.1016/j.plrev.2010.02.001; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Chomsky N, 1980, RULES REPRESENTATION; CMU, 2008, PRON DICT; Cunillera T, 2010, EXP PSYCHOL, V57, P134, DOI 10.1027/1618-3169/a000017; Daland R, 2011, COGNITIVE SCI, V35, P119, DOI 10.1111/j.1551-6709.2010.01160.x; de Boer B, 2000, J PHONETICS, V27, P1; de Boisson-Bardies B., 1999, LANGUAGE COMES CHILD; Dominey PF, 2004, IEEE-RAS INT C HUMAN, P168; Dominey PF, 2004, J NEUROLINGUIST, V17, P121, DOI 10.1016/S0911-6044(03)00056-3; Fernald A., 2006, HDB PSYCHOLINGUISTIC, P1027, DOI DOI 10.1016/B978-012369374-7/50028-6; Fischer K, 2011, INTERACT STUD, V12, P134, DOI 10.1075/is.12.1.06fis; Greenberg S, 1999, SPEECH COMMUN, V29, P159, DOI 10.1016/S0167-6393(99)00050-3; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Gupta P, 2009, PHILOS T R SOC B, V364, P3755, DOI 10.1098/rstb.2009.0132; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Hickok G, 2010, BRAIN LANG, V112, P1, DOI 10.1016/j.bandl.2009.10.006; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; ITALK, 2008, EU FRAM 7 PROJ INT; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lyon C, 2006, PLAGIARISM IS EASY A; Lyon C, 2009, IEEE T AUTON MENT DE, V1, P187, DOI 10.1109/TAMD.2009.2037731; MacWhinney B, 2010, J CHILD LANG, V37, P477, DOI 10.1017/S0305000910000139; Manning C. D., 2001, FDN STAT NATURAL LAN; Monaghan P, 2010, J CHILD LANG, V37, P545, DOI 10.1017/S0305000909990511; Morse AF, 2010, P 2010 ANN M COGN SC, P1362; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Oudeyer P.-Y., 2006, SELF ORG EVOLUTION S; Oudeyer PY, 2001, LECT NOTES COMPUTER, V2130, P143; PIERREHUMBERT J, 1990, SYS DEV FDN, P271; Port R, 2007, NEW IDEAS PSYCHOL, V25, P143, DOI 10.1016/j.newideapsych.2007.02.001; Rothwell A., 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P86, DOI 10.1109/ALIFE.2011.5954641; Rytting CA, 2010, J CHILD LANG, V37, P513, DOI 10.1017/S0305000910000085; S Johansson, 1989, AAAI FALL S SERIES, P56; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Samuelson LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028095; Saunders J, 2011, ADV INTERACT STUD, V2, P211; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schutze H., 2008, INTRO INFORM RETRIEV, V39; SCRIBE, 2004, SCRIBE SPOKEN CORPUS; Steels L., 2001, EVOLUTION COMMUNICAT, V4, P3; Stilp CE, 2010, P NATL ACAD SCI USA, V107, P21914, DOI 10.1073/pnas.1009020107; Stoel-Gammon C, 2011, J CHILD LANG, V38, P1, DOI 10.1017/S0305000910000425; Tomasello M., 2003, CONSTRUCTING LANGUAG; Vihman M. M., 2002, MIRROR NEURONS EVOLU, P305, DOI DOI 10.1075/AICR.42; Vihman M. M., 1996, PHONOLOGICAL DEV ORI; Vihman MM, 2009, CAMB HB LANG LINGUIS, P163; VIHMAN MM, 1993, NATO ADV SCI INST SE, V69, P411; Werker JF, 2002, INFANT BEHAV DEV, V25, P121, DOI 10.1016/S0163-6383(02)00093-0; White AM, 2011, P IEEE S SECUR PRIV, P3, DOI 10.1109/SP.2011.34; Wittgenstein L., 2009, PHILOS INVESTIGATION, V4; Wrede B, 2010, J PRAGMATICS, V42, P2369, DOI 10.1016/j.pragma.2010.01.003; Wrede B, 2009, LECT NOTES ARTIF INT, V5436, P139, DOI 10.1007/978-3-642-00616-6_8; Yeung HH, 2009, COGNITION, V113, P234, DOI 10.1016/j.cognition.2009.08.010; Zue V. W., 1996, Recent research towards advanced man-machine interface through spoken language, P515, DOI 10.1016/B978-044481607-8/50088-8	72	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38236	10.1371/journal.pone.0038236	http://dx.doi.org/10.1371/journal.pone.0038236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719871	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900022
J	Beckett, EL; Phipps, S; Starkey, MR; Horvat, JC; Beagley, KW; Foster, PS; Hansbro, PM				Beckett, Emma L.; Phipps, Simon; Starkey, Malcolm R.; Horvat, Jay C.; Beagley, Kenneth W.; Foster, Paul S.; Hansbro, Philip M.			TLR2, but Not TLR4, Is Required for Effective Host Defence against Chlamydia Respiratory Tract Infection in Early Life	PLOS ONE			English	Article							ALLERGIC AIRWAYS DISEASE; MYELOID DENDRITIC CELLS; TRANSCUTANEOUS IMMUNIZATION; PNEUMONIAE INFECTION; MURIDARUM INFECTION; PROTECTIVE IMMUNITY; TH2 IMMUNITY; RECEPTOR; INDUCTION; ASTHMA	Chlamydia pneumoniae commonly causes respiratory tract infections in children, and epidemiological investigations strongly link infection to the pathogenesis of asthma. The immune system in early life is immature and may not respond appropriately to pathogens. Toll-like receptor (TLR)2 and 4 are regarded as the primary pattern recognition receptors that sense bacteria, however their contribution to innate and adaptive immunity in early life remains poorly defined. We investigated the role of TLR2 and 4 in the induction of immune responses to Chlamydia muridarum respiratory infection, in neonatal wild-type (Wt) or TLR2-deficient ((-/-)), 4(-/-) or 2/4(-/-) BALB/c mice. Wt mice had moderate disease and infection. TLR2(-/-) mice had more severe disease and more intense and prolonged infection compared to other groups. TLR4(-/-) mice were asymptomatic. TLR2/4(-/-) mice had severe early disease and persistent infection, which resolved thereafter consistent with the absence of symptoms in TLR4(-/-) mice. Wt mice mounted robust innate and adaptive responses with an influx of natural killer (NK) cells, neutrophils, myeloid (mDCs) and plasmacytoid (pDCs) dendritic cells, and activated CD4(+) and CD8(+) T-cells into the lungs. Wt mice also had effective production of interferon (IFN)gamma in the lymph nodes and lung, and proliferation of lymph node T-cells. TLR2(-/-) mice had more intense and persistent innate (particularly neutrophil) and adaptive cell responses and IL-17 expression in the lung, however IFN gamma responses and T-cell proliferation were reduced. TLR2/4(-/-) mice had reduced innate and adaptive responses. Most importantly, neutrophil phagocytosis was impaired in the absence of TLR2. Thus, TLR2 expression, particularly on neutrophils, is required for effective control of Chlamydia respiratory infection in early life. Loss of control of infection leads to enhanced but ineffective TLR4-mediated inflammatory responses that prolong disease symptoms. This indicates that TLR2 agonists may be beneficial in the treatment of early life Chlamydia infections and associated diseases.	[Beckett, Emma L.; Starkey, Malcolm R.; Horvat, Jay C.; Foster, Paul S.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Beckett, Emma L.; Starkey, Malcolm R.; Horvat, Jay C.; Foster, Paul S.; Hansbro, Philip M.] Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Phipps, Simon] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Phipps, Simon] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Queensland; University of Queensland; Queensland University of Technology (QUT)	Beckett, EL (corresponding author), Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia.	Paul.Foster@newcastle.edu.au; Philip.Hansbro@newcastle.edu.au	Phipps, Simon/F-9170-2010; Hansbro, Phil/G-7486-2013; Beagley, Kenneth/J-1129-2012; Beckett, Emma/AAU-8537-2021; Foster, Paul/G-5057-2013	Phipps, Simon/0000-0002-7388-3612; Hansbro, Phil/0000-0002-4741-3035; Beagley, Kenneth/0000-0003-3112-6557; Beckett, Emma/0000-0002-8888-3789; Starkey, Malcolm/0000-0002-7359-7464; , Paul/0000-0002-0827-8299; Horvat, Jay/0000-0002-8526-0631	National Health and Medical Research Council of Australia [569219]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants from the National Health and Medical Research Council of Australia (Grant #569219, http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins P, 2001, J IMMUNOL, V166, P918, DOI 10.4049/jimmunol.166.2.918; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Beagley KW, 2009, CRIT REV IMMUNOL, V29, P275, DOI 10.1615/CritRevImmunol.v29.i4.10; Belland RJ, 2004, CELL MICROBIOL, V6, P117, DOI 10.1046/j.1462-5822.2003.00352.x; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Blasi F, 2000, CURR OPIN INFECT DIS, V13, P161, DOI 10.1097/00001432-200004000-00011; Cheng CM, 2011, VACCINE, V29, P6641, DOI 10.1016/j.vaccine.2011.06.105; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Essilfie A, 2012, THORAX IN PRESS; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; Hansbro PM, 2011, BRIT J PHARMACOL, V163, P81, DOI 10.1111/j.1476-5381.2011.01219.x; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; He XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020846; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Jupelli M, 2008, J IMMUNOL, V180, P4148, DOI 10.4049/jimmunol.180.6.4148; Jupelli M, 2011, LAB INVEST, V91, P1530, DOI 10.1038/labinvest.2011.103; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kovarik J, 1998, IMMUNOL TODAY, V19, P150, DOI 10.1016/S0167-5699(97)01230-9; Lambrecht BN, 2001, EUR RESPIR J, V18, P692; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Oyoshi MK, 2007, IMMUNOLOGY, V120, P303, DOI 10.1111/j.1365-2567.2006.02499.x; Penttila JM, 1998, INFECT IMMUN, V66, P3290; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Principi Nicola, 2001, Clinical Infectious Diseases, V32, P1281, DOI 10.1086/319981; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rothfuchs AG, 2004, J IMMUNOL, V172, P2407, DOI 10.4049/jimmunol.172.4.2407; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Shin S, 2008, FASEB J, V22, P5; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Takenaka S, 2007, J IMMUNOL, V178, P7984, DOI 10.4049/jimmunol.178.12.7984; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Webley WC, 2009, EUR RESPIR J, V33, P360, DOI 10.1183/09031936.00019508; Webley WC, 2005, AM J RESP CRIT CARE, V171, P1083, DOI 10.1164/rccm.200407-917OC; Williams DM, 1997, INFECT IMMUN, V65, P2876, DOI 10.1128/IAI.65.7.2876-2882.1997; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	56	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39460	10.1371/journal.pone.0039460	http://dx.doi.org/10.1371/journal.pone.0039460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724018	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700081
J	Haring, R; Rosvall, M; Volker, U; Volzke, H; Kroemer, H; Nauck, M; Wallaschofski, H				Haring, Robin; Rosvall, Martin; Voelker, Uwe; Voelzke, Henry; Kroemer, Heyo; Nauck, Matthias; Wallaschofski, Henri			A Network-Based Approach to Visualize Prevalence and Progression of Metabolic Syndrome Components	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR EVENTS; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; SYNDROME CRITERIA; RISK-FACTORS; PRIME-TIME; MORTALITY; MEN; HEALTH; ASSOCIATION	Background: The additional clinical value of clustering cardiovascular risk factors to define the metabolic syndrome (MetS) is still under debate. However, it is unclear which cardiovascular risk factors tend to cluster predominately and how individual risk factor states change over time. Methods & Results: We used data from 3,187 individuals aged 20-79 years from the population-based Study of Health in Pomerania for a network-based approach to visualize clustered MetS risk factor states and their change over a five-year follow-up period. MetS was defined by harmonized Adult Treatment Panel III criteria, and each individual's risk factor burden was classified according to the five MetS components at baseline and follow-up. We used the map generator to depict 32 (2(5)) different states and highlight the most important transitions between the 1,024 (32(2)) possible states in the weighted directed network. At baseline, we found the largest fraction (19.3%) of all individuals free of any MetS risk factors and identified hypertension (15.4%) and central obesity (6.3%), as well as their combination (19.0%), as the most common MetS risk factors. Analyzing risk factor flow over the five-year follow-up, we found that most individuals remained in their risk factor state and that low high-density lipoprotein cholesterol (HDL) (6.3%) was the most prominent additional risk factor beyond hypertension and central obesity. Also among individuals without any MetS risk factor at baseline, low HDL (3.5%), hypertension (2.1%), and central obesity (1.6%) were the first risk factors to manifest during follow-up. Conclusions: We identified hypertension and central obesity as the predominant MetS risk factor cluster and low HDL concentrations as the most prominent new onset risk factor.	[Haring, Robin; Nauck, Matthias; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Rosvall, Martin] Umea Univ, Dept Phys, Umea, Sweden; [Voelker, Uwe] Univ Med Greifswald, Dept Funct Genom, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Kroemer, Heyo] Univ Med Greifswald, Inst Pharmacol, Greifswald, Germany	Greifswald Medical School; Umea University; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Haring, R (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	robin.haring@uni-greifswald.de	Rosvall, Martin/ABD-6411-2020; Wilkening, Robin/J-5535-2018; Rosvall, Martin/A-9488-2015	Wilkening, Robin/0000-0002-8332-5016; Rosvall, Martin/0000-0002-7181-9940; Volker, Uwe/0000-0002-5689-3448	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg, West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania [03IS2061A]; Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania, Germany; Swedish Research Council [2009-5344]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg, West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania, Germany; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Study of Health in Pomerania is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg, West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania (03IS2061A). This study was carried out in collaboration with the German Centre for Cardiovascular Research which is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania, Germany. MR was supported by Swedish Research Council grant 2009-5344. RH is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis. Furthermore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Borch-Johnsen K, 2010, DIABETOLOGIA, V53, P597, DOI 10.1007/s00125-010-1659-2; Chimonas T, 2010, METAB SYNDR RELAT D, V8, P523, DOI 10.1089/met.2010.0023; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Franco OH, 2009, CIRCULATION, V120, P1943, DOI 10.1161/CIRCULATIONAHA.109.855817; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hannemann A, 2011, EUR J ENDOCRINOL, V164, P751, DOI 10.1530/EJE-10-1074; Haring R, 2010, EXP CLIN ENDOCR DIAB, V118, P685, DOI 10.1055/s-0030-1261876; Haring R, 2012, OMICS, V16, P231, DOI 10.1089/omi.2011.0108; Haring R, 2011, EUR J CARDIOV PREV R, V18, P86, DOI 10.1097/HJR.0b013e32833c1a8d; Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Lidfeldt J, 2003, DIABETES OBES METAB, V5, P106, DOI 10.1046/j.1463-1326.2003.00250.x; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Nagaretani H, 2001, DIABETES CARE, V24, P2127, DOI 10.2337/diacare.24.12.2127; NAUCK M, 1995, CLIN CHEM, V41, P1761; Preiss D, 2009, DIABETIC MED, V26, P457, DOI 10.1111/j.1464-5491.2009.02717.x; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Qiao Q, 2009, STROKE, V40, P337, DOI 10.1161/STROKEAHA.108.518878; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Sattar N, 2008, INT J OBESITY, V32, pS30, DOI 10.1038/ijo.2008.33; Sattar N, 2005, EUR HEART J, V26, P1249, DOI 10.1093/eurheartj/ehi296; Schipf S, 2010, DIABETOL STOFFWECHS, V5, P161, DOI 10.1055/s-0030-1247406; Scuteri A, 2010, EUR HEART J, V31, P602, DOI 10.1093/eurheartj/ehp491; Scuteri A, 2009, J GERONTOL A-BIOL, V64, P590, DOI 10.1093/gerona/glp004; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Tuomilehto J, 2011, DIABETES CARE, V34, pS210, DOI 10.2337/dc11-s222; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	43	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39461	10.1371/journal.pone.0039461	http://dx.doi.org/10.1371/journal.pone.0039461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724019	gold, Green Published			2022-12-27	WOS:000305652700082
J	Laitinen, EM; Tommiska, J; Sane, T; Vaaralahti, K; Toppari, J; Raivio, T				Laitinen, Eeva-Maria; Tommiska, Johanna; Sane, Timo; Vaaralahti, Kirsi; Toppari, Jorma; Raivio, Taneli			Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations	PLOS ONE			English	Article							KALLMANN-SYNDROME; CHARGE SYNDROME; HORMONE RECEPTOR; LUTEINIZING-HORMONE; DELAYED PUBERTY; HOMOZYGOUS MUTATION; FERTILE EUNUCH; NEURAL CREST; GONADOTROPIN; TESTOSTERONE	Background: Congenital hypogonadotropic hypogonadism (HH) is a rare cause for delayed or absent puberty. These patients may recover from HH spontaneously in adulthood. To date, it is not possible to predict who will undergo HH reversal later in life. Herein we investigated whether Finnish patients with reversal of congenital hypogonadotropic hypogonadism (HH) have common phenotypic or genotypic features. Methods and Findings: Thirty-two male HH patients with anosmia/hyposmia (Kallmann Syndrome, KS; n = 26) or normal sense of smell (nHH; n = 6) were enrolled (age range, 18-61 yrs). The patients were clinically examined, and reversal of HH was assessed after treatment withdrawal. KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, WDR11, GNRHR, GNRH1, KISS1R, KISS1, TAC3, TACR3, and LH beta were screened for mutations. Six HH patients (2 KS, 4 nHH) were verified to have reversal of HH. In the majority of cases, reversal occurred early in adulthood (median age, 23 yrs; range, 21-39 yrs). All had spontaneous testicular growth while on testosterone replacement therapy (TRT). One nHH subject was restarted on TRT due to a decline in serum T. Two reversal variants had a same GNRHR mutation (R262Q), which was accompanied by another GNRHR mutation (R139H or del309F). In addition, both of the KS patients had a mutation in CHD7 (p.Q51X) or FGFR1 (c.91+2T>A). Conclusions: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.	[Laitinen, Eeva-Maria; Tommiska, Johanna; Vaaralahti, Kirsi; Raivio, Taneli] Univ Helsinki, Inst Biomed Physiol, Biomedicum Helsinki, Helsinki, Finland; [Tommiska, Johanna; Vaaralahti, Kirsi; Raivio, Taneli] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Sane, Timo] Univ Helsinki, Cent Hosp, Div Endocrinol, Dept Med, Helsinki, Finland; [Toppari, Jorma] Univ Turku, Dept Physiol, Turku, Finland; [Toppari, Jorma] Univ Turku, Dept Pediat, Turku, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku	Laitinen, EM (corresponding author), Univ Helsinki, Inst Biomed Physiol, Biomedicum Helsinki, Helsinki, Finland.	taneli.raivio@helsinki.fi		Raivio, Taneli/0000-0001-5385-434X; Tommiska, Johanna/0000-0001-7958-8262	Helsinki University Central Hospital; Academy of Finland; Sigrid Juselius Foundation; Foundation for Pediatric Research; Emil Aaltonen Foundation; Research Foundation of the University of Helsinki; Finnish Cultural Foundation	Helsinki University Central Hospital; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Foundation for Pediatric Research; Emil Aaltonen Foundation; Research Foundation of the University of Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by grants from the Helsinki University Central Hospital Research Funds, Academy of Finland, Sigrid Juselius Foundation, Foundation for Pediatric Research, Emil Aaltonen Foundation, Research Foundation of the University of Helsinki, and Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard C, 2009, NEW ENGL J MED, V361, P1856, DOI 10.1056/NEJMoa0805792; BAGATELL CJ, 1994, FERTIL STERIL, V61, P392; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; BAUMAN A, 1986, J ANDROL, V7, P224; Bergman JEH, 2011, J PEDIATR-US, V158, P474, DOI 10.1016/j.jpeds.2010.08.032; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Cariboni A, 2006, CELL MOL LIFE SCI, V63, P2512, DOI 10.1007/s00018-005-5604-3; Dauber A, 2010, PEDIATRICS, V126, pE1594, DOI 10.1542/peds.2010-0164; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dewailly D, 2002, FERTIL STERIL, V77, P1288, DOI 10.1016/S0015-0282(02)03102-3; Feret H, 2010, 60 ANN M AM SOC HUM; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Han TS, 2010, CLIN ENDOCRINOL, V72, P731, DOI 10.1111/j.1365-2265.2009.03746.x; Jongmans MCJ, 2009, CLIN GENET, V75, P65, DOI 10.1111/j.1399-0004.2008.01107.x; Kadva A, 1996, CLIN ENDOCRINOL, V44, P103, DOI 10.1046/j.1365-2265.1996.00650.x; Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005; Koenigkam-Santos M, 2011, NEUROENDOCRINOLOGY, V94, P209, DOI 10.1159/000328437; Laitinen EM, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-41; Layman WS, 2011, HUM MOL GENET, V20, P3138, DOI 10.1093/hmg/ddr216; Lin L, 2006, J CLIN ENDOCR METAB, V91, P5117, DOI 10.1210/jc.2006-0807; MATSUMOTO AM, 1990, J CLIN ENDOCR METAB, V70, P282, DOI 10.1210/jcem-70-1-282; Morelli A, 2009, J SEX MED, V6, P397, DOI 10.1111/j.1743-6109.2008.01084.x; Pinto G, 2005, J CLIN ENDOCR METAB, V90, P5621, DOI 10.1210/jc.2004-2474; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P1317, DOI 10.1210/jc.2004-1361; Pitteloud N, 2001, J CLIN ENDOCR METAB, V86, P2470, DOI 10.1210/jc.86.6.2470; Quinton R, 1999, CLIN ENDOCRINOL, V50, P481; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; Raivio T, 2009, J CLIN ENDOCR METAB, V94, P4380, DOI 10.1210/jc.2009-0179; Rezvani I., 1975, PAEDIAT RES, V9, P224; Ribeiro RS, 2007, EUR J ENDOCRINOL, V156, P285, DOI 10.1530/eje.1.02342; ROGOL AD, 1980, J CLIN ENDOCR METAB, V51, P275, DOI 10.1210/jcem-51-2-275; ROWE RC, 1983, FERTIL STERIL, V40, P400; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sinisi AA, 2008, HUM REPROD, V23, P2380, DOI 10.1093/humrep/den247; Teixeira L, 2010, J CLIN INVEST, V120, P3668, DOI 10.1172/JCI43699; Vaaralahti K, 2011, FERTIL STERIL, V95, P2756, DOI 10.1016/j.fertnstert.2010.12.059; Wortsman J, 1996, AM J MED SCI, V311, P135, DOI 10.1097/00000441-199603000-00005; Zenaty D, 2006, MOL CELL ENDOCRINOL, V254, P78, DOI 10.1016/j.mce.2006.04.006	40	50	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39450	10.1371/journal.pone.0039450	http://dx.doi.org/10.1371/journal.pone.0039450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724017	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700080
J	Calahorro, F; Ruiz-Rubio, M				Calahorro, Fernando; Ruiz-Rubio, Manuel			Functional Phenotypic Rescue of Caenorhabditis elegans Neuroligin-Deficient Mutants by the Human and Rat NLGN1 Genes	PLOS ONE			English	Article							SWISS-MODEL; C. ELEGANS; TOUCH SENSITIVITY; PROTEIN; AUTISM; NEUREXIN; EXPRESSION; COMPLEX; SYNAPSE; INTERFERENCE	Neuroligins are cell adhesion proteins that interact with neurexins at the synapse. This interaction may contribute to differentiation, plasticity and specificity of synapses. In humans, single mutations in neuroligin encoding genes lead to autism spectrum disorder and/or mental retardation. Caenorhabditis elegans mutants deficient in nlg-1, an orthologue of human neuroligin genes, have defects in different behaviors. Here we show that the expression of human NLGN1 or rat Nlgn1 cDNAs in C. elegans nlg-1 mutants rescues the fructose osmotic strength avoidance and gentle touch response phenotypes. Two specific point mutations in NLGN3 and NLGN4 genes, involved in autistic spectrum disorder, were further characterized in this experimental system. The R451C allele described in NLGN3, was analyzed with both human NLGN1 (R453C) and worm NLG-1 (R437C) proteins, and both were not functional in rescuing the osmotic avoidance behavior and the gentle touch response phenotype. The D396X allele described in NLGN4, which produces a truncated protein, was studied with human NLGN1 (D432X) and they did not rescue any of the behavioral phenotypes analyzed. In addition, RNAi feeding experiments measuring gentle touch response in wild type strain and worms expressing SID-1 in neurons (which increases the response to dsRNA), both fed with bacteria expressing dsRNA for nlg-1, provided evidence for a postsynaptic in vivo function of neuroligins both in muscle cells and neurons, equivalent to that proposed in mammals. This finding was further confirmed generating transgenic nlg-1 deficient mutants expressing NLG-1 under pan-neuronal (nrx-1) or pan-muscular (myo-3) specific promoters. All these results suggest that the nematode could be used as an in vivo model for studying particular synaptic mechanisms with proteins orthologues of humans involved in pervasive developmental disorders.	[Calahorro, Fernando; Ruiz-Rubio, Manuel] Univ Cordoba, Fac Ciencias, Dept Genet, E-14004 Cordoba, Spain; [Calahorro, Fernando; Ruiz-Rubio, Manuel] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain	Universidad de Cordoba	Calahorro, F (corresponding author), Univ Cordoba, Fac Ciencias, Dept Genet, E-14004 Cordoba, Spain.	ge1rurum@uco.es	Ruiz-Rubio, Manuel/K-5591-2014; Calahorro, Fernando/H-3294-2013	Ruiz-Rubio, Manuel/0000-0001-8733-4377; Alejandre Duran, Encarnacion/0000-0002-0476-3393	Consejeria de Salud, Junta de Andalucia Spain [PI0197]	Consejeria de Salud, Junta de Andalucia Spain(Junta de Andalucia)	The research work has been supported by grant number PI0197 to MRR from Consejeria de Salud, Junta de Andalucia Spain, http://www.juntadeandalucia.es/salud/sites/csalud/portal/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asikainen S, 2005, NEUROREPORT, V16, P1995, DOI 10.1097/00001756-200512190-00005; BARGMANN CI, 1990, COLD SH Q B, V55, P529; Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BRENNER S, 1974, GENETICS, V77, P71; Calahorro F, 2009, J VIS EXP, V34; Calahorro F, 2011, INVERTEBR NEUROSCI, V11, P73, DOI 10.1007/s10158-011-0126-1; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; CHALFIE M, 1985, J NEUROSCI, V5, P956; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; CULOTTI JG, 1978, GENETICS, V90, P243; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haklai-Topper L, 2011, GENE EXPR PATTERNS, V11, P144, DOI 10.1016/j.gep.2010.10.008; Hunter JW, 2010, DIS MODEL MECH, V3, P366, DOI 10.1242/dmm.003442; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shatsky M, 2002, PROTEINS, V48, P242, DOI 10.1002/prot.10100; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Talebizadeh Z, 2004, J AUTISM DEV DISORD, V34, P735, DOI 10.1007/s10803-004-5295-x; Teng MS, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-22; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39277	10.1371/journal.pone.0039277	http://dx.doi.org/10.1371/journal.pone.0039277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723984	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300125
J	Klimek, P; Hausmann, R; Thurner, S				Klimek, Peter; Hausmann, Ricardo; Thurner, Stefan			Empirical Confirmation of Creative Destruction from World Trade Data	PLOS ONE			English	Article								We show that world trade network datasets contain empirical evidence that the dynamics of innovation in the world economy indeed follows the concept of creative destruction, as proposed by J.A. Schumpeter more than half a century ago. National economies can be viewed as complex, evolving systems, driven by a stream of appearance and disappearance of goods and services. Products appear in bursts of creative cascades. We find that products systematically tend to co-appear, and that product appearances lead to massive disappearance events of existing products in the following years. The opposite-disappearances followed by periods of appearances-is not observed. This is an empirical validation of the dominance of cascading competitive replacement events on the scale of national economies, i.e., creative destruction. We find a tendency that more complex products drive out less complex ones, i.e., progress has a direction. Finally we show that the growth trajectory of a country's product output diversity can be understood by a recently proposed evolutionary model of Schumpeterian economic dynamics.	[Klimek, Peter; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria; [Hausmann, Ricardo] Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA; [Hausmann, Ricardo] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Hausmann, Ricardo; Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Thurner, Stefan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	Medical University of Vienna; Harvard University; Harvard University; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Klimek, P (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria.	stefan.thurner@meduniwien.ac.at	Klimek, Peter/AAC-2723-2019	Klimek, Peter/0000-0003-1187-6713	EU [288501]	EU(European Commission)	Funding was provided by EU FP7 project CRISIS, agreement no. 288501, homepage: http://cordis.europa.eu/fp7/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHION P, 1992, ECONOMETRICA, V60, P323, DOI 10.2307/2951599; Aghion P, 2008, TESTING CREATIVE DES; Bartelsmann EJ, 2004, MICROECONOMIC EVIDEN; Caballero RJ, 1996, Q J ECON, V111, P805, DOI 10.2307/2946673; Feenstra R. C., 2005, NBER WORKING PAPER S; GROSSMAN GM, 1991, REV ECON STUD, V58, P43, DOI 10.2307/2298044; Hanel R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036117; Hanel R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036110; Hausmann R., 2012, ATLAS EC COMPLEXITY; Hausmann R, 2007, J ECON GROWTH, V12, P1, DOI 10.1007/s10887-006-9009-4; Hausmann R, 2011, J ECON GROWTH, V16, P309, DOI 10.1007/s10887-011-9071-4; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Leamer EE, 1984, SOURCE COMP ADVANTAG; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; REBELO S, 1991, J POLIT ECON, V99, P500, DOI 10.1086/261764; ROMER PM, 1994, J ECON PERSPECT, V8, P3, DOI 10.1257/jep.8.1.3; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Schumpeter J. A., 1943, CAPITALISM SOCIALISM, DOI DOI 10.1007/s11135-015-0230-0; Thurner S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/075029; Tripsas M, 1997, STRATEGIC MANAGE J, V18, P119, DOI 10.1002/(SICI)1097-0266(199707)18:1+<119::AID-SMJ921>3.3.CO;2-S	21	28	30	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38924	10.1371/journal.pone.0038924	http://dx.doi.org/10.1371/journal.pone.0038924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22719989	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305583300066
J	Leversen, JSR; Haga, M; Sigmundsson, H				Leversen, Jonas S. R.; Haga, Monika; Sigmundsson, Hermundur			From Children to Adults: Motor Performance across the Life-Span	PLOS ONE			English	Article							GROUP SELECTION THEORY; BRAIN-DEVELOPMENT; PROCESSING-SPEED; WORKING-MEMORY; OLDER-ADULTS; AGE; CONNECTION	The life-span approach to development provides a theoretical framework to examine the general principles of life-long development. This study aims to investigate motor performance across the life span. It also aims to investigate if the correlations between motor tasks increase with aging. A cross-sectional design was used to describe the effects of aging on motor performance across age groups representing individuals from childhood to young adult to old age. Five different motor tasks were used to study changes in motor performance within 338 participants (7-79 yrs). Results showed that motor performance increases from childhood (7-9) to young adulthood (19-25) and decreases from young adulthood (19-25) to old age (66-80). These results are mirroring results from cognitive research. Correlation increased with increasing age between two fine motor tasks and two gross motor tasks. We suggest that the findings might be explained, in part, by the structural changes that have been reported to occur in the developing and aging brain and that the theory of Neural Darwinism can be used as a framework to explain why these changes occur.	[Leversen, Jonas S. R.; Sigmundsson, Hermundur] Norwegian Univ Sci & Technol, Dept Psychol, N-7034 Trondheim, Norway; [Haga, Monika] Sor Trondelag Univ Coll, Dept Physiotherapy, Fac Hlth & Social Work, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Leversen, JSR (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, N-7034 Trondheim, Norway.	hermundurs@svt.ntnu.no	Sigmundsson, Hermundur/R-7796-2019					Adler CH, 2002, PARKINSONISM RELAT D, V9, P103, DOI 10.1016/S1353-8020(02)00012-3; BALTES PB, 1987, DEV PSYCHOL, V23, P611, DOI 10.1037/0012-1649.23.5.611; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; CRAIK FIM, 1994, CURR DIR PSYCHOL SCI, V3, P155, DOI 10.1111/1467-8721.ep10770653; Edelman G.M., 1992, BRIGHT AIR BRILLIANT; Edelman GM, 1987, NEURAL DARWINISM THE; Escorial A, 2003, PERSONALITY INDIVIDU, V34, P1525; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Garrett HE, 1946, AM PSYCHOL, V1, P372, DOI 10.1037/h0056380; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gottlieb G, 2000, CURR DIR PSYCHOL SCI, V9, P93, DOI 10.1111/1467-8721.00068; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P707, DOI 10.1017/S0012162200001316; Hadders-Algra M, 2002, INFANT BEHAV DEV, V25, P433, DOI 10.1016/S0163-6383(02)00144-3; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P566, DOI 10.1017/S0012162200001067; Hadders-Algra Mijna, 2001, Neural Plasticity, V8, P31, DOI 10.1155/NP.2001.31; Haga M, 2008, CHILD CARE HLTH DEV, V34, P245, DOI 10.1111/j.1365-2214.2007.00793.x; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; Haywood K., 2020, HUMAN KINETICS; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Lindenberger U, 2001, PSYCHOL AGING, V16, P196, DOI 10.1037//0882-7974.16.2.196; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Miall RC, 2007, NAT NEUROSCI, V10, P940, DOI 10.1038/nn0807-940; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; PARKER H., 2002, DEV COORDINATION DIS, P235; Posthuma D, 2003, TWIN RES, V6, P131, DOI 10.1375/twin.6.2.131; Rabbitt P, 2007, NEUROPSYCHOLOGY, V21, P363, DOI 10.1037/0894-4105.21.3.363; Resnick SM, 2003, J NEUROSCI, V23, P3295; Revie G, 1993, ADAPT PHYS ACT Q, V10, P29, DOI DOI 10.1123/APAQ.10.1.29; Sachdev PS, 2005, J NEUROL NEUROSUR PS, V76, P362, DOI 10.1136/jnnp.2004.042945; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schaie K.W., 1993, CURR DIR PSYCHOL SCI, V2, P171, DOI DOI 10.1111/1467-8721.EP; Sigmundsson H, 2005, TEST MOTOR COM UNPUB; Smith CD, 1999, NEUROLOGY, V53, P1458, DOI 10.1212/WNL.53.7.1458; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Thelen E., 1994, DYNAMIC SYSTEMS APPR; THOMAS JR, 1987, PERCEPT MOTOR SKILL, V64, P503, DOI 10.2466/pms.1987.64.2.503; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; Ward NS, 2006, AGEING RES REV, V5, P239, DOI 10.1016/j.arr.2006.04.003	48	58	58	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38830	10.1371/journal.pone.0038830	http://dx.doi.org/10.1371/journal.pone.0038830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22719958	Green Published, gold			2022-12-27	WOS:000305583300058
J	Liu, B; Staron, M; Li, ZH				Liu, Bei; Staron, Matthew; Li, Zihai			Murine but Not Human Basophil Undergoes Cell-Specific Proteolysis of a Major Endoplasmic Reticulum Chaperone	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UNFOLDED PROTEIN RESPONSE; ANTIGEN-CAPTURING CELLS; MAST-CELL; SERINE-PROTEASE; B-CELLS; GP96; EXPRESSION; IMMUNITY; GRP94	Introduction: Basophil has been implicated in anti-parasite defense, allergy and in polarizing T(H)2 response. Mouse model has been commonly used to study basophil function although the difference between human and mouse basophils is underappreciated. As an essential chaperone for multiple Toll-like receptors and integrins in the endoplasmic reticulum, gp96 also participates in general protein homeostasis and in the ER unfolded protein response to ensure cell survival during stress. The roles of gp96 in basophil development are unknown. Methods: We genetically delete gp96 in mice and examined the expression of gp96 in basophils by Western blot and flow cytometry. We compared the expression pattern of gp96 between human and mouse basophils. Results: We found that gp96 was dispensable for murine basophil development. Moreover, gp96 was cleaved by serine protease(s) in murine but not human basophils leading to accumulation of a nun-functional N-terminal similar to 50 kDa fragment and striking induction of the unfolded protein response. The alteration of gp96 was unique to basophils and was not observed in any other cell types including mast cells. We also demonstrated that the ectopic expression of a mouse-specific tryptase mMCP11 does not lead to gp96 cleavage in human basophils. Conclusions: Our study revealed a remarkable biochemical event of gp96 silencing in murine but not human basophils, highlighting the need for caution in using mouse models to infer the function of basophils in human immune response. Our study also reveals a novel mechanism of shutting down gp96 post-translationally in regulating its function.	[Liu, Bei; Staron, Matthew; Li, Zihai] Med Univ S Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina	Liu, B (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA.	liube@musc.edu			National Institutes of Health [KL2 RR029880, AI070603, AI076468, HL097391]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000060] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (http://nih.gov) grant KL2 RR029880 (to B.L.), AI070603, AI076468, and HL097391 (to Z.L.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; Bieneman AP, 2005, J ALLERGY CLIN IMMUN, V115, P295, DOI 10.1016/j.jaci.2004.10.018; Chen TY, 2009, J FOOD DRUG ANAL, V17, P363; de Bruin EC, 2003, CELL DEATH DIFFER, V10, P1204, DOI 10.1038/sj.cdd.4401296; Falcone FH, 2000, BLOOD, V96, P4028; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hosoi T, 2007, EUR J PHARMACOL, V554, P8, DOI 10.1016/j.ejphar.2006.09.063; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Komiya A, 2006, INT ARCH ALLERGY IMM, V140, P23, DOI 10.1159/000092707; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; Lunderius C, 2001, IMMUNOGENETICS, V53, P225, DOI 10.1007/s002510100316; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Maquarre E, 2005, LEUKEMIA, V19, P2296, DOI 10.1038/sj.leu.2403944; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Nagasaka A, 2008, EUR J IMMUNOL, V38, P489, DOI 10.1002/eji.200737057; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; QU DF, 1994, DNA CELL BIOL, V13, P117, DOI 10.1089/dna.1994.13.117; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; VALENT P, 1989, BLOOD, V73, P1763; Vogen S, 2002, J BIOL CHEM, V277, P40742, DOI 10.1074/jbc.M205323200; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39442	10.1371/journal.pone.0039442	http://dx.doi.org/10.1371/journal.pone.0039442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724016	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300141
J	Peterson, SH; Lance, MM; Jeffries, SJ; Acevedo-Gutierrez, A				Peterson, Sarah H.; Lance, Monique M.; Jeffries, Steven J.; Acevedo-Gutierrez, Alejandro			Long Distance Movements and Disjunct Spatial Use of Harbor Seals (Phoca vitulina) in the Inland Waters of the Pacific Northwest	PLOS ONE			English	Article							FORAGING ACTIVITY; WASHINGTON-STATE; MARINE PREDATOR; ARGOS LOCATIONS; MORAY FIRTH; HOME-RANGE; GREY SEALS; RICHARDSI; ALASKA; OREGON	Background: Worldwide, adult harbor seals (Phoca vitulina) typically limit their movements and activity to <50 km from their primary haul-out site. As a result, the ecological impact of harbor seals is viewed as limited to relatively small spatial scales. Harbor seals in the Pacific Northwest are believed to remain <30 km from their primary haul-out site, one of several contributing factors to the current stock designation. However, movement patterns within the region are not well understood because previous studies have used radio-telemetry, which has range limitations. Our objective was to use satellite-telemetry to determine the regional spatial scale of movements. Methodology/Principal Findings: Satellite tags were deployed on 20 adult seals (n = 16 males and 4 females) from two rocky reefs and a mudflat-bay during April-May 2007. Standard filtering algorithms were used to remove outliers, resulting in an average (+/- SD) of 693 (+/- 377) locations per seal over 110 (+/- 32) days. A particle filter was implemented to interpolate locations temporally and decrease erroneous locations on land. Minimum over-water distances were calculated between filtered locations and each seal's capture site to show movement of seals over time relative to their capture site, and we estimated utilization distributions from kernel density analysis to reflect spatial use. Eight males moved > 100 km from their capture site at least once, two of which traveled round trip to and from the Pacific coast, a total distance >400 km. Disjunct spatial use patterns observed provide new insight into general harbor seal behavior. Conclusions/Significance: Long-distance movements and disjunct spatial use of adult harbor seals have not been reported for the study region and are rare worldwide in such a large proportion of tagged individuals. Thus, the ecological influence of individual seals may reach farther than previously assumed.	[Peterson, Sarah H.; Acevedo-Gutierrez, Alejandro] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Lance, Monique M.; Jeffries, Steven J.] Washington Dept Fish & Wildlife, Wildlife Sci Program, Lakewood, WA USA	Western Washington University; Washington Department of Fish & Wildlife (WDFW)	Peterson, SH (corresponding author), Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95064 USA.	saepeter@ucsc.edu		Peterson, Sarah/0000-0003-2773-3901; Acevedo-Gutierrez, Alejandro/0000-0002-9128-826X	National Science Foundation; Padilla Bay National Estuarine Research; Western Washington University BiologyDepartment; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	National Science Foundation(National Science Foundation (NSF)); Padilla Bay National Estuarine Research; Western Washington University BiologyDepartment; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	This project was supported in part by Award #0550443 from the National Science Foundation (http://www.nsf.gov/) (A.A.) and by funds from a Research Assistantship in Estuarine Science and Coastal Zone Management from the Padilla Bay National Estuarine Research Reserve (http://www.padillabay.gov/) (S.P.), a GK-12 Fellowship from the National Science Foundation (http://www.gk12.org/) (S.P.), the Western Washington University BiologyDepartment (http://www.biol.wwu.edu/biology/ (S.P.), the Office of Research for Sponsored Programs (http://www.wwu.edu/rsp/) (S.P.) and the Washington Department of Fish and Wildlife (http://wdfw.wa.gov) (S.J. and M.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SG, 1987, US DEP COMMERCE TECH, V5; Argos, 2007, US MAN; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bigg MA, 1969, HARBOUR SEAL BRIT CO; BROWN RF, 1983, FISH B-NOAA, V81, P291; Burg TM, 1999, CAN J ZOOL, V77, P930, DOI 10.1139/cjz-77-6-930; Cordes LS, 2011, ANIM CONSERV, V14, P430, DOI 10.1111/j.1469-1795.2011.00445.x; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Cottrell PE, 1995, DIET ACTIVITY BUDGET; Cunningham L, 2009, AQUAT CONSERV, V19, P398, DOI 10.1002/aqc.983; Duffy EJ, 2005, ESTUAR COAST SHELF S, V64, P94, DOI 10.1016/j.ecss.2005.02.009; Fowler SL, 2007, MAR MAMMAL SCI, V23, P598, DOI 10.1111/j.1748-7692.2007.00134.x; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Greig D.J., 2002, PREGNANCY PARTURITIO; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; Hauser Donna D. W., 2008, Aquatic Mammals, V34, P303, DOI 10.1578/AM.34.3.2008.303; Hay D. E., 1985, CANADIAN J FISHERIES, V42, ps111, DOI DOI 10.1139/F85-267; Herreman JK, 2009, CAN J ZOOL, V87, P498, DOI 10.1139/Z09-033; Huber HR, 2010, CAN J ZOOL, V88, P280, DOI 10.1139/Z09-141; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries S, 1986, SEASONAL MOVEMENTS P; Jeffries S. J., 2000, ATLAS SEAL SEA LION; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Johnson A, 2007, CAN J ZOOL, V85, P290, DOI 10.1139/Z06-213; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lamont MM, 1996, MAR MAMMAL SCI, V12, P402, DOI 10.1111/j.1748-7692.1996.tb00592.x; Lance M.M., 2007, TEMPORAL SPATIAL VAR; Lance MM, 2006, ESTIMATING IMPORTANC; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Lesage W, 2004, CAN J ZOOL, V82, P1070, DOI 10.1139/Z04-084; London JM, 2001, OBSERVATIONS HARBOR; Lowry LF, 2001, MAR MAMMAL SCI, V17, P835, DOI 10.1111/j.1748-7692.2001.tb01301.x; Luxa K, 2008, FOOD HABITS HARBOR S; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; McLanahan EC, 1984, RADIOBIOTELEMETRY IN; Orr AJ, 2004, FISH B-NOAA, V102, P108; Perry MJ, 2008, LIMNOL OCEANOGR, V53, P2169, DOI 10.4319/lo.2008.53.5_part_2.2169; Reuland K, 2008, SEASONAL VARIATION F; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Sackmann B, 2004, DEEP-SEA RES PT II, V51, P945, DOI 10.1016/j.dsr2.2003.09.004; Scheffer TH, 1944, AM MIDL NAT, V32, P373; Small RJ, 2005, MAR MAMMAL SCI, V21, P671, DOI 10.1111/j.1748-7692.2005.tb01259.x; STEWART BS, 1989, MAR MAMMAL SCI, V5, P361, DOI 10.1111/j.1748-7692.1989.tb00348.x; Suryan RM, 1998, MAR MAMMAL SCI, V14, P361, DOI 10.1111/j.1748-7692.1998.tb00728.x; TEMTE JL, 1991, J ZOOL, V224, P617, DOI 10.1111/j.1469-7998.1991.tb03790.x; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; THOMPSON PM, 1990, J APPL ECOL, V27, P492, DOI 10.2307/2404296; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Tougaard J, 2003, SATELLITE TRACKING H; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; WALKER BG, 1993, J ZOOL, V231, P423, DOI 10.1111/j.1469-7998.1993.tb01929.x; Wand MP., 1994, KERNEL SMOOTHING; Ward EJ, 2012, CONSERV LETT, V5, P37, DOI 10.1111/j.1755-263X.2011.00210.x; WILLIAMS TM, 1985, PHYSIOL ZOOL, V58, P576, DOI 10.1086/physzool.58.5.30158584; Wright BE, 2007, ECOL APPL, V17, P338, DOI 10.1890/05-1941	60	37	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39046	10.1371/journal.pone.0039046	http://dx.doi.org/10.1371/journal.pone.0039046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723925	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300083
J	Srinivasan, S; Hoffman, NG; Morgan, MT; Matsen, FA; Fiedler, TL; Hall, RW; Ross, FJ; McCoy, CO; Bumgarner, R; Marrazzo, JM; Fredricks, DN				Srinivasan, Sujatha; Hoffman, Noah G.; Morgan, Martin T.; Matsen, Frederick A.; Fiedler, Tina L.; Hall, Robert W.; Ross, Frederick J.; McCoy, Connor O.; Bumgarner, Roger; Marrazzo, Jeanne M.; Fredricks, David N.			Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; VAGINAL MICROBIOTA; DIVERSITY; IDENTIFICATION; ASSOCIATION; PREVALENCE; SAMPLES; COLONIZATION; SEQUENCES; INFERENCE	Background: Bacterial vaginosis (BV) is a common condition that is associated with numerous adverse health outcomes and is characterized by poorly understood changes in the vaginal microbiota. We sought to describe the composition and diversity of the vaginal bacterial biota in women with BV using deep sequencing of the 16S rRNA gene coupled with species-level taxonomic identification. We investigated the associations between the presence of individual bacterial species and clinical diagnostic characteristics of BV. Methodology/Principal Findings: Broad-range 16S rRNA gene PCR and pyrosequencing were performed on vaginal swabs from 220 women with and without BV. BV was assessed by Amsel's clinical criteria and confirmed by Gram stain. Taxonomic classification was performed using phylogenetic placement tools that assigned 99% of query sequence reads to the species level. Women with BV had heterogeneous vaginal bacterial communities that were usually not dominated by a single taxon. In the absence of BV, vaginal bacterial communities were dominated by either Lactobacillus crispatus or Lactobacillus iners. Leptotrichia amnionii and Eggerthella sp. were the only two BV-associated bacteria (BVABs) significantly associated with each of the four Amsel's criteria. Co-occurrence analysis revealed the presence of several sub-groups of BVABs suggesting metabolic co-dependencies. Greater abundance of several BVABs was observed in Black women without BV. Conclusions/Significance: The human vaginal bacterial biota is heterogeneous and marked by greater species richness and diversity in women with BV; no species is universally present. Different bacterial species have different associations with the four clinical criteria, which may account for discrepancies often observed between Amsel and Nugent (Gram stain) diagnostic criteria. Several BVABs exhibited race-dependent prevalence when analyzed in separate groups by BV status which may contribute to increased incidence of BV in Black women. Tools developed in this project can be used to study microbial ecology in diverse settings at high resolution.	[Srinivasan, Sujatha; Fiedler, Tina L.; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Morgan, Martin T.; Matsen, Frederick A.; Ross, Frederick J.; McCoy, Connor O.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hall, Robert W.; Bumgarner, Roger; Fredricks, David N.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Marrazzo, Jeanne M.; Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	ssriniva@fhcrc.org; dfredric@fhcrc.org	Bumgarner, Roger E/K-3531-2015; Bumgarner, Roger/AAA-6846-2020	Bumgarner, Roger E/0000-0002-8168-6985; Marrazzo, Jeanne/0000-0002-9277-7364; Morgan, Martin/0000-0002-5874-8148	National Institute of Allergy and Infectious Diseases (NIAID), division of National Institutes of Health (NIH) [R01 AI061628]; National Human Genome Research Institute (NHGRI), division of National Institutes of Health (NIH) [R01 HG005966-01]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), division of National Institutes of Health (NIH); National Human Genome Research Institute (NHGRI), division of National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded with grants R01 AI061628 to Dr. Fredricks from the National Institute of Allergy and Infectious Diseases (NIAID) (www3.niaid.nih.gov), division of National Institutes of Health (NIH) and R01 HG005966-01 to Dr. Fredricks (PI) and Dr. Matsen (co-PI) from the National Human Genome Research Institute (NHGRI) (www.genome.gov), division of National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Atassi F, 2010, FEMS MICROBIOL LETT, V304, P29, DOI 10.1111/j.1574-6968.2009.01887.x; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Evans SN, 2012, J ROYAL STA IN PRESS; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haggerty CL, 2004, CLIN INFECT DIS, V39, P990, DOI 10.1086/423963; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hastie T., 2009, UNSUPERVISED LEARNIN; Hay PE, 1998, J ANTIMICROB CHEMOTH, V41, P6, DOI 10.1093/jac/41.1.6; HILLIER SL, 1995, CLIN INFECT DIS, V20, pS276, DOI 10.1093/clinids/20.Supplement_2.S276; HILLIER SL, 1993, AM J OBSTET GYNECOL, V169, P455, DOI 10.1016/0002-9378(93)90340-O; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jackman S, 2011, PSCL CLASSES METHODS; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139; Matsen FA, 2011, EDGE PRINCIPAL COMPO; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Matu MN, 2010, ANAEROBE, V16, P210, DOI 10.1016/j.anaerobe.2009.11.002; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Peipert JF, 2008, SEX TRANSM DIS, V35, P363, DOI 10.1097/OLQ.0b013e31815e4179; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Regan JA, 1996, AM J OBSTET GYNECOL, V174, P1354, DOI 10.1016/S0002-9378(96)70684-1; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Spear GT, 2011, APPL ENVIRON MICROB, V77, P378, DOI 10.1128/AEM.00973-10; Srinivasan S., 2008, INTERDISCIP PERSPECT, V2008; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolrath H, 2001, J CLIN MICROBIOL, V39, P4026, DOI 10.1128/JCM.39.11.4026-4031.2001; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	75	385	409	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37818	10.1371/journal.pone.0037818	http://dx.doi.org/10.1371/journal.pone.0037818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719852	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300014
J	Grose, WE; Clark, KR; Griffin, D; Malik, V; Shontz, KM; Montgomery, CL; Lewis, S; Brown, RH; Janssen, PML; Mendell, JR; Rodino-Klapac, LR				Grose, William E.; Clark, K. Reed; Griffin, Danielle; Malik, Vinod; Shontz, Kimberly M.; Montgomery, Chrystal L.; Lewis, Sarah; Brown, Robert H., Jr.; Janssen, Paul M. L.; Mendell, Jerry R.; Rodino-Klapac, Louise R.			Homologous Recombination Mediates Functional Recovery of Dysferlin Deficiency following AAV5 Gene Transfer	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DEFECTIVE MEMBRANE REPAIR; SKELETAL-MUSCLE; PACKAGING CAPACITY; MIYOSHI MYOPATHY; EXPRESSION; MUTATIONS; THERAPY; MICE; MDX	The dysferlinopathies comprise a group of untreatable muscle disorders including limb girdle muscular dystrophy type 2B, Miyoshi myopathy, distal anterior compartment syndrome, and rigid spine syndrome. As with other forms of muscular dystrophy, adeno-associated virus (AAV) gene transfer is a particularly auspicious treatment strategy, however the size of the DYSF cDNA (6.5 kb) negates packaging into traditional AAV serotypes known to express well in muscle (i.e. rAAV1, 2, 6, 8, 9). Potential advantages of a full cDNA versus a mini-gene include: maintaining structural-functional protein domains, evading protein misfolding, and avoiding novel epitopes that could be immunogenic. AAV5 has demonstrated unique plasticity with regards to packaging capacity and recombination of virions containing homologous regions of cDNA inserts has been implicated in the generation of full-length transcripts. Herein we show for the first time in vivo that homologous recombination following AAV5. DYSF gene transfer leads to the production of full length transcript and protein. Moreover, gene transfer of full-length dysferlin protein in dysferlin deficient mice resulted in expression levels sufficient to correct functional deficits in the diaphragm and importantly in skeletal muscle membrane repair. Intravascular regional gene transfer through the femoral artery produced high levels of transduction and enabled targeting of specific muscle groups affected by the dysferlinopathies setting the stage for potential translation to clinical trials. We provide proof of principle that AAV5 mediated delivery of dysferlin is a highly promising strategy for treatment of dysferlinopathies and has far-reaching implications for the therapeutic delivery of other large genes.	[Grose, William E.; Clark, K. Reed; Griffin, Danielle; Malik, Vinod; Shontz, Kimberly M.; Montgomery, Chrystal L.; Lewis, Sarah; Mendell, Jerry R.; Rodino-Klapac, Louise R.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Mendell, Jerry R.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Janssen, Paul M. L.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Grose, William E.; Clark, K. Reed; Griffin, Danielle; Malik, Vinod; Shontz, Kimberly M.; Montgomery, Chrystal L.; Lewis, Sarah; Mendell, Jerry R.; Rodino-Klapac, Louise R.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Grose, WE (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.	Jerry.Mendell@nationwidechildrens.org; Louise.Rodino-Klapac@nationwidechildrens.org	Rodino-Klapac, Louise/E-3968-2011; Clark, Kelly/E-2900-2011; Janssen, Paul ML/E-3307-2011	Janssen, Paul/0000-0002-9682-3014; Rodino-Klapac, Louise/0000-0002-8966-5177	Day Foundation; MDA; Jesse's Journey Foundation for Gene and Cell Therapy; National Institutes of Health (NIH) [P30 NS045758]; National Center For Research Resources [UL1RR025755]; NIH [1F32AR055008]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR055008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758] Funding Source: NIH RePORTER	Day Foundation; MDA(Muscular Dystrophy Association); Jesse's Journey Foundation for Gene and Cell Therapy; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Day Foundation, MDA, and Jesse's Journey Foundation for Gene and Cell Therapy. The muscle physiology core is supported by National Institutes of Health (NIH) P30 NS045758. The project described was also supported by Award Number UL1RR025755 from the National Center For Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health. Dr. Rodino-Klapac was supported by an NIH sponsored NRSA Fellowship (1F32AR055008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Bushby K M D, 2003, Neuromuscul Disord, V13, P80, DOI 10.1016/S0960-8966(02)00183-9; Cenacchi G, 2005, J CLIN PATHOL, V58, P190, DOI 10.1136/jcp.2004.018978; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Duan DS, 2000, NAT MED, V6, P595, DOI 10.1038/75080; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Ghosh A, 2007, MOL THER, V15, P750, DOI 10.1038/sj.mt.6300081; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hermonat PL, 1997, FEBS LETT, V407, P78, DOI 10.1016/S0014-5793(97)00311-6; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Klinge L, 2008, NEUROMUSCULAR DISORD, V18, P288, DOI 10.1016/j.nmd.2008.01.004; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, GENOMICS, V49, P23, DOI 10.1006/geno.1998.5204; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Martin PT, 2009, AM J PHYSIOL-CELL PH, V296, pC476, DOI 10.1152/ajpcell.00456.2008; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732; Moore SA, 2006, J NEUROPATH EXP NEUR, V65, P995, DOI 10.1097/01.jnen.0000235854.77716.6c; Nagashima T, 2004, NEUROPATHOLOGY, V24, P341, DOI 10.1111/j.1440-1789.2004.00573.x; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Rafael-Fortney JA, 2011, CIRCULATION, V124, P582, DOI 10.1161/CIRCULATIONAHA.111.031716; Roche JA, 2011, J HISTOCHEM CYTOCHEM, V59, P964, DOI 10.1369/0022155411423274; Rodino-Klapac LR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-45; Rodino-Klapac LR, 2010, MOL THER, V18, P109, DOI 10.1038/mt.2009.254; Rosales XQ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-39; Rosales XQ, 2010, MUSCLE NERVE, V42, P14, DOI 10.1002/mus.21650; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Seror P, 2008, MUSCLE NERVE, V37, P410, DOI 10.1002/mus.20910; Takahashi T, 2003, NEUROLOGY, V60, P1799, DOI 10.1212/01.WNL.0000068333.43005.12; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; WELLS DJ, 1995, HUM MOL GENET, V4, P1245, DOI 10.1093/hmg/4.8.1245; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255	48	45	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39233	10.1371/journal.pone.0039233	http://dx.doi.org/10.1371/journal.pone.0039233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720081	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000052
J	States, JC; Singh, AV; Knudsen, TB; Rouchka, EC; Ngalame, NO; Arteel, GE; Piao, YL; Ko, MSH				States, J. Christopher; Singh, Amar V.; Knudsen, Thomas B.; Rouchka, Eric C.; Ngalame, Ntube O.; Arteel, Gavin E.; Piao, Yulan; Ko, Minoru S. H.			Prenatal Arsenic Exposure Alters Gene Expression in the Adult Liver to a Proinflammatory State Contributing to Accelerated Atherosclerosis	PLOS ONE			English	Article							SYSTEMIC ARTERIAL-DISEASE; DRINKING-WATER; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; EPIDEMIOLOGIC EVIDENCE; HEPATIC EXPRESSION; TRAUMA-HEMORRHAGE; OXIDATIVE STRESS; IN-UTERO; MICE	The mechanisms by which environmental toxicants alter developmental processes predisposing individuals to adult onset chronic disease are not well-understood. Transplacental arsenic exposure promotes atherogenesis in apolipoprotein E-knockout (ApoE(-/-)) mice. Because the liver plays a central role in atherosclerosis, diabetes and metabolic syndrome, we hypothesized that accelerated atherosclerosis may be linked to altered hepatic development. This hypothesis was tested in ApoE(-/-) mice exposed to 49 ppm arsenic in utero from gestational day (GD) 8 to term. GD18 hepatic arsenic was 1.2 mu g/g in dams and 350 ng/g in fetuses. The hepatic transcriptome was evaluated by microarray analysis to assess mRNA and microRNA abundance in control and exposed pups at postnatal day (PND) 1 and PND70. Arsenic exposure altered postnatal developmental trajectory of mRNA and microRNA profiles. We identified an arsenic exposure related 51-gene signature at PND1 and PND70 with several hubs of interaction (Hspa8, IgM and Hnf4a). Gene ontology (GO) annotation analyses indicated that pathways for gluconeogenesis and glycolysis were suppressed in exposed pups at PND1, and pathways for protein export, ribosome, antigen processing and presentation, and complement and coagulation cascades were induced by PND70. Promoter analysis of differentially-expressed transcripts identified enriched transcription factor binding sites and clustering to common regulatory sites. SREBP1 binding sites were identified in about 16% of PND70 differentially-expressed genes. Western blot analysis confirmed changes in the liver at PND70 that included increases of heat shock protein 70 (Hspa8) and active SREBP1. Plasma AST and ALT levels were increased at PND70. These results suggest that transplacental arsenic exposure alters developmental programming in fetal liver, leading to an enduring stress and proinflammatory response postnatally that may contribute to early onset of atherosclerosis. Genes containing SREBP1 binding sites also suggest pathways for diabetes mellitus and rheumatoid arthritis, both diseases that contribute to increased cardiovascular disease in humans.	[States, J. Christopher; Ngalame, Ntube O.; Arteel, Gavin E.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [States, J. Christopher; Singh, Amar V.; Knudsen, Thomas B.; Rouchka, Eric C.; Arteel, Gavin E.] Univ Louisville, Ctr Environm Genom & Integrat Biol, Louisville, KY 40292 USA; [States, J. Christopher; Knudsen, Thomas B.; Rouchka, Eric C.; Arteel, Gavin E.] Univ Louisville, Ctr Genet & Mol Med, Louisville, KY 40292 USA; [Singh, Amar V.; Knudsen, Thomas B.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40292 USA; [Rouchka, Eric C.] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA; [Piao, Yulan; Ko, Minoru S. H.] Natl Inst Aging, Genet Lab, Baltimore, MD USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	States, JC (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	jcstates@louisville.edu	Arteel, Gavin/AAE-2440-2022; Ko, Minoru S. H./B-7969-2009; Singh, Amar/K-4400-2013; States, J. Christopher/H-4246-2011	Arteel, Gavin/0000-0002-2253-5984; Ko, Minoru S. H./0000-0002-3530-3015; Singh, Amar/0000-0003-3780-8233; States, J. Christopher/0000-0003-4717-4422; Ngalame, Ntube/0000-0003-4482-7272	National Institutes of Health [R01ES011314, R21ES015812, P20RR016481, P20RR016481S1, P30ES014443]; University of Louisville Center for Genetics and Molecular Medicine; University of Louisville Collaborative Planning and Development Grant; Intramural Research Program of NIA/NIH; Bioinformatics, Biostatistics and Computational Biology Core of the Center for Environmental Genomics and Integrative Biology [P30ES014443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011314, P30ES014443, R21ES015812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville Center for Genetics and Molecular Medicine; University of Louisville Collaborative Planning and Development Grant; Intramural Research Program of NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bioinformatics, Biostatistics and Computational Biology Core of the Center for Environmental Genomics and Integrative Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (http://projectreporter.nih.gov/reporter.cfm) grants R01ES011314 (JCS), R21ES015812 (JCS), P20RR016481 (ECR), P20RR016481S1 (ECR), P30ES014443, a pilot grant from University of Louisville Center for Genetics and Molecular Medicine (JCS), a University of Louisville Collaborative Planning and Development Grant (TBK), and the Intramural Research Program of NIA/NIH (MSHK). Bioinformatics support was provided by the Bioinformatics, Biostatistics and Computational Biology Core of the Center for Environmental Genomics and Integrative Biology (P30ES014443). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Arteel GE, 2008, TOXICOL APPL PHARM, V226, P128, DOI 10.1016/j.taap.2007.08.020; Binet F, 2010, INT IMMUNOPHARMACOL, V10, P508, DOI 10.1016/j.intimp.2010.01.013; Calderon RL, 2000, FOOD CHEM TOXICOL, V38, pS13, DOI 10.1016/S0278-6915(99)00133-7; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Cave M, 2010, HEPATOLOGY, V51, P474, DOI 10.1002/hep.23321; Chen TY, 2010, EUR J IMMUNOL, V40, P1541, DOI 10.1002/eji.201040616; Christodoulou A, 2006, J CELL SCI, V119, P2035, DOI 10.1242/jcs.02922; Diehl JA, 2003, MOL CELL BIOL, V23, P1764, DOI 10.1128/MCB.23.5.1764-1774.2003; Doran M, 2007, J RHEUMATOL, V34, P460; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ENGEL RR, 1994, EPIDEMIOL REV, V16, P184, DOI 10.1093/oxfordjournals.epirev.a036150; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Frink M, 2007, MOL IMMUNOL, V44, P2625, DOI 10.1016/j.molimm.2006.12.009; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gremese E, 2011, AUTOIMMUN REV, V10, P582, DOI 10.1016/j.autrev.2011.04.018; Gruss HJ, 1996, ANN ONCOL, V7, P19; Guha Mazumder D N, 2001, J Indian Med Assoc, V99, P314; Hildebrand F, 2006, AM J PATHOL, V169, P784, DOI 10.2353/ajpath.2006.060010; Hill DS, 2008, BIRTH DEFECTS RES B, V83, P40, DOI 10.1002/bdrb.20142; Hollan I, 2007, ARTHRITIS RHEUM, V56, P2072, DOI 10.1002/art.22690; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Ku IA, 2009, CIRC J, V73, P977, DOI 10.1253/circj.CJ-09-0274; Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lindholm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002546; Liu J, 2004, TOXICOL SCI, V77, P249, DOI 10.1093/toxsci/kfh055; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Lu KP, 2002, ATHEROSCLEROSIS, V160, P273, DOI 10.1016/S0021-9150(01)00581-0; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Ma TH, 1996, GENOMICS, V35, P543, DOI 10.1006/geno.1996.0396; Salazar AM, 2010, CHEM RES TOXICOL, V23, P357, DOI 10.1021/tx900353v; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MAZUMDER DNG, 2001, J INDIAN MED ASSOC, V99, P320; MILATOVICH A, 1991, GENOMICS, V11, P1040, DOI 10.1016/0888-7543(91)90030-I; National Research Council, 1999, ARS DRINK WAT; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; NRC (National Research Council), 2001, ARSENIC DRINKING WAT; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Punthakee Z, 2007, REV CARDIOVASC MED, V8, P145; Rahman MM, 2005, CLIN TOXICOL, V43, P823, DOI 10.1080/15563650500357461; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; ROSENBERG HG, 1973, CIRCULATION, V47, P270, DOI 10.1161/01.CIR.47.2.270; ROSENBERG HG, 1974, ARCH PATHOL, V97, P360; Salbaum JM, 2009, BIRTH DEFECTS RES A, V85, P303, DOI 10.1002/bdra.20537; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sookoian S, 2010, ATHEROSCLEROSIS, V209, P585, DOI 10.1016/j.atherosclerosis.2009.10.011; Srivastava S, 2002, AM J PHYSIOL-HEART C, V283, pH2612, DOI 10.1152/ajpheart.00592.2002; Srivastava S, 2007, REPROD TOXICOL, V23, P449, DOI 10.1016/j.reprotox.2007.01.005; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; States JC, 2011, ENVIRON HEALTH PERSP, V119, P1356, DOI 10.1289/ehp.1103441; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Straub AC, 2007, HEPATOLOGY, V45, P205, DOI 10.1002/hep.21444; Tang CH, 2009, TOXICOL APPL PHARM, V241, P173, DOI 10.1016/j.taap.2009.08.011; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tokar EJ, 2011, TOXICOL SCI, V119, P73, DOI 10.1093/toxsci/kfq315; Tokar EJ, 2010, JNCI-J NATL CANCER I, V102, P638, DOI 10.1093/jnci/djq093; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Tseng CH, 2002, TOXICOL LETT, V133, P69, DOI 10.1016/S0378-4274(02)00085-1; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wlodarczyk BJ, 2006, NEUROTOXICOLOGY, V27, P547, DOI 10.1016/j.neuro.2006.02.005; Yang YZ, 2004, ATHEROSCLEROSIS, V173, P211, DOI 10.1016/j.atherosclerosis.2003.12.023; Zhang H, 2007, EXP EYE RES, V85, P825, DOI 10.1016/j.exer.2007.08.018; Zhang XM, 2010, CELL STRESS CHAPERON, V15, P675, DOI 10.1007/s12192-010-0180-3	79	47	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38713	10.1371/journal.pone.0038713	http://dx.doi.org/10.1371/journal.pone.0038713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719926	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000021
J	Wang, XL; Tu, F; Zhu, YP; Gao, GX				Wang, Xinlu; Tu, Fan; Zhu, Yiping; Gao, Guangxia			Zinc-Finger Antiviral Protein Inhibits XMRV Infection	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; VIRAL MESSENGER-RNAS; PROSTATE-CANCER; RETROVIRUS XMRV; NO EVIDENCE; CELLS; SUSCEPTIBILITY; REPLICATION; HELICASE	Background: The zinc-finger antiviral protein (ZAP) is a host factor that specifically inhibits the replication of certain viruses, including Moloney murine leukemia virus (MoMLV), HIV-1, and certain alphaviruses and filoviruses. ZAP binds to specific viral mRNAs and recruits cellular mRNA degradation machinery to degrade the target RNA. The common features of ZAP-responsive RNA sequences remain elusive and thus whether a virus is susceptible to ZAP can only be determined experimentally. Xenotropic murine leukemia virus-related virus (XMRV) is a recently identified gamma-retrovirus that was originally thought to be involved in prostate cancer and chronic fatigue syndrome but recently proved to be a laboratory artefact. Nonetheless, XMRV as a new retrovirus has been extensively studied. Since XMRV and MoMLV share only 67.9% sequence identity in the 3'UTRs, which is the target sequence of ZAP in MoMLV, whether XMRV is susceptible to ZAP remains to be determined. Findings: We constructed an XMRV-luc vector, in which the coding sequences of Gag-Pol and part of Env were replaced with luciferase-coding sequence. Overexpression of ZAP potently inhibited the expression of XMRV-luc in a ZAP expression-level-dependent manner, while downregulation of endogenous ZAP rendered cells more sensitive to infection. Furthermore, ZAP inhibited the spreading of replication-competent XMRV. Consistent with the previously reported mechanisms by which ZAP inhibits viral infection, ZAP significantly inhibited the accumulation of XMRV-luc mRNA in the cytoplasm. The ZAP-responsive element in XMRV mRNA was mapped to the 3'UTR. Conclusions: ZAP inhibits XMRV replication by preventing the accumulation of viral mRNA in the cytoplasm. Documentation of ZAP inhibiting XMRV helps to broaden the spectrum of ZAP's antiviral activity. Comparison of the target sequences of ZAP in XMRV and MoMLV helps to better understand the features of ZAP-responsive elements.	[Wang, Xinlu; Tu, Fan; Zhu, Yiping; Gao, Guangxia] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Tu, Fan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XL (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	gaogx@moon.ibp.ac.cn			National Science Foundation [30530020, 81028011]; Ministry of Science and Technology (973 Program) of China	National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology (973 Program) of China(National Basic Research Program of China)	This work was supported by grants to Guangxia Gao from the National Science Foundation (30530020 and 81028011), and the Ministry of Science and Technology (973 Program 2012CB910203) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Chen S, 2012, NAT STRUCT MOL BIOL; Cote M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033734; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Li M, 2011, NAT STRUCT MOL BIOL, V18, P227, DOI 10.1038/nsmb.1964; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-70; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	35	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39159	10.1371/journal.pone.0039159	http://dx.doi.org/10.1371/journal.pone.0039159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720057	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000044
J	Rossi, E; Giorda, R; Bonaglia, MC; Di Candia, S; Grechi, E; Franzese, A; Soli, F; Rivieri, F; Patricelli, MG; Saccilotto, D; Bonfante, A; Giglio, S; Beri, S; Rocchi, M; Zuffardi, O				Rossi, Elena; Giorda, Roberto; Bonaglia, Maria Clara; Di Candia, Stefania; Grechi, Elena; Franzese, Adriana; Soli, Fiorenza; Rivieri, Francesca; Patricelli, Maria Grazia; Saccilotto, Donatella; Bonfante, Aldo; Giglio, Sabrina; Beri, Silvana; Rocchi, Mariano; Zuffardi, Orsetta			De Novo Unbalanced Translocations in Prader-Willi and Angelman Syndrome Might Be the Reciprocal Product of inv dup(15)s	PLOS ONE			English	Article							RECEPTOR-GENE CLUSTERS; INVERTED DUPLICATIONS; MARKER CHROMOSOMES; MOLECULAR CHARACTERIZATION; 15Q11-Q13 REARRANGEMENTS; INVERSION POLYMORPHISMS; SEGMENTAL DUPLICATIONS; JUMPING TRANSLOCATION; UNIPARENTAL DISOMY; ARRAY-CGH	The 15q11-q13 region is characterized by high instability, caused by the presence of several paralogous segmental duplications. Although most mechanisms dealing with cryptic deletions and amplifications have been at least partly characterized, little is known about the rare translocations involving this region. We characterized at the molecular level five unbalanced translocations, including a jumping one, having most of 15q transposed to the end of another chromosome, whereas the der(15)(pter->q11-q13) was missing. Imbalances were associated either with Prader-Willi or Angelman syndrome. Array-CGH demonstrated the absence of any copy number changes in the recipient chromosome in three cases, while one carried a cryptic terminal deletion and another a large terminal deletion, already diagnosed by classical cytogenetics. We cloned the breakpoint junctions in two cases, whereas cloning was impaired by complex regional genomic architecture and mosaicism in the others. Our results strongly indicate that some of our translocations originated through a prezygotic/postzygotic two-hit mechanism starting with the formation of an acentric 15qter->q1::q1->qter representing the reciprocal product of the inv dup(15) supernumerary marker chromosome. An embryo with such an acentric chromosome plus a normal chromosome 15 inherited from the other parent could survive only if partial trisomy 15 rescue would occur through elimination of part of the acentric chromosome, stabilization of the remaining portion with telomere capture, and formation of a derivative chromosome. All these events likely do not happen concurrently in a single cell but are rather the result of successive stabilization attempts occurring in different cells of which only the fittest will finally survive. Accordingly, jumping translocations might represent successful rescue attempts in different cells rather than transfer of the same 15q portion to different chromosomes. We also hypothesize that neocentromerization of the original acentric chromosome during early embryogenesis may be required to avoid its loss before cell survival is finally assured.	[Rossi, Elena; Zuffardi, Orsetta] Univ Pavia, I-27100 Pavia, Italy; [Giorda, Roberto; Bonaglia, Maria Clara; Beri, Silvana] Sci Inst Eugenio Medea, Bosisio Parini, Lecco, Italy; [Di Candia, Stefania; Grechi, Elena] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Pediat, Milan, Italy; [Franzese, Adriana] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Soli, Fiorenza; Rivieri, Francesca] APSS Trento, Dept Med Genet, Trento, Italy; [Patricelli, Maria Grazia] San Raffaele SPA, Biol Mol Clin & Citogenet Diagnost & Ric, Milan, Italy; [Saccilotto, Donatella; Bonfante, Aldo] Osped Civile, Bassano Del Grappa, Italy; [Giglio, Sabrina] Univ Florence, Meyer Childrens Hosp, Med Genet Unit, Florence, Italy; [Rocchi, Mariano] Univ Bari, Dept Biol, Bari, Italy; [Zuffardi, Orsetta] IRCCS C Mondino Natl Neurol Inst Fdn, Pavia, Italy	University of Pavia; IRCCS Eugenio Medea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Naples Federico II; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Universita degli Studi di Bari Aldo Moro; IRCCS Fondazione Casimiro Mondino	Rossi, E (corresponding author), Univ Pavia, Via Palestro 3, I-27100 Pavia, Italy.	zuffardi@unipv.it	Rossi, Elena/O-1664-2016; Bonaglia, Maria Clara/K-2775-2016; Giorda, Roberto/Q-6010-2019; Giorda, Roberto/J-1052-2014; Giglio, Sabrina Rita/ABB-1093-2020; Giglio, Sabrina SG/K-9109-2016	Rossi, Elena/0000-0001-9152-435X; Bonaglia, Maria Clara/0000-0002-7121-7712; Giorda, Roberto/0000-0001-8175-9606; Giorda, Roberto/0000-0001-8175-9606; Giglio, Sabrina Rita/0000-0002-3954-326X; Giglio, Sabrina SG/0000-0002-3954-326X; zuffardi, orsetta/0000-0002-1466-4559; Rocchi, Mariano/0000-0002-9451-5616	Cassa di Risparmio delle Provincie Lombarde [CARIPLO:2007.5197]; Ministry of Health [RF-AOM-2007-636538]	Cassa di Risparmio delle Provincie Lombarde(Fondazione Cariplo); Ministry of Health	Orsetta Zuffardi is funded by Cassa di Risparmio delle Provincie Lombarde(CARIPLO:2007.5197, bando 2007) and by Ministry of Health Grant (RF-AOM-2007-636538 "Genomic structural variation studies in mentally retarded and normal individuals in Italy''). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, USER B, V02, P1; BLENNOW E, 1994, AM J HUM GENET, V54, P877; Boyd L, 2005, AM J MED GENET A, V138A, P181, DOI 10.1002/ajmg.a.30819; Carrozzo R, 1997, AM J HUM GENET, V61, P228, DOI 10.1086/513907; CROLLA JA, 1995, HUM GENET, V95, P161; Devriendt K, 1997, J MED GENET, V34, P395, DOI 10.1136/jmg.34.5.395; FRACCARO M, 1983, HUM GENET, V64, P388, DOI 10.1007/BF00292373; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Hasson D, 2011, CHROMOSOMA, V120, P621, DOI 10.1007/s00412-011-0337-6; Horsthemke B, 2003, HUM MOL GENET, V12, P2723, DOI 10.1093/hmg/ddg291; Kleefstra T, 2010, AM J MED GENET A, V152A, P2221, DOI 10.1002/ajmg.a.33529; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Liehr T, 2005, EUR J MED GENET, V48, P175, DOI 10.1016/j.ejmg.2005.01.004; Liehr T, 2010, CYTOGENET GENOME RES, V128, P189, DOI 10.1159/000271471; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Makoff A, 2009, EUR J HUM GENET, V17, P149, DOI 10.1038/ejhg.2008.189; Makoff AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r114; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Mignon-Ravix C, 2007, EUR J HUM GENET, V15, P432, DOI 10.1038/sj.ejhg.5201775; Murmann AE, 2009, HUM MOL GENET, V18, P2241, DOI 10.1093/hmg/ddp160; Oracova E, 2009, J ANDROL, V30, P233, DOI 10.2164/jandrol.108.006783; Pasantes JJ, 2012, CYTOGENET GENOME RES, V136, P157, DOI 10.1159/000335705; Pramparo T, 2004, EUR J HUM GENET, V12, P713, DOI 10.1038/sj.ejhg.5201240; Pujana MA, 2002, EUR J HUM GENET, V10, P26, DOI 10.1038/sj.ejhg.5200760; Reddy KS, 2010, AM J MED GENET A, V152A, P2924, DOI 10.1002/ajmg.a.33710; RIVERA H, 1990, AM J MED GENET, V37, P311, DOI 10.1002/ajmg.1320370304; Roberts SE, 2003, AM J HUM GENET, V73, P1061, DOI 10.1086/379155; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; Sahoo T, 2007, EUR J HUM GENET, V15, P943, DOI 10.1038/sj.ejhg.5201859; Saitoh S, 2007, CLIN GENET, V72, P378, DOI 10.1111/j.1399-0004.2007.00860.x; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Soler A, 2003, PRENATAL DIAG, V23, P319, DOI 10.1002/pd.590; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Wandstrat AE, 2000, CHROMOSOMA, V109, P498, DOI 10.1007/s004120000103; Wang NJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-2; Wang NJ, 2004, AM J HUM GENET, V75, P267, DOI 10.1086/422854; Webb T, 1998, CLIN GENET, V53, P34, DOI 10.1034/j.1399-0004.1998.531530107.x; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601; Zuffardi O, 2009, CLIN GENET, V75, P505, DOI 10.1111/j.1399-0004.2009.01187.x	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39180	10.1371/journal.pone.0039180	http://dx.doi.org/10.1371/journal.pone.0039180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720067	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800052
J	Clavien, C; Tanner, CJ; Clement, F; Chapuisat, M				Clavien, Christine; Tanner, Colby J.; Clement, Fabrice; Chapuisat, Michel			Choosy Moral Punishers	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; STRONG RECIPROCITY; COSTLY PUNISHMENT; POPULATIONS; COOPERATION; ENFORCEMENT; MOTIVATION; SOCIETIES; EVOLUTION; FAIRNESS	The punishment of social misconduct is a powerful mechanism for stabilizing high levels of cooperation among unrelated individuals. It is regularly assumed that humans have a universal disposition to punish social norm violators, which is sometimes labelled "universal structure of human morality" or "pure aversion to social betrayal". Here we present evidence that, contrary to this hypothesis, the propensity to punish a moral norm violator varies among participants with different career trajectories. In anonymous real-life conditions, future teachers punished a talented but immoral young violinist: they voted against her in an important music competition when they had been informed of her previous blatant misconduct toward fellow violin students. In contrast, future police officers and high school students did not punish. This variation among socio-professional categories indicates that the punishment of norm violators is not entirely explained by an aversion to social betrayal. We suggest that context specificity plays an important role in normative behaviour; people seem inclined to enforce social norms only in situations that are familiar, relevant for their social category, and possibly strategically advantageous.	[Clavien, Christine; Tanner, Colby J.; Chapuisat, Michel] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Clement, Fabrice] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland	University of Lausanne; University of Neuchatel	Clavien, C (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	christine.clavien@unil.ch	Chapuisat, Michel/T-8686-2017; Tanner, Colby/H-4653-2012	Chapuisat, Michel/0000-0001-7207-199X; Clavien, Christine/0000-0003-0968-144X	Fondation du 450eme; Irish Research Council for Science, Engineering and Technology-Marie Curie fellowship; Swiss National Science Foundation	Fondation du 450eme; Irish Research Council for Science, Engineering and Technology-Marie Curie fellowship(Irish Research Council for Science, Engineering and Technology); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Fondation du 450eme (http://www.unil.ch/450e). Colby Tanner was funded by an Irish Research Council for Science, Engineering and Technology-Marie Curie fellowship (http://cordis.europa.eu/improving/fellowships/home.htm) and Michel Chapuisat by the Swiss National Science Foundation (http://www.snf.ch/E/funding/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay P, 2006, EVOL HUM BEHAV, V27, P325, DOI 10.1016/j.evolhumbehav.2006.01.003; Bates D., 2009, IME4 LINEAR MIXED EF; Batson CD., 1991, ALTRUISM QUESTION SO; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bicchieri C, 2009, J BEHAV DECIS MAKING, V22, P191, DOI 10.1002/bdm.621; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Bowles S., 2004, ROUNDTABLE SER BEHAV; Brink D., 1989, MORAL REALISM FDN ET, DOI [10.1017/CBO9780511624612, DOI 10.1017/CBO9780511624612]; Carpenter J, 2004, J EVOL ECON, V14, P407, DOI 10.1007/s00191-004-0212-1; Carpenter JP, 2007, J ECON BEHAV ORGAN, V62, P522, DOI 10.1016/j.jebo.2005.05.004; Carpenter JP, 2012, J EUR ECON ASSOC, V10, P555, DOI 10.1111/j.1542-4774.2011.01059.x; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; Clavien C, 2010, ECON PHILOS, V26, P267, DOI 10.1017/S0266267110000374; Copp D, 1997, ETHICS, V108, P33, DOI 10.1086/233787; Dancy Jonathan, 2000, PRACTICAL REALITY; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Gachter S, 2011, EUR ECON REV, V55, P193, DOI 10.1016/j.euroecorev.2010.04.003; Gigerenzer G., 2000, ADAPTIVE THINKING RA; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gintis H, 2008, SOC JUSTICE RES, V21, P241, DOI 10.1007/s11211-008-0067-y; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guala F, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11000069; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Houser D, 2002, AM ECON REV, V92, P1062, DOI 10.1257/00028280260344605; Kallgren CA, 2000, PERSONALITY SOCIAL P, P26; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; Lewisch P, 2011, REV LAW ECON, V7, P165, DOI 10.2202/1555-5879.1460; Marlowe FW, 2009, HUM NATURE-INT BIOS, V20, P417, DOI 10.1007/s12110-009-9072-6; Ostrom E., 1990, GOVERNING COMMONS EV; Ottone S, 2008, EC B, V3, P1; Pandelaere M, 2010, J CONSUM PSYCHOL, V20, P442, DOI 10.1016/j.jcps.2010.07.003; Pelham B.W., 2007, CONDUCTING RES PSYCH; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Stich SP, 2010, MORAL PSYCHOL HDB, P147; Svavarsdottir S, 1999, PHILOS REV, V108, P161, DOI 10.2307/2998300	45	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39002	10.1371/journal.pone.0039002	http://dx.doi.org/10.1371/journal.pone.0039002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959UV	22720012	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900072
J	El Agha, E; Al Alam, D; Carraro, G; MacKenzie, B; Goth, K; De Langhe, SP; Voswinckel, R; Hajihosseini, MK; Rehan, VK; Bellusci, S				El Agha, Elie; Al Alam, Denise; Carraro, Gianni; MacKenzie, BreAnne; Goth, Kerstin; De Langhe, Stijn P.; Voswinckel, Robert; Hajihosseini, Mohammad K.; Rehan, Virender K.; Bellusci, Saverio			Characterization of a Novel Fibroblast Growth Factor 10 (Fgf10) Knock-In Mouse Line to Target Mesenchymal Progenitors during Embryonic Development	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-10; FGF10-EXPRESSING CELLS; INDUCTION; LIMB; ATRESIA; GENES; FGFR2	Fibroblast growth factor 10 (Fgf10) is a key regulator of diverse organogenetic programs during mouse development, particularly branching morphogenesis. Fgf10-null mice suffer from lung and limb agenesis as well as cecal and colonic atresia and are thus not viable. To date, the Mlcv1v-nLacZ-24 transgenic mouse strain (referred to as Fgf10(LacZ)), which carries a LacZ insertion 114 kb upstream of exon 1 of Fgf10 gene, has been the only strain to allow transient lineage tracing of Fgf10-positive cells. Here, we describe a novel Fgf10(Cre-ERT2) knock-in line (Fgf10(iCre)) in which a Cre-ERT2-IRES-YFP cassette has been introduced in frame with the ATG of exon 1 of Fgf10 gene. Our studies show that Cre-ERT2 insertion disrupts Fgf10 function. However, administration of tamoxifen to Fgf10(iCre); Tomato(flox) double transgenic embryos or adult mice results in specific labeling of Fgf10-positive cells, which can be lineage-traced temporally and spatially. Moreover, we show that the Fgf10(iCre) line can be used for conditional gene inactivation in an inducible fashion during early developmental stages. We also provide evidence that transcription factors located in the first intron of Fgf10 gene are critical for maintaining Fgf10 expression over time. Thus, the Fgf10(iCre) line should serve as a powerful tool to explore the functions of Fgf10 in a controlled and stage-specific manner.	[El Agha, Elie; Carraro, Gianni; MacKenzie, BreAnne; Goth, Kerstin; Bellusci, Saverio] UGMLC, Giessen, Hessen, Germany; [Al Alam, Denise; Bellusci, Saverio] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA USA; [De Langhe, Stijn P.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO USA; [Voswinckel, Robert] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, Bad Nauheim, Hessen, Germany; [Hajihosseini, Mohammad K.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Rehan, Virender K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles Biomed Res Inst Harbor UCLA, Harbor UCLA Med Ctr,Dept Pediat, Torrance, CA USA	Children's Hospital Los Angeles; University of Southern California; National Jewish Health; Max Planck Society; University of East Anglia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute	El Agha, E (corresponding author), UGMLC, Giessen, Hessen, Germany.	saverio.bellusci@innere.med.uni-giessen.de	De Langhe, Stijn/ABH-6876-2020; MacKenzie, BreAnne/F-5700-2014; Alam, Denise Al/AAG-9406-2019	De Langhe, Stijn/0000-0003-3867-4572; MacKenzie, BreAnne/0000-0002-8336-6408; Carraro, Gianni/0000-0003-0824-7692; El Agha, Elie/0000-0001-7504-3417	National Institutes of Health (NIH) [RO1]; Excellence Cluster in Cardio-Pulmonary system; Deutsche Forschungsgemeinschaft (DFG), LOEWE; American Heart Association (AHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092967] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Cluster in Cardio-Pulmonary system(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG), LOEWE(German Research Foundation (DFG)); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Bellusci received funding from the National Institutes of Health (NIH) RO1 grants as well as Excellence Cluster in Cardio-Pulmonary system, Deutsche Forschungsgemeinschaft (DFG), LOEWE. Dr. Al Alam received funding from the American Heart Association (AHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler LL, 2009, DEV DYNAM, V238, P1999, DOI 10.1002/dvdy.22032; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Brocard J, 1998, NUCLEIC ACIDS RES, V26, P4086, DOI 10.1093/nar/26.17.4086; Cebra-Thomas JA, 2003, DEV DYNAM, V226, P82, DOI 10.1002/dvdy.10208; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fairbanks TJ, 2005, J PEDIATR SURG, V40, P390, DOI 10.1016/j.jpedsurg.2004.10.023; Fairbanks TJ, 2004, J SURG RES, V120, P201, DOI 10.1016/j.jss.2003.12.017; Golzio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030677; Gupte VV, 2009, AM J RESP CRIT CARE, V180, P424, DOI 10.1164/rccm.200811-1794OC; Hajihosseini MK, 2008, MOL CELL NEUROSCI, V37, P857, DOI 10.1016/j.mcn.2008.01.008; Hamada K, 1999, Exp Dermatol, V8, P347; Kanard RC, 2005, J PEDIATR SURG, V40, P313, DOI 10.1016/j.jpedsurg.2004.10.057; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Liu Y, 2002, DEVELOPMENT, V129, P5289; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Sala FG, 2011, DEVELOPMENT, V138, P273, DOI 10.1242/dev.051680; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Tiozzo C, 2009, PEDIATR RES, V66, P386, DOI 10.1203/PDR.0b013e3181b45580; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394	26	40	40	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38452	10.1371/journal.pone.0038452	http://dx.doi.org/10.1371/journal.pone.0038452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719891	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305341900029
J	Horimatsu, T; Muto, M; Yoda, Y; Yano, T; Ezoe, Y; Miyamoto, S; Chiba, T				Horimatsu, Takahiro; Muto, Manabu; Yoda, Yusuke; Yano, Tomonori; Ezoe, Yasumasa; Miyamoto, Shinichi; Chiba, Tsutomu			Tissue Damage in the Canine Normal Esophagus by Photoactivation with Talaporfin Sodium (Laserphyrin): A Preclinical Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PHOTODYNAMIC THERAPY; NPE6; CANCER; CHEMORADIOTHERAPY; ESOPHAGECTOMY; LUNG	Background: Treatment failure at the primary site after chemoradiotherapy is a major problem in achieving a complete response. Photodynamic therapy (PDT) with porfimer sodium (Photofrin (R)) has some problems such as the requirement for shielding from light for several weeks and a high incidence of skin phototoxicity. PDT with talaporfin sodium (Laserphyrin) is less toxic and is expected to have a better effect compared with Photofrin PDT. However, Laserphyrin PDT is not approved for use in the esophagus. In this preclinical study, we investigated tissue damage of the canine normal esophagus caused by photoactivation with Laserphyrin. Methodology/Principal Findings: Diode laser irradiation was performed at 60 min after administration. An area 5 cm oral to the esophagogastric junction was irradiated at 25 J/cm(2), 50 J/cm(2), and 100 J/cm(2) using a three-step escalation. The irradiated areas were evaluated endoscopically on postirradiation days 1 and 7, and were subjected to histological examination after autopsy. The areas injured by photoactivation were 52 mm(2), 498 mm(2), and 831 mm(2) after irradiation at 25 J/cm(2), 50 J/cm(2), and 100 J/cm(2), respectively. Tissue injury was observed in the muscle layer or even deeper at any irradiation level and became more severe as the irradiation dose increased. At 100 J/cm(2) both inflammatory changes and necrosis were seen histologically in extra-adventitial tissue. Conclusions/Significance: To minimize injury of the normal esophagus by photoactivation with Laserphyrin, diode laser irradiation at 25 J/cm(2) appears to be safe. For human application, it would be desirable to investigate the optimal laser dose starting from this level.	[Horimatsu, Takahiro; Muto, Manabu; Yoda, Yusuke; Yano, Tomonori; Ezoe, Yasumasa; Miyamoto, Shinichi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Kyoto, Japan	Kyoto University	Horimatsu, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Kyoto, Japan.	thorimat@kuhp.kyoto-u.ac.jp		Horimatsu, Takahiro/0000-0002-4188-9059	Ministry of Health, Labor, and Welfare of Japan [H21-Rinshokenkyu-Ippan-018]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by grants-in-aid for cancer research from the Ministry of Health (H21-Rinshokenkyu-Ippan-018), Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA K, 1987, PHOTOCHEM PHOTOBIOL, V46, P789, DOI 10.1111/j.1751-1097.1987.tb04849.x; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; DOUGHERTY TJ, 1992, EUR J CANCER, V28A, P1734, DOI 10.1016/0959-8049(92)90080-L; DOUGHERTY TJ, 1990, LASER SURG MED, V10, P485, DOI 10.1002/lsm.1900100514; Kato H, 2003, LUNG CANCER, V42, P103, DOI 10.1016/S0169-5002(03)00242-3; MANYAK MJ, 1988, J CLIN ONCOL, V6, P380, DOI 10.1200/JCO.1988.6.2.380; NELSON JS, 1987, CANCER RES, V47, P4681; Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2; PASS HI, 1993, JNCI-J NATL CANCER I, V85, P443, DOI 10.1093/jnci/85.6.443; Savary JF, 1998, ENDOSCOPY, V30, P258, DOI 10.1055/s-2007-1001252; Swisher SG, 2002, J THORAC CARDIOV SUR, V123, P175, DOI 10.1067/mtc.2002.119070; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; Usuda J, 2007, LUNG CANCER, V58, P317, DOI 10.1016/j.lungcan.2007.06.026; Usuda J, 2010, CLIN CANCER RES, V16, P2198, DOI 10.1158/1078-0432.CCR-09-2520; Yano T, 2005, GASTROINTEST ENDOSC, V62, P31, DOI 10.1016/S0016-5107(05)00545-6; Yano T, 2011, ENDOSCOPY, V43, P657, DOI 10.1055/s-0030-1256373; Yoshida K, 1993, Gan To Kagaku Ryoho, V20, P2063	17	17	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38308	10.1371/journal.pone.0038308	http://dx.doi.org/10.1371/journal.pone.0038308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719875	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900023
J	Nakamura, GR; Fonseca, DPAJ; O'Rourke, SM; Vollrath, AL; Berman, PW				Nakamura, Gerald R.; Fonseca, Dora P. A. J.; O'Rourke, Sara M.; Vollrath, Aaron L.; Berman, Phillip W.			Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of alpha 4 beta 7 Binding	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; PREVENT HIV-1 INFECTION; T-CELL-ACTIVATION; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; V1/V2 DOMAIN; INTEGRIN ALPHA(4)BETA(7); EFFICACY TRIAL; UNITED-STATES	Background: Recombinant gp120 (MN-rgp120) was a major component of the AIDSVAX B/E vaccine used in the RV144 trial. This was the first clinical trial to show that vaccination could prevent HIV infection in humans. A recent RV144 correlates of protection study found that protection correlated with the presence of antibodies to the V2 domain. It has been proposed that antibodies to the alpha 4 beta 7 binding site in the V2 domain might prevent HIV-1 infection by blocking the ability of virions to recognize alpha 4 beta 7 on activated T-cells. In this study we investigated the specificity of monoclonal antibodies (MAbs) to the V2 domain of MN-rgp120 and examined the possibility that these antibodies could inhibit the binding of MN-rgp120 to the alpha 4 beta 7 integrin. Methodology/Principal Findings: Nine MAbs to the V2 domain were isolated from mice immunized with recombinant envelope proteins. The ability of these MAbs to inhibit HIV infection, block the binding of gp120 to CD4, and block the binding of MN-rgp120 to the alpha 4 beta 7 integrin was measured. Mutational analysis showed that eight of the MAbs recognized two immunodominant clusters of amino acids (166-168 and 178-183) located at either end of the C strand within the four-strand anti-parallel sheet structure comprising the V1/V2 domain. Conclusions/Significance: These studies showed that the antigenic structure of the V2 domain is exceedingly complex and that MAbs isolated from mice immunized with MN-rgp120 exhibited a high level of strain specificity compared to MAbs to the V2 domain isolated from HIV-infected humans. We found that immunization with MN-rgp120 readily elicits antibodies to the V2 domain and some of these were able to block the binding of MN-rgp120 to the alpha 4 beta 7 integrin.	[Nakamura, Gerald R.] Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA; [Fonseca, Dora P. A. J.; O'Rourke, Sara M.; Vollrath, Aaron L.; Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Roche Holding; Genentech; University of California System; University of California Santa Cruz	Nakamura, GR (corresponding author), Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA.	pwb@soe.ucsc.edu						Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P475, DOI 10.1001/jama.272.6.475; Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1996, J INFECT DIS, V173, P52, DOI 10.1093/infdis/173.1.52; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; Berman PW, 1997, J INFECT DIS, V176, P384, DOI 10.1086/514055; BERMAN PW, 1992, J VIROL, V66, P4464, DOI 10.1128/JVI.66.7.4464-4469.1992; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Callaway E., 2011, NATURENEWS, DOI [10.1038/news.2011.541, DOI 10.1038/NEWS.2011.541]; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; ERLE DJ, 1994, J IMMUNOL, V153, P517; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Francis DP, 1998, AIDS RES HUM RETROV, V14, pS325; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; GOWDA SD, 1989, J IMMUNOL, V142, P773; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori D, 2012, J INFECT DI IN PRESS; Montefiori D.C., 2004, CURRENT PROTOCOLS IM; MOORE JP, 1993, J VIROL, V67, P3656, DOI 10.1128/JVI.67.6.3656-3659.1993; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; NAKAMURA GR, 1992, AIDS RES HUM RETROV, V8, P1875, DOI 10.1089/aid.1992.8.1875; NAKAMURA GR, 1993, J VIROL, V67, P6179, DOI 10.1128/JVI.67.10.6179-6191.1993; NAKANE PK, 1975, ANN NY ACAD SCI, V254, P203, DOI 10.1111/j.1749-6632.1975.tb29170.x; O'Rourke SM, 2010, J VIROL, V84, P11200, DOI 10.1128/JVI.00790-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Perez-Losada M, 2010, MOL BIOL EVOL, V27, P417, DOI 10.1093/molbev/msp254; Pinter A, 2005, J VIROL, V79, P6909, DOI 10.1128/JVI.79.11.6909-6917.2005; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; SHOTTON C, 1995, J VIROL, V69, P222, DOI 10.1128/JVI.69.1.222-230.1995; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; STUPACK DG, 1991, SCAND J IMMUNOL, V34, P761, DOI 10.1111/j.1365-3083.1991.tb01601.x; Tidswell M, 1997, J IMMUNOL, V159, P1497; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2011, NATURE; WU Z, 1995, J VIROL, V69, P2271, DOI 10.1128/JVI.69.4.2271-2278.1995; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zolla-Pazner S, 2012, J VIROL IN PRESS; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	60	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39045	10.1371/journal.pone.0039045	http://dx.doi.org/10.1371/journal.pone.0039045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720026	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900077
J	Song, ZQ; Li, Y; Liu, Y; Xin, JQ; Zou, XH; Sun, WJ				Song, Zhiqiang; Li, Yuan; Liu, Yang; Xin, Jiuqing; Zou, Xiaohui; Sun, Wenjing			alpha-Enolase, an Adhesion-Related Factor of Mycoplasma bovis	PLOS ONE			English	Article							PLASMINOGEN; SURFACE; BINDS; FERMENTANS; PNEUMONIA; MASTITIS; INVASION; PROTEIN; CELLS	Mycoplasma bovis is the causative agent of Mycoplasma bovis-associated disease (MbAD). Although the mechanisms underlying M. bovis adherence to host cells is not clear, recent studies have shown that the cell surface protein alpha-enolase facilitates bacterial invasion and dissemination in the infected host. In this study, we cloned, expressed and purified recombinant M. bovis alpha-enolase and induced polyclonal anti-alpha-enolase antibodies in rabbits. M. bovis alpha-enolase was detected in the cytoplasmic and membrane protein fractions by these antibodies. Triple immunofluorescence labeling combined with confocal laser scanning microscopy (CLSM) revealed that the plasminogen (Plg) enhanced the adherence of M. bovis to embryonic bovine lung (EBL) cells; the values obtained for adherence and inhibition are consistent with this finding. Interestingly, we found that trace amounts of trypsin acted as a more effective enhancer of cell adherence than Plg. Hence, our data indicate that surface-associated M. bovis alpha-enolase is an adhesion-related factor of M. bovis that contributes to adherence by binding Plg.	[Song, Zhiqiang; Li, Yuan; Xin, Jiuqing; Zou, Xiaohui; Sun, Wenjing] CAAS, Harbin Vet Res Inst, State Key Lab Vet Biotechnol,Div Bacterial Dis, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China; [Liu, Yang] Natl Engn Res Ctr Vet Biolog, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Song, ZQ (corresponding author), CAAS, Harbin Vet Res Inst, State Key Lab Vet Biotechnol,Div Bacterial Dis, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China.	xinjiuqing2001@126.com			National Natural Science Foundations of China [31072131]; Harbin Science and Technology Program, China [2010AA6AN019]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology Program, China	This work was supported by National Natural Science Foundations of China No. 31072131 (http://www.nsfc.gov.cn/Portal0/default152.htm) and by Harbin Science and Technology Program, China, No. 2010AA6AN019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammersbach M, 2008, VET PATHOL, V45, P663, DOI 10.1354/vp.45-5-663; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Gao Y, 2011, CHINESE J PREVENTIVE, V33, P225; HALE HH, 1962, CORNELL VET, V52, P582; Jones MN, 2007, BIOCHEM BIOPH RES CO, V364, P924, DOI 10.1016/j.bbrc.2007.10.098; Kornspan JD, 2010, INFECT IMMUN, V78, P611, DOI 10.1128/IAI.01017-09; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lottenberg R, 1997, TRENDS MICROBIOL, V5, P466, DOI 10.1016/S0966-842X(97)01171-2; Maunsell FP, 2009, VET CLIN N AM-FOOD A, V25, P139, DOI 10.1016/j.cvfa.2008.10.011; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; Nicholas RAJ, 2002, VACCINE, V20, P3569, DOI 10.1016/S0264-410X(02)00340-7; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987; Radaelli E, 2008, RES VET SCI, V85, P282, DOI 10.1016/j.rvsc.2007.11.012; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Thomas A, 2003, MICROB PATHOGENESIS, V34, P141, DOI 10.1016/S0882-4010(03)00003-2; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Xin JiuQing, 2008, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V30, P661; Yavlovich A, 2004, INFECT IMMUN, V72, P5004, DOI 10.1128/IAI.72.9.5004-5011.2004; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	24	47	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38836	10.1371/journal.pone.0038836	http://dx.doi.org/10.1371/journal.pone.0038836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719960	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900052
J	Padro, T; Lugano, R; Garcia-Arguinzonis, M; Badimon, L				Padro, Teresa; Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina			LDL-Induced Impairment of Human Vascular Smooth Muscle Cells Repair Function Is Reversed by HMG-CoA Reductase Inhibition	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; MYOSIN LIGHT-CHAIN; AGGREGATED LDL; SULFATE PROTEOGLYCANS; STATIN THERAPY; HEART-DISEASE; RISK-FACTORS; RHO-GTPASES	Growing human atherosclerotic plaques show a progressive loss of vascular smooth muscle cells (VSMC) becoming soft and vulnerable. Lipid loaded-VSMC show impaired vascular repair function and motility due to changes in cytoskeleton proteins involved in cell-migration. Clinical benefits of statins reducing coronary events have been related to repopulation of vulnerable plaques with VSMC. Here, we investigated whether HMG-CoA reductase inhibition with rosuvastatin can reverse the effects induced by atherogenic concentrations of LDL either in the native (nLDL) form or modified by aggregation (agLDL) on human VSMC motility. Using a model of wound repair, we showed that treatment of human coronary VSMC with rosuvastatin significantly prevented (and reversed) the inhibitory effect of nLDL and agLDL in the repair of the cell depleted areas. In addition, rosuvastatin significantly abolished the agLDL-induced dephosphorylation of myosin regulatory light chain as demonstrated by 2DE-electrophoresis and mass spectrometry. Besides, confocal microscopy showed that rosuvastatin enhances actin-cytoskeleton reorganization during lipid-loaded-VSMC attachment and spreading. The effects of rosuvastatin on actin-cytoskeleton dynamics and cell migration were dependent on ROCK-signalling. Furthermore, rosuvastatin caused a significant increase in RhoA-GTP in the cytosol of VSMC. Taken together, our study demonstrated that inhibition of HMG-CoA reductase restores the migratory capacity and repair function of VSMC that is impaired by native and aggregated LDL. This mechanism may contribute to the stabilization of lipid-rich atherosclerotic plaques afforded by statins.	[Padro, Teresa; Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina] Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain; [Padro, Teresa; Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina] Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina] Inst Carlos III, CiberOBN, Barcelona, Spain; [Badimon, Lina] Autonomous Univ Barcelona, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Autonomous University of Barcelona	Padro, T (corresponding author), Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain.	lbadimon@csic-iccc.org	BADIMON, LINA/S-2950-2019; BADIMON, LINA/O-4711-2014	BADIMON, LINA/0000-0002-9162-2459; Padro, Teresa/0000-0003-1921-954X; Lugano, Roberta/0000-0002-7294-345X	Spanish Ministery of Science [SAF SAF2010-16549]; Instituto Carlos III (Spanish Ministry of Health) [FIS-PI071070, FISPI10-01115]; CIBEROBN [CB06/03]; REDINSCOR [RD06/0003/0015]; TERCEL [RD06/0010/0017]; Spanish Society of Atherosclerosis (SEA); Fundacion Jesus Serra; CIBEROBN; ICCC	Spanish Ministery of Science(Spanish Government); Instituto Carlos III (Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government); CIBEROBN; REDINSCOR; TERCEL; Spanish Society of Atherosclerosis (SEA); Fundacion Jesus Serra; CIBEROBN; ICCC	This work was supported by grants from the Spanish Ministery of Science (SAF SAF2010-16549 to LB); from the Instituto Carlos III (Spanish Ministry of Health), FIS-PI071070 and FISPI10-01115 (to TP), CIBEROBN CB06/03 (to LB), REDINSCOR RD06/0003/0015 (to TP), TERCEL RD06/0010/0017 (to LB); Spanish Society of Atherosclerosis (SEA) and "Fundacion Jesus Serra". This project is part of the PROMISE European Training Program (Germany and Spain). RL is recipient of a predoctoral grant from the CIBEROBN (2008-2009) and ICCC (2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Badimon L, 2006, CURR MOL MED, V6, P439, DOI 10.2174/156652406778018725; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bentzon JF, 2007, CIRCULATION, V116, P2053, DOI 10.1161/CIRCULATIONAHA.107.722355; Brookes ZLS, 2009, BRIT J ANAESTH, V103, P99, DOI 10.1093/bja/aep149; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Burke AP, 2001, HERZ, V26, P239, DOI 10.1007/PL00002026; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; Camino-Lopez S, 2007, CARDIOVASC RES, V73, P208, DOI 10.1016/j.cardiores.2006.10.017; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Corti R, 2001, CIRCULATION, V104, P249, DOI 10.1161/01.CIR.104.3.249; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FLUGELMAN MY, 1993, CIRCULATION, V88, P2493, DOI 10.1161/01.CIR.88.6.2493; Garcia-Arguinzonis M, 2010, ARTERIOSCL THROM VAS, V30, P1212, DOI 10.1161/ATVBAHA.109.198440; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gronros J, 2008, AM J PHYSIOL-HEART C, V295, pH2046, DOI 10.1152/ajpheart.00133.2008; GUYTON JR, 1991, J LIPID RES, V32, P953; Heasman Sarah J, 2010, Small GTPases, V1, P174, DOI 10.4161/sgtp.1.3.14724; Hirano Katsuya, 2004, Journal of Smooth Muscle Research, V40, P219, DOI 10.1540/jsmr.40.219; Kadoglou NPE, 2010, J VASC SURG, V51, P114, DOI 10.1016/j.jvs.2009.07.119; Kiyan J, 2007, ATHEROSCLEROSIS, V195, P254, DOI 10.1016/j.atherosclerosis.2006.12.030; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Llorente-Cortes V, 1998, ARTERIOSCL THROM VAS, V18, P738, DOI 10.1161/01.ATV.18.5.738; Llorente-Cortes V, 2004, EUR J CLIN INVEST, V34, P182, DOI 10.1111/j.1365-2362.2004.01316.x; Llorente-Cortes V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P1905, DOI 10.1161/01.ATV.0000035391.46201.9A; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Llorente-Cortes V, 2011, EUR J CLIN INVEST, V41, P1087, DOI 10.1111/j.1365-2362.2011.02513.x; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; LUPU F, 1994, ARTERIOSCLER THROMB, V14, P1438, DOI 10.1161/01.ATV.14.9.1438; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Menna PL, 2009, MOL MED REP, V2, P97, DOI 10.3892/mmr_00000068; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Oorni K, 2000, J LIPID RES, V41, P1703; Padro T, 2008, CARDIOVASC RES, V77, P211, DOI 10.1093/cvr/cvm045; PEDERSEN TR, 1994, LANCET, V344, P1383; Pentikainen MO, 1996, J LIPID RES, V37, P2638; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schafer K, 2005, THROMB HAEMOSTASIS, V93, P145, DOI 10.1160/TH04-07-0415; Seasholtz TM, 2004, MOL INTERV, V4, P348, DOI 10.1124/mi.4.6.8; Sendra J, 2008, CARDIOVASC RES, V78, P581, DOI 10.1093/cvr/cvn043; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Suzuki Hideo, 2003, J Atheroscler Thromb, V10, P109; Turner SJ, 2008, BIOCHEM PHARMACOL, V75, P405, DOI 10.1016/j.bcp.2007.08.031; Underhill HR, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.018; Watanabe K, 2005, J AM COLL CARDIOL, V46, P2022, DOI 10.1016/j.jacc.2005.04.070; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Weiss S, 2007, J VASC RES, V44, P149, DOI 10.1159/000099141; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Williams KJ, 2001, CURR OPIN LIPIDOL, V12, P477, DOI 10.1097/00041433-200110000-00002; Wu Chuanshen, 2011, Commun Integr Biol, V4, P703; Yamagami H, 2008, ULTRASOUND MED BIOL, V34, P1353, DOI 10.1016/j.ultrasmedbio.2008.01.019	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38935	10.1371/journal.pone.0038935	http://dx.doi.org/10.1371/journal.pone.0038935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719992	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340000054
J	Foulongne, V; Sauvage, V; Hebert, C; Dereure, O; Cheval, J; Gouilh, MA; Pariente, K; Segondy, M; Burguiere, A; Manuguerra, JC; Caro, V; Eloit, M				Foulongne, Vincent; Sauvage, Virginie; Hebert, Charles; Dereure, Olivier; Cheval, Justine; Gouilh, Meriadeg Ar; Pariente, Kevin; Segondy, Michel; Burguiere, Ana; Manuguerra, Jean-Claude; Caro, Valerie; Eloit, Marc			Human Skin Microbiota: High Diversity of DNA Viruses Identified on the Human Skin by High Throughput Sequencing	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; HUMAN-PAPILLOMAVIRUS INFECTIONS; GENOMIC CHARACTERIZATION; MOLECULAR ANALYSIS; SAMPLES; PREVALENCE; SPECTRUM; INSIGHTS	The human skin is a complex ecosystem that hosts a heterogeneous flora. Until recently, the diversity of the cutaneous microbiota was mainly investigated for bacteria through culture based assays subsequently confirmed by molecular techniques. There are now many evidences that viruses represent a significant part of the cutaneous flora as demonstrated by the asymptomatic carriage of beta and gamma-human papillomaviruses on the healthy skin. Furthermore, it has been recently suggested that some representatives of the Polyomavirus genus might share a similar feature. In the present study, the cutaneous virome of the surface of the normal-appearing skin from five healthy individuals and one patient with Merkel cell carcinoma was investigated through a high throughput metagenomic sequencing approach in an attempt to provide a thorough description of the cutaneous flora, with a particular focus on its viral component. The results emphasize the high diversity of the viral cutaneous flora with multiple polyomaviruses, papillomaviruses and circoviruses being detected on normal-appearing skin. Moreover, this approach resulted in the identification of new Papillomavirus and Circovirus genomes and confirmed a very low level of genetic diversity within human polyomavirus species. Although viruses are generally considered as pathogen agents, our findings support the existence of a complex viral flora present at the surface of healthy-appearing human skin in various individuals. The dynamics and anatomical variations of this skin virome and its variations according to pathological conditions remain to be further studied. The potential involvement of these viruses, alone or in combination, in skin proliferative disorders and oncogenesis is another crucial issue to be elucidated.	[Foulongne, Vincent; Dereure, Olivier; Segondy, Michel] Univ Montpellier I, Montpellier Univ Hosp, INSERM, Dept Biol & Pathol,Lab Virol,U1058, Montpellier, France; [Foulongne, Vincent; Dereure, Olivier; Segondy, Michel] Dept Dermatol, Montpellier, France; [Sauvage, Virginie; Gouilh, Meriadeg Ar; Burguiere, Ana; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Hebert, Charles; Cheval, Justine; Pariente, Kevin; Eloit, Marc] Pathoquest, Paris, France; [Eloit, Marc] ANSES, INRA, Ecole Natl Vet Alfort, UMR Virol ENVA 1161, Maisons Alfort, France; [Eloit, Marc] Inst Pasteur, Dept Virol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Foulongne, V (corresponding author), Univ Montpellier I, Montpellier Univ Hosp, INSERM, Dept Biol & Pathol,Lab Virol,U1058, Montpellier, France.	marc.eloit@pasteur.fr	Gouilh, Meriadeg Ar/E-4896-2017; Gouilh, Meriadeg Ar/O-4357-2019	Gouilh, Meriadeg Ar/0000-0002-3672-9974; Gouilh, Meriadeg Ar/0000-0002-3672-9974	Institut de Veille Sanitaire (Saint-Maurice, France); region Ile de France; Montpellier University Hospital [AOI 2008, UF8425]	Institut de Veille Sanitaire (Saint-Maurice, France); region Ile de France(Region Ile-de-France); Montpellier University Hospital	The platform "Genotyping of Pathogens and Public Health" is supported in part by the Institut de Veille Sanitaire (Saint-Maurice, France). This study was partly supported by grants from both region Ile de France and the Programme Hospitalier de Recherche Clinique of the Montpellier University Hospital (AOI 2008, Protocole UF8425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Arron ST, 2011, BRIT J DERMATOL, V164, P1201, DOI 10.1111/j.1365-2133.2011.10322.x; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Biagini P, 2004, VET MICROBIOL, V98, P95, DOI 10.1016/j.vetmic.2003.10.004; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Calder KB, 2010, ADV ANAT PATHOL, V17, P155, DOI 10.1097/PAP.0b013e3181d97836; Chen ACH, 2008, J GEN VIROL, V89, P2891, DOI 10.1099/vir.0.2008/003665-0; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubina M, 2009, AM J DERMATOPATH, V31, P561, DOI 10.1097/DAD.0b013e3181a58234; Duncavage EJ, 2011, J CUTAN PATHOL, V38, P790, DOI 10.1111/j.1600-0560.2011.01765.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Foulongne V, 2010, EMERG INFECT DIS, V16, P685, DOI 10.3201/eid1604.091278; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Giardina E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-159; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hsu JYC, 2009, J MED VIROL, V81, P1444, DOI 10.1002/jmv.21529; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Kohler A, 2010, VIROLOGY, V399, P129, DOI 10.1016/j.virol.2009.12.023; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Li SK, 2011, CLIN MICROBIOL  1004, DOI [10.1111/j.1469-0691.2011.03690, DOI 10.1111/J.1469-0691.2011.03690]; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Sauvage V, 2011, EMERG INFECT DIS, V17, P1364, DOI 10.3201/eid1708.110278; Sauvage V, 2011, J VIROL, V85, P7948, DOI 10.1128/JVI.00639-11; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Schrama D, 2012, J INVEST DERMATOL, V132, P239, DOI 10.1038/jid.2011.261; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Weissenborn SJ, 2009, J VIROL METHODS, V161, P280, DOI 10.1016/j.jviromet.2009.06.024; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575	44	255	260	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38499	10.1371/journal.pone.0038499	http://dx.doi.org/10.1371/journal.pone.0038499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723863	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700017
J	Li, YF; Zhu, XM; Liu, F; Xiao, CS; Bian, YF; Li, H; Cai, J; Li, RS; Yang, XC				Li, Ya-Feng; Zhu, Xiao-Ming; Liu, Fan; Xiao, Chuan-Shi; Bian, Yun-Fei; Li, Hong; Cai, Jun; Li, Rong-Shan; Yang, Xin-Chun			Angiotensin-Converting Enzyme (ACE) Gene Insertion/Deletion Polymorphism and ACE Inhibitor-Related Cough: A Meta-Analysis	PLOS ONE			English	Article							BRADYKININ B2 RECEPTOR; 2 ACTIVE-SITES; SUBSTANCE-P; ASSOCIATION; CHINESE; REFLEX; SUSCEPTIBILITY; HYPERTENSION; INPATIENTS; REDUCTION	Objective: An insertion/deletion (I/D) variant in the angiotensin-converting enzyme (ACE) gene was associated with ACE inhibitor (ACEI)-related cough in previous studies. However, the results were inconsistent. Our objective was to assess the relationship between the ACE I/D polymorphism and ACEI-related cough by meta-analysis and to summarize all studies that are related to ACE I/D polymorphism and ACEI-cough and make a summary conclusion to provide reference for the researchers who attempt to conduct such a study. Methods: Databases including PubMed, EMbase, Cochrane Library, and China National Knowledge Infrastructure, were searched for genetic association studies. Data were extracted by two independent authors and pooled odds ratio (OR) with 95% confidence interval (CI) was calculated. Metaregression and subgroup analyses were performed to identify the source of heterogeneity. Results: Eleven trials, including 906 cases (ACEI-related cough) and 1,175 controls, were reviewed in the present meta-analysis. The random effects pooled OR was 1.16 (95% CI: 0.78-1.74, p = 0.46) in the dominant model and 1.61 (95% CI: 1.18-2.20, p = 0.003) in the recessive model. Heterogeneity was found among and within studies. Metaregression indicated that the effect size was positively associated with age and negatively associated with follow-up duration of ACEI treatment. Subgroup analysis revealed a significant association between ACE I/D polymorphism and ACEI-related cough in studies with mean age >60 y, but not in studies with mean age <= 60 y. No heterogeneity was found within each mean age subgroup. We also found no association between ACE I/D polymorphism and ACEI-related cough in studies with follow-up >2 mo or in studies in Caucasians. No heterogeneity was detected in these two subgroups. Conclusions: Synthesis of the available evidence supports ACE I/D polymorphism as an age-dependent predictor for risk of ACEI-related cough.	[Li, Ya-Feng; Li, Rong-Shan] Shanxi Med Univ, Hosp 2, Dept Nephrol, Taiyuan, Shanxi, Peoples R China; [Li, Ya-Feng; Li, Rong-Shan] Shanxi Med Univ, Hosp 2, Hemodialysis Ctr, Taiyuan, Shanxi, Peoples R China; [Zhu, Xiao-Ming; Cai, Jun; Yang, Xin-Chun] Capital Med Univ, Dept Cardiol, Chaoyang Hosp, Beijing, Peoples R China; [Li, Ya-Feng; Xiao, Chuan-Shi; Bian, Yun-Fei; Li, Hong] Shanxi Med Univ, Hosp 2, Dept Cardiol, Taiyuan, Shanxi, Peoples R China; [Liu, Fan] Xiamen Univ, Coll Med, Xiamen, Fujian, Peoples R China	Shanxi Medical University; Shanxi Medical University; Capital Medical University; Shanxi Medical University; Xiamen University	Li, YF (corresponding author), Shanxi Med Univ, Hosp 2, Dept Nephrol, Taiyuan, Shanxi, Peoples R China.	rongshanli@yahoo.com.cn; yangxc2010@homail.com	Li, YaFeng/J-6247-2013; Zhu, XM/G-3435-2010	Li, YaFeng/0000-0002-7500-0959; li, rongshan/0000-0002-8082-4389				BUCKNALL CE, 1988, BRIT MED J, V296, P86, DOI 10.1136/bmj.296.6615.86; CATTANEO M, 1993, LANCET, V342, P812, DOI 10.1016/0140-6736(93)91581-6; CHADWICK IG, 1994, LANCET, V343, P740; Chalmers J, 1999, J HYPERTENS, V17, P151; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FULLER RW, 1987, BMJ-BRIT MED J, V295, P1025, DOI 10.1136/bmj.295.6605.1025-a; FURUYA K, 1994, LANCET, V343, P354, DOI 10.1016/S0140-6736(94)91190-8; Grilo A, 2011, PHARMACOGENET GENOM, V21, P10, DOI 10.1097/FPC.0b013e328341041c; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; JASPARD E, 1995, BIOCHEM BIOPH RES CO, V211, P528, DOI 10.1006/bbrc.1995.1845; JASPARD E, 1993, J BIOL CHEM, V268, P9496; JUST PM, 1989, PHARMACOTHERAPY, V9, P82; KAUFMAN MP, 1980, J APPL PHYSIOL, V48, P511, DOI 10.1152/jappl.1980.48.3.511; Kim JH, 1999, TUBERCUL RESP DIS, V46, P241; KREFTJAIS C, 1994, LANCET, V343, P740, DOI 10.1016/S0140-6736(94)91627-6; Lee YJ, 2001, METABOLISM, V50, P1346, DOI 10.1053/meta.2001.27212; Lu Jun, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P498; Morice AH, 1997, THORAX, V52, P111, DOI 10.1136/thx.52.2.111; MORICE AH, 1987, LANCET, V2, P1116; Mukae S, 2002, J HUM HYPERTENS, V16, P857, DOI 10.1038/sj.jhh.1001486; Newnham DM, 1997, AGE AGEING, V26, P185, DOI 10.1093/ageing/26.3.185; Nishio K, 2011, WORLD J CARDIOL, V3, P329, DOI 10.4330/wjc.v3.i10.329; Okaishi K, 1999, AM J HYPERTENS, V12, P778, DOI 10.1016/S0895-7061(99)00035-7; Okumura H, 2001, YAKUGAKU ZASSHI, V121, P253, DOI 10.1248/yakushi.121.253; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Shi M, 2008, RELATIONSHIP POLYMOR, DOI CNKI:SUN:HBYK.0.2008-01-026; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Takahashi T, 2005, AM J HYPERTENS, V18, P1353, DOI 10.1016/j.amjhyper.2005.04.020; Takahashi T, 2001, RESP MED, V95, P130, DOI 10.1053/rmed.2000.1005; [唐晓鸿 TANG XiaoHong], 2008, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V16, P376; The SOLVD Investigators, 1997, NEW ENGL J MED, V325, P293; TIRET L, 1992, AM J HUM GENET, V51, P197; Tomaki M, 1996, THORAX, V51, P199, DOI 10.1136/thx.51.2.199; UJIIE Y, 1993, AM REV RESPIR DIS, V148, P1628, DOI 10.1164/ajrccm/148.6_Pt_1.1628; Waeber B, 1996, J CARDIOVASC PHARM, V27, pS36; WANG H.J., 2003, LINKAGE ANAL ASS GEN; WOO J, 1991, BRIT J CLIN PRACT, V45, P178; WOO KS, 1995, BRIT J CLIN PHARMACO, V40, P141; WOO KS, 1995, AM J CARDIOL, V75, P967; Woo SW, 2009, J CLIN PHARM THER, V34, P561, DOI 10.1111/j.1365-2710.2009.01028.x; Wu J, 1999, ASS GENE POLYMORPHIS, DOI CNKI:SUN:YIYA. 0.1999-03-002; Yang Su-min, 2003, Zhonghua Jiehe He Huxi Zazhi, V26, P203; Ye Ruan-jian, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P581; YEO WW, 1990, J HUM HYPERTENS, V4, P517; Yeo WW, 1992, P BPS 9 11 SEPT 1992; Zee RYL, 1998, HYPERTENSION, V31, P925, DOI 10.1161/01.HYP.31.4.925; Zhou TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019599	51	17	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37396	10.1371/journal.pone.0037396	http://dx.doi.org/10.1371/journal.pone.0037396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723835	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700004
J	Shang, L; Xu, WJ; Ozer, S; Gutell, RR				Shang, Lei; Xu, Weijia; Ozer, Stuart; Gutell, Robin R.			Structural Constraints Identified with Covariation Analysis in Ribosomal RNA	PLOS ONE			English	Article							HIGHER-ORDER STRUCTURE; SIGNAL RECOGNITION PARTICLE; PHENYLALANINE TRANSFER-RNA; SECONDARY STRUCTURE MODEL; CRYSTAL-STRUCTURE; BASE-TRIPLES; SEQUENCE; INFORMATION; PATTERNS; DOMAIN	Covariation analysis is used to identify those positions with similar patterns of sequence variation in an alignment of RNA sequences. These constraints on the evolution of two positions are usually associated with a base pair in a helix. While mutual information (MI) has been used to accurately predict an RNA secondary structure and a few of its tertiary interactions, early studies revealed that phylogenetic event counting methods are more sensitive and provide extra confidence in the prediction of base pairs. We developed a novel and powerful phylogenetic events counting method (PEC) for quantifying positional covariation with the Gutell lab's new RNA Comparative Analysis Database (rCAD). The PEC and MI-based methods each identify unique base pairs, and jointly identify many other base pairs. In total, both methods in combination with an N-best and helix-extension strategy identify the maximal number of base pairs. While covariation methods have effectively and accurately predicted RNAs secondary structure, only a few tertiary structure base pairs have been identified. Analysis presented herein and at the Gutell lab's Comparative RNA Web (CRW) Site reveal that the majority of these latter base pairs do not covary with one another. However, covariation analysis does reveal a weaker although significant covariation between sets of nucleotides that are in proximity in the three-dimensional RNA structure. This reveals that covariation analysis identifies other types of structural constraints beyond the two nucleotides that form a base pair.	[Shang, Lei; Gutell, Robin R.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Xu, Weijia] Univ Texas Austin, Texas Adv Comp Ctr, Austin, TX 78712 USA; [Ozer, Stuart] Microsoft Corp, Redmond, WA 98052 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Microsoft	Shang, L (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	robin.gutell@mail.utexas.edu			Microsoft Research; National Institutes of Health [GM067317, GM085337]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085337, R01GM067317] Funding Source: NIH RePORTER	Microsoft Research(Microsoft); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded by an External Research grant from Microsoft Research (awarded to RRG), and the National Institutes of Health (GM067317(awarded to RRG) and GM085337(awarded to RRG and WX)). Lei Shang was supported by NIH grants GM067317 and GM085337. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. While Stuart Ozer is an employee of Microsoft, no one else at Microsoft / Microsoft Research was involved with any aspect of this manuscript. No additional external funding received for this study.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNHART SH, 2008, BMC BIOINFORMATICS, V9; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHARGAFF E, 1951, J CELL COMPAR PHYSL, V38, P41, DOI 10.1002/jcp.1030380406; CHARGAFF E, 1950, EXPERIENTIA, V6, P201, DOI 10.1007/BF02173653; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Conn GL, 1998, BIOCHEMISTRY-US, V37, P11980, DOI 10.1021/bi980825+; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; FOX GE, 1975, NATURE, V256, P505, DOI 10.1038/256505a0; Gautheret D, 1997, NUCLEIC ACIDS RES, V25, P1559, DOI 10.1093/nar/25.8.1559; GAUTHERET D, 1995, J MOL BIOL, V248, P27, DOI 10.1006/jmbi.1995.0200; GUTELL RR, 1993, CURR OPIN STRUC BIOL, V3, P313, DOI 10.1016/S0959-440X(05)80101-0; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1990, P NATL ACAD SCI USA, V87, P663, DOI 10.1073/pnas.87.2.663; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; GUTELL RR, 1986, EMBO J, V5, P1111, DOI 10.1002/j.1460-2075.1986.tb04330.x; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; Hainzl T, 2002, NATURE, V417, P767, DOI 10.1038/nature00768; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kazantsev AV, 2005, P NATL ACAD SCI USA, V102, P13392, DOI 10.1073/pnas.0506662102; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Lee JC, 2004, J MOL BIOL, V344, P1225, DOI 10.1016/j.jmb.2004.09.072; Lindgreen S, 2006, BIOINFORMATICS, V22, P2988, DOI 10.1093/bioinformatics/btl514; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; Olsen GJ, 1983, COMP ANAL NUCLEOTIDE; Ozer S, 2011, 7 IEEE INT C E SCI; PACE NR, 1989, GENE, V82, P65, DOI 10.1016/0378-1119(89)90031-0; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Sadowski MI, 2011, COMPUT BIOL CHEM, V35, P323, DOI 10.1016/j.compbiolchem.2011.08.002; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SUDDATH FL, 1974, NATURE, V248, P20, DOI 10.1038/248020a0; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Tuffery P, 2000, MOL BIOL EVOL, V17, P1753, DOI 10.1093/oxfordjournals.molbev.a026273; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Williams KP, 1996, RNA, V2, P1306; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; Xu WJ, 2009, LECT NOTES COMPUT SC, V5566, P200; Yeang CH, 2007, MOL BIOL EVOL, V24, P2119, DOI 10.1093/molbev/msm142; ZWIEB C, 1985, NUCLEIC ACIDS RES, V13, P6105, DOI 10.1093/nar/13.17.6105	69	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39383	10.1371/journal.pone.0039383	http://dx.doi.org/10.1371/journal.pone.0039383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724009	gold, Green Submitted, Green Published			2022-12-27	WOS:000305652700074
J	Scherrer, AU; Ledergerber, B; von Wyl, V; Boni, J; Yerly, S; Klimkait, T; Cellerai, C; Furrer, H; Calmy, A; Cavassini, M; Elzi, L; Vernazza, PL; Bernasconi, E; Gunthard, HF				Scherrer, Alexandra U.; Ledergerber, Bruno; von Wyl, Viktor; Boeni, Juerg; Yerly, Sabine; Klimkait, Thomas; Cellerai, Cristina; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Guenthard, Huldrych F.		Swiss HIV Cohort Study SHCS	Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; PROPENSITY SCORE; NATURAL POLYMORPHISMS; IMPACT; REGRESSION; SELECTION; STRAINS	Background: Minor protease inhibitor (PI) mutations often exist as polymorphisms in HIV-1 sequences from treatment-naive patients. Previous studies showed that their presence impairs the antiretroviral treatment (ART) response. Evaluating these findings in a larger cohort is essential. Methods: To study the impact of minor PI mutations on time to viral suppression and time to virological failure, we included patients from the Swiss HIV Cohort Study infected with HIV-1 subtype B who started first-line ART with a PI and two nucleoside reverse transcriptase inhibitors. Cox regression models were performed to compare the outcomes among patients with 0 and >= 1 minor PI mutation. Models were adjusted for baseline HIV-1 RNA, CD4 cell count, sex, transmission category, age, ethnicity, year of ART start, the presence of nucleoside reverse transcriptase inhibitor mutations, and stratified for the administered PIs. Results: We included 1199 patients of whom 944 (78.7%) received a boosted PI. Minor PI mutations associated with the administered PI were common: 41.7%, 16.1%, 4.7% and 1.9% had 1, 2, 3 or >= 4 mutations, respectively. The time to viral suppression was similar between patients with 0 (reference) and >= 1 minor PI mutation (multivariable hazard ratio (HR): 1.1 [95% confidence interval (CI): 1.0-1.3], P =.196). The time to virological failure was also similar (multivariable HR:.9 [95% CI:.5-1.6], P =.765). In addition, the impact of each single minor PI mutation was analyzed separately: none was significantly associated with the treatment outcome. Conclusions: The presence of minor PI mutations at baseline has no effect on the therapy outcome in HIV infected individuals.	[Scherrer, Alexandra U.; Ledergerber, Bruno; von Wyl, Viktor; Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Hosp Zurich, Zurich, Switzerland; [Boeni, Juerg] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Zurich, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Klimkait, Thomas] Univ Basel, Inst Med Microbiol, Basel, Switzerland; [Cellerai, Cristina] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland; [Furrer, Hansjakob] Univ Bern, Div Infect Dis, Univ Hosp Berne, Bern, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Cavassini, Matthias] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Elzi, Luigia] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Elzi, Luigia] Univ Basel Hosp, Hosp Epidemiol, CH-4031 Basel, Switzerland; [Vernazza, Pietro L.] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Geneva; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Basel; Kantonsspital St. Gallen	Scherrer, AU (corresponding author), Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Hosp Zurich, Zurich, Switzerland.	alexandra.scherrer@usz.ch	Furrer, Hansjakob/G-6768-2013; Ledergerber, Bruno/B-5656-2009; Boeni, Juerg/B-8386-2015; Pantaleo, Giuseppe/K-6163-2016; gunthard, huldrych f/F-1724-2011; cavassini, matthias/F-8987-2017	Furrer, Hansjakob/0000-0002-1375-3146; Ledergerber, Bruno/0000-0002-6881-4401; gunthard, huldrych f/0000-0002-1142-6723; von Wyl, Viktor/0000-0002-8754-9797; Klimkait, Thomas/0000-0003-4945-6511; cavassini, matthias/0000-0003-0933-7833	Swiss National Science Foundation (SNF) [33CS30-134277, 3247B0-112594, 324730-130865]; SHCS [470, 528, 569, 683]; European Community under Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) [223131]; Novartis Foundation; SHCS Research Foundation	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SHCS; European Community under Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); Novartis Foundation(Novartis); SHCS Research Foundation	This work was supported in the framework of the Swiss HIV Cohort Study, by the Swiss National Science Foundation (SNF grant # 33CS30-134277). Further support was provided by SNF grant # 3247B0-112594 (to HFG, SY and BL), SNF grant # 324730-130865 and the SHCS projects # 470, 528, 569, 683 the SHCS Research Foundation, the European Community's Seventh Framework Programme (grant FP7/2007-2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131). VvW was supported by a fellowship of the Novartis Foundation (formerly Ciba-Geigy Jubilee Foundation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brumme CJ, 2005, J INFECT DIS, V191, P1778, DOI 10.1086/429672; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Champenois K, 2008, J MED VIROL, V80, P1871, DOI 10.1002/jmv.21315; Frater AJ, 2001, AIDS, V15, P1493, DOI 10.1097/00002030-200108170-00006; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Holguin A, 2004, J CLIN VIROL, V31, P215, DOI 10.1016/j.jcv.2004.03.015; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kinomoto M, 2005, CLIN INFECT DIS, V41, P243, DOI 10.1086/431197; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Perno CF, 2004, J INFECT DIS, V189, P1983, DOI 10.1086/386307; Perno CF, 2001, J INFECT DIS, V184, P983, DOI 10.1086/323604; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; Ribaudo H, 2011, RACE DIFFERENCES EFF; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Servais J, 2001, ANTIVIR THER, V6, P239; Shafer RW, 2008, AIDS REV, V10, P67; Staehelin C, 2011, J ACQ IMMUN DEF SYND, V59, P79; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van Maarseveen NM, 2006, JAIDS-J ACQ IMM DEF, V42, P162, DOI 10.1097/01.qai.0000219787.65915.56; Velazquez-Campoy A, 2001, P NATL ACAD SCI USA, V98, P6062, DOI 10.1073/pnas.111152698; Vergne L, 2003, AIDS, V17, P1105, DOI 10.1097/00002030-200305020-00028; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Vergne L, 2006, J CLIN VIROL, V36, P43, DOI 10.1016/j.jcv.2006.01.012; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Weitzen S, 2005, PHARMACOEPIDEM DR S, V14, P227, DOI 10.1002/pds.986; Young J, 2011, CLIN INFECT DIS, V52, P154, DOI 10.1093/cid/ciq079	32	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37983	10.1371/journal.pone.0037983	http://dx.doi.org/10.1371/journal.pone.0037983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719859	gold, Green Published, Green Accepted			2022-12-27	WOS:000305583300016
J	Mayr, LM; Powell, RL; Ngai, JN; Takang, WA; Nadas, A; Nyambi, PN				Mayr, Luzia M.; Powell, Rebecca L.; Ngai, Johnson N.; Takang, William A.; Nadas, Arthur; Nyambi, Phillipe N.			Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus	PLOS ONE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; PROXIMAL EXTERNAL REGION; TYPE-1 INFECTION; MONOCLONAL-ANTIBODIES; GENETIC SUBTYPES; CHIMERIC VIRUS; IN-DEPTH; GP120; PROTECTION; SEROTYPES	Recent studies have demonstrated that both the potency and breadth of the humoral anti-HIV-1 immune response in generating neutralizing antibodies (nAbs) against heterologous viruses are significantly enhanced after superinfection by discordant HIV-1 subtypes, suggesting that repeated exposure of the immune system to highly diverse HIV-1 antigens can significantly improve anti-HIV-1 immunity. Thus, we investigated whether sequential plasma from these subjects superinfected with discordant HIV-1 subtypes, who exhibit broad nAbs against heterologous viruses, also neutralize their discordant early autologous viruses with increasing potency. Comparing the neutralization capacities of sequential plasma obtained before and after superinfection of 4 subjects to those of matched plasma obtained from 4 singly infected control subjects, no difference in the increase in neutralization capacity was observed between the two groups (p = 0.328). Overall, a higher increase in neutralization over time was detected in the singly infected patients (mean change in IC50 titer from first to last plasma sample: 183.4) compared to the superinfected study subjects (mean change in IC50 titer from first to last plasma sample: 66.5). Analysis of the Breadth-Potency Scores confirmed that there was no significant difference in the increase in superinfected and singly infected study subjects (p = 0.234). These studies suggest that while superinfection by discordant subtypes induces antibodies with enhanced neutralizing breadth and potency against heterologous viruses, the potency to neutralize their autologous viruses is not better than those seen in singly infected patients.	[Mayr, Luzia M.; Nyambi, Phillipe N.] NYU, Sch Med, Dept Pathol, New York, NY 10012 USA; [Powell, Rebecca L.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ngai, Johnson N.; Takang, William A.] Med Diagnost Ctr, Serol Unit, Yaounde, Cameroon; [Takang, William A.] Univ Yaounde, Teaching Hosp, Dept Obstet & Gynaecol, Yaounde, Cameroon; [Nadas, Arthur] NYU, Sch Med, Inst Environm Med, New York, NY USA; [Nyambi, Phillipe N.] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	New York University; New York University; University of Yaounde I; New York University	Mayr, LM (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10012 USA.	phillipe.nyambi@nyumc.org			National Institute of Allergy and Infectious Diseases (NIAID) [AI083142]; National Cancer Institute (NCI) [CA153726]; Fogarty International Center (FIC) [TW01409]; Department of Veterans Affairs; FOGARTY INTERNATIONAL CENTER [D43TW001409] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083142, R01AI083142] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Veterans Affairs(US Department of Veterans Affairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI083142 from the National Institute of Allergy and Infectious Diseases (NIAID), CA153726 from the National Cancer Institute (NCI), TW01409 from Fogarty International Center (FIC), and funds from the Department of Veterans Affairs (Merit Review Award and the Research Enhancement Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Barin F, 2004, J INFECT DIS, V189, P322, DOI 10.1086/380099; Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt;14::AID-JMV3&gt;3.0.CO;2-L; Blish CA, 2008, J VIROL; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; DOWBENKO D, 1988, J VIROL, V62, P4703, DOI 10.1128/JVI.62.12.4703-4711.1988; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GAUDUIN MC, 1995, J INFECT DIS, V171, P1203, DOI 10.1093/infdis/171.5.1203; Geffin R, 2003, VIROLOGY, V310, P207, DOI 10.1016/S0042-6822(03)00137-5; Gerhardt M, 2005, J VIROL, V79, P8249, DOI 10.1128/JVI.79.13.8249-8261.2005; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; GOUDSMIT J, 1988, AIDS, V2, pS41, DOI 10.1097/00002030-198800001-00006; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kostrikis LG, 1996, AIDS RES HUM RETROV, V12, P1667, DOI 10.1089/aid.1996.12.1667; Kostrikis LG, 1996, J VIROL, V70, P445, DOI 10.1128/JVI.70.1.445-458.1996; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; Legrand E, 1997, AIDS RES HUM RETROV, V13, P1383, DOI 10.1089/aid.1997.13.1383; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Louisirirotchanakul S, 1998, J ACQ IMMUN DEF SYND, V19, P315, DOI 10.1097/00042560-199812010-00001; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McCutchan FE, 2005, J VIROL, V79, P11693, DOI 10.1128/JVI.79.18.11693-11704.2005; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; Moore JP, 2001, J VIROL, V75, P5721, DOI 10.1128/JVI.75.13.5721-5729.2001; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nyambi PN, 1996, J VIROL, V70, P6235, DOI 10.1128/JVI.70.9.6235-6243.1996; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; Powell RLR, 2010, AIDS RES HUM RETROV, V26, P253, DOI 10.1089/aid.2009.0174; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Powell RLR, 2008, HIGH FREQUENCY HIV 1; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Staden R, 2000, Methods Mol Biol, V132, P115; Weber J, 1996, J VIROL, V70, P7827, DOI 10.1128/JVI.70.11.7827-7832.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38989	10.1371/journal.pone.0038989	http://dx.doi.org/10.1371/journal.pone.0038989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720009	Green Published, gold			2022-12-27	WOS:000305347800034
J	Benesova, M; Hola, D; Fischer, L; Jedelsky, PL; Hnilicka, F; Wilhelmova, N; Rothova, O; Kocova, M; Prochazkova, D; Honnerova, J; Fridrichova, L; Hnilickova, H				Benesova, Monika; Hola, Dana; Fischer, Lukas; Jedelsky, Petr L.; Hnilicka, Frantisek; Wilhelmova, Nada; Rothova, Olga; Kocova, Marie; Prochazkova, Dagmar; Honnerova, Jana; Fridrichova, Lenka; Hnilickova, Helena			The Physiology and Proteomics of Drought Tolerance in Maize: Early Stomatal Closure as a Cause of Lower Tolerance to Short-Term Dehydration?	PLOS ONE			English	Article							WATER-DEFICIT; GLUTATHIONE-REDUCTASE; OXIDATIVE STRESS; WHEAT CULTIVARS; RICE LEAVES; DIFFERENTIAL RESPONSES; SUPEROXIDE-DISMUTASE; PROGRESSIVE DROUGHT; GENE-EXPRESSION; ABSCISIC-ACID	Understanding the response of a crop to drought is the first step in the breeding of tolerant genotypes. In our study, two maize (Zea mays L.) genotypes with contrasting sensitivity to dehydration were subjected to moderate drought conditions. The subsequent analysis of their physiological parameters revealed a decreased stomatal conductance accompanied by a slighter decrease in the relative water content in the sensitive genotype. In contrast, the tolerant genotype maintained open stomata and active photosynthesis, even under dehydration conditions. Drought-induced changes in the leaf proteome were analyzed by two independent approaches, 2D gel electrophoresis and iTRAQ analysis, which provided compatible but only partially overlapping results. Drought caused the up-regulation of protective and stress-related proteins (mainly chaperones and dehydrins) in both genotypes. The differences in the levels of various detoxification proteins corresponded well with the observed changes in the activities of antioxidant enzymes. The number and levels of up-regulated protective proteins were generally lower in the sensitive genotype, implying a reduced level of proteosynthesis, which was also indicated by specific changes in the components of the translation machinery. Based on these results, we propose that the hypersensitive early stomatal closure in the sensitive genotype leads to the inhibition of photosynthesis and, subsequently, to a less efficient synthesis of the protective/detoxification proteins that are associated with drought tolerance.	[Benesova, Monika; Hola, Dana; Rothova, Olga; Kocova, Marie; Honnerova, Jana; Fridrichova, Lenka] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Fischer, Lukas] Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Lab Mass Spectrometry, Prague, Czech Republic; [Hnilicka, Frantisek; Hnilickova, Helena] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Bot & Plant Physiol, Prague, Czech Republic; [Wilhelmova, Nada] Acad Sci Czech Republ, Inst Expt Bot, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Benesova, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	danahola@natur.cuni.cz	Fischer, Lukáš/M-6516-2017; Hnilička, František/E-3932-2018; Holá, Dana/H-9344-2016; Kočová, Marie/S-7733-2017; Procházková, Dagmar/F-7806-2014; Jedelsky, Petr/C-5879-2009; Wilhelmova, Nada/G-7239-2014; Hniličková, Helena/E-2314-2018; Rothova, Olga/S-7688-2017	Fischer, Lukáš/0000-0003-1852-0461; Hnilička, František/0000-0002-3223-9062; Holá, Dana/0000-0002-2080-8774; Kočová, Marie/0000-0001-7354-7937; Jedelsky, Petr/0000-0003-3813-2343; Wilhelmova, Nada/0000-0002-5546-5513; Hniličková, Helena/0000-0003-0057-8139; Rothova, Olga/0000-0002-2811-6967	Czech Science Foundation [521/07/0470]; Grant Agency of Charles University [101808 B-BIO, SVV-2012-265202]; Ministry of Education, Youth, and Sports of the Czech Republic [LC06034, MSM0021620858, MSM6046070901]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was financially supported by grants No. 521/07/0470 of the Czech Science Foundation, Nos. 101808 B-BIO and SVV-2012-265202 of the Grant Agency of Charles University, and Nos. LC06034, MSM0021620858, and MSM6046070901 from the Ministry of Education, Youth, and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Huerta-Ocampo JA, 2009, INT J PLANT SCI, V170, P990, DOI 10.1086/605119; Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Ashraf M, 2010, Biotechnol Adv, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; Bonhomme L, 2009, PROTEOMICS, V9, P4121, DOI 10.1002/pmic.200900047; Bonhomme L, 2009, PHYTOCHEMISTRY, V70, P988, DOI 10.1016/j.phytochem.2009.05.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bray E. A., 2007, ADV MOL BREEDING DRO, P121; Caruso G, 2009, PLANT SCI, V177, P570, DOI 10.1016/j.plantsci.2009.08.007; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Cellier F, 1998, PLANT PHYSIOL, V116, P319, DOI 10.1104/pp.116.1.319; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chernyad'ev II, 2005, APPL BIOCHEM MICRO+, V41, P115, DOI 10.1007/s10438-005-0021-9; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Contour-Ansel D, 2006, ANN BOT-LONDON, V98, P1279, DOI 10.1093/aob/mcl217; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; D'Arcy-Lameta A, 2006, ANN BOT-LONDON, V97, P133, DOI 10.1093/aob/mcj010; de Vienne D, 1999, J EXP BOT, V50, P303, DOI 10.1093/jexbot/50.332.303; Edjolo A, 2001, J PLANT PHYSIOL, V158, P1511, DOI 10.1078/0176-1617-00544; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Fenta BA, 2012, J AGRON CROP SCI, V198, P92, DOI 10.1111/j.1439-037X.2011.00491.x; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Fulda S, 2011, PLANT BIOLOGY, V13, P632, DOI 10.1111/j.1438-8677.2010.00426.x; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Grzesiak MT, 2007, PHOTOSYNTHETICA, V45, P280, DOI 10.1007/s11099-007-0045-x; Grzesiak MT, 2006, PHOTOSYNTHETICA, V44, P561, DOI 10.1007/s11099-006-0072-z; Guo Z, 2006, PLANT PHYSIOL BIOCH, V44, P828, DOI 10.1016/j.plaphy.2006.10.024; Hajheidari M, 2005, PROTEOMICS, V5, P950, DOI 10.1002/pmic.200401101; Hajheidari M, 2007, J PROTEOME RES, V6, P1451, DOI 10.1021/pr060570j; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hola D, 2007, J PLANT PHYSIOL, V164, P868, DOI 10.1016/j.jplph.2006.04.016; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Kottapalli KR, 2009, PLANT CELL ENVIRON, V32, P380, DOI 10.1111/j.1365-3040.2009.01933.x; Kumari Meena, 2004, Indian Journal of Plant Physiology, V9, P203; Langridge Peter, 2006, Briefings in Functional Genomics & Proteomics, V4, P343, DOI 10.1093/bfgp/eli005; Lascano HR, 2001, AUST J PLANT PHYSIOL, V28, P1095, DOI 10.1071/PP01061; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Loggini B, 1999, PLANT PHYSIOL, V119, P1091, DOI 10.1104/pp.119.3.1091; Lopes MS, 2011, J EXP BOT, V62, P3135, DOI 10.1093/jxb/err105; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mechin V, 2004, PHYTOCHEMISTRY, V65, P1609, DOI 10.1016/j.phytochem.2004.04.035; Medrano H, 2002, ANN BOT-LONDON, V89, P895, DOI 10.1093/aob/mcf079; Mohammadkhani N, 2008, TURK J BIOL, V32, P23; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Oliver MJ, 2011, PHYTOCHEMISTRY, V72, P1273, DOI 10.1016/j.phytochem.2010.10.020; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Parry MAJ, 2002, ANN BOT-LONDON, V89, P833, DOI 10.1093/aob/mcf103; PASTORI GM, 1992, PLANT CELL PHYSIOL, V33, P957; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; Pinheiro C, 2005, PLANTA, V221, P716, DOI 10.1007/s00425-004-1478-0; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Pospisilova J, 2005, BIOL PLANTARUM, V49, P533, DOI 10.1007/s10535-005-0047-0; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Ribaut JM, 2012, HDB MAIZE ITS BIOL, P311; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Riccardi F, 2004, PLANT PHYSIOL BIOCH, V42, P1003, DOI 10.1016/j.plaphy.2004.09.009; ROSIELLE AA, 1981, CROP SCI, V21, P943, DOI 10.2135/cropsci1981.0011183X002100060033x; Sairam RK, 2000, J AGRON CROP SCI, V184, P55, DOI 10.1046/j.1439-037x.2000.00358.x; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Salekdeh GH, 2002, FIELD CROP RES, V76, P199, DOI 10.1016/S0378-4290(02)00040-0; Salekdeh GH, 2007, PROTEOMICS, V7, P2976, DOI 10.1002/pmic.200700181; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M., 2007, PLANT GENE, V12, P261, DOI [10.1007/978-1-4020-5578-2_11, DOI 10.1007/978-1-4020-5578-2_11]; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Shu LB, 2010, J INTEGR PLANT BIOL, V52, P981, DOI 10.1111/j.1744-7909.2010.00986.x; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Tai FJ, 2011, PLANT OMICS, V4, P250; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; Taylor NL, 2009, J PROTEOMICS, V72, P367, DOI 10.1016/j.jprot.2008.11.006; Thomas DJ, 1998, PLANT PHYSIOL, V116, P1593, DOI 10.1104/pp.116.4.1593; Torres-Franklin ML, 2008, J PLANT PHYSIOL, V165, P514, DOI 10.1016/j.jplph.2007.03.011; TRACHSEL H, 1979, BIOCHIM BIOPHYS ACTA, V565, P305, DOI 10.1016/0005-2787(79)90207-7; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Veeranagamallaiah G, 2011, J PLANT PHYSIOL, V168, P671, DOI 10.1016/j.jplph.2010.09.007; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Vincent D, 2007, J EXP BOT, V58, P1873, DOI 10.1093/jxb/erm012; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wood AJ, 1997, PHYSIOL PLANTARUM, V99, P144, DOI 10.1034/j.1399-3054.1997.990120.x; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xiao XW, 2009, PHYSIOL PLANTARUM, V136, P150, DOI 10.1111/j.1399-3054.2009.01222.x; Xiong JH, 2010, BOT STUD, V51, P137; Xu CP, 2010, CROP SCI, V50, P2543, DOI 10.2135/cropsci2010.03.0152; Xu CP, 2010, J PLANT PHYSIOL, V167, P1477, DOI 10.1016/j.jplph.2010.05.006; Yang F, 2010, PHYSIOL PLANTARUM, V139, P388, DOI 10.1111/j.1399-3054.2010.01375.x; Yordanov I., 2003, Bulgarian Journal of Plant Physiology, P187; Zarco-Perello E, 2005, AGROCIENCIA-MEXICO, V39, P517; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x; Zheng J, 2004, PLANT MOL BIOL, V55, P807, DOI 10.1007/s11103-005-1969-9	106	151	161	1	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38017	10.1371/journal.pone.0038017	http://dx.doi.org/10.1371/journal.pone.0038017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719860	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900017
J	Park, KE; Inerowicz, HD; Wang, X; Li, YF; Koser, S; Cabot, RA				Park, Ki-Eun; Inerowicz, H. Dorota; Wang, Xin; Li, Yanfang; Koser, Stephanie; Cabot, Ryan A.			Identification of Karyopherin alpha 1 and alpha 7 Interacting Proteins in Porcine Tissue	PLOS ONE			English	Article							IMPORTIN-ALPHA; NUCLEAR IMPORT; PIG OOCYTES; IN-VITRO; TRANSPORT; FAMILY; FERTILIZATION; SUBTYPE; SIGNALS; MEMBERS	Specialized trafficking systems in eukaryotic cells serve a critical role in partitioning intracellular proteins between the nucleus and cytoplasm. Cytoplasmic proteins (including chromatin remodeling enzymes and transcription factors) must gain access to the nucleus to exert their functions to properly program fundamental cellular events ranging from cell cycle progression to gene transcription. Knowing that nuclear import mediated by members of the karyopherin alpha family of transport receptors plays a critical role in regulating development and differentiation, we wanted to determine the identity of proteins that are trafficked by this karyopherin alpha pathway. To this end, we performed a GST pull-down assay using porcine orthologs of karyopherin alpha 1 (KPNA1) and karyopherin alpha 7 (KPNA7) and prey protein derived from porcine fibroblast cells and used a liquid chromatography and tandem mass spectrometry (LC-MS/MS) approach to determine the identity of KPNA1 and KPNA7 interacting proteins. Our screen revealed that the proteins that interact with KPNA1 and KPNA7 are generally nuclear proteins that possess nuclear localization signals. We further validated two candidate proteins from this screen and showed that they are able to be imported into the nucleus in vivo and also interact with members of the karyopherin alpha family of proteins in vitro. Our results also reveal the utility of using a GST pull-down approach coupled with LC-MS/MS to screen for protein interaction partners in a non-traditional model system.	[Park, Ki-Eun; Wang, Xin; Li, Yanfang; Koser, Stephanie; Cabot, Ryan A.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Inerowicz, H. Dorota] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Park, KE (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	rcabot@purdue.edu	Li, Yanfang/X-2055-2019		Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture [2009-65203-05667]	Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture	This project was supported in part by Agriculture and Food Research Initiative Competitive grant no. 2009-65203-05667 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abeydeera LR, 1997, BIOL REPROD, V57, P729, DOI 10.1095/biolreprod57.4.729; Abeydeera LR, 1998, BIOL REPROD, V58, P1316, DOI 10.1095/biolreprod58.5.1316; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Cabot RA, 2003, MOL REPROD DEV, V64, P292, DOI 10.1002/mrd.10238; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fukumoto M, 2011, CELL STRUCT FUNCT, V36, P57, DOI 10.1247/csf.10026; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Jimenez C., 1998, CURRENT PROTOCOLS PR; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Ly-Huynh JD, 2011, BIOL REPROD, V85, P1191, DOI 10.1095/biolreprod.111.091686; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Pumroy RA, 2012, J BIOL CHEM, V287, P2022, DOI 10.1074/jbc.M111.315838; Rother F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018310; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Shmidt T, 2007, NAT CELL BIOL, V9, P1337, DOI 10.1038/ncb1207-1337; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wang X, 2012, REPROD FERT DEVELOP, V24, P382, DOI 10.1071/RD11119; Welch K, 1999, MOL CELL BIOL, V19, P8400; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38990	10.1371/journal.pone.0038990	http://dx.doi.org/10.1371/journal.pone.0038990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720010	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900070
J	Ho, JR; Chapeaublanc, E; Kirkwood, L; Nicolle, R; Benhamou, S; Lebret, T; Allory, Y; Southgate, J; Radvanyi, F; Goud, B				Ho, Joel R.; Chapeaublanc, Elodie; Kirkwood, Lisa; Nicolle, Remy; Benhamou, Simone; Lebret, Thierry; Allory, Yves; Southgate, Jennifer; Radvanyi, Francois; Goud, Bruno			Deregulation of Rab and Rab Effector Genes in Bladder Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; EXCHANGE FACTOR; BREAST-CANCER; UROPLAKIN-IB; PPAR-GAMMA; EXPRESSION; MUTATIONS; PROTEIN; FGFR3; PROLIFERATION	Growing evidence indicates that Rab GTPases, key regulators of intracellular transport in eukaryotic cells, play an important role in cancer. We analysed the deregulation at the transcriptional level of the genes encoding Rab proteins and Rab-interacting proteins in bladder cancer pathogenesis, distinguishing between the two main progression pathways so far identified in bladder cancer: the Ta pathway characterized by a high frequency of FGFR3 mutation and the carcinoma in situ pathway where no or infrequent FGFR3 mutations have been identified. A systematic literature search identified 61 genes encoding Rab proteins and 223 genes encoding Rab-interacting proteins. Transcriptomic data were obtained for normal urothelium samples and for two independent bladder cancer data sets corresponding to 152 and 75 tumors. Gene deregulation was analysed with the SAM (significant analysis of microarray) test or the binomial test. Overall, 30 genes were down-regulated, and 13 were up-regulated in the tumor samples. Five of these deregulated genes (LEPRE1, MICAL2, RAB23, STXBP1, SYTL1) were specifically deregulated in FGFR3-non-mutated muscle-invasive tumors. No gene encoding a Rab or Rab-interacting protein was found to be specifically deregulated in FGFR3-mutated tumors. Cluster analysis showed that the RAB27 gene cluster (comprising the genes encoding RAB27 and its interacting partners) was deregulated and that this deregulation was associated with both pathways of bladder cancer pathogenesis. Finally, we found that the expression of KIF20A and ZWINT was associated with that of proliferation markers and that the expression of MLPH, MYO5B, RAB11A, RAB11FIP1, RAB20 and SYTL2 was associated with that of urothelial cell differentiation markers. This systematic analysis of Rab and Rab effector gene deregulation in bladder cancer, taking relevant tumor subgroups into account, provides insight into the possible roles of Rab proteins and their effectors in bladder cancer pathogenesis. This approach is applicable to other group of genes and types of cancer.	[Ho, Joel R.; Chapeaublanc, Elodie; Nicolle, Remy; Radvanyi, Francois; Goud, Bruno] Inst Curie, Ctr Rech, Paris, France; [Ho, Joel R.; Chapeaublanc, Elodie; Nicolle, Remy; Radvanyi, Francois; Goud, Bruno] CNRS, UMR 144, Paris, France; [Kirkwood, Lisa; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [Nicolle, Remy] Univ Evry, ISSB, Evry, France; [Benhamou, Simone] Inst Cancerol Gustave Roussy, UMR 8200, CNRS, Villejuif, France; [Benhamou, Simone] INSERM, U946, Paris, France; [Lebret, Thierry] Hop Foch, Dept Urol, Suresnes, France; [Allory, Yves] Grp Hosp Henri Mondor, AP HP, Dept Pathol, Creteil, France; [Allory, Yves] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of York - UK; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ho, JR (corresponding author), Inst Curie, Ctr Rech, Paris, France.	bruno.goud@curie.fr	Benhamou, Simone/K-6554-2015; Nicolle, Rémy/P-7983-2019; Southgate, Jennifer/AAJ-9089-2021; Goud, Bruno/GWC-4807-2022; Benhamou, Simone/ABD-2590-2020	Nicolle, Rémy/0000-0001-8084-1173; Southgate, Jennifer/0000-0002-0135-480X; BENHAMOU, Simone/0000-0001-5853-8047; Radvanyi, Francois/0000-0002-5696-6424; Chapeaublanc, Elodie/0000-0002-9668-7753	Centre national de la recherche scientifique (CNRS); Institut Curie; La Ligue Nationale Contre le Cancer ("Equipe labellisee'')	Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; La Ligue Nationale Contre le Cancer ("Equipe labellisee'')	The work was supported by grants from the Centre national de la recherche scientifique (CNRS) and the Institut Curie. The Molecular Oncology team is supported by La Ligue Nationale Contre le Cancer ("Equipe labellisee''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, TRAFFIC, V10, P1561, DOI 10.1111/j.1600-0854.2009.00969.x; Amillet JM, 2006, HUM PATHOL, V37, P256, DOI 10.1016/j.humpath.2005.10.017; Andrade VCC, 2010, LEUKEMIA LYMPHOMA, V51, P1543, DOI 10.3109/10428194.2010.491136; Ashida S, 2006, CLIN CANCER RES, V12, P2767, DOI 10.1158/1078-0432.CCR-05-1995; Bellmunt J, 2003, CRIT REV ONCOL HEMAT, V46, pS85, DOI 10.1016/S1040-8428(03)00067-2; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Croizet-Berger K, 2002, P NATL ACAD SCI USA, V99, P8277, DOI 10.1073/pnas.122187699; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; deMedina SGD, 1997, ONCOGENE, V14, P323, DOI 10.1038/sj.onc.1200830; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Fang ZY, 2010, J CELL BIOCHEM, V110, P1130, DOI 10.1002/jcb.22626; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Fukui K, 2007, HEPATOL RES, V37, P957, DOI 10.1111/j.1872-034X.2007.00143.x; Gebhardt C, 2005, AM J PATHOL, V167, P243, DOI 10.1016/S0002-9440(10)62969-0; GERDES J, 1991, AM J PATHOL, V138, P867; Goi T, 2002, ONCOL REP, V9, P1189; Goldenring JR, 2011, BRIT J CANCER, V104, P33, DOI 10.1038/sj.bjc.6605983; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; HENEY NM, 1983, J UROLOGY, V130, P1083, DOI 10.1016/S0022-5347(17)51695-X; Hou QS, 2008, CANCER RES, V68, P4623, DOI 10.1158/0008-5472.CAN-07-5870; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Kim Kyong Rae, 2007, Korean J Gastroenterol, V49, P209; Kimura T, 2001, CANCER-AM CANCER SOC, V92, P2555, DOI 10.1002/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Kotzsch M, 2008, BREAST CANCER RES TR, V111, P229, DOI 10.1007/s10549-007-9782-6; LANKATBUTTGEREIT B, 1994, PANCREAS, V9, P434, DOI 10.1097/00006676-199407000-00004; Liu YJ, 2007, WORLD J GASTROENTERO, V13, P1010, DOI 10.3748/wjg.v13.i7.1010; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; Lu Y, 2011, AM J TRANSL RES, V3, P8; Luis NM, 2007, CLIN TRANSL ONCOL, V9, P5, DOI 10.1007/s12094-007-0003-x; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Mostofi FK, 1973, INT HISTOLOGICAL CLA; Neef R, 2005, METHOD ENZYMOL, V403, P618, DOI 10.1016/S0076-6879(05)03054-5; Ng EL, 2009, J CELL PHYSIOL, V221, P716, DOI 10.1002/jcp.21911; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Olsburgh J, 2002, BBA-GENE STRUCT EXPR, V1576, P163, DOI 10.1016/S0167-4781(02)00304-4; Pei L, 2002, CANCER RES, V62, P5420; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Starr DA, 2000, J CELL SCI, V113, P1939; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tang BL, 2010, TUMOR BIOL, V31, P359, DOI 10.1007/s13277-010-0030-z; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Vallot C, 2011, JNCI-J NATL CANCER I, V103, P47, DOI 10.1093/jnci/djq470; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; Varley CL, 2009, CELL DEATH DIFFER, V16, P103, DOI 10.1038/cdd.2008.116; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Wang Y, 2006, TRAFFIC, V7, P746, DOI 10.1111/j.1600-0854.2006.00416.x; Wu CY, 2009, LUNG CANCER, V63, P360, DOI 10.1016/j.lungcan.2008.06.014; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zieger K, 2005, CLIN CANCER RES, V11, P7709, DOI 10.1158/1078-0432.CCR-05-1130	77	81	87	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39469	10.1371/journal.pone.0039469	http://dx.doi.org/10.1371/journal.pone.0039469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724020	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700083
J	Jugessur, A; Skare, O; Lie, RT; Wilcox, AJ; Christensen, K; Christiansen, L; Nguyen, TT; Murray, JC; Gjessing, HK				Jugessur, Astanand; Skare, Oivind; Lie, Rolv T.; Wilcox, Allen J.; Christensen, Kaare; Christiansen, Lene; Truc Trung Nguyen; Murray, Jeffrey C.; Gjessing, Hakon K.			X-Linked Genes and Risk of Orofacial Clefts: Evidence from Two Population-Based Studies in Scandinavia	PLOS ONE			English	Article							CASE-PARENT TRIADS; FAMILY-BASED ASSOCIATION; ORAL CLEFTS; TRANSMISSION/DISEQUILIBRIUM TEST; SUSCEPTIBILITY LOCI; MENTAL-RETARDATION; LIP/CLEFT PALATE; TBX22 MUTATIONS; FREQUENT CAUSE; LINKAGE	Background: Orofacial clefts are common birth defects of complex etiology, with an excess of males among babies with cleft lip and palate, and an excess of females among those with cleft palate only. Although genes on the X chromosome have been implicated in clefting, there has been no association analysis of X-linked markers. Methodology/Principal Findings: We added new functionalities in the HAPLIN statistical software to enable association analysis of X-linked markers and an exploration of various causal scenarios relevant to orofacial clefts. Genotypes for 48 SNPs in 18 candidate genes on the X chromosome were analyzed in two population-based samples from Scandinavia (562 Norwegian and 235 Danish case-parent triads). For haplotype analysis, we used a sliding-window approach and assessed isolated cleft lip with or without cleft palate (iCL/P) separately from isolated cleft palate only (iCPO). We tested three statistical models in HAPLIN, allowing for: i) the same relative risk in males and females, ii) sex-specific relative risks, and iii) X-inactivation in females. We found weak but consistent associations with the oral-facial-digital syndrome 1 (OFD1) gene (formerly known as CXORF5) in the Danish iCL/P samples across all models, but not in the Norwegian iCL/P samples. In sex-specific analyses, the association with OFD1 was in male cases only. No analyses showed associations with iCPO in either the Norwegian or the Danish sample. Conclusions: The association of OFD1 with iCL/P is plausible given the biological relevance of this gene. However, the lack of replication in the Norwegian samples highlights the need to verify these preliminary findings in other large datasets. More generally, the novel analytic methods presented here are widely applicable to investigations of the role of X-linked genes in complex traits.	[Jugessur, Astanand; Skare, Oivind; Gjessing, Hakon K.] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Jugessur, Astanand] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Skare, Oivind; Lie, Rolv T.; Gjessing, Hakon K.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Lie, Rolv T.; Truc Trung Nguyen] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Wilcox, Allen J.] Natl Inst Environm Hlth Sci, Epidemiol Branch, NIH, Durham, NC USA; [Christensen, Kaare; Christiansen, Lene] Univ So Denmark, Dept Epidemiol, Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Murray, Jeffrey C.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Biol Sci, Iowa City, IA USA	Norwegian Institute of Public Health (NIPH); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Bergen; Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Iowa; University of Iowa; University of Iowa	Jugessur, A (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.	astanand.jugessur@fhi.no	Wilcox, Allen J/C-7723-2019; Skare, Øivind/C-6330-2016; Christensen, Kaare/C-2360-2009; Gjessing, Hakon K/A-5871-2012	Wilcox, Allen J/0000-0002-3376-1311; Skare, Øivind/0000-0001-8043-2820; Christensen, Kaare/0000-0002-5429-5292; 	Center for Inherited Disease Research (CIDR); National Institutes of Health (NIH) [N01-HG-65403, DE08559, P60 DE13076, NIH P30 ES05605, RO1 DE-11948-04]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; Norwegian Research Council [NFR 177522]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027] Funding Source: NIH RePORTER	Center for Inherited Disease Research (CIDR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Center for Inherited Disease Research (CIDR) is fully funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University, Contract Number N01-HG-65403. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; by NIH grants DE08559, P60 DE13076, NIH P30 ES05605, and RO1 DE-11948-04; and by the Norwegian Research Council (NFR 177522). The authors also thank the United States National Institute of Dental and Craniofacial Research for underwriting a significant proportion of the genotyping costs by CIDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi FE, 2007, CLIN GENET, V72, P19, DOI 10.1111/j.1399-0004.2007.00817.x; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Bille C, 2005, CLEFT PALATE-CRAN J, V42, P255, DOI 10.1597/03-139.1; Braybrook C, 2002, HUM MOL GENET, V11, P2793, DOI 10.1093/hmg/11.22.2793; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Burkhardt J, 2009, J RHEUMATOL, V36, P2149, DOI 10.3899/jrheum.090059; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Ding J, 2006, AM J HUM GENET, V79, P567, DOI 10.1086/507609; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Fisher R.A., 1958, STAT METHODS RES WOR; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Grosen D, 2011, EPIDEMIOLOGY, V22, P313, DOI 10.1097/EDE.0b013e3182125f9c; Grosen D, 2010, J MED GENET, V47, P162, DOI 10.1136/jmg.2009.069385; Ho GYF, 2000, AM J HUM GENET, V66, P1158, DOI 10.1086/302822; Horvath S, 2000, AM J HUM GENET, V66, P1161, DOI 10.1086/302823; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Jones KL, 2006, ORAL FACIAL DIGITAL; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Knapp M, 2001, THEOR POPUL BIOL, V60, P141, DOI 10.1006/tpbi.2001.1540; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lu LY, 2009, CANCER EPIDEM BIOMAR, V18, P2132, DOI 10.1158/1055-9965.EPI-08-1221; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Mangold E, 2009, AM J MED GENET A, V149A, P2680, DOI 10.1002/ajmg.a.33136; Marcano ACB, 2004, J MED GENET, V41, P68, DOI 10.1136/jmg.2003.010868; Migeon BR, 2011, HUM GENET, V130, P281, DOI 10.1007/s00439-011-1016-7; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; Mossey P., 2002, CLEFT LIP PALATE, P127; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Pankratz N, 2003, HUM MOL GENET, V12, P2599, DOI 10.1093/hmg/ddg270; Pauws E, 2009, HUM MOL GENET, V18, P4171, DOI 10.1093/hmg/ddp368; PAWITAN Y., 2001, ALL LIKELIHOOD; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; R Development Core Team, 2006, R LANG ENV STAT COMP; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Scapoli L, 2008, EUR J ORAL SCI, V116, P507, DOI 10.1111/j.1600-0722.2008.00574.x; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; StataCorp, 2009, STAT REL 1 1 STAT SO; Strauss RP, 1999, CLEFT PALATE-CRAN J, V36, P189, DOI 10.1597/1545-1569(1999)036<0189:TOADOC>2.3.CO;2; Suphapeetiporn K, 2007, CLIN GENET, V72, P478, DOI 10.1111/j.1399-0004.2007.00891.x; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Umbach DH, 2000, AM J HUM GENET, V66, P251, DOI 10.1086/302707; Umbach DM, 1997, STAT MED, V16, P1731, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1731::AID-SIM595>3.0.CO;2-S; Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x; Weinberg CR, 2000, AM J EPIDEMIOL, V152, P197, DOI 10.1093/aje/152.3.197; Weinberg CR, 2005, AM J HUM GENET, V77, P627, DOI 10.1086/496900; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Weinberg CR, 2003, AM J EPIDEMIOL, V158, P401, DOI 10.1093/aje/kwg151; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Zhang L, 2008, GENET EPIDEMIOL, V32, P370, DOI 10.1002/gepi.20311; Zhang L, 2009, AM J HUM GENET, V84, P431, DOI 10.1016/j.ajhg.2009.02.010; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	61	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39240	10.1371/journal.pone.0039240	http://dx.doi.org/10.1371/journal.pone.0039240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723972	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700057
J	McFarland, HI; Puig, M; Grajkowska, LT; Tsuji, K; Lee, JP; Mason, KP; Verthelyi, D; Rosenberg, AS				McFarland, Hugh I.; Puig, Montserrat; Grajkowska, Lucja T.; Tsuji, Kazuhide; Lee, Jay P.; Mason, Karen P.; Verthelyi, Daniela; Rosenberg, Amy S.			Regulatory T Cells in gamma Irradiation-Induced Immune Suppression	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; CD4(+)CD25(+); LYMPHOCYTES; DISEASE; TRANSPLANTATION; PROLIFERATION; LYMPHOPENIA; EXPRESSION; RESPONSES; EXPOSURE	Sublethal total body gamma irradiation (TBI) of mammals causes generalized immunosuppression, in part by induction of lymphocyte apoptosis. Here, we provide evidence that a part of this immune suppression may be attributable to dysfunction of immune regulation. We investigated the effects of sublethal TBI on T cell memory responses to gain insight into the potential for loss of vaccine immunity following such exposure. We show that in mice primed to an MHC class I alloantigen, the accelerated graft rejection T memory response is specifically lost several weeks following TBI, whereas identically treated naive mice at the same time point had completely recovered normal rejection kinetics. Depletion in vivo with anti-CD4 or anti-CD25 showed that the mechanism involved cells consistent with a regulatory T cell (T reg) phenotype. The loss of the T memory response following TBI was associated with a relative increase of CD4+CD25+Foxp3+ expressing T regs, as compared to the CD8+ T effector cells requisite for skin graft rejection. The radiation-induced T memory suppression was shown to be antigen-specific in that a third party ipsilateral graft rejected with normal kinetics. Remarkably, following the eventual rejection of the first MHC class I disparate skin graft, the suppressive environment was maintained, with markedly prolonged survival of a second identical allograft. These findings have potential importance as regards the immunologic status of T memory responses in victims of ionizing radiation exposure and apoptosis-inducing therapies.	[McFarland, Hugh I.; Puig, Montserrat; Grajkowska, Lucja T.; Tsuji, Kazuhide; Lee, Jay P.; Mason, Karen P.; Verthelyi, Daniela; Rosenberg, Amy S.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	McFarland, HI (corresponding author), US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	hugh.mcfarland@fda.hhs.gov	McFarland, Hugh I/K-1503-2016	McFarland, Hugh I/0000-0002-3322-038X	U.S. Food and Drug Administration	U.S. Food and Drug Administration	This work was funded by the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA M, 1983, RADIAT RES, V93, P572, DOI 10.2307/3576036; AKIYAMA M, 1989, RADIAT RES, V117, P26, DOI 10.2307/3577274; Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; Baeva E V, 1998, Radiats Biol Radioecol, V38, P893; Chen X, 2004, EUR J IMMUNOL, V34, P859, DOI 10.1002/eji.200324506; Chernyshov VP, 1997, CLIN IMMUNOL IMMUNOP, V84, P122, DOI 10.1006/clin.1997.4369; Clark FJ, 2004, BLOOD, V103, P2410, DOI 10.1182/blood-2003-06-2073; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; Hansal SA, 1998, J IMMUNOL, V161, P1063; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Hudak S, 2002, J IMMUNOL, V169, P1189, DOI 10.4049/jimmunol.169.3.1189; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Kusunoki Y, 2001, RADIAT RES, V155, P81, DOI 10.1667/0033-7587(2001)155[0081:TCRTMI]2.0.CO;2; Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McFarland HI, 2009, CURRENT PROTOCOLS IM, V84, P441; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Moxham VF, 2008, J IMMUNOL, V180, P3910, DOI 10.4049/jimmunol.180.6.3910; Nomura M, 2006, TRANSPL IMMUNOL, V15, P311, DOI 10.1016/j.trim.2006.01.003; Qu YY, 2010, CELL MOL IMMUNOL, V7, P419, DOI 10.1038/cmi.2010.45; Qu YY, 2010, RADIAT RES, V173, P148, DOI 10.1667/RR0978.1; ROSENBERG AS, 1987, J EXP MED, V165, P1296, DOI 10.1084/jem.165.5.1296; SASAKI H, 1991, J RADIAT RES, V32, P310, DOI 10.1269/jrr.32.SUPPLEMENT_310; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sharma S, 2006, J IMMUNOL, V177, P8348, DOI 10.4049/jimmunol.177.12.8348; Simone R, 2008, J LEUKOCYTE BIOL, V84, P1454, DOI 10.1189/jlb.0907627; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tago F, 2008, RADIAT RES, V169, P59, DOI 10.1667/RR1013.1; Torkabadi E, 2007, IRAN J ALLERGY ASTHM, V6, P181; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Winstead CJ, 2008, J IMMUNOL, V180, P7305, DOI 10.4049/jimmunol.180.11.7305; Xing SJ, 2010, JAIDS-J ACQ IMM DEF, V54, P455, DOI 10.1097/QAI.0b013e3181e453b9; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312	37	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39092	10.1371/journal.pone.0039092	http://dx.doi.org/10.1371/journal.pone.0039092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723935	Green Submitted, Green Published, gold			2022-12-27	WOS:000305652700047
J	Osorio, J; Carvajal, A; Naharro, G; La, T; Phillips, ND; Rubio, P; Hampson, DJ				Osorio, Jesus; Carvajal, Ana; Naharro, German; La, Tom; Phillips, Nyree D.; Rubio, Pedro; Hampson, David J.			Dissemination of Clonal Groups of Brachyspira hyodysenteriae amongst Pig Farms in Spain, and Their Relationships to Isolates from Other Countries	PLOS ONE			English	Article							SERPULINA-HYODYSENTERIAE; SWINE-DYSENTERY; GENE-TRANSFER; IDENTIFICATION; VSH-1	Background: Swine dysentery (SD) is a widespread diarrhoeal disease of pigs caused by infection of the large intestine with the anaerobic intestinal spirochaete Brachyspira hyodysenteriae. Understanding the dynamics of SD, and hence being able to develop more effective measures to counter its spread, depends on the ability to characterise B. hyodysenteriae variants and trace relationships of epidemic strains. Methodology/Principal Findings: A collection of 51 Spanish and 1 Portuguese B. hyodysenteriae isolates was examined using a multilocus sequence typing (MLST) scheme based on the sequences of seven conserved genomic loci. The isolates were allocated to 10 sequence types (STs) in three major groups of descent. Isolates in four of the STs were widely distributed in farms around Spain. One farm was infected with isolates from more than one ST. Sequence data obtained from PubMLST for 111 other B. hyodysenteriae strains from other countries then were included in the analysis. Two of the predominant STs that were found in Spain also were present in other European countries. The 73 STs were arranged in eleven clonal complexes (Cc) containing between 2 and 26 isolates. A population snapshot based on amino acid types (AATs) placed 75% of the isolates from 32 of the 48 AATs into one major cluster. The founder type AAT9 included 22 isolates from 10 STs that were recovered in Spain, Australia, Sweden, Germany, Belgium, the UK, Canada, and the USA. Conclusions/Significance: This MLST scheme provided sufficient resolution power to unambiguously characterise B. hyodysenteriae isolates, and can be recommended as a routine typing tool that rapidly enables comparisons of isolates. Using this method it was shown that some of the main genetic lineages of B. hyodysenteriae in Spain also occurred in other countries, providing further evidence for international transmission. Finally, analysis of AATs appeared useful for deducing putative ancestral relationships between strains.	[Osorio, Jesus; Carvajal, Ana; Naharro, German; Rubio, Pedro] Univ Leon, Fac Vet Sci, Dept Anim Hlth, E-24071 Leon, Spain; [La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA 6150, Australia	Universidad de Leon; Murdoch University	Osorio, J (corresponding author), Univ Leon, Fac Vet Sci, Dept Anim Hlth, E-24071 Leon, Spain.	d.hampson@murdoch.edu.au	Naharro, Germán/AAA-6572-2019; Hampson, David J/A-9464-2008; Carvajal, Ana/P-2351-2017; Hampson, David/AAE-3666-2019	Naharro, Germán/0000-0002-7391-4378; Hampson, David J/0000-0002-7729-0427; Carvajal, Ana/0000-0001-8961-636X; Rubio, Pedro/0000-0002-4267-5650	FPU from the Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation) [AP 2003-3438]; Australian Cooperative Research Centre for an Internationally Competitive Pork Industry (the Pork CRC)	FPU from the Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation); Australian Cooperative Research Centre for an Internationally Competitive Pork Industry (the Pork CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was the result of an ongoing international collaboration between the University of Leon, Spain, and Murdoch University, Perth, Australia. Jesus Osorio was in receipt of an FPU Research Fellowship AP 2003-3438 from the Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation) allowing him to undertake the MLST analysis at Murdoch University. Part of the work conducted in Australia was supported by funds from the Australian Cooperative Research Centre for an Internationally Competitive Pork Industry (the Pork CRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyeo RF, 1999, EPIDEMIOL INFECT, V123, P133, DOI 10.1017/S0950268899002691; Carvajal A, 2006, VET REC, V158, P700, DOI 10.1136/vr.158.20.700; COMBS BG, 1992, VET MICROBIOL, V31, P273, DOI 10.1016/0378-1135(92)90085-8; Dugourd D, 1996, VET MICROBIOL, V48, P305, DOI 10.1016/0378-1135(95)00149-2; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fellstrom C., 2005, Svensk Veterinartidning, V57, P19; Fellstrom C, 1999, VET MICROBIOL, V70, P225, DOI 10.1016/S0378-1135(99)00146-7; Fisher LN, 1997, CLIN DIAGN LAB IMMUN, V4, P681, DOI 10.1128/CDLI.4.6.681-686.1997; Gresham ACJ, 1998, VET REC, V143, P619; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hampson D. J., 1997, P175; Hampson DJ, 2012, DIS SWINE, P680; HAREL J, 1994, CAN J VET RES, V58, P302; Hidalgo A, 2010, EPIDEMIOL INFECT, V138, P76, DOI 10.1017/S0950268809002817; Hidalgo A, 2010, J CLIN MICROBIOL, V48, P2859, DOI 10.1128/JCM.00348-10; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Karlsson M, 2004, J MED MICROBIOL, V53, P281, DOI 10.1099/jmm.0.05395-0; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE JI, 1993, VET MICROBIOL, V34, P35, DOI 10.1016/0378-1135(93)90005-R; Leser TD, 1997, MOL CELL PROBE, V11, P363, DOI 10.1006/mcpr.1997.0129; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Phillips ND, 2010, VET MICROBIOL, V143, P246, DOI 10.1016/j.vetmic.2009.10.020; Rasback T, 2007, MICROBIOL-SGM, V153, P4074, DOI 10.1099/mic.0.2007/008540-0; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stanton TB, 2008, APPL ENVIRON MICROB, V74, P2950, DOI 10.1128/AEM.00189-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson J. R., 2001, Animal Health Research Reviews, V2, P31; Trott DJ, 1997, MICROBIOL-SGM, V143, P3357, DOI 10.1099/00221287-143-10-3357; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006	33	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39082	10.1371/journal.pone.0039082	http://dx.doi.org/10.1371/journal.pone.0039082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723934	Green Published, gold			2022-12-27	WOS:000305652700046
J	Vielsmeier, V; Strutz, J; Kleinjung, T; Schecklmann, M; Kreuzer, PM; Landgrebe, M; Langguth, B				Vielsmeier, Veronika; Strutz, Juergen; Kleinjung, Tobias; Schecklmann, Martin; Kreuzer, Peter Michael; Landgrebe, Michael; Langguth, Berthold			Temporomandibular Joint Disorder Complaints in Tinnitus: Further Hints for a Putative Tinnitus Subtype	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; MECHANISMS; PLASTICITY; HYPERACTIVITY; MODULATION; DEPRESSION; SYMPTOMS; COMPLEX; INPUTS	Objective: Tinnitus is considered to be highly heterogeneous with respect to its etiology, its comorbidities and the response to specific interventions. Subtyping is recommended, but it remains to be determined which criteria are useful, since it has not yet been clearly demonstrated whether and to which extent etiologic factors, comorbid states and interventional response are related to each other and are thus applicable for subtyping tinnitus. Analyzing the Tinnitus Research Initiative Database we differentiated patients according to presence or absence of comorbid temporomandibular joint (TMJ) disorder complaints and compared the two groups with respect to etiologic factors. Methods: 1204 Tinnitus patients from the Tinnitus Research Initiative (TRI) Database with and without subjective TMJ complaints were compared with respect to demographic, tinnitus and audiological characteristics, questionnaires, and numeric ratings. Data were analysed according to a predefined statistical analysis plan. Results: Tinnitus patients with TMJ complaints (22% of the whole group) were significantly younger, had a lower age at tinnitus onset, and were more frequently female. They could modulate or mask their tinnitus more frequently by somatic maneuvers and by music or sound stimulation. Groups did not significantly differ for tinnitus duration, type of onset (gradual/abrupt), onset related events (whiplash etc.), character (pulsatile or not), hyperacusis, hearing impairment, tinnitus distress, depression, quality of life and subjective ratings (loudness etc.). Conclusion: Replicating previous work in tinnitus patients with TMJ complaints, classical risk factors for tinnitus like older age and male gender are less relevant in tinnitus patients with TMJ complaints. By demonstrating group differences for modulation of tinnitus by movements and sounds our data further support the notion that tinnitus with TMJ complaints represents a subgroup of tinnitus with clinical features that are highly relevant for specific therapeutic management.	[Vielsmeier, Veronika; Strutz, Juergen] Univ Regensburg, Dept Otorhinolaryngol, Regensburg, Germany; [Kleinjung, Tobias] Univ Zurich, Dept Otorhinolaryngol, Zurich, Switzerland; [Schecklmann, Martin; Kreuzer, Peter Michael; Landgrebe, Michael; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany	University of Regensburg; University of Zurich; University of Regensburg	Vielsmeier, V (corresponding author), Univ Regensburg, Dept Otorhinolaryngol, Regensburg, Germany.	veronika.vielsmeier@klinik.uni-regensburg.de	Kleinjung, Tobias/AAJ-3141-2020; Langguth, Berthold/AAP-2638-2021	Kleinjung, Tobias/0000-0003-3867-234X; 	Tinnitus Research Initiative	Tinnitus Research Initiative	The study was funded by the Tinnitus Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt O, 2011, J ORAL REHABIL; Biesinger E, 2008, HNO, V56, P673, DOI 10.1007/s00106-008-1721-2; Biesinger E, 2010, J PSYCHOSOM RES, V69, P299, DOI 10.1016/j.jpsychores.2010.04.013; Chandra RK, 2009, OTOLARYNG HEAD NECK, V141, P136, DOI 10.1016/j.otohns.2009.03.030; CHOLE RA, 1992, ARCH OTOLARYNGOL, V118, P817; Costen JB, 1997, ANN OTO RHINOL LARYN, V106, P805, DOI 10.1177/000348949710601002; Dehmel S, 2008, AM J AUDIOL, V17, pS193, DOI 10.1044/1059-0889(2008/07-0045); Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; DOLOWITZ D A, 1964, Laryngoscope, V74, P790; Kaltenbach JA, 2007, PROG BRAIN RES, V166, P89, DOI 10.1016/S0079-6123(07)66009-9; Kaltenbach JA, 2006, ACTA OTO-LARYNGOL, V126, P20, DOI 10.1080/03655230600895309; Kapoula Zoi, 2011, Front Neurol, V2, P35, DOI 10.3389/fneur.2011.00035; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2011, WORLD J BIOL PSYCHIA; Langguth B, 2011, EVAL HLTH PROF; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Langguth B, 2011, OTOLARYNG HEAD NECK, V145, P519, DOI 10.1177/0194599811411851; Lanting CP, 2010, HEARING RES, V267, P78, DOI 10.1016/j.heares.2010.04.006; Latifpour David Homayoun, 2009, Int Tinnitus J, V15, P94; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Moller AR, 2007, PROG BRAIN RES, V166, P37, DOI 10.1016/S0079-6123(07)66003-8; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; MOLLER AR, 1992, LARYNGOSCOPE, V102, P1165; MOLLER AR, 1992, LARYNGOSCOPE, V102, P187; Nam EC, 2010, J NEUROL NEUROSUR PS, V81, P456, DOI 10.1136/jnnp.2009.173104; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Sanchez TG, 2002, AUDIOL NEURO-OTOL, V7, P370, DOI 10.1159/000066155; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Shore SE, 2011, HEAR RES; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Tyler R, 2008, AM J AUDIOL, V17, pS176, DOI 10.1044/1059-0889(2008/07-0044); Tzounopoulos T, 2008, AM J AUDIOL, V17, pS170, DOI 10.1044/1059-0889(2008/07-0030); Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vernon JA, 2003, OTOLARYNG CLIN N AM, V36, P307, DOI 10.1016/S0030-6665(02)00163-9; Vielsmeier V, 2011, OTOLARYNGOL HEAD NEC; Wright EF, 2007, QUINTESSENCE INT, V38; Wright EF, 1997, J AM DENT ASSOC, V128, P1424, DOI 10.14219/jada.archive.1997.0062; Zhou JX, 2004, J NEUROSCI RES, V78, P901, DOI 10.1002/jnr.20343	41	37	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38887	10.1371/journal.pone.0038887	http://dx.doi.org/10.1371/journal.pone.0038887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723902	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305652700037
J	Jadaliha, M; Lee, HJ; Pakzad, M; Fathi, A; Jeong, SK; Cho, SY; Baharvand, H; Paik, YK; Salekdeh, GH				Jadaliha, Mahdieh; Lee, Hyoung-Joo; Pakzad, Mohammad; Fathi, Ali; Jeong, Seul-Ki; Cho, Sang-Yun; Baharvand, Hossein; Paik, Young-Ki; Salekdeh, Ghasem Hosseini			Quantitative Proteomic Analysis of Human Embryonic Stem Cell Differentiation by 8-Plex iTRAQ Labelling	PLOS ONE			English	Article							SELF-RENEWAL; NEURAL DIFFERENTIATION; GROWTH; PROTEIN; PLURIPOTENCY; TRANSLATION; NANOG; LINES	Analysis of gene expression to define molecular mechanisms and pathways involved in human embryonic stem cells (hESCs) proliferation and differentiations has allowed for further deciphering of the self-renewal and pluripotency characteristics of hESC. Proteins associated with hESCs were discovered through isobaric tags for relative and absolute quantification (iTRAQ). Undifferentiated hESCs and hESCs in different stages of spontaneous differentiation by embryoid body (EB) formation were analyzed. Using the iTRAQ approach, we identified 156 differentially expressed proteins involved in cell proliferation, apoptosis, transcription, translation, mRNA processing, and protein synthesis. Proteins involved in nucleic acid binding, protein synthesis, and integrin signaling were downregulated during differentiation, whereas cytoskeleton proteins were upregulated. The present findings added insight to our understanding of the mechanisms involved in hESC proliferation and differentiation.	[Jadaliha, Mahdieh; Fathi, Ali; Salekdeh, Ghasem Hosseini] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran; [Jadaliha, Mahdieh] Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran; [Lee, Hyoung-Joo; Jeong, Seul-Ki; Cho, Sang-Yun; Paik, Young-Ki] Yonsei Univ, Dept Biochem, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Lee, Hyoung-Joo; Jeong, Seul-Ki; Cho, Sang-Yun; Paik, Young-Ki] Yonsei Univ, Biomed Proteome Res Ctr, Seoul 120749, South Korea; [Pakzad, Mohammad; Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, ACECR, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran	Academic Center for Education, Culture & Research (ACECR); University of Tehran; Yonsei University; Yonsei University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Jadaliha, M (corresponding author), ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran.	paikyk@yonsei.ac.kr; salekdeh@royaninstitute.org	Salekdeh, Ghasem Hosseini/E-4198-2012; Jadaliha, Mahdieh/ABI-6109-2020; Pakzad, Mohammad/AAD-8905-2022	Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Pakzad, Mohammad/0000-0003-1494-3619	Royan Institute of Iran; Yonsei Proteome Research Center	Royan Institute of Iran; Yonsei Proteome Research Center	This project was funded by grants from the Royan Institute of Iran to G.H.S. and from the Yonsei Proteome Research Center to Y-K.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chaerkady R, 2009, J PROTEOME RES, V8, P1315, DOI 10.1021/pr8006667; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Fassler R, 1996, CURR OPIN CELL BIOL, V8, P641, DOI 10.1016/S0955-0674(96)80105-0; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ivanova M, 2005, MOL CELL BIOL, V25, P2995, DOI 10.1128/MCB.25.8.2995-3006.2005; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Kaufman L., 1990, FINDING GROUPS DATA; Kurisaki A, 2005, BIOCHEM BIOPH RES CO, V335, P667, DOI 10.1016/j.bbrc.2005.07.128; Larijani MR, 2011, STEM CELLS DEV, V20, P1911, DOI 10.1089/scd.2010.0517; Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li H, 2009, STEM CELLS, V27, P1244, DOI 10.1002/stem.55; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nasrabadi D, 2009, J PROTEOME RES, V8, P1527, DOI 10.1021/pr800880v; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; O'Brien RN, 2010, MOL CELL PROTEOMICS, V9, P2238, DOI 10.1074/mcp.M110.000281; Oesterreich S, 2003, J CELL BIOCHEM, V90, P653, DOI 10.1002/jcb.10685; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ray S., 1999, P 4 INT C ADV PATTER, P137; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Wang DJ, 2005, PROTEOMICS, V5, P4414, DOI 10.1002/pmic.200401304; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yocum AK, 2008, MOL CELL PROTEOMICS, V7, P750, DOI 10.1074/mcp.M700399-MCP200	41	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38532	10.1371/journal.pone.0038532	http://dx.doi.org/10.1371/journal.pone.0038532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723866	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300031
J	Lee, J; van Hummelen, P; Go, C; Palescandolo, E; Jang, J; Park, HY; Kang, SY; Park, JO; Kang, WK; MacConaill, L; Kim, KM				Lee, Jeeyun; van Hummelen, Paul; Go, Christina; Palescandolo, Emanuele; Jang, Jiryeon; Park, Ha Young; Kang, So Young; Park, Joon Oh; Kang, Won Ki; MacConaill, Laura; Kim, Kyoung-Mee			High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma	PLOS ONE			English	Article							CANCER; GENE; PIK3CA; P53	Background: Gastric cancer is one of the leading cancer types in incidence and mortality, especially in Asia. In order to improve survival, identification of a catalogue of molecular alterations underlying gastric cancer is a critical step for developing and designing genome-directed therapies. Methodology/Principal Findings: The Center for Cancer Genome Discovery (CCGD) at the Dana-Farber Cancer Institute (DFCI) has adapted a high-throughput genotyping platform to determine the mutation status of a large panel of known cancer genes. The mutation detection platform, termed OncoMap v4, interrogates 474 "hotspot'' mutations in 41 genes that are relevant for cancer. We performed OncoMap v4 in formalin-fixed paraffin-embedded (FFPE) tissue specimens from 237 gastric adenocarcinomas. Using OncoMap v4, we found that 34 (14.4%) of 237 gastric cancer patients harbored mutations. Among mutations we screened, PIK3CA mutations were the most frequent (5.1%) followed by p53 (4.6%), APC (2.5%), STK11 (2.1%), CTNNB1 (1.7%), and CDKN2A (0.8%). Six samples harbored concomitant somatic mutations. Mutations of CTNNB1 were significantly more frequent in EBV-associated gastric carcinoma (P=0.046). Our study led to the detection of potentially druggable mutations in gastric cancer which may guide novel therapies in subsets of gastric cancer patients. Conclusions/Significance: Using high throughput mutation screening platform, we identified that PIK3CA mutations were the most frequently observed target for gastric adenocarcinoma.	[Lee, Jeeyun; Jang, Jiryeon; Park, Joon Oh; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [van Hummelen, Paul; Go, Christina; Palescandolo, Emanuele; MacConaill, Laura] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [van Hummelen, Paul; Go, Christina; Palescandolo, Emanuele; MacConaill, Laura] Harvard Univ, Sch Med, Boston, MA USA; [Park, Ha Young; Kang, So Young; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea.	kkmkys@skku.edu	Lee, Jee Yun/C-9646-2011; Go, Christina/I-6475-2018; Lee, Jeeyun/I-7171-2015	Go, Christina/0000-0002-7716-8720; van hummelen, paul/0000-0002-4801-8600	Korea Healthcare Technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea [A092255, A101130]; Samsung Biomedical Research Institute [SBRI-CB11031, SBRICB02202]; Sungkyunkwan University [S-2009-1181-000]	Korea Healthcare Technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea; Samsung Biomedical Research Institute(Samsung); Sungkyunkwan University	This paper was supported by the grant from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A092255 & A101130), Samsung Biomedical Research Institute grant (# SBRI-CB11031, SBRICB02202) & Sungkyunkwan University grant (# S-2009-1181-000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; HORII A, 1992, CANCER RES, V52, P6696; Hsieh LL, 1998, CANCER LETT, V129, P125, DOI 10.1016/S0304-3835(98)00111-6; Kim Jin C, 2004, Fam Cancer, V3, P129; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li VSW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-29; MacConaill LE, 2011, CANCER DISCOV, V1, P297, DOI 10.1158/2159-8290.CD-11-0110; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Matulonis UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024433; Oki E, 2009, DIGESTION, V79, P33, DOI 10.1159/000167864; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Song HJ, 2010, GASTROENTEROLOGY, V139, P84, DOI 10.1053/j.gastro.2010.04.002; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang YP, 1998, HUM HERED, V48, P87, DOI 10.1159/000022786; Zang ZJ, 2012, NAT GENET	19	62	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38892	10.1371/journal.pone.0038892	http://dx.doi.org/10.1371/journal.pone.0038892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723903	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300065
J	Lee, YC; Yang, YC; Huang, CL; Kuo, TY; Lin, JH; Yang, DM; Huang, NK				Lee, Yi-Chao; Yang, Ying-Chen; Huang, Chuen-Lin; Kuo, Tsun-Yung; Lin, Jung-Hsin; Yang, De-Ming; Huang, Nai-Kuei			When Cytokinin, a Plant Hormone, Meets the Adenosine A(2A) Receptor: A Novel Neuroprotectant and Lead for Treating Neurodegenerative Disorders?	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; PROTEIN-KINASE-A; HUNTINGTONS-DISEASE; GASTRODIA-ELATA; PC12 CELLS; KINETIN; MODEL; PATHOPHYSIOLOGY; THERAPEUTICS; ACTIVATION	It is well known that cytokinins are a class of phytohormones that promote cell division in plant roots and shoots. However, their targets, biological functions, and implications in mammalian systems have rarely been examined. In this study, we show that one cytokinin, zeatin riboside, can prevent pheochromocytoma (PC12) cells from serum deprivation-induced apoptosis by acting on the adenosine A(2A) receptor (A(2A)-R), which was blocked by an A(2A)-R antagonist and a protein kinase A (PKA)inhibitor, demonstrating the functional ability of zeatin riboside by mediating through A(2A)-R signaling event. Since the A(2A)-R was implicated as a therapeutic target in treating Huntington's disease (HD), a cellular model of HD was applied by transfecting mutant huntingtin in PC12 cells. By using filter retardation assay and confocal microscopy we found that zeatin riboside reversed mutant huntingtin (Htt)-induced protein aggregations and proteasome deactivation through A(2A)-R signaling. PKA inhibitor blocked zeatin riboside-induced suppression of mutant Htt aggregations. In addition, PKA activated proteasome activity and reduced mutant Htt protein aggregations. However, a proteasome inhibitor blocked both zeatin riboside- and PKA activator-mediated suppression of mutant Htt aggregations, confirming mediation of the A(2A)-R/PKA/proteasome pathway. Taken together, zeatin riboside might have therapeutic potential as a novel neuroprotectant and a lead for treating neurodegenerative disorders.	[Lee, Yi-Chao] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Yang, Ying-Chen; Kuo, Tsun-Yung] Natl Ilan Univ, Dept Anim Sci, Ilan, Taiwan; [Huang, Chuen-Lin] Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Grad Inst Physiol, Taipei, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Kuo, Tsun-Yung] Natl Ilan Univ, Inst Biotechnol, Ilan, Taiwan; [Lin, Jung-Hsin] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Lin, Jung-Hsin] Acad Sinica, Div Mech, Res Ctr Appl Sci, Taipei 115, Taiwan; [Lin, Jung-Hsin] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yang, De-Ming] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Yang, De-Ming; Huang, Nai-Kuei] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Huang, Nai-Kuei] Natl Res Inst Chinese Med, Taipei, Taiwan	Taipei Medical University; National Ilan University; Cardinal Tien Hospital; National Defense Medical Center; National Defense Medical Center; National Ilan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine	Lee, YC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan.	andrew@nricm.edu.tw	Lin, Jung-Hsin/T-7390-2019; Lin, Jung-Hsin/B-7512-2012; Yang, De-Ming/AAW-9886-2020	Lin, Jung-Hsin/0000-0002-6712-4994; Yang, De-Ming/0000-0002-6923-4855; Lee, Yi-Chao/0000-0003-3451-183X	Cardinal Tien Hospital [CTH-98-1-2A18]; National Research Institute of Chinese Medicine [NRICM99-DBCM-07]; National Science Council, R.O.C. [NSC99-2320-B-077-006]	Cardinal Tien Hospital; National Research Institute of Chinese Medicine; National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by Cardinal Tien Hospital (CTH-98-1-2A18), the National Research Institute of Chinese Medicine (NRICM99-DBCM-07), and the National Science Council, R.O.C. (NSC99-2320-B-077-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2008, ANN NY ACAD SCI, P1147; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bifulco M, 2008, ANTI-CANCER AGENT ME, V8, P200, DOI 10.2174/187152008783497028; Blum D, 2003, LANCET NEUROL, V2, P366, DOI 10.1016/S1474-4422(03)00411-3; Brusa L, 2009, MOVEMENT DISORD, V24, P126, DOI 10.1002/mds.22376; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Chen JB, 2011, CHEMMEDCHEM, V6, P1390, DOI 10.1002/cmdc.201100126; Chen PJ, 2009, AM J CHINESE MED, V37, P1113, DOI 10.1142/S0192415X09007533; Choi SJ, 2009, J MED FOOD, V12, P271, DOI 10.1089/jmf.2007.0678; Choi YS, 2009, NEUROBIOL DIS, V36, P259, DOI 10.1016/j.nbd.2009.07.014; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Froldi G, 1999, PLANTA MED, V65, P245, DOI 10.1055/s-1999-13987; Fukui H, 2007, HUM MOL GENET, V16, P783, DOI 10.1093/hmg/ddm023; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Guillon-Munos A, 2005, APOPTOSIS, V10, P1031, DOI 10.1007/s10495-005-0741-6; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Hartig K, 2006, PLANT BIOLOGY, V8, P389, DOI 10.1055/s-2006-923797; Havlicek L, 1997, J MED CHEM, V40, P408, DOI 10.1021/jm960666x; Honma Y, 2002, LEUKEMIA LYMPHOMA, V43, P1729, DOI 10.1080/1042819021000006493; Huang CL, 2011, J ETHNOPHARMACOL, V138, P162, DOI 10.1016/j.jep.2011.08.075; Huang NK, 2007, J NAT PROD, V70, P571, DOI 10.1021/np0605182; Huang NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020934; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; JAYABASKARAN C, 1981, J BIOSCIENCE, V3, P269, DOI 10.1007/BF02702937; Kaiser SM, 1999, DRUG DISCOV TODAY, V4, P542, DOI 10.1016/S1359-6446(99)01421-X; Kim MJ, 2008, BIOSCI BIOTECH BIOCH, V72, P577, DOI 10.1271/bbb.70480; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mievis S, 2011, NEUROBIOL DIS, V41, P570, DOI 10.1016/j.nbd.2010.09.021; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Olsen A, 1999, BIOCHEM BIOPH RES CO, V265, P499, DOI 10.1006/bbrc.1999.1669; Popoli P, 2007, PROG NEUROBIOL, V81, P331, DOI 10.1016/j.pneurobio.2006.12.005; Ralevic V, 1998, PHARMACOL REV, V50, P413; RATTAN SIS, 1994, BIOCHEM BIOPH RES CO, V201, P665, DOI 10.1006/bbrc.1994.1752; Simons C, 2005, CURR TOP MED CHEM, V5, P1191, DOI 10.2174/156802605774463051; Spichal L, 2007, J BIOL CHEM, V282, P14356, DOI 10.1074/jbc.M609750200; Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17; Tiedemann RE, 2008, J CLIN INVEST, V118, P1750, DOI 10.1172/JCI34149; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Verbeke P, 2000, BIOCHEM BIOPH RES CO, V276, P1265, DOI 10.1006/bbrc.2000.3616; Vieira Helena L. A., 2002, Oncogene, V21, P1963, DOI 10.1038/sj.onc.1205270; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wellington CL, 1997, BRAIN PATHOL, V7, P979, DOI 10.1111/j.1750-3639.1997.tb00897.x; Williams M, 2000, BIOCHEM PHARMACOL, V59, P1173, DOI 10.1016/S0006-2952(99)00341-X; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	57	16	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38865	10.1371/journal.pone.0038865	http://dx.doi.org/10.1371/journal.pone.0038865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719969	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300061
J	Polimeni, M; Valente, E; Aldieri, E; Khadjavi, A; Giribaldi, G; Prato, M				Polimeni, Manuela; Valente, Elena; Aldieri, Elisabetta; Khadjavi, Amina; Giribaldi, Giuliana; Prato, Mauro			Haemozoin Induces Early Cytokine-Mediated Lysozyme Release from Human Monocytes through p38 MAPK- and NF-kappaB-Dependent Mechanisms	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN ADHERENT MONOCYTES; PLASMODIUM-FALCIPARUM; MALARIAL PIGMENT; IN-VITRO; FACTOR-ALPHA; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; CEREBRAL MALARIA; IMMUNE-RESPONSE	Malarial pigment (natural haemozoin, HZ) is a ferriprotoporphyrin IX crystal produced by Plasmodium parasites after haemoglobin catabolism. HZ-fed human monocytes are functionally compromised, releasing increased amounts of pro-inflammatory molecules, including cytokines, chemokines and cytokine-related proteolytic enzyme Matrix Metalloproteinase-9 (MMP-9), whose role in complicated malaria has been recently suggested. In a previous work HZ was shown to induce through TNFalpha production the release of monocytic lysozyme, an enzyme stored in gelatinase granules with MMP-9. Here, the underlying mechanisms were investigated. Results showed that HZ lipid moiety promoted early but not late lysozyme release. HZ-dependent lysozyme induction was abrogated by anti-TNFalpha/IL-1beta/MIP-1alpha blocking antibodies and mimicked by recombinant cytokines. Moreover, HZ early activated either p38 MAPK or NF-kappaB pathways by inducing: p38 MAPK phosphorylation; cytosolic I-kappaBalpha phosphorylation and degradation; NF-kappaB nuclear translocation and DNA-binding. Inhibition of both routes through selected molecules (SB203580, quercetin, artemisinin, parthenolide) prevented HZ-dependent lysozyme release. These data suggest that HZ-triggered overproduction of TNFalpha, IL-1beta and MIP-1alpha mediates induction of lysozyme release from human monocytes through activation of p38 MAPK and NF-kappaB pathways, providing new evidence on mechanisms underlying the HZ-enhanced monocyte degranulation in falciparum malaria and the potential role for lysozyme as a new affordable marker in severe malaria.	[Polimeni, Manuela; Valente, Elena; Aldieri, Elisabetta; Khadjavi, Amina; Giribaldi, Giuliana; Prato, Mauro] Univ Turin, Dipartimento Genet Biol & Biochim, Fac Med & Chirurg, Turin, Italy	University of Turin	Polimeni, M (corresponding author), Univ Turin, Dipartimento Genet Biol & Biochim, Fac Med & Chirurg, Turin, Italy.	mauro.prato@unito.it	Giribaldi, Giuliana/I-8115-2018; Aldieri, Elisabetta/AAX-7129-2020	Giribaldi, Giuliana/0000-0003-1374-1919; ALDIERI, Elisabetta/0000-0002-0236-6175	Intramural Funds from Universita degli Studi di Torino; Charity Funds; Universita degli Studi di Torino; Azienda Sanitaria Locale-19 [ASL-19]	Intramural Funds from Universita degli Studi di Torino; Charity Funds; Universita degli Studi di Torino; Azienda Sanitaria Locale-19	This study was supported by Intramural Funds from Universita degli Studi di Torino to Giuliana Giribaldi, and by Charity Funds from Mrs. Franca Squazza to Mauro Prato. Mauro Prato holds a professorship granted by Universita degli Studi di Torino and Azienda Sanitaria Locale-19 (ASL-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldieri E, 2003, FEBS LETT, V552, P141, DOI 10.1016/S0014-5793(03)00905-0; Amina K, 2010, ASIAN PAC J TROP MED, V3, P412, DOI 10.1016/S1995-7645(10)60101-0; [Anonymous], ADV INTEGRATED PEST; BERGER M, 1988, BLOOD, V71, P151; Billig EMW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-64; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007; Ciacci C, 2010, J INVERTEBR PATHOL, V105, P49, DOI 10.1016/j.jip.2010.05.010; D'Alessandro S, 2012, ASIAN PAC J IN PRESS; Das B. S., 2008, Journal of Vector Borne Diseases, V45, P83; Dasari P, 2011, BLOOD, V118, P4946, DOI 10.1182/blood-2011-05-353920; Dell'Agli M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-208; Di Mari JF, 2007, AM J PHYSIOL-GASTR L, V293, pG719, DOI 10.1152/ajpgi.00117.2007; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; FIORI PL, 1993, PARASITE IMMUNOL, V15, P647, DOI 10.1111/j.1365-3024.1993.tb00579.x; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Giribaldi G, 2004, HAEMATOLOGICA, V89, P492; Giribaldi G, 2011, ASIAN PAC J TROP MED, V4, P925, DOI 10.1016/S1995-7645(11)60220-4; Giribaldi G, 2010, INFECT IMMUN, V78, P4912, DOI 10.1128/IAI.00455-10; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Kajla MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019649; KHALID SA, 1986, J ETHNOPHARMACOL, V15, P201, DOI 10.1016/0378-8741(86)90156-X; Lapcharoen P, 2012, DEV COMP IMMUNOL, V36, P104, DOI 10.1016/j.dci.2011.06.010; LEWIS CE, 1990, IMMUNOLOGY, V69, P402; Lu ZY, 2006, J IMMUNOL, V177, P6344, DOI 10.4049/jimmunol.177.9.6344; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Mauro P, 2010, ASIAN PAC J TROP MED, V3, P85, DOI 10.1016/S1995-7645(10)60041-7; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mohamed AO, 1996, T ROY SOC TROP MED H, V90, P277, DOI 10.1016/S0035-9203(96)90246-1; Mohammed AO, 2003, ACTA TROP, V87, P279, DOI 10.1016/S0001-706X(03)00116-5; Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179; Nair MP, 2006, CLIN VACCINE IMMUNOL, V13, P319, DOI 10.1128/CVI.13.3.319-328.2006; PETERS CWB, 1989, EUR J BIOCHEM, V182, P507, DOI 10.1111/j.1432-1033.1989.tb14857.x; Prato M, 2005, J IMMUNOL, V175, P6436, DOI 10.4049/jimmunol.175.10.6436; Prato M, 2009, ASIAN PAC J TROP MED, V2, P35; Prato M, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/628435; Prato M, 2011, ASIAN PAC J TROP MED, V4, P756, DOI 10.1016/S1995-7645(11)60187-9; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Prato M, 2010, ASIAN PAC J TROP MED, V3, P934, DOI 10.1016/S1995-7645(11)60003-5; Prato M, 2010, CELL MICROBIOL, V12, P1780, DOI 10.1111/j.1462-5822.2010.01508.x; Prato M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-157; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; Shio MT, 2010, MICROBES INFECT, V12, P889, DOI 10.1016/j.micinf.2010.07.001; SueAQuan AK, 1997, J CELL PHYSIOL, V172, P94, DOI 10.1002/(SICI)1097-4652(199707)172:1<94::AID-JCP11>3.0.CO;2-O; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; Van LP, 1996, BIOCHEM J, V313, P39; Were T, 2009, MICROBES INFECT, V11, P811, DOI 10.1016/j.micinf.2009.04.021; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	58	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39497	10.1371/journal.pone.0039497	http://dx.doi.org/10.1371/journal.pone.0039497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724024	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300142
J	Wey, S; Luo, BQ; Lee, AS				Wey, Shiuan; Luo, Biquan; Lee, Amy S.			Acute Inducible Ablation of GRP78 Reveals Its Role in Hematopoietic Stem Cell Survival, Lymphogenesis and Regulation of Stress Signaling	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER; IL-7; APOPTOSIS; MICE; PROLIFERATION; ACTIVATION; INDUCTION; SECRETION; CHEMOKINE	GRP78, a master regulator of the unfolded protein response (UPR) and cell signaling, is required for inner cell mass survival during early embryonic development. However, little is known about its role in adult hematopoietic stem cells (HSCs) and hematopoiesis. Here we generated a conditional knockout mouse model that acutely deletes Grp78 in the adult hematopoietic system. Acute GRP78 ablation resulted in a significant reduction of HSCs, common lymphoid and myeloid progenitors, and lymphoid cell populations in the mutant mice. The GRP78-null induced reduction of the HSC pool could be attributed to increased apoptosis. Chimeric mice with Grp78 deletion only in the hematopoietic cells also showed a loss of HSCs and lymphopenia, suggesting a cell intrinsic effect. Analysis of GRP78 deficient bone marrow (BM) cells showed constitutive activation of all the major UPR signaling pathways, including activation of eIF2 alpha, ATF6, xbp-1 splicing, as well as caspase activation. A multiplex cytokine assay further revealed alteration in select cytokine and chemokine serum levels in the mutant mice. Collectively, these studies demonstrate that GRP78 plays a pleiotropic role in BM cells and contributes to HSC survival and the maintenance of the lymphoid lineage.	[Wey, Shiuan; Luo, Biquan; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Wey, S (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607]; National Cancer Institute [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA027607, R37CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant CA027607 (A.S.L.). The USC core facilities described were supported by National Institutes of Health P30 CA014089 from the National Cancer Institute. URL: http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; CERRETTI DP, 1986, P NATL ACAD SCI USA, V83, P3223, DOI 10.1073/pnas.83.10.3223; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Choong ML, 2004, CYTOKINE, V25, P239, DOI 10.1016/j.cyto.2003.11.002; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DORNER AJ, 1994, BIOLOGICALS, V22, P103, DOI 10.1006/biol.1994.1016; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hetz C, 2009, LEUKEMIA RES, V33, P880, DOI 10.1016/j.leukres.2009.02.017; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Koh YT, 2009, PROSTATE, V69, P571, DOI 10.1002/pros.20906; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Luo B, 2012, ONCOGENE IN PRESS; Luo BQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020364; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Murray R, 1989, Int Immunol, V1, P526, DOI 10.1093/intimm/1.5.526; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Ota J, 2003, ONCOGENE, V22, P5720, DOI 10.1038/sj.onc.1206855; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Qian YC, 2007, AM J PHYSIOL-CELL PH, V293, pC897, DOI 10.1152/ajpcell.00059.2007; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosati E, 2010, BLOOD, V116, P2713, DOI 10.1182/blood-2010-03-275628; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Uckun FM, 2011, BRIT J HAEMATOL, V153, P741, DOI 10.1111/j.1365-2141.2011.08671.x; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	41	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39047	10.1371/journal.pone.0039047	http://dx.doi.org/10.1371/journal.pone.0039047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723926	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300084
J	Liu, HL; Xu, R; Feng, LL; Guo, WJ; Cao, N; Qian, C; Teng, P; Wang, L; Wu, XF; Sun, Y; Li, JX; Shen, Y; Xu, Q				Liu, Hailiang; Xu, Rui; Feng, Lili; Guo, Wenjie; Cao, Ning; Qian, Cheng; Teng, Peng; Wang, Lu; Wu, Xuefeng; Sun, Yang; Li, Jianxin; Shen, Yan; Xu, Qiang			A Novel Chromone Derivative with Anti-Inflammatory Property via Inhibition of ROS-Dependent Activation of TRAF6-ASK1-p38 Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; KINASE INHIBITOR; PROTEIN; SEPSIS; EXPRESSION; APOPTOSIS; RECOGNITION; MACROPHAGES; INDUCTION	The p38 MAPK signaling pathway plays a pivotal role in inflammation. Targeting p38 MAPK may be a potential strategy for the treatment of inflammatory diseases. In the present study, we show that a novel chromone derivative, DCO-6, significantly reduced lipopolysaccharide (LPS)-induced production of nitric oxide, IL-1 beta and IL-6, decreased the levels of iNOS, IL-1 beta and IL-6 mRNA expression in both RAW264.7 cells and mouse primary peritoneal macrophages, and inhibited LPS-induced activation of p38 MAPK but not of JNK, ERK. Moreover, DCO-6 specifically inhibited TLR4-dependent p38 activation without directly inhibiting its kinase activity. LPS-induced production of intracellular reactive oxygen species (ROS) was remarkably impaired by DCO-6, which disrupted the formation of the TRAF6-ASK1 complex. Administering DCO-6 significantly protected mice from LPS-induced septic shock in parallel with the inhibition of p38 activation and ROS production. Our results indicate that DCO-6 showed anti-inflammatory properties through inhibition of ROS-dependent activation of TRAF6-ASK1-p38 pathway. Blockade of the upstream events required for p38 MAPK action by DCO-6 may provide a new therapeutic option in the treatment of inflammatory diseases.	[Liu, Hailiang; Xu, Rui; Feng, Lili; Guo, Wenjie; Cao, Ning; Qian, Cheng; Wang, Lu; Wu, Xuefeng; Sun, Yang; Shen, Yan; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Teng, Peng; Li, Jianxin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Liu, HL (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	shenyan@nju.edu.cn; molpharm@163.com	Guo, Wenjie/AAQ-7553-2020; Teng, Peng/K-1046-2015; Qian, Cheng/ACI-6931-2022; Teng, Peng/AAS-4575-2020	Teng, Peng/0000-0002-7412-9646; Qian, Cheng/0000-0001-7573-3717; Teng, Peng/0000-0002-7412-9646	National Natural Science Foundation of China [30730107, 90913023, 30973546]; Natural Science Foundation of Jiangsu Province [BK2008022, BK2009238]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (Nos. 30730107, 90913023 and 30973546) and the Natural Science Foundation of Jiangsu Province (Nos. BK2008022, BK2009238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cohen S, 2010, CURR OPIN RHEUMATOL, V22, P330, DOI 10.1097/BOR.0b013e3283378e6f; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; Dyrager C, 2011, J MED CHEM; Funakoshi-Tago M, 2003, EUR J BIOCHEM, V270, P1257, DOI 10.1046/j.1432-1033.2003.03487.x; Guan ZH, 1998, J BIOL CHEM, V273, P12901, DOI 10.1074/jbc.273.21.12901; Haschemi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026376; Ho FM, 2004, BRIT J PHARMACOL, V141, P1037, DOI 10.1038/sj.bjp.0705700; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kirkwood KL, 2009, CURR DRUG METAB, V10, P55, DOI 10.2174/138920009787048347; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Liu GB, 2010, BIOORGAN MED CHEM, V18, P2864, DOI 10.1016/j.bmc.2010.03.020; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ramos L, 2010, J IMMUNOL, V185, P709, DOI 10.4049/jimmunol.1000273; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sharma SK, 2011, CURR MED CHEM, V18, P3825; Song R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004450; Takatsuna H, 2003, J BIOL CHEM, V278, P12144, DOI 10.1074/jbc.M300720200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Wang L, 2009, MOL PHARMACOL, V76, P1238, DOI 10.1124/mol.109.059105; Xu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027165; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	37	30	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37168	10.1371/journal.pone.0037168	http://dx.doi.org/10.1371/journal.pone.0037168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720096	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000003
J	Li, LK; Wen, L; Gong, Y; Mei, GQ; Liu, JS; Chen, YL; Peng, T				Li, Leike; Wen, Luan; Gong, Yu; Mei, Guoqiang; Liu, Jinsong; Chen, Yonglong; Peng, Tao			Xenopus as a Model System for the Study of GOLPH2/GP73 Function: Xenopus golph2 Is Required for Pronephros Development	PLOS ONE			English	Article							GOLGI MEMBRANE-PROTEIN; KIDNEY DEVELOPMENT; LIVER-DISEASE; BARTTER-SYNDROME; DISTAL TUBULE; EXPRESSION; GP73; GENES; NOTCH; EMBRYOS	GOLPH2 is a highly conserved protein. It is upregulated in a number of tumors and is being considered as an emerging biomarker for related diseases. However, the function of GOLPH2 remains unknown. The Xenopus model is used to study the function of human proteins. We describe the isolation and characterization of Xenopus golph2, which dimerizes and localizes to the Golgi in a manner similar to human GOLPH2. Xenopus golph2 is expressed in the pronephros during early development. The morpholino-mediated knockdown of golph2 results in edema formation. Additionally, Nephrin expression is enhanced in the glomus, and the expression of pronephric marker genes, such as atp1b1, ClC-K, NKCC2, and NBC1, is diminished in the tubules and duct. Expression patterns of the transcription factors WT1, Pax2, Pax8, Lim1, GATA3, and HNF1 beta are also examined in the golph2 knockdown embryos, the expression of WT1 is increased in the glomus and expanded laterally in the pronephric region. We conclude that the deletion of golph2 causes an increase in the expression of WT1, which may promote glomus formation and inhibit pronephric tubule differentiation.	[Li, Leike; Gong, Yu; Mei, Guoqiang; Liu, Jinsong; Peng, Tao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Leike; Mei, Guoqiang; Peng, Tao] Univ Sci & Technol, Hefei, Peoples R China; [Wen, Luan; Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Wen, Luan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, Program Cellular Regulat & Metab,NIH, Bethesda, MD USA	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Li, LK (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chen_yonglong@gibh.ac.cn; peng_tao@gibh.ac.cn	Wen, Luan/ABH-3991-2020	Wen, Luan/0000-0001-9408-8709; Li, Leike/0000-0002-1379-1396; Peng, Tao/0000-0001-5260-7128; Wen, Luan/0000-0001-5080-0469	National Science Foundation [309701647]; National Basic Research Program (973) [2009CB522300, 2009CB941202]; Chinese Academy of Sciences [KSCX2-YW-R-083]	National Science Foundation(National Science Foundation (NSF)); National Basic Research Program (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Science Foundation (309701647), National Basic Research Program (973) (Grant No. 2009CB522300 and 2009CB941202), Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-YW-R-083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, TRAFFIC, V8, P1415, DOI 10.1111/j.1600-0854.2007.00621.x; Bettinelli A, 2005, PEDIATR RES, V58, P1269, DOI 10.1203/01.pdr.0000185267.95466.41; Carroll TJ, 1996, DEV DYNAM, V206, P131, DOI 10.1002/(SICI)1097-0177(199606)206:2<131::AID-AJA2>3.3.CO;2-I; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fritzsche Florian Rudolf, 2008, BMC Urol, V8, P15, DOI 10.1186/1471-2490-8-15; Gerth VE, 2005, DEV DYNAM, V233, P1131, DOI 10.1002/dvdy.20415; Gong Y, 2012, BIOCH BIOPHYS RES CO; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Howland RB, 1916, P NATL ACAD SCI USA, V2, P231, DOI 10.1073/pnas.2.4.231; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Jones EA, 2005, J AM SOC NEPHROL, V16, P313, DOI 10.1681/ASN.2004070617; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Li XJ, 2010, DEV DYNAM, V239, P2742, DOI 10.1002/dvdy.22401; McLaughlin KA, 2000, DEV BIOL, V227, P567, DOI 10.1006/dbio.2000.9913; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Romano PR, 2003, HEPATOLOGY, V38, p768A; RYAN G, 1995, DEVELOPMENT, V121, P867; Saxen L., 1987, ORGANOGENESIS KIDNEY; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Taelman V, 2006, DEVELOPMENT, V133, P2961, DOI 10.1242/dev.02458; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; Vize PD, 2003, GENE EXPR PATTERNS, V3, P347, DOI 10.1016/S1567-133X(03)00032-2; Wei SZ, 2008, PROSTATE, V68, P1387, DOI 10.1002/pros.20806; Wen LA, 2010, DEV DYNAM, V239, P2198, DOI 10.1002/dvdy.22356; Wessely O, 2011, PEDIAT NEPHROLOGY; Wild W, 2000, P NATL ACAD SCI USA, V97, P4695, DOI 10.1073/pnas.080010897; Wright LM, 2009, INT J CLIN EXP PATHO, V2, P34; Yamazaki H, 2009, PEDIATR NEPHROL, V24, P415, DOI 10.1007/s00467-008-0999-3; Zhang FF, 2010, CLIN BIOCHEM, V43, P983, DOI 10.1016/j.clinbiochem.2010.05.010; Zhou XL, 2004, DEV BIOL, V271, P322, DOI 10.1016/j.ydbio.2004.03.036; Zhou Y, 2011, MOL BIOL REP, V38, P1457, DOI 10.1007/s11033-010-0251-7	46	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38939	10.1371/journal.pone.0038939	http://dx.doi.org/10.1371/journal.pone.0038939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719994	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800029
J	Dikovskaya, D; Khoudoli, G; Newton, IP; Chadha, GS; Klotz, D; Visvanathan, A; Lamond, A; Swedlow, JR; Nathke, IS				Dikovskaya, Dina; Khoudoli, Guennadi; Newton, Ian P.; Chadha, Gaganmeet S.; Klotz, Daniel; Visvanathan, Ashwat; Lamond, Angus; Swedlow, Jason R.; Naethke, Inke S.			The Adenomatous Polyposis Coli Protein Contributes to Normal Compaction of Mitotic Chromatin	PLOS ONE			English	Article							TOPOISOMERASE-II; CHROMOSOME ARCHITECTURE; CONDENSIN-I; APC MUTATIONS; EGG EXTRACTS; LIVING CELLS; REVEALS; VITRO; DECONDENSATION; PROLIFERATION	The tumour suppressor Adenomatous Polyposis Coli (APC) is required for proper mitosis; however, the exact role of APC in mitosis is not understood. Using demembranated sperm chromatin exposed to meiotic Xenopus egg extract and HeLa cells expressing fluorescently labelled histones, we established that APC contributes to chromatin compaction. Sperm chromatin in APC-depleted Xenopus egg extract frequently formed tight round or elongated structures. Such abnormally compacted chromatin predominantly formed spindles with low microtubule content. Furthermore, in mitotic HeLa cells expressing GFP- and mCherry-labelled H2B histones, depletion of APC caused a decrease in the donor fluorescence lifetime of neighbouring fluorophores, indicative of excessive chromatin compaction. Profiling the chromatin-associated proteome of sperm chromatin incubated with Xenopus egg extracts revealed temporal APC-dependent changes in the abundance of histones, closely mirrored by chromatin-associated Topoisomerase IIa, condensin I complex and Kif4. In the absence of APC these factors initially accumulated on chromatin, but then decreased faster than in controls. We also found and validated significant APC-dependent changes in chromatin modifiers Set-a and Rbbp7. Both were decreased on chromatin in APC-depleted extract; in addition, the kinetics of association of Set-a with chromatin was altered in the absence of APC.	[Dikovskaya, Dina; Newton, Ian P.; Klotz, Daniel; Naethke, Inke S.] Univ Dundee, Dundee, Scotland; [Khoudoli, Guennadi; Chadha, Gaganmeet S.; Visvanathan, Ashwat; Lamond, Angus; Swedlow, Jason R.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee; University of Dundee	Dikovskaya, D (corresponding author), Univ Glasgow, Canc Res UK Beatson Labs, Glasgow, Lanark, Scotland.	i.s.nathke@lifesci.dundee.ac.uk	Chadha, Gaganmeet Singh/G-8843-2013	Chadha, Gaganmeet Singh/0000-0003-2921-3504; Lamond, Angus/0000-0001-6204-6045; Nathke, Inke/0000-0003-2420-4385; Swedlow, Jason/0000-0002-2198-1958	Cancer Research UK [C430/A11243, C303/A7399]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H013024/1]; BBSRC [BB/H013024/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013024/1] Funding Source: researchfish; Cancer Research UK [11243] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK program grant C430/A11243 to ISN and by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/H013024/1 and Cancer Research UK grant C303/A7399. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daban JR, 2011, MICRON; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dikovskaya D, 2010, J CELL SCI, V123, P736, DOI 10.1242/jcs.060806; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Freedman BS, 2010, CURR BIOL, V20, P1048, DOI 10.1016/j.cub.2010.04.025; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; Karetsou Z, 2004, FEBS LETT, V577, P496, DOI 10.1016/j.febslet.2004.09.091; KATAGIRI C, 1994, INT J DEV BIOL, V38, P209; Khoudoli GA, 2008, CURR BIOL, V18, P838, DOI 10.1016/j.cub.2008.04.075; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Konig P, 2007, CHROMOSOMA, V116, P349, DOI 10.1007/s00412-007-0101-0; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Leung JW, 2011, J BIOL CHEM, V286, P21393, DOI 10.1074/jbc.M110.208793; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Martin RM, 2010, FASEB J, V24, P1066, DOI 10.1096/fj.08-128959; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nishijima H, 2000, Prog Cell Cycle Res, V4, P145; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Samoshkin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006831; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Scrittori L, 2001, J BIOL CHEM, V276, P30002, DOI 10.1074/jbc.M102701200; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Steigerwald K, 2005, MOL CANCER RES, V3, P78, DOI 10.1158/1541-7786.MCR-03-0189; Swedlow JR, 1999, PRACT APPROACH SER, P165; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	55	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38102	10.1371/journal.pone.0038102	http://dx.doi.org/10.1371/journal.pone.0038102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719865	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305341900019
J	Ellison, AM; Butler, ED; Hicks, EJ; Naczi, RFC; Calie, PJ; Bell, CD; Davis, CC				Ellison, Aaron M.; Butler, Elena D.; Hicks, Emily Jean; Naczi, Robert F. C.; Calie, Patrick J.; Bell, Charles D.; Davis, Charles C.			Phylogeny and Biogeography of the Carnivorous Plant Family Sarraceniaceae	PLOS ONE			English	Article							RIBOSOMAL DNA-SEQUENCES; FLORAL EVOLUTION; PURPUREA SARRACENIACEAE; MOLECULAR PHYLOGENETICS; GEOGRAPHIC RANGE; CARIBBEAN REGION; TREE SELECTION; PITCHER PLANT; HELIAMPHORA; ERICALES	The carnivorous plant family Sarraceniaceae comprises three genera of wetland-inhabiting pitcher plants: Darlingtonia in the northwestern United States, Sarracenia in eastern North America, and Heliamphora in northern South America. Hypotheses concerning the biogeographic history leading to this unusual disjunct distribution are controversial, in part because genus-and species-level phylogenies have not been clearly resolved. Here, we present a robust, species-rich phylogeny of Sarraceniaceae based on seven mitochondrial, nuclear, and plastid loci, which we use to illuminate this family's phylogenetic and biogeographic history. The family and genera are monophyletic: Darlingtonia is sister to a clade consisting of Heliamphora+Sarracenia. Within Sarracenia, two clades were strongly supported: one consisting of S. purpurea, its subspecies, and S. rosea; the other consisting of nine species endemic to the southeastern United States. Divergence time estimates revealed that stem group Sarraceniaceae likely originated in South America 44-53 million years ago (Mya) (highest posterior density [HPD] estimate = 47 Mya). By 25-44 (HPD = 35) Mya, crown-group Sarraceniaceae appears to have been widespread across North and South America, and Darlingtonia (western North America) had diverged from Heliamphora+Sarracenia (eastern North America+South America). This disjunction and apparent range contraction is consistent with late Eocene cooling and aridification, which may have severed the continuity of Sarraceniaceae across much of North America. Sarracenia and Heliamphora subsequently diverged in the late Oligocene, 14-32 (HPD = 23) Mya, perhaps when direct overland continuity between North and South America became reduced. Initial diversification of South American Heliamphora began at least 8 Mya, but diversification of Sarracenia was more recent (2-7, HPD = 4 Mya); the bulk of southeastern United States Sarracenia originated co-incident with Pleistocene glaciation, <3 Mya. Overall, these results suggest climatic change at different temporal and spatial scales in part shaped the distribution and diversity of this carnivorous plant clade.	[Ellison, Aaron M.; Butler, Elena D.; Davis, Charles C.] Harvard Univ, Petersham, MA USA; [Hicks, Emily Jean; Calie, Patrick J.] Eastern Kentucky Univ, Richmond, KY 40475 USA; [Hicks, Emily Jean] Univ Kentucky, Regulatory Serv, Lexington, KY USA; [Naczi, Robert F. C.] New York Bot Garden, Bronx, NY 10458 USA; [Bell, Charles D.] Univ New Orleans, New Orleans, LA 70148 USA	Harvard University; University of Kentucky; New York Botanical Garden; University of Louisiana System; University of New Orleans	Ellison, AM (corresponding author), Harvard Univ, Petersham, MA USA.	aellison@fas.harvard.edu; cdavis@oeb.harvard.edu		Ellison, Aaron/0000-0003-4151-6081; Butler, Elena/0000-0002-0147-5150	Harvard University Herbaria; Harvard College Research Program; NSF [EF 04-31242, DEB 05-41680]; NSF-Kentucky EPSCoR Program, NIH/NCRR [P20 RR16481]; L. R. Hesler Award from the University of Tennessee Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER	Harvard University Herbaria; Harvard College Research Program; NSF(National Science Foundation (NSF)); NSF-Kentucky EPSCoR Program, NIH/NCRR; L. R. Hesler Award from the University of Tennessee Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Grant-in-Aid of Undergraduate Research from the Harvard University Herbaria; the Harvard College Research Program; NSF grants EF 04-31242 and DEB 05-41680 http://www.nsf.gov/; NSF-Kentucky EPSCoR Program, NIH/NCRR grant P20 RR16481 http://www.nih.gov/; and the L. R. Hesler Award from the University of Tennessee Department of Ecology and Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Arber A, 1941, ANN BOT-LONDON, V5, P563, DOI 10.1093/oxfordjournals.aob.a087407; Baum DA, 1998, SYST BIOL, V47, P181, DOI 10.1080/106351598260879; Bayer RJ, 1996, SYST BOT, V21, P121, DOI 10.2307/2419743; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bromham L, 2002, EVOLUTION, V56, P1921; Cameron KM, 2001, AM J BOT, V88, P1847, DOI 10.2307/3558361; Croizat L., 1960, PRINCIPIA BOT BEGINN; Darwin C., 1875, INSECTIVOROUS PLANTS; Davis CC, 2002, AM J BOT, V89, P699, DOI 10.3732/ajb.89.4.699; Davis CC, 2007, SCIENCE, V315, P1812, DOI 10.1126/science.1135260; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elansary HOM, 2010, AQUAT BOT, V92, P214, DOI 10.1016/j.aquabot.2009.12.002; Ellison AM, 2011, OIKOS, V120, P1721, DOI 10.1111/j.1600-0706.2011.19604.x; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Ellison AM, 2002, AM J BOT, V89, P1024, DOI 10.3732/ajb.89.6.1024; Ellison AM, 2001, AM J BOT, V88, P429, DOI 10.2307/2657107; Fleischmann A, 2010, MOL PHYLOGENET EVOL, V56, P768, DOI 10.1016/j.ympev.2010.03.009; Fleischmann Andreas, 2009, Willdenowia, V39, P273, DOI 10.3372/wi.39.39206; Fleischmann A, 2009, ANAL JARDIN BOT MAD, V66, P209, DOI 10.3989/ajbm.2198; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Graham A, 2003, SYST BOT, V28, P378; Graham A., 2011, NATURAL HIST NEW WOR; Heads Michael, 1984, TUATARA, V27, P26; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hicks EJ, 2010, THESIS E KENTUCKY U; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Jobson RW, 2003, SYST BOT, V28, P157; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Juniper B. E., 1989, CARNIVOROUS PLANTS; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Kuzoff RK, 1998, MOL BIOL EVOL, V15, P251, DOI 10.1093/oxfordjournals.molbev.a025922; Li HQ, 2005, ACTA BOT GALLICA, V152, P227, DOI 10.1080/12538078.2005.10515473; MacPhee R. D. E., 1995, American Museum Novitates, V0, P1; MAGUIRE B, 1970, Biotropica, V2, P85, DOI 10.2307/2989766; Maguire B., 1978, MEMOIRS NEW YORK BOT, V29, P36; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Mathews S, 2000, INT J PLANT SCI, V161, pS41, DOI 10.1086/317582; MCDANIEL S, 1966, THESIS FLORIDA STATE; McDaniel S., 1971, B TALL TIMBERS RES S, V9, P1; Meindl George A., 2011, Madrono, V58, P22, DOI 10.3120/0024-9637-58.1.22; Mellichamp T.L., 2009, FLORA N AM N MEXICO, V8, P348; Mellichamp TL, 1983, NAT HIST, V4, P47; Miller M.A., 2009, CIPRES PORTALS CIPRE; Naczi Robert F. C., 1999, SIDA Contributions to Botany, V18, P1183; Ne'eman G, 2006, AM J BOT, V93, P1660, DOI 10.3732/ajb.93.11.1660; Neyland Ray, 2006, Madrono, V53, P223, DOI 10.3120/0024-9637(2006)53[223:SROSIF]2.0.CO;2; Oswald WW, 2011, RHODORA, V113, P235, DOI 10.3119/0035-4902-113.955.235; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; RENNER SS, 1989, PLANT SYST EVOL, V163, P21, DOI 10.1007/BF00936149; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Rutherford S, 2000, NATURE, V408, P72, DOI 10.1038/35040533; Santos JOS, 2003, GEOL SOC AM BULL, V115, P331, DOI 10.1130/0016-7606(2003)115<0331:ASARSO>2.0.CO;2; SCHNELL D E, 1976, Castanea, V41, P165; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Schonenberger J, 2005, INT J PLANT SCI, V166, P265, DOI 10.1086/427198; Schonenberger J, 2010, PHILOS T R SOC B, V365, P437, DOI 10.1098/rstb.2009.0247; SCHUBERT C, 1994, QUATERN INT, V21, P81, DOI DOI 10.1016/1040-6182%2894%2990022-1; SCHWAEGERLE KE, 1983, OHIO J SCI, V83, P19; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THANIKAIMONI G, 1972, Pollen et Spores, V14, P143; Wang ZF, 2004, J HERED, V95, P234, DOI 10.1093/jhered/esh043; WEAKLEY A. S, 2011, FLORA SO MI IN PRESS; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wurdack KJ, 2009, AM J BOT, V96, P1551, DOI 10.3732/ajb.0800207; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-217	78	39	39	8	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39291	10.1371/journal.pone.0039291	http://dx.doi.org/10.1371/journal.pone.0039291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720090	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900094
J	Gomes, J; Magalhaes, A; Carvalho, AS; Hernandez, GE; Papp, SL; Head, SR; Michel, V; David, L; Gartner, F; Touati, E; Reis, CA				Gomes, Joana; Magalhaes, Ana; Carvalho, Ana S.; Hernandez, Gilberto E.; Papp, Suzanne L.; Head, Steven R.; Michel, Valerie; David, Leonor; Gaertner, Fatima; Touati, Eliette; Reis, Celso A.			Glycophenotypic Alterations Induced by Pteridium aquilinum in Mice Gastric Mucosa: Synergistic Effect with Helicobacter pylori Infection	PLOS ONE			English	Article							SIALYL-LEWIS-X; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; UDP-GALACTOSE; BRACKEN FERN; INTESTINAL METAPLASIA; EPITHELIAL-CELLS; EXPRESSION; CANCER; FAMILY	The bracken fern Pteridium aquilinum is a plant known to be carcinogenic to animals. Epidemiological studies have shown an association between bracken fern exposure and gastric cancer development in humans. The biological effects of exposure to this plant within the gastric carcinogenesis process are not fully understood. In the present work, effects in the gastric mucosa of mice treated with Pteridium aquilinum were evaluated, as well as molecular mechanisms underlying the synergistic role with Helicobacter pylori infection. Our results showed that exposure to Pteridium aquilinum induces histomorphological modifications including increased expression of acidic glycoconjugates in the gastric mucosa. The transcriptome analysis of gastric mucosa showed that upon exposure to Pteridium aquilinum several glycosyltransferase genes were differently expressed, including Galntl4, C1galt1 and St3gal2, that are mainly involved in the biosynthesis of simple mucin-type carbohydrate antigens. Concomitant treatment with Pteridium aquilinum and infection with Helicobacter pylori also resulted in differently expressed glycosyltransferase genes underlying the biosynthesis of terminal sialylated Lewis antigens, including Sialyl-Lewis x. These results disclose the molecular basis for the altered pattern of glycan structures observed in the mice gastric mucosa. The gene transcription alterations and the induced glycophenotypic changes observed in the gastric mucosa contribute for the understanding of the molecular mechanisms underlying the role of Pteridium aquilinum in the gastric carcinogenesis process.	[Gomes, Joana; Magalhaes, Ana; Carvalho, Ana S.; David, Leonor; Gaertner, Fatima; Reis, Celso A.] Univ Porto, Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Gomes, Joana; Michel, Valerie; Touati, Eliette] Inst Pasteur, Unite Pathogenese Helicobacter, Paris, France; [Hernandez, Gilberto E.; Papp, Suzanne L.; Head, Steven R.] Scripps Res Inst, La Jolla, CA 92037 USA; [David, Leonor; Reis, Celso A.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Gaertner, Fatima; Reis, Celso A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Scripps Research Institute; Universidade do Porto; Universidade do Porto	Gomes, J (corresponding author), Univ Porto, Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	celsor@ipatimup.pt	REIS, Celso A/B-9969-2008; de Fátima Gärtner, Maria/A-3530-2010; Magalhaes, Ana/I-1510-2013; Gomes, Joana/K-9031-2013; Magalhaes, Ana/O-9990-2019; David, Leonor/A-4829-2008	REIS, Celso A/0000-0002-0286-6639; de Fátima Gärtner, Maria/0000-0002-5302-0086; Magalhaes, Ana/0000-0003-4863-6668; Gomes, Joana/0000-0002-8832-2703; Magalhaes, Ana/0000-0003-4863-6668; David, Leonor/0000-0003-4207-9258; Touati, Eliette/0000-0002-3450-1773; Carvalho, Ana Sofia/0000-0003-0657-1907	Fundacao para a Ciencia e a Tecnologia - [FCT] [PIC/IC/82716/2007, SFRH/BD/40563/2007, SFRH/BPD/75871/2011]; Programa de Accoes Universitarias Integradas Luso-Francesas - PAULIF [LC/HS/ED/2010-308, F-TC04/11];  [NIGMS-GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia - [FCT](Portuguese Foundation for Science and Technology); Programa de Accoes Universitarias Integradas Luso-Francesas - PAULIF; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Fundacao para a Ciencia e a Tecnologia - [FCT (PIC/IC/82716/2007), grant number SFRH/BD/40563/2007 to J.G and SFRH/BPD/75871/2011 to A. M.]; and the Programa de Accoes Universitarias Integradas Luso-Francesas - PAULIF [grant number LC/HS/ED/2010-308; F-TC04/11]. The resources and collaborative efforts provided by the Consortium for Functional Glycomics were funded by grant NIGMS-GM62116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Alonso-Amelot ME, 2001, INT J CANCER, V91, P252, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1028&gt;3.0.CO;2-; AlonsoAmelot ME, 1997, NUTRITION, V13, P694, DOI 10.1016/S0899-9007(97)83017-1; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; [Anonymous], 1986, IARC Monogr Eval Carcinog Risk Chem Hum, V40, P47; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P177; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Chandrasekaran EV, 2011, BIOCHEMISTRY-US, V50, P9475, DOI 10.1021/bi200301w; CORREA P, 1992, CANCER RES, V52, P6735; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; DAVID L, 1992, APMIS, V100, P162; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ferrero RL, 1998, INFECT IMMUN, V66, P1349, DOI 10.1128/IAI.66.4.1349-1355.1998; Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200; Filipe MI, 1990, HISTOCHEMISTRY PATHO, P451; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GALPIN OP, 1990, BRIT J CANCER, V61, P737, DOI 10.1038/bjc.1990.165; Gomes J, 2012, TOXICOL SCI, V126, P60, DOI 10.1093/toxsci/kfr329; Gornes J, 2009, J HISTOCHEM CYTOCHEM, V57, P79, DOI 10.1369/jhc.2008.952283; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hennet T, 1998, J BIOL CHEM, V273, P58, DOI 10.1074/jbc.273.1.58; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen PH, 2008, J AGR FOOD CHEM, V56, P9848, DOI 10.1021/jf801986u; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; KJELDSEN T, 1988, CANCER RES, V48, P2214; LEE YC, 1993, EUR J BIOCHEM, V216, P377, DOI 10.1111/j.1432-1033.1993.tb18155.x; LEE YC, 1994, J BIOL CHEM, V269, P10028; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Liu H, 2009, GASTROENTEROLOGY, V137, P1367, DOI 10.1053/j.gastro.2009.07.041; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Magalhaes A, 2009, GLYCOBIOLOGY, V19, P1525, DOI 10.1093/glycob/cwp131; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Marcos NT, 2008, J CLIN INVEST, V118, P2325, DOI [10.1172/JC134324, 10.1172/JCI34324]; MARLIERE C, 1999, BRACKEN FERN TOXICIT, P144; Matsuda M, 2011, J GASTROEN HEPATOL, V26, P1451, DOI 10.1111/j.1440-1746.2011.06779.x; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Okajima T, 2000, J BIOL CHEM, V275, P6717, DOI 10.1074/jbc.275.10.6717; Ota H, 1998, VIRCHOWS ARCH, V433, P419, DOI 10.1007/s004280050269; Ozawa M, 1996, J BIOCHEM-TOKYO, V119, P302; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Rasmussen LH, 2005, CHEMOSPHERE, V58, P823, DOI 10.1016/j.chemosphere.2004.08.088; Reis CA, 1999, CANCER RES, V59, P1003; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Shahin M, 1999, MUTAT RES-GEN TOX EN, V443, P69, DOI 10.1016/S1383-5742(99)00011-3; Silva E, 2002, VIRCHOWS ARCH, V440, P311, DOI 10.1007/s004280100531; Smith BL, 2004, POISONOUS PLANTS AND RELATED TOXINS, P227, DOI 10.1079/9780851996141.0227; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Vetter J, 2009, ACTA VET HUNG, V57, P183, DOI 10.1556/AVet.57.2009.1.18; Yamada K, 2007, NAT PROD REP, V24, P798, DOI 10.1039/b614160a; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Zen K, 1998, AM J PHYSIOL-LUNG C, V275, pL172, DOI 10.1152/ajplung.1998.275.1.L172	66	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38353	10.1371/journal.pone.0038353	http://dx.doi.org/10.1371/journal.pone.0038353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719879	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900025
J	Masan, P; Simpson, C; Perotti, MA; Braig, HR				Masan, Peter; Simpson, Christopher; Perotti, M. Alejandra; Braig, Henk R.			Mites Parasitic on Australasian and African Spiders Found in the Pet Trade; a Redescription of Ljunghia pulleinei Womersley	PLOS ONE			English	Article							ARANEAE; ACARI	Parasitic mites associated with spiders are spreading world-wide through the trade in tarantulas and other pet species. Ljunghia pulleinei Womersley, a mesostigmatic laelapid mite originally found in association with the mygalomorph spider Selenocosmia stirlingi Hogg (Theraphosidae) in Australia, is redescribed and illustrated on the basis of specimens from the African theraphosid spider Pterinochilus chordatus (Gerstacker) kept in captivity in the British Isles (Wales). The mite is known from older original descriptions of Womersley in 1956; the subsequent redescription of Domrow in 1975 seems to be questionable in conspecificity of treated specimens with the type material. Some inconsistencies in both descriptions are recognised here as intraspecific variability of the studied specimens. The genus Arachnyssus Ma, with species A. guangxiensis (type) and A. huwenae, is not considered to be a valid genus, and is included in synonymy with Ljunghia Oudemans. A new key to world species of the genus Ljunghia is provided.	[Masan, Peter; Simpson, Christopher; Braig, Henk R.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Masan, Peter] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Reading, Berks, England	Bangor University; Slovak Academy of Sciences; University of Reading	Masan, P (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	peter.masan@savba.sk	Braig, Henk/I-5477-2013; Mašán, Peter/HGA-1690-2022	Braig, Henk/0000-0001-9592-1141; 				Baker A., 1991, Bulletin of the British Arachnological Society, V8, P219; Baker A.S., 1992, P126; Casanueva Maria E., 1993, Gayana Zoologia, V57, P21; DOMROW R, 1975, Records of the South Australian Museum (Adelaide), V17, P31; Dunlop JA, 2012, BIOL LETTERS, V8, P457, DOI 10.1098/rsbl.2011.0923; Ebermann Ernst, 2002, Acarologia (Paris), V42, P173; FAIN A, 1991, Records of the Western Australian Museum, V15, P69; FAIN A, 1991, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V61, P183; FAIN A, 1991, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V61, P199; FAIN A, 1989, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V59, P157; Finnegan S, 1933, P ZOOL SOC LOND, V1993, P413; Gallon Richard C., 2002, Bulletin of the British Arachnological Society, V12, P201; Lindquist E. E., 1965, Mem ent Soc Canada Ottawa, VNo. 47, P1; Ma Liming, 2002, Acta Arachnologica Sinica, V11, P8; Moraza ML, 2009, ZOOSYSTEMA, V31, P117, DOI 10.5252/z2009n1a6; OUDEMANS A. C., 1932, TIJDSCHR ENT [AMSTERDAM], V75 (suppl.), P202; Pizzi Romain, 2009, Journal of Exotic Pet Medicine, V18, P283, DOI 10.1053/j.jepm.2009.09.006; Schwendinger PJ, 2011, REV SUISSE ZOOL, V118, P599; WELBOURN WC, 1988, J ARACHNOL, V16, P373; Womersley H., 1956, Journal of the Linnean Society London Zoology, V42, P505; Wunderlich Joerg, 2004, Beitraege zur Araneologie, V3B, P1761; Zhu MS, 2008, J ARACHNOL, V36, P425, DOI 10.1636/CA07-94.1	22	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39019	10.1371/journal.pone.0039019	http://dx.doi.org/10.1371/journal.pone.0039019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720019	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305341900073
J	Munsters, MJM; Saris, WHM				Munsters, Marjet J. M.; Saris, Wim H. M.			Effects of Meal Frequency on Metabolic Profiles and Substrate Partitioning in Lean Healthy Males	PLOS ONE			English	Article							RESPIRATION CHAMBER; FEEDING FREQUENCY; INSULIN; GLUCOSE; CARBOHYDRATE; EXPENDITURE; EXERCISE; SYSTEM; FAT; MEN	Introduction: The daily number of meals has an effect on postprandial glucose and insulin responses, which may affectsubstrate partitioning and thus weight control. This study investigated the effects of meal frequency on 24 h profiles of metabolic markers and substrate partitioning. Methods: Twelve (BMI: 21.6 +/- 0.6 kg/m(2)) healthy male subjects stayed after 3 days of food intake and physical activity standardization 2636 hours in a respiration chamber to measure substrate partitioning. All subjects randomly received two isoenergetic diets with a Low meal Frequency (36; LFr) or a High meal Frequency (146; HFr) consisting of 15 En% protein, 30 En% fat, and 55 En% carbohydrates. Blood was sampled at fixed time points during the day to measure metabolic markers and satiety hormones. Results: Glucose and insulin profiles showed greater fluctuations, but a lower AUC of glucose in the LFr diet compared with the HFr diet. No differences between the frequency diets were observed on fat and carbohydrate oxidation. Though, protein oxidation and RMR (in this case SMR + DIT) were significantly increased in the LFr diet compared with the HFr diet. The LFr diet increased satiety and reduced hunger ratings compared with the HFr diet during the day. Conclusion: The higher rise and subsequently fall of insulin in the LFr diet did not lead to a higher fat oxidation as hypothesized. The LFr diet decreased glucose levels throughout the day (AUC) indicating glycemic improvements. RMR and appetite control increased in the LFr diet, which can be relevant for body weight control on the long term.	[Munsters, Marjet J. M.; Saris, Wim H. M.] MUMC, Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Human Biol, Maastricht, Netherlands	Maastricht University	Munsters, MJM (corresponding author), MUMC, Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Human Biol, Maastricht, Netherlands.	M.Munsters@maastrichtuniversity.nl			Dutch Dairy Association	Dutch Dairy Association	The study was funded by the Dutch Dairy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRUP A, 1995, INT J OBESITY, V19, pS27; Bellisle F, 1997, BRIT J NUTR, V77, pS57, DOI 10.1079/BJN19970104; BERNE C, 1992, DIABETOLOGIA, V35, P873, DOI 10.1007/BF00399935; Berteus-Forslund H, 2005, INT J OBESITY, V29, P711, DOI 10.1038/sj.ijo.0802950; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Chapelot D, 2011, J NUTR, V141, P158, DOI 10.3945/jn.109.114330; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Frayn K. N., 2010, METABOLIC REGULATION; Goodyear MDE, 2007, BRIT MED J, V335, P624, DOI 10.1136/bmj.39339.610000.BE; Leidy HJ, 2011, J NUTR, V141, P154, DOI 10.3945/jn.109.114389; MANDARINO LJ, 1987, J CLIN INVEST, V80, P655, DOI 10.1172/JCI113118; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCrory MA, 2011, J NUTR, V141, P148, DOI 10.3945/jn.109.114991; McCrory MA, 2011, J NUTR, V141, P144, DOI 10.3945/jn.109.114918; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241; MILLER WC, 1990, AM J CLIN NUTR, V52, P426, DOI 10.1093/ajcn/52.3.426; NAIR KS, 1988, AM J PHYSIOL, V254, pE208, DOI 10.1152/ajpendo.1988.254.2.E208; Palmer MA, 2009, NUTR REV, V67, P379, DOI 10.1111/j.1753-4887.2009.00204.x; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; RAVUSSIN E, 1992, LANCET, V340, P404, DOI 10.1016/0140-6736(92)91480-V; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; ROWE JW, 1981, DIABETES, V30, P219, DOI 10.2337/diab.30.3.219; Samuelson G, 2000, EUR J CLIN NUTR, V54, pS21, DOI 10.1038/sj.ejcn.1600980; Saris WHM, 2004, INT J OBESITY, V28, P759, DOI 10.1038/sj.ijo.0802631; Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Solomon TPJ, 2008, BRIT J NUTR, V100, P810, DOI 10.1017/S000711450896757X; Taylor MA, 2001, INT J OBESITY, V25, P519, DOI 10.1038/sj.ijo.0801572; VERBOEKETVANDEVENNE WPHG, 1991, EUR J CLIN NUTR, V45, P161; Wentholt IME, 2008, DIABETOLOGIA, V51, P183, DOI 10.1007/s00125-007-0842-6; Westerterp KR, 1999, INT J OBESITY, V23, P287, DOI 10.1038/sj.ijo.0800810	34	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38632	10.1371/journal.pone.0038632	http://dx.doi.org/10.1371/journal.pone.0038632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719910	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900038
J	Tian, J; Qi, WB; Li, XK; He, J; Jiao, PR; Zhang, CH; Liu, GQ; Liao, M				Tian, Jin; Qi, Wenbao; Li, Xiaokang; He, Jun; Jiao, Peirong; Zhang, Changhui; Liu, Guo-Qian; Liao, Ming			A Single E627K Mutation in the PB2 Protein of H9N2 Avian Influenza Virus Increases Virulence by Inducing Higher Glucocorticoids (GCs) Level	PLOS ONE			English	Article							CD8 T-CELLS; A VIRUS; THYMOCYTE APOPTOSIS; IMMUNE FUNCTION; AMINO-ACID; TRANSMISSION; INFECTION; ADAPTATION; REPLICATION; LYMPHOCYTES	While repeated infection of humans and enhanced replication and transmission in mice has attracted more attention to it, the pathogenesis of H9N2 virus was less known in mice. PB2 residue 627 as the virulent determinant of H5N1 virus is associated with systemic infection and impaired TCR activation, but the impact of this position in H9N2 virus on the host immune response has not been evaluated. In this study, we quantified the cellular immune response to infection in the mouse lung and demonstrate that V-K627 and rTs(E627K) infection caused a significant reduction in the numbers of T cells and inflammatory cells (Macrophage, Neutrophils, Dendritic cells) compared to mice infected with rV(K627E) and Ts-E627. Further, we discovered (i) a high level of thymocyte apoptosis resulted in impaired T cell development, which led to the reduced amount of mature T cells into lung, and (ii) the reduced inflammatory cells entering into lung was attributed to the diminished levels in pro-inflammatory cytokines and chemokines. Thereafter, we recognized that higher GCs level in plasma induced by V-K627 and rTs(E627K) infection was associated with the increased apoptosis in thymus and the reduced pro-inflammatory cytokines and chemokines levels in lung. These data demonstrated that V-K627 and rTs(E627K) infection contributing to higher GCs level would decrease the magnitude of antiviral response in lung, which may be offered as a novel mechanism of enhanced pathogenicity for H9N2 AIV.	[Tian, Jin; Qi, Wenbao; He, Jun; Jiao, Peirong; Zhang, Changhui; Liu, Guo-Qian; Liao, Ming] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Tian, Jin; Qi, Wenbao; He, Jun; Jiao, Peirong; Zhang, Changhui; Liu, Guo-Qian; Liao, Ming] MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China; [Li, Xiaokang] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Henan, Peoples R China	South China Agricultural University; Henan University of Science & Technology	Tian, J (corresponding author), S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	mliao@scau.edu.cn	Jiao, Peirong/R-3060-2019	Jiao, Peirong/0000-0001-7750-239X	National Natural Science Foundation of China [81001375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81001375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, J BIOL CHEM, V286, P34504, DOI 10.1074/jbc.M111.262048; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Berg RE, 2006, CURR OPIN IMMUNOL, V18, P338, DOI 10.1016/j.coi.2006.03.010; Bhattacharyya S, 2011, P NATL ACAD SCI USA, V108, P9554, DOI 10.1073/pnas.1017296108; Bi JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013063; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chrousos GP, 2000, ANN NY ACAD SCI, V917, P38, DOI 10.1111/j.1749-6632.2000.tb05371.x; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Elftman MD, 2010, J IMMUNOL, V184, P1867, DOI 10.4049/jimmunol.0902469; Fornek JL, 2009, J VIROL, V83, P11102, DOI 10.1128/JVI.00994-09; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Hughes FM, 1998, J STEROID BIOCHEM, V65, P207, DOI 10.1016/S0960-0760(97)00188-X; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Julkunen I, 2001, VACCINE, V19, P6; Kim HR, 2010, J GEN VIROL, V91, P1978, DOI 10.1099/vir.0.021238-0; Lee DCW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-71; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Park KJ, 2011, J GEN VIROL, V92, P36, DOI 10.1099/vir.0.024992-0; Peiris JSK, 2009, CELL REV, V747, P11; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Takizawa T, 2010, OPEN ANTIMICROB AGEN, V2, P22; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vogel AB, 2010, J IMMUNOL, V185, P4824, DOI 10.4049/jimmunol.0903631; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wiegers GJ, 2001, EUR J IMMUNOL, V31, P2293, DOI 10.1002/1521-4141(200108)31:8<2293::AID-IMMU2293>3.0.CO;2-I; Wilckens T, 1997, IMMUNOL TODAY, V18, P418, DOI 10.1016/S0167-5699(97)01111-0; Wu R, 2010, VET MICROBIOL, V142, P211, DOI 10.1016/j.vetmic.2009.09.068; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Xie DX, 2009, INT IMMUNOL, V21, P1251, DOI 10.1093/intimm/dxp087; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09	46	33	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38233	10.1371/journal.pone.0038233	http://dx.doi.org/10.1371/journal.pone.0038233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719870	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900021
J	D'Addario, C; Di Francesco, A; Arosio, B; Gussago, C; Dell'Osso, B; Bari, M; Galimberti, D; Scarpini, E; Altamura, AC; Mari, D; Maccarrone, M				D'Addario, Claudio; Di Francesco, Andrea; Arosio, Beatrice; Gussago, Cristina; Dell'Osso, Bernardo; Bari, Monica; Galimberti, Daniela; Scarpini, Elio; Altamura, A. Carlo; Mari, Daniela; Maccarrone, Mauro			Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease	PLOS ONE			English	Article							CANNABINOID RECEPTOR-BINDING; CENTRAL-NERVOUS-SYSTEM; ENDOCANNABINOID SYSTEM; DNA METHYLATION; MESSENGER-RNA; ANANDAMIDE; EXPRESSION; CELLS; BRAIN; CB1	Objective: Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes. Methods: We have studied the gene expression status and the epigenetic regulation of ECS components in peripheral blood mononuclear cells (PBMCs) of subjects with late-onset AD (LOAD) and age-matched controls (CT). Results: We found an increase in fatty acid amide hydrolase (faah) gene expression in LOAD subjects (2.30 +/- 0.48) when compared to CT (1.00 +/- 0.14; *p<0.05) and no changes in the mRNA levels of any other gene of ECS elements. Consistently, we also observed in LOAD subjects an increase in FAAH protein levels (CT: 0.75 +/- 0.04; LOAD: 1.11 +/- 0.15; *p<0.05) and activity (pmol/min per mg protein CT: 103.80 +/- 8.73; LOAD: 125.10 +/- 4.00; *p<0.05), as well as a reduction in DNA methylation at faah gene promoter (CT: 55.90 +/- 4.60%; LOAD: 41.20 +/- 4.90%; *p<0.05). Conclusions: Present findings suggest the involvement of FAAH in the pathogenesis of AD, highlighting the importance of epigenetic mechanisms in enzyme regulation; they also point to FAAH as a new potential biomarker for AD in easily accessible peripheral cells.	[D'Addario, Claudio; Di Francesco, Andrea; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Arosio, Beatrice; Gussago, Cristina; Mari, Daniela] Univ Milan, Geriatr Unit, Dept Med Sci & Community Hlth, Fdn Ca Granda,IRCCS Osped Maggiore Policlin, Milan, Italy; [Dell'Osso, Bernardo; Altamura, A. Carlo] Univ Milan, Dept Psychiat, Fdn Ca Granda, IRCCS Osped Maggiore Policlin, Milan, Italy; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, Fdn Ca Granda,IRCCS Osped Maggiore Policlin, Milan, Italy; [Bari, Monica] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Bari, Monica; Maccarrone, Mauro] IRCCS Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy	University of Teramo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Rome Tor Vergata; IRCCS Santa Lucia	D'Addario, C (corresponding author), Univ Teramo, Dept Biomed Sci, Teramo, Italy.	mmaccarrone@unite.it	Mari, Daniela/K-5663-2016; Dell'Osso, Bernardo/K-8030-2016; DAddario, Claudio/A-5970-2010; Galimberti, Daniela/N-7209-2019; Di Francesco, Andrea/G-8016-2011; Maccarrone, Mauro/K-5398-2012; Scarpini, Elio/K-6547-2016	Mari, Daniela/0000-0002-6950-0789; Galimberti, Daniela/0000-0002-9284-5953; Maccarrone, Mauro/0000-0002-3990-2963; Di Francesco, Andrea/0000-0001-6867-8203; Gussago, Cristina/0000-0002-2708-3112; Arosio, Beatrice/0000-0002-0615-3580; Scarpini, Elio/0000-0002-6395-2119; dell'osso, bernardo/0000-0001-9370-5365; d'addario, claudio/0000-0002-1275-098X	Fondazione TERCAS	Fondazione TERCAS	This investigation was partially supported by Fondazione TERCAS (grant 2009-2012 to MM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arosio B, 2012, NEURODEGENER DIS, V10, P207, DOI 10.1159/000333799; Arosio B, 2004, NEUROBIOL AGING, V25, P1009, DOI 10.1016/j.neurobiolaging.2003.10.009; Benito C, 2003, J NEUROSCI, V23, P11136; Benito C, 2007, MOL NEUROBIOL, V36, P75, DOI 10.1007/s12035-007-8006-8; Bisogno T, 2008, CURR PHARM DESIGN, V14, P2299, DOI 10.2174/138161208785740027; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Catani MV, 2010, CELL MOL LIFE SCI, V67, P601, DOI 10.1007/s00018-009-0198-9; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; D'Addario C, 2012, NEUROPSYCHOPHARMACOL, V37, P1647, DOI 10.1038/npp.2012.10; Dangond F, 1998, BIOCHEM BIOPH RES CO, V247, P833, DOI 10.1006/bbrc.1998.8891; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Grunblatt E, 2009, J ALZHEIMERS DIS, V16, P627, DOI 10.3233/JAD-2009-0996; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Jung KM, 2012, NEUROBIOL AGING, V33, P1522, DOI 10.1016/j.neurobiolaging.2011.03.012; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Lee JH, 2010, NEUROCHEM INT, V57, P985, DOI 10.1016/j.neuint.2010.10.010; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Maccarrone M, 2002, BLOOD, V100, P4040, DOI 10.1182/blood-2002-05-1444; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; MAILLEUX P, 1992, NEUROSCI LETT, V147, P179, DOI 10.1016/0304-3940(92)90589-Y; Marchalant Y, 2008, NEUROBIOL AGING, V29, P1894, DOI 10.1016/j.neurobiolaging.2007.04.028; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mechoulam R, 2000, CHEM PHYS LIPIDS, V108, P1, DOI 10.1016/S0009-3084(00)00184-5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Nunez E, 2008, NEUROSCIENCE, V151, P104, DOI 10.1016/j.neuroscience.2007.10.029; Paradisi A, 2006, CURR DRUG TARGETS, V7, P1539, DOI 10.2174/1389450110607011539; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pidsley R, 2011, BIOL PSYCHIAT, V69, P146, DOI 10.1016/j.biopsych.2010.03.029; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani A, 2005, ANN NEUROL, V57, P777, DOI 10.1002/ana.20462; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; RICHFIELD EK, 1994, ANN NEUROL, V36, P577, DOI 10.1002/ana.410360406; Romero J, 1998, SYNAPSE, V30, P298, DOI 10.1002/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6; Romero J, 2002, MOL BRAIN RES, V100, P85; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Scarpa S, 2006, J ALZHEIMERS DIS, V9, P407; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Wan Y, 2007, BIOSENS BIOELECTRON, V22, P2415, DOI 10.1016/j.bios.2006.08.033; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; WESTLAKE TM, 1994, NEUROSCIENCE, V63, P637, DOI 10.1016/0306-4522(94)90511-8; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	55	64	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39186	10.1371/journal.pone.0039186	http://dx.doi.org/10.1371/journal.pone.0039186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720070	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340000068
J	Kaveh, DA; Whelan, AO; Hogarth, PJ				Kaveh, Daryan A.; Whelan, Adam O.; Hogarth, Philip J.			The Duration of Antigen-Stimulation Significantly Alters the Diversity of Multifunctional CD4 T Cells Measured by Intracellular Cytokine Staining	PLOS ONE			English	Article							TUBERCULOSIS VACCINE; PROTEIN ANTIGENS; FLOW-CYTOMETRY; BREFELDIN-A; PROTECTION; OPTIMIZATION; RESPONSES; MEMORY; EFFECTOR; MUCOSAL	The assessment of antigen-specific T cell responses by intracellular cytokine staining (ICS) has become a routine technique in studies of vaccination and immunity. Here, we highlight how the duration of in vitro antigen pre-stimulation, combined with the cytokine accumulation period, are critical parameters of these methods. The effect of varying these parameters upon the diversity and frequency of multifunctional CD4 T cell subsets has been investigated using a murine model of TB vaccination and in cattle naturally infected with Mycobacterium bovis. We demonstrate a substantial influence of the duration of the antigen pre-stimulation period on the repertoire of the antigen-specific CD4 T cell responses. Increasing pre-stimulation from 2 to 6 hours amplified the diversity of the seven potential multifunctional CD4 T cell subsets that secreted any combination of IFN-gamma, IL-2 and TNF-alpha. However, increasing pre-stimulation from 6 to 16 hours markedly altered the multifunctional CD4 T cell repertoire to a dominant IFN-gamma(+) only response. This was observed in both murine and cattle models. Whilst these data are of particular relevance to the measurement of vaccine and infection induced immunity in TB, more generally, they demonstrate the importance of the empirical determination of the optimum duration of the individual culture steps of ICS assays for any model. We highlight the potential significance of variations in these parameters, particularly when comparing data between studies and/or models including clinical trials.	[Kaveh, Daryan A.; Whelan, Adam O.; Hogarth, Philip J.] AHVLA, TB Res Grp, Surrey, England		Kaveh, DA (corresponding author), AHVLA, TB Res Grp, Surrey, England.	philip.hogarth@ahvla.gsi.gov.uk	Hogarth, Philip/C-6085-2011; Whelan, Adam O/C-9497-2011	Hogarth, Philip/0000-0002-6343-7846; Kaveh, Daryan/0000-0002-1451-0082	Department for Environment, Food and Rural Affairs, United Kingdom	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs, United Kingdom (www.defra.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; ADORINI L, 1990, NATURE, V346, P63, DOI 10.1038/346063a0; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Billeskov R, 2010, EUR J IMMUNOL, V40, P1342, DOI 10.1002/eji.200939830; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Combadiere B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010818; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Gauduin MC, 2004, J IMMUNOL METHODS, V288, P61, DOI 10.1016/j.jim.2004.02.007; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Llanos-Cuentas A, 2010, VACCINE, V28, P7427, DOI 10.1016/j.vaccine.2010.08.092; MACHAMER CE, 1984, P NATL ACAD SCI-BIOL, V81, P1287, DOI 10.1073/pnas.81.5.1287; Madhun AS, 2011, VACCINE, V29, P4973, DOI 10.1016/j.vaccine.2011.04.094; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Meier S, 2008, CYTOM PART A, V73A, P1035, DOI 10.1002/cyto.a.20640; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Nomura L, 2008, CYTOM PART A, V73A, P984, DOI 10.1002/cyto.a.20602; Nomura LE, 2000, CYTOMETRY, V40, P60, DOI 10.1002/(SICI)1097-0320(20000501)40:1<60::AID-CYTO8>3.0.CO;2-J; O'Neil-Andersen NJ, 2002, CLIN DIAGN LAB IMMUN, V9, P243, DOI 10.1128/CDLI.9.2.243-250.2001; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Perfetto Stephen P, 2010, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0934s53; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sopp P, 2001, VET IMMUNOL IMMUNOP, V81, P85, DOI 10.1016/S0165-2427(01)00334-8; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Vordermeier HM, 2009, CLIN VACCINE IMMUNOL, V16, P1443, DOI 10.1128/CVI.00229-09; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Weynants V, 1998, VET IMMUNOL IMMUNOP, V66, P309, DOI 10.1016/S0165-2427(98)00205-0; Whelan AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029194; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266	47	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38926	10.1371/journal.pone.0038926	http://dx.doi.org/10.1371/journal.pone.0038926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719990	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000053
J	Magnussen, GI; Holm, R; Emilsen, E; Rosnes, AKR; Slipicevic, A; Florenes, VA				Magnussen, Gry Irene; Holm, Ruth; Emilsen, Elisabeth; Rosnes, Anne Katrine Ree; Slipicevic, Ana; Florenes, Vivi Ann			High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy	PLOS ONE			English	Article							CELL-CYCLE REGULATION; KINASE INHIBITOR; DNA-DAMAGE; PROTEIN; CANCER; P53; PD0166285; MITOSIS; PHASE	Notoriously resistant malignant melanoma is one of the most increasing forms of cancer worldwide; there is thus a precarious need for new treatment options. The Wee1 kinase is a major regulator of the G(2)/M checkpoint, and halts the cell cycle by adding a negative phosphorylation on CDK1 (Tyr15). Additionally, Wee1 has a function in safeguarding the genome integrity during DNA synthesis. To assess the role of Wee1 in development and progression of malignant melanoma we examined its expression in a panel of paraffin-embedded patient derived tissue of benign nevi and primary-and metastatic melanomas, as well as in agarose-embedded cultured melanocytes. We found that Wee1 expression increased in the direction of malignancy, and showed a strong, positive correlation with known biomarkers involved in cell cycle regulation: Cyclin A (p<0.0001), Ki67 (p<0.0001), Cyclin D3 (p=0.001), p21(Cip1/WAF1) (p=0.003), p53 (p=0.025). Furthermore, high Wee1 expression was associated with thicker primary tumors (p=0.001), ulceration (p=0.005) and poor disease-free survival (p=0.008). Transfections using siWee1 in metastatic melanoma cell lines; WM239(WTp53), WM45.1(MUTp53) and LOXWTp53, further support our hypothesis of a tumor promoting role of Wee1 in melanomas. Whereas no effect was observed in LOX cells, transfection with siWee1 led to accumulation of cells in G(1)/S and S phase of the cell cycle in WM239 and WM45.1 cells, respectively. Both latter cell lines displayed DNA damage and induction of apoptosis, in the absence of Wee1, indicating that the effect of silencing Wee1 may not be solely dependent of the p53 status of the cells. Together these results reveal the importance of Wee1 as a prognostic biomarker in melanomas, and indicate a potential role for targeted therapy, alone or in combination with other agents.	[Magnussen, Gry Irene; Holm, Ruth; Emilsen, Elisabeth; Rosnes, Anne Katrine Ree; Slipicevic, Ana; Florenes, Vivi Ann] Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Slipicevic, Ana] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Oslo; The Wistar Institute	Magnussen, GI (corresponding author), Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	vivi.ann.florenes@radiumhospitalet.no			South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Cancer Cluster	South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Cancer Cluster	This work was financially supported by The South-Eastern Norway Regional Health Authority (Helse Sor-Ost) and The Norwegian Cancer Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Cancer Registry of Norway, 2011, CANC NORW 2009; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Dominguez-Kelly R, 2011, J CELL BIOL, V194, P567, DOI 10.1083/jcb.201101047; Essner R, 1998, CANCER, V82, P309, DOI 10.1002/(SICI)1097-0142(19980115)82:2<317::AID-CNCR10>3.0.CO;2-1; Florenes VA, 1999, ONCOGENE, V18, P1023, DOI 10.1038/sj.onc.1202382; Florenes VA, 2004, MELANOMA RES, V14, P173, DOI 10.1097/01.cmr.0000129579.49313.26; FLORENES VA, 1995, MELANOMA RES, V5, P183, DOI 10.1097/00008390-199506000-00007; Florenes VA, 2001, J PATHOL, V195, P530; Florenes VA, 2000, CLIN CANCER RES, V6, P3614; Florenes VA, 1998, AM J PATHOL, V153, P305, DOI 10.1016/S0002-9440(10)65572-1; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; Gwosdz C, 2006, INT J CANCER, V118, P577, DOI 10.1002/ijc.21366; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Hashimoto O, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-292; HERLYN M, 1985, J NATL CANCER I, V74, P283; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Leijen S, 2010, CURR CLIN PHARMACOL, V5, P186, DOI 10.2174/157488410791498824; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Maelandsmo GM, 1996, AM J PATHOL, V149, P1813; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Panek RL, 1997, J PHARMACOL EXP THER, V283, P1433; PosthumaDeBoer J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-156; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sorensen CS, 2011, NUCL ACIDS RES; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; very-Kiejda KA, 2011, BMC CANCER, V11, P203; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang YL, 2001, CANCER RES, V61, P8211; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073	37	91	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38254	10.1371/journal.pone.0038254	http://dx.doi.org/10.1371/journal.pone.0038254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719872	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340000016
J	Cardona, A; Saalfeld, S; Schindelin, J; Arganda-Carreras, I; Preibisch, S; Longair, M; Tomancak, P; Hartenstein, V; Douglas, RJ				Cardona, Albert; Saalfeld, Stephan; Schindelin, Johannes; Arganda-Carreras, Ignacio; Preibisch, Stephan; Longair, Mark; Tomancak, Pavel; Hartenstein, Volker; Douglas, Rodney J.			TrakEM2 Software for Neural Circuit Reconstruction	PLOS ONE			English	Article							IMAGE DATA; TOMOGRAPHY; MICROSCOPY; VISUALIZATION; REGISTRATION; SYSTEM	A key challenge in neuroscience is the expeditious reconstruction of neuronal circuits. For model systems such as Drosophila and C. elegans, the limiting step is no longer the acquisition of imagery but the extraction of the circuit from images. For this purpose, we designed a software application, TrakEM2, that addresses the systematic reconstruction of neuronal circuits from large electron microscopical and optical image volumes. We address the challenges of image volume composition from individual, deformed images; of the reconstruction of neuronal arbors and annotation of synapses with fast manual and semi-automatic methods; and the management of large collections of both images and annotations. The output is a neural circuit of 3d arbors and synapses, encoded in NeuroML and other formats, ready for analysis.	[Cardona, Albert; Longair, Mark; Douglas, Rodney J.] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Cardona, Albert; Longair, Mark; Douglas, Rodney J.] ETH, Zurich, Switzerland; [Saalfeld, Stephan; Schindelin, Johannes; Preibisch, Stephan; Tomancak, Pavel] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Arganda-Carreras, Ignacio] MIT, Boston, MA USA; [Hartenstein, Volker] Univ Calif Los Angeles, Mol Cell & Dev Biol Dept, Los Angeles, CA USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles	Cardona, A (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	sapristi@gmail.com	Arganda-Carreras, Ignacio/L-4605-2014; Tomancak, Pavel/C-2109-2009	Arganda-Carreras, Ignacio/0000-0003-0229-5722; Tomancak, Pavel/0000-0002-2222-9370; Cardona, Albert/0000-0003-4941-6536; Saalfeld, Stephan/0000-0002-4106-1761; Longair, Mark/0000-0002-2192-438X; Preibisch, Stephan/0000-0002-0276-494X	Institute of Neuroinformatics; University of Zurich; ETH Zurich;  [NIH 1-R01 NS054814-05];  [SNSF 31003A_132969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054814] Funding Source: NIH RePORTER	Institute of Neuroinformatics; University of Zurich; ETH Zurich(ETH Zurich); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded primarily by Kevan A. Martin and the Institute of Neuroinformatics, University of Zurich and ETH Zurich; and also by grant NIH 1-R01 NS054814-05 to VH and grant SNSF 31003A_132969 to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Botha D, 1987, J PHYSIOL-LONDON, V394; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Briggman K, 2011, CURR OPIN NEUROBIOL; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Cardona A, 2010, J NEUROSCI, V30, P7538, DOI 10.1523/JNEUROSCI.0186-10.2010; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; da Costa NM, 2011, J NEUROSCI, V31, P2925, DOI 10.1523/JNEUROSCI.5961-10.2011; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; GLASER JR, 1990, COMPUT MED IMAG GRAP, V14, P307, DOI 10.1016/0895-6111(90)90105-K; Gleeson P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000815; Grigorian M, 2011, DEV BIOL, V353, P105, DOI 10.1016/j.ydbio.2011.02.024; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Kaynig V, 2010, P IEEE COMP SOC C CO; Kaynig V, 2010, J STRUCT BIOL, V171, P163, DOI 10.1016/j.jsb.2010.04.012; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kreshuk A, 2011, AUTOMATED SEGMENTATI; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Longair M, 2011, BIOINFORMATICS; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Oberti D, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00024; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Saalfeld S, 2012, NATURE METH IN PRESS; Saalfeld S, 2010, BIOINFORMATICS, V26, pi57, DOI 10.1093/bioinformatics/btq219; Schindelin J, 2012, NATURE METH IN PRESS; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; Stevens B J, 1979, Methods Enzymol, V56, P718; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Veeraraghavan A, 2010, P IEEE COMP SOC C CO; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	42	545	548	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38011	10.1371/journal.pone.0038011	http://dx.doi.org/10.1371/journal.pone.0038011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723842	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305652700008
J	Kishore, M; Ma, L; Cornish, G; Nourshargh, S; Marelli-Berg, FM				Kishore, Madhav; Ma, Liang; Cornish, Georgina; Nourshargh, Sussan; Marelli-Berg, Federica M.			Primed T Cell Responses to Chemokines Are Regulated by the Immunoglobulin-Like Molecule CD31	PLOS ONE			English	Article							LYMPHOCYTE TRANSENDOTHELIAL MIGRATION; VERSUS-HOST-DISEASE; CLONAL EXPANSION; ADHESION; PECAM-1; RECEPTOR; POLYMORPHISM; REQUIREMENTS; ASSOCIATION; TRANSPLANT	CD31, an immunoglobulin-like molecule expressed by leukocytes and endothelial cells, is thought to contribute to the physiological regulation T cell homeostasis due to the presence of two immunotyrosine-based inhibitory motifs in its cytoplasmic tail. Indeed, loss of CD31 expression leads to uncontrolled T cell-mediated inflammation in a variety of experimental models of disease and certain CD31 polymorphisms correlate with increased disease severity in human graft-versus-host disease and atherosclerosis. The molecular mechanisms underlying CD31-mediated regulation of T cell responses have not yet been clarified. We here show that CD31-mediated signals attenuate T cell chemokinesis both in vitro and in vivo. This effect selectively affects activated/memory T lymphocytes, in which CD31 is clustered on the cell membrane where it segregates to the leading edge. We provide evidence that this molecular segregation, which does not occur in naive T lymphocytes, might lead to cis-CD31 engagement on the same membrane and subsequent interference with the chemokine-induced PI3K/Akt signalling pathway. We propose that CD31-mediated modulation of memory T cell chemokinesis is a key mechanism by which this molecule contributes to the homeostatic regulation of effector T cell immunity.	[Kishore, Madhav; Nourshargh, Sussan; Marelli-Berg, Federica M.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Ma, Liang; Cornish, Georgina; Marelli-Berg, Federica M.] Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Immunol, London, England	University of London; Queen Mary University London; Imperial College London	Kishore, M (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	f.marelli-berg@qmul.ac.uk		Cornish, Georgina/0000-0002-1984-6677; Nourshargh, Sussan/0000-0001-5677-1806	British Heart Foundation [PG/05/136/19997, RG/09/002]; British Heart Foundation [RG/09/002/26425] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by funds from the British Heart Foundation (Ref: PG/05/136/19997 and RG/09/002 to FM-B) and facilitated by National Institute For Health Research Cardiovascular Biomedical Research Unit at Barts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer Johann, 2003, Am J Pharmacogenomics, V3, P317, DOI 10.2165/00129785-200303050-00003; Balduini CL, 2001, BRIT J HAEMATOL, V114, P951, DOI 10.1046/j.1365-2141.2001.03035.x; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Behar E, 1996, NEW ENGL J MED, V334, P286, DOI 10.1056/NEJM199602013340502; BIRD IN, 1993, IMMUNOLOGY, V80, P553; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Cavanagh G, 2005, TRANSPLANTATION, V79, P602, DOI 10.1097/01.TP.0000153153.94195.87; David R, 2009, BLOOD, V113, P3696, DOI 10.1182/blood-2008-09-176511; Donath C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-84; Duncan GS, 1999, J IMMUNOL, V162, P3022; El-Chennawi FA, 2006, HEMATOLOGY, V11, P227, DOI 10.1080/10245330600954189; Elrayess MA, 2004, ATHEROSCLEROSIS, V177, P127, DOI 10.1016/j.atherosclerosis.2004.06.009; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fornasa G, 2010, J IMMUNOL; Goodman RS, 2008, TRANSPLANTATION, V85, P471, DOI 10.1097/TP.0b013e3181622d65; Goodman RS, 2005, BONE MARROW TRANSPL, V36, P151, DOI 10.1038/sj.bmt.1705013; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Groyer E, 2007, J AM COLL CARDIOL, V50, P344, DOI 10.1016/j.jacc.2007.04.040; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Harris SJ, 2011, J IMMUNOL, V186, P4936, DOI 10.4049/jimmunol.1002350; Jarmin SJ, 2008, J CLIN INVEST, V118, P1154, DOI 10.1172/JCI33267; Ma LA, 2010, P NATL ACAD SCI USA, V107, P19461, DOI 10.1073/pnas.1011748107; Manes TD, 2010, J IMMUNOL, V184, P5186, DOI 10.4049/jimmunol.0902938; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Marelli-Berg FM, 2004, BLOOD, V103, P3111, DOI 10.1182/blood-2003-08-2717; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Pumphrey NJ, 1999, FEBS LETT, V450, P77, DOI 10.1016/S0014-5793(99)00446-9; Ross EA, 2011, J IMMUNOL, V187, P1553, DOI 10.4049/jimmunol.1000502; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Tada Y, 2003, ARTHRITIS RHEUM-US, V48, P3280, DOI 10.1002/art.11268; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wong MX, 2005, J CLIN IMMUNOL, V25, P19, DOI 10.1007/s10875-005-0354-7; Wu Y, 2005, J IMMUNOL, V175, P3484, DOI 10.4049/jimmunol.175.6.3484; Zhao TM, 2001, J CELL BIOL, V152, P65, DOI 10.1083/jcb.152.1.65	38	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39433	10.1371/journal.pone.0039433	http://dx.doi.org/10.1371/journal.pone.0039433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724015	gold, Green Published			2022-12-27	WOS:000305652700079
J	Williams, AJ; Farley, JH; Hoyle, SD; Davies, CR; Nicol, SJ				Williams, Ashley J.; Farley, Jessica H.; Hoyle, Simon D.; Davies, Campbell R.; Nicol, Simon J.			Spatial and Sex-Specific Variation in Growth of Albacore Tuna (Thunnus alalunga) across the South Pacific Ocean	PLOS ONE			English	Article							BLUEFIN TUNA; FOOD AVAILABILITY; FISH GROWTH; COUNTERGRADIENT VARIATION; DEMOGRAPHIC VARIATION; POPULATION-STRUCTURE; AGE; MACCOYII; DIFFERENTIATION; PATTERNS	Spatial variation in growth is a common feature of demersal fish populations which often exist as discrete adult sub-populations linked by a pelagic larval stage. However, it remains unclear whether variation in growth occurs at similar spatial scales for populations of highly migratory pelagic species, such as tuna. We examined spatial variation in growth of albacore Thunnus alalunga across 90 degrees of longitude in the South Pacific Ocean from the east coast of Australia to the Pitcairn Islands. Using length-at-age data from a validated ageing method we found evidence for significant variation in length-at-age and growth parameters (L-infinity and k) between sexes and across longitudes. Growth trajectories were similar between sexes up until four years of age, after which the length-at-age for males was, on average, greater than that for females. Males reached an average maximum size more than 8 cm larger than females. Length-at-age and growth parameters were consistently greater at more easterly longitudes than at westerly longitudes for both females and males. Our results provide strong evidence that finer spatial structure exists within the South Pacific albacore stock and raises the question of whether the scale of their "highly migratory" nature should be re-assessed. Future stock assessment models for South Pacific albacore should consider sex-specific growth curves and spatial variation in growth within the stock.	[Williams, Ashley J.; Hoyle, Simon D.; Nicol, Simon J.] Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea, New Caledonia; [Farley, Jessica H.; Davies, Campbell R.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Williams, AJ (corresponding author), Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea, New Caledonia.	Ashleyw@spc.int	Williams, Ashley/ABA-5921-2020; Hoyle, Simon D/G-1201-2015; Williams, Ashley J/J-7565-2013; Williams, Ashley J/G-2017-2014; Farley, Jessica/E-4957-2014; Davies, Campbell R/N-8086-2013	Williams, Ashley/0000-0002-5530-0073; Hoyle, Simon D/0000-0002-1787-6565; Williams, Ashley J/0000-0002-5530-0073; Farley, Jessica/0000-0002-5047-746X; Davies, Campbell R/0000-0002-2028-1060; Nicol, Simon/0000-0001-8193-8719	9th European Union Development Fund (SCIFISH project); Australian Fisheries Research and Development Corporation; CSIRO Wealth from Oceans Flaship [2009/012]; Western Central Pacific Fisheries Commission	9th European Union Development Fund (SCIFISH project); Australian Fisheries Research and Development Corporation; CSIRO Wealth from Oceans Flaship; Western Central Pacific Fisheries Commission	This work was supported by funding from the 9th European Union Development Fund (SCIFISH project), the Australian Fisheries Research and Development Corporation and the CSIRO Wealth from Oceans Flaship (Project # 2009/012). Additional funding was provided by the Western Central Pacific Fisheries Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain V, 2010, 6 SCI COMM M W CENTR; [Anonymous], QUANTITATIVE FISHERI; Arrizabalaga H, 2004, MAR ECOL PROG SER, V282, P245, DOI 10.3354/meps282245; BOEHLERT GW, 1980, MAR ECOL PROG SER, V3, P1, DOI 10.3354/meps003001; BRANDT SB, 1993, ESTUARIES, V16, P142, DOI 10.2307/1352771; BRANDT SB, 1981, MAR ECOL PROG SER, V6, P19, DOI 10.3354/meps006019; Bromhead D, 2009, 5 SCI COMM M W CENTR; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Childers J, 2011, FISH OCEANOGR, V20, P157, DOI 10.1111/j.1365-2419.2011.00575.x; Clear NP, 2000, FISH B-NOAA, V98, P25; CLIFTON KE, 1995, MAR ECOL PROG SER, V116, P39, DOI 10.3354/meps116039; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Conover DO, 1997, CAN J FISH AQUAT SCI, V54, P2401, DOI 10.1139/cjfas-54-10-2401; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; Davies CA, 2011, MAR BIOL, V158, P2727, DOI 10.1007/s00227-011-1772-x; Domokos R, 2007, FISH OCEANOGR, V16, P555, DOI 10.1111/j.1365-2419.2007.00451.x; Farley J., 2011, W CENTR PAC FISH COM; Farley JH, 2006, MAR FRESHWATER RES, V57, P713, DOI 10.1071/MF05255; Gompertz B., 1825, PHILOS T ROYAL SOC A, V115, P515, DOI DOI 10.1098/RSTL.1825.0026; Griffiths SP, 2010, ICES J MAR SCI, V67, P125, DOI 10.1093/icesjms/fsp223; Gulland J. A., 1988, FISH POPULATION DYNA; Gunn JS, 2008, FISH RES, V92, P207, DOI 10.1016/j.fishres.2008.01.018; Gust N, 2002, MAR BIOL, V140, P1039, DOI 10.1007/s00227-001-0773-6; Haddon M., 2011, MODELLING QUANTITATI; Harley S, 2011, 11 SECR PAC COMM TUN; Hoyle S, 2011, 7 SCI COMM M W CENTR; Hoyle S, 2008, 4 SCI COMM M W CENTR; ISSF, 2011, 201105 ISSF; JONES GP, 1986, OECOLOGIA, V70, P136, DOI 10.1007/BF00377123; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; KERRIGAN BA, 1994, MAR ECOL PROG SER, V111, P7, DOI 10.3354/meps111007; Kritzer J.P., 2006, MARINE METAPOPULATIO; Kritzer JP, 2005, ECOL MODEL, V182, P49, DOI 10.1016/j.ecolmodel.2004.07.010; LABELLE M, 1993, FISH B-NOAA, V91, P649; Labelle M, 2003, 16 STAND COMM TUN BE; Langley A, 2005, 1 M SCI COMM W CENTR; LAURS RM, 1981, FISH B-NOAA, V79, P293; Lee Liang-Kang, 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V60, P443; Lin Yu-Ting, 2010, Journal of the Fisheries Society of Taiwan, V37, P135; Meekan MG, 2001, MAR ECOL PROG SER, V212, P223, DOI 10.3354/meps212223; Megalofonou P, 2000, J FISH BIOL, V57, P700, DOI 10.1006/jfbi.2000.1345; Neilson JD, 2008, CAN J FISH AQUAT SCI, V65, P1523, DOI 10.1139/F08-127; PARRISH RH, 1985, FISH B-NOAA, V83, P483; Pauly D., 1979, THESIS U KIEL KIEL; PITCHER CR, 1992, AUST J MAR FRESH RES, V43, P1129; Punt AE, 2003, FISH RES, V65, P391, DOI 10.1016/j.fishres.2003.09.028; Qiu B, 2004, J PHYS OCEANOGR, V34, P1515, DOI 10.1175/1520-0485(2004)034<1515:SMITEF>2.0.CO;2; Quinn T.J., 1999, BIOL RES MANAG SER; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramon D, 1996, FISH B-NOAA, V94, P725; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Ricker W. E., 1975, B FISHERIES RES BOAR, P191; Robertson DR, 2005, MAR ECOL PROG SER, V295, P229, DOI 10.3354/meps295229; Santiago J, 2005, ICES J MAR SCI, V62, P740, DOI 10.1016/j.icesjms.2005.01.015; Sassa C, 2002, FISH OCEANOGR, V11, P193, DOI 10.1046/j.1365-2419.2002.00199.x; SCHNUTE JT, 1990, CAN J FISH AQUAT SCI, V47, P24, DOI 10.1139/f90-003; Takagi M, 2001, FISH B-NOAA, V99, P697; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Weatherley AH, 1987, BIOL FISH GROWTH; Wu GCC, 2009, FISH RES, V95, P125, DOI 10.1016/j.fishres.2008.07.014; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2	65	48	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39318	10.1371/journal.pone.0039318	http://dx.doi.org/10.1371/journal.pone.0039318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723993	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700066
J	Appleby, BS; Rincon-Beardsley, TD; Appleby, KK; Wallin, MT				Appleby, Brian S.; Rincon-Beardsley, Tonya D.; Appleby, Kristin K.; Wallin, Mitchell T.			Racial and Ethnic Differences in Individuals with Sporadic Creutzfeldt-Jakob Disease in the United States of America	PLOS ONE			English	Article							HUMAN PRION DISEASES; SURVEILLANCE; JAPAN	Background: Little is known about racial and ethnic differences in individuals with sporadic Creutzfeldt-Jakob disease (sCJD). The authors sought to examine potential clinical, diagnostic, genetic, and neuropathological differences in sCJD patients of different races/ethnicities. Methodology/Principal Findings: A retrospective study of 116 definite and probable sCJD cases from Johns Hopkins and the Department of Veterans Affairs Healthcare Systems was conducted that examined differences in demographic, clinical, diagnostic, genetic, and neuropathological characteristics among racial/ethnic groups. Age at disease onset differed among racial/ethnic groups. Non-Hispanic Whites had a significantly older age at disease onset compared to the other groups (65 vs. 60, p = 0.036). Non-Whites were accurately diagnosed more rapidly than Whites (p = 0.008) and non-Hispanic Whites were more likely to have normal appearing basal ganglia on brain magnetic resonance imaging (MRI) compared to minorities (p = 0.02). Whites were also more likely to undergo post-mortem evaluation compared to non-Whites (p = 0.02). Conclusions/Significance: Racial/ethnic groups affected by sCJD demonstrated differences in age at disease onset, time to correct diagnosis, clinical presentation, and diagnostic test results. Whites were more likely to undergo autopsy compared to non-Whites. These results have implications in regards to case ascertainment, diagnosis, and surveillance of sCJD and possibly other human prion diseases.	[Appleby, Brian S.] Cleveland Clin Fdn, Dept Psychiat & Psychol, Lou Ruvo Ctr Brain Hlth, Neurol Inst, Cleveland, OH 44195 USA; [Appleby, Brian S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21205 USA; [Rincon-Beardsley, Tonya D.] Johns Hopkins Univ, Sch Arts & Sci, Adv Acad Programs, Baltimore, MD USA; [Appleby, Kristin K.; Wallin, Mitchell T.] Vet Affairs Healthcare Syst, Dept Neurol, Washington, DC USA; [Appleby, Kristin K.] Cleveland Clin, Ctr Reg Neurol, Neurol Inst, Cleveland, OH 44106 USA; [Wallin, Mitchell T.] Georgetown Univ Hosp, Dept Neurol, Washington, DC 20007 USA	Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins University; Cleveland Clinic Foundation; Georgetown University	Appleby, BS (corresponding author), Cleveland Clin Fdn, Dept Psychiat & Psychol, Lou Ruvo Ctr Brain Hlth, Neurol Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	applebb@ccf.org	Appleby, Brian/A-3390-2008; Wallin, Mitchell T./J-8190-2019; Weiderpass, Elisabete/AAP-2747-2021	Wallin, Mitchell T./0000-0003-1061-5714; Weiderpass, Elisabete/0000-0003-2237-0128	Richmond Family Foundation for Alzheimer's and Related Diseases; Stempler Dementia Fund	Richmond Family Foundation for Alzheimer's and Related Diseases; Stempler Dementia Fund	This research was partially supported by the Richmond Family Foundation for Alzheimer's and Related Diseases and the Stempler Dementia Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DEM PROF MIL COMM; Appleby BS, 2007, J NEUROPSYCH CLIN N, V19, P428, DOI 10.1176/appi.neuropsych.19.4.428; Appleby BS, 2009, ARCH NEUROL-CHICAGO, V66, P208, DOI 10.1001/archneurol.2008.533; DESLYS JP, 1994, J GEN VIROL, V75, P23, DOI 10.1099/0022-1317-75-1-23; Gelpi E, 2008, NEUROEPIDEMIOLOGY, V30, P215, DOI 10.1159/000126915; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Holman RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008521; Lai CH, 2009, NEUROEPIDEMIOLOGY, V33, P247, DOI 10.1159/000229779; Mercier G, 2008, HUM BIOL, V80, P181, DOI 10.3378/1534-6617(2008)80[181:PDOTMA]2.0.CO;2; Nagoshi K, 2011, J EPIDEMIOL, V21, P255, DOI 10.2188/jea.JE20100085; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; Office of the Deputy Under Secretary of Defense, 2009, DEM 2009 PROF MIL CO; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Stoeck K, 2008, J NEUROL, V255, P1464, DOI 10.1007/s00415-008-0900-0; Wallin M, 2012, BRAIN IN PRESS; WHO, 1998, GLOBAL SURVEILLANCE; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38884	10.1371/journal.pone.0038884	http://dx.doi.org/10.1371/journal.pone.0038884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723901	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300064
J	Kebede, B; Kemal, T; Abera, S				Kebede, Biruktawit; Kemal, Temam; Abera, Solomon			Oral Health Status of Patients with Mental Disorders in Southwest Ethiopia	PLOS ONE			English	Article							DENTAL-CARIES; PATTERNS; ISRAEL	Background: Psychiatric disorders are known to be a risk factor for the development of different oral health problems especially for dental caries and periodontal diseases. In spite of this fact, no study has been conducted to reveal its magnitude in Ethiopia. Hence, this study was conducted to determine the oral health status of psychiatric patients at Jimma University Specialized Hospital (JUSH), Psychiatric Clinic. Methods: A hospital based cross-sectional study was used from January to May 2011. A total of 240 participants were included in the study. Dental examination was done to measure indices of oral health: decayed, missing, and filled teeth (DMFT) index and community periodontal index (CPI). Oral examination was performed using mirror, probe and explorer by experienced dental doctors. A simple random sampling technique was implemented to collect data. ANOVA test, binary logistic and multinomial logistic regression analyses were done using SPSS 16.0 statistical software. Results: The mean DMFT score among the psychiatric patients was 1.94 +/- 2.12 (mean +/- SD) with 1.28 +/- 1.69, 0.51 +/- 1.19 and 0.14 +/- 0.48 (mean +/- SD) for decayed, missed and filled teeth respectively. Only about 24% of the psychiatric patients had a healthy CPI score. Incorrect tooth brushing technique was significantly associated with a DMFT score greater than 2 (AOR=3.58; 95% CI: 1.65, 7.79). The habit of sweet intake was also associated with dental caries (AOR=2.91; 95% CI: 1.43, 5.95). Similarly, patients with a smoking habit also demonstrated statistically significant association with dental caries (AOR=18.98; 95% CI: 5.06, 71.24). Conclusion: The oral health status of the psychiatric patients was poor. Thus, health education about oral hygiene should be given for psychiatric patients so they can avoid the frequent intake of sweets, smoking and learn correct tooth brushing technique.	[Kebede, Biruktawit; Kemal, Temam] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Dent, Jimma, Ethiopia; [Abera, Solomon] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Abera, Solomon] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia	Jimma University; Jimma University; Addis Ababa University	Kebede, B (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Dent, Jimma, Ethiopia.	bruktawit.kebede@ju.edu.et			Jimma University (JU); JU	Jimma University (JU); JU	The authors acknowledge Jimma University (JU) for the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the study participants and their guardians/care-givers for their participation in the study and provision of necessary information. We also acknowledge JU for the grant.	Adeniyi AA, 2011, SPEC CARE DENT, V31, P134, DOI 10.1111/j.1754-4505.2011.00193.x; [Anonymous], J HLTH SCI; Bardow A, 2001, ARCH ORAL BIOL, V46, P413, DOI 10.1016/S0003-9969(01)00003-6; Chu KY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-482; Clifton A, 2011, SCHIZOPHRENIA BULL, V37, P464, DOI 10.1093/schbul/sbq169; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; Funk M., 2008, INT MENT HLTH PRIM C; Girma E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-138; Jared H., 2008, J DENT HYG, V82, P24; Jovanovic S, 2010, CROAT MED J, V51, P443, DOI 10.3325/cmj.2010.51.443; Kumar Manish, 2006, Indian J Dent Res, V17, P171; Lewis S, 2001, Spec Care Dentist, V21, P182, DOI 10.1111/j.1754-4505.2001.tb00252.x; Millar WJ, 2007, J CAN DENT ASSOC, V73, P2; Mirza I., 2001, PSYCHIATRI B, V25, P143, DOI DOI 10.1192/PB.25.4.143; Petersen PE, 2005, COMMUNITY DENT HLTH, V22, P71; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ramon T, 2003, EUR PSYCHIAT, V18, P101, DOI 10.1016/S0924-9338(03)00023-3; Ravald N, 2012, J CLIN PERIODONTOL, V39, P73, DOI 10.1111/j.1600-051X.2011.01811.x; Rekha R, 2002, J Indian Soc Pedod Prev Dent, V20, P63; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Stevens T, 2010, PSYCHIATR BULL, V34, P518, DOI 10.1192/pb.bp.109.029157; Terezakis E, 2011, J CLIN PERIODONTOL, V38, P628, DOI 10.1111/j.1600-051X.2011.01727.x; Vered Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-345; *WHO, 2003, WHO PUBL; WHO, 2008, MHGAP MENTAL HLTH GA; World Health Organization, 2003, INV MENT HLTH; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; World Health Organization, 2006, OR HLTH AG SOC INT O; Zusman SP, 2010, SPEC CARE DENT, V30, P18, DOI 10.1111/j.1754-4505.2009.00118.x	29	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39142	10.1371/journal.pone.0039142	http://dx.doi.org/10.1371/journal.pone.0039142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22723950	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300103
J	Orr, ME; Pitstick, R; Canine, B; Ashe, KH; Carlson, GA				Orr, Miranda E.; Pitstick, Rose; Canine, Brenda; Ashe, Karen H.; Carlson, George A.			Genotype-Specific Differences between Mouse CNS Stem Cell Lines Expressing Frontotemporal Dementia Mutant or Wild Type Human Tau	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HELICAL FILAMENT-TAU; MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; TRANSGENIC MICE; IN-VITRO; DENDRITIC FILOPODIA; HIPPOCAMPAL-NEURONS; FTDP-17 MUTATIONS; PROTEIN-TAU	Stem cell (SC) lines that capture the genetics of disease susceptibility provide new research tools. To assess the utility of mouse central nervous system (CNS) SC-containing neurosphere cultures for studying heritable neurodegenerative disease, we compared neurosphere cultures from transgenic mice that express human tau with the P301L familial frontotemporal dementia (FTD) mutation, rTg(tau(P301L)) 4510, with those expressing comparable levels of wild type human tau, rTg(tau(wt)) 21221. rTg( tau(P301L)) 4510 mice express the human tau(P301L) variant in their forebrains and display cellular, histological, biochemical and behavioral abnormalities similar to those in human FTD, including age-dependent differences in tau phosphorylation that distinguish them from rTg(tau(wt)) 21221 mice. We compared FTD-hallmark tau phosphorylation in neurospheres from rTg(tau(P301L)) 4510 mice and from rTg(tau(wt)) 21221 mice. The tau genotype-specific phosphorylation patterns in neurospheres mimicked those seen in mice, validating use of neurosphere cultures as models for studying tau phosphorylation. Genotype-specific tau phosphorylation was observed in 35 independent cell lines from individual fetuses; tau in rTg(tau(P301L)) 4510 cultures was hypophosphorylated in comparison with rTg(tau(wt)) 21221 as was seen in young adult mice. In addition, there were fewer human tau-expressing cells in rTg(tau(P301L)) 4510 than in rTg(tau(wt)) 21221 cultures. Following differentiation, neuronal filopodia-spine density was slightly greater in rTg(tau(P301L)) 4510 than rTg(tau(wt)) 21221 and control cultures. Together with the recapitulation of genotype-specific phosphorylation patterns, the observation that neurosphere lines maintained their cell line-specific-differences and retained SC characteristics over several passages supports the utility of SC cultures as surrogates for analysis of cellular disease mechanisms.	[Orr, Miranda E.; Pitstick, Rose; Canine, Brenda; Carlson, George A.] McLaughlin Res Inst, Great Falls, MT USA; [Orr, Miranda E.] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Ashe, Karen H.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Ashe, Karen H.] Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA	McLaughlin Research Institute for Biomedical Sciences, Inc.; Montana State University System; Montana State University Bozeman; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Orr, ME (corresponding author), McLaughlin Res Inst, Great Falls, MT USA.	gac@mri.montana.edu			National Institutes of Health, USPHS [P01NS04199, R01AG026252]; NIH [F31AG031630]; NATIONAL INSTITUTE ON AGING [R01AG026252, F31AG031630] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants P01NS04199 and R01AG026252 from the National Institutes of Health, USPHS. MEO was supported by NIH predoctoral fellowship award F31AG031630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Barten DM, J ALZHEIMERS DIS S2, V24, P127; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; BRION JP, 1994, NEUROSCIENCE, V63, P895, DOI 10.1016/0306-4522(94)90533-9; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; CACERES A, 1984, J NEUROSCI, V4, P394; Ciccolini F, 2001, MOL CELL NEUROSCI, V17, P895, DOI 10.1006/mcne.2001.0980; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gilley J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.014; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Haas MA, 2007, CELL MOTIL CYTOSKEL, V64, P274, DOI 10.1002/cm.20182; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hundelt M, 2011, NEUROBIOL AGING, V32, P991, DOI 10.1016/j.neurobiolaging.2009.06.007; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jessberger S, 2007, STEM CELLS, V25, P871, DOI 10.1634/stemcells.2006-0620; Kempf M, 1996, J NEUROSCI, V16, P5583; KLEIMAN R, 1994, J NEUROSCI, V14, P1130, DOI 10.1523/JNEUROSCI.14-03-01130.1994; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Klein C, 2004, DEV NEUROSCI-BASEL, V26, P82, DOI 10.1159/000082129; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Mroz K, 1999, DEV BIOL, V207, P229, DOI 10.1006/dbio.1998.9160; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; PAPA M, 1995, J NEUROSCI, V15, P1; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; ROCHER AB, 2009, EXP NEUROL; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Thurston VC, 1997, CELL MOTIL CYTOSKEL, V38, P100, DOI 10.1002/(SICI)1097-0169(1997)38:1<100::AID-CM9>3.0.CO;2-C; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Urbach A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004175; Vandebroek T, 2006, J BIOL CHEM, V281, P25388, DOI 10.1074/jbc.M602792200; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	91	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39328	10.1371/journal.pone.0039328	http://dx.doi.org/10.1371/journal.pone.0039328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723997	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300133
J	Wang, D; Su, LY; Zhang, AM; Li, YY; Li, XA; Chen, LL; Long, H; Yao, YG				Wang, Dong; Su, Ling-Yan; Zhang, A-Mei; Li, Yu-Ye; Li, Xiao-An; Chen, Ling-Ling; Long, Heng; Yao, Yong-Gang			Mitochondrial DNA Copy Number, but Not Haplogroup, Confers a Genetic Susceptibility to Leprosy in Han Chinese from Southwest China	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; CLINICAL EXPRESSION; SURVIVAL; SEPSIS; ASSOCIATION; SEQUENCE; CELLS; RISK	Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an unculturable pathogen with an exceptionally eroded genome. The high level of inactivation of gene function in M. leprae, including many genes in its metabolic pathways, has led to a dependence on host energy production and nutritional products. We hypothesized that host cellular powerhouse - the mitochondria - may affect host susceptibility to M. leprae and the onset of clinical leprosy, and this may be reflected by mitochondrial DNA (mtDNA) background and mtDNA copy number. Methods: We analyzed the mtDNA sequence variation of 534 leprosy patients and 850 matched controls from Yunnan Province and classified each subject by haplogroup. mtDNA copy number, taken to be proportional to mtDNA content, was measured in a subset of these subjects (296 patients and 231 controls) and 12 leprosy patients upon diagnosis. Results: Comparison of matrilineal components of the case and control populations revealed no significant difference. However, measurement of mtDNA copy number showed that lepromatous leprosy patients had a significantly higher mtDNA content than controls (P = 0.008). Past medical treatments had no effect on the alteration of mtDNA copy number. Conclusions: Our results suggested that mtDNA content, but not haplogroup, affects leprosy and this influence is limited to the clinical subtype of lepromatous leprosy.	[Wang, Dong; Su, Ling-Yan; Zhang, A-Mei; Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Li, Yu-Ye; Chen, Ling-Ling] Kunming Med Coll, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Li, Xiao-An] Yuxi City Ctr Dis Control & Prevent, Yuxi, Yunnan, Peoples R China; [Long, Heng] Wenshan Inst Dermatol, Wenshan, Yunnan, Peoples R China; [Wang, Dong; Su, Ling-Yan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, D (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; Chen, Ling-Ling/AAY-3547-2021	Yao, Yong-Gang/0000-0002-2955-0693; 	Ministry of Science and Technology of China [2011CB910900]; National Natural Science Foundation of China [30925021]; Yunnan Province [2009CI119]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported by the Ministry of Science and Technology of China (2011CB910900), the National Natural Science Foundation of China (30925021), and Yunnan Province (2009CI119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021029; Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P337; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bi R, 2010, HUM MUTAT, V31, P538, DOI 10.1002/humu.21220; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cote HC, 2007, CRIT CARE, V11, DOI 10.1186/cc6096; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Garcia-Alvarez M, 2011, AIDS, V25, P1619, DOI 10.1097/QAD.0b013e328349820f; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Huebinger RM, 2010, SHOCK, V33, P19, DOI 10.1097/SHK.0b013e3181a99508; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Li YY, 2011, LEPROSY REV, V82, P6; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Misch EA, 2010, MICROBIOL MOL BIOL R, V74, P589, DOI 10.1128/MMBR.00025-10; Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Montoya D, 2010, ADV IMMUNOL, V105, P1, DOI 10.1016/S0065-2776(10)05001-7; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rotig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Soriano A, 2005, NEW ENGL J MED, V353, P2305, DOI 10.1056/NEJM200511243532123; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Walker SL, 2006, BRIT MED BULL, V77-78, P103, DOI 10.1093/bmb/ldl010; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; WHO, 1982, WHO TECHN REP SER; World Health Organization, 1988, WHO TECHN REP SER, V768; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343; Yao YG, 2007, STEM CELLS, V25, P2670, DOI 10.1634/stemcells.2007-0269; Zhang AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027750	44	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38848	10.1371/journal.pone.0038848	http://dx.doi.org/10.1371/journal.pone.0038848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719964	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300059
J	Al-Houqani, M; Ali, R; Hajat, C				Al-Houqani, Mohammed; Ali, Raghib; Hajat, Cother			Tobacco Smoking Using Midwakh Is an Emerging Health Problem - Evidence from a Large Cross-Sectional Survey in the United Arab Emirates	PLOS ONE			English	Article							PREVALENCE	Introduction: Accurate information about the prevalence and types of tobacco use is essential to deliver effective public health policy. We aimed to study the prevalence and modes of tobacco consumption in the United Arab Emirates (UAE), particularly focusing on the use of Midwakh (Arabic traditional pipe). Methods: We studied 170,430 UAE nationals aged >= 18 years (44% males and 56% females) in the Weqaya population-based screening program in Abu Dhabi residents during the period April 2008-June 2010. Self-reported smoking status, type, quantity and duration of tobacco smoked were recorded. Descriptive statistics were used to describe the study findings; prevalence rates used the screened sample as the denominator. Result: The prevalence of smoking overall was 24.3% in males and 0.8% in females and highest in males aged 20-39. Mean age (SD) of smokers was 32.8 (11.1) years, 32.7 (11.1) in males and 35.7 (12.1) in females. Cigarette smoking was the commonest form of tobacco use (77.4% of smokers), followed by Midwakh (15.0%), shisha (waterpipe) (6.8%), and cigar (0.66%). The mean durations of smoking for cigarettes, Midwakh, shisha and cigars were 11.4, 9.3, 7.6 and 11.0 years, respectively. Conclusions: Smoking is most common among younger UAE national men. The use of Midwakh and the relatively young age of onset of Midwakh smokers is of particular concern as is the possibility of the habit spreading to other countries. Comprehensive tobacco control laws targeting the young and the use of Midwakh are needed.	[Al-Houqani, Mohammed; Ali, Raghib] UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Ali, Raghib] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Hajat, Cother] Hlth Author Abu Dhabi, Publ Hlth & Res Dept, Abu Dhabi, U Arab Emirates	United Arab Emirates University; University of Oxford	Al-Houqani, M (corresponding author), UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	alhouqani@uaeu.ac.ae		Al-Houqani, Mohammed/0000-0003-4481-3911; Hajat, Cother/0000-0002-1763-3010				Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Al Zaabi A, 2011, RESP MED, V105, P566, DOI 10.1016/j.rmed.2010.12.008; Al-Hamdan N., 2009, Eastern Mediterranean Health Journal, V15, P600; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Enviromental Health & Saftey & Risk Management Services, 2007, ENV HLTH SAFT RISK M; Fendrich M, 2005, ADDICTION, V100, P143, DOI 10.1111/j.1360-0443.2005.00993.x; Freund K M, 1993, Ann Epidemiol, V3, P417, DOI 10.1016/1047-2797(93)90070-K; Hajat C, 2012, AM J PUBLIC HEALTH, V102, P909, DOI 10.2105/AJPH.2011.300290; Hajat C, 2010, PROG CARDIOVASC DIS, V53, P28, DOI 10.1016/j.pcad.2010.05.002; Health Authority-Abu Dhabi, 2011, HLTH STAT; Jayakumary M, 2010, ASIAN PAC J CANCER P, V11, P1547; Mandil Ahmed, 2010, J Infect Public Health, V3, P179, DOI 10.1016/j.jiph.2010.10.003; Maziak W, 2005, PUBLIC HEALTH, V119, P400, DOI 10.1016/j.puhe.2004.08.002; McCormick LK, 1999, J SCHOOL HEALTH, V69, P95, DOI 10.1111/j.1746-1561.1999.tb07215.x; Muslim Nina, 2006, GULFNEWS TEENAGERS R; Nakkash RT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-315; Olrate O, 2011, KHALEEJ TIMES CAPITA; Parra GR, 2003, PSYCHOL ADDICT BEHAV, V17, P211, DOI 10.1037/0893-164X.17.3.211; Saeed A A, 1996, Tob Control, V5, P215, DOI 10.1136/tc.5.3.215; Shafey O, 2009, TOBACCO ATLAS, V3, P37; Sohn Sunghwan, 2009, AMIA Annu Symp Proc, V2009, P619; US Department of State, 2011, BACKGR NOT UN AR EM; WHO Tobacco Free Initiative (TFI), 2009, GATS GLOB AD TOB SUR; WHO Tobacco Free Initiative (TFI), 2002, GLOB YOUTH TOB SURV; World Health Organization, 2010, GLOB SCH BAS STUD HL; World Health Organization, 2019, WHO REPORT GLOBAL TO	26	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39189	10.1371/journal.pone.0039189	http://dx.doi.org/10.1371/journal.pone.0039189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WX	22720071	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000048
J	McGorry, RW; Lin, JH				McGorry, Raymond W.; Lin, Jia-Hua			Flexion Relaxation and Its Relation to Pain and Function over the Duration of a Back Pain Episode	PLOS ONE			English	Article							LUMBAR FLEXION; SURFACE ELECTROMYOGRAPHY; ERECTORES SPINAE; MUSCLE ACTIVATION; HEALTHY CONTROLS; TRUNK FLEXION; BEHAVIOR; MOVEMENTS; EXTENSION; PATTERNS	Background: Relaxation of the erector spinae often occurs in healthy individuals as full trunk flexion is achieved when bending forward from standing. This phenomenon, referred to as flexion relaxation is often absent or disrupted (EMG activity persists) in individuals reporting low back pain (LBP). Methods and Results: Self-reported pain and disability scores were compared to EMG measures related to the flexion relaxation (FR) phenomenon by 33 participants with LBP at up to eight sessions over a study period of up to eight weeks. Fourteen participants served as a control group. In the protocol, starting from standing participants bent forward to a fully flexed posture, and then extended the trunk to return to standing position. A thoracic inclinometer was used to measure trunk posture. Surface electrodes located at the L2 and L5 levels recorded EMG amplitudes of the erector spinae. Ratios of EMG amplitudes recorded during forward bending to amplitudes at full flexion, and ratios of extension to full flexion were calculated. EMG amplitudes and their ratios were compared between control and LBP groups at the initial visit. No significant differences between groups were found except at the L5 location at full flexion. Correlations of the ratios to pain and function scores recorded in repeated sessions over the LBP episode also were compared between LBP group participants classified as having transient, recurrent or chronic symptoms. In another analysis participants were grouped by whether their symptoms resolved over the study period. Conclusions: The transient LBP group had significantly stronger correlations between pain and function to both ratios, than did those with more chronic LBP symptoms. Participants who experienced symptom resolution generally had stronger correlations of ratios to both pain and function than those with partial or no resolution. Improved understanding of these relationships may provide insight in clinical management of LBP.	[McGorry, Raymond W.; Lin, Jia-Hua] Liberty Mutual Res Inst Safety, Hopkinton, MA USA	Liberty Mutual Research Institute for Safety	McGorry, RW (corresponding author), Liberty Mutual Res Inst Safety, Hopkinton, MA USA.	Raymond.mcgorry@libertymutual.com		Lin, Jia-Hua/0000-0001-8908-9328				ADAMS MA, 1980, SPINE, V5, P245, DOI 10.1097/00007632-198005000-00007; AHERN DK, 1988, PAIN, V34, P153, DOI 10.1016/0304-3959(88)90160-1; AHERN DK, 1990, SPINE, V15, P92, DOI 10.1097/00007632-199002000-00008; Alschuler Kevin N, 2009, Clin J Pain, V25, P760, DOI 10.1097/AJP.0b013e3181b56db6; Ambroz C, 2000, J OCCUP ENVIRON MED, V42, P660, DOI 10.1097/00043764-200006000-00018; Descarreau M, 2008, BMC MUSCULOSKEL DIS, V24, P10; FLOYD WF, 1955, J PHYSIOL-LONDON, V129, P184, DOI 10.1113/jphysiol.1955.sp005347; Geisser ME, 2005, J PAIN, V6, P711, DOI 10.1016/j.jpain.2005.06.008; HAIG AJ, 1993, SPINE, V18, P926, DOI 10.1097/00007632-199306000-00020; Hides JA, 1996, SPINE, V21, P2763, DOI 10.1097/00007632-199612010-00011; Holleran K, 1995, Iowa Orthop J, V15, P24; JENSEN MP, 1992, CLIN J PAIN, V8, P123, DOI 10.1097/00002508-199206000-00010; Kaigle AM, 1998, J SPINAL DISORD, V11, P163; KIPPERS V, 1984, SPINE, V9, P740, DOI 10.1097/00007632-198410000-00015; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Mannion AF, 2001, SPINE, V26, P897, DOI 10.1097/00007632-200104150-00013; Marshall P, 2006, SPINE, V31, pE877, DOI 10.1097/01.brs.0000244557.56735.05; Matheron E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018110; Mayer TG, 2009, SPINE, V34, P2458, DOI 10.1097/BRS.0b013e3181b20070; MCGILL SM, 1994, SPINE, V19, P2190, DOI 10.1097/00007632-199410000-00013; Murphy BA, 2010, SPINE, V35, P2103, DOI 10.1097/BRS.0b013e3181cbc7d8; Neblett R, 2003, SPINE, V28, P1435, DOI 10.1097/00007632-200307010-00015; Neblett R, 2010, CLIN J PAIN, V26, P403, DOI 10.1097/AJP.0b013e3181d2bd8c; Olson MW, 2004, CLIN BIOMECH, V19, P769, DOI 10.1016/j.clinbiomech.2004.05.007; PAQUET N, 1994, SPINE, V19, P596, DOI 10.1097/00007632-199403000-00016; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; Sarti M A, 2001, Spine (Phila Pa 1976), V26, pE421, DOI 10.1097/00007632-200109150-00019; SCHULTZ AB, 1985, J ORTHOPAED RES, V3, P189, DOI 10.1002/jor.1100030208; SHIRADO O, 1995, AM J PHYS MED REHAB, V74, P139, DOI 10.1097/00002060-199503000-00010; SIHVONEN T, 1991, ARCH PHYS MED REHAB, V72, P1080; Solomonow M, 2003, CLIN BIOMECH, V18, P273, DOI 10.1016/S0268-0033(03)00024-X; Stratford PW, 2000, SPINE, V25, P2095, DOI 10.1097/00007632-200008150-00015; TANII K, 1985, ERGONOMICS, V28, P883, DOI 10.1080/00140138508963209; Thomas JS, 2008, EUR SPINE J, V17, P97, DOI 10.1007/s00586-007-0532-6; TRIANO JJ, 1987, SPINE, V12, P561, DOI 10.1097/00007632-198707000-00010; VONKORFF M, 1994, SPINE, V19, pS2041; Wallbom AS, 2009, AM J PHYS MED REHAB, V88, P302, DOI 10.1097/PHM.0b013e318198b6ed; Watson PJ, 1997, CLIN BIOMECH, V12, P165, DOI 10.1016/S0268-0033(97)00065-X	38	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39207	10.1371/journal.pone.0039207	http://dx.doi.org/10.1371/journal.pone.0039207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720077	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000051
J	Hong, S; Cheng, TY; Layre, E; Sweet, L; Young, DC; Posey, JE; Butler, WR; Moody, DB				Hong, Sunhee; Cheng, Tan-Yun; Layre, Emilie; Sweet, Lindsay; Young, David C.; Posey, James E.; Butler, W. Ray; Moody, D. Branch			Ultralong C100 Mycolic Acids Support the Assignment of Segniliparus as a New Bacterial Genus	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; OUTER-MEMBRANE; BIOSYNTHESIS; RUGOSUS	Mycolic acid-producing bacteria isolated from the respiratory tract of human and non-human mammals were recently assigned as a distinct genus, Segniliparus, because they diverge from rhodococci and mycobacteria in genetic and chemical features. Using high accuracy mass spectrometry, we determined the chemical composition of 65 homologous mycolic acids in two Segniliparus species and separately analyzed the three subclasses to measure relative chain length, number and stereochemistry of unsaturations and cyclopropyl groups within each class. Whereas mycobacterial mycolate subclasses are distinguished from one another by R groups on the meromycolate chain, Segniliparus species synthesize solely non-oxygenated alpha-mycolates with high levels of cis unsaturation. Unexpectedly Segniliparus alpha-mycolates diverge into three subclasses based on large differences in carbon chain length with one bacterial culture producing mycolates that range from C58 to C100. Both the overall chain length (C100) and the chain length diversity (C42) are larger than previously seen for mycolic acid-producing organisms and provide direct chemical evidence for assignment of Segniliparus as a distinct genus. Yet, electron microscopy shows that the long and diverse mycolates pack into a typical appearing membrane. Therefore, these new and unexpected extremes of mycolic acid chemical structure raise questions about the modes of mycolic acid packing and folding into a membrane.	[Hong, Sunhee; Cheng, Tan-Yun; Layre, Emilie; Sweet, Lindsay; Young, David C.; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hong, Sunhee; Cheng, Tan-Yun; Layre, Emilie; Sweet, Lindsay; Young, David C.; Moody, D. Branch] Harvard Univ, Sch Med, Boston, MA USA; [Posey, James E.; Butler, W. Ray] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA	Hong, S (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	wrb1@cdc.gov; bmoody@rics.bwh.harvard.edu		Layre, Emilie/0000-0001-8024-8513; Layre, Emilie/0000-0003-3044-1299	National Institutes of Health [AI RO1 071155, AI RO1 049393]; Burroughs Wellcome Fund Program in Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Program in Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants: AI RO1 071155 and AI RO1 049393 and the Burroughs Wellcome Fund Program in Translational Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Gutierrez J, 2009, APPL ENVIRON MICROB, V75, P3407, DOI 10.1128/AEM.01776-08; Asselineau C, 2002, PROG LIPID RES, V41, P501, DOI 10.1016/S0163-7827(02)00008-5; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Butler WR, 2007, J CLIN MICROBIOL, V45, P3449, DOI 10.1128/JCM.00765-07; Butler WR, 2005, INT J SYST EVOL MICR, V55, P1615, DOI 10.1099/ijs.0.63465-0; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Evans RH, 2011, EMERG INFECT DIS, V17, P311, DOI 10.3201/eid1702.101511; GOODFELLOW M, 1976, J GEN MICROBIOL, V96, P351, DOI 10.1099/00221287-96-2-351; Hansen T, 2009, EMERG INFECT DIS, V15, P611, DOI 10.3201/eid1504.081479; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hsu FF, 2011, ANAL BIOCHEM, V409, P112, DOI 10.1016/j.ab.2010.10.006; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Marrakchi H, 2008, MYCOBACTERIAL CELL ENVELOPE, P41; Mederos L, 2007, MICROBIOL-SGM, V153, P4159, DOI 10.1099/mic.0.2007/011262-0; MINNIKIN DE, 1980, J CHROMATOGR, V188, P221, DOI 10.1016/S0021-9673(00)88433-2; Minnikin DE, 1998, BACTERIAL CELL SURFA, P125; Quemard A, 1997, EUR J BIOCHEM, V250, P758, DOI 10.1111/j.1432-1033.1997.00758.x; Schroeder BG, 2001, BIOORG CHEM, V29, P164, DOI 10.1006/bioo.2001.1207; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Sommerville J., 1987, ELECT MICROSCOPY MOL; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005; Villeneuve M, 2007, BBA-BIOMEMBRANES, V1768, P1717, DOI 10.1016/j.bbamem.2007.04.003; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	28	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39017	10.1371/journal.pone.0039017	http://dx.doi.org/10.1371/journal.pone.0039017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720018	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800038
J	Pedergnana, V; Abdel-Hamid, M; Guergnon, J; Mohsen, A; Le Fouler, L; Theodorou, I; Mohamed, MK; Fontanet, A; Plancoulaine, S; Abel, L				Pedergnana, Vincent; Abdel-Hamid, Mohamed; Guergnon, Julien; Mohsen, Amira; Le Fouler, Lenaig; Theodorou, Ioannis; Mohamed, Mostafa Kamal; Fontanet, Arnaud; Plancoulaine, Sabine; Abel, Laurent			Analysis of IL28B Variants in an Egyptian Population Defines the 20 Kilobases Minimal Region Involved in Spontaneous Clearance of Hepatitis C Virus	PLOS ONE			English	Article							LIVER-DISEASE; INFECTION; CAIRO; TRANSMISSION; ASSOCIATION; COMMUNITY; HOST	Spontaneous clearance of hepatitis C virus (HCV) occurs in similar to 30% of acute infections. Host genetics play a major role in HCV clearance, with a strong effect of single nucleotide polymorphisms (SNPs) of the IL28B gene already found in different populations, mostly infected with viral genotypes 1 and 3. Egypt has the highest prevalence of HCV infection in the world, which is mostly due to viral genotype 4. We investigated the role of several IL28B SNPs in HCV spontaneous clearance in an Egyptian population. We selected nine SNPs within the IL28B genomic region covering the linkage disequilibrium (LD) block known to be associated with HCV clearance in European populations. These SNPs were genotyped in 261 HCV-infected Egyptian subjects (130 with spontaneous clearance and 131 with chronic infection). The most associated SNPs were rs12979860 (P = 1.6x10(-7)) and the non-synonymous IL28B SNP, rs8103142 (P = 1.6x10(-7)). Interestingly, three SNPs at the two bounds of the region were monomorphic, reducing the size of the LD block in which the causal variants are potentially located to similar to 20 kilobases. HCV clearance in Egypt was associated with a region of IL28B smaller than that identified in European populations, and involved the non-synonymous IL28B SNP, rs8103142.	[Pedergnana, Vincent; Plancoulaine, Sabine; Abel, Laurent] INSERM, Lab Human Genet Infect Dis, U980, Paris, France; [Pedergnana, Vincent; Plancoulaine, Sabine; Abel, Laurent] Univ Paris 05, Paris, France; [Abdel-Hamid, Mohamed] Natl Hepatol & Trop Med Res Inst, Viral Hepatitis Res Lab, Cairo, Egypt; [Abdel-Hamid, Mohamed] Minia Fac Med, Dept Microbiol, Al Minya, Egypt; [Guergnon, Julien] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Lab Immun & Infect,INSERM,UMR S 945, Paris, France; [Mohsen, Amira; Mohamed, Mostafa Kamal] Ain Shams Univ, Fac Med, Dept Commun Environm & Occupat Med, Cairo, Egypt; [Le Fouler, Lenaig; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers Chaire Sante &, Paris, France; [Abel, Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Egyptian Knowledge Bank (EKB); Minia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Egyptian Knowledge Bank (EKB); Ain Shams University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Rockefeller University	Pedergnana, V (corresponding author), INSERM, Lab Human Genet Infect Dis, U980, Paris, France.	laurent.abel@inserm.fr	Abel, Laurent/H-8888-2017; mohamed, mostafa/AFE-7371-2022; PLANCOULAINE, Sabine/E-2824-2017	Abel, Laurent/0000-0001-7016-6493; mohamed, mostafa/0000-0002-1421-2667; PLANCOULAINE, Sabine/0000-0003-0725-8306; Pedergnana, Vincent/0000-0002-7852-5339; Mohsen, Amira/0000-0003-4528-2243; , arnaud/0000-0002-5239-6110	EC FP7 Coordinated Actions - The SPHINX Consortium; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales [ANRS 12107, 12122, 12210]	EC FP7 Coordinated Actions - The SPHINX Consortium; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR))	This work was supported by grants from the EC FP7 Coordinated Actions - The SPHINX Consortium, and the Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (Grant numbers ANRS 12107, 12122 and 12210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Darwish MA, 2001, AM J TROP MED HYG, V64, P147, DOI 10.4269/ajtmh.2001.64.147; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; El Gaafary MM, 2005, J MED VIROL, V76, P520, DOI 10.1002/jmv.20392; Guerra J, J VIRAL HEP IN PRESS; Jimenez AP, 2010, GUT, V59, P1554, DOI 10.1136/gut.2009.194266; Jimenez AP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007193; Kurbanov F, 2011, J INFECT DIS, V204, P1391, DOI 10.1093/infdis/jir536; Mohamed MK, 2006, J MED VIROL, V78, P1185, DOI 10.1002/jmv.20679; Plancoulaine S, 2008, GUT, V57, P1268, DOI 10.1136/gut.2007.140681; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Soliman C, 2010, AIDS, V24, pS33, DOI 10.1097/01.aids.0000386731.94800.e6; Strickland GT, 2002, AM J TROP MED HYG, V67, P436, DOI 10.4269/ajtmh.2002.67.436; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450	21	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38578	10.1371/journal.pone.0038578	http://dx.doi.org/10.1371/journal.pone.0038578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719902	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800009
J	Omura, DT; Clark, DA; Samuel, ADT; Horvitz, HR				Omura, Daniel T.; Clark, Damon A.; Samuel, Aravinthan D. T.; Horvitz, H. Robert			Dopamine Signaling Is Essential for Precise Rates of Locomotion by C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PARKINSONS-DISEASE; SENSORY NEURONS; SEROTONIN; TRANSPORTER; BEHAVIOR; RECEPTOR; IDENTIFICATION; CONTROVERSIES; CHEMOTAXIS	Dopamine is an important neuromodulator in both vertebrates and invertebrates. We have found that reduced dopamine signaling can cause a distinct abnormality in the behavior of the nematode C. elegans, which has only eight dopaminergic neurons. Using an automated particle-tracking system for the analysis of C. elegans locomotion, we observed that individual wild-type animals made small adjustments to their speed to maintain constant rates of locomotion. By contrast, individual mutant animals defective in the synthesis of dopamine made larger adjustments to their speeds, resulting in large fluctuations in their rates of locomotion. Mutants defective in dopamine signaling also frequently exhibited both abnormally high and abnormally low average speeds. The ability to make small adjustments to speed was restored to these mutants by treatment with dopamine. These behaviors depended on the D2-like dopamine receptor DOP-3 and the G-protein subunit GOA-1. We suggest that C. elegans and other animals, including humans, might share mechanisms by which dopamine restricts motor activity levels and coordinates movement.	[Omura, Daniel T.; Horvitz, H. Robert] MIT, Dept Biol, Cambridge, MA 02139 USA; [Omura, Daniel T.; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Omura, Daniel T.; Horvitz, H. Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Clark, Damon A.; Samuel, Aravinthan D. T.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Clark, Damon A.; Samuel, Aravinthan D. T.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University	Omura, DT (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	horvitz@mit.edu		Clark, Damon/0000-0001-8487-700X	National Science Foundation; Sloan; McKnight; National Institutes of Health (NIH) [GM24663]; NIH National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024663, R37GM024663] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Sloan(Alfred P. Sloan Foundation); McKnight; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.T.O. and D.A.C. were supported by the National Science Foundation (www.nsf.gov). H.R.H. is the David H.Koch Professor of Biology at MIT, a member of the McGovern Institute for Brain Research at MIT and an Investigator of the Howard Hughes Medical Institute (www.hhmi.org). A.D.T.S. was supported by the Sloan (www.sloan.org), McKnight (www.mcknight.org) and National Science Foundations. D.T.O. and H.R.H. were supported by National Institutes of Health (NIH) grant GM24663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Niels Ringstad, Megan Gustafson, Joseph Paton, Hillel Schwartz, and Daniel Denning for comments concerning this manuscript. We thank Niels Ringstad for isolation of the cat-2(n4547) mutant strain. We also thank Andy Leifer for hosting our software. Some strains were provided by the Caenorhabditis Genetics Center, which is supported by the NIH National Center for Research Resources.	ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI [DOI 10.1126/SCIENCE.282.5396.2028, DOI 10.1126/science.282.5396.2028]; BRENNER S, 1974, GENETICS, V77, P71; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; COTZIAS GC, 1969, NEW ENGL J MED, V281, P272; CULOTTI JG, 1978, GENETICS, V90, P243; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gustafson MA, 2007, THESIS MIT CAMBRIDGE; Hamdan FF, 1999, J NEUROCHEM, V72, P1372, DOI 10.1046/j.1471-4159.1999.721372.x; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hornykiewicz O, 2006, J NEURAL TRANSM-SUPP, P9; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lints R, 1999, DEVELOPMENT, V126, P5819; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; Rex E, 2002, J NEUROCHEM, V82, P1352, DOI 10.1046/j.1471-4159.2002.01065.x; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin E. R., 1996, THESIS MIT CAMBRIDGE; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Stern MB, 1997, NEUROLOGY, V49, pS1, DOI 10.1212/WNL.49.1_Suppl_1.S1; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tulloch IF, 1997, NEUROLOGY, V49, pS58, DOI 10.1212/WNL.49.1_Suppl_1.S58; Vidal-Gadea A, 2011, P NATL ACAD SCI USA, V108, P17504, DOI 10.1073/pnas.1108673108; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Watts RL, 1997, NEUROLOGY, V49, pS34, DOI 10.1212/WNL.49.1_Suppl_1.S34; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITE JG, 1986, PHILOS T R SOC LON B, V314, P340; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	45	41	44	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38649	10.1371/journal.pone.0038649	http://dx.doi.org/10.1371/journal.pone.0038649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719914	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900040
J	Sluik, D; Boeing, H; Montonen, J; Kaaks, R; Lukanova, A; Sandbaek, A; Overvad, K; Arriola, L; Ardanaz, E; Saieva, C; Grioni, S; Tumino, R; Sacerdote, C; Mattiello, A; Spijkerman, AMW; van der A, DL; Beulens, JWJ; van Dieren, S; Nilsson, PM; Groop, LC; Franks, PW; Rolandsson, O; Bueno-de-Mesquita, B; Nothlings, U				Sluik, Diewertje; Boeing, Heiner; Montonen, Jukka; Kaaks, Rudolf; Lukanova, Annekatrin; Sandbaek, Annelli; Overvad, Kim; Arriola, Larraitz; Ardanaz, Eva; Saieva, Calogero; Grioni, Sara; Tumino, Rosario; Sacerdote, Carlotta; Mattiello, Amalia; Spijkerman, Annemieke M. W.; van der A, Daphne L.; Beulens, Joline W. J.; van Dieren, Susan; Nilsson, Peter M.; Groop, Leif C.; Franks, Paul W.; Rolandsson, Olov; Bueno-de-Mesquita, Bas; Noethlings, Ute			HbA(1c) Measured in Stored Erythrocytes Is Positively Linearly Associated with Mortality in Individuals with Diabetes Mellitus	PLOS ONE			English	Article							WHOLE-BLOOD SAMPLES; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; FOLLOW-UP; GLYCATED HEMOGLOBIN; CLINICAL-RESEARCH; NATURAL-HISTORY; GLUCOSE CONTROL; HEART-DISEASE	Introduction: Observational studies have shown that glycated haemoglobin (HbA(1c)) is related to mortality, but the shape of the association is less clear. Furthermore, disease duration and medication may modify this association. This observational study explored the association between HbA(1c) measured in stored erythrocytes and mortality. Secondly, it was assessed whether disease duration and medication use influenced the estimates or were independently associated with mortality. Methods: Within the European Prospective Investigation into Cancer and Nutrition a cohort was analysed of 4,345 individuals with a confirmed diagnosis of diabetes at enrolment. HbA(1c) was measured in blood samples stored up to 19 years. Multivariable Cox proportional hazard regression models for all-cause mortality investigated HbA(1c) in quartiles as well as per 1% increment, diabetes medication in seven categories of insulin and oral hypoglycaemic agents, and disease duration in quartiles. Results: After a median follow-up of 9.3 years, 460 participants died. Higher HbA(1c) was associated with higher mortality: Hazard Ratio for 1%-increase was 1.11 (95% CI 1.06, 1.17). This association was linear (P-nonlinearity = 0.15) and persistent across categories of medication use, disease duration, and co-morbidities. Compared with metformin, other medication types were not associated with mortality. Longer disease duration was associated with mortality, but not after adjustment for HbA(1c) and medication. Conclusion: This prospective study showed that persons with lower HbA(1c) had better survival than those with higher HbA(1c). The association was linear and independent of disease duration, type of medication use, and presence of co-morbidities. Any improvement of HbA(1c) appears to be associated with reduced mortality risk.	[Sluik, Diewertje; Boeing, Heiner; Montonen, Jukka; Noethlings, Ute] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kaaks, Rudolf; Lukanova, Annekatrin] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Sandbaek, Annelli] Aarhus Univ, Sch Publ Hlth, Dept Gen Practice, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Arriola, Larraitz] Basque Govt, Publ Hlth Dept Gipuzkoa, San Sebastian, Spain; [Arriola, Larraitz] Consortium Biomed Res Epidemiol & Publ Hlth, San Sebastian, Spain; [Ardanaz, Eva] Consortium Biomed Res Epidemiol & Publ Hlth, Pamplona, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Pamplona, Spain; [Saieva, Calogero] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Grioni, Sara] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] Piedmont Ctr Canc Prevent, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn, Turin, Italy; [Mattiello, Amalia] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Beulens, Joline W. J.; van Dieren, Susan] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Div Med, Umea, Sweden; [Franks, Paul W.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Bueno-de-Mesquita, Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Noethlings, Ute] Univ Kiel, Inst Expt Med, Epidemiol Sect, Kiel, Germany; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Div Nutr Res, Umea, Sweden	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Aarhus University; Aarhus University; Basque Government; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Umea University; Lund University; Skane University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Utrecht University; Utrecht University Medical Center; University of Kiel; Umea University	Sluik, D (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	Diewertje.Sluik@dife.de	Franks, Paul/AAA-3300-2020; Grioni, Sara/K-5320-2016; Mattiello, Amalia AM/K-5112-2016; Nöthlings, Ute/B-2713-2010; Saieva, Calogero/AAC-2611-2019	Grioni, Sara/0000-0002-5891-8426; Mattiello, Amalia AM/0000-0003-3676-7353; Saieva, Calogero/0000-0002-0117-1608; Franks, Paul/0000-0002-0520-7604; Beulens, Joline/0000-0002-4181-0937; tumino, rosario/0000-0003-2666-414X; Overvad, Kim/0000-0001-6429-7921; Arriola, Larraitz/0000-0001-8487-7181; Sluik, Diewertje/0000-0001-6304-0913; Montonen, Jukka/0000-0002-4366-9439; Sacerdote, Carlotta/0000-0002-8008-5096	European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant	European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant	This study was supported by a European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Cox D. R., 1984, ANAL SURVIVAL DATA; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Dale AC, 2009, EUR HEART J, V30, P1372, DOI 10.1093/eurheartj/ehp039; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Gale EAM, 2008, DIABETIC MED, V25, P9, DOI 10.1111/j.1464-5491.2008.02503.x; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Kleinbaum DG, 2011, COX PROPORTIONAL HAZ, P139; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Landman GW, 2010, BRIT J GEN PRACT, V60, P172, DOI 10.3399/bjgp10X483517; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Milicevic Z, 2008, DIABETES CARE, V31, pS155, DOI 10.2337/dc08-s240; MOSS SE, 1994, ARCH INTERN MED, V154, P2473; Nothlings U, 2011, EUR J CLIN NUTR, V65, P635, DOI 10.1038/ejcn.2011.11; Pfister R, 2011, DIABETOLOGIA; Ramlo-Halsted BA, 1999, PRIMARY CARE, V26, P771, DOI 10.1016/S0095-4543(05)70130-5; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Rolandsson O, 2004, METABOLISM, V53, P1496, DOI 10.1016/j.metabol.2004.04.015; Saydah S, 2009, DIABETES CARE, V32, P1440, DOI 10.2337/dc09-0117; Selvin E, 2005, DIABETIC MED, V22, P1726, DOI 10.1111/j.1464-5491.2005.01705.x; Selvin E, 2010, J DIABETES, V2, P118, DOI 10.1111/j.1753-0407.2010.00070.x; Sluik D, 2011, AM J EPIDEMIOL, V174, P22, DOI 10.1093/aje/kwr048; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; Verma M, 2006, INDIAN J CLIN BIOCHE, V21, P142, DOI 10.1007/BF02913083; Yu PC, 2010, DIABETES RES CLIN PR, V89, P1, DOI 10.1016/j.diabres.2009.12.009	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38877	10.1371/journal.pone.0038877	http://dx.doi.org/10.1371/journal.pone.0038877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719972	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900059
J	Ferreira, DS; Amaral, FG; Mesquita, CC; Barbosa, APL; Lellis-Santos, C; Turati, AO; Santos, LR; Sollon, CS; Gomes, PR; Faria, JA; Cipolla-Neto, J; Bordin, S; Anhe, GF				Ferreira, Danilo S.; Amaral, Fernanda G.; Mesquita, Caroline C.; Barbosa, Ana Paula L.; Lellis-Santos, Camilo; Turati, Ariane O.; Santos, Laila R.; Sollon, Carolina S.; Gomes, Patricia R.; Faria, Juliana A.; Cipolla-Neto, Jose; Bordin, Silvana; Anhe, Gabriel F.			Maternal Melatonin Programs the Daily Pattern of Energy Metabolism in Adult Offspring	PLOS ONE			English	Article							INHIBITS INSULIN-SECRETION; CAUSES GLUCOSE-INTOLERANCE; RAT PANCREATIC-ISLETS; CORTISOL PRODUCTION; SIGNALING PATHWAYS; SKELETAL-MUSCLE; LIGHT EXPOSURE; ADRENAL-GLAND; SHIFT WORK; RECEPTOR	Background: Shift work was recently described as a factor that increases the risk of Type 2 diabetes mellitus. In addition, rats born to mothers subjected to a phase shift throughout pregnancy are glucose intolerant. However, the mechanism by which a phase shift transmits metabolic information to the offspring has not been determined. Among several endocrine secretions, phase shifts in the light/dark cycle were described as altering the circadian profile of melatonin production by the pineal gland. The present study addresses the importance of maternal melatonin for the metabolic programming of the offspring. Methodology/Principal Findings: Female Wistar rats were submitted to SHAM surgery or pinealectomy (PINX). The PINX rats were divided into two groups and received either melatonin (PM) or vehicle. The SHAM, the PINX vehicle and the PM females were housed with male Wistar rats. Rats were allowed to mate and after weaning, the male and female offspring were subjected to a glucose tolerance test (GTT), a pyruvate tolerance test (PTT) and an insulin tolerance test (ITT). Pancreatic islets were isolated for insulin secretion, and insulin signaling was assessed in the liver and in the skeletal muscle by western blots. We found that male and female rats born to PINX mothers display glucose intolerance at the end of the light phase of the light/dark cycle, but not at the beginning. We further demonstrate that impaired glucose-stimulated insulin secretion and hepatic insulin resistance are mechanisms that may contribute to glucose intolerance in the offspring of PINX mothers. The metabolic programming described here occurs due to an absence of maternal melatonin because the offspring born to PINX mothers treated with melatonin were not glucose intolerant. Conclusions/Significance: The present results support the novel concept that maternal melatonin is responsible for the programming of the daily pattern of energy metabolism in their offspring.	[Ferreira, Danilo S.; Mesquita, Caroline C.; Barbosa, Ana Paula L.; Sollon, Carolina S.; Faria, Juliana A.; Anhe, Gabriel F.] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, Brazil; [Amaral, Fernanda G.; Lellis-Santos, Camilo; Turati, Ariane O.; Santos, Laila R.; Gomes, Patricia R.; Cipolla-Neto, Jose; Bordin, Silvana] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Ferreira, DS (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, Brazil.	anhegf@fcm.unicamp.br	Gomes, Patricia RL/G-2484-2014; Cipolla-Neto, Jose/B-1619-2009; Anhe, Gabriel F/C-1980-2012; de Almeida Faria, Juliana/C-5931-2015; Lellis-Santos, Camilo/D-9195-2015; Amaral, Fernanda/O-3071-2019; Bordin, Silvana/G-3147-2012; Amaral, Fernanda G/K-5395-2017	Gomes, Patricia RL/0000-0003-2884-7599; Cipolla-Neto, Jose/0000-0003-3748-3731; de Almeida Faria, Juliana/0000-0002-7276-6924; Lellis-Santos, Camilo/0000-0002-7882-7548; Amaral, Fernanda/0000-0003-4492-4822; Bordin, Silvana/0000-0002-0192-8869; Amaral, Fernanda G/0000-0003-4492-4822; Mesquita, Caroline Costa/0000-0001-5471-2343; Anhe, Gabriel/0000-0002-7694-8397	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPq (Conselho Nacional de Aperfeicoameno Cientifico)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Aperfeicoameno Cientifico)	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and CNPq (Conselho Nacional de Aperfeicoameno Cientifico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Vale MIC, 2005, AM J PHYSIOL-ENDOC M, V288, pE805, DOI 10.1152/ajpendo.00478.2004; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; ARMSTRONG SM, 1989, EXPERIENTIA, V45, P932, DOI 10.1007/BF01953050; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; BONADONNA RC, 1993, J CLIN INVEST, V92, P486, DOI 10.1172/JCI116592; BONORA E, 1987, DIABETES METAB, V13, P116; BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; Borugian MJ, 2005, J OCCUP ENVIRON MED, V47, P1268, DOI 10.1097/01.jom.0000184855.87223.77; Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dijk DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030037; Drijfhout WJ, 1997, NEUROSCIENCE, V80, P233, DOI 10.1016/S0306-4522(97)00080-8; Dumont M, 2012, CHRONOBIOL INT, V29, P203, DOI 10.3109/07420528.2011.647177; ERLICH SS, 1985, J NEUROSURG, V63, P321, DOI 10.3171/jns.1985.63.3.0321; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Kennaway DJ, 2003, AM J PHYSIOL-REG I, V284, pR1231, DOI 10.1152/ajpregu.00697.2002; Kivimaki M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001138; Li PM, 1996, J CELL BIOCHEM, V61, P31, DOI 10.1002/(SICI)1097-4644(19960401)61:1<31::AID-JCB5>3.0.CO;2-3; Lima FB, 1998, AM J PHYSIOL-ENDOC M, V275, pE934; LIMA FB, 1994, BRAZ J MED BIOL RES, V27, P995; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Martins E, 2001, J PINEAL RES, V31, P363, DOI 10.1034/j.1600-079X.2001.310412.x; Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x; McPherson M, 2011, J OCCUP ENVIRON MED, V53, P716, DOI 10.1097/JOM.0b013e31822282fd; Muhlbauer E, 2011, J PINEAL RES, V51, P361, DOI 10.1111/j.1600-079X.2011.00898.x; Nagai R, 2008, J PINEAL RES, V45, P271, DOI 10.1111/j.1600-079X.2008.00586.x; Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Picinato MC, 2008, J PINEAL RES, V44, P88, DOI 10.1111/j.1600-079X.2007.00493.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Picinato MC, 2002, J PINEAL RES, V33, P172, DOI 10.1034/j.1600-079X.2002.02925.x; PLOS Medicine Editors, 2011, PLOS MED, V8; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; ROTHENBERG PL, 1991, J BIOL CHEM, V266, P8302; Tamura H, 2008, J PINEAL RES, V44, P335, DOI 10.1111/j.1600-079X.2007.00537.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Torres-Farfan C, 2004, J PHYSIOL-LONDON, V554, P841, DOI 10.1113/jphysiol.2003.056465; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Torres-Farfan C, 2003, J CLIN ENDOCR METAB, V88, P450, DOI 10.1210/jc.2002-021048; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; Zanquetta MM, 2003, J PINEAL RES, V35, P141, DOI 10.1034/j.1600-079X.2003.00067.x	43	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38795	10.1371/journal.pone.0038795	http://dx.doi.org/10.1371/journal.pone.0038795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719949	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000045
J	Mordecai, EA				Mordecai, Erin A.			Soil Moisture and Fungi Affect Seed Survival in California Grassland Annual Plants	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; MAINTENANCE; COEXISTENCE; MORTALITY; LOSSES; BANKS	Survival of seeds in the seed bank is important for the population dynamics of many plant species, yet the environmental factors that control seed survival at a landscape level remain poorly understood. These factors may include soil moisture, vegetation cover, soil type, and soil pathogens. Because many soil fungi respond to moisture and host species, fungi may mediate environmental drivers of seed survival. Here, I measure patterns of seed survival in California annual grassland plants across 15 species in three experiments. First, I surveyed seed survival for eight species at 18 grasslands and coastal sage scrub sites ranging across coastal and inland Santa Barbara County, California. Species differed in seed survival, and soil moisture and geographic location had the strongest influence on survival. Grasslands had higher survival than coastal sage scrub sites for some species. Second, I used a fungicide addition and exotic grass thatch removal experiment in the field to tease apart the relative impact of fungi, thatch, and their interaction in an invaded grassland. Seed survival was lower in the winter (wet season) than in the summer (dry season), but fungicide improved winter survival. Seed survival varied between species but did not depend on thatch. Third, I manipulated water and fungicide in the laboratory to directly examine the relationship between water, fungi, and survival. Seed survival declined from dry to single watered to continuously watered treatments. Fungicide slightly improved seed survival when seeds were watered once but not continually. Together, these experiments demonstrate an important role of soil moisture, potentially mediated by fungal pathogens, in driving seed survival.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Mordecai, EA (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	Mordecai@lifesci.ucsb.edu		Mordecai, Erin/0000-0002-4402-5547	Mildred E. Mathias Foundation; United States Department of Agriculture (USDA) National Research Initiative [2005-02252]	Mildred E. Mathias Foundation; United States Department of Agriculture (USDA) National Research Initiative(United States Department of Agriculture (USDA))	Funding was provided by the Mildred E. Mathias Foundation and United States Department of Agriculture (USDA) National Research Initiative Grant 2005-02252 (http://www.csrees.usda.gov/funding rfas/nri_rfa.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Beckstead J, 2007, ANN BOT-LONDON, V99, P907, DOI 10.1093/aob/mcm028; Blaney CS, 2001, J APPL ECOL, V38, P1104, DOI 10.1046/j.1365-2664.2001.00663.x; BROWN JS, 1986, AM NAT, V127, P31, DOI 10.1086/284465; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CRIST TO, 1993, ECOLOGY, V74, P2231, DOI 10.2307/1939576; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fenner M., 2000, SEEDS ECOLOGY REGENE; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; KIRKPATRICK BL, 1979, J APPL ECOL, V16, P515, DOI 10.2307/2402526; KREMER RJ, 1993, ECOL APPL, V3, P42, DOI 10.2307/1941791; Levine JM, 2008, J ECOL, V96, P795, DOI 10.1111/j.1365-2745.2008.01375.x; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; O'Hanlon-Manners DL, 2006, PLANT ECOL, V187, P49, DOI 10.1007/s11258-006-9132-5; Orrock JL, 2005, J TORREY BOT SOC, V132, P613, DOI 10.3159/1095-5674(2005)132[613:FMOSOT]2.0.CO;2; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Schafer M, 2004, PLANT ECOL, V175, P19, DOI 10.1023/B:VEGE.0000048096.00772.23; Schafer M, 2003, ACTA OECOL, V24, P255, DOI 10.1016/j.actao.2003.09.001; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]	25	42	45	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39083	10.1371/journal.pone.0039083	http://dx.doi.org/10.1371/journal.pone.0039083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720037	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000065
J	Manasherob, R; Miller, C; Kim, KS; Cohen, SN				Manasherob, Robert; Miller, Christine; Kim, Kwang-sun; Cohen, Stanley N.			Ribonuclease E Modulation of the Bacterial SOS Response	PLOS ONE			English	Article							COLI RNA DEGRADOSOME; GROWING ESCHERICHIA-COLI; DNA-DAMAGE; STAPHYLOCOCCUS-AUREUS; PROTEIN INHIBITOR; CLPXP PROTEASE; BINDING-SITES; CELL-DIVISION; LEXA; RECOGNITION	Plants, animals, bacteria, and Archaea all have evolved mechanisms to cope with environmental or cellular stress. Bacterial cells respond to the stress of DNA damage by activation of the SOS response, the canonical RecA/LexA-dependent signal transduction pathway that transcriptionally derepresses a multiplicity of genes-leading to transient arrest of cell division and initiation of DNA repair. Here we report the previously unsuspected role of E. coli endoribonuclease RNase E in regulation of the SOS response. We show that RNase E deletion or inactivation of temperature-sensitive RNase E protein precludes normal initiation of SOS. The ability of RNase E to regulate SOS is dynamic, as down regulation of RNase E following DNA damage by mitomycin C resulted in SOS termination and restoration of RNase E function leads to resumption of a previously aborted response. Overexpression of the RraA protein, which binds to the C-terminal region of RNase E and modulates the actions of degradosomes, recapitulated the effects of RNase E deficiency. Possible mechanisms for RNase E effects on SOS are discussed.	[Manasherob, Robert; Miller, Christine; Kim, Kwang-sun; Cohen, Stanley N.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Cohen, Stanley N.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Kim, Kwang-sun] KRIBB, Syst & Synthet Biol Res Ctr, Taejon, South Korea	Stanford University; Stanford University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Manasherob, R (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	sncohen@stanford.edu	Kim, Kwang-sun/AAB-6478-2020	Kim, Kwang-sun/0000-0003-3703-5461	National Institutes of Health [GM54158, AI08619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI008619, R01AI008619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM54158 and AI08619 to SNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Cohen SN, 1997, MOL MICROBIOL, V23, P1099, DOI 10.1111/j.1365-2958.1997.tb02593.x; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DRI AM, 1994, MOL MICROBIOL, V12, P621, DOI 10.1111/j.1365-2958.1994.tb01049.x; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gao JJ, 2006, MOL MICROBIOL, V61, P394, DOI 10.1111/j.1365-2958.2006.05246.x; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Hastings PJ, 2004, PLOS BIOL, V2, P2220, DOI 10.1371/journal.pbio.0020399; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Little JW, 1983, CELLULAR RESPONSES D, P369; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; MOSTELLER RD, 1980, J BIOL CHEM, V255, P2524; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; PINE MJ, 1970, J BACTERIOL, V103, P207, DOI 10.1128/JB.103.1.207-215.1970; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Radman M, 1975, Basic Life Sci, V5A, P355; Sambrook J., 2002, MOL CLONING LAB MANU; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; SIMMONS LA, 2008, ECOSAL ESCHERICHIA C; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; TARASEVICIENE L, 1995, J BIOL CHEM, V270, P26391, DOI 10.1074/jbc.270.44.26391; WALKER GC, 1985, ENVIRON HEALTH PERSP, V62, P115, DOI 10.2307/3430102; Zhao M, 2006, J BACTERIOL, V188, P3257, DOI 10.1128/JB.188.9.3257-3263.2006	51	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38426	10.1371/journal.pone.0038426	http://dx.doi.org/10.1371/journal.pone.0038426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22719885	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336800023
J	Schoening, T; Bergmann, M; Ontrup, J; Taylor, J; Dannheim, J; Gutt, J; Purser, A; Nattkemper, TW				Schoening, Timm; Bergmann, Melanie; Ontrup, Joerg; Taylor, James; Dannheim, Jennifer; Gutt, Julian; Purser, Autun; Nattkemper, Tim W.			Semi-Automated Image Analysis for the Assessment of Megafaunal Densities at the Arctic Deep-Sea Observatory HAUSGARTEN	PLOS ONE			English	Article							CONTINENTAL-SLOPE; BENTHIC MACROFAUNA; ASSEMBLAGES; COMMUNITIES; DIVERSITY; ABUNDANCE; ECOLOGY; IMPACT; SCALE; WEST	Megafauna play an important role in benthic ecosystem function and are sensitive indicators of environmental change. Non-invasive monitoring of benthic communities can be accomplished by seafloor imaging. However, manual quantification of megafauna in images is labor-intensive and therefore, this organism size class is often neglected in ecosystem studies. Automated image analysis has been proposed as a possible approach to such analysis, but the heterogeneity of megafaunal communities poses a non-trivial challenge for such automated techniques. Here, the potential of a generalized object detection architecture, referred to as iSIS (intelligent Screening of underwater Image Sequences), for the quantification of a heterogenous group of megafauna taxa is investigated. The iSIS system is tuned for a particular image sequence (i.e. a transect) using a small subset of the images, in which megafauna taxa positions were previously marked by an expert. To investigate the potential of iSIS and compare its results with those obtained from human experts, a group of eight different taxa from one camera transect of seafloor images taken at the Arctic deep-sea observatory HAUSGARTEN is used. The results show that inter-and intra-observer agreements of human experts exhibit considerable variation between the species, with a similar degree of variation apparent in the automatically derived results obtained by iSIS. Whilst some taxa (e. g. Bathycrinus stalks, Kolga hyalina, small white sea anemone) were well detected by iSIS (i.e. overall Sensitivity: 87%, overall Positive Predictive Value: 67%), some taxa such as the small sea cucumber Elpidia heckeri remain challenging, for both human observers and iSIS.	[Schoening, Timm; Ontrup, Joerg; Nattkemper, Tim W.] Univ Bielefeld, Fac Technol, Biodata Min Grp, D-33615 Bielefeld, Germany; [Bergmann, Melanie; Dannheim, Jennifer; Gutt, Julian] Alfred Wegener Inst Polar & Marine Res, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Taylor, James] Univ Glasgow, Glasgow, Lanark, Scotland; [Purser, Autun] Jacobs Univ, Sch Sci & Engn, Bremen, Germany	University of Bielefeld; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Glasgow; Jacobs University	Schoening, T (corresponding author), Univ Bielefeld, Fac Technol, Biodata Min Grp, D-33615 Bielefeld, Germany.	tschoeni@cebitec.uni-bielefeld.de	Nattkemper, Tim W/F-3332-2017; Bergmann, Melanie/H-3347-2015	Nattkemper, Tim W/0000-0002-7986-1158; Bergmann, Melanie/0000-0001-5212-9808; Dannheim, Jennifer/0000-0002-3737-5872; Gutt, Julian/0000-0003-3773-9370; Purser, Autun/0000-0001-5427-0151	DFG Leibniz program; European Communitys Seventh Framework programme under the HERMIONE project [226354]; Kongsfjord-HAUSGARTEN	DFG Leibniz program(German Research Foundation (DFG)); European Communitys Seventh Framework programme under the HERMIONE project; Kongsfjord-HAUSGARTEN	This study was funded by the DFG Leibniz program to Antje Boetius. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks go to Muhammet Bastan for providing us the source code of the MPEG7 feature extractors. Thomas Soltwedel provided the map of HAUSGARTEN. We thank Antje Boetius for comments to the manuscript and financial support by the DFG Leibniz program. Three anonymous reviewers improved an earlier draft of this paper. This is publication 10013/epic.39189 of the Alfred Wegener Institute for Polar and Marine Research. MB was funded by KongHAU (The Kongsfjord-HAUSGARTEN transect case study: Impact of climate change on Arctic marine community structures and food webs). KongHAU is closely linked to the EU project HERMIONE. AP was funded by the European Communitys Seventh Framework programme (FP7/2007-2013) under the HERMIONE project (grant agreement no. 226354).	AFANASEV IF, 1978, OKEANOLOGIYA+, V18, P950; [Anonymous], 2006, IEEE OCEANS; Bandyopadhyay S, 2007, IEEE T GEOSCI REMOTE, V45, P1506, DOI 10.1109/TGRS.2007.892604; Barat C, 2006, OCEANS 2006, V2006, P1, DOI [DOI 10.1109/OCEANS.2006.306810, 10.1109/OCEANS.2006.306810]; Bastan M, 2010, IEEE MULTIMEDIA, V17, P62, DOI 10.1109/MMUL.2010.5692184; Bergmann M, 2011, DEEP-SEA RES PT I, V58, P711, DOI 10.1016/j.dsr.2011.03.007; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Bluhm BA, 2005, POLAR BIOL, V28, P218, DOI 10.1007/s00300-004-0675-4; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Carney RS, 1997, BIODIVERS CONSERV, V6, P1463, DOI 10.1023/A:1018310302215; CHEN YQ, 1995, PATTERN RECOGN, V28, P537, DOI 10.1016/0031-3203(94)00116-4; CHRISTIANSEN B, 1992, NATO ADV SCI I C-MAT, V360, P125; Clement R, 2005, AUSTR C ROB AUT AUST; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Cristianini N, 2000, INTRO SUPPORT VECTOR; Culverhouse PF, 2003, MAR ECOL PROG SER, V247, P17, DOI 10.3354/meps247017; DAUGMAN JG, 1988, IEEE T ACOUST SPEECH, V36, P1169, DOI 10.1109/29.1644; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; de Groot S.J, 1998, 19981 NIOZ; Di Gesu V, 2003, 12TH INTERNATIONAL CONFERENCE ON IMAGE ANALYSIS AND PROCESSING, PROCEEDINGS, P504, DOI 10.1109/ICIAP.2003.1234100; FEDER HM, 1988, J EXP MAR BIOL ECOL, V116, P99, DOI 10.1016/0022-0981(88)90050-0; Foresti GL, 2002, IEEE J OCEANIC ENG, V27, P66, DOI 10.1109/48.989889; Frauenheim K., 1989, Senckenbergiana Maritima, V20, P101; Freire J, 1996, MAR BIOL, V126, P297, DOI 10.1007/BF00347454; Gage JD, 2004, DEEP-SEA RES PT II, V51, P1689, DOI 10.1016/j.dsr2.2004.07.013; Gallucci F, 2008, DEEP-SEA RES PT I, V55, P332, DOI 10.1016/j.dsr.2007.12.001; Gallucci F, 2008, J EXP MAR BIOL ECOL, V354, P39, DOI 10.1016/j.jembe.2007.10.006; Gordan M, 2006, 2006 IEEE-TTTC INTERNATIONAL CONFERENCE ON AUTOMATION, QUALITY AND TESTING, ROBOTICS, VOL 2, PROCEEDINGS, P327; GRASSLE JF, 1975, DEEP-SEA RES, V22, P457, DOI 10.1016/0011-7471(75)90020-0; GRAY JS, 1981, MAR POLLUT BULL, V12, P173, DOI 10.1016/0025-326X(81)90230-7; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; Guillen J, 2008, CONT SHELF RES, V28, P2382, DOI 10.1016/j.csr.2008.05.003; Hartmut Bluhm, 2001, DEEP SEA RES 2, V48, P3841; Hasemann Christiane, 2006, Berichte zur Polar- und Meeresforschung, V527, P1; HECKER B, 1994, DEEP-SEA RES PT II, V41, P809, DOI 10.1016/0967-0645(94)90050-7; Howland J., 2006, OCEANS 2006, P1, DOI [10.1109/OCEANS.2006.307098, DOI 10.1109/OCEANS.2006.307098]; HUETTEL M, 1992, MAR ECOL PROG SER, V89, P253, DOI 10.3354/meps089253; Huettel M, 1992, MARINE ECOLOGY PROGR, V89, P267; HUNKINS KL, 1960, LIMNOL OCEANOGR, V5, P154, DOI 10.4319/lo.1960.5.2.0154; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Jones DOB, 2007, MAR BIOL RES, V3, P191, DOI 10.1080/17451000701455287; Kaiser MJ, 1998, AM FISH S S, V22, P212; Kanzog C, 2009, MAR ECOL-EVOL PERSP, V30, P391, DOI 10.1111/j.1439-0485.2009.00290.x; Kanzog C, 2009, POLAR BIOL, V32, P105, DOI 10.1007/s00300-008-0510-4; Kaufmann RS, 1997, DEEP-SEA RES PT I, V44, P559, DOI 10.1016/S0967-0637(97)00005-8; Kogan I, 2006, CONT SHELF RES, V26, P771, DOI 10.1016/j.csr.2006.01.010; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; Lauerman LML, 1996, DEEP-SEA RES PT I, V43, P1075, DOI 10.1016/0967-0637(96)00045-3; Lochte K, 2003, PROCESSES DRIVEN SMA; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mayer M, 1996, MAR ECOL PROG SER, V143, P151, DOI 10.3354/meps143151; Nybakken J, 1998, DEEP-SEA RES PT II, V45, P1753, DOI 10.1016/S0967-0645(98)80016-7; Ontrup J., 2009, OCEANS 2009 EUROPE, V17, DOI [10.1109/OCEANSE.2009.5278332, DOI 10.1109/OCEANSE.2009.5278332]; Ontrup J., 2004, COGN PROCESS, V5, P31; PAUL AZ, 1974, MAR BIOL, V27, P251, DOI 10.1007/BF00391950; Piepenburg D, 1996, POLAR BIOL, V16, P431, DOI 10.1007/BF02390425; PIEPENBURG D, 1995, MAR ECOL PROG SER, V118, P199, DOI 10.3354/meps118199; Platt JC, 2000, ADV NEUR IN, P61; Powell JR, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P175; Premke K, 2003, J EXP MAR BIOL ECOL, V285, P283, DOI 10.1016/S0022-0981(02)00533-6; Premke K, 2006, MAR ECOL PROG SER, V325, P121, DOI 10.3354/meps325121; Purser A., 2009, MARINE ECOLOGY PROGR; Queric NV, 2007, MAR ECOL-EVOL PERSP, V28, P66, DOI 10.1111/j.1439-0485.2007.00177.x; Quric N, 2008, MARINE ECOLOGY PROGR, P87; Reiss H, 2006, ICES J MAR SCI, V63, P1453, DOI 10.1016/j.icesjms.2006.06.001; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rigby P, 2010, J FIELD ROBOT, V27, P741, DOI 10.1002/rob.20372; Robertson P, 2009, WORKSH APPL COMP VIS, P1, DOI [10.1109/WACV.2009.5403037, DOI 10.1109/WACV.2009.5403037]; Rosenfeld A., 1982, DIGITAL PICTURE PROC; Rova A, 2007, IAPR C MACH VIS APPL; Ruhl HA, 2007, ECOLOGY, V88, P1250, DOI 10.1890/06-0890; Sarda R, 1998, ESTUAR COAST SHELF S, V46, P657, DOI 10.1006/ecss.1997.0322; Schulz M, 2010, POLAR BIOL, V33, P1359, DOI 10.1007/s00300-010-0825-9; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; Sikora T, 2001, IEEE T CIRC SYST VID, V11, P696, DOI 10.1109/76.927422; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; SMITH KL, 1993, DEEP-SEA RES PT I, V40, P2307, DOI 10.1016/0967-0637(93)90106-D; Solan M, 2003, J EXP MAR BIOL ECOL, V285, P313, DOI 10.1016/S0022-0981(02)00535-X; Soltwedel T, 2001, MAR ECOL PROG SER, V219, P291, DOI 10.3354/meps219291; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Soltwedel T, 2009, DEEP-SEA RES PT I, V56, P1856, DOI 10.1016/j.dsr.2009.05.012; Spampinato C., 2010, P 1 ACM INT WORKSH A, P45, DOI [DOI 10.1145/1877868.1877881, 10.1145/1877868.1877881]; Starmans A, 2002, MAR ECOL PROG SER, V225, P45, DOI 10.3354/meps225045; Sumida PYG, 2008, DEEP-SEA RES PT II, V55, P2465, DOI 10.1016/j.dsr2.2008.06.006; TAYLOR R, 2008, OCEANS, V2008, P1, DOI DOI 10.1109/OCEANS.2008.5152032; Teixido N, 2011, MAR ECOL PROG SER, V431, P45, DOI 10.3354/meps09127; Thomson J, 1987, M MAR STUD GROUP GEO; Tyler P, 2003, ECOSYSTEMS DEEP OCEA, V28; van Leeuwen P, 1994, VARIATIONS ABUNDANCE; van Oevelen D, 2011, DEEP-SEA RES PT I, V58, P1069, DOI 10.1016/j.dsr.2011.08.002; Vapnik V.N., 1995, NATURE STAT LEARNING; White OR, METHODS ESTIMATING E; York A., 2008, OCEANS 2008, P19, DOI [10.1109/OCEANS.2008.5152001, DOI 10.1109/OCEANS.2008.5152001]	97	72	72	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38179	10.1371/journal.pone.0038179	http://dx.doi.org/10.1371/journal.pone.0038179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22719868	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343900020
J	Abrams, MB; Nilsson, I; Lewandowski, SA; Kjell, J; Codeluppi, S; Olson, L; Eriksson, U				Abrams, Mathew B.; Nilsson, Ingrid; Lewandowski, Sebastian A.; Kjell, Jacob; Codeluppi, Simone; Olson, Lars; Eriksson, Ulf			Imatinib Enhances Functional Outcome after Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CELLULAR INFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; PROGENITOR-CELL; VASCULAR WALL; ACUTE-PHASE; PDGF-CC; RECOVERY; MACROPHAGES	We investigated whether imatinib (Gleevec (R), Novartis), a tyrosine kinase inhibitor, could improve functional outcome in experimental spinal cord injury. Rats subjected to contusion spinal cord injury were treated orally with imatinib for 5 days beginning 30 minutes after injury. We found that imatinib significantly enhanced blood-spinal cord-barrier integrity, hindlimb locomotor function, sensorimotor integration, and bladder function, as well as attenuated astrogliosis and deposition of chondroitin sulfate proteoglycans, and increased tissue preservation. These improvements were associated with enhanced vascular integrity and reduced inflammation. Our results show that imatinib improves recovery in spinal cord injury by preserving axons and other spinal cord tissue components. The rapid time course of these beneficial effects suggests that the effects of imatinib are neuroprotective rather than neurorestorative. The positive effects on experimental spinal cord injury, obtained by oral delivery of a clinically used drug, makes imatinib an interesting candidate drug for clinical trials in spinal cord injury.	[Abrams, Mathew B.; Kjell, Jacob; Codeluppi, Simone; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Nilsson, Ingrid; Lewandowski, Sebastian A.; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Abrams, MB (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	mathew.abrams@ki.se	Kjell, Jacob/HDN-4979-2022; codeluppi, simone/I-4143-2012; Lewandowski, Sebastian A./K-2492-2019	codeluppi, simone/0000-0002-7053-0520; Lewandowski, Sebastian A./0000-0002-5935-0211; Kjell, Jacob/0000-0002-8335-0780	Swedish Agency for Innovations (VINNOVA); Hallsten's Foundation; Swedish Brain Foundation; Wings for Life; Swedish Research Council; Anna-Stina och John Mattsons Minnesstiftelse for sonen Johan; AFA Insurance Company; Torsten och Ragnar Soderbergs stiftelser; United States Public Health Service grant; Swedish Stroke Foundation; Karolinska Institute; LeDucq Foundation	Swedish Agency for Innovations (VINNOVA); Hallsten's Foundation; Swedish Brain Foundation; Wings for Life; Swedish Research Council(Swedish Research CouncilEuropean Commission); Anna-Stina och John Mattsons Minnesstiftelse for sonen Johan; AFA Insurance Company; Torsten och Ragnar Soderbergs stiftelser; United States Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Swedish Stroke Foundation; Karolinska Institute(Karolinska Institutet); LeDucq Foundation(Leducq Foundation)	This research was conducted with support from the following foundations: the Swedish Agency for Innovations (VINNOVA), Hallsten's Foundation, the Swedish Brain Foundation, Wings for Life, the Swedish Research Council, Anna-Stina och John Mattsons Minnesstiftelse for sonen Johan, AFA Insurance Company, Torsten och Ragnar Soderbergs stiftelser, a United States Public Health Service grant, the Swedish Stroke Foundation (to IN), and the Karolinska Institute, and the LeDucq Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bao F, 2012, J NEUROTRAUMA; Barbas D, 2005, J COMP NEUROL, V490, P295, DOI 10.1002/cne.20666; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Carroll WM, 1998, BRAIN, V121, P293, DOI 10.1093/brain/121.2.293; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Flanders AE, 1996, RADIOLOGY, V201, P649, DOI 10.1148/radiology.201.3.8939210; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hugenholtz H, 2003, CAN MED ASSOC J, V168, P1145; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Lassila M, 2004, ARTERIOSCL THROM VAS, V24, P935, DOI 10.1161/01.ATV.0000124105.39900.db; Leder C, 2007, EXP HEMATOL, V35, P1266, DOI 10.1016/j.exphem.2007.04.016; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; MERRILL JE, 1991, GLIA, V4, P327, DOI 10.1002/glia.440040311; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Morelli PI, 2006, ATHEROSCLEROSIS, V184, P39, DOI 10.1016/j.atherosclerosis.2005.03.026; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Neumann H, 1998, J NEUROPATH EXP NEUR, V57, P1, DOI 10.1097/00005072-199801000-00001; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Potas JR, 2006, J NEUROTRAUM, V23, P660, DOI 10.1089/neu.2006.23.660; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009	49	42	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38760	10.1371/journal.pone.0038760	http://dx.doi.org/10.1371/journal.pone.0038760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723886	Green Published, Green Submitted, gold			2022-12-27	WOS:000305652700029
J	Wu, TF; Xie, C; Han, J; Ye, YJ; Weiel, J; Li, Q; Blanco, I; Ahn, C; Olsen, N; Putterman, C; Saxena, R; Mohan, C				Wu, Tianfu; Xie, Chun; Han, Jie; Ye, Yujin; Weiel, Jim; Li, Quan; Blanco, Irene; Ahn, Chul; Olsen, Nancy; Putterman, Chaim; Saxena, Ramesh; Mohan, Chandra			Metabolic Disturbances Associated with Systemic Lupus Erythematosus	PLOS ONE			English	Article							DISEASE-ACTIVITY; FATTY-ACIDS; PROFILES; ATHEROSCLEROSIS; ANTIOXIDANTS	The metabolic disturbances that underlie systemic lupus erythematosus are currently unknown. A metabolomic study was executed, comparing the sera of 20 SLE patients against that of healthy controls, using LC/MS and GC/MS platforms. Validation of key differences was performed using an independent cohort of 38 SLE patients and orthogonal assays. SLE sera showed evidence of profoundly dampened glycolysis, Krebs cycle, fatty acid beta oxidation and amino acid metabolism, alluding to reduced energy biogenesis from all sources. Whereas long-chain fatty acids, including the n3 and n6 essential fatty acids, were significantly reduced, medium chain fatty acids and serum free fatty acids were elevated. The SLE metabolome exhibited profound lipid peroxidation, reflective of oxidative damage. Deficiencies were noted in the cellular anti-oxidant, glutathione, and all methyl group donors, including cysteine, methionine, and choline, as well as phosphocholines. The best discriminators of SLE included elevated lipid peroxidation products, MDA, gamma-glutamyl peptides, GGT, leukotriene B4 and 5-HETE. Importantly, similar elevations were not observed in another chronic inflammatory autoimmune disease, rheumatoid arthritis. To sum, comprehensive profiling of the SLE metabolome reveals evidence of heightened oxidative stress, inflammation, reduced energy generation, altered lipid profiles and a prothrombotic state. Resetting the SLE metabolome, either by targeting selected molecules or by supplementing the diet with essential fatty acids, vitamins and methyl group donors offers novel opportunities for disease modulation in this disabling systemic autoimmune ailment.	[Wu, Tianfu; Xie, Chun; Han, Jie; Ye, Yujin; Li, Quan; Ahn, Chul; Olsen, Nancy; Saxena, Ramesh; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Weiel, Jim] Metabolon Inc, Res Triangle Pk, NC USA; [Putterman, Chaim] Albert Einstein Coll Med, New York, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Metabolon; Yeshiva University	Wu, TF (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	Chandra.mohan@utsouthwestern.edu	Putterman, Chaim/AFR-0429-2022; Wu, Tianfu/G-6672-2019; Wu, Tianfu/F-7071-2012; Mohan, Chandra/GPX-8233-2022	Wu, Tianfu/0000-0003-4406-1449; Wu, Tianfu/0000-0001-8235-5929	National Institutes of Health [R01 DK 081872]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 DK 081872. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SC, 2002, RHEUMATOL INT, V22, P238, DOI 10.1007/s00296-002-0241-8; Balada E, 2007, ANN NY ACAD SCI, V1108, P127, DOI 10.1196/annals.1422.015; Boffa JJ, 2009, NEPHROL THER, V5, P595, DOI 10.1016/j.nephro.2009.06.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534; Deckelbaum RJ, 2010, ARTERIOSCL THROM VAS, V30, P2325, DOI 10.1161/ATVBAHA.110.214353; Fernandez D, 2009, AUTOIMMUN REV, V8, P184, DOI 10.1016/j.autrev.2008.07.041; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gladman DD, 2002, J RHEUMATOL, V29, P288; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; Lutz NW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000595; McMahon M, 2007, CURR OPIN IMMUNOL, V19, P633, DOI 10.1016/j.coi.2007.11.001; Nuttall SL, 2003, RHEUMATOLOGY, V42, P758, DOI 10.1093/rheumatology/keg212; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Suwannaroj S, 2001, LUPUS, V10, P258, DOI 10.1191/096120301680416940; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wan JB, 2010, ARTERIOSCL THROM VAS, V30, P2487, DOI 10.1161/ATVBAHA.110.210054; Wright SA, 2008, ANN RHEUM DIS, V67, P841, DOI 10.1136/ard.2007.077156	20	120	125	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37210	10.1371/journal.pone.0037210	http://dx.doi.org/10.1371/journal.pone.0037210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723834	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700003
J	Korenromp, EL; Glaziou, P; Fitzpatrick, C; Floyd, K; Hosseini, M; Raviglione, M; Atun, R; Williams, B				Korenromp, Eline L.; Glaziou, Philippe; Fitzpatrick, Christopher; Floyd, Katherine; Hosseini, Mehran; Raviglione, Mario; Atun, Rifat; Williams, Brian			Implementing the Global Plan to Stop TB, 2011-2015-Optimizing Allocations and the Global Fund's Contribution: A Scenario Projections Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; COMMUNITY-BASED CARE; COST-EFFECTIVENESS; RUSSIAN-FEDERATION; HIV; COHORT; FEASIBILITY; PREVALENCE; STRATEGIES; RESOURCES	Background: The Global Plan to Stop TB estimates funding required in low- and middle-income countries to achieve TB control targets set by the Stop TB Partnership within the context of the Millennium Development Goals. We estimate the contribution and impact of Global Fund investments under various scenarios of allocations across interventions and regions. Methodology/Principal Findings: Using Global Plan assumptions on expected cases and mortality, we estimate treatment costs and mortality impact for diagnosis and treatment for drug-sensitive and multidrug-resistant TB (MDR-TB), including antiretroviral treatment (ART) during DOTS for HIV-co-infected patients, for four country groups, overall and for the Global Fund investments. In 2015, China and India account for 24% of funding need, Eastern Europe and Central Asia (EECA) for 33%, sub-Saharan Africa (SSA) for 20%, and other low-and middle-income countries for 24%. Scale-up of MDR-TB treatment, especially in EECA, drives an increasing global TB funding need - an essential investment to contain the mortality burden associated with MDR-TB and future disease costs. Funding needs rise fastest in SSA, reflecting increasing coverage need of improved TB/HIV management, which saves most lives per dollar spent in the short term. The Global Fund is expected to finance 8-12% of Global Plan implementation costs annually. Lives saved through Global Fund TB support within the available funding envelope could increase 37% if allocations shifted from current regional demand patterns to a prioritized scale-up of improved TB/HIV treatment and secondly DOTS, both mainly in Africa - with EECA region, which has disproportionately high per-patient costs, funded from alternative resources. Conclusions/Significance: These findings, alongside country funding gaps, domestic funding and implementation capacity and equity considerations, should inform strategies and policies for international donors, national governments and disease control programs to implement a more optimal investment approach focusing on highest-impact populations and interventions.	[Korenromp, Eline L.; Hosseini, Mehran] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Glaziou, Philippe; Fitzpatrick, Christopher; Floyd, Katherine; Raviglione, Mario] WHO, CH-1211 Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England; [Williams, Brian] SACEMA, Stellenbosch, South Africa	Erasmus University Rotterdam; Erasmus MC; World Health Organization; Imperial College London	Korenromp, EL (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	eline.korenromp@theglobalfund.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Williams, Brian/0000-0002-3174-4876; Glaziou, Philippe/0000-0002-0649-1272; RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 2011, GLOB TUB CONTR 2011; Atun RA, 2006, HEALTH POLICY PLANN, V21, P353, DOI 10.1093/heapol/czl023; Balabanova Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-44; Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Cohen Ted, 2009, Expert Rev Respir Med, V3, P67, DOI 10.1586/17476348.3.1.67; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Dye C, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000346; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P43, DOI 10.2471/BLT.04.018705; Floyd K, 2008, B WORLD HEALTH ORGAN, V86, P568, DOI 10.2471/BLT.07.049767; Floyd K, 2007, B WORLD HEALTH ORGAN, V85, P334, DOI 10.2471/BLT.06.034942; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P437, DOI 10.2471/BLT.05.024109; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; International Monetary Fund (IMF), 2022, WORLD EC OUTLOOK DAT; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Kazatchkine MD, 2010, LANCET, V376, P1439, DOI 10.1016/S0140-6736(10)61970-8; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Lal SS, 2011, TROP MED INT HEALTH, V16, P685, DOI 10.1111/j.1365-3156.2011.02749.x; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Pitter C, 2007, JAIDS-J ACQ IMM DEF, V44, P336, DOI 10.1097/QAI.0b013e31802f12b5; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; The Global Fund to Fight AIDS, 2011, GLOB FUND STRAT 2012; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, REPL 2011 2013 RES S; The Global Fund to fight AIDS Tuberculosis and Malaria, 2011, GFB2313GFB2313; The Global Fund to fight AIDS Tuberculosis and Malaria, 2011, GLOB FUNDS PROGR SEE; The Global Fund to fight AIDS Tuberculosis and Malaria, 2012, TRANS FUND MECH; The Global Fund to fight AIDS Tuberculosis and Malaria, 2012, APPR GRANT AM DISB D; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, POL EL CRIT COUNT FI; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, GLOB FUND RES REP 20; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; WHO, 2010, ANT THER HIV INF AD; *WHO, 2011, GLOB PLAN STOP TB 20; WHO, 2010, GLOB TUB CONTR 2010; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; [World Health Organization Stop TB Partnership], 2010, GLOB PLAN STOP TB 20; World Health Organization, 2006, TB PLANN BUDG TOOL; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	49	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38816	10.1371/journal.pone.0038816	http://dx.doi.org/10.1371/journal.pone.0038816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719954	gold, Green Published			2022-12-27	WOS:000305583300053
J	Li, YH; Wang, XX; Pan, YF; Lee, DH; Chowdhury, D; Kimmelman, AC				Li, Ying-Hua; Wang, Xiaoxu; Pan, Yunfeng; Lee, Dong-Hyun; Chowdhury, Dipanjan; Kimmelman, Alec C.			Inhibition of Non-Homologous End Joining Repair Impairs Pancreatic Cancer Growth and Enhances Radiation Response	PLOS ONE			English	Article							UP-REGULATION; BREAK REPAIR; DNA-PKCS; RECRUITMENT	Pancreatic ductal adenocarcinoma (PDAC) is amongst the deadliest of human cancers, due to its late diagnosis as well as its intense resistance to currently available therapeutics. To identify mechanisms as to why PDAC are refractory to DNA damaging cytoxic chemotherapy and radiation, we performed a global interrogation of the DNA damage response of PDAC. We find that PDAC cells generally harbor high levels of spontaneous DNA damage. Inhibition of Non-Homologous End Joining (NHEJ) repair either pharmacologically or by RNAi resulted in a further accumulation of DNA damage, inhibition of growth, and ultimately apoptosis even in the absence of exogenous DNA damaging agents. In response to radiation, PDAC cells rely on the NHEJ pathway to rapidly repair DNA double strand breaks. Mechanistically, when NHEJ is inhibited there is a compensatory increase in Homologous Recombination (HR). Despite this upregulation of HR, DNA damage persists and cells are significantly more sensitive to radiation. Together, these findings support the incorporation of NHEJ inhibition into PDAC therapeutic approaches, either alone, or in combination with DNA damaging therapies such as radiation.	[Li, Ying-Hua; Wang, Xiaoxu; Pan, Yunfeng; Lee, Dong-Hyun; Chowdhury, Dipanjan; Kimmelman, Alec C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Li, YH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	Alec_Kimmelman@DFCI.HARVARD.EDU			National Cancer Institute Grant [R01CA157490]; Kimmel Scholar Award; AACR-PanCAN Career Development Award; Karyopharm therapeutics; NATIONAL CANCER INSTITUTE [R01CA157490, R01CA142698] Funding Source: NIH RePORTER	National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Scholar Award; AACR-PanCAN Career Development Award; Karyopharm therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ACK is supported by the National Cancer Institute Grant R01CA157490, Kimmel Scholar Award, and AACR-PanCAN Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; ACK is a Consultant for Forma Therapeutics and for Dainippon Pharma. He has received research funding from Karyopharm therapeutics for an unrelated project and has received a speaking honorarium from Pfizer. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen C, 2003, MOL CANCER RES, V1, P913; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Ben-Josef E, 2008, INT J CLIN ONCOL, V13, P121, DOI 10.1007/s10147-007-0763-x; Beskow C, 2009, BRIT J CANCER, V101, P816, DOI 10.1038/sj.bjc.6605201; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hollick JJ, 2003, BIOORG MED CHEM LETT, V13, P3083, DOI 10.1016/S0960-894X(03)00652-8; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hosoi Y, 2004, INT J ONCOL, V25, P461; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Lee JM, 2011, MOL CELL, V4, P797; Lee SH, 2002, MOL CELLS, V13, P159; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; Shintani S, 2003, CANCER SCI, V94, P894, DOI 10.1111/j.1349-7006.2003.tb01372.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; van Veelen LR, 2005, MUTAT RES-FUND MOL M, V574, P22, DOI 10.1016/j.mrfmmm.2005.01.019; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200	35	49	50	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39588	10.1371/journal.pone.0039588	http://dx.doi.org/10.1371/journal.pone.0039588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724027	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300144
J	Triplett, JK; Wang, YJ; Zhong, JS; Kellogg, EA				Triplett, Jimmy K.; Wang, Yunjing; Zhong, Jinshun; Kellogg, Elizabeth A.			Five Nuclear Loci Resolve the Polyploid History of Switchgrass (Panicum virgatum L.) and Relatives	PLOS ONE			English	Article							CHROMOSOME-NUMBERS; CHLOROPLAST DNA; PHYLOGENETIC-RELATIONSHIPS; PANICOIDEAE POACEAE; MOLECULAR PHYLOGENY; SEQUENCES; DIVERSITY; EVOLUTION; ORIGINS; PLANTS	Polyploidy poses challenges for phylogenetic reconstruction because of the need to identify and distinguish between homoeologous loci. This can be addressed by use of low copy nuclear markers. Panicum s.s. is a genus of about 100 species in the grass tribe Paniceae, subfamily Panicoideae, and is divided into five sections. Many of the species are known to be polyploids. The most well-known of the Panicum polyploids are switchgrass (Panicum virgatum) and common or Proso millet (P. miliaceum). Switchgrass is in section Virgata, along with P. tricholaenoides, P. amarum, and P. amarulum, whereas P. miliaceum is in sect. Panicum. We have generated sequence data from five low copy nuclear loci and two chloroplast loci and have clarified the origin of P. virgatum. We find that all members of sects. Virgata and Urvilleana are the result of diversification after a single allopolyploidy event. The closest diploid relatives of switchgrass are in sect. Rudgeana, native to Central and South America. Within sections Virgata and Urvilleana, P. tricholaenoides is sister to the remaining species. Panicum racemosum and P. urvilleanum form a clade, which may be sister to P. chloroleucum. Panicum amarum, P. amarulum, and the lowland and upland ecotypes of P. virgatum together form a clade, within which relationships are complex. Hexaploid and octoploid plants are likely allopolyploids, with P. amarum and P. amarulum sharing genomes with P. virgatum. Octoploid P. virgatum plants are formed via hybridization between disparate tetraploids. We show that polyploidy precedes diversification in a complex set of polyploids; our data thus suggest that polyploidy could provide the raw material for diversification. In addition, we show two rounds of allopolyploidization in the ancestry of switchgrass, and identify additional species that may be part of its broader gene pool. This may be relevant for development of the crop for biofuels.	[Triplett, Jimmy K.; Wang, Yunjing; Zhong, Jinshun; Kellogg, Elizabeth A.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Triplett, JK (corresponding author), Jacksonville State Univ, Dept Biol, Jacksonville, AL 36265 USA.	jtriplett@jsu.edu; kellogge@umsl.edu	Kellogg, Elizabeth/M-2845-2013	Kellogg, Elizabeth/0000-0003-1671-7447; Zhong, Jinshun/0000-0001-7086-5470	University of Missouri-Research Board; E. Desmond Lee and Family Endowment for Botanical Studies	University of Missouri-Research Board; E. Desmond Lee and Family Endowment for Botanical Studies	This work was funded by the University of Missouri-Research Board, and the E. Desmond Lee and Family Endowment for Botanical Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; AHSAN SMN, 1994, ANN MO BOT GARD, V81, P775, DOI 10.2307/2399922; Ainouche ML, 2004, NEW PHYTOL, V161, P165, DOI 10.1046/j.1469-8137.2003.00926.x; Alderson J. S, 1995, GRASS VARIETIES US; Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; [Anonymous], 1991, VERH ZOOL BOT GES OS; Avdulov N., 1931, T PRIKL BOT SELEKTS, V44, P1, DOI [10.1017/cbo9780511525445.002, DOI 10.1017/CBO9780511525445.002]; BARNETT FL, 1967, CROP SCI, V7, P301, DOI 10.2135/cropsci1967.0011183X000700040005x; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; Brassac J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033808; BROWN WV, 1948, AM J BOT, V35, P382, DOI 10.2307/2437938; BRUNKEN J N, 1975, Southwestern Naturalist, V19, P379, DOI 10.2307/3670396; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Cronn R, 2004, NEW PHYTOL, V161, P133, DOI [10.1111/j.1469-8137.2004.00947.x, 10.1046/j.1469-8137.2003.00947.x]; Devesa J. A., 1991, Boletim da Sociedade Broteriana, V64, P35; Doust AN, 2007, SYST BOT, V32, P531, DOI 10.1600/036364407782250670; Doyle JJ, 2004, NEW PHYTOL, V161, P121, DOI 10.1046/j.1469-8137.2003.00949.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Feltus FA, 2006, PLANT PHYSIOL, V140, P1183, DOI 10.1104/pp.105.074203; Freckmann RW, 2003, FLORA N AM N MEXIC 2; Frey L., 1981, FRAGM FLORIST GEOBOT, V27, P581; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Giussani LM, 2001, AM J BOT, V88, P1993, DOI 10.2307/3558427; GOULD FW, 1958, AM J BOT, V45, P757, DOI 10.2307/2439737; Gunter LE, 1996, CROP SCI, V36, P1017, DOI 10.2135/cropsci1996.0011183X003600040034x; HAMOUD MA, 1994, BIOL PLANTARUM, V36, P37, DOI 10.1007/BF02921265; Haroun Soliman A., 1995, Cytologia (Tokyo), V60, P347, DOI 10.1508/cytologia.60.347; Hattersley PW, 1987, GRASS SYSTEMATICS EV; Hilden L, 2004, BIOTECHNOL LETT, V26, P1683, DOI 10.1007/s10529-004-4579-8; Hitchcock A. S., 1971, MANUAL GRASSES US; Hopkins AA, 1996, CROP SCI, V36, P1192, DOI 10.2135/cropsci1996.0011183X003600050021x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hultquist SJ, 1997, CROP SCI, V37, P595, DOI 10.2135/cropsci1997.0011183X003700020047x; Hultquist SJ, 1996, CROP SCI, V36, P1049, DOI 10.2135/cropsci1996.0011183X003600040039x; Hunziker Juan H., 1998, Darwiniana (San Isidro), V35, P29; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JUNG GA, 1990, AGRON J, V82, P21, DOI 10.2134/agronj1990.00021962008200010005x; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Libertini E, 2004, J MOL EVOL, V58, P506, DOI 10.1007/s00239-003-2571-x; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Love A., 1981, Taxon, V30, P508; Love A, 1980, TAXON, V29, P709; Lu K., 1998, GREAT PLAINS RES, V8, P269; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maddison WP, 2005, MACCLADE ANAL PHYLOG; Martinez-Reyna JM, 2002, CROP SCI, V42, P1800, DOI 10.2135/cropsci2002.1800; Martinez-Reyna JM, 2001, CROP SCI, V41, P1579, DOI 10.2135/cropsci2001.4151579x; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; MCMILLAN C, 1959, AM J BOT, V46, P590, DOI 10.2307/2439303; Missaoui AM, 2006, GENET RESOUR CROP EV, V53, P1291, DOI 10.1007/s10722-005-3878-9; Missaoui AM, 2005, THEOR APPL GENET, V110, P1372, DOI 10.1007/s00122-005-1935-6; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Morris GP, 2011, MOL ECOL, V20, P4938, DOI 10.1111/j.1365-294X.2011.05335.x; Morrone O, 2008, SYST BOT, V33, P66, DOI 10.1600/036364408783887393; Morrone O, 2007, TAXON, V56, P521, DOI 10.1002/tax.562023; Moser LE, 1995, FORAGES INTRO GRASSL, V1, P409; MURIN A, 1993, BIOLOGIA, V48, P441; Murin Augustin, 1999, Thaiszia, V9, P31; Nielson EL, 1944, J AGRIC RES, V69, P0327; NORRMANN GA, 1994, ANN MO BOT GARD, V81, P768, DOI 10.2307/2399921; Nunez O., 1952, REV FAC AGRON U NAC, V28, P229; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; PALMER PG, 1975, BRITTONIA, V27, P142, DOI 10.2307/2805475; Parodi LR, 1946, GRAMINEAS BONARIENSE; POHL RW, 1971, BRITTONIA, V23, P293, DOI 10.2307/2805632; PORTER CL, 1966, ECOLOGY, V47, P980, DOI 10.2307/1935646; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PROBATOVA N S, 1983, Botanicheskii Zhurnal (St. Petersburg), V68, P1683; RILEY RD, 1982, CROP SCI, V22, P1082, DOI 10.2135/cropsci1982.0011183X002200050047x; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Saggoo MIS, 1981, TAXON, V30, P515; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sang T, 1999, SYST BOT, V24, P148, DOI 10.2307/2419546; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simon Bryan K., 2003, Austrobaileya, V6, P571; Sinha RRP, 1990, J CYTOLOGY GENETICS, V25, P140; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TALBERT LE, 1983, CROP SCI, V23, P725, DOI 10.2135/cropsci1983.0011183X002300040029x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Triplett JK, 2010, SYST BOT, V35, P102, DOI 10.1600/036364410790862678; Urbani MH, 1990, B SOC ARGENT BOT, V26, P205; VAHIDY AA, 1987, ANN MO BOT GARD, V74, P432, DOI 10.2307/2399415; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Vogel K.P., 2004, WARM SEASON C4 GRASS, P561, DOI DOI 10.2134/AGRONMONOGR45.C16; VOGEL KP, 1991, CROP SCI, V31, P1388, DOI 10.2135/cropsci1991.0011183X003100050080x; Vogel KP, 2001, CRIT REV PLANT SCI, V20, P15, DOI 10.1016/S0735-2689(01)80011-3; Vogel KP, 1985, P M SOC RANG MAN SAL; Warwick SI, 1997, NEWSL INT ORGAN PLAN, V27, P25; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Yamane K, 2005, AM J BOT, V92, P1887, DOI 10.3732/ajb.92.11.1887; Young HA, 2010, BIOENERG RES, V3, P305, DOI 10.1007/s12155-010-9081-7; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zuloaga F. O., 2000, Grasses: systematics and evolution., P123; Zuloaga FO, 2006, SYST BOT, V31, P497, DOI 10.1600/036364406778388548; Zuloaga FO, 2011, SYST BOTANY MONOGR, V94, P1; ZULOAGA FO, 1987, ANN MO BOT GARD, V74, P463, DOI 10.2307/2399313; Zuloaga FO, 1998, ANN MO BOT GARD, V85, P631, DOI 10.2307/2992019; Zwickl D. J, 2006, GENETIC ALGORITHM AP	108	50	50	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38702	10.1371/journal.pone.0038702	http://dx.doi.org/10.1371/journal.pone.0038702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719924	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300041
J	Vasilev, F; Chun, JT; Gragnaniello, G; Garante, E; Santella, L				Vasilev, Filip; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia			Effects of Ionomycin on Egg Activation and Early Development in Starfish	PLOS ONE			English	Article							SEA-URCHIN EGGS; CORTICAL GRANULE TRANSLOCATION; MEIOTIC MATURATION; NEUROENDOCRINE CELLS; INTRACELLULAR CA2+; OOCYTES REQUIRES; HIGH-AFFINITY; CALCIUM; ACTIN; RELEASE	Ionomycin is a Ca2+-selective ionophore that is widely used to increase intracellular Ca2+ levels in cell biology laboratories. It is also occasionally used to activate eggs in the clinics practicing in vitro fertilization. However, neither the precise molecular action of ionomycin nor its secondary effects on the eggs' structure and function is well known. In this communication we have studied the effects of ionomycin on starfish oocytes and zygotes. By use of confocal microscopy, calcium imaging, as well as light and transmission electron microscopy, we have demonstrated that immature oocytes exposed to ionomycin instantly increase intracellular Ca2+ levels and undergo structural changes in the cortex. Surprisingly, when microinjected into the cells, ionomycin produced no Ca2+ increase. The ionomycin-induced Ca2+ rise was followed by fast alteration of the actin cytoskeleton displaying conspicuous depolymerization at the oocyte surface and in microvilli with concomitant polymerization in the cytoplasm. In addition, cortical granules were disrupted or fused with white vesicles few minutes after the addition of ionomycin. These structural changes prevented cortical maturation of the eggs despite the normal progression of nuclear envelope breakdown. At fertilization, the ionomycin-pretreated eggs displayed reduced Ca2+ response, no elevation of the fertilization envelope, and the lack of orderly centripetal translocation of actin fibers. These alterations led to difficulties in cell cleavage in the monospermic zygotes and eventually to a higher rate of abnormal development. In conclusion, ionomycin has various deleterious impacts on egg activation and the subsequent embryonic development in starfish. Although direct comparison is difficult to make between our findings and the use of the ionophore in the in vitro fertilization clinics, our results call for more defining investigations on the issue of a potential risk in artificial egg activation.	[Vasilev, Filip; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia] Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Vasilev, F (corresponding author), Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy.	santella@szn.it	Santella, Luigia/AAM-3524-2020; Chun, Jong Tai/AAM-3394-2020	Santella, Luigia/0000-0001-7159-0499; Chun, Jong Tai/0000-0002-6070-4953	Stazione Zoologica Napoli institutional funds	Stazione Zoologica Napoli institutional funds	This work has been supported by Stazione Zoologica Napoli institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Chun JT, 2009, ACTA PHYSIOL, V195, P61, DOI 10.1111/j.1748-1716.2008.01921.x; Chun JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014100; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Ciapa B, 2011, INT J DEV BIOL, V55, P143, DOI 10.1387/ijdb.103122bc; DALE B, 1981, DEV BIOL, V83, P232, DOI 10.1016/0012-1606(81)90469-3; Darbellay B, 2011, J CELL BIOL, V194, P335, DOI 10.1083/jcb.201012157; EPEL D, 1990, CELL DIFFER DEV, V29, P1, DOI 10.1016/0922-3371(90)90019-S; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; GERSHMAN LC, 1986, BIOCHEM BIOPH RES CO, V135, P607, DOI 10.1016/0006-291X(86)90036-7; GILLOT I, 1991, DEV BIOL, V146, P396, DOI 10.1016/0012-1606(91)90241-T; Heytens E, 2010, REPROD BIOMED ONLINE, V21, P742, DOI 10.1016/j.rbmo.2010.07.006; Hirohashi N, 2008, DEV BIOL, V318, P194, DOI 10.1016/j.ydbio.2008.03.029; Jaffe LF, 2002, CELL CALCIUM, V32, P217, DOI 10.1016/S0143416002001574; KASAI M, 1969, BIOCHIM BIOPHYS ACTA, V172, P300, DOI 10.1016/0005-2728(69)90072-3; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KAUFFMAN RF, 1980, J BIOL CHEM, V255, P2735; Lange K, 2006, J CELL PHYSIOL, V209, P270, DOI 10.1002/jcp.20717; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; LIU CM, 1978, J BIOL CHEM, V253, P5892; LIU WC, 1978, J ANTIBIOT, V31, P815, DOI 10.7164/antibiotics.31.815; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Mason MJ, 1993, BIOCHEM J, V296, P22; MCPHERSON SM, 1992, J CELL BIOL, V116, P1111, DOI 10.1083/jcb.116.5.1111; MIYAZAKI S, 1991, CELL CALCIUM, V12, P205, DOI 10.1016/0143-4160(91)90021-6; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; MOREAU M, 1978, NATURE, V272, P251, DOI 10.1038/272251a0; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Morgan AJ, 2011, CELL CALCIUM, V50, P147, DOI 10.1016/j.ceca.2010.12.007; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nasr-Esfahani MH, 2008, FERTIL STERIL, V90, P2231, DOI 10.1016/j.fertnstert.2007.10.047; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; OBERDORF JA, 1986, J CELL BIOL, V102, P2205, DOI 10.1083/jcb.102.6.2205; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; Ramos IB, 2010, BIOCHEM J, V429, P485, DOI 10.1042/BJ20091956; Reunov AA, 2010, ZOOLOGY, V113, P295, DOI 10.1016/j.zool.2010.07.001; RIDGWAY EB, 1977, P NATL ACAD SCI USA, V74, P623, DOI 10.1073/pnas.74.2.623; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Santella L, 1999, EXP CELL RES, V248, P567, DOI 10.1006/excr.1999.4425; SANTELLA L, 1994, BIOCHEM BIOPH RES CO, V203, P674, DOI 10.1006/bbrc.1994.2235; Santella L, 2011, SCI CHINA LIFE SCI, V54, P733, DOI 10.1007/s11427-011-4202-x; SCHUETZ AW, 1975, J CELL BIOL, V66, P86, DOI 10.1083/jcb.66.1.86; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; STEINHAR.RA, 1974, P NATL ACAD SCI USA, V71, P1915, DOI 10.1073/pnas.71.5.1915; STEINHAR.RA, 1974, NATURE, V252, P41, DOI 10.1038/252041a0; Terada Y, 2009, FERTIL STERIL, V91, DOI 10.1016/j.fertnstert.2008.09.043; Terasaki M, 1996, CELL MOTIL CYTOSKEL, V34, P48, DOI 10.1002/(SICI)1097-0169(1996)34:1<48::AID-CM5>3.0.CO;2-E; Terasaki M, 2010, EXP CELL RES, V316, P2654, DOI 10.1016/j.yexcr.2010.05.031; TRIMMER JS, 1986, ANNU REV CELL BIOL, V2, P1; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Wessel GM, 2002, DEVELOPMENT, V129, P4315; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; YOSHIDA S, 1992, J PHYSIOL-LONDON, V458, P307, DOI 10.1113/jphysiol.1992.sp019419; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	64	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39231	10.1371/journal.pone.0039231	http://dx.doi.org/10.1371/journal.pone.0039231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723970	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300119
J	Brock, O; Keller, M; Douhard, Q; Bakker, J				Brock, Olivier; Keller, Matthieu; Douhard, Quentin; Bakker, Julie			Female Mice Deficient in Alpha-Fetoprotein Show Female-Typical Neural Responses to Conspecific-Derived Pheromones	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FOREBRAIN FOS RESPONSES; SEXUAL-DIFFERENTIATION; VOMERONASAL ORGAN; ANDROGEN RECEPTOR; RAPID ACTIVATION; OLFACTORY SYSTEM; MATE RECOGNITION; KNOCKOUT MICE; MALE-RAT	The neural mechanisms controlling sexual behavior are sexually differentiated by the perinatal actions of sex steroid hormones. We recently observed using female mice deficient in alpha-fetoprotein (AFP-KO) and which lack the protective actions of AFP against maternal estradiol, that exposure to prenatal estradiol completely defeminized the potential to show lordosis behavior in adulthood. Furthermore, AFP-KO females failed to show any male-directed mate preferences following treatment with estradiol and progesterone, indicating a reduced sexual motivation to seek out the male. In the present study, we asked whether neural responses to male-and female-derived odors are also affected in AFP-KO female mice. Therefore, we compared patterns of Fos, the protein product of the immediate early gene, c-fos, commonly used as a marker of neuronal activation, between wild-type (WT) and AFP-KO female mice following exposure to male or estrous female urine. We also tested WT males to confirm the previously observed sex differences in neural responses to male urinary odors. Interestingly, AFP-KO females showed normal, female-like Fos responses, i.e. exposure to urinary odors from male but not estrous female mice induced equivalent levels of Fos protein in the accessory olfactory pathways (e.g. the medial part of the preoptic nucleus, the bed nucleus of the stria terminalis, the amygdala, and the lateral part of the ventromedial hypothalamic nucleus) as well as in the main olfactory pathways (e.g. the piriform cortex and the anterior cortical amygdaloid nucleus), as WT females. By contrast, WT males did not show any significant induction of Fos protein in these brain areas upon exposure to either male or estrous female urinary odors. These results thus suggest that prenatal estradiol is not involved in the sexual differentiation of neural Fos responses to male-derived odors.	[Brock, Olivier; Bakker, Julie] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Keller, Matthieu] Univ Tours, CNRS, INRA, Behav & Reprod Physiol, Nouzilly, France; [Douhard, Quentin; Bakker, Julie] Univ Liege, GIGA Neurosci, Liege, Belgium; [Bakker, Julie] Vrije Univ, Med Ctr, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours; University of Liege; Vrije Universiteit Amsterdam	Brock, O (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	o.brock@nin.knaw.nl	Keller, Matthieu/Q-1431-2019	Keller, Matthieu/0000-0002-5445-7431; Brock, Olivier/0000-0003-1965-7531	Fonds National de la Recherche Scientifique (FNRS) (Mandat d'Impulsion Scientifique) [F.4502.07]; National Institutes of Child Health and Human Development (NICHD) [HD044897]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044897] Funding Source: NIH RePORTER	Fonds National de la Recherche Scientifique (FNRS) (Mandat d'Impulsion Scientifique)(Fonds de la Recherche Scientifique - FNRS); National Institutes of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the following grants: Fonds National de la Recherche Scientifique (FNRS) (Mandat d'Impulsion Scientifique F.4502.07) and the National Institutes of Child Health and Human Development (NICHD - HD044897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aste N, 2003, BRAIN RES BULL, V60, P191, DOI 10.1016/S0361-9230(03)00035-2; Bakker J, 2007, J NEUROENDOCRINOL, V19, P329, DOI 10.1111/j.1365-2826.2007.01540.x; Bakker J, 2006, NAT NEUROSCI, V9, P220, DOI 10.1038/nn1624; Bakker J, 2003, J NEUROENDOCRINOL, V15, P615, DOI 10.1046/j.1365-2826.2003.01036.x; Bakker J, 1996, NEUROSCIENCE, V74, P251, DOI 10.1016/0306-4522(96)00096-6; Bakker J, 1996, PHYSIOL BEHAV, V60, P489, DOI 10.1016/S0031-9384(96)80023-0; Bakker J, 2010, HORM BEHAV, V57, P390, DOI 10.1016/j.yhbeh.2009.11.005; Bodo C, 2008, ENDOCRINOLOGY, V149, P4142, DOI 10.1210/en.2008-0183; Bodo C, 2007, EUR J NEUROSCI, V25, P2182, DOI 10.1111/j.1460-9568.2007.05484.x; Bressler SC, 1996, NEUROSCIENCE, V71, P1063, DOI 10.1016/0306-4522(95)00493-9; Brock O, 2011, HORM BEHAV, V59, P83, DOI 10.1016/j.yhbeh.2010.10.012; Brown R.E., 1979, Advances in the Study of Behavior, V10, P103, DOI 10.1016/S0065-3454(08)60094-7; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; De Mees C, 2006, MOL CELL BIOL, V26, P2012, DOI 10.1128/MCB.26.5.2012-2018.2006; Dudley CA, 2001, BRAIN RES, V915, P32, DOI 10.1016/S0006-8993(01)02820-7; EDWARDS DA, 1973, PHYSIOL BEHAV, V11, P867, DOI 10.1016/0031-9384(73)90282-5; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gabant P, 2002, P NATL ACAD SCI USA, V99, P12865, DOI 10.1073/pnas.202215399; Gonzalez-Martinez D, 2008, ENDOCRINOLOGY, V149, P2333, DOI 10.1210/en.2007-1422; Guillamon A, 1997, BRAIN RES BULL, V44, P377, DOI 10.1016/S0361-9230(97)00217-7; Halem HA, 1999, J NEUROBIOL, V39, P249, DOI 10.1002/(SICI)1097-4695(199905)39:2<249::AID-NEU9>3.3.CO;2-I; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hosokawa N, 2005, BRAIN RES, V1066, P101, DOI 10.1016/j.brainres.2005.10.036; Kang ND, 2006, NEUROSCI LETT, V398, P59, DOI 10.1016/j.neulet.2005.12.062; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Keller M, 2006, CHEM SENSES, V31, P315, DOI 10.1093/chemse/bjj035; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; Keller M, 2010, HORM BEHAV, V57, P434, DOI 10.1016/j.yhbeh.2010.01.013; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Pankevich DE, 2006, PHYSIOL BEHAV, V87, P781, DOI 10.1016/j.physbeh.2006.01.020; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PFAFF DW, 1969, BRAIN RES, V15, P137, DOI 10.1016/0006-8993(69)90315-1; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; RAYNAUD JP, 1973, MOL PHARMACOL, V9, P520; Reyes R, 2004, BRAIN RES BULL, V63, P301, DOI 10.1016/j.brainresbull.2004.03.006; Robarts DW, 2007, HORM BEHAV, V51, P104, DOI 10.1016/j.yhbeh.2006.08.009; Swaney WT, 2008, BEHAV NEUROSCI, V122, P963, DOI 10.1037/a0012706; Taziaux M, 2011, NEUROREPORT, V22, P294, DOI 10.1097/WNR.0b013e3283460f35; THOMPSON ML, 1972, PHYSIOL BEHAV, V8, P1141, DOI 10.1016/0031-9384(72)90210-7; Wersinger SR, 2000, J NEUROENDOCRINOL, V12, P103, DOI 10.1046/j.1365-2826.2000.00418.x	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39204	10.1371/journal.pone.0039204	http://dx.doi.org/10.1371/journal.pone.0039204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720075	Green Published, gold			2022-12-27	WOS:000305350000049
J	Peterson, AE; Davis, MF; Julian, KG; Awantang, G; Greene, WH; Price, LB; Waters, A; Doppalapudi, A; Krain, LJ; Nelson, K; Silbergeld, EK; Whitener, CJ				Peterson, Amy E.; Davis, Meghan F.; Julian, Kathleen G.; Awantang, Grace; Greene, Wallace H.; Price, Lance B.; Waters, Andrew; Doppalapudi, Avanthi; Krain, Lisa J.; Nelson, Kenrad; Silbergeld, Ellen K.; Whitener, Cynthia J.			Molecular and Phenotypic Characteristics of Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus at a Rural Hospital	PLOS ONE			English	Article							SINGLE-DISK METHOD; UNITED-STATES; RISK-FACTORS; ANTIBIOTIC SUSCEPTIBILITY; NASAL COLONIZATION; INFECTIONS; PREVALENCE; MRSA; SURVEILLANCE; EMERGENCE	Background: While methicillin-resistant Staphylococcus aureus (MRSA) originally was associated with healthcare, distinct strains later emerged in patients with no prior hospital contact. The epidemiology of MRSA continues to evolve. Methods: To characterize the current epidemiology of MRSA-colonized patients entering a hospital serving both rural and urban communities, we interviewed patients with MRSA-positive admission nasal swabs between August 2009 and March 2010. We applied hospitalization risk factor, antimicrobial resistance phenotype, and multi-locus sequence genotype (MLST) classification schemes to 94 case-patients. Results: By MLST analysis, we identified 15 strains with two dominant clonal complexes (CCs)-CC5 (51 isolates), historically associated with hospitals, and CC8 (27 isolates), historically of community origin. Among patients with CC5 isolates, 43% reported no history of hospitalization within the past six months; for CC8, 67% reported the same. Classification by hospitalization risk factor did not correlate strongly with genotypic classification. Sensitivity of isolates to ciprofloxacin, clindamycin, or amikacin was associated with the CC8 genotype; however, among CC8 strains, 59% were resistant to ciprofloxacin, 15% to clindamycin, and 15% to amikacin. Conclusions: Hospitalization history was not a strong surrogate for the CC5 genotype. Conversely, patients with a history of hospitalization were identified with the CC8 genotype. Although ciprofloxacin, clindamycin, and amikacin susceptibility distinguished CC8 strains, the high prevalence of ciprofloxacin resistance limited its predictive value. As CC8 strains become established in healthcare settings and CC5 strains disseminate into the community, community-associated MRSA definitions based on case-patient hospitalization history may prove less valuable in tracking community MRSA strains.	[Peterson, Amy E.; Davis, Meghan F.; Awantang, Grace; Krain, Lisa J.; Nelson, Kenrad; Silbergeld, Ellen K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Julian, Kathleen G.; Greene, Wallace H.; Doppalapudi, Avanthi; Whitener, Cynthia J.] Penn State Hershey Med Ctr, Hershey, PA USA; [Price, Lance B.; Waters, Andrew] Translat Genom Res Inst, Flagstaff, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Translational Genomics Research Institute	Peterson, AE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	mdavis@jhsph.edu	Davis, Meghan F./C-1494-2013	Davis, Meghan F./0000-0002-3475-4578; Krain, Lisa/0000-0002-8498-7177	Johns Hopkins Center for a Livable Future; Heinz Foundation; Johns Hopkins Center for a Livable Future Predoctoral Fellowships; Sommer Scholarship	Johns Hopkins Center for a Livable Future; Heinz Foundation; Johns Hopkins Center for a Livable Future Predoctoral Fellowships; Sommer Scholarship	Research was supported by grants from the Johns Hopkins Center for a Livable Future (http://www.jhsph.edu/clf/) and the Heinz Foundation (http://www.heinzfamily.org/aboutus/philanthropies_02.html). AEP and MFD were supported by Johns Hopkins Center for a Livable Future Predoctoral Fellowships. Additionally, MFD was supported by a Sommer Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CA, 2010, AM J INFECT CONTROL, V38, P315, DOI 10.1016/j.ajic.2009.05.013; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BARRY AL, 1970, AM J CLIN PATHOL, V53, P149; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2006, M2A9 CLIN LAB STAND; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Freitas EAF, 2010, INFECT CONT HOSP EP, V31, P469, DOI 10.1086/651672; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Klein E, 2009, EMERG INFECT DIS, V15, P1925, DOI 10.3201/eid1512.081341; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, EMERG INFECT DIS, V12, P1991; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Marschall J, 2006, INFECT CONT HOSP EP, V27, P1206, DOI 10.1086/507917; McDougal LK, 2010, ANTIMICROB AGENTS CH, V54, P3804, DOI 10.1128/AAC.00351-10; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Millar BC, 2007, J HOSP INFECT, V67, P109, DOI 10.1016/j.jhin.2007.06.003; Miller R, 2010, EPIDEMIOL INFECT, V138, P655, DOI 10.1017/S0950268809991294; Milstone AM, 2010, EMERG INFECT DIS, V16, P647, DOI 10.3201/eid1604.090107; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nakagawa S, 2005, BIOCHEM BIOPH RES CO, V328, P995, DOI 10.1016/j.bbrc.2005.01.054; Nonhoff C, 2009, EUR J CLIN MICROBIOL, V28, P363, DOI 10.1007/s10096-008-0637-9; Oberdorfer K, 2006, EUR J CLIN MICROBIOL, V25, P657, DOI 10.1007/s10096-006-0203-2; Orendi JM, 2010, J HOSP INFECT, V75, P258, DOI 10.1016/j.jhin.2010.03.023; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Popovich K, 2007, J CLIN MICROBIOL, V45, P2293, DOI 10.1128/JCM.00044-07; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Skov RL, 2009, J HOSP INFECT, V73, P364, DOI 10.1016/j.jhin.2009.07.004	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38354	10.1371/journal.pone.0038354	http://dx.doi.org/10.1371/journal.pone.0038354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719880	gold, Green Submitted, Green Published			2022-12-27	WOS:000305350000013
J	Chang, CS; Chang, YF; Liu, PY; Chen, CY; Tsai, YS; Wu, CH				Chang, Chin-Sung; Chang, Yin-Fan; Liu, Ping-Yen; Chen, Chuan-Yu; Tsai, Yau-Sheng; Wu, Chih-Hsing			Smoking, Habitual Tea Drinking and Metabolic Syndrome in Elderly Men Living in Rural Community: The Tianliao Old People (TOP) Study 02	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GREEN TEA; CIGARETTE-SMOKING; RISK-FACTORS; CARDIOVASCULAR RISK; CONSUMPTION; ASSOCIATION; PREVALENCE; ALCOHOL	The literature shows an inconsistent relationship between lifestyle behaviors and metabolic syndrome (MetS), especially in the elderly. We designed this study to investigate the interrelationships among cigarette smoking, tea drinking and MetS, and to verify the factors associated with MetS in elderly males dwelling in rural community. In July 2010, with a whole community sampling method, 414 male subjects aged over 65 dwelling in Tianliao township were randomly sampled. The response rate was 60.8%. Each subject completed the structured questionnaires including sociodemographic characteristics, habitual behaviors (including cigarette smoking and tea drinking habits) and medical history. After an overnight fast, the laboratory and anthropometric data were obtained. MetS was confirmed according to the criteria defined by the modified NCEP ATP III for the male Chinese population. Subjects were split into either non-MetS or MetS groups for further analysis. Of the 361 subjects with complete data, 132 (36.6%) elderly men were classified as having MetS. Using binary logistic regression, body mass index, serum uric acid, high sensitivity C-reactive protein, HOMA index, current smokers (OR = 2.72, 95%CI: 1.03 similar to 7.19), total smoking amount > = 30 (OR = 2.78, 95%CI: 1.31 similar to 5.90) and more than 20 cigarettes daily (OR = 2.54, 95%CI: 1.24 similar to 5.18) were positively associated with MetS. Current un- or partial fermented tea drinker (OR = 0.42, 95%CI: 0.22 similar to 0.84), tea drinking habit for 1-9 years (OR = 0.36, 95% CI: 0.15 similar to 0.90) and more than 240cc daily (OR = 0.35, 95%CI: 0.17 similar to 0.72) were negatively associated with MetS. In conclusion, this study suggests that smoking habit was positively associated with MetS, but tea drinking habit was negatively associated with MetS in elderly men dwelling in rural community.	[Chang, Chin-Sung; Chang, Yin-Fan; Wu, Chih-Hsing] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Liu, Ping-Yen] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Chen, Chuan-Yu] Tianliao Dist Publ Hlth Ctr, Kaohsiung, Taiwan; [Tsai, Yau-Sheng] Natl Cheng Kung Univ, Coll Med, Grad Inst Clin Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, CS (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	paulo@mail.ncku.edu.tw			National Cheng Kung University Medical College	National Cheng Kung University Medical College	This work was supported by the grant received from National Cheng Kung University Medical College for the students' summer study program, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bianchi G, 2008, QJM-INT J MED, V101, P713, DOI 10.1093/qjmed/hcn084; Cao H, 2007, J AGR FOOD CHEM, V55, P6372, DOI 10.1021/jf070695o; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Chang CH, 2009, ARCH GERONTOL GERIAT, V49, pS46, DOI 10.1016/S0167-4943(09)70013-5; Chen AR, 2010, CLIN INVEST MED, V33, pE290, DOI 10.25011/cim.v33i5.14354; Chen CC, 2008, METABOLISM, V57, P544, DOI 10.1016/j.metabol.2007.11.018; Chen H., 2011, TAIWAN GERIATR GERON, V6, P116; Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003; Cheriyath P, 2010, EUR J CARDIOV PREV R, V17, P309, DOI 10.1097/HJR.0b013e32833189b8; Chiang PH, 2009, WORLD J GASTROENTERO, V15, P5334, DOI 10.3748/wjg.15.5334; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Chiou WK, 2010, J EPIDEMIOL, V20, P219, DOI 10.2188/jea.JE20090078; Dalacorte RR, 2008, J AM GERIATR SOC, V56, P1372, DOI 10.1111/j.1532-5415.2008.01750.x; DECODA Study Grp, 2007, DIABETES RES CLIN PR, V76, P57, DOI 10.1016/j.diabres.2006.07.020; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Falkner KL, 1999, AM J EPIDEMIOL, V150, P195; Ferrannini E, 1997, DIABETES METAB REV, V13, P81; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Hahn V, 2009, DIABETES CARE, V32, P511, DOI 10.2337/dc08-1285; Hanyu O, 2009, J ATHEROSCLER THROMB, V16, P560, DOI 10.5551/jat.869; He Y, 2009, J AM COLL CARDIOL, V53, P363, DOI 10.1016/j.jacc.2008.08.073; Hosoda K, 2003, DIABETES CARE, V26, P1714, DOI 10.2337/diacare.26.6.1714; Hotta Y, 2008, DIABETES RES CLIN PR, V81, P358, DOI 10.1016/j.diabres.2008.05.005; Indraratna PL, 2009, J RHEUMATOL, V36, P2842, DOI 10.3899/jrheum.090500; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Katano S, 2010, J ATHEROSCLER THROMB, V17, P644, DOI 10.5551/jat.3699; Kawada Tomoyuki, 2006, J Cardiometab Syndr, V1, P313, DOI 10.1111/j.1524-6175.2006.05951.x; Kim BJ, 2009, DIABETES CARE, V32, P1314, DOI 10.2337/dc09-0060; Kim MH, 2007, ANN NUTR METAB, V51, P533, DOI 10.1159/000112977; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Liu PY, 2007, J AM COLL CARDIOL, V49, P1619, DOI 10.1016/j.jacc.2006.12.043; Lu FH, 2000, J GERONTOL A-BIOL, V55, pM463, DOI 10.1093/gerona/55.8.M463; Manu P, 2010, EUR J INTERN MED, V21, P409, DOI 10.1016/j.ejim.2010.05.015; Minich DM, 2008, NUTR REV, V66, P429, DOI 10.1111/j.1753-4887.2008.00075.x; Mitu F, 2009, Rev Med Chir Soc Med Nat Iasi, V113, P1001; Moon HS, 2007, CHEM-BIOL INTERACT, V167, P85, DOI 10.1016/j.cbi.2007.02.008; Nakashita Y, 2010, J EPIDEMIOL, V20, P391, DOI 10.2188/jea.JE20100043; Panagiotakos DB, 2007, ASIA-PAC J PUBLIC HE, V19, P22, DOI 10.1177/101053950701900305; Puig JG, 2008, CURR OPIN RHEUMATOL, V20, P187, DOI 10.1097/BOR.0b013e3282f4b1ed; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Takeuchi T, 2009, NICOTINE TOB RES, V11, P1093, DOI 10.1093/ntr/ntp106; Tamba S, 2008, INTERNAL MED, V47, P1175, DOI 10.2169/internalmedicine.47.0603; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Wolfram S, 2007, J AM COLL NUTR, V26, p373S, DOI 10.1080/07315724.2007.10719626; Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534; Zhu YX, 2011, BIOMED ENVIRON SCI, V24, P475, DOI 10.3967/0895-3988.2011.05.004	54	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38874	10.1371/journal.pone.0038874	http://dx.doi.org/10.1371/journal.pone.0038874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22719971	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800024
J	Gruenwald, K; Holland, JT; Stromberg, V; Ahmad, A; Watcharakichkorn, D; Okumoto, S				Gruenwald, Katrin; Holland, John Todd; Stromberg, Verlyn; Ahmad, Altaf; Watcharakichkorn, Daisy; Okumoto, Sakiko			Visualization of Glutamine Transporter Activities in Living Cells Using Genetically Encoded Glutamine Sensors	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; FLUORESCENT PROTEIN; BINDING-PROTEIN; FUNCTIONAL-CHARACTERIZATION; EPILEPTIFORM ACTIVITY; ESCHERICHIA-COLI; HEPATOMA-CELLS; RAT-LIVER; SYNTHETASE; METABOLISM	Glutamine plays a central role in the metabolism of critical biological molecules such as amino acids, proteins, neurotransmitters, and glutathione. Since glutamine metabolism is regulated through multiple enzymes and transporters, the cellular glutamine concentration is expected to be temporally dynamic. Moreover, differentiation in glutamine metabolism between cell types in the same tissue (e.g. neuronal and glial cells) is often crucial for the proper function of the tissue as a whole, yet assessing cell-type specific activities of transporters and enzymes in such heterogenic tissue by physical fractionation is extremely challenging. Therefore, a method of reporting glutamine dynamics at the cellular level is highly desirable. Genetically encoded sensors can be targeted to a specific cell type, hence addressing this knowledge gap. Here we report the development of Foster Resonance Energy Transfer (FRET) glutamine sensors based on improved cyan and yellow fluorescent proteins, monomeric Teal Fluorescent Protein (mTFP) 1 and venus. These sensors were found to be specific to glutamine, and stable to pH-changes within a physiological range. Using cos7 cells expressing the human glutamine transporter ASCT2 as a model, we demonstrate that the properties of the glutamine transporter can easily be analyzed with these sensors. The range of glutamine concentration change in a given cell can also be estimated using sensors with different affinities. Moreover, the mTFP1-venus FRET pair can be duplexed with another FRET pair, mAmetrine and tdTomato, opening up the possibility for real-time imaging of another molecule. These novel glutamine sensors will be useful tools to analyze specificities of glutamine metabolism at the single-cell level.	[Gruenwald, Katrin; Holland, John Todd; Stromberg, Verlyn; Watcharakichkorn, Daisy; Okumoto, Sakiko] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Ahmad, Altaf] Hamdard Univ, Fac Sci, Dept Bot, New Delhi, India	Virginia Polytechnic Institute & State University; Jamia Hamdard University	Gruenwald, K (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	sokumoto@vt.edu	AHMAD, ALTAF/AAE-9371-2020	AHMAD, ALTAF/0000-0003-4099-7338	National Institutes of Health [1R21NS064412]; National Science Foundation (NSF) [1052048]; Jeffress Memorial Trust [J-908]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Jeffress Memorial Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant 1R21NS064412, National Science Foundation (NSF) grant 1052048 and Jeffress Memorial Trust grant J-908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Albrecht J, 2011, NEURON GLIA BIOL, P1; Bacci A, 2002, J NEUROPHYSIOL, V88, P2302, DOI 10.1152/jn.00665.2001; Barnett NL, 2000, GLIA, V30, P64, DOI 10.1002/(SICI)1098-1136(200003)30:1<64::AID-GLIA7>3.0.CO;2-I; Bode BP, 1998, SURGERY, V124, P260, DOI 10.1016/S0039-6060(98)70129-1; Bode BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1062, DOI 10.1152/ajpgi.00031.2002; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; BRIGHT GR, 1987, J CELL BIOL, V104, P1019, DOI 10.1083/jcb.104.4.1019; Broer A, 1999, J NEUROCHEM, V73, P2184; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Corless M, 2006, J ENDOCRINOL, V190, P719, DOI 10.1677/joe.1.06892; Curi R, 1999, BRAZ J MED BIOL RES, V32, P15, DOI 10.1590/S0100-879X1999000100002; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; DENMAN RB, 1984, ARCH BIOCHEM BIOPHYS, V232, P427, DOI 10.1016/0003-9861(84)90559-9; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dun Y, 2007, EXP EYE RES, V84, P191, DOI 10.1016/j.exer.2006.09.015; FAFOURNOUX P, 1983, BIOCHEM J, V216, P401, DOI 10.1042/bj2160401; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; FONNUM F, 1993, PROG BIOPHYS MOL BIO, V60, P47, DOI 10.1016/0079-6107(93)90012-9; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2004, AM J PHYSIOL-GASTR L, V286, pG467, DOI 10.1152/ajpgi.00344.2003; Gebhardt R, 2007, PROG HISTOCHEM CYTO, V41, P201, DOI 10.1016/j.proghi.2006.12.001; GHOSH S, 1960, J BIOL CHEM, V235, P1265; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Gu SM, 2005, J BIOL CHEM, V280, P26055, DOI 10.1074/jbc.M504401200; HAUSSINGER D, 1986, ADV ENZYME REGUL, V25, P159, DOI 10.1016/0065-2571(86)90013-0; HAUSSINGER D, 1985, EUR J BIOCHEM, V152, P597, DOI 10.1111/j.1432-1033.1985.tb09237.x; Haussinger D, 1987, Beitr Infusionther Klin Ernahr, V17, P144; Hayashi M, 2001, J BIOL CHEM, V276, P43400, DOI 10.1074/jbc.M106244200; HIGASHIGUCHI T, 1993, JPEN-PARENTER ENTER, V17, P307, DOI 10.1177/0148607193017004307; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Kung HN, PLOS GENET, V7; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAPING NJ, 1994, ENDOCRINOLOGY, V135, P1928, DOI 10.1210/en.135.5.1928; Lavoinne A, 1998, BIOCHIMIE, V80, P807, DOI 10.1016/S0300-9084(00)88875-6; Lim J, 2006, EXP EYE RES, V83, P447, DOI 10.1016/j.exer.2006.01.028; Mizoguchi K, 2001, KIDNEY INT, V59, P1821, DOI 10.1046/j.1523-1755.2001.0590051821.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Palmada M, 2005, BIOCHEM BIOPH RES CO, V331, P272, DOI 10.1016/j.bbrc.2005.03.159; Paquette JC, 2005, J CELL PHYSIOL, V202, P912, DOI 10.1002/jcp.20194; Pawlik TM, 2000, J SURG RES, V90, P149, DOI 10.1006/jsre.2000.5872; Petroff OAC, 2002, EPILEPSIA, V43, P703, DOI 10.1046/j.1528-1157.2002.38901.x; POW DV, 1994, NEUROSCIENCE, V60, P355, DOI 10.1016/0306-4522(94)90249-6; Roth E, 2002, NUTRITION, V18, P217, DOI 10.1016/S0899-9007(01)00797-3; ROTHSTEIN JD, 1984, J NEUROCHEM, V43, P1438, DOI 10.1111/j.1471-4159.1984.tb05406.x; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Tani H, 2007, NEUROBIOL DIS, V25, P230, DOI 10.1016/j.nbd.2006.08.025; TATE SS, 1971, P NATL ACAD SCI USA, V68, P781, DOI 10.1073/pnas.68.4.781; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; VARDIMON L, 1993, DEV DYNAM, V196, P276, DOI 10.1002/aja.1001960410; Watford M, 2002, NUTRITION, V18, P301, DOI 10.1016/S0899-9007(02)00739-6; WEINER JH, 1971, ARCH BIOCHEM BIOPHYS, V142, P715, DOI 10.1016/0003-9861(71)90538-8; Wiren M, 1998, INT J BIOCHEM CELL B, V30, P1331, DOI 10.1016/S1357-2725(98)00104-6; Yang HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008917	66	45	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38591	10.1371/journal.pone.0038591	http://dx.doi.org/10.1371/journal.pone.0038591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22723868	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347800010
J	Shen, XX; Liang, D; Zhang, P				Shen, Xing-Xing; Liang, Dan; Zhang, Peng			The Development of Three Long Universal Nuclear Protein-Coding Locus Markers and Their Application to Osteichthyan Phylogenetics with Nested PCR	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; SISTER GROUP; TREE; DIVERSIFICATION; POSITION; TURTLES; INFORMATIVENESS; RECONSTRUCTION; HYPOTHESES	Background: Universal nuclear protein-coding locus (NPCL) markers that are applicable across diverse taxa and show good phylogenetic discrimination have broad applications in molecular phylogenetic studies. For example, RAG1, a representative NPCL marker, has been successfully used to make phylogenetic inferences within all major osteichthyan groups. However, such markers with broad working range and high phylogenetic performance are still scarce. It is necessary to develop more universal NPCL markers comparable to RAG1 for osteichthyan phylogenetics. Methodology/Principal Findings: We developed three long universal NPCL markers (>1.6 kb each) based on single-copy nuclear genes (KIAA1239, SACS and TTN) that possess large exons and exhibit the appropriate evolutionary rates. We then compared their phylogenetic utilities with that of the reference marker RAG1 in 47 jawed vertebrate species. In comparison with RAG1, each of the three long universal markers yielded similar topologies and branch supports, all in congruence with the currently accepted osteichthyan phylogeny. To compare their phylogenetic performance visually, we also estimated the phylogenetic informativeness (PI) profile for each of the four long universal NPCL markers. The PI curves indicated that SACS performed best over the whole timescale, while RAG1, KIAA1239 and TTN exhibited similar phylogenetic performances. In addition, we compared the success of nested PCR and standard PCR when amplifying NPCL marker fragments. The amplification success rate and efficiency of the nested PCR were overwhelmingly higher than those of standard PCR. Conclusions/Significance: Our work clearly demonstrates the superiority of nested PCR over the conventional PCR in phylogenetic studies and develops three long universal NPCL markers (KIAA1239, SACS and TTN) with the nested PCR strategy. The three markers exhibit high phylogenetic utilities in osteichthyan phylogenetics and can be widely used as pilot genes for phylogenetic questions of osteichthyans at different taxonomic levels.	[Shen, Xing-Xing; Liang, Dan; Zhang, Peng] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Shen, XX (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	alarzhang@gmail.com	Shen, Xing-Xing/V-4610-2019; Zhang, Peng/F-9664-2013	Shen, Xing-Xing/0000-0001-5765-1419; 	National Natural Science Foundation of China [30900136]; Natural Science Foundation of Guangdong Province [9151027501000084]; Grant of Excellent PhD thesis of Guangdong Province [sybzzxm201012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Grant of Excellent PhD thesis of Guangdong Province	This work was supported by National Natural Science Foundation of China (No. 30900136), Natural Science Foundation of Guangdong Province (9151027501000084), and Grant of Excellent PhD thesis of Guangdong Province (sybzzxm201012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Benton Michael J., 2009, P35; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Cao Y, 2000, GENE, V259, P139, DOI 10.1016/S0378-1119(00)00425-X; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Karanth KP, 2008, MOL PHYLOGENET EVOL, V46, P683, DOI 10.1016/j.ympev.2007.11.026; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krenz JG, 2005, MOL PHYLOGENET EVOL, V37, P178, DOI 10.1016/j.ympev.2005.04.027; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nylander JAA, 2004, MRMODELTEST V2 0; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rasmussen MD, 2007, GENOME RES, V17, P1932, DOI 10.1101/gr.7105007; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saint KM, 1998, MOL PHYLOGENET EVOL, V10, P259, DOI 10.1006/mpev.1998.0515; San Mauro D, 2004, MOL PHYLOGENET EVOL, V33, P413, DOI 10.1016/j.ympev.2004.05.014; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson RC, 2008, MOL PHYLOGENET EVOL, V49, P514, DOI 10.1016/j.ympev.2008.08.006; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	55	65	65	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39256	10.1371/journal.pone.0039256	http://dx.doi.org/10.1371/journal.pone.0039256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720083	gold, Green Published, Green Submitted			2022-12-27	WOS:000305347800060
J	Wong, IOL; Cowling, BJ; Leung, GM; Schooling, CM				Wong, Irene O. L.; Cowling, Benjamin J.; Leung, Gabriel M.; Schooling, C. Mary			Trends in Mortality from Septicaemia and Pneumonia with Economic Development: An Age-Period-Cohort Analysis	PLOS ONE			English	Article							CANCER INCIDENCE; GROWTH; UNDERNUTRITION; BACTEREMIA; SEPSIS; GENDER; IMPACT	Background: Hong Kong population has experienced drastic changes in its economic development in the 1940s. Taking advantage of Hong Kong's unique demographic and socioeconomic history, characterized by massive, punctuated migration waves from Southern China, and recent, rapid transition from a pre-industrialized society to the first ethnic Chinese community reaching "first world" status over the last 60 years (i.e., in two or three generations), we examined the longitudinal trends in infection related mortality including septicemia compared to trends in non-bacterial pneumonia to generate hypotheses for further testing in other recently transitioned economies and to provide generalized aetiological insights on how economic transition affects infection-related mortality. Methods: We used deaths from septicemia and pneumonia not specified as bacterial, and population figures in Hong Kong from 1976-2005. We fitted age-period-cohort models to decompose septicemia and non-bacterial pneumonia mortality rates into age, period and cohort effects. Results: Septicaemia-related deaths increased exponentially with age, with a downturn by period. The birth cohort curves had downward inflections in both sexes in the 1940s, with a steeper deceleration for women. Non-bacterial pneumonia-related deaths also increased exponentially with age, but the birth cohort patterns showed no downturns for those born in the 1940s. Conclusion: The observed changes appeared to suggest that better early life conditions may enable better development of adaptive immunity, thus enhancing immunity against bacterial infections, with greater benefits for women than men. Given the interaction between the immune system and the gonadotropic axis, these observations are compatible with the hypothesis that upregulation of the gonadotropic axis underlies some of the changes in disease patterns with economic development.	[Wong, Irene O. L.; Cowling, Benjamin J.; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Sch Publ Hlth, Hunter Coll, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; Hunter College (CUNY)	Wong, IOL (corresponding author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Cowling, Benjamin John/C-4263-2009; Wong, Oi Ling/C-4538-2009	Cowling, Benjamin John/0000-0002-6297-7154; Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; MedImmune Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; MedImmune Inc.(AstraZenecaMedimmune); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BJC was supported by the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BJC received research funding from MedImmune Inc., and consults for Crucell MV. BJC is an Academic Editor of the journal PLoS ONE. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have declared that no competing interest exist.	Adam CL, 1997, J REPROD FERTIL, V111, P121, DOI 10.1530/jrf.0.1110121; Bray I, 2002, J ROY STAT SOC C-APP, V51, P151, DOI 10.1111/1467-9876.00260; Campbell BC, 2004, ANN HUM BIOL, V31, P213, DOI 10.1080/03014460310001656604; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Choudhry Mashkoor A., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P127; Dorgan JF, 2003, J NATL CANCER I, V95, P132, DOI 10.1093/jnci/95.2.132; Falsey AR, 2006, CLIN INFECT DIS, V42, P518, DOI 10.1086/499955; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Hall AJ, 2002, INT J EPIDEMIOL, V31, P300, DOI 10.1093/ije/31.2.300; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Hollander GA, 2010, CURR OPIN PHARMACOL, V10, P443, DOI 10.1016/j.coph.2010.04.008; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Johnston SL, 2006, P ROY SOC B-BIOL SCI, V273, P1369, DOI 10.1098/rspb.2005.3456; Loucks EB, 2010, SOC SCI MED, V71, P187, DOI 10.1016/j.socscimed.2010.03.012; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Madsen KM, 1999, APMIS, V107, P346, DOI 10.1111/j.1699-0463.1999.tb01563.x; Martins VJB, 2011, INT J ENV RES PUB HE, V8, P1817, DOI 10.3390/ijerph8061817; McDade TW, 2005, AM J HUM BIOL, V17, P81, DOI 10.1002/ajhb.20095; McDade TW, 2001, J NUTR, V131, P1225, DOI 10.1093/jn/131.4.1225; Moore SE, 2006, P NUTR SOC, V65, P311, DOI 10.1079/PNS2006503; Nazmi A, 2010, SOC SCI MED, V70, P1229, DOI 10.1016/j.socscimed.2009.12.014; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Rosenberg PS, 2010, STAT MED, V29, P1228, DOI 10.1002/sim.3865; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Schooling CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-345; Schooling CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019675; Schooling CM, 2011, ANN EPIDEMIOL, V21, P56, DOI 10.1016/j.annepidem.2010.05.005; Schooling CM, 2011, INT J EPIDEMIOLOGY; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; SLOB AK, 1979, BRIT J NUTR, V41, P231, DOI 10.1079/BJN19790032; Sogaard M, 2011, EPIDEMIOL INFECT, V139, P772, DOI 10.1017/S095026881000169X; Speigelhalter DJ, 2002, J ROYAL STAT SOC B, P583; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255; Tsang S., 2004, MODERN HIST HONG KON; Van Bodegom D, 2007, ANN NY ACAD SCI, V1100, P84, DOI 10.1196/annals.1395.007; Wong IOL, 2007, INT J CANCER, V121, P1556, DOI 10.1002/ijc.22731; Wong IOL, 2010, J EPIDEMIOL COMMUN H, V64, P596, DOI 10.1136/jech.2008.080788; Wu P, 2008, THORAX, V63, P312, DOI 10.1136/thx.2007.082354	40	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38988	10.1371/journal.pone.0038988	http://dx.doi.org/10.1371/journal.pone.0038988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22720008	Green Published, gold			2022-12-27	WOS:000305347800033
J	Kirillova, O				Kirillova, Olga			Results and Outcome Reporting ClinicalTrials.gov, What Makes it Happen?	PLOS ONE			English	Article							CLINICAL-TRIALS; REGISTRATION; PROTOCOLS; ISSUES; TIME	Background: At the end of the past century there were multiple concerns regarding lack of transparency in the conduct of clinical trials as well as some ethical and scientific issues affecting the trials' design and reporting. In 2000 ClinicalTrials.gov data repository was developed and deployed to serve public and scientific communities with valid data on clinical trials. Later in order to increase deposited data completeness and transparency of medical research a set of restrains had been imposed making the results deposition compulsory for multiple cases. Methods: We investigated efficiency of the results deposition and outcome reporting as well as what factors make positive impact on providing information of interest and what makes it more difficult, whether efficiency depends on what kind of institution was a trial sponsor. Data from the ClinicalTrials.gov repository has been classified based on what kind of institution a trial sponsor was. The odds ratio was calculated for results and outcome reporting by different sponsors' class. Results: As of 01/01/2012 118,602 clinical trials data deposits were made to the depository. They came from 9068 different sources. 35344 (29.8%) of them are assigned as FDA regulated and 25151 (21.2%) as Section 801 controlled substances. Despite multiple regulatory requirements, only about 35% of trials had clinical study results deposited, the maximum 55.56% of trials with the results, was observed for trials completed in 2008. Conclusions: The most positive impact on depositing results, the imposed restrains made for hospitals and clinics. Health care companies showed much higher efficiency than other investigated classes both in higher fraction of trials with results and in providing at least one outcome for their trials. They also more often than others deposit results when it is not strictly required, particularly, in the case of non-interventional studies.	IICOLL LLC, Portland, OR USA		Kirillova, O (corresponding author), IICOLL LLC, Portland, OR USA.	olga@iicoll.com						[Anonymous], 2004, JAMA, V292, P1363; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Bourgeois FT, 2012, PLOS ONE, V10, P1371; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Dilts DM, 2012, CLIN CANCER RES, V18, P3, DOI 10.1158/1078-0432.CCR-11-2586; Hartling L, 1992, JAMA-J AM MED ASSOC, V267, P374; Law MR, 2011, HEALTH AFFAIR, V30, P2338, DOI 10.1377/hlthaff.2011.0172; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Smyth RMD, 2011, BRIT MED J, V342, P7153; Thomas KB, 2010, DRUG INF J, V44, P213, DOI 10.1177/009286151004400303; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	19	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37847	10.1371/journal.pone.0037847	http://dx.doi.org/10.1371/journal.pone.0037847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719853	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900015
J	Rai, D; Golding, J; Magnusson, C; Steer, C; Lewis, G; Dalman, C				Rai, Dheeraj; Golding, Jean; Magnusson, Cecilia; Steer, Colin; Lewis, Glyn; Dalman, Christina			Prenatal and Early Life Exposure to Stressful Life Events and Risk of Autism Spectrum Disorders: Population-Based Studies in Sweden and England	PLOS ONE			English	Article							PREVALENCE; CHILDREN; PREGNANCY; COHORT	Background and Aim: Exposure to stressful life events during pregnancy has been suggested as a potential risk factor for offspring Autism Spectrum Disorders (ASD), but the literature is limited and inconsistent. We tested the hypothesis that maternal exposure to stressful life events would be associated with increased risks of offspring ASD, and that these risks would be highest for exposures during the prenatal period. Methods and Results: We used prospectively collected data from two large population based studies in Sweden and England. In the Swedish study of 4429 ASD cases and 43277 controls, our exposure comprised the occurrence of any severe life event before and during pregnancy and the child's early life. In the English study (maximum n = 11554, ASD n = 72), we studied the risk of offspring ASD in relation to a combined maternal exposure to multiple (up to 42) common and rare life events, as well as their perceived impact upon the mother during pregnancy and early life. In crude and adjusted regression analyses in both studies, we found no evidence of an association between prenatal life events, or their number and perceived impact and the risk of offspring ASD. Sub-group analysis of ASD with and without intellectual disability in the Swedish study yielded similar results. Conclusion: We found no evidence to support the hypotheses that exposure to stressful life events during the prenatal period is associated with an increased risk of offspring ASD.	[Rai, Dheeraj; Lewis, Glyn] Univ Bristol, Sch Social & Community Med, Acad Unit Psychiat, Bristol, Avon, England; [Rai, Dheeraj; Magnusson, Cecilia; Dalman, Christina] Karolinska Inst, Dept Publ Hlth Sci, Div Publ Hlth Epidemiol, Stockholm, Sweden; [Rai, Dheeraj] Avon & Wiltshire Partnership Mental Hlth NHS Trus, Bristol, Avon, England; [Golding, Jean; Steer, Colin] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Bristol; Karolinska Institutet; University of Bristol	Rai, D (corresponding author), Univ Bristol, Sch Social & Community Med, Acad Unit Psychiat, Bristol, Avon, England.	dheeraj.rai@bristol.ac.uk	Lewis, Glyn/E-9944-2012	Lewis, Glyn/0000-0001-5205-8245; Magnusson, Cecilia/0000-0002-8567-6725; Golding, Jean/0000-0003-2826-3307; Dalman, Christina/0000-0002-3579-2357; Rai, Dheeraj/0000-0002-7239-3523	Stockholm County Council [2007008]; Swedish Council for Working Life and Social Research [2007-2064]; Swedish Research Council [523-2010-1052]; Regional agreement on medical training and clinical research (ALF); ALSPAC: The UK Medical Research Council [74882]; Wellcome Trust [076467]; UK MRC [G0400085 PI]; Clinical Lectureship award; Severn Deanery, Bristol, UK; MRC [G0400085] Funding Source: UKRI; Medical Research Council [G9815508, G0400085] Funding Source: researchfish	Stockholm County Council(Stockholm County Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Regional agreement on medical training and clinical research (ALF); ALSPAC: The UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Clinical Lectureship award; Severn Deanery, Bristol, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Stockholm Youth Cohort: The data linkages and staff costs for the Stockholm Youth Cohort have been supported by grants from the Stockholm County Council (2007008), Swedish Council for Working Life and Social Research (2007-2064), Swedish Research Council (523-2010-1052), and Regional agreement on medical training and clinical research (ALF). ALSPAC: The UK Medical Research Council (Grant ref: 74882) the Wellcome Trust (Grant ref: 076467) and the University of Bristol currently provide core support for ALSPAC. Autism research within ALSPAC has supported by a UK MRC grant (grant ref. G0400085 PI: JG). DR is supported by a Clinical Lectureship award funded by the Severn Deanery, Bristol, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This publication is the work of the authors and DR will serve as guarantor for the contents of this paper.	American Psychiatric Association, 2010, PROP REV AUT SPECTR; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; BARNETT BEW, 1983, J PSYCHOSOM RES, V27, P313, DOI 10.1016/0022-3999(83)90054-5; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Brown G., 1978, SOCIAL ORIGINS DEPRE; Centers for Disease Control and Prevention, 2009, MMWR, V58; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; HONNOR MJ, 1994, EUR J EPIDEMIOL, V10, P181, DOI 10.1007/BF01730368; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kinney DK, 2008, J AUTISM DEV DISORD, V38, P481, DOI 10.1007/s10803-007-0414-0; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Lee BK, 2012, J AUTISM DEV DISORD, V42, P2000, DOI 10.1007/s10803-011-1425-4; Li J, 2009, PEDIATRICS, V123, P1102, DOI 10.1542/peds.2008-1734; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Magnusson C, 2012, BRIT J PSYCHIAT, V201, P109, DOI 10.1192/bjp.bp.111.095125; Methe Axen, 2010, ADHD LINDR UTV AUT H; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Ronald A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00223; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Szatmari P, 2011, ARCH GEN PSYCHIAT, V68, P1091, DOI 10.1001/archgenpsychiatry.2011.99; WARD AJ, 1990, CHILD PSYCHIAT HUM D, V20, P279, DOI 10.1007/BF00706020; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751	29	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38893	10.1371/journal.pone.0038893	http://dx.doi.org/10.1371/journal.pone.0038893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719977	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900060
J	Tasca, G; Pescatori, M; Monforte, M; Mirabella, M; Iannaccone, E; Frusciante, R; Cubeddu, T; Laschena, F; Ottaviani, P; Ricci, E				Tasca, Giorgio; Pescatori, Mario; Monforte, Mauro; Mirabella, Massimiliano; Iannaccone, Elisabetta; Frusciante, Roberto; Cubeddu, Tiziana; Laschena, Francesco; Ottaviani, Pierfrancesco; Ricci, Enzo			Different Molecular Signatures in Magnetic Resonance Imaging-Staged Facioscapulohumeral Muscular Dystrophy Muscles	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; GENE-EXPRESSION; ADIPOSE-TISSUE; SKELETAL-MUSCLE; FSHD PATIENTS; FACTOR-ALPHA; IN-VITRO; OBESITY; MRI; ADIPONECTIN	Background: Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common muscular dystrophies and is characterized by a non-conventional genetic mechanism activated by pathogenic D4Z4 repeat contractions. By muscle Magnetic Resonance Imaging (MRI) we observed that T2-short tau inversion recovery (T2-STIR) sequences identify two different conditions in which each muscle can be found before the irreversible dystrophic alteration, marked as T1-weighted sequence hyperintensity, takes place. We studied these conditions in order to obtain further information on the molecular mechanisms involved in the selective wasting of single muscles or muscle groups in this disease. Methods: Histopathology, gene expression profiling and real time PCR were performed on biopsies from FSHD muscles with different MRI pattern (T1-weighted normal/T2-STIR normal and T1-weighted normal/T2-STIR hyperintense). Data were compared with those from inflammatory myopathies, dysferlinopathies and normal controls. In order to validate obtained results, two additional FSHD samples with different MRI pattern were analyzed. Results: Myopathic and inflammatory changes characterized T2-STIR hyperintense FSHD muscles, at variance with T2-STIR normal muscles. These two states could be easily distinguished from each other by their transcriptional profile. The comparison between T2-STIR hyperintense FSHD muscles and inflammatory myopathy muscles showed peculiar changes, although many alterations were shared among these conditions. Conclusions: At the single muscle level, different stages of the disease correspond to the two MRI patterns. T2-STIR hyperintense FSHD muscles are more similar to inflammatory myopathies than to T2-STIR normal FSHD muscles or other muscular dystrophies, and share with them upregulation of genes involved in innate and adaptive immunity. Our data suggest that selective inflammation, together with perturbation in biological processes such as neoangiogenesis, lipid metabolism and adipokine production, may contribute to the sequential bursts of muscle degeneration that involve individual muscles in an asynchronous manner in this disease.	[Tasca, Giorgio] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Pescatori, Mario] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Pescatori, Mario] Crosslinks BV, Rotterdam, Netherlands; [Pescatori, Mario; Cubeddu, Tiziana] Porto Conte Ric Srl, Alghero, SS, Italy; [Monforte, Mauro; Mirabella, Massimiliano; Iannaccone, Elisabetta; Frusciante, Roberto; Ricci, Enzo] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurol, Rome, Italy; [Laschena, Francesco; Ottaviani, Pierfrancesco] Ist Dermopat Immacolata IRCCS, Dept Radiol, Rome, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; Erasmus University Rotterdam; Erasmus MC; Porto Conte Ricerche; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Tasca, G (corresponding author), Don Carlo Gnocchi Onlus Fdn, Milan, Italy.	ericci@rm.unicatt.it	Monforte, Mauro/J-2918-2018; MIRABELLA, Massimiliano/AAC-4016-2020; Ricci, Enzo/AAC-4448-2020; Monforte, Mauro/AAS-7120-2021; Tasca, Giorgio/J-5153-2018	Monforte, Mauro/0000-0002-4327-6969; MIRABELLA, Massimiliano/0000-0002-7783-114X; Monforte, Mauro/0000-0002-4327-6969; Tasca, Giorgio/0000-0003-0849-9144; RICCI, Enzo/0000-0003-3092-3597	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente)	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente)	This work was supported by funding from Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente) to E.R. and G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cheng BH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-103; Delaigle AM, 2004, ENDOCRINOLOGY, V145, P5589, DOI 10.1210/en.2004-0503; Dempsey PW, 2003, CELL MOL LIFE SCI, V60, P2604, DOI 10.1007/s00018-003-3180-y; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dobbin K, 2005, BIOSTATISTICS, V6, P27, DOI 10.1093/biostatistics/kxh015; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Gummesson A, 2007, J CLIN ENDOCR METAB, V92, P4759, DOI 10.1210/jc.2007-1136; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Kan HE, 2010, NMR BIOMED, V23, P563, DOI 10.1002/nbm.1494; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Laufer J, 2001, MOL IMMUNOL, V38, P221, DOI 10.1016/S0161-5890(01)00044-X; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Padberg GW, 2009, CURR OPIN NEUROL, V22, P539, DOI 10.1097/WCO.0b013e328330a572; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3; Straub V, NEUROMUSCUL IN PRESS; Tasca G, 2011, NEUROMUSCULAR DISORD, V21, P671, DOI 10.1016/j.nmd.2011.06.860; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327	44	74	74	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38779	10.1371/journal.pone.0038779	http://dx.doi.org/10.1371/journal.pone.0038779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719944	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900050
J	Cohen, TS; DiPaolo, BC; Lawrence, GG; Margulies, SS				Cohen, Taylor S.; DiPaolo, Brian C.; Lawrence, Gladys Gray; Margulies, Susan S.			Sepsis Enhances Epithelial Permeability with Stretch in an Actin Dependent Manner	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; LIGHT-CHAIN KINASE; TIGHT-JUNCTION PROTEINS; TIDAL VOLUME VENTILATION; BARRIER FUNCTION; ALVEOLAR EPITHELIA; IN-VITRO; ACTIVATION; CELLS	Ventilation of septic patients often leads to the development of edema and impaired gas exchange. We hypothesized that septic alveolar epithelial monolayers would experience stretch-induced barrier dysfunction at a lower magnitude of stretch than healthy alveolar epithelial monolayers. Alveolar epithelial cells were isolated from rats 24 hours after cecal ligation and double puncture (2CLP) or sham surgery. Following a 5-day culture period, monolayers were cyclically stretched for 0, 10, or 60 minutes to a magnitude of 12% or 25% change in surface area (Delta SA). Barrier function, MAPk and myosin light chain (MLC) phosphorylation, tight junction (TJ) protein expression and actin cytoskeletal organization were examined after stretch. Significant increases in epithelial permeability were observed only in 2CLP monolayers at the 12% Delta SA stretch level, and in both 2CLP and sham monolayers at the 25% Delta SA stretch level. Increased permeability in 2CLP monolayers was not associated with MAPk signaling or alterations in expression of TJ proteins. 2CLP monolayers had fewer actin stress fibers before stretch, a more robust stretch-induced actin redistribution, and reduced phosphorylated MLCK than sham monolayers. Jasplakinolide stabilization of the actin cytoskeleton in 2CLP monolayers prevented significant increases in permeability following 60 minutes of stretch to 12% Delta SA. We concluded that septic alveolar epithelial monolayers are more susceptible to stretch-induced barrier dysfunction than healthy monolayers due to actin reorganization.	[Cohen, Taylor S.; DiPaolo, Brian C.; Lawrence, Gladys Gray; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Cohen, TS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	National Institutes of Health [RO1-HL057204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by National Institutes of Health RO1-HL057204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azghani AO, 2002, INFLAMM RES, V51, P506, DOI 10.1007/PL00012420; Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cavanaugh KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1179, DOI 10.1152/ajpcell.00355.2004; Cavanaugh KJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1801, DOI 10.1152/ajpcell.00341.2002; Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011322; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Desai LP, 2009, AM J PHYSIOL-LUNG C, V297, pL520, DOI 10.1152/ajplung.00076.2009; DiPaolo BC, 2012, AM J PHYSIOL-LUNG C, V302, pL992, DOI 10.1152/ajplung.00175.2011; DiPaolo BC, 2010, AM J PHYSIOL-CELL PH, V299, pC345, DOI 10.1152/ajpcell.00379.2009; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Groppera MA, 2008, CURR OPIN CRIT CARE, V14, P11, DOI 10.1097/MCC.0b013e3282f417a0; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Ikenouchi J, 2008, MOL BIOL CELL, V19, P4687, DOI 10.1091/mbc.E08-05-0530; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Levine GK, 2006, CRIT CARE MED, V34, P1746, DOI 10.1097/01.CCM.0000218813.77367.E2; Li KZ, 2007, CHINESE MED J-PEKING, V120, P1451, DOI 10.1097/00029330-200708020-00014; LUBMAN RL, 1997, LUNG SCI FDN, P585; MADARA JL, 1987, AM J PHYSIOL, V253, pC171, DOI 10.1152/ajpcell.1987.253.1.C171; Martin Thomas R, 2008, Proc Am Thorac Soc, V5, P291, DOI 10.1513/pats.200801-005DR; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Nagumo Y, 2008, BIOCHEM BIOPH RES CO, V377, P921, DOI 10.1016/j.bbrc.2008.10.071; Nin N, 2009, SHOCK, V31, P429, DOI 10.1097/SHK.0b013e318188b720; O'Mahony DS, 2006, CRIT CARE, V10, DOI 10.1186/cc5050; Raina H, 2009, J PHYSIOL-LONDON, V587, P2599, DOI 10.1113/jphysiol.2008.165258; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen LH, 2009, SHOCK, V31, P500, DOI 10.1097/SHK.0b013e318189017a; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Upadhyay D, 2003, AM J PHYSIOL-LUNG C, V284, pL350, DOI 10.1152/ajplung.00161.2002; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	48	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38748	10.1371/journal.pone.0038748	http://dx.doi.org/10.1371/journal.pone.0038748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723883	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700026
J	Derumeaux, G; Ernande, L; Serusclat, A; Servan, E; Bruckert, E; Rousset, H; Senn, S; Van Gaal, L; Picandet, B; Gavini, F; Moulin, P				Derumeaux, Genevieve; Ernande, Laura; Serusclat, Andre; Servan, Evelyne; Bruckert, Eric; Rousset, Hugues; Senn, Stephen; Van Gaal, Luc; Picandet, Brigitte; Gavini, Francois; Moulin, Philippe		REGULATE Trial Investigators	Echocardiographic Evidence for Valvular Toxicity of Benfluorex: A Double-Blind Randomised Trial in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							HEART-DISEASE; VALVE ABNORMALITIES; PARKINSONS-DISEASE; 5-HT2B RECEPTORS; FENFLURAMINE; SEROTONIN; VALVULOPATHY; PHENTERMINE; REGURGITATION; PERGOLIDE	Objectives: REGULATE trial was designed to compare the efficacy and safety of benfluorex versus pioglitazone in type 2 diabetes mellitus (DM) patients. Methods: Double-blind, parallel-group, international, randomised, non-inferiority trial. More than half of the 196 participating centres were primary care centres. Patients eligible had type 2 DM uncontrolled on sulfonylurea. 846 were randomised. They received study treatment for 1 year. 423 patients were allocated to benfluorex (150 to 450 mg/day) and 423 were allocated to pioglitazone (30 to 45 mg/day). Primary efficacy criterion was HbA(1c). Safety assessment included blinded echocardiographic evaluation of cardiac and valvular status. Results: At baseline, patients were 59.1+/-10.5 years old with HbA(1c) 8.3+/-0.8%, and DM duration 7.1+/-6.0 years. During the study, mean HbA(1c) significantly decreased in both groups (benfluorex: from 8.30+/-0.80 to 7.77+/-1.31 versus pioglitazone: from 8.30+/-0.80 to 7.45+/-1.30%). The last HbA(1c) value was significantly lower with pioglitazone than with benfluorex (p<0.001) and non-inferiority of benfluorex was not confirmed (p = 0.19). Among the 615 patients with assessable paired echocardiography (310 benfluorex, 305 pioglitazone), 314 (51%) had at least one morphological valvular abnormality and 515 (84%) at least one functional valvular abnormality at baseline. Emergent morphological abnormalities occurred in 8 patients with benfluorex versus 4 with pioglitazone (OR 1.99), 95% CI (0.59 to 6.69). Emergent regurgitation (new or increased by one grade or more) occurred more frequently with benfluorex (82 patients, 27%) than with pioglitazone (33 patients, 11%) (OR 2.97), 95% CI (1.91 to 4.63) and were mainly rated grade 1; grade 2 (mild) was detected in 2 patients with benfluorex and 3 with pioglitazone. There was no moderate or severe regurgitation. Conclusion: After 1 year of exposure, our results show a 2.97 fold increase in the incidence of valvular regurgitation with benfluorex and provide evidence for the valvular toxicity of this drug.	[Derumeaux, Genevieve; Ernande, Laura; Servan, Evelyne] Hop Louis Pradel, Echocardiog Lab, Lyon, France; [Serusclat, Andre] Hop Louis Pradel, Dept Med Imaging & Endocrinol, Lyon, France; [Bruckert, Eric] Hop La Pitie Salpetriere, Dept Endocrinol & Metab, Paris, France; [Rousset, Hugues] Ctr Hosp, Pierre Benite, France; [Senn, Stephen] Univ Glasgow, Dept Stat, Glasgow, Lanark, Scotland; [Van Gaal, Luc] Univ Antwerp Hosp, Fac Med, Dept Diabetol Metab & Clin Nutr, Edegem, Belgium; [Picandet, Brigitte; Gavini, Francois] Inst Rech Int Servier, F-92415 Courbevoie, France; [Moulin, Philippe] Univ Lyon 1, Hosp Civils Lyon, Hop Louis Pradel, Dept Endocrinol, F-69365 Lyon, France	CHU Lyon; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; University of Glasgow; University of Antwerp; Servier; Institut de Recherches Internationales Servier; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Derumeaux, G (corresponding author), Hop Louis Pradel, Echocardiog Lab, Lyon, France.	philippe.moulin@chu-lyon.fr	DERUMEAUX, Genevieve A/T-2489-2018; Spiess, Hans Wolfgang/G-6777-2011; Senn, Stephen/B-2903-2013	DERUMEAUX, Genevieve A/0000-0003-1471-1631; Spiess, Hans Wolfgang/0000-0002-4779-654X; Senn, Stephen/0000-0002-7558-8473	Servier	Servier(Servier)	The trial was fully funded by Servier. There was no additional external funding. The study was designed by the principal investigator (PM) submitted and discussed by the scientific committee and finally approved by the funder. The funder delegated data collection to contract research organization (Euraxi France; Chiltern International SARL Germany, Czechia, India, Roumania; Clindev Pty Ltd South Africa; Gecem Tunisia; Parexel International Argentina). Statistical analysis was performed by one of the co-authors (FG) under the supervision of the scientific committee. Funder had no role in the decision to publish, the manuscript was fully written by the first and the last authors, revised and approved by the co-authors.	AFSSAPS, 2009, NAT PHARM COMM M TUE; Bhattacharyya S, 2009, LANCET, V374, P577, DOI 10.1016/S0140-6736(09)60252-X; Boutet K, 2009, EUR RESPIR J, V33, P684, DOI 10.1183/09031936.00086308; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Dahl CF, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-34; Droogmans S, 2009, AM J PHYSIOL-HEART C, V296, pH1940, DOI 10.1152/ajpheart.01177.2008; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Frachon I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010128; Gustafsson BI, 2005, CIRCULATION, V111, P1517, DOI 10.1161/01.CIR.0000159356.42064.48; Huang XP, 2009, MOL PHARMACOL, V76, P710, DOI 10.1124/mol.109.058057; Jollis JG, 2000, CIRCULATION, V101, P2071, DOI 10.1161/01.CIR.101.17.2071; Levy RJ, 2006, CIRCULATION, V113, P2, DOI 10.1161/CIRCULATIONAHA.105.593459; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; Moulin P, 2006, DIABETES CARE, V29, P515, DOI 10.2337/diacare.29.03.06.dc05-1439; Nebigil CG, 2003, CIRCULATION, V108, P902, DOI 10.1161/01.CIR.0000081520.25714.D9; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Noize P, 2006, FUND CLIN PHARMACOL, V20, P577, DOI 10.1111/j.1472-8206.2006.00441.x; Rafel RJ, 2003, REV ESP CARDIOL, V56, P215; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, AM J CARDIOL, V85, P913, DOI 10.1016/S0002-9149(99)00896-6; Rothman RB, 2000, CIRCULATION, V102, P2836; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; SEUWEN K, 1988, NATURE, V335, P254, DOI 10.1038/335254a0; Thevis M, 2010, ANAL BIOAN IN PRESS; Van Camp G, 2004, LANCET, V363, P1179, DOI 10.1016/S0140-6736(04)15945-X; Weill A, 2010, PHARMACOEPIDEM DR S, V19, P1256, DOI 10.1002/pds.2044; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	29	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38273	10.1371/journal.pone.0038273	http://dx.doi.org/10.1371/journal.pone.0038273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723853	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700013
J	Hagedorn, M; McCarthy, M; Carter, VL; Meyers, SA				Hagedorn, Mary; McCarthy, Megan; Carter, Virginia L.; Meyers, Stuart A.			Oxidative Stress in Zebrafish (Danio rerio) Sperm	PLOS ONE			English	Article							SPONTANEOUS LIPID-PEROXIDATION; OXYGEN SPECIES GENERATION; HUMAN-SPERMATOZOA; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; DNA-DAMAGE; GLUTATHIONE-PEROXIDASE; EQUINE SPERMATOZOA; MOUSE SPERMATOZOA; HIGH-THROUGHPUT	Laboratories around the world have produced tens of thousands of mutant and transgenic zebrafish lines. As with mice, maintaining all of these valuable zebrafish genotypes is expensive, risky, and beyond the capacity of even the largest stock centers. Because reducing oxidative stress has become an important aspect of reducing the variability in mouse sperm cryopreservation, we examined whether antioxidants might improve cryopreservation of zebrafish sperm. Four experiments were conducted in this study. First, we used the xanthine-xanthine oxidase (X-XO) system to generate reactive oxygen species (ROS). The X-XO system was capable of producing a stress reaction in zebrafish sperm reducing its sperm motility in a concentration dependent manner (P<0.05). Second, we examined X-XO and the impact of antioxidants on sperm viability, ROS and motility. Catalase (CAT) mitigated stress and maintained viability and sperm motility (P>0.05), whereas superoxide dismutase (SOD) and vitamin E did not (P<0.05). Third, we evaluated ROS in zebrafish spermatozoa during cryopreservation and its effect on viability and motility. Methanol (8%) reduced viability and sperm motility (P<0.05), but the addition of CAT mitigated these effects (P>0.05), producing a mean 2.0 to 2.9-fold increase in post-thaw motility. Fourth, we examined the effect of additional cryoprotectants and CAT on fresh sperm motility. Cryoprotectants, 8% methanol and 10% dimethylacetamide (DMA), reduced the motility over the control value (P<0.5), whereas 10% dimethylformamide (DMF) with or without CAT did not (P>0.05). Zebrafish sperm protocols should be modified to improve the reliability of the cryopreservation process, perhaps using a different cryoprotectant. Regardless, the simple addition of CAT to present-day procedures will significantly improve this process, assuring increased and less variable fertilization success and allowing resource managers to dependably plan how many straws are needed to safely cryopreserve a genetic line.	[Hagedorn, Mary; Carter, Virginia L.] Smithsonian Conservat Biol Inst, Dept Reprod Sci, Washington, DE USA; [Hagedorn, Mary; Carter, Virginia L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [McCarthy, Megan; Meyers, Stuart A.] Univ Calif Davis, Dept Anat, Sch Vet Med, Davis, CA 95616 USA	University of Hawaii System; University of California System; University of California Davis	Hagedorn, M (corresponding author), Smithsonian Conservat Biol Inst, Dept Reprod Sci, Washington, DE USA.	hagedornm@si.edu			National Institutes of Health (NIH) [R24 RR016581, RO1 2RR016581]; Zebrafish International Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR016581] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zebrafish International Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant to MM from National Institutes of Health (NIH) # R24 RR016581 and SM from NIH # RO1 2RR016581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Bruce Draper for his kind assistance during the preliminary studies for this work and the Zebrafish International Research Center for their support and comments on this manuscript. In addition, we would like to thank the three anonymous reviewers whose comments greatly improved this paper. This manuscript has been approved for publication by the Hawaii Institute of Marine Biology as contribution #1490.	Aitken RJ, 2007, MOL HUM REPROD, V13, P203, DOI 10.1093/molehr/gal119; AITKEN RJ, 1993, J REPROD FERTIL, V97, P441; AITKEN RJ, 1989, J ANDROL, V10, P214; AITKEN RJ, 1988, J ANDROL, V9, P367; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Aitken RJ, 1994, MOL REPROD DEV, V39, P268; ALVAREZ JG, 1989, GAMETE RES, V23, P77, DOI 10.1002/mrd.1120230108; ALVAREZ JG, 1987, J ANDROL, V8, P338; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Baiardi G, 1997, CAN J PHYSIOL PHARM, V75, P173, DOI 10.1139/cjpp-75-3-173; Ball BA, 2001, J ANDROL, V22, P1061; Baumber J, 2000, J ANDROL, V21, P895; Baumber J, 2003, J ANDROL, V24, P621; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; BLOCK ER, 1991, J CELL PHYSIOL, V146, P362, DOI 10.1002/jcp.1041460305; Blondin P, 1997, J ANDROL, V18, P454; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; DELAMIRANDE E, 1992, J ANDROL, V13, P379; DELAMIRANDE E, 1992, J ANDROL, V13, P368; Donnelly ET, 2000, MUTAGENESIS, V15, P61, DOI 10.1093/mutage/15.1.61; Donnelly ET, 1999, MUTAGENESIS, V14, P505, DOI 10.1093/mutage/14.5.505; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Gadea J, 2004, THERIOGENOLOGY, V62, P690, DOI 10.1016/j.theriogenology.2003.11.013; GRIVEAU JF, 1995, J REPROD FERTIL, V103, P17; Griveau JF, 1997, INT J ANDROL, V20, P195, DOI 10.1046/j.1365-2605.1997.00049.x; Hagedorn M, 2009, CRYOBIOLOGY, V58, P12, DOI 10.1016/j.cryobiol.2008.09.013; Hagedorn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021059; Halliwell B, 1996, PATHOL BIOL, V44, P6; HALLIWELL B, 1991, AM J MED S3C, V91, P14, DOI DOI 10.1016/0002-9343(91)90279-7; HARVEY B, 1982, CAN J ZOOL, V60, P1867, DOI 10.1139/z82-242; IWASAKI A, 1992, FERTIL STERIL, V57, P409, DOI 10.1016/s0015-0282(16)54855-9; JONES R, 1979, AM J ANAT, V156, P373, DOI 10.1002/aja.1001560307; Katkov II, 1998, CRYOBIOLOGY, V37, P325, DOI 10.1006/cryo.1998.2128; Knight J, 2002, NATURE, V417, P785, DOI 10.1038/417785a; Koshimoto C, 2002, CRYOBIOLOGY, V45, P80, DOI 10.1016/S0011-2240(02)00108-6; LASSO JL, 1994, J ANDROL, V15, P255; Lewis SE, 1996, MOL HUM REPROD, V2, P873, DOI 10.1093/molehr/2.11.873; McCarthy MJ, 2011, THERIOGENOLOGY, V76, P168, DOI 10.1016/j.theriogenology.2011.01.029; McCarthy MJ, 2010, BIOL REPROD, V82, P644, DOI 10.1095/biolreprod.109.080507; Morris JP, 2003, BIOTECHNIQUES, V35, P956; MORRIS SM, 1981, CELL TISSUE RES, V220, P739; OHYASHIKI T, 1988, BIOCHIM BIOPHYS ACTA, V939, P383, DOI 10.1016/0005-2736(88)90084-3; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; RAO B, 1989, GAMETE RES, V24, P127, DOI 10.1002/mrd.1120240202; Rocha Maria Joao, 2003, BMC Biochem, V4, P2, DOI 10.1186/1471-2091-4-2; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Storey BT, 1997, MOL HUM REPROD, V3, P203, DOI 10.1093/molehr/3.3.203; Storey BT, 1998, CRYOBIOLOGY, V37, P46, DOI 10.1006/cryo.1998.2097; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Takagi Y, 2004, BIOCHEM BIOPH RES CO, V320, P62, DOI 10.1016/j.bbrc.2004.05.131; Twigg J, 1998, HUM REPROD, V13, P1429, DOI 10.1093/humrep/13.6.1429; Van der Schans GP, 2000, J ANDROL, V21, P250; VANLOON AAWM, 1991, EXP CELL RES, V193, P303, DOI 10.1016/0014-4827(91)90101-Y; Vernet P, 2004, MOL CELL ENDOCRINOL, V216, P31, DOI 10.1016/j.mce.2003.10.069; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Westerfield M., 2005, ZEBRAFISH BOOK GUIDE; Williams J., 2000, MANUAL FISHERIES SUR, VII; Yang HP, 2007, THERIOGENOLOGY, V68, P128, DOI 10.1016/j.theriogenology.2007.02.015; Zhou BS, 2006, AQUAT TOXICOL, V77, P136, DOI 10.1016/j.aquatox.2005.11.006	59	66	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39397	10.1371/journal.pone.0039397	http://dx.doi.org/10.1371/journal.pone.0039397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724013	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700078
J	Riccio, AM; Saverino, D; Pesce, G; Rogkakou, A; Severino, M; Bonadonna, P; Ridolo, E; Mauro, M; Canonica, GW; Bagnasco, M; Passalacqua, G				Riccio, Anna Maria; Saverino, Daniele; Pesce, Giampaola; Rogkakou, Anthi; Severino, Maurizio; Bonadonna, Patrizia; Ridolo, Erminia; Mauro, Marina; Canonica, Giorgio Walter; Bagnasco, Marcello; Passalacqua, Giovanni			Effects of Different Up-Dosing Regimens for Hymenoptera Venom Immunotherapy on Serum CTLA-4 and IL-10	PLOS ONE			English	Article							SOLUBLE CTLA-4; CELL; CD28; MECHANISMS; PLASMA; CD86	Background: Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) is involved in the activation pathways of T lymphocytes. It has been shown that the circulating form of CTLA-4 is elevated in patients with hymenoptera allergy and can be down regulated by immunotherapy. Objective: to assess the effects on CTLA-4 of venom immunotherapy, given with different induction protocols: conventional (6 weeks), rush (3 days) or ultra rush (1 day). Methods: Sera from patients with hymenoptera allergy were collected at baseline and at the end of the induction phase. CTLA-4 and IL-10 were assayed in the same samples. A subset of patients were assayed also after 12 months of VIT maintenance. Results: Ninety-four patients were studied. Of them, 50 underwent the conventional induction, 20 the rush and 24 the ultra-rush. Soluble CTLA-4 was detectable in all patients at baseline, and significantly decreased at the end of the induction, irrespective of its duration. Of note, a significant decrease of sCTLA-4 could be seen already at 24 hours. In parallel, IL-10 significantly increased at the end of the induction. At 12 months, sCTLA-4 remained low, whereas IL-10 returned to the baseline values. Conclusions: Serum CTLA4 is an early marker of the immunological effects of venom immunotherapy, and its changes persist after one year of maintenance treatment.	[Riccio, Anna Maria; Pesce, Giampaola; Rogkakou, Anthi; Canonica, Giorgio Walter; Bagnasco, Marcello; Passalacqua, Giovanni] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Saverino, Daniele] Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy; [Severino, Maurizio] Osped San Giovanni di Dio, Allergy Unit, Florence, Italy; [Bonadonna, Patrizia] Verona Gen Hosp, Allergy Serv, Verona, Italy; [Ridolo, Erminia] Univ Parma, I-43100 Parma, Italy; [Mauro, Marina] St Anna Hosp, Allergy Unit, Como, Italy	University of Genoa; University of Genoa; University of Parma; University of Ferrara; Arcispedale Sant'Anna	Riccio, AM (corresponding author), Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy.	passalacqua@unige.it	canonica, giorgio walter/ABF-2037-2020; Saverino, Daniele/I-4741-2014	canonica, giorgio walter/0000-0001-8467-2557; RICCIO, ANNA MARIA/0000-0001-8392-533X; Pesce, Giampaola/0000-0002-6294-9110				Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Burr JS, 2001, AM J RESP CELL MOL, V24, P563, DOI 10.1165/ajrcmb.24.5.4375; Bussmann C, 2010, ALLERGY, V65, P1558, DOI 10.1111/j.1398-9995.2010.02430.x; Dreschler K, 2011, J ALLERGY CLIN IMMUN, V127, P487, DOI 10.1016/j.jaci.2010.12.003; Ip WK, 2006, PEDIATR PULM, V41, P674, DOI 10.1002/ppul.20432; Jasek M, 2006, INT ARCH ALLERGY IMM, V141, P223, DOI 10.1159/000095292; Kawayama T, 2008, RESPIROLOGY, V13, P1000, DOI 10.1111/j.1440-1843.2008.01381.x; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Rueff F, 2005, ALLERGY, V60, P1339; Saverino D, 2009, J ALLERGY CLIN IMMUN, V123, P258, DOI 10.1016/j.jaci.2008.09.023; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wong CK, 2005, CLIN EXP IMMUNOL, V141, P122, DOI 10.1111/j.1365-2249.2005.02815.x	19	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37980	10.1371/journal.pone.0037980	http://dx.doi.org/10.1371/journal.pone.0037980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723841	Green Submitted, Green Published, gold			2022-12-27	WOS:000305652700007
J	Du, LQ; Subauste, MC; DeSevo, C; Zhao, ZZ; Baker, M; Borkowski, R; Schageman, JJ; Greer, R; Yang, CR; Suraokar, M; Wistuba, II; Gazdar, AF; Minna, JD; Pertsemlidis, A				Du, Liqin; Subauste, Maria C.; DeSevo, Christopher; Zhao, Zhenze; Baker, Michael; Borkowski, Robert; Schageman, Jeoffrey J.; Greer, Rachel; Yang, Chin-Rang; Suraokar, Milind; Wistuba, Ignacio I.; Gazdar, Adi F.; Minna, John D.; Pertsemlidis, Alexander			miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers	PLOS ONE			English	Article							MESSENGER-RNA; SIGNAL TRANSDUCER; MICRORNA TARGETS; MAP KINASE; PHASE-II; EXPRESSION; PROTEIN; RESISTANCE; PACLITAXEL; TAXOL	NSCLC (non-small cell lung cancer) often exhibits resistance to paclitaxel treatment. Identifying the elements regulating paclitaxel response will advance efforts to overcome such resistance in NSCLC therapy. Using in vitro approaches, we demonstrated that over-expression of the microRNA miR-337-3p sensitizes NCI-H1155 cells to paclitaxel, and that miR-337-3p mimic has a general effect on paclitaxel response in NSCLC cell lines, which may provide a novel adjuvant strategy to paclitaxel in the treatment of lung cancer. By combining in vitro and in silico approaches, we identified STAT3 and RAP1A as direct targets that mediate the effect of miR-337-3p on paclitaxel sensitivity. Further investigation showed that miR-337-3p mimic also sensitizes cells to docetaxel, another member of the taxane family, and that STAT3 levels are significantly correlated with taxane resistance in lung cancer cell lines, suggesting that endogenous STAT3 expression is a determinant of intrinsic taxane resistance in lung cancer. The identification of a miR-337-3p as a modulator of cellular response to taxanes, and STAT3 and RAP1A as regulatory targets which mediate that response, defines a novel regulatory pathway modulating paclitaxel sensitivity in lung cancer cells, which may provide novel adjuvant strategies along with paclitaxel in the treatment of lung cancer and may also provide biomarkers for predicting paclitaxel response in NSCLC.	[Du, Liqin; Zhao, Zhenze; Pertsemlidis, Alexander] UT Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX USA; [Du, Liqin; Pertsemlidis, Alexander] UT Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX USA; [Pertsemlidis, Alexander] UT Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX USA; [DeSevo, Christopher; Baker, Michael; Borkowski, Robert; Greer, Rachel] UT SW Med Ctr, SW Grad Sch Biomed Sci, Div Basic Sci, Dallas, TX USA; [Subauste, Maria C.; Schageman, Jeoffrey J.] UT SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Yang, Chin-Rang; Gazdar, Adi F.; Minna, John D.] UT SW Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX USA; [Gazdar, Adi F.; Minna, John D.] UT SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; [Minna, John D.] UT SW Med Ctr, Dept Pharmacol, Dallas, TX USA; [Minna, John D.] UT SW Med Ctr, Dept Internal Med, Dallas, TX USA; [Gazdar, Adi F.; Minna, John D.] UT SW Med Ctr, Dept Pathol, Dallas, TX USA; [Suraokar, Milind; Wistuba, Ignacio I.] UT MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA; [Wistuba, Ignacio I.] UT MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Du, LQ (corresponding author), UT Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX USA.	pertsemlidis@uthscsa.edu	Pertsemlidis, Alexander/Q-7899-2017; Zhao, Zhenze/AAW-5870-2020	Pertsemlidis, Alexander/0000-0003-1624-9372; 	Lung Cancer SPORE [P50 CA70907, R01 CA129632]; National Cancer Institute, and Academic Excellence [EDUD-7824-021007-US]; Sun Microsystems; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA129632] Funding Source: NIH RePORTER	Lung Cancer SPORE; National Cancer Institute, and Academic Excellence; Sun Microsystems; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by Lung Cancer SPORE P50 CA70907 (J. D. Minna), R01 CA129632 (A. Pertsemlidis) from the National Cancer Institute, and Academic Excellence Grant EDUD-7824-021007-US (A. Pertsemlidis) from Sun Microsystems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Caesar GJ, COMMENTARII BELLO GA, V6, P31; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; CHANG AY, 1993, J NATL CANCER I, V85, P388, DOI 10.1093/jnci/85.5.388; d'Amato TA, 2007, J THORAC CARDIOV SUR, V133, P352, DOI 10.1016/j.jtcvs.2006.10.019; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hari M, 2006, MOL CANCER THER, V5, P270, DOI 10.1158/1535-7163.MCT-05-0190; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hawthorne VS, 2009, MOL CANCER RES, V7, P592, DOI 10.1158/1541-7786.MCR-08-0316; Holmfeldt P, 2002, CURR BIOL, V12, P1034, DOI 10.1016/S0960-9822(02)00897-7; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; HOSHI M, 1992, EUR J BIOCHEM, V203, P43, DOI 10.1111/j.1432-1033.1992.tb19825.x; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Miller ML, 2001, CHEM REC, V1, P195, DOI 10.1002/tcr.1008; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; MURPHY WK, 1993, J NATL CANCER I, V85, P384, DOI 10.1093/jnci/85.5.384; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Oie HK, 1996, J CELL BIOCHEM, P24; Pensa S, 2009, JAK STAT PATHWAY DIS; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Phelps RM, 1996, J CELL BIOCHEM, P32; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sangrajrang S, 2000, CHEMOTHERAPY, V46, P327, DOI 10.1159/000007306; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Walker SR, 2010, MOL PHARM; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	52	80	85	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39167	10.1371/journal.pone.0039167	http://dx.doi.org/10.1371/journal.pone.0039167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723956	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300110
J	Isbister, GK; Shahmy, S; Mohamed, F; Abeysinghe, C; Karunathilake, H; Ariaratnam, A				Isbister, Geoffrey K.; Shahmy, Seyed; Mohamed, Fahim; Abeysinghe, Chandana; Karunathilake, Harendra; Ariaratnam, Ariaranee			A Randomised Controlled Trial of Two Infusion Rates to Decrease Reactions to Antivenom	PLOS ONE			English	Article							ACUTE ADVERSE-REACTIONS; SNAKE ANTIVENOMS; ANAPHYLAXIS; SERUM	Background: Snake envenoming is a major clinical problem in Sri Lanka, with an estimated 40,000 bites annually. Antivenom is only available from India and there is a high rate of systemic hypersensitivity reactions. This study aimed to investigate whether the rate of infusion of antivenom reduced the frequency of severe systemic hypersensitivity reactions. Methods and Findings: This was a randomized comparison trial of two infusion rates of antivenom for treatment of non-pregnant adult patients (> 14 y) with snake envenoming in Sri Lanka. Snake identification was by patient or hospital examination of dead snakes when available and confirmed by enzyme-immunoassay for Russell's viper envenoming. Patients were blindly allocated in a 11 randomisation schedule to receive antivenom either as a 20 minute infusion (rapid) or a two hour infusion (slow). The primary outcome was the proportion with severe systemic hypersensitivity reactions (grade 3 by Brown grading system) within 4 hours of commencement of antivenom. Secondary outcomes included the proportion with mild/moderate hypersensitivity reactions and repeat antivenom doses. Of 1004 patients with suspected snakebites, 247 patients received antivenom. 49 patients were excluded or not recruited leaving 104 patients allocated to the rapid antivenom infusion and 94 to the slow antivenom infusion. The median actual duration of antivenom infusion in the rapid group was 20 min (Interquartile range[IQR]:20-25 min) versus 120 min (IQR:75-120 min) in the slow group. There was no difference in severe systemic hypersensitivity reactions between those given rapid and slow infusions (32% vs. 35%; difference 3%; 95%CI:-10% to + 17%;p = 0.65). The frequency of mild/moderate reactions was also similar. Similar numbers of patients in each arm received further doses of antivenom (30/104 vs. 23/94). Conclusions: A slower infusion rate would not reduce the rate of severe systemic hypersensitivity reactions from current high rates. More effort should be put into developing better quality antivenoms.	[Isbister, Geoffrey K.] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia; [Isbister, Geoffrey K.; Shahmy, Seyed; Mohamed, Fahim] S Asian Clin Toxicol Res Collaborat, Peradeniya, Central Provinc, Sri Lanka; [Abeysinghe, Chandana; Karunathilake, Harendra] Polonnaruwa Gen Hosp, Dept Med, Polonnaruwa, North Central P, Sri Lanka; [Ariaratnam, Ariaranee] Univ Colombo, Fac Med, Dept Clin Med, Colombo, Sri Lanka	University of Newcastle; University of Colombo	Isbister, GK (corresponding author), Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia.	geoff.isbister@gmail.com	Shahmy, Seyed/I-7654-2017	Shahmy, Seyed/0000-0002-2339-1572; Mohamed, Fahim/0000-0003-2849-7269	National Health and Medical Research Council (NHMRC) [631073, 605817]; IRQUE [C1A2 MBBS SPQEF]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); IRQUE	The study was supported in part by National Health and Medical Research Council (NHMRC) Project Grant 631073 and by IRQUE Project Grant C1A2 MBBS SPQEF. GKI is funded by an NHMRC Clinical Career Development Award ID 605817. CA is funded by an IRQUE Project. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariaratnam CA, 2001, T ROY SOC TROP MED H, V95, P74, DOI 10.1016/S0035-9203(01)90339-6; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; de Silva HA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000435; Gawarammana IB, 2004, MED J AUSTRALIA, V180, P20, DOI 10.5694/j.1326-5377.2004.tb05768.x; Habib AG, 2011, DRUG SAFETY, V34, P869, DOI 10.2165/11592050-000000000-00000; Isbister GK, 2008, MED J AUSTRALIA, V188, P473, DOI 10.5694/j.1326-5377.2008.tb01721.x; Isbister GK, 2010, VACCINE, V28, P798, DOI 10.1016/j.vaccine.2009.10.055; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kerr F, 2005, ANN EMERG MED, V45, P402, DOI 10.1016/j.annemergmed.2004.08.040; Kulawickrama S, 2010, TOXICON, V55, P1510, DOI 10.1016/j.toxicon.2010.03.003; Lalloo DG, 2003, J TOXICOL-CLIN TOXIC, V41, P277, DOI 10.1081/CLT-120021113; Premawardhena AP, 1999, BRIT MED J, V318, P1041, DOI 10.1136/bmj.318.7190.1041; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; SUTHERLAND SK, 1978, MED J AUSTRALIA, V2, P620, DOI 10.5694/j.1326-5377.1978.tb131783.x; Tan CH, 2011, ACTA TROP, V117, P119, DOI 10.1016/j.actatropica.2010.11.001	16	58	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38739	10.1371/journal.pone.0038739	http://dx.doi.org/10.1371/journal.pone.0038739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719932	gold, Green Published			2022-12-27	WOS:000305583300046
J	Lu, R; Bian, F; Lin, J; Su, ZT; Qu, YLW; Pflugfelder, SC; Li, DQ				Lu, Rong; Bian, Fang; Lin, Jing; Su, Zhitao; Qu, Yangluowa; Pflugfelder, Stephen C.; Li, De-Quan			Identification of Human Fibroblast Cell Lines as a Feeder Layer for Human Corneal Epithelial Regeneration	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN OCULAR SURFACE; IN-VITRO; MESENCHYMAL INTERACTIONS; MICROARRAY DATA; CULTURE; TRANSPLANTATION; GROWTH; DIFFERENTIATION; EXPRESSION	There is a great interest in using epithelium generated in vitro for tissue bioengineering. Mouse 3T3 fibroblasts have been used as a feeder layer to cultivate human epithelia including corneal epithelial cells for more than 3 decades. To avoid the use of xeno-components, we evaluated human fibroblasts as an alternative feeder supporting human corneal epithelial regeneration. Five human fibroblast cell lines were used for evaluation with mouse 3T3 fibroblasts as a control. Human epithelial cells isolated from fresh corneal limbal tissue were seeded on these feeders. Colony forming efficiency (CFE) and cell growth capacity were evaluated on days 5-14. The phenotype of the regenerated epithelia was evaluated by morphology and immunostaining with epithelial markers. cDNA microarray was used to analyze the gene expression profile of the supportive human fibroblasts. Among 5 strains of human fibroblasts evaluated, two newborn foreskin fibroblast cell lines, Hs68 and CCD1112Sk, were identified to strongly support human corneal epithelial growth. Tested for 10 passages, these fibroblasts continually showed a comparative efficiency to the 3T3 feeder layer for CFE and growth capacity of human corneal epithelial cells. Limbal epithelial cells seeded at 1 x 10(4) in a 35-mm dish (9.6 cm(2)) grew to confluence (about 1.87-2.41 x 10(6) 6 cells) in 12-14 days, representing 187-241 fold expansion with over 7-8 doublings on these human feeders. The regenerated epithelia expressed K3, K12, connexin 43, p63, EGFR and integrin beta 1, resembling the phenotype of human corneal epithelium. DNA microarray revealed 3 up-regulated and 10 down-regulated genes, which may be involved in the functions of human fibroblast feeders. These findings demonstrate that commercial human fibroblast cell lines support human corneal epithelial regeneration, and have potential use in tissue bioengineering for corneal reconstruction.	[Lu, Rong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Rong; Bian, Fang; Lin, Jing; Su, Zhitao; Qu, Yangluowa; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Bian, Fang] Huazhong Sci & Technol Univ, Dept Ophthalmol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Lin, Jing] Qingdao Univ, Coll Med, Dept Ophthalmol, Qingdao 266071, Peoples R China	Sun Yat Sen University; Baylor College of Medicine; Huazhong University of Science & Technology; Qingdao University	Lu, R (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	dequanl@bcm.tmc.edu			Department of Defense CDMRP PRMRP [FY06 PR064719]; Lions Foundation for Sight; Fundamental Research Funds of State Key Laboratory of Ophthalmology (China); Research to Prevent Blindness, Oshman Foundation; William Stamps Farish Fund	Department of Defense CDMRP PRMRP; Lions Foundation for Sight; Fundamental Research Funds of State Key Laboratory of Ophthalmology (China); Research to Prevent Blindness, Oshman Foundation(Research to Prevent Blindness (RPB)); William Stamps Farish Fund	This study was supported by Department of Defense CDMRP PRMRP FY06 PR064719 (DQL), Lions Foundation for Sight, Fundamental Research Funds of State Key Laboratory of Ophthalmology (China), Research to Prevent Blindness, Oshman Foundation, and William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1985, EXP LUNG RES, V8, P261, DOI 10.3109/01902148509087808; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; Choo ABH, 2004, BIOTECHNOL BIOENG, V88, P321, DOI 10.1002/bit.20247; CUNHA GR, 1985, CELL DIFFER DEV, V17, P137, DOI 10.1016/0045-6039(85)90481-6; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093; DELUCA M, 1992, BURNS, V18, pS5, DOI 10.1016/0305-4179(92)90103-2; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dua H S, 2000, Indian J Ophthalmol, V48, P83; Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; HOWLETT AR, 1986, DEV BIOL, V118, P403, DOI 10.1016/0012-1606(86)90011-4; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kinoshita S, 2004, EXP EYE RES, V78, P483, DOI 10.1016/j.exer.2003.09.004; Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Liu JY, 2005, DERMATOLOGY, V210, P45, DOI 10.1159/000081483; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003; SHARPE PM, 1988, J CELL SCI, P195; SLAVKIN HC, 1984, J CELL BIOCHEM, V26, P117, DOI 10.1002/jcb.240260207; SUN TT, 1977, NATURE, V269, P489, DOI 10.1038/269489a0; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1996, CORNEA, V15, P168, DOI 10.1097/00003226-199603000-00010; Tseng SCG, 1996, CURR EYE RES, V15, P973, DOI 10.3109/02713689609017643; van Rossum MM, 2002, J IMMUNOL METHODS, V267, P109, DOI 10.1016/S0022-1759(02)00151-5; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814; Zipori D, 2004, BLOOD CELL MOL DIS, V33, P211, DOI 10.1016/j.bcmd.2004.08.019	37	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38825	10.1371/journal.pone.0038825	http://dx.doi.org/10.1371/journal.pone.0038825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723892	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300056
J	Shariff, AF; Rhemtulla, M				Shariff, Azim F.; Rhemtulla, Mijke			Divergent Effects of Beliefs in Heaven and Hell on National Crime Rates	PLOS ONE			English	Article							BEHAVIOR; PATTERNS; GOD	Though religion has been shown to have generally positive effects on normative 'prosocial' behavior, recent laboratory research suggests that these effects may be driven primarily by supernatural punishment. Supernatural benevolence, on the other hand, may actually be associated with less prosocial behavior. Here, we investigate these effects at the societal level, showing that the proportion of people who believe in hell negatively predicts national crime rates whereas belief in heaven predicts higher crime rates. These effects remain after accounting for a host of covariates, and ultimately prove stronger predictors of national crime rates than economic variables such as GDP and income inequality. Expanding on laboratory research on religious prosociality, this is the first study to tie religious beliefs to large-scale cross-national trends in pro- and anti-social behavior.	[Shariff, Azim F.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Rhemtulla, Mijke] Univ Kansas, Ctr Res Methods & Data Anal, Lawrence, KS 66045 USA	University of Oregon; University of Kansas	Shariff, AF (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	shariff@uoregon.edu	Rhemtulla, Mijke/ABA-5452-2021	Rhemtulla, Mijke/0000-0003-2572-2424; Shariff, Azim/0000-0003-4444-460X				Ahmed AM, 2011, J SOCIO-ECON, V43, P242, DOI 10.1016/j.socec.2010.12.013; [Anonymous], 2009, SPIRIT LEVEL; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P41, DOI 10.1016/j.evolhumbehav.2010.07.008; Barro RJ, 2003, AM SOCIOL REV, V68, P760, DOI 10.2307/1519761; *CENTR INT AG, 2007, WORLD FACTB; Central Intelligence Agency, 2011, WORLD FACTB; DeBono A, 2012, FORGIVE US OUR UNPUB; Francis L. J., 2001, MENTAL HLTH RELIG CU, V4, P103, DOI [DOI 10.1080/13674670126955, 10.1080/13674670126955]; Ironson G, 2011, J BEHAV MED, V34, P414, DOI 10.1007/s10865-011-9314-z; Johnson D, 2011, RELIG BRAIN BEHAV, V1, P77, DOI 10.1080/2153599X.2011.558714; Johnson DP, 2004, POLITICAL THEOLOGY, V5, P159, DOI DOI 10.1558/poth.2004.5.2.159; LAMBORN SD, 1991, CHILD DEV, V62, P1049, DOI 10.2307/1131151; Monsma S., 2007, INTERDISCIPLINARY J, V3, P1; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; PATTERSON EB, 1991, CRIMINOLOGY, V29, P755, DOI 10.1111/j.1745-9125.1991.tb01087.x; Randolph-Seng Brandon, 2007, INT J PSYCHOL RELIG, V17, P303, DOI [DOI 10.1080/10508610701572812, 10.1080/10508610701572812]; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shariff AF, 2011, INT J PSYCHOL RELIG, V21, P85, DOI 10.1080/10508619.2011.556990; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; United Nations Department of Economic and Social Affairs, 2010, POP DENS URB; United Nations Office on Drugs and Crime, 2011, CRIM CRIM JUST STAT; Walmsley R, 2011, WORLD PRISON POPULAT; World Values Survey, 1981, OFF AGGR V 20090901; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	25	76	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39048	10.1371/journal.pone.0039048	http://dx.doi.org/10.1371/journal.pone.0039048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22723927	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300085
J	Adesida, AB; Mulet-Sierra, A; Laouar, L; Jomha, NM				Adesida, Adetola B.; Mulet-Sierra, Aillette; Laouar, Leila; Jomha, Nadr M.			Oxygen Tension Is a Determinant of the Matrix-Forming Phenotype of Cultured Human Meniscal Fibrochondrocytes	PLOS ONE			English	Article							TISSUE ENGINEERED MENISCUS; ARTICULAR-CARTILAGE; GROWTH-FACTORS; CELLS; DIFFERENTIATION; EXPRESSION; COLLAGEN; MICROVASCULATURE; TRANSPLANTATION; PROLIFERATION	Background: Meniscal cartilage displays a poor repair capacity, especially when injury is located in the avascular region of the tissue. Cell-based tissue engineering strategies to generate functional meniscus substitutes is a promising approach to treat meniscus injuries. Meniscus fibrochondrocytes (MFC) can be used in this approach. However, MFC are unable to retain their phenotype when expanded in culture. In this study, we explored the effect of oxygen tension on MFC expansion and on their matrix-forming phenotype. Methodology/Principal Findings: MFC were isolated from human menisci followed by basic fibroblast growth factor (FGF-2) mediated cell expansion in monolayer culture under normoxia (21%O-2) or hypoxia (3%O-2). Normoxia and hypoxia expanded MFC were seeded on to a collagen scaffold. The MFC seeded scaffolds (constructs) were cultured in a serum free chondrogenic medium for 3 weeks under normoxia and hypoxia. Constructs containing normoxia-expanded MFC were subsequently cultured under normoxia while those formed from hypoxia-expanded MFC were subsequently cultured under hypoxia. After 3 weeks of in vitro culture, the constructs were assessed biochemically, histologically and for gene expression via real-time reverse transcription-PCR assays. The results showed that constructs under normoxia produced a matrix with enhanced mRNA ratio (3.5-fold higher; p<0.001) of collagen type II to I. This was confirmed by enhanced deposition of collagen II using immuno-histochemistry. Furthermore, the constructs under hypoxia produced a matrix with higher mRNA ratio of aggrecan to versican (3.5-fold, p<0.05). However, both constructs had the same capacity to produce a glycosaminoglycan (GAG) -specific extracellular matrix. Conclusions: Our data provide evidence that oxygen tension is a key player in determining the matrix phenotype of cultured MFC. These findings suggest that the use of normal and low oxygen tension during MFC expansion and subsequent neo-tissue formation cultures may be important in engineering different regions of the meniscus.	[Adesida, Adetola B.; Mulet-Sierra, Aillette; Laouar, Leila; Jomha, Nadr M.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta	Adesida, AB (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	adesida@ualberta.ca	Adesida, Adetola B/H-3549-2011	Adesida, Adetola B/0000-0003-1798-6251	Edmonton Orthopaedic Research Committee, University of Alberta Hospital Foundation; Department of Surgery, University of Alberta	Edmonton Orthopaedic Research Committee, University of Alberta Hospital Foundation; Department of Surgery, University of Alberta(University of Alberta)	Financial support was provided in part by Edmonton Orthopaedic Research Committee, University of Alberta Hospital Foundation to ABA and new investigator startup fund by Department of Surgery, University of Alberta to ABA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard H, 1999, SCAND J MED SCI SPOR, V9, P134; Adams M.E., 1992, KNEE MENISCUS BASIC, P15; Adams Samuel B Jr, 2005, J Knee Surg, V18, P25; Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Adesida AB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2267; Ahmed A.M., 1992, KNEE MENISCUS BASIC, P59; Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0; Arnoczky S., 1992, KNEE MENISCUS BASIC, P1; ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205; Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS293; ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305; Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Brew CJ, 2010, ANN RHEUM DIS, V69, P234, DOI 10.1136/ard.2008.097139; FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664, DOI 10.1302/0301-620X.30B4.664; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Gebhard PM, 2003, J ORTHOPAED RES, V21, P96, DOI 10.1016/S0736-0266(02)00094-3; Gruber HE, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-54; Ibarra C, 1997, TRANSPL P, V29, P986, DOI 10.1016/S0041-1345(96)00337-5; Ibarra C, 2000, ORTHOP CLIN N AM, V31, P411, DOI 10.1016/S0030-5898(05)70160-7; Kang SW, 2006, J BIOMED MATER RES A, V77A, P659, DOI 10.1002/jbm.a.30579; Le Graverand MPH, 2001, J ANAT, V198, P525, DOI 10.1046/j.1469-7580.2000.19850525.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009; Marsano A, 2006, BIOMATERIALS, V27, P5927, DOI 10.1016/j.biomaterials.2006.08.020; Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1; Mauck RL, 2007, ANAT REC, V290, P48, DOI 10.1002/ar.20419; McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140; MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8; McDevitt CA, 2002, CURR OPIN ORTHOP, V13, P345, DOI DOI 10.1097/00001433-200210000-00004; McDevitt CA, 1992, KNEE MENISCUS BASIC, P29; Melrose J, 2005, HISTOCHEM CELL BIOL, V124, P225, DOI 10.1007/s00418-005-0005-0; Messner K, 1998, J ANAT, V193, P161, DOI 10.1046/j.1469-7580.1998.19320161.x; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Nakata K, 2001, CLIN ORTHOP RELAT R, pS208; Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023; Pangborn CA, 2005, TISSUE ENG, V11, P1141, DOI 10.1089/ten.2005.11.1141; Pangborn CA, 2005, J ORTHOP RES, V23, P1184, DOI 10.1016/j.orthres.2005.01.019; Pradel W, 2008, J PHYSIOL PHARMACOL, V59, P47; Rodkey WG, 2010, MENISCUS, P367, DOI 10.1007/978-3-642-02450-4_11.1; Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281, DOI 10.1097/00003086-199910001-00027; Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656; Setton LA, 1999, CLIN ORTHOP RELAT R, pS254, DOI 10.1097/00003086-199910001-00025; Stone KR, 2010, J BONE JOINT SURG BR, V92B, P941, DOI 10.1302/0301-620X.92B7.23182; Tanaka T, 1999, KNEE SURG SPORT TR A, V7, P75, DOI 10.1007/s001670050125; VERDONK R, 1994, ORTHOPADE, V23, P153	49	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39339	10.1371/journal.pone.0039339	http://dx.doi.org/10.1371/journal.pone.0039339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720095	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000060
J	Chandramouli, KH; Reish, D; Qian, PY				Chandramouli, Kondethimmanahalli H.; Reish, Donald; Qian, Pei-Yuan			Gel-Based and Gel-Free Identification of Proteins and Phosphopeptides during Egg-to-Larva Transition in Polychaete Neanthes arenaceodentata	PLOS ONE			English	Article							SEA-URCHIN EGGS; PHOSPHOPROTEOME ANALYSIS; PROTEOMIC ANALYSIS; PHOSPHORYLATION; METAMORPHOSIS; EXPRESSION; DYNAMICS; ACTIVATION; ANNELIDA; CHAIN	The polychaete Neanthes arenaceodentata- is cosmopolitan in distribution-, has been used as a laboratory test animal. Life history of this species has several unique features; the female dies after spawning and the male incubates the fertilized eggs through the 21-segmented stage. The larvae leave the tube and commence feeding. Changes in protein abundance and phosphorylation were examined during early development of N. arenaceodentata. A gel-based approach and gel-free enrichment of phosphopeptides coupled with mass spectrometry were used to identify proteins and phosphopeptides in fertilized ova and larval stages. Patterns of proteins and phosphoproteins changed from fertilized ova to larval stages. Twelve proteins occurred in phosphorylated form and nine as stage specific proteins. Cytoskeletal proteins have exhibited differential phosphorylation from ova to larval stages; whereas, other proteins exhibited stage-specific phosphorylation patterns. Ten phosphopeptides were identified that showed phosphorylation sites on serine or threonine residues. Sixty percent of the identified proteins were related to structural reorganization and others with protein synthesis, stress response and attachment. The abundance and distribution of two cytoskeleton proteins were examined further by 2-DE Western blot analysis. This is the first report on changes in protein expression and phosphorylation sites at Thr/Ser in early development of N. arenaceodentata. The 2-DE proteome maps and identified phosphoproteins contributes toward understanding the state of fertilized ova and early larval stages and serves as a basis for further studies on proteomics changes under different developmental conditions in this and other polychaete species.	[Chandramouli, Kondethimmanahalli H.; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong Sar, Peoples R China; [Reish, Donald] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	Hong Kong University of Science & Technology; California State University System; California State University Long Beach	Chandramouli, KH (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong Sar, Peoples R China.	djreish@aol.com; boqianpy@ust.hk		Qian, Pei-Yuan/0000-0003-4074-9078	King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of the Hong Kong Special Administrative Region [AoE/P-04/04-II]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This study was supported by an award from King Abdullah University of Science and Technology (SA-C0040/UK-C0016), and grants from the Research Grants Council of the Hong Kong Special Administrative Region (AoE/P-04/04-II) to P.-Y. Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barritt J A, 2002, Reprod Biomed Online, V4, P243; Bleidorn C, 2003, MOL PHYLOGENET EVOL, V29, P279, DOI 10.1016/S1055-7903(03)00107-6; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Carpizo-Ituarte E, 2003, BIOL BULL-US, V204, P114, DOI 10.2307/1543547; Chandramouli KH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-51; Chandramouli KH, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-31; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; CURCI A, 1991, DEV BIOL, V144, P362, DOI 10.1016/0012-1606(91)90428-6; DAVIDSON EH, 1982, SCIENCE, V217, P17, DOI 10.1126/science.6178156; Deng X, 2011, CELL PROLIFERAT, V44, P156, DOI 10.1111/j.1365-2184.2011.00743.x; EPEL D, 1967, P NATL ACAD SCI USA, V57, P899, DOI 10.1073/pnas.57.4.899; EPEL D, 1997, HDB PHYSIOL 14, P859; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Herpin R, 1925, B SOC SCI NATURELLES, V5, P1; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Janssen EML, 2010, ENVIRON SCI TECHNOL, V44, P2857, DOI 10.1021/es901632e; Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Lee RF, 2005, COMP BIOCHEM PHYS B, V140, P381, DOI 10.1016/j.cbpc.2004.11.002; Leese HJ, 1995, HUM REPROD UPDATE, V1, P63, DOI 10.1093/humupd/1.1.63; MANEJWALA FM, 1991, DEV BIOL, V144, P301, DOI 10.1016/0012-1606(91)90423-Z; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Raggiaschi R, 2006, PROTEOMICS, V6, P748, DOI 10.1002/pmic.200500064; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; Reintsch WE, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-21; Reish DJ, 1997, B MAR SCI, V60, P584; Reish DJ, 2009, ZOOSYMPOSIA, V2, P391, DOI 10.11646/zoosymposia.2.1.27; REISH DONALD J., 1957, PACIFIC SCI, V11, P216; Rosen G, 2011, ENVIRON TOXICOL CHEM, V30, P730, DOI 10.1002/etc.438; Roux MM, 2008, DEV BIOL, V313, P630, DOI 10.1016/j.ydbio.2007.10.053; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sun J, 2010, PROTEOMICS, V10, P2701, DOI 10.1002/pmic.200900846; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; Uehara R, 2008, CELL MOTIL CYTOSKEL, V65, P100, DOI 10.1002/cm.20246; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Winchell CJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-17; Wong GK, 1997, CELL MOTIL CYTOSKEL, V36, P30, DOI 10.1002/(SICI)1097-0169(1997)36:1<30::AID-CM3>3.0.CO;2-L; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538; Zhang Y, 2010, J PROTEOME RES, V9, P4851, DOI 10.1021/pr100645z	49	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38814	10.1371/journal.pone.0038814	http://dx.doi.org/10.1371/journal.pone.0038814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719953	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000024
J	Aknin, LB; Hamlin, JK; Dunn, EW				Aknin, Lara B.; Hamlin, J. Kiley; Dunn, Elizabeth W.			Giving Leads to Happiness in Young Children	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; POSITIVE EMOTIONS; INFANTS; EVOLUTION; LIFE	Evolutionary models of cooperation require proximate mechanisms that sustain prosociality despite inherent costs to individuals. The "warm glow'' that often follows prosocial acts could provide one such mechanism; if so, these emotional benefits may be observable very early in development. Consistent with this hypothesis, the present study finds that before the age of two, toddlers exhibit greater happiness when giving treats to others than receiving treats themselves. Further, children are happier after engaging in costly giving - forfeiting their own resources - than when giving the same treat at no cost. By documenting the emotionally rewarding properties of costly prosocial behavior among toddlers, this research provides initial support for the claim that experiencing positive emotions when giving to others is a proximate mechanism for human cooperation.	[Aknin, Lara B.; Hamlin, J. Kiley; Dunn, Elizabeth W.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Aknin, LB (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	laknin@psych.ubc.ca			Social Sciences and Humanities Research Council of Canada [410-2011-0780]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by a grant awarded to the second author from the Social Sciences and Humanities Research Council of Canada (410-2011-0780; Granting agency website http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aknin L. B., 2010, 16415 NBER; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Buchanan KE, 2010, J SOC PSYCHOL, V150, P235, DOI 10.1080/00224540903365554; Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; EISENBERG N, 1992, J GENET PSYCHOL, V153, P19; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hamlin JK, COGN DEV IN PRESS; Hamlin JK, 21 MONTH OL IN PRESS; Hamlin JK, CAN I HAVE IN PRESS; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Henrich J, 2006, COGN SYST RES, V7, P220, DOI 10.1016/j.cogsys.2005.11.010; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Johnson S, 1998, DEVELOPMENTAL SCI, V1, P233, DOI 10.1111/1467-7687.00036; LEGERSTEE M, 1991, J EXP CHILD PSYCHOL, V51, P423, DOI 10.1016/0022-0965(91)90086-8; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oster H, 2003, ANN NY ACAD SCI, V1000, P197, DOI 10.1196/annals.1280.024; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Shimizu YA, 2004, DEVELOPMENTAL SCI, V7, P425, DOI 10.1111/j.1467-7687.2004.00362.x; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tomasello M., 2009, QUESTION ANIMAL CULT; Vaish A, 2011, BRIT J DEV PSYCHOL, V29, P124, DOI 10.1348/026151010X532888; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2008, DEV PSYCHOL, V44, P1785, DOI 10.1037/a0013860; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	37	167	170	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39211	10.1371/journal.pone.0039211	http://dx.doi.org/10.1371/journal.pone.0039211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22720078	Green Published, gold			2022-12-27	WOS:000305347800057
J	Clark, TD; Donaldson, MR; Pieperhoff, S; Drenner, SM; Lotto, A; Cooke, SJ; Hinch, SG; Patterson, DA; Farrell, AP				Clark, Timothy D.; Donaldson, Michael R.; Pieperhoff, Sebastian; Drenner, S. Matthew; Lotto, Andrew; Cooke, Steven J.; Hinch, Scott G.; Patterson, David A.; Farrell, Anthony P.			Physiological Benefits of Being Small in a Changing World: Responses of Coho Salmon (Oncorhynchus kisutch) to an Acute Thermal Challenge and a Simulated Capture Event	PLOS ONE			English	Article							CLIMATE-CHANGE; PACIFIC SALMON; MARINE FISHES; EXHAUSTIVE EXERCISE; OXYGEN-CONSUMPTION; NORTH PACIFIC; FRASER-RIVER; BODY-MASS; ION LOSS; TEMPERATURE	Evidence is building to suggest that both chronic and acute warm temperature exposure, as well as other anthropogenic perturbations, may select for small adult fish within a species. To shed light on this phenomenon, we investigated physiological and anatomical attributes associated with size-specific responses to an acute thermal challenge and a fisheries capture simulation (exercise+air exposure) in maturing male coho salmon (Oncorhynchus kisutch). Full-size females were included for a sex-specific comparison. A size-specific response in haematology to an acute thermal challenge (from 7 to 20 degrees C at 3 degrees C h(-1)) was apparent only for plasma potassium, whereby full-size males exhibited a significant increase in comparison with smaller males ('jacks'). Full-size females exhibited an elevated blood stress response in comparison with full-size males. Metabolic recovery following exhaustive exercise at 7 degrees C was size-specific, with jacks regaining resting levels of metabolism at 9.3+/-0.5 h post-exercise in comparison with 12.3+/-0.4 h for full-size fish of both sexes. Excess post-exercise oxygen consumption scaled with body mass in male fish with an exponent of b = 1.20+/-0.08. Jacks appeared to regain osmoregulatory homeostasis faster than full-size males, and they had higher ventilation rates at 1 h post-exercise. Peak metabolic rate during post-exercise recovery scaled with body mass with an exponent of b similar to 1, suggesting that the slower metabolic recovery in large fish was not due to limitations in diffusive or convective oxygen transport, but that large fish simply accumulated a greater 'oxygen debt' that took longer to pay back at the size-independent peak metabolic rate of similar to 6 mg min(-1) kg(-1). Post-exercise recovery of plasma testosterone was faster in jacks compared with full-size males, suggesting less impairment of the maturation trajectory of smaller fish. Supporting previous studies, these findings suggest that environmental change and non-lethal fisheries interactions have the potential to select for small individuals within fish populations over time.	[Clark, Timothy D.; Donaldson, Michael R.; Drenner, S. Matthew; Lotto, Andrew; Hinch, Scott G.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Pieperhoff, Sebastian] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Cooke, Steven J.] Carleton Univ, Fish Ecol & Conservat Physiol Lab, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Cooperat Resource Management Inst, Fisheries & Oceans Canada, Burnaby, BC V5A 1S6, Canada; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia; University of Edinburgh; Carleton University; Carleton University; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia	Clark, TD (corresponding author), Australian Inst Marine Sci, Townsville MC, PMB 3, Townsville, Qld 4810, Australia.	timothy.clark.mail@gmail.com	Clark, Timothy Darren/K-7129-2012; Cooke, Steven J/F-4193-2010	Clark, Timothy Darren/0000-0001-8738-3347; Cooke, Steven J/0000-0002-5407-0659; Donaldson, Michael/0000-0002-1178-5988	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Research funding was provided by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Baker MR, 2011, EVOL APPL, V4, P429, DOI 10.1111/j.1752-4571.2010.00154.x; Bigler BS, 1996, CAN J FISH AQUAT SCI, V53, P455, DOI 10.1139/cjfas-53-2-455; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Clark TD, 2011, J FISH BIOL, V79, P1322, DOI 10.1111/j.1095-8649.2011.03118.x; Clark TD, 2008, AM J PHYSIOL-REG I, V295, pR1631, DOI 10.1152/ajpregu.90461.2008; Clark TD, 2011, J EXP BIOL, V214, P3074, DOI 10.1242/jeb.060517; Clark TD, 2011, J EXP BIOL, V214, P887, DOI 10.1242/jeb.051607; Clark TD, 2010, J COMP PHYSIOL B, V180, P673, DOI 10.1007/s00360-009-0442-5; Clark TD, 2009, J COMP PHYSIOL B, V179, P663, DOI 10.1007/s00360-009-0349-1; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Cooke SJ, 2006, ECOLOGY, V87, P1575, DOI 10.1890/0012-9658(2006)87[1575:MBOIMI]2.0.CO;2; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DFO, 2006, CONS STRAT COH SALM; Donaldson MR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P973, DOI 10.1086/656336; Farrell AP, 2001, CAN J FISH AQUAT SCI, V58, P1932, DOI 10.1139/cjfas-58-10-1932; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Gallaugher PE, 2001, J EXP BIOL, V204, P2861; GONZALEZ RJ, 1994, J EXP BIOL, V190, P95; GONZALEZ RJ, 1992, J EXP BIOL, V163, P317; IWAMOTO RN, 1984, AQUACULTURE, V43, P105, DOI 10.1016/0044-8486(84)90015-2; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jeffries KM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P62, DOI 10.1086/663770; Kendall NW, 2009, EVOL APPL, V2, P523, DOI 10.1111/j.1752-4571.2009.00086.x; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Martins EG, 2011, CANADIAN J IN PRESS; Morita K, 2010, OIKOS, V119, P1265, DOI 10.1111/j.1600-0706.2009.18125.x; Morrison J, 2002, J HYDROL, V263, P230, DOI 10.1016/S0022-1694(02)00065-3; OIKAWA S, 1985, J EXP BIOL, V117, P1; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; PAULY D, 1981, MEERESFORSCHUNG, V28, P251; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; REIDY SP, 1995, J FISH BIOL, V47, P377, DOI 10.1111/j.1095-8649.1995.tb01907.x; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Ricker WE, 1981, CANADIAN J FISHERIES, V38, P1656; Sandblom E, 2009, AM J PHYSIOL-REG I, V297, pR1136, DOI 10.1152/ajpregu.00363.2009; SCARABELLO M, 1991, RESP PHYSIOL, V84, P245, DOI 10.1016/0034-5687(91)90121-X; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; SILVERSTEIN JT, 1992, J HERED, V83, P282, DOI 10.1093/oxfordjournals.jhered.a111214; SLATER CH, 1994, COMP BIOCHEM PHYS A, V109, P167, DOI 10.1016/0300-9629(94)90323-9; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Walker RV, 2000, FISH OCEANOGR, V9, P171, DOI 10.1046/j.1365-2419.2000.00131.x; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; WOOD CM, 1991, J EXP BIOL, V160, P285	49	65	66	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39079	10.1371/journal.pone.0039079	http://dx.doi.org/10.1371/journal.pone.0039079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720035	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900080
J	Liu, Y; Li, YJ; Luo, EP; Lu, HB; Yin, H				Liu, Yang; Li, Yi-Jun; Luo, Er-Ping; Lu, Hong-Bing; Yin, Hong			Cortical Thinning in Patients with Recent Onset Post-Traumatic Stress Disorder after a Single Prolonged Trauma Exposure	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; HIPPOCAMPAL VOLUME; CEREBRAL-CORTEX; BRAIN; THICKNESS; MEMORY; CINGULATE; SURVIVORS; FMRI	Most of magnetic resonance imaging (MRI) studies about post-traumatic stress disorder (PTSD) focused primarily on measuring of small brain structure volume or regional brain volume changes. There were rare reports investigating cortical thickness alterations in recent onset PTSD. Recent advances in computational analysis made it possible to measure cortical thickness in a fully automatic way, along with voxel-based morphometry (VBM) that enables an exploration of global structural changes throughout the brain by applying statistical parametric mapping (SPM) to high-resolution MRI. In this paper, Laplacian method was utilized to estimate cortical thickness after automatic segmentation of gray matter from MR images under SPM. Then thickness maps were analyzed by SPM8. Comparison between 10 survivors from a mining disaster with recent onset PTSD and 10 survivors without PTSD from the same trauma indicates cortical thinning in the left parietal lobe, right inferior frontal gyrus, and right parahippocampal gyrus. The regional cortical thickness of the right inferior frontal gyrus showed a significant negative correlation with the CAPS score in the patients with PTSD. Our study suggests that shape-related cortical thickness analysis may be more sensitive than volumetric analysis to subtle alteration at early stage of PTSD.	[Liu, Yang; Li, Yi-Jun; Luo, Er-Ping; Lu, Hong-Bing] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Shaanxi, Peoples R China; [Yin, Hong] Xijing Hosp, Dept Radiol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, Y (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Shaanxi, Peoples R China.	luhb@fmmu.edu.cn; yinhong@fmmu.edu.cn	Yin, Hong/AAC-5784-2020; Yin, Hong/G-3877-2014	Yin, Hong/0000-0002-5215-1455	National Natural Science Foundation of China [81071220, 81171278]; National Science & Technology Pillar Program [2011BAI12B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program	This work was partially supported by the National Natural Science Foundation of China under Grant No. 81071220 and 81171278, and the National Science & Technology Pillar Program under Grant No. 2011BAI12B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Chen Z, 2011, EUR J RADIOL    0503; Corbo V, 2005, BIOL PSYCHIAT, V58, P119, DOI 10.1016/j.biopsych.2005.02.032; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Diep TM, 2007, I S BIOMED IMAGING, P592, DOI 10.1109/ISBI.2007.356921; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Geuze E, 2007, PROG BRAIN RES, V167, P293, DOI 10.1016/S0079-6123(07)67026-5; GRIFFIN LD, 1994, J THEOR BIOL, V166, P261, DOI 10.1006/jtbi.1994.1024; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; Haidar H, 2006, J NEUROIMAGING, V16, P146, DOI 10.1111/j.1552-6569.2006.00036.x; HAIDAR H, 2005, J MATH MODELLING ALG, V4, P83, DOI DOI 10.1007/S10852-004-3524-0; Hou CL, 2007, BRAIN RES, V1144, P165, DOI 10.1016/j.brainres.2007.01.089; Hutton C, 2008, NEUROIMAGE, V40, P1701, DOI 10.1016/j.neuroimage.2008.01.027; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Karama S, 2011, NEUROIMAGE, V55, P1443, DOI 10.1016/j.neuroimage.2011.01.016; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landre L, 2010, PSYCHIAT RES-NEUROIM, V183, P181, DOI 10.1016/j.pscychresns.2010.01.015; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Liberzon I, 1996, Depress Anxiety, V4, P146; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Lyons DM, 2007, BIOL PSYCHIAT, V62, P1171, DOI 10.1016/j.biopsych.2007.03.012; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Moores KA, 2008, PSYCHIAT RES-NEUROIM, V163, P156, DOI 10.1016/j.pscychresns.2007.08.011; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Spitzer B, 1996, STRUCT CLIN INT DSMI; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Taylor JG, 2000, NEURAL NETWORKS, V13, P923, DOI 10.1016/S0893-6080(00)00054-X; Thomaes K, 2009, PSYCHIAT RES-NEUROIM, V171, P44, DOI 10.1016/j.pscychresns.2008.03.003; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; Wager TD, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P19, DOI 10.1017/CBO9780511546396.002; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Woodward SH, 2006, AM J PSYCHIAT, V163, P674, DOI 10.1176/appi.ajp.163.4.674; Woodward SH, 2009, ARCH GEN PSYCHIAT, V66, P1373, DOI 10.1001/archgenpsychiatry.2009.160; Wu K.K., 2004, HONG KONG J PSYCHIAT, V14, P2, DOI DOI 10.1007/S00127-003-0611-X; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yehuda R, 2007, J PSYCHIATR RES, V41, P435, DOI 10.1016/j.jpsychires.2005.12.002; Yezzi AJ, 2003, IEEE T MED IMAGING, V22, P1332, DOI 10.1109/TMI.2003.817775; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	63	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39025	10.1371/journal.pone.0039025	http://dx.doi.org/10.1371/journal.pone.0039025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720021	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900075
J	Dai, L; Carter, CS; Ying, J; Bellugi, U; Pournajafi-Nazarloo, H; Korenberg, JR				Dai, Li; Carter, C. Sue; Ying, Jian; Bellugi, Ursula; Pournajafi-Nazarloo, Hossein; Korenberg, Julie R.			Oxytocin and Vasopressin Are Dysregulated in Williams Syndrome, a Genetic Disorder Affecting Social Behavior	PLOS ONE			English	Article							PLASMA OXYTOCIN; NEURAL BASIS; PSYCHOLOGICAL STRESS; AMYGDALA; RELEASE; RESPONSES; BRAIN; MUSIC; CIRCUITRY; ANXIETY	The molecular and neural mechanisms regulating human social-emotional behaviors are fundamentally important but largely unknown; unraveling these requires a genetic systems neuroscience analysis of human models. Williams Syndrome (WS), a condition caused by deletion of similar to 28 genes, is associated with a gregarious personality, strong drive to approach strangers, difficult peer interactions, and attraction to music. WS provides a unique opportunity to identify endogenous human gene-behavior mechanisms. Social neuropeptides including oxytocin (OT) and arginine vasopressin (AVP) regulate reproductive and social behaviors in mammals, and we reasoned that these might mediate the features of WS. Here we established blood levels of OT and AVP in WS and controls at baseline, and at multiple timepoints following a positive emotional intervention (music), and a negative physical stressor (cold). We also related these levels to standardized indices of social behavior. Results revealed significantly higher median levels of OT in WS versus controls at baseline, with a less marked increase in AVP. Further, in WS, OT and AVP increased in response to music and to cold, with greater variability and an amplified peak release compared to controls. In WS, baseline OT but not AVP, was correlated positively with approach, but negatively with adaptive social behaviors. These results indicate that WS deleted genes perturb hypothalamic-pituitary release not only of OT but also of AVP, implicating more complex neuropeptide circuitry for WS features and providing evidence for their roles in endogenous regulation of human social behavior. The data suggest a possible biological basis for amygdalar involvement, for increased anxiety, and for the paradox of increased approach but poor social relationships in WS. They also offer insight for translating genetic and neuroendocrine knowledge into treatments for disorders of social behavior.	[Dai, Li; Korenberg, Julie R.] Univ Utah, Ctr Integrated Neurosci & Human Behav, Salt Lake City, UT 84112 USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Carter, C. Sue; Pournajafi-Nazarloo, Hossein] Univ Illinois, Brain Body Ctr, Chicago, IL USA; [Ying, Jian] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Bellugi, Ursula] Salk Inst Biol Studies, Lab Cognit Neurosci, La Jolla, CA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Utah System of Higher Education; University of Utah; Salk Institute	Dai, L (corresponding author), Univ Utah, Ctr Integrated Neurosci & Human Behav, Salt Lake City, UT 84112 USA.	julie.korenberg@hsc.utah.edu			National Institutes of Health (NIH) [P01 HD33113]; McDonnell Foundation; NIH [MH072935]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD033113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072935] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) P01 HD33113, the McDonnell Foundation (Dr. Bellugi, Dr. Korenberg) and NIH MH072935 (Dr. Carter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Balding DJ, 2004, APPL LONGITUDINAL AN; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Bartz J, 2011, SOC COGN AFFECT NEUR, V6, P556, DOI 10.1093/scan/nsq085; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bellugi U, 1999, NEUROREPORT, V10, P1653, DOI 10.1097/00001756-199906030-00006; Belo CJ, 2010, J DAIRY SCI, V93, P63, DOI 10.3168/jds.2009-2084; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Bruininks RH., 1996, SCALES INDEPENDENT B; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carter CS, 2007, BEHAV BRAIN RES, V176, P170, DOI 10.1016/j.bbr.2006.08.025; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Cherniske EM, 2004, AM J MED GENET A, V131A, P255, DOI 10.1002/ajmg.a.30400; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Choleris E, 2008, PROG BRAIN RES, V170, P291, DOI 10.1016/S0079-6123(08)00424-X; Cyranowski JM, 2008, PSYCHOSOM MED, V70, P967, DOI 10.1097/PSY.0b013e318188ade4; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Dykens EM, 2005, AM J MENT RETARD, V110, P346, DOI 10.1352/0895-8017(2005)110[346:MAAIWS]2.0.CO;2; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Engelmann M, 2000, EXP PHYSIOL, V85, p125S; FALKE N, 1989, NEUROPEPTIDES, V14, P269, DOI 10.1016/0143-4179(89)90056-5; FERRIS C, 1992, ANN NY ACAD SCI, V652, P212, DOI 10.1111/j.1749-6632.1992.tb34357.x; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Goldman M, 2008, SCHIZOPHR RES, V98, P247, DOI 10.1016/j.schres.2007.09.019; Goodson JL, 2010, CURR OPIN NEUROBIOL, V20, P784, DOI 10.1016/j.conb.2010.08.020; Gothelf D, 2008, AM J MED GENET A, V146A, P2753, DOI 10.1002/ajmg.a.32507; Gouin JP, 2010, PSYCHONEUROENDOCRINO, V35, P1082, DOI 10.1016/j.psyneuen.2010.01.009; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P1220, DOI 10.1016/j.biopsych.2010.03.014; Haas BW, 2009, J NEUROSCI, V29, P1132, DOI 10.1523/JNEUROSCI.5324-08.2009; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hoge EA, 2008, CNS NEUROSCI THER, V14, P165, DOI 10.1111/j.1755-5949.2008.00051.x; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Jansen LMC, 2006, J AUTISM DEV DISORD, V36, P891, DOI 10.1007/s10803-006-0124-z; Jarvinen-Pasley A, 2008, DEV PSYCHOPATHOL, V20, P1, DOI 10.1017/S0954579408000011; Jarvinen-Pasley A, 2010, NEUROPSYCHOLOGIA, V48, P456, DOI 10.1016/j.neuropsychologia.2009.10.003; Jones W, 2000, J COGNITIVE NEUROSCI, V12, P30, DOI 10.1162/089892900561968; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Korenberg J.R., 2008, INBORN ERRORS DEV MO, P1544; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LECKMAN JF, 1994, PSYCHONEUROENDOCRINO, V19, P723, DOI 10.1016/0306-4530(94)90021-3; Levitin DJ, 2005, ANN NY ACAD SCI, V1060, P325, DOI 10.1196/annals.1360.027; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Levitin DJ, 2003, NEUROIMAGE, V18, P74, DOI 10.1006/nimg.2002.1297; Mervis CB, 2003, DEV NEUROPSYCHOL, V23, P243, DOI 10.1207/S15326942DN231&2_11; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Meyer-Lindenberg A, 2008, PROG BRAIN RES, V170, P463, DOI 10.1016/S0079-6123(08)00436-6; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Morin V, 2008, J PHARM PHARM SCI, V11, P12; Murphy DJ, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-36; Nilsson U, 2009, J CLIN NURS, V18, P2153, DOI 10.1111/j.1365-2702.2008.02718.x; Nishioka T, 1998, BRAIN RES, V781, P57, DOI 10.1016/S0006-8993(97)01159-1; PEDERSEN FA, 1964, AM J ORTHOPSYCHIAT, V34, P575, DOI 10.1111/j.1939-0025.1964.tb02228.x; Pober Barbara R, 2010, N Engl J Med, V362, P239, DOI 10.1056/NEJMra0903074; Reilly J., 1990, DEV PSYCHOPATHOL, V2, P367, DOI [DOI 10.1017/S0954579400005782, 10.1017/S0954579400005782]; Riby D, 2009, J INTELL DISABIL RES, V53, P169, DOI 10.1111/j.1365-2788.2008.01142.x; Riby DM, 2011, J AUTISM DEV DISORD, V41, P1228, DOI 10.1007/s10803-010-1141-5; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Rosner S, 2003, UNDERSTANDING WILLIA; Ruble LH, 2010, SCHIZOPHR RES, V124, P13, DOI 10.1016/j.schres.2010.09.014; SANDERS G, 1990, PSYCHONEUROENDOCRINO, V15, P47, DOI 10.1016/0306-4530(90)90046-C; Seltzer LJ, 2010, P ROY SOC B-BIOL SCI, V277, P2661, DOI 10.1098/rspb.2010.0567; Semel E., 2003, UNDERSTANDING WILLIA, DOI [10.4324/9781410607416, DOI 10.4324/9781410607416]; Skwerer DP, 2009, SOC COGN AFFECT NEUR, V4, P93, DOI 10.1093/scan/nsn041; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; Taylor SE, 2010, PSYCHOL SCI, V21, P3, DOI 10.1177/0956797609356507; THAUT MH, 1993, J MUSIC THER, V30, P210, DOI 10.1093/jmt/30.4.210; Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; WANG ZX, 1994, P NATL ACAD SCI USA, V91, P400, DOI 10.1073/pnas.91.1.400; Wotjak CT, 1998, NEUROSCIENCE, V85, P1209, DOI 10.1016/S0306-4522(97)00683-0; Yee J. R., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zarchi Omer, 2010, Isr J Psychiatry Relat Sci, V47, P125; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	103	65	65	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38513	10.1371/journal.pone.0038513	http://dx.doi.org/10.1371/journal.pone.0038513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719898	Green Published, gold			2022-12-27	WOS:000305340000027
J	Huang, LL; Yang, X; Sun, P; Tong, W; Hu, SQ				Huang Lulin; Yang Xiao; Sun Pei; Tong Wen; Hu Shangqin			The First Illumina-Based De Novo Transcriptome Sequencing and Analysis of Safflower Flowers	PLOS ONE			English	Article							CARTHAMUS-TINCTORIUS L.; HYDROXYSAFFLOR-YELLOW-A; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; ENDOTHELIAL-CELLS; LINOLEIC-ACID; RNA-SEQ; GENE; OIL; FLAVONOIDS	Background: The safflower, Carthamus tinctorius L., is a worldwide oil crop, and its flowers, which have a high flavonoid content, are an important medicinal resource against cardiovascular disease in traditional medicine. Because the safflower has a large and complex genome, the development of its genomic resources has been delayed. Second-generation Illumina sequencing is now an efficient route for generating an enormous volume of sequences that can represent a large number of genes and their expression levels. Methodology/Principal Findings: To investigate the genes and pathways that might control flavonoids and other secondary metabolites in the safflower, we used Illumina sequencing to perform a de novo assembly of the safflower tubular flower tissue transcriptome. We obtained a total of 4.69 Gb in clean nucleotides comprising 52,119,104 clean sequencing reads, 195,320 contigs, and 120,778 unigenes. Based on similarity searches with known proteins, we annotated 70,342 of the unigenes (about 58% of the identified unigenes) with cut-off E-values of 10(-5). In total, 21,943 of the safflower unigenes were found to have COG classifications, and BLAST2GO assigned 26,332 of the unigenes to 1,754 GO term annotations. In addition, we assigned 30,203 of the unigenes to 121 KEGG pathways. When we focused on genes identified as contributing to flavonoid biosynthesis and the biosynthesis of unsaturated fatty acids, which are important pathways that control flower and seed quality, respectively, we found that these genes were fairly well conserved in the safflower genome compared to those of other plants. Conclusions/Significance: Our study provides abundant genomic data for Carthamus tinctorius L. and offers comprehensive sequence resources for studying the safflower. We believe that these transcriptome datasets will serve as an important public information platform to accelerate studies of the safflower genome, and may help us define the mechanisms of flower tissue-specific and secondary metabolism in this non-model plant.	[Huang Lulin; Yang Xiao; Sun Pei; Tong Wen; Hu Shangqin] Sichuan Acad Agr Sci, Ind Crop Inst, Dept Tradit Chinese Med Study, Jianyang, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS)	Huang, LL (corresponding author), Sichuan Acad Agr Sci, Ind Crop Inst, Dept Tradit Chinese Med Study, Jianyang, Sichuan, Peoples R China.	jysqhu@163.com			foundations of Genetic Engineering of Special Funds by Sichuan province [2011LWJJ-001, 2011JYGC02-006]; Youth Foundation of Sichuan Academy of Agricultural Sciences [2009QNJJ-005]	foundations of Genetic Engineering of Special Funds by Sichuan province; Youth Foundation of Sichuan Academy of Agricultural Sciences	This work was supported by the foundations of Genetic Engineering of Special Funds by Sichuan province (No. 2011LWJJ-001 and No. 2011JYGC02-006) and Youth Foundation of Sichuan Academy of Agricultural Sciences (2009QNJJ-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Chapman MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-60; Chapman MA, 2010, AM J BOT, V97, P831, DOI 10.3732/ajb.0900137; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; De Franco M, 2010, CANCER LETT, V294, P187, DOI 10.1016/j.canlet.2010.01.038; Fan L, 2009, J CHROMATOGR A, V1216, P2063, DOI 10.1016/j.chroma.2008.03.046; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Gecgel U, 2007, J AM OIL CHEM SOC, V84, P47, DOI 10.1007/s11746-006-1007-3; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Higa R, 2010, MOL HUM REPROD, V16, P286, DOI 10.1093/molehr/gap109; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwashina T, 2007, J HERED, V98, P250, DOI 10.1093/jhered/esm012; Ji DB, 2008, J CARDIOVASC PHARM, V52, P191, DOI 10.1097/FJC.0b013e318181fb02; Ji DB, 2009, VASC PHARMACOL, V50, P137, DOI 10.1016/j.vph.2008.11.009; Jiang TF, 2005, J SEP SCI, V28, P1244, DOI 10.1002/jssc.200500001; Jin Y, 2000, Zhongguo Zhong Xi Yi Jie He Za Zhi, V20, P430; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KNUTZON DS, 1992, P NATL ACAD SCI USA, V89, P2624, DOI 10.1073/pnas.89.7.2624; Koyama N, 2009, BRIT J NUTR, V101, P568, DOI 10.1017/S0007114508025786; Li HY, 2011, PLANTA, V233, P611, DOI 10.1007/s00425-010-1327-2; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li Yanmei, 1998, Yaoxue Xuebao, V33, P626; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MELANCON SB, 1982, CAN J NEUROL SCI, V9, P155, DOI 10.1017/S0317167100043870; MESELHY MR, 1993, CHEM PHARM BULL, V41, P1796, DOI 10.1248/cpb.41.1796; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nakao, 1999, Genome Inform Ser Workshop Genome Inform, V10, P94; Natale DA, 2000, GENOME BIOL, V1; Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Pahlavani MH, 2004, J HERED, V95, P265, DOI 10.1093/jhered/esh030; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Shi Ning-ning, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1322; Srinivas CVS, 1999, PLANT FOOD HUM NUTR, V54, P89, DOI 10.1023/A:1008107521247; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Sun CY, 2010, PHYTOTHER RES, V24, P1788, DOI 10.1002/ptr.3166; TABRETT DG, 1982, ANAESTH INTENS CARE, V10, P258, DOI 10.1177/0310057X8201000316; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tian Jing-wei, 2004, Yaoxue Xuebao, V39, P774; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Qiong, 2005, Chin J Integr Med, V11, P222; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015; Zhu HB, 2003, PLANTA MED, V69, P429, DOI 10.1055/s-2003-39714	51	86	109	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38653	10.1371/journal.pone.0038653	http://dx.doi.org/10.1371/journal.pone.0038653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723874	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700019
J	Santos-Valle, P; Guijarro-Munoz, I; Cuesta, AM; Alonso-Camino, V; Villate, M; Alvarez-Cienfuegos, A; Blanco, FJ; Sanz, L; Alvarez-Vallina, L				Santos-Valle, Patricia; Guijarro-Munoz, Irene; Cuesta, Angel M.; Alonso-Camino, Vanesa; Villate, Maider; Alvarez-Cienfuegos, Ana; Blanco, Francisco J.; Sanz, Laura; Alvarez-Vallina, Luis			The Heterotrimeric Laminin Coiled-Coil Domain Exerts Anti-Adhesive Effects and Induces a Pro-Invasive Phenotype	PLOS ONE			English	Article							HUMAN BREAST-CANCER; LARGE GENE LISTS; EXTRACELLULAR-MATRIX; CELL-MIGRATION; MULTIDOMAIN PROTEIN; BINDING SITE; CHAIN; EXPRESSION; CLEAVAGE; ARRAY	Laminins are large heterotrimeric cross-shaped extracellular matrix glycoproteins with terminal globular domains and a coiled-coil region through which the three chains are assembled and covalently linked. Laminins are key components of basement membranes, and they serve as attachment sites for cell adhesion, migration and proliferation. In this work, we produced a recombinant fragment comprising the entire laminin coiled-coil of the alpha 1-, beta 1-, and gamma 1-chains that assemble into a stable heterotrimeric coiled-coil structure independently of the rest of the molecule. This domain was biologically active and not only failed to serve as a substrate for cell attachment, spreading and focal adhesion formation but also inhibited cell adhesion to laminin when added to cells in a soluble form at the time of seeding. Furthermore, gene array expression profiling in cells cultured in the presence of the laminin coiled-coil domain revealed up-regulation of genes involved in cell motility and invasion. These findings were confirmed by real-time quantitative PCR and zymography assays. In conclusion, this study shows for the first time that the laminin coiled-coil domain displays anti-adhesive functions and has potential implications for cell migration during matrix remodeling.	[Santos-Valle, Patricia; Guijarro-Munoz, Irene; Cuesta, Angel M.; Alonso-Camino, Vanesa; Alvarez-Cienfuegos, Ana; Sanz, Laura; Alvarez-Vallina, Luis] Hosp Univ Puerta Hierro, Mol Immunol Unit, Madrid, Spain; [Villate, Maider; Blanco, Francisco J.] CIC BioGUNE, Struct Biol Unit, Derio, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Hospital Puerta de Hierro-Majadahonda; CIC bioGUNE; Basque Foundation for Science	Santos-Valle, P (corresponding author), Hosp Univ Puerta Hierro, Mol Immunol Unit, Madrid, Spain.	lsanz.hpth@salud.madrid.org; lalvarezv.hpth@salud.madrid.org	Alvarez-Vallina, Luis/A-2033-2010; Sanz, Laura/F-8542-2010; AM, Cuesta/AAA-9356-2020; cancer, biogune/H-7276-2012; Blanco, Francisco J/D-4401-2009; Cuesta, Angel/F-1668-2011; Alvarez-Vallina, Luis/ABD-2431-2020	Sanz, Laura/0000-0002-3119-3218; AM, Cuesta/0000-0002-6596-9600; Blanco, Francisco J/0000-0003-2545-4319; Cuesta, Angel/0000-0002-6596-9600; Alvarez-Vallina, Luis/0000-0003-3053-6757	Ministerio de Ciencia e Innovacion [BIO2008-03233]; Comunidad Autonoma de Madrid [S-BIO-0236-2006]; European Union [SUDOE-FEDER] [IMMUNONET-SOE1/P1/E014]; Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III [PI08/90856, PS09/00227]; Fundacion Investigacion Biomedica-Hospital Universitario Puerta de Hierro;  [CTQ2011-28680]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); European Union [SUDOE-FEDER]; Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacion Investigacion Biomedica-Hospital Universitario Puerta de Hierro; 	This study was supported by grants from the Ministerio de Ciencia e Innovacion (BIO2008-03233), the Comunidad Autonoma de Madrid (S-BIO-0236-2006) and the European Union [SUDOE-FEDER (IMMUNONET-SOE1/P1/E014)] to LA-V; from the Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III (PI08/90856 and PS09/00227) and the Fundacion Investigacion Biomedica-Hospital Universitario Puerta de Hierro to LS; and CTQ2011-28680 to FJB and PS-V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; CHIQUETEHRISMANN R, 1995, CURR OPIN CELL BIOL, V7, P715, DOI 10.1016/0955-0674(95)80114-6; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao YH, 2005, BIOCHEM BIOPH RES CO, V335, P343, DOI 10.1016/j.bbrc.2005.07.087; Garamszegi N, 2009, MOL CANCER RES, V7, P319, DOI 10.1158/1541-7786.MCR-08-0227; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Koshikawa N, 2003, FASEB J, V17, P364, DOI 10.1096/fj.03-0584fje; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Mole DJ, 2011, BRIT J CANCER, V104, P1007, DOI 10.1038/bjc.2011.33; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Nomizu M, 1996, BIOCHEMISTRY-US, V35, P2885, DOI 10.1021/bi951555n; NOMIZU M, 1994, J BIOL CHEM, V269, P30386; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; Patani N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-29; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Ramesh R, 2004, MOL THER, V9, P510, DOI 10.1016/j.ymthe.2004.01.019; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Sanchez-Martin D, 2011, J BIOL CHEM, V286, P5197, DOI 10.1074/jbc.M110.161927; Sanz L, 2003, TRENDS MOL MED, V9, P256, DOI 10.1016/S1471-4914(03)00070-4; Sanz L, 2003, EMBO J, V22, P1508, DOI 10.1093/emboj/cdg150; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STEADMAN R, 1993, J LEUKOCYTE BIOL, V53, P354, DOI 10.1002/jlb.53.4.354; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zimmerman T, 2007, J BIOMOL STRUCT DYN, V24, P413, DOI 10.1080/07391102.2007.10507129	45	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39097	10.1371/journal.pone.0039097	http://dx.doi.org/10.1371/journal.pone.0039097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723936	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700048
J	Koo, JE; Hong, HJ; Dearth, A; Kobayashi, KS; Koh, YS				Koo, Jung-Eun; Hong, Hye-Jin; Dearth, Andrea; Kobayashi, Koichi S.; Koh, Young-Sang			Intracellular Invasion of Orientia tsutsugamushi Activates Inflammasome in ASC-Dependent Manner	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; RICKETTSIA-TSUTSUGAMUSHI; SCRUB TYPHUS; CELL-DEATH; AIM2 INFLAMMASOME; HOST-DEFENSE; MICE; RECEPTORS; MACROPHAGES; APOPTOSIS	Orientia tsutsugamushi, a causative agent of scrub typhus, is an obligate intracellular bacterium, which escapes from the endo/phagosome and replicates in the host cytoplasm. O. tsutsugamushi infection induces production of pro-inflammatory mediators including interleukin-1 beta (IL-1 beta), which is secreted mainly from macrophages upon cytosolic stimuli by activating cysteine protease caspase-1 within a complex called the inflammasome, and is a key player in initiating and maintaining the inflammatory response. However, the mechanism for IL-1 beta maturation upon O. tsutsugamushi infection has not been identified. In this study, we show that IL-1 receptor signaling is required for efficient host protection from O. tsutsugamushi infection. Live Orientia, but not heat-or UV-inactivated Orientia, activates the inflammasome through active bacterial uptake and endo/phagosomal maturation. Furthermore, Orientia-stimulated secretion of IL-1 beta and activation of caspase-1 are ASC- and caspase-1- dependent since IL-1 beta production was impaired in Asc- and caspase-1-deficient macrophages but not in Nlrp3-, Nlrc4- and Aim2-deficient macrophages. Therefore, live O. tsutsugamushi triggers ASC inflammasome activation leading to IL-1 beta production, which is a critical innate immune response for effective host defense.	[Koo, Jung-Eun; Hong, Hye-Jin; Koh, Young-Sang] Jeju Natl Univ, Sch Med, Dept Microbiol & Immunol, Brain Korea Program 21, Cheju, Jeju Do, South Korea; [Koo, Jung-Eun; Hong, Hye-Jin; Koh, Young-Sang] Jeju Natl Univ, Inst Med Sci, Cheju, Jeju Do, South Korea; [Dearth, Andrea; Kobayashi, Koichi S.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Jeju National University; Jeju National University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Koo, JE (corresponding author), Jeju Natl Univ, Sch Med, Dept Microbiol & Immunol, Brain Korea Program 21, Cheju, Jeju Do, South Korea.	Koichi_Kobayashi@dfci.harvard.edu; yskoh7@jejunu.ac.kr		Kobayashi, Koichi/0000-0003-2930-0114	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0023645]; NIH [R01DK074738]; Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0023645) to YSK and a grant from the NIH (R01DK074738) to KSK. KSK is a recipient of the Investigator Award from the Cancer Research Institute and the Claudia Adams Barr Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chi WC, 1997, SCAND J INFECT DIS, V29, P634, DOI 10.3109/00365549709035911; Cho BA, 2010, INFECT IMMUN, V78, P1915, DOI 10.1128/IAI.01316-09; Chu H, 2006, INFECT IMMUN, V74, P4246, DOI 10.1128/IAI.01620-05; Chung DR, 2008, J INFECTION, V56, P44, DOI 10.1016/j.jinf.2007.09.009; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim MK, 2002, INFECT IMMUN, V70, P4692, DOI 10.1128/IAI.70.8.4692-4696.2002; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Koh YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011758; Koo JE, 2010, WORLD J MICROB BIOT, V26, P753, DOI 10.1007/s11274-009-0215-z; Koo JE, 2009, MICROBIOL IMMUNOL, V53, P123, DOI 10.1111/j.1348-0421.2008.00098.x; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moron CG, 2001, MODERN PATHOL, V14, P752, DOI 10.1038/modpathol.3880385; MURATA M, 1985, JPN J EXP MED, V55, P193; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; NG FKP, 1985, JPN J MED SCI BIOL, V38, P125, DOI 10.7883/yoken1952.38.125; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; RIKIHISA Y, 1979, J EXP MED, V150, P703, DOI 10.1084/jem.150.3.703; Roy CR, 2006, NAT IMMUNOL, V7, P549, DOI 10.1038/ni0606-549; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Singhsilarak T, 2005, AM J TROP MED HYG, V72, P640, DOI 10.4269/ajtmh.2005.72.640; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Walsh DS, 2001, AM J TROP MED HYG, V65, P899, DOI 10.4269/ajtmh.2001.65.899; WATT G, 1994, CLIN INFECT DIS, V18, P624, DOI 10.1093/clinids/18.4.624; Whitfield NN, 2010, INFECT IMMUN, V78, P423, DOI 10.1128/IAI.00070-09; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	53	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39042	10.1371/journal.pone.0039042	http://dx.doi.org/10.1371/journal.pone.0039042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723924	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300082
J	Lawson, L; Zhang, J; Gomgnimbou, MK; Abdurrahman, ST; Le Moullec, S; Mohamed, F; Uzoewulu, GN; Sogaolu, OM; Goh, KS; Emenyonu, N; Refregier, G; Cuevas, LE; Sola, C				Lawson, Lovett; Zhang, Jian; Gomgnimbou, Michel K.; Abdurrahman, Saddiq T.; Le Moullec, Stephanie; Mohamed, Fatima; Uzoewulu, Gertrude N.; Sogaolu, Olumide M.; Goh, Khye Seng; Emenyonu, Nnamdi; Refregier, Guislaine; Cuevas, Luis E.; Sola, Christophe			A Molecular Epidemiological and Genetic Diversity Study of Tuberculosis in Ibadan, Nnewi and Abuja, Nigeria	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; COMPLEX STRAINS; BURKINA-FASO; BACTERIA; CLASSIFICATION; HYBRIDIZATION; THROUGHPUT; RESISTANCE; CAMEROON; CLUSTER	Background: Nigeria has the tenth highest burden of tuberculosis (TB) among the 22 TB high-burden countries in the world. This study describes the biodiversity and epidemiology of drug-susceptible and drug-resistant TB in Ibadan, Nnewi and Abuja, using 409 DNAs extracted from culture positive TB isolates. Methodology/Principal Findings: DNAs extracted from clinical isolates of Mycobacterium tuberculosis complex were studied by spoligotyping and 24 VNTR typing. The Cameroon clade (CAM) was predominant followed by the M. africanum (West African 1) and T (mainly T2) clades. By using a smooth definition of clusters, 32 likely epi-linked clusters related to the Cameroon genotype family and 15 likely epi-linked clusters related to other "modern'' genotypes were detected. Eight clusters concerned M. africanum West African 1. The recent transmission rate of TB was 38%. This large study shows that the recent transmission of TB in Nigeria is high, without major regional differences, with MDR-TB clusters. Improvement in the TB control programme is imperative to address the TB control problem in Nigeria.	[Lawson, Lovett; Emenyonu, Nnamdi] Zankli Med Ctr, Abuja, Nigeria; [Zhang, Jian; Gomgnimbou, Michel K.; Le Moullec, Stephanie; Mohamed, Fatima; Refregier, Guislaine; Sola, Christophe] Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR8621, F-91405 Orsay, France; [Abdurrahman, Saddiq T.] Natl TB & Leprosy Control Programme, Abuja, Nigeria; [Uzoewulu, Gertrude N.] Nnamdi Azikiwe Teaching Hosp, Nnewi, Nigeria; [Sogaolu, Olumide M.] Univ Coll Hosp, Ibadan, Nigeria; [Emenyonu, Nnamdi; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Ibadan; University College Hospital, Ibadan; Liverpool School of Tropical Medicine; University of Liverpool	Lawson, L (corresponding author), Zankli Med Ctr, Abuja, Nigeria.	christophe.sola@u-psud.fr	Cuevas, Luis E/I-3697-2015; Sola, Christophe/A-7992-2016; Refregier, Guislaine/AAU-8777-2021	Cuevas, Luis E/0000-0002-6581-0587; Sola, Christophe/0000-0003-4672-2140; Refregier, Guislaine/0000-0003-3749-7981; Lawson, Lovett/0000-0001-9019-7537	CNRS; Fondation Merieux, (Lyon, France); Luminex Corp. Austin, TX	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Merieux, (Lyon, France); Luminex Corp. Austin, TX	M. Francois Topin, Luminex BV, The Netherlands, is acknowledged for technical support. M.K.G is a PhD fellow of the IGEPE Team supported by the CNRS and the Fondation Merieux, (Lyon, France).; All authors, except CS, declare to have no competing interests. CS is an Academic Editor of PLoS ONE. CS also acknowledges receiving travel grants for speaking or participation at Luminex meetings. He does not have stocks or shares, is not paid, employed or consultant, does not belong to the Board membership, does not hold Patent applications (pending or actual) or benefitted from Research grants from Luminex Corp. Austin, TX. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Akhtar P, 2009, J MED MICROBIOL, V58, P798, DOI 10.1099/jmm.0.002550-0; Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Jong BC, 2009, J CLIN MICROBIOL; Demay C, 2012, INFECT GENET EV 0217, V17; Diguimbaye C, 2006, J CLIN MICROBIOL, V44, P1575, DOI 10.1128/JCM.44.4.1575-1577.2006; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Fabre L, 2012, PLOS ONE IN PRESS; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Godreuil S, 2007, AIDS, V21, P248, DOI 10.1097/QAD.0b013e328011ec64; Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275; Jenkins AO, 2011, VET MICROBIOL, V151, P139, DOI 10.1016/j.vetmic.2011.02.037; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Lawson L, 2011, TROP MED INT HLTH; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Muller B, 2009, J BACTERIOL, V191, P1951, DOI 10.1128/JB.01590-08; Murray M, 2002, P NATL ACAD SCI USA, V99, P1538, DOI 10.1073/pnas.022618299; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Streicher EM, 2011, INFECT GENET EVOL; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tafaj S, 2009, J CLIN MICROBIOL, V47, P1581, DOI 10.1128/JCM.02284-08; Thumamo BP, 2011, INFECT GENET EVOL; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Zhang J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-42; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	41	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38409	10.1371/journal.pone.0038409	http://dx.doi.org/10.1371/journal.pone.0038409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723859	Green Published, Green Accepted, gold			2022-12-27	WOS:000305583300027
J	Liu, Y; Wu, BQ; Zhong, HH; Tian, XX; Fang, WG				Liu, Yan; Wu, Bing-quan; Zhong, Hao-hao; Tian, Xin-xia; Fang, Wei-gang			Quantification of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase and Correlations with Telomerase Activity in Lung Cancer	PLOS ONE			English	Article							REPEAT AMPLIFICATION PROTOCOL; MESSENGER-RNA; QUANTITATIVE-ANALYSIS; HTERT EXPRESSION; DELETION VARIANT; ASSAY; GENE; CARCINOMA; CELLS; DIFFERENTIATION	Telomerase plays important roles in the development and progression of malignant tumors, and its activity is primarily determined by transcriptional regulation of human telomerase reverse transcriptase (hTERT). Several mRNA alternative splicing variants (ASVs) for hTERT have been identified, but it remains unclear whether telomerase activity is directly associated with hTERT splicing transcripts. In this study, we developed novel real-time PCR protocols using molecular beacons and applied to lung carcinoma cell lines and cancerous tissues for quantification of telomerase activity and three essential hTERT deletion transcripts respectively. The results showed that lung carcinoma cell lines consistently demonstrated telomerase activity (14.22-31.43 TPG units per 100 cells) and various hTERT alternative splicing transcripts. For 165 lung cancer cases, telomerase activity showed significant correlation with tumor differentiation (poorly-> moderately-> well-differentiated, P < 0.01) and with histotypes (combined small cell and squamous cell carcinoma > squamous cell carcinoma > adenosquamous carcinoma > adenocarcinoma, P < 0.05). Although the overall hTERT transcripts were detected in all the samples, they were not associated with telomerase activity (r = 0.092, P = 0.24). Telomerase activity was significantly correlated with the transcriptional constituent ratio of alpha-deletion (r = -0.267, P = 0.026), beta-deletion (r = -0.693, P = 0.0001) and gamma-deletion (r = -0.614, P = 0.001). The positive rate and average constituent ratio of beta-deletion transcripts (92.12%, 0.23) were higher than those of alpha-deletion (41.82%, 0.12) or gamma-deletion (16.36%, 0.18) transcripts. The combined small-cell and squamous cell carcinomas expressed less deletion transcripts, especially beta-deletion, than other histotypes, which might explain their higher telomerase activity. In conclusion, the molecular beacon-based real-time PCR protocols are rapid, sensitive and specific methods to quantify telomerase activity and hTERT ASVs. Telomerase activity may serve as a reliable and effective molecular marker to assist the evaluation of histological subtype and differentiation of lung carcinomas. Further studies on hTERT deletion splicing transcripts, rather than the overall hTERT transcripts, may improve our understanding of telomerase regulation.	[Liu, Yan; Wu, Bing-quan; Zhong, Hao-hao; Tian, Xin-xia; Fang, Wei-gang] Peking Univ, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci, Minist Educ,Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University	Liu, Y (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci, Minist Educ,Hlth Sci Ctr, Beijing 100871, Peoples R China.	tianxinxia@yahoo.com; wgfang@bjmu.edu.cn			Ministry of Science and Technology of China [2010CB529402]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants to WG Fang from the 973 Program (2010CB529402) from The Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchler P, 2001, PANCREAS, V22, P331, DOI 10.1097/00006676-200105000-00001; Colgin LM, 2000, NEOPLASIA, V2, P426, DOI 10.1038/sj.neo.7900112; Elmore LW, 2002, DIAGN MOL PATHOL, V11, P177, DOI 10.1097/00019606-200209000-00009; Fujiwara M, 2000, MODERN PATHOL, V13, P723, DOI 10.1038/modpathol.3880125; Hara T, 2001, UROL RES, V29, P1, DOI 10.1007/s002400000156; Hartmann U, 2005, HAEMATOLOGICA, V90, P307; Hisatomi H, 2003, NEOPLASIA, V5, P193, DOI 10.1016/S1476-5586(03)80051-9; Hou M, 2001, CLIN CHEM, V47, P519; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lantuejoul S, 2004, BRIT J CANCER, V90, P1222, DOI 10.1038/sj.bjc.6601643; Lincz LF, 2008, NEOPLASIA, V10, P1131, DOI 10.1593/neo.08644; Liu Y, 2010, PATHOL INT, V60, P386, DOI 10.1111/j.1440-1827.2010.02529.x; Maniwa Y, 2001, CHEST, V120, P589, DOI 10.1378/chest.120.2.589; Marchetti A, 2002, LAB INVEST, V82, P729, DOI 10.1097/01.LAB.0000017165.26718.60; Mavrogiannou E, 2007, CLIN CHEM, V53, P53, DOI 10.1373/clinchem.2006.073015; McGruder BM, 2006, CANCER LETT, V244, P91, DOI 10.1016/j.canlet.2005.12.012; Ohmura Y, 2000, CLIN CANCER RES, V6, P2980; Piotrowska K, 2005, LAB INVEST, V85, P1565, DOI 10.1038/labinvest.3700352; Rha SY, 2009, ONCOL RES, V18, P213, DOI 10.3727/096504009X12596189659123; Saeboe-Larssen S, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-26; Taveau M, 2002, ANAL BIOCHEM, V305, P227, DOI 10.1006/abio.2002.5664; Ulaner GA, 2001, INT J CANCER, V91, P644, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.3.CO;2-M; Wang J, 2000, CHINESE MED J-PEKING, V113, P985; Wang L, 2002, CLIN CANCER RES, V8, P2883; Wang YC, 2008, THYROID, V18, P1055, DOI 10.1089/thy.2008.0101; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wu TC, 2003, LUNG CANCER-J IASLC, V41, P163, DOI 10.1016/S0169-5002(03)00195-8; Xu JH, 2009, PATHOBIOLOGY, V76, P23, DOI 10.1159/000178152; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818	30	22	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38868	10.1371/journal.pone.0038868	http://dx.doi.org/10.1371/journal.pone.0038868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723897	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300062
J	Podlesakova, K; Zalabak, D; Cudejkova, M; Plihal, O; Szucova, L; Dolezal, K; Spichal, L; Strnad, M; Galuszka, P				Podlesakova, Katerina; Zalabak, David; Cudejkova, Maria; Plihal, Ondrej; Szuecova, Lucie; Dolezal, Karel; Spichal, Lukas; Strnad, Miroslav; Galuszka, Petr			Novel Cytokinin Derivatives Do Not Show Negative Effects on Root Growth and Proliferation in Submicromolar Range	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; BIOLOGICAL-ACTIVITY; SOMACLONAL VARIATION; MERISTEM ACTIVITY; HISTIDINE KINASE; LEAF SENESCENCE; PLANT-TISSUES; METABOLISM; RECEPTOR; SPECIFICITY	Background: When applied to a nutrition solution or agar media, the non-substituted aromatic cytokinins caused thickening and shortening of the primary root, had an inhibitory effect on lateral root branching, and even showed some negative effects on development of the aerial part at as low as a 10 nanomolar concentration. Novel analogues of aromatic cytokinins ranking among topolins substituted on N9-atom of adenine by tetrahydropyranyl or 4-chlorobutyl group have been prepared and tested in standardized cytokinin bioassays [1]. Those showing comparable activities with N-6 benzylaminopurine were further tested in planta. Methodology/Principal Findings: The main aim of the study was to explain molecular mechanism of function of novel cytokinin derivatives on plant development. Precise quantification of cytokinin content and profiling of genes involved in cytokinin metabolism and perception in treated plants revealed several aspects of different action of m-methoxytopolin base and its substituted derivative on plant development. In contrast to standard cytokinins, N9- tetrahydropyranyl derivative of m-topolin and its methoxy-counterpart showed the negative effects on root development only at three orders of magnitude higher concentrations. Moreover, the methoxy-derivative demonstrates a positive effect on lateral root branching and leaf emerging in a nanomolar range of concentrations, in comparison with untreated plants. Conclusions/Significance: Tetrahydropyranyl substitution at N9-position of cytokinin purine ring significantly enhances acropetal transport of a given cytokinins. Together with the methoxy-substitution, impedes accumulation of non-active cytokinin glucoside forms in roots, allows gradual release of the active base, and has a significant effect on the distribution and amount of endogenous isoprenoid cytokinins in different plant tissues. The utilization of novel aromatic cytokinin derivatives can distinctively improve expected hormonal effects in plant propagation techniques in the future.	[Podlesakova, Katerina; Galuszka, Petr] Palacky Univ, Fac Sci, Dept Biochem, CR-77147 Olomouc, Czech Republic; [Zalabak, David; Cudejkova, Maria; Plihal, Ondrej; Szuecova, Lucie; Dolezal, Karel; Spichal, Lukas; Strnad, Miroslav; Galuszka, Petr] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Podlesakova, K (corresponding author), Palacky Univ, Fac Sci, Dept Biochem, CR-77147 Olomouc, Czech Republic.	petr.galuszka@upol.cz	Spichal, Lukas/H-6873-2014; Plíhalová, Lucie/F-6118-2014; Doležal, Karel/H-2436-2014; PLÍHAL, Ondřej/AAC-9319-2021; Strnad, Miroslav/H-1858-2014	Doležal, Karel/0000-0003-4938-0350; PLÍHAL, Ondřej/0000-0003-0645-2019; Strnad, Miroslav/0000-0002-2806-794X; Zalabak, David/0000-0002-4825-8321; Spichal, Lukas/0000-0001-6483-8628	Czech Ministry of Education Youth and Sports [OP RDI ED0007/01/01]; National Science Foundation, Czech Republic [522/08/0920, P501/10/1141]	Czech Ministry of Education Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); National Science Foundation, Czech Republic(Czech Republic Government)	This work was supported by the Czech Ministry of Education Youth and Sports (grant number OP RD&I ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research) and the National Science Foundation, Czech Republic (grant numbers 522/08/0920 and P501/10/1141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer CA, 1996, J PLANT GROWTH REGUL, V15, P201, DOI 10.1007/BF00190585; Bairu MW, 2008, PLANT CELL TISS ORG, V95, P373, DOI 10.1007/s11240-008-9451-4; Bairu MW, 2006, SCI HORTIC-AMSTERDAM, V108, P347, DOI 10.1016/j.scienta.2006.01.039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTELL G, 1992, PHYSIOL PLANTARUM, V84, P255, DOI 10.1111/j.1399-3054.1992.tb04662.x; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; CORSE J, 1989, J PLANT GROWTH REGUL, V8, P211, DOI 10.1007/BF02308090; Debnath SC, 2008, PLANT CELL TISS ORG, V93, P231, DOI 10.1007/s11240-008-9366-0; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Filipi T, 2012, PHYTOCHEMISTRY, V74, P40, DOI 10.1016/j.phytochem.2011.10.008; FOX JE, 1971, PLANT PHYSIOL, V47, P275, DOI 10.1104/pp.47.2.275; Gallie DR, 2004, MOL GENET GENOMICS, V271, P267, DOI 10.1007/s00438-004-0977-9; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Holub J, 1998, PLANT GROWTH REGUL, V26, P109, DOI 10.1023/A:1006192619432; Hothorn M, 2011, NAT CHEM BIOL, V7, P766, DOI 10.1038/nchembio.667; Kopecny D, 2010, BIOCHIMIE, V92, P1052, DOI 10.1016/j.biochi.2010.05.006; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; LETHAM DS, 1978, PHYTOCHEMISTRY, V17, P2053, DOI 10.1016/S0031-9422(00)89279-1; MCGAW BA, 1984, PHYTOCHEMISTRY, V23, P1373, DOI 10.1016/S0031-9422(00)80468-9; MCGAW BA, 1985, PHYTOCHEMISTRY, V24, P9, DOI 10.1016/S0031-9422(00)80797-9; Mik V, 2011, PHYTOCHEMISTRY, V72, P821, DOI 10.1016/j.phytochem.2011.02.002; Mok MC, 2005, PLANT PHYSIOL, V137, P1057, DOI 10.1104/pp.104.057174; Nisler J, 2010, PHYTOCHEMISTRY, V71, P823, DOI 10.1016/j.phytochem.2010.01.018; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; PIETRAFACE WJ, 1981, PHYSIOL PLANTARUM, V53, P249, DOI 10.1111/j.1399-3054.1981.tb04495.x; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; Saleem M, 2010, PLANT PHYSIOL, V152, P4, DOI 10.1104/pp.109.150425; Spichal L, 2004, PLANT CELL PHYSIOL, V45, P1299, DOI 10.1093/pcp/pch132; Spichal L, 2009, FEBS J, V276, P244, DOI 10.1111/j.1742-4658.2008.06777.x; SUL IW, 1994, IN VITRO CELL DEV-PL, V30P, P131; Suttle JC, 2005, J PLANT PHYSIOL, V162, P1189, DOI 10.1016/j.jplph.2005.03.012; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Szucova L, 2009, BIOORGAN MED CHEM, V17, P1938, DOI 10.1016/j.bmc.2009.01.041; Tarkowska D, 2003, PHYSIOL PLANTARUM, V117, P579, DOI 10.1034/j.1399-3054.2003.00071.x; Valero-Aracama C, 2010, PLANT GROWTH REGUL, V60, P43, DOI 10.1007/s10725-009-9417-5; Vyroubalova S, 2009, PLANT PHYSIOL, V151, P433, DOI 10.1104/pp.109.142489; WEAVER RJ, 1965, NATURE, V206, P952, DOI 10.1038/206952b0; WERBROUCK SPO, 1995, PLANT CELL REP, V14, P662, DOI 10.1007/BF00232734; Werbrouck SPO, 1996, PHYSIOL PLANTARUM, V98, P291, DOI 10.1034/j.1399-3054.1996.980210.x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; West T.P., 2004, ACTA HORTIC, V630, P293; WINKLER R, 1992, J AGR FOOD CHEM, V40, P2008, DOI 10.1021/jf00022a054; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yonekura-Sakakibara K, 2004, PLANT PHYSIOL, V134, P1654, DOI 10.1104/pp.103.037176; ZHANG R, 1989, J PLANT GROWTH REGUL, V8, P181, DOI 10.1007/BF02308087	54	43	44	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39293	10.1371/journal.pone.0039293	http://dx.doi.org/10.1371/journal.pone.0039293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723989	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300130
J	van Oterendorp, C; Sgouris, S; Bach, M; Martin, G; Biermann, J; Jordan, JF; Lagreze, WA				van Oterendorp, Christian; Sgouris, Stavros; Bach, Michael; Martin, Gottfried; Biermann, Julia; Jordan, Jens F.; Lagreze, Wolf A.			Quantification of Retrograde Axonal Transport in the Rat Optic Nerve by Fluorogold Spectrometry	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; CELL-DEATH; GLAUCOMA; PROJECTIONS; NEURONS; ROLES; MODEL	Purpose: Disturbed axonal transport is an important pathogenic factor in many neurodegenerative diseases, such as glaucoma, an eye disease characterised by progressive atrophy of the optic nerve. Quantification of retrograde axonal transport in the optic nerve usually requires labour intensive histochemical techniques or expensive equipment for in vivo imaging. Here, we report on a robust alternative method using Fluorogold (FG) as tracer, which is spectrometrically quantified in retinal tissue lysate. Methods: To determine parameters reflecting the relative FG content of a sample FG was dissolved in retinal lysates at different concentrations and spectra were obtained. For validation in vivo FG was injected uni- or bilaterally into the superior colliculus (SC) of Sprague Dawley rats. The retinal lysate was analysed after 3, 5 and 7 days to determine the time course of FG accumulation in the retina (n = 15). In subsequent experiments axona transport was impaired by optic nerve crush (n = 3), laser-induced ocular hypertension (n = 5) or colchicine treatment to the SC (n = 10). Results: Spectrometry at 370 nm excitation revealed two emission peaks at 430 and 610 nm. We devised a formula to calculate the relative FG content (c(FG)), from the emission spectrum. c(FG) is proportional to the real FG concentration as it corrects for variations of retinal protein concentration in the lysate. After SC injection, c(FG) monotonously increases with time (p = 0.002). Optic nerve axonal damage caused a significant decrease of c(FG) (crush p = 0.029; hypertension p = 0.025; colchicine p = 0.006). Lysates are amenable to subsequent protein analysis. Conclusions: Spectrometrical FG detection in retinal lysates allows for quantitative assessment of retrograde axonal transport using standard laboratory equipment. It is faster than histochemical techniques and may also complement morphological in vivo analyses.	[van Oterendorp, Christian; Sgouris, Stavros; Bach, Michael; Martin, Gottfried; Biermann, Julia; Jordan, Jens F.; Lagreze, Wolf A.] Univ Eye Hosp Freiburg, Freiburg, Germany	University of Freiburg	van Oterendorp, C (corresponding author), Univ Eye Hosp Freiburg, Freiburg, Germany.	christian.oterendorp@uniklinik-freiburg.de	Bach, Michael/A-6637-2010	Bach, Michael/0000-0003-2028-535X				Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Catapano Lisa A., 2008, V438, P353, DOI 10.1007/978-1-59745-133-8_27; Chan KC, 2008, NEUROIMAGE, V40, P1166, DOI 10.1016/j.neuroimage.2008.01.002; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Grieshaber P, 2010, J NEUROSCI METH, V192, P233, DOI 10.1016/j.jneumeth.2010.07.037; Haenold R, 2012, NEUROIMAGE, V59, P363, DOI 10.1016/j.neuroimage.2011.07.069; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; JOHANSSON JO, 1988, EXP EYE RES, V46, P223, DOI 10.1016/S0014-4835(88)80079-4; Johnson EC, 2009, EXP EYE RES, V88, P808, DOI 10.1016/j.exer.2009.02.004; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; KUYPERS HGJ, 1974, BRAIN RES, V67, P211, DOI 10.1016/0006-8993(74)90273-X; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; LYNCH G, 1974, BRAIN RES, V65, P373, DOI 10.1016/0006-8993(74)90229-7; Matsuda K, 2010, NEUROIMAGE, V50, P366, DOI 10.1016/j.neuroimage.2010.01.008; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; MUFSON EJ, 1994, EXP NEUROL, V129, P15, DOI 10.1006/exnr.1994.1143; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1995, AUST NZ J OPHTHALMOL, V23, P85, DOI 10.1111/j.1442-9071.1995.tb00135.x; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; SCHMUED LC, 1986, BRAIN RES, V377, P147, DOI 10.1016/0006-8993(86)91199-6; van Oterendorp C, 2011, EXP EYE RES, V92, P138, DOI 10.1016/j.exer.2010.11.013; Vavlitou N, 2010, J NEUROPATH EXP NEUR, V69, P945, DOI 10.1097/NEN.0b013e3181efa658; Vrabec JP, 2007, EYE, V21, pS11, DOI 10.1038/sj.eye.6702880	25	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38820	10.1371/journal.pone.0038820	http://dx.doi.org/10.1371/journal.pone.0038820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719956	gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300054
J	Craig, JM; Vena, N; Ramkissoon, S; Idbaih, A; Fouse, SD; Ozek, M; Sav, A; Hill, DA; Margraf, LR; Eberhart, CG; Kieran, MW; Norden, AD; Wen, PY; Loda, M; Santagata, S; Ligon, KL; Ligon, AH				Craig, Justin M.; Vena, Natalie; Ramkissoon, Shakti; Idbaih, Ahmed; Fouse, Shaun D.; Ozek, Memet; Sav, Aydin; Hill, D. Ashley; Margraf, Linda R.; Eberhart, Charles G.; Kieran, Mark W.; Norden, Andrew D.; Wen, Patrick Y.; Loda, Massimo; Santagata, Sandro; Ligon, Keith L.; Ligon, Azra H.			DNA Fragmentation Simulation Method (FSM) and Fragment Size Matching Improve aCGH Performance of FFPE Tissues	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HIGH-RESOLUTION ANALYSIS; COPY-NUMBER; ARRAY-CGH; SYSTEM	Whole-genome copy number analysis platforms, such as array comparative genomic hybridization (aCGH) and single nucleotide polymorphism (SNP) arrays, are transformative research discovery tools. In cancer, the identification of genomic aberrations with these approaches has generated important diagnostic and prognostic markers, and critical therapeutic targets. While robust for basic research studies, reliable whole-genome copy number analysis has been unsuccessful in routine clinical practice due to a number of technical limitations. Most important, aCGH results have been suboptimal because of the poor integrity of DNA derived from formalin-fixed paraffin-embedded (FFPE) tissues. Using self-hybridizations of a single DNA sample we observed that aCGH performance is significantly improved by accurate DNA size determination and the matching of test and reference DNA samples so that both possess similar fragment sizes. Based on this observation, we developed a novel DNA fragmentation simulation method (FSM) that allows customized tailoring of the fragment sizes of test and reference samples, thereby lowering array failure rates. To validate our methods, we combined FSM with Universal Linkage System (ULS) labeling to study a cohort of 200 tumor samples using Agilent 1 M feature arrays. Results from FFPE samples were equivalent to results from fresh samples and those available through the glioblastoma Cancer Genome Atlas (TCGA). This study demonstrates that rigorous control of DNA fragment size improves aCGH performance. This methodological advance will permit the routine analysis of FFPE tumor samples for clinical trials and in daily clinical practice.	[Craig, Justin M.; Vena, Natalie; Ramkissoon, Shakti; Ligon, Keith L.; Ligon, Azra H.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Craig, Justin M.; Vena, Natalie; Loda, Massimo; Ligon, Keith L.; Ligon, Azra H.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti; Loda, Massimo; Santagata, Sandro; Ligon, Keith L.; Ligon, Azra H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Idbaih, Ahmed] Hop La Pitie Salpetriere, Serv Neurol Mazarin, Paris, France; [Fouse, Shaun D.] Univ Calif San Francisco, Brain Tumor Res Ctr, Dept Neurosurg, San Francisco, CA 94143 USA; [Ozek, Memet] Acibadem Univ, Med Ctr, Div Pediat Neurosurg, Istanbul, Turkey; [Sav, Aydin] Acibadem Univ, Med Ctr, Dept Pathol, Istanbul, Turkey; [Hill, D. Ashley] Childrens Natl Med Ctr, Dept Pathol, Washington, DC 20010 USA; [Margraf, Linda R.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol Oncol & Ophthalmol, Baltimore, MD USA; [Kieran, Mark W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kieran, Mark W.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Norden, Andrew D.; Wen, Patrick Y.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Norden, Andrew D.; Wen, Patrick Y.] Dana Farber Canc Inst, Ctr Neuro Oncol, Boston, MA 02115 USA; [Santagata, Sandro; Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Kieran, Mark W.; Norden, Andrew D.; Wen, Patrick Y.; Loda, Massimo; Santagata, Sandro; Ligon, Keith L.; Ligon, Azra H.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco; Acibadem University; Acibadem University; Children's National Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Craig, JM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	keith_ligon@dfci.harvard.edu; aligon@rics.bwh.harvard.edu	SAV, Aydin/ABI-3989-2020; Wen, Patrick/AAE-3776-2022; Idbaih, Ahmed/N-8746-2017	SAV, Aydin/0000-0002-7326-7801; Idbaih, Ahmed/0000-0001-5290-1204; Ligon, Keith/0000-0002-7733-600X; Kieran, Mark/0000-0003-2184-7692; Santagata, Sandro/0000-0002-7528-9668	National Institutes of Health (NIH) [CA142536, CA095616, NS064168]; Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine; Goldhirsh Foundation; Sontag Foundation; American Brain Tumor Association; Friends of Dana-Farber Cancer Institute; DFCI Pediatric Low Grade Astrocytoma Foundation; NATIONAL CANCER INSTITUTE [P01CA142536, P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine; Goldhirsh Foundation; Sontag Foundation; American Brain Tumor Association; Friends of Dana-Farber Cancer Institute; DFCI Pediatric Low Grade Astrocytoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) grant CA142536 (KLL), CA095616 (KLL), NS064168 (SS), the Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine (AHL), the Goldhirsh Foundation (KLL), the Sontag Foundation (KLL), the American Brain Tumor Association (AI), Friends of Dana-Farber Cancer Institute (ADN) and the DFCI Pediatric Low Grade Astrocytoma Foundation (MWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2011, METHODS MOL BIOL, V724, P131, DOI 10.1007/978-1-61779-055-3_9; Alers JC, 1999, GENE CHROMOSOME CANC, V25, P301, DOI 10.1002/(SICI)1098-2264(199907)25:3<301::AID-GCC13>3.0.CO;2-1; Alers JC, 1997, LAB INVEST, V77, P437; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Braggio E, 2011, CLIN CANCER RES, V17, P4245, DOI 10.1158/1078-0432.CCR-11-0395; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Buffart TE, 2007, CELL ONCOL, V29, P351; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corless CL, 2011, SCIENCE, V334, P1217, DOI 10.1126/science.1216427; DeVries S, 2005, J MOL DIAGN, V7, P65, DOI 10.1016/S1525-1578(10)60010-4; GUSTAFSON CE, 1993, GENE, V123, P241, DOI 10.1016/0378-1119(93)90130-U; Harada S, 2011, J MOL DIAGN, V13, P541, DOI 10.1016/j.jmoldx.2011.05.009; Heetebrij RJ, 2003, CHEMBIOCHEM, V4, P573, DOI 10.1002/cbic.200200498; Hostetter G, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp881; Idbaih A, 2010, BRAIN PATHOL, V20, P28, DOI 10.1111/j.1750-3639.2009.00274.x; Johnson NA, 2006, LAB INVEST, V86, P968, DOI 10.1038/labinvest.3700441; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Mc Sherry EA, 2007, CLIN GENET, V72, P441, DOI 10.1111/j.1399-0004.2007.00882.x; Mohapatra G, 2011, ACTA NEUROPATHOL, V121, P529, DOI 10.1007/s00401-010-0773-z; Nowak NJ, 2007, GENET MED, V9, P585, DOI 10.1097/GIM.0b013e3181461c4a; Paris PL, 2007, PROSTATE, V67, P1447, DOI 10.1002/pros.20632; Paris PL, 2003, AM J PATHOL, V162, P763, DOI 10.1016/S0002-9440(10)63873-4; Peytavi R, 2005, BIOTECHNIQUES, V39, P89, DOI 10.2144/05391RR01; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Przybytkowski E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-16; Savage SJ, 2011, METHODS MOL BIOL, V700, P185, DOI 10.1007/978-1-61737-954-3_13; SUZUKI T, 1994, NUCLEIC ACIDS RES, V22, P4997, DOI 10.1093/nar/22.23.4997; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; van Gijlswijk R P, 2001, Expert Rev Mol Diagn, V1, P81, DOI 10.1586/14737159.1.1.81; Wessels LFA, 2002, CANCER RES, V62, P7110	36	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38881	10.1371/journal.pone.0038881	http://dx.doi.org/10.1371/journal.pone.0038881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719973	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000025
J	Drury, PP; Bennet, L; Booth, LC; Davidson, JO; Wassink, G; Gunn, AJ				Drury, Paul P.; Bennet, Laura; Booth, Lindsea C.; Davidson, Joanne O.; Wassink, Guido; Gunn, Alistair J.			Maturation of the Mitochondrial Redox Response to Profound Asphyxia in Fetal Sheep	PLOS ONE			English	Article							UMBILICAL-CORD OCCLUSION; CEREBRAL-BLOOD-FLOW; NEAR-INFRARED SPECTROSCOPY; MAGNETIC-RESONANCE-SPECTROSCOPY; CYTOCHROME-OXIDASE; ISCHEMIC BRAIN; RAT-BRAIN; ELECTROCORTICAL ACTIVITY; EPILEPTIFORM ACTIVITY; ENERGY-METABOLISM	Fetal susceptibility to hypoxic brain injury increases over the last third of gestation. This study examined the hypothesis that this is associated with impaired mitochondrial adaptation, as measured by more rapid oxidation of cytochrome oxidase (CytOx) during profound asphyxia. Methods: Chronically instrumented fetal sheep at 0.6, 0.7, and 0.85 gestation were subjected to either 30 min (0.6 gestational age (ga), n = 6), 25 min (0.7 ga, n = 27) or 15 min (0.85 ga, n = 17) of complete umbilical cord occlusion. Fetal EEG, cerebral impedance (to measure brain swelling) and near-infrared spectroscopy-derived intra-cerebral oxygenation (Delta Hb = HbO(2) - Hb), total hemoglobin (THb) and CytOx redox state were monitored continuously. Occlusion was associated with profound, rapid fall in DHb in all groups to a plateau from 6 min, greatest at 0.85 ga compared to 0.6 and 0.7 ga (p<0.05). THb initially increased at all ages, with the greatest rise at 0.85 ga (p<0.05), followed by a progressive fall from 7 min in all groups. CytOx initially increased in all groups with the greatest rise at 0.85 ga (p<0.05), followed by a further, delayed increase in preterm fetuses, but a striking fall in the 0.85 group after 6 min of occlusion. Cerebral impedance (a measure of cytotoxic edema) increased earlier and more rapidly with greater gestation. In conclusion, the more rapid rise in CytOx and cortical impedance during profound asphyxia with greater maturation is consistent with increasing dependence on oxidative metabolism leading to earlier onset of neural energy failure before the onset of systemic hypotension.	[Drury, Paul P.; Bennet, Laura; Booth, Lindsea C.; Davidson, Joanne O.; Wassink, Guido; Gunn, Alistair J.] Univ Auckland, Dept Physiol, Fetal Physiol & Neurosci Grp, Auckland 1, New Zealand; [Booth, Lindsea C.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic, Australia; [Gunn, Alistair J.] Starship Childrens Hosp, Auckland, New Zealand	University of Auckland; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Starship Children's Hospital	Drury, PP (corresponding author), Univ Auckland, Dept Physiol, Fetal Physiol & Neurosci Grp, Auckland 1, New Zealand.	aj.gunn@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021	Bennet, Laura/0000-0002-4336-7596; Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Booth, Lindsea/0000-0003-3093-5766	Health Research Council of New Zealand; Auckland Medical Research Foundation; National Institutes of Health [R21 NS063141-01A1]; New Zealand Neurological Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063141] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Neurological Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Health Research Council of New Zealand, the Auckland Medical Research Foundation and National Institutes of Health grant R21 NS063141-01A1. P Drury is supported by the New Zealand Neurological Foundation W&B Miller Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; AZZOPARDI D, 1989, PEDIATR RES, V25, P440, DOI 10.1203/00006450-198905000-00003; BALL RH, 1994, AM J OBSTET GYNECOL, V171, P1549, DOI 10.1016/0002-9378(94)90400-6; Barcroft J., 1946, RESEARCHES PRENATAL; Barfield CP, 1999, PEDIATR RES, V46, P50, DOI 10.1203/00006450-199907000-00009; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; BARTELDS B, 1993, PEDIATR RES, V34, P51, DOI 10.1203/00006450-199307000-00013; Bennet L, 2006, J PHYSIOL-LONDON, V572, P141, DOI 10.1113/jphysiol.2006.105197; Bennet L, 1999, J PHYSIOL-LONDON, V517, P247, DOI 10.1111/j.1469-7793.1999.0247z.x; Bennet L, 2007, AM J PHYSIOL-REG I, V292, pR1569, DOI 10.1152/ajpregu.00743.2006; BERGER R, 1991, J DEV PHYSIOL, V16, P317; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Boushel R, 2000, ACTA PHYSIOL SCAND, V168, P615, DOI 10.1046/j.1365-201x.2000.00713.x; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; Brun NC, 1997, AM J PHYSIOL-HEART C, V273, pH682, DOI 10.1152/ajpheart.1997.273.2.H682; DAWES GS, 1959, J PHYSIOL-LONDON, V146, P516, DOI 10.1113/jphysiol.1959.sp006208; Dean JM, 2008, NEUROPHARMACOLOGY, V55, P166, DOI 10.1016/j.neuropharm.2008.05.009; Dieni S, 2003, J NEUROBIOL, V55, P41, DOI 10.1002/neu.10194; Downen M, 1999, J NEUROPATH EXP NEUR, V58, P12, DOI 10.1097/00005072-199901000-00002; DUFFY TE, 1975, J NEUROCHEM, V24, P271, DOI 10.1111/j.1471-4159.1975.tb11875.x; DUNNIHOO DR, 1973, AM J OBSTET GYNECOL, V116, P648, DOI 10.1016/S0002-9378(15)33129-X; DUPLESSIS AJ, 1995, ANN NEUROL, V37, P488; Fraser M, 2005, DEV BRAIN RES, V154, P45, DOI 10.1016/j.devbrainres.2004.10.002; Gagnon RE, 2005, COMP BIOCHEM PHYS A, V141, P264, DOI 10.1016/j.cbpb.2005.04.003; George S, 2004, AM J PHYSIOL-REG I, V287, pR925, DOI 10.1152/ajpregu.00263.2004; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; GLEASON CA, 1989, AM J PHYSIOL, V256, pR1264, DOI 10.1152/ajpregu.1989.256.6.R1264; GLEASON CA, 1990, AM J PHYSIOL, V258, pH1064, DOI 10.1152/ajpheart.1990.258.4.H1064; Gonzalez H, 2005, J CEREBR BLOOD F MET, V25, P911, DOI 10.1038/sj.jcbfm.9600087; GOPLERUD JM, 1989, J APPL PHYSIOL, V66, P2827, DOI 10.1152/jappl.1989.66.6.2827; Gunn AJ, 2001, DEV NEUROSCI-BASEL, V23, P175, DOI 10.1159/000046139; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Ilie A, 2006, J NEUROPHYSIOL, V96, P2809, DOI 10.1152/jn.00466.2006; ITSKOVITZ J, 1982, AM J PHYSIOL, V242, pH916, DOI 10.1152/ajpheart.1982.242.5.H916; JENSEN A, 1987, J DEV PHYSIOL, V9, P543; JENSEN A, 1991, J DEV PHYSIOL, V16, P181; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; JOHNSON GN, 1979, AM J OBSTET GYNECOL, V135, P48; Kaneko M, 2003, AM J OBSTET GYNECOL, V188, P961, DOI 10.1067/mob.2003.219; Keunen H, 1997, AM J OBSTET GYNECOL, V176, P515, DOI 10.1016/S0002-9378(97)70539-8; LAWLER FH, 1982, AM J PHYSIOL, V243, pR433, DOI 10.1152/ajpregu.1982.243.3.R433; Ley D, 2004, PEDIATR RES, V55, P568, DOI 10.1203/01.PDR.0000113785.66455.E7; LOU HC, 1985, EUR J PEDIATR, V144, P225, DOI 10.1007/BF00451945; MALLARD EC, 1994, AM J OBSTET GYNECOL, V170, P206; MALLARD EC, 1992, AM J OBSTET GYNECOL, V167, P1423, DOI 10.1016/S0002-9378(11)91728-1; Marks KA, 1996, PEDIATR RES, V39, P48, DOI 10.1203/00006450-199601000-00007; Matsumoto H, 1996, ANESTH ANALG, V83, P513, DOI 10.1097/00000539-199609000-00012; Matsunaga A, 1998, AM J PHYSIOL-CELL PH, V275, pC1022, DOI 10.1152/ajpcell.1998.275.4.C1022; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Moroz T, 2012, J ROYAL SOC INTERFAC; Mortola JP, 2004, RESP PHYSIOL NEUROBI, V141, P345, DOI 10.1016/j.resp.2004.01.011; Newman JP, 2000, J APPL PHYSIOL, V88, P82, DOI 10.1152/jappl.2000.88.1.82; Nilsson GE, 2004, J CEREBR BLOOD F MET, V24, P475, DOI 10.1097/00004647-200405000-00001; Nishidate I, 2010, APPL OPTICS, V49, P6617, DOI 10.1364/AO.49.006617; PAPILE LA, 1985, PEDIATR RES, V19, P159, DOI 10.1203/00006450-198502000-00001; Reddy K, 1998, PEDIATR RES, V43, P674, DOI 10.1203/00006450-199805000-00017; REYNOLDS EOR, 1988, BRIT MED BULL, V44, P1052, DOI 10.1093/oxfordjournals.bmb.a072289; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Shadid M, 1999, EARLY HUM DEV, V55, P169, DOI 10.1016/S0378-3782(99)00024-9; Springett RJ, 2003, ADV EXP MED BIOL, V530, P555; SYLVIA AL, 1989, J DEV PHYSIOL, V12, P287; Tan WKM, 1996, PEDIATR RES, V39, P791, DOI 10.1203/00006450-199605000-00008; TWEED A, 1986, PEDIATR RES, V20, P516, DOI 10.1203/00006450-198606000-00007; VANBEL F, 1994, PEDIATR RES, V35, P329; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Wassink G, 2007, J APPL PHYSIOL, V103, P1311, DOI 10.1152/japplphysiol.00396.2007; Wibbens B, 2005, AM J OBSTET GYNECOL, V193, P803, DOI 10.1016/j.ajog.2005.01.058; WILLIAMS CE, 1991, STROKE, V22, P516, DOI 10.1161/01.STR.22.4.516; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104; Wood CE, 2005, AM J PHYSIOL-REG I, V289, pR613, DOI 10.1152/ajpregu.00722.2004; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; Yager JY, 1996, BRAIN RES, V712, P230, DOI 10.1016/0006-8993(95)01423-3; Yawno T, 2007, NEUROSCIENCE, V146, P1726, DOI 10.1016/j.neuroscience.2007.03.023	75	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39273	10.1371/journal.pone.0039273	http://dx.doi.org/10.1371/journal.pone.0039273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720088	Green Published, gold			2022-12-27	WOS:000305350000056
J	Pons, V; Ustunel, C; Rolland, C; Torti, E; Parton, RG; Gruenberg, J				Pons, Veronique; Ustunel, Cansel; Rolland, Corinne; Torti, Eleonora; Parton, Robert G.; Gruenberg, Jean			SNX12 Role in Endosome Membrane Transport	PLOS ONE			English	Article							SORTING NEXIN; PROTEIN; ENDOCYTOSIS; VESICLES; BIOGENESIS; RETRIEVAL; COMPONENT; RETROMER; PATHWAYS; DOMAIN	In this paper, we investigated the role of sorting nexin 12 (SNX12) in the endocytic pathway. SNX12 is a member of the PX domain-containing sorting nexin family and shares high homology with SNX3, which plays a central role in the formation of intralumenal vesicles within multivesicular endosomes. We found that SNX12 is expressed at very low levels compared to SNX3. SNX12 is primarily associated with early endosomes and this endosomal localization depends on the binding to 3-phosphoinositides. We find that overexpression of SNX12 prevents the detachment (or maturation) of multivesicular endosomes from early endosomes. This in turn inhibits the degradative pathway from early to late endosomes/lysosomes, much like SNX3 overexpression, without affecting endocytosis, recycling and retrograde transport. In addition, while previous studies showed that Hrs knockdown prevents EGF receptor sorting into multivesicular endosomes, we find that overexpression of SNX12 restores the sorting process in an Hrs knockdown background. Altogether, our data show that despite lower expression level, SNX12 shares redundant functions with SNX3 in the biogenesis of multivesicular endosomes.	[Pons, Veronique; Ustunel, Cansel; Torti, Eleonora; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Pons, Veronique] Univ Toulouse III, Inst Malad Metab & Cardiovasc, INSERM, UMR 1048, Toulouse, France; [Rolland, Corinne] CPTP, UPS, INSERM, U1043, Toulouse, France; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Queensland; University of Queensland	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@unige.ch	Parton, Robert G/C-5673-2009	Parton, Robert G/0000-0002-7494-5248; PONS, Veronique/0000-0001-5821-8481	Swiss National Science Foundation [31003A_124776]; EU; Swiss SystemsX initiative in Systems Biology; L'Association pour la Recherche contre le Cancer (ARC); Roche Foundation; EMBO	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Swiss SystemsX initiative in Systems Biology; L'Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Roche Foundation; EMBO(European Molecular Biology Organization (EMBO))	Support was from the Swiss National Science Foundation (grant number: 31003A_124776), PRISM from the EU Sixth Framework Programme, LipidX from the Swiss SystemsX initiative in Systems Biology, evaluated by the Swiss National Science Foundation and the National Center for Competence in Research (NCCR) in Chemical Biology (to J.G.), and the Human Frontier Science Program Organization (R.G.P.). V.P. was supported by L'Association pour la Recherche contre le Cancer (ARC), the Roche Foundation, and EMBO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr VA, 2000, TRAFFIC, V1, P904, DOI 10.1034/j.1600-0854.2000.011109.x; Bissig C, 2012, METHOD CELL BIOL, V108, P19, DOI 10.1016/B978-0-12-386487-1.00002-X; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Brankatschk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021771; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Choi JH, 2004, J CELL SCI, V117, P4209, DOI 10.1242/jcs.01233; GRUENBERG J, 1985, EUR J CELL BIOL, V38, P312; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hao X, 2011, CELL SIGNAL; Harterink M, 2011, NAT CELL BIOL; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Malaval C, 2009, CELL SIGNAL, V21, P120, DOI 10.1016/j.cellsig.2008.09.016; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhang J, 2009, J BIOL CHEM, V284, P21659, DOI 10.1074/jbc.M109.007278; Zheng B, 2006, P NATL ACAD SCI USA, V103, P16776, DOI 10.1073/pnas.0607974103	41	17	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38949	10.1371/journal.pone.0038949	http://dx.doi.org/10.1371/journal.pone.0038949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719997	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000030
J	Ata, H; Shrestha, D; Oka, M; Ochi, R; Jong, CJ; Gebb, S; Benjamin, J; Schaffer, S; Hobart, HH; Downey, J; McMurtry, I; Gupte, R				Ata, Hirotaka; Shrestha, Deepa; Oka, Masahiko; Ochi, Rikuo; Jong, Chian Ju; Gebb, Sarah; Benjamin, John; Schaffer, Stephen; Hobart, Holly H.; Downey, James; McMurtry, Ivan; Gupte, Rakhee			Down-Regulation of Replication Factor C-40 (RFC40) Causes Chromosomal Missegregation in Neonatal and Hypertrophic Adult Rat Cardiac Myocytes	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CELL NUCLEAR ANTIGEN; VENTRICULAR MYOCYTES; ALZHEIMERS-DISEASE; DNA-SYNTHESIS; HEART-FAILURE; CARDIOMYOCYTE PROLIFERATION; MYOCARDIAL-INFARCTION; POLYMERASE-ALPHA; MITOTIC DIVISION	Background: Adult mammalian cardiac myocytes are generally assumed to be terminally differentiated; nonetheless, a small fraction of cardiac myocytes have been shown to replicate during ventricular remodeling. However, the expression of Replication Factor C (RFC; RFC140/40/38/37/36) and DNA polymerase delta (Pol delta) proteins, which are required for DNA synthesis and cell proliferation, in the adult normal and hypertrophied hearts has been rarely studied. Methods: We performed qRT-PCR and Western blot analysis to determine the levels of RFC and Pol delta message and proteins in the adult normal cardiac myocytes and cardiac fibroblasts, as well as in adult normal and pulmonary arterial hypertension induced right ventricular hypertrophied hearts. Immunohistochemical analyses were performed to determine the localization of the re-expressed DNA replication and cell cycle proteins in adult normal (control) and hypertrophied right ventricle. We determined right ventricular cardiac myocyte polyploidy and chromosomal missegregation/aneuploidy using Fluorescent in situ hybridization (FISH) for rat chromosome 12. Results: RFC40-mRNA and protein was undetectable, whereas Pol delta message was detectable in the cardiac myocytes isolated from control adult hearts. Although RFC40 and Pol delta message and protein significantly increased in hypertrophied hearts as compared to the control hearts; however, this increase was marginal as compared to the fetal hearts. Immunohistochemical analyses revealed that in addition to RFC40, proliferative and mitotic markers such as cyclin A, phospho-Aurora A/B/C kinase and phospho-histone 3 were also re-expressed/up-regulated simultaneously in the cardiac myocytes. Interestingly, FISH analyses demonstrated cardiac myocytes polyploidy and chromosomal missegregation/aneuploidy in these hearts. Knock-down of endogenous RFC40 caused chromosomal missegregation/aneuploidy and decrease in the rat neonatal cardiac myocyte numbers. Conclusion: Our novel findings suggest that transcription of RFC40 is suppressed in the normal adult cardiac myocytes and its insufficient re-expression may be responsible for causing chromosomal missegregation/aneuploidy and in cardiac myocytes during right ventricular hypertrophy.	[Ata, Hirotaka; Oka, Masahiko; Jong, Chian Ju; Schaffer, Stephen] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama	Ata, H (corresponding author), Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA.	rakheegupte@usouthal.edu	Jong, Chian Ju/AAL-4026-2020	Jong, Chian Ju/0000-0003-0505-5185; Ata, Hirotaka/0000-0003-0027-205X	University of South Alabama, College of Medicine Funds	University of South Alabama, College of Medicine Funds	This work was supported by University of South Alabama, College of Medicine Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Ahuja P, 2007, EXP CELL RES, V313, P1270, DOI 10.1016/j.yexcr.2007.01.009; Anversa P, 1997, CURR OPIN NEPHROL HY, V6, P169, DOI 10.1097/00041552-199703000-00011; Arendt T, 2010, AM J PATHOL, V177, P15, DOI 10.2353/ajpath.2010.090955; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Chim SS, 2000, J CELL BIOCHEM, V78, P533, DOI 10.1002/1097-4644(20000915)78:4<533::AID-JCB2>3.0.CO;2-7; Engel FB, 2005, CELL CYCLE, V4, P1360, DOI 10.4161/cc.4.10.2081; Geller LN, 1999, NEUROBIOL DIS, V6, P167, DOI 10.1006/nbdi.1999.0236; GERDES AM, 1994, CARDIOSCIENCE, V5, P203; Granata R, 2009, CARDIOVASC RES, V83, P303, DOI 10.1093/cvr/cvp090; Gupte RS, 2005, CELL CYCLE, V4, P323; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; KELLERMAN S, 1992, J MOL CELL CARDIOL, V24, P497, DOI 10.1016/0022-2828(92)91839-W; King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007; Koudssi F, 1998, J BIOL CHEM, V273, P25796, DOI 10.1074/jbc.273.40.25796; Kozlovskis PL, 1996, CIRC RES, V78, P289, DOI 10.1161/01.RES.78.2.289; Krause SA, 2001, MOL CELL BIOL, V21, P5156, DOI 10.1128/MCB.21.15.5156-5168.2001; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Leeuwenburgh BPJ, 2008, J ANAT, V212, P286, DOI 10.1111/j.1469-7580.2008.00853.x; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Marino TA, 1996, ANAT RECORD, V245, P677, DOI 10.1002/(SICI)1097-0185(199608)245:4<677::AID-AR8>3.0.CO;2-L; Matouskova E, 2005, ANTICANCER RES, V25, P1051; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Meckert PC, 2005, CARDIOVASC RES, V67, P116, DOI 10.1016/j.cardiores.2005.02.017; Minegishi S, 2011, INT HEART J, V52, P56, DOI 10.1536/ihj.52.56; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050; Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; Setoguchi M, 1999, LAB INVEST, V79, P1545; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Tasara T, 2003, NUCLEIC ACIDS RES, V31, P2636, DOI 10.1093/nar/gkg371; Tsujikawa H, 2008, AM J PHYSIOL-HEART C, V294, pH285, DOI 10.1152/ajpheart.00824.2007; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; Vliegen H W, 1995, Am J Cardiovasc Pathol, V5, P27; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wohlschlaeger J, 2010, CIRCULATION, V121, P989, DOI 10.1161/CIRCULATIONAHA.108.808071; Yang AH, 2003, J NEUROSCI, V23, P10454; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; ZHANG SJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P24, DOI 10.1016/0003-9861(87)90004-X	54	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39009	10.1371/journal.pone.0039009	http://dx.doi.org/10.1371/journal.pone.0039009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720015	Green Published, gold			2022-12-27	WOS:000305347800036
J	Brand, IL; Civciristov, S; Taylor, NL; Talbo, GH; Pantaki-Eimany, D; Levina, V; Clem, RJ; Perugini, MA; Kvansakul, M; Hawkins, CJ				Brand, Ingo L.; Civciristov, Srgjan; Taylor, Nicole L.; Talbo, Gert H.; Pantaki-Eimany, Delara; Levina, Vita; Clem, Rollie J.; Perugini, Matthew A.; Kvansakul, Marc; Hawkins, Christine J.			Caspase Inhibitors of the P35 Family Are More Active When Purified from Yeast than Bacteria	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; SIZE-DISTRIBUTION ANALYSIS; REACTIVE-SITE LOOP; BACULOVIRUS P35; CRYSTAL-STRUCTURE; IN-VIVO; METHIONINE AMINOPEPTIDASES; SACCHAROMYCES-CEREVISIAE; EFFECTOR CASPASE	Many insect viruses express caspase inhibitors of the P35 superfamily, which prevent defensive host apoptosis to enable viral propagation. The prototypical P35 family member, AcP35 from Autographa californica M nucleopolyhedrovirus, has been extensively studied. Bacterially purified AcP35 has been previously shown to inhibit caspases from insect, mammalian and nematode species. This inhibition occurs via a pseudosubstrate mechanism involving caspase-mediated cleavage of a "reactive site loop'' within the P35 protein, which ultimately leaves cleaved P35 covalently bound to the caspase's active site. We observed that AcP35 purifed from Saccharomyces cerevisae inhibited caspase activity more efficiently than AcP35 purified from Escherichia coli. This differential potency was more dramatic for another P35 family member, MaviP35, which inhibited human caspase 3 almost 300-fold more potently when purified from yeast than bacteria. Biophysical assays revealed that MaviP35 proteins produced in bacteria and yeast had similar primary and secondary structures. However, bacterially produced MaviP35 possessed greater thermal stability and propensity to form higher order oligomers than its counterpart purified from yeast. Caspase 3 could process yeast-purified MaviP35, but failed to detectably cleave bacterially purified MaviP35. These data suggest that bacterially produced P35 proteins adopt subtly different conformations from their yeast-expressed counterparts, which hinder caspase access to the reactive site loop to reduce the potency of caspase inhibition, and promote aggregation. These data highlight the differential caspase inhibition by recombinant P35 proteins purified from different sources, and caution that analyses of bacterially produced P35 family members ( and perhaps other types of proteins) may underestimate their activity.	[Brand, Ingo L.; Civciristov, Srgjan; Taylor, Nicole L.; Talbo, Gert H.; Pantaki-Eimany, Delara; Levina, Vita; Perugini, Matthew A.; Kvansakul, Marc; Hawkins, Christine J.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia; [Taylor, Nicole L.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Clem, Rollie J.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Hawkins, Christine J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	La Trobe University; University of Melbourne; Kansas State University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Brand, IL (corresponding author), La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia.	c.hawkins@latrobe.edu.au	Hawkins, Christine/B-8769-2011; Kvansakul, Marc/AAF-2453-2019	Hawkins, Christine/0000-0001-8120-1071; Kvansakul, Marc/0000-0003-2639-2498; Civciristov, Srgjan/0000-0002-9320-9668; Clem, Rollie/0000-0002-2368-720X; Perugini, Matthew/0000-0001-8052-5584	National Health and Medical Research Council project grant [602525, 637372]; Australian Research Council Future Fellowships [FT0991464, FT0991245]; La Trobe University; Cooperative Research Centre for Biomarker Translation	National Health and Medical Research Council project grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowships(Australian Research Council); La Trobe University; Cooperative Research Centre for Biomarker Translation(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by a National Health and Medical Research Council project grant to CJH and RJC (#602525) and a fellowship to MK (#637372), Australian Research Council Future Fellowships to CJH (#FT0991464) and MAP (#FT0991245), and scholarships to ILB from La Trobe University and the Cooperative Research Centre for Biomarker Translation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1997, J BIOL CHEM, V272, P1421, DOI 10.1074/jbc.272.3.1421; Bertin J, 1996, J VIROL, V70, P6251, DOI 10.1128/JVI.70.9.6251-6259.1996; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Brand IL, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.127; Brondyk WH, 2009, METHOD ENZYMOL, V463, P131, DOI 10.1016/S0076-6879(09)63011-1; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Chen SP, 2002, ARCH BIOCHEM BIOPHYS, V398, P87, DOI 10.1006/abbi.2001.2675; Chen YR, 2008, J GEN VIROL, V89, P2315, DOI 10.1099/vir.0.2008/001412-0; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; dela Cruz WP, 2001, J BIOL CHEM, V276, P32933, DOI 10.1074/jbc.M103930200; Du QS, 1999, J VIROL, V73, P1278, DOI 10.1128/JVI.73.2.1278-1285.1999; Eddins MJ, 2002, ACTA CRYSTALLOGR D, V58, P299, DOI 10.1107/S0907444901018753; Fisher AJ, 1999, EMBO J, V18, P2031, DOI 10.1093/emboj/18.8.2031; Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guy MP, 2008, J VIROL, V82, P7504, DOI 10.1128/JVI.00231-08; Hawkins CJ, 2000, METHOD ENZYMOL, V322, P162; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Jabbour AM, 2004, CELL DEATH DIFFER, V11, P1309, DOI 10.1038/sj.cdd.4401501; Jabbour AM, 2004, CURR GENOMICS, V5, P215, DOI 10.2174/1389202043349417; Jabbour AM, 2002, CELL DEATH DIFFER, V9, P1311, DOI 10.1038/sj.cdd.4401135; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; LaCount DJ, 2000, J BIOL CHEM, V275, P15657, DOI 10.1074/jbc.M000791200; Lannan E, 2007, J VIROL, V81, P9319, DOI 10.1128/JVI.00247-07; Laue TM, 1992, COMPUTER AIDED INTER, P90; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; Means JC, 2007, VIROLOGY, V358, P436, DOI 10.1016/j.virol.2006.08.043; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Pei Z, 2002, J BIOL CHEM; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Riedl SJ, 2001, BIOCHEMISTRY-US, V40, P13274, DOI 10.1021/bi010574w; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Snipas SJ, 2001, BIOCHEM J, V357, P575, DOI 10.1042/0264-6021:3570575; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vier J, 2000, BIOCHEM BIOPH RES CO, V276, P855, DOI 10.1006/bbrc.2000.3560; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Xu GZ, 2003, J BIOL CHEM, V278, P5455, DOI 10.1074/jbc.M211607200; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yu M, 2005, VIRUS GENES, V31, P145, DOI 10.1007/s11262-005-1786-x; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w; Zhou Q, 2000, METHOD ENZYMOL, V322, P143; Zoog SJ, 1999, J BIOL CHEM, V274, P25995, DOI 10.1074/jbc.274.37.25995; Zoog SJ, 2002, EMBO J, V21, P5130	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39248	10.1371/journal.pone.0039248	http://dx.doi.org/10.1371/journal.pone.0039248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720082	Green Published, gold			2022-12-27	WOS:000305347800059
J	Chen, WT; Sun, SS; Li, Z				Chen, Wentian; Sun, Shisheng; Li, Zheng			Two Glycosylation Sites in H5N1 Influenza Virus Hemagglutinin That Affect Binding Preference by Computer-Based Analysis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; RECEPTOR-BINDING; GLYCAN TOPOLOGY; PROTEIN; SPECIFICITY; RECOGNITION; FUSION; GLYCOPROTEIN; MUTATIONS; SEQUENCE	Increasing numbers of H5N1 influenza viruses (IVs) are responsible for human deaths, especially in North Africa and Southeast Asian. The binding of hemagglutinin (HA) on the viral surface to host sialic acid (SA) receptors is a requisite step in the infection process. Phylogenetic analysis reveals that H5N1 viruses can be divided into 10 clades based on their HA sequences, with most human IVs centered from clade 1 and clade 2.1 to clade 2.3. Protein sequence alignment in various clades indicates the high conservation in the receptor-binding domains (RBDs) is essential for binding with the SA receptor. Two glycosylation sites, 158N and 169N, also participate in receptor recognition. In the present work, we attempted to construct a serial H5N1 HA models including diverse glycosylated HAs to simulate the binding process with various SA receptors in silico. As the SA-alpha-2,3-Gal and SA-alpha-2,6-Gal receptor adopted two distinctive topologies, straight and fishhook-like, respectively, the presence of N-glycans at 158N would decrease the affinity of HA for all of the receptors, particularly SA-alpha-2,6-Gal analogs. The steric clashes of the huge glycans shown at another glycosylation site, 169N, located on an adjacent HA monomer, would be more effective in preventing the binding of SA-alpha-2,3-Gal analogs.	[Chen, Wentian; Li, Zheng] NW Univ Xian, Coll Life Sci, Lab Funct Glyc, Xian 710069, Peoples R China; [Sun, Shisheng] Johns Hopkins Univ, Div Clin Chem, Dept Pathol, Baltimore, MD USA	Northwest University Xi'an; Johns Hopkins University	Chen, WT (corresponding author), NW Univ Xian, Coll Life Sci, Lab Funct Glyc, Xian 710069, Peoples R China.	zhengli@nwu.edu.cn	Sun, Shisheng/P-5027-2019	Sun, Shisheng/0000-0002-7242-7164	International Science & Technology Cooperation Program [2009DFA32730]; Key Science and Technology Program of the Shaanxi Province of China [2010K12-02(5)]	International Science & Technology Cooperation Program; Key Science and Technology Program of the Shaanxi Province of China	This work was supported by the International Science & Technology Cooperation Program (2009DFA32730) and the Key Science and Technology Program (2010K12-02(5)) of the Shaanxi Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Bohne A, 2002, Pac Symp Biocomput, P285; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen JR, 2011, TRENDS BIOTECHNOL, V29, P426, DOI 10.1016/j.tibtech.2011.04.007; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gambaryan AS, 2004, VIROLOGY, V326, P310, DOI 10.1016/j.virol.2004.06.002; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwata T, 2008, COMPUT BIOL CHEM, V32, P198, DOI 10.1016/j.compbiolchem.2008.03.006; Karthik V, 2002, PLOS ONE, V5; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leo F, 2010, BIOSCI BIOTECH BIOCH, V74, P298, DOI 10.1271/bbb.90614; Li MY, 2006, BIOCHEM BIOPH RES CO, V347, P662, DOI 10.1016/j.bbrc.2006.06.179; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Morris GM, 2009, J COMPUT CHEM, V0, P1; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ohuchi R, 1997, J VIROL, V71, P3719, DOI 10.1128/JVI.71.5.3719-3725.1997; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Raman EP, 2009, J CHEM THEORY COMPUT, V5, P23; Rebecca MD, 2010, J VIROL, V85, P865; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Salahuddin P, 2009, BIOINFORMATION, V4, P30, DOI 10.6026/97320630004030; Sammalkorpi M, 2007, BBA-BIOMEMBRANES, V1768, P30, DOI 10.1016/j.bbamem.2006.08.008; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shriver Z, 2009, CHEM BIOL, V16, P803, DOI 10.1016/j.chembiol.2009.08.002; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; WHO/OIE/FAO H5N1 Evolution Working Group, 2012, CUM NUMB CONF HUM CA; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	61	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38794	10.1371/journal.pone.0038794	http://dx.doi.org/10.1371/journal.pone.0038794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719948	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800020
J	Fruchart-Gaillard, C; Mourier, G; Blanchet, G; Vera, L; Gilles, N; Menez, R; Marcon, E; Stura, EA; Servent, D				Fruchart-Gaillard, Carole; Mourier, Gilles; Blanchet, Guillaume; Vera, Laura; Gilles, Nicolas; Menez, Renee; Marcon, Elodie; Stura, Enrico A.; Servent, Denis			Engineering of Three-Finger Fold Toxins Creates Ligands with Original Pharmacological Profiles for Muscarinic and Adrenergic Receptors	PLOS ONE			English	Article							MAMBA DENDROASPIS-ANGUSTICEPS; SITE-DIRECTED MUTAGENESIS; GREEN MAMBA; ACETYLCHOLINE-RECEPTOR; FUNCTIONAL-PROPERTIES; ANIMAL TOXINS; SNAKE TOXINS; M-1 RECEPTOR; VENOM; IDENTIFICATION	Protein engineering approaches are often a combination of rational design and directed evolution using display technologies. Here, we test "loop grafting," a rational design method, on three-finger fold proteins. These small reticulated proteins have exceptional affinity and specificity for their diverse molecular targets, display protease-resistance, and are highly stable and poorly immunogenic. The wealth of structural knowledge makes them good candidates for protein engineering of new functionality. Our goal is to enhance the efficacy of these mini-proteins by modifying their pharmacological properties in order to extend their use in imaging, diagnostics and therapeutic applications. Using the interaction of three-finger fold toxins with muscarinic and adrenergic receptors as a model, chimeric toxins have been engineered by substituting loops on toxin MT7 by those from toxin MT1. The pharmacological impact of these grafts was examined using binding experiments on muscarinic receptors M1 and M4 and on the alpha(1A)-adrenoceptor. Some of the designed chimeric proteins have impressive gain of function on certain receptor subtypes achieving an original selectivity profile with high affinity for muscarinic receptor M1 and alpha(1A)-adrenoceptor. Structure-function analysis supported by crystallographic data for MT1 and two chimeras permits a molecular based interpretation of these gains and details the merits of this protein engineering technique. The results obtained shed light on how loop permutation can be used to design new three-finger proteins with original pharmacological profiles.	[Fruchart-Gaillard, Carole; Mourier, Gilles; Blanchet, Guillaume; Vera, Laura; Gilles, Nicolas; Menez, Renee; Marcon, Elodie; Stura, Enrico A.; Servent, Denis] CEA, IBiTecS, Serv Ingn Mol Prot, Lab Toxinol Mol & Biotechnol, Gif Sur Yvette, France; [Blanchet, Guillaume] Univ Paris 06, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Fruchart-Gaillard, C (corresponding author), CEA, IBiTecS, Serv Ingn Mol Prot, Lab Toxinol Mol & Biotechnol, Gif Sur Yvette, France.	denis.servent@cea.fr	Stura, Enrico A./A-2793-2010; Fruchart Gaillard, Carole/GWV-2801-2022	Stura, Enrico A./0000-0001-6718-2118; Fruchart Gaillard, Carole/0000-0002-3149-4774; Servent, Denis/0000-0002-0774-1691				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADEM A, 1988, BIOCHIM BIOPHYS ACTA, V968, P340, DOI 10.1016/0167-4889(88)90025-0; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Doley R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-146; Doley R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-196; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fruchart-Gaillard C, 2006, MOL PHARMACOL, V69, P1641, DOI 10.1124/mol.105.020883; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Gilquin B, 2003, PROTEIN SCI, V12, P266, DOI 10.1110/ps.0227703; Harvey AL, 2002, NEUROCHEM RES, V27, P1543, DOI 10.1023/A:1021660708187; JOLKKONEN M, 1994, FEBS LETT, V352, P91, DOI 10.1016/0014-5793(94)00933-3; KARLSSON E, 1994, ANN NY ACAD SCI, V710, P153, DOI 10.1111/j.1749-6632.1994.tb26623.x; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Koivula K, 2010, TOXICON, V56, P440, DOI 10.1016/j.toxicon.2010.05.001; Krajewski JL, 2001, MOL PHARMACOL, V60, P725; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Du MH, 2000, J MOL BIOL, V296, P1017; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marchot P, 1997, J BIOL CHEM, V272, P3502, DOI 10.1074/jbc.272.6.3502; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; MAX SI, 1993, J NEUROSCI, V13, P4293; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUTTER M, 1995, PEPTIDE RES, V8, P145; Naimuddin M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-2; Nareoja K, 2011, BRIT J PHARMACOL, V164, P538, DOI 10.1111/j.1476-5381.2011.01468.x; Olianas MC, 2000, BRIT J PHARMACOL, V131, P447, DOI 10.1038/sj.bjp.0703606; PILLET L, 1993, J BIOL CHEM, V268, P909; Quinton L, 2010, BRIT J PHARMACOL, V159, P316, DOI 10.1111/j.1476-5381.2009.00532.x; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; Rouget C, 2010, BRIT J PHARMACOL, V161, P1361, DOI 10.1111/j.1476-5381.2010.00966.x; Servent D, 2011, TOXICON, V58, P455, DOI 10.1016/j.toxicon.2011.08.004; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589	46	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39166	10.1371/journal.pone.0039166	http://dx.doi.org/10.1371/journal.pone.0039166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720062	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800050
J	Urbina, H; Blackwell, M				Urbina, Hector; Blackwell, Meredith			Multilocus Phylogenetic Study of the Scheffersomyces Yeast Clade and Characterization of the N-Terminal Region of Xylose Reductase Gene	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAIN; PICHIA-STIPITIS; CANDIDA-SHEHATAE; ETHANOL-PRODUCTION; FERMENTING YEAST; SP-NOV; RPB1 SEQUENCES; RIBOSOMAL DNA; CORN STOVER; FERMENTATION	Many of the known xylose-fermenting (X-F) yeasts are placed in the Scheffersomyces clade, a group of ascomycete yeasts that have been isolated from plant tissues and in association with lignicolous insects. We formally recognize fourteen species in this clade based on a maximum likelihood (ML) phylogenetic analysis using a multilocus dataset. This clade is divided into three subclades, each of which exhibits the biochemical ability to ferment cellobiose or xylose. New combinations are made for seven species of Candida in the clade, and three X-F taxa associated with rotted hardwood are described: Scheffersomyces illinoinensis (type strain NRRL Y-48827(T) = CBS 12624), Scheffersomyces quercinus (type strain NRRL Y-48825(T) = CBS 12625), and Scheffersomyces virginianus (type strain NRRL Y-48822(T) = CBS 12626). The new X-F species are distinctive based on their position in the multilocus phylogenetic analysis and biochemical and morphological characters. The molecular characterization of xylose reductase (XR) indicates that the regions surrounding the conserved domain contain mutations that may enhance the performance of the enzyme in X-F yeasts. The phylogenetic reconstruction using XYL1 or RPB1 was identical to the multilocus analysis, and these loci have potential for rapid identification of cryptic species in this clade.	[Urbina, Hector; Blackwell, Meredith] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Urbina, H (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mblackwell@lsu.edu		Urbina, Hector/0000-0002-5570-4537	National Science Foundation (NSF) [DEB-0417180, 0732671]; Department of Energy [DE-AC52-07NA27344]; LSU Boyd Professor Research Fund	National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); LSU Boyd Professor Research Fund	This work was supported by the National Science Foundation grants (NSF DEB-0417180 and 0732671), Department of Energy contract to Lawrence Livermore National Laboratory (DE-AC52-07NA27344), and the LSU Boyd Professor Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Agbogbo FK, 2008, APPL BIOCHEM BIOTECH, V145, P53, DOI 10.1007/s12010-007-8056-4; Agbogbo FK, 2007, J IND MICROBIOL BIOT, V34, P723, DOI 10.1007/s10295-007-0247-z; Agbogbo FK, 2006, BIOTECHNOL LETT, V28, P2065, DOI 10.1007/s10529-006-9192-6; ALEXANDER MA, 1988, APPL MICROBIOL BIOT, V28, P478, DOI 10.1007/BF00268219; ALEXANDER MA, 1987, BIOTECHNOL BIOENG, V30, P685, DOI 10.1002/bit.260300515; Bajwa PK, 2011, BIORESOURCE TECHNOL, V102, P9965, DOI 10.1016/j.biortech.2011.08.027; BARNETT JA, 2000, YEASTS CHARACTERISTI; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Cadete RM, 2011, INT J SYST IN PRESS; Cadez N, 2006, INT J SYST EVOL MICR, V56, P1157, DOI 10.1099/ijs.0.64052-0; Chang CF, 2011, INT J SYST EVOL MICR, V61, P690, DOI 10.1099/ijs.0.020511-0; Chu BCH, 2006, CURR MICROBIOL, V53, P118, DOI 10.1007/s00284-005-0325-2; DELGENES JP, 1986, BIOTECHNOL LETT, V8, P897, DOI 10.1007/BF01078656; DELGENES JP, 1989, BIOTECHNOL BIOENG, V34, P398, DOI 10.1002/bit.260340314; DUPREEZ JC, 1986, ENZYME MICROB TECH, V8, P360, DOI 10.1016/0141-0229(86)90136-5; Fadda ME, 2010, INT J FOOD MICROBIOL, V136, P376, DOI 10.1016/j.ijfoodmicro.2009.10.007; Fadda ME, 2004, INT J FOOD MICROBIOL, V95, P51, DOI 10.1016/j.ijfoodmicro.2004.02.001; Fromanger R, 2010, J IND MICROBIOL BIOT, V37, P437, DOI 10.1007/s10295-009-0688-7; Fuentefria AM, 2008, MYCOL RES, V112, P93, DOI 10.1016/j.mycres.2007.05.001; Ganter PF, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P303, DOI 10.1007/3-540-30985-3_14; Grunwald S, 2010, SYST APPL MICROBIOL, V33, P25, DOI 10.1016/j.syapm.2009.10.002; Hahn-Hagerdal B, 2007, ADV BIOCHEM ENG BIOT, V108, P147, DOI 10.1007/10_2007_062; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Han JH, 2011, ARCH MICROBIOL, V193, P335, DOI 10.1007/s00203-011-0678-9; Hector RE, 2008, APPL MICROBIOL BIOT, V80, P675, DOI 10.1007/s00253-008-1583-2; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903, DOI 10.1093/oxfordjournals.molbev.a025658; HO NWY, 1990, ENZYME MICROB TECH, V12, P33, DOI 10.1016/0141-0229(90)90177-R; Houseknecht JL, 2011, INT J SYST EVOL MICR, V61, P1751, DOI 10.1099/ijs.0.026427-0; Hughes SR, 2012, J IND MICROBIOL BIOT, V39, P163, DOI 10.1007/s10295-011-1012-x; Hughes SR, 2009, PLASMID, V61, P22, DOI 10.1016/j.plasmid.2008.09.001; Jeffries T W, 1999, Adv Biochem Eng Biotechnol, V65, P117; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; JEFFRIES TW, 1986, ABSTR PAP AM CHEM S, V192, P51; JEFFRIES TW, 1994, ENZYME MICROB TECH, V16, P922, DOI 10.1016/0141-0229(94)90001-9; Jeppsson M, 2006, BIOTECHNOL BIOENG, V93, P665, DOI 10.1002/bit.20737; Jin YS, 2003, APPL ENVIRON MICROB, V69, P495, DOI 10.1128/AEM.69.1.495-503.2003; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; Karhumaa K, 2007, APPL MICROBIOL BIOT, V73, P1039, DOI 10.1007/s00253-006-0575-3; Khattab SMR, 2011, BIOCHEM BIOPH RES CO, V404, P634, DOI 10.1016/j.bbrc.2010.12.028; Knapp S, 2011, TAXON, V60, P1498, DOI 10.1002/tax.605031; Kreger-van Rij NJW, 1970, YEASTS TAXONOMIC STU, P455; Kumar S, 2011, APPL MICROBIOL BIOT, V89, P1405, DOI 10.1007/s00253-010-2997-1; Kurtzman CP, 2007, FEMS YEAST RES, V7, P141, DOI 10.1111/j.1567-1364.2006.00157.x; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, pXIII, DOI 10.1016/B978-0-444-52149-1.00180-4; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; KURTZMAN CP, 1990, ANTON LEEUW INT J G, V57, P215, DOI 10.1007/BF00400153; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2010, ANTON LEEUW INT J G, V97, P155, DOI 10.1007/s10482-009-9399-3; Lee JW, 2011, APPL BIOCHEM BIOTECH, V165, P814, DOI 10.1007/s12010-011-9299-7; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Maddison WP, 2005, EVOLUTION, V62, P1103; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Milan EP, 2001, MYCOSES, V44, P273, DOI 10.1111/j.1439-0507.2001.00652.x; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Nardi JB, 2006, ARTHROPOD STRUCT DEV, V35, P57, DOI 10.1016/j.asd.2005.06.003; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; OHAMA T, 1993, NUCLEIC ACIDS RES, V21, P4039, DOI 10.1093/nar/21.17.4039; PALNITKAR S, 1992, CAN J MICROBIOL, V38, P258, DOI 10.1139/m92-043; PALNITKAR SS, 1990, APPL BIOCHEM BIOTECH, V26, P151, DOI 10.1007/BF02921531; PAREKH S, 1986, BIOTECHNOL LETT, V8, P597, DOI 10.1007/BF01028092; PAREKH SR, 1986, APPL MICROBIOL BIOT, V25, P300, DOI 10.1007/BF00253667; PASSOTH V, 1992, CURR GENET, V22, P429, DOI 10.1007/BF00352445; PRIOR BA, 1988, BIOTECHNOL LETT, V10, P37, DOI 10.1007/BF01030021; Robbertse B, 2006, FUNGAL GENET BIOL, V43, P715, DOI 10.1016/j.fgb.2006.05.001; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ryabova EB, 2003, FEMS YEAST RES, V4, P157, DOI 10.1016/S1567-1356(03)00146-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; Shi NQ, 1999, YEAST, V15, P1021, DOI 10.1002/(SICI)1097-0061(199908)15:11<1021::AID-YEA429>3.0.CO;2-V; SREENATH HK, 1986, APPL MICROBIOL BIOT, V24, P294, DOI 10.1007/BF00257052; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suh SO, 2004, INT J SYST EVOL MICR, V54, P2409, DOI 10.1099/ijs.0.63246-0; Suh SO, 2004, MYCOLOGIA, V96, P756, DOI 10.2307/3762109; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suh SO, 2006, MYCOLOGIA, V98, P1006, DOI 10.3852/mycologia.98.6.1006; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Tanahashi M, 2010, NATURWISSENSCHAFTEN, V97, P311, DOI 10.1007/s00114-009-0643-5; TOIVOLA A, 1984, APPL ENVIRON MICROB, V47, P1221, DOI 10.1128/AEM.47.6.1221-1223.1984; Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; Vaughan-Martini A., 1984, ANN FAC AGRAR U PERU, V66, P331; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Zhang J, 2010, Prikl Biokhim Mikrobiol, V46, P456; Zhang N, 2003, J INVERTEBR PATHOL, V84, P226, DOI 10.1016/j.jip.2003.10.002; Zhang QS, 2010, PLANT PHYSIOL, V153, P555, DOI 10.1104/pp.110.157644	93	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39128	10.1371/journal.pone.0039128	http://dx.doi.org/10.1371/journal.pone.0039128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720049	Green Published, gold, Green Submitted			2022-12-27	WOS:000305347800046
J	Ferrao, PM; de Oliveira, FL; Degrave, WM; Araujo-Jorge, TC; Mendonca-Lima, L; Waghabi, MC				Ferrao, Patricia M.; de Oliveira, Fabiane L.; Degrave, Wim M.; Araujo-Jorge, Tania C.; Mendonca-Lima, Leila; Waghabi, Mariana C.			A Phosphoproteomic Approach towards the Understanding of the Role of TGF-beta in Trypanosoma cruzi Biology	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAJOR CYSTEINE PROTEINASE; PARASITE CYCLE COMPLETION; COLI RNA DEGRADOSOME; PROTEOMIC ANALYSIS; SIGNAL-TRANSDUCTION; LEISHMANIA-DONOVANI; CHAGAS-DISEASE; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS	Transforming growth factor beta (TGF-beta) plays a pivotal role in Chagas disease, not only in the development of chagasic cardiomyopathy, but also in many stages of the T. cruzi life cycle and survival in the host cell environment. The intracellular signaling pathways utilized by T. cruzi to regulate these mechanisms remain unknown. To identify parasite proteins involved in the TGF-beta response, we utilized a combined approach of two-dimensional gel electrophoresis (2DE) analysis and mass spectrometry (MS) protein identification. Signaling via TGF-beta is dependent on events of phosphorylation, which is one of the most relevant and ubiquitous post-translational modifications for the regulation of gene expression, and especially in trypanosomatids, since they lack several transcriptional control mechanisms. Here we show a kinetic view of T. cruzi epimastigotes (Y strain) incubated with TGF-beta for 1, 5, 30 and 60 minutes, which promoted a remodeling of the parasite phosphorylation network and protein expression pattern. The altered molecules are involved in a variety of cellular processes, such as proteolysis, metabolism, heat shock response, cytoskeleton arrangement, oxidative stress regulation, translation and signal transduction. A total of 75 protein spots were up-or down-regulated more than twofold after TGF-beta treatment, and from these, 42 were identified by mass spectrometry, including cruzipain-the major T. cruzi papain-like cysteine proteinase that plays an important role in invasion and participates in the escape mechanisms used by the parasite to evade the host immune system. In our study, we observed that TGF-beta addition favored epimastigote proliferation, corroborating 2DE data in which proteins previously described to be involved in this process were positively stimulated by TGF-beta.	[Ferrao, Patricia M.; de Oliveira, Fabiane L.; Degrave, Wim M.; Mendonca-Lima, Leila; Waghabi, Mariana C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil; [Araujo-Jorge, Tania C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Inovacoes Terapias Ensino & Bioprod, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Ferrao, PM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil.	lmlima@ioc.fiocruz.br; mariana@ioc.fiocruz.br	Araujo-Jorge, Tania/F-1030-2014; Degrave, Wim/B-4162-2009; Waghabi, Mariana C/J-3391-2014; Mendonça-Lima, Leila/J-3390-2014	Araujo-Jorge, Tania/0000-0002-8233-5845; Mendonça-Lima, Leila/0000-0003-4388-5083	Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work received financial support from Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude, Instituto Oswaldo Cruz, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AD, 2003, INFECT IMMUN, V71, P4201, DOI 10.1128/IAI.71.7.4201-4205.2003; Andrade HM, 2008, J PROTEOME RES, V7, P2357, DOI 10.1021/pr700659m; Araujo-Jorge TC, 2002, J INFECT DIS, V186, P1823, DOI 10.1086/345882; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bente M, 2003, PROTEOMICS, V3, P1811, DOI 10.1002/pmic.200300462; Berredo-Pinho M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-80; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; Chin D, 2004, BRIT J PLAST SURG, V57, P215, DOI 10.1016/j.bjps.2003.12.012; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Clayton J, 2010, NATURE, V465, pS4, DOI 10.1038/nature09220; de Graauw M, 2006, ELECTROPHORESIS, V27, P2676, DOI 10.1002/elps.200600018; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Ellis J, 2004, MOL MICROBIOL, V53, P1487, DOI 10.1111/j.1365-2958.2004.04218.x; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Ghansah TJ, 2002, J EUKARYOT MICROBIOL, V49, P383, DOI 10.1111/j.1550-7408.2002.tb00216.x; Giotto MTD, 2003, J MOL BIOL, V331, P653, DOI 10.1016/S0022-2836(03)00752-6; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; Gull K, 2001, CURR OPIN MICROBIOL, V4, P427, DOI 10.1016/S1369-5274(00)00230-7; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hall BS, 2000, INFECT IMMUN, V68, P2077, DOI 10.1128/IAI.68.4.2077-2081.2000; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Imamura T, 2004, BIOCHEM BIOPH RES CO, V318, P289, DOI 10.1016/j.bbrc.2004.04.029; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; Kuhnel K, 2001, J MOL BIOL, V313, P583, DOI 10.1006/jmbi.2001.5065; LAWRENCE DA, 1995, KIDNEY INT, V47, pS19; Li YH, 2011, J GENET GENOMICS, V38, P111, DOI 10.1016/j.jgg.2011.02.001; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Magalhaes AD, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-24; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697; Mottram JC, 1998, CURR OPIN MICROBIOL, V1, P455, DOI 10.1016/S1369-5274(98)80065-9; Moustakas A, 2001, J CELL SCI, V114, P4359; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Nagano-Ito M, 2009, FEBS LETT, V583, P1363, DOI 10.1016/j.febslet.2009.03.045; Nakayasu ES, 2009, PROTEOMICS, V9, P3489, DOI 10.1002/pmic.200800874; Nepomuceno-Silva JL, 2001, J BIOL CHEM, V276, P29711, DOI 10.1074/jbc.M102920200; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nowicki C, 2008, COMP BIOCHEM PHYS A, V151, P381, DOI 10.1016/j.cbpa.2007.03.010; Paba J, 2004, PROTEOMICS, V4, P1052, DOI 10.1002/pmic.200300637; Parodi-Talice A, 2004, INT J PARASITOL, V34, P881, DOI 10.1016/j.ijpara.2004.05.002; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; Ruan L, 2010, MED ONCOL, V27, P1407, DOI 10.1007/s12032-009-9394-6; Samudio M, 1999, PARASITE IMMUNOL, V21, P451, DOI 10.1046/j.1365-3024.1999.00242.x; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; Sodre CL, 2009, ARCH MICROBIOL, V191, P177, DOI 10.1007/s00203-008-0439-6; Sowa MPK, 1999, GENE, V230, P155, DOI 10.1016/S0378-1119(99)00072-4; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; TEIXEIRA SMR, 1995, J BIOL CHEM, V270, P22586, DOI 10.1074/jbc.270.38.22586; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; Ulrich PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018013; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; Waghabi MC, 2007, ANTIMICROB AGENTS CH, V51, P2905, DOI 10.1128/AAC.00022-07; Waghabi MC, 2009, MEM I OSWALDO CRUZ, V104, P1083, DOI 10.1590/S0074-02762009000800004; Waghabi MC, 2009, ANTIMICROB AGENTS CH, V53, P4694, DOI 10.1128/AAC.00580-09; Waghabi MC, 2005, AM J PATHOL, V167, P993, DOI 10.1016/S0002-9440(10)61189-3; Waghabi MC, 2005, CELL MICROBIOL, V7, P511, DOI 10.1111/j.1462-5822.2004.00481.x; Waghabi MC, 2002, INFECT IMMUN, V70, P5115, DOI 10.1128/IAI.70.9.5115-5123.2002; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Xiao Lin, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P854; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	70	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38736	10.1371/journal.pone.0038736	http://dx.doi.org/10.1371/journal.pone.0038736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719930	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340000042
J	Liu, K; Zhang, Y; Hu, SZ; Yu, Y; Yang, QT; Jin, DD; Chen, XC; Jin, Q; Liu, HY				Liu, Kai; Zhang, Yan; Hu, Shizong; Yu, Yang; Yang, Qianting; Jin, Dongdong; Chen, Xinchun; Jin, Qi; Liu, Haiying			Increased Levels of BAFF and APRIL Related to Human Active Pulmonary Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; B-CELL; T-CELL; LATENT TUBERCULOSIS; MYELOID CELLS; LIGAND BAFF; IFN-GAMMA; EXPRESSION; MICE	Background: Despite great efforts to improve diagnosis and treatment, tuberculosis (TB) remains a major health problem worldwide, especially in developing countries. Lack of concrete immune markers is still the obstacle to properly evaluate active TB. Therefore, identification of more validated biomarkers and phenotypic signatures is imperative. In particular, T cell-related biomarkers are more significant. Methodology: To understand the nature of CD4(+) T cell-derived signatures involved in infection and disease development, we examined and analyzed whole genome expression profiles of purified CD4(+) T cells from healthy individuals (HD), two distinct populations with latent infection (with low or high IFN-gamma levels, LTBL/LTBH) and untreated TB patients. Following, we validated the expression profiles of genes in the peripheral CD4(+) T cells from each group and examined secretion levels of distinct cytokines in serum and pleural effusion. Principal Findings: Our bio-informatic analyses indicate that the two latent populations and clinical TB patients possess distinct CD4+ T cell gene expression profiles. Furthermore, The mRNA and protein expression levels of B cell activating factor (BAFF), which belongs to the TNF family, and a proliferation-inducing ligand (APRIL) were markedly up-regulated at the disease stage. In particular, the dramatic enhancement of BAFF and APRIL in the pleural effusion of patients with tuberculosis pleurisy suggests that these proteins may present disease status. In addition, we found that the BAFF/APRIL system was closely related to the Th1 immune response. Our study delineates previously unreported roles of BAFF and APRIL in the development of tuberculosis, and these findings have implications for the diagnosis of the disease. Our study also identifies a number of transcriptional signatures in CD4(+) T cells that have the potential to be utilized as diagnostic and prognostic tools to combat the tuberculosis epidemic.	[Liu, Kai; Zhang, Yan; Hu, Shizong; Yu, Yang; Jin, Dongdong; Jin, Qi; Liu, Haiying] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Liu, Kai; Zhang, Yan; Hu, Shizong; Yu, Yang; Jin, Dongdong; Jin, Qi; Liu, Haiying] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Qianting; Chen, Xinchun] Shenzhen Third Peoples Hosp, Shenzhen Hong Kong Inst Infect Dis, Guangdong Med Coll, Shenzhen, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangdong Medical University	Liu, K (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China.	jinqi@ipbcams.ac.cn; haiyingbj@gmail.com			National Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" [2008ZX10003-012, 2008ZX10003-005, 2012ZX10003-002]; China PR; National Natural Science Foundation of China [NSFC863367, NSFC81000716]	National Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases"; China PR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is sponsored by National Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" (2008ZX10003-012 & 2008ZX10003-005, 2012ZX10003-002), by China PR and by the National Natural Science Foundation of China (NSFC863367 & NSFC81000716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Budak F, 2008, LUNG, V186, P337, DOI 10.1007/s00408-008-9107-5; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Craxton A, 2003, BLOOD, V101, P4464, DOI 10.1182/blood-2002-10-3123; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Daridon C, 2008, AUTOIMMUN REV, V7, P267, DOI 10.1016/j.autrev.2007.05.002; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Dillon SR, 2006, NAT REV DRUG DISCOV, V5, P235, DOI 10.1038/nrd1982; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hanekom WA, 1999, CLIN DIAGN LAB IMMUN, V6, P204, DOI 10.1128/CDLI.6.2.204-208.1999; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Huard B, 2004, INT IMMUNOL, V16, P467, DOI 10.1093/intimm/dxh043; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Oddo M, 1998, J IMMUNOL, V160, P5448; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rahman ZSM, 2004, J IMMUNOL, V173, P6179, DOI 10.4049/jimmunol.173.10.6179; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Scapini P, 2010, J EXP MED, V207, P1757, DOI 10.1084/jem.20100086; Sutherland APR, 2005, J IMMUNOL, V174, P5537, DOI 10.4049/jimmunol.174.9.5537; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Wang IM, 2008, AM J RESP CRIT CARE, V177, P402, DOI 10.1164/rccm.200703-390OC; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	42	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38429	10.1371/journal.pone.0038429	http://dx.doi.org/10.1371/journal.pone.0038429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719887	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000022
J	Cubeddu, L; Joseph, S; Richard, DJ; Matthews, JM				Cubeddu, Liza; Joseph, Soumya; Richard, Derek J.; Matthews, Jacqueline M.			Contribution of DEAF1 Structural Domains to the Interaction with the Breast Cancer Oncogene LMO4	PLOS ONE			English	Article							NUCLEAR-EXPORT SIGNALS; MAMMARY EPITHELIAL-CELLS; COILED-COIL; SUBCELLULAR-LOCALIZATION; PROTEIN LMO4; CYCLE ENTRY; LIM; EXPRESSION; IDENTIFICATION; SUPPRESSOR	The proteins LMO4 and DEAF1 contribute to the proliferation of mammary epithelial cells. During breast cancer LMO4 is upregulated, affecting its interaction with other protein partners. This may set cells on a path to tumour formation. LMO4 and DEAF1 interact, but it is unknown how they cooperate to regulate cell proliferation. In this study, we identify a specific LMO4-binding domain in DEAF1. This domain contains an unstructured region that directly contacts LMO4, and a coiled coil that contains the DEAF1 nuclear export signal (NES). The coiled coil region can form tetramers and has the typical properties of a coiled coil domain. Using a simple cell-based assay, we show that LMO4 modulates the activity of the DEAF NES, causing nuclear accumulation of a construct containing the LMO4-interaction region of DEAF1.	[Cubeddu, Liza; Joseph, Soumya; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Richard, Derek J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	University of Sydney; Queensland University of Technology (QUT)	Cubeddu, L (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia.	liza.cubeddu@sydney.edu.au; jacqueline.matthews@sydney.edu.au	Richard, Derek/J-1338-2012; Matthews, Jacqueline/A-7322-2013	Richard, Derek/0000-0002-4839-8471; Joseph, Soumya/0000-0002-0487-1378; Matthews, Jacqueline/0000-0001-8518-3472	Australian Research Council; Association for International Cancer Research	Australian Research Council(Australian Research Council); Association for International Cancer Research	This work was supported by grants from the Australian Research Council and the Association for International Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; Dixon AS, 2010, BIOTECHNIQUES, V49, P519, DOI 10.2144/000113452; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Dubin MJ, 2004, J BIOL CHEM, V279, P26932, DOI 10.1074/jbc.M313974200; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hermanson O, 1999, CELL MOL BIOL, V45, P677; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kenny DA, 1998, P NATL ACAD SCI USA, V95, P11257, DOI 10.1073/pnas.95.19.11257; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LeBoeuf RD, 1998, J BIOL CHEM, V273, P361, DOI 10.1074/jbc.273.1.361; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu Z, 2006, ONCOGENE, V25, P2920, DOI 10.1038/sj.onc.1209318; Manne U, 2001, CLIN CANCER RES, V7, P3495; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Michelson RJ, 1999, J BIOL CHEM, V274, P30510, DOI 10.1074/jbc.274.43.30510; Mizuno T, 1996, J CELL SCI, V109, P2627; Montanez-Wiscovich ME, 2010, J PATHOL, V222, P271, DOI 10.1002/path.2762; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Spinola-Amilibia M, 2011, J MOL BIOL, V411, P1114, DOI 10.1016/j.jmb.2011.07.006; Stokes PH, 2007, BIOCHEM BIOPH RES CO, V354, P197, DOI 10.1016/j.bbrc.2006.12.178; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Tickenbrock L, 2002, J BIOL CHEM, V277, P32332, DOI 10.1074/jbc.M203990200; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Wang N, 2004, ONCOGENE, V23, P1507, DOI 10.1038/sj.onc.1207288; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150	45	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39218	10.1371/journal.pone.0039218	http://dx.doi.org/10.1371/journal.pone.0039218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723967	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700055
J	Lyngdoh, T; Vuistiner, P; Marques-Vidal, P; Rousson, V; Waeber, G; Vollenweider, P; Bochud, M				Lyngdoh, Tanica; Vuistiner, Philippe; Marques-Vidal, Pedro; Rousson, Valentin; Waeber, Gerard; Vollenweider, Peter; Bochud, Murielle			Serum Uric Acid and Adiposity: Deciphering Causality Using a Bidirectional Mendelian Randomization Approach	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-FAT DISTRIBUTION; FTO GENE; URATE EXCRETION; BLOOD-PRESSURE; WEIGHT-LOSS; ASSOCIATION; HYPERURICEMIA; OBESITY; HYPERTENSION	Background: Although the relationship between serum uric acid (SUA) and adiposity is well established, the direction of the causality is still unclear in the presence of conflicting evidences. We used a bidirectional Mendelian randomization approach to explore the nature and direction of causality between SUA and adiposity in a population-based study of Caucasians aged 35 to 75 years. Methods and Findings: We used, as instrumental variables, rs6855911 within the SUA gene SLC2A9 in one direction, and combinations of SNPs within the adiposity genes FTO, MC4R and TMEM18 in the other direction. Adiposity markers included weight, body mass index, waist circumference and fat mass. We applied a two-stage least squares regression: a regression of SUA/adiposity markers on our instruments in the first stage and a regression of the response of interest on the fitted values from the first stage regression in the second stage. SUA explained by the SLC2A9 instrument was not associated to fat mass (regression coefficient [95% confidence interval]: 0.05 [-0.10, 0.19] for fat mass) contrasting with the ordinary least square estimate (0.37 [0.34, 0.40]). By contrast, fat mass explained by genetic variants of the FTO, MC4R and TMEM18 genes was positively and significantly associated to SUA (0.31 [0.01, 0.62]), similar to the ordinary least square estimate (0.27 [0.25, 0.29]). Results were similar for the other adiposity markers. Conclusions: Using a bidirectional Mendelian randomization approach in adult Caucasians, our findings suggest that elevated SUA is a consequence rather than a cause of adiposity.	[Lyngdoh, Tanica; Vuistiner, Philippe; Marques-Vidal, Pedro; Rousson, Valentin; Bochud, Murielle] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lyngdoh, T (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	murielle.bochud@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; Bochud, Murielle/A-3981-2010; Vuistiner, Philippe/AAD-5010-2020; Colaus, PsyColaus/K-6607-2013	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bochud, Murielle/0000-0002-5727-0218; Rousson, Valentin/0000-0001-8092-4446; Waeber, Gerard/0000-0003-4193-788X; Vuistiner, Philippe/0000-0002-2661-4970	Swiss National Science Foundation [33CSCO-122661, PRODOC PDFMP3_127393/1]; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	The CoLaus study was supported by research grants from the Swiss National Science Foundation (grant no: 33CSCO-122661), GlaxoSmithKline and the Faculty of Biology and Medicine of Lausanne, Switzerland. Tanica Lyngdoh is supported by a grant from the Swiss National Science Foundation (PRODOC PDFMP3_127393/1). Murielle Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Bochud M, 2010, INT J ENV RES PUB HE, V7, P711, DOI 10.3390/ijerph7030711; Bochud M, 2009, J CLIN ENDOCR METAB, V94, P3969, DOI 10.1210/jc.2008-2428; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Burgess S, 2011, STAT MED, V30, P1312, DOI 10.1002/sim.4197; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P1058, DOI 10.1093/aje/kwg260; Chang CH, 2009, ARCH GERONTOL GERIAT, V49, pS46, DOI 10.1016/S0167-4943(09)70013-5; Chauhan G, 2011, J HUM GENET, V56, P720, DOI 10.1038/jhg.2011.87; Chen JH, 2012, CLIN RHEUMATOL, V31, P239, DOI 10.1007/s10067-011-1802-6; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; CIGOLINI M, 1995, INT J OBESITY, V19, P92; Costa A, 2002, METABOLISM, V51, P372, DOI 10.1053/meta.2002.30523; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; GILLUM RF, 1987, J CHRON DIS, V40, P413, DOI 10.1016/0021-9681(87)90174-3; GLYNN RJ, 1983, ARTHRITIS RHEUM-US, V26, P87, DOI 10.1002/art.1780260115; Goncalves JP, 2012, ENDOCRINE; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Hikita M, 2007, INTERNAL MED, V46, P1353, DOI 10.2169/internalmedicine.46.0045; Ishizaka N, 2010, J RHEUMATOL, V37, P410, DOI 10.3899/jrheum.090736; KLEIN R, 1973, ARCH INTERN MED, V132, P401, DOI 10.1001/archinte.132.3.401; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Lei MT, 2008, NEPHROL DIAL TRANSPL, V23, P2746, DOI 10.1093/ndt/gfn349; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nakanishi N, 2001, METABOLISM, V50, P621, DOI 10.1053/meta.2001.24196; NICHOLLS A, 1972, LANCET, V2, P1223; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Palmer T.M., 2011, STAT METHODS MED RES; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; RAMYA K, 2011, DIABETES TECHNOL THE, V13, P33, DOI DOI 10.1089/dia.2010.0071; Rattarasarn C, 2003, DIABETES RES CLIN PR, V60, P87, DOI 10.1016/S0168-8227(03)00017-2; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schmidt MI, 1996, METABOLISM, V45, P699, DOI 10.1016/S0026-0495(96)90134-1; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Viazzi F, 2011, DIABETES CARE, V34, P126, DOI 10.2337/dc10-0918; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Welsh P, 2010, J CLIN ENDOCR METAB, V95, P93, DOI 10.1210/jc.2009-1064; WEXLER BC, 1977, METABOLISM, V26, P1309, DOI 10.1016/0026-0495(77)90027-0; YAMASHITA S, 1986, INT J OBESITY, V10, P255; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zhu YY, 2010, RHEUMATOLOGY, V49, P2391, DOI 10.1093/rheumatology/keq256	59	88	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39321	10.1371/journal.pone.0039321	http://dx.doi.org/10.1371/journal.pone.0039321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723994	gold, Green Published, Green Submitted			2022-12-27	WOS:000305652700067
J	Zamora-Vilchis, I; Williams, SE; Johnson, CN				Zamora-Vilchis, Itzel; Williams, Stephen E.; Johnson, Christopher N.			Environmental Temperature Affects Prevalence of Blood Parasites of Birds on an Elevation Gradient: Implications for Disease in a Warming Climate	PLOS ONE			English	Article							RAIN-FOREST BIRDS; AUSTRALIAN WET TROPICS; ASSEMBLAGE STRUCTURE; SPECIES RICHNESS; POPULATION; ABUNDANCE; MALARIA; HAEMOPROTEUS; HEMATOZOA; PATTERNS	Background: The rising global temperature is predicted to expand the distribution of vector-borne diseases both in latitude and altitude. Many host communities could be affected by increased prevalence of disease, heightening the risk of extinction for many already threatened species. To understand how host communities could be affected by changing parasite distributions, we need information on the distribution of parasites in relation to variables like temperature and rainfall that are predicted to be affected by climate change. Methodology/Principal Findings: We determined relations between prevalence of blood parasites, temperature, and seasonal rainfall in a bird community of the Australian Wet Tropics along an elevation gradient. We used PCR screening to investigate the prevalence and lineage diversity of four genera of blood parasites (Plasmodium, Haemoproteus, Leucocytozoon and Trypanosoma) in 403 birds. The overall prevalence of the four genera of blood parasites was 32.3%, with Haemoproteus the predominant genus. A total of 48 unique lineages were detected. Independent of elevation, parasite prevalence was positively and strongly associated with annual temperature. Parasite prevalence was elevated during the dry season. Conclusions/Significance: Low temperatures of the higher elevations can help to reduce both the development of avian haematozoa and the abundance of parasite vectors, and hence parasite prevalence. In contrast, high temperatures of the lowland areas provide an excellent environment for the development and transmission of haematozoa. We showed that rising temperatures are likely to lead to increased prevalence of parasites in birds, and may force shifts of bird distribution to higher elevations. We found that upland tropical areas are currently a low-disease habitat and their conservation should be given high priority in management plans under climate change.	[Zamora-Vilchis, Itzel; Williams, Stephen E.; Johnson, Christopher N.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia	James Cook University	Zamora-Vilchis, I (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.	Itzel.ZamoraVilchis@my.jcu.edu.au	Johnson, Chris N/A-7275-2008; Johnson, Christopher/J-7894-2014; Williams, Stephen E/A-7250-2008	Johnson, Christopher/0000-0002-9719-3771; Williams, Stephen E/0000-0002-2510-7408	Stuart Leslie Bird Research Award of Birds Australia; Joyce W. Vickery Scientific Research Fund of The Linnean Society of New South Wales; Earthwatch Institute; James Cook University Research Advancement Program; Mexican Science Council (CONACYT)	Stuart Leslie Bird Research Award of Birds Australia; Joyce W. Vickery Scientific Research Fund of The Linnean Society of New South Wales; Earthwatch Institute; James Cook University Research Advancement Program; Mexican Science Council (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by Stuart Leslie Bird Research Award of Birds Australia (http://www.birdsaustralia.com.au/), Joyce W. Vickery Scientific Research Fund of The Linnean Society of New South Wales (http://linneansocietynsw.org.au/), Earthwatch Institute (http://www.earthwatch.org/australia/) and James Cook University Research Advancement Program. IZV benefited from a doctoral grant from the Mexican Science Council (CONACYT; http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi LR, 2011, J ZOOL, V283, P126, DOI 10.1111/j.1469-7998.2010.00753.x; Arriero E, 2008, J EVOLUTION BIOL, V21, P1504, DOI 10.1111/j.1420-9101.2008.01613.x; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Atkinson CT, 2009, HAEMOPROTEUS PARASIT, P11; Atkinson CT, 2008, PARASITIC DIS WILD B; Bartlett CM, 2009, FILARIOID NEMATODES, P439; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; Cumming GS, 2006, GLOBAL ECOL BIOGEOGR, V15, P486, DOI 10.1111/j.1466-822x.2006.00241.x; Dawson RD, 2005, ENVIRON ENTOMOL, V34, P563, DOI 10.1603/0046-225X-34.3.563; Donovan TA, 2008, J VET DIAGN INVEST, V20, P304, DOI 10.1177/104063870802000307; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Folland CK, 2001, GEOPHYS RES LETT, V28, P2621, DOI 10.1029/2001GL012877; Foufopoulos J, 2011, AM NAT, V177, P119, DOI 10.1086/657624; Garvin MC, 1997, AUK, V114, P179, DOI 10.2307/4089159; Gasner MR, 2010, BIOL CONSERV, V143, P1250, DOI 10.1016/j.biocon.2010.02.034; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; HIGGINS PJ, 2002, HDB AUSTR NZ ANTARTI, V6; HOUGHTON JT, 2001, IPCC 3 ASSESSMENT RE; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; LaPointe Dennis, 2005, P317; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; MacDonald GT, 2000, SECURING WET TROPICS; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Meik JM, 2008, J ARID ENVIRON, V72, P1193, DOI 10.1016/j.jaridenv.2008.01.003; Norte AC, 2009, IBIS, V151, P677, DOI 10.1111/j.1474-919X.2009.00960.x; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Patz JA, 2001, TRENDS IMMUNOL, V22, P171, DOI 10.1016/S1471-4906(01)01867-1; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Rohan DW, 2007, BIODIVERS CONSERV, V16, P3163, DOI 10.1007/s10531-007-9170-x; Sehgal RNM, 2001, MOL ECOL, V10, P2319, DOI 10.1046/j.1365-294X.2001.01339.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shoo LP, 2005, GLOBAL CHANGE BIOL, V11, P1469, DOI 10.1111/j.1365-2486.2005.00995.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Tella JL, 1999, P NATL ACAD SCI USA, V96, P1785, DOI 10.1073/pnas.96.4.1785; Tracey JG, 1982, VEGETATION HUMID TRO; Tryjanowski P, 2005, DIVERS DISTRIB, V11, P219, DOI 10.1111/j.1366-9516.2005.00140.x; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Walsh KJE, 2000, J CLIMATE, V13, P3029, DOI 10.1175/1520-0442(2000)013<3029:TCIINA>2.0.CO;2; Webb LJ, 1981, ECOLOGICAL BIOGEOGRA, P605, DOI DOI 10.1007/978-94-009-8629-9_22; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x	45	121	123	4	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39208	10.1371/journal.pone.0039208	http://dx.doi.org/10.1371/journal.pone.0039208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723966	gold, Green Accepted, Green Published			2022-12-27	WOS:000305652700054
J	Chen, K; Ahmed, S; Adeyi, O; Dick, JE; Ghanekar, A				Chen, Kui; Ahmed, Sharif; Adeyi, Oyedele; Dick, John E.; Ghanekar, Anand			Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus	PLOS ONE			English	Article							CANCER XENOGRAFTS; CELLS; IDENTIFICATION; ESTABLISHMENT	Xenografting primary human solid tumor tissue into immunodeficient mice is a widely used tool in studies of human cancer biology; however, care must be taken to prove that the tumors obtained recapitulate parent tissue. We xenografted primary human hepatocellular carcinoma (HCC) tumor fragments or bulk tumor cell suspensions into immunodeficient mice. We unexpectedly observed that 11 of 21 xenografts generated from 16 independent patient samples resembled lymphoid neoplasms rather than HCC. Immunohistochemistry and flow cytometry analyses revealed that the lymphoid neoplasms were comprised of cells expressing human CD45 and CD19/20, consistent with human B lymphocytes. In situ hybridization was strongly positive for Epstein-Barr virus (EBV) encoded RNA. Genomic analysis revealed unique monoclonal or oligoclonal immunoglobulin heavy chain gene rearrangements in each B-cell neoplasm. These data demonstrate that the lymphoid neoplasms were EBV-associated human B-cell lymphomas. Analogous to EBV-associated lymphoproliferative disorders in immunocompromised humans, the human lymphomas in these HCC xenografts likely developed from reactivation of latent EBV in intratumoral passenger B lymphocytes following their xenotransplantation into immunodeficient recipient mice. Given the high prevalence of latent EBV infection in humans and the universal presence of B lymphocytes in solid tumors, this potentially confounding process represents an important pitfall of human solid tumor xenografting. This phenomenon can be recognized and avoided by routine phenotyping of primary tumors and xenografts with human leukocyte markers, and provides a compelling biological rationale for exclusion of these cells from human solid tumor xenotransplantation assays.	[Chen, Kui; Ahmed, Sharif; Dick, John E.; Ghanekar, Anand] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Adeyi, Oyedele] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M4X 1K9, Canada; [Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ghanekar, Anand] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Chen, K (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	anand.ghanekar@uhn.ca		Dick, John/0000-0002-9527-8317; Adeyi, Oyedele/0000-0003-4272-1095	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported in part by a Canadian Institutes of Health Research (www.cihr.ca) Phase 1 Clinician-Scientist Award (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allen U, 2009, AM J TRANSPLANT, V9, pS87, DOI 10.1111/j.1600-6143.2009.02898.x; BIRX DL, 1986, NEW ENGL J MED, V314, P874, DOI 10.1056/NEJM198604033141403; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Dainiak MB, 2007, ADV BIOCHEM ENG BIOT, V106, P1, DOI 10.1007/10_2007_069; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; MOSIER DE, 1992, CANCER RES, V52, pS5552; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Petrova M, 2010, WORLD J GASTROENTERO, V16, P4130, DOI 10.3748/wjg.v16.i33.4130; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sausville E.A., 2006, CANCER RES, V66; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Utsunomiya T, 2009, SURG TODAY, V39, P1010, DOI 10.1007/s00595-009-3966-0; Vereide D, 2010, ADV CANCER RES, V108, P1, DOI 10.1016/S0065.230X(10)08004.8; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	27	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39294	10.1371/journal.pone.0039294	http://dx.doi.org/10.1371/journal.pone.0039294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723990	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300131
J	Kuipers, I; Bracke, KR; Brusselle, GG; Aesif, SW; Krijgsman, R; Arts, IC; Wouters, EFM; Reynaert, NL				Kuipers, Ine; Bracke, Ken R.; Brusselle, Guy G.; Aesif, Scott W.; Krijgsman, Renske; Arts, Ilja C.; Wouters, Emiel F. M.; Reynaert, Niki L.			Altered Cigarette Smoke-Induced Lung Inflammation Due to Ablation of Grx1	PLOS ONE			English	Article							S-GLUTATHIONYLATION; KAPPA-B; EPITHELIAL-CELLS; GLUTAREDOXIN 1; REDOX CONTROL; ACTIVATION; MICE; MODULATION; MECHANISMS	Glutaredoxins (Grx) are redox enzymes that remove glutathione bound to protein thiols, know as S-glutathionylation (PSSG). PSSG is a reservoir of GSH and can affect the function of proteins. It inhibits the NF-kappa B pathway and LPS aspiration in Grx1 KO mice with decreased inflammatory cytokine levels. In this study we investigated whether absence of Grx1 similarly repressed cigarette smoke-induced inflammation in an exposure model in mice. Cigarette smoke exposure for four weeks decreased lung PSSG levels, but increased PSSG in lavaged cells and lavage fluid (BALF). Grx1 KO mice had increased levels of PSSG in lung tissue, BALF and BAL cells in response to smoke compared to wt mice. Importantly, levels of multiple inflammatory mediators in the BALF were decreased in Grx1 KO animals following cigarette smoke exposure compared to wt mice, as were levels of neutrophils, dendritic cells and lymphocytes. On the other hand, macrophage numbers were higher in Grx1 KO mice in response to smoke. Although cigarette smoke in vivo caused inverse effects in inflammatory and resident cells with respect to PSSG, primary macrophages and epithelial cells cultured from Grx1 KO mice both produced less KC compared to cells isolated from WT mice after smoke extract exposure. In this manuscript, we provide evidence that Grx1 has an important role in regulating cigarette smoke-induced lung inflammation which seems to diverge from its effects on total PSSG. Secondly, these data expose the differential effect of cigarette smoke on PSSG in inflammatory versus resident lung cells.	[Kuipers, Ine; Krijgsman, Renske; Wouters, Emiel F. M.; Reynaert, Niki L.] Maastricht Univ, Med Ctr, Dept Resp Med, Nutrim Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Bracke, Ken R.; Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Aesif, Scott W.] George Washington Univ Hosp, Dept Pathol, Washington, DC USA; [Arts, Ilja C.] Maastricht Univ, Med Ctr, Dept Epidemiol, Nutrim Sch Nutr Toxicol & Metab, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Ghent University; Ghent University Hospital; George Washington University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kuipers, I (corresponding author), Maastricht Univ, Med Ctr, Dept Resp Med, Nutrim Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	n.reynaert@maastrichtuniversity.nl	Wouters, Emiel/ABD-6200-2021; Bracke, Ken R/GSN-7630-2022; Arts, Ilja CW/C-6946-2008; Reynaert, Niki L/C-5491-2014	Bracke, Ken R/0000-0001-5906-4605; Arts, Ilja CW/0000-0001-6462-6692; Aesif, Scott/0000-0002-4798-7290; Reynaert, Niki/0000-0002-8577-8094; Brusselle, Guy/0000-0001-7021-8505	School for Nutrition, Toxicology and Metabolism of Maastricht University (NUTRIM); Fund for Scientific Research in Flanders (FWO Vlaanderen) [G.0011.03]; Ghent University [BOF/GOA 01G01009]; Interuniversity Attraction Poles (Belgian State, Belgian Science Policy) [P6/35]; NWO/ZonMW [016.086.090]	School for Nutrition, Toxicology and Metabolism of Maastricht University (NUTRIM); Fund for Scientific Research in Flanders (FWO Vlaanderen)(FWO); Ghent University(Ghent University); Interuniversity Attraction Poles (Belgian State, Belgian Science Policy); NWO/ZonMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was supported by School for Nutrition, Toxicology and Metabolism of Maastricht University (NUTRIM), the Fund for Scientific Research in Flanders (FWO Vlaanderen, Research Project G.0011.03), the Concerted Research Action of the Ghent University (BOF/GOA 01G01009) and the Interuniversity Attraction Poles (Belgian State, Belgian Science Policy, Project P6/35). NLR is a recipient of a VENI grant from NWO/ZonMW (016.086.090) and KRB is a post-doctoral researcher of the Fund for Scientific Research in Flanders (FWO Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aesif SW, 2011, AM J RESP CELL MOL, V44, P491, DOI 10.1165/rcmb.2009-0136OC; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Kuipers I, 2012, FREE RADICAL RES, V46, P164, DOI 10.3109/10715762.2011.647011; Kuipers I, 2011, AM J RESP CELL MOL, V45, P931, DOI 10.1165/rcmb.2010-0249OC; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; Peltoniemi MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-133; Rahman I, 2005, MUTAT RES-FUND MOL M, V579, P58, DOI 10.1016/j.mrfmmm.2005.02.025; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Reynaert NL, 2006, AM J RESP CELL MOL B; REYNAERT NL, 2006, BIOCHIM BIOPHYS ACTA, V1760, P180; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; WU R, 1982, IN VITRO CELL DEV B, V18, P800; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504	21	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38984	10.1371/journal.pone.0038984	http://dx.doi.org/10.1371/journal.pone.0038984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723915	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300077
J	Mader, A; Kunert, R				Mader, Alexander; Kunert, Renate			Evaluation of the Potency of the Anti-Idiotypic Antibody Ab2/3H6 Mimicking gp41 as an HIV-1 Vaccine in a Rabbit Prime/Boost Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; PROXIMAL EXTERNAL REGION; T-CELL EPITOPES; NEUTRALIZING ANTIBODIES; IN-VITRO; IMMUNE-RESPONSES; CHO-CELLS; 2F5; MEMBRANE	The HIV-1 envelope protein harbors several conserved epitopes that are recognized by broadly neutralizing antibodies. One of these neutralizing sites, the MPER region of gp41, is targeted by one of the most potent and broadly neutralizing monoclonal antibody, 2F5. Different vaccination strategies and a lot of efforts have been undertaken to induce MPER neutralizing antibodies but little success has been achieved so far. We tried to consider the alternative anti-idiotypic vaccination approach for induction of 2F5-like antibodies. The previously developed and characterized anti-idiotypic antibody Ab2/3H6 was expressed as antibody fragment fusion protein with C-terminally attached immune-modulators and used for immunization of rabbits to induce antibodies specific for HIV-1. Only those rabbits immunized with immunogens fused with the immune-modulators developed HIV-1 specific antibodies. Anti-anti-idiotypic antibodies were affinity purified using a two-step affinity purification protocol which revealed that only little amount of the total rabbit IgG fraction contained HIV-1 specific antibodies. The characterization of the induced anti-anti-idiotypic antibodies showed specificity for the linear epitope of 2F5 GGGELDKWASL and the HIV-1 envelope protein gp140. Despite specificity for the linear epitope and the truncated HIV-1 envelope protein these antibodies were not able to exhibit virus neutralization activities. These results suggest that Ab2/3H6 alone might not be suitable as a vaccine.	[Mader, Alexander; Kunert, Renate] Univ Nat Resources & Life Sci Vienna, BOKU, VIBT, Dept Biotechnol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Mader, A (corresponding author), Univ Nat Resources & Life Sci Vienna, BOKU, VIBT, Dept Biotechnol, Vienna, Austria.	renate.kunert@boku.ac.at	Kunert, Renate E/B-9185-2018	Kunert, Renate E/0000-0002-3397-3621	Austrian Science Fund (FWF) [P20603-B13]; Austrian Science Fund (FWF) [P 20603] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF; www.fwf.ac.at), project number P20603-B13. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; Benferhat R, 2009, MOL IMMUNOL, V46, P705, DOI 10.1016/j.molimm.2008.10.001; Bryson S, 2008, J MOL BIOL, V382, P910, DOI 10.1016/j.jmb.2008.07.057; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; de Cerio ALD, 2007, ONCOGENE, V26, P3594, DOI 10.1038/sj.onc.1210371; Gach JS, 2008, MOL IMMUNOL, V45, P1027, DOI 10.1016/j.molimm.2007.07.030; Gach JS, 2007, AIDS RES HUM RETROV, V23, P1405, DOI 10.1089/aid.2007.0089; Gach JS, 2007, J BIOTECHNOL, V128, P735, DOI 10.1016/j.jbiotec.2006.12.020; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; HIV/AIDS UJPo, 2010, GLOB REP UNAIDS REP; Ho J, 2002, VACCINE, V20, P1169, DOI 10.1016/S0264-410X(01)00441-8; HO PC, 1990, EUR J IMMUNOL, V20, P477, DOI 10.1002/eji.1830200304; Hu SL, 2007, CURR HIV RES, V5, P507, DOI 10.2174/157016207782418542; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kaumaya Pravin T. P., 1993, Journal of Molecular Recognition, V6, P81, DOI 10.1002/jmr.300060206; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Kunert R, 2000, BIOTECHNOL BIOENG, V67, P97, DOI 10.1002/(SICI)1097-0290(20000105)67:1<97::AID-BIT11>3.0.CO;2-2; Kunert RE, 2002, AIDS, V16, P667, DOI 10.1097/00002030-200203080-00020; Ladjemi MZ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2826; Lee G, 2010, CANCER IMMUNOL IMMUN, V59, P1347, DOI 10.1007/s00262-010-0864-7; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lorizate M, 2006, J BIOL CHEM, V281, P39598, DOI 10.1074/jbc.M605998200; Mader A, 2010, PROTEIN ENG DES SEL, V23, P947, DOI 10.1093/protein/gzq092; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Nishiyama Y, 2009, J BIOL CHEM, V284, P30627, DOI 10.1074/jbc.M109.032185; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Opalka D, 2004, J IMMUNOL METHODS, V287, P49, DOI 10.1016/j.jim.2004.01.016; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Perera LP, 2007, J VIROL, V81, P8774, DOI 10.1128/JVI.00538-07; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Ramos AS, 2011, CANCER SCI, V102, P64, DOI 10.1111/j.1349-7006.2010.01771.x; Rodrigues L, 2009, EXPERT REV VACCINES, V8, P167, DOI 10.1586/14760584.8.2.167; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Stoiber H, 1997, MOL IMMUNOL, V34, P855, DOI 10.1016/S0161-5890(97)00108-9; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang JJ, 2010, INT IMMUNOPHARMACOL, V10, P707, DOI 10.1016/j.intimp.2010.04.001; Wang ZG, 2005, MICROBIOL IMMUNOL, V49, P703, DOI 10.1111/j.1348-0421.2005.tb03657.x; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	61	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39063	10.1371/journal.pone.0039063	http://dx.doi.org/10.1371/journal.pone.0039063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720027	Green Published, Green Submitted, gold			2022-12-27	WOS:000305350000035
J	Jonasson, JM; Cederholm, J; Eliasson, B; Zethelius, B; Eeg-Olofsson, K; Gudbjornsdottir, S				Jonasson, Junmei Miao; Cederholm, Jan; Eliasson, Bjorn; Zethelius, Bjorn; Eeg-Olofsson, Katarina; Gudbjornsdottir, Soffia			HbA1C and Cancer Risk in Patients with Type 2 Diabetes - A Nationwide Population-Based Prospective Cohort Study in Sweden	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; COLORECTAL-CANCER; GLYCOSYLATED HEMOGLOBIN; BREAST-CANCER; MEN; HYPERGLYCEMIA; CONSENSUS; ASSOCIATIONS; GLUCOSE; BLOOD	Background: Diabetes is associated with increased cancer risk. The underlying mechanisms remain unclear. Hyperglycemia might be one risk factor. HbA1c is an indicator of the blood glucose level over the latest 1 to 3 months. This study aimed to investigate association between HbA1c level and cancer risks in patients with type 2 diabetes based on real life situations. Methods: This is a cohort study on 25,476 patients with type 2 diabetes registered in the Swedish National Diabetes Register from 1997-1999 and followed until 2009. Follow-up for cancer was accomplished through register linkage. We calculated incidences of and hazard ratios (HR) for cancer in groups categorized by HbA1c <= 58 mmol/mol (7.5%) versus >58 mmol/mol, by quartiles of HbA1c, and by HbA1c continuously at Cox regression, with covariance adjustment for age, sex, diabetes duration, smoking and insulin treatment, or adjusting with a propensity score. Results: Comparing HbA1c >58 mmol/mol with <= 58 mmol/mol, adjusted HR for all cancer was 1.02 [95% CI 0.95-1.10] using baseline HbA1c, and 1.04 [95% CI 0.97-1.12] using updated mean HbA1c, and HRs were all non-significant for specific cancers of gastrointestinal, kidney and urinary organs, respiratory organs, female genital organs, breast or prostate. Similarly, no increased risks of all cancer or the specific types of cancer were found with higher quartiles of baseline or updated mean HbA1c, compared to the lowest quartile. HR for all cancer was 1.01 [0.98-1.04] per 1%-unit increase in HbA1c used as a continuous variable, with non-significant HRs also for the specific types of cancer per unit increase in HbA1c. Conclusions: In this study there were no associations between HbA1c and risks for all cancers or specific types of cancer in patients with type 2 diabetes.	[Jonasson, Junmei Miao; Gudbjornsdottir, Soffia] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden; [Jonasson, Junmei Miao] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Cederholm, Jan] Uppsala Univ, Dept Publ Hlth & Caring Sci Family Med & Clin Epi, Uppsala, Sweden; [Eliasson, Bjorn; Eeg-Olofsson, Katarina; Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden; [Zethelius, Bjorn] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden; [Zethelius, Bjorn] Med Prod Agcy, Uppsala, Sweden	University of Gothenburg; Uppsala University; Sahlgrenska University Hospital; University of Gothenburg; Uppsala University; Medical Products Agency	Jonasson, JM (corresponding author), Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden.	junmei.miao.jonasson@gmail.com	Miao Jonasson, Junmei/B-3242-2014; Eliasson, Bjorn/H-5783-2016	Miao Jonasson, Junmei/0000-0003-0206-8538; Eliasson, Bjorn/0000-0003-2569-4160	VINNMER; VINNOVA; Lion's Cancer Fund in Western Sweden; Konrad and Helfrid Johansson Foundation; Swedish Society of Medicine; Swedish Diabetes Fund; AGFOND	VINNMER; VINNOVA(Vinnova); Lion's Cancer Fund in Western Sweden; Konrad and Helfrid Johansson Foundation; Swedish Society of Medicine; Swedish Diabetes Fund; AGFOND	This study was funded by VINNMER fellow, VINNOVA (JMJ), Lion's Cancer Fund in Western Sweden (JMJ), Konrad and Helfrid Johansson Foundation (JMJ), Swedish Society of Medicine (JMJ), Swedish Diabetes Fund (JMJ, SG), and AGFOND (JMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best JD, 2000, DRUGS, V59, P1101, DOI 10.2165/00003495-200059050-00006; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Driver JA, 2010, AM J EPIDEMIOL, V172, P299, DOI 10.1093/aje/kwq127; Fowke JH, 2008, PROSTATE CANCER P D, V11, P264, DOI 10.1038/sj.pcan.4501022; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Ikeda F, 2009, GASTROENTEROLOGY, V136, P1234, DOI 10.1053/j.gastro.2008.12.045; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Johnson JA, 2011, DIABETOLOGIA, V54, P25, DOI 10.1007/s00125-010-1933-3; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Khaw KT, 2004, CANCER EPIDEM BIOMAR, V13, P915; Lin J, 2006, CANCER RES, V66, P2869, DOI 10.1158/0008-5472.CAN-05-3922; Lin J, 2005, CANCER EPIDEM BIOMAR, V14, P3010, DOI 10.1158/1055-9965.EPI-05-0533; Lipscombe LL, 2006, BREAST CANCER RES TR, V98, P349, DOI 10.1007/s10549-006-9172-5; Ljung R, 2011, ACTA ONCOLOGICA; Muller H, 2009, CANCER EPIDEM BIOMAR, V18, P1350, DOI 10.1158/1055-9965.EPI-08-0794; Ohwaki K, 2011, EUR J CANCER, V47, P262, DOI 10.1016/j.ejca.2010.09.023; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Platz EA, 1999, CANCER CAUSE CONTROL, V10, P379, DOI 10.1023/A:1008953611657; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Renehan A, 2010, LANCET, V375, P2201, DOI 10.1016/S0140-6736(10)60706-4; Rinaldi S, 2008, CANCER EPIDEM BIOMAR, V17, P3108, DOI 10.1158/1055-9965.EPI-08-0495; Rothman K., 1998, MODERN EPIDEMIOLOGY; Smith U, 2010, DIABETOLOGIA, V53, P1541, DOI 10.1007/s00125-010-1815-8; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Stefansdottir G, 2011, DIABETOLOGIA, V54, P1608, DOI 10.1007/s00125-011-2104-x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Staa TP, 2011, DIABETOLOGIA; Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474; Yang XL, 2010, DIABETES, V59, P1254, DOI 10.2337/db09-1371; Yang YX, 2010, CANCER EPIDEM BIOMAR, V19, P3027, DOI 10.1158/1055-9965.EPI-10-0486; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	35	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38784	10.1371/journal.pone.0038784	http://dx.doi.org/10.1371/journal.pone.0038784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719946	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800018
J	Kross, SM; Tylianakis, JM; Nelson, XJ				Kross, Sara M.; Tylianakis, Jason M.; Nelson, Ximena J.			Translocation of Threatened New Zealand Falcons to Vineyards Increases Nest Attendance, Brooding and Feeding Rates	PLOS ONE			English	Article							CONSERVATION; BEHAVIOR; FOOD; BIRDS; PREY; NOVAESEELANDIAE; ELECTROCUTION; WILDLIFE; ECOLOGY; BIOLOGY	Anthropogenic landscapes can be rich in resources, and may in some cases provide potential habitat for species whose natural habitat has declined. We used remote videography to assess whether reintroducing individuals of the threatened New Zealand falcon Falco novaeseelandiae into a highly modified agricultural habitat affected the feeding rates of breeding falcons or related breeding behavior such as nest attendance and brooding rates. Over 2,800 recording hours of footage were used to compare the behavior of falcons living in six natural nests (in unmanaged, hilly terrain between 4 km and 20 km from the nearest vineyard), with that of four breeding falcon pairs that had been transported into vineyards and nested within 500 m of the nearest vineyard. Falcons in vineyard nests had higher feeding rates, higher nest attendance, and higher brooding rates. As chick age increased, parents in vineyard nests fed chicks a greater amount of total prey and larger prey items on average than did parents in hill nests. Parents with larger broods brought in larger prey items and a greater total sum of prey biomass. Nevertheless, chicks in nests containing siblings received less daily biomass per individual than single chicks. Some of these results can be attributed to the supplementary feeding of falcons in vineyards. However, even after removing supplementary food from our analysis, falcons in vineyards still fed larger prey items to chicks than did parents in hill nests, suggesting that the anthropogenic habitat may be a viable source of quality food. Although agricultural regions globally are rarely associated with raptor conservation, these results suggest that translocating New Zealand falcons into vineyards has potential for the conservation of this species.	[Kross, Sara M.; Tylianakis, Jason M.; Nelson, Ximena J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Kross, SM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	Saramaekross@gmail.com	Kross, Sara Mae/E-2747-2013; Tylianakis, Jason/B-6634-2011	Kross, Sara Mae/0000-0002-5650-5839; Tylianakis, Jason/0000-0001-7402-5620; Nelson, Ximena/0000-0003-4301-2928	University of Canterbury Doctoral Scholarship; Brian-Mason Scientific & Technical Trust; Canon New Zealand	University of Canterbury Doctoral Scholarship; Brian-Mason Scientific & Technical Trust; Canon New Zealand	This research was supported by a University of Canterbury Doctoral Scholarship (to S.M.K.) and grants from the Brian-Mason Scientific & Technical Trust (to S.M.K. and X.J.N.; www.brianmasontrust.org) and Canon New Zealand (to S.M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Baayen RH, 2008, LANGUAGER DATA SETS; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Bird DM, 1996, RAPTORS HUMAN LANDSC; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Cade Tom. J., 2000, P343; CARLIER P, 1995, BEHAV PROCESS, V33, P247, DOI 10.1016/0376-6357(94)00027-E; Daan S, 1996, J ANIM ECOL, V65, P539, DOI 10.2307/5734; Dai B., 2008, IME4 LINEAR MIXED EF; Edwards PJ, 1998, BIOL CONSERV, V83, P239, DOI 10.1016/S0006-3207(97)00141-9; Fischer J, 2011, SCIENCE, V334, P593, DOI 10.1126/science.334.6056.593-a; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fox NC, 1977, BIOL NZ FALCON; Fox Nick C., 2010, Notornis, V57, P71; Gaze Peter, 2004, Notornis, V51, P117; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hudson R, 2011, DEV PSYCHOBIOL, V53, P564, DOI 10.1002/dev.20535; Knight J, 2001, NATURE, V414, P246, DOI 10.1038/35104708; Kross SM, 2012, CONSERV BIOL, V26, P142, DOI 10.1111/j.1523-1739.2011.01756.x; Kross SM, 2011, METHODS ECOL EVOL, V2, P191, DOI 10.1111/j.2041-210X.2010.00064.x; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lewis SB, 2004, WILDLIFE SOC B, V32, P373, DOI 10.2193/0091-7648(2004)32[373:ACOMFA]2.0.CO;2; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; MacLeod CJ, 2008, NEW ZEAL J ECOL, V32, P240; MAF (Ministry of Agriculture and Forestry), 2009, SFF PROJ SUMM FALC G; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Miskelly Colin M., 2008, Notornis, V55, P117; Moore JA, 2008, BIOSCIENCE, V58, P454, DOI 10.1641/B580513; Negro JJ, 2007, RAPTOR RES MANAGEMEN; NEWTON I, 1981, ORNIS SCAND, V12, P224, DOI 10.2307/3676082; Newton I., 1979, POPULATION ECOLOGY R; Palmer AG, 2001, ARCTIC, V54, P105; R Core Development Team, 2008, R LANG ENV STAT COMP; Rands SA, 2000, J THEOR BIOL, V202, P161, DOI 10.1006/jtbi.1999.1048; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Salafsky SR, 2007, J WILDLIFE MANAGE, V71, P2274, DOI 10.2193/2006-357; Seaton R, 2009, NEW ZEAL J ECOL, V33, P32; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Venables WN., 2002, MODERN APPL STAT S 4; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wiehn J, 1997, ECOLOGY, V78, P2043, DOI 10.1890/0012-9658(1997)078[2043:FLOBSE]2.0.CO;2; Wilson K. J., 2004, FLIGHT HUIA ECOLOGY	43	8	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38679	10.1371/journal.pone.0038679	http://dx.doi.org/10.1371/journal.pone.0038679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719921	Green Submitted, Green Published, gold			2022-12-27	WOS:000305347800013
J	Bauer, U; Di Giusto, B; Skepper, J; Grafe, TU; Federle, W				Bauer, Ulrike; Di Giusto, Bruno; Skepper, Jeremy; Grafe, T. Ulmar; Federle, Walter			With a Flick of the Lid: A Novel Trapping Mechanism in Nepenthes gracilis Pitcher Plants	PLOS ONE			English	Article							INSECT ATTACHMENT; STRATEGIES; SLIPPERY; BORNEO; SIZE; RAFFLESIANA; ROUGHNESS; PATTERNS; CAPTURE; SURFACE	Carnivorous pitcher plants capture prey with modified leaves (pitchers), using diverse mechanisms such as 'insect aquaplaning' on the wet pitcher rim, slippery wax crystals on the inner pitcher wall, and viscoelastic retentive fluids. Here we describe a new trapping mechanism for Nepenthes gracilis which has evolved a unique, semi-slippery wax crystal surface on the underside of the pitcher lid and utilises the impact of rain drops to 'flick' insects into the trap. Depending on the experimental conditions (simulated 'rain', wet after 'rain', or dry), insects were captured mainly by the lid, the peristome, or the inner pitcher wall, respectively. The application of an anti-slip coating to the lower lid surface reduced prey capture in the field. Compared to sympatric N. rafflesiana, N. gracilis pitchers secreted more nectar under the lid and less on the peristome, thereby directing prey mainly towards the lid. The direct contribution to prey capture represents a novel function of the pitcher lid.	[Bauer, Ulrike] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Bauer, Ulrike; Grafe, T. Ulmar] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei; [Di Giusto, Bruno] Ming Chuan Univ, English Language Ctr, Taipei, Taiwan; [Skepper, Jeremy] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge; University Brunei Darussalam; Ming Chuan University; University of Cambridge; University of Cambridge	Bauer, U (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ub213@cam.ac.uk	Di Giusto, Bruno/AAL-2166-2020; Federle, Walter/K-8263-2014	Di Giusto, Bruno/0000-0002-1037-276X; Federle, Walter/0000-0002-6375-3005; Bauer, Ulrike/0000-0002-4701-793X	Henslow Research Fellowship of the Cambridge Philosophical Society; Charles Slater Fund, Cambridge; BBSRC [BB/I008667/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008667/1] Funding Source: researchfish	Henslow Research Fellowship of the Cambridge Philosophical Society; Charles Slater Fund, Cambridge; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Henslow Research Fellowship of the Cambridge Philosophical Society and a field work grant by the Charles Slater Fund, Cambridge, to UB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer U, 2012, J EVOLUTION BIOL, V25, P90, DOI 10.1111/j.1420-9101.2011.02406.x; Bauer U, 2008, P ROY SOC B-BIOL SCI, V275, P259, DOI 10.1098/rspb.2007.1402; Bauer U, 2011, J EXP BOT, V62, P3683, DOI 10.1093/jxb/err082; Bauer U, 2009, ANN BOT-LONDON, V103, P1219, DOI 10.1093/aob/mcp065; Bidin K, 2006, HYDROL PROCESS, V20, P3835, DOI 10.1002/hyp.6160; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bonhomme V, 2011, NEW PHYTOL, V191, P545, DOI 10.1111/j.1469-8137.2011.03696.x; BRANDT CJ, 1989, CATENA, V16, P507, DOI 10.1016/0341-8162(89)90032-5; Chin LJ, 2010, NEW PHYTOL, V186, P461, DOI 10.1111/j.1469-8137.2009.03166.x; Clarke C., 1997, NEPENTHES OF BORNEO; Cranbrook GG-H, 1994, BELALONG TROPICAL RA; Dai ZD, 2002, J EXP BIOL, V205, P2479; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Gaume L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001185; Gorb E, 2005, J EXP BIOL, V208, P4651, DOI 10.1242/jeb.01939; Grafe TU, 2011, BIOL LETTERS, V7, P436, DOI 10.1098/rsbl.2010.1141; GUNN R, 1949, J METEOROL, V6, P243, DOI 10.1175/1520-0469(1949)006<0243:TTVOFF>2.0.CO;2; Juniper B. E., 1989, CARNIVOROUS PLANTS; Juniper BE., 1962, NEW SCI, V13, P75; Kimble P.D., 1996, THESIS W KENTUCKY U; KNOLL F, 1914, JB WISS BOT, V54, P448; Merbach MA, 2001, FLORA, V196, P153, DOI 10.1016/S0367-2530(17)30030-0; Moran JA, 2010, J EXP BOT, V61, P1365, DOI 10.1093/jxb/erq004; Scholz I, 2010, J EXP BIOL, V213, P1115, DOI 10.1242/jeb.035618; Ulbrich CW, 2007, J APPL METEOROL CLIM, V46, P1777, DOI 10.1175/2007JAMC1649.1	25	27	27	1	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38951	10.1371/journal.pone.0038951	http://dx.doi.org/10.1371/journal.pone.0038951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719998	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341900067
J	Evans, DW; Orr, PT; Lazar, SM; Breton, D; Gerard, J; Ledbetter, DH; Janosco, K; Dotts, J; Batchelder, H				Evans, David W.; Orr, Patrick T.; Lazar, Steven M.; Breton, Daniel; Gerard, Jennifer; Ledbetter, David H.; Janosco, Kathleen; Dotts, Jessica; Batchelder, Holly			Human Preferences for Symmetry: Subjective Experience, Cognitive Conflict and Cortical Brain Activity	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; EVENT-RELATED POTENTIALS; FACIAL ATTRACTIVENESS; DISGUST SENSITIVITY; BEHAVIOR; ASYMMETRY; SYMPTOMS; AUTISM; MODEL; TASK	This study examines the links between human perceptions, cognitive biases and neural processing of symmetrical stimuli. While preferences for symmetry have largely been examined in the context of disorders such as obsessive-compulsive disorder and autism spectrum disorders, we examine various these phenomena in non-clinical subjects and suggest that such preferences are distributed throughout the typical population as part of our cognitive and neural architecture. In Experiment 1, 82 young adults reported on the frequency of their obsessive-compulsive spectrum behaviors. Subjects also performed an emotional Stroop or variant of an Implicit Association Task (the OC-CIT) developed to assess cognitive biases for symmetry. Data not only reveal that subjects evidence a cognitive conflict when asked to match images of positive affect with asymmetrical stimuli, and disgust with symmetry, but also that their slowed reaction times when asked to do so were predicted by reports of OC behavior, particularly checking behavior. In Experiment 2, 26 participants were administered an oddball Event-Related Potential task specifically designed to assess sensitivity to symmetry as well as the OC-CIT. These data revealed that reaction times on the OC-CIT were strongly predicted by frontal electrode sites indicating faster processing of an asymmetrical stimulus (unparallel lines) relative to a symmetrical stimulus (parallel lines). The results point to an overall cognitive bias linking disgust with asymmetry and suggest that such cognitive biases are reflected in neural responses to symmetrical/asymmetrical stimuli.	[Evans, David W.; Orr, Patrick T.; Lazar, Steven M.; Breton, Daniel; Gerard, Jennifer; Ledbetter, David H.; Janosco, Kathleen; Dotts, Jessica; Batchelder, Holly] Bucknell Univ, Program Neurosci, Lewisburg, PA 17837 USA; [Evans, David W.; Orr, Patrick T.; Ledbetter, David H.] Geisinger Hlth Syst, Danville, PA USA	Bucknell University; Geisinger Health System	Evans, DW (corresponding author), Bucknell Univ, Program Neurosci, Lewisburg, PA 17837 USA.	dwevans@bucknell.edu	Lazar, Steven M./AAN-4462-2020	Lazar, Steven M./0000-0002-2815-6045	National Institutes of Health [2R01 MH074090-06]; Bucknell University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bucknell University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by National Institutes of Health Grant 2R01 MH074090-06 and Bucknell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; BAXTER LR, 1990, J CLIN PSYCHIAT, V51, P70; BAXTER LR, 1990, J CLIN PSYCHIAT, V51, P61; BORNSTEIN MH, 1981, DEV PSYCHOL, V17, P82, DOI 10.1037/0012-1649.17.1.82; Boyer P, 2008, CURR DIR PSYCHOL SCI, V17, P291, DOI 10.1111/j.1467-8721.2008.00592.x; Burriss RP, 2011, PERS SOC PSYCHOL B, V37, P601, DOI 10.1177/0146167211399584; Cavedini P, 2010, BIOL PSYCHIAT, V67, P1178, DOI 10.1016/j.biopsych.2010.02.012; Ciesielski KT, 2011, CLIN NEUROPHYSIOL, V122, P107, DOI 10.1016/j.clinph.2010.05.027; CIESIELSKI KT, 1990, ELECTROEN CLIN NEURO, V75, P207, DOI 10.1016/0013-4694(90)90174-I; COURCHESNE E, 1985, J AUTISM DEV DISORD, V15, P55, DOI 10.1007/BF01837899; COURCHESNE E, 1989, J AUTISM DEV DISORD, V19, P1, DOI 10.1007/BF02212714; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Evans DW, 2011, BEHAV BRAIN RES, V224, P174, DOI 10.1016/j.bbr.2011.05.025; Evans DW, 1997, CHILD DEV, V68, P58, DOI 10.2307/1131925; Evans DW, 2004, BRAIN COGNITION, V55, P220, DOI 10.1016/s0278-2626(03)00274-4; Evans DW, 2006, DEV PSYCHOPATHOL, P404; Foa EB, 1998, PSYCHOL ASSESSMENT, V10, P206, DOI 10.1037/1040-3590.10.3.206; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; FREESTON MH, 1991, BEHAV RES THER, V29, P585, DOI 10.1016/0005-7967(91)90008-Q; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Hartston HJ, 1999, NEUROPSYCHOLOGY, V13, P447, DOI 10.1037/0894-4105.13.3.447; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; Judge PG, 2011, BEHAV BRAIN RES, V222, P57, DOI 10.1016/j.bbr.2011.03.016; Kemner C, 1998, J AUTISM DEV DISORD, V28, P61, DOI 10.1023/A:1026015120128; Kivircik BB, 2003, PROG NEURO-PSYCHOPH, V27, P601, DOI 10.1016/S0278-5846(03)00047-2; Leckman JF, 2008, AM J PSYCHIAT, V165, P1229, DOI 10.1176/appi.ajp.2008.08060891; Leckman JF, 1999, CHILD ADOL PSYCH CL, V8, P635; Leckman JF, 1999, ACTA PSYCHIAT SCAND, V100, P1, DOI 10.1111/j.1600-0447.1999.tb10951.x; Little AC, 2007, P ROY SOC B-BIOL SCI, V274, P3113, DOI 10.1098/rspb.2007.0895; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Mataix-Cols D, 2008, J AM ACAD CHILD PSY, V47, P773, DOI 10.1097/CHI.0b013e31816b73c0; Mavrogiorgou P, 2002, J PSYCHIATR RES, V36, P399, DOI 10.1016/S0022-3956(02)00055-9; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Perreault A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019519; RACHMAN S, 1978, BEHAV RES THER, V16, P233, DOI 10.1016/0005-7967(78)90022-0; Rao NP, 2010, PSYCHIAT RES, V180, P99, DOI 10.1016/j.psychres.2009.10.017; SALKOVSKIS PM, 1984, BEHAV RES THER, V22, P549, DOI 10.1016/0005-7967(84)90057-3; Schienle A, 2003, J NERV MENT DIS, V191, P831, DOI 10.1097/01.nmd.0000100928.99910.2d; Schultz RT, 1999, CHILD ADOL PSYCH CL, V8, P513; Schultz RT, 1999, CHILD ADOL PSYCH CL, V8, pviii; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWADDLE JP, 1995, P ROY SOC B-BIOL SCI, V261, P111, DOI 10.1098/rspb.1995.0124; Tolin DF, 2006, J BEHAV THER EXP PSY, V37, P30, DOI 10.1016/j.jbtep.2005.09.003; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; WATSON PJ, 1994, TRENDS ECOL EVOL, V9, P21, DOI 10.1016/0169-5347(94)90227-5; Wignall AE, 2006, ETHOLOGY, V112, P510, DOI 10.1111/j.1439-0310.2006.01199.x	47	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38966	10.1371/journal.pone.0038966	http://dx.doi.org/10.1371/journal.pone.0038966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22720004	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900069
J	Hebner, CM; Han, B; Brendza, KM; Nash, M; Sulfab, M; Tian, Y; Hung, M; Fung, WC; Vivian, RW; Trenkle, J; Taylor, J; Bjornson, K; Bondy, S; Liu, XH; Link, J; Neyts, J; Sakowicz, R; Zhong, WD; Tang, HL; Schmitz, U				Hebner, Christy M.; Han, Bin; Brendza, Katherine M.; Nash, Michelle; Sulfab, Maisoun; Tian, Yang; Hung, Magdeleine; Fung, Wanchi; Vivian, Randall W.; Trenkle, James; Taylor, James; Bjornson, Kyla; Bondy, Steven; Liu, Xiaohong; Link, John; Neyts, Johan; Sakowicz, Roman; Zhong, Weidong; Tang, Hengli; Schmitz, Uli			The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; PLUS RIBAVIRIN; PROTEASE INHIBITOR; VIRUS; REPLICATION; BOCEPREVIR; MUTATIONS; THERAPY	Tegobuvir (TGV) is a novel non-nucleoside inhibitor (NNI) of HCV RNA replication with demonstrated antiviral activity in patients with genotype 1 chronic HCV infection. The mechanism of action of TGV has not been clearly defined despite the identification of resistance mutations mapping to the NS5B polymerase region. TGV does not inhibit NS5B enzymatic activity in biochemical assays in vitro, suggesting a more complex antiviral mechanism with cellular components. Here, we demonstrate that TGV exerts anti-HCV activity utilizing a unique chemical activation and subsequent direct interaction with the NS5B protein. Treatment of HCV subgenomic replicon cells with TGV results in a modified form of NS5B with a distinctly altered mobility on a SDS-PAGE gel. Further analysis reveals that the aberrantly migrating NS5B species contains the inhibitor molecule. Formation of this complex does not require the presence of any other HCV proteins. The intensity of the aberrantly migrating NS5B species is strongly dependent on cellular glutathione levels as well as CYP 1A activity. Furthermore analysis of NS5B protein purified from a heterologous expression system treated with TGV by mass spectrometry suggests that TGV undergoes a CYP-mediated intracellular activation step and the resulting metabolite, after forming a glutathione conjugate, directly and specifically interacts with NS5B. Taken together, these data demonstrate that upon metabolic activation TGV is a specific, covalent inhibitor of the HCV NS5B polymerase and is mechanistically distinct from other classes of the non-nucleoside inhibitors (NNI) of the viral polymerase.	[Hebner, Christy M.; Han, Bin; Brendza, Katherine M.; Nash, Michelle; Sulfab, Maisoun; Tian, Yang; Hung, Magdeleine; Fung, Wanchi; Vivian, Randall W.; Trenkle, James; Taylor, James; Bjornson, Kyla; Bondy, Steven; Liu, Xiaohong; Link, John; Sakowicz, Roman; Schmitz, Uli] Gilead Sci Inc, Foster City, CA 94404 USA; [Neyts, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Rega Inst, Louvain, Belgium; [Zhong, Weidong] Novartis, Emeryville, CA USA; [Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Gilead Sciences; KU Leuven; Novartis; State University System of Florida; Florida State University	Hebner, CM (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	uli.schmitz@gilead.com	Neyts, Johan/U-8267-2017; Tang, Hengli/F-2085-2014	Neyts, Johan/0000-0002-0033-7514; 	Gilead Sciences	Gilead Sciences(Gilead Sciences)	All authors with the exception of JN and HT were employees of Gilead Sciences. JN and HT receive funds and/or compounds from Gilead Sciences. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bondy S, 2008, WORLD INTELLECTUAL P; Chen KX, 2012, J MED CHEM; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Foster G, 2010, J HEPATOL, V54, ps172; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hebner C, 2011, J HEPATOL, V54, pS478, DOI 10.1016/S0168-8278(11)61213-0; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lok A, 2011, J HEPATOL, V54, pS536, DOI 10.1016/S0168-8278(11)61358-5; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mo H, 2011, J HEPATOL, V54, pS484, DOI 10.1016/S0168-8278(11)61227-0; Paeshuyse J, 2006, J VIROL, V80, P149, DOI 10.1128/JVI.80.1.149-160.2006; Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Powers JP, 2006, J MED CHEM, V49, P1034, DOI 10.1021/jm050859x; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Shih IH, 2011, ANTIMICROB AGENTS CH, V55, P4196, DOI 10.1128/AAC.00307-11; Vrancken R, 2008, ANTIVIR RES, V77, P114, DOI 10.1016/j.antiviral.2007.09.006; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Yan SQ, 2007, BIOORG MED CHEM LETT, V17, P28, DOI 10.1016/j.bmcl.2006.10.002; Yang H, 2006, J CLIN VIROL, V36, pS109, DOI 10.1016/S1386-6532(06)80339-2; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	25	37	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39163	10.1371/journal.pone.0039163	http://dx.doi.org/10.1371/journal.pone.0039163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720059	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900088
J	Sayama, H; Akaishi, J				Sayama, Hiroki; Akaishi, Jin			Characterizing Interdisciplinarity of Researchers and Research Topics Using Web Search Engines	PLOS ONE			English	Article							NETWORKS; COCITATION	Researchers' networks have been subject to active modeling and analysis. Earlier literature mostly focused on citation or co-authorship networks reconstructed from annotated scientific publication databases, which have several limitations. Recently, general-purpose web search engines have also been utilized to collect information about social networks. Here we reconstructed, using web search engines, a network representing the relatedness of researchers to their peers as well as to various research topics. Relatedness between researchers and research topics was characterized by visibility boost-increase of a researcher's visibility by focusing on a particular topic. It was observed that researchers who had high visibility boosts by the same research topic tended to be close to each other in their network. We calculated correlations between visibility boosts by research topics and researchers' interdisciplinarity at the individual level (diversity of topics related to the researcher) and at the social level (his/her centrality in the researchers' network). We found that visibility boosts by certain research topics were positively correlated with researchers' individual-level interdisciplinarity despite their negative correlations with the general popularity of researchers. It was also found that visibility boosts by network-related topics had positive correlations with researchers' social-level interdisciplinarity. Research topics' correlations with researchers' individual- and social-level interdisciplinarities were found to be nearly independent from each other. These findings suggest that the notion of "interdisciplinarity" of a researcher should be understood as a multi-dimensional concept that should be evaluated using multiple assessment means.	[Sayama, Hiroki; Akaishi, Jin] Binghamton Univ, Collect Dynam Complex Syst Res Grp, Binghamton, NY USA; [Sayama, Hiroki] Binghamton Univ, Dept Bioengn & Syst Sci, Binghamton, NY USA; [Sayama, Hiroki] Binghamton Univ, Dept Ind Engn, Binghamton, NY USA; [Akaishi, Jin] Kumamoto Natl Coll Technol, Fac Liberal Studies, Yatsushiro, Kumamoto, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Sayama, H (corresponding author), Binghamton Univ, Collect Dynam Complex Syst Res Grp, Binghamton, NY USA.	sayama@binghamton.edu	Sayama, Hiroki/GQH-1782-2022	Sayama, Hiroki/0000-0002-2670-5864	National Science Foundation [1027752]; Division Of Behavioral and Cognitive Sci [1027752] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported in part by the National Science Foundation (award #1027752). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akaishi J, 2010, P BIONETICS 2010; Asada Y, 2005, T JAP SOC ART INTEL, V20, P370; Astrom F, 2007, J AM SOC INF SCI TEC, V58, P947, DOI 10.1002/asi.20567; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BarabSSsi, 2003, LINKED; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; BRAAM RR, 1991, J AM SOC INFORM SCI, V42, P233, DOI 10.1002/(SICI)1097-4571(199105)42:4<233::AID-ASI1>3.0.CO;2-I; Dionne SD, 2012, ORG RES MET IN PRESS, DOI [10.1177/1094428112442572, DOI 10.1177/10944281124]; Eaton J. P., 1999, J CONSUM PSYCHOL, V8, P39, DOI DOI 10.1207/S15327663JCP0801_02; FRIEDKIN NE, 1978, AM J SOCIOL, V83, P1444, DOI 10.1086/226708; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Janssens F, 2008, SCIENTOMETRICS, V75, P607, DOI 10.1007/s11192-007-2002-7; Kautz H, 1997, AI MAG, V18, P27; Klavans R, 2011, J AM SOC INF SCI TEC, V62, P1, DOI 10.1002/asi.21444; L?vy P., 1997, COLLECTIVE INTELLIGE; Lee SH, 2010, PLOS ONE; Leydesdorff L, 2007, J AM SOC INF SCI TEC, V58, P1303, DOI 10.1002/asi.20614; Liu XH, 2010, J AM SOC INF SCI TEC, V61, P1105, DOI 10.1002/asi.21312; Malone T.W., 2009, 473209 MIT SLOAN SCH, P4732; Matsuo Y, 2007, J WEB SEMANT, V5, P262, DOI 10.1016/j.websem.2007.09.002; Mika P., 2004, P 1 WORKSH FRIEND FR; Mori J, 2004, ISWC WORKSH NOT 8 W8, P51; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; PRICE DJD, 1965, SCIENCE, V149, P510; Rafols I, 2010, SCIENTOMETRICS, V82, P263, DOI 10.1007/s11192-009-0041-y; Shiffrin RM, 2004, PNAS S1, V101; Sullivan D, 2011, WHY GOOGLE CANT COUN; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478	33	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38747	10.1371/journal.pone.0038747	http://dx.doi.org/10.1371/journal.pone.0038747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719935	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341900046
J	Furlan, S; Comparini, D; Ciszak, M; Beccai, L; Mancuso, S; Mazzolai, B				Furlan, Silvano; Comparini, Diego; Ciszak, Marzena; Beccai, Lucia; Mancuso, Stefano; Mazzolai, Barbara			Origin of Polar Order in Dense Suspensions of Phototactic Micro-Swimmers	PLOS ONE			English	Article							FLUID-DYNAMICS; RANDOM-WALK; CHLAMYDOMONAS; LOCOMOTION; MOTION; LIGHT	A main question for the study of collective motion in living organisms is the origin of orientational polar order, i.e., how organisms align and what are the benefits of such collective behaviour. In the case of micro-organisms swimming at a low Reynolds number, steric repulsion and long-range hydrodynamic interactions are not sufficient to explain a homogeneous polar order state in which the direction of motion is aligned. An external symmetry-breaking guiding field such as a mechanism of taxis appears necessary to understand this phonemonon. We have investigated the onset of polar order in the velocity field induced by phototaxis in a suspension of a motile micro-organism, the algae Chlamydomonas reinhardtii, for density values above the limit provided by the hydrodynamic approximation of a force dipole model. We show that polar order originates from a combination of both the external guiding field intensity and the population density. In particular, we show evidence for a linear dependence of a phototactic guiding field on cell density to determine the polar order for dense suspensions and demonstrate the existence of a density threshold for the origin of polar order. This threshold represents the density value below which cells undergoing phototaxis are not able to maintain a homogeneous polar order state and marks the transition to ordered collective motion. Such a transition is driven by a noise dominated phototactic reorientation where the noise is modelled as a normal distribution with a variance that is inversely proportional to the guiding field strength. Finally, we discuss the role of density in dense suspensions of phototactic micro-swimmers.	[Furlan, Silvano; Beccai, Lucia; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Furlan, Silvano] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Comparini, Diego; Ciszak, Marzena; Mancuso, Stefano] Univ Florence, Dept Plant Soil & Environm Sci, Lab Int Neurobiol Vegetale, Florence, Italy; [Ciszak, Marzena] CNR, Ist Nazl Ott, Florence, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Furlan, S (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy.	silvano.furlan@iit.it	Mazzolai, Barbara/I-8876-2016; Mancuso, Stefano/G-6515-2012	Mazzolai, Barbara/0000-0003-0722-8350; Mancuso, Stefano/0000-0003-1752-3986; Beccai, Lucia/0000-0002-8754-5155				Baskaran A, 2009, P NATL ACAD SCI USA, V106, P15567, DOI 10.1073/pnas.0906586106; Baskaran A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011920; Baskaran A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.268101; Bastiaans RJM, 2000, 99W001 EUT TU EINDH; Bayly PV, 2011, BIOPHYS J, V100, P2716, DOI 10.1016/j.bpj.2011.05.001; Bertin E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.022101; Cavagna A, 2010, P NATL ACAD SCI US; Cisneros LH, 2007, EXP FLUIDS, V43, P737, DOI 10.1007/s00348-007-0387-y; Cisneros LH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061907; Czirok A, 1997, J PHYS A-MATH GEN, V30, P1375, DOI 10.1088/0305-4470/30/5/009; Drescher K, 2011, P NATL ACAD SCI USA, V108, P10940, DOI 10.1073/pnas.1019079108; Drescher K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168101; Dusenbery DB, 1997, P NATL ACAD SCI USA, V94, P10949, DOI 10.1073/pnas.94.20.10949; Ebbens SJ, 2010, SOFT MATTER, V6, P726, DOI 10.1039/b918598d; Elfring GJ, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3532954; Evans AA, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3660268; FOSTER KW, 1980, MICROBIOL REV, V44, P572, DOI 10.1128/MMBR.44.4.572-630.1980; Fujiu K, 2011, NAT CELL BIOL, V13, P630, DOI 10.1038/ncb2214; Goldstein RE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.148103; Goldstein RE, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168103; Guasto JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168102; Haeder D, 2001, COMPREHENSIVE SERIES, V1; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Hill NA, 2005, FLUID DYN RES, V37, P1, DOI 10.1016/j.fluiddyn.2005.03.002; HYAMS JS, 1978, J CELL SCI, V33, P235; Jaffe LF, 2007, BIOL CELL, V99, P175, DOI 10.1042/BC20060031; Kotar J, 2010, P NATL ACAD SCI USA, V107, P7669, DOI 10.1073/pnas.0912455107; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Mardia KV, 2000, DIRECTIONAL STAT; MORELLAURENS N, 1987, PHOTOCHEM PHOTOBIOL, V45, P119, DOI 10.1111/j.1751-1097.1987.tb08412.x; Mori N, 2003, INTRO MPIV MATLAB; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; Pooley CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228103; Prost, 1995, PHYS LIQUID CRYSTALS; Rao JS., 2001, TOPICS CIRCULAR STAT; Saintillan D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058102; Schaller K, 1997, BIOPHYS J, V73, P1562, DOI 10.1016/S0006-3495(97)78188-8; SCHIENBEIN M, 1994, PHYS REV E, V49, P5462, DOI 10.1103/PhysRevE.49.5462; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vilfan A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058102; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	47	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38895	10.1371/journal.pone.0038895	http://dx.doi.org/10.1371/journal.pone.0038895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723904	Green Submitted, Green Published, gold			2022-12-27	WOS:000305652700038
J	Beaman, RS; Traub, GH; Dell, CA; Santiago, N; Koh, J; Cellinese, N				Beaman, Reed S.; Traub, Greg H.; Dell, Christopher A.; Santiago, Nestor; Koh, Jin; Cellinese, Nico			TOLKIN - Tree of Life Knowledge and Information Network: Filling a Gap for Collaborative Research in Biological Systematics	PLOS ONE			English	Article								The development of biological informatics infrastructure capable of supporting growing data management and analysis environments is an increasing need within the systematics biology community. Although significant progress has been made in recent years on developing new algorithms and tools for analyzing and visualizing large phylogenetic data and trees, implementation of these resources is often carried out by bioinformatics experts, using one-off scripts. Therefore, a gap exists in providing data management support for a large set of non-technical users. The TOLKIN project (Tree of Life Knowledge and Information Network) addresses this need by supporting capabilities to manage, integrate, and provide public access to molecular, morphological, and biocollections data and research outcomes through a collaborative, web application. This data management framework allows aggregation and import of sequences, underlying documentation about their source, including vouchers, tissues, and DNA extraction. It combines features of LIMS and workflow environments by supporting management at the level of individual observations, sequences, and specimens, as well as assembly and versioning of data sets used in phylogenetic inference. As a web application, the system provides multi-user support that obviates current practices of sharing data sets as files or spreadsheets via email.	[Beaman, Reed S.; Traub, Greg H.; Dell, Christopher A.; Santiago, Nestor; Koh, Jin; Cellinese, Nico] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Koh, Jin] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Beaman, RS (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	ncellinese@flmnh.ufl.edu		Cellinese, Nico/0000-0002-7157-9414	National Science Foundation [DEB-0431258, DEB-0829313, DEB-0827609, DEB-0953677, IOS-0827254]; Direct For Biological Sciences [0827609, 0953677] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation grants DEB-0431258, DEB-0829313, DEB-0827609, DEB-0953677, and IOS-0827254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas I, 2004, KEPLER EXTENSIBLE SY, P423; Carneiro-Torres DS, 2012, SYSTEMATIC IN PRESS; Esser Hans-Joachim, 2012, Rodriguésia, V63, P209; Gross M, 2011, CURR BIOL, V21, pR204, DOI 10.1016/j.cub.2011.03.009; Jones MB, 2001, IEEE INTERNET COMPUT, V5, P59, DOI 10.1109/4236.957896; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ludascher B, 2006, CONCURR COMP-PRACT E, V18, P1039, DOI 10.1002/cpe.994; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; Michener WK, 2006, ECOL INFORM, V1, P3, DOI 10.1016/j.ecoinf.2005.08.004; O'Leary MA, 2011, CLADISTICS, V27, P529, DOI 10.1111/j.1096-0031.2011.00355.x; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Pahlevani AH, 2011, WILLDENOWIA, V41, P267, DOI 10.3372/wi.41.41208; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Pennisi E, 2011, SCIENCE, V331, P666, DOI 10.1126/science.331.6018.666; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vision TJ, 2010, BIOSCIENCE, V60, P330, DOI 10.1525/bio.2010.60.5.2; Vos R. A., 2012, SYSTEMATIC BIOL; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715; Yang Y, TAXON IN PRESS; Zhimin Wang, 2009, 2009 WRI World Congress on Computer Science and Information Engineering (CSIE 2009), P731, DOI 10.1109/CSIE.2009.948	22	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39352	10.1371/journal.pone.0039352	http://dx.doi.org/10.1371/journal.pone.0039352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724002	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300137
J	Dittmar, MS; Petermichl, W; Schlachetzki, F; Graf, BM; Gruber, M				Dittmar, Michael S.; Petermichl, Walter; Schlachetzki, Felix; Graf, Bernhard M.; Gruber, Michael			Isoflurane Induces Endothelial Apoptosis of the Post-Hypoxic Blood-Brain Barrier in a Transdifferentiated Human Umbilical Vein Edothelial Cell Model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEUROVASCULAR UNIT; ARTERY OCCLUSION; NITRIC-OXIDE; RATS; INJURY; STROKE; PERMEABILITY; INHIBITION; ANESTHESIA	Isoflurane is a popular volatile anesthetic agent used in humans as well as in experimental animal research. In previous animal studies of the blood-brain barrier (BBB), observations towards an increased permeability after exposure to isoflurane are reported. In this study we investigated the effect of a 2-hour isoflurane exposure on apoptosis of the cerebral endothelium following 24 hours of hypoxia in an in vitro BBB model using astrocyte-conditioned human umbilical vein endothelial cells (AC-HUVECs). Apoptosis of AC-HUVECs was investigated using light microscopy of the native culture for morphological changes, Western blot (WB) analysis of Bax and Bcl-2, and a TUNEL assay. Treatment of AC-HUVECs with isoflurane resulted in severe cellular morphological changes and a significant dose-dependent increase in DNA fragmentation, which was observed during the TUNEL assay analysis. WB analysis confirmed increases in pro-apoptotic Bax levels at 4 hours and 24 hours and decreases in anti-apoptotic Bcl-2 in a dose-dependent manner compared with the control group. These negative effects of isoflurane on the BBB after a hypoxic challenge need to be taken into account not only in experimental stroke research, but possibly also in clinical practice.	[Dittmar, Michael S.; Petermichl, Walter; Graf, Bernhard M.; Gruber, Michael] Univ Regensburg, Dept Anesthesiol, Med Ctr, Regensburg, Germany; [Schlachetzki, Felix] Univ Regensburg, Dept Neurol, Bezirksklinikum Regensburg, Regensburg, Germany	University of Regensburg; University of Regensburg	Dittmar, MS (corresponding author), Univ Regensburg, Dept Anesthesiol, Med Ctr, Regensburg, Germany.	michael.dittmar@ukr.de	Gruber, Michael/A-5342-2012	Gruber, Michael/0000-0002-5509-9760; Dittmar, Michael S./0000-0002-8687-5830	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The project was financed by institutional funds. Cost of publication was covered by financial means from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Chi OZ, 2010, ANESTH ANALG, V110, P1412, DOI 10.1213/ANE.0b013e3181d6c0ae; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DRUMMOND JC, 1995, NEUROSURGERY, V37, P742, DOI 10.1227/00006123-199510000-00019; DRUMMOND JC, 1995, NEUROSURGERY, V37, P748; Eisert Wolfgang G, 2009, Handb Clin Neurol, V92, P197, DOI 10.1016/S0072-9752(08)01910-6; Engelhard K, 1999, BRIT J ANAESTH, V83, P415, DOI 10.1093/bja/83.3.415; FLYNN NM, 1992, ANESTHESIOLOGY, V76, P461, DOI 10.1097/00000542-199203000-00021; Gwak MS, 2011, ENVIRON TOXICOL PHAR, V31, P262, DOI 10.1016/j.etap.2010.10.009; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Inoue S, 2004, ANESTHESIOLOGY, V101, P75, DOI 10.1097/00000542-200407000-00013; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JENSEN NF, 1992, ANESTHESIOLOGY, V76, P624, DOI 10.1097/00000542-199204000-00021; Kawaguchi M, 2004, ANESTH ANALG, V98, P798; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; KOENIG HM, 1994, ANESTH ANALG, V79, P886; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; MILDE LN, 1988, ANESTHESIOLOGY, V69, P905, DOI 10.1097/00000542-198812000-00017; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Okamoto H, 1997, ANESTHESIOLOGY, V86, P875, DOI 10.1097/00000542-199704000-00018; OLSSON Y, 1971, ACTA NEUROPATHOL, V18, P89, DOI 10.1007/BF00687597; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; PRESTON E, 1993, NEUROSCI LETT, V149, P75, DOI 10.1016/0304-3940(93)90351-K; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; YAMAGISHI S, 1993, BIOCHEM BIOPH RES CO, V190, P418, DOI 10.1006/bbrc.1993.1064; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	42	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38260	10.1371/journal.pone.0038260	http://dx.doi.org/10.1371/journal.pone.0038260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723852	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300023
J	Kukita, A; Ichigi, Y; Takigawa, I; Watanabe, T; Kukita, T; Miyamoto, H				Kukita, Akiko; Ichigi, Yuka; Takigawa, Ippei; Watanabe, Toshiyuki; Kukita, Toshio; Miyamoto, Hiroshi			Infection of RANKL-Primed RAW-D Macrophages with Porphyromonas gingivalis Promotes Osteoclastogenesis in a TNF-alpha-Independent Manner	PLOS ONE			English	Article							KAPPA-B LIGAND; CYTOKINE PRODUCTION; BONE LOSS; DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR; DIRECT STIMULATION; GENE-EXPRESSION; IN-VIVO; C-FOS; LIPOPOLYSACCHARIDE	Infection of macrophages with bacteria induces the production of pro-inflammatory cytokines including TNF-alpha. TNF-alpha directly stimulates osteoclast differentiation from bone marrow macrophages in vitro as well as indirectly via osteoblasts. Recently, it was reported that bacterial components such as LPS inhibited RANKL-induced osteoclastogenesis in early stages, but promoted osteoclast differentiation in late stages. However, the contribution to osteoclast differentiation of TNF-alpha produced by infected macrophages remains unclear. We show here that Porphyromonas gingivalis, one of the major pathogens in periodontitis, directly promotes osteoclastogenesis from RANKL-primed RAW-D (subclone of RAW264) mouse macrophages, and we show that TNF-alpha is not involved in the stimulatory effect on osteoclastogenesis. P. gingivalis infection of RANKL-primed RAW-D macrophages markedly stimulated osteoclastogenesis in a RANKL-independent manner. In the presence of the TLR4 inhibitor, polymyxin B, infection of RANKL-primed RAW-D cells with P. gingivalis also induced osteoclastogenesis, indicating that TLR4 is not involved. Infection of RAW-D cells with P. gingivalis stimulated the production of TNF-alpha, whereas the production of TNF-alpha by similarly infected RANKL-primed RAW-D cells was markedly down-regulated. In addition, infection of RANKL-primed macrophages with P. gingivalis induced osteoclastogenesis in the presence of neutralizing antibody against TNF-alpha. Inhibitors of NFATc1 and p38MAPK, but not of NF-kappa B signaling, significantly suppressed P. gingivalis-induced osteoclastogenesis from RANKL-primed macrophages. Moreover, re-treatment of RANKL-primed macrophages with RANKL stimulated osteoclastogenesis in the presence or absence of P. gingivalis infection, whereas re-treatment of RANKL-primed macrophages with TNF-alpha did not enhance osteoclastogenesis in the presence of live P. gingivalis. Thus, P. gingivalis infection of RANKL-primed macrophages promoted osteoclastogenesis in a TNF-a independent manner, and RANKL but not TNF-alpha was effective in inducing osteoclastogenesis from RANKL-primed RAW-D cells in the presence of P. gingivalis.	[Kukita, Akiko; Ichigi, Yuka; Takigawa, Ippei; Miyamoto, Hiroshi] Saga Univ, Dept Microbiol, Fac Med, Saga 840, Japan; [Watanabe, Toshiyuki; Kukita, Toshio] Kyushu Univ, Fac Dent Sci, Fukuoka 812, Japan	Saga University; Kyushu University	Kukita, A (corresponding author), Saga Univ, Dept Microbiol, Fac Med, Saga 840, Japan.	kukita@cc.saga-u.ac.jp			 [21592366]		Financial support for this study was provided by Grant-in-Aid for Scientific Research (C) of Japan, grant number 21592366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Aoki Y, 2010, BIOCHEM BIOPH RES CO, V398, P86, DOI 10.1016/j.bbrc.2010.06.040; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688; Jin QM, 2007, J PERIODONTOL, V78, P1300, DOI 10.1902/jop.2007.070073; Kajiya M., 2010, J ORAL MICROBIOL, V2; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Mabilleau G, 2011, J BIOL CHEM, V286, P3242, DOI 10.1074/jbc.M110.150300; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Sakuma Y, 2000, INFECT IMMUN, V68, P6819, DOI 10.1128/IAI.68.12.6819-6825.2000; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Schwartz Z, 1997, PERIODONTOL 2000, V14, P158, DOI 10.1111/j.1600-0757.1997.tb00196.x; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Ukai T, 2008, INFECT IMMUN, V76, P812, DOI 10.1128/IAI.01241-07; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206; Yang SH, 2005, J IMMUNOL, V175, P1956, DOI 10.4049/jimmunol.175.3.1956; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yuan HP, 2011, J CLIN PERIODONTOL, V38, P1029, DOI 10.1111/j.1600-051X.2011.01780.x; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	43	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38500	10.1371/journal.pone.0038500	http://dx.doi.org/10.1371/journal.pone.0038500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723864	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300030
J	Lu, CH; Lin, YF; Lin, JJ; Yu, CS				Lu, Chih-Hao; Lin, Yu-Feng; Lin, Jau-Ji; Yu, Chin-Sheng			Prediction of Metal Ion-Binding Sites in Proteins Using the Fragment Transformation Method	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ZINC-BINDING; ESCHERICHIA-COLI; NEURAL-NETWORKS; IDENTIFICATION; SEQUENCE; CLASSIFICATION; TEMPLATES; EVOLUTION; REDUCTASE	The structure of a protein determines its function and its interactions with other factors. Regions of proteins that interact with ligands, substrates, and/or other proteins, tend to be conserved both in sequence and structure, and the residues involved are usually in close spatial proximity. More than 70,000 protein structures are currently found in the Protein Data Bank, and approximately one-third contain metal ions essential for function. Identifying and characterizing metal ion-binding sites experimentally is time-consuming and costly. Many computational methods have been developed to identify metal ion-binding sites, and most use only sequence information. For the work reported herein, we developed a method that uses sequence and structural information to predict the residues in metal ion-binding sites. Six types of metal ion-binding templates-those involving Ca2+, Cu2+, Fe3+, Mg2+, Mn2+, and Zn2+-were constructed using the residues within 3.5 angstrom of the center of the metal ion. Using the fragment transformation method, we then compared known metal ion-binding sites with the templates to assess the accuracy of our method. Our method achieved an overall 94.6 % accuracy with a true positive rate of 60.5 % at a 5 % false positive rate and therefore constitutes a significant improvement in metal-binding site prediction.	[Lu, Chih-Hao; Lin, Yu-Feng] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Lin, Yu-Feng; Lin, Jau-Ji] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Lin, Jau-Ji] Acad Sinica, Bioinformat Program, Taiwan Int Grad Program, Inst Informat Sci, Taipei 115, Taiwan; [Lin, Jau-Ji] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Masters Program Biomed Informat & Biomed Engn, Taichung 40724, Taiwan	China Medical University Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Feng Chia University; Feng Chia University	Lu, CH (corresponding author), China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan.	chlu@mail.cmu.edu.tw			National Science Council [NSC 99-2113-M-039-002-MY2]; China Medical University Taiwan [CMU98-N2-19]; National Science Council Taiwan [NSC 98-2627-B-035-001-]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University Taiwan(China Medical University); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council(NSC 99-2113-M-039-002-MY2) and China Medical University(CMU98-N2-19), Taiwan to CHL and the National Science Council(NSC 98-2627-B-035-001-), Taiwan to CSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ana V, 1997, J BIOL INORG CHEM, V2, P10; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Binet MRB, 2003, ANAL BIOCHEM, V318, P30, DOI 10.1016/S0003-2697(03)00190-8; Bond CS, 1999, ACTA CRYSTALLOGR D, V55, P414, DOI 10.1107/S0907444998012074; Dautant A, 1998, ACTA CRYSTALLOGR D, V54, P16, DOI 10.1107/S0907444997006811; Degtyarenko K, 2000, BIOINFORMATICS, V16, P851, DOI 10.1093/bioinformatics/16.10.851; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Golovin A, 2005, PROTEINS, V58, P190, DOI 10.1002/prot.20288; Govindarajan S, 1997, PROTEINS, V29, P461, DOI 10.1002/(SICI)1097-0134(199712)29:4<461::AID-PROT6>3.0.CO;2-B; Gower JC, 1969, J ROY STAT SOC, V18, P11; Goyal K, 2008, PROTEINS, V70, P1206, DOI 10.1002/prot.21601; Guntinas MBDC, 2002, ANAL BIOANAL CHEM, V374, P369, DOI 10.1007/s00216-002-1508-3; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Herald VL, 2003, FEBS LETT, V537, P96, DOI 10.1016/S0014-5793(03)00101-7; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Jensen MR, 2005, BIOCHEMISTRY-US, V44, P11014, DOI 10.1021/bi0508136; Levy R, 2009, PROTEINS, V76, P365, DOI 10.1002/prot.22352; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lin HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S13; Lu CH, 2006, PROTEINS, V63, P636, DOI 10.1002/prot.20904; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Parisi G, 2001, MOL BIOL EVOL, V18, P750, DOI 10.1093/oxfordjournals.molbev.a003857; Passerini A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-39; Passerini A, 2006, PROTEINS, V65, P305, DOI 10.1002/prot.21135; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Reed GH, 2000, MET IONS BIOL SYST, V37, P183; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Sandier A, 1997, J CHROMATOGR A, V776, P93, DOI 10.1016/S0021-9673(97)00450-0; Schrodinger L., 2020, PYMOL; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sieker LC, 1999, NAT STRUCT BIOL, V6, P308; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; TAINER JA, 1991, CURR OPIN BIOTECH, V2, P582, DOI 10.1016/0958-1669(91)90084-I; Tseng YY, 2009, PROTEINS, V76, P959, DOI 10.1002/prot.22402; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P9	44	53	53	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39252	10.1371/journal.pone.0039252	http://dx.doi.org/10.1371/journal.pone.0039252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723976	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300122
J	Mitchell, GB; Sigurdson, CJ; O'Rourke, KI; Algire, J; Harrington, NP; Walther, I; Spraker, TR; Balachandran, A				Mitchell, Gordon B.; Sigurdson, Christina J.; O'Rourke, Katherine I.; Algire, James; Harrington, Noel P.; Walther, Ines; Spraker, Terry R.; Balachandran, Aru			Experimental Oral Transmission of Chronic Wasting Disease to Reindeer (Rangifer tarandus tarandus)	PLOS ONE			English	Article							DEER ODOCOILEUS-HEMIONUS; WHITE-TAILED DEER; RESISTANT PRION PROTEIN; CERVUS-ELAPHUS-NELSONI; CAPTIVE MULE DEER; SPONGIFORM ENCEPHALOPATHY; STRAIN MUTATION; TRANSGENIC MICE; FALLOW DEER; ELK	Chronic wasting disease (CWD), a transmissible spongiform encephalopathy of cervids, remains prevalent in North American elk, white-tailed deer and mule deer. A natural case of CWD in reindeer (Rangifer tarandus tarandus) has not been reported despite potential habitat overlap with CWD-infected deer or elk herds. This study investigates the experimental transmission of CWD from elk or white-tailed deer to reindeer by the oral route of inoculation. Ante-mortem testing of the three reindeer exposed to CWD from white-tailed deer identified the accumulation of pathological PrP (PrPCWD) in the recto-anal mucosa associated lymphoid tissue (RAMALT) of two reindeer at 13.4 months post-inoculation. Terminal CWD occurred in the two RAMALT-positive reindeer at 18.5 and 20 months post-inoculation while one other reindeer in the white-tailed deer CWD inoculum group and none of the 3 reindeer exposed to elk CWD developed disease. Tissue distribution analysis of PrPCWD in CWD-affected reindeer revealed widespread deposition in central and peripheral nervous systems, lymphoreticular tissues, the gastrointestinal tract, neuroendocrine tissues and cardiac muscle. Analysis of prion protein gene (PRNP) sequences in the 6 reindeer identified polymorphisms at residues 2 (V/M), 129 (G/S), 138 (S/N) and 169 (V/M). These findings demonstrate that (i) a sub-population of reindeer are susceptible to CWD by oral inoculation implicating the potential for transmission to other Rangifer species, and (ii) certain reindeer PRNP polymorphisms may be protective against CWD infection.	[Mitchell, Gordon B.; Algire, James; Harrington, Noel P.; Walther, Ines; Balachandran, Aru] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Natl & OIE Reference Lab Scrapie & CWD, Ottawa, ON, Canada; [Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Sigurdson, Christina J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [O'Rourke, Katherine I.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Spraker, Terry R.] Colorado State Univ, Vet Diagnost Lab, Ft Collins, CO 80523 USA	Canadian Food Inspection Agency; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; United States Department of Agriculture (USDA); Colorado State University	Mitchell, GB (corresponding author), Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Natl & OIE Reference Lab Scrapie & CWD, Ottawa, ON, Canada.	Aru.Balachandran@inspection.gc.ca			Canadian Food Inspection Agency; Agriculture and Agri-Food Canada [C00233]; United States Department of Agriculture Agricultural Research Service [CRIS 5348-32000-026-00-D]; United States National Institutes of Health [NS069566, U54AI0359]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069566, R01NS076896] Funding Source: NIH RePORTER	Canadian Food Inspection Agency; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Canadian Food Inspection Agency and Agriculture and Agri-Food Canada under C00233, the United States Department of Agriculture Agricultural Research Service under CRIS 5348-32000-026-00-D and the United States National Institutes of Health under NS069566 and U54AI0359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2007, ARCH NEUROL-CHICAGO, V64, P439, DOI 10.1001/archneur.64.3.439; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; Balachandran A, 2010, CAN VET J, V51, P169; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Brayton KA, 2004, GENE, V326, P167, DOI 10.1016/j.gene.2003.10.022; Collinge J, 2010, SCIENCE, V328, P1111, DOI 10.1126/science.1190815; Cronin MA, 2003, ANIM GENET, V34, P33, DOI 10.1046/j.1365-2052.2003.00927.x; Cronin MRA, 2005, J MAMMAL, V86, P495, DOI 10.1644/1545-1542(2005)86[495:VIMDAM]2.0.CO;2; Daus ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018345; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Hamir AN, 2011, CAN J VET RES, V75, P152; Hamir AN, 2004, VET PATHOL, V41, P78, DOI 10.1354/vp.41-1-78; Happ GM, 2007, J WILDLIFE DIS, V43, P224, DOI 10.7589/0090-3558-43.2.224; Heaton MP, 2003, MAMM GENOME, V14, P765, DOI 10.1007/s00335-003-2283-y; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Lapointe JM, 2002, CAN VET J, V43, P886; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Pushie MJ, 2011, J TOXICOL ENV HEAL A, V74, P1476, DOI 10.1080/15287394.2011.618977; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Rhyan JC, 2011, J WILDLIFE DIS, V47, P739, DOI 10.7589/0090-3558-47.3.739; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264	48	60	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39055	10.1371/journal.pone.0039055	http://dx.doi.org/10.1371/journal.pone.0039055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723928	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300086
J	Muret, J; Hasmim, M; Stasik, I; Jalil, A; Mallavialle, A; Nanbakhsh, A; Lacroix, L; Billot, K; Baud, V; Thiery, J; Vielh, P; Terrier, P; Wiels, J; Vassilev, L; Lecesne, A; Bonvalot, S; Chouaib, S				Muret, Jane; Hasmim, Meriem; Stasik, Izabela; Jalil, Abdelali; Mallavialle, Aude; Nanbakhsh, Arash; Lacroix, Ludovic; Billot, Katy; Baud, Veronique; Thiery, Jerome; Vielh, Philippe; Terrier, Philippe; Wiels, Joelle; Vassilev, Lyubomir; Lecesne, Axel; Bonvalot, Sylvie; Chouaib, Salem			Attenuation of Soft-Tissue Sarcomas Resistance to the Cytotoxic Action of TNF-alpha by Restoring p53 Function	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ISOLATED LIMB PERFUSION; NF-KAPPA-B; ANTITUMOR-ACTIVITY; HUMAN-MELANOMA; CELL-DEATH; MDM2; ACTIVATION; MELPHALAN; PATHWAY	Background: Isolated limb perfusion with TNF-alpha and melphalan is used with remarkable efficiency to treat unresectable limb sarcomas. Here we tested the ability of TNF-alpha to directly induce apoptosis of sarcoma cells. In addition, we investigated the impact of p53 in the regulation of such effect. Methodology/Principal Findings: We first analysed the ability of TNF-alpha to induce apoptosis in freshly isolated tumour cells. For this purpose, sarcoma tumours (n = 8) treated ex vivo with TNF-alpha were processed for TUNEL staining. It revealed substantial endothelial cell apoptosis and levels of tumour cell apoptosis that varied from low to high. In order to investigate the role of p53 in TNF-alpha-induced cell death, human sarcoma cell lines (n = 9) with different TP53 and MDM2 status were studied for their sensitivity to TNF-alpha. TP53(Wt) cell lines were sensitive to TNF-alpha unless MDM2 was over-expressed. However, TP53(Mut) and TP53(Null) cell lines were resistant. TP53 suppression in TP53(Wt) cell lines abrogated TNF-alpha sensitivity and TP53 overexpression in TP53(Null) cell lines restored it. The use of small molecules that restore p53 activity, such as CP-31398 or Nutlin-3a, in association with TNF-alpha, potentiated the cell death of respectively TP53(Mut) and TP53(Wt) /MDM2(Ampl). In particular, CP-31398 was able to induce p53 as well as some of its apoptotic target genes in TP53(Mut) cells. In TP53(Wt)/MDM2(Ampl) cells, Nutlin-3a effects were associated with a decrease of TNF-alpha-induced NF-kappa B-DNA binding and correlated with a differential regulation of pro- and anti-apoptotic genes such as TP53BP2, GADD45, TGF-beta 1 and FAIM. Conclusion/Significance: More effective therapeutic approaches are critically needed for the treatment of unresectable limb sarcomas. Our results show that restoring p53 activity in sarcoma cells correlated with increased sensitivity to TNF-alpha, suggesting that this strategy may be an important determinant of TNF-alpha-based sarcomas treatment.	[Muret, Jane; Hasmim, Meriem; Stasik, Izabela; Jalil, Abdelali; Nanbakhsh, Arash; Thiery, Jerome; Chouaib, Salem] Inst Cancerol Gustave Roussy, Unite INSERM, U753, Villejuif, France; [Muret, Jane] Inst Cancerol Gustave Roussy, Dept Anesthesie, Villejuif, France; [Mallavialle, Aude] Grp Hosp Archet, Unite INSERM, U576, Nice, France; [Lacroix, Ludovic; Vielh, Philippe] Inst Cancerol Gustave Roussy, Lab Rech Translat, Villejuif, France; [Billot, Katy; Baud, Veronique] Inst Cochin, Unite INSERM, U1016, Paris, France; [Billot, Katy; Baud, Veronique] CNRS, UMR 8104, Paris, France; [Billot, Katy; Baud, Veronique] Univ Paris 05, Paris, France; [Terrier, Philippe] Inst Cancerol Gustave Roussy, Dept Pathol, Villejuif, France; [Wiels, Joelle] Univ Paris 11, CNRS, IGR, Inst Cancerol Gustave Roussy,UMR 8126, Villejuif, France; [Vassilev, Lyubomir] Hoffmann La Roche Inc, Roche Res Ctr, Discovery Oncol, Nutley, NJ 07110 USA; [Lecesne, Axel] Inst Cancerol Gustave Roussy, Dept Med, Villejuif, France; [Bonvalot, Sylvie] Inst Cancerol Gustave Roussy IGR, Dept Chirurg, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Roche Holding; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Muret, J (corresponding author), Inst Cancerol Gustave Roussy, Unite INSERM, U753, Villejuif, France.	muret@igr.fr	Baud, Veronique/F-7699-2013; Baud, Veronique/AAL-3950-2020; Wiels, Joëlle/AGL-2319-2022; THIERY, Jerome/N-2469-2018	Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X; Wiels, Joëlle/0000-0002-3313-2937; THIERY, Jerome/0000-0002-0998-3627; JALIL, Abdelali/0000-0003-2710-8735; Hasmim, Meriem/0000-0002-7920-2443; Stasik, Izabela/0000-0002-7756-4731; mallavialle, aude/0000-0002-9380-6788	Conticanet; Fondation de Recherche Gustave Roussy and Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche	Conticanet; Fondation de Recherche Gustave Roussy and Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This research was supported by grants to JM from Conticanet, Fondation de Recherche Gustave Roussy and Association pour la Recherche sur le Cancer and to VB from Agence Nationale pour la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 1999, ONCOGENE, V18, P5464, DOI 10.1038/sj.onc.1202919; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEYAERT R, 1994, FEBS LETT, V340, P9, DOI 10.1016/0014-5793(94)80163-0; Bezzi M, 2003, J BIOL CHEM, V278, P43603, DOI 10.1074/jbc.M308114200; Bonvalot S, 2005, ANN ONCOL, V16, P1061, DOI 10.1093/annonc/mdi229; Cai ZZ, 1997, ONCOGENE, V15, P2817, DOI 10.1038/sj.onc.1201445; Casali PG, 2010, ANN ONCOL, V21, pv198, DOI 10.1093/annonc/mdq209; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chibon F, 2002, CANCER GENET CYTOGEN, V139, P24, DOI 10.1016/S0165-4608(02)00614-3; CORDONCARDO C, 1994, CANCER RES, V54, P794; de Wilt JHW, 2000, BRIT J CANCER, V82, P1000, DOI 10.1054/bjoc.1999.1032; Dey A, 2007, CELL CYCLE, V6, P2178, DOI 10.4161/cc.6.17.4643; Drane P, 2002, CELL DEATH DIFFER, V9, P527, DOI 10.1038/sj.cdd.4400983; Eggermont AMM, 1996, ANN SURG, V224, P756, DOI 10.1097/00000658-199612000-00011; Eggermont AMM, 1998, ANTICANCER RES, V18, P3899; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Grimer Robert, 2010, Sarcoma, V2010, P317462, DOI 10.1155/2010/317462; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Lee GH, 2011, INT J ONCOL, V39, P209, DOI 10.3892/ijo.2011.1024; LEJEUNE F, 1994, J CELL BIOCHEM, V56, P52, DOI 10.1002/jcb.240560110; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Menon C, 2003, AM J PHYSIOL-HEART C, V284, pH317, DOI 10.1152/ajpheart.00971.2001; Menon C, 2006, ANN SURG, V244, P781, DOI 10.1097/01.sla.0000231723.81218.72; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Muret J, 2008, ANN ONCOL, V19, P793, DOI 10.1093/annonc/mdm559; Nooijen PTGA, 1996, BRIT J CANCER, V74, P1908, DOI 10.1038/bjc.1996.652; Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211; Perot G, 2010, AM J PATHOL, V177, P2080, DOI 10.2353/ajpath.2010.100104; Perot G, 2009, CANCER RES, V69, P2269, DOI 10.1158/0008-5472.CAN-08-1443; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Plaat BEC, 1999, CLIN CANCER RES, V5, P1650; RENARD N, 1995, J PATHOL, V176, P279, DOI 10.1002/path.1711760310; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; SEKIGUCHI M, 1985, BIOMED PHARMACOTHER, V39, P372; SHERMAN ML, 1988, J CLIN ONCOL, V6, P344, DOI 10.1200/JCO.1988.6.2.344; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38808	10.1371/journal.pone.0038808	http://dx.doi.org/10.1371/journal.pone.0038808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719951	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000305583300051
J	Wu, JCC; Chen, KY; Yu, YW; Huang, SW; Shih, HM; Chiu, WT; Chiang, YH; Shiau, CY				Wu, John Chung-Che; Chen, Kai-Yun; Yu, Yu-Wen; Huang, Song-Wei; Shih, Hsiu-Ming; Chiu, Wen-Ta; Chiang, Yung-Hsiao; Shiau, Chia-Yang			Location and Level of Etk Expression in Neurons Are Associated with Varied Severity of Traumatic Brain Injury	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MEDIATED CYTOSKELETAL DEGRADATION; CALPAIN INHIBITOR MDL-28170; CORTICAL IMPACT INJURY; OXIDATIVE DAMAGE; SERUM MARKERS; PROTEIN; ENOLASE; PEROXYNITRITE; BIOMARKER	Background: Much recent research effort in traumatic brain injury (TBI) has been devoted to the discovery of a reliable biomarker correlating with severity of injury. Currently, no consensus has been reached regarding a representative marker for traumatic brain injury. In this study, we explored the potential of epithelial/endothelial tyrosine kinase (Etk) as a novel marker for TBI. Methodology/Principal Findings: TBI was induced in Sprague Dawley (SD) rats by controlled cortical impact. Brain tissue samples were analyzed by Western blot, Q-PCR, and immunofluorescence staining using various markers including glial fibrillary acidic protein, and epithelial/endothelial tyrosine kinase (Etk). Results show increased Etk expression with increased number and severity of impacts. Expression increased 2.36 to 7-fold relative to trauma severity. Significant upregulation of Etk appeared at 1 hour after injury. The expression level of Etk was inversely correlated with distance from injury site. Etk and trauma/inflammation related markers increased post-TBI, while other tyrosine kinases did not. Conclusion/Significance: The observed correlation between Etk level and the number of impacts, the severity of impact, and the time course after impact, as well as its inverse correlation with distance away from injury site, support the potential of Etk as a possible indicator of trauma severity.	[Wu, John Chung-Che; Shiau, Chia-Yang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wu, John Chung-Che] Taitung Christian Hosp, Taitung, Taiwan; [Wu, John Chung-Che; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chen, Kai-Yun; Yu, Yu-Wen; Chiang, Yung-Hsiao] Coll Med Sci & Technol, Neural Regenerat Program, Taipei, Taiwan; [Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chen, Kai-Yun; Yu, Yu-Wen; Huang, Song-Wei; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chiu, Wen-Ta] Minist Hlth, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Academia Sinica - Taiwan	Wu, JCC (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	ychiang@tmu.edu.tw; cys@ndmctsgh.edu.tw	Shih, Hsiu-Ming/S-7023-2018	YU, YU-WEN/0000-0002-7279-2532	Taipei Medical University-Shuang Ho Hospital [100TMU-SHH-12]; National Taipei University of Technology-Taipei Medical University [NTUT-TMU-100-08]; Center of Excellence for Clinical Trial and Research in Neurology Neurosurgery [DOH99-TD-B-111-003]; National Science Council [NSC98-2314-B038-011-MY3]; Cheng-Hsin Research [100-23]	Taipei Medical University-Shuang Ho Hospital; National Taipei University of Technology-Taipei Medical University; Center of Excellence for Clinical Trial and Research in Neurology Neurosurgery; National Science Council(Ministry of Science and Technology, Taiwan); Cheng-Hsin Research	Funding provided by Taipei Medical University-Shuang Ho Hospital 100TMU-SHH-12, National Taipei University of Technology-Taipei Medical University NTUT-TMU-100-08, Center of Excellence for Clinical Trial and Research in Neurology & Neurosurgery DOH99-TD-B-111-003, and National Science Council Grant NSC98-2314-B038-011-MY3, Cheng-Hsin Research Grant 100-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Cekic M, 2012, RESTORATIVE NEUROLOG; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen KY, 2011, CELL TRANSPLANTATION; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Das A, 2008, J PINEAL RES, V45, P117, DOI 10.1111/j.1600-079X.2008.00582.x; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gyorgy AB, 2011, J NEUROTRAUMA; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Jasielska M, 2010, INVEST OPHTH VIS SCI, V51, P3874, DOI 10.1167/iovs.09-5003; Kasahara Y, 2010, BRAIN RES, V1340, P70, DOI 10.1016/j.brainres.2010.03.101; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI 10.1089/neu.2008-0753; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Wang Y, 1997, J NEUROSCI, V17, P4341; Woertgen C, 2002, ACT NEUR S, V81, P205; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Yu CG, 2008, J NEUROTRAUM, V25, P833, DOI 10.1089/neu.2007.0490; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39226	10.1371/journal.pone.0039226	http://dx.doi.org/10.1371/journal.pone.0039226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723969	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300118
J	Bhasin, M; Huang, Z; Pradhan-Nabzdyk, L; Malek, JY; LoGerfo, PJ; Contreras, M; Guthrie, P; Csizmadia, E; Andersen, N; Kocher, O; Ferran, C; LoGerfo, FW				Bhasin, Manoj; Huang, Zhen; Pradhan-Nabzdyk, Leena; Malek, Junaid Y.; LoGerfo, Philip J.; Contreras, Mauricio; Guthrie, Patrick; Csizmadia, Eva; Andersen, Nicholas; Kocher, Olivier; Ferran, Christiane; LoGerfo, Frank W.			Temporal Network Based Analysis of Cell Specific Vein Graft Transcriptome Defines Key Pathways and Hub Genes in Implantation Injury	PLOS ONE			English	Article							NF-KAPPA-B; ASPIRIN PLUS DIPYRIDAMOLE; INTIMAL HYPERPLASIA; COLLAGEN-SYNTHESIS; ENDOTHELIAL-CELLS; EXPRESSION; ACTIVATION; INTERLEUKIN-8; INCREASES; ARTERIES	Vein graft failure occurs between 1 and 6 months after implantation due to obstructive intimal hyperplasia, related in part to implantation injury. The cell-specific and temporal response of the transcriptome to vein graft implantation injury was determined by transcriptional profiling of laser capture microdissected endothelial cells (EC) and medial smooth muscle cells (SMC) from canine vein grafts, 2 hours (H) to 30 days (D) following surgery. Our results demonstrate a robust genomic response beginning at 2 H, peaking at 12-24 H, declining by 7 D, and resolving by 30 D. Gene ontology and pathway analyses of differentially expressed genes indicated that implantation injury affects inflammatory and immune responses, apoptosis, mitosis, and extracellular matrix reorganization in both cell types. Through backpropagation an integrated network was built, starting with genes differentially expressed at 30 D, followed by adding upstream interactive genes from each prior time-point. This identified significant enrichment of IL-6, IL-8, NF-kappa B, dendritic cell maturation, glucocorticoid receptor, and Triggering Receptor Expressed on Myeloid Cells (TREM-1) signaling, as well as PPAR alpha activation pathways in graft EC and SMC. Interactive network-based analyses identified IL-6, IL-8, IL-1 alpha, and Insulin Receptor (INSR) as focus hub genes within these pathways. Real-time PCR was used for the validation of two of these genes: IL-6 and IL-8, in addition to Collagen 11A1 (COL11A1), a cornerstone of the backpropagation. In conclusion, these results establish causality relationships clarifying the pathogenesis of vein graft implantation injury, and identifying novel targets for its prevention.	[Bhasin, Manoj; LoGerfo, Philip J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Genom & Prote Ctr,Div Interdisciplinary Med & Bio, Boston, MA 02215 USA; [Huang, Zhen; Pradhan-Nabzdyk, Leena; Malek, Junaid Y.; Contreras, Mauricio; Guthrie, Patrick; Andersen, Nicholas; Ferran, Christiane; LoGerfo, Frank W.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Div Vasc & Endovasc Surg, Boston, MA 02215 USA; [Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Csizmadia, Eva; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Nephrol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Bhasin, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Genom & Prote Ctr,Div Interdisciplinary Med & Bio, Boston, MA 02215 USA.	cferran@bidmc.harvard.edu; flogerfo@bidmc.harvard.edu		Bhasin, Manoj/0000-0001-5172-420X; Andersen, Nicholas/0000-0002-0905-1694	NIH [1R01HL086741, 5T32HL007734, R01HL080130, DK063275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080130, R01HL086741, T32HL007734, R01HL021796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK063275, R01DK063275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by NIH 1R01HL086741 and 5T32HL007734 to FWL and NIH R01HL080130 and DK063275 to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ND, 2007, J AM COLL SURGEONS, V204, P399, DOI 10.1016/j.jamcollsurg.2006.12.029; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Belkin M, 2000, VASCULAR SURG; Chung SW, 2010, BIOCHEM BIOPH RES CO, V396, P748, DOI 10.1016/j.bbrc.2010.05.009; Colotti C, 2009, CYTOKINE, V46, P228, DOI 10.1016/j.cyto.2009.02.002; Conte MS, 2007, J VASC SURG, V45, p74A, DOI 10.1016/j.jvs.2007.02.031; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Cooper JAD, 2000, BIOCHEM PHARMACOL, V59, P605, DOI 10.1016/S0006-2952(99)00375-5; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; COX JL, 1991, PROG CARDIOVASC DIS, V34, P45, DOI 10.1016/0033-0620(91)90019-I; DAVIES MG, 1995, EUR J VASC ENDOVASC, V9, P7, DOI 10.1016/S1078-5884(05)80218-7; DHHS, 2010, STAT HOSP BAS CAR US; El-Hamamsy I, 2005, J HEART LUNG TRANSPL, V24, P251, DOI 10.1016/j.healun.2003.12.012; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hall MJ, 2007, NATL HLTH STAT REP; Hamdan AD, 1997, J VASC SURG, V26, P79, DOI 10.1016/S0741-5214(97)70150-2; He XP, 2008, TRANSPL P, V40, P1722, DOI 10.1016/j.transproceed.2008.01.063; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Kalish JA, 2004, J VASC SURG, V39, P645, DOI 10.1016/j.jvs.2003.10.049; Kang SH, 2008, KOREAN J PHYSIOL PHA, V12, P171, DOI 10.4196/kjpp.2008.12.4.171; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kitagaki M, 2012, J ATHEROSCLER THROMB, V19, P36, DOI 10.5551/jat.9746; Kohler T, 2005, VASCULAR SURG BASIC; KOHLER TR, 1984, SURGERY, V96, P462; KUROKI Y, 1992, BIOCHEM BIOPH RES CO, V182, P1389, DOI 10.1016/0006-291X(92)91887-V; Kwon HM, 1998, J AM COLL CARDIOL, V32, P2072, DOI 10.1016/S0735-1097(98)00482-3; Lazar HL, 2004, ANN THORAC SURG, V78, P730, DOI 10.1016/j.athoracsur.2003.12.041; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; LoGerfo F, 2006, J VASC SURG, V43, P750; LOGERFO FW, 1981, SURGERY, V90, P1015; Mako V, 2011, CYTOM PART A, V77, P962; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; MAYER JE, 1981, ANN THORAC SURG, V31, P204, DOI 10.1016/S0003-4975(10)60927-7; MORISHITA R, 1994, J CLIN INVEST, V93, P1458, DOI 10.1172/JCI117123; MORTON LF, 1982, ATHEROSCLEROSIS, V42, P41, DOI 10.1016/0021-9150(82)90124-1; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Mukundan L, 2004, CELL SIGNAL, V16, P375, DOI 10.1016/j.cellsig.2003.08.008; Murayama R, 2011, J PERIODONTAL RES, V46, P568, DOI 10.1111/j.1600-0765.2011.01374.x; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Nagler A, 1997, ARTERIOSCL THROM VAS, V17, P194, DOI 10.1161/01.ATV.17.1.194; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Nowygrod R, 2006, J VASC SURG, V43, P205, DOI 10.1016/j.jvs.2005.11.002; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Perrault LP, 2005, CAN J CARDIOL, V21, P1077; PFISTERER M, 1989, LANCET, V2, P1; QUIST WC, 1992, J THORAC CARDIOV SUR, V103, P671; R Core Team, 2020, R LANG ENV STAT COMP; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Schoneveld AH, 2005, CARDIOVASC RES, V66, P162, DOI 10.1016/j.cardiores.2004.12.016; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Takeuchi K, 2007, SURG TODAY, V37, P575, DOI 10.1007/s00595-007-3469-9; VANDERMEER J, 1994, J AM COLL CARDIOL, V24, P1181, DOI 10.1016/0735-1097(94)90096-5; Wang Chengxiong, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P736; Wang Z, 2010, J SURG RES; Westerband A, 2000, J AM COLL SURGEONS, V191, P264, DOI 10.1016/S1072-7515(00)00320-3; Wolff RA, 2006, J VASC SURG, V43, P1028, DOI 10.1016/j.jvs.2006.01.016; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zimmerman MA, 2002, AM J PHYSIOL-HEART C, V283, pH175, DOI 10.1152/ajpheart.00987.2001	66	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39123	10.1371/journal.pone.0039123	http://dx.doi.org/10.1371/journal.pone.0039123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720046	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350000042
J	Marotta, M; Piontkivska, H; Tanaka, H				Marotta, Michael; Piontkivska, Helen; Tanaka, Hisashi			Molecular Trajectories Leading to the Alternative Fates of Duplicate Genes	PLOS ONE			English	Article							COPY NUMBER VARIATION; CLASS GLUTATHIONE TRANSFERASE; RECENT SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; S-TRANSFERASE; EVOLUTION; GENOME; IDENTIFICATION; REVEALS; PALINDROMES	Gene duplication generates extra gene copies in which mutations can accumulate without risking the function of preexisting genes. Such mutations modify duplicates and contribute to evolutionary novelties. However, the vast majority of duplicates appear to be short-lived and experience duplicate silencing within a few million years. Little is known about the molecular mechanisms leading to these alternative fates. Here we delineate differing molecular trajectories of a relatively recent duplication event between humans and chimpanzees by investigating molecular properties of a single duplicate: DNA sequences, gene expression and promoter activities. The inverted duplication of the Glutathione S-transferase Theta 2 (GSTT2) gene had occurred at least 7 million years ago in the common ancestor of African great apes and is preserved in chimpanzees (Pan troglodytes), whereas a deletion polymorphism is prevalent in humans. The alternative fates are associated with expression divergence between these species, and reduced expression in humans is regulated by silencing mutations that have been propagated between duplicates by gene conversion. In contrast, selective constraint preserved duplicate divergence in chimpanzees. The difference in evolutionary processes left a unique DNA footprint in which dying duplicates are significantly more similar to each other (99.4%) than preserved ones. Such molecular trajectories could provide insights for the mechanisms underlying duplicate life and death in extant genomes.	[Marotta, Michael; Tanaka, Hisashi] Cleveland Clin Fdn, Dept Mol Genet, Cleveland, OH 44195 USA; [Piontkivska, Helen] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Marotta, M (corresponding author), Cleveland Clin Fdn, Dept Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	tanakah@ccf.org	Tanaka, Hisashi/ABE-7637-2020	Tanaka, Hisashi/0000-0001-9223-4186	Cleveland Clinic Foundation; NIH (National Institutes of Health) [CA149385, GM86782-01A1]; NATIONAL CANCER INSTITUTE [R01CA149385] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM086782] Funding Source: NIH RePORTER	Cleveland Clinic Foundation; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the funding from Cleveland Clinic Foundation, NIH (National Institutes of Health) CA149385 to Hisashi Tanaka, and GM86782-01A1 to Helen Piontkivska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bischof JM, 2006, HUM MUTAT, V27, P545, DOI 10.1002/humu.20335; Blekhman R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000271; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Casola C, 2011, GENOME RES; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Coggan M, 1998, BIOCHEM J, V334, P617, DOI 10.1042/bj3340617; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Force A, 1999, GENETICS, V151, P1531; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gazave E, 2011, GENOME RES, V21, P1626, DOI 10.1101/gr.117242.110; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Goidts V, 2006, HUM GENET, V119, P185, DOI 10.1007/s00439-005-0130-9; Gokcumen O, 2009, METHODS, V49, P18, DOI 10.1016/j.ymeth.2009.06.001; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Katju V, 2003, GENETICS, V165, P1793; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; KOCH AL, 1972, GENETICS, V72, P297; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M., 2007, ORIGINS GENOME ARCHI, pxvi; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; OHNO S., 1970, Evolution by gene duplication.; Parl FF, 2005, CANCER LETT, V221, P123, DOI 10.1016/j.canlet.2004.06.016; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shiu SH, 2006, P NATL ACAD SCI USA, V103, P2232, DOI 10.1073/pnas.0510388103; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamura K, 2011, MOL BIOL EVOL; Tan KL, 1996, BIOCHEM J, V315, P727, DOI 10.1042/bj3150727; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tayebi N, 2003, AM J HUM GENET, V72, P519, DOI 10.1086/367850; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WALSH JB, 1987, GENETICS, V117, P543; WALSH JB, 1995, GENETICS, V139, P421; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472	72	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38958	10.1371/journal.pone.0038958	http://dx.doi.org/10.1371/journal.pone.0038958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720000	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800031
J	Berthinussen, A; Altringham, J				Berthinussen, Anna; Altringham, John			Do Bat Gantries and Underpasses Help Bats Cross Roads Safely?	PLOS ONE			English	Article							PIPISTRELLUS-PIPISTRELLUS; ECHOLOCATION BEHAVIOR; CONNECTIVITY; CASUALTIES; ABUNDANCE; WILDLIFE; ECOLOGY; DESIGN; FLIGHT	Major roads can reduce bat abundance and diversity over considerable distances. To mitigate against these effects and comply with environmental law, many European countries install bridges, gantries or underpasses to make roads permeable and safer to cross. However, through lack of appropriate monitoring, there is little evidence to support their effectiveness. Three underpasses and four bat gantries were investigated in northern England. Echolocation call recordings and observations were used to determine the number of bats using underpasses in preference to crossing the road above, and the height at which bats crossed. At gantries, proximity to the gantry and height of crossing bats were measured. Data were compared to those from adjacent, severed commuting routes that had no crossing structure. At one underpass 96% of bats flew through it in preference to crossing the road. This underpass was located on a pre-construction commuting route that allowed bats to pass without changing flight height or direction. At two underpasses attempts to divert bats from their original commuting routes were unsuccessful and bats crossed the road at the height of passing vehicles. Underpasses have the potential to allow bats to cross roads safely if built on pre-construction commuting routes. Bat gantries were ineffective and used by a very small proportion of bats, even up to nine years after construction. Most bats near gantries crossed roads along severed, pre-construction commuting routes at heights that put them in the path of vehicles. Crossing height was strongly correlated with verge height, suggesting that elevated verges may have some value in mitigation, but increased flight height may be at the cost of reduced permeability. Green bridges should be explored as an alternative form of mitigation. Robust monitoring is essential to assess objectively the case for mitigation and to ensure effective mitigation.	[Berthinussen, Anna; Altringham, John] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Leeds	Berthinussen, A (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	j.d.altringham@leeds.ac.uk			University of Leeds Research Postgraduate Scholarships Programme	University of Leeds Research Postgraduate Scholarships Programme	The work was supported by the University of Leeds Research Postgraduate Scholarships Programme. http://scholarships.leeds.ac.uk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IM, 2012, J ZOOLOGY; Altringham J. D., 2008, BAT ECOLOGY MITIGATI; [Anonymous], 2011, DAILY MAIL; Bach L, 2004, MAMMALIA, V68, P411, DOI 10.1515/mamm.2004.041; Bach L, 2005, 022202002LR FE; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bellamy CC, 2011, THESIS U LEEDS UK; Berthinussen A, 2012, J APPL ECOL, V49, P82, DOI 10.1111/j.1365-2664.2011.02068.x; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Cumbria County Council, 2011, CUMBR TRAFF DAT; Entwistle AC, 2000, J ZOOL, V252, P11, DOI 10.1017/S095283690000902X; Fahrig L, 2009, ECOL SOC, V14; Gaisler J, 2009, ACTA THERIOL, V54, P147, DOI 10.1007/BF03193170; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Highways Agency, 2008, ALL FIVEWAYS THETF 4, V2; Holderied MW, 2006, J EXP BIOL, V209, P1816, DOI 10.1242/jeb.02194; Hothorn T, 2008, J STAT SOFTW, V28, P1; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Lambrechts J, 2006, MONITORING ECODUCT W; Lesinski G, 2007, MAMMALIA, V71, P138, DOI 10.1515/MAMM.2007.020; Lesinski G, 2011, EUR J WILDLIFE RES, V57, P217, DOI 10.1007/s10344-010-0414-9; Limpens H.J.G.A., 1991, Myotis, V29, P39; Limpens H.J.G.A., 2005, BATS ROAD CONSTRUCTI; Ng SJ, 2004, BIOL CONSERV, V115, P499, DOI 10.1016/S0006-3207(03)00166-6; O'Connor G., 2011, REV BAT MITIGATION R; Olsson MPO, 2008, LANDSCAPE URBAN PLAN, V85, P133, DOI 10.1016/j.landurbplan.2007.10.006; Papadatou E, 2011, OECOLOGIA, V165, P925, DOI 10.1007/s00442-010-1771-5; Parsons S, 2000, J EXP BIOL, V203, P2641; R Development Core Team, 2006, R LANG ENV STAT COMP; RACEY PA, 1985, J ANIM ECOL, V54, P205, DOI 10.2307/4631; Russell Amy L., 2009, Endangered Species Research, V8, P49, DOI 10.3354/esr00121; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Schaub A, 2007, J COMP PHYSIOL A, V193, P1185, DOI 10.1007/s00359-007-0269-z; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Slater F.M., 2002, Web Ecology, V3, P33; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; The Telegraph, 2011, TELEGRAPH       1015; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Van Der Ree R, 2006, REV MITIGATION MEASU; Verboom B, 1999, CAN J ZOOL, V77, P1393, DOI 10.1139/cjz-77-9-1393; Verboom B, 1997, LANDSCAPE ECOL, V12, P117, DOI 10.1007/BF02698211; Zurcher AA, 2010, ACTA CHIROPTEROL, V12, P337, DOI 10.3161/150811010X537918	44	39	44	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38775	10.1371/journal.pone.0038775	http://dx.doi.org/10.1371/journal.pone.0038775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719941	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341900048
J	Garma, L; Mukherjee, S; Mitra, P; Zhang, Y				Garma, Leonardo; Mukherjee, Srayanta; Mitra, Pralay; Zhang, Yang			How Many Protein-Protein Interactions Types Exist in Nature?	PLOS ONE			English	Article							STRUCTURE PREDICTION; MOLECULAR BIOLOGIST; FAMILIES; FOLDS; NUMBER; DOMAIN; CLASSIFICATION; INTERFACES; COMPLEXES; SEQUENCE	"Protein quaternary structure universe" refers to the ensemble of all protein-protein complexes across all organisms in nature. The number of quaternary folds thus corresponds to the number of ways proteins physically interact with other proteins. This study focuses on answering two basic questions: Whether the number of protein-protein interactions is limited and, if yes, how many different quaternary folds exist in nature. By all-to-all sequence and structure comparisons, we grouped the protein complexes in the protein data bank (PDB) into 3,629 families and 1,761 folds. A statistical model was introduced to obtain the quantitative relation between the numbers of quaternary families and quaternary folds in nature. The total number of possible protein-protein interactions was estimated around 4,000, which indicates that the current protein repository contains only 42% of quaternary folds in nature and a full coverage needs approximately a quarter century of experimental effort. The results have important implications to the protein complex structural modeling and the structure genomics of protein-protein interactions.	[Garma, Leonardo; Mukherjee, Srayanta; Mitra, Pralay; Zhang, Yang] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Garma, Leonardo] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Garma, Leonardo] Univ Oulu, Dept Biochem, Oulu, Finland	University of Michigan System; University of Michigan; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Garma, L (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	zhng@umich.edu	Mitra, Pralay/P-4207-2019; Mitra, Pralay/C-7221-2012	Mitra, Pralay/0000-0003-4119-3788; Garma, Leonardo Daniel/0000-0003-1220-8397	NSF (National Science Foundation) Career Award [DBI 1027394]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084222, R01GM083107] Funding Source: NIH RePORTER	NSF (National Science Foundation) Career Award; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported in part by the NSF (National Science Foundation) Career Award (DBI 1027394), and the National Institute of General Medical Sciences (GM083107, GM084222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Aloy P, 2005, CURR OPIN STRUC BIOL, V15, P15, DOI 10.1016/j.sbi.2005.01.012; Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Burley SK, 2008, STRUCTURE, V16, P5, DOI 10.1016/j.str.2007.12.002; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cramer H., 1946, MATH METHODS STAT; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Douguet D, 2006, BIOINFORMATICS, V22, P2612, DOI 10.1093/bioinformatics/btl447; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Kihara D, 2003, J MOL BIOL, V334, P793, DOI 10.1016/j.jmb.2003.10.027; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Mitra P, 2011, STRUCTURE, V19, P304, DOI 10.1016/j.str.2011.01.009; Mukherjee S, 2009, NUCLEIC ACIDS RES, P1, DOI [10.1093/nar/gkp1318, DOI 10.1093/NAR/GKP1318]; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Szilagyi A, 2005, PHYS BIOL, V2, pS1, DOI 10.1088/1478-3975/2/2/S01; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Vakser IA, 2008, STRUCTURE, V16, P1, DOI 10.1016/j.str.2007.12.005; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wolf YI, 2000, J MOL BIOL, V299, P897, DOI 10.1006/jmbi.2000.3786; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang CO, 1998, J MOL BIOL, V284, P1301, DOI 10.1006/jmbi.1998.2282; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	48	23	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38913	10.1371/journal.pone.0038913	http://dx.doi.org/10.1371/journal.pone.0038913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719985	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341900064
J	Fawehinmi, TO; Ilomaki, J; Voutilainen, S; Kauhanen, J				Fawehinmi, Timothy O.; Ilomaeki, Jenni; Voutilainen, Sari; Kauhanen, Jussi			Alcohol Consumption and Dietary Patterns: The FinDrink Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; RISK-FACTOR; NUTRITIONAL-STATUS; DRINKING PATTERNS; NUTRIENT INTAKE; WINE INTAKE; LIFE-STYLE; DANISH MEN; FOLLOW-UP	The aim of this population-based study was to investigate differences in dietary patterns in relation to the level of alcohol consumption among Finnish adults. This study was part of the FinDrink project, an epidemiologic study on alcohol use among Finnish population. It utilized data from the Kuopio Ischaemic Heart Disease Risk Factor Study. A total of 1720 subjects comprising of 816 men and 904 women aged 53-73 years were included in the study in 1998-2001. Food intake was collected via a 4-day food diary method. Self-reported alcohol consumption was assessed with quantity-frequency method based on the Nordic Alcohol Consumption Inventory. Weekly alcohol consumption was categorized into three groups: non-drinkers (<12 grams), moderate drinkers (12-167.9 grams for men, 12-83.9 grams for women) and heavy drinkers (>= 168 grams for men, >= 84 grams for women). Data were analyzed for men and women separately using multiple linear regression models, adjusted for age, occupational status, marital status, smoking, body mass index and leisure time physical activity. In women, moderate/heavy drinkers had lower fibre intake and moderate drinkers had higher vitamin D intake than non-drinkers. Male heavy drinkers had lower fibre, retinol, calcium and iron intake, and moderate/heavy drinkers had higher vitamin D intake than non-drinkers. Fish intake was higher among women moderate drinkers and men moderate/heavy drinkers than non-drinkers. In men, moderate drinkers had lower fruit intake and heavy drinkers had lower milk intake than non-drinkers. Moderate drinkers had higher energy intake from total fats and monosaturated fatty acids than non-drinkers. In contrast, energy intake from carbohydrates was lower among moderate/heavy drinkers than nondrinkers. In conclusion, especially male heavy drinkers had less favorable nutritional intake than moderate and non-drinkers. Further studies on the relationship between alcohol consumption and dietary habits are needed to plan a comprehensive dietary intervention programs in future.	[Fawehinmi, Timothy O.; Voutilainen, Sari; Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Ilomaeki, Jenni] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia	University of Eastern Finland; University of South Australia	Fawehinmi, TO (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	dapofawehinmi@gmail.com	Ilomaki, Jenni/E-7213-2011; Kauhanen, Jussi/ABC-4064-2021	FAWEHINMI, TIMOTHY/0000-0001-8578-8383; Ilomaki, Jenni/0000-0002-0348-9441	Academy of Finland [201688, 80185, 200942, 118551]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (grants 201688 and 80185 to Dr. Voutilainen, grants 200942 and 118551 to Dr. Kauhanen) http://www.aka.fi/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barefoot JC, 2002, AM J CLIN NUTR, V76, P466, DOI 10.1093/ajcn/76.2.466; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; Breslow RA, 2006, AM J EPIDEMIOL, V163, P359, DOI 10.1093/aje/kwj050; Bunout D, 1999, NUTRITION, V15, P583, DOI 10.1016/S0899-9007(99)00090-8; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; Fawehinmi T, 2011, ANN NUTR METAB, V58, P135; Gonzalez-Reimers E, 2008, ALCOHOL ALCOHOLISM, V43, P314, DOI 10.1093/alcalc/agn011; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Hakala P, 2003, EUR J CLIN NUTR, V57, P1035, DOI 10.1038/sj.ejcn.1601639; Harkonen JT, 2011, ALCOHOL ALCOHOLISM, V46, P349, DOI 10.1093/alcalc/agr025; Ilomaki J, 2011, EUR J PUBLIC HL 0311; Ilomaki J, 2010, EUR J PUBLIC HEALTH, V20, P133, DOI 10.1093/eurpub/ckp079; Imhof A, 2003, ADDICT BIOL, V8, P271, DOI 10.1080/13556210310001602176; IRGENSJENSEN O, 1992, BRUK ALKOHOL NARKOTI; JACQUES PF, 1989, AM J CLIN NUTR, V50, P875, DOI 10.1093/ajcn/50.4.875; Jeeranun K, 2008, NUTR DIET, V65, P272, DOI 10.1111/j.1747-0080.2008.00313.x; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Kesse E, 2001, AM J CLIN NUTR, V74, P322; Kroke A, 2001, BRIT J NUTR, V85, P621, DOI 10.1079/BJN2000289; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lakka TA, 1996, INT J EPIDEMIOL, V25, P86, DOI 10.1093/ije/25.1.86; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Mannisto S, 1997, EUR J CLIN NUTR, V51, P326, DOI 10.1038/sj.ejcn.1600406; Matsui T, 2010, ALCOHOL CLIN EXP RES, V34, P869, DOI 10.1111/j.1530-0277.2010.01159.x; Menotti A, 1999, EUR J EPIDEMIOL, V15, P507, DOI 10.1023/A:1007529206050; Mezzano D, 2001, EUR J CLIN NUTR, V55, P444, DOI 10.1038/sj.ejcn.1601202; Official Statistics of Finland, 2011, CAUS DEATH 2010; Official Statistics of Finland, OFF STAT FINL EMPL 2; Official Statistics of Finland, OFF STAT FINL HOUS C; Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240; Osterberg EL, 2011, DRUG ALCOHOL REV, V30, P124, DOI 10.1111/j.1465-3362.2010.00265.x; Panagiotakos D, 2007, J MED FOOD, V10, P615, DOI 10.1089/jmf.2007.414; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Piazza-Gardner Anna K, 2012, Am J Health Promot, V26, pe95, DOI 10.4278/ajhp.100929-LIT-328; Pietinen P, 1996, CIRCULATION, V94, P2720, DOI 10.1161/01.CIR.94.11.2720; Piirtola M, 2008, EUR J EPIDEMIOL, V23, P747, DOI 10.1007/s10654-008-9289-4; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ruf T, 2005, ANN NUTR METAB, V49, P16, DOI 10.1159/000084173; Ruidavets JB, 2004, EUR HEART J, V25, P1153, DOI 10.1016/j.ehj.2003.12.022; Santolaria F, 2000, DRUG ALCOHOL DEPEN, V59, P295, DOI 10.1016/S0376-8716(99)00129-5; Schroder H, 2005, ANN NUTR METAB, V49, P100, DOI 10.1159/000084889; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; Willenbring ML, 2009, AM FAM PHYSICIAN, V80, P44; WILSON TW, 1993, AM J EPIDEMIOL, V137, P292, DOI 10.1093/oxfordjournals.aje.a116676; World Health Organization Department of Mental Health and Substance Dependence Noncommunicable Diseases and Mental Health Cluster, 2000, INT GUID MON ALC CON	49	43	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38607	10.1371/journal.pone.0038607	http://dx.doi.org/10.1371/journal.pone.0038607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719905	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305340000035
J	Lazard, DS; Marozeau, J; McDermott, HJ				Lazard, Diane S.; Marozeau, Jeremy; McDermott, Hugh J.			The Sound Sensation of Apical Electric Stimulation in Cochlear Implant Recipients with Contralateral Residual Hearing	PLOS ONE			English	Article							PITCH COMPARISONS; ACOUSTIC MODELS; PERCEPTION; MUSIC	Background: Studies using vocoders as acoustic simulators of cochlear implants have generally focused on simulation of speech understanding, gender recognition, or music appreciation. The aim of the present experiment was to study the auditory sensation perceived by cochlear implant (CI) recipients with steady electrical stimulation on the most-apical electrode. Methodology/Principal Findings: Five unilateral CI users with contralateral residual hearing were asked to vary the parameters of an acoustic signal played to the non-implanted ear, in order to match its sensation to that of the electric stimulus. They also provided a rating of similarity between each acoustic sound they selected and the electric stimulus. On average across subjects, the sound rated as most similar was a complex signal with a concentration of energy around 523 Hz. This sound was inharmonic in 3 out of 5 subjects with a moderate, progressive increase in the spacing between the frequency components. Conclusions/Significance: For these subjects, the sound sensation created by steady electric stimulation on the most-apical electrode was neither a white noise nor a pure tone, but a complex signal with a progressive increase in the spacing between the frequency components in 3 out of 5 subjects. Knowing whether the inharmonic nature of the sound was related to the fact that the non-implanted ear was impaired has to be explored in single-sided deafened patients with a contralateral CI. These results may be used in the future to better understand peripheral and central auditory processing in relation to cochlear implants.	[Lazard, Diane S.; Marozeau, Jeremy; McDermott, Hugh J.] Bion Inst, Melbourne, Vic, Australia; [McDermott, Hugh J.] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia	Bionics Institute; University of Melbourne	Lazard, DS (corresponding author), Bion Inst, Melbourne, Vic, Australia.	dianelazard@yahoo.fr	Marozeau, Jeremy/AAA-1880-2021; Marozeau, Jeremy/E-9329-2017; Marozeau, Jeremy/L-2915-2019	Marozeau, Jeremy/0000-0002-4505-135X; Lazard, Diane/0000-0001-8329-1381	Fondation Bettencourt-Schueller; Cochlear(R) France; NHMRC [100882]; Victorian Lions Foundation; Cochlear France; Victorian Government	Fondation Bettencourt-Schueller; Cochlear(R) France; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Lions Foundation; Cochlear France; Victorian Government	Funding came from Fondation Bettencourt-Schueller, Cochlear (R) France, NHMRC Project Grant (No. 100882), and the Victorian Lions Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following conflicts: Cochlear France funded Diane Lazard's plane ticket to Australia. Cochlear France did not fund any other part of the research project, and did not participate in any stage of the project. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The authors acknowledge Bev Sheridan for her help in recruiting patients, and the subjects for their generous participation.	Blamey PJ, 1996, HEARING RES, V99, P139, DOI 10.1016/S0378-5955(96)00095-0; BLAMEY PJ, 1984, J ACOUST SOC AM, V76, P97, DOI 10.1121/1.391012; Boex C, 2006, JARO-J ASSOC RES OTO, V7, P110, DOI 10.1007/s10162-005-0027-2; BYRNE D, 1986, EAR HEARING, V7, P257, DOI 10.1097/00003446-198608000-00007; Carlyon RP, 2010, JARO-J ASSOC RES OTO, V11, P625, DOI 10.1007/s10162-010-0222-7; Deeks JM, 2004, J ACOUST SOC AM, V115, P1736, DOI 10.1121/1.1675814; Dorman MF, 1997, AM J OTOL, V18, pS113; Dorman MF, 2007, JARO-J ASSOC RES OTO, V8, P234, DOI 10.1007/s10162-007-0071-1; Eddington D K, 1978, Ann Otol Rhinol Laryngol, V87, P1; Fu QJ, 2005, J ACOUST SOC AM, V118, P1711, DOI 10.1121/1.1985024; Gfeller K, 2000, J Am Acad Audiol, V11, P390; Green T, 2011, INT J AUDIOL; Kovacic D, 2009, J ACOUST SOC AM, V126, P762, DOI 10.1121/1.3158855; Laneau J, 2006, J ACOUST SOC AM, V119, P491, DOI 10.1121/1.2133391; Leal MC, 2003, ACTA OTO-LARYNGOL, V123, P826, DOI 10.1080/00016480310000386; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; Massida Z, 2011, HEARING RES, V275, P120, DOI 10.1016/j.heares.2010.12.010; McDermott H, 2009, AUDIOL NEURO-OTOL, V14, P2, DOI 10.1159/000206489; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; McKay CM, 1999, J ACOUST SOC AM, V105, P347, DOI 10.1121/1.424553; Moore BC., 1995, PERCEPTUAL CONSEQUEN, DOI 10.1093/acprof:oso/9780198523307.001.0001; Pressnitzer D, 2005, ANN NY ACAD SCI, V1060, P343, DOI 10.1196/annals.1360.050; Reiss LAJ, 2007, JARO-J ASSOC RES OTO, V8, P241, DOI 10.1007/s10162-007-0077-8; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Strydom T, 2011, J ACOUST SOC AM, V129, P920, DOI 10.1121/1.3518760	25	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38687	10.1371/journal.pone.0038687	http://dx.doi.org/10.1371/journal.pone.0038687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723876	Green Published, gold			2022-12-27	WOS:000305652700021
J	Gladwin, TE; Derks, EM; Rietschel, M; Mattheisen, M; Breuer, R; Schulze, TG; Nothen, MM; Levinson, D; Shi, JX; Gejman, PV; Cichon, S; Ophoff, RA				Gladwin, Thomas E.; Derks, Eske M.; Rietschel, Marcella; Mattheisen, Manuel; Breuer, Rene; Schulze, Thomas G.; Noethen, Markus M.; Levinson, Douglas; Shi, Jianxin; Gejman, Pablo V.; Cichon, Sven; Ophoff, Roel A.		Genetic Risk & Outcome Psychosis G	Segment-Wise Genome-Wide Association Analysis Identifies a Candidate Region Associated with Schizophrenia in Three Independent Samples	PLOS ONE			English	Article							COMMON VARIANTS	Recent studies suggest that variation in complex disorders (e.g., schizophrenia) is explained by a large number of genetic variants with small effect size (Odds Ratio similar to 1.05-1.1). The statistical power to detect these genetic variants in Genome Wide Association (GWA) studies with large numbers of cases and controls (similar to 15,000) is still low. As it will be difficult to further increase sample size, we decided to explore an alternative method for analyzing GWA data in a study of schizophrenia, dramatically reducing the number of statistical tests. The underlying hypothesis was that at least some of the genetic variants related to a common outcome are collocated in segments of chromosomes at a wider scale than single genes. Our approach was therefore to study the association between relatively large segments of DNA and disease status. An association test was performed for each SNP and the number of nominally significant tests in a segment was counted. We then performed a permutation-based binomial test to determine whether this region contained significantly more nominally significant SNPs than expected under the null hypothesis of no association, taking linkage into account. Genome Wide Association data of three independent schizophrenia case/control cohorts with European ancestry (Dutch, German, and US) using segments of DNA with variable length (2 to 32 Mbp) was analyzed. Using this approach we identified a region at chromosome 5q23.3-q31.3 (128-160 Mbp) that was significantly enriched with nominally associated SNPs in three independent case-control samples. We conclude that considering relatively wide segments of chromosomes may reveal reliable relationships between the genome and schizophrenia, suggesting novel methodological possibilities as well as raising theoretical questions.	[Gladwin, Thomas E.; Derks, Eske M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Rietschel, Marcella; Breuer, Rene; Schulze, Thomas G.] Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, Mannheim, Germany; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Mattheisen, Manuel] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Schulze, Thomas G.] Univ Gottingen, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-3400 Gottingen, Germany; [Levinson, Douglas] Stanford Univ, Dept Psychiat, Sch Med, Palo Alto, CA USA; [Shi, Jianxin] NCI, Bethesda, MD 20892 USA; [Gejman, Pablo V.] Northshore Univ Hlth Syst, Dept Psychiat & Behav Sci, Evanston, IL USA; [Gejman, Pablo V.] Univ Chicago, Evanston, IL USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA USA; [Gladwin, Thomas E.] Univ Amsterdam, Dept Dev Psychol, ADAPT Lab, Amsterdam, Netherlands; [Derks, Eske M.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Central Institute of Mental Health; University of Bonn; University of Bonn; University of Bonn; University of Gottingen; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NorthShore University Health System; University of Chicago; University of California System; University of California Los Angeles; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Gladwin, TE (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	e.m.derks@amc.uva.nl	Mattheisen, Manuel/S-3725-2019; Cichon, Sven/H-8803-2013; Derks, Eske M/A-1652-2017; Mattheisen, Manuel/B-4949-2012; Schulze, Thomas G/H-2157-2013; Myin-Germeys, Inez/L-5106-2014; van Os, Jim/C-2113-2014; Gladwin, Thomas E./F-6685-2010	Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Derks, Eske M/0000-0002-6292-6883; Mattheisen, Manuel/0000-0002-8442-493X; Nothen, Markus/0000-0002-8770-2464; Gladwin, Thomas/0000-0001-9538-6425; Bruggeman, Richard/0000-0002-3238-8471; Myin-Germeys, Inez/0000-0002-3731-4930	NIMH [RO1 MHO78075]; Foundation for the National Institutes of Health; Dutch Health Research Council(ZON-MW) [10-000-1002]; EU; German Federal Ministry of Education and Research (BMBF); National Genome Research Network plus (NGFNplus); MooDS-Net [01GS08144, 01GS08147]; Alfried Krupp von Bohlen und Halbach-Stiftung; Netherlands Scientific Organization (NWO) [451-080-010, 480-05-003]; Academic Psychiatric Centre AMC, Amsterdam; Ingeest, Amsterdam; Arkin, Amsterdam; Dijk enDuin, Amsterdam; Rivierduinen, Amsterdam; ErasmusMC, Amsterdam; GGZ Noord HollandNoord, Amsterdam; University Medical Centre Utrecht, Utrecht; Altrecht, Utrecht; Symfora, Utrecht; Meerkanten, Utrecht; Riagg Amersfoort, Utrecht; Delta, Utrecht; University Medical CenterGroningen, Groningen; Lentis, Groningen; GGZ Friesland, Groningen; GGZ Drenthe, Groningen; Adhesie, Groningen; Mediant, Groningen; GGZ De Grote Rivieren, Groningen; Parnassia psycho-medical centre, Groningen; MaastrichtUniversity Medical Center, Maastricht; GGZ Eindhoven, Maastricht; GGZMidden-Brabant, Maastricht; GGZ Oost-Brabant, Maastricht; GGZ Noord-Midden Limburg, Maastricht; Mondriaan Zorggroep, Maastricht; Prins Claus-centrum Sittard, Maastricht; RIAGG Roermond, Maastricht; Universitair Centrum Sint-Jozef Kortenberg, Maastricht; CAPRI University ofAntwerp, Maastricht; PC Ziekeren Sint-Truiden, Maastricht; PZ Sancta MariaSint-Truiden, Maastricht; GGZ Overpelt, Maastricht; OPZ Rekem, Maastricht	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Health Research Council(ZON-MW)(Netherlands Organization for Health Research and Development); EU(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); MooDS-Net; Alfried Krupp von Bohlen und Halbach-Stiftung; Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Academic Psychiatric Centre AMC, Amsterdam; Ingeest, Amsterdam; Arkin, Amsterdam; Dijk enDuin, Amsterdam; Rivierduinen, Amsterdam; ErasmusMC, Amsterdam; GGZ Noord HollandNoord, Amsterdam; University Medical Centre Utrecht, Utrecht; Altrecht, Utrecht; Symfora, Utrecht; Meerkanten, Utrecht; Riagg Amersfoort, Utrecht; Delta, Utrecht; University Medical CenterGroningen, Groningen; Lentis, Groningen; GGZ Friesland, Groningen; GGZ Drenthe, Groningen; Adhesie, Groningen; Mediant, Groningen; GGZ De Grote Rivieren, Groningen; Parnassia psycho-medical centre, Groningen; MaastrichtUniversity Medical Center, Maastricht; GGZ Eindhoven, Maastricht; GGZMidden-Brabant, Maastricht; GGZ Oost-Brabant, Maastricht; GGZ Noord-Midden Limburg, Maastricht; Mondriaan Zorggroep, Maastricht; Prins Claus-centrum Sittard, Maastricht; RIAGG Roermond, Maastricht; Universitair Centrum Sint-Jozef Kortenberg, Maastricht; CAPRI University ofAntwerp, Maastricht; PC Ziekeren Sint-Truiden, Maastricht; PZ Sancta MariaSint-Truiden, Maastricht; GGZ Overpelt, Maastricht; OPZ Rekem, Maastricht	Genotyping of the Dutch samples was sponsored by NIMH funding, RO1 MHO78075 (to R.A.O.). Funding support for Linking Genome-Wide Association Study of Schizophrenia was provided by Foundation for the National Institutes of Health and the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The dataset used for the analyses described in this manuscript was obtained from the GAIN Database found at http://view.ncbi.nlm.nih.gov/dbgap-controlled through dbGaP accession number phs000021. The GROUP study was supported by the Geestkrachtprogramme of the Dutch Health Research Council(ZON-MW, grant number 10-000-1002); the EU Seventh Framework Programme (consortium name: EU-GEI)and matching funds from participating universities andmental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk enDuin, Rivierduinen, ErasmusMC, GGZ Noord HollandNoord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical CenterGroningen, Lentis, GGZ Friesland, GGZ Drenthe, Adhesie, Mediant, GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site Maastricht: MaastrichtUniversity Medical Center, GGZ Eindhoven, GGZMidden-Brabant, GGZ Oost-Brabant, GGZ Noord-Midden Limburg, Mondriaan Zorggroep, Prins Claus-centrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University ofAntwerp, PC Ziekeren Sint-Truiden, PZ Sancta MariaSint-Truiden, GGZ Overpelt, OPZ Rekem). The German genome-wide association study of schizophrenia was supported by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network plus (NGFNplus), and the MooDS-Net (grant 01GS08144 to S.C. and M.M.N., grant 01GS08147 to M.R.). M.M.N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. German control genotypes were derived from community-based cohorts collected in the framework of the PopGen (Dr. Stefan Schreiber. Kiel), KORA (Dr. H.-Erich Wichmann, Munich), and Heinz-Nixdorf-Recall (Dr. Susanne Moebus, Essen) studies. PopGen and KORA controls were made available to participants of NGFNplus for use as universal controls in genetic studies of the funded disease phenotypes. Dr. E.M. Derks is supported by the Netherlands Scientific Organization (NWO; project number 451-080-010). Statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Chen YH, 2009, SCHIZOPHR RES, V108, P191, DOI 10.1016/j.schres.2008.12.021; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fernandez-Egea E, 2008, SCHIZOPHR RES, V103, P110, DOI 10.1016/j.schres.2008.04.017; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Woo YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012158	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38828	10.1371/journal.pone.0038828	http://dx.doi.org/10.1371/journal.pone.0038828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723893	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300057
J	Palmer, CNA; Maglio, C; Pirazzi, C; Burza, MA; Adiels, M; Burch, L; Donnelly, LA; Colhoun, H; Doney, AS; Dillon, JF; Pearson, ER; McCarthy, M; Hattersley, AT; Frayling, T; Morris, AD; Peltonen, M; Svensson, PA; Jacobson, P; Boren, J; Sjostrom, L; Carlsson, LMS; Romeo, S				Palmer, Colin N. A.; Maglio, Cristina; Pirazzi, Carlo; Burza, Maria Antonella; Adiels, Martin; Burch, Lindsay; Donnelly, Louise A.; Colhoun, Helen; Doney, Alexander S.; Dillon, John F.; Pearson, Ewan R.; McCarthy, Mark; Hattersley, Andrew T.; Frayling, Tim; Morris, Andrew D.; Peltonen, Markku; Svensson, Per-Arne; Jacobson, Peter; Boren, Jan; Sjostrom, Lars; Carlsson, Lena M. S.; Romeo, Stefano			Paradoxical Lower Serum Triglyceride Levels and Higher Type 2 Diabetes Mellitus Susceptibility in Obese Individuals with the PNPLA3 148M Variant	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DOMAIN-CONTAINING 3; INSULIN-RESISTANCE; FASTING GLUCOSE; I148M; RISK; ASSOCIATION; ADIPONUTRIN; LOCI; GENE	Background: Obesity is highly associated with elevated serum triglycerides, hepatic steatosis and type 2 diabetes (T2D). The I148M (rs738409) genetic variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is known to modulate hepatic triglyceride accumulation, leading to steatosis. No association between PNPLA3 I148M genotype and T2D in Europeans has been reported. Aim of this study is to examine the relationship between PNPLA3 I148M genotypes and serum triglycerides, insulin resistance and T2D susceptibility by testing a gene-environment interaction model with severe obesity. Methods and Findings: PNPLA3 I148M was genotyped in a large obese cohort, the SOS study (n = 3,473) and in the Go-DARTS (n = 15,448), a T2D case-control study. Metabolic parameters were examined across the PNPLA3 I148M genotypes in participants of the SOS study at baseline and at 2- and 10-year follow up after bariatric surgery or conventional therapy. The associations with metabolic parameters were validated in the Go-DARTS study. Serum triglycerides were found to be lower in the PNPLA3 148M carriers from the SOS study at baseline and from the Go-DARTS T2D cohort. An increased risk for T2D conferred by the 148M allele was found in the SOS study (O.R. 1.09, 95% C.I. 1.01-1.39, P = 0.040) and in severely obese individuals in the Go-DARTS study (O. R. 1.37, 95% C.I. 1.13-1.66, P = 0.001). The 148M allele was no longer associated with insulin resistance or T2D after bariatric surgery in the SOS study and no association with the 148M allele was observed in the less obese (BMI<35) individuals in the Go-DARTS study (P for interaction = 0.002). This provides evidence for the obesity interaction with 148M allele and T2D risk in a large-scale cross-sectional and a prospective interventional study. Conclusions: Severely obese individuals carrying the PNPLA3 148M allele have lower serum triglyceride levels, are more insulin resistant and more susceptible to T2D. This study supports the hypothesis that obesity-driven hepatic lipid accumulation may contribute to T2D susceptibility.	[Palmer, Colin N. A.; Burch, Lindsay; Donnelly, Louise A.; Colhoun, Helen; Doney, Alexander S.; Dillon, John F.; Pearson, Ewan R.; Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Maglio, Cristina; Pirazzi, Carlo; Burza, Maria Antonella; Adiels, Martin; Svensson, Per-Arne; Jacobson, Peter; Boren, Jan; Sjostrom, Lars; Carlsson, Lena M. S.; Romeo, Stefano] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Maglio, Cristina; Pirazzi, Carlo; Burza, Maria Antonella; Adiels, Martin; Svensson, Per-Arne; Jacobson, Peter; Boren, Jan; Sjostrom, Lars; Carlsson, Lena M. S.; Romeo, Stefano] Univ Gothenburg, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [McCarthy, Mark] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Hattersley, Andrew T.; Frayling, Tim] Univ Exeter, Peninsula Coll Med & Dent, Peninsula NIHR Clin Res Facil, Exeter, Devon, England; [Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Romeo, Stefano] Univ Catanzaro, Dept Clin & Expt Med, Catanzaro, Italy	University of Dundee; University of Gothenburg; University of Gothenburg; University of Oxford; University of Exeter; University of Plymouth; Finland National Institute for Health & Welfare; Magna Graecia University of Catanzaro	Palmer, CNA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland.	stefano.romeo@wlab.gu.se	Peltonen, Markku/F-3037-2015; Maglio, Cristina/AAN-6004-2021; Romeo, Stefano/L-6861-2015; Svensson, Per-Arne/R-4626-2019; Study, GoDARTS/K-9448-2016; Doney, Alexander SF/P-7437-2017; Palmer, Colin NA/C-7053-2008; Carlsson, Lena/F-7570-2018; McCarthy, Mark/M-3763-2015	Peltonen, Markku/0000-0002-3767-4223; Romeo, Stefano/0000-0001-9168-4898; Doney, Alexander SF/0000-0002-6210-5620; Palmer, Colin NA/0000-0002-6415-6560; Carlsson, Lena/0000-0003-4145-6242; Jacobson, Peter/0000-0002-1769-1827; Dillon, John/0000-0002-2164-4476; Maglio, Cristina/0000-0002-3786-5767; Colhoun, Helen/0000-0002-8345-3288; Pearson, Ewan/0000-0001-9237-8585; McCarthy, Mark/0000-0002-4393-0510; Hattersley, Andrew/0000-0001-5620-473X; Svensson, Per-Arne/0000-0002-6731-806X	Swedish Research Council [K2010-55X-11285-13, K2008-65X-20753-01-04]; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research; Swedish federal government under the LUA/ALF agreement; Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (Go-DARTS); Scottish Health Informatics Programme; Chief Scientist Office of Scotland; UK Medical Research Council [G0601261]; Medical Research Council [G0601261] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish; MRC [G0601261] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research(Swedish Foundation for Strategic Research); Swedish federal government under the LUA/ALF agreement; Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (Go-DARTS); Scottish Health Informatics Programme; Chief Scientist Office of Scotland; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Swedish Research Council (K2010-55X-11285-13, K2008-65X-20753-01-04), the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research and the Swedish federal government under the LUA/ALF agreement. The strategic initiative for foreigner researchers from the Institute of Medicine at the University of Gothenburg supported Cristina Maglio and Carlo Pirazzi. The Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (Go-DARTS) and the Scottish Health Informatics Programme. Further informatics support is provided by the Chief Scientist Office of Scotland. This work was also supported by the UK Medical Research Council (G0601261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2007, DIABETOLOGIA, V50, P2356, DOI 10.1007/s00125-007-0790-1; Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Browning JD, 2010, HEPATOLOGY, V52, P1189, DOI 10.1002/hep.23946; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Doney ASF, 2005, CIRCULATION, V111, P2927, DOI 10.1161/CIRCULATIONAHA.104.509224; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Goran MI, 2010, DIABETES, V59, P3127, DOI 10.2337/db10-0554; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Krawczyk M, 2011, J PHYSIOL PHARMACOL, V62, P369; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Palmer CNA, 2010, DIABETES, V59, P2945, DOI 10.2337/db09-1690; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang CW, 2011, LIVER INT, V31, P1326, DOI 10.1111/j.1478-3231.2011.02526.x; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	36	72	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39362	10.1371/journal.pone.0039362	http://dx.doi.org/10.1371/journal.pone.0039362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724004	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300138
J	Park, SO; Kumar, M; Gupta, S				Park, Sun O.; Kumar, Mukesh; Gupta, Sanjeev			TGF-beta and Iron Differently Alter HBV Replication in Human Hepatocytes through TGF-beta/BMP Signaling and Cellular MicroRNA Expression	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CONSERVED RNA SEQUENCE; TRANSGENIC MICE; SURFACE-ANTIGEN; VIRAL-DNA; CELLS; INHIBITION; HEPCIDIN; PARTICLES; PATHWAYS	The nature of host-virus interactions in hepatitis B virus infection is incompletely understood. Since soluble factors, e.g., cytokines and metals, may exacerbate liver injury in chronic hepatitis, we considered that defining the effects of receptor-mediated signaling upon viral replication will be significant. Consequently, we studied effects of iron or TGF-beta-induced TGF-beta/BMP signaling in the HepG2 2.2.15 cell model of hepatitis B virus replication. We found iron and TGF-beta increased hepcidin mRNA expression or TGF-beta receptor kinase activity, respectively, which indicated that 2.2.15 cells responded appropriately to these substances. However, iron increased but TGF-beta decreased hepatitis B virus mRNA and DNA expression. TGF-beta-induced expression at the mRNA level of multiple TGF-beta/BMP pathway genes. This change was not observed in iron-treated cells. On the other hand, presence of SMAD proteins in iron or TGF-beta-treated cells, including of SMAD4, did confirm convergence of TGF-beta/BMP signaling pathways under these conditions. Since transcription factors in TGF-beta/BMP signaling pathways could not have directly targeted hepatitis B virus itself, we studied whether iron or TGF-beta exerted their effects through alternative mechanisms, such as by involvement of antiviral cellular microRNAs. We discovered cellular microRNA expression profiles were significantly different in iron or TGF-beta-treated cells compared with untreated control cells. In many cases, exposure to iron or TGF-beta changed microRNA expression in opposite directions. Introduction in cells of sequences representing such differentially expressed microRNAs, e.g., hsa-miR-125a-5p and -151-5p, even reproduced effects on virus replication of iron- or TGF-beta. We surmised that TGF-beta/BMP pathway members, i.e., SMADs, likely governed iron or TGF-beta-induced microRNA expression. Iron may have mediated Drosha/DGCR8/heme-mediated processing of microRNAs. In turn, cellular microRNAs regulated replication of hepatitis B virus in iron or TGF-beta-treated cells. This knowledge should advance studies of mechanisms in viral-host interactions, hepatic injury, and therapeutic developments for hepatitis B.	[Park, Sun O.; Kumar, Mukesh; Gupta, Sanjeev] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Gupta, Sanjeev] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Gupta, Sanjeev] Ruth L & David S Gottesman Inst Stem Cell & Regen, Diabet Res Ctr, Ctr Canc, Marion Bessin Liver Res Ctr, Bronx, NY USA; [Gupta, Sanjeev] Inst Clin & Translat Res, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Park, SO (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	sanjeev.gupta@einstein.yu.edu			National Institutes of Health [R01 DK071111, R01 DK088561, P30 DK41296, P30 CA13330, T32 DK007218-35]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007218, P30DK041296, R01DK071111, R01DK088561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These investigators were supported in part by National Institutes of Health grants R01 DK071111, R01 DK088561, P30 DK41296, P30 CA13330, and T32 DK007218-35. The funding provided partial salary support and core services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no other external funding sources for this study.	Barr I, 2012, P NATL ACAD SCI USA, V109, P1919, DOI 10.1073/pnas.1114514109; Bartolomei G, 2011, J GEN VIROL, V92, P2072, DOI 10.1099/vir.0.032706-0; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Cavanaugh VJ, 1997, J VIROL, V71, P3236, DOI 10.1128/JVI.71.4.3236-3243.1997; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Chouteau P, 2001, J HEPATOL, V34, P108, DOI 10.1016/S0168-8278(00)00012-X; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis-Dusenbery BN, 2011, RNA BIOL, V8, P71, DOI 10.4161/rna.8.1.14299; DUBOIS MF, 1980, P NATL ACAD SCI-BIOL, V77, P4549, DOI 10.1073/pnas.77.8.4549; Fein E, 2007, PEPTIDES, V28, P951, DOI 10.1016/j.peptides.2007.01.016; FELTON C, 1979, P NATL ACAD SCI USA, V76, P2438, DOI 10.1073/pnas.76.5.2438; Goodnough JB, 2012, HEPATOLOGY, DOI [10.1002/hep.25615, DOI 10.1002/HEP.25615.]; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kimura K, 2002, J VIROL, V76, P10702, DOI 10.1128/JVI.76.21.10702-10707.2002; Kumar M, 2012, ANTIVIR THER, V17, P519, DOI 10.3851/IMP2014; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liu AM, 2011, OMICS, V15, P187, DOI 10.1089/omi.2010.0098; Masihi KN, 2011, INFECT DIS CLIN N AM, V25, P723, DOI 10.1016/j.idc.2011.07.002; Murakami M, 2009, GENES CELLS, V14, P469, DOI 10.1111/j.1365-2443.2009.01283.x; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Park IH, 2011, MOL CELLS, V32, P167, DOI 10.1007/s10059-011-1059-6; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Robek MD, 2004, P NATL ACAD SCI USA, V101, P1743, DOI 10.1073/pnas.0308340100; Sebastiani G, 2012, J VIRAL HEPATITIS, V19, pE170, DOI 10.1111/j.1365-2893.2011.01508.x; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	30	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39276	10.1371/journal.pone.0039276	http://dx.doi.org/10.1371/journal.pone.0039276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723983	Green Published, Green Submitted, gold			2022-12-27	WOS:000305583300124
J	Gross, A; Ziepert, M; Scholz, M				Gross, Arnd; Ziepert, Marita; Scholz, Markus			KMWin - A Convenient Tool for Graphical Presentation of Results from Kaplan-Meier Survival Time Analysis	PLOS ONE			English	Article							B-CELL LYMPHOMA; CHOP-LIKE CHEMOTHERAPY; YOUNG-PATIENTS; PROGNOSIS; TRIAL; RITUXIMAB; MINT	Background: Analysis of clinical studies often necessitates multiple graphical representations of the results. Many professional software packages are available for this purpose. Most packages are either only commercially available or hard to use especially if one aims to generate or customize a huge number of similar graphical outputs. We developed a new, freely available software tool called KMWin (Kaplan-Meier for Windows) facilitating Kaplan-Meier survival time analysis. KMWin is based on the statistical software environment R and provides an easy to use graphical interface. Survival time data can be supplied as SPSS (sav), SAS export (xpt) or text file (dat), which is also a common export format of other applications such as Excel. Figures can directly be exported in any graphical file format supported by R. Results: On the basis of a working example, we demonstrate how to use KMWin and present its main functions. We show how to control the interface, customize the graphical output, and analyse survival time data. A number of comparisons are performed between KMWin and SPSS regarding graphical output, statistical output, data management and development. Although the general functionality of SPSS is larger, KMWin comprises a number of features useful for survival time analysis in clinical trials and other applications. These are for example number of cases and number of cases under risk within the figure or provision of a queue system for repetitive analyses of updated data sets. Moreover, major adjustments of graphical settings can be performed easily on a single window. Conclusions: We conclude that our tool is well suited and convenient for repetitive analyses of survival time data. It can be used by non-statisticians and provides often used functions as well as functions which are not supplied by standard software packages. The software is routinely applied in several clinical study groups.	[Gross, Arnd; Ziepert, Marita; Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Leipzig, Germany	Leipzig University; Leipzig University	Gross, A (corresponding author), Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.	arnd.gross@imise.uni-leipzig.de		Gross, Arnd/0000-0002-5961-5507	German Federal Research Ministry (BMBF) [01KI1010I]; LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony	German Federal Research Ministry (BMBF)(Federal Ministry of Education & Research (BMBF)); LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony	The work of AG was supported in part by the German Federal Research Ministry (BMBF), grant PROGRESS (01KI1010I). MS was supported by LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GNOME Office, GNUM WELC GNUM; IBM, IBM SPSS SOFTW; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; LCC-Win, FREE COMP SYST WIND; Ott G, 2010, BLOOD, V116, P4916, DOI 10.1182/blood-2010-03-276766; Pfreundschuh M, 2008, LANCET ONCOL, V9, P435, DOI 10.1016/S1470-2045(08)70078-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; *R PROJ, R PROJ STAT COMP; SAS, BUS AN BUS INT SOFTW; Schmitz N, 2010, BLOOD, V116, P3418, DOI 10.1182/blood-2010-02-270785; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	12	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38960	10.1371/journal.pone.0038960	http://dx.doi.org/10.1371/journal.pone.0038960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22723912	Green Submitted, Green Published, gold			2022-12-27	WOS:000305350000032
J	Pan, CY; Chen, H; Wang, LH; Yang, SS; Fu, HL; Zheng, YX; Miao, MY; Jiao, BH				Pan, Chuanyong; Chen, Huan; Wang, Lianghua; Yang, Shengsheng; Fu, Hailong; Zheng, Yongxia; Miao, Mingyong; Jiao, Binghua			Down-Regulation of MiR-127 Facilitates Hepatocyte Proliferation during Rat Liver Regeneration	PLOS ONE			English	Article							CENTER B-CELLS; PARTIAL-HEPATECTOMY; GENE-EXPRESSION; HISTONE METHYLTRANSFERASE; MICRORNA EXPRESSION; S-PHASE; P53; METHYLATION; BCL6; MICE	Liver regeneration (LR) after partial hepatectomy (PH) involves the proliferation and apoptosis of hepatocytes, and microRNAs have been shown to post-transcriptionally regulate genes involved in the regulation of these processes. To explore the role of miR-127 during LR, the expression patterns of miR-127 and its related proteins were investigated. MiR-127 was introduced into a rat liver cell line to examine its effects on the potential target genes Bcl6 and Setd8, and functional studies were undertaken. We discovered that miR-127 was down-regulated and inversely correlated with the expression of Bcl6 and Setd8 at 24 hours after PH, a time at which hypermethylation of the promoter region of the miR-127 gene was detected. Furthermore, in BRL-3A rat liver cells, we observed that overexpression of miR-127 significantly suppressed cell growth and directly inhibited the expression of Bcl6 and Setd8. The results suggest that down-regulation of miR-127 may be due to the rapid methylation of its promoter during the first 24 h after PH, and this event facilitates hepatocyte proliferation by releasing Bcl6 and Setd8. These findings support a miRNA-mediated negative regulation pattern in LR and implicate an anti-proliferative role for miR-127 in liver cells.	[Pan, Chuanyong; Chen, Huan; Wang, Lianghua; Yang, Shengsheng; Zheng, Yongxia; Miao, Mingyong; Jiao, Binghua] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [Fu, Hailong] Second Mil Med Univ, Changzheng Hosp, Dept Anaesthesiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Pan, CY (corresponding author), Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China.	miaomy@163.com; jiaobh@live.cn		Chen, Huan/0000-0001-8648-1631	Basic Research Program of Science and Technology Commission Foundation of Shanghai [10JC1417400]; National Natural Science Foundation of China [30800553]	Basic Research Program of Science and Technology Commission Foundation of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Basic Research Program of Science and Technology Commission Foundation of Shanghai (No. 10JC1417400) to M.Y.M. and the National Natural Science Foundation of China (No. 30800553) to H.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Chen XL, 2011, TRANSPLANTATION, V91, P293, DOI 10.1097/TP.0b013e318204756c; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Eipel C, 2005, J HEPATOL, V43, P829, DOI 10.1016/j.jhep.2005.04.018; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; KOCH KS, 1979, CELL, V18, P153, DOI 10.1016/0092-8674(79)90364-7; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li TT, 2010, MOL GENET GENOMICS, V283, P485, DOI 10.1007/s00438-010-0530-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Margalit O, 2006, BLOOD, V107, P1599, DOI 10.1182/blood-2005-04-1629; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Pager CT, 2009, PROG MOL BIOL TRANSL, V90, P187, DOI 10.1016/S1877-1173(09)90005-9; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shu JM, 2011, HEPATOLOGY, V54, P609, DOI 10.1002/hep.24421; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; THOMPSON NL, 1986, CANCER RES, V46, P3111; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Zimmermann A, 2004, NEPHROL DIAL TRANSPL, V19, P6, DOI 10.1093/ndt/gfh1034	40	52	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39151	10.1371/journal.pone.0039151	http://dx.doi.org/10.1371/journal.pone.0039151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720056	Green Submitted, gold, Green Published			2022-12-27	WOS:000305350000043
J	Saravanaperumal, SA; Pediconi, D; Renieri, C; La Terza, A				Saravanaperumal, Siva Arumugam; Pediconi, Dario; Renieri, Carlo; La Terza, Antonietta			Skipping of Exons by Premature Termination of Transcription and Alternative Splicing within Intron-5 of the Sheep SCF Gene: A Novel Splice Variant	PLOS ONE			English	Article							STEM-CELL FACTOR; C-KIT LIGAND; MULTIPLE SEQUENCE ALIGNMENT; PROTEIN MESSENGER-RNAS; GROWTH-FACTOR; COAT COLOR; DOMINANT BLACK; MELANOCYTE DEVELOPMENT; TRANSLATIONAL CONTROL; MOLECULAR-CLONING	Stem cell factor (SCF) is a growth factor, essential for haemopoiesis, mast cell development and melanogenesis. In the hematopoietic microenvironment (HM), SCF is produced either as a membrane-bound (-) or soluble (+) forms. Skin expression of SCF stimulates melanocyte migration, proliferation, differentiation, and survival. We report for the first time, a novel mRNA splice variant of SCF from the skin of white merino sheep via cloning and sequencing. Reverse transcriptase (RT)-PCR and molecular prediction revealed two different cDNA products of SCF. Full-length cDNA libraries were enriched by the method of rapid amplification of cDNA ends (RACE-PCR). Nucleotide sequencing and molecular prediction revealed that the primary 1519 base pair (bp) cDNA encodes a precursor protein of 274 amino acids (aa), commonly known as 'soluble' isoform. In contrast, the shorter (835 and/or 725 bp) cDNA was found to be a `novel' mRNA splice variant. It contains an open reading frame (ORF) corresponding to a truncated protein of 181 aa (vs 245 aa) with an unique C-terminus lacking the primary proteolytic segment (28 aa) right after the D(175)G site which is necessary to produce 'soluble' form of SCF. This alternative splice (AS) variant was explained by the complete nucleotide sequencing of splice junction covering exon 5-intron (5)- exon 6 (948 bp) with a premature termination codon (PTC) whereby exons 6 to 9/10 are skipped (Cassette Exon, CE 6-9/10). We also demonstrated that the Northern blot analysis at transcript level is mediated via an intron-5 splicing event. Our data refine the structure of SCF gene; clarify the presence (+) and/or absence (2) of primary proteolytic-cleavage site specific SCF splice variants. This work provides a basis for understanding the functional role and regulation of SCF in hair follicle melanogenesis in sheep beyond what was known in mice, humans and other mammals.	[Saravanaperumal, Siva Arumugam; Pediconi, Dario; Renieri, Carlo; La Terza, Antonietta] Univ Camerino, Sch Environm Sci, I-62032 Camerino, MC, Italy	University of Camerino	Saravanaperumal, SA (corresponding author), Univ Camerino, Sch Environm Sci, Via Gentile III Varano, I-62032 Camerino, MC, Italy.	sivabiotech2002@yahoo.com; antonietta.laterza@unicam.it		La Terza, Antonietta/0000-0002-1244-1503	Faculty Research Grant; University of Camerino, Italy	Faculty Research Grant; University of Camerino, Italy	This huge in-house project on 'Molecular Characterization of Pigmentation Genes in Merino Sheep' was supported by the Faculty Research Grant to Dr. Antonietta La Terza and Dr. Carlo Renieri from the University of Camerino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abyzov A, 2005, BIOINFORMATICS, V21, P3677, DOI 10.1093/bioinformatics/bti602; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; ANDERSON DM, 1991, CELL GROWTH DIFFER, V2, P373; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], DES TOOL DNA OL MOD; BAIM SB, 1985, MOL CELL BIOL, V5, P1839, DOI 10.1128/MCB.5.8.1839; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Baxter LL, 2004, PIGM CELL RES, V17, P215, DOI 10.1111/j.1600-0749.2004.00147.x; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Beraldi D, 2006, GENETICS, V173, P1521, DOI 10.1534/genetics.106.057141; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; BESMER P, 1993, DEVELOPMENT, P125; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHENG HJ, 1994, MOL BIOL CELL, V5, P943, DOI 10.1091/mbc.5.9.943; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelen S, 2010, NUCLEIC ACIDS RES, V38, P2453, DOI 10.1093/nar/gkp1067; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukuchi S, 2009, NUCLEIC ACIDS RES, V37, pD333, DOI 10.1093/nar/gkn855; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Gentry PC, 1996, BIOL REPROD, V54, P970, DOI 10.1095/biolreprod54.5.970; Geospiza Inc, FINCHTV; GRABBE J, 1994, ARCH DERMATOL RES, V287, P78, DOI 10.1007/BF00370723; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Hachiya A, 2001, J INVEST DERMATOL, V116, P578, DOI 10.1046/j.1523-1747.2001.01290.x; Hachiya A, 2009, J PATHOL, V218, P30, DOI 10.1002/path.2503; Hadjiconstantouras C, 2008, ANIM GENET, V39, P217, DOI 10.1111/j.1365-2052.2008.01708.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hsu YR, 1998, BIOCHEMISTRY-US, V37, P2251, DOI 10.1021/bi972372z; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kalendar R., 2010, JAVA WEB TOOLS PCR S; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerns JA, 2003, J HERED, V94, P75, DOI 10.1093/jhered/esg016; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LANGLEY KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P55, DOI 10.1006/abbi.1994.1208; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LEV S, 1992, J BIOL CHEM, V267, P15970; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; LONGLEY BJ, 1993, NEW ENGL J MED, V328, P1302, DOI 10.1056/NEJM199305063281803; Longley BJ, 1999, J INVEST DERMATOL, V113, P139, DOI 10.1046/j.1523-1747.1999.00643.x; LU HS, 1991, J BIOL CHEM, V266, P8102; MAJUMDAR MK, 1994, J BIOL CHEM, V269, P1237; Margulies EH, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e60; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYER TC, 1970, DEV BIOL, V23, P297, DOI 10.1016/0012-1606(70)90100-4; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Meyuhas Oded, 1996, V30, P363; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; Mytelka DS, 1996, NUCLEIC ACIDS RES, V24, P2774, DOI 10.1093/nar/24.14.2774; Nei M., 2000, MOL EVOLUTION PHYLOG; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parsons YM, 1999, PIGM CELL RES, V12, P394, DOI 10.1111/j.1600-0749.1999.tb00524.x; Parsons YM, 1999, AUST J AGR RES, V50, P1099, DOI 10.1071/AR98099; Petitte JN, 1996, BBA-GENE STRUCT EXPR, V1307, P149, DOI 10.1016/0167-4781(96)00062-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Renieri C, 2008, SMALL RUMINANT RES, V74, P23, DOI 10.1016/j.smallrumres.2007.03.001; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SHARKEY A, 1992, MOL ENDOCRINOL, V6, P1235, DOI 10.1210/me.6.8.1235; SHULL RM, 1992, EXP HEMATOL, V20, P1118; Silvers W. K., 1979, The coat colours of mice. A model for mammalian gene action and interaction.; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tisdall DJ, 1997, J MOL ENDOCRINOL, V18, P127, DOI 10.1677/jme.0.0180127; Tisdall DJ, 1996, MAMM GENOME, V7, P472, DOI 10.1007/s003359900142; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; Vage DI, 2003, PIGM CELL RES, V16, P693, DOI 10.1046/j.1600-0749.2003.00090.x; Vage DI, 1999, MAMM GENOME, V10, P39, DOI 10.1007/s003359900939; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Welker P, 1999, SCAND J IMMUNOL, V49, P495; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; ZHANG Z, 1994, BIOL REPROD, V50, P95, DOI 10.1095/biolreprod50.1.95; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732; ZHOU JH, 1994, BBA-MOL CELL RES, V1223, P148, DOI 10.1016/0167-4889(94)90084-1; ZHOU JH, 1993, GENE, V127, P269, DOI 10.1016/0378-1119(93)90732-I; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	138	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38657	10.1371/journal.pone.0038657	http://dx.doi.org/10.1371/journal.pone.0038657			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719917	gold, Green Published, Green Submitted			2022-12-27	WOS:000305350000019
J	Liu, T; Xu, YY; Sun, DP; Xie, LX				Liu, Ting; Xu, Yuanyuan; Sun, Dapeng; Xie, Lixin			Histological Evaluation of Corneal Scar Formation in Pseudophakic Bullous Keratopathy	PLOS ONE			English	Article							LAMELLAR ENDOTHELIAL KERATOPLASTY; LASER CONFOCAL MICROSCOPY; TISSUE GROWTH-FACTOR; PENETRATING KERATOPLASTY; EXTRACELLULAR-MATRIX; EXPRESSION; COLLAGEN; CTGF	Purpose: To evaluate histological changes in the corneal stroma in pseudophakic bullous keratopathy. Methods: Twenty-eight patients (28 eyes) with pseudophakic bullous keratopathy underwent therapeutic penetrating keratoplasty at Shandong Eye Institute between January 2006 and November 2011. The patients were divided into two groups according to the duration of bullous keratopathy (<1.0 year group or >1.0 year group), and three buttons from enucleated eyes with choroidal melanoma served as a control. In vivo confocal microscopy examination, hematoxylin-eosin, Masson's trichrome stain and Van Gieson staining were used for microscopic examination. The histological evaluation and scoring of the buttons for morphological changes, including the degree of stromal scars, neovascularization and inflammatory cells within the corneal buttons, were compared. To study the underlying mechanism, connective tissue growth factor (CTGF) and TGF-beta immunohistochemistry were performed. Results: Confocal microscopy examination and histological evaluation and scoring of the buttons showed that compared with the <1.0 year group, stromal scars, neovascularization and inflammatory cells were more severe in the >1.0 year group (P < 0.05). There was an increase in CTGF-and TGF-beta 1-positive stromal cells in the >1.0 year group. Conclusions: During the progression of pseudophakic bullous keratopathy, stromal scars occurred more often in the patients that had a longer duration of disease. Cytokines such as CTGF and TGF-beta 1 may play a role in this pathological process and deserve further investigation.	[Liu, Ting; Xu, Yuanyuan; Sun, Dapeng; Xie, Lixin] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Liu, T (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China.	lixin_xie@yahoo.com	Xie, li/HGE-6052-2022		Research Fund for the Doctoral Program of Higher Education of China [20113706110004]; National Natural Science Foundation of China [30901636]; Foundation of Province of state key laboratory cultivation base construction [SDYK-KF-2010-6]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Province of state key laboratory cultivation base construction	Research was supported by the Research Fund for the Doctoral Program of Higher Education of China (No. 20113706110004), National Natural Science Foundation of China (No. 30901636) and the Foundation of Province of state key laboratory cultivation base construction (No. SDYK-KF-2010-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Basak SK, 2008, INDIAN J OPHTHALMOL, V56, P291, DOI 10.4103/0301-4738.41412; Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Chiou AGY, 1998, CORNEA, V17, P669, DOI 10.1097/00003226-199811000-00016; Garrett Q, 2004, INVEST OPHTH VIS SCI, V45, P1109, DOI 10.1167/iovs.03-0660; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Glasgow BJ, 2009, INVEST OPHTH VIS SCI, V50, P4060, DOI 10.1167/iovs.08-3361; Heidemann DG, 2008, CORNEA, V27, P161, DOI 10.1097/ICO.0b013e31815b8304; Hillenaar T, 2010, OPHTHALMOLOGY, V117, P2255, DOI 10.1016/j.ophtha.2010.03.047; KENNEY MC, 1990, CORNEA, V9, P115; Khor WB, 2011, AM J OPHTHALMOL, V151, P223, DOI 10.1016/j.ajo.2010.08.027; Kobayashi A, 2008, AM J OPHTHALMOL, V145, P977, DOI 10.1016/j.ajo.2008.02.009; Kobayashi A, 2009, OPHTHALMOLOGY, V116, P1306, DOI 10.1016/j.ophtha.2009.01.053; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; LIU GJ, 1993, JPN J OPHTHALMOL, V37, P414; Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997; Mashor RS, 2010, OPHTHALMOLOGY, V117, P680, DOI 10.1016/j.ophtha.2009.12.039; Price MO, 2007, CURR OPIN OPHTHALMOL, V18, P290, DOI 10.1097/ICU.0b013e3281a4775b; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Strzalka-Mrozik B, 2010, MOL VIS, V16, P161; Tall EG, 2010, INVEST OPHTH VIS SCI, V51, P5002, DOI 10.1167/iovs.09-5110; Wunderlich K, 2000, OPHTHALMOLOGICA, V214, P341, DOI 10.1159/000027517; Xie LX, 2007, CORNEA, V26, P158, DOI 10.1097/01.ico.0000248381.24519.0d; Yang M, 2010, CORNEA, V29, P108, DOI 10.1097/ICO.0b013e3181a3c516	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39201	10.1371/journal.pone.0039201	http://dx.doi.org/10.1371/journal.pone.0039201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720074	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347800056
J	Wu, ST; Li, CJ; Huang, W; Li, WZ; Li, RW				Wu, Sitao; Li, Congjun; Huang, Wen; Li, Weizhong; Li, Robert W.			Alternative Splicing Regulated by Butyrate in Bovine Epithelial Cells	PLOS ONE			English	Article							HISTONE DEACETYLASES; GENE FUSION; PROHIBITIN; TRANSCRIPTION; INHIBITORS; VARIANTS; SIRTUINS; TARGET	As a signaling molecule and an inhibitor of histone deacetylases (HDACs), butyrate exerts its impact on a broad range of biological processes, such as apoptosis and cell proliferation, in addition to its critical role in energy metabolism in ruminants. This study examined the effect of butyrate on alternative splicing in bovine epithelial cells using RNA-seq technology. Junction reads account for 11.28 and 12.32% of total mapped reads between the butyrate-treated (BT) and control (CT) groups. 201,326 potential splicing junctions detected were supported by >= 3 junction reads. Approximately 94% of these junctions conformed to the consensus sequence (GT/AG) while similar to 3% were GC/AG junctions. No AT/AC junctions were observed. A total of 2,834 exon skipping events, supported by a minimum of 3 junction reads, were detected. At least 7 genes, their mRNA expression significantly affected by butyrate, also had exon skipping events differentially regulated by butyrate. Furthermore, COL5A3, which was induced 310-fold by butyrate (FDR <0.001) at the gene level, had a significantly higher number of junction reads mapped to Exon#8 (Donor) and Exon#11 (Acceptor) in BT. This event had the potential to result in the formation of a COL5A3 mRNA isoform with 2 of the 69 exons missing. In addition, 216 differentially expressed transcript isoforms regulated by butyrate were detected. For example, Isoform 1 of ORC1 was strongly repressed by butyrate while Isoform 2 remained unchanged. Butyrate physically binds to and inhibits all zinc-dependent HDACs except HDAC6 and HDAC10. Our results provided evidence that butyrate also regulated deacetylase activities of classical HDACs via its transcriptional control. Moreover, thirteen gene fusion events differentially affected by butyrate were identified. Our results provided a snapshot into complex transcriptome dynamics regulated by butyrate, which will facilitate our understanding of the biological effects of butyrate and other HDAC inhibitors.	[Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA; [Li, Congjun; Li, Robert W.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Huang, Wen] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of California System; University of California San Diego; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Wu, ST (corresponding author), Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA.	robert.li@ars.usda.gov	Huang, Wen/B-5005-2011; Li, Weizhong/A-9735-2008; Li, Cong-jun/J-8572-2014	Li, Weizhong/0000-0003-1804-9403; Li, Cong-jun/0000-0003-1389-9820; Huang, Wen/0000-0001-6788-8364	National Human Genome Research Institute (NHGRI) [R01HG005978]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was partly supported by Award R01HG005978 to WL from the National Human Genome Research Institute (NHGRI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Baldwin RLV, 2012, QUANTIFICATION UNPUB; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Carafa V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00004; Churbanov A, 2008, BIOL DIRECT, V3, P1, DOI 10.1186/1745-6150-3-30; Ciura J, 2010, MOL BIOL REP, V37, P3729, DOI 10.1007/s11033-010-0026-1; Corbi Graziamaria, 2012, Front Biosci (Elite Ed), V4, P768; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Jupe ER, 1996, EXP CELL RES, V224, P128, DOI 10.1006/excr.1996.0120; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kinsella M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/bioinformatics/btr085; KRUPITZA G, 1995, CARCINOGENESIS, V16, P1199; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Lee H, 2010, INT J BIOL MACROMOL, V47, P685, DOI 10.1016/j.ijbiomac.2010.08.018; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li CJ, 2008, GENE REGUL SYST BIO, V2, P113; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-114; Li RW, 2011, FUNCTIONAL INTEGRATI; Murray JI, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r97; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Nissim-Rafinia M, 2004, EMBO REP, V5, P1071, DOI 10.1038/sj.embor.7400273; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Puppin C, 2011, ONCOL REP, V25, P393, DOI 10.3892/or.2010.1075; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; Schemies J, 2010, MED RES REV, V30, P861, DOI 10.1002/med.20178; Shin JH, 2012, FUNCT INTEGR GENOMIC, V12, P119, DOI 10.1007/s10142-012-0263-6; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Tazi J, 2010, FEBS J, V277, P867, DOI 10.1111/j.1742-4658.2009.07522.x; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Will C. L., 2011, COLD SPRING HARBOR P, V3, ppii; Wu S, 2012, TRANSCRIPTOME UNPUB; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	45	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39182	10.1371/journal.pone.0039182	http://dx.doi.org/10.1371/journal.pone.0039182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720068	Green Submitted, gold, Green Published			2022-12-27	WOS:000305347800053
J	Iwamori, N; Iwamori, T; Matzuk, MM				Iwamori, Naoki; Iwamori, Tokuko; Matzuk, Martin M.			Characterization of Spermatogonial Stem Cells Lacking Intercellular Bridges and Genetic Replacement of a Mutation in Spermatogonial Stem Cells	PLOS ONE			English	Article							MALE GERM-CELLS; SELF-RENEWAL; UNDIFFERENTIATED SPERMATOGONIA; NUCLEAR TRANSPLANTATION; SEMINIFEROUS TUBULES; MOUSE TESTES; MICE; SPERMATOGENESIS; EXPRESSION; PROTEIN	Stem cells have a potential of gene therapy for regenerative medicine. Among various stem cells, spermatogonial stem cells have a unique characteristic in which neighboring cells can be connected by intercellular bridges. However, the roles of intercellular bridges for stem cell self-renewal, differentiation, and proliferation remain to be elucidated. Here, we show not only the characteristics of testis-expressed gene 14 (TEX14) null spermatogonial stem cells lacking intercellular bridges but also a trial application of genetic correction of a mutation in spermatogonial stem cells as a model for future gene therapy. In TEX14 null testes, some genes important for undifferentiated spermatogonia as well as some differentiation-related genes were activated. TEX14 null spermatogonial stem cells, surprisingly, could form chain-like structures even though they do not form stable intercellular bridges. TEX14 null spermatogonial stem cells in culture possessed both characteristics of undifferentiated and differentiated spermatogonia. Long-term culture of TEX14 null spermatogonial stem cells could not be established likely secondary to up-regulation of CDK4 inhibitors and down-regulation of cyclin E. These results suggest that intercellular bridges are essential for both maintenance of spermatogonial stem cells and their proliferation. Lastly, a mutation in Tex14(+/-) spermatogonial stem cells was successfully replaced by homologous recombination in vitro. Our study provides a therapeutic potential of spermatogonial stem cells for reproductive medicine if they can be cultured long-term.	[Iwamori, Naoki; Iwamori, Tokuko; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Iwamori, Naoki; Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Iwamori, N (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	iwamori@bcm.tmc.edu; mmatzuk@bcm.tmc.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD057880]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057880] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	These studies were supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD057880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005850; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2004, HEMATOL J, V5, pS114, DOI 10.1038/sj.thj.6200435; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; HUCKINS C, 1978, ANAT REC, V192, P519, DOI 10.1002/ar.1091920406; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Kanatsu-Shinohara M, 2011, BIOL REPROD, V85, P208, DOI 10.1095/biolreprod.111.090837; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Wu MH, 2003, GENE EXPR PATTERNS, V3, P231, DOI 10.1016/S1567-133X(03)00036-X; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zhou Q., 2008, REGULATION SPERMATOG; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	39	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38914	10.1371/journal.pone.0038914	http://dx.doi.org/10.1371/journal.pone.0038914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719986	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341900065
J	Fuller, DM; Zhu, MH; Song, XH; Ou-Yang, CW; Sullivan, SA; Stone, JC; Zhang, WG				Fuller, Deirdre M.; Zhu, Minghua; Song, Xiaohua; Ou-Yang, Chih-Wen; Sullivan, Sarah A.; Stone, James C.; Zhang, Weiguo			Regulation of RasGRP1 Function in T Cell Development and Activation by Its Unique Tail Domain	PLOS ONE			English	Article							NEGATIVE SELECTION; THYMIC SELECTION; RAS ACTIVATION; IGE PRODUCTION; C1 DOMAINS; MEMBRANE; LYMPHOCYTES; BINDING; GAMMA; CD4	The Ras-guanyl nucleotide exchange factor RasGRP1 plays a critical role in T cell receptor-mediated Erk activation. Previous studies have emphasized the importance of RasGRP1 in the positive selection of thymocytes, activation of T cells, and control of autoimmunity. RasGRP1 consists of a number of well-characterized domains, which it shares with its other family members; however, RasGRP1 also contains an similar to 200 residue-long tail domain, the function of which is unknown. To elucidate the physiological role of this domain, we generated knock-in mice expressing RasGRP1 without the tail domain. Further analysis of these knock-in mice showed that thymocytes lacking the tail domain of RasGRP1 underwent aberrant thymic selection and, following TCR stimulation, were unable to activate Erk. Furthermore, the deletion of the tail domain led to enhanced CD4(+) T cell expansion in aged mice, as well as the production of autoantibodies. Mechanistically, the tail-deleted form of RasGRP1 was not able to traffic to the cell membrane following stimulation, indicating a potential reason for its inability to activate Erk. While the DAG-binding C1 domain of RasGRP1 has long been recognized as an important factor mediating Erk activation, we have revealed the physiological relevance of the tail domain in RasGRP1 function and control of Erk signaling.	[Fuller, Deirdre M.; Zhu, Minghua; Ou-Yang, Chih-Wen; Sullivan, Sarah A.; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA; [Song, Xiaohua; Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Duke University; University of Alberta	Fuller, DM (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA.	zhang033@mc.duke.edu	Zhu, Minghua/ABH-2671-2020		National Institutes of Health [AI048674, AI056156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI056156, R56AI048674, R01AI056156, R01AI048674, T32AI052077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants AI048674 and AI056156 to WZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Beaulieu N, 2007, MOL BIOL CELL, V18, P3156, DOI 10.1091/mbc.E06-10-0932; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; BRINKMANN V, 1995, J IMMUNOL, V154, P3078; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chen XX, 2008, J IMMUNOL, V180, P5973, DOI 10.4049/jimmunol.180.9.5973; Coughlin JJ, 2006, IMMUNOL LETT, V105, P77, DOI 10.1016/j.imlet.2006.01.005; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Kortum RL, 2011, P NATL ACAD SCI US; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Priatel JJ, 2007, J IMMUNOL, V179, P2143, DOI 10.4049/jimmunol.179.4.2143; Priatel JJ, 2006, J IMMUNOL, V177, P1470, DOI 10.4049/jimmunol.177.3.1470; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; Tazmini G, 2009, BBA-MOL CELL RES, V1793, P447, DOI 10.1016/j.bbamcr.2008.12.019; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Vassiliou GS, 2011, NAT GENET; Yasuda S, 2007, J IMMUNOL, V179, P4890, DOI 10.4049/jimmunol.179.7.4890; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605	35	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38796	10.1371/journal.pone.0038796	http://dx.doi.org/10.1371/journal.pone.0038796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719950	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340000046
J	Garrido, MD; Penna, ML; Perez-Porcuna, TM; de Souza, AB; Marreiro, LD; Albuquerque, BC; Martinez-Espinosa, FE; Buhrer-Sekula, S				Garrido, Marlucia da Silva; Penna, Maria Lucia; Perez-Porcuna, Tomas M.; de Souza, Alexandra Brito; Marreiro, Leni da Silva; Albuquerque, Bernardino Claudio; Martinez-Espinosa, Flor Ernestina; Buehrer-Sekula, Samira			Factors Associated with Tuberculosis Treatment Default in an Endemic Area of the Brazilian Amazon: A Case Control-Study	PLOS ONE			English	Article							PULMONARY TB PATIENTS; RISK-FACTORS; CARE; NONADHERENCE; RETREATMENT; PREDICTORS; KENYA; ABUSE; CITY	Setting: Treatment default is a serious problem in tuberculosis control because it implies persistence of infection source, increased mortality, increased relapse rates and facilitates the development of resistant strains. Objective: This study analyzed tuberculosis treatment default determinants in the Amazonas State to contribute in planning appropriate control interventions. Design: Observational study with a retrospective cohort using Brazilian Disease Notification System data from 2005 to 2010. A nested case control study design was used. Patients defaulting from treatment were considered as 'cases' and those completing treatment as 'controls'. In the analysis, 11,312 tuberculosis patients were included, 1,584 cases and 9,728 controls. Results: Treatment default was observed to be associated to previous default (aOR 3.20; p<0.001), HIV positivity (aOR 1.62; p<0.001), alcoholism (aOR 1.51; p<0.001), low education level (aOR 1.35; p<0.001) and other co-morbidities (aOR 1.31; p = 0.05). Older patients (aOR 0.98; p = 0.001) and DOT (aOR 0,72; p<0.01) were considered as protective factor for default. Conclusions: Associated factors should be considered in addressing care and policy actions to tuberculosis control. Information on disease and treatment should be intensified and appropriate to the level of education of the population, in order to promote adherence to treatment and counter the spread of multidrug resistance to anti-TB drugs.	[Garrido, Marlucia da Silva; Perez-Porcuna, Tomas M.; Martinez-Espinosa, Flor Ernestina; Buehrer-Sekula, Samira] Amazonas State Univ, Trop Med Postgrad Program, Dr Heitor Vieira Dourado Trop Med Fdn, Manaus, Amazonas, Brazil; [Garrido, Marlucia da Silva; Albuquerque, Bernardino Claudio] Hlth Surveillance Fdn Amazonas State, Epidemiol Surveillance Dept, Manaus, Amazonas, Brazil; [Garrido, Marlucia da Silva; Marreiro, Leni da Silva] Municipal Hlth Secretary Manaus, Epidemiol Surveillance Dept, Manaus, Amazonas, Brazil; [Penna, Maria Lucia] Univ Fed Fluminense, Epidemiol & Biostat Dept, Rio De Janeiro, Brazil; [Perez-Porcuna, Tomas M.] Univ Barcelona, Sch Med, Dept Publ Hlth, Barcelona, Catalonia, Spain; [Perez-Porcuna, Tomas M.] Univ Barcelona, Dept Pediat CAP Valdoreix, Univ Hosp MutuaTerrassa, MutuaTerrassa Res Fdn, Catalonia, Spain; [de Souza, Alexandra Brito; Marreiro, Leni da Silva] Dr Heitor Vieira Dourado Trop Med Fdn, Epidemiol & Publ Hlth Dept, Manaus, Amazonas, Brazil; [Martinez-Espinosa, Flor Ernestina] Fundacao Oswaldo Cruz, Leonidas & Maria Deane Inst, Manaus, Amazonas, Brazil; [Buehrer-Sekula, Samira] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil	Universidade do Estado do Amazonas; Universidade Federal Fluminense; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona; Fundacao Oswaldo Cruz; Universidade Federal de Goias	Garrido, MD (corresponding author), Amazonas State Univ, Trop Med Postgrad Program, Dr Heitor Vieira Dourado Trop Med Fdn, Manaus, Amazonas, Brazil.	marlucia.garrido@gmail.com	Garrido, Marlucia/AAK-1001-2020; Bührer-Sékula, Samira/H-5115-2012	Bührer-Sékula, Samira/0000-0002-5984-7770; Perez-Porcuna, Tomas Maria/0000-0002-9951-7768				[Anonymous], 2010, MAN REC CONTR TUB BR; [Anonymous], 2011, GLOB TUB CONTR; Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003; Comolet TM, 1998, INT J TUBERC LUNG D, V2, P891; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Ferreira V, 2011, REV SAUDE PUBL, V45, P40, DOI 10.1590/S0034-89102010005000055; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; IBGE, 2011, CENS 2010; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P353; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Marreiro LD, 2009, EPIDEMIOL SERV SAUDE, V18, P237; Mesfin MM, 2009, HEALTH POLICY PLANN, V24, P457, DOI 10.1093/heapol/czp030; Ministerio da Saude PNCT, 2011, SER HIST TAX INC TUB; Mittal Chhaya, 2011, Indian J Community Med, V36, P27, DOI 10.4103/0970-0218.80789; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Natal S, 1999, B PNEUMOL SANIT, P7; Oeltmann JE, 2009, ARCH INTERN MED, V169, P189, DOI 10.1001/archinternmed.2008.535; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Penna G, 2009, EMERG INFECT DIS, V15, P626, DOI 10.3201/eid1504.081329; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stata Corp, 2005, STAT STAT SOFTW REL; van Altena R, 2007, Ned Tijdschr Geneeskd, V151, P2652; Vijay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010043; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; World Health Organization, 2006, STOP TB STRAT BUILD	30	55	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39134	10.1371/journal.pone.0039134	http://dx.doi.org/10.1371/journal.pone.0039134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720052	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340000067
J	Marijnissen, RJ; Koenders, MI; van de Veerdonk, FL; Dulos, J; Netea, MG; Boots, AMH; Joosten, LAB; van den Berg, WB				Marijnissen, Renoud J.; Koenders, Marije I.; van de Veerdonk, Frank L.; Dulos, John; Netea, Mihai G.; Boots, Annemieke M. H.; Joosten, Leo A. B.; van den Berg, Wim B.			Exposure to Candida albicans Polarizes a T-Cell Driven Arthritis Model towards Th17 Responses, Resulting in a More Destructive Arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; COLLAGEN-INDUCED ARTHRITIS; AUTOIMMUNE ARTHRITIS; CARTILAGE DESTRUCTION; JOINT INFLAMMATION; DIFFERENTIATION; INTERLEUKIN-1; EXPRESSION; INDUCTION; GLUCAN	Background: Fungal components have been shown very effective in generating Th17 responses. We investigated whether exposure to a minute amount of C. albicans in the arthritic joint altered the local cytokine environment, leading to enhanced Th17 expansion and resulting in a more destructive arthritis. Methodology: Chronic SCW arthritis was induced by repeated injection with Streptococcus pyogenes (SCW) cell wall fragments into the knee joint of C57Bl/6 mice, alone or in combination with the yeast of C. albicans or Zymosan A. During the chronic phase of the arthritis, the cytokine levels, mRNA expression and histopathological analysis of the joints were performed. To investigate the phenotype of the IL-17 producing T-cells, synovial cells were isolated and analyzed by flowcytometry. Principal Findings: Intra-articular injection of either Zymosan A or C. albicans on top of the SCW injection both resulted in enhanced joint swelling and inflammation compared to the normal SCW group. However, only the addition of C. albicans during SCW arthritis resulted in severe chondrocyte death and enhanced destruction of cartilage and bone. Additionally, exposure to C. albicans led to increased IL-17 in the arthritic joint, which was accompanied by an increased synovial mRNA expression of T-bet and ROR gamma T. Moreover, the C. albicans-injected mice had significantly more Th17 cells in the synovium, of which a large population also produced IFN-gamma. Conclusion: This study clearly shows that minute amounts of fungal components, like C. albicans, are very potent in interfering with the local cytokine environment in an arthritic joint, thereby polarizing arthritis towards a more destructive phenotype.	[Marijnissen, Renoud J.; Koenders, Marije I.; van den Berg, Wim B.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun N4I, NL-6525 ED Nijmegen, Netherlands; [Dulos, John] Crucell, Dept I&DL, Pharmacol Sect, Leiden, Netherlands; [Boots, Annemieke M. H.] Univ Groningen, Dept Rheumatol & Clin Immunol, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Johnson & Johnson; University of Groningen	Marijnissen, RJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	rjmarijnissen@reuma.umcn.nl	van den Berg, W.B./H-8010-2014; van de Veerdonk, Frank L/C-7256-2008; Koenders, Marije I/A-1341-2012; Boots, Annemieke M/D-7266-2011; Joosten, Leo AB/H-3138-2015; Netea, Mihai/N-5155-2014; Marijnissen, Renoud/M-5541-2013	van de Veerdonk, Frank L/0000-0002-1121-4894; Koenders, Marije I/0000-0001-5845-8362; Joosten, Leo AB/0000-0001-6166-9830; Marijnissen, Renoud/0000-0002-6836-675X				Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Abdollahi-Roodsaz S, 2008, ARTHRITIS RHEUM, V58, P3753, DOI 10.1002/art.24127; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Conrad K, 2010, AUTOIMMUN REV, V9, P431, DOI 10.1016/j.autrev.2009.11.017; Cosmi L., 2011, ARTHRITIS RHEUM; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gullick NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012516; Hauknes HA, 2002, J INFECT DIS, V185, P915, DOI 10.1086/339407; Hida S, 2005, J AUTOIMMUN, V25, P93, DOI 10.1016/j.jaut.2005.06.002; Hida S, 2007, BIOL PHARM BULL, V30, P1589, DOI 10.1248/bpb.30.1589; Hida S, 2006, MICROBIOL IMMUNOL, V50, P453, DOI 10.1111/j.1348-0421.2006.tb03814.x; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Israeli E, 2009, LUPUS, V18, P1217, DOI 10.1177/0961203309345724; JOOSTEN LAB, 1994, CLIN EXP IMMUNOL, V97, P204; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Joosten LAB, 2008, ARTHRITIS RHEUM-US, V58, P98, DOI 10.1002/art.23152; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Koenders MI, 2011, ARTHRITIS RHEUM; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Santegoets KC, 2011, FEBS LETT; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Sonoyama K, 2011, MED MYCOL, V49, P237, DOI 10.3109/13693786.2010.511284; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; van de Veerdonk FL, 2011, ARTHRITIS RHEUM-US, V63, P1507, DOI 10.1002/art.30314; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van den Berg WB, 1999, ANN RHEUM DIS, V58, P40; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; VANDELOO FAJ, 1995, ARTHRITIS RHEUM, V38, P164; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38889	10.1371/journal.pone.0038889	http://dx.doi.org/10.1371/journal.pone.0038889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719976	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340000051
J	Zhang, XJ; Kendrick, KM; Zhou, HF; Zhan, Y; Feng, JF				Zhang, Xuejuan; Kendrick, Keith M.; Zhou, Haifu; Zhan, Yang; Feng, Jianfeng			A Computational Study on Altered Theta-Gamma Coupling during Learning and Phase Coding	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; NEURONAL SYNCHRONIZATION; SPIKING NEURONS; WORKING-MEMORY; SYNAPTIC BASIS; OSCILLATIONS; NETWORKS; DYNAMICS; RHYTHM; HIPPOCAMPUS	There is considerable interest in the role of coupling between theta and gamma oscillations in the brain in the context of learning and memory. Here we have used a neural network model which is capable of producing coupling of theta phase to gamma amplitude firstly to explore its ability to reproduce reported learning changes and secondly to memory-span and phase coding effects. The spiking neural network incorporates two kinetically different GABAA receptor-mediated currents to generate both theta and gamma rhythms and we have found that by selective alteration of both NMDA receptors and GABAA, slow receptors it can reproduce learning-related changes in the strength of coupling between theta and gamma either with or without coincident changes in theta amplitude. When the model was used to explore the relationship between theta and gamma oscillations, working memory capacity and phase coding it showed that the potential storage capacity of short term memories, in terms of nested gamma-subcycles, coincides with the maximal theta power. Increasing theta power is also related to the precision of theta phase which functions as a potential timing clock for neuronal firing in the cortex or hippocampus.	[Zhang, Xuejuan; Zhou, Haifu; Feng, Jianfeng] Zhejiang Normal Univ, Dept Math, Jinhua, Peoples R China; [Kendrick, Keith M.] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Social Cognit & Affect Neurosci Grp, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhan, Yang] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Zhan, Yang] EMBL EBI, Cambridge, England; [Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	Zhejiang Normal University; University of Electronic Science & Technology of China; European Molecular Biology Laboratory (EMBL); Fudan University; European Molecular Biology Laboratory (EMBL); University of Warwick	Zhang, XJ (corresponding author), Zhejiang Normal Univ, Dept Math, Jinhua, Peoples R China.	jianfeng.feng@warwick.ac.uk		Kendrick, Keith/0000-0002-0371-5904; Zhan, Yang/0000-0002-1150-6344; feng, jianfeng/0000-0002-9328-5732	CARMEN e-science project; EPSRC [EP/E002331/1]; EU; Natural Science Foundation of China (NSFC) [10971196]; Royal Society; Zhejiang Innovation Project [T200905]; FANEDD in China	CARMEN e-science project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Royal Society(Royal Society of London); Zhejiang Innovation Project; FANEDD in China	JF is a Royal Society Wolfson Research Award Holder and was partially supported by CARMEN e-science project (www.carmen.org.uk) funded by the EPSRC (EP/E002331/1) and an EU grant BION. XZ was partially supported by the Natural Science Foundation of China (NSFC) (Nos. 10971196), Zhejiang Innovation Project (Grant No. T200905), and the FANEDD in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Banks MI, 1998, J NEUROSCI, V18, P1305; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; Broadbent DE, 1975, MAGIC NUMBER 7 15; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Hyman JM, 2003, J NEUROSCI, V23, P11725; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kaminski J, 2011, NEUROBIOL LEARN MEM, V95, P19, DOI 10.1016/j.nlm.2010.10.001; Kendrick KM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-55; Kopell N, 2010, SPR S COMPUTAT NEURO, P423; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Sceniak MP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-8; Smerieri A, 2010, J NEUROSCI, V30, P14173, DOI 10.1523/JNEUROSCI.0945-10.2010; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Ursino M, 2006, J THEOR BIOL, V242, P171, DOI 10.1016/j.jtbi.2006.02.012; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Wang XJ, 1999, J NEUROSCI, V19, P9587; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122	39	4	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e36472	10.1371/journal.pone.0036472	http://dx.doi.org/10.1371/journal.pone.0036472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737207	Green Published, Green Submitted, gold			2022-12-27	WOS:000305695100002
J	Greth, A; Lampkin, S; Mayura-Guru, P; Rodda, F; Drysdale, K; Roberts-Thomson, M; McMorran, BJ; Foote, SJ; Burgio, G				Greth, Andreas; Lampkin, Shelley; Mayura-Guru, Preethi; Rodda, Fleur; Drysdale, Karen; Roberts-Thomson, Meredith; McMorran, Brendan J.; Foote, Simon J.; Burgio, Gaetan			A Novel ENU-Mutation in Ankyrin-1 Disrupts Malaria Parasite Maturation in Red Blood Cells of Mice	PLOS ONE			English	Article							HEMATOLOGICALLY IMPORTANT MUTATIONS; PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; GENETIC-CONTROL; NATURAL-SELECTION; RESISTANCE LOCUS; GENOME-WIDE; SUSCEPTIBILITY; INFECTION; PROTEINS	The blood stage of the plasmodium parasite life cycle is responsible for the clinical symptoms of malaria. Epidemiological studies have identified coincidental malarial endemicity and multiple red blood cell (RBC) disorders. Many RBC disorders result from mutations in genes encoding cytoskeletal proteins and these are associated with increased protection against malarial infections. However the mechanisms underpinning these genetic, host responses remain obscure. We have performed an N-ethyl-N-nitrosourea (ENU) mutagenesis screen and have identified a novel dominant (haploinsufficient) mutation in the Ank-1 gene (Ank1(MRI23420)) of mice displaying hereditary spherocytosis (HS). Female mice, heterozygous for the Ank-1 mutation showed increased survival to infection by Plasmodium chabaudi adami DS with a concomitant 30% decrease in parasitemia compared to wild-type, isogenic mice (wt). A comparative in vivo red cell invasion and parasite growth assay showed a RBC-autonomous effect characterised by decreased proportion of infected heterozygous RBCs. Within approximately 6-8 hours post-invasion, TUNEL staining of intraerythrocytic parasites, showed a significant increase in dead parasites in heterozygotes. This was especially notable at the ring and trophozoite stages in the blood of infected heterozygous mutant mice compared to wt (p<0.05). We conclude that increased malaria resistance due to ankyrin-1 deficiency is caused by the intraerythrocytic death of P. chabaudi parasites.	[Greth, Andreas; Lampkin, Shelley; Mayura-Guru, Preethi; Rodda, Fleur; Drysdale, Karen; Roberts-Thomson, Meredith; McMorran, Brendan J.; Foote, Simon J.; Burgio, Gaetan] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Greth, Andreas; Lampkin, Shelley; McMorran, Brendan J.; Foote, Simon J.; Burgio, Gaetan] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	University of Tasmania; Macquarie University	Greth, A (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	grburgio@utas.edu.au	Burgio, Gaetan/B-6722-2015; Foote, Simon J/F-2802-2013	Burgio, Gaetan/0000-0002-7434-926X; Foote, Simon/0000-0002-9142-2107; McMorran, Brendan/0000-0003-1845-8872	National Health and Medical Research Council [605524, 490037]; Bill and Melinda Gates Foundation [OPP10070544]; Howard Hughes Medical Institute [55005505]; Department of Innovation, Industry, Science and Research; Tasmania Graduate Research scholarship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Innovation, Industry, Science and Research; Tasmania Graduate Research scholarship	This study was supported by grants from the following institutions; National Health and Medical Research Council Project Grant 605524; Program Grant 490037 (http://www.nhmrc.gov.au/), Bill and Melinda Gates Foundation OPP10070544 (http://www.gatesfoundation.org), Howard Hughes Medical Institute No. 55005505 (www.hhmi.org/), and National Collaborative Research Infrastructure Strategy grant from the Department of Innovation, Industry, Science and Research. (http://ncris.innovation.gov.au). AG is a recipient of a Tasmania Graduate Research scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2008, AM J PHYSIOL-ENDOC M, V294, pE232, DOI 10.1152/ajpendo.00592.2007; Berghout J, 2010, GENES IMMUN, V11, P310, DOI 10.1038/gene.2009.79; Birkenmeier Connie S, 2003, Hematol J, V4, P445, DOI 10.1038/sj.thj.6200307; Burt RA, 2002, INFECT IMMUN, V70, P4750, DOI 10.1128/IAI.70.8.4750-4753.2002; Carvalho LJM, 2010, TRENDS PARASITOL, V26, P271, DOI 10.1016/j.pt.2010.03.001; Chimanuka B, 1999, BIOL RHYTHM RES, V30, P54, DOI 10.1076/brhm.30.1.54.3062; Chishti AH, 1996, BLOOD, V87, P3462, DOI 10.1182/blood.V87.8.3462.bloodjournal8783462; Cooke BM, 2004, SEMIN HEMATOL, V41, P173, DOI 10.1053/j.seminhematol.2004.01.004; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Dhawan S, 2003, J BIOL CHEM, V278, P30180, DOI 10.1074/jbc.M305132200; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Gallagher PG, 1998, BLOOD CELL MOL DIS, V24, P539, DOI 10.1006/bcmd.1998.0217; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101; Hanspal M, 2000, BBA-GENE STRUCT EXPR, V1493, P242, DOI 10.1016/S0167-4781(00)00159-7; Hernandez-Valladares M, 2005, TRENDS PARASITOL, V21, P352, DOI 10.1016/j.pt.2005.06.010; Hoebe K, 2008, ADV DRUG DELIVER REV, V60, P824, DOI 10.1016/j.addr.2008.02.002; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; Koechl Silvano, 2005, V297, P13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin E, 2006, INFECT IMMUN, V74, P5814, DOI 10.1128/IAI.01690-05; Longley R, 2011, MAMM GENOME, V22, P32, DOI 10.1007/s00335-010-9302-6; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Millholland MG, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010678-1, 10.1074/mcp.M111.010678]; Modiano D, 2001, T ROY SOC TROP MED H, V95, P149, DOI 10.1016/S0035-9203(01)90141-5; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Ohno T, 2001, IMMUNOGENETICS, V53, P736, DOI 10.1007/s00251-001-0390-z; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Randon J, 1997, BRIT J HAEMATOL, V96, P500, DOI 10.1046/j.1365-2141.1997.d01-2074.x; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Raphael P, 2000, MOL BIOCHEM PARASIT, V110, P259, DOI 10.1016/S0166-6851(00)00283-8; Richer E, 2010, J IMMUNOL, V185, P3593, DOI 10.4049/jimmunol.1000890; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; SCHULMAN S, 1990, P NATL ACAD SCI USA, V87, P7339, DOI 10.1073/pnas.87.18.7339; SHEAR HL, 1991, BRIT J HAEMATOL, V78, P555, DOI 10.1111/j.1365-2141.1991.tb04488.x; SHEAR HL, 1993, EXPERIENTIA, V49, P37, DOI 10.1007/BF01928786; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; STEVENSON MM, 1990, MICROB PATHOGENESIS, V9, P303, DOI 10.1016/0882-4010(90)90065-X; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0; YAP GS, 1992, EXP PARASITOL, V75, P340, DOI 10.1016/0014-4894(92)90219-Z; Yates L, 2009, BIOCHEM SOC T, V37, P838, DOI 10.1042/BST0370838; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	55	23	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38999	10.1371/journal.pone.0038999	http://dx.doi.org/10.1371/journal.pone.0038999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723917	Green Published, gold, Green Submitted			2022-12-27	WOS:000305652700042
J	Anderson, I; Abt, B; Lykidis, A; Klenk, HP; Kyrpides, N; Ivanova, N				Anderson, Iain; Abt, Birte; Lykidis, Athanasios; Klenk, Hans-Peter; Kyrpides, Nikos; Ivanova, Natalia			Genomics of Aerobic Cellulose Utilization Systems in Actinobacteria	PLOS ONE			English	Article							BINDING PROTEIN; SP-NOV.; SEQUENCE; THERMOMONOSPORA; ACTINOMYCETE; BETA-1,4-ENDOGLUCANASE; PURIFICATION; CLONING	Cellulose degrading enzymes have important functions in the biotechnology industry, including the production of biofuels from lignocellulosic biomass. Anaerobes including Clostridium species organize cellulases and other glycosyl hydrolases into large complexes known as cellulosomes. In contrast, aerobic actinobacteria utilize systems comprised of independently acting enzymes, often with carbohydrate binding domains. Numerous actinobacterial genomes have become available through the Genomic Encyclopedia of Bacteria and Archaea (GEBA) project. We identified putative cellulose-degrading enzymes belonging to families GH5, GH6, GH8, GH9, GH12, GH48, and GH51 in the genomes of eleven members of the actinobacteria. The eleven organisms were tested in several assays for cellulose degradation, and eight of the organisms showed evidence of cellulase activity. The three with the highest cellulase activity were Actinosynnema mirum, Cellulomonas flavigena, and Xylanimonas cellulosilytica. Cellobiose is known to induce cellulolytic enzymes in the model organism Thermobifida fusca, but only Nocardiopsis dassonvillei showed higher cellulolytic activity in the presence of cellobiose. In T. fusca, cellulases and a putative cellobiose ABC transporter are regulated by the transcriptional regulator CelR. Nine organisms appear to use the CelR site or a closely related binding site to regulate an ABC transporter. In some, CelR also regulates cellulases, while cellulases are controlled by different regulatory sites in three organisms. Mining of genome data for cellulose degradative enzymes followed by experimental verification successfully identified several actinobacteria species which were not previously known to degrade cellulose as cellulolytic organisms.	[Anderson, Iain; Lykidis, Athanasios; Kyrpides, Nikos; Ivanova, Natalia] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Abt, Birte; Klenk, Hans-Peter] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Anderson, I (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	IJAnderson@lbl.gov	Kyrpides, Nikos C./A-6305-2014	Kyrpides, Nikos C./0000-0002-6131-0462; Ivanova, Natalia/0000-0002-5802-9485	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt B, 2010, STAND GENOMIC SCI, V3, P15, DOI 10.4056/sigs.1012662; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Busti E, 2006, INT J SYST EVOL MICR, V56, P1741, DOI 10.1099/ijs.0.63858-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chertkov O, 2011, STAND GENOMIC SCI, V4, P13, DOI 10.4056/sigs.1453580; Copeland A, 2009, STAND GENOMIC SCI, V1, P119, DOI [10.4056/sigs.17259, 10.4056/sigs.29547]; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Foster B, 2010, STAND GENOMIC SCI, V2, P1, DOI 10.4056/sigs.571102; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Land M, 2009, STAND GENOMIC SCI, V1, P46, DOI 10.4056/sigs.21137; LIN SB, 1995, J APPL BACTERIOL, V79, P447, DOI 10.1111/j.1365-2672.1995.tb03160.x; Liolios K, 2010, STAND GENOMIC SCI, V2, P318, DOI 10.4056/sigs.962171; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Marushima K, 2009, J BACTERIOL, V191, P5930, DOI 10.1128/JB.00703-09; MCCARTHY AJ, 1984, J GEN MICROBIOL, V130, P5; Mejia-Castillo T, 2008, BIOTECHNOL LETT, V30, P681, DOI 10.1007/s10529-007-9589-x; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Munk C, 2009, STAND GENOMIC SCI, V1, P292, DOI 10.4056/sigs.47643; Nolan M, 2010, STAND GENOMIC SCI, V2, P29, DOI 10.4056/sigs.631049; Pukall R, 2009, STAND GENOMIC SCI, V1, P262, DOI 10.4056/sigs.41646; Rivas R, 2003, INT J SYST EVOL MICR, V53, P99, DOI 10.1099/ijs.0.02207-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlosser A, 1999, APPL ENVIRON MICROB, V65, P2636; Spiridonov NA, 1999, J BIOL CHEM, V274, P13127, DOI 10.1074/jbc.274.19.13127; Spiridonov NA, 2001, CURR MICROBIOL, V42, P295, DOI 10.1007/s002840010220; Stackebrandt E., 1986, BERGEYS MANUAL SYSTE, P1325; Stackebrandt E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P983, DOI 10.1007/0-387-30743-5_40; STUTZENBERGER FJ, 1971, APPL MICROBIOL, V22, P147, DOI 10.1128/AEM.22.2.147-152.1971; Sun H, 2010, STAND GENOMIC SCI, V3, P325, DOI 10.4056/sigs.1363462; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALDRON CR, 1986, APPL MICROBIOL BIOT, V24, P477; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	40	64	65	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39331	10.1371/journal.pone.0039331	http://dx.doi.org/10.1371/journal.pone.0039331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723998	gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300134
J	Andrianaivoarimanana, V; Telfer, S; Rajerison, M; Ranjalahy, MA; Andriamiarimanana, F; Rahaingosoamamitiana, C; Rahalison, L; Jambou, R				Andrianaivoarimanana, Voahangy; Telfer, Sandra; Rajerison, Minoarisoa; Ranjalahy, Michel A.; Andriamiarimanana, Fehivola; Rahaingosoamamitiana, Corinne; Rahalison, Lila; Jambou, Ronan			Immune Responses to Plague Infection in Wild Rattus rattus, in Madagascar: A Role in Foci Persistence?	PLOS ONE			English	Article							YERSINIA-PESTIS; PNEUMONIC PLAGUE; SUSCEPTIBILITY; PROTECTION; VACCINE; SERODIAGNOSIS; IMMUNIZATION; ANTIBODIES; RESERVOIR; ANTIGENS	Background: Plague is endemic within the central highlands of Madagascar, where its main reservoir is the black rat, Rattus rattus. Typically this species is considered susceptible to plague, rapidly dying after infection inducing the spread of infected fleas and, therefore, dissemination of the disease to humans. However, persistence of transmission foci in the same area from year to year, supposes mechanisms of maintenance among which rat immune responses could play a major role. Immunity against plague and subsequent rat survival could play an important role in the stabilization of the foci. In this study, we aimed to investigate serological responses to plague in wild black rats from endemic areas of Madagascar. In addition, we evaluate the use of a recently developed rapid serological diagnostic test to investigate the immune response of potential reservoir hosts in plague foci. Methodology/Principal Findings: We experimentally infected wild rats with Yersinia pestis to investigate short and long-term antibody responses. Anti-F1 IgM and IgG were detected to evaluate this antibody response. High levels of anti-F1 IgM and IgG were found in rats one and three weeks respectively after challenge, with responses greatly differing between villages. Plateau in anti-F1 IgM and IgG responses were reached for as few as 500 and 1500 colony forming units (cfu) inoculated respectively. More than 10% of rats were able to maintain anti-F1 responses for more than one year. This anti-F1 response was conveniently followed using dipsticks. Conclusion/Significance: Inoculation of very few bacteria is sufficient to induce high immune response in wild rats, allowing their survival after infection. A great heterogeneity of rat immune responses was found within and between villages which could heavily impact on plague epidemiology. In addition, results indicate that, in the field, anti-F1 dipsticks are efficient to investigate plague outbreaks several months after transmission.	[Andrianaivoarimanana, Voahangy; Rajerison, Minoarisoa; Ranjalahy, Michel A.; Andriamiarimanana, Fehivola; Rahaingosoamamitiana, Corinne; Rahalison, Lila] Inst Pasteur Madagascar, Unite Peste, Antananarivo, Madagascar; [Telfer, Sandra] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Jambou, Ronan] Inst Pasteur Madagascar, Unite Immunol, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University of Aberdeen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Andrianaivoarimanana, V (corresponding author), Inst Pasteur Madagascar, Unite Peste, Antananarivo, Madagascar.	rjambou@pasteur.mg	JAMBOU, RONAN/CAG-3718-2022	Telfer, Sandra/0000-0002-9596-0711	Institut Pasteur de Madagascar; Wellcome Trust [081705/B/06/Z]	Institut Pasteur de Madagascar; Wellcome Trust(Wellcome TrustEuropean Commission)	This investigation was funded by the Institut Pasteur de Madagascar and the Wellcome Trust (081705/B/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; [Anonymous], 2009, Wkly Epidemiol Rec, V85, P40; Benner GE, 1999, INFECT IMMUN, V67, P1922; Bhattacharya D, 2010, VACCINE, V28, P7683, DOI 10.1016/j.vaccine.2010.09.039; BUTLER T, 1982, INFECT IMMUN, V36, P1160, DOI 10.1128/IAI.36.3.1160-1167.1982; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; CHEN TH, 1974, J INFECT DIS, V129, pS62, DOI 10.1093/infdis/129.Supplement_1.S62; Dromigny J. A., 1998, Archives de l'Institut Pasteur de Madagascar, V64, P18; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Huang J, 2009, CLIN VACCINE IMMUNOL, V16, P719, DOI 10.1128/CVI.00447-08; Jones A, 2010, VACCINE, V28, P5924, DOI 10.1016/j.vaccine.2010.06.020; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Leroy F., 1995, Archives de l'Institut Pasteur de Madagascar, V62, P165; Li B, 2008, INFECT IMMUN, V76, P1804, DOI 10.1128/IAI.01517-07; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Neubauer H, 2000, EPIDEMIOL INFECT, V125, P593, DOI 10.1017/S0950268800004647; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Philipovskiy AV, 2007, INFECT IMMUN, V75, P878, DOI 10.1128/IAI.01529-06; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Quenee LE, 2009, HUM VACCINES, V5, P817, DOI 10.4161/hv.9866; Rahalison L, 2003, ADV EXP MED BIOL, V529, P439; Rahelinirina S, 2010, VECTOR-BORNE ZOONOT, V10, P77, DOI 10.1089/vbz.2009.0019; Rajerison M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000421; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; SHEPHERD AJ, 1986, J CLIN MICROBIOL, V24, P1075, DOI 10.1128/JCM.24.6.1075-1078.1986; Thullier P, 2003, AM J TROP MED HYG, V69, P450, DOI 10.4269/ajtmh.2003.69.450; Tollenaere C, 2008, INFECT GENET EVOL, V8, P891, DOI 10.1016/j.meegid.2008.07.005; Tollenaere C, 2011, MOL ECOL, V20, P1026, DOI 10.1111/j.1365-294X.2010.04633.x; Tollenaere C, 2010, ECOHEALTH, V7, P242, DOI 10.1007/s10393-010-0312-3; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; WAKE A, 1978, IMMUNOLOGY, V34, P1045; Williamson ED, 2007, VACCINE, V25, P1142, DOI 10.1016/j.vaccine.2006.09.052; Williamson ED, 1999, CLIN EXP IMMUNOL, V116, P107	36	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38630	10.1371/journal.pone.0038630	http://dx.doi.org/10.1371/journal.pone.0038630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719908	Green Published, gold			2022-12-27	WOS:000305583300036
J	Cheng, WC; Shu, WY; Li, CY; Tsai, ML; Chang, CW; Chen, CR; Cheng, HT; Wang, TH; Hsu, IC				Cheng, Wei-Chung; Shu, Wun-Yi; Li, Chia-Yang; Tsai, Min-Lung; Chang, Cheng-Wei; Chen, Chaang-Ray; Cheng, Hung-Tsu; Wang, Tzu-Hao; Hsu, Ian C.			Intra- and Inter-Individual Variance of Gene Expression in Clinical Studies	PLOS ONE			English	Article							CONTROL MAQC PROJECT; MICROARRAY PLATFORMS; NATURAL VARIATION; AMNIOTIC-FLUID; BREAST-CANCER; PATTERNS; DESIGN; CELLS; REPRODUCIBILITY; PROPORTION	Background: Variance in microarray studies has been widely discussed as a critical topic on the identification of differentially expressed genes; however, few studies have addressed the influence of estimating variance. Methodology/Principal Findings: To break intra- and inter-individual variance in clinical studies down to three levels-technical, anatomic, and individual-we designed experiments and algorithms to investigate three forms of variances. As a case study, a group of "inter-individual variable genes'' were identified to exemplify the influence of underestimated variance on the statistical and biological aspects in identification of differentially expressed genes. Our results showed that inadequate estimation of variance inevitably led to the inclusion of non-statistically significant genes into those listed as significant, thereby interfering with the correct prediction of biological functions. Applying a higher cutoff value of fold changes in the selection of significant genes reduces/eliminates the effects of underestimated variance. Conclusions/Significance: Our data demonstrated that correct variance evaluation is critical in selecting significant genes. If the degree of variance is underestimated, "noisy'' genes are falsely identified as differentially expressed genes. These genes are the noise associated with biological interpretation, reducing the biological significance of the gene set. Our results also indicate that applying a higher number of fold change as the selection criteria reduces/eliminates the differences between distinct estimations of variance.	[Cheng, Wei-Chung] Taipei Vet Gen Hosp, Div Pediat Neurosurg, Neurol Inst, Taipei, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Li, Chia-Yang] Natl Hlth Res Inst, Div Infect Dis, Miaoli, Taiwan; [Tsai, Min-Lung] Natl Taiwan Sport Univ, Inst Athlet, Taichung, Taiwan; [Chang, Cheng-Wei; Chen, Chaang-Ray; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Cheng, Hung-Tsu] Natl Tsing Hua Univ Hsinchu, Inst Nanoengn & Microsyst, Hsinchu, Taiwan; [Wang, Tzu-Hao] Chang Gung Mem Hosp, Genom Med Res Core Lab, Tao Yuan, Taiwan; [Wang, Tzu-Hao] Chang Gung Mem Hosp, Lin Kou Med Ctr, Dept Obstet & Gynecol, Tao Yuan, Taiwan; [Wang, Tzu-Hao] Chang Gung Univ, Tao Yuan, Taiwan	Taipei Veterans General Hospital; National Tsing Hua University; National Health Research Institutes - Taiwan; National Tsing Hua University; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Cheng, WC (corresponding author), Taipei Vet Gen Hosp, Div Pediat Neurosurg, Neurol Inst, Taipei, Taiwan.	knoxtn@cgmh.org.tw; ichsu@mx.nthu.edu.tw		LI, CHIA-YANG/0000-0001-5689-9850; Cheng, Wei-Chung/0000-0002-1229-4857; Chen, Chaang-Ray/0000-0003-2106-8699				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Boulesteix AL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-78; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Chang SD, 2011, TAIWAN J OBSTET GYNE, V50, P283, DOI 10.1016/j.tjog.2011.07.005; Chen CR, 2012, COMPUT BIOL MED, V42, P228, DOI 10.1016/j.compbiomed.2011.11.012; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Chowers I, 2003, HUM MOL GENET, V12, P2881, DOI 10.1093/hmg/ddg326; Chuchana P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013518; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huang CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029241; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Jung SH, 2010, METHODS MOL BIOL, V620, P203, DOI 10.1007/978-1-60761-580-4_5; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kerr MK, 2007, GENET RES, V89, P509, DOI 10.1017/S0016672308009713; Kerr MK, 2003, BIOMETRICS, V59, P822; Kliebenstein DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001838; Korkola JE, 2003, CANCER RES, V63, P7167; Lage-Castellanos A, 2010, STAT MED, V29, P63, DOI 10.1002/sim.3784; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Liang MY, 2003, PHYSIOL GENOMICS, V14, P199, DOI 10.1152/physiolgenomics.00143.2002; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Peng HH, 2011, KAOHSIUNG J MED SCI, V27, P494, DOI 10.1016/j.kjms.2011.06.012; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Richani K, 2007, HUM PATHOL, V38, P269, DOI 10.1016/j.humpath.2006.08.007; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Severgnini M, 2006, ANAL BIOCHEM, V353, P43, DOI 10.1016/j.ab.2006.03.023; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sohn I, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-336; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Stevens VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011123; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tsai ML, 2009, RADIAT RES, V171, P716, DOI 10.1667/RR1625.1; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; van Beek EA, 2006, PFLUGERS ARCH; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; Wang CN, 2010, J CLIN ENDOCR METAB, V95, P1431, DOI 10.1210/jc.2009-1954; Wang Tzu-Hao, 2007, Taiwan J Obstet Gynecol, V46, P222, DOI 10.1016/S1028-4559(08)60024-8; Wang Tzu-Hao, 2004, Chang Gung Med J, V27, P243; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	63	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38650	10.1371/journal.pone.0038650	http://dx.doi.org/10.1371/journal.pone.0038650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723873	gold, Green Published, Green Submitted			2022-12-27	WOS:000305583300038
J	Meyer, SU; Kaiser, S; Wagner, C; Thirion, C; Pfaffl, MW				Meyer, Swanhild U.; Kaiser, Sebastian; Wagner, Carola; Thirion, Christian; Pfaffl, Michael W.			Profound Effect of Profiling Platform and Normalization Strategy on Detection of Differentially Expressed MicroRNAs - A Comparative Study	PLOS ONE			English	Article							GENE-EXPRESSION; RT-PCR; QUANTIFICATION; QPCR; MICROARRAYS; VARIANCE; IDENTIFY; SKELETAL; TARGETS	Background: Adequate normalization minimizes the effects of systematic technical variations and is a prerequisite for getting meaningful biological changes. However, there is inconsistency about miRNA normalization performances and recommendations. Thus, we investigated the impact of seven different normalization methods (reference gene index, global geometric mean, quantile, invariant selection, loess, loessM, and generalized procrustes analysis) on intra- and inter-platform performance of two distinct and commonly used miRNA profiling platforms. Methodology/Principal Findings: We included data from miRNA profiling analyses derived from a hybridization-based platform (Agilent Technologies) and an RT-qPCR platform (Applied Biosystems). Furthermore, we validated a subset of miRNAs by individual RT-qPCR assays. Our analyses incorporated data from the effect of differentiation and tumor necrosis factor alpha treatment on primary human skeletal muscle cells and a murine skeletal muscle cell line. Distinct normalization methods differed in their impact on (i) standard deviations, (ii) the area under the receiver operating characteristic (ROC) curve, (iii) the similarity of differential expression. Loess, loessM, and quantile analysis were most effective in minimizing standard deviations on the Agilent and TLDA platform. Moreover, loess, loessM, invariant selection and generalized procrustes analysis increased the area under the ROC curve, a measure for the statistical performance of a test. The Jaccard index revealed that inter-platform concordance of differential expression tended to be increased by loess, loessM, quantile, and GPA normalization of AGL and TLDA data as well as RGI normalization of TLDA data. Conclusions/Significance: We recommend the application of loess, or loessM, and GPA normalization for miRNA Agilent arrays and qPCR cards as these normalization approaches showed to (i) effectively reduce standard deviations, (ii) increase sensitivity and accuracy of differential miRNA expression detection as well as (iii) increase inter-platform concordance. Results showed the successful adoption of loessM and generalized procrustes analysis to one-color miRNA profiling experiments.	[Meyer, Swanhild U.; Pfaffl, Michael W.] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Meyer, Swanhild U.] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Kaiser, Sebastian] Univ Munich, Dept Stat, Munich, Germany; [Wagner, Carola] IMGM Labs GmbH, Martinsried, Germany; [Thirion, Christian] SIR Biotech, Martinsried, Germany	Technical University of Munich; University of Munich; University of Munich	Meyer, SU (corresponding author), Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany.	meyers@wzw.tum.de	Pfaffl, Michael/G-6622-2013	Pfaffl, Michael/0000-0002-3192-1019	German ministry of education and research (Bonn, Germany) [01GM0601]; German Federal Ministry of Education and Research [01GM0887]; SIRION BIOTECH GmbH; IMGM Laboratories	German ministry of education and research (Bonn, Germany)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); SIRION BIOTECH GmbH; IMGM Laboratories	The "Muscle Tissue Culture Collection'' is part of the German network on muscular dystrophies (MD-NET, service structure S1, 01GM0601) funded by the German ministry of education and research (Bonn, Germany). The Muscle Tissue Culture Collection is a partner of EuroBioBank (www.eurobiobank.org) and TREAT-NMD (EC, 6th FP, proposal # 036825). The work is an individual research project within the MD-NET and was supported by a grant from the German Federal Ministry of Education and Research [01GM0887] to CT. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript except for CT who holds stock in SIRION BIOTECH GmbH, which has sponsored parts of the research of this project. Funding for this study was provided by IMGM Laboratories. Author CW is employed by IMGM Laboratories, therefore IMGM Laboratories is considered by PLoS ONE to have played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hua YJ, 2008, GENOMICS, V92, P122, DOI 10.1016/j.ygeno.2008.04.002; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Kong W, 2009, J CELL PHYSIOL, V218, P22, DOI 10.1002/jcp.21577; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peng Yahui, 2011, J Pathol Inform, V2, P33, DOI 10.4103/2153-3539.83193; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; R Core Team, 2020, R LANG ENV STAT COMP; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Sarkar D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn932; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Storz P, 1998, FEBS LETT, V440, P41, DOI 10.1016/S0014-5793(98)01421-5; Suo C, 2010, RNA, V16, P2293, DOI 10.1261/rna.2345710; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Xiong HL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-25; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; Zhao YD, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-69	39	44	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38946	10.1371/journal.pone.0038946	http://dx.doi.org/10.1371/journal.pone.0038946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723911	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300070
J	Palmer, ME; Feldman, MW				Palmer, Michael E.; Feldman, Marcus W.			Survivability Is More Fundamental Than Evolvability	PLOS ONE			English	Article							SPECIES SELECTION; CHANGING ENVIRONMENT; ESCHERICHIA-COLI; EVOLUTION; MUTATION; ADAPTATION; MACROEVOLUTION; INDIVIDUALITY; VARIABILITY; FITNESS	For a lineage to survive over long time periods, it must sometimes change. This has given rise to the term evolvability, meaning the tendency to produce adaptive variation. One lineage may be superior to another in terms of its current standing variation, or it may tend to produce more adaptive variation. However, evolutionary outcomes depend on more than standing variation and produced adaptive variation: deleterious variation also matters. Evolvability, as most commonly interpreted, is not predictive of evolutionary outcomes. Here, we define a predictive measure of the evolutionary success of a lineage that we call the k-survivability, defined as the probability that the lineage avoids extinction for k generations. We estimate the k-survivability using multiple experimental replicates. Because we measure evolutionary outcomes, the initial standing variation, the full spectrum of generated variation, and the heritability of that variation are all incorporated. Survivability also accounts for the decreased joint likelihood of extinction of sub-lineages when they 1) disperse in space, or 2) diversify in lifestyle. We illustrate measurement of survivability with in silico models, and suggest that it may also be measured in vivo using multiple longitudinal replicates. The k-survivability is a metric that enables the quantitative study of, for example, the evolution of 1) mutation rates, 2) dispersal mechanisms, 3) the genotype-phenotype map, and 4) sexual reproduction, in temporally and spatially fluctuating environments. Although these disparate phenomena evolve by well-understood microevolutionary rules, they are also subject to the macroevolutionary constraint of long-term survivability.	[Palmer, Michael E.; Feldman, Marcus W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Palmer, ME (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mep@charles.stanford.edu			National Institutes of Health (NIH) [GM28016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) (http://www.nih.gov/) grant GM28016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKAU BJ, 1973, GENETICS, V74, P171; COOPER WS, 1984, J THEOR BIOL, V107, P603, DOI 10.1016/S0022-5193(84)80135-6; Draghi J, 2009, J EVOLUTION BIOL, V22, P599, DOI 10.1111/j.1420-9101.2008.01663.x; Draghi J, 2008, EVOLUTION, V62, P301, DOI 10.1111/j.1558-5646.2007.00303.x; FELDMAN MW, 1986, P NATL ACAD SCI USA, V83, P4824, DOI 10.1073/pnas.83.13.4824; Gould S. J., 1989, WONDERFUL LIFE BURGE; Gould SJ, 1999, P NATL ACAD SCI USA, V96, P11904, DOI 10.1073/pnas.96.21.11904; GRANTHAM TA, 1995, ANNU REV ECOL SYST, V26, P301; Gregory TR, 2004, PALEOBIOLOGY, V30, P179, DOI 10.1666/0094-8373(2004)030<0179:MHTATC>2.0.CO;2; Griswold CK, 2006, EVOL DEV, V8, P81, DOI 10.1111/j.1525-142X.2006.05077.x; HOULE D, 1992, GENETICS, V130, P195; HULL DL, 1980, ANNU REV ECOL SYST, V11, P311, DOI 10.1146/annurev.es.11.110180.001523; ISHII K, 1989, GENETICS, V121, P163; Jones AG, 2007, EVOLUTION, V61, P727, DOI 10.1111/j.1558-5646.2007.00071.x; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; LEIGH EG, 1970, AM NAT, V104, P301, DOI 10.1086/282663; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Liberman U, 2011, GENETICS, V187, P837, DOI 10.1534/genetics.110.123620; LLOYD EA, 1993, P NATL ACAD SCI USA, V90, P595, DOI 10.1073/pnas.90.2.595; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Palmer ME, 2006, GENETICS, V173, P461, DOI 10.1534/genetics.105.049445; Palmer ME, 2011, EVOLUTION, V65, P2345, DOI 10.1111/j.1558-5646.2011.01283.x; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Salathe M, 2009, GENETICS, V182, P1159, DOI 10.1534/genetics.109.103333; SLOBODKIN LB, 1974, Q REV BIOL, V49, P181, DOI 10.1086/408082; Sterelny K., 2001, CYCLES CONTINGENCY D, P331; THODAY JM, 1953, SYM SOC EXP BIOL, V7, P96; VRBA ES, 1984, SYST ZOOL, V33, P318, DOI 10.2307/2413077; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Waxman D, 1999, GENETICS, V153, P1041; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	31	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38025	10.1371/journal.pone.0038025	http://dx.doi.org/10.1371/journal.pone.0038025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723844	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300018
J	Prchal-Murphy, M; Semper, C; Lassnig, C; Wallner, B; Gausterer, C; Teppner-Klymiuk, I; Kobolak, J; Muller, S; Kolbe, T; Karaghiosoff, M; Dinnyes, A; Rulicke, T; Leitner, NR; Strobl, B; Muller, M				Prchal-Murphy, Michaela; Semper, Christian; Lassnig, Caroline; Wallner, Barbara; Gausterer, Christian; Teppner-Klymiuk, Ingeborg; Kobolak, Julianna; Mueller, Simone; Kolbe, Thomas; Karaghiosoff, Marina; Dinnyes, Andras; Ruelicke, Thomas; Leitner, Nicole R.; Strobl, Birgit; Mueller, Mathias			TYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; GAMMA-INDUCIBLE GENE; DISTINCT DOMAINS; ALPHA RECEPTOR; EXPRESSION; ACTIVATION; JAK1; PHOSPHORYLATION; INHIBITORS; MICE	Tyrosine kinase 2 (TYK2) is a member of the Janus kinase (JAK) family and is involved in cytokine signalling. In vitro analyses suggest that TYK2 also has kinase-independent, i.e., non-canonical, functions. We have generated gene-targeted mice harbouring a mutation in the ATP-binding pocket of the kinase domain. The Tyk2 kinase-inactive (Tyk2(K923E)) mice are viable and show no gross abnormalities. We show that kinase-active TYK2 is required for full-fledged type I interferon- (IFN) induced activation of the transcription factors STAT1-4 and for the in vivo antiviral defence against viruses primarily controlled through type I IFN actions. In addition, TYK2 kinase activity was found to be required for the protein's stability. An inhibitory function was only observed upon over-expression of TYK2(K923E) in vitro. Tyk2(K923E) mice represent the first model for studying the kinase-independent function of a JAK in vivo and for assessing the consequences of side effects of JAK inhibitors.	[Prchal-Murphy, Michaela; Semper, Christian; Lassnig, Caroline; Wallner, Barbara; Gausterer, Christian; Teppner-Klymiuk, Ingeborg; Mueller, Simone; Karaghiosoff, Marina; Leitner, Nicole R.; Strobl, Birgit; Mueller, Mathias] Univ Vet Med, Inst Genet & Anim Breeding, Vienna, Austria; [Lassnig, Caroline; Kolbe, Thomas; Ruelicke, Thomas; Mueller, Mathias] Univ Vet Med, Biomodels Austria, Vienna, Austria; [Kobolak, Julianna; Dinnyes, Andras] Agr Biotechnol Ctr, Genet Reprogramming Grp, H-2101 Godollo, Hungary; [Kolbe, Thomas] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Vienna, Austria; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Vienna, Austria; [Dinnyes, Andras] Szent Istvan Univ, Mol Anim Biotechnol Lab, Godollo, Hungary; [Dinnyes, Andras] BioTalentum Ltd, Godollo, Hungary	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; Hungarian University of Agriculture & Life Sciences; BioTalentum Ltd	Prchal-Murphy, M (corresponding author), Univ Vet Med, Inst Genet & Anim Breeding, Vienna, Austria.	mathias.mueller@vetmeduni.ac.at	; Dinnyes, Andras/D-5131-2013	LASSNIG, Caroline/0000-0001-7905-3620; Dinnyes, Andras/0000-0003-3791-2583; Kobolak, Julianna/0000-0002-0986-9517; Strobl, Birgit/0000-0001-5716-3212; Gausterer, Christian/0000-0002-4875-5459; Muller, Mathias/0000-0002-7879-3552	Austrian Science Fund (FWF, SFB F28); Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse''); EU FP6 "Clonet'' [MRTN-CT-2006-035468]; MedRat [LSHG-CT-2006-518240]; Austrian Science Fund (FWF) [F 2808] Funding Source: researchfish	Austrian Science Fund (FWF, SFB F28)(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse''); EU FP6 "Clonet''; MedRat; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF, SFB F28), the Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse''), EU FP6 "Clonet'' (MRTN-CT-2006-035468) and "MedRat'' (LSHG-CT-2006-518240). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frenzel K, 2006, EXP CELL RES, V312, P2735, DOI 10.1016/j.yexcr.2006.05.004; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Haan C, 2010, J CELL MOL MED, V14, P504, DOI 10.1111/j.1582-4934.2010.01018.x; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Krishnan K, 1997, EUR J BIOCHEM, V247, P298, DOI 10.1111/j.1432-1033.1997.00298.x; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Mamo S, 2011, WORLD J STEM CELLS, V26, P127; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Potla R, 2006, MOL CELL BIOL, V26, P8562, DOI 10.1128/MCB.00497-06; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rani MRS, 2007, J INTERF CYTOK RES, V27, P767, DOI 10.1089/jir.2007.0005; Rani MRS, 1999, J BIOL CHEM, V274, P32507, DOI 10.1074/jbc.274.45.32507; Rani MRS, 1999, J BIOL CHEM, V274, P1891, DOI 10.1074/jbc.274.4.1891; Ren JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024496; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Schwarz EM, 1998, J VIROL, V72, P5654, DOI 10.1128/JVI.72.7.5654-5660.1998; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Strobl B, 2005, J IMMUNOL, V175, P4000, DOI 10.4049/jimmunol.175.6.4000; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Teppner I, 2004, LAB ANIM-UK, V38, P406, DOI 10.1258/0023677041958882; Tsui V, 2011, PROTEINS, V79, P393, DOI 10.1002/prot.22889; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; Vogl C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-199; Wilks AF, 2008, SEMIN CELL DEV BIOL, V19, P319, DOI 10.1016/j.semcdb.2008.07.020; Wu WT, 2004, BIOCHEM J, V379, P587, DOI 10.1042/BJ20031579; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	62	48	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39141	10.1371/journal.pone.0039141	http://dx.doi.org/10.1371/journal.pone.0039141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723949	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300102
J	Yang, XD; Liu, XY; Lv, WH; Li, L; Shi, QQ; Yang, JH; Zhang, MF				Yang, Xiaodong; Liu, Xunyan; Lv, Wenhui; Li, Lu; Shi, Qianqian; Yang, Jinghua; Zhang, Mingfang			Reduced Expression of BjRCE1 Gene Modulated by Nuclear-Cytoplasmic Incompatibility Alters Auxin Response in Cytoplasmic Male-Sterile Brassica juncea	PLOS ONE			English	Article							MITOCHONDRIAL RETROGRADE REGULATION; ALTERNATIVE OXIDASE; ARABIDOPSIS-THALIANA; BIOTIC STRESS; PROTEIN RUB1; TUNING FORK; PLANTS; UBIQUITIN; COMMUNICATION; SPECIFICITY	The signal from organelle to nucleus, namely retrograde regulation of nuclear gene expression, was largely unknown. Due to the nuclear-cytoplasmic incompatibility in cytoplasmic male-sterile (CMS) plants, we employed CMS Brassica juncea to investigate the retrograde regulation of nuclear gene expression in this study. We studied how reduced BjRCE1 gene expression caused by the nuclear-cytoplasmic incompatibility altered the auxin response in CMS of B. juncea. We isolated the BjRCE1 gene that was located in the nucleus from B. juncea. Over-expression of BjRCE1 enhanced auxin response in transgenic Arabidopsis. The expression of BjRCE1 was significantly reduced in CMS compared with its maintainer fertile (MF) line of B. juncea. There were fewer lateral roots in CMS than MF under normal and treatment of indole-3-acetic acid (IAA) conditions. Expression patterns of several auxin-related genes together with their phenotypes indicated a reduced auxin response in CMS compared to MF. The phenotypes of auxin response and auxin-related gene expression pattern could be mimicked by inhibiting mitochondrial function in MF. Taken together, we proposed reduced expression of BjRCE1 gene modulated by nuclear-cytoplasmic incompatibility alters auxin response in CMS B. juncea. This may be an important mechanism of retrograde regulation of nuclear gene expression in plants.	[Yang, Xiaodong; Lv, Wenhui; Li, Lu; Shi, Qianqian; Yang, Jinghua; Zhang, Mingfang] Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Xiaodong; Lv, Wenhui; Li, Lu; Shi, Qianqian; Yang, Jinghua; Zhang, Mingfang] Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Liu, Xunyan] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Hangzhou Normal University	Yang, XD (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou 310003, Zhejiang, Peoples R China.	yangjinghua@zju.edu.cn	Yang, Jinghua/G-9164-2016		National Natural Science Foundation of China; Zhejiang Province; Ph.D. Programs Foundation of Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China and Zhejiang Province and the Ph.D. Programs Foundation of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Arimura S, 2002, P NATL ACAD SCI USA, V99, P5727, DOI 10.1073/pnas.082663299; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Carlsson J, 2007, PLANT J, V49, P452, DOI 10.1111/j.1365-313X.2006.02975.x; Chen ZhuJun, 1995, Acta Horticulturae Sinica, V22, P40; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Djajanegara I, 2002, PLANT MOL BIOL, V50, P735, DOI 10.1023/A:1019942720636; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Fujii S, 2008, PLANT CELL PHYSIOL, V49, P1484, DOI 10.1093/pcp/pcn102; Fujii S, 2007, PLANT MOL BIOL, V63, P405, DOI 10.1007/s11103-006-9097-8; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Gray GR, 2004, PLANT CELL REP, V23, P497, DOI 10.1007/s00299-004-0848-1; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Ito J, 2006, J PROTEOME RES, V5, P3459, DOI 10.1021/pr060403j; Karpova OV, 2002, PLANT CELL, V14, P3271, DOI 10.1105/tpc.005603; Kaul, 1988, MALE STERILITY HIGHE; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuzmin EV, 2004, J BIOL CHEM, V279, P20672, DOI 10.1074/jbc.M400640200; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Liu XY, 2012, PHYSIOL PLANTARUM, V145, P332, DOI 10.1111/j.1399-3054.2012.01588.x; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rhoads DM, 2005, PHYSIOL PLANTARUM, V123, P435, DOI 10.1111/j.1399-3054.2005.00473.x; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saisho D, 2001, J PLANT PHYSIOL, V158, P241, DOI 10.1078/0176-1617-00193; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Weijers D, 2004, CURR OPIN PLANT BIOL, V7, P687, DOI 10.1016/j.pbi.2004.09.006; Woo DK, 2009, BBA-GENE REGUL MECH, V1789, P135, DOI 10.1016/j.bbagrm.2008.09.008; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yang JH, 2008, PHYSIOL PLANTARUM, V133, P426, DOI 10.1111/j.1399-3054.2008.01064.x; Yang JH, 2009, MOL BIOL REP, V36, P273, DOI 10.1007/s11033-007-9176-1; Yang JH, 2008, J GENET GENOMICS, V35, P65, DOI 10.1016/S1673-8527(08)60010-7; Yang JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-231; Yu JP, 2001, PLANT PHYSIOL BIOCH, V39, P345, DOI 10.1016/S0981-9428(01)01254-2; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zubko MK, 2004, TRENDS PLANT SCI, V9, P61, DOI 10.1016/j.tplants.2003.12.001	45	5	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38821	10.1371/journal.pone.0038821	http://dx.doi.org/10.1371/journal.pone.0038821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719957	Green Submitted, Green Published, gold			2022-12-27	WOS:000305583300055
J	Hause, BM; Collin, EA; Ran, ZG; Zhu, LH; Webby, RJ; Simonson, RR; Li, F				Hause, Ben M.; Collin, Emily A.; Ran, Zhiguang; Zhu, Laihua; Webby, Richard J.; Simonson, Randy R.; Li, Feng			In Vitro Reassortment between Endemic H1N2 and 2009 H1N1 Pandemic Swine Influenza Viruses Generates Attenuated Viruses	PLOS ONE			English	Article							GENETIC COMPATIBILITY; A VIRUSES; PIGS; ADAPTATION; VIRULENCE; PROTEIN; M1	The pandemic H1N1 (pH1N1) influenza virus was first reported in humans in the spring of 2009 and soon thereafter was identified in numerous species, including swine. Reassortant viruses, presumably arising from the co-infection of pH1N1 and endemic swine influenza virus (SIV), were subsequently identified from diagnostic samples collected from swine. In this study, co-infection of swine testicle (ST) cells with swine-derived endemic H1N2 (MN745) and pH1N1 (MN432) yielded two reassortant H1N2 viruses (R1 and R2), both possessing a matrix gene derived from pH1N1. In ST cells, the reassortant viruses had growth kinetics similar to the parental H1N2 virus and reached titers approximately 2 log(10) TCID50/mL higher than the pH1N1 virus, while in A549 cells these viruses had similar growth kinetics. Intranasal challenge of pigs with H1N2, pH1N1, R1 or R2 found that all viruses were capable of infecting and transmitting between direct contact pigs as measured by real time reverse transcription PCR of nasal swabs. Lung samples were also PCR-positive for all challenge groups and influenza-associated microscopic lesions were detected by histology. Interestingly, infectious virus was detected in lung samples for pigs challenged with the parental H1N2 and pH1N1 at levels significantly higher than either reassortant virus despite similar levels of viral RNA. Results of our experiment suggested that the reassortant viruses generated through in vitro cell culture system were attenuated without gaining any selective growth advantage in pigs over the parental lineages. Thus, reassortant influenza viruses described in this study may provide a good system to study genetic basis of the attenuation and its mechanism.	[Hause, Ben M.; Collin, Emily A.; Simonson, Randy R.] Newport Labs, Worthington, MN USA; [Ran, Zhiguang; Zhu, Laihua; Li, Feng] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Hause, Ben M.; Ran, Zhiguang; Zhu, Laihua; Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Webby, Richard J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA	South Dakota State University; South Dakota State University; St Jude Children's Research Hospital	Hause, BM (corresponding author), Newport Labs, Worthington, MN USA.	bhause@newportlabs.com; feng.li@sdstate.edu	Webby, Richard J/N-5657-2018	Li, Feng/0000-0002-8904-2893	Newport Laboratories	Newport Laboratories	This work was funded by Newport Laboratories who, in consultation with the collaborating authors, contributed to the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; GREGORIADES A, 1984, J VIROL, V49, P229, DOI 10.1128/JVI.49.1.229-235.1984; Harmon K, 2010, INFLUENZA OTHER RESP, V4, P405, DOI 10.1111/j.1750-2659.2010.00153.x; Howard WA, 2011, EMERG INFECT DIS, V17, P1049, DOI [10.3201/eid1706.101886, 10.3201/eid/1706.101886]; Howden KJ, 2009, CAN VET J, V50, P1153; Ilyushina NA, 2010, MBIO, V1, DOI 10.1128/mBio.00249-10; Lohr CV, 2010, VET PATHOL, V47, P378, DOI 10.1177/0300985810368393; Ma WJ, 2012, J GEN VIROL, V93, P1261, DOI 10.1099/vir.0.040535-0; McCullers JA, 2005, VIROLOGY, V336, P318, DOI 10.1016/j.virol.2005.03.028; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Nfon CK, 2011, J VIROL, V85, P8667, DOI 10.1128/JVI.00801-11; Octaviani CP, 2011, VIRUS RES, V156, P147, DOI 10.1016/j.virusres.2010.12.014; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Song MS, 2011, J VIROL, V85, P6275, DOI 10.1128/JVI.02125-10; Starick E, 2011, J GEN VIROL, V92, P1184, DOI 10.1099/vir.0.028662-0; Swenson SL, 2010, J VET DIAGN INVEST, V22, P784, DOI 10.1177/104063871002200525; Tremblay D, 2011, J CLIN MICROBIOL, V49, P4386, DOI 10.1128/JCM.05676-11; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; Zhu HC, 2011, J VIROL, V85, P10432, DOI 10.1128/JVI.05352-11	25	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39177	10.1371/journal.pone.0039177	http://dx.doi.org/10.1371/journal.pone.0039177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720066	gold, Green Published			2022-12-27	WOS:000305341900090
J	Sun, L; Yu, Y; Huang, T; An, P; Yu, DX; Yu, ZJ; Li, HX; Sheng, HG; Cai, L; Xue, J; Jing, M; Li, YX; Lin, X; Wang, FD				Sun, Liang; Yu, Yu; Huang, Tao; An, Peng; Yu, Danxia; Yu, Zhijie; Li, Huaixing; Sheng, Hongguang; Cai, Lu; Xue, Jun; Jing, Miao; Li, Yixue; Lin, Xu; Wang, Fudi			Associations between Ionomic Profile and Metabolic Abnormalities in Human Population	PLOS ONE			English	Article							OXIDATIVE STRESS; MUTUAL INFORMATION; INSULIN-RESISTANCE; BIOLOGICAL SAMPLES; DIABETES-MELLITUS; FEATURE-SELECTION; IRON STORES; VITAMIN-D; TYPE-2; SERUM	Background: Few studies assessed effects of individual and multiple ions simultaneously on metabolic outcomes, due to methodological limitation. Methodology/Principal Findings: By combining advanced ionomics and mutual information, a quantifying measurement for mutual dependence between two random variables, we investigated associations of ion modules/networks with overweight/obesity, metabolic syndrome (MetS) and type 2 diabetes (T2DM) in 976 middle-aged Chinese men and women. Fasting plasma ions were measured by inductively coupled plasma mass spectroscopy. Significant ion modules were selected by mutual information to construct disease related ion networks. Plasma copper and phosphorus always ranked the first two among three specific ion networks associated with overweight/obesity, MetS and T2DM. Comparing the ranking of ion individually and in networks, three patterns were observed (1) "Individual ion," such as potassium and chrome, which tends to work alone; (2) "Module ion," such as iron in T2DM, which tends to act in modules/network; and (3) "odule-individual ion," such as copper in overweight/obesity, which seems to work equivalently in either way. Conclusions: In conclusion, by using the novel approach of the ionomics strategy and the information theory, we observed potential associations of ions individually or as modules/networks with metabolic disorders. Certainly, these findings need to be confirmed in future biological studies.	[Sun, Liang; Yu, Yu; An, Peng; Yu, Danxia; Yu, Zhijie; Li, Huaixing; Lin, Xu; Wang, Fudi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Sun, Liang; Yu, Yu; Huang, Tao; An, Peng; Yu, Danxia; Yu, Zhijie; Li, Huaixing; Li, Yixue; Lin, Xu; Wang, Fudi] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Huang, Tao; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Sheng, Hongguang] Shanghai Xuhui Dist Cent Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Cai, Lu] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA; [Xue, Jun] Nanjing Med Univ, Nanjing People Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China; [Jing, Miao] Agilent Technol Co Ltd, Life Sci & Chem Anal Grp, Shanghai, Peoples R China; [Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Louisville; Nanjing Medical University; Agilent Technologies; Chinese Academy of Sciences	Sun, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	yxli@sibs.ac.cn; xlin@sibs.ac.cn; wangfd@sibs.ac.cn	An, Peng/GWZ-9176-2022; Wang, Fudi/L-7888-2018; Cai, Lu/AAG-9920-2019	Wang, Fudi/0000-0001-8730-0003; Yu, Yu/0000-0003-2291-0606; An, Peng/0000-0002-0421-0035; Yu, Danxia/0000-0002-1710-9382	Ministry of Science and Technology of China (973 Program) [2009CB941400, 2011CB966200, 2011CB504002, 2008DFA31960, 2011CB910200]; National High Technology Research and Development Program (863 Program) [2009AA022704]; National Natural Science Foundation of China [10979071, 30970665, 31030039, 30930081, 81021002, 90913009, 30901193]; Knowledge Innovation Program Project of the Chinese Academy of Sciences [KSCX2-EW-R-10, KSCX2-EW-R-04]; Chinese Academy of Sciences Hundred Talents Program [KSCX2-YW-R-141]; Science & Technology Commission of Shanghai Municipality grant [10JC1416800]; Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2008006]; Clinical Center of Shanghai Xuhui District Central Hospital grant [CRC2010012]; CAS/SAFEA International Partnership Program for Creative Research Teams; China Postdoctoral Science Foundation [20110490751, 2012M510902]; SIBS-CAS Outstanding Youth fellowship [2010KIP309]	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences Hundred Talents Program(Chinese Academy of Sciences); Science & Technology Commission of Shanghai Municipality grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Clinical Center of Shanghai Xuhui District Central Hospital grant; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); SIBS-CAS Outstanding Youth fellowship	This work was supported by research grants from the Ministry of Science and Technology of China (973 Program) (2009CB941400, 2011CB966200 to F. W., 2011CB504002 and 2008DFA31960 to X. L., and 2011CB910200 to Y.L.); the National High Technology Research and Development Program (863 Program) (2009AA022704 to X. L.); the National Natural Science Foundation of China (10979071, 30970665, 31030039 to F. W., 30930081, 81021002 to X. L., 90913009 to Y.L.; 30901193 to Y.Y.); the Knowledge Innovation Program Project of the Chinese Academy of Sciences (KSCX2-EW-R-10 to X. L. and KSCX2-EW-R-04 to Y.L.); Chinese Academy of Sciences Hundred Talents Program (KSCX2-YW-R-141 to F. W.); Science & Technology Commission of Shanghai Municipality grant (10JC1416800 to F. W.); Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006 to X. L.) and Clinical Center of Shanghai Xuhui District Central Hospital grant (CRC2010012 to F. W.), the CAS/SAFEA International Partnership Program for Creative Research Teams and the China Postdoctoral Science Foundation (20110490751 to L. S.; 2012M510902 to Y.Y.) and SIBS-CAS Outstanding Youth fellowship (2010KIP309 to Y.Y.). F. W. is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2009, ARCH GYNECOL OBSTET, V280, P415, DOI 10.1007/s00404-009-0955-x; Aguilar V, 2007, ANN NUTR METAB, V51, P402, DOI 10.1159/000108108; Al-Saleh E, 2007, ACTA DIABETOL, V44, P106, DOI 10.1007/s00592-007-0250-x; Alvarez HM, 2010, SCIENCE, V327, P331, DOI 10.1126/science.1179907; CHAITIN GJ, 1975, J ACM, V22, P329, DOI 10.1145/321892.321894; Chonchol M, 2009, AM J MED, V122, P380, DOI 10.1016/j.amjmed.2008.09.039; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; DEMARTINES P, 1993, LECT NOTES COMPUTER, V686, P328; Deng ZP, 2009, BIOMETALS, V22, P803, DOI 10.1007/s10534-009-9227-2; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; Gan W, 2012, AM J CLIN NUTR, V95, P626, DOI 10.3945/ajcn.111.025684; Gozdasoglu S, 2003, BIOL TRACE ELEM RES, V91, P191, DOI 10.1385/BTER:91:2:191; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guerrero-Romero F, 2002, ACTA DIABETOL, V39, P209, DOI 10.1007/s005920200036; Guo CH, 2011, CLIN BIOCHEM, V44, P275, DOI 10.1016/j.clinbiochem.2010.12.017; Hopping BN, 2010, J NUTR, V140, P68, DOI 10.3945/jn.109.112441; Huang Tao, 2011, International Journal of Computational Biology and Drug Design, V4, P5, DOI 10.1504/IJCBDD.2011.038654; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Jumaan Raba'a M, 2008, Sultan Qaboos Univ Med J, V8, P291; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Kumar PTK, 2011, COMPUT BIOL MED, V41, P357, DOI 10.1016/j.compbiomed.2011.03.013; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Larsson TE, 2010, ARTERIOSCL THROM VAS, V30, P333, DOI 10.1161/ATVBAHA.109.196675; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Liu ZP, 2011, MOL BIOSYST, V7, P1441, DOI 10.1039/c0mb00325e; Malavolta M, 2010, BIOGERONTOLOGY, V11, P309, DOI 10.1007/s10522-009-9251-1; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Marreiro DD, 2006, BIOL TRACE ELEM RES, V112, P109, DOI 10.1385/BTER:112:2:109; Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9; Naziroglu M, 2009, NEUROCHEM RES, V34, P2181, DOI 10.1007/s11064-009-0015-8; Ogra Y, 1999, J INORG BIOCHEM, V75, P199, DOI 10.1016/S0162-0134(99)00057-4; Onufrak SJ, 2008, ATHEROSCLEROSIS, V199, P424, DOI 10.1016/j.atherosclerosis.2007.11.004; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozata M, 2002, CLIN BIOCHEM, V35, P627, DOI 10.1016/S0009-9120(02)00363-6; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Persichini T, 2006, ANTIOXID REDOX SIGN, V8, P1897, DOI 10.1089/ars.2006.8.1897; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Rea PA, 2003, NAT BIOTECHNOL, V21, P1149, DOI 10.1038/nbt1003-1149; Flores CR, 2011, DIABETES RES CLIN PR, V91, P333, DOI 10.1016/j.diabres.2010.12.014; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Salt DE, 2004, PLANT PHYSIOL, V136, P2451, DOI 10.1104/pp.104.047753; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Skalnaya MG, 2007, J TRACE ELEM MED BIO, V21, P59, DOI 10.1016/j.jtemb.2007.09.019; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Szpunar J, 2004, ANAL BIOANAL CHEM, V378, P54, DOI 10.1007/s00216-003-2333-z; Szymczak Silke, 2007, BMC Proc, V1 Suppl 1, pS9; Tanaka A, 2009, ENDOCR J, V56, P699, DOI 10.1507/endocrj.K09E-051; Tourassi GD, 2001, MED PHYS, V28, P2394, DOI 10.1118/1.1418724; Viktorinova A, 2009, METABOLISM, V58, P1477, DOI 10.1016/j.metabol.2009.04.035; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; Zhao T, 2009, ANAL CHEM, V81, P3683, DOI 10.1021/ac900311q	61	61	66	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38845	10.1371/journal.pone.0038845	http://dx.doi.org/10.1371/journal.pone.0038845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719963	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341900054
J	Chen, MJ; Lin, CY; Wu, YT; Wu, PC; Lung, SC; Su, HJ				Chen, Mu-Jean; Lin, Chuan-Yao; Wu, Yi-Ting; Wu, Pei-Chih; Lung, Shih-Chun; Su, Huey-Jen			Effects of Extreme Precipitation to the Distribution of Infectious Diseases in Taiwan, 1994-2008	PLOS ONE			English	Article							CLIMATE-CHANGE; BACILLARY DYSENTERY; POTENTIAL IMPACTS; UNITED-STATES; RAINFALL; MELIOIDOSIS; VARIABILITY; OUTBREAK; HEALTH; LEPTOSPIROSIS	The incidence of extreme precipitation has increased with the exacerbation of worldwide climate disruption. We hypothesize an association between precipitation and the distribution patterns that would affect the endemic burden of 8 infectious diseases in Taiwan, including water- and vector-borne infectious diseases. A database integrating daily precipitation and temperature, along with the infectious disease case registry for all 352 townships in the main island of Taiwan was analysed for the period from 1994 to 2008. Four precipitation levels, <130 mm, 130-200 mm, 200-350 mm and >350 mm, were categorized to represent quantitative differences, and their associations with each specific disease was investigated using the Generalized Additive Mixed Model and afterwards mapped on to the Geographical Information System. Daily precipitation levels were significantly correlated with all 8 mandatory-notified infectious diseases in Taiwan. For water-borne infections, extreme torrential precipitation (>350 mm/day) was found to result in the highest relative risk for bacillary dysentery and enterovirus infections when compared to ordinary rain (<130 mm/day). Yet, for vector-borne diseases, the relative risk of dengue fever and Japanese encephalitis increased with greater precipitation only up to 350 mm. Differential lag effects following precipitation were statistically associated with increased risk for contracting individual infectious diseases. This study's findings can help health resource sector management better allocate medical resources and be better prepared to deal with infectious disease outbreaks following future extreme precipitation events.	[Chen, Mu-Jean; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Lin, Chuan-Yao; Lung, Shih-Chun] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; [Wu, Yi-Ting] Fdn Taiwan Ind Serv, Dept Occupat Safety, Taipei, Taiwan; [Wu, Pei-Chih] Chang Jung Christian Univ, Dept Occupat Safety & Hlth, Tainan, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; Chang Jung Christian University	Chen, MJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw	Lung, Shih-Chun Candice/ABA-1011-2020; Lung, Shih-Chun Candice/GYD-5623-2022; Lin, CY/K-6503-2014; lin, chuan/HHD-2571-2022	Lung, Shih-Chun Candice/0000-0002-4227-0469; Lung, Shih-Chun Candice/0000-0002-4227-0469; Lin, CY/0000-0002-0005-7088; Su, Huey-Jen/0000-0003-3589-9987	Taiwan National Science Council [NSC95-2625-Z-006-018, NSC96-2625-Z-006-016, NSC97-2625-Z-006-016, NSC99-2621-M-006-008]; Taiwan's Centers for Diseases Control [DOH98-DC-1002]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taiwan's Centers for Diseases Control	This supplement received financial support from the Taiwan National Science Council [http://web1.nsc.gov.tw/] (NSC95-2625-Z-006-018, NSC96-2625-Z-006-016, NSC97-2625-Z-006-016, NSC99-2621-M-006-008) and Taiwan's Centers for Diseases Control [http://www.cdc.gov.tw/mp.asp?mp=1] (DOH98-DC-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar R, 1996, LANCET, V348, P1457, DOI 10.1016/S0140-6736(04)70109-9; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Benitez MA, 2009, LANCET, V373, P1070, DOI 10.1016/S0140-6736(09)60634-6; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; Bi P, 2003, VECTOR-BORNE ZOONOT, V3, P111, DOI 10.1089/153036603768395807; Brockmann S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-91; Centers for Disease Control (CDC) Taiwan, TAIW SURV SYST; Chen VYJ, 2010, SCI TOTAL ENVIRON, V408, P2042, DOI 10.1016/j.scitotenv.2009.11.044; Chou DW, 2007, J FORMOS MED ASSOC, V106, P1013, DOI 10.1016/S0929-6646(08)60077-7; Corkeron ML, 2010, EPIDEMIOL INFECT, V138, P1346, DOI 10.1017/S0950268809991634; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Davis J.C., 1986, STAT DATA ANAL GEOLO; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Dura G, 2010, J WATER HEALTH, V8, P513, DOI 10.2166/wh.2010.099; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; ECHEVERRIA P, 1983, DIAGN MICR INFEC DIS, V1, P193, DOI 10.1016/0732-8893(83)90018-4; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Ge XY, 2010, ATMOS SCI LETT, V11, P46, DOI 10.1002/asl.255; Greenough G, 2001, ENVIRON HEALTH PERSP, V109, P191, DOI 10.2307/3435009; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hong CC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042761; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Hung MN, 2009, TAIWAN EPIDEMIOL B, V25, P625; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Islam MS, 2009, T ROY SOC TROP MED H, V103, P1165, DOI 10.1016/j.trstmh.2009.04.016; Jean JS, 2006, J APPL MICROBIOL, V101, P1224, DOI 10.1111/j.1365-2672.2006.03025.x; Lai SK, 2010, TAIWAN EPIDEMIOL B, V26, P178; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Liu SC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040218; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Majani BS, 2007, ANAL EXTERNAL DRIFT; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Pappachan MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1054, DOI 10.1136/jech.2003.018556; Patz JA, 2008, AM J PREV MED, V35, P451, DOI 10.1016/j.amepre.2008.08.026; Qin Juan, 2009, Wei Sheng Yan Jiu, V38, P762; Robertson J, 2010, AM J TROP MED HYG, V82, P88, DOI 10.4269/ajtmh.2010.09-0226; Sam IC, 2007, J INFECTION, V54, P519, DOI 10.1016/j.jinf.2006.07.007; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Shiu CJ, 2009, J CLIMATE, V22, P5635, DOI 10.1175/2009JCLI2514.1; Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931; Slack AT, 2006, EPIDEMIOL INFECT, V134, P1217, DOI 10.1017/S0950268806006352; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Su HP, 2007, EMERG INFECT DIS, V13, P1795, DOI 10.3201/eid1311.061461; SUPUTTAMONGKOL Y, 1994, INT J EPIDEMIOL, V23, P1082, DOI 10.1093/ije/23.5.1082; The Taiwan Central Weather Bureau, PREC CLASS; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; Vecchi GA, 2007, NATURE, V450, P1066, DOI 10.1038/nature06423; WENIGER BG, 1983, AM J PUBLIC HEALTH, V73, P868, DOI 10.2105/AJPH.73.8.868; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu PC, 2011, OCCUP ENVIRON MED, V68, P525, DOI 10.1136/oem.2010.056168; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002	60	185	204	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e34651	10.1371/journal.pone.0034651	http://dx.doi.org/10.1371/journal.pone.0034651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737206	Green Submitted, gold, Green Published			2022-12-27	WOS:000305695100001
J	Zhang, JX; Han, BC; Wei, XN; Tan, CY; Chen, YZ; Jiang, YY				Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang			A Two-Step Target Binding and Selectivity Support Vector Machines Approach for Virtual Screening of Dopamine Receptor Subtype-Selective Ligands	PLOS ONE			English	Article							LARGE COMPOUND LIBRARIES; D-3 RECEPTOR; PARKINSONS-DISEASE; CURRENT PERSPECTIVES; MEDICINAL CHEMISTRY; RECENT PROGRESS; DRUG-DISCOVERY; FINGERPRINTS; QSAR; CLASSIFICATION	Target selective drugs, such as dopamine receptor (DR) subtype selective ligands, are developed for enhanced therapeutics and reduced side effects. In silico methods have been explored for searching DR selective ligands, but encountered difficulties associated with high subtype similarity and ligand structural diversity. Machine learning methods have shown promising potential in searching target selective compounds. Their target selective capability can be further enhanced. In this work, we introduced a new two-step support vector machines target-binding and selectivity screening method for searching DR subtype-selective ligands, which was tested together with three previously-used machine learning methods for searching D1, D2, D3 and D4 selective ligands. It correctly identified 50.6%-88.0% of the 21-408 subtype selective and 71.7%-81.0% of the 39-147 multi-subtype ligands. Its subtype selective ligand identification rates are significantly better than, and its multi-subtype ligand identification rates are comparable to the best rates of the previously used methods. Our method produced low false-hit rates in screening 13.56 M PubChem, 168,016 MDDR and 657,736 ChEMBLdb compounds. Molecular features important for subtype selectivity were extracted by using the recursive feature elimination feature selection method. These features are consistent with literature-reported features. Our method showed similar performance in searching estrogen receptor subtype selective ligands. Our study demonstrated the usefulness of the two-step target binding and selectivity screening method in searching subtype selective ligands from large compound libraries.	[Zhang, Jingxian; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China; [Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Chen, Yuzong] Natl Univ Singapore, Ctr Computat Sci & Engn, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117548, Singapore; [Han, Bucong; Wei, Xiaona] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Zhang, JX (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China.	phacyz@nus.edu.sg; jiangyy@sz.tsinghua.edu.cn	jiang, yu/HGU-0029-2022; Zhang, Jing/GWZ-7332-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Sarkar, Indra Neil/0000-0003-2054-7356; Chen, Yu Zong/0000-0002-5473-8022	Academic Research Funds Singapore [R-148-000-081-112]; Ministry of Science and Technology; 863 Hi-Tech Program China [2007AA02Z160]; Key Special Project [009ZX09501-004]; Ministry of Science and Technology, China	Academic Research Funds Singapore(Ministry of Education, Singapore); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Hi-Tech Program China(National High Technology Research and Development Program of China); Key Special Project; Ministry of Science and Technology, China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	The authors acknowledge the support from Academic Research Funds Singapore (R-148-000-081-112), Ministry of Science and Technology, 863 Hi-Tech Program China (2007AA02Z160), Key Special Project Grant 009ZX09501-004. Y.Z. Chen is supported by Academic Research Funds Singapore. Y.Y. Jiang is supported by the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersen M, 2010, EXPERT OPIN EMERG DR, V15, P467, DOI 10.1517/14728214.2010.480973; Aloisi G, 2011, NEUROPHARMACOLOGY, V60, P439, DOI 10.1016/j.neuropharm.2010.10.018; Audouze K, 2004, J MED CHEM, V47, P3089, DOI 10.1021/jm031111m; Bellis LJ, 2011, BIOCHEM SOC T, V39, P1365, DOI 10.1042/BST0391365; Bender A, 2006, J CHEM INF MODEL, V46, P2445, DOI 10.1021/ci600197y; Boeckler F, 2006, PHARMACOL THERAPEUT, V112, P281, DOI 10.1016/j.pharmthera.2006.04.007; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Carro L, 2009, BIOORG MED CHEM LETT, V19, P6059, DOI 10.1016/j.bmcl.2009.09.041; Cha MY, 2003, BIOORGAN MED CHEM, V11, P1293, DOI 10.1016/S0968-0896(02)00617-X; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; Clark RD, 2009, J COMPUT AID MOL DES, V23, P765, DOI 10.1007/s10822-008-9227-2; Czerminski R, 2001, QUANT STRUCT-ACT REL, V20, P227, DOI 10.1002/1521-3838(200110)20:3<227::AID-QSAR227>3.0.CO;2-Y; Durrant JD, 2010, CURR OPIN PHARMACOL, V10, P770, DOI 10.1016/j.coph.2010.09.001; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Enguehard-Gueiffier C, 2006, CURR MED CHEM, V13, P2981, DOI 10.2174/092986706778521841; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Givehchi A, 2006, J CHEM INF MODEL, V46, P1078, DOI 10.1021/ci0500233; Han LY, 2008, J MOL GRAPH MODEL, V26, P1276, DOI 10.1016/j.jmgm.2007.12.002; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Herm L, 2009, BIOORGAN MED CHEM, V17, P4756, DOI 10.1016/j.bmc.2009.04.047; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huber D, 2009, J MED CHEM, V52, P6860, DOI 10.1021/jm901120h; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Johnson R, 1982, APPL MULTIVARIATE ST; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Li H, 2007, J PHARM SCI-US, V96, P2838, DOI 10.1002/jps.20985; Li ZR, 2007, BIOTECHNOL BIOENG, V97, P389, DOI 10.1002/bit.21214; Liu XH, 2009, J CHEM INF MODEL, V49, P2101, DOI 10.1021/ci900135u; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Lober S, 2009, CHEMMEDCHEM, V4, P325, DOI 10.1002/cmdc.200800395; Lopez L, 2010, CHEMMEDCHEM, V5, P1300, DOI 10.1002/cmdc.201000101; Ma XH, 2010, MOL PHARMACEUT, V7, P1545, DOI 10.1021/mp100179t; Ma XH, 2009, COMB CHEM HIGH T SCR, V12, P344, DOI 10.2174/138620709788167944; Mahe P, 2009, COMB CHEM HIGH T SCR, V12, P409, DOI 10.2174/138620709788167926; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McCall RB, 2005, J PHARMACOL EXP THER, V314, P1248, DOI 10.1124/jpet.105.084202; Micheli F, 2011, CHEMMEDCHEM, V6, P1152, DOI 10.1002/cmdc.201000538; Michielan L, 2009, J CHEM INF MODEL, V49, P2588, DOI 10.1021/ci900299a; Mishra Nitish K., 2010, BMC Pharmacology, V10, P8, DOI 10.1186/1471-2210-10-8; Monge A, 2006, MOL DIVERS, V10, P389, DOI 10.1007/s11030-006-9033-5; Overington John, 2009, J Comput Aided Mol Des, V23, P195, DOI 10.1007/s10822-009-9260-9; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Renner S, 2008, J CHEM INF MODEL, V48, P319, DOI 10.1021/ci7003626; Salama I, 2007, J MED CHEM, V50, P489, DOI 10.1021/jm0611152; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Shi Z, 2012, J MOL GRAPH MODEL, V32, P49, DOI 10.1016/j.jmgm.2011.09.002; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; Singer C, 2007, MOVEMENT DISORD, V22, P476, DOI 10.1002/mds.21361; Sprous DG, 2010, CURR TOP MED CHEM, V10, P619, DOI 10.2174/156802610791111506; Sun HM, 2008, CURR MED CHEM, V15, P1018, DOI 10.2174/092986708784049630; Talevi A, 2009, CURR COMPUT-AID DRUG, V5, P23, DOI 10.2174/157340909787580854; Trotter MWB, 2001, MEAS CONTROL-UK, V34, P235, DOI 10.1177/002029400103400803; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Vapnik V., 2013, NATURE STAT LAERNING; Verheij HJ, 2006, MOL DIVERS, V10, P377, DOI 10.1007/s11030-006-9040-6; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wester MJ, 2008, J CHEM INF MODEL, V48, P1311, DOI 10.1021/ci700342h; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Willett P, 2011, METHODS MOL BIOL, V672, P133, DOI 10.1007/978-1-60761-839-3_5; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1630, DOI 10.1021/ci049869h; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zeng CY, 2011, HYPERTENSION, V57, P11, DOI 10.1161/HYPERTENSIONAHA.110.157727; Zhang A, 2007, CHEM REV, V107, P274, DOI 10.1021/cr050263h; Zhang J, 2009, MED RES REV, V29, P272, DOI 10.1002/med.20130; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019	74	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39076	10.1371/journal.pone.0039076	http://dx.doi.org/10.1371/journal.pone.0039076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720033	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000037
J	Zhou, X; Marian, C; Makambi, KH; Kosti, O; Kallakury, BVS; Loffredo, CA; Zheng, YL				Zhou, Xin; Marian, Catalin; Makambi, Kepher H.; Kosti, Ourania; Kallakury, Bhaskar V. S.; Loffredo, Christopher A.; Zheng, Yun-Ling			MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status	PLOS ONE			English	Article							CONSERVING THERAPY; EXPRESSION PROFILES; EPIGENETIC REGULATION; RISK-FACTORS; CELL; CARCINOMAS; MASTECTOMY; SURVIVAL; SURGERY; RADIOTHERAPY	MicroRNAs (miRs) are small, non-protein coding transcripts involved in many cellular functions. Many miRs have emerged as important cancer biomarkers. In the present study, we investigated whether miR levels in breast tumors are predictive of breast cancer local recurrence (LR). Sixty-eight women who were diagnosed with breast cancer at the Lombardi Comprehensive Cancer Center were included in this study. Breast cancer patients with LR and those without LR were matched on year of surgery, age at diagnosis, and type of surgery. Candidate miRs were identified by screening the expression levels of 754 human miRs using miR arrays in 16 breast tumor samples from 8 cases with LR and 8 cases without LR. Eight candidate miRs that showed significant differences between tumors with and without LR were further verified in 52 tumor samples using real-time PCR. Higher expression of miR-9 was significantly associated with breast cancer LR in all cases as well as the subset of estrogen receptor (ER) positive cases (p = 0.02). The AUCs (Area Under Curve) of receiver operating characteristic (ROC) curves of miR-9 for all tumors and ER positive tumors are 0.68 (p = 0.02) and 0.69 (p = 0.02), respectively. In ER positive cases, Kaplan-Meier analysis showed that patients with lower miR-9 levels had significantly better 10-year LR-free survival (67.9% vs 30.8%, p = 0.02). Expression levels of miR-9 and another miR candidate, miR-375, were also strongly associated with ER status (p<0.001 for both). The potential of miR-9 as a biomarker for LR warrants further investigation with larger sample size.	[Zhou, Xin; Marian, Catalin; Makambi, Kepher H.; Kosti, Ourania; Loffredo, Christopher A.; Zheng, Yun-Ling] Georgetown Univ, Canc Prevent & Control Program, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Kallakury, Bhaskar V. S.] Georgetown Univ, Dept Pathol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University; Georgetown University	Zhou, X (corresponding author), Georgetown Univ, Canc Prevent & Control Program, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	yz37@georgetown.edu	Marian, Catalin/P-2885-2019; Marian, Catalin/B-1750-2012	Marian, Catalin/0000-0002-7749-1384; Marian, Viorica/0000-0002-8335-1433	Susan G Komen for the Cure [BCTR0707157]; CMESR (Clinical and Molecular Epidemiology Shared Resource); HTSR (Histopathology and Tissue Shared Resource); GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health] [P30 CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); CMESR (Clinical and Molecular Epidemiology Shared Resource); HTSR (Histopathology and Tissue Shared Resource); GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health]; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from Susan G Komen for the Cure [BCTR0707157 to YZ, ww5.komen.org/] and by the CMESR (Clinical and Molecular Epidemiology Shared Resource), HTSR (Histopathology and Tissue Shared Resource) and GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health grant P30 CA51008, www.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Basu Aruna, 2011, Genes Cancer, V2, P108, DOI 10.1177/1947601911409212; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; BORGER J, 1994, J CLIN ONCOL, V12, P653, DOI 10.1200/JCO.1994.12.4.653; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Iorio MV, 2008, EUR J CANCER, V44, P2753, DOI 10.1016/j.ejca.2008.09.037; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kong KL, 2011, GUT; Kreike B, 2006, CLIN CANCER RES, V12, P5705, DOI 10.1158/1078-0432.CCR-06-0805; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li XL, 2011, DIGEST DIS SCI, V56, P2849, DOI 10.1007/s10620-011-1711-1; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Magee B, 1996, RADIOTHER ONCOL, V39, P223, DOI 10.1016/0167-8140(96)01747-1; Mazar J, 2011, FEBS LETT, V585, P2467, DOI 10.1016/j.febslet.2011.06.025; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Nuyten DSA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1614; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Shigehara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023584; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Voogd AC, 1999, EUR J CANCER, V35, P1828, DOI 10.1016/S0959-8049(99)00220-8; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Yu L, 2010, INT J CANC; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758; Zhu L, 2011, MED ONCOL	54	116	121	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39011	10.1371/journal.pone.0039011	http://dx.doi.org/10.1371/journal.pone.0039011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22916227	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300080
J	Ou, JJ; Luan, W; Deng, J; Sa, R; Liang, HJ				Ou, Juanjuan; Luan, Wei; Deng, Jia; Sa, Rina; Liang, Houjie			alpha V Integrin Induces Multicellular Radioresistance in Human Nasopharyngeal Carcinoma via Activating SAPK/JNK Pathway	PLOS ONE			English	Article							CELL; INTEGRIN-ALPHA(V)BETA(3); RESISTANCE; APOPTOSIS; INVASION; THERAPY; STRESS; NECTIN; MATRIX; JNK	Background: Tumor cells acquire the capacity of resistance to chemotherapy or radiotherapy via cell-matrix and cell-cell crosstalk. Integrins are the most important cell adhesion molecules, in which alpha V integrin mainly mediating the tight contact between tumor cells. Methodology/Principal Findings: To investigate the role of alpha V integrin in multi-cellular radioresistance (MCR) of human nasopharyngeal carcinoma (NPC), we performed immunohistochemistry and Western blotting to find that the expression of alpha V integrin in the tumor tissue of radioresistant patients is much higher than that in radiosensitive patients. In vitro, we cultured human NPC cell line CNE-2 cells as multi-cellular spheroids (MCSs) or as monolayer cells (MCs), and found that the expression of alpha V integrin in MCSs is significantly higher than that in MCs. MTT, flow cytometry and clonogenic suvival assays showed that MCSs are less sensitive to X-ray irradiation than MCs while blocking of alpha V integrin in MCSs dramatically reversed their radioresistance. Furthermore, as detected by Western blotting, MCSs displayed sustained activation of the stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) pathway in presence of irradiation. Blocking of alpha V integrin in MCSs decreased the expression of phosphorylated JNK. Additionally, blocking of SAPK/JNK signaling pathway synergistically induced apoptosis of MCSs exposed to irradiation by increasing the expression of cleaved caspase-3. In vivo, we found that irradiation combined with alpha V integrin blocking treatment significantly enhanced the radiosensitivity of NPC xenografts. Conclusions: Our results indicate a novel role of alpha V integrin in multi-cellular radioresistance of NPCs.	[Ou, Juanjuan] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Ou, JJ (corresponding author), Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China.	lianghoujie@sina.com	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [81000965]; 973 Program, National Basic Research Program of China [2010cb529403]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program, National Basic Research Program of China(National Basic Research Program of China); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grant number 81000965 from the National Natural Science Foundation of China, and by 973 Program No. 2010cb529403 from the National Basic Research Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Chen QM, 2007, CLIN CANCER RES, V13, P3689, DOI 10.1158/1078-0432.CCR-07-0026; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; He JM, 2009, CANCER LETT, V284, P182, DOI 10.1016/j.canlet.2009.04.023; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hwang R, 2004, HEMATOL ONCOL CLIN N, V18, P991, DOI 10.1016/j.hoc.2004.09.010; Jean C, 2011, ONCOGENE, V30, P2697, DOI 10.1038/onc.2011.27; Le Tourneau C, 2010, B CANCER, V97, P1453, DOI 10.1684/bdc.2010.1226; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Pauwels B, 2010, FUTURE ONCOL, V6, P1485, DOI 10.2217/FON.10.104; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; Stulic M, 2007, CYTOKINE, V37, P163, DOI 10.1016/j.cyto.2007.03.010; Sun HY, 2011, EXP BIOL MED, V236, P352, DOI 10.1258/ebm.2010.010106; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vellon L, 2006, MOL CARCINOGEN, V45, P795, DOI 10.1002/mc.20242; Zhang SY, 2004, CARCINOGENESIS, V25, P2191, DOI 10.1093/carcin/bgh234	31	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38737	10.1371/journal.pone.0038737	http://dx.doi.org/10.1371/journal.pone.0038737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22844484	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341900045
J	Zhang, JB; Hanner, R				Zhang, Junbin; Hanner, Robert			Molecular Approach to the Identification of Fish in the South China Sea	PLOS ONE			English	Article							GENETIC-DIVERGENCE; MITOCHONDRIAL PSEUDOGENES; DNA BARCODES; REEF; POPULATIONS; EVOLUTION; DASCYLLUS; SYSTEM	Background: DNA barcoding is one means of establishing a rapid, accurate, and cost-effective system for the identification of species. It involves the use of short, standard gene targets to create sequence profiles of known species against sequences of unknowns that can be matched and subsequently identified. The Fish Barcode of Life (FISH-BOL) campaign has the primary goal of gathering DNA barcode records for all the world's fish species. As a contribution to FISH-BOL, we examined the degree to which DNA barcoding can discriminate marine fishes from the South China Sea. Methodology/Principal Findings: DNA barcodes of cytochrome oxidase subunit I (COI) were characterized using 1336 specimens that belong to 242 species fishes from the South China Sea. All specimen provenance data (including digital specimen images and geospatial coordinates of collection localities) and collateral sequence information were assembled using Barcode of Life Data System (BOLD; www.barcodinglife.org). Small intraspecific and large interspecific differences create distinct genetic boundaries among most species. In addition, the efficiency of two mitochondrial genes, 16S rRNA (16S) and cytochrome b (cytb), and one nuclear ribosomal gene, 18S rRNA (18S), was also evaluated for a few select groups of species. Conclusions/Significance: The present study provides evidence for the effectiveness of DNA barcoding as a tool for monitoring marine biodiversity. Open access data of fishes from the South China Sea can benefit relative applications in ecology and taxonomy.	[Zhang, Junbin] Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China; [Zhang, Junbin; Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Shanghai Ocean University; University of Guelph	Zhang, JB (corresponding author), Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China.	jb-zhang@shou.edu.cn	jiang, yu/HGU-0029-2022; Zhang, Jing/GWZ-7332-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Sarkar, Indra Neil/0000-0003-2054-7356; Chen, Yu Zong/0000-0002-5473-8022	Genome Canada (through the Ontario Genomics Institute); Chinese National Funding awards [40776089, U0633007]	Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Chinese National Funding awards	This research was supported through funding to the Canadian Barcode of Life Network from Genome Canada (through the Ontario Genomics Institute) and by Chinese National Funding awards 40776089 and U0633007, which supported specimen collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardi G, 2002, P ROY SOC B-BIOL SCI, V269, P599, DOI 10.1098/rspb.2001.1922; Bernardi G, 2001, MAR BIOL, V138, P457, DOI 10.1007/s002270000484; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Chakrabarty Prosanta, 2010, Marine Biodiversity, V40, P107, DOI 10.1007/s12526-010-0037-0; Chen JTF, 1986, SYNOPSIS VERTEBRATES; Chenoweth SF, 1997, J FISH BIOL, V50, P721, DOI 10.1006/jfbi.1996.0336; Comi G, 2005, FOOD CONTROL, V16, P37, DOI 10.1016/j.foodcont.2003.11.003; Cui ZX, 2010, ICHTHYOL RES, V57, P32, DOI 10.1007/s10228-009-0119-9; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doyle JJ, 2000, PLANT MOL BIOL, V42, P1, DOI 10.1023/A:1006349518932; Dudgeon CL, 2000, MAR BIOL, V137, P1059, DOI 10.1007/s002270000403; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Greenstone MH, 2005, MOL ECOL, V14, P3247, DOI 10.1111/j.1365-294X.2005.02628.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HANNER R, 2005, PROPOSED STANDARDS B; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg ME, 2002, B MAR SCI, V70, P273; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Liu Jing, 2002, Studia Marina Sinica, V44, P240; Lucy K, 2010, UNDERGRADUATE RES J; Nei M, 2000, MOL EVOLUTION PHYLOG; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Parin NV, 2004, J ICHTHYOLOGY S1, V44, P33; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Planes S, 2001, EVOLUTION, V55, P2263; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Ruedas LA, 2000, MOL PHYLOGENET EVOL, V17, P129, DOI 10.1006/mpev.2000.0737; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P204, DOI 10.1603/0013-8746(2006)099[0204:DBATIL]2.0.CO;2; Shen SC, COASTAL FISHES TAIWA, P180; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sparks JS, 2005, CLADISTICS, V21, P305, DOI 10.1111/j.1096-0031.2005.00067.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Swartz ER, 2008, S AFR J SCI, V104, P293; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tuckey JW, 1977, EXPLORATORY DATA ANA, P688; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Victor BC, 2009, ZOOTAXA, P24; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xiao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015067; Zhang JB, 2004, J EXP MAR BIOL ECOL, V298, P3, DOI 10.1016/S0022-0981(03)00341-1; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	62	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30621	10.1371/journal.pone.0030621	http://dx.doi.org/10.1371/journal.pone.0030621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22720033	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600041
J	Deng, Q; Hui, DF; Zhang, DQ; Zhou, GY; Liu, JX; Liu, SZ; Chu, GW; Li, J				Deng, Qi; Hui, Dafeng; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong			Effects of Precipitation Increase on Soil Respiration: A Three-Year Field Experiment in Subtropical Forests in China	PLOS ONE			English	Article							CO2 EFFLUX; CARBON-DIOXIDE; TERRESTRIAL ECOSYSTEMS; EXPERIMENTAL DROUGHT; GRASSLAND ECOSYSTEM; ORGANIC-CARBON; TEMPERATURE; RESPONSES; VARIABILITY; DEPENDENCE	Background: The aim of this study was to determine response patterns and mechanisms of soil respiration to precipitation increases in subtropical regions. Methodology/Principal Findings: Field plots in three typical forests [i.e. pine forest (PF), broadleaf forest (BF), and pine and broadleaf mixed forest (MF)] in subtropical China were exposed under either Double Precipitation (DP) treatment or Ambient Precipitation (AP). Soil respiration, soil temperature, soil moisture, soil microbial biomass and fine root biomass were measured over three years. We tested whether precipitation treatments influenced the relationship of soil respiration rate (R) with soil temperature (T) and soil moisture (M) using R=(a+cM)exp(bT), where a is a parameter related to basal soil respiration; b and c are parameters related to the soil temperature and moisture sensitivities of soil respiration, respectively. We found that the DP treatment only slightly increased mean annual soil respiration in the PF (15.4%) and did not significantly change soil respiration in the MF and the BF. In the BF, the increase in soil respiration was related to the enhancements of both soil fine root biomass and microbial biomass. The DP treatment did not change model parameters, but increased soil moisture, resulting in a slight increase in soil respiration. In the MF and the BF, the DP treatment decreased soil temperature sensitivity b but increased basal soil respiration a, resulting in no significant change in soil respiration. Conclusion/Significance: Our results indicate that precipitation increasing in subtropical regions in China may have limited effects on soil respiration.	[Deng, Qi; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Deng, Qi] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Tennessee State University	Deng, Q (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	dhui@tnstate.edu	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Basic Research Program of China [2009CB42110x]; Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences [XDA05050205]; Dinghushan Forest Ecosystem Research Station; National Science Foundation [0933958]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences; Dinghushan Forest Ecosystem Research Station; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by National Basic Research Program of China (2009CB42110x), Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences (XDA05050205), Dinghushan Forest Ecosystem Research Station, and the National Science Foundation (0933958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2006, GLOBAL CHANGE BIOL, V12, P177, DOI 10.1111/j.1365-2486.2005.001058.x; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Chen Xiao-mei, 2010, Yingyong Shengtai Xuebao, V21, P1210; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Deng Q, 2010, BIOGEOSCIENCES, V7, P315, DOI 10.5194/bg-7-315-2010; Deng Q, 2011, ENVIRON MANAGE, V48, P1182, DOI 10.1007/s00267-011-9732-2; Ding M. M., 2001, IITF17 USDA FOR SERV; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; [方运霆 Fang Yun], 2003, [生态学报, Acta Ecologica Sinica], V23, P1685; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; He C., 1982, TROPICAL SUBTROPICAL, V1, P25; Hui D., 1996, PRACTICAL SAS USAGE; Hui DF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002297; Hui DF, 2003, TREE PHYSIOL, V23, P433, DOI 10.1093/treephys/23.7.433; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; Jackson RB, 2009, ECOLOGY, V90, P3352, DOI 10.1890/08-1609.1; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jenerette GD, 2008, FUNCT ECOL, V22, P924, DOI 10.1111/j.1365-2435.2008.01450.x; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Liu JX, 2008, BIOGEOSCIENCES, V5, P1783, DOI 10.5194/bg-5-1783-2008; [刘申 LIU Shen], 2007, [生态科学, Ecologic Science], V26, P387; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo Y., 2006, SOIL RESP ENV, P35, DOI [10.1016/B978-012088782-8/50003-6, DOI 10.1016/B978-012088782-8/50003-6]; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Misson L, 2010, GLOBAL CHANGE BIOL, V16, P2461, DOI 10.1111/j.1365-2486.2009.02121.x; Noormets A, 2008, AGR FOREST METEOROL, V148, P216, DOI 10.1016/j.agrformet.2007.08.002; Palmroth S, 2005, GLOBAL CHANGE BIOL, V11, P421, DOI 10.1111/j.1365-2486.2005.00915.x; Peng Shao-Lin, 1995, Chinese Journal of Botany, V7, P75; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Schaefer K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001928; Schwendenmann L, 2005, ECOSYSTEMS, V8, P339, DOI 10.1007/s10021-003-0088-1; Scotta ED, 2007, GLOBAL CHANGE BIOL, V13, P546; Shen CD, 2001, RADIOCARBON, V43, P671; Shen WJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000685; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowerby A, 2008, GLOBAL CHANGE BIOL, V14, P2388, DOI 10.1111/j.1365-2486.2008.01643.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; van Straaten O, 2010, BIOGEOSCIENCES, V7, P1223, DOI 10.5194/bg-7-1223-2010; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang B. S., 1982, Tropical and Subtropical Forest Ecosystem, Ding Hu Shan Forest Ecosystem Reserve, China, P142; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yan J. H., 2009, SOIL BIOL BIOCHEM, V9, P1, DOI DOI 10.1016/J.S0ILBI0.2008.12.018; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zhang DQ, 2006, SCI CHINA SER D, V49, P139, DOI 10.1007/s11430-006-8139-z; Zhou T, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000850; Zhou XH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002526	61	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41493	10.1371/journal.pone.0041493	http://dx.doi.org/10.1371/journal.pone.0041493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844484	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700095
J	Chen, MN; Li, X; Yang, QL; Chi, XY; Pan, LJ; Chen, N; Yang, Z; Wang, T; Wang, MA; Yu, SL				Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin			Soil Eukaryotic Microorganism Succession as Affected by Continuous Cropping of Peanut - Pathogenic and Beneficial Fungi were Selected	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; SOILBORNE DISEASES; MYCORRHIZAL FUNGI; ENZYME-ACTIVITIES; PLANT-PATHOGENS; YIELD DECLINE; BIOCONTROL; DIVERSITY; TRICHODERMA; POPULATIONS	Peanut is an important oil crop worldwide and shows considerable adaptability but growth and yield are negatively affected by continuous cropping. Soil micro-organisms are efficient bio-indicators of soil quality and plant health and are critical to the sustainability of soil-based ecosystem function and to successful plant growth. In this study, 18S rRNA gene clone library analyses were employed to study the succession progress of soil eukaryotic micro-organisms under continuous peanut cultivation. Eight libraries were constructed for peanut over three continuous cropping cycles and its representative growth stages. Cluster analyses indicated that soil micro-eukaryotic assemblages obtained from the same peanut cropping cycle were similar, regardless of growth period. Six eukaryotic groups were found and fungi predominated in all libraries. The fungal populations showed significant dynamic change and overall diversity increased over time under continuous peanut cropping. The abundance and/or diversity of clones affiliated with Eurotiales, Hypocreales, Glomerales, Orbiliales, Mucorales and Tremellales showed an increasing trend with continuous cropping but clones affiliated with Agaricales, Cantharellales, Pezizales and Pyxidiophorales decreased in abundance and/or diversity over time. The current data, along with data from previous studies, demonstrated that the soil microbial community was affected by continuous cropping, in particular, the pathogenic and beneficial fungi that were positively selected over time, which is commonplace in agro-ecosystems. The trend towards an increase in fungal pathogens and simplification of the beneficial fungal community could be important factors contributing to the decline in peanut growth and yield over many years of continuous cropping.	[Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China		Chen, MN (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	yshanlin1956@163.com	Lung, Shih-Chun Candice/ABA-1011-2020; Lung, Shih-Chun Candice/GYD-5623-2022; Lin, CY/K-6503-2014; lin, chuan/HHD-2571-2022	Lung, Shih-Chun Candice/0000-0002-4227-0469; Lung, Shih-Chun Candice/0000-0002-4227-0469; Lin, CY/0000-0002-0005-7088; Su, Huey-Jen/0000-0003-3589-9987	China Agriculture Research System [CARS-14]; National Natural Science Foundation of China [31000728, 31100205]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province [BS2010NY023]; Qingdao Municipal Science and Technology Plan Project [11-2-4-9-(3)-jch, 11-2-3-26-nsh]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shangdong Province; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from China Agriculture Research System (CARS-14), the National Natural Science Foundation of China (31000728; 31100205), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), the Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province (BS2010NY023), Qingdao Municipal Science and Technology Plan Project (11-2-4-9-(3)-jch; 11-2-3-26-nsh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2008, CROP PROT, V27, P410, DOI 10.1016/j.cropro.2007.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anaissie EJ, 2002, CLIN INFECT DIS, V34, P780, DOI 10.1086/338958; Avidano L, 2005, APPL SOIL ECOL, V30, P21, DOI 10.1016/j.apsoil.2005.01.003; Benhamou N, 2004, PHYTOPATHOLOGY, V94, P693, DOI 10.1094/PHYTO.2004.94.7.693; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Blakney AJC, 2011, FEMS MICROBIOL ECOL, V77, P546, DOI 10.1111/j.1574-6941.2011.01136.x; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bruehl GW., 1987, SOILBORNE PLANT PATH; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Budi SW, 1999, APPL ENVIRON MICROB, V65, P5148; Caesar-TonThat T, 2010, EUR J SOIL BIOL, V46, P119, DOI 10.1016/j.ejsobi.2009.12.004; Cizkova D, 2005, FOLIA MICROBIOL, V50, P59, DOI 10.1007/BF02931294; Cotxarrera L, 2002, SOIL BIOL BIOCHEM, V34, P467, DOI 10.1016/S0038-0717(01)00205-X; CURL EA, 1988, CRIT REV PLANT SCI, V7, P175, DOI 10.1080/07352688809382263; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; DELEIJ FAAM, 1995, APPL ENVIRON MICROB, V61, P3443, DOI 10.1128/AEM.61.9.3443-3453.1995; Dobermann A, 2000, AGRON J, V92, P633, DOI 10.2134/agronj2000.924633x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Heydari A., 2010, Journal of Biological Sciences, V10, P273; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3378, DOI 10.1128/AEM.02715-09; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; JOHNSON NC, 1992, AGRON J, V84, P387, DOI 10.2134/agronj1992.00021962008400030007x; Kandeler E, 2006, SOIL BIOL BIOCHEM, V38, P2448, DOI 10.1016/j.soilbio.2006.02.021; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Kubicek C. P., 2001, Journal of Plant Pathology, V83, P11; Larkin RP, 2008, SOIL BIOL BIOCHEM, V40, P1341, DOI 10.1016/j.soilbio.2007.03.005; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Lithourgidis AS, 2006, EUR J AGRON, V25, P208, DOI 10.1016/j.eja.2006.05.003; Lutz MP, 2003, APPL ENVIRON MICROB, V69, P3077, DOI 10.1128/AEM.69.6.3077-3084.2003; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; Morace Giulia, 2012, Int J Microbiol, V2012, P349278, DOI 10.1155/2012/349278; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nayyar A, 2009, APPL SOIL ECOL, V43, P115, DOI 10.1016/j.apsoil.2009.06.008; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pankhurst CE, 1996, BIODIVERS CONSERV, V5, P197, DOI 10.1007/BF00055830; Pliego C, 2011, PLANT SOIL, V340, P505, DOI 10.1007/s11104-010-0615-8; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Reichardt W, 1997, APPL ENVIRON MICROB, V63, P233, DOI 10.1128/AEM.63.1.233-238.1997; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sharma KK, 2006, METH MOL B, V343, P347; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Sudini H, 2011, PHYTOPATHOLOGY, V101, P819, DOI 10.1094/PHYTO-11-10-0310; Tedersoo L, 2006, NEW PHYTOL, V170, P581, DOI 10.1111/j.1469-8137.2006.01678.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Elsas JD., 2006, MODERN SOIL MICROBIO, DOI [10.1201/9781420015201, DOI 10.1201/9781420015201]; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027381; Wehner J, 2010, PEDOBIOLOGIA, V53, P197, DOI 10.1016/j.pedobi.2009.10.002; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2; Ying SH, 2004, J APPL MICROBIOL, V97, P323, DOI 10.1111/j.1365-2672.2004.02311.x	64	185	204	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40659	10.1371/journal.pone.0040659	http://dx.doi.org/10.1371/journal.pone.0040659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22737206	Green Published, Green Submitted, gold			2022-12-27	WOS:000306355500068
J	Lee, BR; Huseby, S; Koprivova, A; Chetelat, A; Wirtz, M; Mugford, ST; Navid, E; Brearley, C; Saha, S; Mithen, R; Hell, R; Farmer, EE; Kopriva, S				Lee, Bok-Rye; Huseby, Stine; Koprivova, Anna; Chetelat, Aurore; Wirtz, Markus; Mugford, Sam T.; Navid, Emily; Brearley, Charles; Saha, Shikha; Mithen, Richard; Hell, Ruediger; Farmer, Edward E.; Kopriva, Stanislav			Effects of fou8/fry1 Mutation on Sulfur Metabolism: Is Decreased Internal Sulfate the Trigger of Sulfate Starvation Response?	PLOS ONE			English	Article							ADENOSINE 5'-PHOSPHOSULFATE REDUCTASE; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; OF-FUNCTION ALLELE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; 5-PHOSPHOSULFATE REDUCTASE; TRANSCRIPTOME ANALYSIS; GLUTATHIONE-DEFICIENT; NEGATIVE REGULATOR; SALT TOLERANCE	The fou8 loss of function allele of adenosine bisphosphate phosphatase FIERY1 results in numerous phenotypes including the increased enzymatic oxygenation of fatty acids and increased jasmonate synthesis. Here we show that the mutation causes also profound alterations of sulfur metabolism. The fou8 mutants possess lower levels of sulfated secondary compounds, glucosinolates, and accumulate the desulfo-precursors similar to previously described mutants in adenosine 5'phosphosulfate kinase. Transcript levels of genes involved in sulfate assimilation differ in fou8 compared to wild type Col-0 plants and are similar to plants subjected to sulfate deficiency. Indeed, independent microarray analyses of various alleles of mutants in FIERY1 showed similar patterns of gene expression as in sulfate deficient plants. This was not caused by alterations in signalling, as the fou8 mutants contained significantly lower levels of sulfate and glutathione and, consequently, of total elemental sulfur. Analysis of mutants with altered levels of sulfate and glutathione confirmed the correlation of sulfate deficiency-like gene expression pattern with low internal sulfate but not low glutathione. The changes in sulfur metabolism in fou8 correlated with massive increases in 3'-phosphoadenosine 5'-phosphate levels. The analysis of fou8 thus revealed that sulfate starvation response is triggered by a decrease in internal sulfate as opposed to external sulfate availability and that the presence of desulfo-glucosinolates does not induce the glucosinolate synthesis network. However, as well as resolving these important questions on the regulation of sulfate assimilation in plants, fou8 has also opened an array of new questions on the links between jasmonate synthesis and sulfur metabolism.	[Lee, Bok-Rye; Huseby, Stine; Koprivova, Anna; Mugford, Sam T.; Kopriva, Stanislav] Norwich Res Pk, John Innes Ctr, Norwich, Norfolk, England; [Huseby, Stine] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Chetelat, Aurore; Navid, Emily; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Wirtz, Markus; Hell, Ruediger] Heidelberg Inst Plant Sci HIP, Heidelberg, Germany; [Brearley, Charles] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Saha, Shikha; Mithen, Richard] Norwich Res Pk, Inst Food Res, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Norwegian University of Life Sciences; University of Lausanne; Ruprecht Karls University Heidelberg; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Lee, BR (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	stanislav.kopriva@jic.ac.uk	Hell, Ruediger/E-5436-2014; Wirtz, Markus/G-5917-2010; Kopriva, Stanislav/C-7401-2013; Farmer, Edward E/H-1635-2011	Wirtz, Markus/0000-0001-7790-4022; Kopriva, Stanislav/0000-0002-7416-6551; Brearley, Charles/0000-0001-6179-9109; Hell, Ruediger/0000-0002-6238-4818; Mugford, Sam/0000-0002-8537-5578; Mithen, Richard/0000-0001-7307-4324; Ryu, Choong-Min/0000-0002-7276-1189; Saha, Shikha/0000-0002-5010-5105	British Biotechnology and Biological Sciences Research Council (BBSRC); Swiss National Science Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044431] Funding Source: researchfish; BBSRC [BBS/E/F/00044431] Funding Source: UKRI	British Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SK's research is supported by British Biotechnology and Biological Sciences Research Council (BBSRC). EEF is supported by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball L, 2004, PLANT CELL, V16, P2448, DOI 10.1105/tpc.104.022608; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bonaventure G, 2007, PLANT CELL PHYSIOL, V48, P1775, DOI 10.1093/pcp/pcm151; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Burstenbinder K, 2007, PLANT J, V49, P238, DOI 10.1111/j.1365-313X.2006.02942.x; Caldelari D, 1998, PHYTOCHEMISTRY, V47, P599, DOI 10.1016/S0031-9422(97)00443-3; Carland F, 2009, PLANT J, V59, P895, DOI 10.1111/j.1365-313X.2009.03920.x; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Chen H, 2010, PLANT CELL ENVIRON, V33, P2180, DOI 10.1111/j.1365-3040.2010.02218.x; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Cobbett CS, 1998, PLANT J, V16, P73, DOI 10.1046/j.1365-313x.1998.00262.x; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harada E, 2000, J PLANT PHYSIOL, V156, P272, DOI 10.1016/S0176-1617(00)80317-X; Hartmann T, 2004, J EXP BOT, V55, P837, DOI 10.1093/jxb/erh094; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Hirsch J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016724; Jost R, 2005, PHOTOSYNTH RES, V86, P491, DOI 10.1007/s11120-005-7386-8; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Klein M, 2006, FEBS J, V273, P122, DOI 10.1111/j.1742-4658.2005.05048.x; Kopriva S, 1999, PLANT J, V20, P37, DOI 10.1046/j.1365-313X.1999.00573.x; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Koprivova A, 2010, PLANT CELL REP, V29, P1157, DOI 10.1007/s00299-010-0902-0; Lee BR, 2011, PLANT J, V67, P1042, DOI 10.1111/j.1365-313X.2011.04656.x; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; Maruyama-Nakashita A, 2003, PLANT PHYSIOL, V132, P597, DOI 10.1104/pp.102.019802; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Nikiforova V, 2003, PLANT J, V33, P633, DOI 10.1046/j.1365-313X.2003.01657.x; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Piotrowski M, 2004, J BIOL CHEM, V279, P50717, DOI 10.1074/jbc.M407681200; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; Scheerer U, 2010, J EXP BOT, V61, P609, DOI 10.1093/jxb/erp327; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Troufflard S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-172; Underhill E. W., 1973, BIOCH SOC S, V38, P303; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Wirtz M, 2003, AMINO ACIDS, V24, P195, DOI 10.1007/s00726-002-0313-9; Xiong LM, 2004, PLANT J, V40, P536, DOI 10.1111/j.1365-313X.2004.02225.x; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x	58	148	155	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39425	10.1371/journal.pone.0039425	http://dx.doi.org/10.1371/journal.pone.0039425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	23209558	gold, Green Submitted, Green Published			2022-12-27	WOS:000305583300140
J	Chen, QY; Wang, H; Liu, Y; Song, YJ; Lai, LH; Han, Q; Cao, XT; Wang, QQ				Chen, Qingyun; Wang, Hui; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing			Inducible MicroRNA-223 Down-Regulation Promotes TLR-Triggered IL-6 and IL-1 beta Production in Macrophages by Targeting STAT3	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; IN-VIVO; TRANSCRIPTION; EXPRESSION; INTERLEUKIN-6; INFLAMMATION; ALPHA; LIPOPOLYSACCHARIDE; DIFFERENTIATION	MicroRNAs are small non-coding RNA molecules that regulate gene expression by either translational inhibition or mRNA degradation. MicroRNAs play pivotal roles in the regulation of both innate and adaptive immune responses, including TLR-triggered inflammatory response. Here we reported that the expression of microRNA-223 (miR-223) was significantly decreased in murine macrophages during activation by lipopolysaccharide (LPS) or poly (I:C) stimulation. The inducible miR-223 down-regulation resulted in the activation of signal transducer and activator of transcription 3 (STAT3), which is directly targeted by miR-223, thus promoting the production of pro-inflammatory cytokines IL-6 and IL-1 beta, but not TNF-alpha. Interestingly, IL-6 was found to be a main factor in inducing the decrease in miR-223 expression after LPS stimulation, which formed a positive feedback loop to regulate IL-6 and IL-1 beta. Herein, our findings provide a new explanation characterizing the molecular mechanism responsible for the regulation of IL-6 production after TLR-triggered macrophage activation.	[Chen, Qingyun; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Chinese Peoples Armed Police Force, Coll Med, Tianjin, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University	Chen, QY (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	wqq@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81072405]; Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China [NCET-08-0486]; Zhejiang Provincial Natural Science Foundation of China [R2100528]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	This work was supported by grants from the National Natural Science Foundation of China (81072405), Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China (NCET-08-0486), grant from Zhejiang Provincial Natural Science Foundation of China (R2100528) and also sponsored by Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; HACK CE, 1989, BLOOD, V74, P1704; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lee C, 2006, MOL PHARMACOL, V69, P1041, DOI 10.1124/mol.105.018481; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; O'Connell RM., 2011, ANN REV IMMUNOL; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Prele CM, 2007, CLIN EXP IMMUNOL, V147, P564, DOI 10.1111/j.1365-2249.2006.03291.x; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547	35	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42971	10.1371/journal.pone.0042971	http://dx.doi.org/10.1371/journal.pone.0042971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22723833	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500025
J	Chen, QY; Park, HC; Goligorsky, MS; Chander, P; Fischer, SM; Gross, SS				Chen, Qiuying; Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen; Fischer, Steven M.; Gross, Steven S.			Untargeted Plasma Metabolite Profiling Reveals the Broad Systemic Consequences of Xanthine Oxidoreductase Inactivation in Mice	PLOS ONE			English	Article							KYNURENINE PATHWAY ENZYMES; CHRONIC KIDNEY-DISEASE; REPERFUSION INJURY; METABOLOMICS; ALLOPURINOL; OXIDASE; IDENTIFICATION; CHROMATOGRAPHY; DEHYDROGENASE; ERYTHROCYTE	A major challenge in systems biology is integration of molecular findings for individual enzyme activities into a cohesive high-level understanding of cellular metabolism and physiology/pathophysiology. However, meaningful prediction for how a perturbed enzyme activity will globally impact metabolism in a cell, tissue or intact organisms is precluded by multiple unknowns, including in vivo enzymatic rates, subcellular distribution and pathway interactions. To address this challenge, metabolomics offers the potential to simultaneously survey changes in thousands of structurally diverse metabolites within complex biological matrices. The present study assessed the capability of untargeted plasma metabolite profiling to discover systemic changes arising from inactivation of xanthine oxidoreductase (XOR), an enzyme that catalyzes the final steps in purine degradation. Using LC-MS coupled with a multivariate statistical data analysis platform, we confidently surveyed >3,700 plasma metabolites (50-1,000 Da) for differential expression in XOR wildtype vs. mice with inactivated XOR, arising from gene deletion or pharmacological inhibition. Results confirmed the predicted derangements in purine metabolism, but also revealed unanticipated perturbations in metabolism of pyrimidines, nicotinamides, tryptophan, phospholipids, Krebs and urea cycles, and revealed kidney dysfunction biomarkers. Histochemical studies confirmed and characterized kidney failure in xor-nullizygous mice. These findings provide new insight into XOR functions and demonstrate the power of untargeted metabolite profiling for systemic discovery of direct and indirect consequences of gene mutations and drug treatments.	[Chen, Qiuying; Gross, Steven S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Med, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pathol, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pharmacol, Renal Res Inst, Valhalla, NY 10595 USA; [Fischer, Steven M.] Agilent Technol, Metab Lab, Santa Clara, CA USA	Cornell University; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; Agilent Technologies	Chen, QY (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA.	ssgross@med.cornell.edu	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		NIH (National Institute of Health) [HL87062, HD067244, K45462, tDK84394]	NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by NIH (National Institute of Health) grants HL87062 (SSG), HD067244 (SSG), K45462 (MSG) and tDK84394 (MSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Barbas C, 2011, J PHARMACEUT BIOMED, V55, P823, DOI 10.1016/j.jpba.2011.02.001; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Battelli MG, 2011, J BIOL REG HOMEOS AG, V25, P77; Biasioli S, 1987, Nephrol Dial Transplant, V2, P313; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Chohan S, 2009, CURR OPIN RHEUMATOL, V21, P143, DOI 10.1097/BOR.0b013e328325bd94; Cubbon S, 2010, MASS SPECTROM REV, V29, P671, DOI 10.1002/mas.20252; Dawson J, 2009, BRIT J CLIN PHARMACO, V68, P662, DOI 10.1111/j.1365-2125.2009.03497.x; Dewan AK, 2010, PEDIATR DERMATOL, V27, P270, DOI 10.1111/j.1525-1470.2009.00983.x; Drexler DM, 2011, ANAL BIOANAL CHEM, V399, P2645, DOI 10.1007/s00216-010-4370-8; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2009, QUALITY CONTROL META; Fini MA, 2011, MOL CANCER RES, V9, P1242, DOI 10.1158/1541-7786.MCR-11-0176; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; George Jacob, 2009, Ther Clin Risk Manag, V5, P799; Gibbings S, 2011, J BIOL CHEM, V286, P961, DOI 10.1074/jbc.M110.150847; Gierasch LM, 2009, NAT CHEM BIOL, V5, P774, DOI 10.1038/nchembio.241; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Govani SM, 2010, J CROHNS COLITIS, V4, P444, DOI 10.1016/j.crohns.2010.02.009; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Huang LY, 2010, NITRIC OXIDE-BIOL CH, V22, P191, DOI 10.1016/j.niox.2010.01.004; Igarashi K, 2006, AMINO ACIDS, V31, P477, DOI 10.1007/s00726-006-0264-7; Issaq HJ, 2009, J SEP SCI, V32, P2183, DOI 10.1002/jssc.200900152; Joel D.KoppleSGM, 2004, UREMIC TOXICITY ITS, P682; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kim AW, 2011, LUNG CANCER, V71, P186, DOI 10.1016/j.lungcan.2010.05.006; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Linder N, 2011, GYNECOL ONCOL; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Martelin E, 2002, AM J PHYSIOL-CELL PH, V283, pC1722, DOI 10.1152/ajpcell.00280.2002; McManaman JL, 2002, J BIOL CHEM, V277, P21261, DOI 10.1074/jbc.M200828200; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Michopoulos F, 2009, J PROTEOME RES, V8, P2114, DOI 10.1021/pr801045q; Nagrath D, 2011, BBA-BIOENERGETICS, V1807, P650, DOI 10.1016/j.bbabio.2011.03.006; Nishino T, 2002, J BIOCHEM, V132, P597, DOI 10.1093/oxfordjournals.jbchem.a003262; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pesek JJ, 2009, J SEP SCI, V32, P2200, DOI 10.1002/jssc.200900270; Reaves ML, 2011, CURR OPIN BIOTECH, V22, P17, DOI 10.1016/j.copbio.2010.10.001; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Sanders SA, 1999, ANTIOXID REDOX SIGN, V1, P371, DOI 10.1089/ars.1999.1.3-371; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; SPECTOR T, 1986, BIOCHEM PHARMACOL, V35, P3109, DOI 10.1016/0006-2952(86)90394-1; Stamp LK, 2010, ARTHRITIS RHEUM; SWENDSEID ME, 1978, AM J CLIN NUTR, V31, P1581, DOI 10.1093/ajcn/31.9.1581; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Tankiewicz A, 2003, ADV EXP MED BIOL, V527, P409; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Wei XL, 2011, ANAL CHEM, V83, P7668, DOI 10.1021/ac2017025; Weisenberg SA, 2009, J SEP SCI, V32, P2262, DOI 10.1002/jssc.200900256; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P66, DOI 10.1016/S0891-5849(97)00165-2; Zhang Z, 1998, FREE RADICAL RES, V28, P151, DOI 10.3109/10715769809065801	60	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37149	10.1371/journal.pone.0037149	http://dx.doi.org/10.1371/journal.pone.0037149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723833	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300005
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
